PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Trausch-Azar, J; Leone, TC; Kelly, DP; Schwartz, AL				Trausch-Azar, Julie; Leone, Teresa C.; Kelly, Daniel P.; Schwartz, Alan L.			Ubiquitin Proteasome-dependent Degradation of the Transcriptional Coactivator PGC-1 alpha via the N-terminal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DEGRADATION; MITOCHONDRIAL BIOGENESIS; GAMMA COACTIVATOR-1; TUMOR-SUPPRESSOR; PROTEIN; MYOD; LOCALIZATION; SYSTEM; ID1; RESIDUE	PGC-1 alpha is a potent, inducible transcriptional coactivator that exerts control on mitochondrial biogenesis and multiple cellular energy metabolic pathways. PGC-1 alpha levels are controlled in a highly dynamic manner reflecting regulation at both transcriptional and post-transcriptional levels. Here, we demonstrate that PGC-1 alpha is rapidly degraded in the nucleus (t(1/2) 0.3 h) via the ubiquitin proteasome system. An N-terminal deletion mutant of 182 residues, PGC182, as well as a lysine-less mutant form, are nuclear and rapidly degraded (t(1/2) 0.5 h), consistent with degradation via the N terminus-dependent ubiquitin sub-pathway. Both PGC-1 alpha and PGC182 degradation rates are increased in cells under low serum conditions. However, a naturally occurring N-terminal splice variant of 270 residues, NT-PGC-1 alpha is cytoplasmic and stable (t(1/2) > 7 h), providing additional evidence that PGC-1 alpha is degraded in the nucleus. These results strongly suggest that the nuclear N terminus-dependent ubiquitin proteasome pathway governs PGC-1 alpha cellular degradation. In contrast, the cellular localization of NT-PCG-1 alpha results in a longer-half-life and possible distinct temporal and potentially biological actions.	[Trausch-Azar, Julie; Schwartz, Alan L.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Trausch-Azar, Julie; Schwartz, Alan L.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Trausch-Azar, Julie; Schwartz, Alan L.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst, Orlando, FL 32827 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute	Schwartz, AL (corresponding author), Washington Univ, Sch Med, Dept Pediat, CB 8116,660 S Euclid Ave, St Louis, MO 63110 USA.	schwartz@wustl.edu	Kelly, Daniel/ABG-2056-2021		National Institutes of Health [GM067620, DK045416]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045416, R01DK045416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM067620 and DK045416 (to A.L.S. and D.P.K.).	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lingbeck JM, 2003, J BIOL CHEM, V278, P1817, DOI 10.1074/jbc.M208815200; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sun L, 2008, P NATL ACAD SCI USA, V105, P3339, DOI 10.1073/pnas.0800165105; Sun LP, 2005, J BIOL CHEM, V280, P26448, DOI 10.1074/jbc.M500373200; Trausch-Azar JS, 2004, J BIOL CHEM, V279, P32614, DOI 10.1074/jbc.M403794200; Vosper JMD, 2009, J BIOL CHEM, V284, P15458, DOI 10.1074/jbc.M809366200; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	35	59	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40192	40200		10.1074/jbc.M110.131615	http://dx.doi.org/10.1074/jbc.M110.131615			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20713359	hybrid, Green Published			2022-12-25	WOS:000285185500064
J	Golfier, S; Kondo, S; Schulze, T; Takeuchi, T; Vassileva, G; Achtman, AH; Graler, MH; Abbondanzo, SJ; Wiekowski, M; Kremmer, E; Endo, Y; Lira, SA; Bacon, KB; Lipp, M				Golfier, Sven; Kondo, Shinichi; Schulze, Tobias; Takeuchi, Tomomi; Vassileva, Galya; Achtman, Ariel H.; Graeler, Markus H.; Abbondanzo, Susan J.; Wiekowski, Maria; Kremmer, Elisabeth; Endo, Yasuhisa; Lira, Sergio A.; Bacon, Kevin B.; Lipp, Martin			Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P(4)	FASEB JOURNAL			English	Article						platelets; lysophospholipids; receptor-deficient mice	SPHINGOSINE 1-PHOSPHATE RECEPTOR; WISKOTT-ALDRICH SYNDROME; PROTEIN; PLATELETS; IDENTIFICATION; STEM; THROMBOCYTOPENIA; TRANSDUCTION; PROGENITORS; ACTIVATION	Megakaryocytes, which mature from hematopoietic progenitors in the bone marrow, further differentiate by reorganizing their cytoplasm into long proplatelet extensions that release platelets into the circulation. The molecular mechanisms underlying this highly dynamic cytoplasmic and cytoskeletal remodeling process are only poorly understood. Here we report that sphingosine 1-phosphate receptor 4 (S1P(4)) is specifically up-regulated during the development of human megakaryocytes from progenitor cells and is expressed in mature murine megakaryocytes. Megakaryocytes generated from S1P(4)-deficient murine bone marrow showed atypical and reduced formation of proplatelets in vitro. The recovery of platelet numbers after experimental thrombocytopenia was significantly delayed in S1p4(-/-) mice. Remarkably, overexpression and stimulation of S1P(4) in human erythroleukemia HEL cells promoted endomitosis, formation of cytoplasmic extensions, and subsequent release of platelet-like particles. These observations indicate that S1P(4) is involved in shaping the terminal differentiation of megakaryocytes.-Golfier, S., Kondo, S., Schulze, T., Takeuchi, T., Vassileva, G., Achtman, A. H., Graler, M. H., Abbondanzo, S. J., Wiekowski, M., Kremmer, E., Endo, Y., Lira, S. A., Bacon, K. B., Lipp, M. Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P(4). FASEB J. 24, 4701-4710 (2010). www.fasebj.org	[Golfier, Sven; Schulze, Tobias; Achtman, Ariel H.; Graeler, Markus H.; Lipp, Martin] Max Delbruck Ctr Mol Med, Dept Tumor Genet & Immunogenet, D-13125 Berlin, Germany; [Kondo, Shinichi; Takeuchi, Tomomi; Bacon, Kevin B.] Res Ctr Kyoto, Kyoto, Japan; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Endo, Yasuhisa] Kyoto Inst Technol Matsugasaki, Dept Appl Biol, Kyoto, Japan; [Lira, Sergio A.] Mt Sinai Sch Med, Immunobiol Ctr, New York, NY USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Kyoto Institute of Technology; Icahn School of Medicine at Mount Sinai	Lipp, M (corresponding author), Max Delbruck Ctr Mol Med, Dept Tumor Genet & Immunogenet, Robert Rossle Str 10, D-13125 Berlin, Germany.	mlipp@mdc-berlin.de	Gräler, Markus/ABH-1905-2021	Gräler, Markus/0000-0001-6650-7849; Lipp, Martin/0000-0002-0087-2672				BERRIDGE MV, 1985, BLOOD, V66, P76; Bunting S, 1997, BLOOD, V90, P3423, DOI 10.1182/blood.V90.9.3423; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Cheng EC, 2009, BLOOD, V113, P2826, DOI 10.1182/blood-2008-09-180596; CHOI ES, 1995, BLOOD, V85, P402; Cramer EM, 1997, BLOOD, V89, P2336, DOI 10.1182/blood.V89.7.2336; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Kajiwara M, 1999, BRIT J HAEMATOL, V107, P254, DOI 10.1046/j.1365-2141.1999.01694.x; Kaushansky K, 2002, BLOOD, V99, P3573, DOI 10.1182/blood.V99.10.3573; KAUSHANSKY K, 1995, BLOOD, V86, P419, DOI 10.1182/blood.V86.2.419.bloodjournal862419; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kohno T, 2003, GENES CELLS, V8, P685, DOI 10.1046/j.1365-2443.2003.00667.x; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LONG MW, 1990, J CLIN INVEST, V85, P1072, DOI 10.1172/JCI114538; Motohashi K, 2000, FEBS LETT, V468, P189, DOI 10.1016/S0014-5793(00)01222-9; Nieswandt B, 2000, BLOOD, V96, P2520; PAPAYANNOPOULOU T, 1983, BLOOD, V62, P832; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Rojnuckarin P, 2001, BLOOD, V97, P154, DOI 10.1182/blood.V97.1.154; SCHMUZIGER M, 1995, EUR J CARDIO-THORAC, V9, P393, DOI 10.1016/S1010-7940(05)80172-1; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; Siehler S, 2002, BBA-MOL CELL BIOL L, V1582, P94, DOI 10.1016/S1388-1981(02)00142-7; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; Teeling JL, 2001, BLOOD, V98, P1095, DOI 10.1182/blood.V98.4.1095; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91; Yatomi Y, 1997, J BIOCHEM, V121, P969	39	52	56	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4701	4710		10.1096/fj.09-141473	http://dx.doi.org/10.1096/fj.09-141473			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20686109				2022-12-25	WOS:000284824400011
J	Booker, ML; Bastos, CM; Kramer, ML; Barker, RH; Skerlj, R; Sidhu, AB; Deng, XY; Celatka, C; Cortese, JF; Bravo, JEG; Llado, KNC; Serrano, AE; Angulo-Barturen, I; Jimenez-Diaz, MB; Viera, S; Garuti, H; Wittlin, S; Papastogiannidis, P; Lin, JW; Janse, CJ; Khan, SM; Duraisingh, M; Coleman, B; Goldsmith, EJ; Phillips, MA; Munoz, B; Wirth, DF; Klinger, JD; Wiegand, R; Sybertz, E				Booker, Michael L.; Bastos, Cecilia M.; Kramer, Martin L.; Barker, Robert H., Jr.; Skerlj, Renato; Sidhu, Amar Bir; Deng, Xiaoyi; Celatka, Cassandra; Cortese, Joseph F.; Bravo, Jose E. Guerrero; Llado, Keila N. Crespo; Serrano, Adelfa E.; Angulo-Barturen, Inigo; Belen Jimenez-Diaz, Maria; Viera, Sara; Garuti, Helen; Wittlin, Sergio; Papastogiannidis, Petros; Lin, Jing-wen; Janse, Chris J.; Khan, Shahid M.; Duraisingh, Manoj; Coleman, Bradley; Goldsmith, Elizabeth J.; Phillips, Margaret A.; Munoz, Benito; Wirth, Dyann F.; Klinger, Jeffrey D.; Wiegand, Roger; Sybertz, Edmund			Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-EFFICIENCY TRANSFECTION; IN-VITRO; SACCHAROMYCES-CEREVISIAE; PYRIMIDINE PATHWAY; ESCHERICHIA-COLI; RODENT MALARIA; ENZYMES; BERGHEI; BIOSYNTHESIS; IDENTIFICATION	Plasmodium falciparum, the causative agent of the most deadly form of human malaria, is unable to salvage pyrimidines and must rely on de novo biosynthesis for survival. Dihydroorotate dehydrogenase (DHODH) catalyzes the rate-limiting step in the pyrimidine biosynthetic pathway and represents a potential target for anti-malarial therapy. A high throughput screen and subsequent medicinal chemistry program identified a series of N-alkyl-5-(1H-benzimidazol-1-yl) thiophene-2-carboxamides with low nanomolar in vitro potency against DHODH from P. falciparum, P. vivax, and P. berghei. The compounds were selective for the parasite enzymes over human DHODH, and x-ray structural data on the analog Genz-667348, demonstrated that species selectivity could be attributed to amino acid differences in the inhibitor-binding site. Compounds from this series demonstrated in vitro potency against the 3D7 and Dd2 strains of P. falciparum, good tolerability and oral exposure in the mouse, and ED50 values in the 4-day murine P. berghei efficacy model of 13-21 mg/kg/day with oral twice-daily dosing. In particular, treatment with Genz-667348 at 100 mg/kg/day resulted in sterile cure. Two recent analogs of Genz-667348 are currently undergoing pilot toxicity testing to determine suitability as clinical development candidates.	[Booker, Michael L.; Bastos, Cecilia M.; Kramer, Martin L.; Barker, Robert H., Jr.; Skerlj, Renato; Celatka, Cassandra; Klinger, Jeffrey D.; Sybertz, Edmund] Genzyme Corp, Waltham, MA 02451 USA; [Sidhu, Amar Bir; Cortese, Joseph F.; Munoz, Benito; Wiegand, Roger] Harvard & MIT, Broad Inst, Cambridge, MA 02141 USA; [Bravo, Jose E. Guerrero; Llado, Keila N. Crespo; Serrano, Adelfa E.] Univ Puerto Rico, Sch Med, Dept Microbiol & Med Zool, San Juan, PR 00936 USA; [Angulo-Barturen, Inigo; Belen Jimenez-Diaz, Maria; Viera, Sara; Garuti, Helen] GlaxoSmithKline, Dis Developing World, Tres Cantos 28760, Spain; [Wittlin, Sergio; Papastogiannidis, Petros] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Wittlin, Sergio; Papastogiannidis, Petros] Univ Basel, CH-4003 Basel, Switzerland; [Lin, Jing-wen; Janse, Chris J.; Khan, Shahid M.] Leiden Univ, Med Ctr, Ctr Infect Dis, Leiden Malaria Res Grp,Dept Parasitol, NL-2333 ZA Leiden, Netherlands; [Duraisingh, Manoj; Coleman, Bradley; Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Deng, Xiaoyi; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Goldsmith, Elizabeth J.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Sanofi-Aventis; Genzyme Corporation; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; GlaxoSmithKline; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Booker, ML (corresponding author), Genzyme Corp, 153 2nd Ave, Waltham, MA 02451 USA.	michael.booker@genzyme.com	Deng, Xiaoyi/E-4394-2011	Coleman, Bradley/0000-0003-4217-508X; Khan, Shahid/0000-0002-0533-4670; Lin, Jing-wen/0000-0003-3338-8788; Janse, Chris J/0000-0002-6410-6205	National Institutes of Health [U01AI075594, AI053680]; Medicines for Malaria Venture and the Humanitarian Assistance for Neglected Diseases Initiative of Genzyme Corp; Welch Foundation [I-1257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI053680, R21AI053680, R01AI053680, U01AI075594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicines for Malaria Venture and the Humanitarian Assistance for Neglected Diseases Initiative of Genzyme Corp; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants U01AI075594 and AI053680 (to M. A. P.). This work was also supported by the Medicines for Malaria Venture and the Humanitarian Assistance for Neglected Diseases Initiative of Genzyme Corp.; Supported by the Welch Foundation (Grant I-1257). Holds the Carolyn R. Bacon Professorship in Medical Science and Education.	Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Baldwin J, 2002, J BIOL CHEM, V277, P41827, DOI 10.1074/jbc.M206854200; CAROLINE DF, 1969, J BACTERIOL, V100, P1371, DOI 10.1128/JB.100.3.1371-1377.1969; CHEN JJ, 1976, ARCH BIOCHEM BIOPHYS, V176, P82, DOI 10.1016/0003-9861(76)90143-0; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng XY, 2009, J BIOL CHEM, V284, P26999, DOI 10.1074/jbc.M109.028589; DENISDUPHIL M, 1989, BIOCHEM CELL BIOL, V67, P612, DOI 10.1139/o89-094; EAKIN RT, 1969, ARCH BIOCHEM BIOPHYS, V134, P160, DOI 10.1016/0003-9861(69)90262-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; GERO AM, 1985, BIOCHEM MED METAB B, V34, P60, DOI 10.1016/0006-2944(85)90062-6; Giao PT, 2001, CLIN PHARMACOKINET, V40, P343, DOI 10.2165/00003088-200140050-00003; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; Hersh EV, 2004, J AM DENT ASSOC, V135, P298, DOI 10.14219/jada.archive.2004.0178; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hurt DE, 2006, BIOORG MED CHEM LETT, V16, P1610, DOI 10.1016/j.bmcl.2005.12.029; Hurt DE, 2006, ACTA CRYSTALLOGR D, V62, P312, DOI 10.1107/S0907444905042642; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Jimenez-Diaz MB, 2009, CYTOM PART A, V75A, P225, DOI 10.1002/cyto.a.20647; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Jordan DB, 2000, ARCH BIOCHEM BIOPHYS, V378, P84, DOI 10.1006/abbi.2000.1823; Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e; KENNEDY J, 1973, ARCH BIOCHEM BIOPHYS, V157, P369, DOI 10.1016/0003-9861(73)90651-6; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Knecht W, 1998, BIOCHEM PHARMACOL, V56, P1259, DOI 10.1016/S0006-2952(98)00145-2; Kocken CHM, 2002, INFECT IMMUN, V70, P655, DOI 10.1128/IAI.70.2.655-660.2002; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MILLER RW, 1969, CAN J BIOCHEM CELL B, V47, P725, DOI 10.1139/o69-110; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; National Research Council, 1996, GUID CAR US LAB AN N; Obach RS, 1997, J PHARMACOL EXP THER, V283, P46; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Patel V, 2008, J BIOL CHEM, V283, P35078, DOI 10.1074/jbc.M804990200; PETERS W, 1975, ANN TROP MED PARASIT, V69, P155, DOI 10.1080/00034983.1975.11686997; Peters W., 1987, CHEMOTHERAPY DRUG RE, P145; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Saul A, 1997, MOL BIOCHEM PARASIT, V84, P143, DOI 10.1016/S0166-6851(96)02779-X; Skophammer RG, 2007, MOL BIOL EVOL, V24, P1761, DOI 10.1093/molbev/msm096; Subbayya INS, 1997, INDIAN J MED RES, V106, P79; TAYLOR ML, 1971, J BACTERIOL, V105, P1015, DOI 10.1128/JB.105.3.1015-1027.1971; TAYLOR WH, 1964, J BACTERIOL, V88, P105, DOI 10.1128/JB.88.1.105-110.1964; VANDERPLAS J, 1983, J BACTERIOL, V153, P1027, DOI 10.1128/JB.153.2.1027-1037.1983; WILLIAMS JC, 1973, J BACTERIOL, V115, P1071, DOI 10.1128/JB.115.3.1071-1076.1973	56	107	111	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33054	33064		10.1074/jbc.M110.162081	http://dx.doi.org/10.1074/jbc.M110.162081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702404	Green Published, hybrid			2022-12-25	WOS:000283048200043
J	Tokuhara, N; Namiki, K; Uesugi, M; Miyamoto, C; Ohgoh, M; Ido, K; Yoshinaga, T; Yamauchi, T; Kuromitsu, J; Kimura, S; Miyamoto, N; Kasuya, Y				Tokuhara, Naoki; Namiki, Kana; Uesugi, Mai; Miyamoto, Chihiro; Ohgoh, Makoto; Ido, Katsutoshi; Yoshinaga, Takashi; Yamauchi, Toshihiko; Kuromitsu, Junro; Kimura, Sadao; Miyamoto, Norimasa; Kasuya, Yoshitoshi			N-type Calcium Channel in the Pathogenesis of Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS LESIONS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MICE LACKING; ALPHA(1B) SUBUNIT; CA2+ CHANNEL; BRAIN-INJURY; CHEMOKINE EXPRESSION; CELL ACTIVATION; NERVOUS-SYSTEM; MCP-1	One of the family of voltage-gated calcium channels (VGCC), the N-type Ca2+ channel, is located predominantly in neurons and is associated with a variety of neuronal responses, including neurodegeneration. A precise mechanism for how the N-type Ca2+ channel plays a role in neurodegenerative disease, however, is unknown. In this study, we immunized N-type Ca2+ channel alpha(1B)-deficient (alpha(-/-)(1B)) mice and their wild type (WT) littermates with myelin oligodendrocyte glycoprotein 35-55 and analyzed the progression of experimental autoimmune encephalomyelitis (EAE). The neurological symptoms of EAE in the alpha(-/-)(1B) mice were less severe than in the WT mice. In conjunction with these results, sections of the spinal cord (SC) from alpha(-/-)(1B) mice revealed a reduction in both leukocytic infiltration and demyelination compared with WT mice. No differences were observed in the delayed-type hypersensitivity response, spleen cell proliferation, or cytokine production from splenocytes between the two genotypes. On the other hand, Western blot array analysis and RT-PCR revealed that a typical increase in the expression of MCP-1 in the SC showed a good correlation with the infiltration of leukocytes into the SC. Likewise, immunohistochemical analysis showed that the predominant source of MCP-1 was activated microglia. The cytokine-induced production of MCP-1 in primary cultured microglia from WT mice was significantly higher than that from alpha(-/-)(1B) mice and was significantly inhibited by a selective N-type Ca2+ channel antagonist, omega-conotoxin GVIA or a withdrawal of extracellular Ca2+. These results suggest that the N-type Ca2+ channel is involved in the pathogenesis of EAE at least in part by regulating MCP-1 production by microglia.	Chiba Univ, Grad Sch Med, Dept Biochem & Mol Pharmacol, Chiba 2608670, Japan; [Tokuhara, Naoki; Ohgoh, Makoto; Ido, Katsutoshi; Yamauchi, Toshihiko] Eisai & Co Ltd, Dept Biol Pharmacol, Neurosci Prod Creat Unit, Tsukuba, Ibaraki 3002635, Japan; [Uesugi, Mai] Eisai & Co Ltd, Dept Genom, Biomarkers & Personalized Med Core Funct Unit, Tsukuba, Ibaraki 3002635, Japan; [Miyamoto, Chihiro; Kuromitsu, Junro; Miyamoto, Norimasa] Eisai & Co Ltd, Dept Tsukuba Discovery Res, KAN Prod Creat Unit, Tsukuba, Ibaraki 3002635, Japan; [Yoshinaga, Takashi] Eisai & Co Ltd, Biopharmaceut Assessment Core Funct Unit, Dept Global Drug Safety, Tsukuba, Ibaraki 3002635, Japan	Chiba University; Eisai Co Ltd; Eisai Co Ltd; Eisai Co Ltd; Eisai Co Ltd	Kasuya, Y (corresponding author), 1-8-1 Inohana,Chuo Ku, Chiba 2608670, Japan.	kasuya@faculty.chiba-u.jp		Kimura, Sadao/0000-0001-6768-7474; Kasuya, Yoshitoshi/0000-0003-0614-5836	Ministry of Education, Science, Sports and Culture of Japan [19590529, 21390172]; Eisai Co. Ltd.	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Eisai Co. Ltd.(Eisai Co Ltd)	This work was supported in part by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan ((C), 19590529 and (B), 21390172) (to Y. K.) and the Eisai Co. Ltd.	Ayoub AE, 2003, J NEUROSCI, V23, P7759; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Beuckmann CT, 2003, J NEUROSCI, V23, P6793; Bowersox SS, 1997, BRAIN RES, V747, P343; Brabb T, 1997, J IMMUNOL, V159, P497; Brand-Schieber E, 2004, EXP NEUROL, V189, P5, DOI 10.1016/j.expneurol.2004.05.023; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fassbender K, 1998, NEUROLOGY, V51, P753, DOI 10.1212/WNL.51.3.753; FERN R, 1995, J NEUROPHYSIOL, V74, P369, DOI 10.1152/jn.1995.74.1.369; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Guo X, 2007, NEUROSCI RES, V59, P457, DOI 10.1016/j.neures.2007.08.014; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Kennedy KJ, 1998, J NEUROIMMUNOL, V92, P98, DOI 10.1016/S0165-5728(98)00187-8; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; Kornek B, 2001, BRAIN, V124, P1114, DOI 10.1093/brain/124.6.1114; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Latour I, 2003, GLIA, V41, P347, DOI 10.1002/glia.10162; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Madrigal JLM, 2009, J NEUROSCI, V29, P263, DOI 10.1523/JNEUROSCI.4926-08.2009; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; McManus CM, 1998, J IMMUNOL, V160, P1449; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Moldovan IR, 2003, J NEUROIMMUNOL, V141, P132, DOI 10.1016/S0165-5728(03)00221-2; Muller K, 2003, INFECT IMMUN, V71, P6178, DOI 10.1128/IAI.71.11.6178-6183.2003; Nygardas PT, 2000, EUR J IMMUNOL, V30, P1911, DOI 10.1002/1521-4141(200007)30:7<1911::AID-IMMU1911>3.0.CO;2-E; PLATT JL, 1983, J EXP MED, V158, P1227, DOI 10.1084/jem.158.4.1227; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Takahashi E, 2005, INT J MOL MED, V15, P937; Taneja V, 2001, NAT IMMUNOL, V2, P781, DOI 10.1038/ni0901-781; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; TRAUGOTT U, 1985, CELL IMMUNOL, V91, P240, DOI 10.1016/0008-8749(85)90047-4; TRAUGOTT U, 1989, CELL IMMUNOL, V119, P114, DOI 10.1016/0008-8749(89)90228-1; VAN BOXELDEZAIRE, 1999, ANN NEUROL, V45, P695; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Youssef S, 1999, J AUTOIMMUN, V13, P21, DOI 10.1006/jaut.1999.0306	48	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33294	33306		10.1074/jbc.M109.089805	http://dx.doi.org/10.1074/jbc.M109.089805			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720005	Green Published, hybrid			2022-12-25	WOS:000283048200065
J	Patel, S; Djerdjouri, B; Raoul-Des-Essarts, Y; Dang, PMC; El-Benna, J; Perianin, A				Patel, Satyananda; Djerdjouri, Bahia; Raoul-Des-Essarts, Yannick; Dang, Pham My-Chan; El-Benna, Jamel; Perianin, Axel			Protein Kinase B (AKT) Mediates Phospholipase D Activation via ERK1/2 and Promotes Respiratory Burst Parameters in Formylpeptide-stimulated Neutrophil-like HL-60 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE COMPONENT; PHOSPHATIDIC-ACID; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; P47(PHOX); ZETA; IDENTIFICATION; TRANSLOCATION; MECHANISMS; PHAGOCYTES	Phospholipase D (PLD), a major source of lipid second messengers (phosphatidic acid, diglycerides) in many cell types, is tightly regulated by protein kinases, but only a few of them have been identified. We show here that protein kinase B (AKT) is a novel major signaling effector of PLD activity induced by the formylpeptide f-Met-Leu-Phe (fMLP) in human neutrophil-like HL-60 cells (dHL-60 cells). AKT inhibition with the selective antagonist AKTib1/2 almost completely prevented fMLP-mediated activity of PLD, its upstream effector ERK1/2, but not p38 MAPK. Immunoprecipitation studies show that phosphorylated AKT, ERK, and PLD2 form a complex induced by fMLP, which can be prevented by AKTib1/2. In cell-free systems, AKT1 stimulated PLD activity via activation of ERK. AKT1 actually phosphorylated ERK2 as a substrate (K-m 1 mu M). Blocking AKT activation with AKTib1/2 also prevented fMLP-but not phorbol 12-myristate 13-acetate-mediated NADPH oxidase activation (respiratory burst, RB) of dHL-60 cells. Impaired RB was associated with defective membrane translocation of NADPH oxidase components p67(phox) and p47(phox), ERK, AKT1, AKT2, but not AKT3. Depletion of AKT1 or AKT2 with antisense oligonucleotides further indicates a partial contribution of both isoforms in fMLP-induced activation of ERK, PLD, and RB, with a predominant role of AKT1. Thus, formylpeptides induce sequential activation of AKT, ERK1/2, and PLD, which represents a novel signaling pathway. A major primarily role of this AKT signaling pathway also emerges in membrane recruitment of NOX2 components p47(phox), p67(phox), and ERK, which may contribute to assembly and activation of the RB motor system, NADPH oxidase.	[Djerdjouri, Bahia; Raoul-Des-Essarts, Yannick; Dang, Pham My-Chan; El-Benna, Jamel; Perianin, Axel] INSERM, CRB3, U773, Fac Med 10, F-75018 Paris, France; [Patel, Satyananda; Raoul-Des-Essarts, Yannick; Perianin, Axel] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Patel, Satyananda; Perianin, Axel] INSERM, U567, F-75014 Paris, France; [Djerdjouri, Bahia] Univ Sci & Technol Houari Boumediene, Fac Biol Sci, Algiers 16111, Algeria	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University Science & Technology Houari Boumediene	Perianin, A (corresponding author), INSERM, CRB3, U773, Fac Med 10, 16 Rue H Huchard, F-75018 Paris, France.	axel.perianin@inserm.fr	Djerdjouri, Bahia/I-2533-2019	/0000-0003-4087-1866	Universite Paris Descartes; Agence Nationale pour la Recherche	Universite Paris Descartes; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by a grant from the Universite Paris Descartes (S. P.) and l'Agence Nationale pour la Recherche.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; BONSER RW, 1991, BRIT J PHARMACOL, V103, P1237, DOI 10.1111/j.1476-5381.1991.tb12330.x; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; DANG PMC, 1994, FEBS LETT, V349, P338, DOI 10.1016/0014-5793(94)00700-4; Dang PMC, 2001, P NATL ACAD SCI USA, V98, P3001, DOI 10.1073/pnas.061029698; Di Fulvio M, 2008, CELL SIGNAL, V20, P176, DOI 10.1016/j.cellsig.2007.10.009; Djerdjouri B, 1999, BIOCHEM BIOPH RES CO, V264, P371, DOI 10.1006/bbrc.1999.1533; ElBenna J, 1996, J BIOL CHEM, V271, P6374; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Foster DA, 2003, MOL CANCER RES, V1, P789; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; KOCHS G, 1993, EUR J BIOCHEM, V216, P597, DOI 10.1111/j.1432-1033.1993.tb18179.x; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lenoir M, 2004, J IMMUNOL, V172, P7136, DOI 10.4049/jimmunol.172.11.7136; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; NACCACHE PH, 1991, CELL SIGNAL, V3, P635, DOI 10.1016/0898-6568(91)90040-2; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; OLSON SC, 1991, J BIOL CHEM, V266, P17236; Paruch S, 2005, FASEB J, V19, P142, DOI 10.1096/fj.05-3881fje; Paruch S, 2007, FASEB J, V21, P4038, DOI 10.1096/fj.06-7325com; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	42	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32055	32063		10.1074/jbc.M110.171058	http://dx.doi.org/10.1074/jbc.M110.171058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693286	hybrid, Green Published			2022-12-25	WOS:000282683000019
J	Diao, L; Li, N; Brayman, TG; Hotz, KJ; Lai, YR				Diao, Lei; Li, Na; Brayman, Timothy G.; Hotz, Kathy J.; Lai, Yurong			Regulation of MRP2/ABCC2 and BSEP/ABCB11 Expression in Sandwich Cultured Human and Rat Hepatocytes Exposed to Inflammatory Cytokines TNF-alpha, IL-6, and IL-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; DRUG TRANSPORTER EXPRESSION; ACUTE-PHASE RESPONSE; SALT EXPORT PUMP; DOWN-REGULATION; CELL-LINES; IN-VITRO; CYTOCHROME-P450 REGULATION; ABSOLUTE QUANTIFICATION; MOUSE-LIVER	In the present study MRP2/ABCC2 and BSEP/ABCB11 expression were investigated in sandwich cultured (SC) human and rat hepatocytes exposed to the proinflammatory cytokines. The investigation was also done in lipopolysaccharide (LPS)treated rats. In SC human hepatocytes, both absolute protein and mRNA levels of MRP2/ABCC2 were significantly down-regulated by TNF-alpha, IL-6, or IL-1 beta. In contrast to mRNA decrease, which was observed for BSEP/ABCB11, the protein amount was significantly increased by IL-6 or IL-1 beta. A discrepancy between the change in BSEP/ABCB11 mRNA and protein levels was encountered in SC human hepatocytes treated with proinflammatory cytokines. In SC rat hepatocytes, Mrp2/Abcc2 mRNA was down-regulated by TNF-alpha and IL-6, whereas the protein level was decreased by all three cytokines. Down-regulations of both Bsep/Abcb11 mRNA and protein levels were found in SC rat hepatocytes exposed to TNF-alpha or IL-1 beta. Administration of LPS triggered the release of the proinflammatory cytokines and caused the decrease of Mrp2/Abcc2 and Bsep/Abcb11 protein in liver at 24 h post-treatment; however, the Mrp2 and Bsep protein levels rebounded at 48 h post-LPS treatment. In total, our results indicate that proinflammatory cytokines regulate the expression of MRP2/Mrp2 and BSEP/Bsep and for the first time demonstrate the differential effects on BSEP/Bsep expression between SC human and rat hepatocytes. Furthermore, the agreement between transporter regulation in vitro in SC rat hepatocytes and in vivo in LPS-treated rats during the acute response phase demonstrates the utility of in vitro SC hepatocyte models for predicting in vivo effects.	[Diao, Lei; Li, Na; Brayman, Timothy G.; Hotz, Kathy J.; Lai, Yurong] Pfizer Inc, Groton Labs, Pfizer Global Res & Dev, Dept Pharmacokinet Dynam & Drug Metab, Groton, CT 06340 USA	Pfizer	Lai, YR (corresponding author), Pfizer Inc, Groton Lab, Pharmacokinet Dynam & Metab, Eastern Point Rd,Mail Stop 8220-2475, Groton, CT 06340 USA.	yurong.lai@pfizer.com	Lai, Yurong/GWV-6243-2022; Lai, Yurong/ABG-4485-2021	Lai, Yurong/0000-0001-9505-333X				ARIAS IM, 1993, GASTROENTEROLOGY, V104, P1558, DOI 10.1016/0016-5085(93)90371-I; Beigneux AP, 2002, BIOCHEM BIOPH RES CO, V293, P145, DOI 10.1016/S0006-291X(02)00196-1; Bi YA, 2006, DRUG METAB DISPOS, V34, P1658, DOI 10.1124/dmd.105.009118; Bow DAJ, 2008, DRUG METAB DISPOS, V36, P198, DOI 10.1124/dmd.107.018200; Donner MG, 2007, AM J PHYSIOL-GASTR L, V293, pG1134, DOI 10.1152/ajpgi.00079.2007; Elferink MGL, 2004, AM J PHYSIOL-GASTR L, V287, pG1008, DOI 10.1152/ajpgi.00071.2004; Evseenko DA, 2006, AM J PHYSIOL-REG I, V290, pR1357, DOI 10.1152/ajpregu.00630.2005; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Fardel O, 2009, EXPERT OPIN DRUG MET, V5, P1469, DOI 10.1517/17425250903304056; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Geier A, 2005, AM J PHYSIOL-GASTR L, V289, pG831, DOI 10.1152/ajpgi.00307.2004; Ghibellini G, 2007, DRUG METAB DISPOS, V35, P345, DOI 10.1124/dmd.106.012278; Goh LB, 2002, BIOCHEM PHARMACOL, V64, P1569, DOI 10.1016/S0006-2952(02)01355-2; Gomez-Lechon MJ, 2004, CURR DRUG METAB, V5, P443, DOI 10.2174/1389200043335414; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; Hartmann G, 2002, J PHARMACOL EXP THER, V303, P273, DOI 10.1124/jpet.102.039404; Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902; Le Vee M, 2008, DRUG METAB DISPOS, V36, P217, DOI 10.1124/dmd.107.016907; Le Vee M, 2009, DRUG METAB DISPOS, V37, P2228, DOI 10.1124/dmd.109.028035; Lee G, 2003, J PHARM SCI-US, V92, P2152, DOI 10.1002/jps.10493; Li N, 2008, ANAL BIOCHEM, V380, P211, DOI 10.1016/j.ab.2008.05.032; Li N, 2010, MOL PHARMACEUT, V7, P630, DOI 10.1021/mp9001574; Li N, 2009, ANAL CHEM, V81, P2251, DOI 10.1021/ac8024009; Li N, 2009, MOL PHARMACEUT, V6, P1180, DOI 10.1021/mp900044x; Liss G, 2009, EXPERT OPIN DRUG MET, V5, P843, DOI 10.1517/17425250903018904; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Morgan ET, 2002, TOXICOLOGY, V181, P207, DOI 10.1016/S0300-483X(02)00283-4; Pascussi JM, 2000, BIOCHEM BIOPH RES CO, V274, P707, DOI 10.1006/bbrc.2000.3219; Petrovic V, 2007, MOL INTERV, V7, P99, DOI 10.1124/mi.7.2.10; Renton KW, 2004, CURR DRUG METAB, V5, P235, DOI 10.2174/1389200043335559; Renton KW, 2001, PHARMACOL THERAPEUT, V92, P147, DOI 10.1016/S0163-7258(01)00165-6; ROELOFSEN H, 1995, HEPATOLOGY, V21, P1649, DOI 10.1002/hep.1840210625; Siewert E, 2004, BIOCHEM BIOPH RES CO, V322, P232, DOI 10.1016/j.bbrc.2004.07.102; Slaviero KA, 2003, LANCET ONCOL, V4, P224, DOI 10.1016/S1470-2045(03)01034-9; Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141; Trauner M, 1999, CURR OPIN GASTROEN, V15, P217, DOI 10.1097/00001574-199905000-00006; Trauner M, 1999, J GASTROEN HEPATOL, V14, P946, DOI 10.1046/j.1440-1746.1999.01982.x; Turnbull AV, 1998, ENDOCRINOLOGY, V139, P119, DOI 10.1210/en.139.1.119; Vee ML, 2009, DRUG METAB DISPOS, V37, P685, DOI DOI 10.1124/DMD.108.023630; Zhang X, 2009, CLIN PHARMACOL THER, V85, pS59; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646	41	50	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31185	31192		10.1074/jbc.M110.107805	http://dx.doi.org/10.1074/jbc.M110.107805			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20702406	hybrid, Green Published			2022-12-25	WOS:000282764600012
J	Chung, RS; Howells, C; Eaton, ED; Shabala, L; Zovo, K; Palumaa, P; Sillard, R; Woodhouse, A; Bennett, WR; Ray, S; Vickers, JC; West, AK				Chung, Roger S.; Howells, Claire; Eaton, Emma D.; Shabala, Lana; Zovo, Kairit; Palumaa, Peep; Sillard, Rannar; Woodhouse, Adele; Bennett, William R.; Ray, Shannon; Vickers, James C.; West, Adrian K.			The Native Copper- and Zinc- Binding Protein Metallothionein Blocks Copper-Mediated A beta Aggregation and Toxicity in Rat Cortical Neurons	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HYDROGEN-PEROXIDE; DOWN-REGULATION; NEURITE GROWTH; PEPTIDE; EXPRESSION; INJURY; BRAIN; PURIFICATION; POSTINJURY	Background: A major pathological hallmark of AD is the deposition of insoluble extracellular beta-amyloid (A beta) plaques. There are compelling data suggesting that A beta aggregation is catalysed by reaction with the metals zinc and copper. Methodology/Principal Findings: We now report that the major human-expressed metallothionein (MT) subtype, MT-2A, is capable of preventing the in vitro copper-mediated aggregation of A beta(1-40) and A beta(1-42). This action of MT-2A appears to involve a metal-swap between Zn(7)MT-2A and Cu(II)-A beta, since neither Cu(10)MT-2A or carboxymethylated MT-2A blocked Cu(II)-A beta aggregation. Furthermore, Zn7MT-2A blocked Cu(II)-A beta induced changes in ionic homeostasis and subsequent neurotoxicity of cultured cortical neurons. Conclusions/Significance: These results indicate that MTs of the type represented by MT-2A are capable of protecting against A beta aggregation and toxicity. Given the recent interest in metal-chelation therapies for AD that remove metal from A beta leaving a metal-free A beta that can readily bind metals again, we believe that MT-2A might represent a different therapeutic approach as the metal exchange between MT and A beta leaves the A beta in a Zn-bound, relatively inert form.	[Chung, Roger S.; Howells, Claire; Eaton, Emma D.; Shabala, Lana; Woodhouse, Adele; Bennett, William R.; Ray, Shannon; Vickers, James C.; West, Adrian K.] Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas, Australia; [Zovo, Kairit; Palumaa, Peep; Sillard, Rannar] Tallinn Univ Technol, Dept Gene Technol, EE-200108 Tallinn, Estonia	University of Tasmania; Menzies Institute for Medical Research; Tallinn University of Technology	Chung, RS (corresponding author), Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas, Australia.	Roger.Chung@utas.edu.au	Vickers, James C/J-7464-2014; Palumaa, Peep/B-4668-2019; Palumaa, Peep/AAF-7617-2020; West, Adrian/AAR-8857-2021; Chung, Roger/ABF-8395-2020; Bennett, Bill/A-4039-2010	Vickers, James C/0000-0001-5671-4879; Palumaa, Peep/0000-0002-3505-3466; Palumaa, Peep/0000-0002-3505-3466; Bennett, Bill/0000-0002-1559-3027; Zovo, Kairit/0000-0001-5834-5157; Woodhouse, Adele/0000-0002-4246-7624; Chung, Roger/0000-0002-9286-947X; Shabala, Lana/0000-0002-5360-8496	Australian Research Council (ARC) [DP0556630, DP0984673, LP0774820]; National Health and Medical Research Council [490025, 544913]; Jack & Ethel Goldin Foundation	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Jack & Ethel Goldin Foundation	This work was supported by research grants from the Australian Research Council (ARC, ID# DP0556630; DP0984673; LP0774820), National Health and Medical Research Council (ID# 490025, 544913) and Jack & Ethel Goldin Foundation. RSC holds an ARC Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 1998, NEUROBIOL DIS, V5, P349, DOI 10.1006/nbdi.1998.0203; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cardoso SM, 2005, NEUROTOX RES, V7, P273, DOI 10.1007/BF03033885; Carrasco J, 2006, NEUROSCIENCE, V143, P911, DOI 10.1016/j.neuroscience.2006.08.054; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2005, EXP NEUROL, V193, P481, DOI 10.1016/j.expneurol.2005.01.005; Chung RS, 2004, J NEUROCHEM, V88, P454, DOI 10.1046/j.1471-4159.2003.02193.x; Chung RS, 2003, J NEUROSCI, V23, P3336; Chung RS, 2002, EXP NEUROL, V178, P1, DOI 10.1006/exnr.2002.8017; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; ERICKSON JC, 1994, BRAIN RES, V649, P297, DOI 10.1016/0006-8993(94)91076-6; Eriste E, 2003, PROTEIN EXPRES PURIF, V31, P161, DOI 10.1016/S1046-5928(03)00144-X; Fitzgerald M, 2007, EXP BRAIN RES, V183, P171, DOI 10.1007/s00221-007-1032-y; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Guilloreau L, 2006, J BIOL INORG CHEM, V11, P1024, DOI 10.1007/s00775-006-0154-1; HAASS C, 1992, NATURE, V359, P325; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Hegde ML, 2009, J ALZHEIMERS DIS, V17, P457, DOI 10.3233/JAD-2009-1068; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Kagi J H, 1987, Experientia Suppl, V52, P25; Kelly EJ, 1996, NAT GENET, V13, P219, DOI 10.1038/ng0696-219; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Penkowa M, 1999, J NEUROSCI, V19, P2535; Pouokam E, 2009, EUR J PHARMACOL, V615, P40, DOI 10.1016/j.ejphar.2009.04.066; Richarz AN, 2002, ANAL BIOANAL CHEM, V372, P412, DOI 10.1007/s00216-001-1187-5; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shabala L, 2006, FEMS MICROBIOL REV, V30, P472, DOI 10.1111/j.1574-6976.2006.00019.x; Shabala L, 2001, J MICROBIOL METH, V46, P119, DOI 10.1016/S0167-7012(01)00270-6; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Townsend AT, 2000, FRESEN J ANAL CHEM, V367, P614, DOI 10.1007/s002160000416; TRENDELENBURG G, J NEUROSCI, V22, P5879; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Zambenedetti P, 1998, J CHEM NEUROANAT, V15, P21, DOI 10.1016/S0891-0618(98)00024-6	47	55	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12030	10.1371/journal.pone.0012030	http://dx.doi.org/10.1371/journal.pone.0012030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711450	Green Published, gold, Green Submitted			2022-12-25	WOS:000280849100007
J	Casorelli, I; Pannellini, T; De Luca, G; Degan, P; Chiera, F; Iavarone, I; Giuliani, A; Butera, A; Boirivant, M; Musiani, P; Bignami, M				Casorelli, Ida; Pannellini, Tania; De Luca, Gabriele; Degan, Paolo; Chiera, Federica; Iavarone, Ivano; Giuliani, Alessandro; Butera, Alessia; Boirivant, Monica; Musiani, Piero; Bignami, Margherita			The Mutyh Base Excision Repair Gene Influences the Inflammatory Response in a Mouse Model of Ulcerative Colitis	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; MICROSATELLITE INSTABILITY; INTESTINAL TUMORIGENESIS; COLON CARCINOGENESIS; COLORECTAL TUMORS; T-CELLS; MICE; MYH; PROTEIN; SUSCEPTIBILITY	Background: The Mutyh DNA glycosylase is involved in the repair of oxidized DNA bases. Mutations in the human MUTYH gene are responsible for colorectal cancer in familial adenomatous polyposis. Since defective DNA repair genes might contribute to the increased cancer risk associated with inflammatory bowel diseases, we compared the inflammatory response of wild-type and Mutyh(-/-) mice to oxidative stress. Methodology/Principal Findings: The severity of colitis, changes in expression of genes involved in DNA repair and inflammation, DNA 8-oxoguanine levels and microsatellite instability were analysed in colon of mice treated with dextran sulfate sodium (DSS). The Mutyh(-/-) phenotpe was associated with a significant accumulation of 8-oxoguanine in colon DNA of treated mice. A single DSS cycle induced severe acute ulcerative colitis in wild-type mice, whereas lesions were modest in Mutyh(-/-) mice, and this was associated with moderate variations in the expression of several cytokines. Eight DSS cycles caused chronic colitis in both wild-type and Mutyh(-/-) mice. Lymphoid hyperplasia and a significant reduction in Foxp3(+) regulatory T cells were observed only in Mutyh(-/-) mice. Conclusions: The findings indicate that, in this model of ulcerative colitis, Mutyh plays a major role in maintaining intestinal integrity by affecting the inflammatory response.	[Casorelli, Ida; De Luca, Gabriele; Chiera, Federica; Iavarone, Ivano; Giuliani, Alessandro; Bignami, Margherita] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Pannellini, Tania; Musiani, Piero] Gabriele DAnnunzio Univ Chieti, Aging Res Ctr, Chieti, Italy; [Degan, Paolo] Ist Tumori Genova, Genoa, Italy; [Butera, Alessia; Boirivant, Monica] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); G d'Annunzio University of Chieti-Pescara; Istituto Superiore di Sanita (ISS)	Casorelli, I (corresponding author), Ist Super Sanita, Dept Environm & Primary Prevent, Viale Regina Elena 299, I-00161 Rome, Italy.	ida.casorelli@ospedalesantandrea.it; margherita.bignami@iss.it	Butera, Alessia/I-3399-2014; Giuliani, Alessandro/K-7589-2016; degan, paolo/AAB-4093-2019; Giuliani, Alessandro/AAF-1740-2020; BOIRIVANT, MONICA/B-9977-2016; de luca, gabriele/J-6655-2018; degan, paolo/AAB-6713-2019	Butera, Alessia/0000-0002-7659-4066; Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; BOIRIVANT, MONICA/0000-0003-3665-7058; de luca, gabriele/0000-0003-2918-0124; degan, paolo/0000-0003-0855-8896; Iavarone, Ivano/0000-0001-5856-9484	Association for International Cancer Research; Associazione Italiana Ricerca sul Cancro; Alleanza Contro il Cancro; Fondo per gli Investimenti della Ricerca di Base	Association for International Cancer Research; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Alleanza Contro il Cancro; Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants from Association for International Cancer Research, Associazione Italiana Ricerca sul Cancro, Alleanza Contro il Cancro and Fondo per gli Investimenti della Ricerca di Base to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; Beck PL, 2007, GASTROENTEROLOGY, V132, P1778, DOI 10.1053/j.gastro.2007.01.032; Chiera F, 2008, FREE RADICAL BIO MED, V44, P332, DOI 10.1016/j.freeradbiomed.2007.09.018; Choi S, 2007, FREE RADICAL BIO MED, V43, P1594, DOI 10.1016/j.freeradbiomed.2007.08.022; D'Errico M, 2008, MUTAT RES-REV MUTAT, V659, P4, DOI 10.1016/j.mrrev.2007.10.003; D'Inca R, 2004, INFLAMM BOWEL DIS, V10, P23, DOI 10.1097/00054725-200401000-00003; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; De Zoeten EF, 2008, GASTROENTEROLOGY, V134, P2171, DOI 10.1053/j.gastro.2008.04.030; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Eijkelkamp N, 2007, GUT, V56, P847, DOI 10.1136/gut.2006.107094; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gushima M, 2009, J PATHOL, V219, P77, DOI 10.1002/path.2570; Hirano S, 2003, J BIOL CHEM, V278, P38121, DOI 10.1074/jbc.C300316200; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; Kim HJ, 2007, FREE RADICAL RES, V41, P655, DOI 10.1080/10715760701250270; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kohonen-Corish MRJ, 2002, CANCER RES, V62, P2092; Liao J, 2008, MOL CARCINOGEN, V47, P638, DOI 10.1002/mc.20427; Lipton L, 2003, CANCER RES, V63, P7595; LUO M, 2009, ANTIOXID REDOX SIGNA; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Oda S, 2005, NUCLEIC ACIDS RES, V33, P1628, DOI 10.1093/nar/gki303; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; Risques RA, 2006, CURR OPIN GASTROEN, V22, P382, DOI 10.1097/01.mog.0000231812.95525.a7; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; Russo MT, 2004, CANCER RES, V64, P4411, DOI 10.1158/0008-5472.CAN-04-0355; Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802; Sieber OM, 2004, CANCER RES, V64, P8876, DOI 10.1158/0008-5472.CAN-04-2958; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Slupska MM, 1999, J BACTERIOL, V181, P6210, DOI 10.1128/JB.181.19.6210-6213.1999; *STATACORP, 2003, STAT STAT SOFTW REL; Taniguchi K, 2006, ONCOLOGY-BASEL, V71, P124, DOI 10.1159/000100522; Tardieu D, 1998, CANCER LETT, V134, P1, DOI 10.1016/S0304-3835(98)00228-6; Touati E, 2006, HELICOBACTER, V11, P494, DOI 10.1111/j.1523-5378.2006.00442.x; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yao X, 1999, P NATL ACAD SCI USA, V96, P6850, DOI 10.1073/pnas.96.12.6850	45	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12070	10.1371/journal.pone.0012070	http://dx.doi.org/10.1371/journal.pone.0012070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706593	Green Published, Green Submitted, gold			2022-12-25	WOS:000280811900029
J	Santoro, A; Balbi, V; Balducci, E; Pirazzini, C; Rosini, F; Tavano, F; Achilli, A; Siviero, P; Minicuci, N; Bellavista, E; Mishto, M; Salvioli, S; Marchegiani, F; Cardelli, M; Olivieri, F; Nacmias, B; Chiamenti, AM; Benussi, L; Ghidoni, R; Rose, G; Gabelli, C; Binetti, G; Sorbi, S; Crepaldi, G; Passarino, G; Torroni, A; Franceschi, C				Santoro, Aurelia; Balbi, Valentina; Balducci, Elisa; Pirazzini, Chiara; Rosini, Francesca; Tavano, Francesca; Achilli, Alessandro; Siviero, Paola; Minicuci, Nadia; Bellavista, Elena; Mishto, Michele; Salvioli, Stefano; Marchegiani, Francesca; Cardelli, Maurizio; Olivieri, Fabiola; Nacmias, Benedetta; Chiamenti, Andrea Maria; Benussi, Luisa; Ghidoni, Roberta; Rose, Giuseppina; Gabelli, Carlo; Binetti, Giuliano; Sorbi, Sandro; Crepaldi, Gaetano; Passarino, Giuseppe; Torroni, Antonio; Franceschi, Claudio			Evidence for Sub-Haplogroup H5 of Mitochondrial DNA as a Risk Factor for Late Onset Alzheimer's Disease	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MTDNA HAPLOGROUPS; HUMAN-POPULATIONS; NEAR-EASTERN; EPIDEMIOLOGY; INVOLVEMENT; MUTATIONS; LONGEVITY; SELECTION; VARIANTS	Background: Alzheimer's Disease (AD) is the most common neurodegenerative disease and the leading cause of dementia among senile subjects. It has been proposed that AD can be caused by defects in mitochondrial oxidative phosphorylation. Given the fundamental contribution of the mitochondrial genome (mtDNA) for the respiratory chain, there have been a number of studies investigating the association between mtDNA inherited variants and multifactorial diseases, however no general consensus has been reached yet on the correlation between mtDNA haplogroups and AD. Methodology/Principal Findings: We applied for the first time a high resolution analysis (sequencing of displacement loop and restriction analysis of specific markers in the coding region of mtDNA) to investigate the possible association between mtDNA-inherited sequence variation and AD in 936 AD patients and 776 cognitively assessed normal controls from central and northern Italy. Among over 40 mtDNA sub-haplogroups analysed, we found that sub-haplogroup H5 is a risk factor for AD (OR = 1.85, 95% CI: 1.04-3.23) in particular for females (OR = 2.19, 95% CI: 1.06-4.51) and independently from the APOE genotype. Multivariate logistic regression revealed an interaction between H5 and age. When the whole sample is considered, the H5a subgroup of molecules, harboring the 4336 transition in the tRNA(Gln) gene, already associated to AD in early studies, was about threefold more represented in AD patients than in controls (2.0% vs 0.8%; p = 0.031), and it might account for the increased frequency of H5 in AD patients (4.2% vs 2.3%). The complete re-sequencing of the 56 mtDNAs belonging to H5 revealed that AD patients showed a trend towards a higher number (p = 0.052) of sporadic mutations in tRNA and rRNA genes when compared with controls. Conclusions: Our results indicate that high resolution analysis of inherited mtDNA sequence variation can help in identifying both ancient polymorphisms defining sub-haplogroups and the accumulation of sporadic mutations associated with complex traits such as AD.	[Santoro, Aurelia; Balbi, Valentina; Balducci, Elisa; Pirazzini, Chiara; Rosini, Francesca; Tavano, Francesca; Achilli, Alessandro; Bellavista, Elena; Mishto, Michele; Salvioli, Stefano; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Santoro, Aurelia; Bellavista, Elena; Mishto, Michele; Salvioli, Stefano; Franceschi, Claudio] Univ Bologna, CIG Interdept Ctr Biophys & Biocomplex Studies, Bologna, Italy; [Achilli, Alessandro; Torroni, Antonio] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ Perugia, Dept Cell & Environm Biol, I-06100 Perugia, Italy; [Siviero, Paola; Minicuci, Nadia; Crepaldi, Gaetano] CNR, Inst Neurosci, Padua, Italy; [Mishto, Michele] Fac Med Charite, Inst Biochem, Berlin, Germany; [Marchegiani, Francesca; Cardelli, Maurizio; Olivieri, Fabiola] Italian Natl Res Ctr Aging INRCA, Ancona, Italy; [Olivieri, Fabiola] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Ancona, Italy; [Nacmias, Benedetta; Sorbi, Sandro] Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; [Chiamenti, Andrea Maria; Gabelli, Carlo] Reg Ctr Cerebral Aging, Vicenza, Italy; [Benussi, Luisa; Ghidoni, Roberta; Binetti, Giuliano] Ctr S Giovanni di Dio Fatebenefratelli, NeuroBioGen Lab Memory Clin, Brescia, Italy; [Ghidoni, Roberta] Ctr S Giovanni di Dio Fatebenefratelli, Prote Unit, Brescia, Italy; [Rose, Giuseppina; Passarino, Giuseppe] Univ Calabria, Dept Cell Biol, I-87036 Cosenza, Italy	University of Bologna; University of Bologna; University of Pavia; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS INRCA; Marche Polytechnic University; University of Florence; IRCCS Fatebenefratelli; IRCCS Fatebenefratelli; University of Calabria	Santoro, A (corresponding author), Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.	aurelia.santoro@unibo.it	Binetti, Giuliano/K-4519-2016; Salvioli, Stefano/K-6663-2016; Marchegiani, Francesca/AAB-8925-2019; mishto, michele/A-5592-2010; Nacmias, Benedetta/J-5084-2018; Tavano, Francesca/K-2203-2016; Franceschi, Claudio/L-4484-2017; Olivieri, Fabiola/K-6465-2016; pirazzini, chiara/K-2258-2018; MINICUCI, NADIA/D-5237-2016; Achilli, Alessandro/I-9236-2012; Cardelli, Maurizio/I-5505-2014; Ghidoni, Roberta/K-4507-2016; Pirazzini, Chiara/AAD-9318-2021; BENUSSI, LUISA/K-4409-2016; Torroni, Antonio/E-1557-2011	Binetti, Giuliano/0000-0003-2759-5844; Salvioli, Stefano/0000-0002-6191-1225; mishto, michele/0000-0003-3042-2792; Nacmias, Benedetta/0000-0001-9338-9040; Tavano, Francesca/0000-0002-8831-7349; Franceschi, Claudio/0000-0001-9841-6386; Olivieri, Fabiola/0000-0002-9606-1144; MINICUCI, NADIA/0000-0002-0970-6531; Achilli, Alessandro/0000-0001-6871-3451; Cardelli, Maurizio/0000-0002-4480-2473; Ghidoni, Roberta/0000-0002-7691-1957; Pirazzini, Chiara/0000-0001-8248-0295; BENUSSI, LUISA/0000-0003-2836-8141; Torroni, Antonio/0000-0002-4163-4478; Rose, Giuseppina/0000-0002-4264-4184; sorbi, sandro/0000-0002-0380-6670; Santoro, Aurelia/0000-0002-7187-1116	Emilia-Romagna Region; University of Bologna [RFO ex 60%]; Programma Strategico [conv. PS39]; Ricerca Corrente; Italian Ministry of Health; Roberto and Cornelia Pallotti Legacy for Cancer Research	Emilia-Romagna Region(Regione Emilia Romagna); University of Bologna; Programma Strategico; Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Italian Ministry of Health(Ministry of Health, Italy); Roberto and Cornelia Pallotti Legacy for Cancer Research	This work was supported by the "Promozione Regionale della Ricerca Industriale, dell'Innovazione e del Trasferimento Tecnologico'' (PRRIITT) program of the Emilia-Romagna Region, the University of Bologna Grant "Ricerca Fondamentale Orientata (RFO ex 60%) 2008'', the Programma Strategico 2007, conv. PS39, the Ricerca Corrente, Italian Ministry of Health Grant "An integrated approach to identify functional, biochemical and genetic markers in centenarians and Alzheimer's Disease patients'' and the Roberto and Cornelia Pallotti Legacy for Cancer Research Grants (to C. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Azad NA, 2007, GENDER MED, V4, P120, DOI 10.1016/S1550-8579(07)80026-X; BANDELT HJ, 1995, GENETICS, V141, P743; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421; Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Cottrell DA, 2002, NEUROPATH APPL NEURO, V28, P390, DOI 10.1046/j.1365-2990.2002.00414.x; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8; Ferrucci L, 2008, RADIOL CLIN N AM, V46, P643, DOI 10.1016/j.rcl.2008.07.005; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Gaweda-Walerych K, 2008, J NEURAL TRANSM, V115, P1521, DOI 10.1007/s00702-008-0121-9; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Hendrickson SL, 2009, JAIDS-J ACQ IMM DEF, V51, P111, DOI 10.1097/QAI.0b013e3181a324d6; HIXSON JE, 1990, J LIPID RES, V31, P545; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; Kamboh MI, 2004, ANN HUM GENET, V68, P381, DOI 10.1046/j.1529-8817.2004.00110.x; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z; Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Santoro A, 2006, BBA-BIOENERGETICS, V1757, P1388, DOI 10.1016/j.bbabio.2006.05.040; Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van der Walt JM, 2005, HUM GENET, V118, P115, DOI 10.1007/s00439-005-0032-x; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	54	88	90	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12037	10.1371/journal.pone.0012037	http://dx.doi.org/10.1371/journal.pone.0012037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700462	Green Published, gold			2022-12-25	WOS:000280687900021
J	Jackson, C; Welch, HC; Bellamy, TC				Jackson, Claire; Welch, Heidi C.; Bellamy, Tomas C.			Control of Cerebellar Long-Term Potentiation by P-Rex-Family Guanine-Nucleotide Exchange Factors and Phosphoinositide 3-Kinase	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; SMALL-MOLECULE INHIBITOR; PURKINJE-CELL; SYNAPTIC PLASTICITY; NITRIC-OXIDE; PHOSPHATIDYLINOSITOL 3-KINASE; MORPHOLOGICAL-CHANGES; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; PARALLEL	Background: Long-term potentiation (LTP) at the parallel fibre-Purkinje cell synapse in the cerebellum is a recently described and poorly characterized form of synaptic plasticity. The induction mechanism for LTP at this synapse is considered reciprocal to "classical'' LTP at hippocampal CA1 pyramidal neurons: kinases promote increased trafficking of AMPA receptors into the postsynaptic density in the hippocampus, whereas phosphatases decrease internalization of AMPA receptors in the cerebellum. In the hippocampus, LTP occurs in overlapping phases, with the transition from early to late phases requiring the consolidation of initial induction processes by structural re-arrangements at the synapse. Many signalling pathways have been implicated in this process, including PI3 kinases and Rho GTPases. Principal Findings: We hypothesized that analogous phases are present in cerebellar LTP, and took as the starting point for investigation our recent discovery that P-Rex - a Rac guanine nucleotide exchange factor which is activated by PtdIns(3,4,5)P(3) - is highly expressed in mouse cerebellar Purkinje neurons and plays a role in motor coordination. We found that LTP evoked at parallel fibre synapses by 1 Hz stimulation or by NO donors was not sustained beyond 30 min when P-Rex was eliminated or Rac inhibited, suggesting that cerebellar LTP exhibits a late phase analogous to hippocampal LTP. In contrast, inhibition of PI3 kinase activity eliminated LTP at the induction stage. Conclusions: Our data suggest that a PI3K/P-Rex/Rac pathway is required for late phase LTP in the mouse cerebellum, and that other PI3K targets, which remain to be discovered, control LTP induction.	[Jackson, Claire; Bellamy, Tomas C.] Babraham Inst, Mol Signalling Lab, Cambridge, England; [Jackson, Claire; Welch, Heidi C.] Babraham Inst, Inositide Lab, Cambridge, England; [Bellamy, Tomas C.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Nottingham	Jackson, C (corresponding author), Babraham Inst, Mol Signalling Lab, Cambridge, England.	tomas.bellamy@nottingham.ac.uk		Bellamy, Tomas/0000-0003-0204-7366; Welch, Heidi/0000-0001-7865-7000	Biotechnology and Biological Sciences Research Council, UK [BB/B500958/1]; Babraham Institute; Biotechnology and Biological Sciences Research Council [BB/B500958/1, BBS/E/B/0000C231] Funding Source: researchfish; BBSRC [BBS/E/B/0000C231] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK (grant number: BB/B500958/1), and a Synergy grant from the Babraham Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Balakrishnan S, 2009, GLIA, V57, P393, DOI 10.1002/glia.20768; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Belmeguenai A, 2005, J NEUROSCI, V25, P10768, DOI 10.1523/JNEUROSCI.2876-05.2005; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Canepari M, 2003, J NEUROSCI, V23, P4066; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Donald S, 2008, P NATL ACAD SCI USA, V105, P4483, DOI 10.1073/pnas.0712324105; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kakegawa W, 2005, P NATL ACAD SCI USA, V102, P17846, DOI 10.1073/pnas.0508910102; Lee KJ, 2007, NEUROBIOL LEARN MEM, V88, P445, DOI 10.1016/j.nlm.2007.06.001; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Opazo P, 2003, J NEUROSCI, V23, P3679; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Sanna PP, 2002, J NEUROSCI, V22, P3359; Sdrulla AD, 2007, NAT NEUROSCI, V10, P546, DOI 10.1038/nn1889; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, TRENDS NEUROSCI, V27, P378, DOI 10.1016/j.tins.2004.05.006	44	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11962	10.1371/journal.pone.0011962	http://dx.doi.org/10.1371/journal.pone.0011962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694145	Green Published, Green Submitted, gold			2022-12-25	WOS:000280574300014
J	Nair, R; Junankar, S; O'Toole, S; Shah, J; Borowsky, AD; Bishop, JM; Swarbrick, A				Nair, Radhika; Junankar, Simon; O'Toole, Sandra; Shah, Jaynish; Borowsky, Alexander D.; Bishop, J. Michael; Swarbrick, Alexander			Redefining the Expression and Function of the Inhibitor of Differentiation 1 in Mammary Gland Development	PLOS ONE			English	Article							LOOP-HELIX PROTEIN; EPITHELIAL-CELLS; BREAST-CANCER; ID-1; ID1; CARCINOGENESIS; PROLIFERATION; PREGNANCY; PROSTATE; GENES	The accumulation of poorly differentiated cells is a hallmark of breast neoplasia and progression. Thus an understanding of the factors controlling mammary differentiation is critical to a proper understanding of breast tumourigenesis. The Inhibitor of Differentiation 1 (Id1) protein has well documented roles in the control of mammary epithelial differentiation and proliferation in vitro and breast cancer progression in vivo. However, it has not been determined whether Id1 expression is sufficient for the inhibition of mammary epithelial differentiation or the promotion of neoplastic transformation in vivo. We now show that Id1 is not commonly expressed by the luminal mammary epithelia, as previously reported. Generation and analysis of a transgenic mouse model of Id1 overexpression in the mammary gland reveals that Id1 is insufficient for neoplastic progression in virgin animals or to prevent terminal differentiation of the luminal epithelia during pregnancy and lactation. Together, these data demonstrate that there is no luminal cell-autonomous role for Id1 in mammary epithelial cell fate determination, ductal morphogenesis and terminal differentiation.	[Nair, Radhika; Junankar, Simon; O'Toole, Sandra; Shah, Jaynish; Swarbrick, Alexander] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [O'Toole, Sandra] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Camperdown, NSW 2050, Australia; [O'Toole, Sandra] Univ Sydney, Sch Clin, Sydney Med Sch, Sydney, NSW 2006, Australia; [Borowsky, Alexander D.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Bishop, J. Michael] Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA; [O'Toole, Sandra; Swarbrick, Alexander] Univ New S Wales, St Vincents Clin Sch, Kensington, NSW 2033, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Sydney; University of Sydney; University of California System; University of California Davis; University of California System; University of California San Francisco; University of New South Wales Sydney	Nair, R (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia.	a.swarbrick@garvan.org.au	Swarbrick, Alexander/E-6107-2010; Borowsky, Alexander D/S-5404-2017; Junankar, Simon/O-2009-2019; Junankar, Simon/B-7677-2019	Swarbrick, Alexander/0000-0002-3051-5676; Junankar, Simon/0000-0002-3965-8278; Shah, Jaynish/0000-0002-1089-7355; Nair, Radhika/0000-0002-6585-3384	Cancer Council NSW, Australia [RG-0812]; Cancer Institute NSW; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024037] Funding Source: NIH RePORTER	Cancer Council NSW, Australia(Cancer Council New South Wales); Cancer Institute NSW; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant RG-0812 from the Cancer Council NSW, Australia. AS is the recipient of a Cancer Institute NSW early career development fellowship. JS is a recipient of a Cancer Institute NSW research scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Caldon CE, 2008, CANCER RES, V68, P3026, DOI 10.1158/0008-5472.CAN-07-3079; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Itahana Y, 2003, CANCER RES, V63, P7098; Itahana Y, 2008, BIOCHEM BIOPH RES CO, V372, P826, DOI 10.1016/j.bbrc.2008.05.139; KHIDR L, ONCOGENE, V25, P5210; Lin CQ, 1999, ENDOCR-RELAT CANCER, V6, P49, DOI 10.1677/erc.0.0060049; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; OTOOLE S, 2009, EXPERT OPIN IN PRESS; Parrinello S, 2001, J BIOL CHEM, V276, P39213, DOI 10.1074/jbc.M104473200; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Salomon R, 2009, J HISTOCHEM CYTOCHEM, V57, P599, DOI 10.1369/jhc.2009.953182; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Uehara N, 2003, BREAST CANCER RES, V5, pR25, DOI 10.1186/bcr560	24	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11947	10.1371/journal.pone.0011947	http://dx.doi.org/10.1371/journal.pone.0011947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689821	gold, Green Submitted, Green Published			2022-12-25	WOS:000280520500009
J	Scott, A; Powner, MB; Gandhi, P; Clarkin, C; Gutmann, DH; Johnson, RS; Ferrara, N; Fruttiger, M				Scott, Andrew; Powner, Michael B.; Gandhi, Pranita; Clarkin, Claire; Gutmann, David H.; Johnson, Randall S.; Ferrara, Napoleone; Fruttiger, Marcus			Astrocyte-Derived Vascular Endothelial Growth Factor Stabilizes Vessels in the Developing Retinal Vasculature	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; MESSENGER-RNA STABILITY; BLOOD-VESSELS; VEGF EXPRESSION; CELL; HYPOXIA; PREMATURITY; SURVIVAL; MOUSE; MICE	Vascular endothelial growth factor (VEGF) plays a critical role in normal development as well as retinal vasculature disease. During retinal vascularization, VEGF is most strongly expressed by not yet vascularized retinal astrocytes, but also by retinal astrocytes within the developing vascular plexus, suggesting a role for retinal astrocyte-derived VEGF in angiogenesis and vessel network maturation. To test the role of astrocyte-derived VEGF, we used Cre-lox technology in mice to delete VEGF in retinal astrocytes during development. Surprisingly, this only had a minor impact on retinal vasculature development, with only small decreases in plexus spreading, endothelial cell proliferation and survival observed. In contrast, astrocyte VEGF deletion had more pronounced effects on hyperoxia-induced vaso-obliteration and led to the regression of smooth muscle cell-coated radial arteries and veins, which are usually resistant to the vessel-collapsing effects of hyperoxia. These results suggest that VEGF production from retinal astrocytes is relatively dispensable during development, but performs vessel stabilizing functions in the retinal vasculature and might be relevant for retinopathy of prematurity in humans.	[Scott, Andrew; Powner, Michael B.; Gandhi, Pranita; Fruttiger, Marcus] UCL, UCL Inst Ophthalmol, London, England; [Clarkin, Claire] Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England; [Gutmann, David H.] Washington Univ, Dept Neurol, St Louis, MO USA; [Johnson, Randall S.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	University of London; University College London; University of London; King's College London; Washington University (WUSTL); University of California System; University of California San Diego; Roche Holding; Genentech	Scott, A (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	m.fruttiger@ucl.ac.uk	Johnson, Randall/AAM-1189-2021; Powner, Michael/CAG-7455-2022; Clarkin, Claire/AAC-2980-2019	Johnson, Randall/0000-0002-4084-6639; Fruttiger, Marcus/0000-0002-6962-5485; Gutmann, David/0000-0002-3127-5045; Powner, Michael/0000-0003-4913-1004	Fight for Sight, the Moorfields Biomedical Research Centre; Moorfields Special Trustees; Wellcome Trust; Genentech Inc	Fight for Sight, the Moorfields Biomedical Research Centre; Moorfields Special Trustees; Wellcome Trust(Wellcome TrustEuropean Commission); Genentech Inc(Roche HoldingGenentech)	This work was supported by grants from Fight for Sight, the Moorfields Biomedical Research Centre, Moorfields Special Trustees, the Wellcome Trust and Genentech Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; with the exception of Genentech Inc. who supplied materials (Vegf-floxed mice) and were involved in the preparation of the manuscript.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Claxton S, 2003, EXP EYE RES, V77, P305, DOI 10.1016/S0014-4835(03)00153-2; CLAXTON S, 2005, OXYGEN MODIFIES ARTE; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Diez-Roux G, 1999, DEVELOPMENT, V126, P2141; DORRELL MI, 2009, MAINTAINING RETINAL; Downie LE, 2008, GLIA, V56, P1076, DOI 10.1002/glia.20680; ENGERMAN RL, 1965, AM J OPHTHALMOL, V60, P628, DOI 10.1016/0002-9394(65)92251-8; FAVARD C, 1991, BIOL CELL, V73, P1, DOI 10.1016/0248-4900(91)90002-5; Ferrara N, 1991, Growth Factors, V5, P141, DOI 10.3109/08977199109000278; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gerhardinger C, 1998, AM J PATHOL, V152, P1453; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gu XL, 2002, INVEST OPHTH VIS SCI, V43, P496; Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314; Hellstrom A, 2001, P NATL ACAD SCI USA, V98, P5804, DOI 10.1073/pnas.101113998; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Levy AP, 1998, TRENDS CARDIOVAS MED, V8, P246, DOI 10.1016/S1050-1738(98)00020-6; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; MAGAUD JP, 1989, J HISTOCHEM CYTOCHEM, V37, P1517, DOI 10.1177/37.10.2476478; Meeson AP, 1999, DEVELOPMENT, V126, P1407; Micieli JA, 2009, AM J OPHTHALMOL, V148, P536, DOI 10.1016/j.ajo.2009.05.031; PEER J, 1995, LAB INVEST, V72, P638; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Provis JM, 2000, INVEST OPHTH VIS SCI, V41, P2827; Provis JM, 1997, EXP EYE RES, V65, P555, DOI 10.1006/exer.1997.0365; Ryan HE, 2000, CANCER RES, V60, P4010; SCHNITZER J, 1988, GLIA, V1, P74, DOI 10.1002/glia.440010109; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2004, GROWTH HORM IGF RES, V14, pS140, DOI 10.1016/j.ghir.2004.03.030; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; TAILOI CL, 1992, INVEST OPHTH VIS SCI, V33, P2148; Trollmann R, 2009, BRAIN DEV-JPN, V31, P503, DOI 10.1016/j.braindev.2009.03.007; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; Vinores SA, 2006, J CELL PHYSIOL, V206, P749, DOI 10.1002/jcp.20525; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Zhang L, 2002, BIOCHEM BIOPH RES CO, V292, P860, DOI 10.1006/bbrc.2002.6710	51	107	113	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11863	10.1371/journal.pone.0011863	http://dx.doi.org/10.1371/journal.pone.0011863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686684	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000280520200027
J	Thurstan, RH; Roberts, CM				Thurstan, Ruth H.; Roberts, Callum M.			Ecological Meltdown in the Firth of Clyde, Scotland: Two Centuries of Change in a Coastal Marine Ecosystem	PLOS ONE			English	Article							NEPHROPS FISHERY; SEA AREA; ESTUARY; DISTURBANCE; MANAGEMENT; COMMUNITY; ABUNDANCE; COLLAPSE; IMPACTS; BIOLOGY	Background: The Firth of Clyde is a large inlet of the sea that extends over 100 km into Scotland's west coast. Methods: We compiled detailed fisheries landings data for this area and combined them with historical accounts to build a picture of change due to fishing activity over the last 200 years. Findings: In the early 19(th) century, prior to the onset of industrial fishing, the Firth of Clyde supported diverse and productive fisheries for species such as herring (Clupea harengus, Clupeidae), cod (Gadus morhua, Gadidae), haddock (Melanogrammus aeglefinus, Gadidae), turbot (Psetta maxima, Scophthalmidae) and flounder (Platichthys flesus, Pleuronectidae). The 19(th) century saw increased demand for fish, which encouraged more indiscriminate methods of fishing such as bottom trawling. During the 1880s, fish landings began to decline, and upon the recommendation of local fishers and scientists, the Firth of Clyde was closed to large trawling vessels in 1889. This closure remained in place until 1962 when bottom trawling for Norway lobster (Nephrops norvegicus, Nephropidae) was approved in areas more than three nautical miles from the coast. During the 1960s and 1970s, landings of bottomfish increased as trawling intensified. The trawl closure within three nautical miles of the coast was repealed in 1984 under pressure from the industry. Thereafter, bottomfish landings went into terminal decline, with all species collapsing to zero or near zero landings by the early 21(st) century. Herring fisheries collapsed in the 1970s as more efficient mid-water trawls and fish finders were introduced, while a fishery for mid-water saithe (Pollachius virens, Gadidae) underwent a boom and bust shortly after discovery in the late 1960s. The only commercial fisheries that remain today are for Nephrops and scallops (Pecten maximus, Pectinidae). Significance: The Firth of Clyde is a marine ecosystem nearing the endpoint of overfishing, a time when no species remain that are capable of sustaining commercial catches. The evidence suggests that trawl closures helped maintain productive fisheries through the mid-20(th) century, and their reopening precipitated collapse of bottomfish stocks. We argue that continued intensive bottom trawling for Nephrops with fine mesh nets will prevent the recovery of other species. This once diverse and highly productive environment will only be restored if trawl closures or other protected areas are re-introduced. The Firth of Clyde represents at a small scale a process that is occurring ocean-wide today, and its experience serves as a warning to others.	[Thurstan, Ruth H.; Roberts, Callum M.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	University of York - UK	Thurstan, RH (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	cr10@york.ac.uk	Thurstan, Ruth/K-5551-2014	Thurstan, Ruth/0000-0002-8045-1631	Marine Conservation Biology Institute	Marine Conservation Biology Institute	This study was partly funded by a Mia Tegner Memorial Grant in Historical Ecology from the Marine Conservation Biology Institute (www.mcbi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1866, REPORT COMMISSIONERS; BAILEY N, 1986, P ROY SOC EDINB B, V90, P501, DOI 10.1017/S0269727000005194; BAILEY RS, 1986, P ROY SOC EDINB B, V90, P407, DOI 10.1017/S0269727000005121; BEAUFOY H, 1785, REPORTS COMMITTEES H, V10, P18; Beevers N., 2007, 8 INT C WORKSH LOBST; Bergmann M, 2002, FISH RES, V57, P169, DOI 10.1016/S0165-7836(01)00345-9; Bergmann M, 2002, MAR ECOL PROG SER, V233, P185, DOI 10.3354/meps233185; Bergmann M, 2001, ICES J MAR SCI, V58, P531, DOI 10.1006/jmsc.2001.1046; Bjornsson B, 2004, ICES J MAR SCI, V61, P983, DOI 10.1016/j.icesjms.2004.06.017; BLAKE G, 1952, FIRTH CLYDE; BOYD JM, 1986, P ROY SOC EDINB B, V90, P1; BOYD TJ, 1892, 10 FISH BOARD SCOT 1, P1; BOYD TJ, 2001, 8 FISH BOARD SCOT 1, P1; BOYD TJ, 1891, 9 FISH BOARD SCOTL 1, P1; Bradshaw C, 2002, J SEA RES, V47, P161, DOI 10.1016/S1385-1101(02)00096-5; BROOK G, 1985, 4 FISH BOARD SCOTL 1, P47; Carr MH, 2003, ECOL APPL, V13, pS90; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; *COAST, 2006, CAUGHT TIM COMM ARR; *DEP AGR FISH SCOT, 1978, FISH SCOTL REP 1977; *DEP AGR FISH SCOT, 1963, FISH SCOTL REP 1962; *DEP AGR FISH SCOT, 1981, FISH SCOTL REP 1980; *DEP AGR FISH SCOT, 1973, FISH SCOTL REP 1972; Duncan C, 2003, LAMLASH BAY SEASEARC; ESSLEMONT P, 1894, 12 FISH BOARD SCOT 1, P132; ESSLEMONT P, 1893, 11 FISH BOARD SCOT 1, P1; EWART JC, 1888, 6 FISH BOARD SCOTL 3, P25; EWART JC, 1888, FISHERY BOARD SCOTLA; EWART JC, 1888, FISHERY BOARD SCOTLA, P98; EWART JC, 1987, 6 FISH BOARD SCOT 3, P1; Fairfax D., 1998, BASKING SHARK SCOTLA; Fisher JAD, 2002, MAR ECOL PROG SER, V240, P249, DOI 10.3354/meps240249; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fulton Thomas W, 1911, SOVEREIGNTY SEA; FULTON TW, 1900, 18 FISH BOARD SCOT 3, P242; FULTON TW, 1994, 13 FISH BOARD SCOT 3, P17; GIBSON JA, 1986, P ROY SOC EDINB B, V90, P451, DOI 10.1017/S0269727000005157; HAIG AJN, 1986, P ROY SOC EDINB B, V90, P393, DOI 10.1017/S026972700000511X; Hall-Spencer JM, 2000, ICES J MAR SCI, V57, P1407, DOI 10.1006/jmsc.2000.0918; HENDERSON AR, 1986, P ROY SOC EDINB B, V90, P157, DOI 10.1017/S0269727000004966; HISLOP JRG, 1986, P ROY SOC EDINB B, V90, P423, DOI 10.1017/S0269727000005133; HOGARTH G, 1937, 55 FISH BOARD SCOT; HOGARTH G, 1938, 56 FISH BOARD SCOTL; HOGARTH GED, 1936, 54 FISH BOARD SCOT; HOWDEN T, 2004, THESIS KINGS COLL LO; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; *ICES, 2008, REP WORKSH GROUP ASS; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaworski A, 2006, ICES J MAR SCI, V63, P897, DOI 10.1016/j.icesjms.2006.03.001; JONES DT, 1923, 41 FISH BOARD SCOT; JONES DT, 1927, 45 FISH BOARD SCOT; JONES DT, 1924, 42 FISH BOARD SCOT 1; JONES DT, 1921, 39 FISH BOARD SCOT; Karagiannakos A, 1996, MAR POLICY, V20, P235, DOI 10.1016/0308-597X(96)86986-7; MAITLAND JRG, 1988, FISHERY BOARD SCOTLA, P3; MARTIN A, 2002, HERRING FISHERMEN KI; MCCRINDLE H, 2006, GLASGOW NATURALIST 4, V24, P77; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D., 2003, PERFECT OCEAN STATE, P175; POLTE P, 2004, THESIS BREMEN U; RAE BB, 1959, SCOTTISH FISHERIES B, V14, P14; Roberts C., 2008, RETURN ABUNDANCE CAS; Roberts C., 2007, UNNATURAL HIST SEA F; Roberts CM, 1998, FISHERIES, V23, P16; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Robinson Gwen, 2018, NIKKEI ASIA; Robinson R, 2000, ENGLANDS SEA FISHERI, P72; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; SAVILLE A, 1959, SCOTTISH FISHERIES B, V12, P9; *SCOTT HOM DEP, 1949, REP FISH SCOTL 1939; *SCOTT HOM DEP, 1958, REP FISH SCOTL 1957; SCOTT T, 1999, 18 FISH BOARD SCOT 3, P272; SKINNER J, 1898, 16 FISH BOARD SCOTL, P232; Smith Tim D., 2002, P61; Staneck RS, 1998, TRENDS ECOL EVOL, V13, P429, DOI 10.1016/S0169-5347(98)01494-3; Stentiford GD, 2000, J EXP MAR BIOL ECOL, V247, P169, DOI 10.1016/S0022-0981(00)00146-5; STEVEN JM, 1971, SCOTTISH FISHERIES B, V35, P21; Stone HH, 2004, J SEA RES, V51, P261, DOI 10.1016/j.seares.2003.08.004; SUTHERLAND A, 1897, 15 FISH BOARD SCOT 1, P1; SUTHERLAND A, 1911, 29 FISH BOARD SCOT 1, P1; SUTHERLAND A, 1896, 14 FISH BOARD SCOT 1, P205; SUTHERLAND A, 1914, 32 FISH BOARD SCOT 1, P171; SUTHERLAND A, 2001, 17 FISH BOARD SCOT 1, P170; THOMSON D, 2001, 401 FOOD AGR ORG UN; TIVY J, 1986, P ROY SOC EDINB B, V90, P7, DOI 10.1017/S026972700000484X; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Wilson P., 1887, 5 FISH BOARD SCOT 1, P431; WOOD H, 1960, SCOTTISH FISHERIES B, V13, P23; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; YOUNG A, 1885, 3 FISH BOARD SCOTL, P91; 1756, J HOUSE COMMONS 1688, V27; [No title captured]	96	64	64	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11767	10.1371/journal.pone.0011767	http://dx.doi.org/10.1371/journal.pone.0011767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686614	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200005
J	Rabot, S; Membrez, M; Bruneau, A; Gerard, P; Harach, T; Moser, M; Raymond, F; Mansourian, R; Chou, CJ				Rabot, Sylvie; Membrez, Mathieu; Bruneau, Aurelia; Gerard, Philippe; Harach, Taoufiq; Moser, Mireille; Raymond, Frederic; Mansourian, Robert; Chou, Chieh J.			Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism	FASEB JOURNAL			English	Article						insulin sensitivity; obesity; inflammation	GUT MICROBIOTA; INDUCED OBESITY; LIVER; RECEPTOR; ALPHA; ABCG8; INFLAMMATION; MACROPHAGES; ABSORPTION; PROTECTION	Recent studies showed that germ-free (GF) mice are resistant to obesity when consuming a high-fat, high-carbohydrate Western diet. However, it remains unclear what mechanisms are involved in the antiobesity phenotype and whether GF mice develop insulin resistance and dyslipidemia with high-fat (HF) feeding. In the present study, we compared the metabolic consequences of HF feeding on GF and conventional (conv) C57BL/6J mice. GF mice consumed fewer calories, excreted more fecal lipids, and weighed significantly less than conv mice. GF/HF animals also showed enhanced insulin sensitivity with improved glucose tolerance, reduced fasting and nonfasting insulinemia, and increased phospho-Akt((Ser-473)) in adipose tissue. In association with enhanced insulin sensitivity, GF/HF mice had reduced plasma TNF-alpha and total serum amyloid A concentrations. Reduced hyperchole-sterolemia, a moderate accretion of hepatic cholesterol, and an increase in fecal cholesterol excretion suggest an altered cholesterol metabolism in GF/HF mice. Pronounced nucleus SREBP2 proteins and up-regulation of cholesterol biosynthesis genes indicate that enhanced cholesterol biosynthesis contributed to the cholesterol homeostasis in GF/HF mice. Our results demonstrate that fewer calorie consumption and increased lipid excretion contributed to the obesity-resistant phenotype of GF/HF mice and reveal that insulin sensitivity and cholesterol metabolism are metabolic targets influenced by the gut microbiota.-Rabot, S., Membrez, M., Bruneau, A., Gerard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R., Chou. C. J. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J. 24, 4948-4959 (2010). www.fasebj.org	[Membrez, Mathieu; Harach, Taoufiq; Chou, Chieh J.] Nestle Res Ctr, Dept Nutr & Hlth, CH-1000 Lausanne 26, Switzerland; [Moser, Mireille; Raymond, Frederic; Mansourian, Robert] Nestle Res Ctr, Dept Bioanalyt Sci, CH-1000 Lausanne 26, Switzerland; [Rabot, Sylvie; Bruneau, Aurelia; Gerard, Philippe] INRA, Micalis UMR1319, Jouy En Josas, France	Nestle SA; Nestle SA; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chou, CJ (corresponding author), Nestle Res Ctr, Dept Nutr & Hlth, Rte Jorat 57, CH-1000 Lausanne 26, Switzerland.	chieh-jason.chou@rdls.nestle.com	Gérard, Philippe/H-8138-2019; Eckhardt, Erik/G-1567-2010	Gérard, Philippe/0000-0001-9521-0067; Raymond, Frederic/0000-0002-6148-6898; Rabot, Sylvie/0000-0002-4603-2038	Nestec S.A.	Nestec S.A.	The authors thank Drs. Kevin Acheson and Katherine Mace for valuable scientific comments, Alain Joffre (Institut National de la Recherche Agronomique, Jouy-en-Josas, France) for breeding and husbandry of GF mice, Sylviane Metairon for microarry analysis, Sylvie Pridmore-Merten (Nestle Research Center, Lausanne, Switzerland) for providing mouse fecal sample and Irian Monnard of fecal sample analysis. Nestec S.A. Provided funding to S.R., A.B., and P.G. for the present work. M.M., T.H., M.M., F.R., S.M., R.M., and C.J.C. are employees of Nestec S.A.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; Calpe-Berdiel L, 2008, J LIPID RES, V49, P1904, DOI 10.1194/jlr.M700470-JLR200; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; CANI PD, 2007, SDA, V50, P2374; Chan MY, 2008, OBESITY, V16, P972, DOI 10.1038/oby.2008.32; Dam H, 1934, BIOCHEM J, V28, P820, DOI 10.1042/bj0280820; EYSSEN HJ, 1973, DSA, V36, P411; FLEISSNER CK, 2010, BR J NUTR, V5, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gerard P, 2007, APPL ENVIRON MICROB, V73, P5742, DOI 10.1128/AEM.02806-06; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; HOTAMISLIGIL GS, 1993, DFA, V259, P87; HWA JJ, 1992, J LIPID RES, V33, P711; Jahnel J, 2009, LIVER INT, V29, P1316, DOI 10.1111/j.1478-3231.2009.02044.x; Khovidhunkit W, 2003, J LIPID RES, V44, P1728, DOI 10.1194/jlr.M300100-JLR200; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lin CC, 2008, BRIT J NUTR, V99, P37, DOI 10.1017/S0007114507793881; Mansourian R, 2004, BIOINFORMATICS, V20, P2726, DOI 10.1093/bioinformatics/bth319; MCGILLICUDDY FC, 2009, DA, V119, P1135; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; *R DEV COR TEAM, 2007, R 2 6 1; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; WOSTMANN BS, 1961, AM J PHYSIOL, V201, P1027, DOI 10.1152/ajplegacy.1961.201.6.1027; WOSTMANN BS, 1973, J NUTR, V103, P982, DOI 10.1093/jn/103.7.982; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ye XY, 2009, J ENDOCRINOL INVEST, V32, P568, DOI [10.1007/BF03346510, 10.3275/6111]; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	39	408	442	5	79	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4948	+		10.1096/fj.10-164921	http://dx.doi.org/10.1096/fj.10-164921			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20724524				2022-12-25	WOS:000284824400033
J	Mahfoud, R; Manis, A; Binnington, B; Ackerley, C; Lingwood, CA				Mahfoud, Radhia; Manis, Adam; Binnington, Beth; Ackerley, Cameron; Lingwood, Clifford A.			A Major Fraction of Glycosphingolipids in Model and Cellular Cholesterol-containing Membranes Is Undetectable by Their Binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; HUMAN-IMMUNODEFICIENCY-VIRUS; GLOBOTRIAOSYL CERAMIDE; LIPID RAFTS; RECEPTOR FUNCTION; MONOCLONAL-ANTIBODY; SURFACE EXPRESSION; SACCHARIDE CHAINS; STEM-CELLS; RECOGNITION	Glycosphingolipids (GSLs) accumulate in cholesterol-enriched cell membrane domains and provide receptors for protein ligands. Lipid-based "aglycone" interactions can influence GSL carbohydrate epitope presentation. To evaluate this relationship, Verotoxin binding its receptor GSL, globotriaosyl ceramide (Gb(3)), was analyzed in simple GSL/cholesterol, detergent-resistant membrane vesicles by equilibrium density gradient centrifugation. Vesicles separated into two Gb(3)/cholesterol-containing populations. The lighter, minor fraction (<5% total GSL), bound VT1, VT2, IgG/IgM mAb anti-Gb(3), HIVgp120 or Bandeiraea simplicifolia lectin. Only IgM anti-Gb(3), more tolerant of carbohydrate modification, bound both vesicle fractions. Post-embedding cryo-immuno-EM confirmed these results. This appears to be a general GSL-cholesterol property, because similar receptor-inactive vesicles were separated for other GSL-protein ligand systems; cholera toxin (CTx)-GM1, HIVgp120-galactosyl ceramide/sulfatide. Inclusion of galactosyl or glucosyl ceramide (GalCer and GlcCer) rendered VT1-unreactive Gb(3)/cholesterol vesicles, VT1-reactive. We found GalCer and GlcCer bind Gb(3), suggesting GSL-GSL interaction can counter cholesterol masking of Gb(3). The similar separation of Vero cell membrane-derived vesicles into minor "binding," and major " non-binding" fractions when probed with VT1, CTx, or anti-SSEA4 (a human GSL stem cell marker), demonstrates potential physiological relevance. Cell membrane GSL masking was cholesterol- and actin-dependent. Cholesterol depletion of Vero and HeLa cells enabled differential VT1B subunit labeling of "available" and " cholesterol-masked" plasma membrane Gb(3) pools by fluorescence microscopy. Thus, the model GSL/cholesterol vesicle studies predicted two distinct membrane GSL formats, which were demonstrated within the plasma membrane of cultured cells. Cholesterol masking of most cell membrane GSLs may impinge many GSL receptor functions.	[Mahfoud, Radhia; Manis, Adam; Binnington, Beth; Lingwood, Clifford A.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Ackerley, Cameron; Lingwood, Clifford A.] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Manis, Adam; Lingwood, Clifford A.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5S 1A8, Canada; [Lingwood, Clifford A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Lingwood, CA (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cling@sickkids.ca			CIHR [MT 13747]; Ontario HIV Treatment Network; Canfar; Research Training Centre at the Research Institute, Hospital for Sick Children	CIHR(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Canfar; Research Training Centre at the Research Institute, Hospital for Sick Children	This work was supported by CIHR Grant MT 13747, grants from Ontario HIV Treatment Network and Canfar and by the Research Training Centre at the Research Institute, Hospital for Sick Children.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ACKERMAN GA, 1980, J HISTOCHEM CYTOCHEM, V28, P1334, DOI 10.1177/28.12.7014713; Angstrom J, 1998, GLYCOBIOLOGY, V8, P297, DOI 10.1093/glycob/8.4.297; Bartz R, 2008, EMBO J, V27, P948, DOI 10.1038/emboj.2008.36; BENGOECHEAALONS.MT, 2005, J P NATL ACAD SCI U, V102, P11681; BHAT S, 1991, P NATL ACAD SCI USA, V88, P7131, DOI 10.1073/pnas.88.16.7131; Binnington B, 2002, NEUROCHEM RES, V27, P807, DOI 10.1023/A:1020261125008; BOYD B, 1994, EUR J BIOCHEM, V223, P873, DOI 10.1111/j.1432-1033.1994.tb19064.x; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chen X, 2009, BIOCHEM J, V417, P525, DOI 10.1042/BJ20081385; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; CROOK SJ, 1986, BIOCHEMISTRY-US, V25, P7488, DOI 10.1021/bi00371a035; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Das P, 2003, LIFE SCI, V72, P2617, DOI 10.1016/S0024-3205(03)00163-2; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; DIBIASE A, 1990, NEUROCHEM RES, V15, P519, DOI 10.1007/BF00966210; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Fernandez C, 2004, EXP CELL RES, V300, P109, DOI 10.1016/j.yexcr.2004.06.029; Fielding CJ, 2004, BIOCHEM SOC T, V32, P65, DOI 10.1042/BST0320065; Fong CY, 2009, STEM CELL REV REP, V5, P72, DOI 10.1007/s12015-009-9054-4; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Hagerstrand H, 2006, MOL MEMBR BIOL, V23, P277, DOI 10.1080/09687860600682536; Hakomori S, 2004, ARCH BIOCHEM BIOPHYS, V426, P173, DOI 10.1016/j.abb.2004.02.032; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hammache D, 1999, J VIROL, V73, P5244, DOI 10.1128/JVI.73.6.5244-5248.1999; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006; Hinoi E, 2004, EUR J BIOCHEM, V271, P1, DOI 10.1046/j.1432-1033.2003.03907.x; Hirai M, 2005, J PHYS-CONDENS MAT, V17, pS2965, DOI 10.1088/0953-8984/17/31/025; Hutterer R, 1993, J Fluoresc, V3, P257, DOI 10.1007/BF00865274; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Jarvis RM, 2007, BIOCHEM BIOPH RES CO, V355, P944, DOI 10.1016/j.bbrc.2007.02.053; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KANNAGI R, 1983, CANCER RES, V43, P4997; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; Kawano N, 2008, BIOL REPROD, V79, P1153, DOI 10.1095/biolreprod.108.069054; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kolling GL, 2008, HISTOCHEM CELL BIOL, V130, P157, DOI 10.1007/s00418-008-0417-8; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Lingwood CA, 1996, GLYCOCONJUGATE J, V13, P495, DOI 10.1007/BF00731435; Lingwood CA, 1999, BBA-MOL BASIS DIS, V1455, P375, DOI 10.1016/S0925-4439(99)00062-9; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LIPPINCOTTSCHWA.J, 2010, R D ANNU REV BIOPHYS, V39, P559; LOWRY RR, 1968, J LIPID RES, V9, P397; Lund N, 2006, AIDS, V20, P333, DOI 10.1097/01.aids.0000206499.78664.58; Lund N, 2009, BLOOD, V113, P4980, DOI 10.1182/blood-2008-03-143396; LUNDEN BM, 1977, CHEM PHYS LIPIDS, V20, P263, DOI 10.1016/0009-3084(77)90067-6; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Mahfoud R, 2009, J LIPID RES, V50, P1744, DOI 10.1194/jlr.M800385-JLR200; Mamelak D, 2001, BIOCHEMISTRY-US, V40, P3572, DOI 10.1021/bi001643u; Manes S, 2004, TRENDS CELL BIOL, V14, P275, DOI 10.1016/j.tcb.2004.04.008; MCMULLEN TPW, 1993, BIOCHEMISTRY-US, V32, P516, DOI 10.1021/bi00053a016; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Mylvaganam M, 1999, J BIOL CHEM, V274, P20725, DOI 10.1074/jbc.274.29.20725; MYLVAGANAM M, 2003, CARBOHYDRATE BASED D, P761; NAKAKUMA H, 1992, JPN J CLIN ONCOL, V22, P308; NAKAKUMA H, 1989, FEBS LETT, V258, P230, DOI 10.1016/0014-5793(89)81660-6; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Nutikka A, 2003, GLYCOCONJUGATE J, V20, P33, DOI 10.1023/B:GLYC.0000016740.69726.fb; Nutikka Anita, 2003, Methods Mol Med, V73, P187; Nutikka Anita, 2003, Methods Mol Med, V73, P197; NYHOLM PG, 1993, BIOCHEMISTRY-US, V32, P1225, DOI 10.1021/bi00056a005; NYHOLM PG, 1993, INT J BIOL MACROMOL, V15, P43, DOI 10.1016/S0141-8130(05)80087-X; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; PELLIZZARI A, 1992, BIOCHEMISTRY-US, V31, P1363, DOI 10.1021/bi00120a011; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Rog T, 2006, BIOPHYS J, V91, P3756, DOI 10.1529/biophysj.106.080887; Sakumoto Y, 2009, ARCH HISTOL CYTOL, V72, P77, DOI 10.1679/aohc.72.77; Sato B, 2007, BIOCHEM BIOPH RES CO, V364, P838, DOI 10.1016/j.bbrc.2007.10.093; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; STEWART RJ, 1993, BIOCHEMISTRY-US, V32, P5605, DOI 10.1021/bi00072a016; STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340; STROMBERG N, 1990, J BIOL CHEM, V265, P11244; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Tam P, 2008, J CELL PHYSIOL, V216, P750, DOI 10.1002/jcp.21456; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Villard R, 2002, CHEMBIOCHEM, V3, P517, DOI 10.1002/1439-7633(20020603)3:6<517::AID-CBIC517>3.0.CO;2-N; WIELS J, 1981, P NATL ACAD SCI-BIOL, V78, P6485, DOI 10.1073/pnas.78.10.6485; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079	96	62	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36049	36059		10.1074/jbc.M110.110189	http://dx.doi.org/10.1074/jbc.M110.110189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20716521	hybrid, Green Published			2022-12-25	WOS:000283845300081
J	Pan, WW; Li, JD; Huang, SA; Papadimos, TJ; Pan, ZK; Chen, LY				Pan, Warren W.; Li, Jain-Dong; Huang, Shuang; Papadimos, Thomas J.; Pan, Zhixing K.; Chen, Ling-Yu			Synergistic Activation of NF-kappa B by Bacterial Chemoattractant and TNF alpha Is Mediated by p38 MAPK-dependent RelA Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FMET-LEU-PHE; PERIPHERAL-BLOOD MONOCYTES; SIGNAL-TRANSDUCTION PATHWAY; PROTEIN-KINASE; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; GENE-EXPRESSION; IMMUNE-SYSTEM; FMLP; RECEPTOR	In the host immune system, leukocytes are often exposed to multiple inflammation inducers. NF-kappa B is of considerable importance in leukocyte function because of its ability to activate the transcription of many proinflammatory immediate-early genes. Tremendous efforts have been made toward understanding how NF-kappa B is activated by various inducers. However, most research on NF-kappa B regulation has been focused on understanding how NF-kappa B is activated by a single inducer. This is unlike the situation in the human immune system where multiple inflammation inducers, including both exogenous and endogenous mediators, are present concurrently. We now present evidence that the formylated peptide f-Met-Leu-Phe (fMLP), a bacterial chemoattractant, synergizes with TNF alpha to induce NF-kappa B activation and the resultant inflammatory response in vitro and in vivo. The mechanism of synergistic activation of NF-kappa B by bacterial fMLP and TNF alpha may be involved in the induction of RelA acetylation, which is regulated by p38 MAPK. Thus, this study provides direct evidence for the synergistic induction of NF-kappa B-dependent inflammatory responses by both exogenous and endogenous inducers. The ability of fMLP to synergize with TNF alpha and activate NF-kappa B represents a novel and potentially important mechanism through which bacterial fMLP not only attracts leukocytes but also directly contributes to inflammation by synergizing with the endogenous mediator TNF alpha.	[Pan, Warren W.; Papadimos, Thomas J.; Pan, Zhixing K.; Chen, Ling-Yu] Univ Toledo, Med Ctr, Dept Med, Toledo, OH 43614 USA; [Li, Jain-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Huang, Shuang; Pan, Zhixing K.; Chen, Ling-Yu] Scripps Res Inst, Dept Immunol & Mol & Expt Med, La Jolla, CA 92037 USA	University System of Ohio; University of Toledo; University of Rochester; Scripps Research Institute	Pan, ZK (corresponding author), 3035 Arlington Ave, Toledo, OH 43614 USA.	kevin.pan@utoledo.edu; lingyu.chen@utoledo.edu		Li, Jian-Dong/0000-0002-5593-050X; Papadimos, Thomas/0000-0002-4024-227X; Pan, Warren/0000-0003-4931-8864	National Institutes of Health, USPHS [AI43524, M01RR00833]; Sam and Ross Stein Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI043524, R01AI043524] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Sam and Ross Stein Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI43524 from USPHS and Grant M01RR00833 (to General Clinical Research Center, Scripps Research Institute). This work was also supported in part by the Sam and Ross Stein Charitable Trust.	Adams J L, 1999, Curr Opin Drug Discov Devel, V2, P96; ALLEN R A, 1990, P83; Ayala JM, 2000, J LEUKOCYTE BIOL, V67, P869, DOI 10.1002/jlb.67.6.869; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Browning DD, 1997, J BIOL CHEM, V272, P7995, DOI 10.1074/jbc.272.12.7995; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chen Ling-Yu, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P361; Chen LY, 2009, J IMMUNOL, V182, P2518, DOI 10.4049/jimmunol.0713933; Chen LY, 2005, J BIOL CHEM, V280, P22497, DOI 10.1074/jbc.M413033200; Chen LY, 2004, BIOCHEM BIOPH RES CO, V319, P629, DOI 10.1016/j.bbrc.2004.05.038; Chen LY, 2004, J BIOL CHEM, V279, P7208, DOI 10.1074/jbc.M309542200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Huang S, 2001, J BIOL CHEM, V276, P40977, DOI 10.1074/jbc.M105242200; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009; PAN ZX, 1995, J BIOL CHEM, V270, P7787, DOI 10.1074/jbc.270.14.7787; Pan ZXK, 2000, J IMMUNOL, V164, P404, DOI 10.4049/jimmunol.164.1.404; ROT A, 1987, P NATL ACAD SCI USA, V84, P7967, DOI 10.1073/pnas.84.22.7967; Schiff DE, 1997, J LEUKOCYTE BIOL, V62, P786, DOI 10.1002/jlb.62.6.786; Schulze-Osthoff K, 1997, IMMUNOBIOLOGY, V198, P35, DOI 10.1016/S0171-2985(97)80025-3; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; SNYDERMAN R, 1988, INFLAMMATION BASIC P, P309; TRUETT AP, 1988, P NATL ACAD SCI USA, V85, P1549, DOI 10.1073/pnas.85.5.1549; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Zu YL, 1998, J IMMUNOL, V160, P1982	38	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34348	34354		10.1074/jbc.M110.109165	http://dx.doi.org/10.1074/jbc.M110.109165			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20729202	Green Published, hybrid			2022-12-25	WOS:000283659100008
J	Cui, YP; Cheng, XL; Zhang, C; Zhang, YY; Li, SJ; Wang, CG; Guadagno, TM				Cui, Yongping; Cheng, Xiaolong; Zhang, Ce; Zhang, Yanyan; Li, Shujing; Wang, Chuangui; Guadagno, Thomas M.			Degradation of the Human Mitotic Checkpoint Kinase Mps1 Is Cell Cycle-regulated by APC-c(Cdc20) and APC-c(Cdh1) Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLE BODY DUPLICATION; SPINDLE ASSEMBLY CHECKPOINT; CENTROSOME DUPLICATION; MEDIATED DEGRADATION; CHROMOSOME ALIGNMENT; EARLY MITOSIS; GENE MPS1; ANAPHASE; APC/C; ANEUPLOIDY	Mps1 is a dual specificity protein kinase with key roles in regulating the spindle assembly checkpoint and chromosome-microtubule attachments. Consistent with these mitotic functions, Mps1 protein levels fluctuate during the cell cycle, peaking at early mitosis and abruptly declining during mitotic exit and progression into the G(1) phase. Although evidence in budding yeast indicates that Mps1 is targeted for degradation at anaphase by the anaphase-promoting complex (APC)-c(Cdc20) complex, little is known about the regulatory mechanisms that govern Mps1 protein levels in human cells. Here, we provide evidence for the ubiquitin ligase/proteosome pathway in regulating human Mps1 levels during late mitosis through G(1) phase. First, we showed that treatment of HEK 293T cells with the proteosome inhibitor MG132 resulted in an increase in both the polyubiquitination and the accumulation of Mps1 protein levels. Next, Mps1 was shown to co-precipitate with APC and its activators Cdc20 and Cdh1 in a cell cycle-dependent manner. Consistent with this, overexpression of Cdc20 or Cdh1 led to a marked reduction of endogenous Mps1 levels during anaphase or G(1) phase, respectively. In contrast, depletion of Cdc20 or Cdh1 by RNAi treatment both led to the stabilization of Mps1 protein during mitosis or G(1) phase, respectively. Finally, we identified a single D-box motif in human Mps1 that is required for its ubiquitination and degradation. Failure to appropriately degrade Mps1 is sufficient to trigger centrosome amplification and mitotic abnormalities in human cells. Thus, our results suggest that the sequential actions of the APC-c(Cdc20) andAPC-c(Cdh1) ubiquitin ligases regulate the clearance of Mps1 levels and are critical for Mps1 functions during the cell cycle in human cells.	[Cui, Yongping; Zhang, Ce] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China; [Cui, Yongping; Zhang, Yanyan; Li, Shujing] Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Shanxi, Peoples R China; [Cheng, Xiaolong] Shanxi Med Univ, Dept Anat, Taiyuan 030001, Shanxi, Peoples R China; [Wang, Chuangui] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Guadagno, Thomas M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; East China Normal University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cui, YP (corresponding author), Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China.	cuiy0922@yahoo.com; Thomas.Guadagno@yahoo.com			Program for New Century Excellent Talents University of China [NCET-10-0872]; National Nature Science Foundation of China [30872932]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2009-8]; Bankhead Coley Program [30-15066-02-07]; Department of Defense, National Functional Genomics Center [DAMD17-02-2-0051]	Program for New Century Excellent Talents University of China(Program for New Century Excellent Talents in University (NCET)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Bankhead Coley Program; Department of Defense, National Functional Genomics Center(United States Department of Defense)	This work was supported by Program for New Century Excellent Talents University of China Grant NCET-10-0872, National Nature Science Foundation of China Grant 30872932, Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry Grant 2009-8, Trainee Development Award from Bankhead Coley Program Grant 30-15066-02-07 (to Y. C.), and the Department of Defense, National Functional Genomics Center Project Award DAMD17-02-2-0051 (to T. M. G.).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Cui YP, 2010, CANCER RES, V70, P675, DOI 10.1158/0008-5472.CAN-09-1491; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Fry AM, 2006, CELL CYCLE, V5, P1487, DOI 10.4161/cc.5.14.3003; Gilliland WD, 2005, CURR BIOL, V15, P672; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kasbek C, 2009, ENVIRON MOL MUTAGEN, V50, P654, DOI 10.1002/em.20476; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Straight PD, 2000, MOL BIOL CELL, V11, P3525, DOI 10.1091/mbc.11.10.3525; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	36	35	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32988	32998		10.1074/jbc.M110.140905	http://dx.doi.org/10.1074/jbc.M110.140905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729194	Green Published, hybrid			2022-12-25	WOS:000283048200036
J	Leloup, L; Shao, HS; Bae, YH; Deasy, B; Stolz, D; Roy, P; Wells, A				Leloup, Ludovic; Shao, Hanshuang; Bae, Yong Ho; Deasy, Bridget; Stolz, Donna; Roy, Partha; Wells, Alan			m-calpain Activation Is Regulated by Its Membrane Localization and by Its Binding to Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL-MIGRATION; SIGNALING PATHWAYS; WOUND REPAIR; INDUCIBLE PROTEIN-9; COLLOIDAL SILICA; INDUCED MOTILITY; PLASMA-MEMBRANE; KINASE; FIBROBLASTS	m-calpain plays a critical role in cell migration enabling rear de-adhesion of adherent cells by cleaving structural components of the adhesion plaques. Growth factors and chemokines regulate keratinocyte, fibroblast, and endothelial cell migration by modulating m-calpain activity. Growth factor receptors activate m-calpain secondary to phosphorylation on serine 50 by ERK. Concurrently, activated m-calpain is localized to its inner membrane milieu by binding to phosphatidylinositol 4,5-bisphosphate (PIP2). Opposing this, CXCR3 ligands inhibit cell migration by blocking m-calpain activity secondary to a PKA-mediated phosphorylation in the C2-like domain. The failure of m-calpain activation in the absence of PIP2 points to a key regulatory role, although whether this PIP2-mediated membrane localization is regulatory for m-calpain activity or merely serves as a docking site for ERK phosphorylation is uncertain. Herein, we report the effects of two CXCR3 ligands, CXCL11/IP-9/I-TAC and CXCL10/IP-10, on the EGF- and VEGF-induced redistribution of m-calpain in human fibroblasts and endothelial cells. The two chemokines block the tail retraction and, thus, the migration within minutes, preventing and reverting growth factor-induced relocalization of m-calpain to the plasma membrane of the cells. PKA phosphorylation of m-calpain blocks the binding of the protease to PIP2. Unexpectedly, we found that this was due to membrane anchorage itself and not merely serine 50 phosphorylation, as the farnesylation-induced anchorage of m-calpain triggers a strong activation of this protease, leading notably to an increased cell death. Moreover, the ERK and PKA phosphorylations have no effect on this membrane-anchored m-calpain. However, the presence of PIP2 is still required for the activation of the anchored m-calpain. In conclusion, we describe a novel mechanism of m-calpain activation by interaction with the plasma membrane and PIP2 specifically, this phosphoinositide acting as a cofactor for the enzyme. The phosphorylation of m-calpain by ERK and PKA by growth factors and chemokines, respectively, act in cells to regulate the enzyme only indirectly by controlling its redistribution.	[Leloup, Ludovic; Shao, Hanshuang; Roy, Partha; Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Bae, Yong Ho; Roy, Partha; Wells, Alan] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA; [Deasy, Bridget] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA 15261 USA; [Stolz, Donna] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Wells, Alan] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, Scaife Hall S713,3550 Terrace St, Pittsburgh, PA 15261 USA.	wellsa@upmc.edu	Bae, Yong Ho/M-8427-2015; Leloup, Ludovic/AAF-3045-2020	Bae, Yong Ho/0000-0002-1838-1652; Roy, Partha/0000-0002-4946-8531; Leloup, Ludovic/0000-0001-9369-5689; Wells, Alan/0000-0002-1637-8150	National Institutes of Health NIGMS [GM069668]; NATIONAL CANCER INSTITUTE [R01CA108607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS grant GM069668.	Allen FD, 2002, WOUND REPAIR REGEN, V10, P67, DOI 10.1046/j.1524-475X.2002.10701.x; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; BROUGHTON G, 2006, PLAST RECONSTR SU S7, V117; CHANEY LK, 1983, J BIOL CHEM, V258, P62; Chou J, 2003, EXP CELL RES, V287, P47, DOI 10.1016/S0014-4827(03)00119-8; Chou J, 2002, INT J BIOCHEM CELL B, V34, P776, DOI 10.1016/S1357-2725(01)00177-7; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Goalstone ML, 1996, J BIOL CHEM, V271, P27585, DOI 10.1074/jbc.271.44.27585; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hautaniemi S, 2005, BIOINFORMATICS, V21, P2027, DOI 10.1093/bioinformatics/bti278; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Kharait S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-9; Kulkarni S, 1999, J BIOL CHEM, V274, P21265, DOI 10.1074/jbc.274.30.21265; Kunimoto B T, 1999, Ostomy Wound Manage, V45, P56; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Moldoveanu T, 2001, BBA-PROTEIN STRUCT M, V1545, P245, DOI 10.1016/S0167-4838(00)00286-7; Nedelec B, 2000, HAND CLIN, V16, P289; Palecek SP, 1998, J CELL SCI, V111, P929; PONTREMOLI S, 1985, BIOCHEM BIOPH RES CO, V129, P389, DOI 10.1016/0006-291X(85)90163-9; RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Satish L, 2005, MOL CELL BIOL, V25, P1922, DOI 10.1128/MCB.25.5.1922-1941.2005; Satish L, 2004, WOUND REPAIR REGEN, V12, P183, DOI 10.1111/j.1067-1927.2004.012111.x; Satish L, 2003, J INVEST DERMATOL, V120, P1110, DOI 10.1046/j.1523-1747.2003.12230.x; Serrano K, 2004, CELL MOTIL CYTOSKEL, V58, P242, DOI 10.1002/cm.20011; Shao HS, 2008, WOUND REPAIR REGEN, V16, P551, DOI 10.1111/j.1524-475X.2008.00402.x; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Shiraha H, 1999, J CELL BIOL, V146, P243; Shiraha H, 2002, MOL CELL BIOL, V22, P2716, DOI 10.1128/MCB.22.8.2716-2727.2002; Smith KD, 2006, EXP CELL RES, V312, P1970, DOI 10.1016/j.yexcr.2006.02.022; Smith SD, 2003, FEBS LETT, V542, P115, DOI 10.1016/S0014-5793(03)00361-2; STOLZ DB, 1992, J CELL SCI, V103, P39; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Wells A, 1998, MICROSC RES TECHNIQ, V43, P395, DOI 10.1002/(SICI)1097-0029(19981201)43:5<395::AID-JEMT6>3.0.CO;2-T; Yates CC, 2008, AM J PATHOL, V173, P643, DOI 10.2353/ajpath.2008.070990; Yates CC, 2009, WOUND REPAIR REGEN, V17, P34, DOI 10.1111/j.1524-475X.2008.00439.x	49	61	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33549	33566		10.1074/jbc.M110.123604	http://dx.doi.org/10.1074/jbc.M110.123604			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729206	Green Published, hybrid			2022-12-25	WOS:000283048200089
J	Chang, CR; Manlandro, CM; Arnoult, D; Stadler, J; Posey, AE; Hill, RB; Blackstone, C				Chang, Chuang-Rung; Manlandro, Cara Marie; Arnoult, Damien; Stadler, Julia; Posey, Ammon E.; Hill, R. Blake; Blackstone, Craig			A Lethal de Novo Mutation in the Middle Domain of the Dynamin-related GTPase Drp1 Impairs Higher Order Assembly and Mitochondrial Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; LIGHT-SCATTERING; PROTEIN DLP1; CELLULAR SENESCENCE; FUSION MEDIATORS; MAMMALIAN-CELLS; FISSION; APOPTOSIS; MORPHOLOGY; BINDING	Mitochondria dynamically fuse and divide within cells, and the proper balance of fusion and fission is necessary for normal mitochondrial function, morphology, and distribution. Drp1 is a dynamin-related GTPase required for mitochondrial fission in mammalian cells. It harbors four distinct domains: GTP-binding, middle, insert B, and GTPase effector. A lethal mutation (A395D) within the Drp1 middle domain was reported in a neonate with microcephaly, abnormal brain development, optic atrophy, and lactic acidemia (Waterham, H. R., Koster, J., van Roermund, C. W., Mooyer, P. A., Wanders, R. J., and Leonard, J. V. (2007) N. Engl. J. Med. 356, 1736-1741). Mitochondria within patient-derived fibroblasts were markedly elongated, but the molecular mechanisms underlying these findings were not demonstrated. Because the middle domain is particularly important for the self-assembly of some dynamin superfamily proteins, we tested the hypothesis that this A395D mutation, and two other middle domain mutations (G350D, G363D) were important for Drp1 tetramerization, higher order assembly, and function. Although tetramerization appeared largely intact, each of these mutations compromised higher order assembly and assembly-dependent stimulation of Drp1 GTPase activity. Moreover, mutant Drp1 proteins exhibited impaired localization to mitochondria, indicating that this higher order assembly is important for mitochondrial recruitment, retention, or both. Overexpression of these middle domain mutants markedly inhibited mitochondrial division in cells. Thus, the Drp1 A395D lethal defect likely resulted in impaired higher order assembly of Drp1 at mitochondria, leading to decreased fission, elongated mitochondria, and altered cellular distribution of mitochondria.	[Manlandro, Cara Marie; Posey, Ammon E.; Hill, R. Blake] Johns Hopkins Univ, Dept Biol & Chem, Baltimore, MD 21218 USA; [Chang, Chuang-Rung] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; [Chang, Chuang-Rung] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Arnoult, Damien] INSERM, U542, F-94807 Villejuif, France; [Arnoult, Damien] Univ Paris Sud, Hop Paul Brousse, F-94807 Villejuif, France; [Stadler, Julia; Blackstone, Craig] NINDS, Cellular Neurol Unit, Neurogenet Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Tsing Hua University; National Tsing Hua University; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hill, RB (corresponding author), Johns Hopkins Univ, Dept Biol & Chem, Baltimore, MD 21218 USA.	hill@jhu.edu; blackstc@ninds.nih.gov	Arnoult, Damien/R-2032-2018; Chang, Chuang-Rung/C-1815-2012; Posey, Ammon/H-6505-2013	Chang, Chuang-Rung/0000-0002-6124-5429; Hill, Blake/0000-0001-6228-3905	National Institutes of Health Intramural Research Program of the NINDS [5T32GM080189, 5T32GM008403, RO1GM067180]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180, T32GM080189, T32GM008403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003025] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NINDS (to C.-R.C., J.S., and C.B.), Training Grant 5T32GM080189 (to C.M.M.), Training Grant 5T32GM008403 (to A.E.P.), and Grant RO1GM067180 (to R.B.H.).	Andersson M, 2003, ANAL CHEM, V75, P4279, DOI 10.1021/ac030128+; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Hinshaw JE, 1999, CURR OPIN STRUC BIOL, V9, P260, DOI 10.1016/S0959-440X(99)80036-0; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pitts KR, 2004, J BIOL CHEM, V279, P50286, DOI 10.1074/jbc.M405531200; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Rismanchi N., 2007, MOL NEUROLOGY, P29; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Schrader M, 2006, BBA-MOL CELL RES, V1763, P531, DOI 10.1016/j.bbamcr.2006.01.004; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; Shin HW, 1999, J BIOL CHEM, V274, P2780, DOI 10.1074/jbc.274.5.2780; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tan FJ, 2008, J CELL SCI, V121, P3373, DOI 10.1242/jcs.032904; Tanaka A, 2006, EXP CELL RES, V312, P1671, DOI 10.1016/j.yexcr.2006.01.028; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Westermann B, 2008, J BIOL CHEM, V283, P13501, DOI 10.1074/jbc.R800011200; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Ye HP, 2006, ANAL BIOCHEM, V356, P76, DOI 10.1016/j.ab.2006.05.025; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	46	125	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32494	32503		10.1074/jbc.M110.142430	http://dx.doi.org/10.1074/jbc.M110.142430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696759	Green Published, hybrid			2022-12-25	WOS:000282683000063
J	Walerych, D; Gutkowska, M; Klejman, MP; Wawrzynow, B; Tracz, Z; Wiech, M; Zylicz, M; Zylicz, A				Walerych, Dawid; Gutkowska, Malgorzata; Klejman, Marcin P.; Wawrzynow, Bartosz; Tracz, Zuzanna; Wiech, Milena; Zylicz, Maciej; Zylicz, Alicja			ATP Binding to Hsp90 Is Sufficient for Effective Chaperoning of p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; WILD-TYPE P53; MOLECULAR CHAPERONE; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; COCHAPERONE AHA1; CLIENT PROTEIN; IN-VIVO; HYDROLYSIS; CYCLE	Hsp90 is a ubiquitous, ATP-dependent chaperone, essential for eukaryotes. It possesses a broad spectrum of substrates, among which is the p53 transcription factor, encoded by a tumor-suppressor gene. Here, we elucidate the role of the adenine nucleotide in the Hsp90 chaperone cycle, by taking advantage of a unique in vitro assay measuring Hsp90-dependent p53 binding to the promoter sequence. E42A and D88N Hsp90 beta variants bind but do not hydrolyze ATP, whereas E42A has increased and D88N decreased ATP affinity, compared with WT Hsp90 beta. Nevertheless, both of these mutants interact with WT p53 with a similar affinity. Surprisingly, in the case of WT, but also E42A Hsp90 beta, the presence of ATP stimulates dissociation of Hsp90-p53 complexes and results in p53 binding to the promoter sequence. D88N Hsp90 beta is not efficient in both of these reactions. Using a trap version of the chaperonin GroEL, which irreversibly captures unfolded proteins, we show that Hsp90 chaperone action on WT p53 results in a partial unfolding of the substrate. The ATP-dependent dissociation of p53-Hsp90 complex allows further folding of p53 protein to an active conformation, able to bind to the promoter sequence. Furthermore, in support of these results, the overproduction of WT or E42A Hsp90 beta stimulates transcription from the WAF1 gene promoter in H1299 cells. Altogether, our research indicates that ATP binding to Hsp90 beta is a sufficient step for effective WT p53 client protein chaperoning.	[Wiech, Milena; Zylicz, Maciej; Zylicz, Alicja] Int Inst Mol & Cell Biol Warsaw, PL-02109 Warsaw, Poland; [Gutkowska, Malgorzata; Wawrzynow, Bartosz; Wiech, Milena] PAS, M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Tracz, Zuzanna] PAS, Inst Biochem & Biophys, PL-02109 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zylicz, M (corresponding author), Int Inst Mol & Cell Biol Warsaw, Ks Trojdena Str 4, PL-02109 Warsaw, Poland.	mzylicz@iimcb.gov.pl; alicja.zylicz@iimcb.gov.pl	Wiech, Milena/AAC-5188-2020; Walerych, Dawid/I-2517-2016	Wiech, Milena/0000-0003-4388-1648; Gutkowska, Malgorzata/0000-0001-6584-7964; Tracz-Gaszewska, Zuzanna/0000-0003-1340-6379; Walerych, Dawid/0000-0002-8440-1375; Zylicz, Alicja/0000-0003-4174-3073	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported, in part, by a grant from the Polish Ministry of Science and Higher Education.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Bron P, 2008, BIOL CELL, V100, P413, DOI 10.1042/BC20070149; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; Graf C, 2009, EMBO J, V28, P602, DOI 10.1038/emboj.2008.306; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Jakob U, 1996, J BIOL CHEM, V271, P10035, DOI 10.1074/jbc.271.17.10035; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Miao RQ, 2008, ARTERIOSCL THROM VAS, V28, P105, DOI 10.1161/ATVBAHA.107.155499; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Minami Y, 1999, GENES CELLS, V4, P721, DOI 10.1046/j.1365-2443.1999.00299.x; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; Scheibel T, 1999, MOL MICROBIOL, V34, P701, DOI 10.1046/j.1365-2958.1999.01632.x; Sepehrnia B, 1996, J BIOL CHEM, V271, P15084, DOI 10.1074/jbc.271.25.15084; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Voss AK, 2000, DEVELOPMENT, V127, P1; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wawrzynow A, 1996, MOL MICROBIOL, V21, P895, DOI 10.1046/j.1365-2958.1996.421404.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930	50	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32020	32028		10.1074/jbc.M110.112110	http://dx.doi.org/10.1074/jbc.M110.112110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688913	Green Published, hybrid			2022-12-25	WOS:000282683000015
J	Arias-Romero, LE; Villamar-Cruz, O; Pacheco, A; Kosoff, R; Huang, M; Muthuswamy, SK; Chernoff, J				Arias-Romero, L. E.; Villamar-Cruz, O.; Pacheco, A.; Kosoff, R.; Huang, M.; Muthuswamy, S. K.; Chernoff, J.			A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells	ONCOGENE			English	Article						transformation; small GTPase; protein kinase; ErbB2; signal transduction; breast cancer	REGULATED KINASE; P21-ACTIVATED KINASES; TAMOXIFEN RESISTANCE; ACTIVATION; PROGRESSION; VECTORS; ISOFORM; TARGETS; ERBB2	The activation of receptor tyrosine kinases, particularly ErbB2, has an important role in the genesis of breast cancer. ErbB2 kinase activity promotes Ras-mediated stimulation of downstream protein kinase cascades, including the Ras/Raf-1/MAPK/ERK kinase (Mek)/extra-cellular signal-regulated kinase (Erk) pathway, leading to tumor cell growth and migration. Signaling through the Ras-Erk pathway can be influenced by p21-activated kinase-1 (Pak1), an effector of the Rho family GTPases Rac and Cdc42. In this study, we asked if ErbB2 expression correlates with Pak1 and Erk activity in human breast cancer specimens, and if Pak1 signaling is required for ErbB2 transformation in a three-dimensional (3D) in vitro setting and in xenografts. We found a correlation between ErbB2 expression and activation of Pak in estrogen receptor-positive human breast tumor samples and observed that in 3D cultures, activation of Rac-Pak1 pathway by ErbB2 homodimers induced growth factor-independent proliferation and promoted disruption of 3D mammary acinar-like structures through activation of the Erk and Akt pathways. Further, we found that inhibition of Pak1 by small molecules compromised activation of Erk and Akt, resulting in reversion of the malignant phenotype and restoration of normal acinar architecture. Finally, ErbB2-amplified breast cancer cells expressing a specific Pak inhibitor showed delayed tumor formation and downregulation of Erk and Akt signaling in vivo. These data imply that the Rac-Pak pathway is vital to ErbB2-mediated transformation and that Pak inhibitors represent plausible drug targets in breast cancers in which ErbB2 signaling is activated. Oncogene (2010) 29, 5839-5849; doi: 10.1038/onc.2010.318; published online 16 August 2010	[Arias-Romero, L. E.; Villamar-Cruz, O.; Pacheco, A.; Huang, M.; Chernoff, J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Kosoff, R.] Univ Penn, Canc Biol Program, Philadelphia, PA 19104 USA; [Muthuswamy, S. K.] Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada	Fox Chase Cancer Center; University of Pennsylvania; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Chernoff, J (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014; Muthuswamy, Senthil K/AGY-2834-2022	Chernoff, Jonathan/0000-0002-4803-7836; Muthuswamy, Senthil K/0000-0001-6564-9634; Villamar-Cruz, Olga/0000-0003-4265-9367; Arias-Romero, Luis E./0000-0001-5676-2483	NIH [R01 CA58836, R01 CA098830, P30 CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA058836, R56CA098830, R01CA098830] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dan Kalman (Emory University School of Medicine) and Ariad Pharmaceuticals, for their gifts of pAdlox vectors and AP1510, respectively, and Fang Zhu, of the FCCC Biostatistics Facility, for statistical analysis of TMA and xengraft data. This work was supported by grants from the NIH to JC (R01 CA58836) and SM (R01 CA098830) and to the Fox Chase Cancer Center (P30 CA006927), as well as by an appropriation from the state of Pennsylvania.	Amundadottir LT, 1998, ONCOGENE, V16, P737, DOI 10.1038/sj.onc.1201829; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Li QW, 2008, NEOPLASIA, V10, P314, DOI 10.1593/neo.07970; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; Maksimoska J, 2008, J AM CHEM SOC, V130, P15764, DOI 10.1021/ja805555a; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; Menard RE, 2003, CELL SIGNAL, V15, P1099, DOI 10.1016/S0898-6568(03)00087-1; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Porchia LM, 2007, MOL PHARMACOL, V72, P1124, DOI 10.1124/mol.107.037556; Rayala SK, 2006, CANCER RES, V66, P5985, DOI 10.1158/0008-5472.CAN-06-0978; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; SHALABY MR, 1992, J EXP MED, V175, P217, DOI 10.1084/jem.175.1.217; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; SOULE HD, 1990, CANCER RES, V50, P6075; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Treeck O, 2003, EUR J CANCER, V39, P1302, DOI 10.1016/S0959-8049(02)00777-3; Viaud J, 2009, MOL CANCER THER, V8, P2559, DOI 10.1158/1535-7163.MCT-09-0102; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081	36	69	71	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	43					5839	5849		10.1038/onc.2010.318	http://dx.doi.org/10.1038/onc.2010.318			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	672LY	20711231	Green Accepted			2022-12-25	WOS:000283586200009
J	Briatore, F; Patrizi, A; Viltono, L; Sassoe-Pognetto, M; Wulff, P				Briatore, Federica; Patrizi, Annarita; Viltono, Laura; Sassoe-Pognetto, Marco; Wulff, Peer			Quantitative Organization of GABAergic Synapses in the Molecular Layer of the Mouse Cerebellar Cortex	PLOS ONE			English	Article							GABA(A) RECEPTOR SUBTYPES; INHIBITORY SYNAPTIC CURRENTS; PURKINJE-CELLS; PARALLEL FIBER; STELLATE CELLS; SUBUNIT GENE; SPIKE OUTPUT; LUGARO CELL; A RECEPTORS; RAT	In the cerebellar cortex, interneurons of the molecular layer (stellate and basket cells) provide GABAergic input to Purkinje cells, as well as to each other and possibly to other interneurons. GABAergic inhibition in the molecular layer has mainly been investigated at the interneuron to Purkinje cell synapse. In this study, we used complementary subtractive strategies to quantitatively assess the ratio of GABAergic synapses on Purkinje cell dendrites versus those on interneurons. We generated a mouse model in which the GABA(A) receptor alpha 1 subunit (GABA(A)R alpha 1) was selectively removed from Purkinje cells using the Cre/loxP system. Deletion of the a1 subunit resulted in a complete loss of GABA(A)R aggregates from Purkinje cells, allowing us to determine the density of GABA(A)R clusters in interneurons. In a complementary approach, we determined the density of GABA synapses impinging on Purkinje cells using alpha-dystroglycan as a specific marker of inhibitory postsynaptic sites. Combining these inverse approaches, we found that synapses received by interneurons represent approximately 40% of all GABAergic synapses in the molecular layer. Notably, this proportion was stable during postnatal development, indicating synchronized synaptogenesis. Based on the pure quantity of GABAergic synapses onto interneurons, we propose that mutual inhibition must play an important, yet largely neglected, computational role in the cerebellar cortex.	[Briatore, Federica; Patrizi, Annarita; Viltono, Laura; Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Briatore, Federica; Patrizi, Annarita; Viltono, Laura; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [Wulff, Peer] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Turin; University of Aberdeen	Briatore, F (corresponding author), Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy.	marco.sassoe@unito.it	Sassoe-Pognetto, Marco/AAE-3536-2022	Wulff, Peer/0000-0002-0282-7832; Sassoe-Pognetto, Marco/0000-0001-8906-0613	Compagnia di San Paolo; Regione Piemonte [A218]; Royal Society [RG081195]; Medical Research Council [G0800399]; Fondazione CRT; Italian MUR; Medical Research Council [G0601498] Funding Source: researchfish; MRC [G0800399, G0601498] Funding Source: UKRI	Compagnia di San Paolo(Compagnia di San Paolo); Regione Piemonte(Regione Piemonte); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondazione CRT(Fondazione CRT); Italian MUR(Ministry of Education, Universities and Research (MIUR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Compagnia di San Paolo (2007) and Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata 2006 and 2008) to M. S. P., and grants from The Royal Society (RG081195) and the Medical Research Council (G0800399) to P. W. F. B. received financial support from Fondazione CRT (Progetto Lagrange, Borse di Ricerca bando n. 6, 2007) and the Italian MUR (Assegno di Ricerca, XIII tornata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Benke D, 1996, NEUROPHARMACOLOGY, V35, P1413, DOI 10.1016/S0028-3908(96)00068-8; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chavas J, 2003, J NEUROSCI, V23, P2019; Dean I, 2003, J NEUROSCI, V23, P4457; Dieudonne S, 2000, J NEUROSCI, V20, P1837; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; Eccles JC, 1967, CEREBELLUM NEURONAL; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FOX FA, 1967, PROG BRAIN RES, V25, P174; Fritschy JM, 2006, CEREBELLUM, V5, P275, DOI 10.1080/14734220600962805; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; GAO B, 1993, NEUROSCIENCE, V54, P881, DOI 10.1016/0306-4522(93)90582-Z; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Grady RM, 2006, J NEUROSCI, V26, P2841, DOI 10.1523/JNEUROSCI.4823-05.2006; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Howard CV, 2005, UNBIASED STEREOLOGY; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; Jakovcevski I, 2009, J COMP NEUROL, V513, P496, DOI 10.1002/cne.21981; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; KORBO L, 1993, BRAIN RES, V609, P262, DOI 10.1016/0006-8993(93)90881-M; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Laine J, 2002, NEUROSCIENCE, V115, P363, DOI 10.1016/S0306-4522(02)00421-9; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LLANO I, 1995, J PHYSIOL-LONDON, V486, P163, DOI 10.1113/jphysiol.1995.sp020800; Llinas R.R., 2004, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.003.0007, DOI 10.1093/ACPR0F:0S0/9780195159561.003.0007, DOI 10.1093/ACPROF:OSO/9780195159561.003.0007]; Maex R, 2003, J NEUROSCI, V23, P10503; Maex R, 2005, PROG BRAIN RES, V148, P181, DOI 10.1016/S0079-6123(04)48015-7; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; Nakanishi S, 2005, TRENDS NEUROSCI, V28, P93, DOI 10.1016/j.tins.2004.12.004; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Palay S. L., 1974, CEREBELLAR CORTEX CY; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; PHEND KD, 1992, J HISTOCHEM CYTOCHEM, V40, P1011, DOI 10.1177/40.7.1376741; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; Ramon y Cajal S., 1911, HISTOLOGIE SYSTEME N, VII; Rokni D, 2008, FRONT NEUROSCI-SWITZ, V2, P186, DOI 10.3389/neuro.01.036.2008; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Santamaria F, 2002, J COMPUT NEUROSCI, V13, P217, DOI 10.1023/A:1020266315730; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; Schilling K, 2008, HISTOCHEM CELL BIOL, V130, P601, DOI 10.1007/s00418-008-0483-y; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sillitoe RV, 2008, J NEUROSCI, V28, P2820, DOI 10.1523/JNEUROSCI.4145-07.2008; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Solinas S, 2003, NEUROCOMPUTING, V52-4, P97, DOI 10.1016/S0925-2312(02)00846-9; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Stell BM, 2007, J NEUROSCI, V27, P9022, DOI 10.1523/JNEUROSCI.1954-07.2007; Sultan F, 1998, J COMP NEUROL, V393, P353; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; Viltono L, 2008, J COMP NEUROL, V508, P579, DOI 10.1002/cne.21713; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Yee BK, 2005, P NATL ACAD SCI USA, V102, P17154, DOI 10.1073/pnas.0508752102	69	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12119	10.1371/journal.pone.0012119	http://dx.doi.org/10.1371/journal.pone.0012119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711348	gold, Green Submitted, Green Published			2022-12-25	WOS:000280859700012
J	Meijaard, E; Welsh, A; Ancrenaz, M; Wich, S; Nijman, V; Marshall, AJ				Meijaard, Erik; Welsh, Alan; Ancrenaz, Marc; Wich, Serge; Nijman, Vincent; Marshall, Andrew J.			Declining Orangutan Encounter Rates from Wallace to the Present Suggest the Species Was Once More Abundant	PLOS ONE			English	Article							POPULATION-DENSITY; PONGO-PYGMAEUS; KALIMANTAN; FORESTS; INDONESIA; QUALITY	Background: Bornean orangutans (Pongo pygmaeus) currently occur at low densities and seeing a wild one is a rare event. Compared to present low encounter rates of orangutans, it is striking how many orangutan each day historic collectors like Alfred Russel Wallace were able to shoot continuously over weeks or even months. Does that indicate that some 150 years ago encounter rates with orangutans, or their densities, were higher than now? Methodology/Principal Findings: We test this hypothesis by quantifying encounter rates obtained from hunting accounts, museum collections, and recent field studies, and analysing whether there is a declining trend over time. Logistic regression analyses of our data support such a decline on Borneo between the mid-19th century and the present. Even when controlled for variation in the size of survey and hunting teams and the durations of expeditions, mean daily encounter rates appear to have declined about 6-fold in areas with little or no forest disturbance. Conclusions/Significance: This finding has potential consequences for our understanding of orangutans, because it suggests that Bornean orangutans once occurred at higher densities. We explore potential explanations-habitat loss and degradation, hunting, and disease-and conclude that hunting fits the observed patterns best. This suggests that hunting has been underestimated as a key causal factor of orangutan density and distribution, and that species population declines have been more severe than previously estimated based on habitat loss only. Our findings may require us to rethink the biology of orangutans, with much of our ecological understanding possibly being based on field studies of animals living at lower densities than they did historically. Our approach of quantifying species encounter rates from historic data demonstrates that this method can yield valuable information about the ecology and population density of species in the past, providing new insight into species' conservation needs.	[Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Welsh, Alan] Australian Natl Univ, Inst Math Sci, Ctr Math & Its Applicat, Canberra, ACT, Australia; [Ancrenaz, Marc] Kinabatangan Orangutan Conservat Project, Sandakan, Sabah, Malaysia; [Wich, Serge] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Wich, Serge] Sumatran Orangutan Conservat Programme PanEco YEL, Medan, Sumatra, Indonesia; [Nijman, Vincent] Zool Museum Amsterdam, Amsterdam, Netherlands; [Nijman, Vincent] Oxford Brookes Univ, Sch Social Sci & Law, Dept Geog & Anthropol, Oxford OX3 0BP, England; [Marshall, Andrew J.] Univ Calif Davis, Dept Anthropol, Grad Grp Ecol, Davis, CA 95616 USA; [Marshall, Andrew J.] Univ Calif Davis, Anim Behav Grad Grp, Davis, CA 95616 USA	People & Nature Consulting International; Australian National University; Australian National University; University of Zurich; University of Amsterdam; Oxford Brookes University; University of California System; University of California Davis; University of California System; University of California Davis	Meijaard, E (corresponding author), People & Nat Consulting Int, Jakarta, Indonesia.	emeijaard@pnc-int.com	Nijman, Vincent/AHD-8685-2022; Meijaard, Erik/A-2687-2016	Meijaard, Erik/0000-0001-8685-3685; Nijman, Vincent/0000-0002-5600-4276; Wich, Serge/0000-0003-3954-5174; Welsh, Alan/0000-0002-3165-9559				BANKS E, 1931, J MAL BR AS SOC, V9, P137; Beccari O., 1904, WANDERINGS GREAT FOR; BROOKE J, 1841, P ZOOL SOC LOND, P55; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DAVENPORT RK, 1967, ORYX, V20, P40; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; DeMatteo KE, 2008, BIOL CONSERV, V141, P2494, DOI 10.1016/j.biocon.2008.07.010; DERUITER LC, 1932, UIT BORNEOS WONDERWE; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Hampel F. R., 1986, ROBUST STAT APPROACH; Harrington D, 2000, SERV IND J, V20, P133; Hooijer D. A., 1948, ZOOL MEDEDEEL LEYDEN, V29, P175; Hornaday William Temple, 1885, 2 YEARS JUNGLE EXPER; Hui C, 2006, ECOL MODEL, V192, P317, DOI 10.1016/j.ecolmodel.2005.07.001; Husson Simon J., 2009, P77; Johnson Osa., 1966, LAST ADVENTURE M JOH LAST ADVENTURE M JOH; Knapen Han, 2001, FORESTS FORTUNE ENV, P1600; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lumholtz Carl, 1920, CENTRAL BORNEO ACCOU; MacKinnon Kathy, 1996, ECOLOGY KALIMANTAN I; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall Andrew J., 2009, P311; Marshall Andrew J., 2009, P97; MEIJAARD E, PLOSONE; MEIJAARD E, 2005, RAFFLES B ZOOL, V53, P121; MENGERSEN K, SIGNIFICANC IN PRESS; MOHNICKE O, 1883, BLICKE PFLANZEN THIE; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Rijksen H. D, 1978, THESIS AGR U WAGENIN; Rijksen HD, 1999, OUR VANISHING RELATI; Russon Anne E., 2009, P327; SCHALLER GEORGE B., 1961, ZOOLOGICA [NEW YORK], V46, P73; SELENKA E, 1898, SITZ KONIGL PREUSS A, V16, P1; Singleton I., 2004, ORANGUTAN POPULATION; STEWARTOATEN A, 1995, ECOLOGY, V76, P2001, DOI 10.2307/1940736; Veth P.J., 1854, BORNEOS WESTER AFDEE; WALLACE AR, 1869, MALAY ARCHIPELAGO LA; WECHELTE G, 1911, TROP NAT, V1, P49; WEITZEL V, 1988, Raffles Bulletin of Zoology, V36, P1; Wich S, 2004, PRIMATES, V45, P177, DOI 10.1007/s10329-004-0080-1	43	27	27	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12042	10.1371/journal.pone.0012042	http://dx.doi.org/10.1371/journal.pone.0012042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711451	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000280849100008
J	Moran, AL; Woods, HA				Moran, Amy L.; Woods, H. Arthur			Limits to Diffusive O-2 Transport: Flow, Form, and Function in Nudibranch Egg Masses from Temperate and Polar Regions	PLOS ONE			English	Article							ANTARCTIC SEA-URCHIN; EMBRYONIC-DEVELOPMENT; OPISTHOBRANCH MOLLUSKS; ULTRAVIOLET-RADIATION; OXYGEN AVAILABILITY; AMBYSTOMA-MACULATUM; DEVELOPMENTAL MODE; MARINE GASTROPODS; PACIFIC-OCEAN; CLUTCH SIZE	Background: Many aquatic animals enclose embryos in gelatinous masses, and these embryos rely on diffusion to supply oxygen. Mass structure plays an important role in limiting or facilitating O-2 supply, but external factors such as temperature and photosynthesis can play important roles as well. Other external factors are less well understood. Methodology/Principal Findings: We first explored the effects of water flow on O-2 levels inside nudibranch embryo masses and compared the effects of flow on masses from temperate and polar regions. Water flow (still vs. vigorously bubbled) had a strong effect on central O-2 levels in all masses; in still water, masses were considerably more hypoxic than in bubbled water. This effect was stronger in temperate than in polar masses, likely due to the increased metabolic demand and O-2 consumption of temperate masses. Second, we made what are to our knowledge the first measurements of O-2 in invertebrate masses in the field. Consistent with laboratory experiments, O-2 in Antarctic masses was high in masses in situ, suggesting that boundary-layer effects do not substantially limit O-2 supply to polar embryos in the field. Conclusions/Significance: All else being equal, boundary layers are more likely to depress O-2 in masses in temperate or tropical regions; thus, selection on parents to choose high-flow sites for mass deposition is likely greater in warm water. Because of the large number of variables affecting diffusive O-2 supply to embryos in their natural environment, field observations are necessary to test hypotheses generated from laboratory experiments and mathematical modeling.	[Moran, Amy L.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Woods, H. Arthur] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Clemson University; University of Montana System; University of Montana	Moran, AL (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	moran@clemson.edu	Moran, Amy/F-7072-2011	Moran, Amy/0000-0002-0604-5096	National Science Foundation [ANT-0551969, ANT-0440577]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, Office of Polar Programs (ANT-0551969 to ALM and ANT-0440577 to HAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cancino JM, 2000, MAR ECOL PROG SER, V200, P141, DOI 10.3354/meps200141; CHAFFEE C, 1984, J EXP MAR BIOL ECOL, V84, P73, DOI 10.1016/0022-0981(84)90231-4; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chapelle G, 2004, OIKOS, V106, P167, DOI 10.1111/j.0030-1299.2004.12934.x; Cohen CS, 1996, BIOL BULL, V190, P8, DOI 10.2307/1542671; Fernandez M, 2007, MAR ECOL PROG SER, V348, P229, DOI 10.3354/meps07032; Finelli CM, 2007, MAR ECOL PROG SER, V349, P103, DOI 10.3354/meps07101; Finelli CM, 2006, CORAL REEFS, V25, P47, DOI 10.1007/s00338-005-0055-8; GIORGI AE, 1984, ENVIRON BIOL FISH, V10, P15, DOI 10.1007/BF00001659; Goddard JHR, 2008, VELIGER, V50, P83; Goddard JHR, 2004, CAN J ZOOL, V82, P1954, DOI 10.1139/Z05-008; Lee CE, 1998, AM NAT, V151, P293, DOI 10.1086/286120; Marsh AG, 2000, MAR BIOL, V137, P215, DOI 10.1007/s002270000364; Marsh AG, 1999, J EXP BIOL, V202, P2041; Mills NE, 1999, PHYSIOL BIOCHEM ZOOL, V72, P179, DOI 10.1086/316657; Mitchell NJ, 2003, PHYSIOL BIOCHEM ZOOL, V76, P60, DOI 10.1086/345486; Moran AL, 2007, J EXP BIOL, V210, P722, DOI 10.1242/jeb.02702; PATYLER, GENETICS, V201, P209; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Peck LS, 2002, MAR BIOL, V141, P271, DOI 10.1007/s00227-002-0834-5; PINDER AW, 1994, J EXP BIOL, V197, P17; PINHEIRO JC, 2000, SPRINGER; PO R, 2007, SCIENCES, V362, P2233; Przeslawski R, 2004, MAR ECOL PROG SER, V268, P151, DOI 10.3354/meps268151; RAWLINGS TA, 1994, EVOLUTION, V48, P1301, DOI 10.1111/j.1558-5646.1994.tb05314.x; Rawlings TA, 1996, MAR ECOL PROG SER, V136, P81, DOI 10.3354/meps136081; Rawlings TA, 1999, AM ZOOL, V39, P230; Steer MA, 2007, REV FISH BIOL FISHER, V17, P173, DOI 10.1007/s11160-006-9023-9; STRATHMANN MF, 1987, METHODS, P670; Strathmann RR, 2006, POLAR BIOL, V29, P495, DOI 10.1007/s00300-005-0080-7; STRATHMANN RR, 1984, J EXP MAR BIOL ECOL, V84, P85, DOI 10.1016/0022-0981(84)90232-6; STRATHMANN RR, 1995, J MAR BIOL ASSOC UK, V75, P413, DOI 10.1017/S0025315400018270; STRATHMANN RR, 1989, CONSTRAINTS; Thompson TE., 1976, BIOL OPISTHOBRANCH M, V1; Valls JH, 2007, J EXP BIOL, V210, P2430, DOI 10.1242/jeb.003541; von Dassow YJ, 2005, MAR ECOL PROG SER, V294, P23, DOI 10.3354/meps294023; Woods HA, 2008, J EXP BIOL, V211, P798, DOI 10.1242/jeb.014621; Woods HA, 2008, J EXP BIOL, V211, P790, DOI 10.1242/jeb.014613; Woods HA, 2007, BIOL BULL-US, V213, P88, DOI 10.2307/25066621; WOODS HA, 2009, SCIENCES, V276, P1069	40	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12113	10.1371/journal.pone.0012113	http://dx.doi.org/10.1371/journal.pone.0012113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711406	Green Submitted, gold, Green Published			2022-12-25	WOS:000280849100028
J	Politis, A; Park, AY; Hyung, SJ; Barsky, D; Ruotolo, BT; Robinson, CV				Politis, Argyris; Park, Ah Young; Hyung, Suk-Joon; Barsky, Daniel; Ruotolo, Brandon T.; Robinson, Carol V.			Integrating Ion Mobility Mass Spectrometry with Molecular Modelling to Determine the Architecture of Multiprotein Complexes	PLOS ONE			English	Article							DNA-POLYMERASE-III; INTACT PROTEIN COMPLEXES; N-TERMINAL DOMAIN; SUBUNIT ARCHITECTURE; CRYSTAL-STRUCTURE; SLIDING-CLAMP; HELICASE; HOLOENZYME; PEPTIDES; DYNAMICS	Current challenges in the field of structural genomics point to the need for new tools and technologies for obtaining structures of macromolecular protein complexes. Here, we present an integrative computational method that uses molecular modelling, ion mobility-mass spectrometry (IM-MS) and incomplete atomic structures, usually from X-ray crystallography, to generate models of the subunit architecture of protein complexes. We begin by analyzing protein complexes using IM-MS, and by taking measurements of both intact complexes and sub-complexes that are generated in solution. We then examine available high resolution structural data and use a suite of computational methods to account for missing residues at the subunit and/or domain level. High-order complexes and sub-complexes are then constructed that conform to distance and connectivity constraints imposed by IM-MS data. We illustrate our method by applying it to multimeric protein complexes within the Escherichia coli replisome: the sliding clamp, (beta(2)), the c complex (gamma(3)delta delta'), the DnaB helicase (DnaB(6)) and the Single-Stranded Binding Protein (SSB(4)).	[Politis, Argyris; Park, Ah Young; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford, England; [Hyung, Suk-Joon; Barsky, Daniel] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Ruotolo, Brandon T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Oxford; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Michigan System; University of Michigan	Politis, A (corresponding author), Univ Oxford, Dept Chem, Oxford, England.	carol.robinson@chem.ox.ac.uk	Politis, Argyris/R-4333-2019; Hyung, Suk-Joon/N-6449-2014; Ruotolo, Brandon/F-2669-2013	Hyung, Suk-Joon/0000-0001-6759-4219; Ruotolo, Brandon/0000-0002-6084-2328; Park, Ahyoung/0000-0002-5212-4369; robinson, carol/0000-0001-7829-5505	British Biotechnology and Biological Sciences Research Council [BB/G000360/1]; BBSRC [BB/G000360/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G000360/1] Funding Source: researchfish	British Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the British Biotechnology and Biological Sciences Research Council. Grant Reference: BB/G000360/1. URL: http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Baumketner A, 2006, PROTEIN SCI, V15, P1239, DOI 10.1110/ps.062076806; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Clemmer DE, 1997, J MASS SPECTROM, V32, P577; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; Fass D, 1999, STRUCTURE, V7, P691, DOI 10.1016/S0969-2126(99)80090-2; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hoaglund-Hyzer CS, 1999, CHEM REV, V99, P3037, DOI 10.1021/cr980139g; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Jarrold MF, 2000, ANNU REV PHYS CHEM, V51, P179, DOI 10.1146/annurev.physchem.51.1.179; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Kinnear BS, 2002, J AM CHEM SOC, V124, P4422, DOI 10.1021/ja012150v; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Korkut A, 2009, P NATL ACAD SCI USA, V106, P15673, DOI 10.1073/pnas.0907684106; Korkut A, 2009, P NATL ACAD SCI USA, V106, P15667, DOI 10.1073/pnas.0907674106; Kundu S, 2004, PROTEINS, V57, P725, DOI 10.1002/prot.20268; Kundu S, 2002, BIOPHYS J, V83, P723, DOI 10.1016/S0006-3495(02)75203-X; Lane LA, 2009, INT J MASS SPECTROM, V283, P169, DOI 10.1016/j.ijms.2009.03.006; Leary JA, 2009, J AM SOC MASS SPECTR, V20, P1699, DOI 10.1016/j.jasms.2009.05.003; Loo JA, 2005, J AM SOC MASS SPECTR, V16, P998, DOI 10.1016/j.jasms.2005.02.017; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; Matsumoto T, 2000, J BIOCHEM, V127, P329, DOI 10.1093/oxfordjournals.jbchem.a022611; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; O'Donnell M, 2006, CURR OPIN STRUC BIOL, V16, P35, DOI 10.1016/j.sbi.2005.12.004; Oakley AJ, 2003, ACTA CRYSTALLOGR D, V59, P1192, DOI 10.1107/S0907444903009958; Park AY, 2010, STRUCTURE, V18, P285, DOI 10.1016/j.str.2010.01.009; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Pukala TL, 2009, STRUCTURE, V17, P1235, DOI 10.1016/j.str.2009.07.013; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2007, ANGEW CHEM INT EDIT, V46, P8001, DOI 10.1002/anie.200702161; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Smith DP, 2009, EUR J MASS SPECTROM, V15, P113, DOI 10.1255/ejms.947; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; van Duijn E, 2009, J AM CHEM SOC, V131, P1452, DOI 10.1021/ja8055134; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Weigelt J, 1999, STRUCT FOLD DES, V7, P681, DOI 10.1016/S0969-2126(99)80089-6; Wijffels G, 2004, BIOCHEMISTRY-US, V43, P5661, DOI 10.1021/bi036229j; Wyttenbach T, 2007, ANNU REV PHYS CHEM, V58, P511, DOI 10.1146/annurev.physchem.58.032806.104515; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	50	108	108	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12080	10.1371/journal.pone.0012080	http://dx.doi.org/10.1371/journal.pone.0012080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711472	Green Submitted, Green Published, gold			2022-12-25	WOS:000280811900024
J	Hong, YJ; Marjoram, P; Shibata, D; Siegmund, KD				Hong, You Jin; Marjoram, Paul; Shibata, Darryl; Siegmund, Kimberly D.			Using DNA Methylation Patterns to Infer Tumor Ancestry	PLOS ONE			English	Article							COLORECTAL CANCERS; EVOLUTION	Background: Exactly how human tumors grow is uncertain because serial observations are impractical. One approach to reconstruct the histories of individual human cancers is to analyze the current genomic variation between its cells. The greater the variations, on average, the greater the time since the last clonal evolution cycle ("a molecular clock hypothesis''). Here we analyze passenger DNA methylation patterns from opposite sides of 12 primary human colorectal cancers (CRCs) to evaluate whether the variation (pairwise distances between epialleles) is consistent with a single clonal expansion after transformation. Methodology/Principal Findings: Data from 12 primary CRCs are compared to epigenomic data simulated under a single clonal expansion for a variety of possible growth scenarios. We find that for many different growth rates, a single clonal expansion can explain the population variation in 11 out of 12 CRCs. In eight CRCs, the cells from different glands are all equally distantly related, and cells sampled from the same tumor half appear no more closely related than cells sampled from opposite tumor halves. In these tumors, growth appears consistent with a single "symmetric'' clonal expansion. In three CRCs, the variation in epigenetic distances was different between sides, but this asymmetry could be explained by a single clonal expansion with one region of a tumor having undergone more cell division than the other. The variation in one CRC was complex and inconsistent with a simple single clonal expansion. Conclusions: Rather than a series of clonal expansion after transformation, these results suggest that the epigenetic variation of present-day cancer cells in primary CRCs can almost always be explained by a single clonal expansion.	[Hong, You Jin; Marjoram, Paul; Siegmund, Kimberly D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Shibata, Darryl] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Hong, YJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	kims@usc.edu			National Cancer Institute (NCI) [2R01 CA097346]; NATIONAL CANCER INSTITUTE [R21CA149990, R01CA097346] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) grant number 2R01 CA097346. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617; Anderson A., 2007, SINGLE CELL BASED MO; Beaumont MA, 2002, GENETICS, V162, P2025; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; Gerlee P, 2009, J THEOR BIOL, V259, P67, DOI 10.1016/j.jtbi.2009.03.005; Lacey MR, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1489; Nicolas P, 2007, PLOS COMPUT BIOL, V3, P364, DOI 10.1371/journal.pcbi.0030028; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Siegmund KD, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1374; Siegmund KD, 2009, CELL CYCLE, V8, P2187, DOI 10.4161/cc.8.14.9151; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998	13	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12002	10.1371/journal.pone.0012002	http://dx.doi.org/10.1371/journal.pone.0012002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711251	Green Published, gold, Green Submitted			2022-12-25	WOS:000280776800004
J	Johannesson, K; Saltin, SH; Duranovic, I; Havenhand, JN; Jonsson, PR				Johannesson, Kerstin; Saltin, Sara H.; Duranovic, Iris; Havenhand, Jon N.; Jonsson, Per R.			Indiscriminate Males: Mating Behaviour of a Marine Snail Compromised by a Sexual Conflict?	PLOS ONE			English	Article							LITTORINA-SAXATILIS OLIVI; INTERTIDAL SNAIL; EVOLUTION; PROSOBRANCHIA; DISCRIMINATION; POLYMORPHISM; DAMSELFLIES; POLYANDRY; PREDATION; SELECTION	Background: In promiscuous species, male fitness is expected to increase with repeated matings in an open-ended fashion (thereby increasing number of partners or probability of paternity) whereas female fitness should level out at some optimal number of copulations when direct and indirect benefits still outweigh the costs of courtship and copulation. After this fitness peak, additional copulations would incur female fitness costs and be under opposing selection. Hence, a sexual conflict over mating frequency may evolve in species where females are forced to engage in costly matings. Under such circumstance, if females could avoid male detection, significant fitness benefits from such avoidance strategies would be predicted. Methodology/Principal Findings: Among four Littorina species, one lives at very much higher densities and has a longer mating season than the other three species. Using video records of snail behaviour in a laboratory arena we show that males of the low-density species discriminate among male and female mucous trails, trailing females for copulations. In the high-density species, however, males fail to discriminate between male and female trails, not because males are unable to identify female trails (which we show using heterospecific females), but because females do not, as the other species, add a gender-specific cue to their trail. Conclusions/Significance: We conclude that there is likely a sexual conflict over mating frequency in the high-density species (L. saxatilis) owing to females most likely being less sperm-limited in this species. This has favoured the evolution of females that permanently or optionally do not release a cue in the mucus to decrease excessive and costly matings resulting in unusually high frequencies of male-male copulating attempts in the wild. This is one of few examples of masking gender identity to obtain fewer matings.	[Johannesson, Kerstin; Saltin, Sara H.; Duranovic, Iris; Havenhand, Jon N.; Jonsson, Per R.] Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden	University of Gothenburg	Johannesson, K (corresponding author), Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden.	Kerstin.Johannesson@marecol.gu.se	Jonsson, Per R/E-6707-2013; Johannesson, Kerstin/B-5528-2013; Johannesson, Kerstin/X-7994-2019; Havenhand, Jon N/F-5435-2013	Johannesson, Kerstin/0000-0003-0176-7986; Johannesson, Kerstin/0000-0003-0176-7986; Havenhand, Jon N/0000-0003-0253-3428; Havenhand, Jonathan/0000-0001-6721-7763; Jonsson, Per/0000-0002-1793-5473	Swedish Research Councils	Swedish Research Councils(Swedish Research Council)	This study was performed at the Linnaeus Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu/) and supported by grants from the Swedish Research Councils (VR and Formas) to KJ, JNH and PRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres JA, 2002, ANIM BEHAV, V63, P677, DOI 10.1006/anbe.2001.1948; Arnqvist G, 2002, EVOLUTION, V56, P936; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Buschbaum C, 1999, HELGOLAND MAR RES, V53, P56, DOI 10.1007/PL00012138; Byrne PG, 2009, P R SOC B, V276, P115, DOI 10.1098/rspb.2008.0794; Clifford KT, 2003, BEHAV NEUROSCI, V117, P1086, DOI 10.1037/0735-7044.117.5.1086; Cordero A, 1998, ANIM BEHAV, V55, P185, DOI 10.1006/anbe.1997.0603; CROLL RP, 1983, BIOL REV, V58, P293, DOI 10.1111/j.1469-185X.1983.tb00391.x; Davies MS, 2007, P ROY SOC B-BIOL SCI, V274, P1233, DOI 10.1098/rspb.2007.0046; DAVIES MS, 1992, P 3 INT S LITT BIOL, P221; ERLANDSSON J, 1995, MAR BIOL, V122, P87, DOI 10.1007/BF00349281; Erlandsson J, 2002, INVERTEBR REPROD DEV, V41, P53, DOI 10.1080/07924259.2002.9652735; Fox CW, 2003, EVOL ECOL RES, V5, P273; Gaylord B, 1999, J EXP MAR BIOL ECOL, V239, P85, DOI 10.1016/S0022-0981(99)00031-3; Hanlon RT, 2005, NATURE, V433, P212, DOI 10.1038/433212a; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Hollander J, 2005, ANIM BEHAV, V70, P1209, DOI 10.1016/j.anbehav.2005.03.014; JANSON K, 1982, J MOLLUS STUD, V48, P167; JOHANNESSON B, 1986, J EXP MAR BIOL ECOL, V102, P183, DOI 10.1016/0022-0981(86)90175-9; Johannesson K, 2008, EVOLUTION, V62, P3178, DOI 10.1111/j.1558-5646.2008.00510.x; Kemppainen P, 2005, OECOLOGIA, V143, P402, DOI 10.1007/s00442-004-1819-5; Koch N, 2007, INVERTEBR BIOL, V126, P257, DOI 10.1111/j.1744-7410.2007.00095.x; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; RAFFAELLI D G, 1977, Veliger, V20, P75; Reid 0. G., 1986, LITTORINID MOLLUSCS; Reid DG, 1996, SYSTEMATICS EVOLUTIO, P463; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Saetre GP, 1996, AM NAT, V147, P981, DOI 10.1086/285889; Sarhan A, 2007, EVOLUTION, V61, P606, DOI 10.1111/j.1558-5646.2007.00053.x; SAUR M, 1990, DEV HYDROB, V56, P261, DOI 10.1007/BF00028082; Sirot LK, 2003, ANIM BEHAV, V66, P763, DOI 10.1006/anbe.2003.2279; Struhsaker J. W., 1966, Proceedings of the Malacological Society of London, V37, P137; Takeichi M, 2007, J MOLLUS STUD, V73, P275, DOI 10.1093/mollus/eym027; Winnepenninckx B, 1998, MOL PHYLOGENET EVOL, V9, P55, DOI 10.1006/mpev.1997.0439	37	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12005	10.1371/journal.pone.0012005	http://dx.doi.org/10.1371/journal.pone.0012005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711254	gold, Green Published			2022-12-25	WOS:000280776800006
J	O'Connell, RM; Balazs, AB; Rao, DS; Kivork, C; Yang, LL; Baltimore, D				O'Connell, Ryan M.; Balazs, Alejandro B.; Rao, Dinesh S.; Kivork, Christine; Yang, Lili; Baltimore, David			Lentiviral Vector Delivery of Human Interleukin-7 (hIL-7) to Human Immune System (HIS) Mice Expands T Lymphocyte Populations	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VIVO; GENE DELIVERY; SCID MICE; IL-7; HOMEOSTASIS; BLOOD; NAIVE; PROLIFERATION; TRANSDUCTION	Genetically modified mice carrying engrafted human tissues provide useful models to study human cell biology in physiologically relevant contexts. However, there remain several obstacles limiting the compatibility of human cells within their mouse hosts. Among these is inadequate cross-reactvitiy between certain mouse cytokines and human cellular receptors, depriving the graft of important survival and growth signals. To circumvent this problem, we utilized a lentivirus-based delivery system to express physiologically relevant levels of human interleukin-7 (hIL-7) in Rag2-/-gamma c-/-mice following a single intravenous injection. hIL-7 promoted homeostatic proliferation of both adoptively transferred and endogenously generated T-cells in Rag2-/-gamma c-/-Human Immune System (HIS) mice. Interestingly, we found that hIL-7 increased T lymphocyte numbers in the spleens of HIV infected HIS mice without affecting viral load. Taken together, our study unveils a versatile approach to deliver human cytokines to HIS mice, to both improve engraftment and determine the impact of cytokines on human diseases.	[O'Connell, Ryan M.; Balazs, Alejandro B.; Rao, Dinesh S.; Kivork, Christine; Yang, Lili; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	O'Connell, RM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	liyang@caltech.edu; baltimo@caltech.edu	Rao, Dinesh/AAE-9625-2019; Rao, Dinesh/ABG-1257-2021	Rao, Dinesh/0000-0002-0794-9337; Balazs, Alejandro/0000-0002-1767-3944	Bill and Melinda Gates Foundation (Seattle, WA) [37866]; National Heart, Lung and Blood Institute [K99HL102228]; amfAR fellowship [107756-47-RFVA]; NATIONAL CANCER INSTITUTE [K08CA133521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL102228] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation (Seattle, WA)(Bill & Melinda Gates Foundation); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); amfAR fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Bill and Melinda Gates Foundation (Seattle, WA) through the Grand Challenges in Global Health Initiative (awarded to D.B.) Grand Challenge Grant #37866 (http://www.grandchallenges.org/Pages/default.aspx). R.M.O. was funded by award number K99HL102228 from the National Heart, Lung and Blood Institute (http://www.nhlbi.nih.gov/). A.B.B. is supported by amfAR fellowship #107756-47-RFVA (http://www.amfar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; BOCK TA, 1995, J EXP MED, V182, P2037, DOI 10.1084/jem.182.6.2037; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; van Lent AU, 2009, J IMMUNOL, V183, P7645, DOI 10.4049/jimmunol.0902019; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	29	43	53	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12009	10.1371/journal.pone.0012009	http://dx.doi.org/10.1371/journal.pone.0012009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700454	gold, Green Published, Green Accepted			2022-12-25	WOS:000280687900009
J	Hayman, DTS; Emmerich, P; Yu, M; Wang, LF; Suu-Ire, R; Fooks, AR; Cunningham, AA; Wood, JLN				Hayman, David T. S.; Emmerich, Petra; Yu, Meng; Wang, Lin-Fa; Suu-Ire, Richard; Fooks, Anthony R.; Cunningham, Andrew A.; Wood, James L. N.			Long-Term Survival of an Urban Fruit Bat Seropositive for Ebola and Lagos Bat Viruses	PLOS ONE			English	Article							RABIES; PREVALENCE; MARBURG; ANTIBODIES	Ebolaviruses (EBOV) (family Filoviridae) cause viral hemorrhagic fevers in humans and non-human primates when they spill over from their wildlife reservoir hosts with case fatality rates of up to 90%. Fruit bats may act as reservoirs of the Filoviridae. The migratory fruit bat, Eidolon helvum, is common across sub-Saharan Africa and lives in large colonies, often situated in cities. We screened sera from 262 E. helvum using indirect fluorescent tests for antibodies against EBOV subtype Zaire. We detected a seropositive bat from Accra, Ghana, and confirmed this using western blot analysis. The bat was also seropositive for Lagos bat virus, a Lyssavirus, by virus neutralization test. The bat was fitted with a radio transmitter and was last detected in Accra 13 months after release post-sampling, demonstrating long-term survival. Antibodies to filoviruses have not been previously demonstrated in E. helvum. Radio-telemetry data demonstrates long-term survival of an individual bat following exposure to viruses of families that can be highly pathogenic to other mammal species. Because E. helvum typically lives in large urban colonies and is a source of bushmeat in some regions, further studies should determine if this species forms a reservoir for EBOV from which spillover infections into the human population may occur.	[Hayman, David T. S.; Wood, James L. N.] Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England; [Hayman, David T. S.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Hayman, David T. S.; Fooks, Anthony R.] Vet Labs Agcy, Rabies & Wildlife Zoonoses Grp, Weybridge, Surrey, England; [Emmerich, Petra] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Yu, Meng; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Suu-Ire, Richard] Ghana Forestry Commiss, Wildlife Div, Accra, Ghana; [Fooks, Anthony R.] Univ Liverpool, Natl Ctr Zoonoses Res, Liverpool L69 3BX, Merseyside, England	University of Cambridge; Zoological Society of London; Veterinary Laboratories Agency; Bernhard Nocht Institut fur Tropenmedizin; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Liverpool	Hayman, DTS (corresponding author), Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England.	dtsh2@cam.ac.uk	Cunningham, Andrew A/E-7536-2010; Wood, James/A-1626-2008; Fooks, Anthony R/F-5418-2010; wang, lin/GSE-3040-2022	Wood, James/0000-0002-0258-3188; Wang, Lin-Fa/0000-0003-2752-0535; Hayman, David/0000-0003-0087-3015	The Wellcome Trust, Defra [VT0105]; Science and Technology Directorate, Department of Homeland Security; The Lubee Foundation; UK Department for Environment, Food and Rural Affairs (Defra) [SEV3500]	The Wellcome Trust, Defra(Department for Environment, Food & Rural Affairs (DEFRA)Wellcome Trust); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); The Lubee Foundation; UK Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA))	The Wellcome Trust, Defra grant VT0105, Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, and The Lubee Foundation Luis F. Bacardi Bat Conservation and Research Fund supported the study. A.R.F. was funded by the UK Department for Environment, Food and Rural Affairs (Defra) by grant SEV3500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARANGA J, 1980, AFRICAN J ECOLOGY, V20, P223; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; DEFREES SL, 1988, MAMMAL SPECIES, V312, P1, DOI DOI 10.2307/3504095; Dimitrov DT, 2007, J THEOR BIOL, V245, P498, DOI 10.1016/j.jtbi.2006.11.001; Feller MJ, 1997, J AM VET MED ASSOC, V210, P195; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Kuzmin IV, 2008, J CLIN MICROBIOL, V46, P1451, DOI 10.1128/JCM.00016-08; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; LEROY EM, 2009, VECTOR BORNE ZOONOTI; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; PRICE JL, 1977, J WILDLIFE DIS, V13, P131, DOI 10.7589/0090-3558-13.2.131; Richter HV, 2006, J ZOOL, V268, P35, DOI 10.1111/j.1469-7998.2005.00020.x; STEECE R, 1989, J WILDLIFE DIS, V25, P490, DOI 10.7589/0090-3558-25.4.490; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; THOMAS DW, 1983, CAN J ZOOL, V61, P2266, DOI 10.1139/z83-299; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; VANDERGROEN G, 1983, LANCET, V1, P654; WACHARAPLUESADE.S, 2009, VECTOR BORNE ZOONOTI; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wang LF, 1997, ARCH VIROL, V142, P2269, DOI 10.1007/s007050050241	22	106	116	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11978	10.1371/journal.pone.0011978	http://dx.doi.org/10.1371/journal.pone.0011978			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694141	gold, Green Submitted, Green Published			2022-12-25	WOS:000280574300018
J	Lopez, LC; Quinzii, CM; Area, E; Naini, A; Rahman, S; Schuelke, M; Salviati, L; DiMauro, S; Hirano, M				Lopez, Luis C.; Quinzii, Catarina M.; Area, Estela; Naini, Ali; Rahman, Shamima; Schuelke, Markus; Salviati, Leonardo; DiMauro, Salvatore; Hirano, Michio			Treatment of CoQ(10) Deficient Fibroblasts with Ubiquinone, CoQ Analogs, and Vitamin C: Time- and Compound-Dependent Effects	PLOS ONE			English	Article							COENZYME Q(10) DEFICIENCY; DIPHOSPHATE SYNTHASE SUBUNIT-2; RESPIRATORY-CHAIN DYSFUNCTION; MITOCHONDRIAL COMPLEX I; FRIEDREICH ATAXIA; CEREBELLAR-ATAXIA; OXIDATIVE STRESS; MUTATIONS; MUTANTS; NEPHROPATHY	Background: Coenzyme Q(10) (CoQ(10)) and its analogs are used therapeutically by virtue of their functions as electron carriers, antioxidant compounds, or both. However, published studies suggest that different ubiquinone analogs may produce divergent effects on oxidative phosphorylation and oxidative stress. Methodology/Principal Findings: To test these concepts, we have evaluated the effects of CoQ(10), coenzyme Q(2) (CoQ(2)), idebenone, and vitamin C on bioenergetics and oxidative stress in human skin fibroblasts with primary CoQ(10) deficiency. A final concentration of 5 mu M of each compound was chosen to approximate the plasma concentration of CoQ(10) of patients treated with oral ubiquinone. CoQ(10) supplementation for one week but not for 24 hours doubled ATP levels and ATP/ADP ratio in CoQ(10) deficient fibroblasts therein normalizing the bioenergetics status of the cells. Other compounds did not affect cellular bioenergetics. In COQ2 mutant fibroblasts, increased superoxide anion production and oxidative stress-induced cell death were normalized by all supplements. Conclusions/Significance: These results indicate that: 1) pharmacokinetics of CoQ(10) in reaching the mitochondrial respiratory chain is delayed; 2) short-tail ubiquinone analogs cannot replace CoQ(10) in the mitochondrial respiratory chain under conditions of CoQ(10) deficiency; and 3) oxidative stress and cell death can be counteracted by administration of lipophilic or hydrophilic antioxidants. The results of our in vitro experiments suggest that primary CoQ(10) deficiencies should be treated with CoQ(10) supplementation but not with short-tail ubiquinone analogs, such as idebenone or CoQ(2). Complementary administration of antioxidants with high bioavailability should be considered if oxidative stress is present.	[Lopez, Luis C.; Quinzii, Catarina M.; Area, Estela; Naini, Ali; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA; [Rahman, Shamima] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Schuelke, Markus] Charite Virchow Univ Hosp, Dept Neuropediat, Berlin, Germany; [Salviati, Leonardo] Univ Padua, Dept Pediat, Serv Genet Clin & Epidemiol, Padua, Italy	Columbia University; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Padua	Lopez, LC (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA.	mh29@columbia.edu	Rahman, Shamima/M-7904-2019; Salviati, Leonardo/L-1007-2016; Lopez, Luis Carlos/L-5129-2014; Lopez, Luis Carlos/AAP-9411-2020; Rahman, Shamima/C-5232-2008	Salviati, Leonardo/0000-0001-5642-9963; Lopez, Luis Carlos/0000-0003-3355-0298; Lopez, Luis Carlos/0000-0003-3355-0298; Rahman, Shamima/0000-0003-2088-730X; Schuelke, Markus/0000-0003-2824-3891; Area, Estela/0000-0002-0962-1570	U.S. National Institutes of Health (NIH) [HD32062, NS11766]; Muscular Dystrophy Association (MDA); Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF); Ministerio de Educacion y Ciencia, Spain; Telethon [GGP09207]; MRC [G0200335] Funding Source: UKRI; Medical Research Council [G0200335] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1220] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057543, P01HD032062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, P01NS011766] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF); Ministerio de Educacion y Ciencia, Spain(Spanish Government); Telethon(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health (NIH) grants HD32062 and NS11766, by grants from the Muscular Dystrophy Association (MDA), and by the Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF). LCL was supported by a post-doctoral fellowship from the Ministerio de Educacion y Ciencia, Spain. CMQ is supported by the MDA. LS is supported by Telethon grant GGP09207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aure K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2; Beal F, 2004, METHOD ENZYMOL, V382, P473; Bentinger M, 2003, FREE RADICAL BIO MED, V34, P563, DOI 10.1016/S0891-5849(02)01357-6; Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; Blanchard-Fillion B, 2006, J NEUROSCI, V26, P6124, DOI 10.1523/JNEUROSCI.1038-06.2006; CORNELL BA, 1987, BIOCHEMISTRY-US, V26, P7702, DOI 10.1021/bi00398a025; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Esposti MD, 1996, ARCH BIOCHEM BIOPHYS, V330, P395, DOI 10.1006/abbi.1996.0267; Esposti MD, 1996, BIOCHEM J, V313, P327, DOI 10.1042/bj3130327; Fato R, 2009, BBA-BIOENERGETICS, V1787, P384, DOI 10.1016/j.bbabio.2008.11.003; Ferrante KL, 2005, NEUROLOGY, V65, P1834, DOI 10.1212/01.wnl.0000187070.35365.d7; Geromel V, 2002, MOL GENET METAB, V77, P21, DOI 10.1016/S1096-7192(02)00145-2; Gille L, 2008, BIOCHEM PHARMACOL, V76, P289, DOI 10.1016/j.bcp.2008.04.003; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Kaufmann P, 2009, ANN NEUROL, V66, P235, DOI 10.1002/ana.21743; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317; Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC; LENAZ G, 1992, BIOCHEM CELL BIOL, V70, P504, DOI 10.1139/o92-078; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; Mancuso M, 2010, CURR DRUG TARGETS, V11, P111, DOI 10.2174/138945010790031018; Miles MV, 2007, MITOCHONDRION, V7, pS72, DOI 10.1016/j.mito.2007.02.012; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582; Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; QUINZII CM, 2010, FASEB J IN PRESS; Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Saiki R, 2008, AM J PHYSIOL-RENAL, V295, pF1535, DOI 10.1152/ajprenal.90445.2008; Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7; Santos-Ocana C, 2002, J BIOL CHEM, V277, P10973, DOI 10.1074/jbc.M112222200; Schulz JB, 2009, J NEUROL, V256, P42, DOI 10.1007/s00415-009-1008-x; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; SODERBERG K, 1980, J CELL PHYSIOL, V103, P169, DOI 10.1002/jcp.1041030121; Takahashi M, 2008, MECH AGEING DEV, V129, P291, DOI 10.1016/j.mad.2008.01.008; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473	52	81	83	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11897	10.1371/journal.pone.0011897	http://dx.doi.org/10.1371/journal.pone.0011897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689595	Green Published, gold			2022-12-25	WOS:000280520300012
J	Thrush, SF; Hewitt, JE; Cummings, VJ; Norkko, A; Chiantore, M				Thrush, Simon F.; Hewitt, Judi E.; Cummings, Vonda J.; Norkko, Alf; Chiantore, Mariachiara			beta-Diversity and Species Accumulation in Antarctic Coastal Benthos: Influence of Habitat, Distance and Productivity on Ecological Connectivity	PLOS ONE			English	Article							LATITUDINAL GRADIENTS; MCMURDO SOUND; PATTERNS; BIODIVERSITY; SCALE; RESILIENCE; RICHNESS; HOMOGENIZATION; VARIABILITY; RECRUITMENT	High Antarctic coastal marine environments are comparatively pristine with strong environmental gradients, which make them important places to investigate biodiversity relationships. Defining how different environmental features contribute to shifts in beta-diversity is especially important as these shifts reflect both spatio-temporal variations in species richness and the degree of ecological separation between local and regional species pools. We used complementary techniques (species accumulation models, multivariate variance partitioning and generalized linear models) to assess how the roles of productivity, bio-physical habitat heterogeneity and connectivity change with spatial scales from metres to 100's of km. Our results demonstrated that the relative importance of specific processes influencing species accumulation and beta-diversity changed with increasing spatial scale, and that patterns were never driven by only one factor. Bio-physical habitat heterogeneity had a strong influence on beta-diversity at scales <290 km, while the effects of productivity were low and significant only at scales >40 km. Our analysis supports the emphasis on the analysis of diversity relationships across multiple spatial scales and highlights the unequal connectivity of individual sites to the regional species pool. This has important implications for resilience to habitat loss and community homogenisation, especially for Antarctic benthic communities where rates of recovery from disturbance are slow, there is a high ratio of poor-dispersing and brooding species, and high biogenic habitat heterogeneity and spatio-temporal variability in primary production make the system vulnerable to disturbance. Consequently, large areas need to be included within marine protected areas for effective management and conservation of these special ecosystems in the face of increasing anthropogenic disturbance.	[Thrush, Simon F.; Hewitt, Judi E.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [Thrush, Simon F.; Chiantore, Mariachiara] Univ Genoa, DipTeRis, Genoa, Italy; [Cummings, Vonda J.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Norkko, Alf] Finnish Environm Inst SYKE, Ctr Marine Res, Helsinki, Finland; [Norkko, Alf] Univ Gothenburg, Dept Marine Ecol Kristineberg, Fiskebackskil, Sweden	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Genoa; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Finnish Environment Institute; University of Gothenburg	Thrush, SF (corresponding author), Natl Inst Water & Atmospher Res, Hamilton, New Zealand.	s.thrush@niwa.cri.nz	Norkko, Alf/K-2341-2019; Norkko, Alf/A-1856-2012; Norkko, Alf/L-8736-2019; Chiantore, Mariachiara/C-7070-2017	Norkko, Alf/0000-0002-9741-4458; Norkko, Alf/0000-0002-9741-4458; Chiantore, Mariachiara/0000-0002-5862-1470; Cummings, Vonda/0000-0003-1076-3995; Thrush, Simon/0000-0002-4005-3882	New Zealand Ministry of Fisheries [ZBD2001/02, ZBD2002/01, ZBD2006/03]; National Institute of Water and Atmospheric Research; NZ Foundation for Research Science and Technology [COX01707]; Marie Curie International Incoming Fellowship [FP7-PEOPLE-2007-4-2-IIF-ENV221065]	New Zealand Ministry of Fisheries; National Institute of Water and Atmospheric Research; NZ Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Marie Curie International Incoming Fellowship(European Commission)	This work has been funded by the New Zealand Ministry of Fisheries (ZBD2001/02, ZBD2002/01 and ZBD2006/03), National Institute of Water and Atmospheric Research-Non-Specific Output Funding and the NZ Foundation for Research Science and Technology International Polar Year project COX01707. Write up was partially funded by Marie Curie International Incoming Fellowship (FP7-PEOPLE-2007-4-2-IIF-ENV221065) to SFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Barnes DKA, 2007, PHILOS T R SOC B, V362, P11, DOI 10.1098/rstb.2006.1951; BARRY JP, 1988, POLAR BIOL, V8, P377, DOI 10.1007/BF00442029; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; BELL SS, 1991, HABITAT STRUCTURE PH; BELSLEY D. A, 1980, REGRESSION DIAGNOSTI; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Clarke K.R, 2006, PRIMER V6 USER MANUA; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cottenie K, 2004, ECOLOGY, V85, P114, DOI 10.1890/03-3004; Crawley M.J., 1993, GLIM ECOLOGISTS; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Crooks K. R., 2006, CONNECTIVITY CONSERV; Cummings V, 2006, ANTARCT SCI, V18, P633, DOI 10.1017/S0954102006000666; DAYTON PK, 1986, POLAR BIOL, V6, P207, DOI 10.1007/BF00443397; Dayton PK, 2003, AM NAT, V162, P1, DOI 10.1086/376572; DAYTON PK, 1994, AM ZOOL, V34, P90; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Gray JS, 2001, POLAR BIOL, V24, P633, DOI 10.1007/s003000100244; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; Jobe RT, 2008, ECOLOGY, V89, P174, DOI 10.1890/06-1722.1; KNOX GA, 1994, BIOL SO OCEAN; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Levin LA, 2002, ECOL APPL, V12, P1785, DOI 10.1890/1051-0761(2002)012[1785:NAMSOH]2.0.CO;2; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Lundquist CJ, 2006, MAR ECOL PROG SER, V324, P67, DOI 10.3354/meps324067; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Norkko A, 2007, ECOLOGY, V88, P2810, DOI 10.1890/06-1396.1; Orejas C, 2002, MAR ECOL PROG SER, V231, P101, DOI 10.3354/meps231101; PEARSE JS, 1991, AM ZOOL, V31, P65; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Poulin E, 2002, TRENDS ECOL EVOL, V17, P218, DOI 10.1016/S0169-5347(02)02493-X; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SARTORY DP, 1982, 115163 TR HYDR RES I; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; StanwellSmith D, 1997, J EXP MAR BIOL ECOL, V212, P61, DOI 10.1016/S0022-0981(96)02754-2; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3; Thrush SF, 2001, MAR ECOL PROG SER, V221, P255, DOI 10.3354/meps221255; Thrush S, 2006, DEEP-SEA RES PT II, V53, P959, DOI 10.1016/j.dsr2.2006.02.006; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; WHITTAKER R H, 1975, P385; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	57	49	50	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11899	10.1371/journal.pone.0011899	http://dx.doi.org/10.1371/journal.pone.0011899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689578	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520300014
J	Kellett, DO; Fukunaga, I; Chen-Kubota, E; Dean, P; Yeo, CH				Kellett, Daniel O.; Fukunaga, Izumi; Chen-Kubota, Eva; Dean, Paul; Yeo, Christopher H.			Memory Consolidation in the Cerebellar Cortex	PLOS ONE			English	Article							CONDITIONED EYELID RESPONSES; NICTITATING-MEMBRANE RESPONSES; VESTIBULOOCULAR REFLEX; PURKINJE-CELL; INFERIOR OLIVE; MOTOR CONTROL; PLASTICITY; ACQUISITION; EXTINCTION; NUCLEI	Several forms of learning, including classical conditioning of the eyeblink, depend upon the cerebellum. In examining mechanisms of eyeblink conditioning in rabbits, reversible inactivations of the control circuitry have begun to dissociate aspects of cerebellar cortical and nuclear function in memory consolidation. It was previously shown that post-training cerebellar cortical, but not nuclear, inactivations with the GABA(A) agonist muscimol prevented consolidation but these findings left open the question as to how final memory storage was partitioned across cortical and nuclear levels. Memory consolidation might be essentially cortical and directly disturbed by actions of the muscimol, or it might be nuclear, and sensitive to the raised excitability of the nuclear neurons following the loss of cortical inhibition. To resolve this question, we simultaneously inactivated cerebellar cortical lobule HVI and the anterior interpositus nucleus of rabbits during the post-training period, so protecting the nuclei from disinhibitory effects of cortical inactivation. Consolidation was impaired by these simultaneous inactivations. Because direct application of muscimol to the nuclei alone has no impact upon consolidation, we can conclude that post-training, consolidation processes and memory storage for eyeblink conditioning have critical cerebellar cortical components. The findings are consistent with a recent model that suggests the distribution of learning-related plasticity across cortical and nuclear levels is task-dependent. There can be transfer to nuclear or brainstem levels for control of high-frequency responses but learning with lower frequency response components, such as in eyeblink conditioning, remains mainly dependent upon cortical memory storage.	[Kellett, Daniel O.; Fukunaga, Izumi; Chen-Kubota, Eva; Yeo, Christopher H.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Dean, Paul] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; University of Sheffield	Kellett, DO (corresponding author), Lilly UK, Surrey, England.	c.yeo@ucl.ac.uk			Biotechnology and Biological Sciences Research Council, UK [BBS/B/16984]; Biotechnology and Biological Sciences Research Council [BBS/B/16984] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK, http://www.bbsrc.ac.uk/, Grant No. BBS/B/16984. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 2000, PROG BRAIN RES, V124, P257; Aksenov D, 2004, J NEUROPHYSIOL, V91, P719, DOI 10.1152/jn.00859.2003; ANDERSSON G, 1988, EXP BRAIN RES, V72, P450; Attwell PJE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0003.1999; Attwell PJE, 2001, J NEUROSCI, V21, P5715, DOI 10.1523/JNEUROSCI.21-15-05715.2001; Attwell PJE, 2002, ANN NY ACAD SCI, V978, P79, DOI 10.1111/j.1749-6632.2002.tb07557.x; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; Bengtsson F, 2004, EUR J NEUROSCI, V20, P2999, DOI 10.1111/j.1460-9568.2004.03789.x; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Bracha V, 2009, NEUROSCIENCE, V162, P787, DOI 10.1016/j.neuroscience.2008.12.042; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Cooke SF, 2004, J NEUROSCI, V24, P2934, DOI 10.1523/JNEUROSCI.5505-03.2004; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; Delgado-Garcia JM, 2006, TRENDS NEUROSCI, V29, P330, DOI 10.1016/j.tins.2006.05.003; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; GORMEZANO I, 1962, SCIENCE, V138, P33, DOI 10.1126/science.138.3536.33; GRUART A, 1995, EXP BRAIN RES, V104, P431; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hesslow Germund, 2002, P86; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jirenhed DA, 2007, J NEUROSCI, V27, P2493, DOI 10.1523/JNEUROSCI.4202-06.2007; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; Kleim JA, 2002, P NATL ACAD SCI USA, V99, P13228, DOI 10.1073/pnas.202483399; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Lepora NF, 2007, J NEUROPHYSIOL, V98, P2074, DOI 10.1152/jn.00210.2007; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Ohyama T, 2003, LEARN MEMORY, V10, P346, DOI 10.1101/lm.67103; Ohyama T, 2006, J NEUROSCI, V26, P12656, DOI 10.1523/JNEUROSCI.4023-06.2006; PERRETT SP, 1993, J NEUROSCI, V13, P1708; Porrill J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000085; Porrill J, 2007, PLOS COMPUT BIOL, V3, P1935, DOI 10.1371/journal.pcbi.0030197; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, J NEUROSCI, V16, P7791; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; Welsh JP, 1998, EUR J NEUROSCI, V10, P3321, DOI 10.1046/j.1460-9568.1998.00400.x; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4; YEO CH, 1992, EXP BRAIN RES, V88, P623; Yeo CH, 1997, LEARN MEMORY, V3, P557, DOI 10.1101/lm.3.6.557; Zbarska S, 2007, BEHAV BRAIN RES, V178, P128, DOI 10.1016/j.bbr.2006.12.012	49	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11737	10.1371/journal.pone.0011737	http://dx.doi.org/10.1371/journal.pone.0011737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686596	gold, Green Published, Green Accepted			2022-12-25	WOS:000280520200004
J	Yu, CH; Wu, HJ; Kaizuka, Y; Vale, RD; Groves, JT				Yu, Cheng-han; Wu, Hung-Jen; Kaizuka, Yoshihisa; Vale, Ronald D.; Groves, Jay T.			Altered Actin Centripetal Retrograde Flow in Physically Restricted Immunological Synapses	PLOS ONE			English	Article							T-CELL-RECEPTOR; GRADIENT VECTOR FLOW; ACTIVATION; MICROCLUSTERS; NETWORKS; CYTOSKELETON; MOLECULES; MEMBRANES; CLUSTER; SLP-76	Antigen recognition by T cells involves large scale spatial reorganization of numerous receptor, adhesion, and costimulatory proteins within the T cell-antigen presenting cell (APC) junction. The resulting patterns can be distinctive, and are collectively known as the immunological synapse. Dynamical assembly of cytoskeletal network is believed to play an important role in driving these assembly processes. In one experimental strategy, the APC is replaced with a synthetic supported membrane. An advantage of this configuration is that solid structures patterned onto the underlying substrate can guide immunological synapse assembly into altered patterns. Here, we use mobile anti-CD3 epsilon on the spatial-partitioned supported bilayer to ligate and trigger T cell receptor (TCR) in live Jurkat T cells. Simultaneous tracking of both TCR clusters and GFP-actin speckles reveals their dynamic association and individual flow patterns. Actin retrograde flow directs the inward transport of TCR clusters. Flow-based particle tracking algorithms allow us to investigate the velocity distribution of actin flow field across the whole synapse, and centripetal velocity of actin flow decreases as it moves toward the center of synapse. Localized actin flow analysis reveals that, while there is no influence on actin motion from substrate patterns directly, velocity differences of actin are observed over physically trapped TCR clusters. Actin flow regains its velocity immediately after passing through confined TCR clusters. These observations are consistent with a dynamic and dissipative coupling between TCR clusters and viscoelastic actin network.	[Yu, Cheng-han; Groves, Jay T.] Natl Univ Singapore, Res Ctr Excellence Mechanobiol, Singapore 117548, Singapore; [Yu, Cheng-han; Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Kaizuka, Yoshihisa; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Kaizuka, Yoshihisa] Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki, Japan; [Vale, Ronald D.; Groves, Jay T.] Howard Hughes Med Inst, Chevy Chase, MD USA	National University of Singapore; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; National Institute for Materials Science; Howard Hughes Medical Institute	Yu, CH (corresponding author), Natl Univ Singapore, Res Ctr Excellence Mechanobiol, Singapore 117548, Singapore.	JTGroves@lbl.gov	KAIZUKA, Yoshihisa/H-2789-2011; Yu, Cheng-han/K-8732-2013; Wu, Hung-Jen/H-3769-2016	Yu, Cheng-han/0000-0002-8821-8877; Wu, Hung-Jen/0000-0003-3082-7431	U.S. Department of Energy [DE-AC02-05CH11231]; Sandler Foundation; National Science Council of Taiwan [NSC98-2917-I-564-165]	U.S. Department of Energy(United States Department of Energy (DOE)); Sandler Foundation; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	U.S. Department of Energy, Contract No. DE-AC02-05CH11231. (to J.T. Groves) Sandler Foundation (to R.D. Vale). National Science Council of Taiwan, Grant NSC98-2917-I-564-165 (to C. Yu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; BROWN CM, 2006, PROBING INTEGRIN ACT, P5204; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Claessens MMAE, 2006, NAT PHYS, V2, P186, DOI 10.1038/nphys241; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Groves JT, 2002, ACCOUNTS CHEM RES, V35, P149, DOI 10.1021/ar950039m; GROVES JT, 1997, MICROPATTERNING FLUI, P651; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; JONKMAN JEN, 2002, CONFOCAL 2 PHOTON MI, P101; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Parthasarathy R, 2006, LANGMUIR, V22, P5095, DOI 10.1021/la060390o; Rubinstein B, 2009, BIOPHYS J, V97, P1853, DOI 10.1016/j.bpj.2009.07.020; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Uhde J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061916; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu CY, 1998, SIGNAL PROCESS, V71, P131, DOI 10.1016/S0165-1684(98)00140-6; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	33	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11878	10.1371/journal.pone.0011878	http://dx.doi.org/10.1371/journal.pone.0011878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686692	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200040
J	Breton, B; Lagace, M; Bouvier, M				Breton, Billy; Lagace, Monique; Bouvier, Michel			Combining resonance energy transfer methods reveals a complex between the alpha(2A)-adrenergic receptor, G alpha(i1)beta(1)gamma(2), and GRK2	FASEB JOURNAL			English	Article						bioluminescence; fluorescence; G-protein-coupled receptors; arrestins; signaling	PROTEIN-COUPLED-RECEPTOR; BETA-GAMMA-SUBUNITS; REAL-TIME DETECTION; SELECTIVE REGULATION; SIGNAL-TRANSDUCTION; GABA(B) RECEPTOR; HORMONE RECEPTOR; HOMOLOGY DOMAIN; LIVING CELLS; KINASE 2	Traditionally, G-protein-coupled receptor (GPCR) interactions with their G proteins and regulatory proteins, GPCR kinases (GRKs) and arrestins, are described as sequential events involving rapid assemblies/disassemblies. To directly monitor the dynamics of these interactions in living cells, we combined two spectrally resolved bioluminescence and one fluorescence resonance energy transfer (RET) methods. The RET combination analysis revealed that stimulation of the alpha(2A)-adrenergic receptor (alpha(2A)AR) leads to the recruitment of GRK2 at a receptor still associated with the G alpha(i1)beta(1)gamma(2) complex. The interaction kinetics of GRKs with G gamma(2) (2.8 +/- 0.4 s) and alpha(2A)AR (5.2 +/- 0.5 s) were similar to that of the receptor-promoted change in RET between G alpha(i1) and G gamma(2) (5.2 +/- 1.2 s), and persisted until the translocation of beta arrestin2 to the receptor, indicating that GRK2 remains associated to the receptor/G-protein complex for longer periods than anticipated. Moreover, GRK2 or a kinase-deficient GRK2 mutant, but not GRK5, potentiated the receptor-promoted changes in RET between G alpha(i1) and G gamma(2) and abrogated the alpha(2A)AR-stimulated calcium response, suggesting that the recruitment of GRK2 to the complex contributes to the structural rearrangement and functional regulation of the signaling unit, independently of the kinase activity. RET combination analysis revealed unanticipated dynamics in GPCR signaling and will be applicable to many biological systems.-Breton, B., Lagace, M., Bouvier, M. Combining resonance energy transfer methods reveals a complex between the alpha(2A)-adrenergic receptor, G alpha(i1)beta(1)gamma(2), and GRK2. FASEB J. 24, 4733-4743 (2010). www.fasebj.org	[Bouvier, Michel] Univ Montreal, IRIC, Dept Biochem, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Bouvier, M (corresponding author), Univ Montreal, IRIC, Dept Biochem, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100	Canadian Institute for Health Research; Heart and Stroke Foundation of Canada; Fonds de la Recherche en Sante du Quebec; Canada Research Chair in Signal Transduction and Molecular Pharmacology	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canada Research Chair in Signal Transduction and Molecular Pharmacology	The authors thank Herve Paris and Celine Gales (Institut National de la Sante et de la Recherche Medicale, Toulouse, France) for the gift of the alpha<INF>2A</INF>AR-venus plasmid, Stephane Laporte (McGill University, Montreal, QC, Canada) for the gift of GRK2-eYFP, and M. Heroux and C. Le Gouill for critical reading of the manuscript. This work was supported by a grant from Canadian Institute for Health Research and the Heart and Stroke Foundation of Canada. B.B. holds a studentship from the Fonds de la Recherche en Sante du Quebec, and M.B. is the recipient of the Canada Research Chair in Signal Transduction and Molecular Pharmacology.	Aiyar N, 2000, EUR J PHARMACOL, V403, P1, DOI 10.1016/S0014-2999(00)00419-2; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; CAMPBELL AK, 1975, BIOCHEM SOC T, V3, P709, DOI 10.1042/bst0030709; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Charest PG, 2003, J BIOL CHEM, V278, P41541, DOI 10.1074/jbc.M306589200; Chuang TT, 1996, J BIOL CHEM, V271, P28691, DOI 10.1074/jbc.271.45.28691; DEBBURMAN SK, 1995, J BIOL CHEM, V270, P5742, DOI 10.1074/jbc.270.11.5742; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Diviani D, 1996, J BIOL CHEM, V271, P5049; Eichmann T, 2003, J BIOL CHEM, V278, P8052, DOI 10.1074/jbc.M204795200; Evanko DS, 2005, CELL SIGNAL, V17, P1218, DOI 10.1016/j.cellsig.2004.12.008; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HAGA T, 1993, LIFE SCI, V52, P421, DOI 10.1016/0024-3205(93)90297-G; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hamdan Fadi F, 2006, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0523s34; Hasbi A, 2004, MOL ENDOCRINOL, V18, P1277, DOI 10.1210/me.2003-0440; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Heroux M, 2007, J BIOL CHEM, V282, P31610, DOI 10.1074/jbc.M701790200; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; Iacovelli L, 1999, MOL PHARMACOL, V56, P316, DOI 10.1124/mol.56.2.316; KAMEYAMA K, 1993, J BIOL CHEM, V268, P7753; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Klein S, 2000, P NATL ACAD SCI USA, V97, P3219, DOI 10.1073/pnas.050015797; Lee HJ, 2007, BIOCHEM J, V404, P141, DOI 10.1042/BJ20061826; LEVITZKI A, 1986, PHYSIOL REV, V66, P819, DOI 10.1152/physrev.1986.66.3.819; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; PAO CS, 2002, SCI STKE, pE42; PEI G, 1994, P NATL ACAD SCI USA, V91, P3633, DOI 10.1073/pnas.91.9.3633; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pfleger KDG, 2006, CELL SIGNAL, V18, P1664, DOI 10.1016/j.cellsig.2006.01.004; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Usui K, 2000, INT J MOL MED, V5, P335; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Vrecl M, 2004, J BIOMOL SCREEN, V9, P322, DOI 10.1177/1087057104263212; Willets JM, 2003, TRENDS PHARMACOL SCI, V24, P626, DOI 10.1016/j.tips.2003.10.003; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	61	19	22	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4733	4743		10.1096/fj.10-164061	http://dx.doi.org/10.1096/fj.10-164061			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20696855				2022-12-25	WOS:000284824400014
J	Kim, SH; Shanware, NP; Bowler, MJ; Tibbetts, RS				Kim, Sang Hwa; Shanware, Naval P.; Bowler, Michael J.; Tibbetts, Randal S.			Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; IN-VIVO; CELLULAR TOXICITY; DROSOPHILA MODEL; MUTATIONS; ALS; AGGREGATION; GENE; NEURODEGENERATION	Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that preferentially targets motor neurons. It was recently found that dominant mutations in two related RNA-binding proteins, TDP-43 (43-kDa TAR DNA-binding domain protein) and FUS/TLS (fused in sarcoma/translated in liposarcoma) cause a subset of ALS. The convergent ALS phenotypes associated with TDP-43 and FUS/TLS mutations are suggestive of a functional relationship; however, whether or not TDP-43 and FUS/TLS operate in common biochemical pathways is not known. Here we show that TDP-43 and FUS/TLS directly interact to form a complex at endogenous expression levels in mammalian cells. Binding was mediated by an unstructured TDP-43 C-terminal domain and occurred within the context of a 300-400-kDa complex that also contained C-terminal cleavage products of TDP-43 linked to neuropathology. TDP-43 C-terminal fragments were excluded from large molecular mass TDP-43 ribonucleoprotein complexes but retained FUS/TLS binding activity. The functional significance of TDP-43-FUS/TLS complexes was established by showing that RNAi silencing of either TDP-43 or FUS/TLS reduced the expression of histone deacetylase (HDAC) 6 mRNA. TDP-43 and FUS/TLS associated with HDAC6 mRNA in intact cells and in vitro, and competition experiments suggested that the proteins occupy overlapping binding sites. The combined findings demonstrate that TDP-43 and FUS/TLS form a functional complex in intact cells and suggest that convergent ALS phenotypes associated with TDP-43 and FUS/TLS mutations may reflect their participation in common biochemical processes.	[Kim, Sang Hwa; Shanware, Naval P.; Bowler, Michael J.; Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [CA124722, NS059001]; American Cancer Society; Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124722 and NS059001. This work was also supported by the American Cancer Society and a Shaw Scientist Award (to R. S. T.) from the Greater Milwaukee Foundation.	Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zinszner H, 1997, J CELL SCI, V110, P1741	44	160	165	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34097	34105		10.1074/jbc.M110.154831	http://dx.doi.org/10.1074/jbc.M110.154831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20720006	hybrid, Green Published			2022-12-25	WOS:000283354000055
J	Kamioka, Y; Yasuda, S; Fujita, Y; Aoki, K; Matsuda, M				Kamioka, Yuji; Yasuda, Shuhei; Fujita, Yoshihisa; Aoki, Kazuhiro; Matsuda, Michiyuki			Multiple Decisive Phosphorylation Sites for the Negative Feedback Regulation of SOS1 via ERK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE PHOSPHORYLATION; PROTEIN IN-VIVO; PC12 CELLS; ACTIVATION; RAS; IDENTIFICATION; SEVENLESS; PATHWAY; INSULIN; GRB2	EGF-induced activation of ERK has been extensively studied by both experimental and theoretical approaches. Here, we used a simulation model based mostly on experimentally determined parameters to study the ERK-mediated negative feedback regulation of the Rasguanine nucleotide exchange factor, son of sevenless (SOS). Because SOS1 is phosphorylated at multiple serine residues upon stimulation, we evaluated the role of the multiplicity by building two simulation models, which we termed the decisive and cooperative phosphorylation models. The two models were constrained by the duration of Ras activation and basal phosphorylation level of SOS1. Possible solutions were found only in the decisive model wherein at least three, and probably more than four, phosphorylation sites decisively suppress the SOS activity. Thus, the combination of experimental approaches and the model analysis has suggested an unexpected role of multiple phosphorylations of SOS1 in the negative regulation.	[Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Kamioka, Yuji; Fujita, Yoshihisa; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto 6068501, Japan; [Aoki, Kazuhiro] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	matsudam@lif.kyoto-u.ac.jp	Aoki, Kazuhiro/I-5483-2019	Aoki, Kazuhiro/0000-0001-7263-1555; Matsuda, Michiyuki/0000-0002-5876-9969; Fujita, Yoshihisa/0000-0002-5086-8188	Ministry of Education, Culture, Sports, Science and Technology, Japan; Sagawa Cancer Research grant; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology; Kyoto University Global Center of Excellence Program Center for Frontier Medicine	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sagawa Cancer Research grant; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology(Japan Science & Technology Agency (JST)); Kyoto University Global Center of Excellence Program Center for Frontier Medicine	This work was supported by the Cell Innovation Program and Innovative Techno-Hub for Integrated Medical Bio-imaging Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan; a Sagawa Cancer Research grant; the Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology program; and the Kyoto University Global Center of Excellence Program Center for Frontier Medicine.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; BARSAGI D, 1994, TRENDS ENDOCRIN MET, V5, P165, DOI 10.1016/1043-2760(94)90014-0; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; CHERNIACK AD, 1995, J BIOL CHEM, V270, P1485, DOI 10.1074/jbc.270.4.1485; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; CorbalanGarcia S, 1996, ONCOGENE, V12, P1063; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kiel C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000397; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kurokawa K, 2001, J BIOL CHEM, V276, P31305, DOI 10.1074/jbc.M104341200; Lockyer PJ, 1999, CURR BIOL, V9, P265, DOI 10.1016/S0960-9822(99)80116-X; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; ROZAKISADCOCK M, 1995, ONCOGENE, V11, P1417; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tachibana M, 2009, EXP CELL RES, V315, P863, DOI 10.1016/j.yexcr.2008.12.005; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; Yamada S, 2004, BIOCHEM BIOPH RES CO, V314, P1113, DOI 10.1016/j.bbrc.2004.01.009; Zhou B, 2002, J BIOL CHEM, V277, P13889, DOI 10.1074/jbc.M200377200	37	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33540	33548		10.1074/jbc.M110.135517	http://dx.doi.org/10.1074/jbc.M110.135517			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724475	Green Published, hybrid			2022-12-25	WOS:000283048200088
J	Odho, Z; Southall, SM; Wilson, JR				Odho, Zain; Southall, Stacey M.; Wilson, Jon R.			Characterization of a Novel WDR5-binding Site That Recruits RbBP5 through a Conserved Motif to Enhance Methylation of Histone H3 Lysine 4 by Mixed Lineage Leukemia Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR RECOGNITION; STRUCTURAL BASIS; CHROMATIN MODIFICATIONS; SET1 COMPLEX; WDR5; EXPRESSION; DOMAIN; MLL1; COMPASS; TRITHORAX	Histone modification is well established as a fundamental mechanism driving the regulation of transcription, replication, and DNA repair through the control of chromatin structure. Likewise, it is apparent that incorrect targeting of histone modifications contributes to misregulated gene expression and hence to developmental disorders and diseases of genomic instability such as cancer. The KMT2 family of SET domain methyltransferases, typified by mixed lineage leukemia protein-1 (MLL1), is responsible for histone H3 lysine 4 methylation, a marker of active genes. To ensure that this modification is correctly targeted, a multiprotein complex associates with the methyltransferase and directs activity. We have identified a novel interaction site on the core complex protein WD repeat protein-5 (WDR5), and we mapped the complementary site on its partner retinoblastoma-binding protein-5 (RbBP5). We have characterized this interaction by x-ray crystallography and show how it is fundamental to the assembly of the complex and to the regulation of methyltransferase activity. We show which region of RbBP5 contributes directly to mixed lineage leukemia activation, and we combine our structural and biochemical data to produce a model to show how WDR5 and RbBP5 act cooperatively to stimulate activity.	[Odho, Zain; Southall, Stacey M.; Wilson, Jon R.] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Wilson, JR (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	jon.wilson@icr.ac.uk	Wilson, Jon R/B-7362-2019	Wilson, Jon R/0000-0002-5157-5432	Institute of Cancer Research; Medical Research Council; National Health Service	Institute of Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Service	This work was supported by the Career Development Faculty Programme of the Institute of Cancer Research (to J. R. W.) and benefits from infrastructural support for structural biology at ICR by Cancer Research UK.; Supported by a studentship from the Medical Research Council.; We thank S. M. Roe for assistance with crystallography in the preliminary stages of this project and La'Verne Rennalls for assistance with protein expression in insect cells. National Institute of Health Research Biomedical Research Centre is recipient of National Health Service funding.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Assenberg R, 2008, ACTA CRYSTALLOGR F, V64, P258, DOI 10.1107/S1744309108004557; Bach C, 2009, FUTURE ONCOL, V5, P1271, DOI [10.2217/fon.09.96, 10.2217/FON.09.96]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Garapaty S, 2009, J BIOL CHEM, V284, P7542, DOI 10.1074/jbc.M805872200; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Ireton GC, 2004, ACTA CRYSTALLOGR D, V60, P601, DOI 10.1107/S0907444903029664; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Yates JA, 2010, FEBS LETT, V584, P689, DOI 10.1016/j.febslet.2010.01.022; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	53	69	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32967	32976		10.1074/jbc.M110.159921	http://dx.doi.org/10.1074/jbc.M110.159921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20716525	Green Published, hybrid			2022-12-25	WOS:000283048200034
J	Qi, YM; Schoene, NW; Lartey, FM; Cheng, WH				Qi, Yongmei; Schoene, Norberta W.; Lartey, Frederick M.; Cheng, Wen-Hsing			Selenium Compounds Activate ATM-dependent DNA Damage Response via the Mismatch Repair Protein hMLH1 in Colorectal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; WERNER-SYNDROME PROTEIN; S-PHASE CHECKPOINT; COLON-CANCER; IONIZING-RADIATION; OXIDATIVE STRESS; PROSTATE-CANCER; CYCLE ARREST; G(2) ARREST; MUTL-ALPHA	Epidemiological and animal studies indicate that selenium supplementation suppresses risk of colorectal and other cancers. The majority of colorectal cancers are characterized by a defective DNA mismatch repair (MMR). Here, we have employed the MMR-deficient HCT 116 colorectal cancer cells and the MMR-proficient HCT 116 cells with hMLH1 complementation to investigate the role of hMLH1 in selenium-induced DNA damage response, a tumorigenesis barrier. The ATM (ataxia telangiectasia mutated) protein responds to clastogens and initiates DNA damage response. We show that hMLH1 complementation sensitizes HCT 116 cells to methylseleninic acid, methylselenocysteine, and sodium selenite via reactive oxygen species and facilitates the selenium-induced oxidative 8-oxoguanine damage, DNA breaks, G(2)/M checkpoint response, and ATM pathway activation. Pretreatment of the hMLH1-complemented HCT 116 cells with the antioxidant N-acetylcysteine or 2,2,6,6-tetramethylpiperidine-1-oxyl or the ATM kinase inhibitor KU55933 suppresses hMLH1-dependent DNA damage response to selenium exposure. Selenium treatment stimulates the association between hMLH1 and hPMS2 proteins, a heterodimer critical for functional MMR, in a manner dependent on ATM and reactive oxygen species. Taken together, the results suggest a new role of selenium in mitigating tumorigenesis by targeting the MMR pathway, whereby the lack of hMLH1 renders the HCT 116 colorectal cancer cells resistant to selenium-induced DNA damage response.	[Qi, Yongmei; Lartey, Frederick M.; Cheng, Wen-Hsing] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Qi, Yongmei] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China; [Schoene, Norberta W.] USDA, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA	University System of Maryland; University of Maryland College Park; Lanzhou University; United States Department of Agriculture (USDA)	Cheng, WH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, 0112 Skinner Bldg, College Pk, MD 20742 USA.	whcheng@umd.edu			General Research Board; University of Maryland at College Park; Chinese Top University Graduate Student Studying Abroad Program; China Scholarship Council; U. S. Department of Agriculture [1235-51530-052-00D]	General Research Board; University of Maryland at College Park; Chinese Top University Graduate Student Studying Abroad Program; China Scholarship Council(China Scholarship Council); U. S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was partially supported by the General Research Board, the University of Maryland at College Park (to W.-H. C.), the Chinese Top University Graduate Student Studying Abroad Program, China Scholarship Council (to Y. Q.), and the U. S. Department of Agriculture Agricultural Research Service Project 1235-51530-052-00D (to N. W. S).	Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Arlander SJH, 2008, CANCER RES, V68, P89, DOI 10.1158/0008-5472.CAN-07-0675; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Cheng WH, 2008, MOL BIOL CELL, V19, P3923, DOI 10.1091/mbc.E07-07-0698; Cheng WH, 2004, J BIOL CHEM, V279, P21169, DOI 10.1074/jbc.M312770200; Cheng WH, 2003, MOL CELL BIOL, V23, P6385, DOI 10.1128/MCB.23.18.6385-6395.2003; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Davis CD, 2002, J NUTR, V132, P292, DOI 10.1093/jn/132.2.292; Drake EN, 2006, MED HYPOTHESES, V67, P318, DOI 10.1016/j.mehy.2006.01.058; Feng Y, 1999, TOXICOL APPL PHARM, V157, P36, DOI 10.1006/taap.1999.8623; Finley JW, 2000, J NUTR, V130, P2384, DOI 10.1093/jn/130.9.2384; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Goel A, 2006, CANCER BIOL THER, V5, P529, DOI 10.4161/cbt.5.5.2654; Goulet AC, 2005, CARCINOGENESIS, V26, P109, DOI 10.1093/carcin/bgh306; Grabsch H, 2006, CLIN CANCER RES, V12, P1494, DOI 10.1158/1078-0432.CCR-05-2105; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hardman RA, 2001, CANCER RES, V61, P1392; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Huang F, 2009, FREE RADICAL BIO MED, V46, P1186, DOI 10.1016/j.freeradbiomed.2009.01.026; Hwang JT, 2006, CANCER RES, V66, P10057, DOI 10.1158/0008-5472.CAN-06-1814; IP C, 1991, CANCER RES, V51, P595; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; KOI M, 1994, CANCER RES, V54, P4308; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li GX, 2007, INT J CANCER, V120, P2034, DOI 10.1002/ijc.22480; Lin XJ, 1999, MOL PHARMACOL, V56, P390, DOI 10.1124/mol.56.2.390; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Mirzoeva OK, 2006, MOL CANCER THER, V5, P2757, DOI 10.1158/1535-7163.MCT-06-0183; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Peterson-Roth E, 2005, MOL CELL BIOL, V25, P3596, DOI 10.1128/MCB.25.9.3596-3607.2005; Plotz G, 2002, NUCLEIC ACIDS RES, V30, P711, DOI 10.1093/nar/30.3.711; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Reynolds MF, 2009, CANCER RES, V69, P1071, DOI 10.1158/0008-5472.CAN-08-2306; Rudolf E, 2008, ANTI-CANCER AGENT ME, V8, P598, DOI 10.2174/187152008785133047; SHAMBERGER RJ, 1969, CAN MED ASSOC J, V100, P682; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Shimodaira H, 2003, P NATL ACAD SCI USA, V100, P2420, DOI 10.1073/pnas.0438031100; Stewart MS, 1999, FREE RADICAL BIO MED, V26, P42, DOI 10.1016/S0891-5849(98)00147-6; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Thant AA, 2008, ANTICANCER RES, V28, P3579; Wang HT, 2003, J INORG BIOCHEM, V97, P221, DOI 10.1016/S0162-0134(03)00284-8; Waters R, 2006, EMBO REP, V7, P377, DOI 10.1038/sj.embor.7400659; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003; Yan T, 2001, CANCER RES, V61, P8290; Yanamadala S, 2003, MOL CANCER RES, V1, P747; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zeng HW, 2009, MOLECULES, V14, P1263, DOI 10.3390/molecules14031263; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200	56	41	43	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33010	33017		10.1074/jbc.M110.137406	http://dx.doi.org/10.1074/jbc.M110.137406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20709753	Green Published, hybrid			2022-12-25	WOS:000283048200038
J	Miranda, KJ; Loeser, RF; Yammani, RR				Miranda, Keally J.; Loeser, Richard F.; Yammani, Raghunatha R.			Sumoylation and Nuclear Translocation of S100A4 Regulate IL-1 beta-mediated Production of Matrix Metalloproteinase-13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; FACTOR-KAPPA-B; ARTICULAR CHONDROCYTES; GENE-EXPRESSION; PROTEIN; METASTASIS; RECEPTOR; AP-1; LOCALIZATION; UBIQUITIN	S100A4, a member of the S100 family of proteins, plays an important role in matrix remodeling by up-regulating the expression of matrix metalloproteinases (MMPs). We have previously shown that S100A4 is overexpressed in diseased cartilage and that extracellular S100A4 stimulates MMP-13 production, a major type II collagen-degrading enzyme, via activation of receptor for advanced glycation end product signaling. In the present study, using human articular chondrocytes, we show that intracellular S100A4 translocated into the nucleus upon interleukin-1 beta (IL-1 beta) stimulation and translocation required post-translational modification of S100A4 by the sumo-1 protein. Two sumoylation sites were identified on the S100A4 molecule, Lys(22) and Lys(96). Mutation of these lysine residues abolished the ability of S100A4 to be sumoylated and to translocate into the nucleus. Blocking of sumoylation and nuclear transport of S100A4 inhibited the IL-1 beta -induced production of MMP-13. Nuclear S100A4 was bound to the promoter region of MMP-13 in IL-1 beta-treated cells. Thus, we demonstrate a novel mechanism for sumoylated S100A4 as a regulator of expression of the MMP-13 gene.	[Miranda, Keally J.; Loeser, Richard F.; Yammani, Raghunatha R.] Wake Forest Univ, Bowman Gray Sch Med, Sect Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	Yammani, RR (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	ryammani@wfubmc.edu			National Institutes of Health [P30AG21332, R01AG16697]; Wake Forest University; NATIONAL INSTITUTE ON AGING [P30AG021332, R01AG016697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P30AG21332 (to Wake Forest University Claude D Pepper Older Americans Independence Center) and R01AG16697 (to R. F. L.) and the Wake Forest University Health Sciences Venture Fund (to R.R.Y.).	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; Andrassy M, 2006, AM J PATHOL, V169, P1223, DOI 10.2353/ajpath.2006.050713; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bjornland K, 2001, J PEDIATR SURG, V36, P1040, DOI 10.1053/jpsu.2001.24735; Bjornland K, 1999, CANCER RES, V59, P4702; Cecil DL, 2008, J IMMUNOL, V180, P8378, DOI 10.4049/jimmunol.180.12.8378; Cecil DL, 2005, J IMMUNOL, V175, P8296, DOI 10.4049/jimmunol.175.12.8296; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; Farley AR, 2009, METHOD ENZYMOL, V463, P725, DOI 10.1016/S0076-6879(09)63040-8; Flatmark K, 2003, J PATHOL, V200, P589, DOI 10.1002/path.1381; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; GRIGORIAN MS, 1993, GENE, V135, P229, DOI 10.1016/0378-1119(93)90070-J; Haugen MH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-172; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Kikuchi N, 2006, CANCER SCI, V97, P1061, DOI 10.1111/j.1349-7006.2006.00295.x; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Muehleman C, 1997, OSTEOARTHR CARTILAGE, V5, P23, DOI 10.1016/S1063-4584(97)80029-5; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; Orre LM, 2007, MOL CELL PROTEOMICS, V6, P2122, DOI 10.1074/mcp.M700202-MCP200; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; RAMIREZ VD, 1975, MOL CELL ENDOCRINOL, V3, P339, DOI 10.1016/0303-7207(75)90035-0; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Samuel S, 2007, BBA-GENE STRUCT EXPR, V1769, P525, DOI 10.1016/j.bbaexp.2007.07.003; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shlopov BV, 1997, ARTHRITIS RHEUM-US, V40, P2065, DOI 10.1002/art.1780401120; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; TAKENAGA K, 1994, CELL STRUCT FUNCT, V19, P133, DOI 10.1247/csf.19.133; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042; Yammani RR, 2009, ARTHRITIS RHEUM, V60, P792, DOI 10.1002/art.24295; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955	51	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31517	31524		10.1074/jbc.M110.125898	http://dx.doi.org/10.1074/jbc.M110.125898			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685652	Green Published, hybrid			2022-12-25	WOS:000282764600046
J	Park, J; Oh, Y; Yoo, L; Jung, MS; Song, WJ; Lee, SH; Seo, H; Chung, KC				Park, Joongkyu; Oh, Yohan; Yoo, Lang; Jung, Min-Su; Song, Woo-Joo; Lee, Sang-Hun; Seo, Hyemyung; Chung, Kwang Chul			Dyrk1A Phosphorylates p53 and Inhibits Proliferation of Embryonic Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCED PHOSPHORYLATION; INTERACTING PROTEIN KINASE-2; NEURAL PROGENITOR CELLS; CYCLIN-DEPENDENT KINASE; DOWN-SYNDROME; DNA-DAMAGE; ALZHEIMERS-DISEASE; MIRK/DYRK1B KINASE; FUNCTIONAL-LINK; BINDING PROTEIN	Down syndrome (DS) is associated with many neural defects, including reduced brain size and impaired neuronal proliferation, highly contributing to the mental retardation. Those typical characteristics of DS are closely associated with a specific gene group "Down syndrome critical region" (DSCR) on human chromosome 21. Here we investigated the molecular mechanisms underlying impaired neuronal proliferation in DS and, more specifically, a regulatory role for dual-specificity tyrosine-(Y) phosphorylation-regulated kinase 1A (Dyrk1A), a DSCR gene product, in embryonic neuronal cell proliferation. We found that Dyrk1A phosphorylates p53 at Ser-15 in vitro and in immortalized rat embryonic hippocampal progenitor H19-7 cells. In addition, Dyrk1A-induced p53 phosphorylation at Ser-15 led to a robust induction of p53 target genes (e. g. p21(CIP1)) and impaired G(1)/G(0)-S phase transition, resulting in attenuated proliferation of H19-7 cells and human embryonic stem cell-derived neural precursor cells. Moreover, the point mutation of p53-Ser-15 to alanine rescued the inhibitory effect of Dyrk1A on neuronal proliferation. Accordingly, brains from embryonic DYRK1A transgenic mice exhibited elevated levels of Dyrk1A, Ser-15 (mouse Ser-18)-phosphorylated p53, and p21(CIP1) as well as impaired neuronal proliferation. These findings suggest that up-regulation of Dyrk1A contributes to altered neuronal proliferation in DS through specific phosphorylation of p53 at Ser-15 and subsequent p21(CIP1) induction.	[Park, Joongkyu; Oh, Yohan; Yoo, Lang; Chung, Kwang Chul] Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Jung, Min-Su; Song, Woo-Joo] Inje Univ, Inst Brain Sci & Technol, Grad Program Neurosci, Pusan 633146, South Korea; [Lee, Sang-Hun] Hanyang Univ, Coll Med, Dept Biochem, Seoul 133791, South Korea; [Seo, Hyemyung] Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, Ansan 426791, Gyeonggi Do, South Korea	Yonsei University; Inje University; Hanyang University; Hanyang University	Chung, KC (corresponding author), Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seongsan No 262, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Oh, Yohan/C-9107-2013; rchnds, rchnds/D-7595-2016; PARK, joohyun/D-5808-2012; lee, sang hun/Q-4650-2019; Park, Joongkyu/ADZ-1994-2022	Oh, Yohan/0000-0002-9249-8664; lee, sang hun/0000-0002-9005-5966; Park, Joongkyu/0000-0002-5675-2872				Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chinery R, 1997, NAT MED, V3, P1233, DOI 10.1038/nm1197-1233; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; CURRLE DS, 2007, JOVE-J VIS EXP, V2, P152; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; HARPER JW, 1993, CELL, V75, P805; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hofmann TG, 2000, BIOCHIMIE, V82, P1123, DOI 10.1016/S0300-9084(00)01196-2; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Larsen KB, 2008, ANN ANAT, V190, P421, DOI 10.1016/j.aanat.2008.05.007; LEJEUNE J, 1959, TURPIN R C R HEBD SE, V248, P1721; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Matsumura I, 1997, MOL CELL BIOL, V17, P2933, DOI 10.1128/MCB.17.5.2933; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Seidl R, 1999, NEUROSCI LETT, V260, P9, DOI 10.1016/S0304-3940(98)00945-8; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Tanzi RE, 1996, NAT MED, V2, P31, DOI 10.1038/nm0196-31; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; WISNIEWSKI KE, 1984, NEW ENGL J MED, V311, P1187; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	53	83	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31895	U919		10.1074/jbc.M110.147520	http://dx.doi.org/10.1074/jbc.M110.147520			36	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20696760	hybrid, Green Published			2022-12-25	WOS:000282764600081
J	Laget, S; Joulie, M; Le Masson, F; Sasai, N; Christians, E; Pradhan, S; Roberts, RJ; Defossez, PA				Laget, Sophie; Joulie, Michael; Le Masson, Florent; Sasai, Nobuhiro; Christians, Elisabeth; Pradhan, Sriharsa; Roberts, Richard J.; Defossez, Pierre-Antoine			The Human Proteins MBD5 and MBD6 Associate with Heterochromatin but They Do Not Bind Methylated DNA	PLOS ONE			English	Article							PWWP DOMAIN; MECP2; INHERITANCE; PHENOTYPE; MEIOSIS; COMPLEX; FAMILY; KAISO; PLAY	Background: MBD5 and MBD6 are two uncharacterized mammalian proteins that contain a putative Methyl-Binding Domain (MBD). In the proteins MBD1, MBD2, MBD4, and MeCP2, this domain allows the specific recognition of DNA containing methylated cytosine; as a consequence, the proteins serve as interpreters of DNA methylation, an essential epigenetic mark. It is unknown whether MBD5 or MBD6 also bind methylated DNA; this question has interest for basic research, but also practical consequences for human health, as MBD5 deletions are the likely cause of certain cases of mental retardation. Principal Findings: Here we report the first functional characterization of MBD5 and MBD6. We have observed that the proteins colocalize with heterochromatin in cultured cells, and that this localization requires the integrity of their MBD. However, heterochromatic localization is maintained in cells with severely decreased levels of DNA methylation. In vitro, neither MBD5 nor MBD6 binds any of the methylated sequences DNA that were tested. Conclusions: Our data suggest that MBD5 and MBD6 are unlikely to be methyl-binding proteins, yet they may contribute to the formation or function of heterochromatin. One isoform of MBD5 is highly expressed in oocytes, which suggests a possible role in epigenetic reprogramming after fertilization.	[Laget, Sophie; Pradhan, Sriharsa; Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA; [Laget, Sophie; Joulie, Michael; Sasai, Nobuhiro; Defossez, Pierre-Antoine] Univ Paris Diderot, CNRS, UMR7216, Paris, France; [Le Masson, Florent; Christians, Elisabeth] Univ Toulouse 3, CNRS, UMR 5547, F-31062 Toulouse, France	New England Biolabs; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Laget, S (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	Pierre-Antoine.Defossez@univ-paris-diderot.fr		Defossez, Pierre-Antoine/0000-0002-6463-9263; Roberts, Richard/0000-0002-4348-0169	Centre National de la Recherche Scientifique; New England Biolabs, Inc.; Institut National du Cancer	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); New England Biolabs, Inc.; Institut National du Cancer(Institut National du Cancer (INCA) France)	SL was supported in part by a doctoral fellowship from Centre National de la Recherche Scientifique. SL, SP and RJR acknowledge Don Comb and Jim Ellard for encouraging basic research and New England Biolabs, Inc. for funding. MJ was supported by a doctoral fellowship from Institut National du Cancer, and NS was supported by a postdoctoral fellowship from Institut National du Cancer. Work in the lab of PAD is supported by Association pour la Recherche contre le Cancer and Ligue Nationale contre le Cancer (Comite de Paris). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication charges for open access are covered by New England Biolabs.	Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Carrell DT, 2010, MOL HUM REPROD, V16, P37, DOI 10.1093/molehr/gap090; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Grosso S, 2008, EPILEPSY RES, V79, P63, DOI 10.1016/j.eplepsyres.2007.12.011; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Jaillard S, 2009, J MED GENET, V46, P847, DOI 10.1136/jmg.2008.058156; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Lande-Diner L, 2007, J BIOL CHEM, V282, P12194, DOI 10.1074/jbc.M607838200; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Roloff TC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-1; SASAI N, 2010, NUCL ACIDS IN PRESS; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Williams SR, 2010, EUR J HUM GENET, V18, P436, DOI 10.1038/ejhg.2009.199; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	45	67	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11982	10.1371/journal.pone.0011982	http://dx.doi.org/10.1371/journal.pone.0011982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700456	Green Published, gold, Green Submitted			2022-12-25	WOS:000280687900005
J	Kalapala, SK; Hobbie, SN; Bottger, EC; Shcherbakov, D				Kalapala, Sarath K.; Hobbie, Sven N.; Boettger, Erik C.; Shcherbakov, Dmitry			Mutation K42R in Ribosomal Protein S12 Does Not Affect Susceptibility of Mycobacterium smegmatis 16S rRNA A-Site Mutants to 2-Deoxystreptamines	PLOS ONE			English	Article							AMINOGLYCOSIDE RESISTANCE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; STREPTOMYCIN; ANTIBIOTICS	Recent studies have suggested that ribosomal protein S12 modulates 16S rRNA function and susceptibility to 2-deoxystreptamine aminoglycosides. To study whether the non-restrictive K42R mutation in RpsL affects 2-deoxystreptamine susceptibility in Mycobacterium smegmatis, we studied the drug susceptibility pattern of various mutants with genetic alterations in the 16S rRNA decoding A-site in the context of wild-type and mutant protein S12. RpsL K42R substitution was found not to affect the drug resistance pattern associated with mutational alterations in 16S rRNA H44.	[Kalapala, Sarath K.; Hobbie, Sven N.; Boettger, Erik C.; Shcherbakov, Dmitry] Univ Zurich, Inst Med Mikrobiol, Zurich, Switzerland; [Hobbie, Sven N.] Singapore MIT Alliance Res & Technol SMART, Ctr Life Sci, Singapore, Singapore	University of Zurich; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Kalapala, SK (corresponding author), Univ Zurich, Inst Med Mikrobiol, Zurich, Switzerland.	dscherbakov@imm.uzh.ch	Böttger, Erik C./F-6175-2011	Scherbakov, Dimitri/0000-0001-5462-6584; Hobbie, Sven N./0000-0002-9205-0384	European Community [FP7-HEALTH-2009-241476]	European Community(European Commission)	This work was supported by grant from the European Community (PAR, FP7-HEALTH-2009-241476). URL of funder's website: http://cordis.europa.eu/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PN, 1989, J MOL BIOL, V208, P457, DOI 10.1016/0022-2836(89)90509-3; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fan-Minogue H, 2008, RNA, V14, P148, DOI 10.1261/rna.805208; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; FUNATSU G, 1972, J MOL BIOL, V68, P547, DOI 10.1016/0022-2836(72)90108-8; Gromadski KB, 2004, NAT STRUCT MOL BIOL, V11, P316, DOI 10.1038/nsmb742; Hobbie SN, 2006, BIOCHIMIE, V88, P1033, DOI 10.1016/j.biochi.2006.04.008; Hobbie SN, 2005, ANTIMICROB AGENTS CH, V49, P5112, DOI 10.1128/AAC.49.12.5112-5118.2005; Kurland C.G., 1996, ESCHERICHIA COLI SAL, P979; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; OCONNOR M, 1991, BIOCHIMIE, V73, P1493, DOI 10.1016/0300-9084(91)90183-2; Pfister P, 2005, J MOL BIOL, V346, P467, DOI 10.1016/j.jmb.2004.11.073; Pfister P, 2003, CHEMBIOCHEM, V4, P1078, DOI 10.1002/cbic.200300657; Prammananan T, 1999, ANTIMICROB AGENTS CH, V43, P447, DOI 10.1128/AAC.43.3.447; SANDER P, 1995, MOL MICROBIOL, V16, P991, DOI 10.1111/j.1365-2958.1995.tb02324.x; Sander P, 1996, MOL MICROBIOL, V22, P841, DOI 10.1046/j.1365-2958.1996.01532.x; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; Toivonen JM, 1999, MOL MICROBIOL, V31, P1735, DOI 10.1046/j.1365-2958.1999.01307.x; Vila-Sanjurjo A, 2007, BBA-GENE STRUCT EXPR, V1769, P462, DOI 10.1016/j.bbaexp.2007.04.004	21	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11960	10.1371/journal.pone.0011960	http://dx.doi.org/10.1371/journal.pone.0011960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700526	Green Published, gold			2022-12-25	WOS:000280605400008
J	Zabaneh, D; Balding, DJ				Zabaneh, Delilah; Balding, David J.			A Genome-Wide Association Study of the Metabolic Syndrome in Indian Asian Men	PLOS ONE			English	Article							LOCI; RISK; POPULATION; VARIANT	We conducted a two-stage genome-wide association study to identify common genetic variation altering risk of the metabolic syndrome and related phenotypes in Indian Asian men, who have a high prevalence of these conditions. In Stage 1, approximately 317,000 single nucleotide polymorphisms were genotyped in 2700 individuals, from which 1500 SNPs were selected to be genotyped in a further 2300 individuals. Selection for inclusion in Stage 1 was based on four metabolic syndrome component traits: HDL-cholesterol, plasma glucose and Type 2 diabetes, abdominal obesity measured by waist to hip ratio, and diastolic blood pressure. Association was tested with these four traits and a composite metabolic syndrome phenotype. Four SNPs reaching significance level p<5x10(-7) and with posterior probability of association >0.8 were found in genes CETP and LPL, associated with HDL-cholesterol. These associations have already been reported in Indian Asians and in Europeans. Five additional loci harboured SNPs significant at p<10(-6) and posterior probability >0.5 for HDL-cholesterol, type 2 diabetes or diastolic blood pressure. Our results suggest that the primary genetic determinants of metabolic syndrome are the same in Indian Asians as in other populations, despite the higher prevalence. Further, we found little evidence of a common genetic basis for metabolic syndrome traits in our sample of Indian Asian men.	[Zabaneh, Delilah; Balding, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England	Imperial College London	Zabaneh, D (corresponding author), UCL, UCL Genet Inst, London, England.	d.zabaneh@ucl.ac.uk	Balding, David/G-9898-2011	Balding, David/0000-0002-1480-6115	British Heart Foundation [SP/04/02]	British Heart Foundation(British Heart Foundation)	D. Zabaneh and stage one and two genotyping were funded by the British Heart Foundation [SP/04/02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hiura Y, 2009, CIRC J, V73, P1119, DOI 10.1253/circj.CJ-08-1101; Joy T, 2008, CURR DIABETES REP, V8, P141, DOI 10.1007/s11892-008-0025-y; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sjogren M, 2008, DIABETOLOGIA, V51, P2242, DOI 10.1007/s00125-008-1151-4; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; STEPHENS M, 2009, NATURE REV GENETICS, V10; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; World Health Organization, WHO DEF DIAGN CLASS; YU W, 2009, GENOPEDIA HUGE NAVIG; Zabaneh D, 2009, DIABETOLOGIA, V52, P2585, DOI 10.1007/s00125-009-1504-7; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; BLOOD, V285, P2486	26	93	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11961	10.1371/journal.pone.0011961	http://dx.doi.org/10.1371/journal.pone.0011961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694148	Green Published, gold			2022-12-25	WOS:000280574300013
J	Ahn, AC; Park, M; Shaw, JR; McManus, CA; Kaptchuk, TJ; Langevin, HM				Ahn, Andrew C.; Park, Min; Shaw, Jessica R.; McManus, Claire A.; Kaptchuk, Ted J.; Langevin, Helene M.			Electrical Impedance of Acupuncture Meridians: The Relevance of Subcutaneous Collagenous Bands	PLOS ONE			English	Article							HYPODERMICALLY INJECTED TC-99M; LAPLACE PLANE ANALYSIS; CONNECTIVE-TISSUE; RADIOACTIVE PATHWAYS; TRIGGER POINTS; INVASION; MECHANISMS; ULTRASOUND; NETWORK; HUMANS	Background: The scientific basis for acupuncture meridians is unknown. Past studies have suggested that acupuncture meridians are physiologically characterized by low electrical impedance and anatomically associated with connective tissue planes. We are interested in seeing whether acupuncture meridians are associated with lower electrical impedance and whether ultrasound-derived measures-specifically echogenic collagenous bands - can account for these impedance differences. Methods/Results: In 28 healthy subjects, we assessed electrical impedance of skin and underlying subcutaneous connective tissue using a four needle-electrode approach. The impedances were obtained at 10 kHz and 100 kHz frequencies and at three body sites - upper arm (Large Intestine meridian), thigh (Liver), and lower leg (Bladder). Meridian locations were determined by acupuncturists. Ultrasound images were obtained to characterize the anatomical features at each measured site. We found significantly reduced electrical impedance at the Large Intestine meridian compared to adjacent control for both frequencies. No significant decrease in impedance was found at the Liver or Bladder meridian. Greater subcutaneous echogenic densities were significantly associated with reduced impedances in both within-site (meridian vs. adjacent control) and between-site (arm vs. thigh vs. lower leg) analyses. This relationship remained significant in multivariable analyses which also accounted for gender, needle penetration depth, subcutaneous layer thickness, and other ultrasound-derived measures. Conclusion/Significance: Collagenous bands, represented by increased ultrasound echogenicity, are significantly associated with lower electrical impedance and may account for reduced impedances previously reported at acupuncture meridians. This finding may provide important insights into the nature of acupuncture meridians and the relevance of collagen in bioelectrical measurements.	[Ahn, Andrew C.] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Ahn, Andrew C.; Kaptchuk, Ted J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Park, Min] P Pro Korea Co Ltd, Seoul, South Korea; [Shaw, Jessica R.] AltThera Hlth, Boston, MA USA; [McManus, Claire A.] Spaulding Rehabil Hosp, Dept Res & Training, Boston, MA USA; [Kaptchuk, Ted J.] Harvard Univ, Sch Med, Div Res & Educ Complementary & Integrat Med Thera, Boston, MA USA; [Langevin, Helene M.] Univ Vermont, Dept Neurol, Burlington, VT USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; University of Vermont	Ahn, AC (corresponding author), Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA.	aahn1@partners.org			National Center for Complementary Alternative Medicine (NCCAM) [K23-AT003238, P30AT005895, K24-AT004095]; Clinical Translational Science Award [UL1RR025758]; Bernard Osher Foundation; Beth Israel Deaconess Medical Center from the National Center for Research Resources; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT003238, P30AT005895] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	National Center for Complementary Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Clinical Translational Science Award; Bernard Osher Foundation; Beth Israel Deaconess Medical Center from the National Center for Research Resources; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grant number K23-AT003238, P30AT005895, and K24-AT004095 of the National Center for Complementary Alternative Medicine (NCCAM) and supported in part by a gift from The Bernard Osher Foundation. The project described was supported by Clinical Translational Science Award UL1RR025758 to Harvard University and Beth Israel Deaconess Medical Center from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary Alternative Medicine or the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AC, 2008, BIOELECTROMAGNETICS, V29, P245, DOI 10.1002/bem.20403; Ahn Andrew C, 2005, BMC Complement Altern Med, V5, P10, DOI 10.1186/1472-6882-5-10; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; CHENG XM, 1995, ACUPUNCTURE REFERENC; Deadman P., 1998, J CHINESE MED PUBLIC; DEVERNEJOUL P, 1992, J NUCL MED, V33, P409; Grimnes S, 2007, J PHYS D APPL PHYS, V40, P9, DOI 10.1088/0022-3727/40/1/S02; HEINE H, 1988, Journal of Traditional Chinese Medicine, V8, P207; Ho MW, 1998, AM J CHINESE MED, V26, P251, DOI 10.1142/S0192415X98000294; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; KIM HJ, 2009, IEEE T MED IMAGING; KOVACS FM, 1993, EUR J NUCL MED, V20, P585; KOVACS FM, 1992, J NUCL MED, V33, P403; Kovacs FM, 2000, EUR RADIOL, V10, P1019, DOI 10.1007/s003300051056; Kovacs FM, 1996, AM J CHINESE MED, V24, P101; Langevin Helene M., 2002, Anatomical Record, V269, P257, DOI 10.1002/ar.10185; Langevin HM, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-25; Langevin HM, 2002, FASEB J, V16, P872, DOI 10.1096/fj.01-0925fje; Langevin HM, 2004, ULTRASOUND MED BIOL, V30, P1173, DOI 10.1016/j.ultrasmedbio.2004.07.010; Langevin HM, 2001, FASEB J, V15, P2275, DOI 10.1096/fj.01-0015hyp; Langevin HM, 2001, J APPL PHYSIOL, V91, P2471, DOI 10.1152/jappl.2001.91.6.2471; MELZACK R, 1977, PAIN, V3, P3, DOI 10.1016/0304-3959(77)90032-X; MELZACK R, 1981, ARCH PHYS MED REHAB, V62, P114; Oschman J. L., 2000, ENERGY MED SCI BASIS; Osterman KS, 1999, ANN NY ACAD SCI, V873, P21, DOI 10.1111/j.1749-6632.1999.tb09445.x; RABISCHONG P, 1975, NOUV PRESSE MED, V4, P2021; Regling G, 2000, ELECTRO MAGNETOBIOL, V19, P149, DOI 10.3109/15368370009167833; REICHMANIS M, 1977, COMP MED EAST WEST, V5, P289, DOI 10.1142/S0147291777000416; REICHMANIS M, 1979, AM J CHINESE MED, V7, P188, DOI 10.1142/S0192415X79000167; REICHMANIS M, 1977, IEEE T BIO-MED ENG, V24, P402, DOI 10.1109/TBME.1977.326154; Schwartzman D, 1999, J INTERV CARD ELECTR, V3, P213, DOI 10.1023/A:1009887306055; SENELAR R, 1979, CHARACTERISTIQUES MO; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Tabel GM, 2006, ECHOCARDIOGR-J CARD, V23, P103, DOI 10.1111/j.1540-8175.2006.00178.x; TIBERIU R, 1981, AM J ACUPUNCTURE, V9, P251; VANDERSCHOT L, 1976, American Journal of Acupuncture, V4, P233	36	46	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11907	10.1371/journal.pone.0011907	http://dx.doi.org/10.1371/journal.pone.0011907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689594	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520300021
J	Isomura, H; Stinski, MF; Murata, T; Nakayama, S; Chiba, S; Akatsuka, Y; Kanda, T; Tsurumi, T				Isomura, Hiroki; Stinski, Mark F.; Murata, Takayuki; Nakayama, Sanae; Chiba, Shigeki; Akatsuka, Yoshiki; Kanda, Teru; Tsurumi, Tatsuya			The Human Cytomegalovirus UL76 Gene Regulates the Level of Expression of the UL77 Gene	PLOS ONE			English	Article							OPEN READING FRAME; IMMEDIATE-EARLY PROMOTER; EARLY DISTAL ENHANCER; CIS-ACTING ELEMENTS; VIRAL REPLICATION; TRANSLATIONAL INHIBITION; PROXIMAL ENHANCER; TRANSCRIPTION; DNA; PROTEIN	Background: Human cytomegalovirus (HCMV) can be reactivated under immunosuppressive conditions causing several fatal pneumonitis, hepatitis, retinitis, and gastrointestinal diseases. HCMV also causes deafness and mental retardation in neonates when primary infection has occurred during pregnancy. In the genome of HCMV at least 194 known open reading frames (ORFs) have been predicted, and approximately one-quarter, or 41 ORFs, are required for viral replication in cell culture. In contrast, the majority of the predicted ORFs are nonessential for viral replication in cell culture. However, it is also possible that these ORFs are required for the efficient viral replication in the host. The UL77 gene of HCMV is essential for viral replication and has a role in viral DNA packaging. The function of the upstream UL76 gene in the HCMV-infected cells is not understood. UL76 and UL77 are cistons on the same viral mRNA and a conventional 59 mRNA for UL77 has not been detected. The vast majority of eukaryotic mRNAs are monocistronic, i.e., they encode only a single protein. Methodology/Principal Findings: To determine whether the UL76 ORF affects UL77 gene expression, we mutated UL76 by ORF frame-shifts, stop codons or deletion of the viral gene. The effect on UL77 protein expression was determined by either transfection of expression plasmids or infection with recombinant viruses. Mutation of UL76 ORF significantly increased the level of UL77 protein expression. However, deletion of UL76 upstream of the UL77 ORF had only marginal effects on viral growth. Conclusions/Significance: While UL76 is not essential for viral replication, the UL76 ORF is involved in regulation of the level of UL77 protein expression in a manner dependent on the translation re-initiation. UL76 may fine-tune the UL77 expression for the efficient viral replication in the HCMV-infected cells.	[Isomura, Hiroki; Murata, Takayuki; Nakayama, Sanae; Chiba, Shigeki; Kanda, Teru; Tsurumi, Tatsuya] Aichi Canc Ctr, Res Inst, Div Virol, Nagoya, Aichi 464, Japan; [Akatsuka, Yoshiki] Aichi Canc Ctr, Res Inst, Div Immunol, Nagoya, Aichi 464, Japan; [Stinski, Mark F.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	Aichi Cancer Center; Aichi Cancer Center; University of Iowa	Isomura, H (corresponding author), Aichi Canc Ctr, Res Inst, Div Virol, Nagoya, Aichi 464, Japan.	hisomura@aichi-cc.jp	Kanda, Teru/J-7313-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; akatsuka, yoshiki/0000-0003-3623-2826; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Science, Sports, Culture and Technology of Japan [20012056, 19041078, 20390137, 19590487]; Research on Health Sciences focusing on Drug Innovation [SH54412]; Ministry of Health, Labor and Welfare [19-01]; National Institutes of Health [AI-13562]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI013562, R01AI013562] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research on Health Sciences focusing on Drug Innovation; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, Culture and Technology of Japan (20012056, 19041078, 20390137 to T.T., and 19590487 to H. I.), Research on Health Sciences focusing on Drug Innovation (SH54412 to H.I.), a Grant-in-aid for Cancer Research (19-01 to H.I.) from the Ministry of Health, Labor and Welfare, and grant AI-13562 from the National Institutes of Health (to M.F.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM BL, 1995, J VIROL, V69, P5304, DOI 10.1128/JVI.69.9.5304-5310.1995; Akatsuka Y, 2002, TISSUE ANTIGENS, V59, P502, DOI 10.1034/j.1399-0039.2002.590607.x; Alderete JP, 1999, J VIROL, V73, P8330, DOI 10.1128/JVI.73.10.8330-8337.1999; BIEGALKE BJ, 1990, VIROLOGY, V177, P657, DOI 10.1016/0042-6822(90)90531-U; CAO JH, 1995, J VIROL, V69, P1030, DOI 10.1128/JVI.69.2.1030-1036.1995; Cao JH, 1996, MOL CELL BIOL, V16, P603; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Chambers J, 1999, J VIROL, V73, P5757, DOI 10.1128/JVI.73.7.5757-5766.1999; DEGNIN CR, 1993, J VIROL, V67, P5514, DOI 10.1128/JVI.67.9.5514-5521.1993; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; GEBALLE AP, 1988, J VIROL, V62, P3334, DOI 10.1128/JVI.62.9.3334-3340.1988; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hahn G, 2003, VIROLOGY, V307, P164, DOI 10.1016/S0042-6822(02)00061-2; Horn PA, 2002, BLOOD, V100, P3960, DOI 10.1182/blood-2002-05-1359; Isomura H, 2005, J VIROL, V79, P9597, DOI 10.1128/JVI.79.15.9597-9607.2005; Isomura H, 2004, J VIROL, V78, P12788, DOI 10.1128/JVI.78.23.12788-12799.2004; Isomura H, 2003, J VIROL, V77, P3602, DOI 10.1128/JVI.77.6.3602-3614.2003; Isomura H, 2008, J VIROL, V82, P1638, DOI 10.1128/JVI.01917-07; Isomura H, 2008, J VIROL, V82, P849, DOI 10.1128/JVI.01593-07; Isomura H, 2007, J VIROL, V81, P6197, DOI 10.1128/JVI.00089-07; LIU B, 1992, J VIROL, V66, P4434, DOI 10.1128/JVI.66.7.4434-4444.1992; Meier JL, 1997, J VIROL, V71, P1246, DOI 10.1128/JVI.71.2.1246-1255.1997; Meier JL, 2002, J VIROL, V76, P313, DOI 10.1128/JVI.76.1.313-326.2002; Meier JL, 2000, J VIROL, V74, P1602, DOI 10.1128/JVI.74.4.1602-1613.2000; Mitchell DP, 2009, J VIROL, V83, P10187, DOI 10.1128/JVI.00396-09; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; PARI GS, 1993, J VIROL, V67, P6979, DOI 10.1128/JVI.67.12.6979-6988.1993; SCHLEISS MR, 1991, J VIROL, V65, P6782, DOI 10.1128/JVI.65.12.6782-6789.1991; STINSKI MF, 1978, J VIROL, V26, P686, DOI 10.1128/JVI.26.3.686-701.1978; TENNEY DJ, 1991, VIROLOGY, V182, P199, DOI 10.1016/0042-6822(91)90663-V; Wang SK, 2000, J GEN VIROL, V81, P2407, DOI 10.1099/0022-1317-81-10-2407; Wang SK, 2004, J VIROL, V78, P9750, DOI 10.1128/JVI.78.18.9750-9762.2004; White EA, 2004, J VIROL, V78, P1817, DOI 10.1128/JVI.78.4.1817-1830.2004; White EA, 2007, J VIROL, V81, P2573, DOI 10.1128/JVI.02454-06; WING BA, 1995, J VIROL, V69, P1521, DOI 10.1128/JVI.69.3.1521-1531.1995; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100	39	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11901	10.1371/journal.pone.0011901	http://dx.doi.org/10.1371/journal.pone.0011901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689582	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520300016
J	Muster, B; Kohl, W; Wittig, I; Strecker, V; Joos, F; Haase, W; Bereiter-Hahn, J; Busch, K				Muster, Britta; Kohl, Wladislaw; Wittig, Ilka; Strecker, Valentina; Joos, Friederike; Haase, Winfried; Bereiter-Hahn, Juergen; Busch, Karin			Respiratory Chain Complexes in Dynamic Mitochondria Display a Patchy Distribution in Life Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; QUALITY-CONTROL; FUSION PROTEINS; ATP SYNTHASE; CYTOCHROME-C; IN-VIVO; FISSION; MORPHOLOGY; DIVISION; CRISTAE	Background: Mitochondria, the main suppliers of cellular energy, are dynamic organelles that fuse and divide frequently. Constraining these processes impairs mitochondrial is closely linked to certain neurodegenerative diseases. It is proposed that functional mitochondrial dynamics allows the exchange of compounds thereby providing a rescue mechanism. Methodology/Principal Findings: The question discussed in this paper is whether fusion and fission of mitochondria in different cell lines result in re-localization of respiratory chain (RC) complexes and of the ATP synthase. This was addressed by fusing cells containing mitochondria with respiratory complexes labelled with different fluorescent proteins and resolving their time dependent re-localization in living cells. We found a complete reshuffling of RC complexes throughout the entire chondriome in single HeLa cells within 2-3 h by organelle fusion and fission. Polykaryons of fused cells completely re-mixed their RC complexes in 10-24 h in a progressive way. In contrast to the recently described homogeneous mixing of matrix-targeted proteins or outer membrane proteins, the distribution of RC complexes and ATP synthase in fused hybrid mitochondria, however, was not homogeneous but patterned. Thus, complete equilibration of respiratory chain complexes as integral inner mitochondrial membrane complexes is a slow process compared with matrix proteins probably limited by complete fusion. In co-expressing cells, complex II is more homogenously distributed than complex I and V, resp. Indeed, this result argues for higher mobility and less integration in supercomplexes. Conclusion/Significance: Our results clearly demonstrate that mitochondrial fusion and fission dynamics favours the re-mixing of all RC complexes within the chondriome. This permanent mixing avoids a static situation with a fixed composition of RC complexes per mitochondrion.	[Muster, Britta; Kohl, Wladislaw; Bereiter-Hahn, Juergen; Busch, Karin] Goethe Univ Frankfurt, Inst Kinemat Cell Res, Dept Biol, Frankfurt, Germany; [Kohl, Wladislaw; Busch, Karin] Univ Osnabrueck, Lab Mitochondrial Dynam, Dept Biol, Osnabruck, Germany; [Wittig, Ilka; Strecker, Valentina] Goethe Univ Frankfurt, Inst Mol Bioenerget, Sch Med, Frankfurt, Germany; [Joos, Friederike; Haase, Winfried] Max Planck Inst Biophys, Electron Facil, D-6000 Frankfurt, Germany	Goethe University Frankfurt; University Osnabruck; Goethe University Frankfurt; Max Planck Society	Muster, B (corresponding author), Goethe Univ Frankfurt, Inst Kinemat Cell Res, Dept Biol, Frankfurt, Germany.	busch_k@biologie.uni-osnabrueck.de	Busch, Karin/AAM-8374-2021; Busch, Karin/ABH-8594-2020	Busch, Karin/0000-0003-0525-0191	Deutsche Forschungsgemeinschaft [Bu2288/1, Sonderforschungsbereich 815, Z1]; Bundesministerium fuer Bildung und Forschung (BMBF) [01GM0863]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by a DFG grant (Bu2288/1) http://www.dfg.de. I.W. was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 815, Project Z1 (Redox-Proteomics), and V. S. by the Bundesministerium fuer Bildung und Forschung (BMBF 01GM0863; mitoNET - Deutsches Netzwerk fuer mitochondriale Erkrankungen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2009, FEBS LETT, V583, P113, DOI 10.1016/j.febslet.2008.11.028; Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; BEREITERHAHN J, 1983, CELL BIOCH AND FUNCT, V6, P1; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292; CHANCE B, 1955, J BIOL CHEM, V217, P429; CHEN H, 2003, DEVELOPMENT, V70, P1; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Choksi KB, 2008, FREE RADICAL BIO MED, V44, P1795, DOI 10.1016/j.freeradbiomed.2008.01.032; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; JCELL B, 1960, J CELL BIOL, V189, P200; Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002; Jensen RE, 2000, MICROSC RES TECHNIQ, V51, P573, DOI 10.1002/1097-0029(20001215)51:6<573::AID-JEMT7>3.0.CO;2-2; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Keppler A, 2004, METHODS, V32, P437, DOI 10.1016/j.ymeth.2003.10.007; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kowald A, 2005, AGING CELL, V4, P273, DOI 10.1111/j.1474-9726.2005.00169.x; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Linford NJ, 2006, CANCER RES, V66, P2497, DOI 10.1158/0008-5472.CAN-05-3163; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Lu BW, 2009, CURR NEUROL NEUROSCI, V9, P212, DOI 10.1007/s11910-009-0032-7; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Molina AJA, 2009, METHOD ENZYMOL, V457, P289, DOI 10.1016/S0076-6879(09)05016-2; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Pickrell AM, 2009, J BIOENERG BIOMEMBR, V41, P453, DOI 10.1007/s10863-009-9245-3; Prescott M, 2003, J BIOL CHEM, V278, P251, DOI 10.1074/jbc.M204556200; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; Ramadass R, 2008, BIOPHYS J, V95, P4068, DOI 10.1529/biophysj.108.135079; Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001; Reed JC, 2002, MOL CELL, V9, P1, DOI 10.1016/S1097-2765(02)00437-9; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9; Sato A, 2009, BIOFACTORS, V35, P130, DOI 10.1002/biof.14; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Scorrano L, 2005, J BIOENERG BIOMEMBR, V37, P165, DOI 10.1007/s10863-005-6572-x; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sheahan MB, 2005, PLANT J, V44, P744, DOI 10.1111/j.1365-313X.2005.02561.x; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yaffe MP, 1999, NAT CELL BIOL, V1, pE149, DOI 10.1038/14101; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; ZINN AR, 1987, PLASMID, V17, P248, DOI 10.1016/0147-619X(87)90033-3	81	62	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11910	10.1371/journal.pone.0011910	http://dx.doi.org/10.1371/journal.pone.0011910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689601	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520300024
J	Kapoor, R; van Hogerlinden, M; Wallis, K; Ghosh, H; Nordstrom, K; Vennstrom, B; Vaidya, VA				Kapoor, Richa; van Hogerlinden, Max; Wallis, Karin; Ghosh, Himanish; Nordstrom, Kristina; Vennstrom, Bjorn; Vaidya, Vidita A.			Unliganded thyroid hormone receptor alpha 1 impairs adult hippocampal neurogenesis	FASEB JOURNAL			English	Article						neural stem cell; hypothyroidism; neuronal progenitor	DENTATE GYRUS; DOUBLECORTIN EXPRESSION; BINDING-CAPACITY; GRANULE CELLS; RAT BRAIN; C-ERBA; HYPOTHYROIDISM; PLASTICITY; BEHAVIOR; MEMORY	Thyroid hormone regulates adult hippocampal neurogenesis, a process involved in key functions, such as learning, memory, and mood regulation. We addressed the role of thyroid hormone receptor TR alpha 1 in adult hippocampal neurogenesis, using mice harboring a TR alpha 1 null allele (TR alpha 1(-/-)), overexpressing TR alpha 1 6-fold (TR alpha 2(-/-)), and a mutant TR alpha 1 (TR alpha 1(+/m)) with a 10-fold lower affinity to the ligand. While hippocampal progenitor proliferation was unaltered, TR alpha 1(-/-) mice exhibited a significant increase in doublecortin-positive immature neurons and increased survival of bromodeoxyuridine-positive (BrdU(+)) progenitors as compared to wild-type controls. In contrast, the TR alpha 1(+/m) and the TR alpha 2(-/-) mice, where the over-expressed TR alpha 1 acts as an aporeceptor, showed a significant decline in surviving BrdU(+) progenitors. TR alpha 1(-/-) and TR alpha 2(-/-) mice showed opposing effects on neurogenic markers like polysialylated neural cell adhesion molecule and stathmin. The decreased progenitor survival in the TR alpha 2(-/-) and TR alpha 1(+/m) mice could be rescued by thyroid hormone treatment, as was the decline in neuronal differentiation seen in the TR alpha 1(+/m) mice. These mice also exhibited a decrease in NeuroD(+) cell numbers in the dentate gyrus, suggesting an effect on early postmitotic progenitors. Our results provide the first evidence of a role for unliganded TR alpha 1 in modulating the deleterious effects of hypothyroidism on adult hippocampal neurogenesis.-Kapoor, R., van Hogerlinden, M., Wallis, K., Ghosh, H., Nordstrom, K., Vennstrom, B., Vaidya, V. A. Unliganded thyroid hormone receptor alpha 1 impairs adult hippocampal neurogenesis. FASEB J. 24, 4793-4805 (2010). www.fasebj.org	[Kapoor, Richa; Ghosh, Himanish; Vaidya, Vidita A.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [van Hogerlinden, Max; Wallis, Karin; Nordstrom, Kristina; Vennstrom, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Tata Institute of Fundamental Research (TIFR); Karolinska Institutet	Vaidya, VA (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	bjorn.vennstrom@ki.se; vvaidya@tifr.res.in		Vaidya, Vidita/0000-0002-3907-8580	TIFR; Wellcome Trust [04082003114133]; Swedish Research Council; Swedish Cancer Society; Wallenberg Foundations; Swedish Society for Medical Research (SSMF)	TIFR(Tata Institute of Fundamental Research (TIFR)); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wallenberg Foundations; Swedish Society for Medical Research (SSMF)	This work was supported by intramural funds from TIFR and a Wellcome Trust Senior Overseas Fellowship in biomedical sciences to V.A.V. (04082003114133). Support to B.V. was obtained from the Swedish Research Council, the Swedish Cancer Society, and the Wallenberg Foundations. M.V. received a Swedish Society for Medical Research (SSMF) fellowship. The authors are grateful to Professor T. Seki (Juntendo University School of Medicine, Tokyo, Japan) for the gift of the PSA-NCAM antibody.	Ambrogini P, 2005, NEUROENDOCRINOLOGY, V81, P244, DOI 10.1159/000087648; Baldini IM, 1997, PROG NEURO-PSYCHOPH, V21, P925, DOI 10.1016/S0278-5846(97)00089-4; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268, DOI 10.1007/BF03344003; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Calza L, 1997, BRAIN RES BULL, V44, P549, DOI 10.1016/S0361-9230(97)00241-4; Chantoux F, 2002, MOL CELL ENDOCRINOL, V194, P157, DOI 10.1016/S0303-7207(02)00133-8; Clos J, 1990, GROWTH FACTORS, V3, P205, DOI 10.3109/08977199009043905; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Daury L, 2001, FEBS LETT, V508, P236, DOI 10.1016/S0014-5793(01)03063-0; Desouza LA, 2005, MOL CELL NEUROSCI, V29, P414, DOI 10.1016/j.mcn.2005.03.010; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; ErcanFang S, 1996, ENDOCRINOLOGY, V137, P3228, DOI 10.1210/en.137.8.3228; FUNDARO A, 1989, PROG NEURO-PSYCHOPH, V13, P927, DOI 10.1016/0278-5846(89)90044-4; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Gilbert ME, 2003, DEV BRAIN RES, V145, P19, DOI 10.1016/S0165-3806(03)00191-3; Guadano-Ferraz A, 2003, MOL PSYCHIATR, V8, P30, DOI 10.1038/sj.mp.4001196; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; Kulikov A, 1997, NEUROSCI LETT, V234, P111, DOI 10.1016/S0304-3940(97)00664-2; Lemkine GF, 2005, FASEB J, V19, P863, DOI 10.1096/fj.04-2916fje; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Montero-Pedrazuela A, 2006, MOL PSYCHIATR, V11, P361, DOI 10.1038/sj.mp.4001802; MUNOZ A, 1993, J CELL BIOL, V121, P423, DOI 10.1083/jcb.121.2.423; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; OSTERWEIL D, 1992, J AM GERIATR SOC, V40, P325, DOI 10.1111/j.1532-5415.1992.tb02130.x; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pilhatsch M, 2010, BEHAV BRAIN RES, V214, P187, DOI 10.1016/j.bbr.2010.05.016; Salto C, 2001, MOL ENDOCRINOL, V15, P2115, DOI 10.1210/me.15.12.2115; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHWARTZ HL, 1992, J BIOL CHEM, V267, P11794; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Tinnikov A, 2002, EMBO J, V21, P5079, DOI 10.1093/emboj/cdf523; Vaidya Vidita A, 2007, Expert Rev Neurother, V7, P853, DOI 10.1586/14737175.7.7.853; Venero C, 2005, GENE DEV, V19, P2152, DOI 10.1101/gad.346105; WALLIS K, 2010, MOL ENDOCRI IN PRESS; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	48	43	46	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4793	4805		10.1096/fj.10-161802	http://dx.doi.org/10.1096/fj.10-161802			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20709911	Green Accepted			2022-12-25	WOS:000284824400019
J	Nassini, R; Materazzi, S; Andre, E; Sartiani, L; Aldini, G; Trevisani, M; Carnini, C; Massi, D; Pedretti, P; Carini, M; Cerbai, E; Preti, D; Villetti, G; Civelli, M; Trevisan, G; Azzari, C; Stokesberry, S; Sadofsky, L; McGarvey, L; Patacchini, R; Geppetti, P				Nassini, Romina; Materazzi, Serena; Andre, Eunice; Sartiani, Laura; Aldini, Giancarlo; Trevisani, Marcello; Carnini, Chiara; Massi, Daniela; Pedretti, Pamela; Carini, Marina; Cerbai, Elisabetta; Preti, Delia; Villetti, Gino; Civelli, Maurizio; Trevisan, Gabriela; Azzari, Chiara; Stokesberry, Susan; Sadofsky, Laura; McGarvey, Lorcan; Patacchini, Riccardo; Geppetti, Pierangelo			Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents	FASEB JOURNAL			English	Article						primary sensory neurons; substance P; asthma; chronic obstructive pulmonary disease	GENE-RELATED PEPTIDE; PARACETAMOL USE; BENZOQUINONE IMINE; SENSORY NERVES; ASTHMA; CHILDREN; RISK; ACTIVATION; DISEASE; TRPA1	Acetaminophen [N-acetyl-p-aminophenol (APAP)] is the most common antipyretic/analgesic medicine worldwide. If APAP is overdosed, its metabolite, N-acetyl-p-benzo-quinoneimine (NAPQI), causes liver damage. However, epidemiological evidence has associated previous use of therapeutic APAP doses with the risk of chronic obstructive pulmonary disease (COPD) and asthma. The transient receptor potential ankyrin-1 (TRPA1) channel is expressed by peptidergic primary sensory neurons. Because NAPQI, like other TRPA1 activators, is an electrophilic molecule, we hypothesized that APAP, via NAPQI, stimulates TRPA1, thus causing airway neurogenic inflammation. NAPQI selectively excites human recombinant and native (neuroblastoma cells) TRPA1. TRPA1 activation by NAPQI releases proinflammatory neuropeptides (substance P and calcitonin gene-related peptide) from sensory nerve terminals in rodent airways, thereby causing neurogenic edema and neutrophilia. Single or repeated administration of therapeutic (15-60 mg/kg) APAP doses to mice produces detectable levels of NAPQI in the lung, and increases neutrophil numbers, myeloperoxidase activity, and cytokine and chemokine levels in the airways or skin. Inflammatory responses evoked by NAPQI and APAP are abated by TRPA1 antagonism or are absent in TRPA1-deficient mice. This novel pathway, distinguished from the tissue-damaging effect of NAPQI, may contribute to the risk of COPD and asthma associated with therapeutic APAP use.-Nassini, R., Materazzi, S., Andre, E., Sartiani, L., Aldini, G., Trevisani, M., Carnini, C., Massi, D., Pedretti, P., Carini, M., Cerbai, E., Preti, D., Villetti, G., Civelli, M., Trevisan, G., Azzari, C., Stokesberry, S., Sadofsky, L., McGarvey, L., Patacchini, R., Geppetti, P. Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation causes neurogenic inflammation in the airways and other tissues in rodents. FASEB J. 24, 4904-4916 (2010). www.fasebj.org	[Nassini, Romina; Materazzi, Serena; Andre, Eunice; Sartiani, Laura; Pedretti, Pamela; Cerbai, Elisabetta; Trevisan, Gabriela; Geppetti, Pierangelo] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Massi, Daniela] Univ Florence, Dept Human Pathol & Oncol, I-50139 Florence, Italy; [Azzari, Chiara] Univ Florence, Dept Pediat, I-50139 Florence, Italy; [Aldini, Giancarlo; Carini, Marina] Univ Milan, Dept Pharmaceut Sci, Milan, Italy; [Trevisani, Marcello] Pharmeste Srl, Ferrara, Italy; [Carnini, Chiara; Villetti, Gino; Civelli, Maurizio; Patacchini, Riccardo] Chiesi Farmaceutici SpA, Dept Pharmacol, Parma, Italy; [Preti, Delia] Univ Ferrara, Dept Pharmaceut Chem, I-44100 Ferrara, Italy; [Stokesberry, Susan; McGarvey, Lorcan] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Sadofsky, Laura] Univ Hull, Castle Hill Hosp, Div Cardiovasc & Resp Studies, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Florence; University of Florence; University of Florence; University of Milan; Chiesi Pharmaceuticals Inc; University of Ferrara; Queens University Belfast; University of Hull	Geppetti, P (corresponding author), Univ Florence, Dept Preclin & Clin Pharmacol, Viale Pieraccini 6, I-50139 Florence, Italy.	geppetti@unifi.it	Sartiani, Laura/ABF-5576-2020; aldini, giancarlo/C-3533-2013; Trevisan, Gabriela/AAE-9573-2019; Nassini, Romina/AAC-5051-2022; Sadofsky, Laura/AAK-2029-2020; Geppetti, Pierangelo/AHA-7897-2022; preti, delia/G-9916-2015; Andre, Eunice/AAZ-9417-2021; Trevisan, Gabriela GT/K-8120-2014; Cerbai, Elisabetta/J-2663-2013; Sartiani, Laura/M-1364-2015; Azzari, Chiara/AAB-8584-2019; CARINI, MARINA/D-3084-2015	Sartiani, Laura/0000-0002-4208-0913; aldini, giancarlo/0000-0002-2355-6744; Trevisan, Gabriela/0000-0003-0137-5034; Nassini, Romina/0000-0002-9223-8395; preti, delia/0000-0002-1075-3781; Trevisan, Gabriela GT/0000-0003-0137-5034; Cerbai, Elisabetta/0000-0001-7839-1361; Sartiani, Laura/0000-0002-4208-0913; Azzari, Chiara/0000-0001-7236-1655; CARINI, MARINA/0000-0003-3407-5425; Andre, Eunice/0000-0001-9524-1576	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome [RBIP06YM29]; Programmi di Ricerca di Interesse Nazionale [2003054380]; Ente Cassa di Risparmio di Firenze; Fondazione Amici Facolta di Medicina di Firenze	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome(Ministry of Education, Universities and Research (MIUR)); Programmi di Ricerca di Interesse Nazionale; Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Fondazione Amici Facolta di Medicina di Firenze	The authors are grateful to David Julius (University of California, San Francisco, CA, USA) for TRPA1 heterozygous mice, and to Marco Marchi (University of Florence, Florence, Italy) for advice on statistical analysis. This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome (Fondo per gli Investimenti della Ricerca di Base, RBIP06YM29 to P.G. and R.P.), Programmi di Ricerca di Interesse Nazionale (2003054380), Ente Cassa di Risparmio di Firenze (to P.G), and Fondazione Amici Facolta di Medicina di Firenze (to P.G).	Allmers H, 2009, CURR ALLERGY ASTHM R, V9, P164, DOI 10.1007/s11882-009-0024-3; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; ARROWSMITH JB, 1987, PEDIATRICS, V79, P858; BALUK P, 1995, AM J PHYSIOL-LUNG C, V268, pL263, DOI 10.1152/ajplung.1995.268.2.L263; Banvolgyi A, 2004, NEUROSCIENCE, V125, P449, DOI 10.1016/j.neuroscience.2004.01.009; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Bertrand C, 1996, TRENDS PHARMACOL SCI, V17, P255, DOI 10.1016/S0165-6147(96)10027-4; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2009, FASEB J, V23, P1102, DOI 10.1096/fj.08-117812; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; BUCKLEY TL, 1991, BRIT J PHARMACOL, V103, P1515, DOI 10.1111/j.1476-5381.1991.tb09819.x; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Chen WQ, 1999, BIOCHEMISTRY-US, V38, P8159, DOI 10.1021/bi990125k; Cottrell GS, 2007, J BIOL CHEM, V282, P12260, DOI 10.1074/jbc.M606338200; Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Del-Rio-Navarro BE, 2007, J INVEST ALLERG CLIN, V17, P77; Dykewicz MS, 2009, J ALLERGY CLIN IMMUN, V123, P519, DOI 10.1016/j.jaci.2009.01.061; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Etminan M, 2009, CHEST, V136, P1316, DOI 10.1378/chest.09-0865; FIGINI M, 1995, BRIT J PHARMACOL, V115, P128, DOI 10.1111/j.1476-5381.1995.tb16329.x; Geppetti P, 2006, EUR J PHARMACOL, V533, P207, DOI 10.1016/j.ejphar.2005.12.063; Geppetti P, 1996, NEUROGENIC INFLAMMAT; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Krishna MT, 1997, AM J RESP CRIT CARE, V156, P943, DOI 10.1164/ajrccm.156.3.9612088; Louhivuori LM, 2009, J CELL PHYSIOL, V221, P67, DOI 10.1002/jcp.21828; Malo JL, 2009, AM J RESP CRIT CARE, V179, P923, DOI 10.1164/rccm.200810-1550OC; McKeever TM, 2005, AM J RESP CRIT CARE, V171, P966, DOI 10.1164/rccm.200409-1269OC; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Newson RB, 2000, EUR RESPIR J, V16, P817, DOI 10.1183/09031936.00.16581700; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nuttall SL, 2003, J CLIN PHARM THER, V28, P251, DOI 10.1046/j.1365-2710.2003.00492.x; Sadofsky LR, 2008, EXP LUNG RES, V34, P681, DOI 10.1080/01902140802339623; Sartiani L, 2004, CIRCULATION, V109, P419, DOI 10.1161/01.CIR.0000109497.73223.4D; Shaheen S, 2008, EUR RESPIR J, V32, P1231, DOI 10.1183/09031936.00039208; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Taylor-Clark TE, 2009, AM J RESP CELL MOL, V40, P756, DOI 10.1165/rcmb.2008-0292OC; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Vargas MH, 1998, J APPL PHYSIOL, V84, P1749, DOI 10.1152/jappl.1998.84.5.1749	50	92	93	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4904	4916		10.1096/fj.10-162438	http://dx.doi.org/10.1096/fj.10-162438			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20720158				2022-12-25	WOS:000284824400029
J	Aguilar, H; Sole, X; Bonifaci, N; Serra-Musach, J; Islam, A; Lopez-Bigas, N; Mendez-Pertuz, M; Beijersbergen, RL; Lazaro, C; Urruticoechea, A; Pujana, MA				Aguilar, H.; Sole, X.; Bonifaci, N.; Serra-Musach, J.; Islam, A.; Lopez-Bigas, N.; Mendez-Pertuz, M.; Beijersbergen, R. L.; Lazaro, C.; Urruticoechea, A.; Pujana, M. A.			Biological reprogramming in acquired resistance to endocrine therapy of breast cancer	ONCOGENE			English	Article						aromatase inhibition; breast cancer; estrogen receptor; fibroblast growth factor receptor; long-term estrogen-deprived; MCF7	ESTROGEN-RECEPTOR-ALPHA; REGULATORY FACTOR-I; ONCOLOGY TECHNOLOGY-ASSESSMENT; ACTIVATED PROTEIN-KINASE; GENOME-WIDE ASSOCIATION; ESR1 GENE AMPLIFICATION; AROMATASE INHIBITOR; TAMOXIFEN-RESISTANT; ESTRADIOL HYPERSENSITIVITY; ADAPTIVE HYPERSENSITIVITY	Endocrine therapies targeting the proliferative effect of 17 beta-estradiol through estrogen receptor alpha (ER alpha) are the most effective systemic treatment of ER alpha-positive breast cancer. However, most breast tumors initially responsive to these therapies develop resistance through molecular mechanisms that are not yet fully understood. The long-term estrogen-deprived (LTED) MCF7 cell model has been proposed to recapitulate acquired resistance to aromatase inhibitors in postmenopausal women. To elucidate this resistance, genomic, transcriptomic and molecular data were integrated into the time course of MCF7-LTED adaptation. Dynamic and widespread genomic changes were observed, including amplification of the ESR1 locus consequently linked to an increase in ER alpha. Dynamic transcriptomic profiles were also observed that correlated significantly with genomic changes and were predicted to be influenced by transcription factors known to be involved in acquired resistance or cell proliferation (for example, interferon regulatory transcription factor 1 and E2F1, respectively) but, notably, not by canonical ER alpha transcriptional function. Consistently, at the molecular level, activation of growth factor signaling pathways by EGFR/ERBB/AKT and a switch from phospho-Ser118 (pS118)- to pS167-ER alpha were observed during MCF7-LTED adaptation. Evaluation of relevant clinical settings identified significant associations between MCF7-LTED and breast tumor transcriptome profiles that characterize ER alpha-negative status, early response to letrozole and tamoxifen, and recurrence after tamoxifen treatment. In accordance with these profiles, MCF7-LTED cells showed increased sensitivity to inhibition of FGFR-mediated signaling with PD173074. This study provides mechanistic insight into acquired resistance to endocrine therapies of breast cancer and highlights a potential therapeutic strategy. Oncogene (2010) 29, 6071-6083; doi:10.1038/onc.2010.333; published online 16 August 2010	[Aguilar, H.; Urruticoechea, A.; Pujana, M. A.] Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol, Translat Res Lab, Barcelona, Spain; [Sole, X.; Bonifaci, N.; Serra-Musach, J.; Pujana, M. A.] IDIBELL, Catalan Inst Oncol, Biomarkers & Susceptibil Unit, Barcelona, Spain; [Sole, X.; Bonifaci, N.; Serra-Musach, J.; Pujana, M. A.] IDIBELL, Catalan Inst Oncol, Biomed Res Ctr Network Epidemiol & Publ Hlth, Barcelona, Spain; [Islam, A.; Lopez-Bigas, N.] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain; [Mendez-Pertuz, M.] Spanish Natl Canc Res Ctr, Mol Pathol Programme, Epithelial Carcinogenesis Grp, Madrid, Spain; [Beijersbergen, R. L.] Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Beijersbergen, R. L.] Netherlands Canc Inst, Canc Genom Ctr, Amsterdam, Netherlands; [Lazaro, C.] IDIBELL, Catalan Inst Oncol, Hereditary Canc Program, Mol Diagnost Unit, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Pompeu Fabra University; Centro Nacional de Investigaciones Oncologicas (CNIO); Netherlands Cancer Institute; Netherlands Cancer Institute; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Urruticoechea, A (corresponding author), Bellvitge Inst Biomed Res, Catalan Inst Oncol, Translat Res Lab, Gran Via 199-203, Barcelona 08907, Spain.	anderu@iconcologia.net; mapujana@iconcologia.net	Lopez-Bigas, Nuria/F-6193-2011; bonifaci, nuria/B-8104-2019; Solé, Xavier/AAF-3015-2019; GARCIA, CONXI LAZARO/Q-2410-2016; Pujana, Miquel Angel/N-3127-2014; Gasull, Martina/J-4076-2019	Lopez-Bigas, Nuria/0000-0003-4925-8988; bonifaci, nuria/0000-0002-8193-6825; Solé, Xavier/0000-0002-2197-3325; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Pujana, Miquel Angel/0000-0003-3222-4044; Beijersbergen, Roderick/0000-0003-0116-4130; Urruticoechea, Ander/0000-0003-0359-3641; Islam, Abul/0000-0002-7274-0855	Spanish Ministry of Health CIBERESP; Ministry of Science and Innovation (MICINN) [SAF06/05399]	Spanish Ministry of Health CIBERESP; Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by the Spanish Ministry of Health CIBERESP and grant 06/0545 and the Ministry of Science and Innovation (MICINN) grant SAF06/05399. HA was supported by a MICINN postdoctoral fellowship and MAP was a 'Ramon y Cajal' Researcher with the MICINN.	Adelaide J, 2008, INT J CANCER, V123, P2970, DOI 10.1002/ijc.23786; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Ahn BY, 2010, CANCER RES, V70, P3013, DOI 10.1158/0008-5472.CAN-09-3108; Alvarez MJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r143; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Beeram M, 2007, ANN ONCOL, V18, P1323, DOI 10.1093/annonc/mdm170; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouker KB, 2004, CANCER RES, V64, P4030, DOI 10.1158/0008-5472.CAN-03-3602; Bowie ML, 2004, ONCOGENE, V23, P8743, DOI 10.1038/sj.onc.1208120; Brown LA, 2008, NAT GENET, V40, P806, DOI 10.1038/ng0708-806; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chan CMW, 2002, J STEROID BIOCHEM, V81, P333, DOI 10.1016/S0960-0760(02)00074-2; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chia S, 2008, J CLIN ONCOL, V26, P1664, DOI 10.1200/JCO.2007.13.5822; Chlebowski RT, 2002, J CLIN ONCOL, V20, P3328, DOI 10.1200/JCO.2002.06.029; Clarke M, 1998, LANCET, V351, P1451; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Dowsett M, 2005, J STEROID BIOCHEM, V95, P167, DOI 10.1016/j.jsbmb.2005.04.022; Dowsett M, 2005, BREAST CANCER RES TR, V93, pS11, DOI 10.1007/s10549-005-9037-3; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Ellis MJ, 2006, J CLIN ONCOL, V24, P3019, DOI 10.1200/JCO.2005.04.3034; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geisler J, 2002, J CLIN ONCOL, V20, P751, DOI 10.1200/JCO.2002.20.3.751; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghayad SE, 2010, INT J CANCER, V126, P545, DOI 10.1002/ijc.24750; Gu ZP, 2002, CANCER RES, V62, P3428; Hoch RV, 1999, INT J CANCER, V84, P122; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Horlings HM, 2008, NAT GENET, V40, P807, DOI 10.1038/ng0708-807; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Jelovac D, 2005, CANCER RES, V65, P5380, DOI 10.1158/0008-5472.CAN-04-4502; Jeng MH, 1998, ENDOCRINOLOGY, V139, P4164, DOI 10.1210/en.139.10.4164; Johnston SRD, 2005, J STEROID BIOCHEM, V95, P173, DOI 10.1016/j.jsbmb.2005.04.004; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; JONAT W, 1995, EUR J CANCER, V31A, P137, DOI 10.1016/0959-8049(94)00415-2; Kanai M, 2009, GENE, V438, P49, DOI 10.1016/j.gene.2009.03.004; KATZENELLENBOGEN BS, 1987, CANCER RES, V47, P4355; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Korc M, 2009, CURR CANCER DRUG TAR, V9, P639, DOI 10.2174/156800909789057006; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lewis-Wambi JS, 2008, EUR J CANCER, V44, P1770, DOI 10.1016/j.ejca.2008.05.016; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Martin LA, 2005, ENDOCR-RELAT CANCER, V12, pS75, DOI 10.1677/erc.1.01023; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; MASAMURA S, 1995, J CLIN ENDOCR METAB, V80, P2918, DOI 10.1210/jc.80.10.2918; Masri S, 2008, CANCER RES, V68, P4910, DOI 10.1158/0008-5472.CAN-08-0303; Massarweh S, 2007, CLIN CANCER RES, V13, P1950, DOI 10.1158/1078-0432.CCR-06-2540; Massarweh S, 2006, ENDOCR-RELAT CANCER, V13, pS15, DOI 10.1677/erc.1.01273; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Miller WR, 2007, PHARMACOGENET GENOM, V17, P813, DOI 10.1097/FPC.0b013e32820b853a; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Reis-Filho JS, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809b; Rose C, 2003, EUR J CANCER, V39, P2318, DOI 10.1016/S0959-8049(03)00630-0; Sabnis GJ, 2005, CANCER RES, V65, P3903, DOI 10.1158/0008-5472.CAN-04-4092; Sadler AJ, 2009, J STEROID BIOCHEM, V114, P21, DOI 10.1016/j.jsbmb.2008.12.017; Santen R, 2001, J STEROID BIOCHEM, V79, P115, DOI 10.1016/S0960-0760(01)00151-0; Santen RJ, 2008, ADV EXP MED BIOL, V630, P19; Santen RJ, 2005, ENDOCR-RELAT CANCER, V12, pS61, DOI 10.1677/erc.1.01018; Schild-Hay LJ, 2009, CANCER RES, V69, P1150, DOI 10.1158/0008-5472.CAN-08-2806; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Shaw LE, 2006, J STEROID BIOCHEM, V99, P19, DOI 10.1016/j.jsbmb.2005.11.005; Shen RL, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-28; Shim WS, 2000, ENDOCRINOLOGY, V141, P396, DOI 10.1210/en.141.1.396; Sole X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004544; Song RXD, 2006, ENDOCR-RELAT CANCER, V13, pS3, DOI 10.1677/erc.1.01322; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Stephen R, 2000, BRIT J CANCER, V83, P1183, DOI 10.1054/bjoc.2000.1388; Stephen RL, 2001, J BIOL CHEM, V276, P40080, DOI 10.1074/jbc.M105892200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tashiro E, 2003, ONCOGENE, V22, P5630, DOI 10.1038/sj.onc.1206636; Tomita S, 2009, CANCER SCI, V100, P1012, DOI 10.1111/j.1349-7006.2009.01145.x; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vincent-Salomon A, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809a; Vuaroqueaux V, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1681; WELSHONS WV, 1987, EUR J CANCER CLIN ON, V23, P1935, DOI 10.1016/0277-5379(87)90062-9; Winer EP, 2002, J CLIN ONCOL, V20, P3317, DOI 10.1200/JCO.2002.06.020; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182; Yue W, 2005, INT J CANCER, V117, P746, DOI 10.1002/ijc.21222; Yue W, 2003, J STEROID BIOCHEM, V86, P265, DOI 10.1016/S0960-0760(03)00366-2; Zhang Z, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-331	98	53	54	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	45					6071	6083		10.1038/onc.2010.333	http://dx.doi.org/10.1038/onc.2010.333			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	678VA	20711236				2022-12-25	WOS:000284108700009
J	Ramos, I; Martin-Benito, J; Finn, R; Bretana, L; Aloria, K; Arizmendi, JM; Ausio, J; Muga, A; Valpuesta, JM; Prado, A				Ramos, Isbaal; Martin-Benito, Jaime; Finn, Ron; Bretana, Laura; Aloria, Kerman; Arizmendi, Jesus M.; Ausio, Juan; Muga, Arturo; Valpuesta, Jose M.; Prado, Adelina			Nucleoplasmin Binds Histone H2A-H2B Dimers through Its Distal Face	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN DECONDENSATION ACTIVITY; LAEVIS EGG EXTRACTS; CRYSTAL-STRUCTURE; NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY; NUCLEAR CHAPERONES; CORE HISTONES; NUCLEOSOME; DOMAIN; PHOSPHORYLATION; ACTIVATION	Nucleoplasmin (NP) is a pentameric chaperone that regulates the condensation state of chromatin extracting specific basic proteins from sperm chromatin and depositing H2A-H2B histone dimers. It has been proposed that histones could bind to either the lateral or distal face of the pentameric structure. Here, we combine different biochemical and biophysical techniques to show that natural, hyperphosphorylated NP can bind five H2A-H2B dimers and that the amount of bound ligand depends on the overall charge (phosphorylation level) of the chaperone. Three-dimensional reconstruction of NP/H2A-H2B complex carried out by electron microscopy reveals that histones interact with the chaperone distal face. Limited proteolysis and mass spectrometry indicate that the interaction results in protection of the histone fold and most of the H2A and H2B C-terminal tails. This structural information can help to understand the function of NP as a histone chaperone.	[Martin-Benito, Jaime; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain; [Muga, Arturo; Prado, Adelina] Univ Basque Country, Dept Bioquim & Biol Mol, Fac Ciencia & Tecnol, E-48080 Bilbao, Spain; [Ramos, Isbaal; Bretana, Laura; Muga, Arturo; Prado, Adelina] Univ Basque Country Euskal Herriko Unibertsitatea, CSIC, Unidad Biofis, Bilbao 48080, Spain; [Finn, Ron; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Aloria, Kerman; Arizmendi, Jesus M.] Univ Basque Country, Serv Gen Prote SGIker ProteoRed, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Victoria; University of Basque Country	Valpuesta, JM (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma Madrid,Darwin 3, Madrid 28049, Spain.	jmv@cnb.csic.es; adelina.prado@ehu.es	Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017; Muga, Arturo/N-1174-2014; Aloria, Kerman/D-7321-2011	Valpuesta, José M/0000-0001-7468-8053; Muga, Arturo/0000-0003-0345-6882; Aloria, Kerman/0000-0001-7268-7700; Arizmendi, Jesus M/0000-0002-1412-4042; Martin-Benito Romero, Jaime/0000-0002-8541-4709	Ministerio de Educacion e Innovacion [BFU2007-64452, BFU2007-62382]; Universidad del Pais Vasco and Gobierno Vasco [IT-358-07]; Diputacion Foral de Bizkaia [DIPE 08/18]; Natural Sciences and Engineering Research Council [OGP-46399-07]; Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Ministerio de Ciencia e Innovacion, Gobierno Vasco/Eusko Jaularitza; European Science Foundation	Ministerio de Educacion e Innovacion; Universidad del Pais Vasco and Gobierno Vasco; Diputacion Foral de Bizkaia; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Ministerio de Ciencia e Innovacion, Gobierno Vasco/Eusko Jaularitza(Basque GovernmentMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported in part by the Ministerio de Educacion e Innovacion Grants BFU2007-64452 (to A. M.) and BFU2007-62382 (to J. M. V.), the Universidad del Pais Vasco and Gobierno Vasco Grant IT-358-07, and Diputacion Foral de Bizkaia Grant DIPE 08/18.; Recipient of Natural Sciences and Engineering Research Council Grant OGP-46399-07.; The Servicio General de Proteomica-SGIker (ProteoRed) is supported by Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Ministerio de Ciencia e Innovacion, Gobierno Vasco/Eusko Jaularitza, and European Science Foundation.	Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Arnan C, 2003, J BIOL CHEM, V278, P31319, DOI 10.1074/jbc.M305560200; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Banuelos S, 2003, J MOL BIOL, V334, P585, DOI 10.1016/j.jmb.2003.09.067; Banuelos S, 2007, J BIOL CHEM, V282, P21213, DOI 10.1074/jbc.M702842200; BOHM L, 1984, BIOSCIENCE REP, V4, P365, DOI 10.1007/BF01122502; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; COTTEN M, 1986, BIOCHEMISTRY-US, V25, P5063, DOI 10.1021/bi00366a014; DIMITROV S, 1994, J CELL BIOL, V126, P591, DOI 10.1083/jcb.126.3.591; Dimitrov S, 1996, EMBO J, V15, P5897, DOI 10.1002/j.1460-2075.1996.tb00976.x; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Eirin-Lopez JM, 2006, GENETICS, V173, P1835, DOI 10.1534/genetics.106.058990; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FRANK J, 1996, 3 DIMENSIONAL ELECT, P182; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Hierro A, 2002, BIOCHEMISTRY-US, V41, P6408, DOI 10.1021/bi020002r; Hierro A, 2001, EUR J BIOCHEM, V268, P1739; KARANTZA V, 1995, BIOCHEMISTRY-US, V34, P5988, DOI 10.1021/bi00017a028; Lee HH, 2007, PROTEINS, V69, P672, DOI 10.1002/prot.21504; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Namboodiri VMH, 2003, STRUCTURE, V11, P175, DOI 10.1016/S0969-2126(03)00007-8; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Prado A, 2004, BIOCHEM CELL BIOL, V82, P437, DOI 10.1139/O04-042; Prieto C, 2002, BIOCHEMISTRY-US, V41, P7802, DOI 10.1021/bi020120e; Ramos I, 2005, BIOCHEMISTRY-US, V44, P8274, DOI 10.1021/bi050386w; Salvany L, 2004, FEBS LETT, V576, P353, DOI 10.1016/j.febslet.2004.07.095; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIMPSON RJ, 2003, PROTEINS PROTEOMICS, P713; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Taneva SG, 2009, J MOL BIOL, V393, P448, DOI 10.1016/j.jmb.2009.08.005; Taneva SG, 2008, BIOCHEMISTRY-US, V47, P13897, DOI 10.1021/bi800975r; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	40	21	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33771	33778		10.1074/jbc.M110.150664	http://dx.doi.org/10.1074/jbc.M110.150664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20696766	Green Published, hybrid			2022-12-25	WOS:000283354000023
J	Jeffries, O; Geiger, N; Rowe, ICM; Tian, LJ; McClafferty, H; Chen, L; Bi, DL; Knaus, HG; Ruth, P; Shipston, MJ				Jeffries, Owen; Geiger, Nina; Rowe, Iain C. M.; Tian, Lijun; McClafferty, Heather; Chen, Lie; Bi, Danlei; Knaus, Hans Guenther; Ruth, Peter; Shipston, Michael J.			Palmitoylation of the S0-S1 Linker Regulates Cell Surface Expression of Voltage- and Calcium-activated Potassium (BK) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; ENDOCYTIC TRAFFICKING SIGNALS; LARGE-CONDUCTANCE VOLTAGE; ALPHA-SUBUNIT; N-TERMINUS; CSS-PALM; PHOSPHORYLATION; RECEPTOR; EXCITABILITY; PREDICTION	S-Palmitoylation is rapidly emerging as an important post-translational mechanism to regulate ion channels. We have previously demonstrated that large conductance calcium-and voltage-activated potassium (BK) channels are palmitoylated within an alternatively spliced (STREX) insert. However, these studies also revealed that additional site(s) for palmitoylation must exist outside of the STREX insert, although the identity or the functional significance of these palmitoylated cysteine residues are unknown. Here, we demonstrate that BK channels are palmitoylated at a cluster of evolutionary conserved cysteine residues (Cys-53, Cys-54, and Cys-56) within the intracellular linker between the S0 and S1 transmembrane domains. Mutation of Cys-53, Cys-54, and Cys-56 completely abolished palmitoylation of BK channels lacking the STREX insert (ZERO variant). Palmitoylation allows the S0-S1 linker to associate with the plasma membrane but has no effect on single channel conductance or the calcium/voltage sensitivity. Rather, S0-S1 linker palmitoylation is a critical determinant of cell surface expression of BK channels, as steady state surface expression levels are reduced by similar to 55% in the C53:54:56 A mutant. STREX variant channels that could not be palmitoylated in the S0-S1 linker also displayed significantly reduced cell surface expression even though STREX insert palmitoylation was unaffected. Thus our work reveals the functional independence of two distinct palmitoylation-dependent membrane interaction domains within the same channel protein and demonstrates the critical role of S0-S1 linker palmitoylation in the control of BK channel cell surface expression.	[Jeffries, Owen; Geiger, Nina; Rowe, Iain C. M.; Tian, Lijun; McClafferty, Heather; Chen, Lie; Bi, Danlei; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Knaus, Hans Guenther] Med Univ Innsbruck, Div Mol & Cellular Pharmacol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Geiger, Nina; Ruth, Peter] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	University of Edinburgh; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; Chen, Lie/0000-0001-9764-4299; Rowe, Iain C M/0000-0002-0148-5332; jeffries, owen/0000-0002-8169-1100	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Korovkina VP, 2001, AM J PHYSIOL-CELL PH, V281, pC361, DOI 10.1152/ajpcell.2001.281.1.C361; Liu G, 2008, J GEN PHYSIOL, V131, P537, DOI 10.1085/jgp.200809968; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; MacDonald SHF, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-37; Marijic J, 2001, CIRC RES, V88, P210; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Saleem F, 2009, BRIT J PHARMACOL, V156, P143, DOI 10.1111/j.1476-5381.2008.00011.x; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Song M, 1999, FEBS LETT, V460, P427, DOI 10.1016/S0014-5793(99)01394-0; Sorensen MV, 2008, J PHYSIOL-LONDON, V586, P4251, DOI 10.1113/jphysiol.2008.156968; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Wu RS, 2009, J NEUROSCI, V29, P8321, DOI 10.1523/JNEUROSCI.6191-08.2009; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Zarei MM, 2007, NEUROSCIENCE, V147, P80, DOI 10.1016/j.neuroscience.2007.04.019; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	42	44	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33307	33314		10.1074/jbc.M110.153940	http://dx.doi.org/10.1074/jbc.M110.153940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20693285	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000283048200066
J	Kimura, A; Martin, C; Robinson, GW; Simone, JM; Chen, WP; Wickre, MC; O'Shea, JJ; Hennighausen, L				Kimura, Akiko; Martin, Cyril; Robinson, Gertraud W.; Simone, James M.; Chen, Weiping; Wickre, Mark C.; O'Shea, John J.; Hennighausen, Lothar			The Gene Encoding the Hematopoietic Stem Cell Regulator CCN3/NOV Is under Direct Cytokine Control through the Transcription Factors STAT5A/B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; SELF-RENEWAL; PROGENITOR CELLS; STEM/PROGENITOR CELLS; LYMPHOID DEVELOPMENT; EXPRESSION; ACTIVATION; DIFFERENTIATION; BCR/ABL; GROWTH	Cytokines control the biology of hematopoietic stem cells (HSCs) and progenitor cells in part through the transcription factors STAT5A/B. To investigate the target genes of STAT5A/B activated by cytokines in HSCs and progenitors, we performed microarray analyses using Lineage(-) Sca-1(+) c-Kit(+) (KSL) cells in the presence and absence of STAT5A/B. Stimulation with a mixture containing IL-3, IL-6, stem cell factor, thrombopoietin, and Flt3 ligand induced Ccn3/Nov mRNA over 100-fold in WT (control) but not Stat5a/b-null KSL cells. CCN3/NOV is a positive regulator of human HSC self-renewal and development of committed blood cells. Without stimulation, the Ccn3/Nov signal level was low in control KSL cells similar to Stat5a/b-null KSL cells. To determine which cytokine activates the Ccn3/Nov gene, we analyzed Lineage(-) c-Kit(+) (KL) and 32D cells using quantitative PCR and ChIP assays. Although stimulation with a mixture lacking IL-3 prevented the induction of Ccn3/Nov in control KL cells, IL-3 alone could induce Ccn3/Nov mRNA in control KL and 32D cells. ChIP assays using 32D cells revealed IL-3-induced binding of STAT5A/B to a gamma-interferon-activated sequences site in the Ccn3/Nov gene promoter. This is the first report that Ccn3/Nov is directly induced by cytokines through STAT5A/B.	[Kimura, Akiko; Martin, Cyril; Robinson, Gertraud W.; Wickre, Mark C.; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, Bethesda, MD 20892 USA; [Simone, James M.] NIAMS, Flow Cytometry Sect, Off Sci & Technol, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDK, Microarray Core Facil Genom Core Lab, Bethesda, MD 20892 USA; [O'Shea, John J.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kimura, A (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bldg 37,Rm 3016, Bethesda, MD 20892 USA.	kimuraa@mail.nih.gov	Robinson, Gertraud/I-2136-2012; Chen, Wei/GZK-7348-2022	Hennighausen, Lothar/0000-0001-8319-9841; Kimura, Akiko/0000-0001-8136-5009	NIDDK/National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041169, ZIAAR041159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000] Funding Source: NIH RePORTER	NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural program of the NIDDK/National Institutes of Health. L. H. is a participant in the WCU program (R33-10059) at Chonnam National University, Republic of Korea.	Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; de Groot RP, 1999, BLOOD, V94, P1108, DOI 10.1182/blood.V94.3.1108.415k07_1108_1112; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gupta N, 2001, J CLIN PATHOL-MOL PA, V54, P293, DOI 10.1136/mp.54.5.293; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007989; He XH, 2005, STEM CELLS DEV, V14, P188, DOI 10.1089/scd.2005.14.188; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Huttmann A, 2006, STEM CELLS, V24, P1719, DOI 10.1634/stemcells.2005-0486; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Kimura A, 2009, BLOOD, V114, P4721, DOI 10.1182/blood-2009-04-216390; Manara MC, 2002, AM J PATHOL, V160, P849, DOI 10.1016/S0002-9440(10)64908-5; Martinerie C, 2001, J CLIN ENDOCR METAB, V86, P3929, DOI 10.1210/jc.86.8.3929; McCallum L, 2009, BLOOD REV, V23, P79, DOI 10.1016/j.blre.2008.07.002; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Reindl C, 2006, BLOOD, V107, P3700, DOI 10.1182/blood-2005-06-2596; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Schuringa JJ, 2004, STEM CELLS, V22, P1191, DOI 10.1634/stemcells.2004-0033; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Sillaber C, 2000, BLOOD, V95, P2118, DOI 10.1182/blood.V95.6.2118; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Wierenga ATJ, 2006, BLOOD, V107, P4326, DOI 10.1182/blood-2005-11-4608; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102; Zhu BM, 2008, BLOOD, V112, P2071, DOI 10.1182/blood-2007-12-127480	34	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32704	32709		10.1074/jbc.M110.141804	http://dx.doi.org/10.1074/jbc.M110.141804			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720003	Green Published, hybrid			2022-12-25	WOS:000283048200005
J	Kini, V; Chavez, A; Mehta, D				Kini, Vidisha; Chavez, Alejandra; Mehta, Dolly			A New Role for PTEN in Regulating Transient Receptor Potential Canonical Channel 6-mediated Ca2+ Entry, Endothelial Permeability, and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID PHOSPHATASE-ACTIVITY; CELLS IN-VITRO; TUMOR-SUPPRESSOR; PHOSPHOLIPASE-C; PDZ DOMAIN; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; VASCULAR-PERMEABILITY; CHROMOSOME-10 PTEN; PROTEIN STABILITY; PLASMA-MEMBRANE	Phosphatase and tensin homologue (PTEN) is a dual lipid-protein phosphatase that catalyzes the conversion of phosphoinositol 3,4,5-triphosphate to phosphoinositol 4,5-bisphosphate and thereby inhibits PI3K-Akt-dependent cell proliferation, migration, and tumor vascularization. We have uncovered a previously unrecognized role for PTEN in regulating Ca2+ entry through transient receptor potential canonical channel 6 (TRPC6) that does not require PTEN phosphatase activity. We show that PTEN tail-domain residues 394-403 permit PTEN to associate with TRPC6. The inflammatory mediator thrombin promotes this association. Deletion of PTEN residues 394-403 prevents TRPC6 cell surface expression and Ca2+ entry. However, PTEN mutant, C124S, which lacks phosphatase activity, did not alter TRPC6 activity. Thrombin failed to increase endothelial monolayer permeability in the endothelial cells, transducing the Delta 394-403 PTEN mutant. Paradoxically, we also show that thrombin failed to induce endothelial cell migration and tube formation in cells transducing the Delta 394-403 PTEN mutant. Our results demonstrate that PTEN, through residues 394-403, serves as a scaffold for TRPC6, enabling cell surface expression of the channel. Ca2+ entry through TRPC6 induces an increase in endothelial permeability and directly promotes angiogenesis. Thus, PTEN is indicated to play a role beyond suppressing PI3K signaling.	[Mehta, Dolly] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, D (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, 835 S Wolcott Ave, Chicago, IL 60612 USA.	dmehta@uic.edu			National Institutes of Health [HL71794, HL84153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084153, R01HL071794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL71794 and HL84153.	Adey NB, 2000, CANCER RES, V60, P35; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; Bandyopadhyay BC, 2008, J BIOL CHEM, V283, P32821, DOI 10.1074/jbc.M805382200; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Chen ZL, 2006, FASEB J, V20, P2261, DOI 10.1096/fj.06-6113com; Cheng HW, 2006, ARTERIOSCL THROM VAS, V26, P1768, DOI 10.1161/01.ATV.0000231518.86795.0f; Cioffi DL, 2006, MICROCIRCULATION, V13, P709, DOI 10.1080/10739680600930354; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Ge RL, 2009, CANCER LETT, V283, P43, DOI 10.1016/j.canlet.2009.03.023; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; Hu SY, 2009, ACTA PHARMACOL SIN, V30, P1415, DOI 10.1038/aps.2009.133; Huang J, 2005, ARTERIOSCL THROM VAS, V25, P354, DOI 10.1161/01.ATV.0000151619.54108.a5; Iwatsuki K, 2005, ONCOGENE, V24, P1129, DOI 10.1038/sj.onc.1208287; Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Koide S, 2007, AM J PHYSIOL-HEART C, V292, pH2824, DOI 10.1152/ajpheart.01221.2006; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lussier MP, 2005, J BIOL CHEM, V280, P19393, DOI 10.1074/jbc.M500391200; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Marchant JS, 2005, CURR BIOL, V15, pR493, DOI 10.1016/j.cub.2005.06.035; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mukerji N, 2007, BBA-MOL BASIS DIS, V1772, P859, DOI 10.1016/j.bbadis.2007.03.005; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Nilius Bernd, 2007, Bull Mem Acad R Med Belg, V162, P244; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003; Qiu FY, 2009, J CARDIOVASC PHARM, V53, P209, DOI 10.1097/FJC.0b013e318199f326; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Wang YJ, 2004, J IMMUNOL, V173, P6820, DOI 10.4049/jimmunol.173.11.6820; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199	67	61	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33082	33091		10.1074/jbc.M110.142034	http://dx.doi.org/10.1074/jbc.M110.142034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705603	Green Published, hybrid			2022-12-25	WOS:000283048200046
J	Ryu, H; Azuma, Y				Ryu, Hyunju; Azuma, Yoshiaki			Rod/Zw10 Complex Is Required for PIASy-dependent Centromeric SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II-ALPHA; SUMO E3 LIGASE; ROUGH-DEAL; CHROMOSOME SEGREGATION; MITOTIC CHROMOSOMES; IN-VIVO; KINETOCHORE; CHECKPOINT; CONJUGATION; PROTEINS	SUMO conjugation of cellular proteins is essential for proper progression of mitosis. PIASy, a SUMO E3 ligase, is required for mitotic SUMOylation of chromosomal proteins, yet the regulatory mechanism behind the PIASy-dependent SUMOylation during mitosis has not been determined. Using a series of truncated PIASy proteins, we have found that the N terminus of PIASy is not required for SUMO modification in vitro but is essential for mitotic SUMOylation in Xenopus egg extracts. We demonstrate that swapping the N terminus of PIASy protein with the corresponding region of other PIAS family members abolishes chromosomal binding and mitotic SUMOylation. We further show that the N-terminal domain of PIASy is sufficient for centromeric localization. We identified that the N-terminal domain of PIASy interacts with the Rod/Zw10 complex, and immunofluorescence further reveals that PIASy colocalizes with Rod/Zw10 in the centromeric region. We show that the Rod/Zw10 complex interacts with the first 47 residues of PIASy which were particularly important for mitotic SUMOylation. Finally, we show that depletion of Rod compromises the centromeric localization of PIASy and SUMO2/3 in mitosis. Together, we demonstrate a fundamental mechanism of PIASy to localize in the centromeric region of chromosome to execute centromeric SUMOylation during mitosis.	[Ryu, Hyunju; Azuma, Yoshiaki] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Azuma, Y (corresponding author), 1200 Sunnyside Ave,Haworth Hall,Rm 3037, Lawrence, KS 66045 USA.	azumay@ku.edu			National Institutes of Health/NIGMS [GM80278]; Dept. of Molecular Biosciences at the University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080278] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Dept. of Molecular Biosciences at the University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health/NIGMS Grant GM80278 and a start-up grant from the Dept. of Molecular Biosciences at the University of Kansas.	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2001, FASEB J, V15, P1825, DOI 10.1096/fj.00-0818fje; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Azuma Y, 2009, METHODS MOL BIOL, V582, P221, DOI 10.1007/978-1-60761-340-4_17; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basto R, 2004, CURR BIOL, V14, P56, DOI 10.1016/j.cub.2003.12.025; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Biggins S, 2001, GENETICS, V159, P453; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Duval D, 2003, FEBS LETT, V554, P111, DOI 10.1016/S0014-5793(03)01116-5; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; KORNBLUTH S, 2001, CURRENT PROTOCOLS CE; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Lu YJ, 2009, CELL STRUCT FUNCT, V34, P31, DOI 10.1247/csf.08040; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Ryu H, 2010, J BIOL CHEM, V285, P14415, DOI 10.1074/jbc.M109.074583; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Scaerou F, 2001, J CELL SCI, V114, P3103; Scaerou F, 1999, J CELL SCI, V112, P3757; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Suzuki R, 2009, PROTEINS, V75, P336, DOI 10.1002/prot.22243; Takahashi Y, 2003, J BIOCHEM, V133, P415, DOI 10.1093/jb/mvg054; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tolkunova E, 2007, J MOL BIOL, V374, P1200, DOI 10.1016/j.jmb.2007.09.081; Torras-Llort M, 2009, EMBO J, V28, P2337, DOI 10.1038/emboj.2009.174; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Williams BC, 2003, MOL BIOL CELL, V14, P1379, DOI 10.1091/mbc.E02-09-0624; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013	47	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32576	32585		10.1074/jbc.M110.153817	http://dx.doi.org/10.1074/jbc.M110.153817			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696768	Green Published, hybrid			2022-12-25	WOS:000282683000072
J	Xie, G; Harrison, J; Clapcote, SJ; Huang, Y; Zhang, JY; Wang, LY; Roder, JC				Xie, Gang; Harrison, John; Clapcote, Steven J.; Huang, Yun; Zhang, Jin-Yi; Wang, Lu-Yang; Roder, John C.			A New Kv1.2 Channelopathy Underlying Cerebellar Ataxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; CELL NERVE-TERMINALS; K+ CHANNEL; RAT-BRAIN; ENDOPLASMIC-RETICULUM; TRANSMITTER RELEASE; SURFACE EXPRESSION; MAMMALIAN BRAIN; PURKINJE-CELLS; ALPHA-SUBUNITS	A forward genetic screen of mice treated with the mutagen ENU identified a mutant mouse with chronic motor incoordination. This mutant, named Pingu (Pgu), carries a missense mutation, an I402T substitution in the S6 segment of the voltage-gated potassium channel Kcna2. The gene Kcna2 encodes the voltage-gated potassium channel alpha-subunit Kv1.2, which is abundantly expressed in the large axon terminals of basket cells that make powerful axo-somatic synapses onto Purkinje cells. Patch clamp recordings from cerebellar slices revealed an increased frequency and amplitude of spontaneous GABAergic inhibitory postsynaptic currents and reduced action potential firing frequency in Purkinje cells, suggesting that an increase in GABA release from basket cells is involved in the motor incoordination in Pgu mice. In line with immunochemical analyses showing a significant reduction in the expression of Kv1 channels in the basket cell terminals of Pgu mice, expression of homomeric and heteromeric channels containing the Kv1.2(I402T) alpha-subunit in cultured CHO cells revealed subtle changes in biophysical properties but a dramatic decrease in the amount of functional Kv1 channels. Pharmacological treatment with acetazolamide or transgenic complementation with wildtype Kcna2 cDNA partially rescued the motor incoordination in Pgu mice. These results suggest that independent of known mutations in Kcna1 encoding Kv1.1, Kcna2 mutations may be important molecular correlates underlying human cerebellar ataxic disease.	[Xie, Gang; Clapcote, Steven J.; Zhang, Jin-Yi; Roder, John C.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5S 1A8, Canada; [Harrison, John; Wang, Lu-Yang] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5S 1A8, Canada; [Harrison, John; Wang, Lu-Yang] Hosp Sick Children, Div Neurol, Toronto, ON M5S 1A8, Canada; [Huang, Yun] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Wang, Lu-Yang; Roder, John C.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Roder, John C.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Wang, LY (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	luyang.wang@utoronto.ca	Roder, John/G-6468-2013		Canadian Institute of Health Research (CIHR) [CIHR MOP-77809, MOP-143867, MOP-14692]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grants CIHR MOP-77809 (to J. C. R.) and MOP-143867 and MOP-14692 (to L.-Y. W.).	Arroyo EJ, 1999, J NEUROCYTOL, V28, P333, DOI 10.1023/A:1007009613484; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Bower JM, 2002, ANN NY ACAD SCI, V978, P135, DOI 10.1111/j.1749-6632.2002.tb07562.x; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; DREWE JA, 1992, J NEUROSCI, V12, P538; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hallows JL, 1998, J NEUROSCI, V18, P5682; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HWANG PM, 1993, J NEUROSCI, V13, P1569; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; Klapdor K, 1997, J NEUROSCI METH, V75, P49, DOI 10.1016/S0165-0270(97)00042-3; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; McNamara NMC, 1996, EUR J NEUROSCI, V8, P688, DOI 10.1111/j.1460-9568.1996.tb01254.x; MCNAMARA NMC, 1993, NEUROSCIENCE, V57, P1039, DOI 10.1016/0306-4522(93)90047-J; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Shamotienko O, 1999, BIOCHEMISTRY-US, V38, P16766, DOI 10.1021/bi991039n; SHENG M, 1994, J NEUROSCI, V14, P2408; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Southan AP, 2000, J NEUROSCI, V20, P114, DOI 10.1523/JNEUROSCI.20-01-00114.2000; Southan AP, 1998, J NEUROSCI, V18, P948; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Xie G, 2007, GENES BRAIN BEHAV, V6, P717, DOI 10.1111/j.1601-183X.2007.00302.x; Xu HD, 1996, J GEN PHYSIOL, V108, P405, DOI 10.1085/jgp.108.5.405; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; ZASORIN NL, 1983, NEUROLOGY, V33, P1212, DOI 10.1212/WNL.33.9.1212; Zhu J, 2001, J BIOL CHEM, V276, P39419, DOI 10.1074/jbc.M107399200	44	62	64	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32160	32173		10.1074/jbc.M110.153676	http://dx.doi.org/10.1074/jbc.M110.153676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696761	hybrid, Green Published			2022-12-25	WOS:000282683000029
J	Pradhan, M; Bembinster, LA; Baumgarten, SC; Frasor, J				Pradhan, Madhumita; Bembinster, Leslie A.; Baumgarten, Sarah C.; Frasor, Jonna			Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter Gene ABCG2 through Estrogen Receptor and NF kappa B Cooperativity at Adjacent Response Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-RESISTANCE-PROTEIN; DNA-BINDING; GLUCOCORTICOID-RECEPTOR; UP-REGULATION; TUMOR-CELLS; CROSS-TALK; ER-ALPHA; TRANSCRIPTION; INHIBITION; ACTIVATION	Constitutive activation of NF kappa B in estrogen receptor (ER)-positive breast cancer is associated with tumor recurrence and development of anti-estrogen resistance. Furthermore, a gene expression signature containing common targets for ER and NF kappa B has been identified and found to be associated with the more aggressive luminal B intrinsic subtype of ER-positive breast tumors. Here, we describe a novel mechanism by which ER and NF kappa B cooperate to up-regulate expression of one important gene from this signature, ABCG2, which encodes a transporter protein associated with the development of drug-resistant breast cancer. We and others have confirmed that this gene is regulated primarily by estrogen in an ER- and estrogen response element (ERE)-dependent manner. We found that whereas proinflammatory cytokines have little effect on this gene in the absence of 17 beta-estradiol, they can potentiate ER activity in an NF kappa B-dependent manner. ER allows the NF kappa B family member p65 to access a latent NF kappa B response element located near the ERE in the gene promoter. NF kappa B recruitment to the gene is, in turn, required to stabilize ER occupancy at the functional ERE. The result of this cooperative binding of ER and p65 at adjacent response elements leads to a major increase in both ABCG2 mRNA and protein expression. These findings indicate that estrogen and inflammatory factors can modify each other's activity through modulation of transcription factor accessibility and/or occupancy at adjacent response elements. This novel transcriptional mechanism could have important implications in breast cancer, where both inflammation and estrogen can promote cancer progression.	[Pradhan, Madhumita; Bembinster, Leslie A.; Baumgarten, Sarah C.; Frasor, Jonna] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Frasor, J (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott,MC901, Chicago, IL 60612 USA.	jfrasor@uic.edu			National Institutes of Health [CA130932-2]; NATIONAL CANCER INSTITUTE [R01CA130932] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA130932-2 (to J. F.).	Adamson AD, 2008, ENDOCRINOLOGY, V149, P687, DOI 10.1210/en.2007-1066; ANKENBAUER W, 1988, P NATL ACAD SCI USA, V85, P7526, DOI 10.1073/pnas.85.20.7526; Bodine PVN, 1999, ENDOCRINOLOGY, V140, P2439, DOI 10.1210/en.140.6.2439; BRADSHAW MS, 1991, J BIOL CHEM, V266, P16684; Buchholz TA, 2005, CLIN CANCER RES, V11, P8398, DOI 10.1158/1078-0432.CCR-05-0885; Chu S, 2004, MOL ENDOCRINOL, V18, P1919, DOI 10.1210/me.2004-0021; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; deGraffenried LA, 2004, ANN ONCOL, V15, P885, DOI 10.1093/annonc/mdh232; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Ee PLR, 2004, CANCER RES, V64, P1247, DOI 10.1158/0008-5472.CAN-03-3583; Ellwood K, 1999, MOL CELL BIOL, V19, P2613; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Feldman I, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.033; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Frasor J, 2008, ENDOCRINOLOGY, V149, P6272, DOI 10.1210/en.2008-0352; George AA, 2009, INT J BIOCHEM CELL B, V41, P214, DOI 10.1016/j.biocel.2008.09.019; Gionet N, 2009, J CELL BIOCHEM, V107, P448, DOI 10.1002/jcb.22141; Guzeloglu-Kayisli O, 2008, REPROD SCI, V15, P493, DOI 10.1177/1933719108317583; Harnish DC, 2000, ENDOCRINOLOGY, V141, P3403, DOI 10.1210/en.141.9.3403; Johnson KM, 2004, METHOD ENZYMOL, V380, P207; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; KLINGE CM, 1992, CANCER RES, V52, P1073; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; KUNSCH C, 1994, J IMMUNOL, V153, P153; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mosaffa F, 2009, INFLAMM RES, V58, P669, DOI 10.1007/s00011-009-0034-6; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Pelzer T, 2001, BIOCHEM BIOPH RES CO, V286, P1153, DOI 10.1006/bbrc.2001.5519; Quaedackers ME, 2007, MOL CELL ENDOCRINOL, V273, P42, DOI 10.1016/j.mce.2007.05.002; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; Riggins RB, 2005, MOL CANCER THER, V4, P33; Rubio MF, 2006, ONCOGENE, V25, P1367, DOI 10.1038/sj.onc.1209176; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; Sui M, 2007, CANCER RES, V67, P5337, DOI 10.1158/0008-5472.CAN-06-4582; Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; To KKW, 2008, MOL CANCER RES, V6, P151, DOI 10.1158/1541-7786.MCR-07-0175; To KKW, 2006, MOL CELL BIOL, V26, P8572, DOI 10.1128/MCB.00650-06; To KKW, 2009, MOL CANCER THER, V8, P2959, DOI 10.1158/1535-7163.MCT-09-0292; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Wang HG, 2006, AM J PHYSIOL-ENDOC M, V290, pE798, DOI 10.1152/ajpendo.00397.2005; Wang H, 2008, MOL PHARMACOL, V73, P845, DOI 10.1124/mol.107.041087; Wissink S, 2001, MOL ENDOCRINOL, V15, P543, DOI 10.1210/me.15.4.543; Zhang YH, 2006, ONCOLOGY-BASEL, V71, P446, DOI 10.1159/000108594; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	56	76	83	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31100	31106		10.1074/jbc.M110.155309	http://dx.doi.org/10.1074/jbc.M110.155309			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20705611	Green Published, hybrid			2022-12-25	WOS:000282764600003
J	Kang, DW; Min, DS				Kang, Dong Woo; Min, Do Sik			Positive Feedback Regulation between Phospholipase D and Wnt Signaling Promotes Wnt-Driven Anchorage-Independent Growth of Colorectal Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; COLON-CANCER; HUMAN BREAST; EXPRESSION; TARGET; ACTIVATION; GENE; MUTATIONS; ADHESION; OVEREXPRESSION	Background: Aberrant activation of the canonical Wnt/beta-catenin pathway occurs in almost all colorectal cancers and contributes to their growth, invasion and survival. Phopholipase D (PLD) has been implicated in progression of colorectal carcinoma However, an understanding of the targets and regulation of this important pathway remains incomplete and besides, relationship between Wnt signaling and PLD is not known. Methodology/Principal Findings: Here, we demonstrate that PLD isozymes, PLD1 and PLD2 are direct targets and positive feedback regulators of the Wnt/beta-catenin signaling. Wnt3a and Wnt mimetics significantly enhanced the expression of PLDs at a transcriptional level in HCT116 colorectal cancer cells, whereas silencing of beta-catenin gene expression or utilization of a dominant negative form of T cell factor-4 (TCF-4) inhibited expression of PLDs. Moreover, both PLD1 and PLD2 were highly induced in colon, liver and stomach tissues of mice after injection of LiCl, a Wnt mimetic. Wnt3a stimulated formation of the beta-catenin/TCF complexes to two functional TCF-4-binding elements within the PLD2 promoter as assessed by chromatin immunoprecipitation assay. Suppressing PLD using gene silencing or selective inhibitor blocked the ability of beta-catenin to transcriptionally activate PLD and other Wnt target genes by preventing formation of the beta-catenin/TCF-4 complex, whereas tactics to elevate intracellular levels of phosphatidic acid, the product of PLD activity, enhanced these effects. Here we show that PLD is necessary for Wnt3a-driven invasion and anchorage-independent growth of colon cancer cells. Conclusion/Significance: PLD isozyme acts as a novel transcriptional target and positive feedback regulator of Wnt signaling, and then promotes Wnt-driven anchorage-independent growth of colorectal cancer cells. We propose that therapeutic interventions targeting PLD may confer a clinical benefit in Wnt/beta-catenin-driven malignancies.	[Kang, Dong Woo; Min, Do Sik] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea	Pusan National University	Kang, DW (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea.	minds@pusan.ac.kr			Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080287]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A080287). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ahn BH, 2003, MOL CELL BIOL, V23, P3103, DOI 10.1128/MCB.23.9.3103-3115.2003; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Foster DA, 2003, MOL CANCER RES, V1, P789; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Joseph T, 2001, BIOCHEM BIOPH RES CO, V289, P1019, DOI 10.1006/bbrc.2001.6118; Kang DW, 2008, J BIOL CHEM, V283, P4094, DOI 10.1074/jbc.M707416200; Kikuchi R, 2007, ONCOGENE, V26, P1802, DOI 10.1038/sj.onc.1209973; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; Min DS, 2001, NEUROSCI LETT, V310, P125, DOI 10.1016/S0304-3940(01)02091-2; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Rodrik V, 2005, MOL CELL BIOL, V25, P7917, DOI 10.1128/MCB.25.17.7917-7925.2005; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Saito M, 2007, ONCOL REP, V18, P1329; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Sekine S, 2002, ONCOGENE, V21, P5906, DOI 10.1038/sj.onc.1205756; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Taketo MM, 2004, NAT GENET, V36, P320, DOI 10.1038/ng0404-320; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamada Y, 2003, J MOL MED, V81, P126, DOI 10.1007/s00109-002-0411-x; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191	48	35	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12109	10.1371/journal.pone.0012109	http://dx.doi.org/10.1371/journal.pone.0012109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711340	Green Published, Green Submitted, gold			2022-12-25	WOS:000280859700006
J	Levy, N; Pressman, A; Mussa-Ivaldi, FA; Karniel, A				Levy, Noa; Pressman, Assaf; Mussa-Ivaldi, Ferdinando A.; Karniel, Amir			Adaptation to Delayed Force Perturbations in Reaching Movements	PLOS ONE			English	Article							MOTOR CONTROL; INTERNAL-MODELS; ARM MOVEMENTS; REPRESENTATION; TIME; COMBINATION; PERCEPTION	Adaptation to deterministic force perturbations during reaching movements was extensively studied in the last few decades. Here, we use this methodology to explore the ability of the brain to adapt to a delayed velocity-dependent force field. Two groups of subjects preformed a standard reaching experiment under a velocity dependent force field. The force was either immediately proportional to the current velocity (Control) or lagged it by 50 ms (Test). The results demonstrate clear adaptation to the delayed force perturbations. Deviations from a straight line during catch trials were shifted in time compared to post-adaptation to a non-delayed velocity dependent field (Control), indicating expectation to the delayed force field. Adaptation to force fields is considered to be a process in which the motor system predicts the forces to be expected based on the state that a limb will assume in response to motor commands. This study demonstrates for the first time that the temporal window of this prediction needs not to be fixed. This is relevant to the ability of the adaptive mechanisms to compensate for variability in the transmission of information across the sensory-motor system.	[Levy, Noa; Pressman, Assaf; Karniel, Amir] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel; [Pressman, Assaf; Mussa-Ivaldi, Ferdinando A.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA	Ben Gurion University; Shirley Ryan AbilityLab	Levy, N (corresponding author), Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.	akarniel@bgu.ac.il	Karniel, Amir/F-2066-2012		United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation)	This research was supported by the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; Cunningham DW, 2001, J VISION, V1, P88, DOI 10.1167/1.2.3; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Foulkes AJM, 2000, EXP BRAIN RES, V131, P101, DOI 10.1007/s002219900286; Gribble PL, 2000, EXP BRAIN RES, V135, P474, DOI 10.1007/s002210000547; INBAR GF, 1976, PROGR IN BRAIN RES, P337; Karniel A, 2000, IEEE T SYST MAN CY C, V30, P1, DOI 10.1109/5326.827449; Karniel A, 2003, BIOL CYBERN, V89, P10, DOI 10.1007/s00422-003-0397-7; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; Nisky I, 2010, J NEUROPHYSIOL, V103, P3017, DOI 10.1152/jn.00939.2009; Padoa-Schioppa C, 2004, J NEUROPHYSIOL, V91, P449, DOI 10.1152/jn.00876.2002; Pressman A, 2007, INT J ROBOT RES, V26, P1191, DOI 10.1177/0278364907082611; Rabe K, 2009, J NEUROPHYSIOL, V101, P1961, DOI 10.1152/jn.91069.2008; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; SMITH WM, 1980, J MOTOR BEHAV, V12, P91; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	22	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12128	10.1371/journal.pone.0012128	http://dx.doi.org/10.1371/journal.pone.0012128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711461	gold, Green Published, Green Submitted			2022-12-25	WOS:000280849100031
J	van Etten, J; Hijmans, RJ				van Etten, Jacob; Hijmans, Robert J.			A Geospatial Modelling Approach Integrating Archaeobotany and Genetics to Trace the Origin and Dispersal of Domesticated Plants	PLOS ONE			English	Article							EVOLUTION; SPREAD; PHYLOGEOGRAPHY; CONSERVATION; CALIBRATION; DIVERGENCE; RESISTANCE; REGRESSION; DIVERSITY; FRAMEWORK	Background: The study of the prehistoric origins and dispersal routes of domesticated plants is often based on the analysis of either archaeobotanical or genetic data. As more data become available, spatially explicit models of crop dispersal can be used to combine different types of evidence. Methodology/Principal Findings: We present a model in which a crop disperses through a landscape that is represented by a conductance matrix. From this matrix, we derive least-cost distances from the geographical origin of the crop and use these to predict the age of archaeological crop remains and the heterozygosity of crop populations. We use measures of the overlap and divergence of dispersal trajectories to predict genetic similarity between crop populations. The conductance matrix is constructed from environmental variables using a number of parameters. Model parameters are determined with multiple-criteria optimization, simultaneously fitting the archaeobotanical and genetic data. The consilience reached by the model is the extent to which it converges around solutions optimal for both archaeobotanical and genetic data. We apply the modelling approach to the dispersal of maize in the Americas. Conclusions/Significance: The approach makes possible the integrative inference of crop dispersal processes, while controlling model complexity and computational requirements.	[van Etten, Jacob; Hijmans, Robert J.] Int Rice Res Inst, Los Banos, Philippines; [van Etten, Jacob] IE Univ, Segovia, Spain; [Hijmans, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	CGIAR; International Rice Research Institute (IRRI); IE University; University of California System; University of California Davis	van Etten, J (corresponding author), Int Rice Res Inst, Los Banos, Philippines.	Jacob.vanEtten@ie.edu	Hijmans, Robert/N-3299-2016	Hijmans, Robert/0000-0001-5872-2872; van Etten, Jacob/0000-0001-7554-2558	Consultative Group on International Agricultural Research (CGIAR)	Consultative Group on International Agricultural Research (CGIAR)(CGIAR)	This work was supported by the Global Public Goods II project of the System-wide Genetic Resources Program (SGRP) of the Consultative Group on International Agricultural Research (CGIAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2009, 2 FAO; Bellwood P., 2004, 1 FARMERS ORIGINS AG; Blake Michael, 2006, HIST MAIZE MULTIDISC, P55; Chandra AK, 1997, COMPUT COMPLEX, V6, P312; Chung F., 1997, SPECTRAL GRAPH THEOR; Currat M, 2004, MOL ECOL NOTES, V4, P139, DOI 10.1046/j.1471-8286.2003.00582.x; Davis SM, 2007, HEALTH EDUC BEHAV, V34, P154, DOI 10.1177/1090198106288490; Davison K, 2006, J ARCHAEOL SCI, V33, P641, DOI 10.1016/j.jas.2005.09.017; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; DOEBLEY JF, 1986, AM J BOT, V73, P64, DOI 10.2307/2444278; Doyle P.G., 1984, RANDOM WALKS ELECT N; EDMONSON MS, 1961, CURR ANTHROPOL, V2, P71, DOI 10.1086/200169; Emshwiller E, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P99; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fuller DQ, 2008, NAT GENET, V40, P1264, DOI 10.1038/ng1108-1264; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; HARRIS DR, 1987, PHILOS T R SOC A, V323, P23, DOI 10.1098/rsta.1987.0070; Hijmans RJ, 2010, RASTER PACKAGE READI; Jones M, 2000, HOLOCENE, V10, P769, DOI 10.1191/09596830095024; Kidd DM, 2008, MOL ECOL RESOUR, V8, P88, DOI 10.1111/j.1471-8286.2007.01925.x; Kidd DM, 2006, J BIOGEOGR, V33, P1851, DOI 10.1111/j.1365-2699.2006.01574.x; Koenker R, 1999, J AM STAT ASSOC, V94, P1296, DOI 10.2307/2669943; Koenker R., 2005, QUANTILE REGRESSION, DOI DOI 10.1017/CBO9780511754098; Komuro R, 2006, ECOL MODEL, V197, P320, DOI 10.1016/j.ecolmodel.2006.03.033; Kwak M, 2009, CROP SCI, V49, P554, DOI 10.2135/cropsci2008.07.0421; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Montenegro A, 2008, J ARCHAEOL SCI, V35, P355, DOI 10.1016/j.jas.2007.04.004; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Piperno D. R., 2006, PHYTOLITH COMPREHENS; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; Ruegg KC, 2006, J BIOGEOGR, V33, P1172, DOI 10.1111/j.1365-2699.2006.01517.x; Saerens M, 2009, NEURAL COMPUT, V21, P2363, DOI 10.1162/neco.2009.11-07-643; Smith B.D., 1995, EMERGENCE AGR; STRUEVER S, 1968, AM ANTIQUITY, V33, P353, DOI 10.2307/278703; van Etten J, 2008, GENET RESOUR CROP EV, V55, P303, DOI 10.1007/s10722-007-9235-4; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; VANDIEPEN CA, 1989, SOIL USE MANAGE, V5, P16, DOI 10.1111/j.1475-2743.1989.tb00755.x; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; WILKES G, 2004, CORN ORIGIN HIST TEC, P3; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	65	42	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12060	10.1371/journal.pone.0012060	http://dx.doi.org/10.1371/journal.pone.0012060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637WJ	20711460	Green Published, gold, Green Submitted			2022-12-25	WOS:000280849100012
J	Cocco, E; Paladini, F; Macino, G; Fulci, V; Fiorillo, MT; Sorrentino, R				Cocco, Elisa; Paladini, Fabiana; Macino, Giuseppe; Fulci, Valerio; Fiorillo, Maria Teresa; Sorrentino, Rosa			The Expression of Vasoactive Intestinal Peptide Receptor 1 Is Negatively Modulated by MicroRNA 525-5p	PLOS ONE			English	Article							HUMAN MONOCYTIC CELLS; ALTERED EXPRESSION; GENE-EXPRESSION; TISSUE FACTOR; ACTIVATION; VIP; POLYMORPHISM; ASSOCIATION; POLYPEPTIDE; INHIBITION	Background: The human Vasoactive Intestinal Peptide (VIP) is a neurokine with effects on the immune system where it is involved in promoting tolerance. In this context, one of its receptors, VPAC1, has been found to be down-modulated in cells of the immune network in response to activating stimuli. In particular, the bacterial liposaccaride (LPS), a strong activator of the innate immune system, induces a rapid decrease of VPAC1 expression in monocytes and this event correlates with polymorphisms in the 3'-UTR of the gene. Methodology/Principal Findings: MicroRNA 525-5p, having as putative target the 3'-UTR region of VPAC1, has been analysed for its expression in monocytes and for its role in down-modulating VPAC1 expression. We report here that miR-525-5p is promptly up-regulated in LPS-treated monocytes. This microRNA, when co-transfected in 293T cells together with a construct containing the 3'-UTR of the VPAC1 gene, significantly reduced the luciferase activity in a standard expression assay. The U937 cell line as well as primary monocytes enforced to express miR-525-5p, both down-modulate VPAC1 expression at similar extent. Conclusions/Significance: Our results show that the response to an inflammatory stimulus elicits in monocytes a rapid increase of miR-525-5p that targets a signaling pathway involved in the control of the immune homeostasis.	[Cocco, Elisa; Paladini, Fabiana; Fiorillo, Maria Teresa; Sorrentino, Rosa] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Macino, Giuseppe; Fulci, Valerio] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Cocco, E (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.	rosa.sorrentino@uniroma1.it	Fulci, Valerio/J-1963-2015; Sorrentino, Rosa/G-5472-2012	Fulci, Valerio/0000-0002-1173-585X; Sorrentino, Rosa/0000-0002-9632-2383; FIORILLO, Maria Teresa/0000-0002-6859-5851; Paladini, Fabiana/0000-0003-1040-452X; Tripp, Ralph/0000-0002-2924-9956	Istituto Pasteur-Fondazione Cenci-Bolognetti, Sapienza, University of Rome, Italy; Volkswagen Stingtuf Foundation, Germany	Istituto Pasteur-Fondazione Cenci-Bolognetti, Sapienza, University of Rome, Italy; Volkswagen Stingtuf Foundation, Germany	This study was partially supported by Istituto Pasteur-Fondazione Cenci-Bolognetti, Sapienza, University of Rome, Italy and by Volkswagen Stingtuf Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBEZAT GO, 1971, SCIENCE, V174, P422, DOI 10.1126/science.174.4007.422; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1010, DOI 10.1002/art.23482; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gomariz RP, 2007, PEPTIDES, V28, P1825, DOI 10.1016/j.peptides.2007.07.005; Gonzalez-Rey E, 2006, BLOOD, V107, P3632, DOI 10.1182/blood-2005-11-4497; Gonzalez-Rey E, 2006, ARTHRITIS RHEUM-US, V54, P864, DOI 10.1002/art.21652; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Kojima M, 2005, PANCREAS, V30, P62; Laburthe M, 2002, REGUL PEPTIDES, V108, P165, DOI 10.1016/S0167-0115(02)00099-X; Lara-Marquez ML, 2001, J IMMUNOL, V166, P2522, DOI 10.4049/jimmunol.166.4.2522; Leceta J, 2007, NEUROIMMUNOMODULAT, V14, P134, DOI 10.1159/000110636; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lodde BM, 2006, ANN RHEUM DIS, V65, P195, DOI 10.1136/ard.2005.038232; MACKMAN N, 1994, J BIOL CHEM, V269, P26363; Makhlouf GM, 1997, CELL SIGNAL, V9, P269, DOI 10.1016/S0898-6568(96)00180-5; Martin AJ, 2009, NAT IMMUNOL, V10, P1229, DOI 10.1038/ni1209-1229; Miampamba M, 2002, REGUL PEPTIDES, V105, P145, DOI 10.1016/S0167-0115(02)00003-4; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Paladini F, 2009, NEUROGASTROENT MOTIL, V21, P597, DOI 10.1111/j.1365-2982.2009.01284.x; Paladini F, 2008, GENES IMMUN, V9, P659, DOI 10.1038/gene.2008.60; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pozo D, 2009, J IMMUNOL, V183, P4346, DOI 10.4049/jimmunol.0900400; Rigby RJ, 2008, CURR OPIN RHEUMATOL, V20, P526, DOI 10.1097/BOR.0b013e328304b45e; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; SREEDHARAN SP, 1995, P NATL ACAD SCI USA, V92, P2939, DOI 10.1073/pnas.92.7.2939; Stahl HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007158; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tili E, 2008, NAT CLIN PRACT RHEUM, V4, P534, DOI 10.1038/ncprheum0885; Toumi F, 2004, BIOCHEM BIOPH RES CO, V317, P187, DOI 10.1016/j.bbrc.2004.03.033; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999	42	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12067	10.1371/journal.pone.0012067	http://dx.doi.org/10.1371/journal.pone.0012067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706588	Green Published, Green Submitted, gold			2022-12-25	WOS:000280811900028
J	Murzyn, A; Krasowska, A; Stefanowicz, P; Dziadkowiec, D; Lukaszewicz, M				Murzyn, Anna; Krasowska, Anna; Stefanowicz, Piotr; Dziadkowiec, Dorota; Lukaszewicz, Marcin			Capric Acid Secreted by S. boulardii Inhibits C. albicans Filamentous Growth, Adhesion and Biofilm Formation	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; CELL-SURFACE HYDROPHOBICITY; PLACEBO-CONTROLLED TRIAL; CANDIDA-ALBICANS; SACCHAROMYCES-BOULARDII; ESCHERICHIA-COLI; FATTY-ACIDS; IN-VITRO; VIRULENCE; EXPRESSION	Candidiasis are life-threatening systemic fungal diseases, especially of gastro intestinal track, skin and mucous membranes lining various body cavities like the nostrils, the mouth, the lips, the eyelids, the ears or the genital area. Due to increasing resistance of candidiasis to existing drugs, it is very important to look for new strategies helping the treatment of such fungal diseases. One promising strategy is the use of the probiotic microorganisms, which when administered in adequate amounts confer a health benefit. Such a probiotic microorganism is yeast Saccharomyces boulardii, a close relative of baker yeast. Saccharomyces boulardii cells and their extract affect the virulence factors of the important human fungal pathogen C. albicans, its hyphae formation, adhesion and biofilm development. Extract prepared from S. boulardii culture filtrate was fractionated and GC-MS analysis showed that the active fraction contained, apart from 2-phenylethanol, caproic, caprylic and capric acid whose presence was confirmed by ESI-MS analysis. Biological activity was tested on C. albicans using extract and pure identified compounds. Our study demonstrated that this probiotic yeast secretes into the medium active compounds reducing candidal virulence factors. The chief compound inhibiting filamentous C. albicans growth comparably to S. boulardii extract was capric acid, which is thus responsible for inhibition of hyphae formation. It also reduced candidal adhesion and biofilm formation, though three times less than the extract, which thus contains other factors suppressing C. albicans adherence. The expression profile of selected genes associated with C. albicans virulence by real-time PCR showed a reduced expression of HWP1, INO1 and CSH1 genes in C. albicans cells treated with capric acid and S. boulardii extract. Hence capric acid secreted by S. boulardii is responsible for inhibition of C. albicans filamentation and partially also adhesion and biofilm formation.	[Murzyn, Anna; Krasowska, Anna; Dziadkowiec, Dorota; Lukaszewicz, Marcin] Univ Wroclaw, Fac Biotechnol, PL-50138 Wroclaw, Poland; [Stefanowicz, Piotr] Univ Wroclaw, Fac Chem, PL-50138 Wroclaw, Poland; [Lukaszewicz, Marcin] Wroclaw Univ Technol, Fac Chem, PL-50370 Wroclaw, Poland	University of Wroclaw; University of Wroclaw; Wroclaw University of Science & Technology	Murzyn, A (corresponding author), Univ Wroclaw, Fac Biotechnol, PL-50138 Wroclaw, Poland.	lukasz@biotrans.uni.wroc.pl	Krasowska, Anna/I-5054-2019; Stefanowicz, Piotr/AAF-3445-2020; Łukaszewicz, Marcin/K-8441-2013; Stefanowicz, Piotr/A-4373-2009; Dziadkowiec, Dorota/H-1520-2012	Łukaszewicz, Marcin/0000-0002-1453-8376; Dziadkowiec, Dorota/0000-0003-0912-2111; Krasowska, Anna/0000-0002-1925-193X; Stefanowicz, Piotr/0000-0001-9581-2359	Biocodex, France; National Centre for Research and Development [KB/48/13639/IT1-B/U/08]; Institutional Research Concept [AV0Z50200510]	Biocodex, France; National Centre for Research and Development; Institutional Research Concept	This work was partly supported by a grant from Biocodex, France and by grant KB/48/13639/IT1-B/U/08 from the National Centre for Research and Development and by the Institutional Research Concept AV0Z50200510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG R, 1993, J INFECT DIS, V168, P1314, DOI 10.1093/infdis/168.5.1314; Bergsson G, 2001, ANTIMICROB AGENTS CH, V45, P3209, DOI 10.1128/AAC.45.11.3209-3212.2001; Bleichner G, 1997, INTENS CARE MED, V23, P517, DOI 10.1007/s001340050367; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Buts JP, 2006, PEDIATR RES, V60, P24, DOI 10.1203/01.pdr.0000220322.31940.29; BUTS JP, 1994, PEDIATR RES, V36, P522, DOI 10.1203/00006450-199410000-00019; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Cao YY, 2005, ANTIMICROB AGENTS CH, V49, P584, DOI 10.1128/AAC.49.2.584-589.2005; Castagliuolo I, 1999, INFECT IMMUN, V67, P302, DOI 10.1128/IAI.67.1.302-307.1999; Clement M, 2007, FEMS YEAST RES, V7, P276, DOI 10.1111/j.1567-1364.2006.00166.x; Czerucka D, 1999, DIGEST DIS SCI, V44, P2359, DOI 10.1023/A:1026689628136; Ells R, 2009, J ANTIMICROB CHEMOTH, V63, P124, DOI 10.1093/jac/dkn446; Ene IV, 2009, EUKARYOT CELL, V8, P1909, DOI 10.1128/EC.00245-09; Fidan I, 2009, MYCOSES, V52, P29, DOI 10.1111/j.1439-0507.2008.01545.x; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Jawhara S, 2007, MED MYCOL, V45, P691, DOI 10.1080/13693780701523013; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Konno N, 2006, BIOL PHARM BULL, V29, P923, DOI 10.1248/bpb.29.923; Kotowska M, 2005, ALIMENT PHARM THER, V21, P583, DOI 10.1111/j.1365-2036.2005.02356.x; Krasowska A, 2009, FEMS YEAST RES, V9, P1312, DOI 10.1111/j.1567-1364.2009.00559.x; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Martins M, 2007, EUKARYOT CELL, V6, P2429, DOI 10.1128/EC.00252-07; McLain N, 2000, ANTIMICROB AGENTS CH, V44, P2873, DOI 10.1128/AAC.44.10.2873-2875.2000; Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Rogers PD, 2003, ANTIMICROB AGENTS CH, V47, P1220, DOI 10.1128/AAC.47.4.1220-1227.2003; SAINTMARC T, 1991, ANN MED INTERNE, V142, P64; Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999; Singleton DR, 2005, FEMS MICROBIOL LETT, V244, P373, DOI 10.1016/j.femsle.2005.02.010; Singleton DR, 2001, J BACTERIOL, V183, P3582, DOI 10.1128/JB.183.12.3582-3588.2001; Southern P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002067; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2	37	94	101	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12050	10.1371/journal.pone.0012050	http://dx.doi.org/10.1371/journal.pone.0012050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706577	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900013
J	Maher, AC; Akhtar, M; Vockley, J; Tarnopolsky, MA				Maher, Amy C.; Akhtar, Mahmood; Vockley, Jerry; Tarnopolsky, Mark A.			Women Have Higher Protein Content of beta-Oxidation Enzymes in Skeletal Muscle than Men	PLOS ONE			English	Article							FATTY-ACID OXIDATION; PALMITOYLTRANSFERASE-I ACTIVITY; TISSUE GLYCOGEN-METABOLISM; MESSENGER-RNA EXPRESSION; ACTIVATED RECEPTOR-ALPHA; RAT-LIVER MITOCHONDRIA; MENSTRUAL-CYCLE PHASE; ENDURANCE EXERCISE; MODERATE-INTENSITY; GENDER-DIFFERENCES	It is well recognized that compared with men, women have better ultra-endurance capacity, oxidize more fat during endurance exercise, and are more resistant to fat oxidation defects i.e. diet-induced insulin resistance. Several groups have shown that the mRNA and protein transcribed and translated from genes related to transport of fatty acids into the muscle are greater in women than men; however, the mechanism(s) for the observed sex differences in fat oxidation remains to be determined. Muscle biopsies from the vastus lateralis were obtained from moderately active men (N = 12) and women (N = 11) at rest to examine mRNA and protein content of genes involved in lipid oxidation. Our results show that women have significantly higher protein content for tri-functional protein alpha (TFP alpha), very long chain acyl-CoA dehydrogenase (VLCAD), and medium chain acyl-CoA dehydrogenase (MCAD) (P<0.05). There was no significant sex difference in the expression of short-chain hydroxyacyl-CoA dehydrogenase (SCHAD), or peroxisome proliferator activated receptor alpha (PPAR alpha), or PPAR gamma, genes potentially involved in the transcriptional regulation of lipid metabolism. In conclusion, women have more protein content of the major enzymes involved in long and medium chain fatty acid oxidation which could account for the observed differences in fat oxidation during exercise.	[Maher, Amy C.] McMaster Univ, Dept Med Sci, Hamilton, ON, Canada; [Akhtar, Mahmood; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada; [Vockley, Jerry] Univ Pittsburgh, Sch Med Pediat, Pittsburgh, PA USA; [Vockley, Jerry] Univ Pittsburgh, Grad Sch Publ Hlth Human Genet, Pittsburgh, PA USA	McMaster University; McMaster University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Maher, AC (corresponding author), McMaster Univ, Dept Med Sci, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457	Natural Sciences and Engineering Research Council of Canada; National Institutes of Health [R01 DK78775]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078775] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is primarily funded through Natural Sciences and Engineering Research Council of Canada grant held by MT. AM was supported by a Natural Sciences and Engineering Research Council of Canada Doctoral Research Award. JV was funded in part by National Institutes of Health grant R01 DK78775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN RH, 2009, AM J PHYSL ENDOCRINO; Berthon PM, 1998, J APPL PHYSIOL, V85, P148, DOI 10.1152/jappl.1998.85.1.148; Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Binnert C, 2000, AM J PHYSIOL-ENDOC M, V279, pE1072, DOI 10.1152/ajpendo.2000.279.5.E1072; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Carter S, 2001, J APPL PHYSIOL, V90, P139, DOI 10.1152/jappl.2001.90.1.139; Carter SL, 2001, AM J PHYSIOL-ENDOC M, V280, pE898, DOI 10.1152/ajpendo.2001.280.6.E898; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Devries MC, 2005, J CLIN ENDOCR METAB, V90, P6218, DOI 10.1210/jc.2005-0926; Devries MC, 2006, AM J PHYSIOL-REG I, V291, pR1120, DOI 10.1152/ajpregu.00700.2005; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Fredenrich A, 2005, DIABETES METAB, V31, P23, DOI 10.1016/S1262-3636(07)70162-3; Friedlander AL, 1998, J APPL PHYSIOL, V85, P1175, DOI 10.1152/jappl.1998.85.3.1175; Friedlander AL, 2007, AM J PHYSIOL-ENDOC M, V292, pE107, DOI 10.1152/ajpendo.00148.2006; Fu MHH, 2009, PHYSIOL GENOMICS, V40, P34, DOI 10.1152/physiolgenomics.00115.2009; Hamadeh MJ, 2005, J CLIN ENDOCR METAB, V90, P3592, DOI 10.1210/jc.2004-1743; HATTA H, 1988, HORM METAB RES, V20, P609, DOI 10.1055/s-2007-1010897; HAVEL RJ, 1963, J CLIN INVEST, V42, P1054, DOI 10.1172/JCI104791; HAVEL RJ, 1964, J APPL PHYSIOL, V19, P613, DOI 10.1152/jappl.1964.19.4.613; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Horton TJ, 1998, J APPL PHYSIOL, V85, P1823, DOI 10.1152/jappl.1998.85.5.1823; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Ingelsson E, 2009, J CLIN ENDOCR METAB, V94, P953, DOI 10.1210/jc.2008-1772; IZAI K, 1992, J BIOL CHEM, V267, P1027; KENDRICK ZV, 1987, J APPL PHYSIOL, V63, P492, DOI 10.1152/jappl.1987.63.2.492; KENDRICK ZV, 1991, J APPL PHYSIOL, V71, P1694, DOI 10.1152/jappl.1991.71.5.1694; Kiens B, 2004, J APPL PHYSIOL, V97, P1209, DOI 10.1152/japplphysiol.01278.2003; Knechtle B, 2004, INT J SPORTS MED, V25, P38, DOI 10.1055/s-2003-45232; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luquet S, 2004, BIOCHIMIE, V86, P833, DOI 10.1016/j.biochi.2004.09.024; Maher AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006335; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, pE580, DOI 10.1152/ajpendo.2000.278.4.E580; Mittendorfer B, 2002, AM J PHYSIOL-ENDOC M, V283, pE58, DOI 10.1152/ajpendo.00504.2001; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Perseghin G, 2001, J CLIN ENDOCR METAB, V86, P3188, DOI 10.1210/jc.86.7.3188; PHILLIPS SM, 1993, J APPL PHYSIOL, V75, P2134, DOI 10.1152/jappl.1993.75.5.2134; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265; Riddell MC, 2003, INT J SPORT NUTR EXE, V13, P407, DOI 10.1123/ijsnem.13.4.407; Roepstorff C, 2005, EXERC SPORT SCI REV, V33, P182, DOI 10.1097/00003677-200510000-00006; Roepstorff C, 2005, ACTA PHYSIOL SCAND, V184, P215, DOI 10.1111/j.1365-201X.2005.01442.x; Roepstorff C, 2002, AM J PHYSIOL-ENDOC M, V282, pE435, DOI 10.1152/ajpendo.00266.2001; Roepstorff C, 2006, AM J PHYSIOL-ENDOC M, V291, pE1106, DOI 10.1152/ajpendo.00097.2006; Roepstorff C, 2006, J PHYSIOL-LONDON, V574, P125, DOI 10.1113/jphysiol.2006.108720; Romijn JA, 2000, J APPL PHYSIOL, V88, P1707, DOI 10.1152/jappl.2000.88.5.1707; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Ruby BC, 1997, MED SCI SPORT EXER, V29, P1160, DOI 10.1097/00005768-199709000-00007; Spangenburg EE, 2009, MOL CELL BIOCHEM, V332, P225, DOI 10.1007/s11010-009-0195-1; TARNOPOLSKY LJ, 1990, J APPL PHYSIOL, V68, P302, DOI 10.1152/jappl.1990.68.1.302; TARNOPOLSKY MA, 1995, J APPL PHYSIOL, V78, P1360, DOI 10.1152/jappl.1995.78.4.1360; Tarnopolsky MA, 2000, CAN J APPL PHYSIOL, V25, P312, DOI 10.1139/h00-024; TARNOPOLSKY MA, 2006, AM J PHYSL REGUL INT; Tarnopolsky MA, 2008, MED SCI SPORT EXER, V40, P648, DOI 10.1249/MSS.0b013e31816212ff; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wanders RJA, 1999, J INHERIT METAB DIS, V22, P442, DOI 10.1023/A:1005504223140; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Yang BZ, 1996, GENOMICS, V37, P141, DOI 10.1006/geno.1996.0533; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	63	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12025	10.1371/journal.pone.0012025	http://dx.doi.org/10.1371/journal.pone.0012025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700461	Green Published, Green Accepted, gold			2022-12-25	WOS:000280687900017
J	Menge, DNL; DeNoyer, JL; Lichstein, JW				Menge, Duncan N. L.; DeNoyer, Jeanne L.; Lichstein, Jeremy W.			Phylogenetic Constraints Do Not Explain the Rarity of Nitrogen-Fixing Trees in Late-Successional Temperate Forests	PLOS ONE			English	Article							PHOSPHORUS LIMITATION; FIXATION; EVOLUTION; ACCUMULATION; PRODUCTIVITY; ECOSYSTEMS; SATURATION; RESPONSES; COMPONENT; LEGUMES	Background: Symbiotic nitrogen (N)-fixing trees are rare in late-successional temperate forests, even though these forests are often N limited. Two hypotheses could explain this paradox. The 'phylogenetic constraints hypothesis' states that no late-successional tree taxa in temperate forests belong to clades that are predisposed to N fixation. Conversely, the 'selective constraints hypothesis' states that such taxa are present, but N-fixing symbioses would lower their fitness. Here we test the phylogenetic constraints hypothesis. Methodology/Principal Findings: Using U.S. forest inventory data, we derived successional indices related to shade tolerance and stand age for N-fixing trees, non-fixing trees in the 'potentially N-fixing clade' (smallest angiosperm clade that includes all N fixers), and non-fixing trees outside this clade. We then used phylogenetically independent contrasts (PICs) to test for associations between these successional indices and N fixation. Four results stand out from our analysis of U. S. trees. First, N fixers are less shade-tolerant than non-fixers both inside and outside of the potentially N-fixing clade. Second, N fixers tend to occur in younger stands in a given geographical region than non-fixers both inside and outside of the potentially N-fixing clade. Third, the potentially N-fixing clade contains numerous late-successional non-fixers. Fourth, although the N fixation trait is evolutionarily conserved, the successional traits are relatively labile. Conclusions/Significance: These results suggest that selective constraints, not phylogenetic constraints, explain the rarity of late-successional N-fixing trees in temperate forests. Because N-fixing trees could overcome N limitation to net primary production if they were abundant, this study helps to understand the maintenance of N limitation in temperate forests, and therefore the capacity of this biome to sequester carbon.	[Menge, Duncan N. L.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Menge, Duncan N. L.; DeNoyer, Jeanne L.; Lichstein, Jeremy W.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	National Center for Ecological Analysis & Synthesis; Princeton University	Menge, DNL (corresponding author), Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA.	menge@nceas.ucsb.edu	Lichstein, Jeremy/GMW-6555-2022; Menge, Duncan/A-5417-2011	Menge, Duncan/0000-0003-4736-9844	National Science Foundation [DEB-0608267, EF-0553768]; University of California Santa Barbara; State of California; Princeton University Department of Ecology and Evolutionary Biology; Princeton Carbon Mitigation Initiative, BP and Ford; U.S. Forest Service Northern Research Station	National Science Foundation(National Science Foundation (NSF)); University of California Santa Barbara(University of California System); State of California; Princeton University Department of Ecology and Evolutionary Biology(Princeton University); Princeton Carbon Mitigation Initiative, BP and Ford; U.S. Forest Service Northern Research Station(United States Department of Agriculture (USDA)United States Forest Service)	D.N.L.M. was supported by a National Science Foundation Graduate Research Fellowship and a National Science Foundation Doctoral Dissertation Improvement Grant (DEB-0608267), and performed much of the work while a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant # EF-0553768), the University of California Santa Barbara, and the State of California. J.L.D. was supported by the Princeton University Department of Ecology and Evolutionary Biology. J.W.L. was supported by the Princeton Carbon Mitigation Initiative with funding from BP and Ford and by the U.S. Forest Service Northern Research Station. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; BARRON AR, 2007, THESIS PRINCETON U P; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; BINKLEY D, 1992, ECOLOGY, V73, P2022, DOI 10.2307/1941452; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Boland DJ, 2006, FOREST TREES AUSTR; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; CHRISTENSEN EARL M., 1963, AMER MIDLAND NAT, V70, P133, DOI 10.2307/2422776; CLARKSON BD, 1990, NEW ZEAL J ECOL, V14, P59; Cramer MD, 2007, J ECOL, V95, P1123, DOI 10.1111/j.1365-2745.2007.01285.x; Crews TE, 1999, BIOGEOCHEMISTRY, V46, P233, DOI 10.1007/BF01007581; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Dawson J., 2000, NATURE GUIDE NZ FORE; DEBANO LF, 1978, ECOLOGY, V59, P489, DOI 10.2307/1936579; DEFARIA SM, 1989, NEW PHYTOL, V111, P607, DOI 10.1111/j.1469-8137.1989.tb02354.x; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; DYRNESS CT, 1973, ECOLOGY, V54, P57, DOI 10.2307/1934374; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; GUTSCHICK VP, 1981, AM NAT, V118, P607, DOI 10.1086/283858; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Houlton BZ, 2008, NATURE, V454, P327, DOI 10.1038/nature07028; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; HussDanell K, 1997, NEW PHYTOL, V136, P375, DOI 10.1046/j.1469-8137.1997.00755.x; Kershaw L., 1998, PLANTS ROCKY MOUNTAI; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lesica P, 2001, WEST N AM NATURALIST, V61, P1; Lichstein JW, 2009, ECOL STUD-ANAL SYNTH, V207, P301, DOI 10.1007/978-3-540-92706-8_14; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Menge DNL, 2008, P NATL ACAD SCI USA, V105, P1573, DOI 10.1073/pnas.0711411105; Menge DNL, 2009, AM NAT, V174, P465, DOI 10.1086/605377; Menge DNL, 2009, ECOLOGY, V90, P2190, DOI 10.1890/08-0877.1; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Oh SH, 2008, TAXON, V57, P434, DOI 10.2307/25066014; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Pearson HL, 2001, ECOL APPL, V11, P1381, DOI 10.2307/3060927; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Pojar J., 1994, PLANTS PACIFIC NW CO; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; SCHLESINGER WH, 1981, ECOLOGY, V62, P762, DOI 10.2307/1937744; Sokal R. R., 2012, BIOMETRY; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Sprent JI, 2009, LEGUME NODULATION GL, P183; Uliassi DD, 2002, ECOLOGY, V83, P88, DOI 10.1890/0012-9658(2002)083[0088:LTSNFI]2.0.CO;2; *USDA, 2005, FOR INV AN NAT COR F; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Vitousek PM, 1999, BIOGEOCHEMISTRY, V46, P179, DOI 10.1007/BF01007579; Walker L. R., 1993, PRIMARY SUCCESSION L, P249; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; WARDLE P, 1980, NEW ZEAL J BOT, V18, P221, DOI 10.1080/0028825X.1980.10426921; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053; ZAVITKOVSKI J, 1968, ECOLOGY, V49, P1134, DOI 10.2307/1934497	66	34	34	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12056	10.1371/journal.pone.0012056	http://dx.doi.org/10.1371/journal.pone.0012056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700466	Green Published, Green Submitted, gold			2022-12-25	WOS:000280687900025
J	Yadav, R; Bhowmick, S; Gorecki, P; O'Rourke, J; Cone, RE				Yadav, Rajwahrdhan; Bhowmick, Sourojit; Gorecki, Philip; O'Rourke, James; Cone, Robert E.			Paradoxical Effect of Pertussis Toxin on the Delayed Hypersensitivity Response to Autoantigens in Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ADJUVANT ACTION; CELLS; TH1; SENSITIZATION; BARRIER; ANTIGEN; BRAIN	Background: Pertussis toxin (PTX), an exotoxin of Bordetella pertussis, enhances the development of experimental autoimmune diseases such as experimental autoimmune uveitis (EAU) and experimental autoimmune encephalomyelitis (EAE) in rodent models. The mechanisms of the promotion of experimental autoimmune diseases by PTX may be based upon PTX-induced disruption of the blood eye/brain barriers facilitating the infiltration of inflammatory cells, the modulation of inflammatory cell migration and the enhancement of the activation of inflammatory cells. We hypothesized that the facilitation of experimental autoimmunity by PTX suggests that its influence on the in vivo immune response to auto-antigen may differ from its influence on non-self antigens. Methodology/Principal Findings: We have evaluated the effect of PTX on the simultaneous generation of delayed type hypersensitivity (DTH) responses and autoimmune responses to uveitogenic interphotoreceptor retinoid binding protein peptide (IRBP161-180), encephalitogenic myelin oligodendrocyte glycoprotein peptide (MOG(35-55)) or ovalbumin (OVA). PTX injection of mice immunized to IRBP peptide(161-180) led to (i) the development of EAU as shown by histopathology of the retina, (ii) pro-inflammatory cytokine production by splenocytes in response to IRBP peptide (161-180), and (iii) symptomatic EAE in mice immunized with encephalitogenic MOG peptide(35-55). However, mice that received PTX had a reduced DTH response to IRBP161-180 peptide or MOG peptide(35-55) when challenged distal to the site affected by autoreactive T cells. Moreover, footpad challenge with MOG(35-55) peptide reduced EAE in mice immunized with MOG peptide. In contrast, the use of PTX when immunizing with OVA protein or an OVA immunogenic peptide did not affect the DTH response to OVA. Conclusions/Significance: The results suggest that that the reduced DTH response in mice receiving PTX may be specific for autoantigens and autoantigen-reactive T cells are diverted away from ectopic sites that received the autoantigen and towards the tissue site of the autoantigen.	[Yadav, Rajwahrdhan; Bhowmick, Sourojit; Gorecki, Philip; O'Rourke, James; Cone, Robert E.] Univ Connecticut, Dept Immunol, Connecticut Lions Vasc Vis Ctr, Ctr Hlth, Farmington, CT USA	University of Connecticut	Yadav, R (corresponding author), Univ Connecticut, Dept Immunol, Connecticut Lions Vasc Vis Ctr, Ctr Hlth, Farmington, CT USA.	cone@UCHC.EDU			NIH [EY017537, EY017289]; Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY017289, R01EY017537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH EY017537, NIH EY017289, http://www.nih.gov/, Connecticut Lions Eye Research Foundation http://clerf.lionwap.org. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal RK, 2002, J NEUROIMMUNOL, V129, P133, DOI 10.1016/S0165-5728(02)00203-5; BO SS, 2001, J IMMUNOL, V167, P250; BO SS, 2003, J IMMUNOL, V171, P2314; CASPI R, 2003, CURRENT PROTOCOLS IM; Caspi RR, 2006, IMMUNOL REV, V213, P23, DOI 10.1111/j.1600-065X.2006.00439.x; CASPI RR, 2003, CURRENT PROTOCOLS S, V53; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Denkinger CM, 2007, CELL IMMUNOL, V246, P46, DOI 10.1016/j.cellimm.2007.05.004; Forrester John V, 2007, Chem Immunol Allergy, V92, P228, DOI 10.1159/000099274; GERY I, 1986, PROGR RETINAL RES, V5, P75; Hofstetter HH, 2002, J IMMUNOL, V169, P117, DOI 10.4049/jimmunol.169.1.117; Kugler S, 2007, CELL MICROBIOL, V9, P619, DOI 10.1111/j.1462-5822.2006.00813.x; KUNZ M, 2009, MEDIAT INFLAMM; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Millward JM, 2007, J IMMUNOL, V178, P8175, DOI 10.4049/jimmunol.178.12.8175; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ryan M, 1998, INT IMMUNOL, V10, P651, DOI 10.1093/intimm/10.5.651; Silver PB, 1999, INVEST OPHTH VIS SCI, V40, P2898	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11983	10.1371/journal.pone.0011983	http://dx.doi.org/10.1371/journal.pone.0011983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700542	Green Published, Green Submitted, gold			2022-12-25	WOS:000280605400017
J	Caron, JM; Bannon, M; Rosshirt, L; Luis, J; Monteagudo, L; Caron, JM; Sternstein, GM				Caron, Joan McIntyre; Bannon, Marissa; Rosshirt, Lindsay; Luis, Jessica; Monteagudo, Luke; Caron, John M.; Sternstein, Gerson Marc			Methyl Sulfone Induces Loss of Metastatic Properties and Reemergence of Normal Phenotypes in a Metastatic Cloudman S-91 (M3) Murine Melanoma Cell Line	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; IN-VIVO; SENESCENCE; CANCER; DIMETHYLSULFOXIDE; METHYLSULFONYLMETHANE; CHEMOTHERAPY; CYTOTOXICITY; CULTURE	Background: The most deadly form of cancer is not lung or colon, breast or prostate; it is any cancer that has become metastatic. Mortality due to metastatic melanoma, one of the most aggressive and deadly cancers, has increased steadily over the last several decades. Unfortunately, the arsenal of chemotherapeutic agents available today is most often unsuccessful at extending and improving the life expectancy of afflicted individuals. We sought to identify an effective and nontoxic agent against metastatic melanoma. Methodology/Principal Findings: We chose to study Cloudman S-91 mouse melanoma cells (sub-clone M3, CCL53.1) because these cells are highly aggressive and metastatic, representing one of the deadliest types of cancer. Melanoma cells also had an experimental advantage because their morphology, which is easily monitored, relates to the physiology of metastatic cells and normal melanocytes. We chose to test methyl sulfone as a chemotherapeutic agent for two reasons. Because of its chemical structure, we speculated a potential anti-cancer activity by targeting microtubules. Equally important, methyl sulfone has a well-established safety profile in humans. Surprisingly, we found that malignant melanoma cells exposed to methyl sulfone demonstrated the loss of phenotypes characteristic of malignant cells, and the reemergence of phenotypes characteristic of healthy melanocytes. Briefly, over time methyl sulfone induced contact inhibition, loss of ability to migrate through an extracellular matrix, loss of anchorage-independent growth, proper wound healing followed by contact inhibition, irreversible senescence followed by arborization with melanosomes in arbors as seen in normal melanocytes. Conclusions/Significance: Methyl sulfone may have clinical potential as a non-toxic agent effective against metastatic melanoma. Additionally, methyl sulfone has promise as a tool to explore molecular mechanisms of metastatic transformation as well as fundamental processes such as cell migration, contact inhibition, wound healing and cellular senescence.	[Caron, Joan McIntyre; Bannon, Marissa; Rosshirt, Lindsay; Luis, Jessica; Monteagudo, Luke; Caron, John M.; Sternstein, Gerson Marc] Univ Connecticut, Ctr Hlth, Sch Med, Dept Cell Biol, Farmington, CT USA	University of Connecticut	Caron, JM (corresponding author), Univ Connecticut, Ctr Hlth, Sch Med, Dept Cell Biol, Farmington, CT USA.	caron@nso1.uchc.edu		Caron, Joan/0000-0002-8086-6175	Leas Foundation for Leukemia Research, Inc. [6-33616]; University of Connecticut Health Center	Leas Foundation for Leukemia Research, Inc.; University of Connecticut Health Center	This work was funded by the Leas Foundation for Leukemia Research, Inc., (http://www.leasfoundation.org, Grant Number: 6-33616) to JMC. LR, JL, and LM were funded by the University of Connecticut Health Center Summer Research Program, each for two summers. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Advani SH, 1999, AM J HEMATOL, V60, P87, DOI 10.1002/(SICI)1096-8652(199902)60:2<87::AID-AJH1>3.0.CO;2-5; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barrager E, 2002, J ALTERN COMPLEM MED, V8, P167, DOI 10.1089/107555302317371451; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; CASTAIGNE S, 1990, BLOOD, V76, P1704; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONOSO JA, 1977, BRAIN RES, V120, P287, DOI 10.1016/0006-8993(77)90907-6; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Haldar S, 1996, CANCER RES, V56, P1253; HASHIMOTO H, 1992, UROL RES, V20, P233, DOI 10.1007/BF00299723; Horvath K, 2002, FOOD CHEM TOXICOL, V40, P1459, DOI 10.1016/S0278-6915(02)00086-8; KRUSE PF, 1965, J CELL BIOL, V27, P273, DOI 10.1083/jcb.27.2.273; Lanosa XA, 2008, NEURON GLIA BIOL, V4, P27, DOI 10.1017/S1740925X09000039; LLeonart ME, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-3; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nishikawa SI, 2005, E SCHERING RES FDN W, V54, P1; Roninson IB, 2003, CANCER RES, V63, P2705; Rose SE, 2000, MAGN RESON IMAGING, V18, P95, DOI 10.1016/S0730-725X(99)00110-1; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; *SOC AC, 1983, CA CANC J CLIN, V33; Steely JS, 1994, SULFUR COMPOUNDS FOO; STOKER MGP, 1967, NATURE, V215, P171, DOI 10.1038/215171a0; WALKER L, 1988, UROL RES, V16, P329, DOI 10.1007/BF00263647; Wang YC, 1998, ONCOGENE, V17, P1923, DOI 10.1038/sj.onc.1202113	29	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11788	10.1371/journal.pone.0011788	http://dx.doi.org/10.1371/journal.pone.0011788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694196	Green Published, Green Submitted, gold			2022-12-25	WOS:000280574300002
J	Planque, R; van den Berg, JB; Franks, NR				Planque, Robert; van den Berg, Jan Bouwe; Franks, Nigel R.			Recruitment Strategies and Colony Size in Ants	PLOS ONE			English	Article							DECISION-MAKING; HYMENOPTERA; ORGANIZATION; EVOLUTION; DIVERSIFICATION; FORMICIDAE; DYNAMICS; PATTERNS; BEHAVIOR; MODEL	Ants use a great variety of recruitment methods to forage for food or find new nests, including tandem running, group recruitment and scent trails. It has been known for some time that there is a loose correlation across many taxa between species-specific mature colony size and recruitment method. Very small colonies tend to use solitary foraging; small to medium sized colonies use tandem running or group recruitment whereas larger colonies use pheromone recruitment trails. Until now, explanations for this correlation have focused on the ants' ecology, such as food resource distribution. However, many species have colonies with a single queen and workforces that grow over several orders of magnitude, and little is known about how a colony's organization, including recruitment methods, may change during its growth. After all, recruitment involves interactions between ants, and hence the size of the colony itself may influence which recruitment method is used-even if the ants' behavioural repertoire remains unchanged. Here we show using mathematical models that the observed correlation can also be explained by recognizing that failure rates in recruitment depend differently on colony size in various recruitment strategies. Our models focus on the build up of recruiter numbers inside colonies and are not based on optimality arguments, such as maximizing food yield. We predict that ant colonies of a certain size should use only one recruitment method (and always the same one) rather than a mix of two or more. These results highlight the importance of the organization of recruitment and how it is affected by colony size. Hence these results should also expand our understanding of ant ecology.	[Planque, Robert; van den Berg, Jan Bouwe] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	Vrije Universiteit Amsterdam; University of Bristol	Planque, R (corresponding author), Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands.	rplanque@few.vu.nl	Franks, Nigel/AAG-8207-2019	Franks, Nigel/0000-0001-8139-9604; van den Berg, Jan Bouwe/0000-0003-3503-7535; Planque, Robert/0000-0002-0489-5425	The Netherlands Organisation	The Netherlands Organisation(Netherlands Organization for Scientific Research (NWO))	RP's research was sponsored by the Nonlinear Dynamics of Natural System cluster of The Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 2009, ANIMAL BEHAV EVOLUTI; ARON S, 1990, BIOL MOTION, P534; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Britton NF, 2002, P ROY SOC B-BIOL SCI, V269, P1383, DOI 10.1098/rspb.2002.2001; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; BUSCHINGER A, 1980, Z TIERPSYCHOL, V53, P245; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Dornhaus A, 2004, ANIM BEHAV, V67, P959, DOI 10.1016/j.anbehav.2003.09.004; Franks NR, 1999, P ROY SOC B-BIOL SCI, V266, P1697, DOI 10.1098/rspb.1999.0834; FRANKS NR, 1993, ANIM BEHAV, V45, P197, DOI 10.1006/anbe.1993.1021; FRANKS NR, 1991, J INSECT BEHAV, V4, P583, DOI 10.1007/BF01048072; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Fryxell JM, 2007, NATURE, V449, P1041, DOI 10.1038/nature06177; GOTWALD WH, 1972, ANN ENTOMOL SOC AM, V65, P383, DOI 10.1093/aesa/65.2.383; HOLLDOBLER B, 1971, Z VERGL PHYSIOL, V75, P123; Holldobler B., 1990, pi; HOLLDOBLER B, 1995, J INSECT PHYSIOL, V41, P739, DOI 10.1016/0022-1910(95)00041-R; ITO F, 1993, J NAT HIST, V27, P1315, DOI 10.1080/00222939300770751; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Mallon EB, 2000, P ROY SOC B-BIOL SCI, V267, P765, DOI 10.1098/rspb.2000.1069; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MASUKO K, 1987, THESIS TOKYO METROPO; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Myerscough MR, 2003, P ROY SOC B-BIOL SCI, V270, P577, DOI 10.1098/rspb.2002.2293; Passino KM, 2006, BEHAV ECOL SOCIOBIOL, V59, P427, DOI 10.1007/s00265-005-0067-y; Planque R, 2007, BEHAV ECOL SOCIOBIOL, V61, P347, DOI 10.1007/s00265-006-0263-4; Richardson TO, 2007, CURR BIOL, V17, P1520, DOI 10.1016/j.cub.2007.08.032; Serrano D, 2005, AM NAT, V166, pE22, DOI 10.1086/431255; Sudd JH, 1987, BEHAV ECOLOGY ANTS; TOBIN JE, 1991, ANT - PLANT INTERACTIONS, P536; TOPOFF H, 1984, BEHAV ECOL SOCIOBIOL, V15, P273, DOI 10.1007/BF00292989; TRANIELLO JFA, 1980, NATURWISSENSCHAFTEN, V67, P361, DOI 10.1007/BF01106597; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; URBANI CB, 1993, INSECT SOC, V40, P233, DOI 10.1007/BF01242361; VERHAEGHE JC, 1983, INSECT SOC, V30, P347, DOI 10.1007/BF02223992; WEHNER R, 1983, AKAD WISS LIT MAI MN; Wilson E.O., 1975, P1; Wilson E.O, 1990, SUCCESS DOMINANCE EC; Wilson E.O., 1971, INSECT SOC; Wittlinger M, 2006, SCIENCE, V312, P1965, DOI 10.1126/science.1126912	48	33	34	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11664	10.1371/journal.pone.0011664	http://dx.doi.org/10.1371/journal.pone.0011664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694195	Green Published, Green Submitted, gold			2022-12-25	WOS:000280574300001
J	Rittenhouse, CD; Pidgeon, AM; Albright, TP; Culbert, PD; Clayton, MK; Flather, CH; Huang, CQ; Masek, JG; Stewart, SI; Radeloff, VC				Rittenhouse, Chadwick D.; Pidgeon, Anna M.; Albright, Thomas P.; Culbert, Patrick D.; Clayton, Murray K.; Flather, Curtis H.; Huang, Chengquan; Masek, Jeffrey G.; Stewart, Susan I.; Radeloff, Volker C.			Conservation of Forest Birds: Evidence of a Shifting Baseline in Community Structure	PLOS ONE			English	Article							SPECIES RICHNESS; NESTING SUCCESS; LAND-USE; FRAGMENTATION; HABITAT; DYNAMICS; BIODIVERSITY; ABUNDANCE; EXTINCTION; DIVERSITY	Background: Quantifying changes in forest bird diversity is an essential task for developing effective conservation actions. When subtle changes in diversity accumulate over time, annual comparisons may offer an incomplete perspective of changes in diversity. In this case, progressive change, the comparison of changes in diversity from a baseline condition, may offer greater insight because changes in diversity are assessed over longer periods of times. Our objectives were to determine how forest bird diversity has changed over time and whether those changes were associated with forest disturbance. Methodology/Principal Findings: We used North American Breeding Bird Survey data, a time series of Landsat images classified with respect to land cover change, and mixed-effects models to associate changes in forest bird community structure with forest disturbance, latitude, and longitude in the conterminous United States for the years 1985 to 2006. We document a significant divergence from the baseline structure for all birds of similar migratory habit and nest location, and all forest birds as a group from 1985 to 2006. Unexpectedly, decreases in progressive similarity resulted from small changes in richness (<1 species per route for the 22-year study period) and modest losses in abundance (-28.7--10.2 individuals per route) that varied by migratory habit and nest location. Forest disturbance increased progressive similarity for Neotropical migrants, permanent residents, ground nesting, and cavity nesting species. We also documented highest progressive similarity in the eastern United States. Conclusions/Significance: Contemporary forest bird community structure is changing rapidly over a relatively short period of time (e.g., similar to 22 years). Forest disturbance and forest regeneration are primary factors associated with contemporary forest bird community structure, longitude and latitude are secondary factors, and forest loss is a tertiary factor. Importantly, these findings suggest some regions of the United States may already fall below the habitat amount threshold where fragmentation effects become important predictors of forest bird community structure.	[Rittenhouse, Chadwick D.; Pidgeon, Anna M.; Albright, Thomas P.; Culbert, Patrick D.; Radeloff, Volker C.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Clayton, Murray K.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Flather, Curtis H.] US Forest Serv, USDA, Rocky Mt Res Stn, Ft Collins, CO USA; [Huang, Chengquan] Univ Maryland, Dept Geog, College Pk, MD 20742 USA; [Masek, Jeffrey G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Stewart, Susan I.] US Forest Serv, USDA, No Res Stn, Evanston, IL USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Forest Service; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Agriculture (USDA); United States Forest Service	Rittenhouse, CD (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	cdrittenhous@wisc.edu	Radeloff, Volker C/B-6124-2016; Flather, Curtis H/G-3577-2012; Flather, Curtis/GQA-5543-2022; Rittenhouse, Chadwick/G-7169-2012; Masek, Jeffrey/D-7673-2012	Radeloff, Volker C/0000-0001-9004-221X; Flather, Curtis H/0000-0002-0623-3126; Huang, Chengquan/0000-0003-0055-9798	NASA [NNX07AL14G]	NASA(National Aeronautics & Space Administration (NASA))	The NASA Biodiversity Program and Interdisciplinary Sciences Program (grant #NNX07AL14G) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TP, 2010, GLOBAL CHANGE BIOL, V16, P2158, DOI 10.1111/j.1365-2486.2009.02120.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bellamy PE, 1996, OECOLOGIA, V108, P64, DOI 10.1007/BF00333215; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; Borgella R, 2005, ECOL APPL, V15, P1062, DOI 10.1890/04-0352; Boulinier T, 1998, P NATL ACAD SCI USA, V95, P7497, DOI 10.1073/pnas.95.13.7497; Boulinier T, 2001, ECOLOGY, V82, P1159, DOI 10.1890/0012-9658(2001)082[1159:FFABCD]2.0.CO;2; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; BYSTRAK D, 1981, STUD AVIAN BIOL, V6, P34; Campbell SP, 2007, CONSERV BIOL, V21, P1218, DOI 10.1111/j.1523-1739.2007.00768.x; Carrasco MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008331; Cavitt JF, 2002, STUD AVIAN BIOL-SER, P73; Doherty PF, 2002, ECOLOGY, V83, P844, DOI 10.1890/0012-9658(2002)083[0844:SOPRBI]2.0.CO;2; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Flather CH, 1996, ECOLOGY, V77, P28, DOI 10.2307/2265651; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gram WK, 2003, CONSERV BIOL, V17, P1324, DOI 10.1046/j.1523-1739.2003.02171.x; HABECK J R, 1973, Quaternary Research (Orlando), V3, P408, DOI 10.1016/0033-5894(73)90006-9; HEJL SJ, 2002, STUD AVIAN BIOL, V25, P115; HINSLEY SA, 1995, ECOGRAPHY, V18, P41, DOI 10.1111/j.1600-0587.1995.tb00117.x; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Huang CQ, 2008, REMOTE SENS ENVIRON, V112, P970, DOI 10.1016/j.rse.2007.07.023; Huang CQ, 2009, INT J DIGIT EARTH, V2, P195, DOI 10.1080/17538940902801614; Huang CQ, 2009, REMOTE SENS ENVIRON, V113, P1430, DOI 10.1016/j.rse.2008.06.016; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; LYNCH JF, 1984, BIOL CONSERV, V28, P287, DOI 10.1016/0006-3207(84)90039-9; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; Morrison ML, 2002, STUD AVIAN BIOL-SER, P65; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Philippi TE, 1998, ECOL APPL, V8, P300; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; R Core Development Team, 2006, R LANG ENV STAT COMP; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Rappole JH., 1995, ECOLOGY MIGRANT BIRD; Rittenhouse CD, 2010, GLOBAL CHANGE BIOL, V16, P905, DOI 10.1111/j.1365-2486.2009.02101.x; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rusch D. H., 2000, BIRDS N AM; Sauer J.R., 2008, N AM BREEDING BIRD S; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Smucker KM, 2005, ECOL APPL, V15, P1535, DOI 10.1890/04-1353; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; TURNER MG, 1994, LANDSCAPE ECOL, V9, P59, DOI 10.1007/BF00135079; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	54	21	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11938	10.1371/journal.pone.0011938	http://dx.doi.org/10.1371/journal.pone.0011938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689854	gold, Green Published			2022-12-25	WOS:000280520400015
J	Melchior, L; Lynnerup, N; Siegismund, HR; Kivisild, T; Dissing, J				Melchior, Linea; Lynnerup, Niels; Siegismund, Hans R.; Kivisild, Toomas; Dissing, Jorgen			Genetic Diversity among Ancient Nordic Populations	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; HUMAN REMAINS; MTDNA; PHYLOGEOGRAPHY; CONTAMINATION; EVOLUTION; HISTORY; HUMANS; SINGLE	Using established criteria for work with fossil DNA we have analysed mitochondrial DNA from 92 individuals from 18 locations in Denmark ranging in time from the Mesolithic to the Medieval Age. Unequivocal assignment of mtDNA haplotypes was possible for 56 of the ancient individuals; however, the success rate varied substantially between sites; the highest rates were obtained with untouched, freshly excavated material, whereas heavy handling, archeological preservation and storage for many years influenced the ability to obtain authentic endogenic DNA. While the nucleotide diversity at two locations was similar to that among extant Danes, the diversity at four sites was considerably higher. This supports previous observations for ancient Britons. The overall occurrence of haplogroups did not deviate from extant Scandinavians, however, haplogroup I was significantly more frequent among the ancient Danes (average 13%) than among extant Danes and Scandinavians (similar to 2.5%) as well as among other ancient population samples reported. Haplogroup I could therefore have been an ancient Southern Scandinavian type "diluted" by later immigration events. Interestingly, the two Neolithic samples (4,200 YBP, Bell Beaker culture) that were typed were haplogroup U4 and U5a, respectively, and the single Bronze Age sample (3,300-3,500 YBP) was haplogroup U4. These two haplogroups have been associated with the Mesolithic populations of Central and Northern Europe. Therefore, at least for Southern Scandinavia, our findings do not support a possible replacement of a haplogroup U dominated hunter-gatherer population by a more haplogroup diverse Neolithic Culture.	[Melchior, Linea; Dissing, Jorgen] Univ Copenhagen, Res Lab, Fac Hlth Sci, Inst Forens Med, Copenhagen, Denmark; [Lynnerup, Niels] Univ Copenhagen, Anthropol Lab, Fac Hlth Sci, Inst Forens Med, Copenhagen, Denmark; [Siegismund, Hans R.] Univ Copenhagen, Dept Biol, Fac Nat Sci, Copenhagen, Denmark; [Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Cambridge	Melchior, L (corresponding author), Kennedy Ctr, Ctr Appl Human Mol Genet, Glostrup, Denmark.	lme@kennedy.dk; jdissing@mail.dk	Kivisild, Toomas/P-5889-2017; Siegismund, Hans R./K-4332-2014	Kivisild, Toomas/0000-0002-6297-7808; Siegismund, Hans R./0000-0001-5757-3131	VELUX FOUNDATION	VELUX FOUNDATION(Velux Fonden)	This work was supported by external funding from the VELUX FOUNDATION. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Budowle B, 2008, BIOTECHNIQUES, V44, P603, DOI 10.2144/000112806; Burger J, 1999, ELECTROPHORESIS, V20, P1722; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Cooper A, 2000, SCIENCE, V289, P1139; Di Benedetto G, 2000, EUR J HUM GENET, V8, P669, DOI 10.1038/sj.ejhg.5200514; Dissing J, 2008, J ARCHAEOL SCI, V35, P1445, DOI 10.1016/j.jas.2007.10.009; ETHELBERG P, 2000, SKOVGAARDE BESTAUTTU; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Gilbert MTR, 2007, AM J PHYS ANTHROPOL, V133, P847, DOI 10.1002/ajpa.20602; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; HARRISON D, 2000, STORA DODEN; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000343; Heller R, 2008, MOL ECOL, V17, P4845, DOI 10.1111/j.1365-294X.2008.03961.x; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Jensen J., 1995, PREHISTORY DENMARK, V2nd; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Kieffer-Olsen J, 1993, GRAV GRAVSKIK MIDDEL; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lalueza-Fox C, 2004, P ROY SOC B-BIOL SCI, V271, P941, DOI 10.1098/rspb.2004.2698; Lamers R, 2009, J MOL EVOL, V68, P40, DOI 10.1007/s00239-008-9184-3; LIEBGOTT NK, 1998, DANMARK MIDDELALDERE; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Melchior L, 2008, AM J PHYS ANTHROPOL, V135, P206, DOI 10.1002/ajpa.20721; Melchior L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002214; MIKKELSEN M, 2009, FORENSIC SC IN PRESS; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; NORDBERG M, 1987, DYNAMISKE MIDDELALDE; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Rohl A, 2001, INT J LEGAL MED, V115, P29, DOI 10.1007/s004140100217; Rudbeck L, 2005, AM J PHYS ANTHROPOL, V128, P424, DOI 10.1002/ajpa.20294; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Sampietro ML, 2005, ANN HUM GENET, V69, P535, DOI 10.1111/j.1529-8817.2005.00194.x; Shennan S, 2009, HUM BIOL, V81, P339, DOI 10.3378/027.081.0312; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Topf AL, 2007, BIOL LETTERS, V3, P550, DOI 10.1098/rsbl.2007.0269; Topf AL, 2006, MOL BIOL EVOL, V23, P152, DOI 10.1093/molbev/msj013; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vernesi C, 2004, AM J HUM GENET, V74, P694, DOI 10.1086/383284; WITTLE A, 1996, EUROPE NEOLITHIC CRE; ZIEGLER P, 1982, BLACK DEATH; [No title captured]	61	35	35	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11898	10.1371/journal.pone.0011898	http://dx.doi.org/10.1371/journal.pone.0011898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689597	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520300013
J	Chen, C; Shi, Q; Zhang, BY; Wang, GR; Zhou, W; Gao, C; Tian, C; Mei, GY; Han, YL; Han, J; Dong, XP				Chen, Cao; Shi, Qi; Zhang, Bao-Yun; Wang, Gui-Rong; Zhou, Wei; Gao, Chen; Tian, Chan; Mei, Guo-Yong; Han, Yan-Ling; Han, Jun; Dong, Xiao-Ping			The Prepared Tau Exon-Specific Antibodies Revealed Distinct Profiles of Tau in CSF of the Patients with Creutzfeldt-Jakob Disease	PLOS ONE			English	Article							HUMAN SPONGIFORM ENCEPHALOPATHIES; ALZHEIMERS-DISEASE; PRION DISEASES; CEREBROSPINAL-FLUID; PHOSPHORYLATED-TAU; PROTEIN-TAU; IN-VITRO; DIAGNOSIS; ISOFORMS; PRP	Background: The diagnostic value of CSF tau for Creutzfeldt-Jakob disease (CJD) has been widely evaluated, showing a markedly disease-relative manner. However, the profiles of tau isoforms in CSF of CJD patients remain unknown. Here, we prepared the exon-specific antibodies against the peptides encoded by exon-2, exon-3 and exon-10 of human tau protein and evaluated the reactive profiles of tau in CSF samples from the patients with probable CJD. Methodology/Principal Findings: Sequences encoding exon-2, exon-3 and exon-10 of human tau protein were cloned into a prokaryotic expression vector pGEX-2T. Using recombinant fusion proteins GST-E2, GST-E3 and GST-E10, three tau exon-specific antibodies were elicited. Reliable specificities of the prepared antibodies were obtained after a serial of purification processes, not only in recognizing the tau peptides encoded by exon-2, -3 and -10, but also in distinguishing six recombinant tau isoforms by Western blot and ELISA. Three predominant tau-specific bands were observed in CSF samples with the exon-specific and the commercial tau antibodies, respectively, showing different reactive profiles between the groups of probable CJD and non-CJD. A 65 KD band was detected only in the CSF samples from probable CJD patients, especially with the antibodies against exon-2 (Anti-tE2) and exon-10 (Anit-tE10). The appearances of 65 KD band in CSF correlated well with positive 14-3-3 in CSF and typical abnormality in EEG. Such band was not observed in the CSF samples of six tested genetic CJD patients. Conclusions/Significance: Three exon-specific polyclonal antibodies were successfully prepared. Based on these antibodies, different CSF tau profiles in Western blots were observed between the groups of probable CJD and non-CJD. A disease-specific tau band emerged in the CSF samples from probable sporadic CJD, which may supply a new biomarker for screening sporadic CJD.	[Chen, Cao; Shi, Qi; Zhang, Bao-Yun; Wang, Gui-Rong; Zhou, Wei; Gao, Chen; Tian, Chan; Mei, Guo-Yong; Han, Yan-Ling; Han, Jun; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Chen, C (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	Chinese National Natural Science Foundation [30771914, 30800975]; National Science and Technology Task Force Project [2006BAD06A13-2]; Institution Technique RD [2008EG150300]; National Basic Research Program of China (973 Program) [2007CB310505]; China Mega-Project for Infectious Disease [2009ZX10004-101]; SKLID [2008SKLID102, 2008SKLID202]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Task Force Project; Institution Technique RD; National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Mega-Project for Infectious Disease; SKLID	This work was supported by Chinese National Natural Science Foundation Grants 30771914 and 30800975, National Science and Technology Task Force Project (2006BAD06A13-2), Institution Technique R&D Grant (2008EG150300), National Basic Research Program of China (973 Program) (2007CB310505), China Mega-Project for Infectious Disease (2009ZX10004-101) and the SKLID development Grant (2008SKLID102 and 2008SKLID202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cuadrado-Corrales N, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-25; Dong CF, 2008, ARCH BIOCHEM BIOPHYS, V470, P83, DOI 10.1016/j.abb.2007.11.007; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; LICHTENBERG B, 1988, NATURE, V334, P359, DOI 10.1038/334359a0; Ohkubo T, 2003, ANN NEUROL, V54, P553, DOI 10.1002/ana.10748; Otto M, 2002, NEUROLOGY, V58, P192, DOI 10.1212/WNL.58.2.192; Otto M, 1997, NEUROSCI LETT, V225, P210, DOI 10.1016/S0304-3940(97)00215-2; Pevalova M, 2006, Bratisl Lek Listy, V107, P346; Satoh K, 2006, CELL MOL NEUROBIOL, V26, P45, DOI 10.1007/s10571-006-9370-z; Shi Q, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-360; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Wang XF, 2008, MOL CELL BIOCHEM, V310, P49, DOI 10.1007/s11010-007-9664-6; Weber T, 1997, BIOMED PHARMACOTHER, V51, P381, DOI 10.1016/S0753-3322(97)89430-9; Wieser HG, 2006, CLIN NEUROPHYSIOL, V117, P935, DOI 10.1016/j.clinph.2005.12.007; WILL RG, 1993, BRIT MED BULL, V49, P960, DOI 10.1093/oxfordjournals.bmb.a072655; World Health Organization, 1998, CONS CRIT SPOR CJD; Zerr I, 2000, ANN NEUROL, V48, P323, DOI 10.1002/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5; Zerr I, 2000, NEUROLOGY, V55, P811, DOI 10.1212/WNL.55.6.811; Zhang FP, 2002, VIRUS RES, V87, P145, DOI 10.1016/S0168-1702(02)00089-8	28	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11886	10.1371/journal.pone.0011886	http://dx.doi.org/10.1371/journal.pone.0011886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686702	gold, Green Submitted, Green Published			2022-12-25	WOS:000280520200045
J	Devney, CA; Caley, MJ; Congdon, BC				Devney, Carol A.; Caley, M. Julian; Congdon, Bradley C.			Plasticity of Noddy Parents and Offspring to Sea-Surface Temperature Anomalies	PLOS ONE			English	Article							GREAT-BARRIER-REEF; WEDGE-TAILED SHEARWATER; YELLOW-NOSED ALBATROSS; TERN STERNA-HIRUNDO; CLIMATE-CHANGE; ENVIRONMENTAL VARIABILITY; DEVELOPMENTAL PLASTICITY; REPRODUCTIVE SUCCESS; CALONECTRIS-DIOMEDEA; PUFFINUS-PACIFICUS	Behavioral and/or developmental plasticity is crucial for resisting the impacts of environmental stressors. We investigated the plasticity of adult foraging behavior and chick development in an offshore foraging seabird, the black noddy ( Anous minutus), during two breeding seasons. The first season had anomalously high sea-surface temperatures and 'low' prey availability, while the second was a season of below average sea-surface temperatures and 'normal' food availability. During the second season, supplementary feeding of chicks was used to manipulate offspring nutritional status in order to mimic conditions of high prey availability. When sea-surface temperatures were hotter than average, provisioning rates were significantly and negatively impacted at the day-to-day scale. Adults fed chicks during this low-food season smaller meals but at the same rate as chicks in the unfed treatment the following season. Supplementary feeding of chicks during the second season also resulted in delivery of smaller meals by adults, but did not influence feeding rate. Chick begging and parental responses to cessation of food supplementation suggested smaller meals fed to artificially supplemented chicks resulted from a decrease in chick demands associated with satiation, rather than adult behavioral responses to chick condition. During periods of low prey abundance, chicks maintained structural growth while sacrificing body condition and were unable to take advantage of periods of high prey abundance by increasing growth rates. These results suggest that this species expresses limited plasticity in provisioning behavior and offspring development. Consequently, responses to future changes in sea-surface temperature and other environmental variation may be limited.	[Devney, Carol A.] James Cook Univ, Sch Marine & Trop Biol, Australian Inst Marine Sci, Cairns, Qld, Australia; [Caley, M. Julian] JCU, AIMS, Townsville, Qld, Australia	Australian Institute of Marine Science; James Cook University; Australian Institute of Marine Science	Devney, CA (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Australian Inst Marine Sci, Cairns, Qld, Australia.	carol.devney@jcu.edu.au	Caley, Julian/A-4042-2008; Congdon, Bradley C/J-9181-2012	Caley, Julian/0000-0001-5739-749X; Congdon, Bradley C/0000-0002-8751-0892	James Cook University; Stuart Leslie Bird Research Award; Birds Queensland Research Grant; GBRMPA; Australian Research Council [LP 0562157]; AIMS@JCU PhD Scholarship	James Cook University; Stuart Leslie Bird Research Award; Birds Queensland Research Grant; GBRMPA; Australian Research Council(Australian Research Council); AIMS@JCU PhD Scholarship	Data collection was financially supported by the following: James Cook University Graduate Research Support Scheme Grant, Stuart Leslie Bird Research Award, Birds Queensland Research Grant, GBRMPA Science for Management Award, Australian Research Council LP 0562157, and an, AIMS@JCU PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ashmole N. P., 1967, Bulletin of the Peabody Museum of Natural History, V24, P1; Ashmole N.P, 1971, AVIAN BIOL, VI, P223; ASHMOLE NP, 1962, IBIS B, V103, P255; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Bokony V, 2009, AM NAT, V173, P589, DOI 10.1086/597610; Chiaradia A, 2006, ARDEA, V94, P257; CONGDON BC, 1991, EMU, V91, P158, DOI 10.1071/MU9910158; Congdon BC, 2005, MAR ECOL PROG SER, V301, P293, DOI 10.3354/meps301293; Cooper RP, 1948, EMU, V48, P107; CROXALL JP, 1982, J ANIM ECOL, V63, P275; DIAMOND AW, 1983, STUD AVIAN BIOL, V8, P24; Duriez O, 2000, CAN J ZOOL, V78, P1275, DOI 10.1139/cjz-78-7-1275; Dyer PK, 2005, EMU, V105, P249, DOI 10.1071/MU04011; EMLEN ST, 1991, CONDOR, V93, P591, DOI 10.2307/1368191; Erikstad KE, 1998, ECOLOGY, V79, P1781; Erwin CA, 2007, MAR ECOL PROG SER, V331, P255, DOI 10.3354/meps331255; GAUGER VH, 1999, BIRDS N AM; GBRMPA, 2006, FIN BLEACH SUMM REP; Gebhardt-Henrich S., 1998, AVIAN GROWTH DEV, P324; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Hamer KC, 1999, ANIM BEHAV, V57, P627, DOI 10.1006/anbe.1998.0994; Hamer KC, 2006, BEHAV ECOL, V17, P132, DOI 10.1093/beheco/arj008; HAMER KC, 1993, J ANIM ECOL, V62, P441, DOI 10.2307/5193; HARRISON CS, 1983, WILDLIFE MONOGR, P1; Hedd A, 2002, MAR ECOL PROG SER, V229, P221, DOI 10.3354/meps229221; Higgins P. J., 1996, HDB AUSTR NZ ANTARCT, V3; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HULSMAN K., 1988, SEABIRDS OTHER MARIN; Konarzewski M, 2000, PHYSIOL BIOCHEM ZOOL, V73, P416, DOI 10.1086/317744; Konarzewski M, 1996, FUNCT ECOL, V10, P97, DOI 10.2307/2390267; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; Mangel M, 2001, EVOL ECOL RES, V3, P583; MASSIAS A, 1990, ORNIS SCAND, V21, P187, DOI 10.2307/3676778; Messie M, 2006, DEEP-SEA RES PT I, V53, P1581, DOI 10.1016/j.dsr.2006.06.007; Moe B, 2004, J EXP BIOL, V207, P4067, DOI 10.1242/jeb.01226; MONAGHAN P, 1992, Ardea, V80, P71; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; NISBET ICT, 1995, CONDOR, V97, P335, DOI 10.2307/1369019; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Peck DR, 2004, MAR ECOL PROG SER, V281, P259, DOI 10.3354/meps281259; PIANKA ER, 1976, AM ZOOL, V16, P775; Quilifeldt P, 2007, J AVIAN BIOL, V38, P298, DOI 10.1111/j.2007.0908-8857.03846.x; Quillfeldt P, 2007, BEHAV ECOL SOCIOBIOL, V61, P793, DOI 10.1007/s00265-006-0310-1; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; RICKLEFS RE, 1981, AUK, V98, P361; RICKLEFS RE, 1998, AVIAN GROWTH DEV EVO, P266; Robinson JA, 2002, IBIS, V144, P344, DOI 10.1046/j.1474-919X.2002.00061.x; Schew WA., 1998, AVIAN GROWTH DEV, P288; SCHREIBER RW, 1984, SCIENCE, V225, P713, DOI 10.1126/science.225.4663.713; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Skirving W, 2002, SEA SURFACE TEMPERAT; Smithers BV, 2003, MAR FRESHWATER RES, V54, P973, DOI 10.1071/MF02137; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Surman CA, 2003, J ZOOL, V259, P219, DOI 10.1017/S0952836902003047; Takahashi A, 1999, ECOL RES, V14, P155, DOI 10.1046/j.1440-1703.1999.00285.x; Tilgar V, 2002, J AVIAN BIOL, V33, P407, DOI 10.1034/j.1600-048X.2002.02990.x; Tveraa T, 1998, J ANIM ECOL, V67, P699, DOI 10.1046/j.1365-2656.1998.00234.x; VANHEEZIK Y, 1990, IBIS, V132, P354; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weimerskirch H, 2000, IBIS, V142, P103, DOI 10.1111/j.1474-919X.2000.tb07689.x; Weimerskirch H, 2001, BEHAV ECOL, V12, P22, DOI 10.1093/oxfordjournals.beheco.a000374; Wernham CV, 1998, J ANIM ECOL, V67, P25, DOI 10.1046/j.1365-2656.1998.00166.x; Wilkinson C, 2000, STATUS CORAL REEFS W	64	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11891	10.1371/journal.pone.0011891	http://dx.doi.org/10.1371/journal.pone.0011891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686693	Green Published, Green Accepted, gold			2022-12-25	WOS:000280520200049
J	Liu, YM; Bassham, DC				Liu, Yimo; Bassham, Diane C.			TOR Is a Negative Regulator of Autophagy in Arabidopsis thaliana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; PROTEIN-KINASE; CHLAMYDOMONAS-REINHARDTII; PLANT AUTOPHAGY; RAPAMYCIN TOR; S6 KINASE; TARGET; STRESS; STARVATION	Background: Autophagy is a protein degradation process by which cells recycle cytoplasmic contents under stress conditions or during senescence; a basal level of housekeeping autophagy also occurs under non-stressed conditions. Although a number of genes that function in autophagy (ATG genes) have been identified in plants, the upstream components that regulate the plant autophagy pathway are still obscure. Target of rapamycin (TOR) is a negative regulator of autophagy in both yeast and animals, and homologs of TOR in plants control plant growth and protein synthesis. However, a role for TOR in regulation of autophagy in plants has not been demonstrated previously. Methodology/Principal Findings: In this paper we used RNA interference (RNAi) to generate transgenic plants with reduced AtTOR transcript level. By observing monodansylcadaverine- (MDC) and GFP-AtATG8e-labeled autophagosomes, these plants were demonstrated to have constitutive AtATG18a-dependent autophagy. Reverse transcriptase-PCR also showed increased expression of some AtATG genes in the RNAi-AtTOR plants. Unlike autophagy induced by starvation or salt stress, an NADPH oxidase inhibitor did not inhibit the constitutive autophagy in the RNAi-AtTOR lines, indicating that AtTOR is either downstream of or in a parallel pathway to NADPH oxidase. Conclusions/Significance: Together, our results provide evidence that TOR is a negative regulator of autophagy in plants.	[Liu, Yimo; Bassham, Diane C.] Iowa State Univ, Interdept Genet Program, Ames, IA 50011 USA; [Liu, Yimo; Bassham, Diane C.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA; [Bassham, Diane C.] Iowa State Univ, Inst Plant Sci, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Liu, YM (corresponding author), Iowa State Univ, Interdept Genet Program, Ames, IA 50011 USA.	bassham@iastate.edu	Liu, Yimo/A-2910-2013		National Science Foundation [IOB-0515998]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant no. IOB-0515998 from the National Science Foundation (www.nsf.gov) to DCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GH, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-2; Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; Bassham DC, 2007, CURR OPIN PLANT BIOL, V10, P587, DOI 10.1016/j.pbi.2007.06.006; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chen SX, 1999, EUR J BIOCHEM, V260, P726, DOI 10.1046/j.1432-1327.1999.00199.x; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000; Crespo JL, 2005, PLANT PHYSIOL, V139, P1736, DOI 10.1104/pp.105.070847; de la Cruz HR, 2004, BIOCHEMISTRY-US, V43, P533, DOI 10.1021/bi035222z; Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Perez-Perez ME, 2010, PLANT PHYSIOL, V152, P1874, DOI 10.1104/pp.109.152520; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Honma Y, 2006, EMBO J, V25, P3832, DOI 10.1038/sj.emboj.7601262; Horvath BM, 2006, EMBO J, V25, P4909, DOI 10.1038/sj.emboj.7601362; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P1641, DOI 10.1093/pcp/pcl031; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang MY, 2002, PLANTA, V215, P1022, DOI 10.1007/s00425-002-0829-y; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Li L, 2007, J EXP BOT, V58, P3323, DOI 10.1093/jxb/erm180; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Liu YM, 2009, AUTOPHAGY, V5, P954, DOI 10.4161/auto.5.7.9290; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Matsuoka K, 1997, PLANT CELL, V9, P533; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; MERSEREAU M, 1990, GENE, V90, P149, DOI 10.1016/0378-1119(90)90452-W; Moriyasu Y, 1996, PLANT PHYSIOL, V111, P1233, DOI 10.1104/pp.111.4.1233; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Patel S, 2008, AUTOPHAGY, V4, P20, DOI 10.4161/auto.5056; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rose TL, 2006, BIOL CELL, V98, P53, DOI 10.1042/BC20040516; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shin JH, 2009, MOL CELLS, V27, P67, DOI 10.1007/s10059-009-0006-2; Sormani R, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-26; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Toyooka K, 2006, AUTOPHAGY, V2, P96, DOI 10.4161/auto.2.2.2366; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Xiang Y, 2007, AUTOPHAGY, V3, P257, DOI 10.4161/auto.3847; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xiong Y, 2005, PLANT J, V42, P535, DOI 10.1111/j.1365-313X.2005.02397.x; Xiong Y, 2007, PLANT PHYSIOL, V143, P291, DOI 10.1104/pp.106.092106; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	64	185	196	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11883	10.1371/journal.pone.0011883	http://dx.doi.org/10.1371/journal.pone.0011883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686696	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520200042
J	Beattie, JR; Pawlak, AM; Boulton, ME; Zhang, JY; Monnier, VM; McGarvey, JJ; Stitt, AW				Beattie, J. Renwick; Pawlak, Anna M.; Boulton, Michael E.; Zhang, Jianye; Monnier, Vincent M.; McGarvey, John J.; Stitt, Alan W.			Multiplex analysis of age-related protein and lipid modifications in human Bruch's membrane	FASEB JOURNAL			English	Article						advanced glycation endproducts; advanced lipoxidation endproducts; hemoglobin; Raman spectroscopy; aging	GLYCATION END-PRODUCTS; RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; RAMAN-SPECTROSCOPY; AREA CENTRALIS; VITAMIN-E; MICROSCOPY; PREDICTION; RECEPTORS; DISEASE	Aging of the human retina is characterized by progressive pathology, which can lead to vision loss. This progression is believed to involve reactive metabolic intermediates reacting with constituents of Bruch's membrane, significantly altering its physiochemical nature and function. We aimed to replace a myriad of techniques following these changes with one, Raman spectroscopy. We used multiplexed Raman spectroscopy to analyze the age-related changes in 7 proteins, 3 lipids, and 8 advanced glycation/lipoxidation endproducts (AGEs/ALEs) in 63 postmortem human donors. We provided an important database for Raman spectra from a broad range of AGEs and ALEs, each with a characteristic fingerprint. Many of these adducts were shown for the first time in human Bruch's membrane and are significantly associated with aging. The study also introduced the previously unreported up-regulation of heme during aging of Bruch's membrane, which is associated with AGE/ALE formation. Selection of donors ranged from ages 32 to 92 yr. We demonstrated that Raman spectroscopy can identify and quantify age-related changes in a single nondestructive measurement, with potential to measure age-related changes in vivo. We present the first directly recorded evidence of the key role of heme in AGE/ALE formation.-Beattie, J. R., Pawlak, A. M., Boulton, M. E., Zhang, J., Monnier, V. M., McGarvey, J. J., Stitt, A. W. Multiplex analysis of age-related protein and lipid modifications in human Bruch's membrane. FASEB J. 24, 4816-4824 (2010). www.fasebj.org	[Beattie, J. Renwick; Pawlak, Anna M.; Stitt, Alan W.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Sch Med & Dent, Belfast BT12 6BA, Antrim, North Ireland; [McGarvey, John J.] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast BT12 6BA, Antrim, North Ireland; [Boulton, Michael E.] Univ Florida, Gainesville, FL USA; [Zhang, Jianye; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Queens University Belfast; Queens University Belfast; State University System of Florida; University of Florida; Case Western Reserve University	Stitt, AW (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Sch Med & Dent, Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland.	a.stitt@qub.ac.uk	Beattie, James Renwick/I-4506-2015; Stitt, Alan/A-9842-2009; Pawlak, Anna/A-7904-2016	Beattie, James Renwick/0000-0002-0205-717X; Stitt, Alan/0000-0002-8647-9918; Pawlak, Anna/0000-0002-2911-6125	UK Medical Research Council [G0600053]; Leverhume Trust [EM/2006/0049]; Research and Development Office of Northern Ireland [SPI/2384/03]; U.S. National Institutes of Health [ES011985]; UK Biotechnology and Biological Sciences Research Council [JREI 18471]; Medical Research Council [G0600053] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011985] Funding Source: NIH RePORTER; MRC [G0600053] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhume Trust; Research and Development Office of Northern Ireland; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research was supported by the UK Medical Research Council (G0600053), the Leverhume Trust (EM/2006/0049), the Research and Development Office of Northern Ireland (SPI/2384/03), and the U.S. National Institutes of Health (ES011985). Purchase of the Raman microscope was assisted by funding from the UK Biotechnology and Biological Sciences Research Council (JREI 18471). The authors also thank the Bristol Eye Bank (Bristol, UK) for the donation of clinical material used in this study. Creation of the AGE/ALE database was dependent on the generosity of several individuals: Prof. Uchida (Nagoya University, Japan), Prof. Nagaraj (Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, OH, USA), and Dr. Rozanowska (School of Optometry and Visual Sciences, Cardiff University, Cardiff, UK).	Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Bazan N G, 1989, Prog Clin Biol Res, V312, P95; BAZAN NG, 1982, VISION RES, V22, P1539, DOI 10.1016/0042-6989(82)90221-8; Beattie JR, 2007, MOL VIS, V13, P1106; Beattie JR, 2007, FASEB J, V21, P766, DOI 10.1096/fj.06-7028com; Beattie JR, 2009, J RAMAN SPECTROSC, V40, P429, DOI 10.1002/jrs.2146; Beattie JR, 2005, MOL VIS, V11, P825; Beattie JR, 2004, LIPIDS, V39, P407, DOI 10.1007/s11745-004-1245-z; Beattie RJ, 2004, MEAT SCI, V66, P903, DOI 10.1016/j.meatsci.2003.08.012; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bernstein PS, 2002, OPHTHALMOLOGY, V109, P1780, DOI 10.1016/S0161-6420(02)01173-9; Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002; BORCHMAN D, 1995, CURR EYE RES, V14, P511, DOI 10.3109/02713689509003763; Boulton M, 2004, GRAEF ARCH CLIN EXP, V242, P76, DOI 10.1007/s00417-003-0812-8; Chen L, 2003, BRIT J OPHTHALMOL, V87, P212, DOI 10.1136/bjo.87.2.212; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Ethier CR, 2004, ANNU REV BIOMED ENG, V6, P249, DOI 10.1146/annurev.bioeng.6.040803.140055; Glenn JV, 2007, FASEB J, V21, P3542, DOI 10.1096/fj.06-7896com; Glenn JV, 2009, BBA-GEN SUBJECTS, V1790, P1109, DOI 10.1016/j.bbagen.2009.04.016; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; Guymer R, 1999, PROG RETIN EYE RES, V18, P59, DOI 10.1016/S1350-9462(98)00012-3; Handa JT, 1999, INVEST OPHTH VIS SCI, V40, P775; Harding J., 1991, CATARACT BIOCH EPIDE; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, MOL NEUROBIOL, V41, P290, DOI 10.1007/s12035-010-8110-z; Howes KA, 2004, INVEST OPHTH VIS SCI, V45, pU906; Huang JD, 2007, EXP EYE RES, V85, P202, DOI 10.1016/j.exer.2007.03.011; Ishibashi T, 1998, ARCH OPHTHALMOL-CHIC, V116, P1629, DOI 10.1001/archopht.116.12.1629; Januszewski AS, 2003, BIOCHEM SOC T, V31, P1413; Javitt NB, 2009, CURR OPIN OPHTHALMOL, V20, P151, DOI 10.1097/ICU.0b013e32832af468; Karachalias N, 2010, DIABETOLOGIA, V53, P1506, DOI 10.1007/s00125-010-1722-z; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Long EK, 2010, FREE RADICAL BIO MED, V49, P1, DOI 10.1016/j.freeradbiomed.2010.03.015; MARSHALL GE, 1992, BRIT J OPHTHALMOL, V76, P607, DOI 10.1136/bjo.76.10.607; MARSHALL GE, 1994, GRAEF ARCH CLIN EXP, V232, P133, DOI 10.1007/BF00176781; Monnier VM, 2003, ARCH BIOCHEM BIOPHYS, V419, P1, DOI 10.1016/j.abb.2003.08.014; Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373; Pauleikhoff D, 2000, OPHTHALMOLOGE, V97, P243, DOI 10.1007/s003470050520; Pawlak AM, 2008, ANN NY ACAD SCI, V1126, P59, DOI 10.1196/annals.1433.066; Pawlak AM, 2008, J RAMAN SPECTROSC, V39, P1635, DOI 10.1002/jrs.2011; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Schutt F, 2003, INVEST OPHTH VIS SCI, V44, P3663, DOI 10.1167/iovs.03-0172; Sell DR, 2007, BIOCHEM J, V404, P269, DOI 10.1042/BJ20061645; Sen S, 2005, BIOPHYS CHEM, V113, P289, DOI 10.1016/j.bpc.2004.05.005; Shih S, 2003, ARCH BIOCHEM BIOPHYS, V420, P79, DOI 10.1016/j.abb.2003.09.015; Sideroudi TI, 2006, LASER SURG MED, V38, P695, DOI 10.1002/lsm.20360; Skeie JM, 2008, INVEST OPHTH VIS SCI, V49, P5574, DOI 10.1167/iovs.08-1984; Starita C, 1996, EXP EYE RES, V62, P565, DOI 10.1006/exer.1996.0066; Stitt AW, 1997, AM J PATHOL, V150, P523; Suttnar J, 1997, ANAL BIOCHEM, V249, P20, DOI 10.1006/abio.1997.2157; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Tezel TH, 2009, INVEST OPHTH VIS SCI, V50, P1911, DOI 10.1167/iovs.07-1372; Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102; Wang L, 2009, INVEST OPHTH VIS SCI, V50, P870, DOI 10.1167/iovs.08-2376; Yamada Y, 2006, EXP EYE RES, V82, P840, DOI 10.1016/j.exer.2005.10.005	62	48	48	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2010	24	12					4816	4824		10.1096/fj.10-166090	http://dx.doi.org/10.1096/fj.10-166090			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20686107	Green Published			2022-12-25	WOS:000284824400021
J	Le, LQ; Mahler, V; Scheurer, S; Foetisch, K; Braun, Y; Weigand, D; Enrique, E; Lidholm, J; Paulus, KE; Sonnewald, S; Vieths, S; Sonnewald, U				Le, Lien Q.; Mahler, Vera; Scheurer, Stephan; Foetisch, Kay; Braun, Yvonne; Weigand, Daniela; Enrique, Ernesto; Lidholm, Jonas; Paulus, Kathrin E.; Sonnewald, Sophia; Vieths, Stefan; Sonnewald, Uwe			Yeast profilin complements profilin deficiency in transgenic tomato fruits and allows development of hypoallergenic tomato fruits	FASEB JOURNAL			English	Article						Lyc e 1; RNA interference; tomato allergy; genetically modified food	SACCHAROMYCES-CEREVISIAE; REDUCED ALLERGENICITY; CROSS-REACTIVITY; PLANT PROFILINS; IDENTIFICATION; REDUCTION; EPITOPES; GENE; RNA	Gene silencing of Lyc e 1 leads to reduced allergenicity of tomato fruits but impaired growth of transgenic tomato plants. The aim of the study was to restore growth of Lyc e 1-deficient tomato plants while retaining reduced allergenicity by simultaneous complementation of profilin deficiency by expression of nonallergenic yeast profilin. Transgenic plants were generated and tested by RT-PCR and immunoblotting; allergenicity of yeast profilin and transgenic fruits was investigated by IgE binding, basophil activation, and skin-prick tests. Lyc e 1 content of transgenic tomato fruits was <5% of that of wild-type plants, causing significantly reduced IgE antibody binding. Simultaneous coexpression of yeast profilin restored growth and biomass production almost to wildtype levels. Yeast profilin, sharing 32.6% amino acid sequence identity with Lyc e 1, displayed low IgE-binding capacity and allergenic potency. Among 16 tomato-allergic patients preselected for sensitization to Lyc e 1, none showed significant reactivity to yeast profilin. Yeast profilin did not induce mediator release, and coexpression of yeast profilin did not enhance the allergenicity of Lyc e 1-reduced fruits. Simultanous coexpression of yeast profilin allows silencing of tomato profilin and generation of viable plants with Lyc e 1-deficient tomato fruits. Therefore, a novel approach to allergen avoidance, genetically modified foods with reduced allergen accumulation, can be generated even if the allergen fulfills an essential cellular function in the plant. In summary, our findings of efficiently complementing profilin-deficient tomato plants by coexpression of low allergenic yeast profilin demonstrate the feasibility of creating low-allergenic food even if the allergen fulfills essential cellular functions.-Le, L. Q., Mahler, V., Scheurer, S., Foetisch, K., Braun, Y., Weigand, D., Enrique, E., Lidholm, J., Paulus, K. E., Sonnewald, S., Vieths, S., Sonnewald, U. Yeast profilin complements profilin deficiency in transgenic tomato fruits and allows development of hypoallergenic tomato fruits. FASEB J. 24, 4939-4947 (2010). www.fasebj.org	[Le, Lien Q.; Paulus, Kathrin E.; Sonnewald, Sophia; Sonnewald, Uwe] Univ Erlangen Nurnberg, Dept Biol, Univ Hosp Erlangen, D-91058 Erlangen, Germany; [Mahler, Vera] Univ Erlangen Nurnberg, Dept Dermatol, Univ Hosp Erlangen, D-91058 Erlangen, Germany; [Scheurer, Stephan; Foetisch, Kay; Braun, Yvonne; Weigand, Daniela; Vieths, Stefan] Paul Ehrlich Inst, Div Allergol, D-6070 Langen, Germany; [Enrique, Ernesto] Hosp Gen Castellon, Castellon de La Plana, Spain; [Lidholm, Jonas] Phadia AB, Res & Dev, Uppsala, Sweden	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Paul Ehrlich Institute; Thermo Fisher Scientific; Phadia	Paulus, KE (corresponding author), Univ Erlangen Nurnberg, Lehrstuhl Biochem, Staudtstr 5, D-91058 Erlangen, Germany.	kpaulus@biologie.uni-erlangen.de	Sonnewald, Uwe/J-7875-2012; Scheurer, Stephan/A-6509-2019	Sonnewald, Uwe/0000-0003-1835-5339; Scheurer, Stephan/0000-0002-2859-562X; Lidholm, Jonas/0000-0002-7779-3411	Deutsche Forschungsgemeinschaft (DFG) [PAK 132]; German Research Foundation [DFG-Vi 165/6-1, DFG-Ma 1997/3-1, DFG-So 300/13-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	The authors thank Mechthild Retzek, Andrea Wust, Robert Kammermeier, and Jasmin Drobietz for the excellent technical assistance and Dr. Philippe Deviller (Lyon, France) for providing the anti-ragweed PFN serum. The authors thank Dr. Kamiri (University Gent, Ghent, Belgium) for providing the RNAi-vector p7GWIWG2(II). In addition, the authors thank Andrea Knospe and Sybille Freist for taking care of tissue culture plants and Stefan Hoglander for performing experimental ImmunoCAP couplings of yeast and tomato PFN. The work was funded by Deutsche Forschungsgemeinschaft (DFG) grant PAK 132. This study was supported by grants DFG-Vi 165/6-1, DFG-Ma 1997/3-1, and DFG-So 300/13-1 from the German Research Foundation. None of the authors has a financial relationship with a biotechnology or pharmaceutical manufacturer that has an interest in the subject matter or materials discussed in the submitted manuscript.	BALDO BA, 1988, INT ARCH ALLER A IMM, V86, P201, DOI 10.1159/000234572; BelchiHernandez J, 1996, J ALLERGY CLIN IMMUN, V97, P131, DOI 10.1016/S0091-6749(96)70293-2; Christensen HEM, 1996, PLANT J, V10, P269, DOI 10.1046/j.1365-313X.1996.10020269.x; Codex Alimentarious Commission, 2003, 25 SESS ROM IT 30 JU; DeWitt AM, 2002, CLIN EXP ALLERGY, V32, P1329, DOI 10.1046/j.1365-2222.2002.01467.x; Dodo HW, 2008, PLANT BIOTECHNOL J, V6, P135, DOI 10.1111/j.1467-7652.2007.00292.x; Dreborg S., 1989, ALLERGY S10, V44, P31; GIEHL K, 1994, EUR J BIOCHEM, V226, P681, DOI 10.1111/j.1432-1033.1994.tb20096.x; Gilissen LJWJ, 2005, J ALLERGY CLIN IMMUN, V115, P364, DOI 10.1016/j.jaci.2004.10.014; Goodman RE, 2008, NAT BIOTECHNOL, V26, P73, DOI 10.1038/nbt1343; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; Karakesisoglou I, 1996, CELL MOTIL CYTOSKEL, V34, P36; KORTEKANGASSAVOLAINEN O, 1993, CLIN EXP ALLERGY, V23, P179, DOI 10.1111/j.1365-2222.1993.tb00879.x; Le LQ, 2006, J ALLERGY CLIN IMMUN, V118, P1176, DOI 10.1016/j.jaci.2006.06.031; Le LQ, 2006, PLANT BIOTECHNOL J, V4, P231, DOI 10.1111/j.1467-7652.2005.00175.x; Ling HQ, 1998, PLANT CELL REP, V17, P843, DOI 10.1007/s002990050495; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lopez-Torrejon G, 2007, J ALLERGY CLIN IMMUN, V119, P1481, DOI 10.1016/j.jaci.2007.02.004; Lorenz Y, 2006, J ALLERGY CLIN IMMUN, V118, P711, DOI 10.1016/j.jaci.2006.05.014; MAGDOLEN V, 1988, MOL CELL BIOL, V8, P5108, DOI 10.1128/MCB.8.12.5108; McKinney EC, 2001, PLANT CELL, V13, P1179, DOI 10.1105/tpc.13.5.1179; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; Ramachandran S, 2000, PLANT PHYSIOL, V124, P1637, DOI 10.1104/pp.124.4.1637; Rothkegel M, 1996, J CELL SCI, V109, P83; Scheurer S, 2001, J CHROMATOGR B, V756, P315, DOI 10.1016/S0378-4347(01)00090-1; SHIMADA J, 2005, SCI TECH TRENDS, V16, P26; Sicherer SH, 2006, J ALLERGY CLIN IMMUN, V117, pS470, DOI 10.1016/j.jaci.2005.05.048; Singh MB, 2008, TRENDS PLANT SCI, V13, P257, DOI 10.1016/j.tplants.2008.04.004; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Westphal S, 2004, ALLERGY, V59, P526, DOI 10.1046/j.1398-9995.2003.00413.x	31	12	14	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4939	4947		10.1096/fj.10-163063	http://dx.doi.org/10.1096/fj.10-163063			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20709910				2022-12-25	WOS:000284824400032
J	Mehrara, BJ; Avraham, T; Soares, M; Fernandez, JG; Yan, A; Zampell, JC; Andrade, VP; Cordeiro, AP; Sorrento, CM				Mehrara, Babak J.; Avraham, Tomer; Soares, Marc; Fernandez, John G.; Yan, Alan; Zampell, Jamie C.; Andrade, Victor P.; Cordeiro, Andrew P.; Sorrento, Cristina M.			p21(cip/WAF) is a key regulator of long-term radiation damage in mesenchyme-derived tissues	FASEB JOURNAL			English	Article						p21; mesenchymal stem cell; differentiation; radiation injury; skin fibrosis	DEPENDENT KINASE INHIBITOR; STEM-CELLS; CELLULAR SENESCENCE; IONIZING-RADIATION; BONE; DIFFERENTIATION; P21; GROWTH; EXPRESSION; CYCLIN	This study aimed to determine the mechanisms responsible for long-term tissue damage following radiation injury. We irradiated p21-knockout (p21(-/-)) and wild-type (WT) mice and determined the long-term deleterious effects of this intervention on mesenchyme-derived tissues. In addition, we explored the mechanisms of radiation-induced mesenchymal stem cell (MSC) dysfunction in isolated bone marrow-derived cells. p21 expression was chronically elevated >200-fold in irradiated tissues. Loss of p21 function resulted in a >4-fold increase in the number of skin MSCs remaining after radiation. p21(-/-) mice had significantly less radiation damage, including 6-fold less scarring, 40% increased growth potential, and 4-fold more hypertrophic chondrocytes in the epiphyseal plate (P<0.01). Irradiated p21(-/-) MSCs had 4-fold increased potential for bone or fat differentiation, 4-fold greater proliferation rate, and nearly 7-fold lower senescence as compared to WT MSCs (P<0.01). Ectopic expression of p21 in knockout cells decreased proliferation and differentiation potential and recapitulated the WT phenotype. Loss of p21 function markedly decreases the deleterious effects of radiation injury in mesenchyme-derived tissues and preserves tissue-derived MSCs. In addition, p21 is a critical regulator of MSC proliferation, differentiation, and senescence both at baseline and in response to radiation.-Mehrara, B. J., Avraham, T., Soares, M., Fernandez, J. G., Yan, A., Zampell, J. C., Andrade, V. P., Cordeiro, A. P., Sorrento, C. M. p21(cip/WAF) is a key regulator of long-term radiation damage in mesenchyme-derived tissues. FASEB J. 24, 4877-4888 (2010). www.fasebj.org	[Mehrara, Babak J.; Avraham, Tomer; Soares, Marc; Fernandez, John G.; Yan, Alan; Zampell, Jamie C.; Cordeiro, Andrew P.; Sorrento, Cristina M.] Mem Sloan Kettering Canc Ctr, Div Plast & Reconstruct Surg, Dept Surg, New York, NY USA; [Andrade, Victor P.] Mem Sloan Kettering Canc Ctr, Div Breast Surg, Dept Surg, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Mehrara, BJ (corresponding author), 1275 York Ave,Rm MRI 1005, New York, NY 10065 USA.	mehrarab@mskcc.org	Andrade, Victor/K-6514-2012	Andrade, Victor/0000-0002-2243-8834	Plastic Surgery Education Foundation	Plastic Surgery Education Foundation	Funding for this study was provided in part by a Plastic Surgery Education Foundation National Endowment grant to B.J.M.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104; Bellosta P, 2003, J BONE MINER RES, V18, P818, DOI 10.1359/jbmr.2003.18.5.818; Carrington JL, 2005, BIOCHEM BIOPH RES CO, V328, P700, DOI 10.1016/j.bbrc.2004.12.041; Chang SF, 2009, MOL ENDOCRINOL, V23, P1827, DOI 10.1210/me.2009-0143; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Clavin NW, 2008, PLAST RECONSTR SURG, V122, P739, DOI 10.1097/PRS.0b013e318180edaa; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Crigler L, 2007, FASEB J, V21, P2050, DOI 10.1096/fj.06-5880com; Dickhut A, 2005, ANN HEMATOL, V84, P722, DOI 10.1007/s00277-005-1067-8; Djojosubroto MW, 2003, MOL CELLS, V15, P164; Enomoto K, 2006, INVEST OPHTH VIS SCI, V47, P4330, DOI 10.1167/iovs.05-1581; Fan YP, 2003, MOL CANCER THER, V2, P773; Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Galotto M, 1999, EXP HEMATOL, V27, P1460, DOI 10.1016/S0301-472X(99)00076-4; George RJ, 2009, AM J PHYSIOL-GASTR L, V296, pG245, DOI 10.1152/ajpgi.00021.2008; Inoue N, 2008, J BIOL CHEM, V283, P21220, DOI 10.1074/jbc.M801824200; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ju ZY, 2007, ANN NY ACAD SCI, V1100, P333, DOI 10.1196/annals.1395.036; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Legrier ME, 2001, NEUROREPORT, V12, P3127, DOI 10.1097/00001756-200110080-00029; Mehlhorn AT, 2007, CELL PROLIFERAT, V40, P809, DOI 10.1111/j.1365-2184.2007.00473.x; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mora AL, 2008, J CELL BIOCHEM, V105, P641, DOI 10.1002/jcb.21890; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Park SH, 2008, CANCER BIOL THER, V7, P2015, DOI 10.4161/cbt.7.12.7069; PASILOVA M, 2009, PLAST RECONSTR SUR S, V123, pS149; Petschnik AE, 2010, BRIT J DERMATOL, V162, P380, DOI 10.1111/j.1365-2133.2009.09512.x; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; Rousseau D, 1999, ONCOGENE, V18, P3290, DOI 10.1038/sj.onc.1202681; Schonmeyr BH, 2008, PLAST RECONSTR SURG, V122, P64, DOI 10.1097/PRS.0b013e31817743cd; Schonmeyr BH, 2010, TISSUE ENG PT A, V16, P653, DOI 10.1089/ten.TEA.2009.0426; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P5058, DOI 10.1210/jc.2002-020800; Tiede S, 2007, EUR J CELL BIOL, V86, P355, DOI 10.1016/j.ejcb.2007.03.006; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007; Weiss RH, 2007, J UROLOGY, V177, P63, DOI 10.1016/j.juro.2006.08.073; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Zhang J, 2008, J BIOMED SCI, V15, P585, DOI 10.1007/s11373-008-9256-9; Zhou JX, 2004, CELL BIOL INT, V28, P523, DOI 10.1016/j.cellbi.2004.04.007; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	57	20	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4877	4888		10.1096/fj.10-155762	http://dx.doi.org/10.1096/fj.10-155762			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20720160				2022-12-25	WOS:000284824400027
J	Yang, X; Xie, XQ; Chen, L; Zhou, H; Wang, Z; Zhao, WJ; Tian, R; Zhang, RG; Tian, CL; Long, JF; Shen, YQ				Yang, Xue; Xie, Xingqiao; Chen, Liu; Zhou, Hao; Wang, Zheng; Zhao, Weijing; Tian, Ran; Zhang, Rongguang; Tian, Changlin; Long, Jiafu; Shen, Yuequan			Structural basis for tandem L27 domain-mediated polymerization	FASEB JOURNAL			English	Article						cell polarity; MAGUK protein; tripartite complex; paramagnetic relaxation enhancement	CELL POLARITY COMPLEXES; LARGE TUMOR-SUPPRESSOR; MAGUK PROTEIN; LIN-7; BINDS; LOCALIZATION; MECHANISMS; JUNCTIONS; ADHESION; HOMOLOG	The establishment of epithelial cell polarity requires the assembly of multiprotein complexes and is crucial during epithelial morphogenesis. Three scaffolding proteins, Dlg1, MPP7, and Mals3, can be assembled to form a complex that functions in the establishment and maintenance of apicobasal polarity in epithelial tissues through their L27 domains. Here we report the crystal structure of a 4-L27-domain complex derived from the human tripartite complex Dlg1-MPP7-Mals3 in combination with paramagnetic relaxation enhancement measurements. The heterotrimer consists of 2 pairs of heterodimeric L27 domains. These 2 dimers are asymmetric due to the large difference between the N- and C-terminal tandem L27 domain of MPP7. Structural analysis combined with biochemical experiments further reveals that the loop alpha A-alpha B and helix alpha B of the C-terminal L27 domain of MPP7 play a critical role in assembling the entire tripartite complex, suggesting a synergistic tandem L27-mediated assembling event.-Yang, X., Xie, X., Chen, L., Zhou, H., Wang, Z., Zhao, W., Tian, R., Zhang, R., Tian, C., Long, J., Shen, Y. Structural basis for tandem L27 domain- mediated polymerization. FASEB J. 24, 4806-4815 (2010). www.fasebj.org	[Yang, Xue; Xie, Xingqiao; Zhou, Hao; Wang, Zheng; Zhao, Weijing; Tian, Ran; Long, Jiafu; Shen, Yuequan] Nankai Univ, Tianjin Key Lab Prot Sci, Coll Life Sci, Tianjin 300071, Peoples R China; [Chen, Liu; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Rongguang] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	Nankai University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Long, JF (corresponding author), Nankai Univ, Tianjin Key Lab Prot Sci, Coll Life Sci, Tianjin 300071, Peoples R China.	jflong@nankai.edu.cn; yuequan74@yahoo.com	Zhou, Hao/G-9693-2019; Shen, Yuequan/C-8950-2013; Tian, Changlin/P-1469-2014; Long, Jiafu/B-7420-2012	Zhou, Hao/0000-0001-6813-648X; Shen, Yuequan/0000-0002-3775-0900; Long, Jiafu/0000-0002-6625-0147	973 Program [2007CB914301, 2009CB825504, 2006CB910204]; 863 Program [2006AA02A319, 2006AA02A321]; National Natural Science Foundation of China (NSFC) [30940015, 30700122]; TBR Program [08QTPTJC28200, 08SYSYTC00200, 08JC-ZDJC20500]; New Century Excellent Talents in University (NCET) [NCET-07-0458, NCET-07-0456]	973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); TBR Program; New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET))	The authors thank Dr. Mingjie Zhang (Hong Kong University of Science and Technology, Hong Kong, China) for critical comments, and the staff at the beamline 3W1A of the Beijing Synchrotron Radiation Facility (Beijing, China) and at the beamline 19-ID of the Advanced Photon Source in Argonne National Laboratory (Argonne, IL, USA) for excellent technical assistance during data collection. This work was funded by the 973 Program (grants 2007CB914301, 2009CB825504, and 2006CB910204), the 863 Program (grants 2006AA02A319 and 2006AA02A321), the National Natural Science Foundation of China (NSFC; grants 30940015 and 30700122), and the TBR Program (grants 08QTPTJC28200, 08SYSYTC00200, and 08JC-ZDJC20500). Both Y.S. and J.L. were also supported by New Century Excellent Talents in University (NCET) programs (NCET-07-0458 and NCET-07-0456).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Banks L, 2008, ONCOGENE, V27, P6876, DOI 10.1038/onc.2008.339; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bhoj EJ, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-5; Bohl J, 2007, J BIOL CHEM, V282, P9392, DOI 10.1074/jbc.M610002200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P317, DOI 10.1016/S0968-0004(00)01599-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng W, 2005, P NATL ACAD SCI USA, V102, P6861, DOI 10.1073/pnas.0409346102; Feng W, 2004, NAT STRUCT MOL BIOL, V11, P475, DOI 10.1038/nsmb751; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Hamanoue H, 2009, AM J MED GENET A, V149A, P336, DOI 10.1002/ajmg.a.32656; Harris BZ, 2002, J BIOL CHEM, V277, P34902, DOI 10.1074/jbc.M205856200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karnak D, 2002, J BIOL CHEM, V277, P46730, DOI 10.1074/jbc.M208781200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Li YH, 2004, EMBO J, V23, P2723, DOI 10.1038/sj.emboj.7600294; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Olsen O, 2007, J CELL BIOL, V179, P151, DOI 10.1083/jcb.200702054; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; STEWART M, 1972, DEV BIOL, V27, P71, DOI 10.1016/0012-1606(72)90113-3; Straight SW, 2006, J BIOL CHEM, V281, P37738, DOI 10.1074/jbc.M607059200; Stucke VM, 2007, MOL BIOL CELL, V18, P1744, DOI 10.1091/mbc.E06-11-0980; Van Horn WD, 2010, BBA-BIOMEMBRANES, V1798, P140, DOI 10.1016/j.bbamem.2009.08.022; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	38	9	12	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4806	4815		10.1096/fj.10-163857	http://dx.doi.org/10.1096/fj.10-163857			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20702775				2022-12-25	WOS:000284824400020
J	Madison, DL; Lundblad, JR				Madison, D. L.; Lundblad, J. R.			C-terminal binding protein and poly(ADP)ribose polymerase 1 contribute to repression of the p21(waf1/cip1) promoter	ONCOGENE			English	Article						Poly(ADP)ribose Polymerase; p21; CtBP; PARP inhibitor	ADENOVIRUS E1A; POLY(ADP-RIBOSE) POLYMERASE-1; CELLULAR PHOSPHOPROTEIN; COREPRESSOR FUNCTION; NEGATIVE MODULATION; CANCER-CELLS; TRANSCRIPTION; PARP-1; CTBP; ACTIVATION	Transcriptional repression by the C-terminal binding protein (CtBP) is proposed to require nicotinamide adenine dinucleotide dehydrogenase (NAD(H). Previous studies have implicated CtBP in transcriptional repression of the p21(waf1/cip1) gene. Similarly, the NAD-dependent poly(adenosine diphosphate) ribose polymerase 1 (PARP1) may affect p21 expression via its NAD-dependent enzymatic activity; we therefore asked if PARP1 and CtBP were functionally linked in regulating p21 transcription. We found that restraint of basal p21 transcription requires both CtBP and PARP1. PARP inhibition attenuated activation of p21 transcription by both p53-independent and p53-dependent processes, in a CtBP-dependent manner. CtBP1 + 2 or PARP1 + 2 knockdown partially activated p21 gene expression, suggesting relief of a corepressor function dependent on both proteins. We localized CtBP-responsive repression elements to the proximal promoter region, and found ZBRK1 overexpression could also overcome DNA damage-dependent, but not p53-dependent activation through this region. By chromatin immunoprecipitation we find dismissal of CtBP from the proximal promoter following DNA-damage, and that PARP1 associates with a CtBP corepressor complex in nuclear extracts. We propose a model in which both CtBP and PARP functionally interact in a corepressor complex as components of a molecular switch necessary for p21 repression, and following DNA damage signals activation of p21 transcription by corepressor dismissal and coactivator recruitment. Oncogene (2010) 29, 6027-6039; doi:10.1038/onc.2010.338; published online 16 August 2010	[Madison, D. L.; Lundblad, J. R.] Oregon Hlth & Sci Univ, Div Endocrinol, Dept Med, Portland, OR 97239 USA; [Madison, D. L.] Portland VA Med Ctr, Endocrine Sect, Dept Hosp & Specialty Med, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Madison, DL (corresponding author), Oregon Hlth & Sci Univ, Div Endocrinol, Dept Med, L-604,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	Madisond@ohsu.edu			 [NIDDK R01DK060133];  [NCI K08CA109158]; NATIONAL CANCER INSTITUTE [K08CA109158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060133] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work as supported by Grants (NIDDK R01DK060133) to JRL and DLM (NCI K08CA109158). We thank J Hildebrand (University of Pittsburgh) for the CtBP MEFs, R Klein (OHSU) for access to and assistance with real time PCR, R Kwok (University of Michigan) for the p53 expression construct and Madeleine Pham and Loren Brown for technical assistance.	Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Ambrose HE, 2007, ONCOGENE, V26, P6244, DOI 10.1038/sj.onc.1210434; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Balasubramanian P, 2003, FEBS LETT, V537, P157, DOI 10.1016/S0014-5793(03)00119-4; Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Furusawa T, 1999, MOL CELL BIOL, V19, P8581; Furuta S, 2006, CANCER CELL, V10, P13, DOI 10.1016/j.ccr.2006.05.022; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Haapajarvi T, 1999, EXP CELL RES, V248, P272, DOI 10.1006/excr.1999.4403; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li M, 2004, BIOCHEM J, V382, P323, DOI 10.1042/BJ20040593; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; MOYED HS, 1983, J BACTERIOL, V155, P557, DOI 10.1128/JB.155.2.557-564.1983; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Sundqvist A, 1998, FEBS LETT, V429, P183, DOI 10.1016/S0014-5793(98)00588-2; Takasawa R, 2005, APOPTOSIS, V10, P1121, DOI 10.1007/s10495-005-0901-8; Tan W, 2004, J BIOL CHEM, V279, P6576, DOI 10.1074/jbc.M312270200; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05; Wieler S, 2003, J BIOL CHEM, V278, P18914, DOI 10.1074/jbc.M211641200; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102; Zhang QH, 2002, SCIENCE, V295, P1895; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	52	21	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	45					6027	6039		10.1038/onc.2010.338	http://dx.doi.org/10.1038/onc.2010.338			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	678VA	20711239	Green Accepted			2022-12-25	WOS:000284108700005
J	Marshall, GM; Gherardi, S; Xu, N; Neiron, Z; Trahair, T; Scarlett, CJ; Chang, DK; Liu, PY; Jankowski, K; Iraci, N; Haber, M; Norris, MD; Keating, J; Sekyere, E; Jonquieres, G; Stossi, F; Katzenellenbogen, BS; Biankin, AV; Perini, G; Liu, T				Marshall, G. M.; Gherardi, S.; Xu, N.; Neiron, Z.; Trahair, T.; Scarlett, C. J.; Chang, D. K.; Liu, P. Y.; Jankowski, K.; Iraci, N.; Haber, M.; Norris, M. D.; Keating, J.; Sekyere, E.; Jonquieres, G.; Stossi, F.; Katzenellenbogen, B. S.; Biankin, A. V.; Perini, G.; Liu, T.			Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects	ONCOGENE			English	Article						N-Myc; c-Myc; histone deacetylase 2; cyclin G2; cell proliferation	C-MYC; CYCLIN G2; PANCREATIC-CANCER; GENOMIC TARGETS; IN-VIVO; EXPRESSION; INHIBITION; PROTEIN; CELLS; IDENTIFICATION	Myc oncoproteins and histone deacetylases (HDACs) modulate gene transcription and enhance cancer cell proliferation, and HDAC inhibitors are among the most promising new classes of anticancer drugs. Here, we show that N-Myc and c-Myc upregulated HDAC2 gene expression in neuroblastoma and pancreatic cancer cells, respectively, which contributed to N-Myc- and c-Myc-induced cell proliferation. Cyclin G2 (CCNG2) was commonly repressed by N-Myc and HDAC2 in neuroblastoma cells and by c-Myc and HDAC2 in pancreatic cancer cells, and could be reactivated by HDAC inhibitors. 5-bromo-2'-deoxyuridine incorporation assays showed that transcriptional repression of CCNG2 was, in part, responsible for N-Myc-, c-Myc- and HDAC2-induced cell proliferation. Dual crosslinking chromatin immunoprecipitation assay demonstrated that N-Myc acted as a transrepressor by recruiting the HDAC2 protein to Sp1-binding sites at the CCNG2 gene core promoter. Moreover, HDAC2 was upregulated, and CCNG2 downregulated, in pre-cancerous and neuroblastoma tissues from N-Myc transgenic mice, and c-Myc overexpression correlated with upregulation of HDAC2 and repression of CCNG2 in tumour tissues from pancreatic cancer patients. Taken together, our data indicate the critical roles of upregulation of HDAC2 and suppression of CCNG2 in Myc-induced oncogenesis, and have significant implications for the application of HDAC inhibitors in the prevention and treatment of Myc-driven cancers. Oncogene (2010) 29, 5957-5968; doi:10.1038/onc.2010.332; published online 9 August 2010	[Marshall, G. M.; Xu, N.; Neiron, Z.; Trahair, T.; Liu, P. Y.; Jankowski, K.; Haber, M.; Norris, M. D.; Keating, J.; Sekyere, E.; Jonquieres, G.; Liu, T.] Univ New S Wales, Childrens Canc Inst Australia Med Res, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Marshall, G. M.] Univ New S Wales, Ctr Childrens Canc & Blood Disorders, Sydney Childrens Hosp, Sydney, NSW 2052, Australia; [Gherardi, S.; Iraci, N.; Perini, G.] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Scarlett, C. J.; Chang, D. K.; Biankin, A. V.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Stossi, F.; Katzenellenbogen, B. S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Bologna; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Illinois System; University of Illinois Urbana-Champaign	Liu, T (corresponding author), Univ New S Wales, Childrens Canc Inst Australia Med Res, Lowy Canc Res Ctr C25, POB 81, Sydney, NSW 2052, Australia.	g.marshall@unsw.edu.au; tliu@ccia.unsw.edu.au	Iraci, Nunzio/M-7451-2016; von Jonquieres, Georg/W-1781-2019; Liu, Tao/A-3922-2015	Iraci, Nunzio/0000-0003-2146-9329; von Jonquieres, Georg/0000-0002-7423-3355; Norris, Murray/0000-0002-0632-4589; Scarlett, Christopher/0000-0002-4140-7785; Liu, Tao/0000-0001-6244-7316; Haber, Michelle/0000-0003-2036-8817; Trahair, Toby/0000-0002-3295-228X; Biankin, Andrew/0000-0002-0362-5597; Chang, David/0000-0002-4821-3078	NIH; Cancer Institute NSW; NHMRC; Cancer Council NSW; Italian Association for Research on Cancer	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Institute NSW; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro)	The authors are supported by an NIH project grant (T L), a Career Development and Support Fellowship from Cancer Institute NSW (T L and AVB), NHMRC (TL and GMM) and Cancer Council NSW (TL, AVB and CJS) project grants, NHMRC, Cancer Institute NSW and Cancer Council NSW programme grants (GMM, MH and MDN), Italian Association for Research on Cancer (GP), NHMRC Postdoctoral Training Fellowships (CJS and TT). Children's Cancer Institute Australia is affiliated with University of New South Wales and Sydney Children's Hospital.	Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Biankin AV, 2009, GASTROENTEROLOGY, V137, P558, DOI 10.1053/j.gastro.2009.04.009; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Kurland JF, 2008, CANCER RES, V68, P3624, DOI 10.1158/0008-5472.CAN-07-6552; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Raetz EA, 2003, CANCER, V98, P841, DOI 10.1002/cncr.11584; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Schleger C, 2002, MODERN PATHOL, V15, P462, DOI 10.1038/modpathol.3880547; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Xu GX, 2008, MOL BIOL CELL, V19, P4968, DOI 10.1091/mbc.E08-03-0259; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zimmermann S, 2007, CANCER RES, V67, P9047, DOI 10.1158/0008-5472.CAN-07-0312	29	65	70	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2010	29	44					5957	5968		10.1038/onc.2010.332	http://dx.doi.org/10.1038/onc.2010.332			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	675PS	20697349				2022-12-25	WOS:000283843400009
J	Cagnac, O; Aranda-Sicilia, MN; Leterrier, M; Rodriguez-Rosales, MP; Venema, K				Cagnac, Olivier; Nieves Aranda-Sicilia, Maria; Leterrier, Marina; Rodriguez-Rosales, Maria-Pilar; Venema, Kees			Vacuolar Cation/H+ Antiporters of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; MEMBRANE H+-ATPASE; NA+/H+-ANTIPORTER; YEAST; TRANSPORT; EXCHANGER; GENE; POTASSIUM; CA2+; SODIUM	We previously demonstrated that Saccharomyces cerevisiae vnx1 Delta mutant strains displayed an almost total loss of Na+ and K+/H+ antiporter activity in a vacuole-enriched fraction. However, using different in vitro transport conditions, we were able to reveal additional K+/H+ antiporter activity. By disrupting genes encoding transporters potentially involved in the vnx1 mutant strain, we determined that Vcx1p is responsible for this activity. This result was further confirmed by complementation of the vnx1 Delta vcx1 Delta nhx1 Delta triple mutant with Vcx1p and its inactivated mutant Vcx1p-H303A. Like the Ca2+/H+ antiporter activity catalyzed by Vcx1p, the K+/H+ antiporter activity was strongly inhibited by Cd2+ and to a lesser extend by Zn2+. Unlike as previously observed for NHX1 or VNX1, VCX1 overexpression only marginally improved the growth of yeast strain AXT3 in the presence of high concentrations of K+ and had no effect on hygromycin sensitivity. Subcellular localization showed that Vcx1p and Vnx1p are targeted to the vacuolar membrane, whereas Nhx1p is targeted to prevacuoles. The relative importance of Nhx1p, Vnx1p, and Vcx1p in the vacuolar accumulation of monovalent cations will be discussed.	[Cagnac, Olivier; Nieves Aranda-Sicilia, Maria; Leterrier, Marina; Rodriguez-Rosales, Maria-Pilar; Venema, Kees] CSIC, Dept Bioquim Biol Celular & Mol Plantas, Estn Expt Zaidin, E-18080 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Cagnac, O (corresponding author), CSIC, Dept Bioquim Biol Celular & Mol Plantas, Estn Expt Zaidin, Prof Albareda 1, E-18008 Granada, Spain.	olivier.cagnac@eez.csic.es	Rodriguez-Rosales, Maria Pilar/H-2481-2015; Venema, Kees/G-9558-2015	Venema, Kees/0000-0001-5177-6464; Rodriguez Rosales, Maria Pilar/0000-0001-7711-3239	Spanish Plan Nacional de Biotecnologia-FEDER [BIO2008-01691]; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [AGR436]; Consejo Superior de Investigaciones Cientificas JAE-Doc program; Consejo Superior de Investigaciones Cientificas I3P program	Spanish Plan Nacional de Biotecnologia-FEDER; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); Consejo Superior de Investigaciones Cientificas JAE-Doc program; Consejo Superior de Investigaciones Cientificas I3P program	This work was supported in part by Grants BIO2008-01691 from the Spanish Plan Nacional de Biotecnologia-FEDER and AGR436 from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (to M.-P. R.-R.).; Supported by a grant from Consejo Superior de Investigaciones Cientificas JAE-Doc program.; Supported by a grant from Consejo Superior de Investigaciones Cientificas I3P program.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; BLUMWALD E, 1987, METHOD ENZYMOL, V148, P115; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; De Hertogh B, 2006, GENETICS, V172, P771, DOI 10.1534/genetics.105.046813; Del Pozo L, 1999, YEAST, V15, P371, DOI 10.1002/(SICI)1097-0061(19990330)15:5<371::AID-YEA380>3.3.CO;2-G; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; DeWitt ND, 1998, J BIOL CHEM, V273, P21744, DOI 10.1074/jbc.273.34.21744; DUNN T, 1994, J BIOL CHEM, V269, P7273; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Halachmi D, 1996, FEBS LETT, V392, P194, DOI 10.1016/0014-5793(96)00799-5; Hernandez A, 2009, J BIOL CHEM, V284, P14276, DOI 10.1074/jbc.M806203200; Hirata T, 2002, J BIOCHEM, V131, P261, DOI 10.1093/oxfordjournals.jbchem.a003097; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; Kamiya T, 2004, J BIOL CHEM, V279, P812, DOI 10.1074/jbc.M309726200; Kellermayer R, 2004, FEBS LETT, V571, P55, DOI 10.1016/j.febslet.2004.06.049; Leidi EO, 2010, PLANT J, V61, P495, DOI 10.1111/j.1365-313X.2009.04073.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Martinez-Munoz GA, 2005, YEAST, V22, P689, DOI 10.1002/yea.1238; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; Morris J, 2008, PLANT PHYSIOL, V148, P1474, DOI 10.1104/pp.108.118810; Mukherjee S, 2006, BIOCHEM J, V398, P97, DOI 10.1042/BJ20060388; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; OKOROKOV LA, 1985, FEBS LETT, V192, P303, DOI 10.1016/0014-5793(85)80130-7; OKOROKOV LA, 1980, J BACTERIOL, V144, P661, DOI 10.1128/JB.144.2.661-665.1980; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PINNER E, 1992, J BIOL CHEM, V267, P11064; PINNER E, 1993, J BIOL CHEM, V268, P1729; Pittman JK, 2004, MOL MICROBIOL, V54, P1104, DOI 10.1111/j.1365-2958.2004.04332.x; Pittman JK, 2009, J BIOL CHEM, V284, P525, DOI 10.1074/jbc.M807173200; Pozos TC, 1996, MOL CELL BIOL, V16, P3730; Prior C, 1996, FEBS LETT, V387, P89, DOI 10.1016/0014-5793(96)00470-X; Radchenko MV, 2006, J BIOL CHEM, V281, P19822, DOI 10.1074/jbc.M600333200; Rodriguez-Navarro A, 2000, BBA-REV BIOMEMBRANES, V1469, P1, DOI 10.1016/S0304-4157(99)00013-1; Sambrook J, 2001, MOL CLONING LAB MANU; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; SIKORSKI RS, 1989, GENETICS, V122, P19; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Zhao J, 2009, J BIOL CHEM, V284, P34075, DOI 10.1074/jbc.M109.070235; Zhao J, 2009, J BIOL CHEM, V284, P4605, DOI 10.1074/jbc.M804462200	63	30	35	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33914	33922		10.1074/jbc.M110.116590	http://dx.doi.org/10.1074/jbc.M110.116590			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20709757	hybrid, Green Published			2022-12-25	WOS:000283354000038
J	Dong, XY; Sun, XD; Guo, P; Li, QN; Sasahara, M; Ishii, Y; Dong, JT				Dong, Xue-Yuan; Sun, Xiaodong; Guo, Peng; Li, Qunna; Sasahara, Masakiyo; Ishii, Yoko; Dong, Jin-Tang			ATBF1 Inhibits Estrogen Receptor (ER) Function by Selectively Competing with AIB1 for Binding to the ER in ER-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; TAMOXIFEN RESISTANCE; COACTIVATOR AIB1; PROSTATE-CANCER; REGULATED TRANSCRIPTION; MAMMARY TUMORIGENESIS; EXPRESSION; PROTEIN; MUTATIONS; CANDIDATE	Loss of the q22 band of chromosome 16 is a frequent genetic event in breast cancer, and the candidate tumor suppressor gene, ATBF1, has been implicated in breast cancer by genomic deletion, transcriptional down-regulation, and association with better prognostic parameters. In addition, estrogen receptor (ER)-positive breast cancer expresses a higher level of ATBF1, suggesting a role of ATBF1 in ER-positive breast cancer. In this study, we examined whether and how ATBF1 affects the ER function in breast cancer cells. We found that ATBF1 inhibited ER-mediated gene transcription, cell growth, and proliferation in ER-positive breast cancer cells. In vitro and in vivo immuno-precipitation experiments revealed that ATBF1 interacted physically with the ER and that multiple domains in both ATBF1 and ER proteins mediated the interaction. Furthermore, we demonstrated that ATBF1 inhibited ER function by selectively competing with the steroid receptor coactivator AIB1 but not GRIP1 or SRC1 for binding to the ER. These findings not only support the concept that ATBF1 plays a tumor-suppressive role in breast cancer, they also provide a mechanism for how ATBF1 functions as a tumor suppressor in breast cancer.	[Dong, Xue-Yuan; Sun, Xiaodong; Guo, Peng; Li, Qunna; Dong, Jin-Tang] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Dong, Xue-Yuan; Sun, Xiaodong; Guo, Peng; Li, Qunna; Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Sasahara, Masakiyo; Ishii, Yoko] Toyama Univ, Dept Pathol, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan	Emory University; Emory University; University of Toyama	Dong, JT (corresponding author), 1365-C Clifton Rd, Atlanta, GA 30322 USA.	j.dong@emory.edu	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019	Dong, Jin-Tang/0000-0003-2349-5782; Guo, Peng/0000-0002-4575-8443	National Institutes of Health [CA85560]; Department of Defense [W81XWH-08-1-0328]; Georgia Cancer Coalition Award [GCC130042]; NATIONAL CANCER INSTITUTE [R01CA085560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Georgia Cancer Coalition Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA85560 (to J.-T.D.). This work was also supported by Department of Defense Grant W81XWH-08-1-0328 (to X.-Y.D.) and by Georgia Cancer Coalition Award GCC130042 (to X.-Y.D.).	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BRYANT J, 2001, J NATL CANC I MONOGR, V30, P56; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cleton-Jansen AM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-105; Cottone E, 2001, INT J BIOL MARKER, V16, P151, DOI 10.1177/172460080101600301; Dobrzycka KM, 2003, ENDOCR-RELAT CANCER, V10, P517, DOI 10.1677/erc.0.0100517; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Ferguson AT, 1997, CRIT REV ONCOGENESIS, V8, P29, DOI 10.1615/CritRevOncog.v8.i1.20; Fisher B, 2001, J Natl Cancer Inst Monogr, P62; Gronwald J, 2005, INT J CANCER, V114, P230, DOI 10.1002/ijc.20723; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Hartel A, 2003, J STEROID BIOCHEM, V84, P231, DOI 10.1016/S0960-0760(03)00033-5; HENDERSON IC, 1993, CANCER-AM CANCER SOC, V71, P2127, DOI 10.1002/1097-0142(19930315)71:6+<2127::AID-CNCR2820711602>3.0.CO;2-2; Iwase H, 2003, BREAST CANCER RES TR, V80, P339, DOI 10.1023/A:1024916126532; Kai K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-262; Kuang SQ, 2005, CANCER RES, V65, P7993, DOI 10.1158/0008-5472.CAN-05-1179; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lemieux P, 1996, J STEROID BIOCHEM, V56, P87, DOI 10.1016/0960-0760(95)00269-3; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Louie MC, 2006, MOL CELL BIOL, V26, P3810, DOI 10.1128/MCB.26.10.3810-3823.2006; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Murphy TJ, 2002, METHOD ENZYMOL, V345, P539; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Singh RR, 2006, J BIOL CHEM, V281, P25612, DOI 10.1074/jbc.M604444200; Su QB, 2008, ONCOLOGY-BASEL, V75, P159, DOI 10.1159/000159267; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2007, J CANCER RES CLIN, V133, P103, DOI 10.1007/s00432-006-0148-y; Thorat MA, 2008, HISTOPATHOLOGY, V53, P634, DOI 10.1111/j.1365-2559.2008.03155.x; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Xu JY, 2006, PROSTATE, V66, P1082, DOI 10.1002/pros.20430; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang ZH, 2005, CLIN CANCER RES, V11, P193; Zhao WH, 2009, BIOCHEM BIOPH RES CO, V380, P699, DOI 10.1016/j.bbrc.2009.01.155	48	39	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32801	32809		10.1074/jbc.M110.128330	http://dx.doi.org/10.1074/jbc.M110.128330			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720010	Green Published, hybrid			2022-12-25	WOS:000283048200016
J	Foeger, NC; Marionneau, C; Nerbonne, JM				Foeger, Nicholas C.; Marionneau, Celine; Nerbonne, Jeanne M.			Co-assembly of Kv4 alpha Subunits with K+ Channel-interacting Protein 2 Stabilizes Protein Expression and Promotes Surface Retention of Channel Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; PYRAMIDAL NEURONS; VENTRICULAR HYPERTROPHY; TERMINAL DOMAIN; TRAFFICKING; MODULATION; FAMILY; IDENTIFICATION; COMPONENTS; DELETION	Members of the K+ channel-interacting protein (KChIP) family bind the distal N termini of members of the Shal subfamily of voltage-gated K+ channel (Kv4) pore-forming (alpha) subunits to generate rapidly activating, rapidly inactivating neuronal A-type (I-A) and cardiac transient outward (I-to) currents. In heterologous cells, KChIP co-expression increases cell surface expression of Kv4 alpha subunits and Kv4 current densities, findings interpreted to suggest that Kv4.KChIP complex formation enhances forward trafficking of channels (from the endoplasmic reticulum or the Golgi complex) to the surface membrane. The results of experiments here, however, demonstrate that KChIP2 increases cell surface Kv4.2 protein expression (similar to 40-fold) by an order of magnitude more than the increase in total protein (similar to 2-fold) or in current densities (similar to 3-fold), suggesting that mechanisms at the cell surface regulate the functional expression of Kv4.2 channels. Additional experiments demonstrated that KChIP2 decreases the turnover rate of cell surface Kv4.2 protein by inhibiting endocytosis and/or promoting recycling. Unexpectedly, the experiments here also revealed that Kv4.2.KChIP2 complex formation stabilizes not only (total and cell surface) Kv4.2 but also KChIP2 protein expression. This reciprocal protein stabilization and Kv4.KChIP2 complex formation are lost with deletion of the distal (10 amino acids) Kv4.2 N terminus. Taken together, these observations demonstrate that KChIP2 differentially regulates total and cell surface Kv4.2 protein expression and Kv4 current densities.	[Foeger, Nicholas C.; Marionneau, Celine; Nerbonne, Jeanne M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nerbonne, JM (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, 660 Euclid Ave,Box 8103, St Louis, MO 63110 USA.	jnerbonne@wustl.edu	Marionneau, Céline/D-4011-2015	Marionneau, Céline/0000-0003-0962-9756	National Institutes of Health [HL034161]; NHLBI, National Institutes of Health [T32-007275]; Heartland Affiliate of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Heartland Affiliate of the American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL034161 (to J. M. N.).; Supported by NHLBI, National Institutes of Health Institutional Training Grant T32-007275.; Supported by a Heartland Affiliate of the American Heart Association postdoctoral fellowship. Present address: L'Institut du Thorax, INSERM UMR-915, Institut de Recherche Therapeutique-Universite de Nantes, Nantes, France.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Han W, 2006, J BIOL CHEM, V281, P27134, DOI 10.1074/jbc.M604843200; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Hatano N, 2002, PFLUG ARCH EUR J PHY, V444, P80, DOI 10.1007/s00424-002-0798-9; Johns DC, 1999, J NEUROSCI, V19, P1691; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; PHELAN MC, 2007, BASIC TECHNIQUES CEL, pCH1; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salvador-Recatala V, 2006, J EXP BIOL, V209, P731, DOI 10.1242/jeb.02032; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387	37	31	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33413	33422		10.1074/jbc.M110.145185	http://dx.doi.org/10.1074/jbc.M110.145185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20709747	Green Published, hybrid			2022-12-25	WOS:000283048200076
J	Houmeida, A; Heeley, DH; Belknap, B; White, HD				Houmeida, Ahmed; Heeley, David H.; Belknap, Betty; White, Howard D.			Mechanism of Regulation of Native Cardiac Muscle Thin Filaments by Rigor Cardiac Myosin-S1 and Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; RABBIT SKELETAL-MUSCLE; COOPERATIVE EQUILIBRIUM BINDING; ACTIN-TROPONIN-TROPOMYOSIN; ACTOMYOSIN SUBFRAGMENT-1; FLUORESCENT-PROBE; SLOW SKELETAL; HEART; BOVINE; CONTRACTION	We have studied the mechanism of activation of native cardiac thin filaments by calcium and rigor myosin. The acceleration of the rate of 2' -deoxy-3'-O-(N-methylanthraniloyl) ADP (mdADP) dissociation from cardiac myosin-S1-mdADP-P-i and cardiac myosin-S1-mdADP by native cardiac muscle thin filaments was measured using double mixing stopped-flow fluorescence. Relative to inhibited thin filaments (no bound calcium or rigor S1), fully activated thin filaments (with both calcium and rigor-S1 bound) increase the rate of product dissociation from the physiologically important pre-power stroke myosinmdADP-P-i by a factor of similar to 75. This can be compared with only an similar to 6-fold increase in the rate of nucleotide diphosphate dissociation from nonphysiological myosin-mdADP by the fully activated thin filaments relative to the fully inhibited thin filaments. These results show that physiological levels of regulation are not only dependent on the state of the thin filament but also on the conformation of the myosin. Less than 2-fold regulation is due to a change in affinity of myosin-ADP-P-i for thin filaments such as would be expected by a simple "steric blocking" of the myosin-binding site of the thin filament by tropomyosin. Although maximal activation requires both calcium and rigor myosin-S1 bound to the cardiac filament, association with a single ligand produces similar to 70% maximal activation. This can be contrasted with skeletal thin filaments in which calcium alone only activated the rate of product dissociation similar to 20% of maximum, and rigor myosin produces similar to 30% maximal activation.	[Belknap, Betty; White, Howard D.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; Univ Nouakchott, Dept Biochem, Nouakchott 5026, Mauritania; [Heeley, David H.] Mem Univ, Dept Biochem, St John, NF A1B 3X9, Canada	Eastern Virginia Medical School; University of Nouakchott; Memorial University Newfoundland	White, HD (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	WhiteHD@evms.edu			National Institutes of Health [HL84604, EB00209]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants HL84604 and EB00209 (to H. D. W.). This work was also supported by Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada research grants (to D. H. H.).	ANDERSON PAW, 1991, CIRC RES, V69, P1226, DOI 10.1161/01.RES.69.5.1226; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CabralLilly D, 1997, BIOPHYS J, V73, P1763, DOI 10.1016/S0006-3495(97)78206-7; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; COHEN C, 1975, SCI AM, V233, P36, DOI 10.1038/scientificamerican1175-36; COLLINS JH, 1975, J BIOL CHEM, V250, P5915; COLLINS JH, 1973, FEBS LETT, V36, P268, DOI 10.1016/0014-5793(73)80388-6; COOPER TA, 1985, J BIOL CHEM, V260, P1140; CUMMINS P, 1974, BIOCHEM J, V141, P43, DOI 10.1042/bj1410043; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; GRAND RJA, 1976, BIOCHEM J, V159, P633, DOI 10.1042/bj1590633; HEAD JG, 1995, EUR J BIOCHEM, V227, P694, DOI 10.1111/j.1432-1033.1995.tb20190.x; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; Heeley DH, 2002, P NATL ACAD SCI USA, V99, P16731, DOI 10.1073/pnas.252236399; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; HILL TL, 1983, P NATL ACAD SCI-BIOL, V80, P60, DOI 10.1073/pnas.80.1.60; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; HUMPHREYS JE, 1984, J MOL CELL CARDIOL, V16, P643, DOI 10.1016/S0022-2828(84)80628-8; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; KRETSINGER RH, 1975, BIOCHIM BIOPHYS ACTA, V405, P40, DOI 10.1016/0005-2795(75)90312-8; LESZYK J, 1987, BIOCHEMISTRY-US, V26, P7035, DOI 10.1021/bi00396a027; LEWIS WG, 1980, J BIOL CHEM, V255, P6854; MAK AS, 1981, J MOL BIOL, V149, P541, DOI 10.1016/0022-2836(81)90486-1; Matsumoto F, 2004, J MOL BIOL, V342, P1209, DOI 10.1016/j.jmb.2004.07.086; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Maytum R, 2003, J BIOL CHEM, V278, P6696, DOI 10.1074/jbc.M210690200; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; OHTSUKI I, 1979, J BIOCHEM, V86, P491, DOI 10.1093/oxfordjournals.jbchem.a132549; PEARLSTONE JR, 1976, P NATL ACAD SCI USA, V73, P1902, DOI 10.1073/pnas.73.6.1902; PEARLSTONE JR, 1986, J BIOL CHEM, V261, P6795; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; Spiess M, 1999, J STRUCT BIOL, V126, P98, DOI 10.1006/jsbi.1999.4111; Steffen W, 2004, P NATL ACAD SCI USA, V101, P12904, DOI 10.1073/pnas.0400227101; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2374; TOBACMAN LS, 1986, BIOCHEMISTRY-US, V25, P798, DOI 10.1021/bi00352a010; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; VANDEKERCKHOVE J, 1979, DIFFERENTIATION, V14, P123, DOI 10.1111/j.1432-0436.1979.tb01021.x; VANEERD JP, 1976, BIOCHEMISTRY-US, V15, P1171, DOI 10.1021/bi00650a033; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; WHITE HD, 1985, J BIOL CHEM, V260, P982; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; WHITE HD, 1982, METHOD ENZYMOL, V85, P698; WILKINSON JM, 1978, NATURE, V271, P31, DOI 10.1038/271031a0; WILKINSON JM, 1980, EUR J BIOCHEM, V103, P179, DOI 10.1111/j.1432-1033.1980.tb04302.x; WILLIAMS DL, 1988, BIOCHEMISTRY-US, V27, P6987, DOI 10.1021/bi00418a048; [No title captured]	54	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32760	32769		10.1074/jbc.M109.098228	http://dx.doi.org/10.1074/jbc.M109.098228			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20696756	Green Published, hybrid			2022-12-25	WOS:000283048200011
J	Jiang, YS; Huang, Y; Wong, HC; Zhou, YB; Wang, X; Yang, J; Hall, RA; Brown, EM; Yang, JJ				Jiang, Yusheng; Huang, Yun; Wong, Hing-Cheung; Zhou, Yubin; Wang, Xue; Yang, Jun; Hall, Randy A.; Brown, Edward M.; Yang, Jenny J.			Elucidation of a Novel Extracellular Calcium-binding Site on Metabotropic Glutamate Receptor 1 alpha (mGluR1 alpha) That Controls Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-BINDING SITES; CA2+-SENSING RECEPTORS; SENSING RECEPTOR; STRUCTURAL BASIS; PROTEINS; CA2+; AFFINITY; DOMAIN; CELLS; GLUTAMATE-RECEPTOR-1-ALPHA	Metabotropic glutamate receptor 1 alpha (mGluR1 alpha) exerts important effects on numerous neurological processes. Although mGluR1 alpha is known to respond to extracellular Ca2+ ([Ca2+](o)) and the crystal structures of the extracellular domains (ECDs) of several mGluRs have been determined, the calcium-binding site(s) and structural determinants of Ca2+-modulated signaling in the Glu receptor family remain elusive. Here, we identify a novel Ca2+-binding site in the mGluR1 alpha ECD using a recently developed computational algorithm. This predicted site (comprising Asp-318, Glu-325, and Asp-322 and the carboxylate side chain of the receptor agonist, Glu) is situated in the hinge region in the ECD of mGluR1 alpha adjacent to the reported Glu-binding site, with Asp-318 involved in both Glu and calcium binding. Mutagenesis studies indicated that binding of Glu and Ca2+ to their distinct but partially overlapping binding sites synergistically modulated mGluR1 alpha activation of intracellular Ca2+ ([Ca2+](i)) signaling. Mutating the Glu-binding site completely abolished Glu signaling while leaving its Ca2+-sensing capability largely intact. Mutating the predicted Ca2+-binding residues abolished or significantly reduced the sensitivity of mGluR1 alpha not only to [Ca2+](o) and [Gd3+](o) but also, in some cases, to Glu. The dual activation of mGluR1 alpha by [Ca2+](o) and Glu has important implications for the activation of other mGluR subtypes and related receptors. It also opens up new avenues for developing allosteric modulators of mGluR function that target specific human diseases.	[Yang, Jenny J.] Georgia State Univ, Dept Chem, Nat Sci Ctr 552, Atlanta, GA 30303 USA; [Wang, Xue] Georgia State Univ, Ctr Drug Design & Adv Biotechnol, Dept Comp Sci, Atlanta, GA 30303 USA; [Yang, Jun] Hangzhou Normal Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310036, Zhejiang, Peoples R China; [Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Brown, Edward M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Hangzhou Normal University; Emory University; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Nat Sci Ctr 552, Atlanta, GA 30303 USA.	chejjy@langate.gsu.edu	Jiang, Yusheng/A-1087-2016; Zhou, Yubin/D-4748-2011	Zhou, Yubin/0000-0001-7962-0517; Hall, Randy/0000-0002-8318-8728; Huang, Yun/0000-0001-5950-9168	National Institutes of Health [GM081749-01, DK078331, NS055179]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081749-01 (to J. J. Y.), DK078331 (to E. M. B.), and NS055179 (to R. A. H.).	Abe H, 2003, MOL CELL NEUROSCI, V23, P157, DOI 10.1016/S1044-7431(03)00052-6; Abe H, 2003, FEBS LETT, V545, P233, DOI 10.1016/S0014-5793(03)00569-6; Breitwieser GE, 2004, CELL CALCIUM, V35, P209, DOI 10.1016/j.ceca.2003.10.013; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chou TC, 1996, CALCUSYN WINDOWS SOF; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Deng H, 2006, PROTEINS, V64, P34, DOI 10.1002/prot.20973; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Francesconi A, 2004, J NEUROSCI RES, V75, P472, DOI 10.1002/jnr.10853; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Hardingham NR, 2006, J NEUROSCI, V26, P6337, DOI 10.1523/JNEUROSCI.5128-05.2006; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Jones LM, 2008, PROTEIN SCI, V17, P439, DOI 10.1110/ps.073328208; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kawabata S, 1998, J BIOL CHEM, V273, P17381, DOI 10.1074/jbc.273.28.17381; Kirberger M, 2008, J BIOL INORG CHEM, V13, P1169, DOI 10.1007/s00775-008-0402-7; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Kubokawa K, 1996, FEBS LETT, V392, P71, DOI 10.1016/0014-5793(96)00786-7; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Miyashita T, 2000, RECEPTOR CHANNEL, V7, P25; Mun HC, 2005, J BIOL CHEM, V280, P29067, DOI 10.1074/jbc.M500002200; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nash MS, 2001, J BIOL CHEM, V276, P19286, DOI 10.1074/jbc.M007600200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato T, 2003, J BIOL CHEM, V278, P4314, DOI 10.1074/jbc.M210278200; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Tabata T, 2004, MOL NEUROBIOL, V29, P261, DOI 10.1385/MN:29:3:261; Tabata T, 2002, MOL CELL NEUROSCI, V20, P56, DOI 10.1006/mcne.2002.1118; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Vassilev PM, 1997, BIOPHYS J, V72, P2103, DOI 10.1016/S0006-3495(97)78853-2; Wang X, 2010, PROTEIN SCI, V19, P1180, DOI 10.1002/pro.394; Wang X, 2009, PROTEINS, V75, P787, DOI 10.1002/prot.22285; Yang W, 2005, J AM CHEM SOC, V127, P2085, DOI 10.1021/ja0431307; Ye YM, 2005, J AM CHEM SOC, V127, P3743, DOI 10.1021/ja042786x; Ye YM, 2003, PROTEIN ENG, V16, P429, DOI 10.1093/protein/gzg051; Ye YM, 2001, PROTEIN ENG, V14, P1001, DOI 10.1093/protein/14.12.1001; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200	48	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33463	33474		10.1074/jbc.M110.147033	http://dx.doi.org/10.1074/jbc.M110.147033			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705606	Green Published, hybrid			2022-12-25	WOS:000283048200081
J	Liao, CC; Tsai, CY; Chang, WC; Lee, WH; Wang, JM				Liao, Ching-Chun; Tsai, Connie Y.; Chang, Wen-Chang; Lee, Wen-Hwa; Wang, Ju-Ming			RB center dot E2F1 Complex Mediates DNA Damage Responses through Transcriptional Regulation of ZBRK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL BINDING-PROTEIN; CELL-CYCLE CHECKPOINTS; P53-DEPENDENT APOPTOSIS; REPRESSION; PROMOTER; EXPRESSION; PATHWAY; PRB; PHOSPHORYLATION; COREPRESSOR	RB plays an essential role in DNA damage-induced growth arrest and regulates the expression of several factors essential for DNA repair machinery. However, how RB coordinates DNA damage response through transcriptional regulation of genes involved in growth arrest remains largely unexplored. We examined whether RB can mediate the response to DNA damage through modulation of ZBRK1, a zinc finger-containing transcriptional repressor that can modulate the expression of GADD45A, a DNA damage response gene, to induce cell cycle arrest in response to DNA damage. We found that the ZBRK1 promoter contains an authentic E2F-recognition sequence that specifically binds E2F1, but not E2F4 or E2F6, together with chromatin remodeling proteins CtIP and CtBP to form a repression complex that suppresses ZBRK1 transcription. Furthermore, loss of RB-mediated transcriptional repression led to an increase in ZBRK1 transcript levels, correlating with increased sensitivity to ultraviolet (UV) and methyl methanesulfonate-induced DNA damage. Taken together, these results suggest that the RB center dot CtIP (CtBP interacting protein)/CtBP (C terminus-binding protein) /E2F1 complex plays a critical role in ZBRK1 transcriptional repression, and loss of this repression may contribute to cellular sensitivity of DNA damage, ultimately leading to carcinogenesis.	[Tsai, Connie Y.; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chang, Wen-Chang] Natl Cheng Kung Univ, Inst Pharmacol, Coll Med, Tainan 70101, Taiwan; [Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Biosignal Transduct, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan	University of California System; University of California Irvine; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	whlee@uci.edu; yumingw@mail.ncku.edu.tw	wang, ju-ming/A-1875-2011; Lee, Wen-Hwa/C-2519-2014		National Institutes of Health [CA94170]; NSC (Taiwan) [98-2320-B-006-036-MY3]; National Cheng Kung University [C007]; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSC (Taiwan)(Ministry of Science and Technology, Taiwan); National Cheng Kung University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA94170 (to W.-H. L., who serves on the Board of Directors of GeneTex, Inc. and has an equity interest), NSC Grant 98-2320-B-006-036-MY3 (Taiwan) and National Cheng Kung University landmark Grant C007 (to J.-M. W.), and the Fund for Open Access publication provided by NSC Grant 98-2320-B-006-036-MY3 (Taiwan).	Ahmed KM, 2010, J BIOL CHEM, V285, P4464, DOI 10.1074/jbc.M109.062265; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bosco EE, 2004, NUCLEIC ACIDS RES, V32, P25, DOI 10.1093/nar/gkg919; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feuerhahn S, 2008, TRENDS GENET, V24, P467, DOI 10.1016/j.tig.2008.07.003; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Furuta S, 2006, CANCER CELL, V10, P13, DOI 10.1016/j.ccr.2006.05.022; Garcia V, 2005, J PATHOL, V206, P92, DOI 10.1002/path.1751; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hofferer M, 1999, NUCLEIC ACIDS RES, V27, P491, DOI 10.1093/nar/27.2.491; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Jun DY, 2008, BBA-GENE REGUL MECH, V1779, P356, DOI 10.1016/j.bbagrm.2008.03.013; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Koipally J, 2002, J BIOL CHEM, V277, P23143, DOI 10.1074/jbc.M202079200; Lin LF, 2010, CANCER RES, V70, P192, DOI 10.1158/0008-5472.CAN-09-2641; Liu F, 2006, MOL CELL BIOL, V26, P3124, DOI 10.1128/MCB.26.8.3124-3134.2006; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; MORGENBESSER SD, 1994, NATURE, V371, P72, DOI 10.1038/371072a0; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OHTANIFUJITA N, 1994, ONCOGENE, V9, P1703; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Subramanian T, 2003, FEBS LETT, V540, P255, DOI 10.1016/S0014-5793(03)00275-8; Tanaka M, 2002, J BIOL CHEM, V277, P10719, DOI 10.1074/jbc.M108252200; Wang JM, 2005, MOL BIOL CELL, V16, P3365, DOI 10.1091/mbc.E05-02-0105; Wang WL, 1997, MOL CELL ENDOCRINOL, V133, P49, DOI 10.1016/S0303-7207(97)00142-1; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; Wu LL, 2000, MOL CELL BIOL, V20, P7059, DOI 10.1128/MCB.20.19.7059-7067.2000; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yun JH, 2003, MOL CELL BIOL, V23, P7305, DOI 10.1128/MCB.23.20.7305-7314.2003; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	56	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33134	33143		10.1074/jbc.M110.143461	http://dx.doi.org/10.1074/jbc.M110.143461			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20713352	hybrid, Green Published			2022-12-25	WOS:000283048200051
J	Zhang, XM; Lam, KSL; Ye, HY; Chung, SK; Zhou, MY; Wang, Y; Xu, AM				Zhang, Xinmei; Lam, Karen S. L.; Ye, Hongying; Chung, Sookja K.; Zhou, Mingyan; Wang, Yu; Xu, Aimin			Adipose Tissue-specific Inhibition of Hypoxia-inducible Factor 1 alpha Induces Obesity and Glucose Intolerance by Impeding Energy Expenditure in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; GROWTH-FACTOR; MACROPHAGE INFILTRATION; CHRONIC INFLAMMATION; GENE-EXPRESSION; TRANSGENIC MICE; ANGIOGENESIS; ADIPOCYTES; HYPERLIPIDEMIA	Hypoxia in adipose tissue has been postulated as a possible contributor to obesity-related chronic inflammation, insulin resistance, and metabolic dysfunction. HIF1 alpha (hypoxia-inducible factor 1 alpha), a master signal mediator of hypoxia response, is elevated in obese adipose tissue. However, the role of HIF1 alpha in obesity-related pathologies remains to be determined. Here we show that transgenic mice with adipose tissue-selective expression of a dominant negative version of HIF1 alpha developed more severe obesity and were more susceptible to high fat diet-induced glucose intolerance and insulin resistance compared with their wild type littermates. Obesity in the transgenic mice was attributed to impaired energy expenditure and reduced thermogenesis. Histological examination of interscapular brown adipose tissue (BAT) in the transgenic mice demonstrated a markedly increased size of lipid droplets and decreased mitochondrial density in adipocytes, a phenotype similar to that in white adipose tissue. These changes in BAT of the transgenic mice were accompanied by decreased mitochondrial biogenesis and reduced expression of key thermogenic genes. In the transgenic mice, angiogenesis in BAT was decreased but was little affected in white adipose tissue. These findings support an indispensable role of HIF1 alpha in maintaining the thermogenic functions of BAT, possibly through promoting angiogenesis and mitochondrial biogenesis in this tissue.	[Zhang, Xinmei; Lam, Karen S. L.; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Xinmei; Lam, Karen S. L.; Chung, Sookja K.; Wang, Yu; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Ageing, Hong Kong, Hong Kong, Peoples R China; [Chung, Sookja K.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Zhou, Mingyan; Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Ye, Hongying] Fudan Univ, Hua Shan Hosp, Dept Endocrinol, Shanghai 200040, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Fudan University	Xu, AM (corresponding author), L8-40,New Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	Xu, Aimin/D-3291-2013	Xu, Aimin/0000-0002-0668-033X; wang, yu/0000-0001-8697-2940	Research Grants Council of Hong Kong [HKU 7645/06M]; Collaborative Research Fund [HKU 2/07C]; Natural Science Foundation of China [30600300]; University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Collaborative Research Fund; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Hong Kong(University of Hong Kong)	This work was supported by Research Grants Council of Hong Kong General Research Fund Grant HKU 7645/06M and Collaborative Research Fund Grant HKU 2/07C, Natural Science Foundation of China Grant 30600300, and an Outstanding Young Researcher Award from the University of Hong Kong (to A. X.).	Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; BUKOWIECKI L, 1980, AM J PHYSIOL, V239, pE422, DOI 10.1152/ajpendo.1980.239.6.E422; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Chen BY, 2006, BIOCHEM BIOPH RES CO, V341, P549, DOI 10.1016/j.bbrc.2006.01.004; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hemmeryckx B, 2008, ENDOCRINOLOGY, V149, P2176, DOI 10.1210/en.2007-1272; Hensley LL, 2003, J BIOL CHEM, V278, P32702, DOI 10.1074/jbc.M304200200; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Trayhurn P, 2008, BRIT J NUTR, V100, P227, DOI 10.1017/S0007114508971282; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Valet P, 2000, J BIOL CHEM, V275, P34797, DOI 10.1074/jbc.M005210200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	39	78	80	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32869	32877		10.1074/jbc.M110.135509	http://dx.doi.org/10.1074/jbc.M110.135509			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20716529	Green Published, hybrid			2022-12-25	WOS:000283048200024
J	Zhang, ZQ; Bryan, JL; DeLassus, E; Chang, LW; Liao, WM; Sandell, LJ				Zhang, Zhiqi; Bryan, Jennifer L.; DeLassus, Elizabeth; Chang, Li-Wei; Liao, Weiming; Sandell, Linda J.			CCAAT/Enhancer-binding Protein beta and NF-kappa B Mediate High Level Expression of Chemokine Genes CCL3 and CCL4 by Human Chondrocytes in Response to IL-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR CHONDROCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; CD-RAP GENE; MESSENGER-RNA; MIP-1-BETA PRODUCTION; IKK-BETA; IN-VITRO; CARTILAGE; ALPHA; ACTIVATION	A large set of chemokines is highly up-regulated in human chondrocytes in response to IL-1 beta (Sandell, L.J., Xing, X., Franz, C., Davies, S., Chang, L. W., and Patra, D. (2008) Osteoarthr. Cartil. 16, 1560-1571). To investigate the mechanism of transcriptional regulation, deletion constructs of selected chemokine gene promoters, the human CCL3 (MIP-1 alpha) and CCL4 (MIP-1 beta), were transfected into human chondrocytes with or without IL-1 beta. The results show that an IL-1 beta-responsive element is located between bp -300 and -140 of the CCL3 promoter and between bp -222 and -100 of the CCL4 promoter. Because both of these elements contain CCAAT/enhancer-binding protein beta (C/EBP beta) motifs, the function of C/EBP beta was examined. IL-1 beta stimulated the expression of C/EBP beta, and the direct binding of C/EBP beta to the C/EBP beta motif was confirmed by EMSA and ChIP analyses. The -300 bp CCL3 promoter and -222 bp CCL4 promoter were strongly up-regulated by co-transfection with the C/EBP beta expression vector. Mutation of the C/EBP beta motif and reduction of C/EBP beta expression by siRNA decreased the up-regulation. Additionally, another cytokine-related transcription factor, NF-kappa B, was also shown to be involved in the up-regulation of chemokines in response to IL-1 beta, and the binding site was identified. The regulation of C/EBP beta and NF-kappa B was confirmed by the inhibition by C/EBP beta and NF-kappa B and by transfection with C/EBP beta and NF-kappa B expression vectors in the presence or absence of IL-1 beta. Taken together, our results suggest that C/EBP beta and NF-kappa B are both involved in the IL-1 beta-responsive up-regulation of chemokine genes in human chondrocytes. Time course experiments indicated that C/EBP beta gradually and steadily induces chemokine up-regulation, whereas NF-kappa B activity was highest at the early stage of chemokine up-regulation.	[Zhang, Zhiqi; Bryan, Jennifer L.; DeLassus, Elizabeth; Sandell, Linda J.] Washington Univ, Sch Med, Dept Orthopaed Surg, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Chang, Li-Wei] Washington Univ, Sch Med, Dept Pathol & Immunol, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Sandell, Linda J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Zhang, Zhiqi; Liao, Weiming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Guangzhou 510080, Guangdong, Peoples R China	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Sun Yat Sen University	Sandell, LJ (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, 660 S Euclid Ave,CB 8233, St Louis, MO 63110 USA.	sandelll@wustl.edu			National Institutes of Health, NIAMS [R01 AR050847, R01 AR036994, R01 65554]; Center for Musculoskeletal Research [P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036994, R01AR045550, P30AR057235, R01AR050847] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center for Musculoskeletal Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grants R01 AR050847 and R01 AR036994, R01 65554 and ARRA Supplement, and Center for Musculoskeletal Research P30 AR057235.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Amos N, 2006, RHEUMATOLOGY, V45, P1201, DOI 10.1093/rheumatology/kel078; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Borzi RM, 2000, ARTHRITIS RHEUM, V43, P1734, DOI 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Choi SJ, 2003, BLOOD, V101, P3778, DOI 10.1182/blood-2002-08-2641; Davies SR, 2007, GENOME RES, V17, P1438, DOI 10.1101/gr.6224007; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; El-Asmar B, 2009, J MOL ENDOCRINOL, V42, P131, DOI 10.1677/JME-08-0016; Fukui N, 2003, J BONE JOINT SURG AM, V85A, P59, DOI 10.2106/00004623-200300003-00011; Fukui N, 2006, J BIOL CHEM, V281, P27229, DOI 10.1074/jbc.M603385200; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Haringman JJ, 2004, ANN RHEUM DIS, V63, P1186, DOI 10.1136/ard.2004.020529; He YC, 2002, J BIOL CHEM, V277, P19530, DOI 10.1074/jbc.M201126200; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Imamura T, 2005, J BIOL CHEM, V280, P16625, DOI 10.1074/jbc.M411469200; Imamura T, 2008, ARTHRITIS RHEUM-US, V58, P1366, DOI 10.1002/art.23438; Kristiansson E, 2009, MOL BIOL EVOL, V26, P1299, DOI 10.1093/molbev/msp040; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Lee JH, 2009, OSTEOARTHR CARTILAGE, V17, P613, DOI 10.1016/j.joca.2008.08.007; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lu KT, 2006, BLOOD, V108, P3769, DOI 10.1182/blood-2006-03-008839; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Martel-Pelletier J, 1999, FRONT BIOSCI, V4, pD694; McAlinden A, 2007, J BIOL CHEM, V282, P24444, DOI 10.1074/jbc.M702717200; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Miyamoto K, 2009, BIOCHEM BIOPH RES CO, V383, P373, DOI 10.1016/j.bbrc.2009.04.020; Okazaki K, 2006, J CELL BIOCHEM, V97, P857, DOI 10.1002/jcb.20648; Okazaki K, 2002, J BIOL CHEM, V277, P31526, DOI 10.1074/jbc.M202815200; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Radolph EH, 2005, CURR PHARM DESIGN, V11, P613, DOI 10.2174/1381612053381963; Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; Sow FB, 2009, J LEUKOCYTE BIOL, V86, P1247, DOI 10.1189/jlb.1208719; Tebo JM, 2000, J BIOL CHEM, V275, P12987, DOI 10.1074/jbc.275.17.12987; TIKU K, 1992, CELL IMMUNOL, V140, P1, DOI 10.1016/0008-8749(92)90172-L; Tseng PC, 2008, BIOCHEM PHARMACOL, V76, P1121, DOI 10.1016/j.bcp.2008.08.023; Venza I, 2009, J BIOL CHEM, V284, P4191, DOI 10.1074/jbc.M805429200; Yamasaki K, 2009, ARTHRITIS RHEUM-US, V60, P1035, DOI 10.1002/art.24404; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang ZQ, 2010, ARTHRITIS RHEUM-US, V62, P1993, DOI 10.1002/art.27473; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	54	48	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33092	33103		10.1074/jbc.M110.130377	http://dx.doi.org/10.1074/jbc.M110.130377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702408	hybrid, Green Published			2022-12-25	WOS:000283048200047
J	Zhou, X; Ma, Y; Sugiura, R; Kobayashi, D; Suzuki, M; Deng, L; Kuno, T				Zhou, Xin; Ma, Yan; Sugiura, Reiko; Kobayashi, Daiki; Suzuki, Masahiro; Deng, Lu; Kuno, Takayoshi			MAP Kinase Kinase Kinase ( MAPKKK)-dependent and -independent Activation of Sty1 Stress MAPK in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; ATF1 TRANSCRIPTION FACTOR; MCS4 RESPONSE REGULATOR; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; CELL-CYCLE; SPC1 KINASE; PATHWAY; TOXICITY; HOMOLOG	In fission yeast, the Sty1/Spc1/Phh1 mitogen-activated protein kinase (MAPK) pathway is known to be involved in multiple-stress responses. It is currently thought that the Sty1 MAPK cascade is mediated by histidine kinases and phosphorelay proteins in response to oxidative stress signals. However, studies of the exact transduction mechanism of multiple-stress responses are lacking. Thus, in response to various stimuli, we monitored the Sty1 MAPK pathway through the downstream transcription factor Atf1 in living cells using a highly sensitive luciferase reporter gene. Surprisingly, in cadmium and low glucose (LG) medium, Atf1 activation was observed even in the absence of all of the four fission yeast MAPK kinase kinases (MAPKKKs); whereas in osmotic stress, Atf1 activation was abolished. Thus, the osmotic stress likely mediates the MAPK activation via MAPKKKs, whereas a cadmium or LG condition activates the MAPKin a MAPKKK-independent manner. On the other hand, knockout of tyrosine phosphatase gene pyp1(+) abolished the Atf1 response to cadmium and LG, but not to osmotic stress, suggesting that Pyp1 is a sensor for cadmium and LG.	[Zhou, Xin; Ma, Yan; Kobayashi, Daiki; Suzuki, Masahiro; Deng, Lu; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Div Mol Pharmacol & Pharmacogenom, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogenom, Higashiosaka, Osaka 5778502, Japan	Kobe University; Kindai University (Kinki University)	Kuno, T (corresponding author), Kobe Univ, Grad Sch Med, Div Mol Pharmacol & Pharmacogenom, Dept Biochem & Mol Biol,Chuo Ku, Kusunoki Cho 6-5-1, Kobe, Hyogo 6500017, Japan.	tkuno@med.kobe-u.ac.jp			Global Centers of Excellence; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Global Centers of Excellence; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Global Centers of Excellence Program and research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aoyama K, 2000, J BACTERIOL, V182, P4868, DOI 10.1128/JB.182.17.4868-4874.2000; Avery SV, 2001, ADV APPL MICROBIOL, V49, P111, DOI 10.1016/S0065-2164(01)49011-3; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; CHO HJ, 1992, BIOCHEMISTRY-US, V31, P133, DOI 10.1021/bi00116a019; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Loewith R, 2000, J CELL SCI, V113, P153; Ma Y, 2007, CURR GENET, V52, P97, DOI 10.1007/s00294-007-0142-1; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MASUDA T, 1995, J BIOL CHEM, V270, P1979, DOI 10.1074/jbc.270.5.1979; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Nguyen AN, 2000, MOL BIOL CELL, V11, P1169, DOI 10.1091/mbc.11.4.1169; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Samejima I, 1997, EMBO J, V16, P6162, DOI 10.1093/emboj/16.20.6162; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Shieh JC, 1997, GENE DEV, V11, P1008, DOI 10.1101/gad.11.8.1008; Shiozaki K, 1997, MOL BIOL CELL, V8, P409, DOI 10.1091/mbc.8.3.409; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SHIOZAKI K, 1995, EMBO J, V14, P492, DOI 10.1002/j.1460-2075.1995.tb07025.x; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Toda T, 1996, MOL CELL BIOL, V16, P6752; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635	38	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32818	32823		10.1074/jbc.M110.135764	http://dx.doi.org/10.1074/jbc.M110.135764			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729203	hybrid, Green Published			2022-12-25	WOS:000283048200018
J	Deng, JJ; Liao, XY; Yang, HX; Zhang, XY; Hua, ZC; Masuda, T; Goto, F; Yoshihara, T; Zhao, GH				Deng, Jianjun; Liao, Xiayun; Yang, Haixia; Zhang, Xiangyu; Hua, Zichun; Masuda, Taro; Goto, Fumiyuki; Yoshihara, Toshihiro; Zhao, Guanghua			Role of H-1 and H-2 Subunits of Soybean Seed Ferritin in Oxidative Deposition of Iron in Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PISUM-SATIVUM FERRITIN; H-CHAIN FERRITIN; PLANT FERRITIN; TREMATOMUS-BERNACCHII; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; FE(II) OXIDATION; CORE FORMATION; HORSE SPLEEN; IN-VITRO	Naturally occurring phytoferritin is a heteropolymer consisting of two different H-type subunits, H-1 and H-2. Prior to this study, however, the function of the two subunits in oxidative deposition of iron in ferritin was unknown. The data show that, upon aerobic addition of 48-200 Fe2+/shell to apoferritin, iron oxidation occurs only at the diiron ferroxidase center of recombinant H1 (rH-1). In addition to the diiron ferroxidase mechanism, such oxidation is catalyzed by the extension peptide (a specific domain found in phytoferritin) of rH-2, because the H-1 subunit is able to remove Fe3+ from the center to the inner cavity better than the H-2 subunit. These findings support the idea that the H-1 and H-2 subunits play different roles in iron mineralization in protein. Interestingly, at medium iron loading (200 irons/shell), wild-type (WT) soybean seed ferritin (SSF) exhibits a stronger activity in catalyzing iron oxidation (1.10 +/- 0.13 mu M iron/subunit/s) than rH-1 (0.59 +/- 0.07 mu M iron/subunit/s) and rH-2 (0.48 +/- 0.04 mu M iron/subunit/s), demonstrating that a synergistic interaction exists between the H-1 and H-2 subunits in SSF during iron mineralization. Such synergistic interaction becomes considerably stronger at high iron loading (400 irons/shell) as indicated by the observation that the iron oxidation activity of WT SSF is similar to 10 times larger than those of rH-1 and rH-2. This helps elucidate the widespread occurrence of heteropolymeric ferritins in plants.	[Masuda, Taro] Kyoto Univ, Lab Food Qual Design & Dev, Div Agron & Hort Sci, Grad Sch Agr, Kyoto 6110011, Japan; China Agr Univ, Beijing 100083, Peoples R China; [Zhao, Guanghua] China Agr Univ, ACC Joint Lab Space Food, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Zhang, Xiangyu; Hua, Zichun] Nanjing Univ, Coll Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; [Zhang, Xiangyu; Hua, Zichun] Nanjing Univ, Coll Life Sci, Dept Biochem, Nanjing 210093, Peoples R China; [Goto, Fumiyuki; Yoshihara, Toshihiro] Cent Res Inst Elect Power Ind, Biotechnol Sect, Environm Sci Res Lab, Chiba 2701194, Japan	Kyoto University; China Agricultural University; China Agricultural University; Nanjing University; Nanjing University; Central Research Institute of Electric Power Industry - Japan	Masuda, T (corresponding author), Kyoto Univ, Lab Food Qual Design & Dev, Div Agron & Hort Sci, Grad Sch Agr, Kyoto 6110011, Japan.	masutaro@kais.kyoto-u.ac.jp; gzhao1000@yahoo.com	Jianjun, Deng/U-5306-2019; Zhao, Guanghua/GSE-4215-2022; Masuda, Taro/G-4276-2011; Yang, Haixia/AAH-3819-2020	Jianjun, Deng/0000-0002-3057-6997; Yang, Haixia/0000-0002-4410-9257; Masuda, Taro/0000-0002-5549-375X	National Natural Science Foundation of China [30972045]; Chinese Universities Scientific Fund [2009-3-10]; Innovation Fund for Graduate Students [15059203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; Innovation Fund for Graduate Students	This project was supported by National Natural Science Foundation of China Grant 30972045, Chinese Universities Scientific Fund Grant 2009-3-10, and Innovation Fund for Graduate Students Grant 15059203.	Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; Bou-Abdallah F, 2005, J AM CHEM SOC, V127, P3885, DOI 10.1021/ja044355k; Bou-Abdallah F, 2005, J MOL BIOL, V347, P543, DOI 10.1016/j.jmb.2005.01.007; Cavallo S, 1998, PROTEIN SCI, V7, P427; Chiaraluce R, 2000, EUR J BIOCHEM, V267, P5733, DOI 10.1046/j.1432-1327.2000.01639.x; CRICHTON RR, 1978, J MOL CATAL, V4, P75; Crichton RR, 1996, J BIOL INORG CHEM, V1, P567, DOI 10.1007/s007750050093; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Fu XP, 2010, BIOCHEM J, V427, P313, DOI 10.1042/BJ20100015; Giorgi A, 2008, ARCH BIOCHEM BIOPHYS, V478, P69, DOI 10.1016/j.abb.2008.06.022; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; Kang S, 2008, J AM CHEM SOC, V130, P16527, DOI 10.1021/ja807655t; Kopp DA, 2002, CURR OPIN CHEM BIOL, V6, P568, DOI 10.1016/S1367-5931(02)00366-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Li CR, 2009, BIOCHIMIE, V91, P1475, DOI 10.1016/j.biochi.2009.08.007; Li CR, 2009, J BIOL CHEM, V284, P16743, DOI 10.1074/jbc.M109.011528; Li CR, 2009, BIOCHIMIE, V91, P230, DOI 10.1016/j.biochi.2008.09.008; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; LOBREAUX S, 1991, BIOCHEM J, V274, P601, DOI 10.1042/bj2740601; LOBREAUX S, 1992, PLANT MOL BIOL, V19, P563, DOI 10.1007/BF00026783; LOBREAUX S, 1992, BIOCHEM J, V288, P931, DOI 10.1042/bj2880931; MACARA IG, 1972, BIOCHEM J, V126, P151, DOI 10.1042/bj1260151; Masuda T, 2001, J BIOL CHEM, V276, P19575, DOI 10.1074/jbc.M011399200; Masuda T, 2007, PROTEIN EXPRES PURIF, V56, P237, DOI 10.1016/j.pep.2007.07.011; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Mignogna G, 2002, EUR J BIOCHEM, V269, P1600, DOI 10.1046/j.1432-1327.2002.02762.x; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; PETERMAN BF, 1979, ANAL BIOCHEM, V93, P442, DOI 10.1016/S0003-2697(79)80176-1; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Theil EC, 2004, ANNU REV NUTR, V24, P327, DOI 10.1146/annurev.nutr.24.012003.132212; TREFFRY A, 1992, FEBS LETT, V302, P108, DOI 10.1016/0014-5793(92)80417-F; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P253, DOI 10.1042/bj3050253; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; WICKS RE, 1993, BIOCHEM BIOPH RES CO, V192, P813, DOI 10.1006/bbrc.1993.1487; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v; Zhao GH, 2010, BBA-GEN SUBJECTS, V1800, P815, DOI 10.1016/j.bbagen.2010.01.009; Zhelev N, 2005, BIOTECHNOL BIOTECHNO, V19, P3, DOI DOI 10.1080/13102818.2005.10817219	43	32	36	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32075	32086		10.1074/jbc.M110.130435	http://dx.doi.org/10.1074/jbc.M110.130435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702403	Green Published, hybrid			2022-12-25	WOS:000282683000021
J	Hong, WC; Amara, SG				Hong, Weimin C.; Amara, Susan G.			Membrane Cholesterol Modulates the Outward Facing Conformation of the Dopamine Transporter and Alters Cocaine Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; AMINOBUTYRIC-ACID TRANSPORTER; TRANSMEMBRANE DOMAIN-I; LIPID RAFTS; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; CRYSTAL-STRUCTURE; CELL-MEMBRANES; PROTEIN; PHOSPHORYLATION	Clearance of synaptically released dopamine is regulated by the plasmalemmal dopamine transporter (DAT), an integral membrane protein that resides within a complex lipid milieu. Here we demonstrate that cholesterol, a major component of the lipid bilayer, can modulate the conformation of DAT and alter cocaine binding to DAT. In striatal synaptosomes and transfected cells, DAT was in cholesterol-rich membrane fractions after mild detergent extraction. After increasing the membrane cholesterol content by treatment of water-soluble cholesterol (cholesterol mixed with methyl-beta-cyclodextrin), we observed an increase in DAT binding B-max values for cocaine analogs [H-3]WIN35428 and [I-125]RTI-55, but similar levels of DAT proteins on the cell surface were shown by surface biotinylation assays. Membrane cholesterol addition also markedly enhanced the accessibility of cysteine sulfhydryl moieties in DAT as probed by a membrane-impermeable maleimide-biotin conjugate. We identified cysteine 306, a juxtamembrane residue on transmembrane domain 6 (TM6) of DAT, as the intrinsic residue exhibiting enhanced reactivity. Similar effects on DAT cysteine accessibility and radioligand binding were observed with addition of zinc, a reagent known to promote the outward facing conformation of DAT. Using substituted cysteine mutants on various positions likely to be extracellular, we identified additional residues located on TM1, TM6, TM7, and TM12 of DAT that are sensitive to alterations in the membrane cholesterol content. Our findings in transfected cells and native tissues support the hypothesis that DAT adopts an outward facing conformation in a cholesterol-rich membrane environment, suggesting a novel modulatory role of the surrounding membrane lipid milieu on DAT function.	[Hong, Weimin C.; Amara, Susan G.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Amara, SG (corresponding author), Univ Pittsburgh, Dept Neurobiol, 6068 BST3,3501 5th Ave, Pittsburgh, PA 15213 USA.	amaras@pitt.edu		Amara, Susan/0000-0001-8914-1106	National Institutes of Health [DA007595]; Parkinson's Disease Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007595, R37DA007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA007595 (to S. G. A.). This work was also supported by a postdoctoral fellowship from the Parkinson's Disease Foundation (to W. C. H.).	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Barrantes FJ, 2007, J NEUROCHEM, V103, P72, DOI 10.1111/j.1471-4159.2007.04719.x; BOJA JW, 1992, NEUROREPORT, V3, P247, DOI 10.1097/00001756-199203000-00007; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DALZIEL AW, 1980, FEBS LETT, V122, P193, DOI 10.1016/0014-5793(80)80435-2; Fairman WA, 1998, NAT NEUROSCI, V1, P105, DOI 10.1038/355; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; GRACZ LM, 1995, J PHARMACOL EXP THER, V273, P1224; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Ingram SL, 2000, J NEUROSCI, V20, P550, DOI 10.1523/JNEUROSCI.20-02-00550.2000; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Liang YJ, 2009, J NEUROCHEM, V109, P981, DOI 10.1111/j.1471-4159.2009.06034.x; MADRAS BK, 1989, MOL PHARMACOL, V36, P518; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; NORTH P, 1983, J BIOL CHEM, V258, P1242; Nunez E, 2008, J NEUROCHEM, V105, P2080, DOI 10.1111/j.1471-4159.2008.05292.x; Padmanabhan S, 2008, EUR J NEUROSCI, V28, P2017, DOI 10.1111/j.1460-9568.2008.06496.x; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Reith MEA, 2001, J BIOL CHEM, V276, P29012, DOI 10.1074/jbc.M011785200; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200	40	103	106	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32616	32626		10.1074/jbc.M110.150565	http://dx.doi.org/10.1074/jbc.M110.150565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688912	hybrid, Green Published			2022-12-25	WOS:000282683000076
J	Chen, YW; Wang, JK; Chou, FP; Chen, CY; Rorke, EA; Chen, LM; Chai, KX; Eckert, RL; Johnson, MD; Lin, CY				Chen, Ya-Wen; Wang, Jehng-Kang; Chou, Feng-Pai; Chen, Chiu-Yuan; Rorke, Ellen A.; Chen, Li-Mei; Chai, Karl X.; Eckert, Richard L.; Johnson, Michael D.; Lin, Chen-Yong			Regulation of the Matriptase-Prostasin Cell Surface Proteolytic Cascade by Hepatocyte Growth Factor Activator Inhibitor-1 during Epidermal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE ICHTHYOSIS; SERINE-PROTEASE INHIBITOR; HYPOTRICHOSIS SYNDROME; EPITHELIAL-CELLS; BARRIER FUNCTION; DOMAIN; LOCALIZATION; PURIFICATION; EXPRESSION; REQUIRES	Matriptase, a membrane-tethered serine protease, plays essential roles in epidermal differentiation and barrier function, largely mediated via its activation of prostasin, a glycosylphosphatidylinositol-anchored serine protease. Matriptase activity is tightly regulated by its inhibitor hepatocyte growth factor activator inhibitor-1 (HAI-1) such that free active matriptase is only briefly available to act on its substrates. In the current study we provide evidence for how matriptase activates prostasin under this tight control by HAI-1. When primary human keratinocytes are induced to differentiate in a skin organotypic culture model, both matriptase and prostasin are constitutively activated and then inhibited by HAI-1. These processes also occur in HaCaT human keratinocytes when matriptase activation is induced by exposure of the cells to a pH 6.0 buffer. Using this acid-inducible activation system we demonstrate that prostatin activation is suppressed by matriptase knockdown and by blocking matriptase activation with sodium chloride, suggesting that prostatin activation is dependent on matriptase in this system. Kinetics studies further reveal that the timing of autoactivation of matriptase, prostasin activation, and inhibition of both enzymes by HAI-1 binding are closely correlated. These data suggest that, during epidermal differentiation, the matriptase-prostasin proteolytic cascade is tightly regulated by two mechanisms: 1) prostasin activation temporally coupled to matriptase autoactivation and 2) HAI-1 rapidly inhibiting not only active matriptase but also active prostasin, resulting in an extremely brief window of opportunity for both active matriptase and active prostasin to act on their substrates.	[Chou, Feng-Pai; Rorke, Ellen A.; Eckert, Richard L.; Lin, Chen-Yong] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Chen, Ya-Wen; Chou, Feng-Pai; Lin, Chen-Yong] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Ya-Wen] Univ Maryland, Grad Program Life Sci, Baltimore, MD 21201 USA; [Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 114, Taiwan; [Chen, Chiu-Yuan] Nanhua Univ, Grad Inst Nat Healing Sci, Chiayi, Taiwan; [Chen, Li-Mei; Chai, Karl X.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Johnson, Michael D.] Georgetown Univ, Dept Oncol, Lombardi Canc Comprehens Ctr, Washington, DC 20057 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Defense Medical Center; Nanhua University; State University System of Florida; University of Central Florida; Georgetown University	Lin, CY (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, 655 W Baltimore St,BRB 10-027, Baltimore, MD 21201 USA.	cylin@som.umaryland.edu	Feng-Pai, Chou/AGS-4250-2022	Chen, Ya-Wen/0000-0003-2382-8444; johnson, Michael/0000-0001-6260-7586	National Institutes of Health [R01-CA-104944, R01-CA-123223]; Florida Biomedical Research Program [06NIR-03]; Susan G. Komen for the Cure [BCTR0707538]; NATIONAL CANCER INSTITUTE [R01CA123223, R01CA104944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Biomedical Research Program; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA-104944 (to C.-Y.L.) and R01-CA-123223 (to M.D.J. and C.-Y.L.). This work was also supported by the Florida Biomedical Research Program (Grant 06NIR-03 to L.-M. C.) and the Susan G. Komen for the Cure (Grant BCTR0707538 to K. X. C.).	Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Avrahami L, 2008, CLIN GENET, V74, P47, DOI 10.1111/j.1399-0004.2008.01006.x; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Chen M, 2007, BIOCH BIOPHYS ACTA; Chen MQ, 2007, BBA-MOL CELL RES, V1773, P1133, DOI 10.1016/j.bbamcr.2007.04.013; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; MYERBURG MM, 2010, AM J RESP C IN PRESS; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Stark Hans-Jurgen, 2004, Biol Proced Online, V6, P55, DOI 10.1251/bpo72; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; YU JX, 1994, J BIOL CHEM, V269, P18843	33	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31755	31762		10.1074/jbc.M110.150367	http://dx.doi.org/10.1074/jbc.M110.150367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20696767	hybrid, Green Published			2022-12-25	WOS:000282764600067
J	Tranell, A; Fenyo, EM; Schwartz, S				Tranell, Anna; Fenyo, Eva Maria; Schwartz, Stefan			Serine- and Arginine-rich Proteins 55 and 75 (SRp55 and SRp75) Induce Production of HIV-1 vpr mRNA by Inhibiting the 5 '-Splice Site of Exon 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS TYPE-16; SPLICING FACTOR SF2/ASF; GENE-EXPRESSION; TAT EXON-2; HNRNP A1; UNTRANSLATED REGION; FUNCTIONAL-ANALYSIS; SILENCER ELEMENT/; EPITHELIAL-CELLS	HIV-1 non-coding exon 3 can either be spliced to exons 4, 4a, 4b, 4c, and 5 to generate tat, rev, and nef mRNAs or remain unspliced to produce the 13a7 vpr mRNA. Here we show that serine-and arginine-rich proteins 55 and 75 (SRp55 and SRp75) inhibit splicing from the 5'-splice site of exon 3 thereby causing an accumulation of the partially unspliced 13a7 vpr mRNA. In contrast, serine- and arginine-rich protein 40 (SRp40) induces splicing from exon 3 to exon 4, thereby promoting the production of the 1347 tat mRNA. We demonstrate that SRp55 stimulates vpr mRNA production by interacting with the previously identified HIV-1 splicing enhancer named GAR and inhibiting its function. This inhibition requires both serine arginine-rich and RNA-binding domains of SRp55, indicating that production of HIV-1 vpr mRNA depends on the interaction of SRp55 with an unknown factor.	[Tranell, Anna; Schwartz, Stefan] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, BMC, S-75123 Uppsala, Sweden; [Fenyo, Eva Maria] Lund Univ, Dept Lab Med, S-22362 Lund, Sweden; [Schwartz, Stefan] Dublin Inst Technol, Dublin 8, Ireland	Uppsala University; Lund University; Technological University Dublin	Schwartz, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, BMC, Box 582,Husargatan 3, S-75123 Uppsala, Sweden.	stefan.schwartz@imbim.uu.se						ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; AMENDT BA, 1995, MOL CELL BIOL, V15, P6480; AMENDT BA, 1994, MOL CELL BIOL, V14, P3960, DOI 10.1128/MCB.14.6.3960; ARRIGO SJ, 1990, J VIROL, V64, P4585, DOI 10.1128/JVI.64.9.4585-4588.1990; ARYA SK, 1986, P NATL ACAD SCI USA, V83, P2209, DOI 10.1073/pnas.83.7.2209; Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Caputi M, 2004, J VIROL, V78, P6517, DOI 10.1128/JVI.78.12.6517-6526.2004; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Collier B, 2002, J VIROL, V76, P2739, DOI 10.1128/JVI.76.6.2739-2752.2002; Domsic JK, 2003, MOL CELL BIOL, V23, P8762, DOI 10.1128/MCB.23.23.8762-8772.2003; DYHRMIKKELSEN H, 1995, J BIOL CHEM, V270, P24060, DOI 10.1074/jbc.270.41.24060; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; Exline CM, 2008, J VIROL, V82, P3921, DOI 10.1128/JVI.01558-07; GUATELLI JC, 1990, J VIROL, V64, P4093, DOI 10.1128/JVI.64.9.4093-4098.1990; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Jacquenet S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-33; Jacquenet S, 2001, J BIOL CHEM, V276, P40464, DOI 10.1074/jbc.M104070200; Kammler S, 2001, RNA, V7, P421, DOI 10.1017/S1355838201001212; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Madsen JM, 2005, J VIROL, V79, P10478, DOI 10.1128/JVI.79.16.10478-10486.2005; Maldarelli F, 1998, VIRUS RES, V53, P39, DOI 10.1016/S0168-1702(97)00130-5; Mandal D, 2009, J VIROL, V83, P6067, DOI 10.1128/JVI.02231-08; Marchand V, 2002, J MOL BIOL, V323, P629, DOI 10.1016/S0022-2836(02)00967-1; MAYEDA A, 1993, MOL CELL BIOL, V13, P2993, DOI 10.1128/MCB.13.5.2993; OREILLY MM, 1995, VIROLOGY, V213, P373, DOI 10.1006/viro.1995.0010; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Rush M, 2005, J VIROL, V79, P12002, DOI 10.1128/JVI.79.18.12002-12015.2005; SCHWARTZ S, 1991, VIROLOGY, V183, P677, DOI 10.1016/0042-6822(91)90996-O; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; Si ZH, 1998, MOL CELL BIOL, V18, P5404, DOI 10.1128/MCB.18.9.5404; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; TAN W, 1995, J VIROL, V69, P2932, DOI 10.1128/JVI.69.5.2932-2945.1995; TAN W, 1995, J VIROL, V69, P5607, DOI 10.1128/JVI.69.9.5607-5620.1995; Tange TO, 2001, EMBO J, V20, P5748; Wiklund L, 2002, J BIOL CHEM, V277, P40462, DOI 10.1074/jbc.M205929200; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096	48	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31537	31547		10.1074/jbc.M109.077453	http://dx.doi.org/10.1074/jbc.M109.077453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685659	Green Published, hybrid			2022-12-25	WOS:000282764600048
J	Zhang, XP; Liu, F; Wang, W				Zhang, Xiao-Peng; Liu, Feng; Wang, Wei			Coordination between Cell Cycle Progression and Cell Fate Decision by the p53 and E2F1 Pathways in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; P53-MDM2 FEEDBACK LOOP; TUMOR-SUPPRESSOR; P53-DEPENDENT APOPTOSIS; IONIZING-RADIATION; S-PHASE; ACTIVATION; PROTEIN; DEATH; MDM2	After DNA damage, cells must decide between different fates including growth arrest, DNA repair, and apoptosis. Both p53 and E2F1 are transcription factors involved in the decision process. However, the mechanism for cross-talk between the p53 and E2F1 pathways still remains unclear. Here, we proposed a four-module kinetic model of the decision process and explored the interplay between these two pathways in response to ionizing radiation via computer simulation. In our model the levels of p53 and E2F1 separately exhibit pulsatile and switching behaviors. Upon DNA damage, p53 is first activated, whereas E2F1 is inactivated, leading to cell cycle arrest in the G(1) phase. We found that the ultimate decision between cell life and death is determined by the number of p53 pulses depending on the extent of DNA damage. For repairable DNA damage, the cell can survive and reenter the S phase because of the activation of E2F1 and inactivation of p53. For irreparable DNA damage, growth arrest is overcome by growth factors, and activated p53 and E2F1 cooperate to initiate apoptosis. We showed that E2F1 promotes apoptosis by up-regulating the proapoptotic cofactors of p53 and procaspases. It was also revealed that deregulated E2F1 by oncogene activation can make cells sensitive to DNA damage even in low serum medium. Our model consistently recapitulates the experimental observations of the intricate relationship between p53 and E2F1 in the DNA damage response. This work underscores the significance of E2F1 in p53-mediated cell fate decision and may provide clues to cancer therapy.	[Liu, Feng; Wang, Wei] Nanjing Univ, Dept Phys, Nanjing 210093, Peoples R China; Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Peoples R China	Nanjing University; Nanjing University	Liu, F (corresponding author), Nanjing Univ, Dept Phys, Nanjing 210093, Peoples R China.	fliu@nju.edu.cn; wangwei@nju.edu.cn	Liu, Feng/E-1462-2011; Zhang, Xiao-Peng/E-1973-2011	Zhang, Xiao-Peng/0000-0001-8170-1236; Liu, Feng/0000-0001-9560-8518; Zhang, Xiao-Peng/0000-0002-0183-2760	National Basic Research Program of China [2007CB814806]; National Natural Science Foundation of China [10604028]; Natural Science Foundation of Jiangsu Province [SBK200910089]; Jiangsu Planned Projects for Postdoctoral Research Funds [0204003443]; Program for New Century Excellent Talents in Universities [NCET-08-0269]; Scientific Research Foundation for the Returned Overseas Chinese Scholars	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Planned Projects for Postdoctoral Research Funds; Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Basic Research Program of China (2007CB814806), the National Natural Science Foundation of China (10604028), the Natural Science Foundation of Jiangsu Province (SBK200910089), the Jiangsu Planned Projects for Postdoctoral Research Funds (0204003443), the Program for New Century Excellent Talents in Universities (NCET-08-0269), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars.	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Al Rashid ST, 2005, CANCER RES, V65, P10810, DOI 10.1158/0008-5472.CAN-05-0729; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bill CA, 1997, MUTAT RES-DNA REPAIR, V385, P21, DOI 10.1016/S0921-8777(97)00040-2; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bonner WM, 2003, P NATL ACAD SCI USA, V100, P4973, DOI 10.1073/pnas.1031538100; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chickarmane V, 2007, SIAM J APPL DYN SYST, V6, P61, DOI 10.1137/060653925; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Elkon R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-110; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Garner E, 2008, CELL CYCLE, V7, P277, DOI 10.4161/cc.7.3.5328; Gartel AL, 2002, MOL CANCER THER, V1, P639; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Landers JE, 1997, CANCER RES, V57, P3562; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; McKay BC, 2002, DNA REPAIR, V1, P811, DOI 10.1016/S1568-7864(02)00109-X; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Mouri K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005131; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; NEVINS JR, 1992, SCIENCE, V258, P424; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Pfeuty B, 2008, CELL CYCLE, V7, P3246, DOI 10.4161/cc.7.20.6853; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Rief N, 2002, J BIOL CHEM, V277, P20572, DOI 10.1074/jbc.M200265200; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Stanelle J, 2006, TRENDS MOL MED, V12, P177, DOI 10.1016/j.molmed.2006.02.002; Stewart RD, 2001, RADIAT RES, V156, P365, DOI 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tang W, 1999, CANCER RES, V59, P2562; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wee KB, 2006, BIOPHYS J, V91, P857, DOI 10.1529/biophysj.105.077693; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yang TT, 1997, ONCOGENE, V14, P1511, DOI 10.1038/sj.onc.1200979; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	70	41	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31571	31580		10.1074/jbc.M110.134650	http://dx.doi.org/10.1074/jbc.M110.134650			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685653	Green Published, hybrid			2022-12-25	WOS:000282764600051
J	Li, HM; Wang, ZL; Wang, BP; Guo, QX; Dolios, G; Tabuchi, K; Hammer, RE; Sudhof, TC; Wang, R; Zheng, H				Li, Hongmei; Wang, Zilai; Wang, Baiping; Guo, Qinxi; Dolios, Georgia; Tabuchi, Katsuhiko; Hammer, Robert E.; Suedhof, Thomas C.; Wang, Rong; Zheng, Hui			Genetic Dissection of the Amyloid Precursor Protein in Developmental Function and Amyloid Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MICE LACKING; BETA; APP; PRESENILIN-1; PEPTIDES; DEFICITS; ALPHA	Proteolytic processing of the amyloid precursor protein (APP) generates large soluble APP derivatives, beta-amyloid (A beta) peptides, and APP intracellular domain. Expression of the extracellular sequences of APP or its Caenorhabditis elegans counterpart has been shown to be sufficient in partially rescuing the CNS phenotypes of the APP-deficient mice and the lethality of the apl-1 null C. elegans, respectively, leaving open the question as what is the role of the highly conserved APP intracellular domain? To address this question, we created an APP knock-in allele in which the mouse A beta sequence was replaced by the human A beta. A frameshift mutation was introduced that replaced the last 39 residues of the APP sequence. We demonstrate that the C-terminal mutation does not overtly affect APP processing and amyloid pathology. In contrast, crossing the mutant allele with APP-like protein 2 (APLP2)-null mice results in similar neuromuscular synapse defects and early postnatal lethality as compared with mice doubly deficient in APP and APLP2, demonstrating an indispensable role of the APP C-terminal domain in these development activities. Our results establish an essential function of the conserved APP intracellular domain in developmental regulation, and this activity can be genetically uncoupled from APP processing and A beta pathogenesis.	[Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Wang, Zilai; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Guo, Qinxi; Zheng, Hui] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Li, Hongmei; Tabuchi, Katsuhiko; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Dolios, Georgia; Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Suedhof, Thomas C.] Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Stanford University; Howard Hughes Medical Institute; Stanford University	Zheng, H (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza,MS BCM 230, Houston, TX 77030 USA.	huiz@bcm.edu	Wang, Rong/A-8721-2009; Guo, Qinxi/J-1473-2014; Li, Hongmei/L-2595-2013	Guo, Qinxi/0000-0003-4320-6757; Li, Hongmei/0000-0002-4952-1734; Hammer, Robert E./0000-0001-5487-7551	National Institutes of Health [AG020670, AG032051, NS061777, MH52804]; Alzheimer's Association [IIRG-05-14824]; Baylor College of Medicine Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center [HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804, R01MH052804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032051, R01AG020670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Baylor College of Medicine Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG020670 and AG032051 (to H.Z.), NS061777 (to R.W.), and MH52804 (to T.C.S.). This work was also supported by Alzheimer's Association Grant IIRG-05-14824 (to R.W.).; We thank N. Aithmitti and X. Chen for expert technical assistance and members of the Zheng laboratory for stimulating discussions. We are grateful to the Baylor College of Medicine Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (HD024064) for support in confocal imaging.	Back S, 2007, J NEUROSCI RES, V85, P2580, DOI 10.1002/jnr.21239; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kohler C, 2005, NEUROBIOL DIS, V20, P528, DOI 10.1016/j.nbd.2005.04.009; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lehman EJH, 2003, HUM MOL GENET, V12, P2949, DOI 10.1093/hmg/ddg322; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	31	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30598	30605		10.1074/jbc.M110.137729	http://dx.doi.org/10.1074/jbc.M110.137729			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20693289	Green Published, hybrid			2022-12-25	WOS:000282135500028
J	Chow, AWM; Liang, JFT; Wong, JSC; Fu, Y; Tang, NLS; Ko, WH				Chow, Alison Wai-ming; Liang, Jocelyn Feng-ting; Wong, Janice Siu-chong; Fu, Yan; Tang, Nelson Leung-sang; Ko, Wing-hung			Polarized Secretion of Interleukin (IL)-6 and IL-8 by Human Airway Epithelia 16HBE14o-Cells in Response to Cationic Polypeptide Challenge	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; MAJOR BASIC-PROTEIN; POLY-L-ARGININE; CL-SECRETION; NUCLEAR TRANSLOCATION; MESOTHELIAL CELLS; P38 MAPK; IN-VIVO; EXPRESSION	Background: The airway epithelium participates in asthmatic inflammation in many ways. Target cells of the epithelium can respond to a variety of inflammatory mediators and cytokines. Damage to the surface epithelium occurs following the secretion of eosinophil-derived, highly toxic cationic proteins. Moreover, the surface epithelium itself is responsible for the synthesis and release of cytokines that cause the selective recruitment, retention, and accumulation of various inflammatory cells. To mimic the damage seen during asthmatic inflammation, the bronchial epithelium can be challenged with highly charged cationic polypeptides such as poly-L-arginine. Methodology/Principal Findings: In this study, human bronchial epithelial cells, 16HBE14o-cells, were "chemically injured'' by exposing them to poly-L-arginine as a surrogate of the eosinophil cationic protein. Cytokine antibody array data showed that seven inflammatory mediators were elevated out of the 40 tested, including marked elevation in interleukin (IL)-6 and IL-8 secretion. IL-6 and IL-8 mRNA expression levels were elevated as measured with real-time PCR. Cell culture supernatants from apical and basolateral compartments were collected, and the IL-6 and IL-8 production was quantified with ELISA. IL-6 and IL-8 secretion by 16HBE14o- epithelia into the apical compartment was significantly higher than that from the basolateral compartment. Using specific inhibitors, the production of IL-6 and IL-8 was found to be dependent on p38 MAPK, ERK1/2 MAPK, and NF-kappa B pathways. Conclusions/Significance: The results clearly demonstrate that damage to the bronchial epithelia by poly-L-arginine stimulates polarized IL-6 and IL-8 secretion. This apically directed secretion of cytokines may play an important role in orchestrating epithelial cell responses to inflammation.	[Chow, Alison Wai-ming; Liang, Jocelyn Feng-ting; Wong, Janice Siu-chong; Ko, Wing-hung] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Fu, Yan; Tang, Nelson Leung-sang] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Tang, Nelson Leung-sang; Ko, Wing-hung] Chinese Univ Hong Kong, KIZ CUHK Joint Lab Bioresource & Mol Res Common D, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chow, AWM (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	whko@cuhk.edu.hk	Tang, Nelson L/P-5018-2017; Ko, Hung/R-1802-2018	Tang, Nelson L/0000-0002-3607-5819; Ko, Hung/0000-0002-2041-402X	Chinese University of Hong Kong [2041451]; Research Grant Council General Research Fund [2140595]	Chinese University of Hong Kong(Chinese University of Hong Kong); Research Grant Council General Research Fund	The work was supported by a Direct Grant for Research, The Chinese University of Hong Kong (#2041451), and Research Grant Council General Research Fund (#2140595) awarded to W. H. Ko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER KB, 1994, ANN NY ACAD SCI, V725, P128, DOI 10.1111/j.1749-6632.1994.tb00275.x; Arseneault D, 1999, INFLAMMATION, V23, P287; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Blau H, 2007, AM J PHYSIOL-LUNG C, V292, pL343, DOI 10.1152/ajplung.00030.2006; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Carolan EJ, 1997, AM J RESP CELL MOL, V17, P727, DOI 10.1165/ajrcmb.17.6.2745; Clark K, 2004, J LEUKOCYTE BIOL, V75, P1001, DOI 10.1189/jlb.0803391; Coyle AJ, 2000, PROG INFLAM RES, P147; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Donnelly LE, 2002, AM J RESP CELL MOL, V26, P144, DOI 10.1165/ajrcmb.26.1.4477; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Ebihara N, 2007, J IMMUNOL, V178, P3288, DOI 10.4049/jimmunol.178.5.3288; Eisenhut Michael, 2006, J Inflamm (Lond), V3, P5, DOI 10.1186/1476-9255-3-5; Endo Y, 2007, CLIN EXP ALLERGY, V37, P219, DOI 10.1111/j.1365-2222.2007.02646.x; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Galietta Luis J V, 2004, Proc Am Thorac Soc, V1, P62, DOI 10.1513/pats.2306017; Grace MJ, 2005, J BIOL CHEM, V280, P6327, DOI 10.1074/jbc.M412134200; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; HERBERT CA, 1991, BRIT J PHARMACOL, V104, P391, DOI 10.1111/j.1476-5381.1991.tb12441.x; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holtkamp GM, 1998, CLIN EXP IMMUNOL, V112, P34; Homma T, 2005, AM J PHYSIOL-LUNG C, V289, pL413, DOI 10.1152/ajplung.00059.2005; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Jeffery PK, 2000, PROG INFLAM RES, P1; KITA H, 1995, J IMMUNOL, V154, P4749; Kruger S, 2001, EXP NEPHROL, V9, P223; Kruger S, 2000, INFECT IMMUN, V68, P328, DOI 10.1128/IAI.68.1.328-334.2000; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Nasreen N, 2001, J INFECT DIS, V183, P1638, DOI 10.1086/320700; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Ohtake K, 2003, PHARMACEUT RES, V20, P153, DOI 10.1023/A:1022485816755; Page K, 2003, J ALLERGY CLIN IMMUN, V112, P1112, DOI 10.1016/j.jaci.2003.08.050; Page SM, 1999, AM J RESP CELL MOL, V21, P230, DOI 10.1165/ajrcmb.21.2.3647; Parilla NW, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-84; Pearson AL, 2008, J NEPHROL, V21, P887; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Profita M, 2008, EUR J PHARMACOL, V582, P145, DOI 10.1016/j.ejphar.2007.12.029; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; REED CE, 1994, ANN ALLERGY, V72, P376; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Shi G, 2008, INVEST OPHTH VIS SCI, V49, P4620, DOI 10.1167/iovs.08-1816; Sun Y, 2008, J IMMUNOL, V180, P4173, DOI 10.4049/jimmunol.180.6.4173; Toumi F, 2004, BIOCHEM BIOPH RES CO, V317, P187, DOI 10.1016/j.bbrc.2004.03.033; UCHIDA DA, 1993, AM REV RESPIR DIS, V147, P982, DOI 10.1164/ajrccm/147.4.982; Uchida DA, 1996, EXP LUNG RES, V22, P85, DOI 10.3109/01902149609074019; Wang CB, 2005, ALLERGY, V60, P1378, DOI 10.1111/j.1398-9995.2005.00884.x; White SR, 2008, AM J PHYSIOL-LUNG C, V295, pL1018, DOI 10.1152/ajplung.00065.2008; Wong AM, 2009, AM J RESP CELL MOL, V40, P733, DOI 10.1165/rcmb.2008-0020OC; Wong CHY, 2002, J BIOL CHEM, V277, P9016, DOI 10.1074/jbc.M111917200; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002; Yue GGL, 2004, J BIOL CHEM, V279, P39310, DOI 10.1074/jbc.M406787200; ZEILLEMAKER AM, 1995, IMMUNOLOGY, V84, P227	55	51	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12091	10.1371/journal.pone.0012091	http://dx.doi.org/10.1371/journal.pone.0012091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711426	Green Published, gold, Green Submitted			2022-12-25	WOS:000280859700004
J	Ledesma, MA; Ochoa, SA; Cruz, A; Rocha-Ramirez, LM; Mas-Oliva, J; Eslava, CA; Giron, JA; Xicohtencatl-Cortes, J				Ledesma, Maria A.; Ochoa, Sara A.; Cruz, Ariadnna; Rocha-Ramirez, Luz M.; Mas-Oliva, Jaime; Eslava, Carlos A.; Giron, Jorge A.; Xicohtencatl-Cortes, Juan			The Hemorrhagic Coli Pilus (HCP) of Escherichia coli O157:H7 Is an Inducer of Proinflammatory Cytokine Secretion in Intestinal Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; HEMOLYTIC-UREMIC SYNDROME; GRAM-NEGATIVE FLAGELLIN; INNATE IMMUNE-RESPONSE; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; SHIGA TOXIN; IL-8 EXPRESSION; VIBRIO-CHOLERAE; INTERLEUKIN-8 PRODUCTION	Background: Enterohemorrhagic Escherichia coli (EHEC) O157:H7, the causative agent of hemorrhagic colitis and the hemolytic uremic syndrome (HUS), produces long bundles of type IV pili (TFP) called hemorrhagic coli pili (HCP). HCP are capable of mediating several phenomena associated with pathogenicity: i) adherence to human and bovine epithelial cells; ii) invasion of epithelial cells; iii) hemagglutination of rabbit erythrocytes; iv) biofilm formation; v) twitching motility; and vi) specific binding to laminin and fibronectin. HCP are composed of a 19 kDa pilin subunit (HcpA) encoded by the hcpA chromosomal gene (called prepilin peptidase-dependent gene [ppdD] in E. coli K-12). Methodology/Principal Findings: In this study we investigated the potential role of HCP of E. coli O157:H7 strain EDL933 in activating the release of pro-and anti-inflammatory cytokines from a variety of host epithelial cells. We found that purified HCP and a recombinant HcpA protein induced significant release of IL-8 and TNF-alpha, from cultured polarized intestinal cells (T84 and HT-29 cells) and non-intestinal HeLa cells. Levels of proinflammatory IL-8 and TNF-alpha, but not IL-2, IL6, or IL-10 cytokines, were increased in the presence of HCP and recombinant HcpA after 6 h of incubation with >= 50 ng/ml of protein, suggesting that stimulation of IL-8 and TNF-alpha are dose and time-dependent. In addition, we also demonstrated that flagella are potent inducers of cytokine production. Furthermore, MAPK activation kinetics studies showed that EHEC induces p38 phosphorylation under HCP-producing conditions, and ERK1/2 and JNK activation was detectable after 3 h of EHEC infection. HT-29 cells were stimulated with epidermal growth factor stimulation of HT-29 cells for 30 min leading to activation of three MAPKs. Conclusions/Significance: The HcpA pilin monomer of the HCP produced by EHEC O157:H7 is a potent inducer of IL-8 and TNF-alpha release, an event which could play a significant role in the pathogenesis of hemorrhagic colitis caused by this pathogen.	[Ledesma, Maria A.; Ochoa, Sara A.; Cruz, Ariadnna; Rocha-Ramirez, Luz M.; Xicohtencatl-Cortes, Juan] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Lab Bacteriol Intestinal, Mexico City, DF, Mexico; [Mas-Oliva, Jaime] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Eslava, Carlos A.] Univ Nacl Autonoma Mexico, Dept Salud Publ, Fac Med, Mexico City 04510, DF, Mexico; [Giron, Jorge A.] Univ Florida, Dept Mol Genet & Microbiol, Emerging Pathogens Inst, Gainesville, FL USA	Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; State University System of Florida; University of Florida	Xicohtencatl-Cortes, J (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Lab Bacteriol Intestinal, Mexico City, DF, Mexico.	juanxico@yahoo.com	Xicohtencatl-Cortes, Juan/ABD-5463-2020		Hospital Infantil de Mexico Federico Gomez [HIM/2008/051]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [47333/A-1]; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [AI66012, AI61020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI061020, R01AI066012] Funding Source: NIH RePORTER	Hospital Infantil de Mexico Federico Gomez; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants No. HIM/2008/051 from Hospital Infantil de Mexico Federico Gomez and No. 47333/A-1 from Consejo Nacional de Ciencia y Tecnologia (CONACyT) to JM-O. The project described was also supported in part by Grant Numbers AI66012 and AI61020 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) to JAG and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli SP, 2002, PEDIATR NEPHROL, V17, P293, DOI 10.1007/s00467-001-0783-0; Berin MC, 2002, CELL MICROBIOL, V4, P635, DOI 10.1046/j.1462-5822.2002.00218.x; Cobb LM, 2004, J IMMUNOL, V173, P5659, DOI 10.4049/jimmunol.173.9.5659; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Dahan S, 2002, INFECT IMMUN, V70, P2304, DOI 10.1128/IAI.70.5.2304-2310.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Ebel F, 1996, INFECT IMMUN, V64, P4472, DOI 10.1128/IAI.64.11.4472-4479.1996; Eckmann L, 1997, P NATL ACAD SCI USA, V94, P14456, DOI 10.1073/pnas.94.26.14456; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Edwards RA, 1997, MOL MICROBIOL, V25, P797, DOI 10.1046/j.1365-2958.1997.5161875.x; Elewaut D, 1999, J IMMUNOL, V163, P1457; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Giron JA, 2005, COLONIZATION OF MUCOSAL SURFACES, P213; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Gobert AP, 2007, J IMMUNOL, V178, P8168, DOI 10.4049/jimmunol.178.12.8168; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; GUINEE PAM, 1976, INFECT IMMUN, V13, P1369; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hilbert DW, 2008, MICROBES INFECT, V10, P114, DOI 10.1016/j.micinf.2007.10.012; Isogai E, 1998, INFECT IMMUN, V66, P197, DOI 10.1128/IAI.66.1.197-202.1998; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Low AS, 2006, ENVIRON MICROBIOL, V8, P1033, DOI 10.1111/j.1462-2920.2006.00995.x; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Miyamoto Y, 2006, CELL MICROBIOL, V8, P869, DOI 10.1111/j.1462-5822.2005.00673.x; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Paranjpye RN, 2005, INFECT IMMUN, V73, P1411, DOI 10.1128/IAI.73.3.1411-1422.2005; Patrone JB, 2006, J IMMUNOL, V177, P1314, DOI 10.4049/jimmunol.177.2.1314; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Sambrook J, 2001, MOL CLONING LAB MANU; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Savkovic SD, 2003, AM J PHYSIOL-CELL PH, V285, pC512, DOI 10.1152/ajpcell.00444.2002; Savkovic SD, 2001, AM J PHYSIOL-GASTR L, V281, pG890, DOI 10.1152/ajpgi.2001.281.4.G890; Savkovic SD, 1997, AM J PHYSIOL-CELL PH, V273, pC1160, DOI 10.1152/ajpcell.1997.273.4.C1160; Schuhmacher DA, 1999, J BACTERIOL, V181, P1508, DOI 10.1128/JB.181.5.1508-1514.1999; Sharma SA, 1998, J IMMUNOL, V160, P2401; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thorpe CM, 1999, INFECT IMMUN, V67, P5985, DOI 10.1128/IAI.67.11.5985-5993.1999; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Wyant TL, 1999, INFECT IMMUN, V67, P3619, DOI 10.1128/IAI.67.7.3619-3624.1999; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2006, MOL CELL PROTEOMICS, V5, P2374, DOI 10.1074/mcp.M600228-MCP200; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Zhou X, 2003, INFECT IMMUN, V71, P2120, DOI 10.1128/IAI.71.4.2120-2129.2003	61	30	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12127	10.1371/journal.pone.0012127	http://dx.doi.org/10.1371/journal.pone.0012127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711431	Green Published, gold			2022-12-25	WOS:000280859700019
J	Morice, A; Charreau, B; Neveu, B; Brouard, S; Soulillou, JP; Bonneville, M; Houssaint, E; Degauque, N				Morice, Alexis; Charreau, Beatrice; Neveu, Berangere; Brouard, Sophie; Soulillou, Jean-Paul; Bonneville, Marc; Houssaint, Elisabeth; Degauque, Nicolas			Cross-Reactivity of Herpesvirus-Specific CD8 T Cell Lines Toward Allogeneic Class I MHC Molecules	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LYMPHOCYTE CTL; RECEPTOR USAGE; CYTOMEGALOVIRUS; MEMORY; PEPTIDE; RECOGNITION; RESPONSES; SELECTION; DISEASE	Although association between persistent viral infection and allograft rejection is well characterized, few examples of T-cell cross-reactivity between self-MHC/viral and allogeneic HLA molecules have been documented so far. We appraised in this study the alloreactivity of CD8 T cell lines specific for immunodominant epitopes from human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV). CD8 T cell lines were generated after sorting with immunomagnetic beads coated with either pp65(495-503)/A*0201, BMLF1(259-267)/A*0201, or BZLF1(54-64)/B*3501 multimeric complexes. Alloreactivity of the CD8 T cell lines against allogeneic class I MHC alleles was assessed by screening of (i) TNF-alpha production against COS-7 cells transfected with as many as 39 individual HLA class I-encoding cDNA, and (ii) cytotoxicity activity toward a large panel of HLA-typed EBV-transformed B lymphoblastoid cell lines. We identified several cross-reactive pp65/A*0201-specific T cell lines toward allogeneic HLA-A*3001, A*3101, or A*3201. Moreover, we described here cross-recognition of HLA-Cw*0602 by BZLF1/B*3501-specific T cells. It is noteworthy that these alloreactive CD8 T cell lines showed efficient recognition of endothelial cells expressing the relevant HLA class I allele, with high level TNF-alpha production and cytotoxicity activity. Taken together, our data support the notion that herpes virus-specific T cells recognizing allo-HLA alleles may promote solid organ rejection.	[Morice, Alexis; Neveu, Berangere; Bonneville, Marc; Houssaint, Elisabeth] Univ Nantes, Inst Rech Therapeut, INSERM, UMR892, Nantes, France; [Charreau, Beatrice; Brouard, Sophie; Soulillou, Jean-Paul; Degauque, Nicolas] INSERM, UMR 643, Nantes, France; [Brouard, Sophie; Soulillou, Jean-Paul; Degauque, Nicolas] CHU Nantes, ITUN, F-44035 Nantes 01, France; [Brouard, Sophie; Soulillou, Jean-Paul; Degauque, Nicolas] Univ Nantes, Fac Med, Nantes, France; [Houssaint, Elisabeth] Univ Nantes, Fac Sci, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite	Morice, A (corresponding author), Univ Nantes, Inst Rech Therapeut, INSERM, UMR892, Nantes, France.	nicolas.degauque@univ-nantes.fr	CHARREAU, Beatrice/AAK-8186-2020; Degauque, Nicolas/R-4944-2017; brouard, sophie c/Q-1285-2016	CHARREAU, Beatrice/0000-0001-5870-4615; Degauque, Nicolas/0000-0003-2990-3513; 	Centre Hospitalier Universitaire de Nantes, ANR [A05130GS]; Ligue Nationale Contre le Cancer; INSERM; Xenome; European Commission [LSHB-CT-2006-037377]; la Fondation de l'Avenir [ET8-498]; ARC (Association pour la Recherche sur le Cancer)	Centre Hospitalier Universitaire de Nantes, ANR(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Xenome; European Commission(European CommissionEuropean Commission Joint Research Centre); la Fondation de l'Avenir; ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants from Centre Hospitalier Universitaire de Nantes, ANR (A05130GS), Ligue Nationale Contre le Cancer, and by institutional grants from INSERM, Xenome, a European Commission-funded Integrated Project, Life Sciences, Genomics and Biotechnology for Health LSHB-CT-2006-037377, and by a grant from la Fondation de l'Avenir (contrat ET8-498). A. Morice is funded by ARC (Association pour la Recherche sur le Cancer) and N. Degauque is a Transplantation Society (TTS) post-doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Bodinier M, 2000, NAT MED, V6, P707, DOI 10.1038/76292; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Burrows SR, 1997, EUR J IMMUNOL, V27, P1726, DOI 10.1002/eji.1830270720; Burrows SR, 1999, IMMUNOL TODAY, V20, P203, DOI 10.1016/S0167-5699(98)01429-7; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Cainelli F, 2002, LANCET INFECT DIS, V2, P539, DOI 10.1016/S1473-3099(02)00370-5; DavidAmeline J, 1996, J IMMUNOL, V157, P4697; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; Doxiadis IIN, 1996, LANCET, V348, P850, DOI 10.1016/S0140-6736(96)02296-9; EPPERSON DE, 1994, J IMMUNOL, V153, P5402; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; Finn O J, 1996, Int Rev Immunol, V13, P187, DOI 10.3109/08830189609061747; Gamadia LE, 2004, TRANSPLANTATION, V77, P1879, DOI 10.1097/01.tp.0000131158.81346.64; GASCHET J, 1995, BONE MARROW TRANSPL, V16, P427; GERTH UC, 1995, ANN NY ACAD SCI, V756, P12, DOI 10.1111/j.1749-6632.1995.tb44478.x; Grunewald J, 1999, SPRINGER SEMIN IMMUN, V21, P1, DOI 10.1007/BF00815174; Heemskerk MBA, 2005, HUM IMMUNOL, V66, P969, DOI 10.1016/j.humimm.2005.06.007; Hislop AD, 2001, J IMMUNOL, V167, P2019, DOI 10.4049/jimmunol.167.4.2019; Hodson EM, 2005, LANCET, V365, P2105, DOI 10.1016/S0140-6736(05)66553-1; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; KHANNA R, 1995, MICROBIOL REV, V59, P387, DOI 10.1128/MMBR.59.3.387-405.1995; Koelle DM, 2002, BLOOD, V99, P3844, DOI 10.1182/blood.V99.10.3844; Kreisel D, 2002, NAT MED, V8, P233, DOI 10.1038/nm0302-233; Landais E, 2006, J IMMUNOL, V177, P1427, DOI 10.4049/jimmunol.177.3.1427; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Le Bas-Bernardet S, 2003, AM J TRANSPLANT, V3, P167, DOI 10.1034/j.1600-6143.2003.00021.x; Maruya E, 1993, Clin Transpl, P511; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Moya-Quiles MR, 2003, LIVER TRANSPLANT, V9, P218, DOI 10.1053/jlts.2003.50043; Neveu B, 2006, INT IMMUNOL, V18, P1139, DOI 10.1093/intimm/dxl048; Pober JS, 1996, TRANSPLANTATION, V61, P343, DOI 10.1097/00007890-199602150-00001; Razonable Raymund R, 2003, Herpes, V10, P60; Saulquin X, 2000, EUR J IMMUNOL, V30, P2531, DOI 10.1002/1521-4141(200009)30:9<2531::AID-IMMU2531>3.0.CO;2-O; Scotet E, 1999, EUR J IMMUNOL, V29, P973, DOI 10.1002/(SICI)1521-4141(199903)29:03<973::AID-IMMU973>3.3.CO;2-G; Soderberg-Naucler C, 2001, TRANSPLANTATION, V71, pSS24; Steven NM, 1996, J EXP MED, V184, P1801, DOI 10.1084/jem.184.5.1801; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; Streblow DN, 2007, CURR OPIN IMMUNOL, V19, P577, DOI 10.1016/j.coi.2007.07.012; Suarez Y, 2007, J IMMUNOL, V179, P7488, DOI 10.4049/jimmunol.179.11.7488; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tan LC, 1999, J IMMUNOL, V162, P1827; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996	46	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12120	10.1371/journal.pone.0012120	http://dx.doi.org/10.1371/journal.pone.0012120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711433	Green Published, gold, Green Submitted			2022-12-25	WOS:000280859700013
J	Raychaudhuri, S				Raychaudhuri, Subhadip			A Minimal Model of Signaling Network Elucidates Cell-to-Cell Stochastic Variability in Apoptosis	PLOS ONE			English	Article							DEATH; EXPRESSION; SIMULATION; GENE	Background: Signaling networks are designed to sense an environmental stimulus and adapt to it. We propose and study a minimal model of signaling network that can sense and respond to external stimuli of varying strength in an adaptive manner. The structure of this minimal network is derived based on some simple assumptions on its differential response to external stimuli. Methodology: We employ stochastic differential equations and probability distributions obtained from stochastic simulations to characterize differential signaling response in our minimal network model. Gillespie's stochastic simulation algorithm (SSA) is used in this study. Conclusions/Significance: We show that the proposed minimal signaling network displays two distinct types of response as the strength of the stimulus is decreased. The signaling network has a deterministic part that undergoes rapid activation by a strong stimulus in which case cell-to-cell fluctuations can be ignored. As the strength of the stimulus decreases, the stochastic part of the network begins dominating the signaling response where slow activation is observed with characteristic large cell-to-cell stochastic variability. Interestingly, this proposed stochastic signaling network can capture some of the essential signaling behaviors of a complex apoptotic cell death signaling network that has been studied through experiments and large-scale computer simulations. Thus we claim that the proposed signaling network is an appropriate minimal model of apoptosis signaling. Elucidating the fundamental design principles of complex cellular signaling pathways such as apoptosis signaling remains a challenging task. We demonstrate how our proposed minimal model can help elucidate the effect of a specific apoptotic inhibitor Bcl-2 on apoptotic signaling in a cell-type independent manner. We also discuss the implications of our study in elucidating the adaptive strategy of cell death signaling pathways.	Univ Calif Davis, Dept Biomed Engn, Biophys Grad Grp, Immunol Grad Grp,Grad Grp Appl Math, Davis, CA 95616 USA	University of California System; University of California Davis	Raychaudhuri, S (corresponding author), Univ Calif Davis, Dept Biomed Engn, Biophys Grad Grp, Immunol Grad Grp,Grad Grp Appl Math, Davis, CA 95616 USA.	raychaudhuri@ucdavis.edu		Raychaudhuri, Subhadip/0000-0002-9873-6475; Raychaudhuri, Subhadip/0000-0003-3426-8382	National Institutes of Health (NIH) [R01]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health (NIH) R01 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fedoroff N, 2002, SCIENCE, V297, P1129, DOI 10.1126/science.1075988; Gardiner C. W., 1990, HDB STOCHASTIC METHO; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldkorn T, 2005, ANTIOXID REDOX SIGN, V7, P119, DOI 10.1089/ars.2005.7.119; GOMPERTS BD, 2003, SIGNAL TRANSDUCTION; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Luo KQ, 2003, BIOCHEM BIOPH RES CO, V304, P217, DOI 10.1016/S0006-291X(03)00559-X; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PORWITMACDONALD A, 1995, LEUKEMIA, V9, P1191; Raychaudhuri S, 2008, BIOPHYS J, V95, P3559, DOI 10.1529/biophysj.108.135483; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SKOMMER J, 2010, APOPTOSIS IN PRESS; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; WATTERS D, 1999, SIGNALING PATHWAYS A	19	35	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e11930	10.1371/journal.pone.0011930	http://dx.doi.org/10.1371/journal.pone.0011930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711445	Green Published, Green Submitted, gold			2022-12-25	WOS:000280849100002
J	Norgate, M; Boyd-Gerny, S; Simonov, V; Rosa, MGP; Heard, TA; Dyer, AG				Norgate, Melanie; Boyd-Gerny, Skye; Simonov, Vera; Rosa, Marcello G. P.; Heard, Tim A.; Dyer, Adrian G.			Ambient Temperature Influences Australian Native Stingless Bee (Trigona carbonaria) Preference for Warm Nectar	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; FLIGHT METABOLIC-RATE; POLLINATION; FLOWERS; THERMOREGULATION; BUMBLEBEES; DROSOPHILA; COLOR; MICROCLIMATE; HYMENOPTERA	The interaction between flowers and insect pollinators is an important aspect of the reproductive mechanisms of many plant species. Several laboratory and field studies indicate that raising flower temperature above ambient can be an advantage in attracting pollinators. Here we demonstrate that this preference for warmer flowers is, in fact, context-dependent. Using an Australian native bee as a model, we demonstrate for the first time a significant shift in behaviour when the ambient temperature reaches 34 degrees C, at which point bees prefer ambient temperature nectar over warmer nectar. We then use thermal imaging techniques to show warmer nectar maintains the flight temperature of bees during the period of rest on flowers at lower ambient temperatures but the behavioural switch is associated with the body temperature rising above that maintained during flight. These findings suggest that flower-pollinator interactions are dependent upon ambient temperature and may therefore alter in different thermal environments.	[Norgate, Melanie; Boyd-Gerny, Skye; Simonov, Vera] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Rosa, Marcello G. P.; Dyer, Adrian G.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Heard, Tim A.] CSIRO Entomol, Indooroopilly, Qld, Australia	Monash University; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Norgate, M (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	adrian.dyer@monash.edu	Heard, Tim/Q-7304-2019; Rosa, Marcello G/D-9278-2013; Heard, Tim A/B-1125-2008	Heard, Tim/0000-0003-4975-7314; Rosa, Marcello G/0000-0002-6620-6285; Heard, Tim A/0000-0003-4975-7314	Australian Research Council (ARC) [DP0772837, DP0878968]	Australian Research Council (ARC)(Australian Research Council)	Melanie Norgate is supported by the Australian Research Council (ARC http://www.arc.gov.au/) DP0772837. Adrian Dyer and Marcello Rosa are supported by ARC DP0878968. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH FG, 1985, INSECTS FLOWERS BIOL, P1; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; Carcaud J, 2009, J EXP BIOL, V212, P620, DOI 10.1242/jeb.026641; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Choi HY, 2008, FIBER POLYM, V9, P355, DOI 10.1007/s12221-008-0057-6; COELHO JR, 1991, PHYSIOL ZOOL, V64, P823, DOI 10.1086/physzool.64.3.30158209; Comba L, 2000, PLANT CELL ENVIRON, V23, P639, DOI 10.1046/j.1365-3040.2000.00580.x; COOPER PD, 1985, J EXP BIOL, V114, P1; CORBET SA, 1978, ECOL ENTOMOL, V3, P25, DOI 10.1111/j.1365-2311.1978.tb00900.x; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Engel Michael S., 2000, American Museum Novitates, V3296, P1, DOI 10.1206/0003-0082(2000)3296<0001:ANIOTO>2.0.CO;2; Frisch K. v., 1967, DANCE LANGUAGE ORIEN; Giurfa M, 1997, CURR OPIN NEUROBIOL, V7, P505, DOI 10.1016/S0959-4388(97)80030-X; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARDER LD, 1986, OECOLOGIA, V69, P309, DOI 10.1007/BF00377639; Harrison JF, 2002, COMP BIOCHEM PHYS A, V133, P323, DOI 10.1016/S1095-6433(02)00163-0; HEARD TA, 1988, J AUST ENTOMOL SOC, V27, P303; Heard TA, 1999, ANNU REV ENTOMOL, V44, P183, DOI 10.1146/annurev.ento.44.1.183; HEARD TA, 1993, AUST J ZOOL, V41, P343, DOI 10.1071/ZO9930343; HEINRICH B, 1975, J COMP PHYSIOL, V96, P155, DOI 10.1007/BF00706595; HEINRICH B, 1980, J EXP BIOL, V85, P61; HEINRICH B, 1979, J EXP BIOL, V80, P217; Heinrich B., 1979, BUMBLEBEE EC; HERRERA CM, 1995, ECOLOGY, V76, P218, DOI 10.2307/1940644; HERRERA CM, 1995, ECOLOGY, V76, P1516, DOI 10.2307/1938153; HOCKING B, 1968, OIKOS, V19, P359, DOI 10.2307/3565022; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Kevan P.G., 1984, P607; KEVAN PG, 1975, SCIENCE, V189, P723, DOI 10.1126/science.189.4204.723; Kevan PG, 2001, J EXP BIOL, V204, P2571; KINGSOLVER JG, 1983, ECOLOGY, V64, P534, DOI 10.2307/1939973; Lotz CN, 2003, J COMP PHYSIOL B, V173, P455, DOI 10.1007/s00360-003-0346-8; McKee J, 1998, BOT J LINN SOC, V128, P369; MICHENER CD, BEES WORLD; MOLGAARD P, 1989, ARCTIC ALPINE RES, V21, P83, DOI 10.2307/1551519; MORITZ RFA, 1988, EXPERIENTIA, V44, P1024, DOI 10.1007/BF01939912; Patino S, 2002, PLANT CELL ENVIRON, V25, P41, DOI 10.1046/j.0016-8025.2001.00801.x; Pereboom JJM, 2003, OECOLOGIA, V137, P42, DOI 10.1007/s00442-003-1324-2; Rands SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002007; Reisenman CE, 2008, ARTHROPOD-PLANT INTE, V2, P137, DOI 10.1007/s11829-008-9041-8; Seymour RS, 1998, PHILOS T ROY SOC B, V353, P935, DOI 10.1098/rstb.1998.0258; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; Seymour RS, 2001, BIOSCIENCE REP, V21, P223, DOI 10.1023/A:1013608627084; Sokal R. R, 1981, BIOMETRY; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; Whitney HM, 2008, NATURWISSENSCHAFTEN, V95, P845, DOI 10.1007/s00114-008-0393-9; Woods WA, 2005, J EXP BIOL, V208, P1161, DOI 10.1242/jeb.01510	49	42	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12000	10.1371/journal.pone.0012000	http://dx.doi.org/10.1371/journal.pone.0012000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711250	Green Published, Green Submitted, gold			2022-12-25	WOS:000280776800003
J	Chen, C; Krishnan, R; Zhou, EH; Ramachandran, A; Tambe, D; Rajendran, K; Adam, RM; Deng, LH; Fredberg, JJ				Chen, Cheng; Krishnan, Ramaswamy; Zhou, Enhua; Ramachandran, Aruna; Tambe, Dhananjay; Rajendran, Kavitha; Adam, Rosalyn M.; Deng, Linhong; Fredberg, Jeffrey J.			Fluidization and Resolidification of the Human Bladder Smooth Muscle Cell in Response to Transient Stretch	PLOS ONE			English	Article							FOCAL ADHESIONS; ACTIN POLYMERIZATION; MYOSIN BINDING; SLOW DYNAMICS; ZYXIN; EXPRESSION; LOCOMOTION; MECHANICS; WORMLIKE; STRESSES	Background: Cells resident in certain hollow organs are subjected routinely to large transient stretches, including every adherent cell resident in lungs, heart, great vessels, gut, and bladder. We have shown recently that in response to a transient stretch the adherent eukaryotic cell promptly fluidizes and then gradually resolidifies, but mechanism is not yet understood. Principal Findings: In the isolated human bladder smooth muscle cell, here we applied a 10% transient stretch while measuring cell traction forces, elastic modulus, F-actin imaging and the F-actin/G-actin ratio. Immediately after a transient stretch, F-actin levels and cell stiffness were lower by about 50%, and traction forces were lower by about 70%, both indicative of prompt fluidization. Within 5min, F-actin levels recovered completely, cell stiffness recovered by about 90%, and traction forces recovered by about 60%, all indicative of resolidification. The extent of the fluidization response was uninfluenced by a variety of signaling inhibitors, and, surprisingly, was localized to the unstretch phase of the stretch-unstretch maneuver in a manner suggestive of cytoskeletal catch bonds. When we applied an "unstretch-restretch'' (transient compression), rather than a "stretch-unstretch'' (transient stretch), the cell did not fluidize and the actin network did not depolymerize. Conclusions: Taken together, these results implicate extremely rapid actin disassembly in the fluidization response, and slow actin reassembly in the resolidification response. In the bladder smooth muscle cell, the fluidization response to transient stretch occurs not through signaling pathways, but rather through release of increased tensile forces that drive acute disassociation of actin.	[Chen, Cheng; Deng, Linhong] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China; [Chen, Cheng; Krishnan, Ramaswamy; Zhou, Enhua; Tambe, Dhananjay; Rajendran, Kavitha; Deng, Linhong; Fredberg, Jeffrey J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Ramachandran, Aruna; Adam, Rosalyn M.] Harvard Univ, Sch Med, Urol Dis Res Ctr, Dept Urol,Childrens Hosp Boston, Boston, MA USA; [Ramachandran, Aruna; Adam, Rosalyn M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Chongqing University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Chen, C (corresponding author), Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China.	denglh@cqu.edu.cn	Ladoux, Benoit/A-9879-2013; Deng, Linhong/O-3218-2019; Deng, Linhong/C-1485-2009; Fredberg, Jeffrey/M-9877-2019; Tambe, Dhananjay/E-3511-2010	Deng, Linhong/0000-0003-1970-8239; Tambe, Dhananjay/0000-0002-6534-6577; Chen, Cheng/0000-0002-7323-1104	National Natural Science Foundation of China [30670516, 30770529]; Chongqing Natural Science Foundation (CSTC) [2010BA5001]; China Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077195] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by the National Natural Science Foundation of China (Grant No. 30670516 and Grant No. 30770529 to LD) and Chongqing Natural Science Foundation (Project No. CSTC, 2010BA5001). CC is supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RM, 2004, PHYSIOL GENOMICS, V20, P36, DOI 10.1152/physiolgenomics.00181.2004; Adam RM, 2006, NEPHRON EXP NEPHROL, V102, pE1, DOI 10.1159/000088310; Adam RM, 2003, J UROLOGY, V169, P2388, DOI 10.1097/01.ju.0000063980.99368.35; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Borer JG, 1999, LAB INVEST, V79, P1335; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703, DOI 10.1152/jappl.1996.81.6.2703; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959, DOI 10.1164/ajrccm.159.3.9804060; Gavara N, 2008, BIOPHYS J, V95, P464, DOI 10.1529/biophysj.107.124180; Gunst SJ, 2003, J APPL PHYSIOL, V95, P413, DOI 10.1152/japplphysiol.00277.2003; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kroy K, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/416; Kroy K, 2008, SOFT MATTER, V4, P2323, DOI 10.1039/b807018k; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Lenormand G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041901; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mijailovich SM, 2000, BIOPHYS J, V79, P2667, DOI 10.1016/S0006-3495(00)76505-2; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PENDER N, 1991, J CELL SCI, V100, P187; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; PRATUSEVICH VR, 1995, J GEN PHYSIOL, V105, P73, DOI 10.1085/jgp.105.1.73; Semmrich C, 2007, P NATL ACAD SCI USA, V104, P20199, DOI 10.1073/pnas.0705513104; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Smith D, 2007, BIOPHYS J, V93, P4445, DOI 10.1529/biophysj.106.095919; Stamenovic D, 2004, J APPL PHYSIOL, V96, P1600, DOI 10.1152/japplphysiol.00595.2003; Tolic-Norrelykke IM, 2002, AM J PHYSIOL-CELL PH, V283, pC1254, DOI 10.1152/ajpcell.00169.2002; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wille JJ, 2004, J BIOMECH ENG-T ASME, V126, P545, DOI 10.1115/1.1798053; Wolff L, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053024; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	48	83	85	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12035	10.1371/journal.pone.0012035	http://dx.doi.org/10.1371/journal.pone.0012035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700509	gold, Green Published, Green Submitted			2022-12-25	WOS:000280687900020
J	Grietens, KP; Gies, S; Coulibaly, SO; Ky, C; Somda, J; Toomer, E; Ribera, JM; D'Alessandro, U				Grietens, Koen Peeters; Gies, Sabine; Coulibaly, Sheick Oumar; Ky, Clotilde; Somda, Judith; Toomer, Elizabeth; Ribera, Joan Muela; D'Alessandro, Umberto			Bottlenecks for High Coverage of Intermittent Preventive Treatment in Pregnancy: The Case of Adolescent Pregnancies in Rural Burkina Faso	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; SULFADOXINE-PYRIMETHAMINE; ANTENATAL CARE; POLICY CHANGE; MALARIA; WOMEN; KENYA; KNOWLEDGE; DISEASE; BURDEN	Background: While IPTp-SP is currently being scaled up in sub-Saharan Africa (SSA), the coverage with the required >= 2 doses of SP remains considerably short of the Roll Back Malaria (RBM) goal of 80%, not to mention of the recently advocated universal coverage. Methods: The study triangulates quantitative data from a health center randomized community-based trial on IPTp-SP effectiveness and the additional benefit of a promotional campaign with qualitative data from focused ethnography. Findings: In rural Burkina Faso, despite the significantly higher risk of malaria infection among adolescent primigravidae (PG) (OR 2.44 95% CI 1.81-3.28, p<0.001), making them primary target beneficiaries of IPTp-SP, adolescents adhered to the required three or more ANC visits significantly less (PG: 46.6%; SG 43.7%) than adults (PG: 61.9%; SG 54.9%) and had lower SP uptake during the malaria transmission season, further showing the difficulty of reaching this age group. Adolescents' structural constraints (such as their social position and household labor requirements) and needs (such as anonymity in the health encounter) leave them highly vulnerable during their pregnancies and, especially, during the high malaria transmission season. Conclusion: Our study shows that adolescents need to be targeted specifically, prior to their first pregnancy and with measures adapted to their social context, addressing their structural constraints and needs and going beyond standard health promotion campaigns. Unless such specific measures are taken, adolescents' social vulnerability will present a serious bottleneck for the effectiveness of IPTi-SP.	[Grietens, Koen Peeters; Gies, Sabine; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Grietens, Koen Peeters; Toomer, Elizabeth; Ribera, Joan Muela] PASS Int, Tessenderlo, Belgium; [Coulibaly, Sheick Oumar] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso; [Coulibaly, Sheick Oumar; Ky, Clotilde; Somda, Judith] Lab Natl Sante Publ, Ouagadougou, Burkina Faso	Institute of Tropical Medicine (ITM)	Grietens, KP (corresponding author), Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium.	kpeeters@itg.be	D'Alessandro, Umberto/D-3457-2015; Peeters Grietens, Koen/G-7028-2019; Ribera, JM/B-8181-2009	D'Alessandro, Umberto/0000-0001-6341-5009; Peeters Grietens, Koen/0000-0001-6570-9887; Ribera, JM/0000-0003-1042-6024; muela ribera, joan/0000-0003-2111-6275	European Union [IC4-CT-2002-10022]; Belgian cooperation (Directorate-General for Development Cooperation, DGDC); Institute for Tropical Medicine, Antwerp - Center Muraz, Bobo-Dioulasso; SOFI-A	European Union(European Commission); Belgian cooperation (Directorate-General for Development Cooperation, DGDC); Institute for Tropical Medicine, Antwerp - Center Muraz, Bobo-Dioulasso; SOFI-A	This work was supported by the European Union INCO-DEV program (contract IC4-CT-2002-10022). SG was partly supported by the Belgian cooperation (Directorate-General for Development Cooperation, DGDC) through the framework agreement of the Institute for Tropical Medicine, Antwerp - Center Muraz, Bobo-Dioulasso and the SOFI-A research fund. Neither funding source had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Anthropological Association, 2018, COD ETH AM ANTHR ASS; American Anthropological Association, AM ANTHR ASS STAT ET; [Anonymous], GLOB MAL ACT PLAN; [Anonymous], 2005, GLOB STRAT PLAN 2005; [Anonymous], 2008, WORLD MAL REP 2008; Brabin L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-2; Brabin L, 1998, ACTA OBSTET GYN SCAN, V77, P402, DOI 10.1034/j.1600-0412.1998.770408.x; Brabin L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-25; BRADY M, 2007, TRANSITIONS ADULTHOO, V9; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; DELACRUZ AC, 1996, J PHILIPP MED ASSOC, V71, P255; Gies S, 2009, AM J TROP MED HYG, V80, P460, DOI 10.4269/ajtmh.2009.80.460; Gies S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-180; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hounton SH, 2008, SCAND J PUBLIC HEALT, V36, P310, DOI 10.1177/1403494807085361; Lalloo DG, 2006, LANCET INFECT DIS, V6, P780, DOI 10.1016/S1473-3099(06)70655-7; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Marchant T, 2002, TROP MED INT HEALTH, V7, P149, DOI 10.1046/j.1365-3156.2002.00840.x; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; Newman RD, 2006, TROP MED INT HEALTH, V11, P462, DOI 10.1111/j.1365-3156.2006.01593.x; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Nikiema B, 2008, WORLD DEV, V36, P608, DOI 10.1016/j.worlddev.2007.04.019; OJENGBEDE O A, 1987, African Journal of Medicine and Medical Sciences, V16, P89; OKONOFUA FE, 1992, J TROP MED HYG, V95, P309; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; *RBM, 2005, MON EV REF GROUP MER; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Sauerborn R, 1996, SOC SCI MED, V43, P281, DOI 10.1016/0277-9536(95)00374-6; SCHULTZ LJ, 1994, TROP MED PARASITOL, V45, P65; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; van Eijk AM, 2005, TROP MED INT HEALTH, V10, P1134, DOI 10.1111/j.1365-3156.2005.01497.x; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; Verhoeff FH, 1998, ANN TROP MED PARASIT, V92, P141, DOI 10.1080/00034989859979; *WHO, 2004, AD PREGN	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12013	10.1371/journal.pone.0012013	http://dx.doi.org/10.1371/journal.pone.0012013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	635WK	20700460	Green Published, Green Submitted, gold			2022-12-25	WOS:000280687900012
J	Leadbeater, E; Carruthers, JM; Green, JP; van Heusden, J; Field, J				Leadbeater, Ellouise; Carruthers, Jonathan M.; Green, Jonathan P.; van Heusden, Jasper; Field, Jeremy			Unrelated Helpers in a Primitively Eusocial Wasp: Is Helping Tailored Towards Direct Fitness?	PLOS ONE			English	Article							POLISTES-DOMINULUS; ANIMAL SOCIETIES; PAPER WASP; GENETIC-MARKERS; FUTURE FITNESS; HYMENOPTERA; RECIPROCITY; HIERARCHY; VESPIDAE; DISCRIMINATION	The paper wasp Polistes dominulus is unique among the social insects in that nearly one-third of co-foundresses are completely unrelated to the dominant individual whose offspring they help to rear and yet reproductive skew is high. These unrelated subordinates stand to gain direct fitness through nest inheritance, raising the question of whether their behaviour is adaptively tailored towards maximizing inheritance prospects. Unusually, in this species, a wealth of theory and empirical data allows us to predict how unrelated subordinates should behave. Based on these predictions, here we compare helping in subordinates that are unrelated or related to the dominant wasp across an extensive range of field-based behavioural contexts. We find no differences in foraging effort, defense behaviour, aggression or inheritance rank between unrelated helpers and their related counterparts. Our study provides no evidence, across a number of behavioural scenarios, that the behaviour of unrelated subordinates is adaptively modified to promote direct fitness interests.	[Leadbeater, Ellouise; Carruthers, Jonathan M.; Green, Jonathan P.; van Heusden, Jasper; Field, Jeremy] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Carruthers, Jonathan M.] Univ Sheffield, Nat Environm Res Council NERC, Biomol Anal Facil, Sheffield, S Yorkshire, England	University of Sussex; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield	Leadbeater, E (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	e.leadbeater@sussex.ac.uk			Natural Environment Research Council (NERC) [NE/E017894/1]; NERC [NBAF010001, NE/E017894/1] Funding Source: UKRI; Natural Environment Research Council [NE/E017894/1, NBAF010001] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by Natural Environment Research Council (NERC) grant NE/E017894/1 to Jeremy Field. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, SOCIAL BIOL WASPS; Bourke AFG, 1999, J EVOLUTION BIOL, V12, P245, DOI 10.1046/j.1420-9101.1999.00028.x; Cant MA, 2006, P ROY SOC B-BIOL SCI, V273, P2977, DOI 10.1098/rspb.2006.3669; Cant MA, 2005, BEHAV ECOL, V16, P708, DOI 10.1093/beheco/ari051; Cant MA, 2001, P ROY SOC B-BIOL SCI, V268, P1959, DOI 10.1098/rspb.2001.1754; Cant MA, 2006, AM NAT, V167, P837, DOI 10.1086/503445; CHANDRASHEKARA K, 1992, J INSECT BEHAV, V5, P193, DOI 10.1007/BF01049289; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Clutton-Brock TH, 2001, ANIM BEHAV, V61, P705, DOI 10.1006/anbe.2000.1631; Cronin AL, 2007, BEHAV ECOL, V18, P331, DOI 10.1093/beheco/arl091; Dani FR, 2004, P ROY SOC B-BIOL SCI, V271, P745, DOI 10.1098/rspb.2003.2646; Dapporto L, 2004, BEHAV ECOL SOCIOBIOL, V56, P315, DOI 10.1007/s00265-004-0800-y; Field J, 2006, NATURE, V441, P214, DOI 10.1038/nature04560; Field J, 2007, BEHAV PROCESS, V76, P160, DOI 10.1016/j.beproc.2007.01.019; Field J, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P305, DOI 10.1017/CBO9780511641954.013; Field J, 2009, PHILOS T R SOC B, V364, P3181, DOI 10.1098/rstb.2009.0110; Gamboa George J., 1996, P161; GAMBOA GJ, 1978, SCIENCE, V199, P1463, DOI 10.1126/science.199.4336.1463; GLOOR GB, 1993, GENETICS, V135, P81; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Henshaw MT, 2000, MOL ECOL, V9, P2155, DOI 10.1046/j.1365-294X.2000.01053.x; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Kokko H, 2002, BEHAV ECOL, V13, P291, DOI 10.1093/beheco/13.3.291; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Liebert AE, 2006, ANIM BEHAV, V71, P913, DOI 10.1016/j.anbehav.2005.09.005; LIGON JD, 1978, NATURE, V276, P496, DOI 10.1038/276496a0; POST DC, 1982, BEHAV ECOL SOCIOBIOL, V11, P283, DOI 10.1007/BF00299305; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Queller DC, 2000, NATURE, V405, P784, DOI 10.1038/35015552; RABENOLD KN, 1985, BEHAV ECOL SOCIOBIOL, V17, P1, DOI 10.1007/BF00299422; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Starks PT, 2003, ANN ZOOL FENN, V40, P53; TURILLAZZI S, 1977, MONIT ZOOL ITAL, V11, P101; Zanette LRS, 2008, MOL ECOL, V17, P2590, DOI 10.1111/j.1365-294X.2008.03785.x; [No title captured]	37	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11997	10.1371/journal.pone.0011997	http://dx.doi.org/10.1371/journal.pone.0011997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700463	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000280687900007
J	Nie, HS; Crooijmans, RPMA; Lammers, A; van Schothorst, EM; Keijer, J; Neerincx, PBT; Leunissen, JAM; Megens, HJ; Groenen, MAM				Nie, Haisheng; Crooijmans, Richard P. M. A.; Lammers, Aart; van Schothorst, Evert M.; Keijer, Jaap; Neerincx, Pieter B. T.; Leunissen, Jack A. M.; Megens, Hendrik-Jan; Groenen, Martien A. M.			Gene Expression in Chicken Reveals Correlation with Structural Genomic Features and Conserved Patterns of Transcription in the Terrestrial Vertebrates	PLOS ONE			English	Article							HUMAN HOUSEKEEPING GENES; SALMONELLA INFECTION; RESPONSES; SELECTION; CLUSTERS; LINES	Background: The chicken is an important agricultural and avian-model species. A survey of gene expression in a range of different tissues will provide a benchmark for understanding expression levels under normal physiological conditions in birds. With expression data for birds being very scant, this benchmark is of particular interest for comparative expression analysis among various terrestrial vertebrates. Methodology/Principal Findings: We carried out a gene expression survey in eight major chicken tissues using whole genome microarrays. A global picture of gene expression is presented for the eight tissues, and tissue specific as well as common gene expression were identified. A Gene Ontology (GO) term enrichment analysis showed that tissue-specific genes are enriched with GO terms reflecting the physiological functions of the specific tissue, and housekeeping genes are enriched with GO terms related to essential biological functions. Comparisons of structural genomic features between tissue-specific genes and housekeeping genes show that housekeeping genes are more compact. Specifically, coding sequence and particularly introns are shorter than genes that display more variation in expression between tissues, and in addition intergenic space was also shorter. Meanwhile, housekeeping genes are more likely to co-localize with other abundantly or highly expressed genes on the same chromosomal regions. Furthermore, comparisons of gene expression in a panel of five common tissues between birds, mammals and amphibians showed that the expression patterns across tissues are highly similar for orthologuous genes compared to random gene pairs within each pair-wise comparison, indicating a high degree of functional conservation in gene expression among terrestrial vertebrates. Conclusions: The housekeeping genes identified in this study have shorter gene length, shorter coding sequence length, shorter introns, and shorter intergenic regions, there seems to be selection pressure on economy in genes with a wide tissue distribution, i.e. these genes are more compact. A comparative analysis showed that the expression patterns of orthologous genes are conserved in the terrestrial vertebrates during evolution.	[Nie, Haisheng; Crooijmans, Richard P. M. A.; Megens, Hendrik-Jan; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Lammers, Aart] Wageningen Univ, Adaptat Physiol Grp, Wageningen, Netherlands; [Neerincx, Pieter B. T.; Leunissen, Jack A. M.] Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Nie, HS (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands.	martien.groenen@wur.nl	Megens, Hendrik-Jan/E-9676-2010; Crooijmans, Richard PMA/E-2492-2012; Groenen, Martien/D-8408-2012; Megens, Hendrik-Jan/M-5300-2019; Keijer, Jaap/J-8089-2013	Megens, Hendrik-Jan/0000-0002-3619-7533; Groenen, Martien/0000-0003-0484-4545; Megens, Hendrik-Jan/0000-0002-3619-7533; Keijer, Jaap/0000-0002-9720-7491; van Schothorst, Evert/0000-0002-3036-5903	European Union [FOOD-CT-2004-506416]	European Union(European Commission)	This work was financed by European Union grant FOOD-CT-2004-506416 (EADGENE), website: www.eadgene.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huber W, 2002, BIOINFORMATICS, V18, pS96; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kim DK, 2008, POULTRY SCI, V87, P433, DOI 10.3382/ps.2007-00383; Kim DK, 2008, DEV BIOLOGICALS, V132, P131, DOI 10.1159/000317153; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Mijalski T, 2005, P NATL ACAD SCI USA, V102, P8621, DOI 10.1073/pnas.0407672102; Morgan RW, 2001, J VIROL, V75, P533, DOI 10.1128/JVI.75.1.533-539.2001; Neerincx Pieter B T, 2009, BMC Proc, V3 Suppl 4, pS4, DOI 10.1186/1753-6561-3-S4-S4; Nie HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-28; R Core Team, 2022, R LANG ENV STAT COMP; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Van Hemert S, 2007, VET RES, V38, P51, DOI 10.1051/vetres:2006048; van Hemert S, 2006, VET IMMUNOL IMMUNOP, V114, P247, DOI 10.1016/j.vetimm.2006.08.007; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	26	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11990	10.1371/journal.pone.0011990	http://dx.doi.org/10.1371/journal.pone.0011990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700537	Green Submitted, gold, Green Published			2022-12-25	WOS:000280605400022
J	Ioannoni, R; Beaudoin, J; Mercier, A; Labbe, S				Ioannoni, Raphael; Beaudoin, Jude; Mercier, Alexandre; Labbe, Simon			Copper-Dependent Trafficking of the Ctr4-Ctr5 Copper Transporting Complex	PLOS ONE			English	Article							ZRT1 ZINC TRANSPORTER; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FLUORESCENCE COMPLEMENTATION; BIOCHEMICAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; STIMULATED ENDOCYTOSIS; VACUOLAR DEGRADATION; YEAST; GENE	Background: In Schizosaccharomyces pombe, copper uptake is carried out by a heteromeric complex formed by the Ctr4 and Ctr5 proteins. Copper-induced differential subcellular localization may play a critical role with respect to fine tuning the number of Ctr4 and Ctr5 molecules at the cell surface. Methodology/Principal Findings: We have developed a bimolecular fluorescence complementation (BiFC) assay to analyze protein-protein interactions in vivo in S. pombe. The assay is based on the observation that N- and C-terminal subfragments of the Venus fluorescent protein can reconstitute a functional fluorophore only when they are brought into tight contact. Wild-type copies of the ctr4(+) and ctr5(+) genes were inserted downstream of and in-frame with the nonfluorescent C-terminal (VC) and N- terminal (VN) coding fragments of Venus, respectively. Co-expression of Ctr4-VC and Ctr5-VN fusion proteins allowed their detection at the plasma membrane of copper-limited cells. Similarly, cells co-expressing Ctr4-VN and Ctr4-VC in the presence of Ctr5-Myc(12) displayed a fluorescence signal at the plasma membrane. In contrast, Ctr5-VN and Ctr5-VC co-expressed in the presence of Ctr4-Flag(2) failed to be visualized at the plasma membrane, suggesting a requirement for a combination of two Ctr4 molecules with one Ctr5 molecule. We found that plasma membrane-located Ctr4-VC-Ctr5-VN fluorescent complexes were internalized when the cells were exposed to high levels of copper. The copper-induced internalization of Ctr4-VC-Ctr5-VN complexes was not dependent on de novo protein synthesis. When cells were transferred back from high to low copper levels, there was reappearance of the BiFC fluorescent signal at the plasma membrane. Significance: These findings reveal a copper-dependent internalization and recycling of the heteromeric Ctr4-Ctr5 complex as a function of copper availability.	[Ioannoni, Raphael; Beaudoin, Jude; Mercier, Alexandre; Labbe, Simon] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Ioannoni, R (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X	Foundation of Stars for Children's Health Research; Natural Sciences and Engineering Research Council of Canada; Fonds de la Recherche en Sante du Quebec (FRSQ); Canadian Institutes of Health Research (CIHR) [MOP-36450]	Foundation of Stars for Children's Health Research; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	R.I. is the recipient of studentships from the Foundation of Stars for Children's Health Research and the Natural Sciences and Engineering Research Council of Canada. A.M. (Ph.D. student) and S.L. (Senior investigator) are recipients of scholarships from the Fonds de la Recherche en Sante du Quebec (FRSQ). This study was supported by a Canadian Institutes of Health Research (CIHR, http://www.cihr.ca/e/193.html) grant (MOP-36450) awarded to S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C., 1993, EXPT FISSION YEAST L, P186; Allen LE, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2006/01/006; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bellemare DR, 2001, GENE, V273, P191, DOI 10.1016/S0378-1119(01)00591-1; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; KEENEY JB, 1994, GENETICS, V136, P849; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	41	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11964	10.1371/journal.pone.0011964	http://dx.doi.org/10.1371/journal.pone.0011964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694150	Green Submitted, Green Published, gold			2022-12-25	WOS:000280574300015
J	Laporte, I; Muhly, TB; Pitt, JA; Alexander, M; Musiani, M				Laporte, Isabelle; Muhly, Tyler B.; Pitt, Justin A.; Alexander, Mike; Musiani, Marco			Effects of Wolves on Elk and Cattle Behaviors: Implications for Livestock Production and Wolf Conservation	PLOS ONE			English	Article							GROUP-SIZE; CERVUS-ELAPHUS; PREDATION RISK; HABITAT USE; HEART-RATE; VIGILANCE; RESPONSES; PATTERNS; PREY; FEAR	Background: In many areas, livestock are grazed within wolf (Canis lupus) range. Predation and harassment of livestock by wolves creates conflict and is a significant challenge for wolf conservation. Wild prey, such as elk (Cervus elaphus), perform anti-predator behaviors. Artificial selection of cattle (Bos taurus) might have resulted in attenuation or absence of anti-predator responses, or in erratic and inconsistent responses. Regardless, such responses might have implications on stress and fitness. Methodology/Principal Findings: We compared elk and cattle anti-predator responses to wolves in southwest Alberta, Canada within home ranges and livestock pastures, respectively. We deployed satellite- and GPS-telemetry collars on wolves, elk, and cattle (n = 16, 10 and 78, respectively) and measured seven prey response variables during periods of wolf presence and absence (speed, path sinuosity, time spent head-up, distance to neighboring animals, terrain ruggedness, slope and distance to forest). During independent periods of wolf presence (n = 72), individual elk increased path sinuosity (Z = -2.720, P = 0.007) and used more rugged terrain (Z = -2.856, P = 0.004) and steeper slopes (Z = -3.065, P = 0.002). For cattle, individual as well as group behavioral analyses were feasible and these indicated increased path sinuosity (Z = -2.720, P = 0.007) and decreased distance to neighbors (Z = -2.551, P = 0.011). In addition, cattle groups showed a number of behavioral changes concomitant to wolf visits, with variable direction in changes. Conclusions/Significance: Our results suggest both elk and cattle modify their behavior in relation to wolf presence, with potential energetic costs. Our study does not allow evaluating the efficacy of anti-predator behaviors, but indicates that artificial selection did not result in their absence in cattle. The costs of wolf predation on livestock are often compensated considering just the market value of the animal killed. However, society might consider refunding some additional costs (e.g., weight loss and reduced reproduction) that might be associated with the changes in cattle behaviors that we documented.	[Laporte, Isabelle; Muhly, Tyler B.; Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Pitt, Justin A.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2M7, Canada; [Alexander, Mike] Alberta Sustainable Resource Dev, Lands Div, Pincher Creek, AB, Canada	University of Calgary; University of Alberta	Laporte, I (corresponding author), Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada.	tmuhly@ucalgary.ca	Musiani, Marco/ABB-9387-2021	Musiani, Marco/0000-0002-6097-5841	Alberta Beef Producers; Alberta Community Development; Alberta Conservation Association; Alberta Tourism; Parks and Recreation; Bob Creek Ranch; Defenders of Wildlife; Parks Canada; Institute for Sustainable Energy; Environment and the Economy; Natural Science and Engineering Research Council of Canada; The Rocky Mountain Forest Range Association; Shell Canada; Southern Alberta Land Trust Society	Alberta Beef Producers; Alberta Community Development; Alberta Conservation Association; Alberta Tourism; Parks and Recreation; Bob Creek Ranch; Defenders of Wildlife; Parks Canada; Institute for Sustainable Energy; Environment and the Economy; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); The Rocky Mountain Forest Range Association; Shell Canada; Southern Alberta Land Trust Society	Funding sources: Alberta Beef Producers, Alberta Community Development, Alberta Conservation Association, Alberta Tourism, Parks and Recreation, Bob Creek Ranch, Defenders of Wildlife, Parks Canada, the Institute for Sustainable Energy, Environment and the Economy, the Natural Science and Engineering Research Council of Canada, The Rocky Mountain Forest Range Association, Shell Canada, and the Southern Alberta Land Trust Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; ALCOCK J, 2005, ANIMAL BEHAV EVOLUTI; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Bleich VC, 1999, J MAMMAL, V80, P283, DOI 10.2307/1383228; Boonstra R, 1998, ECOL MONOGR, V68, P371, DOI 10.1890/0012-9615(1998)068[0371:TIOPIS]2.0.CO;2; Chabot D, 1996, J CHEM ECOL, V22, P839, DOI 10.1007/BF02033590; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Coppinger R., 2001, DOGS NEW UNDERSTANDI; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; DICKE M, 1988, PHYSIOL ENTOMOL, V13, P393, DOI 10.1111/j.1365-3032.1988.tb01122.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; FARIES FC, 1997, CONTROLLING BOVINE T; FIEBERG J, 2010, PHILOS T B IN PRESS; Fischhoff IR, 2007, BEHAV ECOL, V18, P725, DOI 10.1093/beheco/arm036; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Fritts Steven H., 2003, P289; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; *GOV ALB, 2003, BOB CREEK WILDL BLAC; Grandin T, 1997, J ANIM SCI, V75, P249; GRANDIN T, 1998, CAN ACTING PREDATOR; Grandin T, 2007, LIVESTOCK HANDLING AND TRANSPORT, 3RD EDITION, P44, DOI 10.1079/9781845932190.0044; Gude JA, 2006, ECOL APPL, V16, P285, DOI 10.1890/04-0623; Hamel S, 2007, CAN J ZOOL, V85, P933, DOI 10.1139/Z07-080; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hebblewhite M, 2006, WILDLIFE SOC B, V34, P1280, DOI 10.2193/0091-7648(2006)34[1280:ITMBOM]2.0.CO;2; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Howery L. D., 2004, Sheep & Goat Research Journal, V19, P53; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Johnsson JI, 2001, CAN J FISH AQUAT SCI, V58, P788, DOI 10.1139/cjfas-58-4-788; Kilgour RJ, 2006, APPL ANIM BEHAV SCI, V99, P21, DOI 10.1016/j.applanim.2005.09.012; Kluever BM, 2009, BEHAV PROCESS, V81, P85, DOI 10.1016/j.beproc.2009.02.004; KONDO S, 1988, CAN J ANIM SCI, V68, P339, DOI 10.4141/cjas88-038; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LEHMKUHLER J, 2007, EFFECTS WOLVES OTHER; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lind J, 2005, BEHAV ECOL, V16, P945, DOI 10.1093/beheco/ari075; Lingle S, 2001, ETHOLOGY, V107, P295, DOI 10.1046/j.1439-0310.2001.00664.x; LYON LJ, 1979, J FOREST, V77, P658; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MCDERMID GJ, 2009, FOR ECOL MANAGE; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; Merrill SB, 2003, WILDLIFE SOC B, V31, P947; Millspaugh JJ, 2004, WILDLIFE SOC B, V32, P506, DOI 10.2193/0091-7648(2004)32[506:HOOCEI]2.0.CO;2; MUEGGLER WALTER F., 1965, J RANGE MANAGE, V18, P255, DOI 10.2307/3895492; MUHLY T, 2010, WORLD WOLVE IN PRESS; MUHLY TB, 2010, OIKOS IN PRESS; Muhly TB, 2009, ECOL ECON, V68, P2439, DOI 10.1016/j.ecolecon.2009.04.008; Muller R, 2006, APPL ANIM BEHAV SCI, V99, P193, DOI 10.1016/j.applanim.2005.05.012; Musiani M, 2005, WILDLIFE SOC B, V33, P876, DOI 10.2193/0091-7648(2005)33[876:SARODA]2.0.CO;2; Musiani M, 2003, CONSERV BIOL, V17, P1538, DOI 10.1111/j.1523-1739.2003.00063.x; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Oakleaf JK, 2003, J WILDLIFE MANAGE, V67, P299, DOI 10.2307/3802771; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Price E. O., 2002, Animal domestication and behavior, P107, DOI 10.1079/9780851995977.0107; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Riley SJ., 1999, INTERMOUNT J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; ROATH LR, 1982, J RANGE MANAGE, V35, P332, DOI 10.2307/3898312; Schwerdtner K, 2007, BIOL CONSERV, V134, P354, DOI 10.1016/j.biocon.2006.08.010; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Skovlin Jon M., 2002, P531; Turchin Peter, 1998; TURNER LW, 2002, CANADIAN J ANIMAL SC, V80, P406; Ungar ED, 2005, RANGELAND ECOL MANAG, V58, P256, DOI 10.2111/1551-5028(2005)58[256:IOAAFG]2.0.CO;2; Voisinet BD, 1997, J ANIM SCI, V75, P892; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Welp T, 2004, APPL ANIM BEHAV SCI, V87, P1, DOI 10.1016/j.applanim.2003.12.013; Zabel A, 2008, CONSERV BIOL, V22, P247, DOI 10.1111/j.1523-1739.2008.00898.x	78	56	56	5	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11954	10.1371/journal.pone.0011954	http://dx.doi.org/10.1371/journal.pone.0011954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694139	Green Published, gold, Green Submitted			2022-12-25	WOS:000280574300010
J	Kelly, WJ; Leahy, SC; Altermann, E; Yeoman, CJ; Dunne, JC; Kong, ZH; Pacheco, DM; Li, D; Noel, SJ; Moon, CD; Cookson, AL; Attwood, GT				Kelly, William J.; Leahy, Sinead C.; Altermann, Eric; Yeoman, Carl J.; Dunne, Jonathan C.; Kong, Zhanhao; Pacheco, Diana M.; Li, Dong; Noel, Samantha J.; Moon, Christina D.; Cookson, Adrian L.; Attwood, Graeme T.			The Glycobiome of the Rumen Bacterium Butyrivibrio proteoclasticus B316(T) Highlights Adaptation to a Polysaccharide-Rich Environment	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; CLOSTRIDIUM-PROTEOCLASTICUM; KYOTO ENCYCLOPEDIA; RUMINAL BACTERIUM; COLONIZATION; FIBRISOLVENS; DIVERSITY; STRAINS; FERMENTATION; METABOLISM	Determining the role of rumen microbes and their enzymes in plant polysaccharide breakdown is fundamental to understanding digestion and maximising productivity in ruminant animals. Butyrivibrio proteoclasticus B316(T) is a Gram-positive, butyrate-forming rumen bacterium with a key role in plant polysaccharide degradation. The 4.4Mb genome consists of 4 replicons; a chromosome, a chromid and two megaplasmids. The chromid is the smallest reported for all bacteria, and the first identified from the phylum Firmicutes. B316 devotes a large proportion of its genome to the breakdown and reassembly of complex polysaccharides and has a highly developed glycobiome when compared to other sequenced bacteria. The secretion of a range of polysaccharide-degrading enzymes which initiate the breakdown of pectin, starch and xylan, a subtilisin family protease active against plant proteins, and diverse intracellular enzymes to break down oligosaccharides constitute the degradative capability of this organism. A prominent feature of the genome is the presence of multiple gene clusters predicted to be involved in polysaccharide biosynthesis. Metabolic reconstruction reveals the absence of an identifiable gene for enolase, a conserved enzyme of the glycolytic pathway. To our knowledge this is the first report of an organism lacking an enolase. Our analysis of the B316 genome shows how one organism can contribute to the multi-organism complex that rapidly breaks down plant material in the rumen. It can be concluded that B316, and similar organisms with broad polysaccharide-degrading capability, are well suited to being early colonizers and degraders of plant polysaccharides in the rumen environment.	[Kelly, William J.; Leahy, Sinead C.; Altermann, Eric; Yeoman, Carl J.; Dunne, Jonathan C.; Kong, Zhanhao; Pacheco, Diana M.; Li, Dong; Noel, Samantha J.; Moon, Christina D.; Cookson, Adrian L.; Attwood, Graeme T.] Grasslands Res Ctr, Palmerston North, New Zealand; [Yeoman, Carl J.] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; [Dunne, Jonathan C.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Dunne, Jonathan C.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Massey University; Victoria University Wellington; Victoria University Wellington	Kelly, WJ (corresponding author), Grasslands Res Ctr, Palmerston North, New Zealand.	graeme.attwood@agresearch.co.nz	Cookson, Adrian/R-6617-2019; Noel, Samantha/AAM-4090-2021; Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Leahy, Sinead/0000-0002-5461-6738; Attwood, Graeme Trevor/0000-0002-6443-8760; Moon, Christina/0000-0001-9692-9559; Altermann, Eric/0000-0003-1376-1549	New Zealand Foundation for Research Science and Technology [C10X0314]; Tertiary Education Commission; Meat and Wool New Zealand	New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Tertiary Education Commission; Meat and Wool New Zealand	This work was supported by the New Economy Research Fund of the New Zealand Foundation for Research Science and Technology (Contract C10X0314), and by an Enterprise Scholarship provided jointly by the Tertiary Education Commission and Meat and Wool New Zealand to CJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; Altermann Eric, 2003, OMICS A Journal of Integrative Biology, V7, P161, DOI 10.1089/153623103322246557; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Attwood GT, 1996, INT J SYST BACTERIOL, V46, P753, DOI 10.1099/00207713-46-3-753; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Colombatto D, 2009, J ANIM SCI, V87, P1097, DOI 10.2527/jas.2008-1262; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Edwards JE, 2007, FEMS MICROBIOL ECOL, V62, P323, DOI 10.1111/j.1574-6941.2007.00392.x; Eun JS, 2005, J DAIRY SCI, V88, P2140, DOI 10.3168/jds.S0022-0302(05)72890-3; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Harrison PW, 2010, TRENDS MICROBIOL, V18, P141, DOI 10.1016/j.tim.2009.12.010; HESPELL RB, 1993, CAN J MICROBIOL, V39, P912, DOI 10.1139/m93-139; Jun HS, 2007, ASIAN AUSTRAL J ANIM, V20, P802, DOI 10.5713/ajas.2007.802; Kalmokoff ML, 2000, ANAEROBE, V6, P93, DOI 10.1006/anae.1999.0308; Kim EJ, 2005, J DAIRY SCI, V88, P3220, DOI 10.3168/jds.S0022-0302(05)73005-8; KISTNER A, 1973, CAN J MICROBIOL, V19, P1119, DOI 10.1139/m73-178; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Liu YS, 2009, CELLULOSE, V16, P587, DOI 10.1007/s10570-009-9306-0; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Ludwig W., 2008, REVISED ROAD MAP PHY; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Moon CD, 2008, INT J SYST EVOL MICR, V58, P2041, DOI 10.1099/ijs.0.65845-0; Morrison M, 2009, CURR OPIN BIOTECH, V20, P358, DOI 10.1016/j.copbio.2009.05.004; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Paillard D, 2007, J APPL MICROBIOL, V103, P1251, DOI 10.1111/j.1365-2672.2007.03349.x; Ramsay AG, 2006, MICROBIOL-SGM, V152, P3281, DOI 10.1099/mic.0.29233-0; Reilly K, 1998, APPL ENVIRON MICROB, V64, P907; Russell JB, 1998, J ANIM SCI, V76, P1955; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SEWELL GW, 1988, APPL ENVIRON MICROB, V54, P1085, DOI 10.1128/AEM.54.5.1085-1090.1988; Shimoyama T, 2009, SCIENCE, V323, P1574, DOI 10.1126/science.1170086; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; STACK RJ, 1988, APPL ENVIRON MICROB, V54, P878, DOI 10.1128/AEM.54.4.878-883.1988; Staden R, 2000, Methods Mol Biol, V132, P115; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; Villas-Boas SG, 2006, ANAL BIOCHEM, V349, P297, DOI 10.1016/j.ab.2005.11.019; Wallace RJ, 2006, FEMS MICROBIOL LETT, V265, P195, DOI 10.1111/j.1574-6968.2006.00487.x	54	60	62	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11942	10.1371/journal.pone.0011942	http://dx.doi.org/10.1371/journal.pone.0011942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689770	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520500007
J	Dehmer, M; Mueller, LAJ; Graber, A				Dehmer, Matthias; Mueller, Laurin A. J.; Graber, Armin			New Polynomial-Based Molecular Descriptors with Low Degeneracy	PLOS ONE			English	Article							DISTANCE; NETWORKS; INDEXES; ENTROPY; GRAPHS	In this paper, we introduce a novel graph polynomial called the 'information polynomial' of a graph. This graph polynomial can be derived by using a probability distribution of the vertex set. By using the zeros of the obtained polynomial, we additionally define some novel spectral descriptors. Compared with those based on computing the ordinary characteristic polynomial of a graph, we perform a numerical study using real chemical databases. We obtain that the novel descriptors do have a high discrimination power.	[Dehmer, Matthias; Mueller, Laurin A. J.; Graber, Armin] Private Univ Med Informat & Tech UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria		Dehmer, M (corresponding author), Private Univ Med Informat & Tech UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at			COMET Center ONCOTYROL; Federal Ministry for Transport Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Tiroler Zukunftsstiftung (TZS); State of Styria represented by the Styrian Business Promotion Agency (SFG); University for Health Sciences, Medical Informatics and Technology; BIOCRATES Life Sciences AG	COMET Center ONCOTYROL; Federal Ministry for Transport Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Tiroler Zukunftsstiftung (TZS); State of Styria represented by the Styrian Business Promotion Agency (SFG); University for Health Sciences, Medical Informatics and Technology; BIOCRATES Life Sciences AG	This work was supported by the COMET Center ONCOTYROL and funded by the Federal Ministry for Transport Innovation and Technology (BMVIT) and the Federal Ministry of Economics and Labour/Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ), the Tiroler Zukunftsstiftung (TZS), and the State of Styria represented by the Styrian Business Promotion Agency (SFG) (and supported by the University for Health Sciences, Medical Informatics and Technology and BIOCRATES Life Sciences AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajorath J., 2004, CHEMOINFORMATICS CON; Balaban A.T, 1999, TOPOLOGICAL INDICES, P59; BangJensen Jorgen, 2002, DIGRAPHS THEORY ALGO; Basak SC, 2000, J CHEM INF COMP SCI, V40, P927, DOI 10.1021/ci990119v; Basak SC, 1999, TOPOLOGICAL INDICES, P563; BONCHEV D, 1995, THEOCHEM-J MOL STRUC, V336, P137, DOI 10.1016/0166-1280(94)04081-3; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D., 1991, CHEM GRAPH THEORY IN, DOI [10.1201/9781315139104, DOI 10.1201/9781315139104]; Bonchev D, 1983, INFORM THEORETIC IND; Bretscher O., 2004, LINEAR ALGEBRA APPL; Chen SJ, 1996, J CHEM PHYS, V104, P5964, DOI 10.1063/1.471328; Cover T.M, 2006, WILEY SERIES TELECOM; CVETKOVIC DM, 1997, SPECTRA GRAPHS; Dehmer M, 2008, COMPUT BIOL CHEM, V32, P131, DOI 10.1016/j.compbiolchem.2007.09.007; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Devillers J, 1999, TOPOLOGICAL INDICES; Diudea M, 2001, MOL TOPOLOGY; Dong F. M., 2005, CHROMATIC POLYNOMIAL; ELLISMONAGHAN JA, 2010, STRUCTURAL IN PRESS; Emmert-Streib F, 2006, J COMPUT BIOL, V13, P1503, DOI 10.1089/cmb.2006.13.1503; Estrada E, 2002, BIOINFORMATICS, V18, P697, DOI 10.1093/bioinformatics/18.5.697; FUKUI M, 1984, NUMBER THEORY COMBIN, P97; Gasteiger J., 2003, CHEMOINFORMATICS TXB; Gutman I, 1991, CHEM GRAPH THEORY IN, P133; HANSEN K, 2009, J CHEM INF MODEL; HOSOYA H, 1988, DISCRETE APPL MATH, V19, P239, DOI 10.1016/0166-218X(88)90017-0; Ivanciuc O., 1999, ROUM CHEM Q REV, V7, P41; Jackson B., 2003, J GEOMETRY, V76, P95; KAMAE T, 1983, J MATH ANAL APPL, V97, P355, DOI 10.1016/0022-247X(83)90202-0; Konstantinova EV, 2006, LECT NOTES COMPUT SC, V4123, P831; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; Kovse M., 2009, ANAL COMPLEX NETWORK, P323; Lovasz L, 1973, PERIOD MATH HUNG, V3, P175, DOI 10.1007/bf02018473; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Mignotte M., 1999, POLYNOMIALS ALGORITH; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Pachter L., 2005, ALGEBRAIC STAT COMPU; *R DEV COR TEAM FD, 2008, R SOFTW LANG ENV STA; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; Randic M., 2001, QSPR QSAR STUDIES MO QSPR QSAR STUDIES MO, P93; Robles-Kelly A, 2005, IEEE T PATTERN ANAL, V27, P365, DOI 10.1109/TPAMI.2005.56; Schwaighofer A, 2008, J CHEM INF MODEL, V48, P785, DOI 10.1021/ci700142c; SCSIBRANY H, 2004, SOFTWARE SUBMAT; Shannon CE, 1997, MATH THEORY COMMUNIC; STEIN SE, 1998, NIST MASS SPECTRAL D; Todeschini R, 1999, CHEMOMETR INTELL LAB, V46, P13, DOI 10.1016/S0169-7439(98)00124-5; TODESCHINI R, 1992, CHEMOMETR INTELL LAB, V15, P51, DOI 10.1016/0169-7439(92)80026-Z; Todeschini R., 2002, HDB MOL DESCRIPTORS; Trinajstic N., 2018, CHEM GRAPH THEORY; Wasserman S., 1994, SOCIAL NETWORK ANAL; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; WOODALL DR, 1992, DISCRETE MATH, V101, P333, DOI 10.1016/0012-365X(92)90614-L	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11393	10.1371/journal.pone.0011393	http://dx.doi.org/10.1371/journal.pone.0011393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689599	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520300002
J	Schlesinger, A; Kramarsky-Winter, E; Rosenfeld, H; Armoza-Zvoloni, R; Loya, Y				Schlesinger, Ami; Kramarsky-Winter, Esti; Rosenfeld, Hanna; Armoza-Zvoloni, Rachel; Loya, Yossi			Sexual Plasticity and Self-Fertilization in the Sea Anemone Aiptasia diaphana	PLOS ONE			English	Article							CORAL STYLOPHORA-PISTILLATA; TROPICAL REEF CORALS; RED-SEA; HALIPLANELLA-LUCIAE; PEDAL LACERATION; REPRODUCTION; EVOLUTION; CNIDARIA; TEMPERATURE; VARIABILITY	Traits that influence reproductive success and contribute to reproductive isolation in animal and plant populations are a central focus of evolutionary biology. In the present study we used an experimental approach to demonstrate the occurrence of environmental effects on sexual and asexual reproduction, and provide evidence for sexual plasticity and inter-clonal fertilization in laboratory-cultured lines of the sea anemone Aiptasia diaphana. We showed that in A. diaphana, both asexual reproduction by pedal laceration, and sexual reproduction have seasonal components. The rate of pedal laceration was ten-fold higher under summer photoperiod and water temperature conditions than under winter conditions. The onset of gametogenesis coincided with the rising water temperatures occurring in spring, and spawning occurred under parameters that emulated summer photoperiod and temperature conditions. In addition, we showed that under laboratory conditions, asexually produced clones derived from a single founder individual exhibit sexual plasticity, resulting in the development of both male and female individuals. Moreover, a single female founder produced not only males and females but also hermaphrodite individuals. We further demonstrated that A. diaphana can fertilize within and between clone lines, producing swimming planula larvae. These diverse reproductive strategies may explain the species success as invader of artificial marine substrates. We suggest that these diverse reproductive strategies, together with their unique evolutionary position, make Aiptasia diaphana an excellent model for studying the evolution of sex.	[Schlesinger, Ami; Kramarsky-Winter, Esti; Armoza-Zvoloni, Rachel; Loya, Yossi] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Rosenfeld, Hanna; Armoza-Zvoloni, Rachel] Natl Ctr Mariculture, Elat, Israel	Tel Aviv University	Schlesinger, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel.	wintere@post.tau.ac.il	Loya, Yossi/J-3039-2012; Kramarsky-Winter, Esti/H-2205-2012; Loya, Joseph/AAJ-9014-2020	Loya, Yossi/0000-0001-6870-9444; 	RAMOT (Horowitz Foundation) Tel Aviv University	RAMOT (Horowitz Foundation) Tel Aviv University	This work was funded by RAMOT (Horowitz Foundation) Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassim KM, 2002, MAR BIOL, V140, P479, DOI 10.1007/s00227-001-0722-4; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Brazeau DA, 1998, J EXP MAR BIOL ECOL, V231, P225, DOI 10.1016/S0022-0981(98)00097-5; Burt A, 2000, EVOLUTION, V54, P337; BUSS LW, 1983, P NATL ACAD SCI-BIOL, V80, P1387, DOI 10.1073/pnas.80.5.1387; Carlon DB, 1999, TRENDS ECOL EVOL, V14, P491, DOI 10.1016/S0169-5347(99)01709-7; Carre D, 2000, J EXP ZOOL, V287, P233, DOI 10.1002/1097-010X(20000801)287:3<233::AID-JEZ5>3.3.CO;2-6; Chadwick-Furman NE, 2000, INVERTEBR BIOL, V119, P361; Chen C, 2008, ZOOL STUD, V47, P37; CHEN CLA, 1995, ZOOL STUD, V34, P82; CLAYTON WS, 1985, MAR ECOL PROG SER, V21, P75, DOI 10.3354/meps021075; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Darwin C., 1877, DIFFERENT FORMS FLOW; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; FAUTIN DG, 1997, 6 INT C COEL BIOL LE; FAUTIN DG, 1990, CNIDARIA REPROD BIOL, P31; Frank U, 2002, CAN J ZOOL, V80, P1723, DOI 10.1139/Z02-131; FUKUI Y, 1993, J MAR BIOL ASSOC UK, V73, P971, DOI 10.1017/S0025315400034858; GHISELIN MT, 1969, Q REV BIOL, V44, P189, DOI 10.1086/406066; GROSBERG RK, 1987, EVOLUTION, V41, P372, DOI 10.1111/j.1558-5646.1987.tb05804.x; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; HUNTER T, 1984, J EXP MAR BIOL ECOL, V83, P127, DOI 10.1016/0022-0981(84)90041-8; Hyman LH., 1940, INVERTEBRATES; Kalisz S, 2004, NATURE, V430, P884, DOI 10.1038/nature02776; KramarskyWinter E, 1997, NATURE, V387, P137, DOI 10.1038/387137a0; Littlefield C. Lynne, 1994, Seminars in Developmental Biology, V5, P13, DOI 10.1006/sedb.1994.1003; Loya Y, 2004, MAR POLLUT BULL, V49, P344, DOI 10.1016/j.marpolbul.2004.06.011; Loya Y, 2008, P ROY SOC B-BIOL SCI, V275, P2335, DOI 10.1098/rspb.2008.0675; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; RINKEVICH B, 1987, BIOL BULL, V173, P335, DOI 10.2307/1541546; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P133, DOI 10.3354/meps001133; SCHLESINGER A, 2008, METHOD APPARATUS PRO; Schlesinger A, 2009, MAR BIOL, V156, P753, DOI 10.1007/s00227-009-1126-0; SHICK J. M., 1991, FUNCTIONAL BIOL SEA; SHICK JM, 1977, BIOL BULL-US, V153, P604, DOI 10.2307/1540609; SOONG KY, 1992, BIOL BULL, V183, P418, DOI 10.2307/1542018; Stephenson T.A., 1928, BRIT SEA ANEMONES, VI; Tang CL, 2007, SCIENCE, V317, P1070, DOI 10.1126/science.1143153; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Weismann A., 1889, ESSAYS HEREDITY KIND; [No title captured]	44	29	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11874	10.1371/journal.pone.0011874	http://dx.doi.org/10.1371/journal.pone.0011874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686700	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520200036
J	Aubert, D; MacDonald, DK; Valvano, MA				Aubert, Daniel; MacDonald, Douglas K.; Valvano, Miguel A.			BcsK(C) Is an Essential Protein for the Type VI Secretion System Activity in Burkholderia cenocepacia That Forms an Outer Membrane Complex with BcsL(B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEPACIA COMPLEX; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; PATHOGENICITY ISLAND; BIOFILM FORMATION; CLINICAL ISOLATE; SIGNAL PEPTIDES; FAMILY PROTEIN	The type VI secretion system (T6SS) contributes to the virulence of Burkholderia cenocepacia, an opportunistic pathogen causing serious chronic infections in patients with cystic fibrosis. BcsK(C) is a highly conserved protein among the T6SSs in Gram-negative bacteria. Here, we show that BcsK(C) is required for Hcp secretion and cytoskeletal redistribution in macrophages upon bacterial infection. These two phenotypes are associated with a functional T6SS in B. cenocepacia. Experiments employing a bacterial two-hybrid system and pulldown assays demonstrated that BcsK(C) interacts with BcsL(B), another conserved T6SS component. Internal deletions within BcsK(C) revealed that its N-terminal domain is necessary and sufficient for interaction with BcsL(B). Fractionation experiments showed that BcsK(C) can be in the cytosol or tightly associated with the outer membrane and that BcsK(C) and BcsL(B) form a high molecular weight complex anchored to the outer membrane that requires BcsF(H) (a ClpV homolog) to be assembled. Together, our data show that BcsK(C)/BcsL(B) interaction is essential for the T6SS activity in B. cenocepacia.	[Aubert, Daniel; MacDonald, Douglas K.; Valvano, Miguel A.] Univ Western Ontario, Siebens Drake Med Res Inst, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Valvano, Miguel A.] Univ Western Ontario, Siebens Drake Med Res Inst, Dept Med, Infect Dis Res Grp, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Valvano, MA (corresponding author), Univ Western Ontario, Siebens Drake Med Res Inst, Dept Microbiol & Immunol, Dent Sci Bldg 3014, London, ON N6A 5C1, Canada.	mvalvano@uwo.ca	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641	Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research in partnership with the Association of Medical Microbiology and Infectious Disease Canada	Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research in partnership with the Association of Medical Microbiology and Infectious Disease Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Cystic Fibrosis Foundation (to M. A. V.).; Supported by a postdoctoral fellowship from the Canadian Institutes of Health Research in partnership with the Association of Medical Microbiology and Infectious Disease Canada.; Canada Research Chair in Infectious Diseases and Microbial Pathogenesis. Recipient of a Senior Researcher Training Award from the Canadian Cystic Fibrosis Foundation. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, Dental Sciences Bldg. 3014, University of Western Ontario, London, Ontario N6A 5C1, Canada. Tel.: 519-661-3427; Fax: 519-661-3499; E-mail: mvalvano@uwo.ca.	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; Das Soumita, 2003, In Silico Biology, V3, P287; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Khajanchi BK, 2009, MICROBIOL-SGM, V155, P3518, DOI 10.1099/mic.0.031575-0; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Mahenthiralingam E, 2001, CLIN INFECT DIS, V33, P1469, DOI 10.1086/322684; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; MOODY MF, 1967, J MOL BIOL, V25, P167, DOI 10.1016/0022-2836(67)90136-2; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; PUTNAM SL, 1975, ANAL BIOCHEM, V63, P350, DOI 10.1016/0003-2697(75)90357-7; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Reik R, 2005, J CLIN MICROBIOL, V43, P2926, DOI 10.1128/JCM.43.6.2926-2928.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Speert DP, 2002, EMERG INFECT DIS, V8, P181; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	55	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35988	35998		10.1074/jbc.M110.120402	http://dx.doi.org/10.1074/jbc.M110.120402			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20729192	Green Published, hybrid			2022-12-25	WOS:000283845300075
J	Aoki, S; Thomas, A; Decaffmeyer, M; Brasseur, R; Epand, RM				Aoki, Satoko; Thomas, Annick; Decaffmeyer, Marc; Brasseur, Robert; Epand, Richard M.			The Role of Proline in the Membrane Re-entrant Helix of Caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; LIPID DROPLETS; MEDIATED ENDOCYTOSIS; CHOLESTEROL-BINDING; PROTEOMIC ANALYSIS; VESICLE FORMATION; TRANSPORT; INTERNALIZATION; EXPRESSION	Caveolin-1 has a segment of hydrophobic amino acids comprising approximately residues 103-122. We have performed an in silico analysis of the conformational preference of this segment of caveolin-1 using PepLook. We find that there is one main group of stable conformations corresponding to a hydrophobic U bent model that would not traverse the membrane. Furthermore, the calculations predict that substituting the Pro(110) residue with an Ala will change the conformation to a straight hydrophobic helix that would traverse the membrane. We have expressed the P110A mutant of caveolin-1, with a FLAG tag at the N terminus, in HEK 293 cells. We evaluate the topology of the proteins with confocal immunofluorescence microscopy in these cells. We find that FLAG tag at the N terminus of the wild type caveolin-1 is not reactive with antibodies unless the cell membrane is permeabilized with detergent. This indicates that in these cells, the hydrophobic segment of this protein is not transmembrane but takes up a bent conformation, making the protein monotopic. In contrast, the FLAG tag at the N terminus of the P110A mutant is equally exposed to antibodies, before and after membrane permeabilization. We also find that the P110A mutation causes a large reduction of endocytosis of caveolae, cellular lipid accumulation, and lipid droplet formulation. In addition, we find that this mutation markedly reduces the ability of caveolin-1 to form structures with the characteristic morphology of caveolae or to partition into the detergent-resistant membranes of these cells. Thus, the single Pro residue in the membrane-inserting segment of caveolin-1 plays an important role in both the membrane topology and localization of the protein as well as its functions.	[Thomas, Annick; Decaffmeyer, Marc; Brasseur, Robert] ULg Gembloux AgrobioTech, Ctr Biophys Mol Numer, B-5030 Gembloux, Belgium; McMaster Univ, Hlth Sci Ctr, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	University of Liege; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba		epand@mcmaster.ca	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	Government of Canada; Natural Sciences and Engineering Research Council of Canada [9848]; Canadian Post-Doctoral Research Fellowships	Government of Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Post-Doctoral Research Fellowships	This work was supported by the Government of Canada, by Canadian Post-Doctoral Research Fellowships 2008-09 and by Natural Sciences and Engineering Research Council of Canada Grant 9848.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BRASAEMLE DL, 2006, CURR PROTOC CELL BIO, V3; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Decaffmeyer M, 2008, J MOL BIOL, V383, P797, DOI 10.1016/j.jmb.2008.08.076; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Ducarme P, 1998, PROTEINS, V30, P357, DOI 10.1002/(SICI)1097-0134(19980301)30:4<357::AID-PROT3>3.0.CO;2-G; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Fielding CJ, 2003, BBA-BIOMEMBRANES, V1610, P219, DOI 10.1016/S0005-2736(03)00020-8; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; GHITESCU L, 1992, J CELL BIOL, V117, P745, DOI 10.1083/jcb.117.4.745; Gleizes PE, 1996, EUR J CELL BIOL, V71, P144; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Karsan A, 2005, J PROTEOME RES, V4, P349, DOI 10.1021/pr049824w; Lahtinen U, 2003, FEBS LETT, V538, P85, DOI 10.1016/S0014-5793(03)00135-2; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Listenberger L. L., 2007, CURR PROTOC CELL BIO, V24.2; Listenberger LL, 2008, CURR BIOL, V18, pR237, DOI 10.1016/j.cub.2008.01.010; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lobie PE, 1999, EXP CELL RES, V246, P47, DOI 10.1006/excr.1998.4288; MacLellan DL, 2005, PROTEOMICS, V5, P4733, DOI 10.1002/pmic.200500044; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Marks DL, 2008, HISTOCHEM CELL BIOL, V130, P819, DOI 10.1007/s00418-008-0509-5; Marks DL, 2005, METHODS, V36, P186, DOI 10.1016/j.ymeth.2004.12.001; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Okamoto Y, 2000, J BIOL CHEM, V275, P6439, DOI 10.1074/jbc.275.9.6439; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pohl J, 2002, J LIPID RES, V43, P1390, DOI 10.1194/jlr.M100404-JLR200; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Robenek MJ, 2004, FASEB J, V18, P866, DOI 10.1096/fj.03-0782fje; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simard JR, 2010, J LIPID RES, V51, P914, DOI 10.1194/jlr.M900251; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; SINGH RD, 2007, CURR PROTOC CELL BIO, V24; Skretting G, 1999, J CELL SCI, V112, P3899; Solomon KR, 1998, BIOCHEM J, V334, P325, DOI 10.1042/bj3340325; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Stan RV, 2002, MICROSC RES TECHNIQ, V57, P350, DOI 10.1002/jemt.10089; Thomas A, 2006, PROTEINS, V65, P889, DOI 10.1002/prot.21151; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123; Uawithya P, 1998, BIOCHEM MOL BIOL INT, V44, P825; Uittenbogaard A, 2000, J BIOL CHEM, V275, P25595, DOI 10.1074/jbc.M003401200; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Wharton J, 2005, J BIOL CHEM, V280, P13483, DOI 10.1074/jbc.M413891200; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Zhuang LY, 2002, CANCER RES, V62, P2227	75	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33371	33380		10.1074/jbc.M110.153569	http://dx.doi.org/10.1074/jbc.M110.153569			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729193	hybrid, Green Published			2022-12-25	WOS:000283048200072
J	Iwai, A; Shiozaki, T; Kawai, T; Akira, S; Kawaoka, Y; Takada, A; Kida, H; Miyazaki, T				Iwai, Atsushi; Shiozaki, Takuya; Kawai, Taro; Akira, Shizuo; Kawaoka, Yoshihiro; Takada, Ayato; Kida, Hiroshi; Miyazaki, Tadaaki			Influenza A Virus Polymerase Inhibits Type I Interferon Induction by Binding to Interferon beta Promoter Stimulator 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; RIG-I; NS1 PROTEIN; IFN-BETA; ENDONUCLEASE ACTIVITY; ADAPTER PROTEIN; MONOCLONAL-ANTIBODIES; ANTIVIRAL RESPONSES; TRANSGENIC MICE	Type I interferons (IFNs) are known to be critical factors in the activation of host antiviral responses and are also important in protection from influenza A virus infection. Especially, the RIG-I- and IPS-1-mediated intracellular type I IFN-inducing pathway is essential in the activation of antiviral responses in cells infected by influenza A virus. Previously, it has been reported that influenza A virus NS1 is involved in the inhibition of this pathway. We show in this report that the influenza A virus utilizes another critical inhibitory mechanism in this pathway. In fact, the viral polymerase complex exhibited an inhibitory activity on IFN beta promoter activation mediated by RIG-I and IPS-1, and this activity was not competitive with the function of NS1. Co-immunoprecipitation analysis revealed that each polymerase subunit bound to IPS-1 in mammalian cells, and each subunit inhibited the activation of IFN beta promoter by IPS-1 independently. In addition, by a combinational expression of each polymerase subunit, IPS-1-induced activation of IFN beta promoter was more efficiently inhibited by the expression of PB2 or PB2-containing complex. Moreover, the expression of PB2 inhibited the transcription of the endogenous IFN beta gene induced after influenza A virus infection. These findings demonstrate that the viral polymerase plays an important role for regulating host anti-viral response through the binding to IPS-1 and inhibition of IFN beta production.	[Iwai, Atsushi; Shiozaki, Takuya; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Global Epidemiol, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Kida, Hiroshi] Hokkaido Univ, Microbiol Lab, Dept Dis Control, Grad Sch Vet Med,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Miyazaki, Tadaaki] OIE, Reference Lab Highly Pathogen Avian Influenza, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Osaka University; Osaka University; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; University of Tokyo; Hokkaido University	Miyazaki, T (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Kita Ku, North 20,West 10, Sapporo, Hokkaido 0010020, Japan.	miyazaki@czc.hokudai.ac.jp	Miyazaki, Tadaaki/D-9368-2012; Kida, Hiroshi/F-7244-2012; Takada, Ayato/A-6679-2012; Iwai, Atsushi/I-6469-2019; Akira, Shizuo/C-3134-2009	Iwai, Atsushi/0000-0002-1491-4693; Kawai, Taro/0000-0001-7510-4662	Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Science and Technology Agency	Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and by a grant from the Japan Science and Technology Agency.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Diamond MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000452; DJEU JY, 1982, J EXP MED, V156, P1222, DOI 10.1084/jem.156.4.1222; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; GARBER EA, 1991, VIROLOGY, V180, P754, DOI 10.1016/0042-6822(91)90088-S; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; HAGEN M, 1994, J VIROL, V68, P1509, DOI 10.1128/JVI.68.3.1509-1515.1994; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hatta M, 2000, ARCH VIROL, V145, P1947, DOI 10.1007/s007050070068; Hatta M, 2000, ARCH VIROL, V145, P895, DOI 10.1007/s007050050682; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Honda A, 2001, J BIOL CHEM, V276, P31179, DOI 10.1074/jbc.M102856200; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Hwang JS, 2000, J VIROL, V74, P4074, DOI 10.1128/JVI.74.9.4074-4084.2000; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kirk P, 2005, IMMUNITY, V23, P347, DOI 10.1016/j.immuni.2005.09.008; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; KOLB E, 1992, J VIROL, V66, P1709, DOI 10.1128/JVI.66.3.1709-1716.1992; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; LAZAROWITZ SG, 1971, VIROLOGY, V46, P830, DOI 10.1016/0042-6822(71)90084-5; Leahy MB, 2001, J VIROL, V75, P134, DOI 10.1128/JVI.75.1.134-142.2001; Leahy MB, 2001, J VIROL, V75, P7042, DOI 10.1128/JVI.75.15.7042-7049.2001; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Li HM, 2009, CELL DEATH DIFFER, V16, P1615, DOI 10.1038/cdd.2009.97; Li ML, 1998, EMBO J, V17, P5844, DOI 10.1093/emboj/17.19.5844; Marcus PI, 2005, J VIROL, V79, P2880, DOI 10.1128/JVI.79.5.2880-2890.2005; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MEIEREWERT H, 1974, J VIROL, V14, P1083, DOI 10.1128/JVI.14.5.1083-1091.1974; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Papon L, 2009, VIROLOGY, V393, P311, DOI 10.1016/j.virol.2009.08.009; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	64	98	102	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32064	32074		10.1074/jbc.M110.112458	http://dx.doi.org/10.1074/jbc.M110.112458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699220	hybrid, Green Published			2022-12-25	WOS:000282683000020
J	Wilkinson, BM; Brownsword, JK; Mousley, CJ; Stirling, CJ				Wilkinson, Barrie M.; Brownsword, Judith K.; Mousley, Carl J.; Stirling, Colin J.			Sss1p Is Required to Complete Protein Translocon Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SEC61P; TRANSPORT; COMPONENT; ENCODES; GENE	Protein translocation across the endoplasmic reticulum membrane occurs at the Sec61 translocon. This has two essential subunits, the channel-forming multispanning membrane protein Sec61p/Sec61 alpha and the tail-anchored Sss1p/Sec61 gamma, which has been proposed to "clamp" the channel. We have analyzed the function of Sss1p using a series of domain mutants and found that both the cytosolic and transmembrane clamp domains of Sss1p are essential for protein translocation. Our data reveal that the cytosolic domain is required for Sec61p interaction but that the transmembrane clamp domain is required to complete activation of the translocon after precursor targeting to Sec61p.	[Wilkinson, Barrie M.; Brownsword, Judith K.; Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Mousley, Carl J.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Manchester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk		Mousley, Carl/0000-0002-0192-7030	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; ESNAULT Y, 1993, EMBO J, V12, P4083, DOI 10.1002/j.1460-2075.1993.tb06092.x; ESNAULT Y, 1994, J BIOL CHEM, V269, P27478; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; SIKORSKI RS, 1989, GENETICS, V122, P19; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wilkinson BM, 1997, EMBO J, V16, P4549, DOI 10.1093/emboj/16.15.4549; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	25	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32671	32677		10.1074/jbc.M110.128256	http://dx.doi.org/10.1074/jbc.M110.128256			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20709746	hybrid, Green Published			2022-12-25	WOS:000282683000081
J	Fieberg, JR; Shertzer, KW; Conn, PB; Noyce, KV; Garshelis, DL				Fieberg, John R.; Shertzer, Kyle W.; Conn, Paul B.; Noyce, Karen V.; Garshelis, David L.			Integrated Population Modeling of Black Bears in Minnesota: Implications for Monitoring and Management	PLOS ONE			English	Article							RECONSTRUCTION; ABUNDANCE; ACCURACY	Background: Wildlife populations are difficult to monitor directly because of costs and logistical challenges associated with collecting informative abundance data from live animals. By contrast, data on harvested individuals (e. g., age and sex) are often readily available. Increasingly, integrated population models are used for natural resource management because they synthesize various relevant data into a single analysis. Methodology/Principal Findings: We investigated the performance of integrated population models applied to black bears (Ursus americanus) in Minnesota, USA. Models were constructed using sex-specific age-at-harvest matrices (1980-2008), data on hunting effort and natural food supplies (which affects hunting success), and statewide mark-recapture estimates of abundance (1991, 1997, 2002). We compared this approach to Downing reconstruction, a commonly used population monitoring method that utilizes only age-at-harvest data. We first conducted a large-scale simulation study, in which our integrated models provided more accurate estimates of population trends than did Downing reconstruction. Estimates of trends were robust to various forms of model misspecification, including incorrectly specified cub and yearling survival parameters, age-related reporting biases in harvest data, and unmodeled temporal variability in survival and harvest rates. When applied to actual data on Minnesota black bears, the model predicted that harvest rates were negatively correlated with food availability and positively correlated with hunting effort, consistent with independent telemetry data. With no direct data on fertility, the model also correctly predicted 2-point cycles in cub production. Model-derived estimates of abundance for the most recent years provided a reasonable match to an empirical population estimate obtained after modeling efforts were completed. Conclusions/Significance: Integrated population modeling provided a reasonable framework for synthesizing age-at-harvest data, periodic large-scale abundance estimates, and measured covariates thought to affect harvest rates of black bears in Minnesota. Collection and analysis of these data appear to form the basis of a robust and viable population monitoring program.	[Fieberg, John R.; Garshelis, David L.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Fieberg, John R.] Minnesota Dept Nat Resources, Biometr Unit, Forest Lake, MN USA; [Shertzer, Kyle W.; Conn, Paul B.] Natl Marine Fisheries Serv, SE Fisheries Sci Ctr, Beaufort, NC USA; [Noyce, Karen V.; Garshelis, David L.] Minnesota Dept Nat Resources, Forest Wildlife Populat & Res Grp, Grand Rapids, MI USA	University of Minnesota System; University of Minnesota Twin Cities; National Oceanic Atmospheric Admin (NOAA) - USA	Fieberg, JR (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	john.fieberg@state.mn.us	Fieberg, John/Y-3988-2019	Fieberg, John/0000-0002-3180-7021; Shertzer, Kyle/0000-0001-7196-5959				Abadi F, 2010, ECOLOGY, V91, P7, DOI 10.1890/08-2235.1; BATES DM, 2004, SPLINES VERSION 1 9; BERKSON J, 1980, ANN STAT, V8, P457, DOI 10.1214/aos/1176345003; Besbeas P, 2002, BIOMETRICS, V58, P540, DOI 10.1111/j.0006-341X.2002.00540.x; Broms K, 2010, J WILDLIFE MANAGE, V74, P310, DOI 10.2193/2008-469; Conn PB, 2009, ENVIRON ECOL STAT SE, V3, P965, DOI 10.1007/978-0-387-78151-8_44; Conn PB, 2008, BIOMETRICS, V64, P1170, DOI 10.1111/j.1541-0420.2008.00987.x; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Davis ML, 2007, J WILDLIFE MANAGE, V71, P2297, DOI 10.2193/2006-427; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Diefenbach DR, 1998, J WILDLIFE MANAGE, V62, P1292, DOI 10.2307/3801993; Downing R., 1980, WILDLIFE MANAGEMENT, P247; Fournier David, 2009, AD MOD BUILD AUT DIF; GARSHELIS D.L, 1991, E WORKSH BLACK BEAR, V10, P120; Garshelis DL, 2006, J WILDLIFE MANAGE, V70, P1634, DOI 10.2193/0022-541X(2006)70[1634:DBIALS]2.0.CO;2; Garshelis DL, 2006, URSUS, V17, P1, DOI 10.2192/1537-6176(2006)17[1:SAPEOA]2.0.CO;2; Garshelis DL, 1997, J WILDLIFE MANAGE, V61, P466, DOI 10.2307/3802605; Garshelis DL, 2008, FRONTIERS WILDLIFE S, P139; Gilbert BA, 2007, J WILDLIFE MANAGE, V71, P144, DOI 10.2193/2005-567; Gove NE, 2002, J WILDLIFE MANAGE, V66, P310, DOI 10.2307/3803163; Harshyne WA, 1998, J WILDLIFE MANAGE, V62, P1281, DOI 10.2307/3801992; Methot R.D., 1990, INPFC B, V50, P259; METHOT RD, 1989, AM FISH SOC S, V6, P66; MILLER SD, 1990, INT C BEAR, V8, P357; Newman KB, 2006, ECOL APPL, V16, P74, DOI 10.1890/04-0592; Noyce KV, 1997, J WILDLIFE MANAGE, V61, P1067, DOI 10.2307/3802103; R Development Core Team, 2009, R FDN STAT COMP; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Skalski JR, 2007, J WILDLIFE MANAGE, V71, P1309, DOI 10.2193/2005-707; Trenkel VM, 2000, J AM STAT ASSOC, V95, P363, DOI 10.2307/2669373; White GC, 2002, J WILDLIFE MANAGE, V66, P300, DOI 10.2307/3803162; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	36	39	39	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12114	10.1371/journal.pone.0012114	http://dx.doi.org/10.1371/journal.pone.0012114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711344	Green Submitted, Green Published, gold			2022-12-25	WOS:000280859700009
J	Drager, LF; Lopes, HF; Maki-Nunes, C; Trombetta, IC; Toschi-Dias, E; Alves, MJNN; Fraga, RF; Jun, JC; Negrao, CE; Krieger, EM; Polotsky, VY; Lorenzi, G				Drager, Luciano F.; Lopes, Heno F.; Maki-Nunes, Cristiane; Trombetta, Ivani C.; Toschi-Dias, Edgar; Alves, Maria Janieire N. N.; Fraga, Raffael F.; Jun, Jonathan C.; Negrao, Carlos E.; Krieger, Eduardo M.; Polotsky, Vsevolod Y.; Lorenzi-Filho, Geraldo			The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic Syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; URIC-ACID LEVELS; INTERMITTENT HYPOXIA; INSULIN-RESISTANCE; DAYTIME SLEEPINESS; RISK; POPULATION; MORTALITY; OBESITY; ATHEROSCLEROSIS	Background: Obstructive Sleep Apnea (OSA) is tightly linked to some components of Metabolic Syndrome (MetS). However, most of the evidence evaluated individual components of the MetS or patients with a diagnosis of OSA that were referred for sleep studies due to sleep complaints. Therefore, it is not clear whether OSA exacerbates the metabolic abnormalities in a representative sample of patients with MetS. Methodology/Principal Findings: We studied 152 consecutive patients (age 48 +/- 9 years, body mass index 32.3 +/- 3.4 Kg/m(2)) newly diagnosed with MetS (Adult Treatment Panel III). All participants underwent standard polysomnography irrespective of sleep complaints, and laboratory measurements (glucose, lipid profile, uric acid and C-reactive protein). The prevalence of OSA (apnea-hypopnea index >= 15 events per hour of sleep) was 60.5%. Patients with OSA exhibited significantly higher levels of blood pressure, glucose, triglycerides, cholesterol, LDL, cholesterol/HDL ratio, triglycerides/HDL ratio, uric acid and C-reactive protein than patients without OSA. OSA was independently associated with 2 MetS criteria: triglycerides: OR: 3.26 (1.47-7.21) and glucose: OR: 2.31 (1.12-4.80). OSA was also independently associated with increased cholesterol/HDL ratio: OR: 2.38 (1.08-5.24), uric acid: OR: 4.19 (1.70-10.35) and C-reactive protein: OR: 6.10 (2.64-14.11). Indices of sleep apnea severity, apnea-hypopnea index and minimum oxygen saturation, were independently associated with increased levels of triglycerides, glucose as well as cholesterol/HDL ratio, uric acid and C-reactive protein. Excessive daytime sleepiness had no effect on the metabolic and inflammatory parameters. Conclusions/Significance: Unrecognized OSA is common in consecutive patients with MetS. OSA may contribute to metabolic dysregulation and systemic inflammation in patients with MetS, regardless of symptoms of daytime sleepiness.	[Drager, Luciano F.; Lopes, Heno F.; Maki-Nunes, Cristiane; Trombetta, Ivani C.; Toschi-Dias, Edgar; Alves, Maria Janieire N. N.; Fraga, Raffael F.; Negrao, Carlos E.; Krieger, Eduardo M.; Lorenzi-Filho, Geraldo] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Drager, Luciano F.; Jun, Jonathan C.; Polotsky, Vsevolod Y.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA	Universidade de Sao Paulo; Johns Hopkins University	Drager, LF (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil.	luciano.drager@incor.usp.br	Lopes, Heno/H-9825-2013; Lorenzi-Filho, Geraldo GLF/E-1062-2012; Toschi-Dias, Edgar/AAP-9528-2020; Toschi-Dias, Edgar/C-9685-2013; KRIEGER, EDUARDO M/E-5883-2012; Alves, Janieire/G-4548-2010; Drager, Luciano F/A-1535-2014; Negrao, Carlos E/C-4281-2012; Trombetta, Ivani C/G-5839-2012	Lopes, Heno/0000-0002-9591-3093; Lorenzi-Filho, Geraldo GLF/0000-0002-7011-7373; Toschi-Dias, Edgar/0000-0002-5226-2956; Toschi-Dias, Edgar/0000-0002-5226-2956; Alves, Janieire/0000-0003-3207-623X; Trombetta, Ivani C/0000-0002-0979-0091; Negrao, Carlos Eduardo/0000-0003-4652-1226	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [200032/2009-7]; Fundacao Zerbini, Brazil; National Sleep Foundation/American Lung Association Pickwick [SF-78568 N]; National Institutes of Health (NIH) [HL07534, R01 HL80105, 5P50HL084945]; American Heart Association [0765293U]; United States Israel Binational Science Foundation [2005265]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084945, R01HL080105, T32HL007534] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Zerbini, Brazil; National Sleep Foundation/American Lung Association Pickwick; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Zerbini, Brazil. Dr. Drager is supported by the CNPq (# 200032/2009-7) and Fundacao Zerbini, Brazil. Dr. Jun is supported by the National Sleep Foundation/American Lung Association Pickwick Grant (SF-78568 N) and National Institutes of Health (NIH) T32 training grant (HL07534). Dr. Polotsky is supported by NIH (R01 HL80105, 5P50HL084945), the American Heart Association (grant 0765293U) and United States Israel Binational Science Foundation (grant BSF No. 2005265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Chen HJ, 2006, STROKE, V37, P1060, DOI 10.1161/01.STR.0000206458.58142.f3; Chin K, 2010, SLEEP, V33, P89, DOI 10.1093/sleep/33.1.89; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; Drager LF, 2010, ATHEROSCLEROSIS, V208, P490, DOI 10.1016/j.atherosclerosis.2009.08.016; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gruber A, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-22; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kano M, 2007, CHEST, V131, P1387, DOI 10.1378/chest.06-1807; Lam JCM, 2006, RESP MED, V100, P980, DOI 10.1016/j.rmed.2005.10.003; Lee K, 2008, OBESITY, V16, P834, DOI 10.1038/oby.2007.109; Lewington S, 2008, LANCET, V372, P292; Li JG, 2005, CIRC RES, V97, P698, DOI 10.1161/01.RES.0000183879.60089.a9; LINN S, 1991, AM J PUBLIC HEALTH, V81, P1038, DOI 10.2105/AJPH.81.8.1038; Lorenzi-Filho G., 2009, J CARDIOMETAB SYNDR, V4, P89, DOI DOI 10.1111/J.1559-4572.2008.00046.X; Lui, 2009, CHEST, V135, P1406; Lui MMS, 2009, CHEST, V135, P950, DOI 10.1378/chest.08-1798; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Nock NL, 2009, SLEEP, V32, P615, DOI 10.1093/sleep/32.5.615; PARISH JM, 2007, J CLIN SLEEP MED, V13, P355; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ruggiero C, 2007, AM J CARDIOL, V100, P115, DOI 10.1016/j.amjcard.2007.02.065; Ryan CM, 2005, J APPL PHYSIOL, V99, P2440, DOI 10.1152/japplphysiol.00772.2005; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Santos RD, 2007, AM J CARDIOL, V99, P42, DOI 10.1016/j.amjcard.2006.07.057; Sasanabe R, 2006, HYPERTENS RES, V29, P315, DOI 10.1291/hypres.29.315; Savransky V, 2008, CIRC RES, V103, P1173, DOI 10.1161/CIRCRESAHA.108.178533; Steiropoulos P, 2009, SLEEP, V32, P537, DOI 10.1093/sleep/32.4.537; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Tsouli SG, 2006, METABOLISM, V55, P1293, DOI 10.1016/j.metabol.2006.05.013; Venkateswaran S, 2007, POSTGRAD MED J, V83, P329, DOI 10.1136/pgmj.2006.051805; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2008, SLEEP, V31, P1071	43	171	179	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12065	10.1371/journal.pone.0012065	http://dx.doi.org/10.1371/journal.pone.0012065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711453	gold, Green Submitted, Green Published			2022-12-25	WOS:000280849100013
J	Farenhorst, M; Knols, BGJ; Thomas, MB; Howard, AFV; Takken, W; Rowland, M; N'Guessan, R				Farenhorst, Marit; Knols, Bart G. J.; Thomas, Matthew B.; Howard, Annabel F. V.; Takken, Willem; Rowland, Mark; N'Guessan, Raphael			Synergy in Efficacy of Fungal Entomopathogens and Permethrin against West African Insecticide-Resistant Anopheles gambiae Mosquitoes	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; CULEX-QUINQUEFASCIATUS; PYRETHROID RESISTANCE; INFECTION; VECTORS; DEUTEROMYCOTINA; BIOPESTICIDES; COLEOPTERA; KNOCKDOWN; STRAIN	Background: Increasing incidences of insecticide resistance in malaria vectors are threatening the sustainable use of contemporary chemical vector control measures. Fungal entomopathogens provide a possible additional tool for the control of insecticide-resistant malaria mosquitoes. This study investigated the compatibility of the pyrethroid insecticide permethrin and two mosquito-pathogenic fungi, Beauveria bassiana and Metarhizium anisopliae, against a laboratory colony and field population of West African insecticide-resistant Anopheles gambiae s.s. mosquitoes. Methodology/Findings: A range of fungus-insecticide combinations was used to test effects of timing and sequence of exposure. Both the laboratory-reared and field-collected mosquitoes were highly resistant to permethrin but susceptible to B. bassiana and M. anisopliae infection, inducing 100% mortality within nine days. Combinations of insecticide and fungus showed synergistic effects on mosquito survival. Fungal infection increased permethrin-induced mortality rates in wild An. gambiae s.s. mosquitoes and reciprocally, exposure to permethrin increased subsequent fungal-induced mortality rates in both colonies. Simultaneous co-exposure induced the highest mortality; up to 70.3 +/- 2% for a combined Beauveria and permethrin exposure within a time range of one gonotrophic cycle (4 days). Conclusions/Significance: Combining fungi and permethrin induced a higher impact on mosquito survival than the use of these control agents alone. The observed synergism in efficacy shows the potential for integrated fungus-insecticide control measures to dramatically reduce malaria transmission and enable control at more moderate levels of coverage even in areas where insecticide resistance has rendered pyrethroids essentially ineffective.	[Farenhorst, Marit; Howard, Annabel F. V.; Takken, Willem] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Knols, Bart G. J.] Univ Amsterdam, Acad Med Ctr, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Thomas, Matthew B.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Rowland, Mark; N'Guessan, Raphael] London Sch Hyg & Trop Med, Malaria Ctr, London WC1, England; [N'Guessan, Raphael] Ctr Rech Entomol Cotonou, Lab Natl Minist Sante, Cotonou, Benin	Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of London; London School of Hygiene & Tropical Medicine; Entomological Research Center of Cotonou (CREC)	Farenhorst, M (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	marit.farenhorst@wur.nl	Knols, Bart/C-5765-2017		Adessium Foundation (Reeuwijk); Royal Dutch Academy of Arts and Sciences [AFD/SSA/125]	Adessium Foundation (Reeuwijk); Royal Dutch Academy of Arts and Sciences	This work has received financial support from the Adessium Foundation (Reeuwijk) and the Royal Dutch Academy of Arts and Sciences (KNAW-DJA travel grant AFD/SSA/125, awarded to Bart G. J. Knols). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahiense TC, 2006, VET PARASITOL, V141, P319, DOI 10.1016/j.vetpar.2006.05.011; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Blanford S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-72; BURT PE, 1974, PESTIC SCI, V5, P625, DOI 10.1002/ps.2780050514; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; COX DR, 1972, J R STAT SOC B, V187, P220; Darbro JM, 2009, AM J TROP MED HYG, V80, P992, DOI 10.4269/ajtmh.2009.80.992; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; FARENHORST M, 2010, MALAR J, V9; Farenhorst M, 2008, AM J TROP MED HYG, V78, P910, DOI 10.4269/ajtmh.2008.78.910; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Hancock PA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000525; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hiromori H, 2001, APPL ENTOMOL ZOOL, V36, P231, DOI 10.1303/aez.2001.231; Howard AFV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-168; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Jaramillo J, 2005, BIOL CONTROL, V34, P12, DOI 10.1016/j.biocontrol.2005.03.021; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Kikankie CK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-71; Knols BGJ, 2010, FUTURE MICROBIOL, V5, P339, DOI 10.2217/FMB.10.11; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; Koppenhofer AM, 1998, J ECON ENTOMOL, V91, P618, DOI 10.1093/jee/91.3.618; LACEY CM, 1988, J INVERTEBR PATHOL, V52, P108, DOI 10.1016/0022-2011(88)90109-7; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mnyone LL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-309; Mnyone LL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-59; Morales-Rodriguez A, 2009, BIOL CONTROL, V51, P169, DOI 10.1016/j.biocontrol.2009.06.008; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; Neves Pedro M. O. J., 2001, Neotropical Entomology, V30, P263, DOI 10.1590/S1519-566X2001000200009; Pachamuthu P, 2000, J ECON ENTOMOL, V93, P60, DOI 10.1603/0022-0493-93.1.60; Quintela ED, 1998, J ECON ENTOMOL, V91, P110, DOI 10.1093/jee/91.1.110; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Sanyang S, 2000, INT J PEST MANAGE, V46, P165, DOI 10.1080/096708700415481; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Scholte EJ, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-29; Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Vulule JM, 1999, MED VET ENTOMOL, V13, P239, DOI 10.1046/j.1365-2915.1999.00177.x; *WHO, 1998, 9812 WHOCDSCPCMAL; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P879, DOI 10.1080/09583150701593963; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006	49	74	87	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12081	10.1371/journal.pone.0012081	http://dx.doi.org/10.1371/journal.pone.0012081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711409	Green Published, gold, Green Accepted			2022-12-25	WOS:000280849100019
J	Vitureira, N; Andres, R; Perez-Martinez, E; Martinez, A; Bribian, A; Blasi, J; Chelliah, S; Lopez-Domenech, G; De Castro, F; Burgaya, F; McNagny, K; Soriano, E				Vitureira, Nathalia; Andres, Rosa; Perez-Martinez, Esther; Martinez, Albert; Bribian, Ana; Blasi, Juan; Chelliah, Shierley; Lopez-Domenech, Guillermo; De Castro, Fernando; Burgaya, Ferran; McNagny, Kelly; Soriano, Eduardo			Podocalyxin Is a Novel Polysialylated Neural Adhesion Protein with Multiple Roles in Neural Development and Synapse Formation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NEURONAL MIGRATION; MICE LACKING; MOUSE-BRAIN; MOLECULE; EXPRESSION; REORGANIZATION; GROWTH; NCAM; CAM	Neural development and plasticity are regulated by neural adhesion proteins, including the polysialylated form of NCAM (PSA-NCAM). Podocalyxin (PC) is a renal PSA-containing protein that has been reported to function as an anti-adhesin in kidney podocytes. Here we show that PC is widely expressed in neurons during neural development. Neural PC interacts with the ERM protein family, and with NHERF1/2 and RhoA/G. Experiments in vitro and phenotypic analyses of podxl-deficient mice indicate that PC is involved in neurite growth, branching and axonal fasciculation, and that PC loss-offunction reduces the number of synapses in the CNS and in the neuromuscular system. We also show that whereas some of the brain PC functions require PSA, others depend on PC per se. Our results show that PC, the second highly sialylated neural adhesion protein, plays multiple roles in neural development.	[Vitureira, Nathalia; Andres, Rosa; Perez-Martinez, Esther; Martinez, Albert; Bribian, Ana; Lopez-Domenech, Guillermo; Burgaya, Ferran; Soriano, Eduardo] Inst Res Biomed, Barcelona, Spain; [Vitureira, Nathalia; Andres, Rosa; Perez-Martinez, Esther; Martinez, Albert; Bribian, Ana; Lopez-Domenech, Guillermo; Burgaya, Ferran; Soriano, Eduardo] CIBERNED, Barcelona, Spain; [Vitureira, Nathalia; Andres, Rosa; Perez-Martinez, Esther; Martinez, Albert; Bribian, Ana; Lopez-Domenech, Guillermo; Burgaya, Ferran; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Bribian, Ana; De Castro, Fernando] Hosp Nacl Paraplejicos, Grp Neurobiol Desarrollo GNDe, Toledo, OH USA; [Blasi, Juan] Univ Barcelona, Dept Expt Pathol, Inst Invest Biomed Bellvitge, Barcelona, Spain; [Chelliah, Shierley; McNagny, Kelly] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBERNED; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of British Columbia	Vitureira, N (corresponding author), Inst Res Biomed, Parc Cient Barcelona, Barcelona, Spain.	eduardo.soriano@irbbarcelona.org	de Castro, Fernando/Q-8624-2018; McNagny, Kelly/P-5239-2014; Andres, Rosa/A-7236-2012; Blasi, Juan/K-7943-2014; IBSAL, Secretaría/H-3719-2011; López Doménech, Guillermo López Doménech/X-6075-2018; Soriano, Eduardo/AAB-3216-2019; Bribian, Ana/M-2978-2014	de Castro, Fernando/0000-0002-7018-8032; McNagny, Kelly/0000-0003-4737-3499; Blasi, Juan/0000-0002-0482-9444; López Doménech, Guillermo López Doménech/0000-0002-3114-2082; Soriano, Eduardo/0000-0002-3204-9285; Vitureira, Nathalia/0000-0003-1196-4094; Martinez, Albert/0000-0003-0831-9916; Andres, Rosa/0000-0002-6818-5203	Ministerio de Ciencia e Innovacion [BFU2008-3980]; La Caixa Foundation; Comunidad de Castilla-La Mancha; Canadian Institute for Heart Research; Heart and Stroke Foundation of BC and Yukon; FIS	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); La Caixa Foundation(La Caixa Foundation); Comunidad de Castilla-La Mancha; Canadian Institute for Heart Research; Heart and Stroke Foundation of BC and Yukon; FIS(Instituto de Salud Carlos III)	This work was supported by grants from Ministerio de Ciencia e Innovacion (BFU2008-3980) and La Caixa Foundation to ES, and the Comunidad de Castilla-La Mancha to FdeC, and FIS to FB. KMM is an MSFHR Scholar. This work was partially funded by a Canadian Institute for Heart Research grant and a Grant-in-Aid from the Heart and Stroke Foundation of BC and Yukon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 2000, DEVELOPMENT, V127, P1359; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; DEKAN G, 1991, P NATL ACAD SCI USA, V88, P5398, DOI 10.1073/pnas.88.12.5398; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Garcia-Frigola C, 2004, MOL BRAIN RES, V122, P133, DOI 10.1016/j.molbrainres.2003.12.014; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Kershaw DB, 1997, J BIOL CHEM, V272, P15708, DOI 10.1074/jbc.272.25.15708; KERSHAW DB, 1995, J BIOL CHEM, V270, P29439, DOI 10.1074/jbc.270.49.29439; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mann F, 2007, PROG NEUROBIOL, V82, P57, DOI 10.1016/j.pneurobio.2007.02.011; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; McNagny KM, 1997, J CELL BIOL, V138, P1395, DOI 10.1083/jcb.138.6.1395; Miettinen A, 1999, AM J PATHOL, V154, P813, DOI 10.1016/S0002-9440(10)65328-X; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Packard M, 2003, CURR OPIN NEUROBIOL, V13, P527, DOI 10.1016/j.conb.2003.09.008; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Rodriguez RB, 2006, TISSUE ANTIGENS, V68, P407, DOI 10.1111/j.1399-0039.2006.00692.x; Rolf B, 2002, J NEUROSCI, V22, P8357; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Seki T, 1998, J NEUROSCI, V18, P3757; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P1565, DOI 10.1177/39.11.1918930; Sotelo C, 2005, PROG BRAIN RES, V148, P3, DOI 10.1016/S0079-6123(04)48001-7; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Takeda Tetsuro, 2003, Clin Exp Nephrol, V7, P260, DOI 10.1007/s10157-003-0257-8; TAN P, 2010, CELL MIGRATION; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Vitureira N, 2005, GENE EXPR PATTERNS, V5, P349, DOI 10.1016/j.modgep.2004.10.002; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2	64	57	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12003	10.1371/journal.pone.0012003	http://dx.doi.org/10.1371/journal.pone.0012003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706633	Green Published, Green Submitted, gold			2022-12-25	WOS:000280811900003
J	Glaser, C; Demmelmair, H; Koletzko, B				Glaser, Claudia; Demmelmair, Hans; Koletzko, Berthold			High-Throughput Analysis of Total Plasma Fatty Acid Composition with Direct In Situ Transesterification	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; ADIPOSE-TISSUE; LIPID ANALYSIS; WHOLE-BLOOD; FISH-OIL; HUMANS; PHOSPHOLIPIDS; EXTRACTION; BIOMARKER; DEATH	Background: Plasma fatty acid (FA) composition reflects dietary intake and endogenous turnover and is associated with health outcomes on a short and long term basis. The total plasma FA pool represents the composition of all FA containing lipid fractions. We developed a simplified and affordable high-throughput method for the analysis of total plasma FA composition, suitable for large studies. Methodology/Principal Findings: The total lipid FA from 100 mu l plasma is transferred in situ into methyl esters, avoiding initial extraction and drying steps. The fatty acid methyl esters are extracted once and analyzed by gas chromatography. For the new direct in situ transesterification method optimal, reaction parameters were determined. Intra-assay analysis (n = 8) revealed coefficients of variation below 4% for FA contributing more than 1% to total FA. Conclusions/Significance: The results show good agreement with FA concentrations obtained by a reference method. The new direct in situ transesterification method is robust and simple. Sample preparation time and analysis costs are reduced to a minimum. This method is an economically and ecologically superior alternative to conventional methods for assessing plasma FA status in large studies.	[Glaser, Claudia; Demmelmair, Hans; Koletzko, Berthold] Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Div Metab & Nutr Med, Munich, Germany	University of Munich	Glaser, C (corresponding author), Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Div Metab & Nutr Med, Munich, Germany.	office.koletzko@med.uni-muenchen.de			Kompetenznetz Adipositas Competence Network for Adiposity; German Federal Ministry of Education and Research [01GI0826]; Munich Center of Health Sciences; Bristol-Myers Squibb Foundation, New York, New York, USA	Kompetenznetz Adipositas Competence Network for Adiposity; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences; Bristol-Myers Squibb Foundation, New York, New York, USA(Bristol-Myers Squibb)	This work was supported financially in part by the Kompetenznetz Adipositas Competence Network for Adiposity (www.kn-adipositas.de) funded by the German Federal Ministry of Education and Research (FKZ: 01GI0826), and by the Munich Center of Health Sciences. Berthold Koletzko is the recipient of a Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, New York, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Bailey-Hall E, 2008, LIPIDS, V43, P181, DOI 10.1007/s11745-007-3140-7; Baylin A, 2005, AM J EPIDEMIOL, V162, P373, DOI 10.1093/aje/kwi213; Beblo S, 2007, J PEDIATR-US, V150, P479, DOI 10.1016/j.jpeds.2006.12.011; Belo L, 2002, EUR J HAEMATOL, V69, P145, DOI 10.1034/j.1600-0609.2002.02788.x; Carrapiso AI, 2000, LIPIDS, V35, P1167, DOI 10.1007/s11745-000-0633-8; CIRILLO M, 1992, HYPERTENSION, V20, P319, DOI 10.1161/01.HYP.20.3.319; Fekete K, 2009, AM J CLIN NUTR, V89, p2070S, DOI 10.3945/ajcn.2009.27230I; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glaser C, 2010, J LIPID RES, V51, P216, DOI 10.1194/jlr.D000547; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Indarti E, 2005, J FOOD COMPOS ANAL, V18, P161, DOI 10.1016/j.jfca.2003.12.007; Jopling J, 2009, PEDIATRICS, V123, pE333, DOI 10.1542/peds.2008-2654; Koletzko B, 2007, BRIT J NUTR, V98, P873, DOI 10.1017/S0007114507764747; Kompauer I, 2005, BRIT J NUTR, V93, P529, DOI 10.1079/BJN20041387; Kramer JKC, 1997, LIPIDS, V32, P1219, DOI 10.1007/s11745-997-0156-3; Leaf A, 2006, FUND CLIN PHARMACOL, V20, P525, DOI 10.1111/j.1472-8206.2006.00438.x; LEPAGE G, 1986, J LIPID RES, V27, P114; Marangoni F, 2004, ANAL BIOCHEM, V326, P267, DOI 10.1016/j.ab.2003.12.016; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; Masood MA, 2008, LIPIDS, V43, P171, DOI 10.1007/s11745-007-3130-9; Muskiet FAJ, 2006, J NUTR BIOCHEM, V17, P717, DOI 10.1016/j.jnutbio.2006.02.001; PHILLIPS GB, 1967, J LIPID RES, V8, P676; Rise P, 2007, PROSTAG LEUKOTR ESS, V76, P363, DOI 10.1016/j.plefa.2007.05.003; SATTLER W, 1991, ANAL BIOCHEM, V198, P184, DOI 10.1016/0003-2697(91)90526-Y	26	63	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12045	10.1371/journal.pone.0012045	http://dx.doi.org/10.1371/journal.pone.0012045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711501	Green Published, Green Submitted, gold			2022-12-25	WOS:000280776800017
J	Rutherford, M; Alisjahbana, B; Maharani, W; Sampurno, H; van Crevel, R; Hill, PC				Rutherford, Merrin; Alisjahbana, Bachti; Maharani, Winni; Sampurno, Hedy; van Crevel, Reinout; Hill, Philip C.			Sensitivity of the Quantiferon-Gold In-Tube Assay in Sputum Smear Positive TB Cases in Indonesia	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS INFECTION; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; SKIN-TEST; DIAGNOSIS; GAMBIA	Background: As part of a formal evaluation of the Quantiferon-Gold in-tube assay (QFT-IT) for latent TB infection we compared its sensitivity to the tuberculin skin test (TST) in confirmed adult TB cases in Indonesia. Smear-positive TB disease was used as a proxy gold standard for latent TB infection. Methods and Findings: We compared the sensitivity of QFT-IT and TST in 98 sputum smear and chest x-ray positive TB cases and investigated risk factors for negative and discordant results in both tests. Both tests showed high sensitivity; (QFT-IT; 88.7%: TST; 94.9%), not significantly different from each other (p value 0.11). Very high sensitivity was seen when tests were combined (98.9%). There were no variables significantly associated with discordant results or with a negative TST. For QFT-IT which particular staff member collected blood was significantly associated with test positivity (p value 0.01). Study limitations include small sample size and lack of culture confirmation or HIV test results. Conclusions: The QFT-IT has similar sensitivity in Indonesian TB cases as in other locations. However, QFT-IT, like the TST cannot distinguish active TB disease from LTBI. In countries such as Indonesia, with high background rates of LTBI, test specificity for TB disease will likely be low. While our study was not designed to evaluate the QFT-IT in the diagnosis of active TB disease in TB suspects, the data suggest that a combination of TST and QFT-IT may prove useful for ruling out TB disease. Further research is required to explore the clinical role of QFT-IT in combination with other TB diagnostic tests.	[Rutherford, Merrin; Hill, Philip C.] Univ Otago, Ctr Int Hlth, Dept Prevent & Social Med, Dunedin, New Zealand; [Alisjahbana, Bachti; Maharani, Winni] Padjadjaran State Univ, Hlth Res Unit, Bandung, Indonesia; [Sampurno, Hedy] Bandung Community Lung Clin, Bandung, Indonesia; [van Crevel, Reinout] Radboud Univ Nijmegen, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands	University of Otago; Universitas Padjadjaran; Radboud University Nijmegen	Rutherford, M (corresponding author), Univ Otago, Ctr Int Hlth, Dept Prevent & Social Med, Dunedin, New Zealand.	merrin.rutherford@gmail.com	van Crevel, reinout/A-6636-2010; Maharani, Winni/ABE-1323-2020	van Crevel, reinout/0000-0002-6233-6410; Maharani, Winni/0000-0003-0469-6247	University of Otago	University of Otago	Research was funded by the University of Otago (www.otago.ac.nz). Kits were donated by Cellestis (www.cellestis.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Bartu V, 2008, J INT MED RES, V36, P434, DOI 10.1177/147323000803600307; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; FALK A, 1978, CHEST, V73, P44, DOI 10.1378/chest.73.1.44; HERRERA V, 2010, J CLIN MICROBIOL; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Miranda C, 2009, INFECT CONT HOSP EP, V30, P296, DOI 10.1086/595732; Organization WH, 2008, GLOB TUB CONTR SURV; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Veening G J, 1968, Bull Int Union Tuberc, V41, P169; 1999, AM J RESP CRIT CARE, V161, P1376	19	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12020	10.1371/journal.pone.0012020	http://dx.doi.org/10.1371/journal.pone.0012020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711257	Green Published, Green Submitted, gold			2022-12-25	WOS:000280776800011
J	Weaver, EA				Weaver, Eric A.			A Detailed Phylogenetic Analysis of FIV in the United States	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; GENETIC DIVERSITY; NUCLEOTIDE-SEQUENCE; IN-VIVO; CATS; INFECTION; LENTIVIRUS; PREVALENCE; SUBTYPE; REPLICATION	Background: Feline immunodeficiency virus (FIV) is a lentivirus associated with AIDS-like illnesses in cats and has been used as a model for the study of human immunodeficiency virus (HIV). A feature of HIV and FIV infection is the continually increasing divergence among viral isolates between different individuals, as well as within the same individuals. Methodology/Principal Findings: The goal of this study was to determine the phylogenetic patterns of viral isolates obtained within the United States (U.S.) by focusing on the variable, V3-V4, region of the FIV envelope gene. Conclusions/Significance: Data indicate that FIV, from within the U.S., localize to four viral clades, A, B, C, and F. Also shown is the geographic isolation of strains where clade A and clade B are found predominately on the west coast; however, clade B is also found throughout the U.S. and represents the predominant clade. This study presents a complete and conclusive analysis of FIV isolates from within the U.S. and may be used as the essential basis for the development of an effective multi-clade vaccine.	Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA	Mayo Clinic	Weaver, EA (corresponding author), Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA.	weaver.eric@mayo.edu			Texas A&M University College of Veterinary Medicine, Department of Pathobiology	Texas A&M University College of Veterinary Medicine, Department of Pathobiology	Funding for this project was supplied by Texas A&M University College of Veterinary Medicine, Department of Pathobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MH, 1997, J VIROL, V71, P4241, DOI 10.1128/JVI.71.6.4241-4253.1997; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20, DOI 10.1002/jlb.62.1.20; BROWN EW, 1994, J VIROL, V68, P5953, DOI 10.1128/JVI.68.9.5953-5968.1994; BROWN WC, 1991, J VIROL, V65, P3359, DOI 10.1128/JVI.65.6.3359-3364.1991; BRUNNER D, 1989, J VIROL, V63, P5483, DOI 10.1128/JVI.63.12.5483-5488.1989; Clapham PR, 2001, BRIT MED BULL, V58, P43, DOI 10.1093/bmb/58.1.43; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; Duarte A, 2006, VET MICROBIOL, V114, P25, DOI 10.1016/j.vetmic.2005.11.056; Duarte A, 2002, ARCH VIROL, V147, P1061, DOI 10.1007/s00705-002-0785-7; ELDER JH, 1993, INFECT AGENT DIS, V2, P361; ENGLISH RV, 1994, J INFECT DIS, V170, P543, DOI 10.1093/infdis/170.3.543; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; GREENE WK, 1993, ARCH VIROL, V132, P369, DOI 10.1007/BF01309546; GREENE WK, 1993, ARCH VIROL, V133, P51, DOI 10.1007/BF01309743; Hartmann K, 1997, ANTIVIR RES, V36, P11, DOI 10.1016/S0166-3542(97)00030-2; HOSIE MJ, 1989, VET REC, V125, P293, DOI 10.1136/vr.125.11.293; Hosie MJ, 2000, J VIROL, V74, P9403, DOI 10.1128/JVI.74.20.9403-9411.2000; Inada G, 1997, ARCH VIROL, V142, P1459, DOI 10.1007/s007050050172; KAKINUMA S, 1995, J VIROL, V69, P3639, DOI 10.1128/JVI.69.6.3639-3646.1995; Kashiwase H, 2000, J VET MED SCI, V62, P499, DOI 10.1292/jvms.62.499; LANGLEY RJ, 1994, VIROLOGY, V202, P853, DOI 10.1006/viro.1994.1407; Mergia A, 1997, AIDS RES HUM RETROV, V13, P1333, DOI 10.1089/aid.1997.13.1333; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P2448, DOI 10.1073/pnas.86.7.2448; OLMSTED RA, 1992, J VIROL, V66, P6008, DOI 10.1128/JVI.66.10.6008-6018.1992; Pecoraro MR, 1996, J GEN VIROL, V77, P2031, DOI 10.1099/0022-1317-77-9-2031; PEDERSEN NC, 1989, VET IMMUNOL IMMUNOP, V21, P111, DOI 10.1016/0165-2427(89)90134-7; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; PHILLIPS TR, 1990, J VIROL, V64, P4605, DOI 10.1128/JVI.64.10.4605-4613.1990; PHILPOTT MS, 1992, VET IMMUNOL IMMUNOP, V35, P155, DOI 10.1016/0165-2427(92)90128-D; Pistello M, 1997, J GEN VIROL, V78, P2247, DOI 10.1099/0022-1317-78-9-2247; Poeschla EM, 1998, J VIROL, V72, P6858, DOI 10.1128/JVI.72.8.6858-6866.1998; Pu RY, 2001, AIDS, V15, P1225, DOI 10.1097/00002030-200107060-00004; RIGBY MA, 1993, J GEN VIROL, V74, P425, DOI 10.1099/0022-1317-74-3-425; SODORA DL, 1994, J VIROL, V68, P2230, DOI 10.1128/JVI.68.4.2230-2238.1994; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weaver EA, 2004, J VIROL, V78, P2158, DOI 10.1128/JVI.78.4.2158-2163.2004; YAMADA H, 1995, ARCH VIROL, V140, P41, DOI 10.1007/BF01309722; YAMAMOTO JK, 1989, J AM VET MED ASSOC, V194, P213; Yang JS, 1996, J VIROL, V70, P3011, DOI 10.1128/JVI.70.5.3011-3017.1996; ZENGER E, 1995, GLIA, V13, P92, DOI 10.1002/glia.440130203	41	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12004	10.1371/journal.pone.0012004	http://dx.doi.org/10.1371/journal.pone.0012004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711253	Green Published, gold			2022-12-25	WOS:000280776800005
J	Bugaysen, J; Bronfeld, M; Tischler, H; Bar-Gad, I; Korngreen, A				Bugaysen, Jenia; Bronfeld, Maya; Tischler, Hadass; Bar-Gad, Izhar; Korngreen, Alon			Electrophysiological Characteristics of Globus Pallidus Neurons	PLOS ONE			English	Article							MPTP-INDUCED PARKINSONISM; BASAL GANGLIA; BRAIN-SLICES; IN-VITRO; RAT; STIMULATION; RESPONSES; RECORDINGS; MORPHOLOGY; MOVEMENT	Extracellular recordings in primates have identified two types of neurons in the external segment of the globus pallidus (GPe): high frequency pausers (HFP) and low frequency bursters (LFB). The aim of the current study was to test whether the properties of HFP and LFB neurons recorded extracellularly in the primate GPe are linked to cellular mechanisms underlying the generation of action potential (AP) firing. Thus, we recorded from primate and rat globus pallidus neurons. Extracellular recordings in primates revealed that in addition to differences in firing patterns the APs of neurons in these two groups have different widths (AP(ex)). To quantitatively investigate this difference and to explore the heterogeneity of pallidal neurons we carried out cell-attached and whole-cell recordings from acute slices of the rat globus pallidus (GP, the rodent homolog of the primate GPe), examining both spontaneous and evoked activity. Several parameters related to the extracellular activity were extracted in order to subdivide the population of recorded GP neurons into groups. Statistical analysis showed that the GP neurons in the rodents may be differentiated along six cellular parameters into three subgroups. Combining two of these groups allowed a better separation of the population along nine parameters. Four of these parameters (F(max), AP(amp), AP(hw), and AHP(s) amplitude) form a subset, suggesting that one group of neurons may generate APs at significantly higher frequencies than the other group. This may suggest that the differences between the HFP and LFB neurons in the primate are related to fundamental underlying differences in their cellular properties.	[Bugaysen, Jenia; Bronfeld, Maya; Tischler, Hadass; Bar-Gad, Izhar; Korngreen, Alon] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel; [Bugaysen, Jenia; Bar-Gad, Izhar; Korngreen, Alon] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Bugaysen, J (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel.	korngra@mail.biu.ac.il		Bar-Gad, Izhar/0000-0002-2999-4083; Bronfeld, Maya/0000-0001-9797-5418; Korngreen, Alon/0000-0002-2036-6160	Israel Science Foundation [1000-05, 1698-07]; Tourette Syndrome Association	Israel Science Foundation(Israel Science Foundation); Tourette Syndrome Association	This study was supported in part by grants from the Israel Science Foundation (no. 1000-05) and the Tourette Syndrome Association to IB and Israel Science Foundation Converging Technologies grant 1698-07 (to AK and IB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Bellman R., 1961, ADAPTIVE CONTROL PRO; Chang JY, 2006, EXP BRAIN RES, V172, P193, DOI 10.1007/s00221-005-0312-7; Cooper AJ, 2000, J PHYSIOL-LONDON, V527, P291, DOI 10.1111/j.1469-7793.2000.t01-1-00291.x; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Erez Y, 2009, J NEUROSCI, V29, P7797, DOI 10.1523/JNEUROSCI.0401-09.2009; FILION M, 1991, BRAIN RES, V547, P142; FILION M, 1991, BRAIN RES, V547, P152; GARDINER TW, 1992, EXP BRAIN RES, V88, P517; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; KELLAND MD, 1995, SYNAPSE, V20, P338, DOI 10.1002/syn.890200407; KITA H, 1991, BRAIN RES, V564, P296, DOI 10.1016/0006-8993(91)91466-E; KITA H, 1994, BRAIN RES, V636, P308, DOI 10.1016/0006-8993(94)91030-8; Kita H, 2007, PROG BRAIN RES, V160, P111, DOI 10.1016/S0079-6123(06)60007-1; Magnin M, 2000, NEUROSCIENCE, V96, P549, DOI 10.1016/S0306-4522(99)00583-7; MILLHOUSE OE, 1986, J COMP NEUROL, V254, P209, DOI 10.1002/cne.902540206; Nambu A, 1997, J COMP NEUROL, V377, P85; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127, DOI 10.1152/jn.1994.72.3.1127; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949	23	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12001	10.1371/journal.pone.0012001	http://dx.doi.org/10.1371/journal.pone.0012001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700458	Green Submitted, Green Published, gold			2022-12-25	WOS:000280687900008
J	Petermann, JS; Muller, CB; Roscher, C; Weigelt, A; Weisser, WW; Schmid, B				Petermann, Jana S.; Mueller, Christine B.; Roscher, Christiane; Weigelt, Alexandra; Weisser, Wolfgang W.; Schmid, Bernhard			Plant Species Loss Affects Life-History Traits of Aphids and Their Parasitoids	PLOS ONE			English	Article							PEA APHID; TROPHIC CASCADES; HOST-PLANT; BOTTOM-UP; SEX-RATIO; NITROGEN; BIODIVERSITY; HERBIVORE; ENDOSYMBIONTS; RESISTANCE	The consequences of plant species loss are rarely assessed in a multi-trophic context and especially effects on life-history traits of organisms at higher trophic levels have remained largely unstudied. We used a grassland biodiversity experiment and measured the effects of two components of plant diversity, plant species richness and the presence of nitrogen-fixing legumes, on several life-history traits of naturally colonizing aphids and their primary and secondary parasitoids in the field. We found that, irrespective of aphid species identity, the proportion of winged aphid morphs decreased with increasing plant species richness, which was correlated with decreasing host plant biomass. Similarly, emergence proportions of parasitoids decreased with increasing plant species richness. Both, emergence proportions and proportions of female parasitoids were lower in plots with legumes, where host plants had increased nitrogen concentrations. This effect of legume presence could indicate that aphids were better defended against parasitoids in high-nitrogen environments. Body mass of emerged individuals of the two most abundant primary parasitoid species was, however, higher in plots with legumes, suggesting that once parasitoids could overcome aphid defenses, they could profit from larger or more nutritious hosts. Our study demonstrates that cascading effects of plant species loss on higher trophic levels such as aphids, parasitoids and secondary parasitoids begin with changed life-history traits of these insects. Thus, life-history traits of organisms at higher trophic levels may be useful indicators of bottom-up effects of plant diversity on the biodiversity of consumers.	[Petermann, Jana S.; Mueller, Christine B.; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Roscher, Christiane] Max Planck Inst Biogeochem, Jena, Germany; [Weigelt, Alexandra; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany	University of Zurich; Max Planck Society; Friedrich Schiller University of Jena	Petermann, JS (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	petermann@zoology.ubc.ca	Weisser, Wolfgang W/B-9718-2014; Petermann, Jana/AAK-9787-2020; Petermann, Jana/E-2130-2013; Schmid, Bernhard/C-8625-2009	Weisser, Wolfgang W/0000-0002-2757-8959; Petermann, Jana/0000-0002-3898-5656; Petermann, Jana/0000-0002-3898-5656; Schmid, Bernhard/0000-0002-8430-3214	German Research Foundation [FOR 456]; Friedrich-Schiller-University of Jena; Max-Planck-Institute for Biogeochemistry, Jena; Swiss National Science Foundation [31-65224-01]	German Research Foundation(German Research Foundation (DFG)); Friedrich-Schiller-University of Jena; Max-Planck-Institute for Biogeochemistry, Jena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Jena Experiment is funded by the German Research Foundation (FOR 456, www.dfg.de) and supported by the Friedrich-Schiller-University of Jena (www.uni-jena.de) and the Max-Planck-Institute for Biogeochemistry, Jena (www.bgc-jena.mpg.de). Additional support was provided by the Swiss National Science Foundation (grant no. 31-65224-01 to BS, www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilino KM, 2005, OIKOS, V108, P275, DOI 10.1111/j.0030-1299.2005.13418.x; Ashouri A, 2001, BIOCONTROL, V46, P401, DOI 10.1023/A:1014123712776; BARBOSA P, 1991, ECOLOGY, V72, P1567, DOI 10.2307/1940956; Belshaw R, 1999, EVOLUTION, V53, P1189, DOI [10.2307/2640822, 10.1111/j.1558-5646.1999.tb04532.x]; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Buhler C, 2001, J APPL ECOL, V38, P689, DOI 10.1046/j.1365-2664.2001.00640.x; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; Cohen JE, 2005, P NATL ACAD SCI USA, V102, P684, DOI 10.1073/pnas.0408780102; DAVIDSON AW, 1995, J ECON ENTOMOL, V88, P367, DOI 10.1093/jee/88.2.367; de Sassi C, 2006, P R SOC B, V273, P1301, DOI 10.1098/rspb.2005.3442; Dixon AF G, 1998, APHID ECOLOGY; DIXON AFG, 1987, AM NAT, V129, P580, DOI 10.1086/284659; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Dyer LA, 2003, BASIC APPL ECOL, V4, P423, DOI 10.1078/1439-1791-00191; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; Francis F, 2001, J CHEM ECOL, V27, P243, DOI 10.1023/A:1005672220342; Gange AC, 2003, ECOL LETT, V6, P1051, DOI 10.1046/j.1461-0248.2003.00540.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Harri SA, 2008, OECOLOGIA, V157, P399, DOI 10.1007/s00442-008-1094-y; Harri SA, 2008, P R SOC B, V275, P2627, DOI 10.1098/rspb.2008.0594; Harvey JA, 2003, J ANIM ECOL, V72, P520, DOI 10.1046/j.1365-2656.2003.00722.x; HUNTER MD, 1992, ECOLOGY, V73, P724; HUNTER MD, 2003, ECOL LETT, V5, P1; Kagata H, 2006, ECOL RES, V21, P26, DOI 10.1007/s11284-005-0124-z; Kempel A, 2009, OIKOS, V118, P634, DOI 10.1111/j.1600-0706.2009.17418.x; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; LAWTON JH, 1979, POPULATION DYNAMICS, P223; Li S, 2002, J INSECT PHYSIOL, V48, P971, DOI 10.1016/S0022-1910(02)00176-2; LYONS PC, 1986, SCIENCE, V232, P487, DOI 10.1126/science.3008328; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Muller CB, 2001, ECOL ENTOMOL, V26, P330, DOI 10.1046/j.1365-2311.2001.00321.x; Otway SJ, 2005, J ANIM ECOL, V74, P234, DOI 10.1111/j.1365-2656.2005.00913.x; Petermann JS, 2010, J ANIM ECOL, V79, P709, DOI 10.1111/j.1365-2656.2010.01674.x; Pfisterer AB, 2003, OECOLOGIA, V135, P234, DOI 10.1007/s00442-002-1169-0; R Core Team, 2022, R LANG ENV STAT COMP; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2008, J ECOL, V96, P477, DOI 10.1111/j.1365-2745.2008.01353.x; ROTHMALER R, 2002, EXKURSIONSFLORA DEUT; Schmid Bernhard, 2009, P14; SEQUEIRA R, 1992, ECOLOGY, V73, P183, DOI 10.2307/1938730; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Sloggett JJ, 2002, OIKOS, V98, P323, DOI 10.1034/j.1600-0706.2002.980213.x; Soler R, 2005, J ANIM ECOL, V74, P1121, DOI 10.1111/j.1365-2656.2005.01006.x; STRESEMANN E, 1994, EXKURSIONSFAUNA DEUT; SUTHERLA.OR, 1967, NATURE, V216, P387, DOI 10.1038/216387a0; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Ueno T, 1999, RES POPUL ECOL, V41, P47, DOI 10.1007/PL00011982; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; Volkl W, 2007, APHIDS AS CROP PESTS, P187, DOI 10.1079/9780851998190.0187; Wacker L, 2009, J PLANT ECOL-UK, V2, P95, DOI 10.1093/jpe/rtp010; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Wurst S, 2003, PEDOBIOLOGIA, V47, P91, DOI 10.1078/0031-4056-00173; Zust T, 2008, ECOL ENTOMOL, V33, P80, DOI 10.1111/j.1365-2311.2007.00940.x	60	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12053	10.1371/journal.pone.0012053	http://dx.doi.org/10.1371/journal.pone.0012053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700511	Green Published, Green Submitted, gold			2022-12-25	WOS:000280687900023
J	Okamoto, J; Hirata, T; Chen, Z; Zhou, HM; Mikami, I; Li, H; Beltran, A; Johansson, M; Coussens, LM; Clement, G; Shi, Y; Zhang, F; Koizumi, K; Shimizu, K; Jablons, D; He, B				Okamoto, J.; Hirata, T.; Chen, Z.; Zhou, H-M; Mikami, I.; Li, H.; Beltran, A.; Johansson, M.; Coussens, L. M.; Clement, G.; Shi, Y.; Zhang, F.; Koizumi, K.; Shimizu, K.; Jablons, D.; He, B.			EMX2 is epigenetically silenced and suppresses growth in human lung cancer	ONCOGENE			English	Article						EMX2; methylation; lung cancer; WNT signaling; tumor suppression	INHIBITORY FACTOR-I; PROMOTER HYPERMETHYLATION; S100 PROTEINS; EXPRESSION; METHYLATION; GENE; METASTASIS; PATHOLOGY; FAMILY; TARGET	Lung cancer is a common cancer and the leading cause of cancer-related death worldwide. Aberrant activation of WNT signaling is implicated in lung carcinogenesis. EMX2, a human homologue of the Drosophila empty spiracles gene is a homeodomain-containing transcription factor. The function of EMX2 has been linked to the WNT signaling pathway during embryonic patterning in mice. However, little is known about the role of EMX2 in human tumorigenesis. In this study, we found that EMX2 was dramatically downregulated in lung cancer tissue samples and this downregulation was associated with methylation of the EMX2 promoter. Restoration of EMX2 expression in lung cancer cells lacking endogenous EMX2 expression suppressed cell proliferation and invasive phenotypes, inhibited canonical WNT signaling, and sensitized lung cancer cells to the treatment of the chemo cytotoxic drug cisplatin. On the other hand, knockdown of EMX2 expression in lung cancer cells expressing endogenous EMX2 promoted cell proliferation, invasive phenotypes and canonical WNT signaling. Taken together, our study suggests that EMX2 may have important roles as a novel suppressor in human lung cancer. Oncogene (2010) 29, 5969-5975; doi:10.1038/onc.2010.330; published online 9 August 2010	[Okamoto, J.; Hirata, T.; Chen, Z.; Mikami, I.; Li, H.; Beltran, A.; Clement, G.; Shi, Y.; Zhang, F.; Jablons, D.; He, B.] Univ Calif San Francisco, Thorac Oncol Program, Dept Surg, San Francisco, CA 94115 USA; [Okamoto, J.; Hirata, T.; Mikami, I.; Koizumi, K.; Shimizu, K.] Nippon Med Sch, Div Thorac Surg, Dept Surg, Tokyo 113, Japan; [Chen, Z.; Zhou, H-M] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Johansson, M.; Coussens, L. M.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA; [Johansson, M.; Coussens, L. M.; Jablons, D.; He, B.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Shi, Y.] SRI Int, Biosci Div, Menlo Pk, CA 94025 USA	University of California System; University of California San Francisco; Nippon Medical School; Tsinghua University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; SRI International	He, B (corresponding author), Univ Calif San Francisco, Thorac Oncol Program, Dept Surg, 2340 Sutter St,Room N222, San Francisco, CA 94115 USA.	biao.he@ucsfmedctr.org	Coussens, Lisa/ABH-9834-2020		Joan's Legacy: uniting against Lung Cancer Research Grant; NIH/NCI [R01CA125030, R01CA130980, R01CA13256]; Eileen D Ludwig endowed for Thoracic Oncology Research; Bonnie J Addario Lung Cancer Foundation; Kazan foundation; McClain foundation; Abrams foundation; Fernandez foundation; Lyons foundation; Greenwood foundation; Harley and Oberman Foundation; Barbara Isackson Lung Cancer Research Fund; Swedish Cancer Institute; DOD [W81XWH-06-1-0416]; NATIONAL CANCER INSTITUTE [R01CA125030, R01CA132566, R01CA130980] Funding Source: NIH RePORTER	Joan's Legacy: uniting against Lung Cancer Research Grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eileen D Ludwig endowed for Thoracic Oncology Research; Bonnie J Addario Lung Cancer Foundation; Kazan foundation; McClain foundation; Abrams foundation; Fernandez foundation; Lyons foundation; Greenwood foundation; Harley and Oberman Foundation; Barbara Isackson Lung Cancer Research Fund; Swedish Cancer Institute; DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grant from Joan's Legacy: uniting against Lung Cancer Research Grant, NIH/NCI grant R01CA125030 and the Eileen D Ludwig endowed for Thoracic Oncology Research (to BH); the Bonnie J Addario Lung Cancer Foundation, the Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley and Oberman Foundation and the Barbara Isackson Lung Cancer Research Fund (DJ); Swedish Cancer Institute (MJ); NIH/NCI grants R01CA130980, R01CA13256 and DOD BCRP Era of Hope Scholar Award (W81XWH-06-1-0416) (to LMC). Microarray profiling was done by the UCSF Shared Microarray Core Facilities. We thank M Roshni Ray for editing this paper.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; American Cancer Society, 2008, CANC FACTS FIG; BOERSMA CJ, 1999, MOL CELL BIOL RES CO, V2, P117; Clement G, 2008, CANCER SCI, V99, P46, DOI 10.1111/j.1349-7006.2007.00663.x; DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fackler MJ, 2004, CANCER RES, V64, P4442, DOI 10.1158/0008-5472.CAN-03-3341; Fong KM, 2003, THORAX, V58, P892, DOI 10.1136/thorax.58.10.892; Fukui T, 2005, ONCOGENE, V24, P6323, DOI 10.1038/sj.onc.1208777; Galli R, 2002, DEVELOPMENT, V129, P1633; Ganesan K, 2008, CANCER RES, V68, P4277, DOI 10.1158/0008-5472.CAN-07-6517; Grote HJ, 2006, CANCER CYTOPATHOL, V108, P129, DOI 10.1002/cncr.21717; Grote HJ, 2005, INT J CANCER, V116, P720, DOI 10.1002/ijc.21090; He B, 2005, CANCER RES, V65, P743; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Huang CL, 2008, EUR J CANCER, V44, P2680, DOI 10.1016/j.ejca.2008.08.004; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Ligon KL, 2003, DEVELOPMENT, V130, P2275, DOI 10.1242/dev.00421; Lind GE, 2006, J PATHOL, V210, P441, DOI 10.1002/path.2064; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Noonan FC, 2003, GENOMICS, V81, P58, DOI 10.1016/S0888-7543(02)00023-X; Noonan FC, 2001, GENOMICS, V76, P37, DOI 10.1006/geno.2001.6590; Raman V, 2000, J BIOL CHEM, V275, P26551, DOI 10.1074/jbc.C000324200; Raz DJ, 2008, CLIN CANCER RES, V14, P5565, DOI 10.1158/1078-0432.CCR-08-0544; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Taylor HS, 2005, MOL ENDOCRINOL, V19, P2839, DOI 10.1210/me.2005-0130; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Yoshida HY, 2006, CANCER RES, V66, P889, DOI 10.1158/0008-5472.CAN-05-2828; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297; Zochbauer-Muller S, 2000, Clin Lung Cancer, V2, P141, DOI 10.3816/CLC.2000.n.027	36	43	45	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	44					5969	5975		10.1038/onc.2010.330	http://dx.doi.org/10.1038/onc.2010.330			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	675PS	20697358	Green Accepted			2022-12-25	WOS:000283843400010
J	Gentzsch, M; Dang, H; Dang, Y; Garcia-Caballero, A; Suchindran, H; Boucher, RC; Stutts, MJ				Gentzsch, Martina; Dang, Hong; Dang, Yan; Garcia-Caballero, Agustin; Suchindran, Hamsa; Boucher, Richard C.; Stutts, M. Jackson			The Cystic Fibrosis Transmembrane Conductance Regulator Impedes Proteolytic Stimulation of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID VOLUME; SODIUM-CHANNEL; GAMMA-SUBUNIT; SERINE PROTEASES; XENOPUS-OOCYTES; ACTIVATING PROTEASE; NASAL EPITHELIUM; AIRWAY EPITHELIA; IN-VIVO; ENAC	Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) that prevent its proper folding and trafficking to the apical membrane of epithelial cells. Absence of cAMP-mediated Cl- secretion in CF airways causes poorly hydrated airway surfaces in CF patients, and this condition is exacerbated by excessive Na+ absorption. The mechanistic link between missing CFTR and increased Na+ absorption in airway epithelia has remained elusive, although substantial evidence implicates hyperactivity of the epithelial Na+ channel (ENaC). ENaC is known to be activated by selective endoproteolysis of the extracellular domains of its alpha- and gamma-subunits, and it was recently reported that ENaC and CFTR physically associate in mammalian cells. We confirmed this interaction in oocytes by co-immunoprecipitation and found that ENaC associated with wild-type CFTR was protected from proteolytic cleavage and stimulation of open probability. In contrast, Delta F508 CFTR, the most common mutant protein in CF patients, failed to protect ENaC from proteolytic cleavage and stimulation. In normal airway epithelial cells, ENaC was contained in the anti-CFTR immunoprecipitate. In CF airway epithelial cultures, the proportion of full-length to total alpha-ENaC protein signal was consistently reduced compared with normal cultures. Our results identify limiting proteolytic cleavage of ENaC as a mechanism by which CFTR down-regulates Na+ absorption.	[Gentzsch, Martina; Dang, Hong; Dang, Yan; Garcia-Caballero, Agustin; Suchindran, Hamsa; Boucher, Richard C.; Stutts, M. Jackson] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Gentzsch, Martina] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Boucher, Richard C.; Stutts, M. Jackson] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gentzsch, M (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 6109A Thur Ston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	gentzsch@med.unc.edu	Gentzsch, Martina/AAY-1815-2021		National Institutes of Health [5P01HL034322, 5R01HL080561, 5P30DK065988]; Cystic Fibrosis Foundation [R026-CR07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080561, P01HL034322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P01HL034322 and 5R01HL080561. Work performed by the Cell Culture Core and the Molecular Biology Core was supported by Cystic Fibrosis Foundation Grant R026-CR07 and National Institutes of Health Grant 5P30DK065988.	Bachhuber T, 2005, J BIOL CHEM, V280, P31587, DOI 10.1074/jbc.M504347200; Benharouga Mohamed, 2002, Methods Mol Med, V70, P229; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; Berdiev BK, 2009, MOL BIOSYST, V5, P123, DOI 10.1039/b810471a; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; CHINET TC, 1994, AM J PHYSIOL, V266, pC1061, DOI 10.1152/ajpcell.1994.266.4.C1061; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Coote K, 2009, J PHARMACOL EXP THER, V329, P764, DOI 10.1124/jpet.108.148155; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ji HL, 2000, J BIOL CHEM, V275, P27947; Jiang QS, 2000, J BIOL CHEM, V275, P13266, DOI 10.1074/jbc.275.18.13266; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; Konig J, 2001, EMBO REP, V2, P1047, DOI 10.1093/embo-reports/kve232; Konstas AA, 2003, PFLUG ARCH EUR J PHY, V445, P513, DOI 10.1007/s00424-002-0957-z; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; Lu C, 2007, J CYST FIBROS, V6, P419, DOI 10.1016/j.jcf.2007.03.001; Mall M, 1999, AM J PHYSIOL-GASTR L, V277, pG709, DOI 10.1152/ajpgi.1999.277.3.G709; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Nagel G, 2005, J PHYSIOL-LONDON, V564, P671, DOI 10.1113/jphysiol.2004.079046; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; Riordan JR, 1999, AM J HUM GENET, V64, P1499, DOI 10.1086/302429; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Verkman AS, 2001, AM J PHYSIOL-LUNG C, V281, pL306, DOI 10.1152/ajplung.2001.281.2.L306; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200	47	73	74	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32227	32232		10.1074/jbc.M110.155259	http://dx.doi.org/10.1074/jbc.M110.155259			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20709758	Green Published, hybrid			2022-12-25	WOS:000282683000035
J	Qin, L; Zhang, M				Qin, Li; Zhang, Ming			Maspin Regulates Endothelial Cell Adhesion and Migration through an Integrin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B/AKT; MAMMARY EPITHELIAL-CELLS; PROSTATE-CANCER CELLS; LINKED KINASE; TUMOR-SUPPRESSOR; ACTIN CYTOSKELETON; EXTRACELLULAR-MATRIX; ANDROGEN RECEPTOR; FOCAL COMPLEXES; RHO-GTPASES	Maspin has been identified as a potent angiogenesis inhibitor. However, the molecular mechanism responsible for its anti-angiogenic property is unclear. In this study, we examined the effect of maspin on endothelial cell (EC) adhesion and migration in a cell culture system. We found that maspin was expressed in blood vessels ECs and human umbilical vein endothelial cells (HUVECs). Maspin significantly enhanced HUVEC cell adhesion to various matrix proteins. This effect was dependent on the activation of integrin beta(1), which subsequently led to distribution pattern changes of vinculin and F-actin. These results indicated that maspin affects cell adhesion and cytoskeleton reorganization through an integrin signal transduction pathway. Analysis of HUVECs following maspin treatment revealed increased integrin-linked kinase activities and phosphorylated FAK levels, consistent with increased cell adhesion. Interestingly, when HUVECs were induced to migrate by migration stimulatory factor bFGF, active Rac1 and cdc42 small GTPase levels were decreased dramatically at 30 min following maspin treatment. Using phosphorylated FAK at Tyr(397) as an indicator of focal adhesion disassembly, maspin-treated HUVECs had elevated FAK phosphorylation compared with the mock treated control. The results were a reduction in focal adhesion disassembly and the retardation in EC migration. This study uncovers a mechanism by which maspin exerts its effect on EC adhesion and migration through an integrin signal transduction pathway.	[Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Baylor College of Medicine	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Mol Pharmacol & Biol Chem, Lurie 6-115,303 E Super St, Chicago, IL 60611 USA.	m-zhang@northwestern.edu		Qin, Li/0000-0003-0099-4992	National Institutes of Health from the NCI [CA79736]; Northwestern University; NATIONAL CANCER INSTITUTE [R01CA079736] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA79736 from the NCI and the Northwestern University Zell fund (to M.Z.).	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Andriani F, 2001, JNCI-J NATL CANCER I, V93, P1314, DOI 10.1093/jnci/93.17.1314; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bass R, 2009, J BIOL CHEM, V284, P27712, DOI 10.1074/jbc.M109.038919; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Boosani CS, 2007, BLOOD, V110, P1168, DOI 10.1182/blood-2007-01-066282; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Cascone I, 2003, J BIOL CHEM, V278, P50702, DOI 10.1074/jbc.M307234200; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Chun SJ, 2003, J CELL BIOL, V163, P397, DOI 10.1083/jcb.200304154; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Ellis PD, 2003, J VASC RES, V40, P234, DOI 10.1159/000071887; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Impagnatiello MA, 1997, TRANSPL P, V29, P1110, DOI 10.1016/S0041-1345(96)00450-2; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Ngamkitidechakul C, 2001, INVEST OPHTH VIS SCI, V42, P3135; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PEMBERTON PA, 1995, J BIOL CHEM, V270, P15832, DOI 10.1074/jbc.270.26.15832; Pemberton PA, 1997, J HISTOCHEM CYTOCHEM, V45, P1697, DOI 10.1177/002215549704501213; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pezzatini S, 2007, BONE, V41, P523, DOI 10.1016/j.bone.2007.06.016; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Rovida E, 2005, BIOL CHEM, V386, P919, DOI 10.1515/BC.2005.107; Sager R, 1996, CURR TOP MICROBIOL, V213, P51; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; SHENG SJ, 1994, J BIOL CHEM, V269, P30988; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yatabe Y, 2004, ONCOGENE, V23, P4041, DOI 10.1038/sj.onc.1207557; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Zhang M, 1997, MOL MED, V3, P49, DOI 10.1007/BF03401667; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	53	43	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32360	32369		10.1074/jbc.M110.131045	http://dx.doi.org/10.1074/jbc.M110.131045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20713357	Green Published, hybrid			2022-12-25	WOS:000282683000049
J	Soetandyo, N; Ye, YH				Soetandyo, Nia; Ye, Yihong			The p97 ATPase Dislocates MHC Class I Heavy Chain in US2-expressing Cells via a Ufd1-Npl4-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; RETRO-TRANSLOCATION; DEUBIQUITINATING ENZYME; MISFOLDED PROTEINS; LIGASE MK3; ER; COMPLEX; CYTOSOL	The human cytomegalovirus (HCMV) protein US2 hijacks the endoplasmic reticulum (ER)-associated degradation machinery to dispose of MHC class I heavy chain (HC) at the ER. This process requires retrotranslocation of newly synthesized HC molecules from the ER membrane into the cytosol, but the mechanism underlying the dislocation reaction has been elusive. Here we establish an in vitro permeabilized cell assay that recapitulates the retrotranslocation of MHC HC in US2-expressing cells. Using this assay, we demonstrate that the dislocation process requires ATP and ubiquitin, as expected. The retrotranslocation also involves the p97 ATPase. However, the mechanism by which p97 dislocates MHC class I HC in US2 cells is distinct from that in US11 cells: the dislocation reaction in US2 cells is independent of the p97 cofactor Ufd1-Npl4. Our results suggest that different retrotranslocation mechanisms can employ distinct p97 ATPase complexes to dislocate substrates.	[Soetandyo, Nia; Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ye, YH (corresponding author), 5 Ctr Dr, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov			National Institutes of Health, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health grant from the Intramural Research Program, NIDDK.	Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Kikkert M, 2001, BIOCHEM J, V358, P369, DOI 10.1042/0264-6021:3580369; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; LEE SO, EMBO J, V29, P363; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2003, MOL BIOL CELL, V14, P3690, DOI 10.1091/mbc.E03-03-0192; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Oresic K, 2009, J BIOL CHEM, V284, P5905, DOI 10.1074/jbc.M807568200; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2006, J BIOL CHEM, V281, P8636, DOI 10.1074/jbc.M513920200; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, ESSAYS BIOCHEM, V41, P99, DOI 10.1042/EB0410099; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	44	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32352	32359		10.1074/jbc.M110.131649	http://dx.doi.org/10.1074/jbc.M110.131649			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702414	Green Published, hybrid			2022-12-25	WOS:000282683000048
J	Li, L; Wei, XH; Pan, YP; Li, HC; Yang, H; He, QH; Pang, Y; Shan, Y; Xiong, FX; Shao, GZ; Zhou, RL				Li, L.; Wei, X. H.; Pan, Y. P.; Li, H. C.; Yang, H.; He, Q. H.; Pang, Y.; Shan, Y.; Xiong, F. X.; Shao, G. Z.; Zhou, R. L.			LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling	ONCOGENE			English	Article						LAPTM4B; multidrug resistance; drug efflux; PI3K-AKT signaling	P-GLYCOPROTEIN; TETRATRANSMEMBRANE PROTEIN; MEMBRANE-PROTEIN; DRUG-RESISTANCE; EXPRESSION; OVEREXPRESSION; MECHANISMS; INHIBITOR; MARKER; GROWTH	LAPTM4B (lysosomal protein transmembrane 4 beta) is a newly identified cancer-associated gene. Both of its mRNA and the encoded LAPTM4B-35 protein are significantly upregulated with more than 70% frequency in a wide variety of cancers. The LAPTM4B-35 level in cancer is evidenced to be an independent prognostic factor and its upregulation promotes cell proliferation, migration and invasion, as well as tumorigenesis in nude mice. In contrary, knockdown of LAPTM4B-35 expression by RNA interference (RNAi) reverses all of the above malignant phenotypes. We herein reveal a new role of LAPTM4B-35 in promoting multidrug resistance of cancer cells. Upregulation of LAPTM4B-35 motivates multidrug resistance by enhancement of efflux from cancer cells of a variety of chemodrugs with variant structures and properties, including doxorubicin, paclitaxel and cisplatin through colocalization and interaction of LAPTM4B-35 with multidrug resistance (MDR) 1 (P-glycoprotein, P-gp), and also by activation of PI3K/AKT signaling pathway through interaction of PPRP motif contained in the N-terminus of LAPTM4B-35 with the p85 alpha regulatory subunit of PI3K. The specific inhibitors of PI3K and knockdown of LAPTM4B-35 expression by RNAi eliminate the multidrug resistance effect motivated by upregulation of LAPTM4B-35. In conclusion, LAPTM4B-35 motivates multidrug resistance of cancer cells by promoting drug efflux through colocalization and interaction with P-gp, and anti-apoptosis by activating PI3K/AKT signaling. These findings provide a promising novel strategy for sensitizing chemical therapy of cancers and increasing the chemotherapeutic efficacy through knockdown LAPTM4B-35 expression by RNAi. Oncogene (2010) 29, 5785-5795; doi: 10.1038/onc.2010.303; published online 16 August 2010	[Li, L.; Wei, X. H.; Pan, Y. P.; Li, H. C.; Yang, H.; He, Q. H.; Pang, Y.; Shan, Y.; Xiong, F. X.; Shao, G. Z.; Zhou, R. L.] Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Beijing 100191, Peoples R China	Peking University	Zhou, RL (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Cell Biol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	rlzhou@bjmu.edu.cn	Shan, Yi/E-3862-2016	Li, Li/0000-0002-8630-3699	211 and 985 Foundation of Peking University; National High-tech R&D Program (863 Program) [2006AA02A305]; 248 major R&D program of Beijing [H020220020310]; NNSFC [90408018]	211 and 985 Foundation of Peking University; National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); 248 major R&D program of Beijing; NNSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grants from 211 and 985 Foundation of Peking University, National High-tech R&D Program (863 Program) (2006AA02A305), 248 major R&D program of Beijing (H020220020310) and NNSFC (90408018).	Abdul-Ghani R, 2006, ONCOGENE, V25, P1743, DOI 10.1038/sj.onc.1209201; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Barancik M, 2006, EUR J PHARM SCI, V29, P426, DOI 10.1016/j.ejps.2006.08.006; Cabrita MA, 1999, CANCER RES, V59, P4890; Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; Duvvuri M, 2005, BIOCHEMISTRY-US, V44, P15743, DOI 10.1021/bi051759w; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; GARCIA MG, 2008, LEUKEMIA RES, V33, P288; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; He Jing, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P348; Hogue DL, 1996, J BIOL CHEM, V271, P9801, DOI 10.1074/jbc.271.16.9801; Hogue DL, 1999, J BIOL CHEM, V274, P12877, DOI 10.1074/jbc.274.18.12877; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Kim H, 1997, AM J PHYSIOL-CELL PH, V273, pC687, DOI 10.1152/ajpcell.1997.273.2.C687; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Lee JT, 2004, CANCER RES, V64, P8397, DOI 10.1158/0008-5472.CAN-04-1612; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Morris DG, 2005, EUR J ENDOCRINOL, V153, P143, DOI 10.1530/eje.1.01937; Peng C, 2005, WORLD J GASTROENTERO, V11, P2704, DOI 10.3748/wjg.v11.i18.2704; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Tazzari PL, 2007, LEUKEMIA, V21, P427, DOI 10.1038/sj.leu.2404523; Tsuruo T, 2003, CANCER SCI, V94, P15, DOI 10.1111/j.1349-7006.2003.tb01345.x; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang TT, 1996, ANAL BIOCHEM, V241, P103, DOI 10.1006/abio.1996.0383; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Zhang XY, 2008, EUR J OBSTET GYN R B, V139, P237, DOI 10.1016/j.ejogrb.2007.12.021; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025	31	95	105	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	43					5785	5795		10.1038/onc.2010.303	http://dx.doi.org/10.1038/onc.2010.303			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	672LY	20711237				2022-12-25	WOS:000283586200004
J	de Oliveira, IFF; Borges, AD; Kooij, V; Bartosiak-Jentys, J; Luirink, J; Scheffers, DJ				Fernandes de Oliveira, Ines Filipa; Borges, Anabela de Sousa; Kooij, Viola; Bartosiak-Jentys, Jeremy; Luirink, Joen; Scheffers, Dirk-Jan			Characterization of ftsZ Mutations that Render Bacillus subtilis Resistant to MinC	PLOS ONE			English	Article							DIVISION INHIBITOR SULA; SITE SELECTION SYSTEM; TO-POLE OSCILLATION; C-TERMINAL TAIL; CELL-DIVISION; ESCHERICHIA-COLI; Z-RING; CRYSTAL-STRUCTURE; ASSEMBLY DYNAMICS; GTPASE ACTIVITY	Background: Cell division in Bacillus subtilis occurs precisely at midcell. Positional control of cell division is exerted by two mechanisms: nucleoid occlusion, through Noc, which prevents division through nucleoids, and the Min system, where the combined action of the MinC, D and J proteins prevents formation of the FtsZ ring at cell poles or recently completed division sites. Methodology/Principal Findings: We used a genetic screen to identify mutations in ftsZ that confer resistance to the lethal overexpression of the MinC/MinD division inhibitor. The FtsZ mutants were purified and found to polymerize to a similar or lesser extent as wild type FtsZ, and all mutants displayed reduced GTP hydrolysis activity indicative of a reduced polymerization turnover. We found that even though the mutations conferred in vivo resistance to MinC/D, the purified FtsZ mutants did not display strong resistance to MinC in vitro. Conclusions/Significance: Our results show that in B. subtilis, overproduction of MinC can be countered by mutations that alter FtsZ polymerization dynamics. Even though it would be very likely that the FtsZ mutants found depend on other Z-ring stabilizing proteins such as ZapA, FtsA or SepF, we found this not to be the case. This indicates that the cell division process in B. subtilis is extremely robust.	[Fernandes de Oliveira, Ines Filipa; Borges, Anabela de Sousa; Scheffers, Dirk-Jan] Univ Nova Lisboa, Bacterial Membrane Prote Lab, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Kooij, Viola; Luirink, Joen; Scheffers, Dirk-Jan] Vrije Univ Amsterdam, Dept Mol Microbiol, Amsterdam, Netherlands; [Bartosiak-Jentys, Jeremy; Scheffers, Dirk-Jan] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Universidade Nova de Lisboa; Vrije Universiteit Amsterdam; University of Oxford	de Oliveira, IFF (corresponding author), Univ Nova Lisboa, Bacterial Membrane Prote Lab, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal.	djscheffers@itqb.unl.pt	Luirink, Joen/AAB-8658-2021; Scheffers, Dirk-Jan/B-9475-2008	Scheffers, Dirk-Jan/0000-0002-9439-9168; Luirink, J./0000-0001-8431-0804	ITQB; Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-MIC/098637/2008]; BBSRC; European Framework Program [F3-2009-223431]; Netherlands Organisation for Scientific Research	ITQB; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Framework Program; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Work done at the Instituto de Tecnologia Quimica e Biologica was funded by an ITQB start-up grant, and by the Fundacao para a Ciencia e Tecnologia (FCT) through a Ciencia2007 fellowship and project grant PTDC/BIA-MIC/098637/2008 (to DJS). Work done in the Sir William Dunn School of Pathology was supported by a BBSRC grant to Jeff Errington. Work done at VU University Amsterdam was supported by European Framework Program DIVINOCELL HEALTH-F3-2009-223431 (to JL) and a VENI grant from the Netherlands Organisation for Scientific Research (to DJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders' websites: FCT (http://alfa.fct.mctes.pt/), BBSRC (http://www.bbsrc.ac.uk/), EU (http://cordis.europa.eu/fp7/home_en.html), NWO (www.nwo.nl).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990; BI E, 1990, J BACTERIOL, V172, P5610, DOI 10.1128/jb.172.10.5610-5616.1990; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; Cordell SC, 2003, P NATL ACAD SCI USA, V100, P7889, DOI 10.1073/pnas.1330742100; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2003, J BACTERIOL, V185, P196, DOI 10.1128/JB.185.1.196-203.2003; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; JENKINSON HF, 1983, J GEN MICROBIOL, V129, P1945; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 2001, J BACTERIOL, V183, P7190, DOI 10.1128/JB.183.24.7190-7197.2001; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Sambrook J., 2002, MOL CLONING LAB MANU; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shiomi D, 2007, J BACTERIOL, V189, P236, DOI 10.1128/JB.00666-06; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12048	10.1371/journal.pone.0012048	http://dx.doi.org/10.1371/journal.pone.0012048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711458	Green Published, gold, Green Submitted			2022-12-25	WOS:000280849100009
J	Cornelissen, M; Zorgdrager, F; Blom, P; Jurriaans, S; Repping, S; van Leeuwen, E; Bakker, M; Berkhout, B; van der Kuyl, AC				Cornelissen, Marion; Zorgdrager, Fokla; Blom, Petra; Jurriaans, Suzanne; Repping, Sjoerd; van Leeuwen, Elisabeth; Bakker, Margreet; Berkhout, Ben; van der Kuyl, Antoinette C.			Lack of Detection of XMRV in Seminal Plasma from HIV-1 Infected Men in The Netherlands	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; PROSTATE-CANCER; GAMMARETROVIRUS XMRV; BLOOD-CELLS; RETROVIRUS; INFECTION; ABSENCE; PREVALENCE; SAMPLES	Background: Xenotropic murine leukaemia virus-related virus (XMRV) is a recently discovered human gammaretrovirus with yet unknown prevalence and transmission route(s). Its presence in prostate stromal fibroblasts and prostatic secretions suggests that XMRV might be sexually transmitted. We chose to study a compartment closely connected to the prostate, a location where XMRV was detected in independent studies. Seminal plasma samples from HIV-1 infected men were examined as they have an increased probability of acquiring sexually transmitted pathogens. Methodology/Principal Findings: We studied the prevalence of XMRV in 93 seminal plasma samples of 54 HIV-1 infected men living in The Netherlands with a nested PCR amplification specifically targeting the XMRV gag gene. As a control for the presence and integrity of retrovirus particles, HIV-1 was amplified from the same samples with a PCR amplification targeting the env gene of the virus, or HIV-1 was quantified with a real-time PCR amplifying part of the pol gene. Conclusions/Significance: Although HIV-1 was amplified from 25% of the seminal plasma samples, no XMRV was detected, suggesting that either the prevalence of XMRV is very low in The Netherlands, or that XMRV is not naturally present in the seminal plasma.	[Cornelissen, Marion; Zorgdrager, Fokla; Bakker, Margreet; Berkhout, Ben; van der Kuyl, Antoinette C.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands; [Blom, Petra; Jurriaans, Suzanne] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands; [Repping, Sjoerd; van Leeuwen, Elisabeth] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Cornelissen, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands.	a.c.vanderkuyl@amc.uva.nl	Van der Kuyl, Antoinette/T-9369-2019	Repping, Sjoerd/0000-0002-6959-149X; van Leeuwen, Elisabeth/0000-0003-2463-9127				Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Calis JCJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-26; Contreras-Galindo R, 2006, J VIROL METHODS, V136, P51, DOI 10.1016/j.jviromet.2006.03.029; DELWART EL, 1995, PCR METH APPL, V4, pS202; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischer N, 2010, EMERG INFECT DIS, V16, P1000, DOI 10.3201/eid1606.100066; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Kunstman KJ, 2010, AIDS, V24, P1784, DOI 10.1097/QAD.0b013e32833b76fb; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Sakuma R, 2010, VIROLOGY, V397, P1, DOI 10.1016/j.virol.2009.11.013; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Singh IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009948; Stang A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-86; Stieler K, 2010, VIROLOGY, V399, P23, DOI 10.1016/j.virol.2009.12.028; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; van Leeuwen E, 2009, NETH J MED, V67, P322; van Leeuwen E, 2008, FERTIL STERIL, V90, P636, DOI 10.1016/j.fertnstert.2007.06.102	25	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12040	10.1371/journal.pone.0012040	http://dx.doi.org/10.1371/journal.pone.0012040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706581	Green Submitted, Green Published, gold			2022-12-25	WOS:000280811900008
J	Douville, RN; Lissitsyn, Y; Hirschfeld, AF; Becker, AB; Kozyrskyj, AL; Liem, J; Bastien, N; Li, Y; Victor, RE; Sekhon, M; Turvey, SE; HayGlass, KT				Douville, Renee N.; Lissitsyn, Yuriy; Hirschfeld, Aaron F.; Becker, Allan B.; Kozyrskyj, Anita L.; Liem, Joel; Bastien, Nathalie; Li, Yan; Victor, Rachel E.; Sekhon, Mehtab; Turvey, Stuart E.; HayGlass, Kent T.			TLR4 Asp299Gly and Thr399Ile Polymorphisms: No Impact on Human Immune Responsiveness to LPS or Respiratory Syncytial Virus	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; FUNCTIONAL CONSEQUENCES; RESPONSES; LIPOPOLYSACCHARIDE; INFECTION; CHILDREN; DISEASE; ASTHMA	Background: A broad variety of natural environmental stimuli, genotypic influences and timing all contribute to expression of protective versus maladaptive immune responses and the resulting clinical outcomes in humans. The role of commonly co-segregating Toll-like receptor 4 (TLR4) non-synonymous single nucleotide polymorphisms Asp299Gly and Thr399Ile in this process remains highly controversial. Moreover, what differential impact these polymorphisms might have in at risk populations with respiratory dysfunction, such as current asthma or a history of infantile bronchiolitis, has never been examined. Here we determine the importance of these polymorphisms in modulating LPS and respiratory syncytial virus (RSV)-driven cytokine responses. We focus on both healthy children and those with clinically relevant respiratory dysfunction. Methodology: To elucidate the impact of TLR4 Asp299Gly and Thr399Ile on cytokine production, we assessed multiple immune parameters in over 200 pediatric subjects aged 7-9. Genotyping was followed by quantification of pro-and anti-inflammatory cytokine responses by fresh peripheral blood mononuclear cells upon acute exposure to LPS or RSV. Principal Findings: In contrast to early reports, neither SNP influenced immune responses evoked by LPS exposure or RSV infection, as measured by the intermediate phenotype of pro-and anti-inflammatory cytokine responses to these ubiquitous agents. There is no evidence of altered sensitivity in populations with "at risk" clinical phenotypes. Conclusions/Significance: Genomic medicine seeks to inform clinical practice. Determination of the TLR4 Asp299Gly/Thr399Ile haplotype is of no clinical benefit in predicting the nature or intensity of cytokine production in children whether currently healthy or among specific at-risk groups characterized by prior infantile broncholitis or current asthma.	[Douville, Renee N.; Lissitsyn, Yuriy; Becker, Allan B.; Kozyrskyj, Anita L.; Liem, Joel; Turvey, Stuart E.; HayGlass, Kent T.] Univ Manitoba, Dept Immunol, CIHR Natl Training Program Allergy & Asthma Res, Winnipeg, MB, Canada; [Li, Yan; HayGlass, Kent T.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Kozyrskyj, Anita L.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Becker, Allan B.; Kozyrskyj, Anita L.; Liem, Joel; HayGlass, Kent T.] Univ Manitoba, Dept Pediat Child Hlth, Winnipeg, MB, Canada; [Bastien, Nathalie; Li, Yan] Canadian Sci Ctr Human & Anim Hlth, Winnipeg, MB, Canada; [Hirschfeld, Aaron F.; Victor, Rachel E.; Sekhon, Mehtab; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, BC Childrens Hosp, Vancouver, BC V6T 1W5, Canada; [Hirschfeld, Aaron F.; Victor, Rachel E.; Sekhon, Mehtab; Turvey, Stuart E.] Child & Family Res Inst, Vancouver, BC, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; Canadian Science Centre for Human & Animal Health; BC Childrens Hospital; University of British Columbia; Child & Family Research Institute	Douville, RN (corresponding author), Univ Manitoba, Dept Immunol, CIHR Natl Training Program Allergy & Asthma Res, Winnipeg, MB, Canada.	sturvey@cw.bc.ca; hayglass@cc.umanitoba.ca	Turvey, Stuart/HGV-1191-2022	Douville, Renee/0000-0002-7854-007X; HayGlass, Kent/0000-0002-4621-7737; Turvey, Stuart/0000-0003-1599-1065	Canadian Institutes for Health Research (CIHR); Canadian Immunodeficiency Society; Canadian Child Health Clinician Scientist Program (CCHCSP); CIHR Team in Mutagenesis and Infectious Diseases	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Immunodeficiency Society; Canadian Child Health Clinician Scientist Program (CCHCSP); CIHR Team in Mutagenesis and Infectious Diseases(Canadian Institutes of Health Research (CIHR))	This work was supported by fellowships and grants from the Canadian Institutes for Health Research (CIHR). R.N.D. was also supported by the Mindel and Tom Olenick Award in Immunology and as a member of the CIHR National Training Program in Allergy and Asthma. S. E. T. is supported by a Chaim Roifman Scholar Award from the Canadian Immunodeficiency Society, a Career Development Award from the Canadian Child Health Clinician Scientist Program (CCHCSP)-a CIHR Strategic Training Program, and the CIHR Team in Mutagenesis and Infectious Diseases. K. T. H. holds the Canada Research Chair in Immune Regulation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Bell J, 2004, NATURE, V429, P453, DOI 10.1038/nature02624; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; Custovic A, 2006, PAEDIATR RESPIR REV, V7, pS90, DOI 10.1016/j.prrv.2006.04.164; Cyr SL, 2009, VACCINE, V27, P421, DOI 10.1016/j.vaccine.2008.10.073; Ehl S, 2004, EUR J IMMUNOL, V34, P1146, DOI 10.1002/eji.200324449; Faisca P, 2006, MICROBES INFECT, V8, P621, DOI 10.1016/j.micinf.2005.08.010; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hirschfeld AF, 2007, CLIN IMMUNOL, V122, P271, DOI 10.1016/j.clim.2006.10.012; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Klouwenberg PK, 2009, CRIT REV IMMUNOL, V29, P531, DOI 10.1615/CritRevImmunol.v29.i6.40; Kozyrskyj AL, 2009, ALLERGY, V64, P1185, DOI 10.1111/j.1398-9995.2009.02033.x; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Moore ML, 2006, PHARMACOL THERAPEUT, V112, P405, DOI 10.1016/j.pharmthera.2006.04.008; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Paulus SC, 2007, CLIN IMMUNOL, V123, P252, DOI 10.1016/j.clim.2007.03.003; Pulendran B, 2007, NEW ENGL J MED, V356, P1776, DOI 10.1056/NEJMcibr070454; Puthothu B, 2006, DIS MARKERS, V22, P303, DOI 10.1155/2006/865890; REIJMERINK NE, ALLERGY, V65, P199; Scagnolari C, 2009, CLIN VACCINE IMMUNOL, V16, P816, DOI 10.1128/CVI.00445-08; Stefura William P., 2008, V138, P107, DOI 10.1007/978-1-59745-366-0_10; Stinson Monique, 2008, V138, P121, DOI 10.1007/978-1-59745-366-0_11; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Tantisira K, 2009, CURR ALLERGY ASTHM R, V9, P10, DOI 10.1007/s11882-009-0002-9; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Turvey SE, 2006, CLIN IMMUNOL, V120, P1, DOI 10.1016/j.clim.2006.02.003; van der Graaf C, 2005, CYTOKINE, V30, P264, DOI 10.1016/j.cyto.2005.02.001; von Aulock S, 2003, J INFECT DIS, V188, P938, DOI 10.1086/378095	38	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12087	10.1371/journal.pone.0012087	http://dx.doi.org/10.1371/journal.pone.0012087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711470	Green Submitted, gold, Green Published			2022-12-25	WOS:000280811900027
J	Ghosal, K; Stathopoulos, A; Pimplikar, SW				Ghosal, Kaushik; Stathopoulos, Andrea; Pimplikar, Sanjay W.			APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; MOUSE MODEL; BETA; HYPOTHESIS; HOMEOSTASIS; ACTIVATION	Background: A devastating aspect of Alzheimer's disease (AD) is the progressive deterioration of memory due to neuronal loss. Amyloid precursor protein (APP) occupies a central position in AD and APP-derived amyloid-beta (A beta) peptides are thought to play a pivotal role in disease pathogenesis. Nonetheless, it is becoming clear that AD etiology is highly complex and that factors other than A beta also contribute to AD pathogenesis. APP intracellular domain (AICD) is generated together with A beta and we recently showed that AICD transgenic mice recapitulate pathological features of AD such as tau hyperphosphorylation, memory deficits and neurodegeneration without increasing the A beta levels. Since impaired adult neurogenesis is shown to augment memory deficits in AD mouse models, here we examined the status of adult neurogenesis in AICD transgenic mice. Methodology/Principal Finding: We previously generated transgenic mice co-expressing 59-residue long AICD fragment and its binding partner Fe65. Hippocampal progenitor cell proliferation was determined by BrdU incorporation at 1.5, 3 and 12 months of age. Only male transgenic and their respective wilt type littermate control mice were used. We find age-dependent decrease in BrdU incorporation and doublecortin-positive cells in the dentate gyrus of AICD transgenic mice suggesting impaired adult neurogenesis. This deficit resulted from decreased proliferation and survival, whereas neuronal differentiation remained unaffected. Importantly, this impairment was independent of A beta since APP-KO mice expressing AICD also exhibit reduced neurogenesis. The defects in adult neurogenesis are prevented by long-term treatment with the non-steroidal anti-inflammatory agents ibuprofen or naproxen suggesting that neuroinflammation is critically involved in impaired adult neurogenesis in AICD transgenic mice. Conclusion/Significance: Since adult neurogenesis is crucial for spatial memory, which is particularly vulnerable in AD, these findings suggest that AICD can exacerbate memory defects in AD by impairing adult neurogenesis. Our findings further establish that AICD, in addition to A beta, contributes to AD pathology and that neuroinflammation plays a much broader role in AD pathogenesis than previously thought.	[Ghosal, Kaushik; Stathopoulos, Andrea; Pimplikar, Sanjay W.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ghosal, K (corresponding author), Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA.	pimplis@ccf.org			National Institutes of Health [R01-AG026146]; Alzheimer's Association; CART-Rotary Funds; NATIONAL INSTITUTE ON AGING [R01AG026146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); CART-Rotary Funds; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01-AG026146 and funding from Alzheimer's Association and CART-Rotary Funds to SWP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; DEMARS M, J NEUROSCI RES; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Ghosal K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.020; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; GLASS CK, CELL, V140, P918; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Klempin F, 2007, EUR ARCH PSY CLIN N, V257, P271, DOI 10.1007/s00406-007-0731-5; Lamb BT, 1999, NAT NEUROSCI, V2, P695, DOI 10.1038/11154; LAZAROV O, 2009, EXP NEUROL; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Taupin Philippe, 2008, Int J Med Sci, V5, P127; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VOGT DL, 2009, NEUROBIOL AGING; WANG JM, P NATL ACAD SCI US, V107, P6498; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; WHITNEY NP, J NEUROCHEM, V108, P1343; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	48	78	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11866	10.1371/journal.pone.0011866	http://dx.doi.org/10.1371/journal.pone.0011866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689579	gold, Green Published			2022-12-25	WOS:000280520300007
J	Ohms, VR; Snelderwaard, PC; ten Cate, C; Beckers, GJL				Ohms, Verena R.; Snelderwaard, Peter Ch.; ten Cate, Carel; Beckers, Gabriel J. L.			Vocal Tract Articulation in Zebra Finches	PLOS ONE			English	Article							OSCINE BIRD SOUND; TRACHEAL ELONGATION; SONG PRODUCTION; BEAK MOVEMENTS; MECHANISMS; RESONANCES; FREQUENCY; SPARROWS; DYNAMICS; SYRINX	Background: Birdsong and human vocal communication are both complex behaviours which show striking similarities mainly thought to be present in the area of development and learning. Recent studies, however, suggest that there are also parallels in vocal production mechanisms. While it has been long thought that vocal tract filtering, as it occurs in human speech, only plays a minor role in birdsong there is an increasing number of studies indicating the presence of sound filtering mechanisms in bird vocalizations as well. Methodology/Principal Findings: Correlating high-speed X-ray cinematographic imaging of singing zebra finches (Taeniopygia guttata) to song structures we identified beak gape and the expansion of the oropharyngeal-esophageal cavity (OEC) as potential articulators. We subsequently manipulated both structures in an experiment in which we played sound through the vocal tract of dead birds. Comparing acoustic input with acoustic output showed that OEC expansion causes an energy shift towards lower frequencies and an amplitude increase whereas a wide beak gape emphasizes frequencies around 5 kilohertz and above. Conclusion: These findings confirm that birds can modulate their song by using vocal tract filtering and demonstrate how OEC and beak gape contribute to this modulation.	[Ohms, Verena R.; Snelderwaard, Peter Ch.; ten Cate, Carel] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [ten Cate, Carel] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Beckers, Gabriel J. L.] Max Planck Inst Ornithol, Seewiesen, Germany	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society	Ohms, VR (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.	v.r.ohms@biology.leidenuniv.nl	Cate, Carel ten/G-2075-2012		Netherlands Organization for Scientific Research (NWO) [815.02.011]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Funding was provided by the Netherlands Organization for Scientific Research (NWO). Grant Number 815.02.011. http://www.nwo.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, COURSE PHONETICS; Ballintijn MR, 1998, J EXP BIOL, V201, P1637; Beckers GJL, 2004, CURR BIOL, V14, P1592, DOI 10.1016/j.cub.2004.08.057; Boersma P, 2001, GLOT INT, V5, P341; CLENCH MH, 1978, CONDOR, V80, P423, DOI 10.2307/1367193; Daley M, 2004, J NEUROBIOL, V59, P319, DOI 10.1002/neu.10332; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Fant G., 1960, ACOUSTIC THEORY SPEE; Fitch WT, 1999, J ZOOL, V248, P31, DOI 10.1017/S095283699900504X; Fitch WT, 2000, ETHOLOGY, V106, P559, DOI 10.1046/j.1439-0310.2000.00572.x; Fletcher NH, 1999, J ACOUST SOC AM, V105, P35, DOI 10.1121/1.424620; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Goller F, 2004, J NEUROBIOL, V59, P289, DOI 10.1002/neu.10327; Greenewalt C.H., 1968, BIRD SONG ACOUSTICS; HAUSBERGER M, 1991, ANIM BEHAV, V42, P319, DOI 10.1016/S0003-3472(05)80565-2; HEIDWEILLER J, 1990, CONDOR, V92, P1, DOI 10.2307/1368379; Hoese WJ, 2000, J EXP BIOL, V203, P1845; Jones E., 2001, LEAST SQUARE REGRESS; Nelson BS, 2005, J EXP BIOL, V208, P297, DOI 10.1242/jeb.01378; NOWICKI S, 1986, SCIENCE, V231, P1297, DOI 10.1126/science.3945824; NOWICKI S, 1987, NATURE, V325, P53, DOI 10.1038/325053a0; Plummer EM, 2008, J EXP BIOL, V211, P66, DOI 10.1242/jeb.011908; Podos J, 2004, J EXP BIOL, V207, P607, DOI 10.1242/jeb.00770; PODOS J, 1995, ANIM BEHAV, V50, P1287, DOI 10.1016/0003-3472(95)80044-1; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Riede T, 2004, J EXP BIOL, V207, P4025, DOI 10.1242/jeb.01256; Riede T, 2009, J COMP PHYSIOL A, V195, P183, DOI 10.1007/s00359-008-0397-0; Snelderwaard PC, 2002, J BIOMECH, V35, P1007, DOI 10.1016/S0021-9290(02)00035-0; Suthers RA, 1997, J NEUROBIOL, V33, P632, DOI 10.1002/(SICI)1097-4695(19971105)33:5<632::AID-NEU10>3.0.CO;2-B; SUTHERS RA, 1990, NATURE, V347, P473, DOI 10.1038/347473a0; Titze I. R., 2000, PRINCIPLES VOICE PRO; WESTNEAT MW, 1993, J EXP BIOL, V182, P147; Williams H, 2001, J EXP BIOL, V204, P3497; Zollinger SA, 2008, J EXP BIOL, V211, P1978, DOI 10.1242/jeb.014092	34	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11923	10.1371/journal.pone.0011923	http://dx.doi.org/10.1371/journal.pone.0011923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689831	Green Published, gold			2022-12-25	WOS:000280520300032
J	Caicedo-Carvajal, CE; Shinbrot, T; Foty, RA				Caicedo-Carvajal, Carlos E.; Shinbrot, Troy; Foty, Ramsey A.			alpha 5 beta 1 Integrin-Fibronectin Interactions Specify Liquid to Solid Phase Transition of 3D Cellular Aggregates	PLOS ONE			English	Article							EMBRYONIC-TISSUES; QUANTITATIVE DIFFERENCES; XENOPUS FIBRILLIN; SURFACE TENSIONS; MATRIX STIFFNESS; ADHESION; CELLS; FIBROBLASTS; EXPRESSION; DETACHMENT	Background: Tissue organization during embryonic development and wound healing depends on the ability of cells on the one hand to exchange adhesive bonds during active rearrangement and on the other to become fixed in place as tissue homeostasis is reached. Cells achieve these contradictory tasks by regulating either cell-cell adhesive bonds, mediated by cadherins, or cell-extracellular matrix (ECM) connections, regulated by integrins. Integrin alpha 5 beta 1 and soluble fibronectin (sFN) are key players in cell-ECM force generation and in ECM polymerization. Here, we explore the interplay between integrin alpha 5 beta 1 and sFN and its influence on tissue mechanical properties and cell sorting behavior. Methodology/Principal Findings: We generated a series of cell lines varying in alpha 5 beta 1 receptor density. We then systematically explored the effects of different sFN concentrations on aggregate biomechanical properties using tissue surface tensiometry. We found previously unreported complex behaviors including the observation that interactions between fibronectin and integrin alpha 5 beta 1 generates biphasic tissue cohesion profiles. Specifically, we show that at constant sFn concentration, aggregate cohesion increases linearly as alpha 5 beta 1 receptor density is increased from low to moderate levels, producing a transition from viscoelastic-liquid to pseudo viscoelastic-solid behavior. However, further increase in receptor density causes an abrupt drop in tissue cohesion and a transition back to viscoelastic-liquid properties. We propose that this may be due to depletion of sFn below a critical value in the aggregate microenvironment at high alpha 5 beta 1 levels. We also show that differential expression of alpha 5 beta 1 integrin can promote phase-separation between cells. Conclusions/Significance: The interplay between alpha 5-integrin and sFn contributes significantly to tissue cohesion and, depending on their level of expression, can mediate a shift from liquid to elastic behavior. This interplay represents a tunable level of control between integrins and the ECM that can influence tissue cohesion and other mechanical properties, which may translate to the specification of tissue structure and function. These studies provide insights into important biological processes such as embryonic development, wound healing, and for tissue engineering applications.	[Caicedo-Carvajal, Carlos E.; Shinbrot, Troy] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA; [Foty, Ramsey A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Caicedo-Carvajal, CE (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA.	fotyra@umdnj.edu			National Institutes of Health (NIH) [1R01CA118755]; NATIONAL CANCER INSTITUTE [R01CA118755] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by National Institutes of Health (NIH) grant # 1R01CA118755 to RAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG PB, 1981, J CELL SCI, V50, P121; ARMSTRONG PB, 1980, J CELL SCI, V44, P263; ARMSTRONG PB, 2000, BIOCHIM BIOPHYS ACTA, V1470, P9; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; BEFFARA V, 2006, POLYM PINNING RANDOM; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; Damon BJ, 2008, DEV BIOL, V321, P319, DOI 10.1016/j.ydbio.2008.06.018; Davies J.T., 1963, INTERFACIAL PHENOMEN; Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741; Downie SA, 1995, DEV BIOL, V172, P519, DOI 10.1006/dbio.1995.8068; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Engler AJ, 2009, J CELL SCI, V122, P1647, DOI 10.1242/jcs.040824; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Foty RA, 1996, DEVELOPMENT, V122, P1611; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Julich D, 2009, DEVELOPMENT, V136, P2913, DOI 10.1242/dev.038935; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; LIU AJ, 2010, ANN REV COND MAT PHY; NEWMAN SA, 1985, SCIENCE, V228, P885, DOI 10.1126/science.4001925; Newman SA, 2004, PHYS BIOL, V1, P100, DOI 10.1088/1478-3967/1/2/006; Palecek SP, 1996, J CELL SCI, V109, P941; Palecek SP, 1998, J CELL SCI, V111, P929; PHILLIPS HM, 1978, J CELL SCI, V30, P1; Robinson EE, 2003, J CELL SCI, V116, P377, DOI 10.1242/jcs.00231; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; Skoglund P, 2006, DEV DYNAM, V235, P1974, DOI 10.1002/dvdy.20818; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STEINBERG MS, 1992, DYNAMICAL PHENOMENA, P3; Winters BS, 2006, MOL BIOL CELL, V17, P3386, DOI 10.1091/mbc.E05-09-0849; WISEMAN LL, 1972, DEV BIOL, V28, P498, DOI 10.1016/0012-1606(72)90033-4; YAMADA KM, 1975, P NATL ACAD SCI USA, V72, P3158, DOI 10.1073/pnas.72.8.3158; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235	42	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11830	10.1371/journal.pone.0011830	http://dx.doi.org/10.1371/journal.pone.0011830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686611	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520200009
J	Tang, JY; Li, S; Li, ZH; Zhang, ZJ; Hu, GA; Cheang, LCV; Alex, D; Hoi, MPM; Kwan, YW; Chan, SW; Leung, GPH; Lee, SMY				Tang, Jing Yan; Li, Shang; Li, Zhen Hua; Zhang, Zai Jun; Hu, Guang; Cheang, Lorita Chi Veng; Alex, Deepa; Hoi, Maggie Pui Man; Kwan, Yiu Wa; Chan, Shun Wan; Leung, George Pak Heng; Lee, Simon Ming Yuen			Calycosin Promotes Angiogenesis Involving Estrogen Receptor and Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Zebrafish and HUVEC	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHINESE HERBAL DECOCTION; RADIX ANGELICAE SINENSIS; IN-VITRO; NITRIC-OXIDE; BIOLOGICAL ASSESSMENT; CORONARY-ARTERY; BREAST-CANCER; CELLS; ASTRAGALI	Background: Angiogenesis plays an important role in a wide range of physiological processes, and many diseases are associated with the dysregulation of angiogenesis. Radix Astragali is a Chinese medicinal herb commonly used for treating cardiovascular disorders and has been shown to possess angiogenic effect in previous studies but its active constituent and underlying mechanism remain unclear. The present study investigates the angiogenic effects of calycosin, a major isoflavonoid isolated from Radix Astragali, in vitro and in vivo. Methodology: Tg(fli1:EGFP) and Tg(fli1:nEGFP) transgenic zebrafish embryos were treated with different concentrations of calycosin (10, 30, 100 mu M) from 72 hpf to 96 hpf prior morphological observation and angiogenesis phenotypes assessment. Zebrafish embryos were exposed to calycosin (10, 100 mu M) from 72 hpf to 78 hpf before gene-expression analysis. The effects of VEGFR tyrosine kinase inhibitor on calycosin-induced angiogenesis were studied using 72 hpf Tg(fli1:EGFP) and Tg(fli1:nEGFP) zebrafish embryos. The pro-angiogenic effects of calycosin were compared with raloxifene and tamoxifen in 72 hpf Tg(fli1:EGFP) zebrafish embryos. The binding affinities of calycosin to estrogen receptors (ERs) were evaluated by cell-free and cell-based estrogen receptor binding assays. Human umbilical vein endothelial cell cultures (HUVEC) were pretreated with different concentrations of calycosin (3, 10, 30, 100 mu M) for 48 h then tested for cell viability and tube formation. The role of MAPK signaling in calycosin-induced angiogenesis was evaluated using western blotting. Conclusion: Calycosin was shown to induce angiogenesis in human umbilical vein endothelial cell cultures (HUVEC) in vitro and zebrafish embryos in vivo via the up-regulation of vascular endothelial growth factor (VEGF), VEGFR1 and VEGFR2 mRNA expression. It was demonstrated that calycosin acted similar to other selective estrogen receptor modulators (SERMs), such as raloxifene and tamoxifen, by displaying selective potency and affinity to estrogen receptors ER alpha and ER beta. Our results further indicated that calycosin promotes angiogenesis via activation of MAPK with the involvement of ERK1/2 and ER. Together, this study revealed, for the first time, that calycosin acts as a selective estrogen receptor modulator (SERM) to promote angiogenesis, at least in part through VEGF-VEGFR2 and MAPK signaling pathways.	[Tang, Jing Yan; Li, Shang; Li, Zhen Hua; Zhang, Zai Jun; Hu, Guang; Cheang, Lorita Chi Veng; Alex, Deepa; Hoi, Maggie Pui Man; Lee, Simon Ming Yuen] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China; [Kwan, Yiu Wa] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, Shun Wan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, State Key Lab Chinese Med & Mol Pharmacol, Hong Kong, Hong Kong, Peoples R China; [Leung, George Pak Heng] Univ Hong Kong, Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China	University of Macau; Chinese University of Hong Kong; Hong Kong Polytechnic University; University of Hong Kong	Tang, JY (corresponding author), Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China.	SimonLee@umac.mo	Philippot, Laurent/G-5598-2011; tang, jing/HHR-9815-2022; Kwan, Yiu Wa/R-6468-2018; Chan, Shun-Wan/K-9363-2013; Hoi, Maggie Pui Man/AAY-5962-2021; Leung, George Pak Heng/B-4529-2009	Philippot, Laurent/0000-0003-3461-4492; Kwan, Yiu Wa/0000-0002-9024-1275; Chan, Shun-Wan/0000-0001-8238-798X; Leung, George Pak Heng/0000-0003-3529-9367; Hoi, Maggie Pui Man/0000-0003-2630-3707	Science and Technology Development Fund of Macau SAR [045/2007/A3]; Research Committee, University of Macau [RG085, UL017/09-Y1]	Science and Technology Development Fund of Macau SAR; Research Committee, University of Macau	This study is supported by grant from the Science and Technology Development Fund of Macau SAR (Ref. No. 045/2007/A3) and Research Committee, University of Macau (Ref. No. RG085 and UL017/09-Y1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhem Tomas, 2004, Am J Pharmacogenomics, V4, P19, DOI 10.2165/00129785-200404010-00003; Bracamonte MP, 2002, J CARDIOVASC PHARM, V39, P704, DOI 10.1097/00005344-200205000-00011; Cai Xiao-yan, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P443; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chan CM, 2007, J ETHNOPHARMACOL, V109, P10, DOI 10.1016/j.jep.2006.06.003; Chen X, 1997, Zhongguo Zhong Yao Za Zhi, V22, P432; Chen XJ, 2006, AM J CHINESE MED, V34, P493, DOI 10.1142/S0192415X06004028; Choi R CY, 2009, EVID BASED COMPLEMEN, DOI 10.1093/ecam/nen085; Cid MC, 2002, ANN NY ACAD SCI, V966, P143, DOI 10.1111/j.1749-6632.2002.tb04211.x; Conner P, 2008, CLIN OBSTET GYNECOL, V51, P592, DOI 10.1097/GRF.0b013e318180b8ed; Dong TTX, 2006, J AGR FOOD CHEM, V54, P2767, DOI 10.1021/jf053163l; Doshida M, 2006, J BIOL CHEM, V281, P24270, DOI 10.1074/jbc.M513251200; Fan TP, 2006, TRENDS PHARMACOL SCI, V27, P297, DOI 10.1016/j.tips.2006.04.006; Fan Y, 2003, EUR J PHARMACOL, V481, P33, DOI 10.1016/j.ejphar.2003.09.007; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Fong TAT, 1999, CANCER RES, V59, P99; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Furet P, 2003, BIOORG MED CHEM LETT, V13, P2967, DOI 10.1016/S0960-894X(03)00626-7; Gao QT, 2007, FEBS LETT, V581, P233, DOI 10.1016/j.febslet.2006.12.018; Geraldes P, 2003, CIRC RES, V93, P399, DOI 10.1161/01.RES.0000088640.18462.42; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; He J, 1999, Zhonghua Yi Xue Za Zhi, V79, P654; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Johns A, 1996, ENDOCRINOLOGY, V137, P4511, DOI 10.1210/en.137.10.4511; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Kim KH, 2008, STEROIDS, V73, P864, DOI 10.1016/j.steroids.2008.01.008; KimSchulze S, 1996, CIRCULATION, V94, P1402, DOI 10.1161/01.CIR.94.6.1402; Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5; Kostelac D, 2003, J AGR FOOD CHEM, V51, P7632, DOI 10.1021/jf034427b; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Leung FP, 2007, BRIT J PHARMACOL, V152, P223, DOI 10.1038/sj.bjp.0707387; Leung HS, 2006, BRIT J PHARMACOL, V149, P703, DOI 10.1038/sj.bjp.0706921; Liu K, 1990, Zhong Xi Yi Jie He Za Zhi, V10, P330; LIU K, 1990, ZHONG XI YI JIE HE Z, V10, P323; Liu L, 2006, J DERMATOL SCI, V44, P48, DOI 10.1016/j.jdermsci.2006.05.009; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Merchan JR, 2003, J NATL CANCER I, V95, P388, DOI 10.1093/jnci/95.5.388; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; Pages G, 2000, ANN NY ACAD SCI, V902, P187; PARK JE, 1994, J BIOL CHEM, V269, P25646; Pinna C, 2006, J PHARMACOL EXP THER, V319, P1444, DOI 10.1124/jpet.106.106062; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Seng Wen Lin, 2004, Angiogenesis, V7, P243, DOI 10.1007/s10456-004-4181-7; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shi Zi-Yi, 2007, Zhongguo Zhong Yao Za Zhi, V32, P779; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Song JZ, 2008, J PHARMACEUT BIOMED, V47, P399, DOI 10.1016/j.jpba.2007.12.036; Song ZH, 2004, PLANTA MED, V70, P1222, DOI 10.1055/s-2004-835855; Suzuma I, 1999, INVEST OPHTH VIS SCI, V40, P2122; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; Valachovicova T, 2004, MINI-REV MED CHEM, V4, P881, DOI 10.2174/1389557043403387; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilkinson JM, 2008, J BIOMOL SCREEN, V13, P755, DOI 10.1177/1087057108322155; Wong CM, 2008, BRIT J PHARMACOL, V155, P326, DOI 10.1038/bjp.2008.262; Wren BG, 2009, MED J AUSTRALIA, V190, P321, DOI 10.5694/j.1326-5377.2009.tb02423.x; Xi Sichuan, 1998, Zhonghua Jiehe He Huxi Zazhi, V21, P303; Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999; Xu XL, 2008, PHYTOTHER RES, V22, P389, DOI 10.1002/ptr.2332; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zhang Y, 2009, PHYTOTHER RES, V23, P1205, DOI 10.1002/ptr.2479; Zhao Zhuanyou, 2009, Chin Med, V4, P6, DOI 10.1186/1749-8546-4-6	64	102	109	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11822	10.1371/journal.pone.0011822	http://dx.doi.org/10.1371/journal.pone.0011822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686605	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520200007
J	Vempati, P; Mac Gabhann, F; Popel, AS				Vempati, Prakash; Mac Gabhann, Feilim; Popel, Aleksander S.			Quantifying the Proteolytic Release of Extracellular Matrix-Sequestered VEGF with a Computational Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL ARTERIAL-DISEASE; METALLOPROTEINASE MMP 2; CELL-SURFACE; TISSUE INHIBITOR; BRANCHING MORPHOGENESIS; PLASMINOGEN-ACTIVATOR; ANGIOGENIC SWITCH; COMPARTMENT MODEL; BASEMENT-MEMBRANE	Background: VEGF proteolysis by plasmin or matrix metalloproteinases (MMPs) is believed to play an important role in regulating vascular patterning in vivo by releasing VEGF from the extracellular matrix (ECM). However, a quantitative understanding of the kinetics of VEGF cleavage and the efficiency of cell-mediated VEGF release is currently lacking. To address these uncertainties, we develop a molecular-detailed quantitative model of VEGF proteolysis, used here in the context of an endothelial sprout. Methodology and Findings: To study a cell's ability to cleave VEGF, the model captures MMP secretion, VEGF-ECM binding, VEGF proteolysis from VEGF(165) to VEGF(114) (the expected MMP cleavage product of VEGF165) and VEGF receptor-mediated recapture. Using experimental data, we estimated the effective bimolecular rate constant of VEGF(165) cleavage by plasmin to be 328 M(-1)s(-1) at 25 degrees C, which is relatively slow compared to typical MMP-ECM proteolysis reactions. While previous studies have implicated cellular proteolysis in growth factor processing, we show that single cells do not individually have the capacity to cleave VEGF to any appreciable extent (less than 0.1% conversion). In addition, we find that a tip cell's receptor system will not efficiently recapture the cleaved VEGF due to an inability of cleaved VEGF to associate with Neuropilin-1. Conclusions: Overall, VEGF(165) cleavage in vivo is likely to be mediated by the combined effect of numerous cells, instead of behaving in a single-cell-directed, autocrine manner. We show that heparan sulfate proteoglycans (HSPGs) potentiate VEGF cleavage by increasing the VEGF clearance time in tissues. In addition, we find that the VEGF-HSPG complex is more sensitive to proteases than is soluble VEGF, which may imply its potential relevance in receptor signaling. Finally, according to our calculations, experimentally measured soluble protease levels are approximately two orders of magnitude lower than that needed to reconcile levels of VEGF cleavage seen in pathological situations.	[Vempati, Prakash; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Mac Gabhann, Feilim] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Vempati, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	pvempat1@jhu.edu	Mac Gabhann, Feilim/A-3436-2010; Popel, Aleksander S/A-6724-2009	Mac Gabhann, Feilim/0000-0003-3481-7740; Popel, Aleksander/0000-0002-6706-9235	National Institutes of Health (NIH) [R01 CA138264, R01 HL101200, U54 CA143868, R00 HL093219]; NATIONAL CANCER INSTITUTE [R01CA138264, U54CA143868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093219, R01HL101200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: the National Institutes of Health (NIH) grants, R01 CA138264, R01 HL101200, and U54 CA143868 (ASP), and R00 HL093219 (FMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGELER J, 1984, J CELL BIOL, V98, P1656, DOI 10.1083/jcb.98.5.1656; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Bendeck MP, 2004, CIRC RES, V94, P138, DOI 10.1161/01.RES.0000117525.23089.1A; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Buczek-Thomas JA, 2004, AM J RESP CELL MOL, V31, P344, DOI 10.1165/rcmb.2003-0420OC; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236; Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08; Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002; ELKAREH AW, 1993, BIOPHYS J, V64, P1638, DOI 10.1016/S0006-3495(93)81532-7; Filion RJ, 2005, AM J PHYSIOL-HEART C, V288, pH263, DOI 10.1152/ajpheart.00205.2004; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Furuya M, 2000, GYNECOL ONCOL, V78, P106, DOI 10.1006/gyno.2000.5856; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/10739680802095964; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Gopalakrishnan M, 2005, BIOPHYS J, V89, P3686, DOI 10.1529/biophysj.105.065300; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; GROSS JL, 1982, J CELL BIOL, V95, P974, DOI 10.1083/jcb.95.3.974; Gutierrez J, 2008, CLIN CHEM, V54, P597, DOI 10.1373/clinchem.2007.096099; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; HERRON GS, 1986, J BIOL CHEM, V261, P2810; Herve MA, 2008, AM J PATHOL, V172, P167, DOI 10.2353/ajpath.2008.070181; Homandberg GA, 1997, BIOCHEM J, V321, P751, DOI 10.1042/bj3210751; Hornebeck W, 1999, ANN NY ACAD SCI, V878, P625, DOI 10.1111/j.1749-6632.1999.tb07745.x; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Jakobsson L, 2008, FASEB J, V22, P1530, DOI 10.1096/fj.07-9617com; Ji JW, 2007, AM J PHYSIOL-HEART C, V293, pH3740, DOI 10.1152/ajpheart.00009.2007; Johnson EM, 1996, BIOPHYS J, V70, P1017, DOI 10.1016/S0006-3495(96)79645-5; Jung S, 2006, J NEURO-ONCOL, V76, P257, DOI 10.1007/s11060-005-6876-z; Kanematsu A, 2004, J CONTROL RELEASE, V99, P281, DOI 10.1016/j.jconrel.2004.07.008; Karagiannis ED, 2006, J THEOR BIOL, V238, P124, DOI 10.1016/j.jtbi.2005.05.020; Karagiannis ED, 2004, J BIOL CHEM, V279, P39105, DOI 10.1074/jbc.M403627200; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; KURTAGIC E, 2009, AM J PHYSL LUNG CELL; Kut C, 2007, BRIT J CANCER, V97, P978, DOI 10.1038/sj.bjc.6603923; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; Lauer G, 2002, FEBS LETT, V531, P309, DOI 10.1016/S0014-5793(02)03545-7; LAUFFENBURGER DA, 1993, RECEPTORS MODELS BIN, P144; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Lundkvist A, 2007, NOVART FDN SYMP, V283, P201; Lundkvist A, 2007, NOVART FDN SYMP, V283, P238; Lundkvist Andrea, 2007, Novartis Found Symp, V283, P194; Mac Gabhann F, 2005, AM J PHYSIOL-HEART C, V288, pH2851, DOI 10.1152/ajpheart.01218.2004; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mac Gabhann F, 2007, ANN BIOMED ENG, V35, P982, DOI 10.1007/s10439-007-9303-0; Magalhaes J, 2005, BASIC APPL MYOL, V15, P29; Maquoi E, 2000, EXP CELL RES, V261, P348, DOI 10.1006/excr.2000.5063; Michizono K, 2001, NEUROLOGY, V56, P807, DOI 10.1212/WNL.56.6.807; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Mineur P, 2007, J CELL BIOL, V179, P1261, DOI 10.1083/jcb.200703052; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Osawa T, 2003, J ELECTRON MICROSC, V52, P435, DOI 10.1093/jmicro/52.4.435; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Owen CA, 2003, AM J RESP CELL MOL, V29, P283, DOI 10.1165/rcmb.2003-0034OC; Paczek L, 2008, AGE AGEING, V37, P318, DOI 10.1093/ageing/afn039; Paczek L, 2009, AGING CLIN EXP RES, V21, P9; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Partridge CA, 1997, AM J PHYSIOL-LUNG C, V272, pL813, DOI 10.1152/ajplung.1997.272.5.L813; Plouet J, 1997, J BIOL CHEM, V272, P13390, DOI 10.1074/jbc.272.20.13390; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; Prause O, 2004, THORAX, V59, P313, DOI 10.1136/thx.2003.008854; Press WH., 2002, NUMERICAL RECIPES C, V2; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Reinhardt D, 2002, HEART, V88, P525, DOI 10.1136/heart.88.5.525; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; SIRES UI, 1993, J BIOL CHEM, V268, P2069; Small AR, 2008, J THEOR BIOL, V252, P593, DOI 10.1016/j.jtbi.2008.02.009; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Staack Andrea, 2006, BMC Urol, V6, P19, DOI 10.1186/1471-2490-6-19; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Vempati P, 2007, J BIOL CHEM, V282, P37585, DOI 10.1074/jbc.M611500200; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Wu FTH, 2010, J CELL MOL MED, V14, P528, DOI 10.1111/j.1582-4934.2009.00941.x; Wu FTH, 2009, PHYSIOL GENOMICS, V38, P29, DOI 10.1152/physiolgenomics.00031.2009; Wu FTH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005108; Yao C, 2006, BIOMATERIALS, V27, P1608, DOI 10.1016/j.biomaterials.2005.08.037; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163; Yuan F, 2001, ANN BIOMED ENG, V29, P1150, DOI 10.1114/1.1424915; Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8; Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje	99	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11860	10.1371/journal.pone.0011860	http://dx.doi.org/10.1371/journal.pone.0011860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686621	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520200024
J	Zeng, H; Guo, M; Martins-Taylor, K; Wang, XF; Zhang, Z; Park, JW; Zhan, SN; Kronenberg, MS; Lichtler, A; Liu, HX; Chen, FP; Yue, LX; Li, XJ; Xu, RH				Zeng, Hui; Guo, Min; Martins-Taylor, Kristen; Wang, Xiaofang; Zhang, Zheng; Park, Jung Woo; Zhan, Shuning; Kronenberg, Mark S.; Lichtler, Alexander; Liu, Hui-Xia; Chen, Fang-Ping; Yue, Lixia; Li, Xue-Jun; Xu, Ren-He			Specification of Region-Specific Neurons Including Forebrain Glutamatergic Neurons from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; FIBROBLAST-GROWTH-FACTOR; SPINAL MOTOR-NEURONS; NEURAL PRECURSORS; DIRECTED DIFFERENTIATION; IPS CELLS; HUMAN ES; INDUCTION; SIGNALS; CONVERSION	Background: Directed differentiation of human induced pluripotent stem cells (hiPSC) into functional, region-specific neural cells is a key step to realizing their therapeutic promise to treat various neural disorders, which awaits detailed elucidation. Methodology/Principal Findings: We analyzed neural differentiation from various hiPSC lines generated by others and ourselves. Although heterogeneity in efficiency of neuroepithelial (NE) cell differentiation was observed among different hiPSC lines, the NE differentiation process resembles that from human embryonic stem cells (hESC) in morphology, timing, transcriptional profile, and requirement for FGF signaling. NE cells differentiated from hiPSC, like those from hESC, can also form rostral phenotypes by default, and form the midbrain or spinal progenitors upon caudalization by morphogens. The rostrocaudal neural progenitors can further mature to develop forebrain glutamatergic projection neurons, midbrain dopaminergic neurons, and spinal motor neurons, respectively. Typical ion channels and action potentials were recorded in the hiPSC-derived neurons. Conclusions/Significance: Our results demonstrate that hiPSC, regardless of how they were derived, can differentiate into a spectrum of rostrocaudal neurons with functionality, which supports the considerable value of hiPSC for study and treatment of patient-specific neural disorders.	[Zeng, Hui; Martins-Taylor, Kristen; Wang, Xiaofang; Park, Jung Woo; Xu, Ren-He] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT USA; [Guo, Min; Li, Xue-Jun] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Neurosci, Farmington, CT USA; [Zeng, Hui; Chen, Fang-Ping] Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha, Hunan, Peoples R China; [Guo, Min; Liu, Hui-Xia] Cent S Univ, Xiang Ya Hosp, Dept Geriatr, Changsha, Hunan, Peoples R China; [Zhang, Zheng; Yue, Lixia] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA; [Zhan, Shuning; Kronenberg, Mark S.; Lichtler, Alexander] Univ Connecticut, Ctr Hlth, Dept Regenerat Sci, Farmington, CT USA	University of Connecticut; University of Connecticut; Central South University; Central South University; University of Connecticut; University of Connecticut	Zeng, H (corresponding author), Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT USA.	xjli@uchc.edu; renhexu@uchc.edu	Xu, Ren-He/M-3125-2016; Park, Jung Woo/R-6263-2019; Xu, Ren-He/AAK-7392-2021	Park, Jung Woo/0000-0003-0657-7401; LI, XUEJUN/0000-0003-1899-9134; Martins-Taylor, Kristen/0000-0002-7004-5867	National Institutes of Health [R21 NS055261]; Connecticut Stem Cell Research [06SCD02, 06SCB14]; University of Connecticut Health Center; China Scholarship Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Stem Cell Research; University of Connecticut Health Center; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Ren-He Xu: Connecticut Stem Cell Research Grants (http://www.ct.gov/dph/cwp/view.asp?a=3142&q = 389700, #06SCD02 and 06SCB14). Xue-Jun Li: National Institutes of Health grant (http://grants.nih.gov/grants/funding/r21.htm, #R21 NS055261) and University of Connecticut Health Center start-up funds. Hui Zeng and Min Guo: China Scholarship Council funds (http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Chamberlain SJ, 2008, NEUROGENETICS, V9, P227, DOI 10.1007/s10048-008-0147-z; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Erceg S, 2009, STEM CELLS, V27, P78, DOI 10.1634/stemcells.2008-0543; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kim GJ, 2001, DEV GROWTH DIFFER, V43, P521; LAMB TM, 1995, DEVELOPMENT, V121, P3627; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; LAVAUTE TM, 2009, STEM CELLS; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2006, METH MOL B, V331, P169; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Martins-Taylor K, 2010, J CELL BIOCHEM, V109, P16, DOI 10.1002/jcb.22402; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pomp O, 2008, BRAIN RES, V1230, P50, DOI 10.1016/j.brainres.2008.07.029; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Shinya M, 2001, DEVELOPMENT, V128, P4153; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; XU RH, 1995, BIOCHEM BIOPH RES CO, V212, P212, DOI 10.1006/bbrc.1995.1958; Xu RH, 1997, J NEUROSCI, V17, P6892; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650	51	151	156	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11853	10.1371/journal.pone.0011853	http://dx.doi.org/10.1371/journal.pone.0011853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686615	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520200018
J	Berg, TJ; Gastonguay, AJ; Lorimer, EL; Kuhnmuench, JR; Li, RS; Fields, AP; Williams, CL				Berg, Tracy J.; Gastonguay, Adam J.; Lorimer, Ellen L.; Kuhnmuench, John R.; Li, Rongshan; Fields, Alan P.; Williams, Carol L.			Splice Variants of SmgGDS Control Small GTPase Prenylation and Membrane Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GERANYLGERANYLTRANSFERASE-I; RAS PROTEINS; NUCLEAR-LOCALIZATION; MOLECULAR-CLONING; BINDING PROTEINS; POLYBASIC REGION; GROWTH-FACTOR; CANCER CELLS; IDENTIFICATION	Ras and Rho small GTPases possessing a C-terminal polybasic region (PBR) are vital signaling proteins whose misregulation can lead to cancer. Signaling by these proteins depends on their ability to bind guanine nucleotides and their prenylation with a geranylgeranyl or farnesyl isoprenoid moiety and subsequent trafficking to cellular membranes. There is little previous evidence that cellular signals can restrain nonprenylated GTPases from entering the prenylation pathway, leading to the general belief that PBR-possessing GTPases are prenylated as soon as they are synthesized. Here, we present evidence that challenges this belief. We demonstrate that insertion of the dominant negative mutation to inhibit GDP/GTP exchange diminishes prenylation of Rap1A and RhoA, enhances prenylation of Rac1, and does not detectably alter prenylation of K-Ras. Our results indicate that the entrance and passage of these small GTPases through the prenylation pathway is regulated by two splice variants of SmgGDS, a protein that has been reported to promote GDP/GTP exchange by PBR-possessing GTPases and to be up-regulated in several forms of cancer. We show that the previously characterized 558-residue SmgGDS splice variant (SmgGDS-558) selectively associates with prenylated small GTPases and facilitates trafficking of Rap1A to the plasma membrane, whereas the less well characterized 607-residue SmgGDS splice variant (SmgGDS-607) associates with nonprenylated GTPases and regulates the entry of Rap1A, RhoA, and Rac1 into the prenylation pathway. These results indicate that guanine nucleotide exchange and interactions with SmgGDS splice variants can regulate the entrance and passage of PBR-possessing small GTPases through the prenylation pathway.	[Williams, Carol L.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Kuhnmuench, John R.; Li, Rongshan] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Li, Rongshan] Plus Diagnost, Union, NJ 07083 USA; [Fields, Alan P.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Medical College of Wisconsin; Medical College of Wisconsin; Mayo Clinic	Williams, CL (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	williams@mcw.edu			National Institutes of Health, NCI [R01 CA136799, R01 CA081436-12]; National Institutes of Health, NIGMS [R01 GM069700]; Rock River Cancer Research Foundation; Advancing a Healthier Wisconsin; Wisconsin Breast Cancer Showhouse; V-Foundation; American Lung Association/LUNGevity; National Cancer Center; NATIONAL CANCER INSTITUTE [R01CA136799, R01CA081436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069700] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Rock River Cancer Research Foundation; Advancing a Healthier Wisconsin; Wisconsin Breast Cancer Showhouse; V-Foundation; American Lung Association/LUNGevity; National Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA136799 from NCI (to C. L. W.), R01 GM069700 from NIGMS (to C. L. W.), and R01 CA081436-12 from NCI (to A. P. F.). This work was also supported by Rock River Cancer Research Foundation (to C. L. W.), Advancing a Healthier Wisconsin (to R. L. and C. L. W.), the Wisconsin Breast Cancer Showhouse (to C. L. W.), the V-Foundation (to A. P. F.), and the American Lung Association/LUNGevity (to A. P. F.).; Recipient of a training grant from the National Cancer Center.	Baron RA, 2008, BIOCHEM J, V415, P67, DOI 10.1042/BJ20080662; BUSS JE, 1991, MOL CELL BIOL, V11, P1523, DOI 10.1128/MCB.11.3.1523; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; FARNSWORTH CC, 1990, SCIENCE, V247, P320, DOI 10.1126/science.2296721; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; FINEGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448, DOI 10.1073/pnas.88.10.4448; Goalstone ML, 1998, J BIOL CHEM, V273, P23892, DOI 10.1074/jbc.273.37.23892; Goalstone ML, 2001, J BIOL CHEM, V276, P12805, DOI 10.1074/jbc.M009443200; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; JOLY A, 1991, J BIOL CHEM, V266, P13495; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; KATAYAMA M, 1991, J BIOL CHEM, V266, P12639; KIKUCHI A, 1992, ONCOGENE, V7, P289; KINSELLA BT, 1991, J BIOL CHEM, V266, P9786; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; Parmeggiani F, 2008, J MOL BIOL, V376, P1282, DOI 10.1016/j.jmb.2007.12.014; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Peterson YK, 2006, J BIOL CHEM, V281, P12445, DOI 10.1074/jbc.M600168200; Philips MR, 2007, J CLIN INVEST, V117, P1223, DOI 10.1172/JCI32108; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Regala RP, 2008, CANCER RES, V68, P5888, DOI 10.1158/0008-5472.CAN-08-0438; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; Rodriguez-Viciana P, 2005, COLD SH Q B, V70, P461, DOI 10.1101/sqb.2005.70.044; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Sebti SM, 2004, SEMIN ONCOL, V31, P28, DOI 10.1053/j.seminoncol.2003.12.012; Shin EY, 2006, J BIOL CHEM, V281, P35954, DOI 10.1074/jbc.M602399200; Strassheim D, 2000, J BIOL CHEM, V275, P6699, DOI 10.1074/jbc.275.10.6699; Swanson KM, 2006, CURR CANCER DRUG TAR, V6, P15, DOI 10.2174/156800906775471743; Takakura A, 2000, MOL BIOL CELL, V11, P1875, DOI 10.1091/mbc.11.5.1875; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Thill R, 2008, J CELL BIOCHEM, V104, P1760, DOI 10.1002/jcb.21740; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456; Zhou XP, 2008, P NATL ACAD SCI USA, V105, P17181, DOI 10.1073/pnas.0800846105	52	56	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35255	35266		10.1074/jbc.M110.129916	http://dx.doi.org/10.1074/jbc.M110.129916			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20709748	Green Published, hybrid			2022-12-25	WOS:000283845300003
J	Licchesi, JDF; Van Neste, L; Tiwari, VK; Cope, L; Lin, X; Baylin, SB; Herman, JG				Licchesi, J. D. F.; Van Neste, L.; Tiwari, V. K.; Cope, L.; Lin, X.; Baylin, S. B.; Herman, J. G.			Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc	ONCOGENE			English	Article						WIF-1; Wnt signaling; c-Myc; Miz-1; DNA methylation	C-MYC; EPIGENETIC INACTIVATION; DNA METHYLATION; CANCER; PROMOTER; GENE; EXPRESSION; MIZ-1; REPRESSES; PROTEIN	The Wnt signaling pathway is capable of self-regulation through positive and negative feedback mechanisms. For example, the oncoprotein c-Myc, which is upregulated by Wnt signaling activity, participates in a positive feedback loop of canonical Wnt signaling through repression of Wnt antagonists DKK1 and SFRP1. In this study, we investigated the mechanism of Wnt inhibitory factor-1 (WIF-1) silencing. Mapping of CpG island methylation of the WIF-1 promoter reveals regional methylation (-295 to -95 bp from the transcription start site) that correlates with transcriptional silencing. We identified Miz-1 as a direct activator of WIF-1 transcriptional activity, which is found at WIF-1 promoter. In addition, we show that c-Myc contributes to WIF-1 transcriptional repression in a Miz-1-dependent manner. Although the transient repression mediated by Miz-1/c-Myc is independent of de novo methylation, the stable repression by this complex is associated with CpG island methylation of the critical -295 to -95-bp region of the WIF-1 promoter. Importantly, Miz-1 and c-Myc are found at WIF-1 promoter in WIF-1 non-expressing cell lines DLD-1 and 209myc. Transient knockdown or somatic knockout of c-Myc in DLD-1 failed to restore WIF-1 expression suggesting that c-Myc is involved in initiating rather than maintaining WIF-1 epigenetic silencing. In a genome-wide screen, DNAJA4, TGF beta-induced and TRIM59 were repressed by c-Myc overexpression and DNA promoter hypermethylation. Our data reveal novel insights into c-Myc-mediated DNA methylation-dependent transcriptional silencing, a mechanism that might contribute to the dysregulation of Wnt signaling in cancer. Oncogene (2010) 29, 5923-5934; doi:10.1038/onc.2010.322; published online 9 August 2010	[Licchesi, J. D. F.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Licchesi, J. D. F.; Tiwari, V. K.; Cope, L.; Baylin, S. B.; Herman, J. G.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Canc Biol Program, Baltimore, MD 21231 USA; [Van Neste, L.] Univ Ghent, Dept Mol Biotechnol, Fac Biosci Engn, B-9000 Ghent, Belgium; [Lin, X.] Johns Hopkins Univ, Dept Appl Math & Stat, Whiting Sch Engn, Baltimore, MD USA	MRC Laboratory Molecular Biology; Johns Hopkins University; Johns Hopkins Medicine; Ghent University; Johns Hopkins University	Licchesi, JDF (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	jlicchesi@yahoo.com; hermanji@jhmi.edu		Licchesi, Julien/0000-0003-3786-3013	NCI [CA058184, P30 CA06973-44]; AICR [07-0040]; Medical Research Council [MC_U105192713, MC_U105184273] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA006973, P50CA058184] Funding Source: NIH RePORTER; MRC [MC_U105184273, MC_U105192713] Funding Source: UKRI	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AICR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge Dr Martin Eilers (Marbourg University, Germany), Dr Arthur Riggs (Beckman Research Institute, Duarte, CA, USA) and Dr Bert Vogelstein (Johns Hopkins School of Medicine, USA) for plasmids, Dr Kurt Bachman (University of Maryland, USA) for the DLD-1 c-Myc -/- DNA and cDNA. We are grateful to Dr Wayne Yu at the Johns Hopkins Microarray Core facility, Dr Kornel Schuebel for his help with the microarray experiment and Dr Mariann Bienz for her support. Finally, we thank all the members of the Baylin/Herman laboratory for useful discussions and Kathy Bender for administrative assistance. This study was supported by NCI/SPORE grant CA058184 to James G Herman, AICR grant 07-0040 to Mariann Bienz (MRC-LMB) and NCI grant P30 CA06973-44 to Leslie Cope.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Ai LB, 2006, CARCINOGENESIS, V27, P1341, DOI 10.1093/carcin/bgi379; Barr LF, 2000, CANCER RES, V60, P143; Benanti JA, 2007, MOL CANCER RES, V5, P1181, DOI 10.1158/1541-7786.MCR-06-0372; Bowen H, 2002, J BIOL CHEM, V277, P34997, DOI 10.1074/jbc.M204232200; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Chan SL, 2007, LAB INVEST, V87, P644, DOI 10.1038/labinvest.3700547; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; de la Roche M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-199; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; GUJRAL TS, 2009, SCI SIGNAL, V2, pNIL6; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Ikegaki N, 2007, CLIN CANCER RES, V13, P6001, DOI 10.1158/1078-0432.CCR-07-0071; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Patel JH, 2007, J BIOL CHEM, V282, P5, DOI 10.1074/jbc.M609138200; Patel JH, 2006, J BIOL CHEM, V281, P3283, DOI 10.1074/jbc.M513038200; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Reguart N, 2004, BIOCHEM BIOPH RES CO, V323, P229, DOI 10.1016/j.bbrc.2004.08.075; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shah JN, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-284; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Taniguchi H, 2005, ONCOGENE, V24, P7946, DOI 10.1038/sj.onc.1208910; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Urakami S, 2006, CLIN CANCER RES, V12, P383, DOI 10.1158/1078-0432.CCR-05-1344; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	52	35	42	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	44					5923	5934		10.1038/onc.2010.322	http://dx.doi.org/10.1038/onc.2010.322			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	675PS	20697356	Green Accepted			2022-12-25	WOS:000283843400006
J	Tran, AX; Dong, CJ; Whitfield, C				Tran, An X.; Dong, Changjiang; Whitfield, Chris			Structure and Functional Analysis of LptC, a Conserved Membrane Protein Involved in the Lipopolysaccharide Export Pathway in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ENVELOPE BIOGENESIS; BACTERIAL OUTER-MEMBRANE; INNER-MEMBRANE; CRYSTAL-STRUCTURES; BINDING-PROTEIN; COG DATABASE; LIPID-A; TRANSPORT; COMPLEX; IDENTIFICATION	LptC is a conserved bitopic inner membrane protein from Escherichia coli involved in the export of lipopolysaccharide from its site of synthesis in the cytoplasmic membrane to the outer membrane. LptC forms a complex with the ATP-binding cassette transporter, LptBFG, which is thought to facilitate the extraction of lipopolysaccharide from the inner membrane and release it into a translocation pathway that includes the putative periplasmic chaperone LptA. Cysteine modification experiments established that the catalytic domain of LptC is oriented toward the periplasm. The structure of the periplasmic domain is described at a resolution of 2.2-angstrom from x-ray crystallographic data. The periplasmic domain of LptC consists of a twisted boat structure with two beta-sheets in apposition to each other. The beta-sheets contain seven and eight antiparallel beta-strands, respectively. This structure bears a high degree of resemblance to the crystal structure of LptA. Like LptA, LptC binds lipopolysaccharide in vitro. In vitro, LptA can displace lipopolysaccharide from LptC (but not vice versa), consistent with their locations and their proposed placement in a unidirectional export pathway.	[Tran, An X.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Dong, Changjiang] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland	University of Guelph; University of St Andrews	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca			Canadian Institutes of Health Research; Wellcome Trust	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Canadian Institutes of Health Research (to C. W.) and a Wellcome Trust Career Development Fellowship (to C. D.).	Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; CORPET F, 1998, NUCLEIC ACIDS RES, V22, P10881; COWTAN K, 1994, INT CCP4 ESF EACBM N, V31, P34; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVENS PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Fu DX, 1998, J BIOL CHEM, V273, P17962, DOI 10.1074/jbc.273.28.17962; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LESLIE AGW, 1998, J APPL CRYSTALLOGR, V30, P1036; Ma B, 2008, P NATL ACAD SCI USA, V105, P13823, DOI 10.1073/pnas.0807028105; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohtsu I, 2004, BIOSCI BIOTECH BIOCH, V68, P458, DOI 10.1271/bbb.68.458; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pristovsek P, 2005, J MED CHEM, V48, P7911, DOI 10.1021/jm050762a; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Taniguchi N, 2008, J BIOL CHEM, V283, P8538, DOI 10.1074/jbc.M800026200; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tefsen B, 2005, J BIOL CHEM, V280, P4504, DOI 10.1074/jbc.M409259200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	59	102	106	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33529	33539		10.1074/jbc.M110.144709	http://dx.doi.org/10.1074/jbc.M110.144709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720015	hybrid, Green Published			2022-12-25	WOS:000283048200087
J	Gebhardt, FM; Mitrovic, AD; Gilbert, DF; Vandenberg, RJ; Lynch, JW; Dodd, PR				Gebhardt, Florian M.; Mitrovic, Ann D.; Gilbert, Daniel F.; Vandenberg, Robert J.; Lynch, Joseph W.; Dodd, Peter R.			Exon-skipping Splice Variants of Excitatory Amino Acid Transporter-2 (EAAT2) Form Heteromeric Complexes with Full-length EAAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DEPENDENT ASPARTATE TRANSPORTER; NEURONAL GLUTAMATE TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; PYROCOCCUS-HORIKOSHII; ENDOPLASMIC-RETICULUM; INDIVIDUAL SUBUNITS; RAT-BRAIN; GLT-1; PROTEIN	The glial transporter excitatory amino acid transporter-2 (EAAT2) is the main mediator of glutamate clearance in brain. The wild-type transporter (EAAT2wt) forms trimeric membrane complexes in which each protomer functions autonomously. Several EAAT2 variants are found in control and Alzheimer-diseased human brains; their expression increases with pathological severity. These variants might alter EAAT2wt-mediated transport by abrogating membrane trafficking, or by changing the configuration or functionality of the assembled transporter complex. HEK293 cells were transfected with EAAT2wt; EAAT2b, a C-terminal variant; or either of two exon-skipping variants: alone or in combination. Surface biotinylation studies showed that only the exon-7 deletion variant was not trafficked to the membrane when transfected alone, and that all variants could reach the membrane when co-transfected with EAAT2wt. Fluorescence resonance energy transfer (FRET) studies showed that co-transfected EAAT2wt and EAAT2 splice variants were expressed in close proximity. Glutamate transporter function was measured using a whole cell patch clamp technique, or by changes in membrane potential indexed by a voltage-sensitive fluorescent dye (FMP assay): the two methods gave comparable results. Cells transfected with EAAT2wt or EAAT2b showed glutamate-dependent membrane potential changes consistent with functional expression. Cells transfected with EAAT2 exon-skipping variants alone gave no response to glutamate. Co-transfection of EAAT2wt(or EAAT2b) and splice variants in various ratios significantly raised glutamate EC50 and decreased Hill coefficients. We conclude that exon-skipping variants form heteromeric complexes with EAAT2wt or EAAT2b that traffic to the membrane but show reduced glutamate-dependent activity. This could allow glutamate to accumulate extracellularly and promote excitotoxicity.	[Gebhardt, Florian M.; Dodd, Peter R.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Gilbert, Daniel F.; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Gilbert, Daniel F.; Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Mitrovic, Ann D.; Vandenberg, Robert J.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Mitrovic, Ann D.; Vandenberg, Robert J.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Queensland; University of Queensland; University of Queensland; University of Sydney; University of Sydney	Dodd, PR (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Bldg 76,Coopers Rd,St Lucia Campus, Brisbane, Qld 4072, Australia.	p.dodd@uq.edu.au	Dodd, Peter Ronald/A-4865-2010; Lynch, Joseph/C-8636-2009; Gilbert, Daniel F./F-8714-2011; Vandenberg, Robert John/E-6018-2016	Dodd, Peter Ronald/0000-0001-5970-0181; Vandenberg, Robert John/0000-0003-1523-4814; /0000-0003-4431-4741	Alzheimer's Association (USA) [RG1-96-005]; Judith Jane Mason and Harold Stannett Williams Memorial Foundation; University of Queensland; University of Sydney; National Health and Medical Research Council of Australia; Australian Research Council	Alzheimer's Association (USA)(Alzheimer's Association); Judith Jane Mason and Harold Stannett Williams Memorial Foundation; University of Queensland(University of Queensland); University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported in part by Alzheimer's Association (USA) Grant RG1-96-005 and the Judith Jane Mason and Harold Stannett Williams Memorial Foundation.; Recipient of an International Post-graduate Research Scholarship from the University of Queensland.; Recipient of a Rolf Edgar Lake Fellowship from the University of Sydney.; Supported by The National Health and Medical Research Council of Australia and the Australian Research Council.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dunlop J, 1999, BRIT J PHARMACOL, V128, P1485, DOI 10.1038/sj.bjp.0702945; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Gilbert DF, 2009, J BIOMOL SCREEN, V14, P944, DOI 10.1177/1087057109339523; Gonzalez-Gonzalez IM, 2008, J NEUROCHEM, V105, P1834, DOI 10.1111/j.1471-4159.2008.05281.x; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Holmseth S, 2009, NEUROSCIENCE, V162, P1055, DOI 10.1016/j.neuroscience.2009.03.048; Honig LS, 2000, NEUROLOGY, V55, P1082, DOI 10.1212/WNL.55.8.1082; Horiuchi M, 2001, P NATL ACAD SCI USA, V98, P1448, DOI 10.1073/pnas.041329498; Jensen AA, 2005, EUR J PHARMACOL, V521, P39, DOI 10.1016/j.ejphar.2005.08.002; Jensen AA, 2004, BIOCHEM PHARMACOL, V67, P2115, DOI 10.1016/j.bcp.2004.02.013; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KINGSTON RE, 2003, CURR PROTOC MOL BIOL, P1; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meyer T, 1998, J NEUROL NEUROSUR PS, V65, P954, DOI 10.1136/jnnp.65.6.954; Mitrovic AD, 1998, J BIOL CHEM, V273, P14698, DOI 10.1074/jbc.273.24.14698; Munch C, 2002, J NEUROCHEM, V82, P594, DOI 10.1046/j.1471-4159.2002.01012.x; Otis TS, 1998, J NEUROSCI, V18, P7099; Peacey E, 2009, MOL PHARMACOL, V75, P1062, DOI 10.1124/mol.108.052829; Pow DV, 2009, NEUROCHEM RES, V34, P1748, DOI 10.1007/s11064-009-9957-0; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; Reye P, 2002, GLIA, V38, P246, DOI 10.1002/glia.10059; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Schmitt A, 2002, NEUROSCIENCE, V109, P45, DOI 10.1016/S0306-4522(01)00451-1; Scott HA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.008; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sullivan R, 2004, GLIA, V45, P155, DOI 10.1002/glia.10317; Toki H, 1998, J NEUROCHEM, V71, P913; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; UtsunomiyaTate N, 1997, FEBS LETT, V416, P312, DOI 10.1016/S0014-5793(97)01232-5; Vallejo-Illarramendi A, 2005, J NEUROCHEM, V95, P341, DOI 10.1111/j.1471-4159.2005.03370.x; VANEERSEL J, 2006, P AUST NEUROSCI SOC, V17, P80; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	47	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31313	31324		10.1074/jbc.M110.153494	http://dx.doi.org/10.1074/jbc.M110.153494			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20688910	hybrid, Green Published			2022-12-25	WOS:000282764600026
J	Lu, S; Xu, X; Zhao, WX; Wu, WW; Yuan, H; Shen, HB; Zhou, CH; Li, S; Ma, L				Lu, Shuai; Xu, Xing; Zhao, Wenxiu; Wu, Weiwei; Yuan, Hang; Shen, Huaibin; Zhou, Changhua; Li, Song; Ma, Lan			Targeting of Embryonic Stem Cells by Peptide-Conjugated Quantum Dots	PLOS ONE			English	Article							PHAGE DISPLAY; ENDOTHELIAL-CELLS; SELECTION; VECTORS; NANOPARTICLES; CYTOTOXICITY; OUTGROWTH; ANTIGENS; THERAPY; MARROW	Background: Targeting stem cells holds great potential for studying the embryonic stem cell and development of stem cell-based regenerative medicine. Previous studies demonstrated that nanoparticles can serve as a robust platform for gene delivery, non-invasive cell imaging, and manipulation of stem cell differentiation. However specific targeting of embryonic stem cells by peptide-linked nanoparticles has not been reported. Methodology/Principal Findings: Here, we developed a method for screening peptides that specifically recognize rhesus macaque embryonic stem cells by phage display and used the peptides to facilitate quantum dot targeting of embryonic stem cells. Through a phage display screen, we found phages that displayed an APWHLSSQYSRT peptide showed high affinity and specificity to undifferentiated primate embryonic stem cells in an enzyme-linked immunoabsorbent assay. These results were subsequently confirmed by immunofluoresence microscopy. Additionally, this binding could be completed by the chemically synthesized APWHLSSQYSRT peptide, indicating that the binding capability was specific and conferred by the peptide sequence. Through the ligation of the peptide to CdSe-ZnS core-shell nanocrystals, we were able to, for the first time, target embryonic stem cells through peptide-conjugated quantum dots. Conclusions/Significance: These data demonstrate that our established method of screening for embryonic stem cell specific binding peptides by phage display is feasible. Moreover, the peptide-conjugated quantum dots may be applicable for embryonic stem cell study and utilization.	[Lu, Shuai; Wu, Weiwei] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Lu, Shuai; Zhao, Wenxiu; Wu, Weiwei; Yuan, Hang; Ma, Lan] Tsinghua Univ, Div Life Sci, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Xu, Xing] Yunnan Univ, Kunming Yunda Monoclonal Antibody Technol Ctr, Kunming 650091, Peoples R China; [Yuan, Hang] Jilin Univ, Coll Chem, State Key Lab Supramol Struct & Mat, Changchun 130023, Peoples R China; [Shen, Huaibin; Zhou, Changhua; Li, Song] Henan Univ, Key Lab Special Funct Mat, Minist Educ, Kaifeng, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Yunnan University; Jilin University; Henan University	Lu, S (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	malan@sz.tsinghua.edu.cn			Chinese Ministry of Science and Technology [2006AA03Z359]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by the Chinese Ministry of Science and Technology 863 projects 2006AA03Z359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299; Baskar S, 2009, BLOOD, V114, P4494, DOI 10.1182/blood-2009-05-222786; Chang E, 2006, SMALL, V2, P1412, DOI 10.1002/smll.200600218; Chen FQ, 2004, NANO LETT, V4, P1827, DOI 10.1021/nl049170q; Cordes MHJ, 1996, CURR OPIN STRUC BIOL, V6, P3, DOI 10.1016/S0959-440X(96)80088-1; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020; Green JJ, 2008, NANO LETT, V8, P3126, DOI 10.1021/nl8012665; Gur D, 2009, BIOTECHNOL PROGR, V25, P1780, DOI 10.1002/btpr.285; HENNING TD, 2008, J VIS EXP; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Lei Y, 2008, BIOCONJUGATE CHEM, V19, P421, DOI 10.1021/bc0700685; Letchford J, 2006, J IMMUNOL METHODS, V308, P124, DOI 10.1016/j.jim.2005.10.015; LI SC, 2010, STEM CELL REV; Lin S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-67; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Meng XL, 2007, ENDOCRINOLOGY, V148, P5865, DOI 10.1210/en.2007-0941; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Morita Y, 2006, BIOTECHNOL PROGR, V22, P974, DOI 10.1021/bp060112f; Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030; Paschke M, 2006, APPL MICROBIOL BIOT, V70, P2, DOI 10.1007/s00253-005-0270-9; Petty NK, 2007, TRENDS BIOTECHNOL, V25, P7, DOI 10.1016/j.tibtech.2006.11.003; Pi QM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-36; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Pouton CW, 2007, NAT REV DRUG DISCOV, V6, P605, DOI 10.1038/nrd2194; Rasmussen UB, 2002, CANCER GENE THER, V9, P606, DOI 10.1038/sj.cgt.7700476; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Slotkin JR, 2007, DEV DYNAM, V236, P3393, DOI 10.1002/dvdy.21235; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Vats A, 2005, LANCET, V366, P592, DOI 10.1016/S0140-6736(05)66879-1; Veleva AN, 2007, BIOTECHNOL BIOENG, V98, P306, DOI 10.1002/bit.21420; Westerlund-Wikstrom B, 2000, INT J MED MICROBIOL, V290, P223; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Woo DG, 2009, BIOMATERIALS, V30, P5631, DOI 10.1016/j.biomaterials.2009.07.026; YAMADA M, 2008, J VIS EXP; Yang F, 2009, GENE THER, V16, P533, DOI 10.1038/gt.2008.182; Yang F, 2010, P NATL ACAD SCI USA, V107, P3317, DOI 10.1073/pnas.0905432106; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134; Yukawa H, 2009, CELL TRANSPLANT, V18, P591, DOI 10.1177/096368970901805-615; ZHAO W, 2010, J BIOMOL SCREEN	44	28	34	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12075	10.1371/journal.pone.0012075	http://dx.doi.org/10.1371/journal.pone.0012075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711469	gold, Green Submitted, Green Published			2022-12-25	WOS:000280811900022
J	van Leeuwen, TM; Petersson, KM; Hagoort, P				van Leeuwen, Tessa M.; Petersson, Karl Magnus; Hagoort, Peter			Synaesthetic Colour in the Brain: Beyond Colour Areas. A Functional Magnetic Resonance Imaging Study of Synaesthetes and Matched Controls	PLOS ONE			English	Article							WORD FORM AREA; SYNESTHETIC COLOR; PARIETAL; HEARING; BINDING; PERCEPTION; ACTIVATION; MECHANISMS; ATTENTION; REAL	Background: In synaesthesia, sensations in a particular modality cause additional experiences in a second, unstimulated modality (e. g., letters elicit colour). Understanding how synaesthesia is mediated in the brain can help to understand normal processes of perceptual awareness and multisensory integration. In several neuroimaging studies, enhanced brain activity for grapheme-colour synaesthesia has been found in ventral-occipital areas that are also involved in real colour processing. Our question was whether the neural correlates of synaesthetically induced colour and real colour experience are truly shared. Methodology/Principal Findings: First, in a free viewing functional magnetic resonance imaging (fMRI) experiment, we located main effects of synaesthesia in left superior parietal lobule and in colour related areas. In the left superior parietal lobe, individual differences between synaesthetes (projector-associator distinction) also influenced brain activity, confirming the importance of the left superior parietal lobe for synaesthesia. Next, we applied a repetition suppression paradigm in fMRI, in which a decrease in the BOLD (blood-oxygenated-level-dependent) response is generally observed for repeated stimuli. We hypothesized that synaesthetically induced colours would lead to a reduction in BOLD response for subsequently presented real colours, if the neural correlates were overlapping. We did find BOLD suppression effects induced by synaesthesia, but not within the colour areas. Conclusions/Significance: Because synaesthetically induced colours were not able to suppress BOLD effects for real colour, we conclude that the neural correlates of synaesthetic colour experience and real colour experience are not fully shared. We propose that synaesthetic colour experiences are mediated by higher-order visual pathways that lie beyond the scope of classical, ventral-occipital visual areas. Feedback from these areas, in which the left parietal cortex is likely to play an important role, may induce V4 activation and the percept of synaesthetic colour.	[van Leeuwen, Tessa M.; Petersson, Karl Magnus; Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Petersson, Karl Magnus; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society	van Leeuwen, TM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands.	t.vanleeuwen@donders.ru.nl	Petersson, Karl Magnus/E-8188-2012; van Leeuwen, Tessa M./K-2718-2015; Petersson, Karl Magnus/HDO-0143-2022; GNC, GNC/B-5716-2013; Hagoort, Peter/B-7417-2012	Petersson, Karl Magnus/0000-0002-8245-0392; van Leeuwen, Tessa M./0000-0001-7810-6348; Petersson, Karl Magnus/0000-0002-8245-0392; 	Volkswagen-Foundation [I/80 743]	Volkswagen-Foundation(Volkswagen)	This study was supported by a research grant from the Volkswagen-Foundation [grant number I/80 743]. URL: http://www.volkswagen-stiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargary G, 2008, TRENDS NEUROSCI, V31, P335, DOI 10.1016/j.tins.2008.03.007; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Beauchamp MS, 1999, CEREB CORTEX, V9, P257, DOI 10.1093/cercor/9.3.257; Beeli G, 2008, CEREB CORTEX, V18, P379, DOI 10.1093/cercor/bhm072; Brett M., 2002, 8 INT C FUNCT MAPP H; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; Edquist J, 2006, CORTEX, V42, P222, DOI 10.1016/S0010-9452(08)70347-2; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Esterman M, 2006, J COGNITIVE NEUROSCI, V18, P1570, DOI 10.1162/jocn.2006.18.9.1570; Flowers DL, 2004, NEUROIMAGE, V21, P829, DOI 10.1016/j.neuroimage.2003.10.002; Garrett AS, 2000, NEUROIMAGE, V11, P111, DOI 10.1006/nimg.1999.0528; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hochel M, 2008, COGN NEUROPSYCHOL, V25, P93, DOI 10.1080/02643290701822815; Hong SW, 2008, VISION RES, V48, P1018, DOI 10.1016/j.visres.2008.01.024; Horner AJ, 2008, NEUROPSYCHOLOGIA, V46, P1979, DOI 10.1016/j.neuropsychologia.2008.01.018; Hubbard Edward M, 2007, Curr Psychiatry Rep, V9, P193, DOI 10.1007/s11920-007-0018-6; Hubbard EM, 2007, NAT NEUROSCI, V10, P671, DOI 10.1038/nn0607-671; Hubbard EM, 2006, CORTEX, V42, P184, DOI 10.1016/S0010-9452(08)70343-5; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Jancke L, 2009, EUR J NEUROSCI, V29, P1287, DOI 10.1111/j.1460-9568.2009.06673.x; Kadosh RC, 2007, J COGNITIVE NEUROSCI, V19, P2050, DOI 10.1162/jocn.2007.19.12.2050; Kim CY, 2006, CORTEX, V42, P195, DOI 10.1016/S0010-9452(08)70344-7; Kim CY, 2005, PERCEPTION, V34, P1501, DOI 10.1068/p5422; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Levy J, 2008, NEUROIMAGE, V43, P581, DOI 10.1016/j.neuroimage.2008.08.008; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; MAURER D, 1996, SYNAESTHESIA CLASSIC, P224; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Muggleton N, 2007, NEUROPSYCHOLOGIA, V45, P1582, DOI 10.1016/j.neuropsychologia.2006.11.021; Nikolic D, 2007, PSYCHOL SCI, V18, P481, DOI 10.1111/j.1467-9280.2007.01925.x; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Pernet C, 2005, NEUROIMAGE, V28, P738, DOI 10.1016/j.neuroimage.2005.06.046; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rich AN, 2006, NEUROPSYCHOLOGIA, V44, P2918, DOI 10.1016/j.neuropsychologia.2006.06.024; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Sagiv N, 2006, CORTEX, V42, P232, DOI 10.1016/S0010-9452(08)70348-4; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Sperling JM, 2006, CORTEX, V42, P295, DOI 10.1016/S0010-9452(08)70355-1; van der Kouwe AJW, 2005, NEUROIMAGE, V27, P222, DOI 10.1016/j.neuroimage.2005.03.035; Ward J, 2007, CONSCIOUS COGN, V16, P913, DOI 10.1016/j.concog.2006.09.012; Weiss PH, 2009, BRAIN, V132, P65, DOI 10.1093/brain/awn304; Weiss PH, 2005, NEUROIMAGE, V28, P859, DOI 10.1016/j.neuroimage.2005.06.052; Wollen KA, 1983, J MENT IMAG, V7, P83	57	46	46	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12074	10.1371/journal.pone.0012074	http://dx.doi.org/10.1371/journal.pone.0012074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711467	gold, Green Published			2022-12-25	WOS:000280811900021
J	Gienapp, P; Merila, J				Gienapp, Phillip; Merila, Juha			High Fidelity - No Evidence for Extra-Pair Paternity in Siberian Jays (Perisoreus infaustus)	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; DELAYED DISPERSAL; CORVUS-MONEDULA; FAIRY-WRENS; BIRDS; BEHAVIOR; FERTILIZATIONS; HYPOTHESIS; MONOGAMY; CARE	Extra-pair paternity (EPP) in birds is related to a number of ecological and social factors. For example, it has been found to be positively related with breeding density, negatively with the amount of paternal care and especially high rates have been observed in group-living species. Siberian jays (Perisoreous infaustus) breed at low densities and have extended parental care, which leads to the expectation of low rates of EPP. On the other hand, Siberian jays live in groups which can include also unrelated individuals, and provide opportunities for extra-pair matings. To assess the potential occurrence of EPP in Siberian jays, we analysed a large data pool (n = 1029 offspring) covering ca. 30 years of samples from a Finnish Siberian jay population. Paternities were assigned based on up to 21 polymorphic microsatellite markers with the additional information from field observations. We were unable to find any evidence for occurrence of EPP in this species. Our findings are in line with earlier studies and confirm the generally low rates of EPP in related Corvid species. These results suggest that ecological factors may be more important than social factors (group living) in determining costs and benefits of extra-pair paternity.	[Gienapp, Phillip; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	University of Helsinki	Gienapp, P (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	phillip.gienapp@helsinki.fi	Merila, Juha/A-4061-2008; Gienapp, Phillip/A-2261-2014	Merila, Juha/0000-0001-9614-0072; Gienapp, Phillip/0000-0002-9368-8769	Academy of Finland; Kone Foundation; Maj and Tor Nessling Foundation	Academy of Finland(Academy of Finland); Kone Foundation; Maj and Tor Nessling Foundation	This work was funded by research grants from the Academy of Finland to PG and JM, from the Kone Foundation to PG and the Maj and Tor Nessling Foundation to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong T, 1996, J WILDLIFE MANAGE, V60, P265, DOI 10.2307/3802224; Bennet P. M., 2002, EVOLUTIONARY ECOLOGY; BERGHOLM T, 2007, KUUKKELIN PERISOREUS; Blomgren A., 1964, LAVSKRIKA; Double M, 2000, P ROY SOC B-BIOL SCI, V267, P465, DOI 10.1098/rspb.2000.1023; EKMAN J, 1994, BEHAV ECOL, V5, P245, DOI 10.1093/beheco/5.3.245; Ekman J, 1999, P ROY SOC B-BIOL SCI, V266, P911, DOI 10.1098/rspb.1999.0723; Ekman J, 2002, ANIM BEHAV, V64, P453, DOI 10.1006/anbe.2002.3075; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; GIENAPP P, 2010, BEHAV ECOLO IN PRESS; GOWATY PA, 1991, ANIM BEHAV, V41, P661, DOI 10.1016/S0003-3472(05)80904-2; Griesser M, 2005, ANIM BEHAV, V69, P345, DOI 10.1016/j.anbehav.2004.05.013; Griesser M, 2003, BEHAV ECOL, V14, P246, DOI 10.1093/beheco/14.2.246; Griesser M, 2006, P R SOC B, V273, P1881, DOI 10.1098/rspb.2006.3527; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hall ML, 2000, BEHAV ECOL SOCIOBIOL, V47, P180, DOI 10.1007/s002650050009; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Henderson IG, 2000, J AVIAN BIOL, V31, P177, DOI 10.1034/j.1600-048X.2000.310209.x; Hoi-Leitner M, 1999, P ROY SOC B-BIOL SCI, V266, P1021, DOI 10.1098/rspb.1999.0738; Jaari S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-1; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Li SH, 2000, ANIM BEHAV, V60, P867, DOI 10.1006/anbe.2000.1554; Liebers D, 1998, ARDEA, V86, P221; Lillandt B.-G., 1993, LAVSKRIKANS PERISORE; Lillandt BG, 2003, CONDOR, V105, P505, DOI 10.1650/7117; Lillandt BG, 2002, HEREDITAS, V137, P157, DOI 10.1034/j.1601-5223.2002.01675.x; Lillandt Bo-Goran, 2001, Avian Science, V1, P3; Moller AP, 2000, BEHAV ECOL, V11, P161, DOI 10.1093/beheco/11.2.161; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Quinn JS, 1999, BEHAV ECOL SOCIOBIOL, V45, P1, DOI 10.1007/s002650050534; Sandvik H, 2001, J FIELD ORNITHOL, V72, P30, DOI 10.1648/0273-8570-72.1.30; SLEPKOVYCH B, 1997, BEHAV ECOL SOCIOBIOL, V40, P287; Vaisanen R., 1998, MUUTTUVA PESIMALINNU; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381	37	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12006	10.1371/journal.pone.0012006	http://dx.doi.org/10.1371/journal.pone.0012006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711255	Green Published, gold, Green Submitted			2022-12-25	WOS:000280776800007
J	Kang, KS; Wen, YJ; Yamabe, N; Fukui, M; Bishop, SC; Zhu, BT				Kang, Ki Sung; Wen, Yujing; Yamabe, Noriko; Fukui, Masayuki; Bishop, Stephanie C.; Zhu, Bao Ting			Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; GREEN TEA POLYPHENOL; PARKINSONS-DISEASE; EPIGALLOCATECHIN GALLATE; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; L-DOPA; INHIBITION; 3-O-METHYLDOPA	Background: A combination of levodopa (L-DOPA) and carbidopa is the most commonly-used treatment for symptom management in Parkinson's disease. Studies have shown that concomitant use of a COMT inhibitor is highly beneficial in controlling the wearing-off phenomenon by improving L-DOPA bioavailability as well as brain entry. The present study sought to determine whether (-)-epigallocatechin-3-gallate (EGCG), a common tea polyphenol, can serve as a naturally-occurring COMT inhibitor that also possesses neuroprotective actions. Methodology/Principal Findings: Using both in vitro and in vivo models, we investigated the modulating effects of EGCG on L-DOPA methylation as well as on chemically induced oxidative neuronal damage and degeneration. EGCG strongly inhibited human liver COMT-mediated O-methylation of L-DOPA in a concentration-dependent manner in vitro, with an average IC50 of 0.36 mu M. Oral administration of EGCG moderately lowered the accumulation of 3-O-methyldopa in the plasma and striatum of rats treated with L-DOPA + carbidopa. In addition, EGCG also reduced glutamate-induced oxidative cytotoxicity in cultured HT22 mouse hippocampal neuronal cells through inactivation of the nuclear factor kappa B-signaling pathway. Under in vivo conditions, administration of EGCG exerted a strong protective effect against kainic acid-induced oxidative neuronal death in the hippocampus of rats. Conclusions/Significance: These observations suggest that oral administration of EGCG may have significant beneficial effects in Parkinson's patients treated with L-DOPA and carbidopa by exerting a modest inhibition of L-DOPA methylation plus a strong neuroprotection against oxidative damage and degeneration.	[Kang, Ki Sung; Wen, Yujing; Yamabe, Noriko; Fukui, Masayuki; Bishop, Stephanie C.; Zhu, Bao Ting] Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Kang, KS (corresponding author), Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu	Bishop, Stephanie/AAU-7712-2021		National Institutes of Health (NIH) [ES015242, P20RR021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015242] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in part, by National Institutes of Health (NIH) grants (ES015242 and P20RR021940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACQUAS E, 1992, J NEUROCHEM, V59, P326, DOI 10.1111/j.1471-4159.1992.tb08907.x; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Bai HW, 2007, CHEM RES TOXICOL, V20, P1409, DOI 10.1021/tx700174w; BARTHOLINI G, 1975, PHARMACOL THER PT B, V1, P407, DOI 10.1016/0306-039X(75)90047-1; Benabou Reina, 2003, Expert Opin Drug Saf, V2, P263, DOI 10.1517/14740338.2.3.263; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Camicioli R, 2003, MOVEMENT DISORD, V18, P784, DOI 10.1002/mds.10444; Chen LS, 1997, DRUG METAB DISPOS, V25, P1045; Choi JY, 2002, NEUROTOXICOLOGY, V23, P367, DOI 10.1016/S0161-813X(02)00079-7; Chow HHS, 2003, CLIN CANCER RES, V9, P3312; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; DAPRADA M, 1984, EXPERIENTIA, V40, P1165; Dingemanse J, 2000, NEUROLOGY, V55, pS24; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; FEUERSTEIN C, 1977, ACTA NEUROL SCAND, V56, P508; Floreani M, 1997, FASEB J, V11, P1309, DOI 10.1096/fasebj.11.14.9409550; Fu Y, 2006, NEUROTOX RES, V10, P23, DOI 10.1007/BF03033331; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; He X, 2006, J NEUROPATH EXP NEUR, V65, P652, DOI 10.1097/01.jnen.0000225906.82428.69; Heikkinen H, 2001, CLIN NEUROPHARMACOL, V24, P150, DOI 10.1097/00002826-200105000-00006; Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P636, DOI 10.1016/j.fct.2005.11.003; KAAKKOLA S, 1993, J NEUROCHEM, V60, P137, DOI 10.1111/j.1471-4159.1993.tb05831.x; Kandinov B, 2009, PARKINSONISM RELAT D, V15, P41, DOI 10.1016/j.parkreldis.2008.02.011; Karimi M, 2006, J CHROMATOGR B, V836, P120, DOI 10.1016/j.jchromb.2006.03.027; KERANEN T, 1993, CLIN NEUROPHARMACOL, V16, P145, DOI 10.1097/00002826-199304000-00007; Koller WC, 1999, NEUROLOGY, V53, P1012, DOI 10.1212/WNL.53.5.1012; Lang AE, 2002, MOV DISORD S4, V17, pS45; Leaver KR, 2009, BRAIN RES BULL, V80, P397, DOI 10.1016/j.brainresbull.2009.08.013; Lee ESY, 2008, NEUROCHEM RES, V33, P401, DOI 10.1007/s11064-007-9442-6; Lee JW, 2009, J NUTR, V139, P1987, DOI 10.3945/jn.109.109785; Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje; Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572; Mabley JG, 2001, BRIT J PHARMACOL, V133, P909, DOI 10.1038/sj.bjp.0704156; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Matsuoka Y, 1999, EXP BRAIN RES, V124, P215, DOI 10.1007/s002210050616; Morgan John C, 2006, Expert Opin Emerg Drugs, V11, P403, DOI 10.1517/14728214.11.3.403; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Nagai M, 2004, DRUG METAB DISPOS, V32, P497, DOI 10.1124/dmd.32.5.497; Nalder J.V., 1980, J COMP NEUROL, V192, P333; Napolitano A, 2003, PARKINSONISM RELAT D, V9, P145, DOI 10.1016/S1353-8020(02)00016-0; NISSINEN E, 1992, N-S ARCH PHARMACOL, V346, P262; Padovani A, 2006, NEUROL SCI, V27, pS40, DOI 10.1007/s10072-006-0546-6; RECHES A, 1981, ANN NEUROL, V10, P94; Schapira AHV, 2000, NEUROLOGY, V55, pS65; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sedek G, 1997, CLIN NEUROPHARMACOL, V20, P531, DOI 10.1097/00002826-199712000-00005; SHARPLES.NS, 1972, CLIN CHIM ACTA, V37, P359, DOI 10.1016/0009-8981(72)90456-1; Shin EJ, 2009, J NEUROSCI RES, V87, P710, DOI 10.1002/jnr.21880; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Tan SL, 1998, J NEUROCHEM, V71, P95; Tedroff J, 1996, NEUROLOGY, V46, P1430, DOI 10.1212/WNL.46.5.1430; TOHGI H, 1991, NEUROSCI LETT, V132, P19, DOI 10.1016/0304-3940(91)90422-P; Toulouse A, 2008, PROG NEUROBIOL, V85, P376, DOI 10.1016/j.pneurobio.2008.05.003; WAGNER J, 1982, J NEUROCHEM, V38, P1241, DOI 10.1111/j.1471-4159.1982.tb07897.x; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023; Zhu BT, 2008, XENOBIOTICA, V38, P130, DOI [10.1080/00498250701744641, 10.1080/00498250701744641 ]; Zhu BT, 2000, DRUG METAB DISPOS, V28, P1024; Zhu BT, 1998, J STEROID BIOCHEM, V64, P207, DOI 10.1016/S0960-0760(97)00163-5; Zhu BT, 2004, INT J MOL MED, V13, P343; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	65	57	57	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11951	10.1371/journal.pone.0011951	http://dx.doi.org/10.1371/journal.pone.0011951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700524	Green Submitted, Green Published, gold			2022-12-25	WOS:000280605400006
J	Dees, ND; Bahar, S				Dees, Nathan D.; Bahar, Sonya			Mutation Size Optimizes Speciation in an Evolutionary Model	PLOS ONE			English	Article							RATES; EVOLVABILITY; POPULATIONS; ADJUSTMENT; ADAPTATION; SELECTION; COSTS	The role of mutation rate in optimizing key features of evolutionary dynamics has recently been investigated in various computational models. Here, we address the related question of how maximum mutation size affects the formation of species in a simple computational evolutionary model. We find that the number of species is maximized for intermediate values of a mutation size parameter mu; the result is observed for evolving organisms on a randomly changing landscape as well as in a version of the model where negative feedback exists between the local population size and the fitness provided by the landscape. The same result is observed for various distributions of mutation values within the limits set by mu. When organisms with various values of mu compete against each other, those with intermediate m values are found to survive. The surviving values of mu from these competition simulations, however, do not necessarily coincide with the values that maximize the number of species. These results suggest that various complex factors are involved in determining optimal mutation parameters for any population, and may also suggest approaches for building a computational bridge between the (micro) dynamics of mutations at the level of individual organisms and (macro) evolutionary dynamics at the species level.	[Dees, Nathan D.] Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA; Univ Missouri, Ctr Neurodynam, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis; University of Missouri System; University of Missouri Saint Louis	Dees, ND (corresponding author), Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA.	bahars@umsl.edu						Bak P., 1996, NATURE WORKS SCI SEL; Bedau MA, 2003, BIOSYSTEMS, V69, P143, DOI 10.1016/S0303-2647(02)00137-5; Bell G, 2005, HEREDITY, V94, P1, DOI 10.1038/sj.hdy.6800608; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Burger R, 2006, EVOLUTION, V60, P2185; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; de Aguiar MAM, 2009, NATURE, V460, P384, DOI 10.1038/nature08168; De Cara MAR, 2008, AM NAT, V171, P580, DOI 10.1086/587062; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; DRAKE JW, 1969, NATURE, V221, P1128, DOI 10.1038/2211128a0; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Fisher R.A., 1930, GENETICAL THEORY NAT; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Gould S. J., 1989, WONDERFUL LIFE BURGE; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Kauffman S.A., 1993, ORIGINS ORDER; KIMURA M, 1967, GENET RES, V9, P23, DOI 10.1017/S0016672300010284; Kondrashov AS, 1998, P ROY SOC B-BIOL SCI, V265, P2273, DOI 10.1098/rspb.1998.0570; Kopp M, 2008, J EVOLUTION BIOL, V21, P1005, DOI 10.1111/j.1420-9101.2008.01547.x; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; NOTHEL H, 1987, P NATL ACAD SCI USA, V84, P1045, DOI 10.1073/pnas.84.4.1045; Otto SP, 2008, GENETICS, V179, P2091, DOI 10.1534/genetics.107.084418; Pennings PS, 2008, AM NAT, V171, pE44, DOI 10.1086/523952; Pennisi E, 2008, SCIENCE, V321, P196, DOI 10.1126/science.321.5886.196; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Pigliucci M, 2007, EVOLUTION, V61, P2743, DOI 10.1111/j.1558-5646.2007.00246.x; Schaaper RM, 1998, GENETICS, V148, P1579; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Sturtevant AH, 1937, Q REV BIOL, V12, P464, DOI 10.1086/394543; Szathmary E, 1995, MAJOR TRANSITIONS EV	34	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11952	10.1371/journal.pone.0011952	http://dx.doi.org/10.1371/journal.pone.0011952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689827	Green Published, gold			2022-12-25	WOS:000280520500010
J	Fakhry, C; Sugar, E; D'Souza, G; Gillison, M				Fakhry, Carole; Sugar, Elizabeth; D'Souza, Gypsyamber; Gillison, Maura			Two-Week versus Six-Month Sampling Interval in a Short-Term Natural History Study of Oral HPV Infection in an HIV-Positive Cohort	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; RISK-FACTOR; HEAD; GENOTYPES; LESIONS	Background: Oral HPV infections detected six-months apart were compared to those detected bi-weekly, in an HIV-positive cohort, during the intervening months to elucidate systematic biases introduced into natural history studies by sampling interval. Methods: Fourteen consecutive oral rinse samples were collected every two weeks for six months from an HIV-positive cohort (n = 112) and evaluated for the presence of 37 HPV types. The cumulative probability of type-specific HPV detection at visits 1 through 14 was determined as a function of infection categorized at visits 1 and 14 as persistent, newly detected, cleared or absent. Transition models were used to evaluate the effect of HPV viral load (measured by RT-PCR for HPV 16, 18, 31, 33, 35) on infection persistence. Results: The average point prevalence of oral HPV infection was similar at two-week and six-month sampling intervals (45% vs. 47%, p = 0.52), but cumulative prevalence was higher with the former (82% vs. 53%, p<0.001) as was the cumulative prevalence of type-specific infections (9.3% vs 3.8%, p<0.0001). Type-specific infections persistent under a six-month sampling interval had a high probability (0.93, 95% CI 0.83-0.98) of detection at 50% or more of the intervening visits and infections that were absent had a high probability (0.94, 95% CI 0.93-0.95) of no interval detection. The odds of detection at any visit significantly increased for each unit increase in HPV viral load at the previous visit. Conclusions: Six-month sampling is appropriate to model factors associated with type-specific oral HPV infection persistence but may misclassify HPV-exposed individuals as unexposed.	[Fakhry, Carole] Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Sugar, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [D'Souza, Gypsyamber] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gillison, Maura] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Fakhry, C (corresponding author), Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA.	Maura.gillison@osumc.edu			National Institute of Dental and Craniofacial Research (NIDCR) [DE016631]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016631] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Institute of Dental and Craniofacial Research (NIDCR grant number DE016631 to Maura L. Gillison). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN D, 2005, LONGITUDINAL STUDY G, P182; D'Souza G, 2005, J CLIN MICROBIOL, V43, P5526, DOI 10.1128/JCM.43.11.5526-5535.2005; D'Souza G, 2007, INT J CANCER, V121, P143, DOI 10.1002/ijc.22667; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gravitt PE, 2007, INT J CANCER, V121, P2787, DOI 10.1002/ijc.23012; Gravitt PE, 2003, CANCER EPIDEM BIOMAR, V12, P477; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305; Yuan CC, 2001, J VIROL METHODS, V91, P109	15	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11918	10.1371/journal.pone.0011918	http://dx.doi.org/10.1371/journal.pone.0011918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689835	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520300028
J	Jung, J; Kang, H; Cho, YS; Oh, JH; Ryu, MH; Chung, HW; Seo, JS; Lee, JE; Oh, B; Bhak, J; Kim, HL				Jung, Jongsun; Kang, Hoyoung; Cho, Yoon Shin; Oh, Ji Hee; Ryu, Min Hyung; Chung, Hye Won; Seo, Jeong-Sun; Lee, Jong-Eun; Oh, Bermseok; Bhak, Jong; Kim, Hyung-Lae			Gene Flow between the Korean Peninsula and Its Neighboring Countries	PLOS ONE			English	Article							POPULATION-STRUCTURE; INDIVIDUALS	SNP markers provide the primary data for population structure analysis. In this study, we employed whole-genome autosomal SNPs as a marker set (54,836 SNP markers) and tested their possible effects on genetic ancestry using 320 subjects covering 24 regional groups including Northern (= 16) and Southern (= 3) Asians, Amerindians (= 1), and four HapMap populations (YRI, CEU, JPT, and CHB). Additionally, we evaluated the effectiveness and robustness of 50K autosomal SNPs with various clustering methods, along with their dependencies on recombination hotspots (RH), linkage disequilibrium (LD), missing calls and regional specific markers. The RH- and LD-free multi-dimensional scaling (MDS) method showed a broad picture of human migration from Africa to North-East Asia on our genome map, supporting results from previous haploid DNA studies. Of the Asian groups, the East Asian group showed greater differentiation than the Northern and Southern Asian groups with respect to Fst statistics. By extension, the analysis of monomorphic markers implied that nine out of ten historical regions in South Korea, and Tokyo in Japan, showed signs of genetic drift caused by the later settlement of East Asia (South Korea, Japan and China), while Gyeongju in South East Korea showed signs of the earliest settlement in East Asia. In the genome map, the gene flow to the Korean Peninsula from its neighboring countries indicated that some genetic signals from Northern populations such as the Siberians and Mongolians still remain in the South East and West regions, while few signals remain from the early Southern lineages.	[Jung, Jongsun] Syntekabio Inc, Seoul, South Korea; [Jung, Jongsun; Lee, Jong-Eun] DNA Link Inc, Seoul, South Korea; [Kang, Hoyoung; Bhak, Jong] KRIBB, Korean Bioinformat Ctr, Taejon, South Korea; [Kang, Hoyoung] Univ Sci & Technol, Taejon, South Korea; [Jung, Jongsun; Cho, Yoon Shin; Oh, Ji Hee; Ryu, Min Hyung; Kim, Hyung-Lae] Korea Natl Inst Hlth, Ctr Genome Sci, Div Struct & Funct Genom, Seoul, South Korea; [Chung, Hye Won] Ewha Womans Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Seo, Jeong-Sun] Seoul Natl Univ Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Oh, Bermseok] Kyung Hee Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea	DNA Link, Inc.; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Ewha Womans University; Seoul National University (SNU); Kyung Hee University	Jung, J (corresponding author), Syntekabio Inc, Seoul, South Korea.	hyung@ewha.ac.kr	Seo, Jeong-Sun/J-2763-2012		Syntekabio Inc.; DNA link Inc.	Syntekabio Inc.; DNA link Inc.	Syntekabio Inc. and DNA link Inc. were funders due to employment of Jongsun Jung of this study. The funders therefore played a role in study design, analysis, and preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; EXCOFFIER L, 1992, GENETICS, V131, P479; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kim JJ, 2005, HUM GENET, V117, P511, DOI 10.1007/s00439-005-1334-8; Lell JT, 2002, AM J HUM GENET, V70, P1380, DOI 10.1086/340389; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Press W., 1992, NUMERICAL RECIPES FO; Pritchard JK, 2000, GENETICS, V155, P945; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; ROSS MT, 2005, NATURE, V325, P37; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P477, DOI 10.1002/gepi.1370100625; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Watanabe RM, 1999, HUM HERED, V49, P159, DOI 10.1159/000022865; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; 2006, AFFYMETRIX TECHNICAL	25	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11855	10.1371/journal.pone.0011855	http://dx.doi.org/10.1371/journal.pone.0011855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686617	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520200020
J	Bralten, LBC; Gravendeel, AM; Kloosterhof, NK; Sacchetti, A; Vrijenhoek, T; Veltman, JA; van den Bent, MJ; Kros, JM; Hoogenraad, CC; Smitt, PAES; French, PJ				Bralten, L. B. C.; Gravendeel, A. M.; Kloosterhof, N. K.; Sacchetti, A.; Vrijenhoek, T.; Veltman, J. A.; van den Bent, M. J.; Kros, J. M.; Hoogenraad, C. C.; Smitt, P. A. E. Sillevis; French, P. J.			The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma	ONCOGENE			English	Article						CASPR2; CNTNAP2; glioma; tumor suppressor gene; NCOAI; translocation	FRAGILE SITE GENES; NEUREXIN SUPERFAMILY; MYELINATED AXONS; EXPRESSION; CNTNAP2; BRAIN; AUTISM; JUXTAPARANODES; CHANNELS; FUSION	Genomic translocations have been implicated in cancer. In this study, we performed a screen for genetic translocations in gliomas based on exon-level expression profiles. We identified a translocation in the contactin-associated protein-like 2 (CASPR2) gene, encoding a cell adhesion molecule. CASPR2 mRNA was fused to an expressed sequence tag that likely is part of the nuclear receptor coactivator 1 gene. Despite high mRNA expression levels, no CASPR2 fusion protein was detected. In a set of 25 glioblastomas and 22 oligodendrogliomas, mutation analysis identified two additional samples with genetic alterations in the CASPR2 gene and all three identified genetic alterations are likely to reduce CASPR2 protein expression levels. Methylation of the CASPR2 gene was also observed in gliomas and glioma cell lines. CASPR2-overexpressing cells showed decreased proliferation rates, likely because of an increase in apoptosis. Moreover, high CASPR2 mRNA expression level is positively correlated with survival and is an independent prognostic factor. These results indicate that CASPR2 acts as a tumor suppressor gene in glioma. Oncogene (2010) 29, 6138-6148; doi:10.1038/onc.2010.342; published online 16 August 2010	[Bralten, L. B. C.; Gravendeel, A. M.; Kloosterhof, N. K.; van den Bent, M. J.; Smitt, P. A. E. Sillevis; French, P. J.] Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Kloosterhof, N. K.] Erasmus MC, Dept Pediat Oncol & Hematol, NL-3000 CA Rotterdam, Netherlands; [Sacchetti, A.; Kros, J. M.] Erasmus MC, Dept Pathol, NL-3000 CA Rotterdam, Netherlands; [Vrijenhoek, T.; Veltman, J. A.] Radboud Univ Nijmegen, Dept Human Genet, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Hoogenraad, C. C.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	French, PJ (corresponding author), Erasmus MC, Dept Neurol, Room Be 462A,POB 2040, NL-3000 CA Rotterdam, Netherlands.	p.french@erasmusmc.nl	Veltman, Joris A/F-5128-2010; Hoogenraad, Casper/B-8866-2011; Sacchetti, Andrea/H-8763-2019	Veltman, Joris A/0000-0002-3218-8250; Hoogenraad, Casper/0000-0002-2666-0758; van den Bent, Martin/0000-0001-5710-5127; French, Pim/0000-0002-0668-9529				Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; Freire P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004076; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Gerber MA, 2006, CANCER RES, V66, P5295, DOI 10.1158/0008-5472.CAN-05-1628; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Gutmann DH, 2000, HUM MOL GENET, V9, P1495, DOI 10.1093/hmg/9.10.1495; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Jackman C, 2009, PEDIATR NEUROL, V40, P310, DOI 10.1016/j.pediatrneurol.2008.10.013; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kleihues P, 2000, PATHOLOGY GENETICS T; KRAUS JA, 1995, J NEUROPATH EXP NEUR, V54, P91, DOI 10.1097/00005072-199501000-00011; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Omura N, 2008, CANCER BIOL THER, V7, P1146, DOI 10.4161/cbt.7.7.6208; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schutte M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003007; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Thorell K, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-53; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tran Y, 1998, ONCOGENE, V17, P3499, DOI 10.1038/sj.onc.1202258; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zecchini S, 2010, ADV EXP MED BIOL, V663, P319, DOI 10.1007/978-1-4419-1170-4_20	43	23	24	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	46					6138	6148		10.1038/onc.2010.342	http://dx.doi.org/10.1038/onc.2010.342			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	681XD	20711234				2022-12-25	WOS:000284356500006
J	Lewis, NE; Marty, NJ; Kathir, KM; Rajalingam, D; Kight, AD; Daily, A; Kumar, TKS; Henry, RL; Goforth, RL				Lewis, Nathaniel E.; Marty, Naomi J.; Kathir, Karuppanan Muthusamy; Rajalingam, Dakshinamurthy; Kight, Alicia D.; Daily, Anna; Kumar, Thallapuranam Krishnaswamy Suresh; Henry, Ralph L.; Goforth, Robyn L.			A Dynamic cpSRP43-Albino3 Interaction Mediates Translocase Regulation of Chloroplast Signal Recognition Particle (cpSRP)-targeting Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; HARVESTING CHLOROPHYLL PROTEINS; THYLAKOID MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; POSTTRANSLATIONAL INTEGRATION; HOMOLOG ALBINO3; BACTERIAL YIDC; OXA1 COMPLEX; GTPASE CYCLE; INSERTION	The chloroplast signal recognition particle (cpSRP) and its receptor, chloroplast FtsY (cpFtsY), form an essential complex with the translocase Albino3 (Alb3) during post-translational targeting of light-harvesting chlorophyll-binding proteins (LHCPs). Here, we describe a combination of studies that explore the binding interface and functional role of a previously identified cpSRP43-Alb3 interaction. Using recombinant proteins corresponding to the C terminus of Alb3 (Alb3-Cterm) and various domains of cpSRP43, we identify the ankyrin repeat region of cpSRP43 as the domain primarily responsible for the interaction with Alb3-Cterm. Furthermore, we show Alb3-Cterm dissociates a cpSRP.LHCP targeting complex in vitro and stimulates GTP hydrolysis by cpSRP54 and cpFtsY in a strictly cpSRP43-dependent manner. These results support a model in which interactions between the ankyrin region of cpSRP43 and the C terminus of Alb3 promote distinct membrane-localized events, including LHCP release from cpSRP and release of targeting components from Alb3.	[Lewis, Nathaniel E.; Marty, Naomi J.; Kight, Alicia D.; Henry, Ralph L.; Goforth, Robyn L.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Kathir, Karuppanan Muthusamy; Rajalingam, Dakshinamurthy; Daily, Anna; Kumar, Thallapuranam Krishnaswamy Suresh; Goforth, Robyn L.] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Henry, RL (corresponding author), Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA.	rahenry@uark.edu; Robyn.Goforth@uark.edu	Kumar, Suresh Thallapuranam/R-5606-2016; Kumar, Dr Suresh/HHZ-2615-2022; KUMAR, P. SURESH/AAT-8951-2020	Kumar, Suresh Thallapuranam/0000-0001-7262-1373; Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604	National Institutes of Health, NCRR [P20 RR15569]; Department of Energy [DE-FG02-01ER15161]; Arkansas Biosciences Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER	National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy(United States Department of Energy (DOE)); Arkansas Biosciences Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR15569 (R. L. G. and T. K. S. K.) from the NCRR. This work was also supported by Department of Energy Grant DE-FG02-01ER15161 (to R. L. H. and T. K. S. K.) and the Arkansas Biosciences Institute.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Chu FX, 2004, P NATL ACAD SCI USA, V101, P16454, DOI 10.1073/pnas.0407456101; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CLINE K, 1989, J BIOL CHEM, V264, P14225; Dalbey RE, 2004, BBA-MOL CELL RES, V1694, P37, DOI 10.1016/j.bbamcr.2004.03.009; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Hermkes R, 2006, FEBS LETT, V580, P3107, DOI 10.1016/j.febslet.2006.04.055; Hutin C, 2002, PLANT J, V29, P531, DOI 10.1046/j.0960-7412.2001.01211.x; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jaru-Ampornpan P, 2009, MOL BIOL CELL, V20, P3965, DOI 10.1091/mbc.E08-10-0989; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Jonas-Straube E, 2001, J BIOL CHEM, V276, P24654, DOI 10.1074/jbc.M100153200; Kathir KM, 2008, J MOL BIOL, V381, P49, DOI 10.1016/j.jmb.2008.05.065; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kogata N, 1999, FEBS LETT, V447, P329, DOI 10.1016/S0014-5793(99)00305-1; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Mandon EC, 2003, J CELL BIOL, V162, P575, DOI 10.1083/jcb.200303143; Marty NJ, 2009, J BIOL CHEM, V284, P14891, DOI 10.1074/jbc.M900775200; MILLER JD, 1993, CIBA F SYMP, V176, P147; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; PAYAN LA, 1991, J CELL BIOL, V112, P603, DOI 10.1083/jcb.112.4.603; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; Roselin LS, 2010, BIOTECHNOL J, V5, P85, DOI 10.1002/biot.200900092; Rutschow H, 2008, PLANT PHYSIOL, V148, P156, DOI 10.1104/pp.108.124545; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schunemann D, 2004, CURR GENET, V44, P295, DOI 10.1007/s00294-003-0450-z; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Stuart RA, 2002, BBA-MOL CELL RES, V1592, P79, DOI 10.1016/S0167-4889(02)00266-5; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; Woolhead CA, 2001, J BIOL CHEM, V276, P40841, DOI 10.1074/jbc.M106523200; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x; Yi L, 2005, MOL MEMBR BIOL, V22, P101, DOI 10.1080/09687860500041718; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	55	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34220	34230		10.1074/jbc.M110.160093	http://dx.doi.org/10.1074/jbc.M110.160093			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729200	Green Published, hybrid			2022-12-25	WOS:000283354000067
J	Harrus, D; Ahmed-El-Sayed, N; Simister, PC; Miller, S; Triconnet, M; Hagedorn, CH; Mahias, K; Rey, FA; Astier-Gin, T; Bressanelli, S				Harrus, Deborah; Ahmed-El-Sayed, Neveen; Simister, Philip C.; Miller, Steve; Triconnet, Martine; Hagedorn, Curt H.; Mahias, Kathleen; Rey, Felix A.; Astier-Gin, Therese; Bressanelli, Stephane			Further Insights into the Roles of GTP and the C Terminus of the Hepatitis C Virus Polymerase in the Initiation of RNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO INITIATION; CRYSTAL-STRUCTURE; IN-VITRO; NS5B POLYMERASE; CDNA-CLONE; REPLICATION; IDENTIFICATION; INHIBITION; MECHANISM; COMPLEX	The hepatitis C virus (HCV) NS5b protein is an RNA-dependent RNA polymerase essential for replication of the viral RNA genome. In vitro and presumably in vivo, NS5b initiates RNA synthesis by a de novo mechanism. Different structural elements of NS5b have been reported to participate in RNA synthesis, especially a so-called "beta-flap" and a C-terminal segment (designated "linker") that connects the catalytic core of NS5b to a transmembrane anchor. High concentrations of GTP have also been shown to stimulate de novo RNA synthesis by HCV NS5b. Here we describe a combined structural and functional analysis of genotype 1 HCV-NS5b of strains H77 (subtype 1a), for which no structure has been previously reported, and J4 (subtype 1b). Our results highlight the linker as directly involved in lifting the first boundary to processive RNA synthesis, the formation of the first dinucleotide primer. The transition from this first dinucleotide primer state to processive RNA synthesis requires removal of the linker and of the beta-flap with which it is shown to strongly interact in crystal structures of HCV NS5b. We find that GTP specifically stimulates this transition irrespective of its incorporation in neosynthesized RNA.	[Harrus, Deborah; Simister, Philip C.; Triconnet, Martine; Rey, Felix A.; Bressanelli, Stephane] CNRS UPR3296, Lab Virol Mol & Struct, F-91198 Gif Sur Yvette, France; [Ahmed-El-Sayed, Neveen; Mahias, Kathleen; Astier-Gin, Therese] Univ Bordeaux 2, IFR66, CNRS UMR 52342, F-33076 Bordeaux, France; [Miller, Steve; Hagedorn, Curt H.] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite de Bordeaux; University of Kansas; University of Kansas Medical Center	Bressanelli, S (corresponding author), CNRS UPR3296, Lab Virol Mol & Struct, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	stephane.bressanelli@vms.cnrs-gif.fr	Rey, Felix/B-6497-2012	Rey, Felix/0000-0002-9953-7988; Bressanelli, Stephane/0000-0002-0921-6727; Harrus, Deborah/0000-0002-7651-672X	National Institutes of Health [RO1 CA63640]; Agence Nationale de Recherche sur le Sida et les Hepatites Virales [AO 2008, CSS4]; Egyptian Ministry of Education; NATIONAL CANCER INSTITUTE [R01CA063640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherche sur le Sida et les Hepatites Virales(ANRSFrench National Research Agency (ANR)); Egyptian Ministry of Education(Ministry of Higher Education & Scientific Research (MHESR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA63640 (to C. H. H.). This work was also supported in part by Agence Nationale de Recherche sur le Sida et les Hepatites Virales Grants AO 2008, CSS4 (to S. B.) and AO 2008, CSS4 (T. A.-G.) and predoctoral (to D. H. and K. M.) and postdoctoral (to P. C. S.) fellowships.; Supported by a Ph.D. fellowship from the Egyptian Ministry of Education.	Adachi T, 2002, BBA-PROTEINS PROTEOM, V1601, P38, DOI 10.1016/S1570-9639(02)00433-8; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Astier-Gin T, 2005, FEBS J, V272, P3872, DOI 10.1111/j.1742-4658.2005.04804.x; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cai ZH, 2004, J VIROL, V78, P3633, DOI 10.1128/JVI.78.7.3633-3643.2004; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; D'Abramo CM, 2006, J BIOL CHEM, V281, P24991, DOI 10.1074/jbc.M600474200; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Ellis DA, 2009, BIOORG MED CHEM LETT, V19, P6047, DOI 10.1016/j.bmcl.2009.09.051; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Ivashkina N, 2002, J VIROL, V76, P13088, DOI 10.1128/JVI.76.24.13088-13093.2002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lescar J, 2009, CURR OPIN STRUC BIOL, V19, P759, DOI 10.1016/j.sbi.2009.10.011; Lohmann V, 1999, J BIOL CHEM, V274, P10807, DOI 10.1074/jbc.274.16.10807; Lou H, 2003, VIROLOGY, V317, P65, DOI 10.1016/j.virol.2003.08.038; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Masante C, 2008, J GEN VIROL, V89, P212, DOI 10.1099/vir.0.83067-0; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; Reigadas S, 2001, EUR J BIOCHEM, V268, P5857, DOI 10.1046/j.0014-2956.2001.02532.x; Rockway TW, 2006, BIOORG MED CHEM LETT, V16, P3833, DOI 10.1016/j.bmcl.2006.04.022; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Schneider TR, 2004, ACTA CRYSTALLOGR D, V60, P2269, DOI 10.1107/S0907444904023492; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Yanagi M, 1998, VIROLOGY, V244, P161, DOI 10.1006/viro.1998.9092; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	49	62	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32906	32918		10.1074/jbc.M110.151316	http://dx.doi.org/10.1074/jbc.M110.151316			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729191	hybrid, Green Published			2022-12-25	WOS:000283048200028
J	Iyappan, S; Wollscheid, HP; Rojas-Fernandez, A; Marquardt, A; Tang, HC; Singh, RK; Scheffner, M				Iyappan, Saravanakumar; Wollscheid, Hans-Peter; Rojas-Fernandez, Alejandro; Marquardt, Andreas; Tang, Hao-Cheng; Singh, Rajesh K.; Scheffner, Martin			Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC LETHALITY; IN-VIVO; NUCLEOLAR-LOCALIZATION; ALLOSTERIC ACTIVATION; MDM2-DEFICIENT MICE; P53 INHIBITION; REGULATE P53; UBIQUITYLATION; DEGRADATION; RESCUE	The related RING domain proteins MdmX and Mdm2 are best known for their role as negative regulators of the tumor suppressor p53. However, although Mdm2 functions as a ubiquitin ligase for p53, MdmX does not have appreciable ubiquitin ligase activity. In this study, we performed a mutational analysis of the RING domain of MdmX, and we identified two distinct regions that, when replaced by the respective regions of Mdm2, turn MdmX into an active ubiquitin ligase for p53. Mdm2 and MdmX form homodimers as well as heterodimers with each other. One of the regions identified localizes to the dimer interface indicating that subtle conformational changes in this region either affect dimer stability and/or the interaction with the ubiquitin-conjugating enzyme UbcH5b. The second region contains the cryptic nucleolar localization signal of Mdm2 but is also assumed to be involved in the interaction with UbcH5b. Here, we show that this region has a significant impact on the ability of respective MdmX mutants to functionally interact with UbcH5b in vitro supporting the notion that this region serves two distinct functional purposes, nucleolar localization and ubiquitin ligase activity. Finally, evidence is provided to suggest that the RING domain of Mdm2 not only binds to UbcH5b but also acts as an allosteric activator of UbcH5b.	[Iyappan, Saravanakumar; Wollscheid, Hans-Peter; Rojas-Fernandez, Alejandro; Tang, Hao-Cheng; Scheffner, Martin] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Iyappan, Saravanakumar; Wollscheid, Hans-Peter; Rojas-Fernandez, Alejandro; Tang, Hao-Cheng; Scheffner, Martin] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Marquardt, Andreas] Univ Konstanz, Prote Facil, D-78457 Constance, Germany; [Singh, Rajesh K.] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA	University of Konstanz; University of Konstanz; University of Konstanz; University System of Maryland; University of Maryland College Park	Scheffner, M (corresponding author), Univ Konstanz, Dept Biol, Box 642, D-78457 Constance, Germany.	martin.scheffner@uni-konstanz.de	Scheffner, Martin/K-2940-2012; Fernandez, Alejandro Rojas/K-3291-2014	Scheffner, Martin/0000-0003-2229-0128; Fernandez, Alejandro Rojas/0000-0002-6004-5425	Deutsche Forschungsgemeinschaft; European Union Network of Excellence RUBICON	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union Network of Excellence RUBICON(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft and by the European Union Network of Excellence RUBICON.	Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Dang JJ, 2002, CANCER RES, V62, P1222; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finch RA, 2002, CANCER RES, V62, P3221; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2004, CELL CYCLE, V3, P900; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Migliorini D, 2002, J BIOL CHEM, V277, P7318, DOI 10.1074/jbc.M108795200; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Singh RK, 2007, J BIOL CHEM, V282, P10901, DOI 10.1074/jbc.M610879200; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103	45	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33065	33072		10.1074/jbc.M110.115113	http://dx.doi.org/10.1074/jbc.M110.115113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705607	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000283048200044
J	Lee, J; Lee, J; Jung, E; Kim, YS; Roh, K; Jung, KH; Park, D				Lee, Jongsung; Lee, Jienny; Jung, Eunsun; Kim, Young-Soo; Roh, Kyungbaeg; Jung, Kyung-Hwan; Park, Deokhoon			Ultraviolet A Regulates Adipogenic Differentiation of Human Adipose Tissue-derived Mesenchymal Stem Cells via Up-regulation of Kruppel-like Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; IRRADIATION; EXPRESSION; OBESITY; 8-METHOXYPSORALEN; FIBROBLASTS; INHIBITION; LKLF; UVB	Adipocyte dysfunction is strongly associated with the development of obesity, which is a major risk factor for many disorders, including diabetes, hypertension, and heart disease. This study shows that ultraviolet A (UVA) inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells and its action mechanisms. The mRNA levels of peroxidase proliferator-activated receptor (PPAR) gamma and CCAAT/enhancer-binding protein alpha (C/EBP alpha), but not CCAAT/enhancer-binding protein ((C/EBP) beta and delta, were reduced by UVA. Moreover, the mRNA levels of PPAR gamma target genes (lipoprotein lipase (LPL), CD36, adipocyte protein (aP2), and liver X receptor alpha (LXR)) were down-regulated by UVA. Additionally, attempts to elucidate a possible mechanism underlying the UVA-mediated effects revealed that UVA induced migration inhibitory factor (MIF) gene expression, and this was mediated through activation of AP-1 (especially JNK and p42/44 MAPK) and nuclear factor-kappa B. In addition, reduced adipogenesis by UVA was recovered upon the treatment with anti-MIF antibodies. AMP-activated protein kinase phosphorylation and up-regulation of Kruppel-like factor 2 (KLF2) were induced by UVA. Taken together, these findings suggest that the inhibition of adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by UVA occurs primarily through the reduced expression of PPAR gamma, which is mediated by up-regulation of KLF2 via the activation of MIF-AMP-activated protein kinase signaling.	[Lee, Jongsung; Lee, Jienny; Jung, Eunsun; Kim, Young-Soo; Roh, Kyungbaeg; Park, Deokhoon] Biospectrum Life Sci Inst, Songnam 462807, Gyunggi Do, South Korea; [Jung, Kyung-Hwan] Chungju Natl Univ, Dept Biotechnol, Jeungpyung 368701, Chungbuk, South Korea		Park, D (corresponding author), Biospectrum Life Sci Inst, Songnam 462807, Gyunggi Do, South Korea.	pdh@biospectrum.com						Alessi MC, 2003, PATHOPHYSIOL HAEMO T, V33, P290, DOI 10.1159/000083816; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bray G A, 2001, Rev Endocr Metab Disord, V2, P403, DOI 10.1023/A:1011808701117; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x; Cabrijan L, 2008, COLLEGIUM ANTROPOL, V32, P53; Chapman MJ, 2003, ATHEROSCLEROSIS, V171, P1, DOI 10.1016/S0021-9150(03)00156-4; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Halliday GM, 2008, PHOTOCHEM PHOTOBIOL, V84, P35, DOI 10.1111/j.1751-1097.2007.00212.x; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KOZAK LP, 1974, J BIOL CHEM, V249, P7775; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; La C, 2006, J MEMBRANE BIOL, V210, P43, DOI 10.1007/s00232-005-0844-6; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Lee J, 2007, BRIT J DERMATOL, V157, P242, DOI 10.1111/j.1365-2133.2007.07934.x; MALININ GI, 1995, BIOCHEM BIOPH RES CO, V207, P877, DOI 10.1006/bbrc.1995.1267; MARCH KL, 1993, CIRCULATION, V87, P184, DOI 10.1161/01.CIR.87.1.184; Martini CN, 2009, MOL CELL ENDOCRINOL, V298, P42, DOI 10.1016/j.mce.2008.10.023; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Noonan FP, 2009, J INVEST DERMATOL, V129, P1608, DOI 10.1038/jid.2009.116; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Potapovich AI, 2009, BRIT J PHARMACOL, V158, P1236, DOI 10.1111/j.1476-5381.2009.00401.x; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tanabe Y, 2004, J CELL SCI, V117, P3605, DOI 10.1242/jcs.01207; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tyrrell RM, 2006, PROG BIOPHYS MOL BIO, V92, P86, DOI 10.1016/j.pbiomolbio.2006.02.002; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Yamauchi T, 2003, NEPHROL DIAL TRANSPL, V18, P1842, DOI 10.1093/ndt/gfg261; Young A, 2009, ARTERIOSCL THROM VAS, V29, P1902, DOI 10.1161/ATVBAHA.109.193540; Zhong JL, 2010, PHOTOCH PHOTOBIO SCI, V9, P18, DOI 10.1039/b9pp00068b	34	31	31	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32647	32656		10.1074/jbc.M110.135830	http://dx.doi.org/10.1074/jbc.M110.135830			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693579	hybrid, Green Published			2022-12-25	WOS:000282683000079
J	Waldron, KJ; Firbank, SJ; Dainty, SJ; Perez-Rama, M; Tottey, S; Robinson, NJ				Waldron, Kevin J.; Firbank, Susan J.; Dainty, Samantha J.; Perez-Rama, Monica; Tottey, Steve; Robinson, Nigel J.			Structure and Metal Loading of a Soluble Periplasm Cuproprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; COPPER CHAPERONE; OXALATE DECARBOXYLASE; THYLAKOID MEMBRANE; BACILLUS-SUBTILIS; MOLECULAR-BASIS; GENE-PRODUCTS; TRANSPORT	A copper-trafficking pathway was found to enable Cu2+ occupancy of a soluble periplasm protein, CucA, even when competing Zn2+ is abundant in the periplasm. Here, we solved the structure of CucA (a new cupin) and found that binding of Cu2+, but not Zn2+, quenches the fluorescence of Trp(165), which is adjacent to the metal site. Using this fluorescence probe, we established that CucA becomes partly occupied by Zn2+ following exposure to equimolar Zn2+ and Cu2+. Cu2(2+)-CucA is more thermodynamically stable than Zn2+-CucA but k((Zn -> Cu) exchange) is slow, raising questions about how the periplasm contains solely the Cu2+ form. We discovered that a copper-trafficking pathway involving two copper transporters (CtaA and PacS) and a metallochaperone (Atx1) is obligatory for Cu2+-CucA to accumulate in the periplasm. There was negligible CucA protein in the periplasm of Delta ctaA cells, but the abundance of cucA transcripts was unaltered. Crucially, Delta ctaA cells overaccumulate low M-r copper complexes in the periplasm, and purified apoCucA can readily acquire Cu2+ from Delta ctaA periplasm extracts, but in vivo apoCucA fails to come into contact with these periplasmic copper pools. Instead, copper traffics via a cytoplasmic pathway that is coupled to CucA translocation to the periplasm.	[Waldron, Kevin J.; Firbank, Susan J.; Dainty, Samantha J.; Perez-Rama, Monica; Tottey, Steve; Robinson, Nigel J.] Univ Newcastle Med Sch, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Robinson, NJ (corresponding author), Univ Newcastle Med Sch, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	n.j.robinson@ncl.ac.uk	Waldron, Kevin John/HHM-8983-2022; Robinson, Nigel J/J-6363-2012; Waldron, Kevin/J-2368-2016	Waldron, Kevin John/0000-0002-5577-7357; Robinson, Nigel J/0000-0001-5586-1092; Waldron, Kevin/0000-0002-5577-7357	Biotechnology and Biological Sciences Research Council PMS Committee [BBS/B/02576, BB/E001688/1]; Biotechnology and Biological Sciences Research Council [BBS/B/02576, BB/E001688/1] Funding Source: researchfish; BBSRC [BB/E001688/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council PMS Committee(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council PMS Committee Grants BBS/B/02576 and BB/E001688/1.	Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Brantner CA, 2000, CURR MICROBIOL, V40, P132, DOI 10.1007/s002849910026; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Hassani BK, 2010, J BIOL CHEM, V285, P19330, DOI 10.1074/jbc.M110.116020; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Just VJ, 2004, J BIOL CHEM, V279, P19867, DOI 10.1074/jbc.M313820200; KANAMARU K, 1994, MOL MICROBIOL, V13, P369, DOI 10.1111/j.1365-2958.1994.tb00430.x; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Lin SJ, 1997, J BIOL CHEM, V272, P9215; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nies DH, 2007, MOL MICROBIOLOGY HEA, V6, P117, DOI DOI 10.1007/7171_2006_075; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; ODERMATT A, 1994, BIOCHEM BIOPH RES CO, V202, P44, DOI 10.1006/bbrc.1994.1891; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; PHUNG LT, 1994, P NATL ACAD SCI USA, V91, P9651, DOI 10.1073/pnas.91.20.9651; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rajalahti T, 2007, J PROTEOME RES, V6, P2420, DOI 10.1021/pr0605973; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Schneider D, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-39; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299; Tottey S, 2002, J BIOL CHEM, V277, P5490, DOI 10.1074/jbc.M105857200; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Whittaker MM, 2006, BIOPHYS J, V90, P598, DOI 10.1529/biophysj.105.071308; ZHANG L, 1992, J BIOL CHEM, V267, P19054	40	22	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32504	32511		10.1074/jbc.M110.153080	http://dx.doi.org/10.1074/jbc.M110.153080			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702411	Green Published, hybrid			2022-12-25	WOS:000282683000064
J	Lysechko, TL; Cheung, SMS; Ostergaard, HL				Lysechko, Tara L.; Cheung, Samuel M. S.; Ostergaard, Hanne L.			Regulation of the Tyrosine Kinase Pyk2 by Calcium Is through Production of Reactive Oxygen Species in Cytotoxic T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROTEIN-KINASE; HYDROGEN-PEROXIDE; CELL-ACTIVATION; PHOSPHORYLATION; RECEPTOR; CA2+; ASSOCIATION; P56(LCK); CLONING	Pyk2 was identified as a Ca2+-dependent kinase, however, the regulation of Pyk2 by Ca2+ in T cells remains controversial. We found that Ca2+ mobilization preferentially induced Pyk2 phosphorylation in cytotoxic T lymphocytes (CTL). Furthermore, Pyk2 phosphorylation in CTL was not absolutely Ca2+ dependent but relied on the strength of T cell receptor stimulation. Ionomycin-stimulated Pyk2 phosphorylation did not require calmodulin activity, because phosphorylation was not inhibited by the calmodulin inhibitor W7, and we detected no Ca2+-regulated association between Pyk2 and calmodulin. Ca2+-stimulated Pyk2 phosphorylation was dependent on Src-family kinase activity, even at the Pyk2 autophosphorylation site. We sought to identify a Ca2+-regulated pathway that could trigger Pyk2 phosphorylation in T cells and found that ionomycin stimulated the production of reactive oxygen species and an H2O2 scavenger inhibited ionomycin-induced Pyk2 phosphorylation. Additionally, H2O2 induced strong Erk activation and ionomycin-stimulated Pyk2 phosphorylation was Erk dependent. These data support the conclusion that Ca2+ mobilization induces the production of reactive oxygen species, which in turn activate the Erk pathway, leading to Src-family kinase-dependent Pyk2 phosphorylation. Our data demonstrate that Pyk2 is not a Ca2+ dependent kinase in T cells but instead, increased intracellular Ca2+ induces Pyk2 phosphorylation through production of reactive oxygen species. These findings are consistent with the possibility that Pyk2 acts as an early sensor of numerous extracellular signals that trigger a Ca2+ flux and/or reactive oxygen species to amplify tyrosine phosphorylation signaling events.	[Lysechko, Tara L.; Cheung, Samuel M. S.; Ostergaard, Hanne L.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Ostergaard, HL (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	hanne.ostergaard@ualberta.ca			Canadian Cancer Society [017111]; AHFMR; Canadian Institutes of Health	Canadian Cancer Society(Canadian Cancer Society (CCS)); AHFMR(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Cancer Society Grant 017111.; Supported by a studentship from AHFMR. Present address: Afexa Life Sciences Inc., 9604 20th Ave., Edmonton, AB T6N 1G1, Canada.; Supported by a Canadian Institutes of Health Research Doctoral Award.	Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Berg NN, 1998, J IMMUNOL, V161, P2919; Berg NN, 1997, J IMMUNOL, V159, P1753; BLAKELY A, 1987, J EXP MED, V166, P1070, DOI 10.1084/jem.166.4.1070; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Daou GB, 2004, FREE RADICAL BIO MED, V37, P208, DOI 10.1016/j.freeradbiomed.2004.04.018; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Frank GD, 2000, BIOCHEM BIOPH RES CO, V270, P761, DOI 10.1006/bbrc.2000.2505; Franklin RA, 2000, MOL IMMUNOL, V37, P675, DOI 10.1016/S0161-5890(00)00087-0; Ganju RK, 1997, J EXP MED, V185, P1055, DOI 10.1084/jem.185.6.1055; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Guo J, 2004, NEUROSCI LETT, V355, P177, DOI 10.1016/j.neulet.2003.10.076; Hardwick JS, 1997, J BIOL CHEM, V272, P25429, DOI 10.1074/jbc.272.41.25429; Herzog H, 1996, GENOMICS, V32, P484, DOI 10.1006/geno.1996.0149; Hiregowdara D, 1997, J BIOL CHEM, V272, P10804; Hirotani S, 2004, J MOL CELL CARDIOL, V36, P799, DOI 10.1016/j.yjmcc.2004.03.002; JOUNG I, 1995, P NATL ACAD SCI USA, V92, P5778, DOI 10.1073/pnas.92.13.5778; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Katagiri T, 2000, J BIOL CHEM, V275, P19645, DOI 10.1074/jbc.M909828199; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li X, 1999, J BIOL CHEM, V274, P8917, DOI 10.1074/jbc.274.13.8917; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Ma EA, 1997, EUR J IMMUNOL, V27, P329, DOI 10.1002/eji.1830270147; MASON MJ, 1991, J BIOL CHEM, V266, P20856; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; OSTERGAARD H, 1987, J IMMUNOL, V139, P3573; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Raja S, 1997, J BIOL CHEM, V272, P10941; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rodriguez-Fernandez JL, 2002, J LEUKOCYTE BIOL, V71, P520; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsuchida M, 1999, EUR J IMMUNOL, V29, P2354, DOI 10.1002/(SICI)1521-4141(199907)29:07<2354::AID-IMMU2354>3.0.CO;2-P; WATTS JD, 1993, J BIOL CHEM, V268, P23275; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993	49	19	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31174	31184		10.1074/jbc.M110.118265	http://dx.doi.org/10.1074/jbc.M110.118265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20688918	Green Published, hybrid			2022-12-25	WOS:000282764600011
J	Apostol, MI; Sawaya, MR; Cascio, D; Eisenberg, D				Apostol, Marcin I.; Sawaya, Michael R.; Cascio, Duilio; Eisenberg, David			Crystallographic Studies of Prion Protein (PrP) Segments Suggest How Structural Changes Encoded by Polymorphism at Residue 129 Modulate Susceptibility to Human Prion Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CROSS-BETA SPINE; CONFORMATIONAL CONVERSION; NMR STRUCTURE; GENOTYPE; VARIANT; MODEL; REPLICATION; DOMAIN; CJD	A single nucleotide polymorphism (SNP) in codon 129 of the human prion gene, leading to a change from methionine to valine at residue 129 of prion protein (PrP), has been shown to be a determinant in the susceptibility to prion disease. However, the molecular basis of this effect remains unexplained. In the current study, we determined crystal structures of prion segments having either Met or Val at residue 129. These 6-residue segments of PrP centered on residue 129 are "steric zippers," pairs of interacting beta-sheets. Both structures of these " homozygous steric zippers" reveal direct intermolecular interactions between Met or Val in one sheet and the identical residue in the mating sheet. These two structures, plus a structure-based model of the heterozygous Met-Val steric zipper, suggest an explanation for the previously observed effects of this locus on prion disease susceptibility and progression.	[Apostol, Marcin I.; Sawaya, Michael R.; Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, UCLA DOE Inst, Dept Chem & Biochem, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Eisenberg, D (corresponding author), 201 Boyer Hall,Box 951570,611 Charles Young Dr E, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu			National Institutes of Health; Ruth L. Kirschstein National Research [GM007185]; National Science Foundation; Department of Defense; Howard Hughes Medical Institute; UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health grant (to D.E.) and Ruth L. Kirschstein National Research Service Award GM007185 (to M.I.A.). This work was also supported by grants from the National Science Foundation, Department of Defense, and Howard Hughes Medical Institute (to D.E.) and the UCLA Dissertation Year Fellowship (to M.I.A.).	Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baskakov I, 2005, FEBS LETT, V579, P2589, DOI 10.1016/j.febslet.2005.03.075; Brandel JP, 2003, LANCET, V362, P128, DOI 10.1016/S0140-6736(03)13867-6; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghani AC, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Hall D, 2004, J MOL BIOL, V336, P775, DOI 10.1016/j.jmb.2003.12.004; Hirschler J, 1996, ACTA CRYSTALLOGR D, V52, P806, DOI 10.1107/S0907444996001813; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jones EM, 2006, J BIOL CHEM, V281, P8190, DOI 10.1074/jbc.M513417200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaski D, 2009, LANCET, V374, P2128, DOI 10.1016/S0140-6736(09)61568-3; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Lewis PA, 2006, J GEN VIROL, V87, P2443, DOI 10.1099/vir.0.81630-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; NGUYEN JT, 1995, J MOL BIOL, V252, P412, DOI 10.1006/jmbi.1995.0507; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Panegyres PK, 2001, ARCH NEUROL-CHICAGO, V58, P1899, DOI 10.1001/archneur.58.11.1899; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Petchanikow C, 2001, FEBS LETT, V509, P451, DOI 10.1016/S0014-5793(01)03147-7; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	49	49	49	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29671	29675		10.1074/jbc.C110.158303	http://dx.doi.org/10.1074/jbc.C110.158303			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20685658	Green Published, hybrid			2022-12-25	WOS:000281984300001
J	Das, S; Saha, S; Majumder, GC; Dungdung, SR				Das, Sujoy; Saha, Sudipta; Majumder, Gopal Chandra; Dungdung, Sandhya Rekha			Purification and Characterization of a Sperm Motility Inhibiting Factor from Caprine Epididymal Plasma	PLOS ONE			English	Article							SEMINAL PLASMA; POLYACRYLAMIDE GELS; SPERMATOZOA; INITIATION; GLYCOPROTEIN; PROTEINS; IDENTIFICATION; POPULATION; MATURATION; PARAMETERS	Several studies have been reported on the occurrence of sperm motility inhibiting factors in the male reproductive fluids of different mammalian species, but these proteins have not been adequately purified and characterized. A novel sperm motility inhibiting factor (MIF-II) has been purified from caprine epididymal plasma (EP) by Hydroxylapatite gel adsorption chromatography, DEAE-Cellulose ion-exchange chromatography and chromatofocusing. The MIF-II has been purified to apparent homogeneity and the molecular weight estimated by Sephacryl S-300 gel filtration is 160 kDa. MIF-II is a dimeric protein, made up of two subunits each having a molecular mass of 80 kDa as shown by SDS-PAGE. The isoelectric point of MIF-II is 5.1 as determined by chromatofocusing and isoelectric focusing. It is a heat labile protein and maximal active at the pH 6.9 to 7.5. The sperm motility inhibiting protein factor at 2 mu g/ml (12.5 nM) level showed maximal motility-inhibiting activity. The observation that the epididymal plasma factor lowered the intracellular cAMP level of spermatozoa in a concentration-dependent manner suggests that it may block the motility of caprine cauda spermatozoa by interfering the cAMP dependent motility function. The results revealed that the purified protein factor has the potential of sperm motility inhibition and may serve as a vaginal contraceptive. The antibody raised against the MIF-II has the potential for enhancement of forward motility of cauda-spermatozoa. This antibody may thus be useful for solving some of the problems of male infertility due to low sperm motility.	[Das, Sujoy; Saha, Sudipta; Dungdung, Sandhya Rekha] Indian Inst Chem Biol, Kolkata, India; [Majumder, Gopal Chandra] Jadavpur Univ, Ctr Rural & Cryogen Technol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Jadavpur University	Das, S (corresponding author), Indian Inst Chem Biol, Kolkata, India.	srdungdung@iicb.res.in	Saha, Sudipta/I-9614-2017; Saha, Sudipta/AAF-9307-2019	Saha, Sudipta/0000-0003-0903-0997; Saha, Sudipta/0000-0003-0903-0997	Indian Council of Medical Research (ICMR), New Delhi, India [5/10/3/2005-RHN]	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	The research work was supported by Indian Council of Medical Research (ICMR), New Delhi, India (www.icmr.nic.in) Grant Number 5/10/3/2005-RHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; BASS JW, 1983, J REPROD FERTIL, V68, P275; Boone William R, 2007, J S C Med Assoc, V103, P8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASCIERI M, 1976, J BIOL CHEM, V251, P787; Chandra Abhishek, 2007, Journal of Ecophysiology and Occupational Health, V7, P201; CORNWALL GA, 2007, SPERM MATURATION EPI, P211; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; DELAMIRANDE E, 1984, ANN NY ACAD SCI, V438, P125, DOI 10.1111/j.1749-6632.1984.tb38281.x; DEVI LG, 1994, MOL REPROD DEV, V38, P94, DOI 10.1002/mrd.1080380116; Dungdung S. R., 1995, MOL ANDROL, V7, P247; Dungdung SR, 2003, CELL MOL BIOL, V49, P413; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; IWAMOTO T, 1988, J ANDROL, V9, P377; IWAMOTO T, 1992, MOL REPROD DEV, V31, P55, DOI 10.1002/mrd.1080310110; Jaiswal BS, 2010, J CELL PHYSIOL, V222, P254, DOI 10.1002/jcp.21947; Jaiswal BS, 1996, BIOCHEM CELL BIOL, V74, P669, DOI 10.1139/o96-072; Jaiswal BS, 1998, REPROD FERT DEVELOP, V10, P299, DOI 10.1071/R98003; JENG H, 1993, BIOCHEM BIOPH RES CO, V191, P435, DOI 10.1006/bbrc.1993.1236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luconi M, 2005, BIOL REPROD, V72, P22, DOI 10.1095/biolreprod.104.032490; MAJUMDER GC, 1984, J REPROD FERTIL, V70, P235, DOI 10.1530/jrf.0.0700235; MANDAL M, 1991, MOL ANDROL, V3, P161; Mandal M, 2006, J CELL PHYSIOL, V209, P353, DOI 10.1002/jcp.20734; Morton B E, 1979, Fertil Steril, V32, P822; PEITZ B, 1988, J REPROD FERTIL, V83, P169, DOI 10.1530/jrf.0.0830169; Robert M, 1996, BIOL REPROD, V55, P813, DOI 10.1095/biolreprod55.4.813; ROY N, 1985, ANDROLOGIA, V17, P200; Saha S, 2007, CYTOM PART A, V71A, P308, DOI 10.1002/cyto.a.20382; SLUYTERMAN LAA, 1978, J CHROMATOGR, V150, P17, DOI 10.1016/S0021-9673(01)92092-8; Tijssen P., 1985, PRACTICE THEORY ENZ; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER TT, 1982, AM J PHYSIOL, V242, P199; USSELMAN MC, 1983, BIOL REPROD, V29, P1241, DOI 10.1095/biolreprod29.5.1241; WISDOM GB, 1976, CLIN CHEM, V22, P1243; WOLLNY E, 1984, J BIOL CHEM, V259, P2484; WONG PYD, 1983, BIOL REPROD, V28, P206, DOI 10.1095/biolreprod28.1.206; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	38	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12039	10.1371/journal.pone.0012039	http://dx.doi.org/10.1371/journal.pone.0012039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706623	gold, Green Submitted, Green Published			2022-12-25	WOS:000280811900007
J	Beziat, V; Descours, B; Parizot, C; Debre, P; Vieillard, V				Beziat, Vivien; Descours, Benjamin; Parizot, Christophe; Debre, Patrice; Vieillard, Vincent			NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs	PLOS ONE			English	Article							HLA-E; INHIBITORY RECEPTORS; CD94/NKG2A; EXPRESSION; EDUCATION; INTERFACE; TOLERANCE; COMPLEX; INNATE; MHC	Background: Terminal differentiation of NK cells is crucial in maintaining broad responsiveness to pathogens and discriminating normal cells from cells in distress. Although it is well established that KIRs, in conjunction with NKG2A, play a major role in the NK cell education that determines whether cells will end up competent or hyporesponsive, the events underlying the differentiation are still debated. Methodology/Principal Findings: A combination of complementary approaches to assess the kinetics of the appearance of each subset during development allowed us to obtain new insights into these terminal stages of differentiation, characterising their gene expression profiles at a pan-genomic level, their distinct surface receptor patterns and their prototypic effector functions. The present study supports the hypothesis that CD56(dim) cells derive from the CD56(bright) subset and suggests that NK cell responsiveness is determined by persistent inhibitory signals received during their education. We report here the inverse correlation of NKG2A expression with KIR expression and explore whether this correlation bestows functional competence on NK cells. We show that CD56(dim)NKG2A(-)KIR(+) cells display the most differentiated phenotype associated to their unique ability to respond against HLA-E+ target cells. Importantly, after IL-12 + IL-18 stimulation, reacquisition of NKG2A strongly correlates with IFN-gamma production in CD56(dim)NKG2A(-) NK cells. Conclusions/Significance: Together, these findings call for the reclassification of mature human NK cells into distinct subsets and support a new model, in which the NK cell differentiation and functional fate are based on a stepwise decrease of NKG2A and acquisition of KIRs.	[Beziat, Vivien; Descours, Benjamin; Debre, Patrice; Vieillard, Vincent] Hop La Pitie Salpetriere, INSERM, UMR S 945, Paris, France; [Beziat, Vivien; Descours, Benjamin; Debre, Patrice; Vieillard, Vincent] Univ Paris 06, Paris, France; [Parizot, Christophe; Debre, Patrice] Lab Immunol Cellulaire & Tissulaire, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Beziat, V (corresponding author), Hop La Pitie Salpetriere, INSERM, UMR S 945, Paris, France.	vincent.vieillard@upmc.fr	Béziat, Vivien/G-2971-2011; Béziat, Vivien/AAT-4097-2021	Béziat, Vivien/0000-0002-4020-824X; Béziat, Vivien/0000-0002-4020-824X; PARIZOT, Christophe/0000-0001-5723-4471	Institut National de la Sante et de la Recherche Medicale (INSERM) [P060206-AOM06206]; association Cent pour Sang la Vie; Agence de la BioMedecine	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); association Cent pour Sang la Vie; Agence de la BioMedecine	This work was supported in part by national funds from the Institut National de la Sante et de la Recherche Medicale (INSERM) under contract PHRC "Minicord'' (P060206-AOM06206), by the association Cent pour Sang la Vie and the Agence de la BioMedecine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Beziat V, 2009, LEUKEMIA, V23, P721, DOI 10.1038/leu.2008.343; Borrego F, 2005, MOL IMMUNOL, V42, P485, DOI 10.1016/j.molimm.2004.07.031; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Carrega P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008132; Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dulphy N, 2008, J IMMUNOL, V181, P2227, DOI 10.4049/jimmunol.181.3.2227; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Gustafson KS, 1996, J BIOL CHEM, V271, P20035, DOI 10.1074/jbc.271.33.20035; Held W, 2008, EUR J IMMUNOL, V38, P2930, DOI 10.1002/eji.200838755; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joncker NT, 2008, IMMUNOL REV, V224, P85, DOI 10.1111/j.1600-065X.2008.00658.x; Juelke K, 2009, EUR J IMMUNOL, V39, P2548, DOI 10.1002/eji.200939307; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Le Garff-Tavernier M, 2010, AGING CELL, V9, P527, DOI 10.1111/j.1474-9726.2010.00584.x; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lopez-Botet M, 2000, HUM IMMUNOL, V61, P7, DOI 10.1016/S0198-8859(99)00161-5; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Nguyen S, 2005, BLOOD, V105, P4135, DOI 10.1182/blood-2004-10-4113; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Ouyang Q, 2007, ANN NY ACAD SCI, V1106, P240, DOI 10.1196/annals.1392.001; Parham P, 2006, IMMUNOL REV, V214, P155, DOI 10.1111/j.1600-065X.2006.00462.x; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saez-Borderias A, 2009, J IMMUNOL, V182, P829, DOI 10.4049/jimmunol.182.2.829; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vago L, 2008, BLOOD, V112, P3488, DOI 10.1182/blood-2007-07-103325; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762	41	146	149	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11966	10.1371/journal.pone.0011966	http://dx.doi.org/10.1371/journal.pone.0011966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700504	Green Submitted, Green Published, gold			2022-12-25	WOS:000280687900003
J	Lettner, T; Zeidler, U; Gimona, M; Hauser, M; Breitenbach, M; Bito, A				Lettner, Thomas; Zeidler, Ute; Gimona, Mario; Hauser, Michael; Breitenbach, Michael; Bito, Arnold			Candida albicans AGE3, the Ortholog of the S. cerevisiae ARF-GAP-Encoding Gene GCS1, Is Required for Hyphal Growth and Drug Resistance	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; SACCHAROMYCES-CEREVISIAE; FLUCONAZOLE RESISTANCE; MULTIDRUG-RESISTANCE; FUNCTIONAL-ANALYSIS; ACTIN CYTOSKELETON; ANTIFUNGAL AGENTS; STATIONARY-PHASE; POLARIZED GROWTH; CELL POLARITY	Background: Hyphal growth and multidrug resistance of C. albicans are important features for virulence and antifungal therapy of this pathogenic fungus. Methodology/Principal Findings: Here we show by phenotypic complementation analysis that the C. albicans gene AGE3 is the functional ortholog of the yeast ARF-GAP-encoding gene GCS1. The finding that the gene is required for efficient endocytosis points to an important functional role of Age3p in endosomal compartments. Most C. albicans age3 Delta mutant cells which grew as cell clusters under yeast growth conditions showed defects in filamentation under different hyphal growth conditions and were almost completely disabled for invasive filamentous growth. Under hyphal growth conditions only a fraction of age3 Delta cells shows a wild-type-like polarization pattern of the actin cytoskeleton and lipid rafts. Moreover, age3 Delta cells were highly susceptible to several unrelated toxic compounds including antifungal azole drugs. Irrespective of the AGE3 genotype, C-terminal fusions of GFP to the drug efflux pumps Cdr1p and Mdr1p were predominantly localized in the plasma membrane. Moreover, the plasma membranes of wild-type and age3 Delta mutant cells contained similar amounts of Cdr1p, Cdr2p and Mdr1p. Conclusions/Significance: The results indicate that the defect in sustaining filament elongation is probably caused by the failure of age3 Delta cells to polarize the actin cytoskeleton and possibly of inefficient endocytosis. The high susceptibility of age3 Delta cells to azoles is not caused by inefficient transport of efflux pumps to the cell membrane. A possible role of a vacuolar defect of age3 Delta cells in drug susceptibility is proposed and discussed. In conclusion, our study shows that the ARF-GAP Age3p is required for hyphal growth which is an important virulence factor of C. albicans and essential for detoxification of azole drugs which are routinely used for antifungal therapy. Thus, it represents a promising antifungal drug target.	[Lettner, Thomas; Gimona, Mario; Breitenbach, Michael; Bito, Arnold] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Zeidler, Ute] Inst Pasteur, Unite Biol & Pathogenicite Fong, Paris, France; [Hauser, Michael] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Salzburg University	Bito, A (corresponding author), Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria.	arnold.bito@sbg.ac.at	Hauser, Michael/P-6148-2017	Hauser, Michael/0000-0001-6558-755X; Lettner, Thomas/0000-0002-8130-8394	Forschungsfoerderungsfonds der Paracelsus Medizinische Privatuniversitaet (PMU) Salzburg [05/01/001]	Forschungsfoerderungsfonds der Paracelsus Medizinische Privatuniversitaet (PMU) Salzburg	Forschungsfoerderungsfonds der Paracelsus Medizinische Privatuniversitaet (PMU) Salzburg ( grant no 05/01/001). http://www.pmu.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI T, 1994, MICROBIOL-SGM, V140, P271, DOI 10.1099/13500872-140-2-271; Baek YU, 2004, FEBS LETT, V556, P47, DOI 10.1016/S0014-5793(03)01363-2; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Bassilana M, 2005, EUKARYOT CELL, V4, P588, DOI 10.1128/EC.4.3.588-603.2005; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; BENYAACOV R, 1994, ANTIMICROB AGENTS CH, V38, P648, DOI 10.1128/AAC.38.4.648; Berman J, 2006, CURR OPIN MICROBIOL, V9, P595, DOI 10.1016/j.mib.2006.10.007; Bernardo SM, 2008, FUNGAL GENET BIOL, V45, P861, DOI 10.1016/j.fgb.2008.01.001; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Blackburn AS, 2003, ANTIMICROB AGENTS CH, V47, P676, DOI 10.1128/AAC.47.2.676-681.2003; Blader IJ, 1999, MOL BIOL CELL, V10, P581, DOI 10.1091/mbc.10.3.581; Brachmann CB, 1998, YEAST, V14, P115; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; BUNICK FJ, 1982, BIOCHEMISTRY-US, V21, P4285, DOI 10.1021/bi00261a017; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Connolly JE, 2006, EUKARYOT CELL, V5, P112, DOI 10.1128/EC.5.1.112-124.2006; Cornet M, 2006, ANTIMICROB AGENTS CH, V50, P3492, DOI 10.1128/AAC.00391-06; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; Crampin H, 2005, J CELL SCI, V118, P2935, DOI 10.1242/jcs.02414; de Micheli M, 2002, MOL MICROBIOL, V43, P1197, DOI 10.1046/j.1365-2958.2002.02814.x; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DREBOT MA, 1987, P NATL ACAD SCI USA, V84, P7948, DOI 10.1073/pnas.84.22.7948; Epp E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000753; Ernst JF, 2000, MICROBIOL-SGM, V146, P1763, DOI 10.1099/00221287-146-8-1763; Gerami-Nejad M, 2004, YEAST, V21, P429, DOI 10.1002/yea.1080; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Harry JB, 2005, ANTIMICROB AGENTS CH, V49, P2785, DOI 10.1128/AAC.49.7.2785-2792.2005; Hazan I, 2002, EUKARYOT CELL, V1, P856, DOI 10.1128/EC.1.6.856-864.2002; Huang CF, 2002, J CELL SCI, V115, P275; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; IRELAND LS, 1994, EMBO J, V13, P3812, DOI 10.1002/j.1460-2075.1994.tb06692.x; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Li CR, 2005, J CELL SCI, V118, P2637, DOI 10.1242/jcs.02393; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; Maebashi K, 2002, MICROBIOL IMMUNOL, V46, P317, DOI 10.1111/j.1348-0421.2002.tb02702.x; Maesaki S, 1999, J ANTIMICROB CHEMOTH, V44, P27, DOI 10.1093/jac/44.1.27; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; Moran GP, 1998, ANTIMICROB AGENTS CH, V42, P1819, DOI 10.1128/AAC.42.7.1819; Morschhauser J, 2002, BBA-MOL BASIS DIS, V1587, P240, DOI 10.1016/S0925-4439(02)00087-X; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; NORMAN AW, 1972, J BIOL CHEM, V247, P1918; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Palmer GE, 2005, EUKARYOT CELL, V4, P1677, DOI 10.1128/EC.4.10.1677-1686.2005; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pasrija R, 2005, J ANTIMICROB CHEMOTH, V55, P905, DOI 10.1093/jac/dki112; Perea S, 2002, CLIN INFECT DIS, V35, P1073, DOI 10.1086/344058; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Prasad R, 2005, INT REV CYTOL, V242, P215; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Pruyne D, 2000, J CELL SCI, V113, P571; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Sakane H, 2006, CELL STRUCT FUNCT, V31, P87, DOI 10.1247/csf.06021; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; Schindler C, 2007, MOL BIOL CELL, V18, P2852, DOI 10.1091/mbc.E06-08-0756; SOLL DR, 1993, TRENDS GENET, V9, P61, DOI 10.1016/0168-9525(93)90189-O; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Theiss S, 2002, MOL MICROBIOL, V43, P571, DOI 10.1046/j.1365-2958.2002.02769.x; Uhl MA, 2001, MICROBIOL-SGM, V147, P1189, DOI 10.1099/00221287-147-5-1189; Ushinsky SC, 2002, EUKARYOT CELL, V1, P95, DOI 10.1128/EC.1.1.95-104.2002; Veal EA, 2002, J BIOL CHEM, V277, P35523, DOI 10.1074/jbc.M111548200; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wirsching S, 2000, MOL MICROBIOL, V36, P856, DOI 10.1046/j.1365-2958.2000.01899.x; Yanagisawa LL, 2002, MOL BIOL CELL, V13, P2193, DOI 10.1091/mbc.01-11-0563; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x; Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966; Zheng XD, 2003, MOL MICROBIOL, V49, P1391, DOI 10.1046/j.1365-2958.2003.03646.x	81	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11993	10.1371/journal.pone.0011993	http://dx.doi.org/10.1371/journal.pone.0011993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700541	gold, Green Published, Green Submitted			2022-12-25	WOS:000280605400025
J	Li, JO; Olsen, J; Vestergaard, M; Obel, C; Baker, JL; Sorensen, TIA				Li, Jiong; Olsen, Jorn; Vestergaard, Mogens; Obel, Carsten; Baker, Jennifer L.; Sorensen, Thorkild I. A.			Prenatal Stress Exposure Related to Maternal Bereavement and Risk of Childhood Overweight	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; ENDOCRINE DISRUPTORS; BODY-MASS; IN-UTERO; OBESITY; PREGNANCY; WEIGHT; COHORT; PREVENTION; ORIGINS	Background: It has been suggested that prenatal stress contributes to the risk of obesity later in life. In a population-based cohort study, we examined whether prenatal stress related to maternal bereavement during pregnancy was associated with the risk of overweight in offspring during school age. Methodology/Principal Findings: We followed 65,212 children born in Denmark from 1970-1989 who underwent health examinations from 7 to 13 years of age in public or private schools in Copenhagen. We identified 459 children as exposed to prenatal stress, defined by being born to mothers who were bereaved by death of a close family member from one year before pregnancy until birth of the child. We compared the prevalence of overweight between the exposed and the unexposed. Body mass index (BMI) values and prevalence of overweight were higher in the exposed children, but not significantly so until from 10 years of age and onwards, as compared with the unexposed children. For example, the adjusted odds ratio (OR) for overweight was 1.68 (95% confidence interval [CI] 1.08-2.61) at 12 years of age and 1.63 (95% CI 1.00-2.61) at 13 years of age. The highest ORs were observed when the death occurred in the period from 6 to 0 month before pregnancy (OR 3.31, 95% CI 1.71-6.42 at age 12, and OR 2.31, 95% CI 1.08-4.97 at age 13). Conclusions/Significance: Our results suggest that severe pre-pregnancy stress is associated with an increased risk of overweight in the offspring in later childhood.	[Li, Jiong; Olsen, Jorn] Univ Aarhus, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Vestergaard, Mogens] Univ Aarhus, Res Unit Gen Practice, Aarhus, Denmark; [Vestergaard, Mogens; Obel, Carsten] Univ Aarhus, Sch Publ Hlth, Dept Gen Practice, Aarhus, Denmark; [Baker, Jennifer L.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark	Aarhus University; University of California System; University of California Los Angeles; Aarhus University; Aarhus University; University of Copenhagen	Li, JO (corresponding author), Univ Aarhus, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark.	jl@soci.au.dk	Ferraro, Alexandre A/G-6440-2013; li, jiong/L-6534-2014; Baker, Jennifer/F-1917-2010; Olsen, Jørn/F-8801-2015; Vestergaard, Mogens/M-9333-2014; Baker, Jennifer L./AAH-4693-2020; Obel, Carsten/H-9605-2016	Ferraro, Alexandre A/0000-0003-1439-8091; li, jiong/0000-0002-1716-8067; Baker, Jennifer/0000-0002-9649-6615; Olsen, Jørn/0000-0001-7462-5140; Vestergaard, Mogens/0000-0001-8830-2174; Baker, Jennifer L./0000-0002-9649-6615; li, jiong/0000-0003-1125-026X; Obel, Carsten/0000-0001-5004-1933	Danish National Science Foundation; Danish Medical Research Council [271-05-0616, 271-07-0437, 09-072986]; Nordic Cancer Union; NordForsk [070331]	Danish National Science Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nordic Cancer Union; NordForsk	The study was supported by the Danish National Science Foundation, Danish Medical Research Council (projects no. 271-05-0616, no. 271-07-0437, no. 09-072986), Nordic Cancer Union (2008), and NordForsk (070331). This study was part of the research activities in the Danish Obesity Research Centre (DanORC, see www.danorc.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008450; *AM I STRESS, 2009, AM HLTH PROBL WHY IS; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bouret SG, 2009, J PEDIATR GASTR NUTR, V48, pS31, DOI 10.1097/MPG.0b013e3181977375; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Denmark Statistics, 1991, IDA AN INT DAT LAB M; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Goodkin K, 2001, HDB BEREAVEMENT RES, P671; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Huang JS, 2007, MATERN CHILD HLTH J, V11, P461, DOI 10.1007/s10995-006-0141-8; Jacobson-Dickman E, 2009, CURR OPIN ENDOCRINOL, V16, P25, DOI 10.1097/MED.0b013e328320d560; Khashan AS, 2009, HUM REPROD, V24, P429, DOI 10.1093/humrep/den418; Knudsen LB, 1998, DAN MED BULL, V45, P320; Labayen I, 2006, J NUTR, V136, P147, DOI 10.1093/jn/136.1.147; Li J, 2009, PSYCHOSOM MED, V71, P615, DOI 10.1097/PSY.0b013e3181a56ca1; MATTHEWS KA, 1992, PSYCHOPHYSIOLOGY, V29, P232, DOI 10.1111/j.1469-8986.1992.tb01691.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MONROE SM, 1990, STRESS MEDICINE, V6, P209, DOI 10.1002/smi.2460060306; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pedersen CB, 2006, DAN MED BULL, V53, P441; Philipsen NM, 2008, J PERINAT EDUC, V17, P44, DOI 10.1624/105812408X266296; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Roy JR, 2009, MED SCI MONITOR, V15, pRA137; Schoeters G, 2008, BASIC CLIN PHARMACOL, V102, P168, DOI 10.1111/j.1742-7843.2007.00180.x; SCHULTE HM, 1990, CLIN ENDOCRINOL, V33, P99, DOI 10.1111/j.1365-2265.1990.tb00470.x; Sharma AJ, 2008, AM J EPIDEMIOL, V168, P995, DOI 10.1093/aje/kwn223; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; SKODOL AE, 1989, AM J PSYCHIAT, V146, P61; Sorensen TIA, 2009, P NUTR SOC, V68, P43, DOI 10.1017/S0029665108008847; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Welberg LAM, 2001, NEUROSCIENCE, V104, P71, DOI 10.1016/S0306-4522(01)00065-3	44	107	109	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11896	10.1371/journal.pone.0011896	http://dx.doi.org/10.1371/journal.pone.0011896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689593	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520300011
J	Choi, MS; Yoo, AS; Greenwald, I				Choi, Min Sung; Yoo, Andrew S.; Greenwald, Iva			sel-11 and cdc-42, Two Negative Modulators of LIN-12/Notch Activity in C. elegans	PLOS ONE			English	Article							MEDIATED DOWN-REGULATION; UBIQUITIN-LIGASE; CAENORHABDITIS-ELEGANS; TUMOR-SUPPRESSOR; RHO GTPASES; NOTCH; REGULATOR; GLP-1; TRAFFICKING; DEGRADATION	Background: LIN-12/Notch signaling is important for cell-cell interactions during development, and mutations resulting in constitutive LIN-12/Notch signaling can cause cancer. Loss of negative regulators of lin-12/Notch activity has the potential for influencing cell fate decisions during development and the genesis or aggressiveness of cancer. Methodology/Principal Findings: We describe two negative modulators of lin-12 activity in C. elegans. One gene, sel-11, was initially defined as a suppressor of a lin-12 hypomorphic allele; the other gene, cdc-42, is a well-studied Rho GTPase. Here, we show that SEL-11 corresponds to yeast Hrd1p and mammalian Synoviolin. We also show that cdc-42 has the genetic properties consistent with negative regulation of lin-12 activity during vulval precursor cell fate specification. Conclusions/Significance: Our results underscore the multiplicity of negative regulatory mechanisms that impact on lin-12/Notch activity and suggest novel mechanisms by which constitutive lin-12/Notch activity might be exacerbated in cancer.	[Choi, Min Sung] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA; [Yoo, Andrew S.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Integrated Program Cellular Mol & Biophys Studies, New York, NY USA; [Greenwald, Iva] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Choi, MS (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA.	isg4@columbia.edu		Yoo, Andrew/0000-0002-0304-3247	National Institutes of Health [R01CA095389]; NATIONAL CANCER INSTITUTE [R01CA095389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant to I.G. from the National Institutes of Health (R01CA095389). I.G. is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Baron M, 2000, MOL GEN GENET, V264, P98, DOI 10.1007/s004380000287; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Grant B, 1997, DEVELOPMENT, V124, P637; Grant B, 1996, GENETICS, V143, P237; Green Iain, 2005, P1; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Levitan D, 1998, DEVELOPMENT, V125, P3101; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Sasagawa Y, 2007, GENES CELLS, V12, P1063, DOI 10.1111/j.1365-2443.2007.01108.x; Shaye DD, 2005, DEVELOPMENT, V132, P5081, DOI 10.1242/dev.02076; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Stetak A, 2006, EMBO J, V25, P2347, DOI 10.1038/sj.emboj.7601137; SUNDARAM M, 1993, GENETICS, V135, P755; SUNDARAM M, 1993, GENETICS, V135, P765; Sundaram MV, 2005, GENE DEV, V19, P1825, DOI 10.1101/gad.1330605; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Welchman DP, 2007, DEV BIOL, V305, P347, DOI 10.1016/j.ydbio.2007.02.022; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639	48	11	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11885	10.1371/journal.pone.0011885	http://dx.doi.org/10.1371/journal.pone.0011885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686701	Green Submitted, gold, Green Published			2022-12-25	WOS:000280520200044
J	Fuentealba, RA; Liu, QA; Zhang, JA; Kanekiyo, T; Hu, XY; Lee, JM; LaDu, MJ; Bu, GJ				Fuentealba, Rodrigo A.; Liu, Qiang; Zhang, Juan; Kanekiyo, Takahisa; Hu, Xiaoyan; Lee, Jin-Moo; LaDu, Mary Jo; Bu, Guojun			Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Mediates Neuronal A beta 42 Uptake and Lysosomal Trafficking	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; SPORADIC ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; LDL RECEPTOR; A-BETA; PRECURSOR PROTEIN; TRANSGENIC MICE; HUMAN BRAIN; INTRACELLULAR ACCUMULATION; MOLECULAR CHAPERONE	Background: Alzheimer's disease (AD) is characterized by the presence of early intraneuronal deposits of amyloid-beta 42 (A beta 42) that precede extracellular amyloid deposition in vulnerable brain regions. It has been hypothesized that endosomal/lysosomal dysfunction might be associated with the pathological accumulation of intracellular A beta 42 in the brain. Our previous findings suggest that the LDL receptor-related protein 1 (LRP1), a major receptor for apolipoprotein E, facilitates intraneuronal A beta 42 accumulation in mouse brain. However, direct evidence of neuronal endocytosis of A beta 42 through LRP1 is lacking. Methodology/Principal Findings: Here we show that LRP1 endocytic function is required for neuronal A beta 42 uptake. Overexpression of a functional LRP1 minireceptor, mLRP4, increases A beta 42 uptake and accumulation in neuronal lysosomes. Conversely, knockdown of LRP1 expression significantly decreases neuronal A beta 42 uptake. Disruptions of LRP1 endocytic function by either clathrin knockdown or by removal of its cytoplasmic tail decreased both uptake and accumulation of A beta 42 in neurons. Finally, we show that LRP1-mediated neuronal accumulation of A beta 42 is associated with increased cellular toxicity. Conclusions/Significance: These results demonstrate that LRP1 endocytic function plays an important role in the uptake and accumulation of A beta 42 in neuronal lysosomes. These findings emphasize the central function of LRP1 in neuronal A beta metabolism.	[Fuentealba, Rodrigo A.; Liu, Qiang; Zhang, Juan; Kanekiyo, Takahisa; Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Fuentealba, Rodrigo A.; Hu, Xiaoyan; Lee, Jin-Moo] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL)	Fuentealba, RA (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	bu@wustl.edu	Zhang, Juan/GRX-2638-2022; Liu, Qiang/E-9245-2011; Lee, Jin-Moo/K-2024-2015	LaDu, Mary Jo/0000-0003-2141-1450; Fuentealba, Rodrigo/0000-0001-8724-091X; Lee, Jin-Moo/0000-0002-3979-0906	National Institutes of Health (NIH) [R01AG027924, R01AG19121, P01AG021184]; Alzheimer's Association; NIH Neuroscience Blueprint Interdisciplinary Center [P30NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027924, R01AG035355, P01AG030128, P01AG021184, R01AG019121] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NIH Neuroscience Blueprint Interdisciplinary Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants R01AG027924 (to G.B.), R01AG19121 (to M.J.L.) and P01AG021184 (to G.B. and M.J.L.), Zenith Fellows Awards from the Alzheimer's Association (to G.B. and M.J.L.), and the NIH Neuroscience Blueprint Interdisciplinary Center Core Grant P30NS057105 (to Washington University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr BA, 1998, J COMP NEUROL, V397, P139; BELINSON H, 2009, J ALZHEIMERS DIS; Belinson H, 2008, J NEUROSCI, V28, P4690, DOI 10.1523/JNEUROSCI.5633-07.2008; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; BU GJ, 1994, J BIOL CHEM, V269, P18521; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 2001, INT REV CYTOL, V209, P79; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Eslami P, 2008, BRAIN RES, V1241, P176, DOI 10.1016/j.brainres.2008.08.086; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris-White ME, 2004, J NEUROSCI RES, V77, P217, DOI 10.1002/jnr.20149; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Li YH, 2001, MOL NEUROBIOL, V23, P53; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Liu JC, 2007, IET SIGNAL PROCESS, V1, P66, DOI 10.1049/iet-spr:20060260; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Roses AD, 2006, J ALZHEIMERS DIS, V9, P361; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; TOOYAMA I, 1995, BRAIN RES, V691, P235, DOI 10.1016/0006-8993(95)00735-9; Van Uden E, 2000, MICROSC RES TECHNIQ, V50, P268, DOI 10.1002/1097-0029(20000815)50:4<268::AID-JEMT3>3.0.CO;2-1; Van Uden E, 2002, J NEUROSCI, V22, P9298; WILLIAMS JK, 1994, HIGH TEMP CHEM PROCE, V3, P719; WOLF BB, 1992, AM J PATHOL, V141, P37; Yamada K, 2008, J BIOL CHEM, V283, P34554, DOI 10.1074/jbc.M801487200; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101	63	76	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11884	10.1371/journal.pone.0011884	http://dx.doi.org/10.1371/journal.pone.0011884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686698	gold, Green Submitted, Green Published			2022-12-25	WOS:000280520200043
J	Olsen, BB; Issinger, OG; Guerra, B				Olsen, B. B.; Issinger, O-G; Guerra, B.			Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cells	ONCOGENE			English	Article						DNA-PK; CK2; autophosphorylation; DNA repair; glioblastoma cells	DOUBLE-STRAND BREAKS; CATALYTIC SUBUNIT; IN-VIVO; IONIZING-RADIATION; CYCLE ARREST; AUTOPHOSPHORYLATION; REPAIR; DAMAGE; PHOSPHORYLATION; APOPTOSIS	The DNA-dependent protein kinase (DNA-PK) is a nuclear serine/threonine protein kinase composed of a large catalytic subunit (DNA-PKcs) and a heterodimeric DNA-targeting subunit Ku. DNA-PK is a major component of the nonhomologous end-joining pathway of DNA double-strand breaks repair. Although DNA-PK has been biochemically characterized in vitro, relatively little is known about its functions in the context of DNA repair and how its kinase activity is precisely regulated in vivo. Here, we report that cellular depletion of the individual catalytic subunits of protein kinase CK2 by RNA interference leads to significant cell death in M059K human glioblastoma cells expressing DNA-PKcs, but not in their isogenic counterpart, that is M059J cells, devoid of DNA-PKcs. The lack of CK2 results in enhanced DNA-PKcs activity and strongly inhibits DNA damage-induced autophosphorylation of DNA-PKcs at S2056 as well as repair of DNA double-strand breaks. By the application of the in situ proximity ligation assay, we show that CK2 interacts with DNA-PKcs in normal growing cells and that the association increases upon DNA damage. These results indicate that CK2 has an important role in the modulation of DNA-PKcs activity and its phosphorylation status providing important insights into the mechanisms by which DNA-PKcs is regulated in vivo. Oncogene (2010) 29, 6016-6026; doi:10.1038/onc.2010.337; published online 16 August 2010	[Olsen, B. B.; Issinger, O-G; Guerra, B.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Fyn, Denmark	University of Southern Denmark	Guerra, B (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense, Fyn, Denmark.	bag@bmb.sdu.dk	Olsen, Birgitte B/U-2382-2017	Olsen, Birgitte B/0000-0002-6130-0387; Guerra, Barbara/0000-0003-1136-2413	Danish Cancer Society [DP08152, DP06083, DP07109]; Danish Natural Science Research Council [272-07-0258]	Danish Cancer Society(Danish Cancer Society); Danish Natural Science Research Council(Danish Natural Science Research Council)	This study was supported by grants from the Danish Cancer Society (DP08152) and the Danish Natural Science Research Council (272-07-0258) to BG. BBO and OGI were supported by grants from the Danish Cancer Society (DP06083, DP07109).	Achari Y, 2000, METH MOL B, V99, P85; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Bibby AC, 2005, INT J BIOL SCI, V1, P67; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Canton DA, 2001, BIOCHEM J, V358, P87, DOI 10.1042/0264-6021:3580087; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Kuo LJ, 2008, IN VIVO, V22, P305; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Matsumoto Y, 1997, BIOCHEM BIOPH RES CO, V234, P568, DOI 10.1006/bbrc.1997.6689; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Niefind K, 2000, ACTA CRYSTALLOGR D, V56, P1680, DOI 10.1107/S0907444900013627; Olsen BB, 2008, MOL CELL BIOCHEM, V316, P115, DOI 10.1007/s11010-008-9817-2; Olsen BB, 2008, MOL CELL BIOCHEM, V316, P37, DOI 10.1007/s11010-008-9824-3; Olsen BB, 2006, PROTEIN EXPRES PURIF, V47, P651, DOI 10.1016/j.pep.2005.12.001; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Sandholt IS, 2009, ANTI-CANCER DRUG, V20, P238, DOI 10.1097/CAD.0b013e328326472e; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Woo RA, 2002, EMBO J, V21, P3000, DOI 10.1093/emboj/cdf307; Yao KC, 2003, J NEUROSURG, V98, P378, DOI 10.3171/jns.2003.98.2.0378; Yde CW, 2007, MOL CANCER THER, V6, P1869, DOI 10.1158/1535-7163.MCT-07-0072; Zhan YH, 2009, BIOCHEM BIOPH RES CO, V378, P273, DOI 10.1016/j.bbrc.2008.11.038	39	35	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	45					6016	6026		10.1038/onc.2010.337	http://dx.doi.org/10.1038/onc.2010.337			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	678VA	20711232				2022-12-25	WOS:000284108700004
J	Bustamante, N; Campillo, NE; Garcia, E; Gallego, C; Pera, B; Diakun, GP; Saiz, JL; Garcia, P; Diaz, JF; Menendez, M				Bustamante, Noemi; Campillo, Nuria E.; Garcia, Ernesto; Gallego, Cristina; Pera, Benet; Diakun, Gregory P.; Saiz, Jose Luis; Garcia, Pedro; Diaz, J. Fernando; Menendez, Margarita			Cpl-7, a Lysozyme Encoded by a Pneumococcal Bacteriophage with a Novel Cell Wall-binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; PROTEIN SECONDARY STRUCTURE; HUMAN GUT MICROBIOTA; LYTIC ENZYMES; STREPTOCOCCUS-PNEUMONIAE; HYDRODYNAMIC PROPERTIES; SOLUTION SCATTERING; SEQUENCE ALIGNMENT; STRUCTURAL BASIS; PHAGE	Bacteriophage endolysins include a group of new antibacterials reluctant to development of resistance. We present here the first structural study of the Cpl-7 endolysin, encoded by pneumococcal bacteriophage Cp-7. It contains an N-terminal catalytic module (CM) belonging to the GH25 family of glycosyl hydrolases and a C-terminal region encompassing three identical repeats of 42 amino acids (CW_7 repeats). These repeats are unrelated to choline-targeting motifs present in other cell wall hydrolases produced by Streptococcus pneumoniae and its bacteriophages, and are responsible for the protein attachment to the cell wall. By combining different biophysical techniques and molecular modeling, a three-dimensional model of the overall protein structure is proposed, consistent with circular dichroism and sequence-based secondary structure prediction, small angle x-ray scattering data, and Cpl-7 hydrodynamic behavior. Cpl-7 is an similar to 115-angstrom long molecule with two well differentiated regions, corresponding to the CM and the cell wall binding region (CWBR), arranged in a lateral disposition. The CM displays the (beta alpha)(5)beta(3) barrel topology characteristic of the GH25 family, and the impact of sequence differences with the CM of the Cpl-1 lysozyme in substrate binding is discussed. The CWBR is organized in three tandemly assembled three-helical bundles whose dispositions remind us of a super-helical structure. Its approximate dimensions are 60 x 20 x 20 angstrom and presents a concave face that might constitute the functional region involved in bacterial surface recognition. The distribution of CW_7 repeats in the sequences deposited in the Entrez Database have been examined, and the results drastically expanded the antimicrobial potential of the Cpl-7 endolysin.	[Saiz, Jose Luis; Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, Madrid 28006, Spain; [Bustamante, Noemi; Garcia, Ernesto; Gallego, Cristina; Saiz, Jose Luis; Garcia, Pedro; Menendez, Margarita] CSIC, CIBER Enfermedades Resp, Madrid 28006, Spain; [Campillo, Nuria E.] CSIC, Inst Quim Med, Madrid 28006, Spain; [Garcia, Ernesto; Pera, Benet; Garcia, Pedro; Diaz, J. Fernando] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Diakun, Gregory P.] CCLRC Daresbury Lab, Warrington WA4 4AD, Cheshire, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); STFC Daresbury Laboratory	Menendez, M (corresponding author), CSIC, Inst Quim Fis Rocasolano, Serrano 119, Madrid 28006, Spain.	mmenendez@iqfr.csic.es	Campillo, Nuria E/J-8810-2014; Díaz, J. Fernando/U-3532-2017; Díaz, J. Fernando/M-6853-2019; García, Pedro/L-2808-2017; Menendez, Margarita/M-1795-2014	Díaz, J. Fernando/0000-0003-2743-3319; Díaz, J. Fernando/0000-0003-2743-3319; García, Pedro/0000-0001-6717-8717; Menendez, Margarita/0000-0002-3267-4443; Gallego Paramo, Cristina/0000-0003-1510-186X; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; /0000-0002-9948-2665	Ministerio de Ciencia e Innovacion [BFU2006-10288, SAF2009-10824, BIO2007-61336, BFU2009-10052]; Comunidad de Madrid; CIBER de Enfermedades Respiratorias (CIBERES); Initiative of the ISCIII; Glycodynamics Network [FP6-UE MCTN-CT-2005-019561]; European Community [48086]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); CIBER de Enfermedades Respiratorias (CIBERES); Initiative of the ISCIII; Glycodynamics Network; European Community(European Commission)	This work was supported by Grants BFU2006-10288, SAF2009-10824, BIO2007-61336, and BFU2009-10052 from Ministerio de Ciencia e Innovacion, Grant BIPPED-CM from the Comunidad de Madrid, the CIBER de Enfermedades Respiratorias (CIBERES), an initiative of the ISCIII, Glycodynamics Network Grant FP6-UE MCTN-CT-2005-019561, and European Community beam time Proposal 48086.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Buey RM, 2009, LECT NOTES PHYS, V776, P245, DOI 10.1007/978-3-540-95968-7_12; Buey RM, 2007, J MOL BIOL, V365, P411, DOI 10.1016/j.jmb.2006.09.091; Chacon P, 1998, BIOPHYS J, V74, P2760, DOI 10.1016/S0006-3495(98)77984-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Davies MR, 2007, J BACTERIOL, V189, P2646, DOI 10.1128/JB.01590-06; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; DIAZ E, 1991, J BIOL CHEM, V266, P5464; Donovan DM, 2008, FEMS MICROBIOL LETT, V287, P22, DOI 10.1111/j.1574-6968.2008.01287.x; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GARCIA JL, 1987, J VIROL, V61, P2573; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; GARCIA P, 1990, GENE, V86, P81, DOI 10.1016/0378-1119(90)90116-9; Garcia P, 2005, PHAGES THEIR ROLE BA, P335; Garneau JE, 2008, VIROLOGY, V373, P298, DOI 10.1016/j.virol.2007.12.002; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; INOUYE S, 1985, NUCLEIC ACIDS RES, V13, P3101, DOI 10.1093/nar/13.9.3101; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Jado I, 2003, J ANTIMICROB CHEMOTH, V52, P967, DOI 10.1093/jac/dkg485; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu S, 2007, PROTEINS, V68, P636, DOI 10.1002/prot.21459; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loeffler JM, 2003, INFECT IMMUN, V71, P6199, DOI 10.1128/IAI.71.11.6199-6204.2003; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; McCullers JA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030028; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Monterroso B, 2008, J BIOL CHEM, V283, P28618, DOI 10.1074/jbc.M802808200; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pritchard DG, 2007, APPL ENVIRON MICROB, V73, P7150, DOI 10.1128/AEM.01783-07; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ragone S, 2008, EMBO J, V27, P2259, DOI 10.1038/emboj.2008.145; Regeard C, 2005, APPL ENVIRON MICROB, V71, P2955, DOI 10.1128/AEM.71.6.2955-2961.2005; Rodriguez-Cerrato V, 2007, J ANTIMICROB CHEMOTH, V60, P1159, DOI 10.1093/jac/dkm342; Rodriguez-Cerrato V, 2007, ANTIMICROB AGENTS CH, V51, P3371, DOI 10.1128/AAC.00137-07; SANZ JM, 1992, MOL MICROBIOL, V6, P921, DOI 10.1111/j.1365-2958.1992.tb01542.x; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Silva-Martin N, 2010, ACTA CRYSTALLOGR F, V66, P670, DOI 10.1107/S1744309110006718; Solis D, 2009, SUGAR CODE FUNDAMENT, P233; Speicher David W., 1994, Methods (Orlando), V6, P262, DOI 10.1006/meth.1994.1028; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turroni F, 2008, ANTON LEEUW INT J G, V94, P35, DOI 10.1007/s10482-008-9232-4; Valas RE, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-30; Varea J, 2004, J BIOL CHEM, V279, P43697, DOI 10.1074/jbc.M407067200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang Y, 2009, CURR MICROBIOL, V58, P609, DOI 10.1007/s00284-009-9379-x; Witzenrath M, 2009, CRIT CARE MED, V37, P642, DOI 10.1097/CCM.0b013e31819586a6; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869	69	35	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33184	33196		10.1074/jbc.M110.154559	http://dx.doi.org/10.1074/jbc.M110.154559			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720016	Green Published, hybrid			2022-12-25	WOS:000283048200056
J	Desuzinges-Mandon, E; Arnaud, O; Martinez, L; Huche, F; Di Pietro, A; Falson, P				Desuzinges-Mandon, Elodie; Arnaud, Ophelie; Martinez, Lorena; Huche, Frederic; Di Pietro, Attilio; Falson, Pierre			ABCG2 Transports and Transfers Heme to Albumin through Its Large Extracellular Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER RESISTANCE PROTEIN; CIRCULAR-DICHROISM SPECTRA; ETCH VIRUS PROTEASE; MULTIDRUG TRANSPORTER; SECONDARY STRUCTURE; EFFLUX PUMP; CELL-LINES; STEM-CELLS; DIFFERENTIATION; INHIBITION	ABCG2 is an ATP-binding cassette (ABC) transporter preferentially expressed by immature human hematopoietic progenitors. Due to its role in drug resistance, its expression has been correlated with a protection role against protoporhyrin IX (PPIX) accumulation in stem cells under hypoxic conditions. We show here that zinc mesoporphyrin, a validated fluorescent heme analog, is transported by ABCG2. We also show that the ABCG2 large extracellular loop ECL3 constitutes a porphyrin-binding domain, which strongly interacts with heme, hemin, PPIX, ZnPPIX, CoPPIX, and much less efficiently with pheophorbide a, but not with vitamin B12. K-d values are in the range 0.5-3.5 mu M, with heme displaying the highest affinity. Nonporphyrin substrates of ABCG2, such as mitoxantrone, doxo/ daunorubicin, and riboflavin, do not bind to ECL3. Single-point mutations H583A and C603A inside ECL3 prevent the binding of hemin but hardly affect that of iron-free PPIX. The extracellular location of ECL3 downstream from the transport sites suggests that, after membrane translocation, hemin is transferred to ECL3, which is strategically positioned to release the bound porphyrin to extracellular partners. We show here that human serum albumin could be one of these possible partners as it removes hemin bound to ECL3 and interacts with ABCG2, with a K-d of about 3 mu M.	[Desuzinges-Mandon, Elodie; Arnaud, Ophelie; Martinez, Lorena; Huche, Frederic; Di Pietro, Attilio; Falson, Pierre] Univ Lyon 1, UMR CNRS 5086, IBCP,Equipe Labellise Ligue 2009, ABC Transporters & Multidrug Resistance Lab,IFR 1, F-69367 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Falson, P (corresponding author), Univ Lyon 1, UMR CNRS 5086, IBCP,Equipe Labellise Ligue 2009, ABC Transporters & Multidrug Resistance Lab,IFR 1, 7 Passage Vercors, F-69367 Lyon, France.	p.falson@ibcp.fr		Falson, Pierre/0000-0002-9760-4577	Centre National de la Recherche Scientifique (CNRS); University Lyon 1 [UMR5086]; Agence Nationale de la Recherche (ANR) [ANR-06-BLANC- 0420, ANR-06-PCVI-0019-01, ANR-09-PIRI-0002-01]; Association pour la Recherche sur le Cancer (ARC); Ligue Nationale Contre le Cancer Labelisation	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Lyon 1; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer Labelisation	This work was supported by the Centre National de la Recherche Scientifique (CNRS) and University Lyon 1 (UMR5086). This work was also supported by Agence Nationale de la Recherche (ANR) Contracts ANR-06-BLANC- 0420, ANR-06-PCVI-0019-01, and ANR-09-PIRI-0002-01, the Association pour la Recherche sur le Cancer (ARC), which funded the thesis of E. D.-M., and the Ligue Nationale Contre le Cancer Labelisation 2009.	Ahmed-Belkacem A, 2005, CANCER RES, V65, P4852, DOI 10.1158/0008-5472.CAN-04-1817; Ahmed-Belkacem A, 2007, J MED CHEM, V50, P1933, DOI 10.1021/jm061450q; Allen JD, 2002, MOL CANCER THER, V1, P417; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BALIGA BS, 1993, CELL PROLIFERAT, V26, P519, DOI 10.1111/j.1365-2184.1993.tb00030.x; Bhatia A, 2005, BIOCHEMISTRY-US, V44, P10893, DOI 10.1021/bi0503807; Bihorel S, 2007, J NEUROCHEM, V102, P1749, DOI 10.1111/j.1471-4159.2007.04808.x; Boumendjel A, 2007, BIOORGAN MED CHEM, V15, P2892, DOI 10.1016/j.bmc.2007.02.017; Dean M, 2001, J LIPID RES, V42, P1007; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FALSON P, 1993, BIOCHEMISTRY-US, V32, P10387, DOI 10.1021/bi00090a014; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186; Kage K, 2005, CANCER SCI, V96, P866, DOI 10.1111/j.1349-7006.2005.00126.x; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Li SD, 2006, ACTA BIOCH BIOPH SIN, V38, P63, DOI 10.1111/j.1745-7270.2006.00127.x; Li YF, 2007, J MOL GRAPH MODEL, V25, P837, DOI 10.1016/j.jmgm.2006.08.005; Litman T, 2000, J CELL SCI, V113, P2011; Maliepaard M, 2001, CANCER RES, V61, P3458; Mohanty AK, 2003, PROTEIN EXPRES PURIF, V27, P109, DOI 10.1016/S1046-5928(02)00589-2; Montigny C, 2004, BBA-BIOMEMBRANES, V1660, P53, DOI 10.1016/j.bbamem.2003.10.013; Monzani E, 2001, BBA-PROTEIN STRUCT M, V1547, P302, DOI 10.1016/S0167-4838(01)00192-3; MULLEREBERHARD U, 1993, AM J HEMATOL, V42, P59, DOI 10.1002/ajh.2830420112; Nicolle E, 2009, ADV DRUG DELIVER REV, V61, P34, DOI 10.1016/j.addr.2008.10.004; Ozvegy C, 2001, BIOCHEM BIOPH RES CO, V285, P111, DOI 10.1006/bbrc.2001.5130; Ozvegy-Laczka C, 2008, J BIOL CHEM, V283, P26059, DOI 10.1074/jbc.M803230200; Polgar O, 2004, BIOCHEMISTRY-US, V43, P9448, DOI 10.1021/bi0497953; Polgar O, 2006, BIOCHEMISTRY-US, V45, P5251, DOI 10.1021/bi0521590; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Ross DD, 1999, J NATL CANCER I, V91, P429, DOI 10.1093/jnci/91.5.429; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; SASSA S, 1988, SEMIN HEMATOL, V25, P312; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SCHEIDT WR, 1987, METAL COMPLEXES TETR, V1, P1; Seamon JA, 2006, MOL CANCER THER, V5, P2459, DOI 10.1158/1535-7163.MCT-06-0339; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trometer C, 2010, METHODS MOL BIOL, V601, P105, DOI 10.1007/978-1-60761-344-2_7; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; van Herwaarden AE, 2006, TRENDS PHARMACOL SCI, V27, P10, DOI 10.1016/j.tips.2005.11.007; van Herwaarden AE, 2007, MOL CELL BIOL, V27, P1247, DOI 10.1128/MCB.01621-06; Wang Xin, 2005, Antiviral Chemistry & Chemotherapy, V16, P213; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhu YH, 1999, BIOCHEM BIOPH RES CO, V258, P87, DOI 10.1006/bbrc.1999.0586	58	68	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33123	33133		10.1074/jbc.M110.139170	http://dx.doi.org/10.1074/jbc.M110.139170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705604	hybrid, Green Published			2022-12-25	WOS:000283048200050
J	Dong, HP; Liu, LH; Zou, G; Zhao, YW; Li, Z; Lim, SP; Shi, PY; Li, HM				Dong, Hongping; Liu, Lihui; Zou, Gang; Zhao, Yiwei; Li, Zhong; Lim, Siew Pheng; Shi, Pei-Yong; Li, Hongmin			Structural and Functional Analyses of a Conserved Hydrophobic Pocket of Flavivirus Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; YELLOW-FEVER VIRUS; RNA-STIMULATED NTPASE; NO-KNOWN-VECTOR; NS5 METHYLTRANSFERASE; CRYSTAL-STRUCTURE; MESSENGER-RNA; POLYMERASE NS5; DOMAIN; CAP	The flavivirus methyltransferase (MTase) sequentially methylates the N7 and 2'-O positions of the viral RNA cap (GpppA-RNA -> m(7)GpppA-RNA -> m(7)GpppAm-RNA), using S-adenosyl-L-methionine (AdoMet) as a methyl donor. We report here that sinefungin (SIN), an AdoMet analog, inhibits several flaviviruses through suppression of viral MTase. The crystal structure of West Nile virus MTase in complex with SIN inhibitor at 2.0-angstrom resolution revealed a flavivirus-conserved hydrophobic pocket located next to the AdoMet-binding site. The pocket is functionally critical in the viral replication and cap methylations. In addition, the N7 methylation efficiency was found to correlate with the viral replication ability. Thus, SIN analogs with modifications that interact with the hydrophobic pocket are potential specific inhibitors of flavivirus MTase.	[Dong, Hongping; Zou, Gang; Lim, Siew Pheng; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Li, Hongmin] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12201 USA	Novartis; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Shi, PY (corresponding author), Novartis Inst Trop Dis, 10 Biopolis Rd, Singapore 138670, Singapore.	pei_yong.shi@novartis.com	Li, Hongmin/ABI-2439-2020; Lim, Siew Pheng/P-8528-2016; Zou, Gang/J-1833-2014; Pheng, Lim Siew/AAG-4368-2021	Li, Hongmin/0000-0002-8684-5308; Zou, Gang/0000-0001-9607-7827; Pheng, Lim Siew/0000-0002-7377-5662; Li, Zhong/0000-0002-1039-7000	National Institutes of Health [AI07079201A1, AI061193]; Department of Energy; New York Structural Biology Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI007079, U01AI061193, R01AI094335, R21AI070792, R37AI007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); New York Structural Biology Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI07079201A1 ( to H.L.) and AI061193 ( to P.-Y.S. and H.L.).; We thank A. Verschoor for a critical reading of the manuscript and the Wadsworth Macromolecular Crystallography Core for facility usage. Diffraction data for this study were measured at beamline X4A of National Synchrotron Light Source, which is supported by the Department of Energy, by grants from the National Institutes of Health, and by the New York Structural Biology Center.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Assenberg R, 2007, J GEN VIROL, V88, P2228, DOI 10.1099/vir.0.82757-0; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Bhattacharya D, 2008, VIROLOGY, V380, P276, DOI 10.1016/j.virol.2008.07.013; Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028; Bollati M, 2009, BIOCHEM BIOPH RES CO, V382, P200, DOI 10.1016/j.bbrc.2009.03.008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P742, DOI 10.1073/pnas.72.2.742; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Jansson AM, 2009, ACTA CRYSTALLOGR D, V65, P796, DOI 10.1107/S0907444909017260; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003; Mastrangelo E, 2007, PROTEIN SCI, V16, P1133, DOI 10.1110/ps.072758107; MUTHUKRISHNAN S, 1975, NATURE, V255, P33, DOI 10.1038/255033a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Puig-Basagoiti F, 2006, ANTIMICROB AGENTS CH, V50, P1320, DOI 10.1128/AAC.50.4.1320-1329.2006; RAY BK, 1985, J BIOL CHEM, V260, P7651; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; WENGLER G, 1981, VIROLOGY, V113, P544, DOI 10.1016/0042-6822(81)90182-3; Wu H, 2008, PROTEINS, V72, P519, DOI 10.1002/prot.22065; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	45	43	45	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32586	32595		10.1074/jbc.M110.129197	http://dx.doi.org/10.1074/jbc.M110.129197			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685660	hybrid, Green Published			2022-12-25	WOS:000282683000073
J	Lee, JM; Seo, WY; Song, KH; Chanda, D; Kim, YD; Kim, DK; Lee, MW; Ryu, D; Kim, YH; Noh, JR; Lee, CH; Chiang, JYL; Koo, SH; Choi, HS				Lee, Ji-Min; Seo, Woo-Young; Song, Kwang-Hoon; Chanda, Dipanjan; Kim, Yong Deuk; Kim, Don-Kyu; Lee, Min-Woo; Ryu, Dongryeol; Kim, Yong-Hoon; Noh, Jung-Ran; Lee, Chul-Ho; Chiang, John Y. L.; Koo, Seung-Hoi; Choi, Hueng-Sik			AMPK-dependent Repression of Hepatic Gluconeogenesis via Disruption of CREB center dot CRTC2 Complex by Orphan Nuclear Receptor Small Heterodimer Partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CREB COACTIVATOR CRTC2; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; BINDING-PROTEIN; SHP; INSULIN; METFORMIN; TORC2; PHOSPHORYLATION	Orphan nuclear receptor small heterodimer partner (SHP) plays a key role in transcriptional repression of gluconeogenic enzyme gene expression. Here, we show that SHP inhibited protein kinase A-mediated transcriptional activity of cAMP-response element-binding protein (CREB), a major regulator of glucose metabolism, to modulate hepatic gluconeogenic gene expression. Deletion analysis of phosphoenolpyruvate carboxykinase (PEPCK) promoter demonstrated that SHP inhibited forskolin-mediated induction of PEPCK gene transcription via inhibition of CREB transcriptional activity. In vivo imaging demonstrated that SHP inhibited CREB-regulated transcription coactivator 2 (CRTC2)-mediated cAMP-response element-driven promoter activity. Furthermore, overexpression of SHP using adenovirus SHP decreased CRTC2-dependent elevations in blood glucose levels and PEPCK or glucose-6-phosphatase (G6Pase) expression in mice. SHP and CREB physically interacted and were co-localized in vivo. Importantly, SHP inhibited both wild type CRTC2 and S171A (constitutively active form of CRTC2) coactivator activity and disrupted CRTC2 recruitment on the PEPCK gene promoter. In addition, metformin or overexpression of a constitutively active form of AMPK (Ad-CA-AMPK) inhibited S171A-mediated PEPCK and G6Pase gene expression, and hepatic glucose production and knockdown of SHP partially relieved the metformin- and Ad-CA-AMPK-mediated repression of hepatic gluconeogenic enzyme gene expression in primary rat hepatocytes. In conclusion, our results suggest that a delayed effect of metformin-mediated induction of SHP gene expression inhibits CREB-dependent hepatic gluconeogenesis.	[Lee, Ji-Min; Chanda, Dipanjan; Kim, Yong Deuk; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea; [Seo, Woo-Young; Lee, Min-Woo; Ryu, Dongryeol; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Seo, Woo-Young; Lee, Min-Woo; Ryu, Dongryeol; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Song, Kwang-Hoon; Chiang, John Y. L.] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Song, Kwang-Hoon; Chiang, John Y. L.] Northeastern Ohio Univ Coll Med & Pharm, Coll Pharm, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Kim, Yong-Hoon; Noh, Jung-Ran; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Chiang, John Y. L./G-2658-2011; Chanda, Dipanjan/AAU-3996-2021; Koo, Seung-Hoi/E-2763-2015; Ryu, Dongryeol/AAQ-3642-2020	Chiang, John Y. L./0000-0001-9360-7650; Chanda, Dipanjan/0000-0003-0685-187X; Koo, Seung-Hoi/0000-0001-8769-2879; Ryu, Dongryeol/0000-0001-5905-6760	Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A100588]; Ministry of Education, Science, and Technology [20100019512]; Brain Korea 21 program; National Institutes of Health [DK44442, DK58379]; Korean government (MEST) [2009-0090321, 2010-0015098]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044442, R01DK058379, R37DK058379, R56DK044442] Funding Source: NIH RePORTER	Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Ministry for Health, Welfare, and Family Affairs, Republic of Korea, Korea Healthcare Technology R&D Project Grant A100588 and National Research Foundation of Korea (NRF) Future-based Technology Development Program (BIO Fields) Grant 20100019512, funded by the Ministry of Education, Science, and Technology.; Supported by the Brain Korea 21 program.; Supported by National Institutes of Health Grants DK44442 and DK58379.; Supported by NRF Grants 2009-0090321 and 2010-0015098, funded by the Korean government (MEST). To whom correspondence may be addressed: Dept. of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 300, Republic of Korea. Tel.: 82-31-299-6122; Fax: 82-31-299-6239; E-mail: shkoo@med.skku.ac.kr.	Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Borgius LJ, 2002, J BIOL CHEM, V277, P49761, DOI 10.1074/jbc.M205641200; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Gobinet J, 2001, BIOCHEMISTRY-US, V40, P15369, DOI 10.1021/bi011384o; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Jiang YW, 2001, P NATL ACAD SCI USA, V98, P10102, DOI 10.1073/pnas.131200398; Johansson L, 1999, J BIOL CHEM, V274, P345, DOI 10.1074/jbc.274.1.345; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim JY, 2004, MOL ENDOCRINOL, V18, P776, DOI 10.1210/me.2003-0311; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Park MJ, 2007, BIOCHEM J, V402, P567, DOI 10.1042/BJ20061549; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Seel WG, 1998, MOL ENDOCRINOL, V12, P1551, DOI 10.1210/mend.12.10.0184; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song KH, 2007, HEPATOLOGY, V46, P1993, DOI 10.1002/hep.21878; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200	42	112	115	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32182	32191		10.1074/jbc.M110.134890	http://dx.doi.org/10.1074/jbc.M110.134890			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688914	Green Published, hybrid			2022-12-25	WOS:000282683000031
J	Liang, WX; Deutscher, MP				Liang, Wenxing; Deutscher, Murray P.			A Novel Mechanism for Ribonuclease Regulation TRANSFER-MESSENGER RNA (tmRNA) AND ITS ASSOCIATED PROTEIN SmpB REGULATE THE STABILITY OF RNase R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; QUALITY-CONTROL; GROWTH; BINDING; STRESS; PHASE; DECAY	The amount of RNase R, an important degradative exoribonuclease, increases 3-10-fold under a variety of stress conditions. This elevation is due to posttranslational regulation in which the highly unstable RNase R protein becomes stabilized during stress. Here we identify two components of the transtranslation machinery, transfer-messenger RNA (tmRNA) and SmpB, that are responsible for the short half-life of RNase R in exponential phase cells. The absence of either lengthens the half-life of RNase R in vivo >6-fold. SmpB directly interacts with RNase R in vitro and is stimulated by tmRNA. The C-terminal region of RNase R, encompassing its basic region and adjacent S1 domain are required for the interaction; their removal eliminates binding and stabilizes RNase R in vivo. However, the binding of SmpB and tmRNA does not alter RNase R activity. These data define a previously unknown regulatory process in which the stability of an RNase is determined by its interaction with an RNA and an RNA-associated protein.	[Liang, Wenxing; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Liang, Wenxing/E-7133-2012		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317 (to M. P. D.).	Andrade JM, 2006, MOL MICROBIOL, V60, P219, DOI 10.1111/j.1365-2958.2006.05092.x; Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cairrao F, 2003, MOL MICROBIOL, V50, P1349, DOI 10.1046/j.1365-2958.2003.03766.x; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Chen CL, 2005, J BIOL CHEM, V280, P34393, DOI 10.1074/jbc.C500333200; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Karzai AW, 2001, P NATL ACAD SCI USA, V98, P3040, DOI 10.1073/pnas.051628298; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Liang WX, 2009, CELL RES, V19, P307, DOI 10.1038/cr.2008.317; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sundermeier T, 2008, METHOD ENZYMOL, V447, P329, DOI 10.1016/S0076-6879(08)02217-9; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; Withey J, 1999, J BACTERIOL, V181, P2148, DOI 10.1128/JB.181.7.2148-2157.1999	23	36	37	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29054	29058		10.1074/jbc.C110.168641	http://dx.doi.org/10.1074/jbc.C110.168641			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20688916	Green Published, hybrid			2022-12-25	WOS:000281740100006
J	Cafini, F; Yuste, J; Gimenez, MJ; Sevillano, D; Aguilar, L; Alou, L; Ramos-Sevillano, E; Torrico, M; Gonzalez, N; Garcia, E; Coronel, P; Prieto, J				Cafini, Fabio; Yuste, Jose; Gimenez, Maria-Jose; Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Ramos-Sevillano, Elisa; Torrico, Martha; Gonzalez, Natalia; Garcia, Ernesto; Coronel, Pilar; Prieto, Jose			Enhanced In Vivo Activity of Cefditoren in Pre-Immunized Mice against Penicillin-Resistant S. pneumoniae (Serotypes 6B, 19F and 23F) in a Sepsis Model	PLOS ONE			English	Article							INVASIVE STREPTOCOCCUS-PNEUMONIAE; ACUTE OTITIS-MEDIA; RETICULOENDOTHELIAL CLEARANCE; PHARMACODYNAMIC PROFILE; PNEUMOCOCCAL CARRIAGE; NON-SUSCEPTIBILITY; ANTIBODIES; COMPLEMENT; OPSONIZATION; BACTEREMIA	Background: Specific antibodies are likely to be present before S. pneumoniae infection. We explored cefditoren (CDN) total and free values of serum concentrations exceeding the MIC (t>MIC) related to efficacy in a mice sepsis model, and the effect of specific gammaglobulins on in-vitro phagocytosis and in-vivo efficacy. Methodology/Principal Findings: We used three pneumococcal isolates (serotype, MIC of CDN): Strain 1 (6B, 1 mu g/ml), Strain 2 (19F, 2 mu g/ml) and Strain 3 (23F, 4 mu g/ml). Hyperimmune serum (HS) was obtained from mice immunized with heat-inactivated strains. In-vitro, phagocytosis by HS diluted 1/10 in presence/absence of sub-inhibitory concentrations was measured by flow cytometry including fluorescent bacteria and a neutrophil cell line. In-vivo dose-ranging experiments with HS (dilutions 1/2-1/16) and CDN (6.25 mg/kg-100 mg/kg tid for 48 h) were performed to determine the minimal protective dilution/dose (highest survival) and the non-protective highest dilution/dose (highest mortality: HS-np dilution and CDN-np dose) over 7 days. Efficacy of CDN-np in animals pre-immunized with HS-np (combined strategy) was explored and blood bacterial clearance determined. The CDN measured protein binding was 86.9%. In-vitro, CDN significantly increased phagocytosis (vs. HS 1/10). In non pre-immunized animals, t>MIC values for CDN of approximate to 35% (total) and approximate to 19% (free) were associated with 100% survival. Significant differences in survival were found between HS-np alone (<= 20%) or CDN-np alone (<= 20%) vs. the combined strategy (90%, 60% and 60% for Stains 1, 2 and 3), with t>MIC (total/free) of 22.8%/14.3%, 26.8%/16.0%, and 22.4%/12.7% for Strains 1, 2 and 3, respectively. Prior to the second dose (8 h), median bacterial counts were significantly lower in animals surviving vs. dead at day 7. Conclusions/Significance: In mice (CDN protein binding similar to humans) total t. MIC values of approximate to 35% (approximate to 19% free) were efficacious, with a decrease in the required values in pre-immunized animals. This reinforces that immunoprotection to overcome resistance may provide lifesaving strategies.	[Cafini, Fabio; Gimenez, Maria-Jose; Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Torrico, Martha; Gonzalez, Natalia; Prieto, Jose] Univ Complutense, Sch Med, Dept Microbiol, E-28040 Madrid, Spain; [Coronel, Pilar] Tedec Meiji Farma SA, Dept Sci, Madrid, Spain; [Yuste, Jose; Ramos-Sevillano, Elisa; Garcia, Ernesto] CSIC, Ctr Invest Biol, Madrid, Spain; [Yuste, Jose; Ramos-Sevillano, Elisa; Garcia, Ernesto] CIBER Enfermedades Resp CIBERES, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Cafini, F (corresponding author), Univ Complutense, Sch Med, Dept Microbiol, E-28040 Madrid, Spain.	laguilar@med.ucm.es	Prieto, José/G-5644-2010; YUSTE, JOSE/ABG-9851-2020; Alou, Luis/B-8170-2011; Gimenez, Maria Jose/GXF-2237-2022; Sevillano, David/G-5661-2010; Hidalgo, Natalia González/X-6840-2018; Cafini, Fabio/AAA-7938-2020; Sevillano, Elisa Ramos/J-4824-2016	Alou, Luis/0000-0002-0859-008X; Gimenez, Maria Jose/0000-0003-0830-4095; Hidalgo, Natalia González/0000-0002-6874-954X; Cafini, Fabio/0000-0002-5442-1674; Sevillano, Elisa Ramos/0000-0003-0803-2755; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; Sevillano Fernandez, David/0000-0003-0212-2194; YUSTE, JOSE/0000-0001-7996-0837	Tedec-Meiji Farma S.A., Madrid, Spain	Tedec-Meiji Farma S.A., Madrid, Spain	This study was supported by an unrestricted grant from Tedec-Meiji Farma S.A., Madrid, Spain. Tedec-Meiji Farma S.A. had a role in providing reagents, materials and analysis tools.	BROWN EJ, 1981, J RETICULOENDOTH SOC, V30, P23; BROWN EJ, 1983, REV INFECT DIS, V5, pS797; Casal J, 2002, ANTIMICROB AGENTS CH, V46, P1340, DOI 10.1128/AAC.46.5.1340-1344.2002; CRAIG W. A., 1991, ANTIBIOTICS LAB MED, P367, DOI Williams & Wilkins; CRAIG WA, 2000, 40 ICAAC 2000 SEPT 1; EGGLETON P, 1989, J IMMUNOL METHODS, V121, P105, DOI 10.1016/0022-1759(89)90425-0; Fenoll A, 2008, J ANTIMICROB CHEMOTH, V62, P1430, DOI 10.1093/jac/dkn413; Fenoll A, 2008, EUR J CLIN MICROBIOL, V27, P75, DOI 10.1007/s10096-007-0402-5; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Fenoll A, 2007, J ANTIMICROB CHEMOTH, V60, P323, DOI 10.1093/jac/dkm209; Fleck RA, 2005, CLIN DIAGN LAB IMMUN, V12, P19, DOI 10.1128/CDLI.12.1.19-27.2005; Fukuoka T, 1998, ANTIMICROB AGENTS CH, V42, P23, DOI 10.1128/AAC.42.1.23; Granizo JJ, 2008, INT J ANTIMICROB AG, V31, P396, DOI 10.1016/j.ijantimicag.2007.10.024; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; LUJAN M, 2010, EUR RESP J      0211; Martinez JE, 1999, CLIN DIAGN LAB IMMUN, V6, P581, DOI 10.1128/CDLI.6.4.581-586.1999; Nicasio AM, 2009, ANTIMICROB AGENTS CH, V53, P2756, DOI 10.1128/AAC.01678-08; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Rodriguez-Cerrato V, 2010, DIAGN MICR INFEC DIS, V66, P336, DOI 10.1016/j.diagmicrobio.2009.10.015; Sevillano D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002717; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Soininen A, 2001, J INFECT DIS, V184, P569, DOI 10.1086/322794; Soriano F, 2008, J ANTIMICROB CHEMOTH, V62, P1234, DOI 10.1093/jac/dkn392; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Yuste J, 2002, J ANTIMICROB CHEMOTH, V49, P331, DOI 10.1093/jac/49.2.331; Yuste J, 2002, CLIN EXP IMMUNOL, V128, P411, DOI 10.1046/j.1365-2249.2002.01860.x; Yuste J, 2002, ANTIMICROB AGENTS CH, V46, P4043, DOI 10.1128/AAC.46.12.4043-4044.2002; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09	31	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12041	10.1371/journal.pone.0012041	http://dx.doi.org/10.1371/journal.pone.0012041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706584	gold, Green Published, Green Submitted			2022-12-25	WOS:000280811900009
J	Negri, M; Recanatini, M; Hartmann, RW				Negri, Matthias; Recanatini, Maurizio; Hartmann, Rolf W.			Insights in 17 beta-HSD1 Enzyme Kinetics and Ligand Binding by Dynamic Motion Investigation	PLOS ONE			English	Article							17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1 17-BETA-HSD1; HUMAN ESTROGENIC 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; SELECTIVE NONSTEROIDAL INHIBITORS; SHORT-CHAIN DEHYDROGENASE/REDUCTASE; HYDROXYSTEROID DEHYDROGENASES; BIOLOGICAL EVALUATION; MOLECULAR-DYNAMICS; BREAST-CANCER; ESTRONE REDUCTION; CRYSTAL-STRUCTURE	Background: Bisubstrate enzymes, such as 17 beta-hydroxysteroid dehydrogenase type 1 (17 beta-HSD1), exist in solution as an ensemble of conformations. 17 beta-HSD1 catalyzes the last step of the biosynthesis of estradiol and, thus, it is a potentially attractive target for breast cancer treatment. Methodology/Principal Findings: To elucidate the conformational transitions of its catalytic cycle, a structural analysis of all available crystal structures was performed and representative conformations were assigned to each step of the putative kinetic mechanism. To cover most of the conformational space, all-atom molecular dynamic simulations were performed using the four crystallographic structures best describing apoform, opened, occluded and closed state of 17 beta-HSD1 as starting structures. With three of them, binary and ternary complexes were built with NADPH and NADPH-estrone, respectively, while two were investigated as apoform. Free energy calculations were performed in order to judge more accurately which of the MD complexes describes a specific kinetic step. Conclusions/Significance: Remarkably, the analysis of the eight long range trajectories resulting from this multi-trajectory/complex approach revealed an essential role played by the backbone and side chain motions, especially of the beta FaG'-loop, in cofactor and substrate binding. Thus, a selected-fit mechanism is suggested for 17 beta-HSD1, where ligand-binding induced concerted motions of the FG-segment and the C-terminal part guide the enzyme along its preferred catalytic pathway. Overall, we could assign different enzyme conformations to the five steps of the random bi-bi kinetic cycle of 17 beta-HSD1 and we could postulate a preferred pathway for it. This study lays the basis for more-targeted biochemical studies on 17 beta-HSD1, as well as for the design of specific inhibitors of this enzyme. Moreover, it provides a useful guideline for other enzymes, also characterized by a rigid core and a flexible region directing their catalysis.	[Negri, Matthias; Hartmann, Rolf W.] Univ Saarland, D-6600 Saarbrucken, Germany; [Recanatini, Maurizio] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Negri, Matthias; Hartmann, Rolf W.] Helmholtz Inst Pharmaceut Res Saarland, Saarbrucken, Germany	Saarland University; University of Bologna; Helmholtz Association; Helmholtz-Center for Infection Research	Negri, M (corresponding author), Univ Saarland, D-6600 Saarbrucken, Germany.	rwh@mx.uni-saarland.de	Recanatini, Maurizio/GXH-1338-2022; Recanatini, Maurizio/AAU-3319-2021	Recanatini, Maurizio/0000-0002-0039-0518				Agarwal AK, 2005, ENDOCRINOLOGY, V146, P2531, DOI 10.1210/en.2005-0061; Aka JA, 2010, MOL ENDOCRINOL, V24, P832, DOI 10.1210/me.2009-0468; Azzi A, 1996, NAT STRUCT BIOL, V3, P665, DOI 10.1038/nsb0896-665; Bennett MJ, 1996, BIOCHEMISTRY-US, V35, P10702, DOI 10.1021/bi9604688; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BETZ G, 1971, J BIOL CHEM, V246, P2063; Bey E, 2008, J MED CHEM, V51, P6725, DOI 10.1021/jm8006917; Bey E, 2009, J MED CHEM, V52, P6724, DOI 10.1021/jm901195w; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; Brozic P, 2008, CURR MED CHEM, V15, P137; Case D, 2006, AMBER 9; Cooper WC, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703414200; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Frotscher MT, 2008, J MED CHEM, V51, P2158, DOI 10.1021/jm701447v; Gangloff A, 2002, FASEB J, V16, P274, DOI 10.1096/fj.02-0397fje; Gangloff A, 2001, BIOCHEM J, V356, P269, DOI 10.1042/0264-6021:3560269; Ghosh D, 2001, CHEM-BIOL INTERACT, V130, P637, DOI 10.1016/S0009-2797(00)00255-6; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; Han Q, 2000, J BIOL CHEM, V275, P1105, DOI 10.1074/jbc.275.2.1105; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibarra CA, 2003, J BIOL CHEM, V278, P19257, DOI 10.1074/jbc.M301566200; Jin JZ, 1999, BIOCHEM BIOPH RES CO, V259, P489, DOI 10.1006/bbrc.1999.0704; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karkola S, 2008, CHEMMEDCHEM, V3, P461, DOI 10.1002/cmdc.200700271; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kruchten P, 2009, J STEROID BIOCHEM, V114, P200, DOI 10.1016/j.jsbmb.2009.02.006; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; Lerner MG, 2007, J CHEM INF MODEL, V47, P2358, DOI 10.1021/ci700167n; Marchais-Oberwinkler S, 2008, J MED CHEM, V51, P4685, DOI 10.1021/jm800367k; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; MAZUMDAR M, 2009, 17BETA HSD1 STIMULAT, DOI DOI 10.2210/PDB3DEY/PDB; Mazumdar M, 2009, BIOCHEM J, V424, P357, DOI 10.1042/BJ20091020; Mazza C, 1998, J BIOL CHEM, V273, P8145, DOI 10.1074/jbc.273.14.8145; Mazza C, 1997, HUMAN TYPE 1 17 BETA, DOI [10.2210/pdb1a27/pdb, DOI 10.2210/PDB1A27/PDB]; Messinger J, 2006, MOL CELL ENDOCRINOL, V248, P192, DOI 10.1016/j.mce.2005.11.044; Miettinen MM, 1996, BIOCHEM J, V314, P839, DOI 10.1042/bj3140839; Miyoshi Y, 2001, INT J CANCER, V94, P685, DOI 10.1002/ijc.1525; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Poirier D, 2005, J MED CHEM, V48, P8134, DOI 10.1021/jm058235e; Poirier D, 2009, ANTI-CANCER AGENT ME, V9, P642, DOI 10.2174/187152009788680000; Prehn C, 2009, J STEROID BIOCHEM, V114, P72, DOI 10.1016/j.jsbmb.2008.12.024; Puranen T, 1997, MOL ENDOCRINOL, V11, P77, DOI 10.1210/me.11.1.77; Qiu W, 2002, FASEB J, V16, P1829, DOI 10.1096/fj.02-0026fje; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sasano H, 1996, J CLIN ENDOCR METAB, V81, P4042, DOI 10.1210/jc.81.11.4042; Sawicki MW, 1999, P NATL ACAD SCI USA, V96, P840, DOI 10.1073/pnas.96.3.840; Sherbet DP, 2007, MOL CELL ENDOCRINOL, V265, P83, DOI 10.1016/j.mce.2006.12.021; Sherbet DP, 2009, ENDOCRINOLOGY, V150, P4154, DOI 10.1210/en.2008-1817; Shi R, 2004, J BIOL CHEM, V279, P16778, DOI 10.1074/jbc.M313156200; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; THORPE MF, CASE DA RIGIDITY THE, P329; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223	59	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12026	10.1371/journal.pone.0012026	http://dx.doi.org/10.1371/journal.pone.0012026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706575	Green Published, Green Submitted, gold			2022-12-25	WOS:000280811900004
J	Hobaiter, C; Byrne, RW				Hobaiter, Catherine; Byrne, Richard W.			Able-Bodied Wild Chimpanzees Imitate a Motor Procedure Used by a Disabled Individual to Overcome Handicap	PLOS ONE			English	Article							TOOL USE; CAPUCHIN MONKEYS; PAN-TROGLODYTES; CULTURE; EVOLUTION; CHILDREN; ANIMALS; COMPLEXITY; CONFORMITY; BEHAVIOR	Chimpanzee culture has generated intense recent interest, fueled by the technical complexity of chimpanzee tool-using traditions; yet it is seriously doubted whether chimpanzees are able to learn motor procedures by imitation under natural conditions. Here we take advantage of an unusual chimpanzee population as a 'natural experiment' to identify evidence for imitative learning of this kind in wild chimpanzees. The Sonso chimpanzee community has suffered from high levels of snare injury and now has several manually disabled members. Adult male Tinka, with near-total paralysis of both hands, compensates inability to scratch his back manually by employing a distinctive technique of holding a growing liana taut while making side-to-side body movements against it. We found that seven able-bodied young chimpanzees also used this 'liana-scratch' technique, although they had no need to. The distribution of the liana-scratch technique was statistically associated with individuals' range overlap with Tinka and the extent of time they spent in parties with him, confirming that the technique is acquired by social learning. The motivation for able-bodied chimpanzees copying his variant is unknown, but the fact that they do is evidence that the imitative learning of motor procedures from others is a natural trait of wild chimpanzees.	[Hobaiter, Catherine] Univ St Andrews, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; Univ St Andrews, Sch Psychol, Scottish Primate Res Grp, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews	Hobaiter, C (corresponding author), Univ St Andrews, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	rwb@st-andrews.ac.uk		Hobaiter, Cat/0000-0002-3893-0524; Byrne, Richard/0000-0001-9862-9373	Wenner-Gren Foundation; Russell Trust	Wenner-Gren Foundation; Russell Trust	Fieldwork of CH was generously supported by grants from the Wenner-Gren Foundation (http://wennergren.org) and the Russell Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates LA, 2010, WIRES COGN SCI, V1, P685, DOI 10.1002/wcs.77; Boesch C, 2003, EVOL ANTHROPOL, V12, P82, DOI 10.1002/evan.10106; Boesch C, 2000, CHIMPANZEES TAI FORE; Boyd R., 1985, CULTURE EVOLUTIONARY; Byrne R., 2006, INT J PSYCHOL PSYCHO, V6, P215; Byrne R.W., 1994, P223; Byrne RW, 2007, PHILOS T R SOC B, V362, P577, DOI 10.1098/rstb.2006.1996; Byrne Richard W., 1999, Animal Cognition, V2, P63, DOI 10.1007/s100710050025; Byrne RW, 2009, CURR BIOL, V19, pR111, DOI 10.1016/j.cub.2008.11.027; Byrne Richard W., 1999, Symposia of the Zoological Society of London, V72, P333; BYRNE RW, 1993, AM J PRIMATOL, V31, P241, DOI 10.1002/ajp.1350310402; Byrne RW, 2004, TRENDS COGN SCI, V8, P341, DOI 10.1016/j.tics.2004.06.002; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Byrne RW, 2003, PHILOS T R SOC B, V358, P529, DOI 10.1098/rstb.2002.1219; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; Byrne RW, 2001, BEHAVIOUR, V138, P525, DOI 10.1163/156853901750382142; BYRNE RW, 2006, ROOTS HUMAN SOCIALIT, P478; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Corp N, 2002, ETHOLOGY, V108, P673, DOI 10.1046/j.1439-0310.2002.00801.x; Corp N, 2002, BEHAVIOUR, V139, P137, DOI 10.1163/15685390252902328; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; DEWAAL F, 1982, CHIMPANZEE POLITICS; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; Fox Elizabeth A., 1999, P99, DOI 10.1017/CBO9780511542305.005; Fragaszy D, 2010, ANIM BEHAV, V79, P321, DOI 10.1016/j.anbehav.2009.11.004; Galef BG, 2008, ANIM BEHAV, V75, P2035, DOI 10.1016/j.anbehav.2007.11.012; Galef Bennett G. Jr, 2003, P159, DOI 10.1017/CBO9780511584022.007; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Goodall J., 1986, CHIMPANZEES GOMBE PA; Greenberg R, 2009, AM J PRIMATOL, V71, P80; Gruber T, 2009, CURR BIOL, V19, P1806, DOI 10.1016/j.cub.2009.08.060; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Hoppitt WJE, 2008, TRENDS ECOL EVOL, V23, P486, DOI 10.1016/j.tree.2008.05.008; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Huffman MA, 1996, SOCIAL LEARNING ANIM; KAWAI M, 1992, PRIMATE REP, V32, P143; Kohler W., 1925, MENTALITY APES; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Laland KN, 2008, CURR BIOL, V18, pR366, DOI 10.1016/j.cub.2008.02.049; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KevinN., 2003, ENCY COGNITIVE SCI, V2, P268; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Liu Q, 2009, AM J PHYS ANTHROPOL, V138, P210, DOI 10.1002/ajpa.20920; Lonsdorf EV, 2006, ANIM COGN, V9, P36, DOI 10.1007/s10071-005-0002-7; Mannu M, 2009, AM J PRIMATOL, V71, P242, DOI 10.1002/ajp.20642; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew WC, 1998, ANNU REV ANTHROPOL, V27, P301, DOI 10.1146/annurev.anthro.27.1.301; Nishida T, 1999, ANTHROPOL SCI, V107, P141, DOI 10.1537/ase.107.141; NISHIDA T, 1986, PRIMATE SOC, P462; Perry S, 2003, EVOL ANTHROPOL, V12, P71, DOI 10.1002/evan.10105; Premack D., 1994, COMPANION ENCY ANTHR, P350; Quiatt D, 2002, AFR J ECOL, V40, P303, DOI 10.1046/j.1365-2028.2002.00356.x; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Reynolds V., 2005, CHIMPANZEES BUDONGO; Russon AE, 1998, PRIMATES, V39, P485, DOI 10.1007/BF02557571; Sanz CM, 2007, J HUM EVOL, V52, P420, DOI 10.1016/j.jhevol.2006.11.001; Spence KW, 1937, PSYCHOL BULL, V34, P806, DOI 10.1037/h0061498; Stokes Emma J., 2001, Animal Cognition, V4, P11, DOI 10.1007/s100710100082; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; TOMASELLO M, 1993, CHILD DEV, V64, P1688, DOI 10.1111/j.1467-8624.1993.tb04207.x; Tomasello M, 1998, BEHAV BRAIN SCI, V21, P703, DOI 10.1017/S0140525X98441748; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tomasello M, 1997, PRIMATE COGNITION; Tomasello M., 2009, CULTURAL ORIGINS HUM; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Van Schaik CP, 2001, AM J PHYS ANTHROPOL, V114, P331, DOI 10.1002/ajpa.1045; Want SC, 2002, DEVELOPMENTAL SCI, V5, P1, DOI 10.1111/1467-7687.00194; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1996, J COMP PSYCHOL, V110, P3, DOI 10.1037/0735-7036.110.1.3; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wood D., 1989, INTERACTION HUMAN DE, P59; Zuberbuhler K., 2005, SONSO CHIMPANZEE DAT	77	30	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11959	10.1371/journal.pone.0011959	http://dx.doi.org/10.1371/journal.pone.0011959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700527	Green Published, gold, Green Submitted			2022-12-25	WOS:000280605400007
J	Lin, KY; Cheng, CP; Chang, BCH; Wang, WC; Huang, YW; Lee, YS; Huang, HD; Hsu, YH; Lin, NS				Lin, Kuan-Yu; Cheng, Chi-Ping; Chang, Bill Chia-Han; Wang, Wei-Chi; Huang, Ying-Wen; Lee, Yun-Shien; Huang, Hsien-Da; Hsu, Yau-Heiu; Lin, Na-Sheng			Global Analyses of Small Interfering RNAs Derived from Bamboo mosaic virus and Its Associated Satellite RNAs in Different Plants	PLOS ONE			English	Article							DICER-LIKE PROTEINS; TRANS-ACTING SIRNAS; TRIPLE-GENE-BLOCK; SUBCELLULAR-LOCALIZATION; SILENCING PATHWAYS; DOWN-REGULATION; GC PREFERENCE; ARABIDOPSIS; DEFENSE; BIOGENESIS	Background: Satellite RNAs (satRNAs), virus parasites, are exclusively associated with plant virus infection and have attracted much interest over the last 3 decades. Upon virus infection, virus-specific small interfering RNAs (vsiRNAs) are produced by dicer-like (DCL) endoribonucleases for anti-viral defense. The composition of vsiRNAs has been studied extensively; however, studies of satRNA-derived siRNAs (satsiRNAs) or siRNA profiles after satRNA co-infection are limited. Here, we report on the small RNA profiles associated with infection with Bamboo mosaic virus (BaMV) and its two satellite RNAs (satBaMVs) in Nicotiana benthamiana and Arabidopsis thaliana. Methodology/Principal Findings: Leaves of N. benthamiana or A. thaliana inoculated with water, BaMV alone or coinoculated with interfering or noninterfering satBaMV were collected for RNA extraction, then large-scale Solexa sequencing. Up to about 20% of total siRNAs as BaMV-specific siRNAs were accumulated in highly susceptible N. benthamiana leaves inoculated with BaMV alone or co-inoculated with noninterfering satBaMV; however, only about 0.1% of vsiRNAs were produced in plants co-infected with interfering satBaMV. The abundant region of siRNA distribution along BaMV and satBaMV genomes differed by host but not by co-infection with satBaMV. Most of the BaMV and satBaMV siRNAs were 21 or 22 nt, of both (+) and (-) polarities; however, a higher proportion of 22-nt BaMV and satBaMV siRNAs were generated in N. benthamiana than in A. thaliana. Furthermore, the proportion of non-viral 24-nt siRNAs was greatly increased in N. benthamiana after virus infection. Conclusions/Significance: The overall composition of vsiRNAs and satsiRNAs in the infected plants reflect the combined action of virus, satRNA and different DCLs in host plants. Our findings suggest that the structure and/or sequence demands of various DCLs in different hosts may result in differential susceptibility to the same virus. DCL2 producing 24-nt siRNAs under biotic stresses may play a vital role in the antiviral mechanism in N. benthamiana.	[Lin, Kuan-Yu; Lin, Na-Sheng] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Cheng, Chi-Ping] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Chang, Bill Chia-Han; Lin, Na-Sheng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Wang, Wei-Chi; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Huang, Ying-Wen; Hsu, Yau-Heiu] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Tao Yuan, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Cheng Kung University; Tzu Chi University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Chung Hsing University; Ming Chuan University; National Yang Ming Chiao Tung University	Lin, KY (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan.	nslin@sinica.edu.tw	Huang, Hsien-Da/AAA-7376-2019	Chang, Bill Chia-Han/0000-0001-5313-4852	National Science Council [NSC-95-2323-B-001-029-]; Academia Sinica, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	This research was supported in part by grants from the National Science Council (NSC-95-2323-B-001-029-) and from Academia Sinica (Investigator Award Project), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai P, 2003, VIROLOGY, V311, P229, DOI 10.1016/S0042-6822(03)00178-8; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baulcombe D, 1999, ARCH VIROL, P189; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chang BY, 1997, J GEN VIROL, V78, P1175, DOI 10.1099/0022-1317-78-5-1175; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen HC, 2007, VIROLOGY, V365, P271, DOI 10.1016/j.virol.2007.03.050; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; DONAIRE L, 2009, VIROLOGY; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Havelda Z, 2005, J VIROL, V79, P450, DOI 10.1128/JVI.79.1.450-457.2005; Herr AJ, 2004, COLD SPRING HARB SYM, V69, P363, DOI 10.1101/sqb.2004.69.363; Ho T, 2008, BIOCHEM BIOPH RES CO, V368, P433, DOI 10.1016/j.bbrc.2008.01.110; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Ho T, 2006, J VIROL METHODS, V136, P217, DOI 10.1016/j.jviromet.2006.05.016; Hsu YH, 2006, J VIROL, V80, P2566, DOI 10.1128/JVI.80.5.2566-2574.2006; Hsu YH, 1998, MOL PLANT MICROBE IN, V11, P1207, DOI 10.1094/MPMI.1998.11.12.1207; Huang YW, 2009, VIROLOGY, V386, P139, DOI 10.1016/j.virol.2009.01.019; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Jones L, 2002, TRENDS PLANT SCI, V7, P473, DOI 10.1016/S1360-1385(02)02361-0; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lin MK, 2004, J GEN VIROL, V85, P251, DOI 10.1099/vir.0.19442-0; LIN NS, 1994, VIROLOGY, V202, P707, DOI 10.1006/viro.1994.1392; Lin NS, 1996, P NATL ACAD SCI USA, V93, P3138, DOI 10.1073/pnas.93.7.3138; LIN NS, 1993, PLANT DIS, V77, P448, DOI 10.1094/PD-77-0448; LIN NS, 1994, J GEN VIROL, V75, P2513, DOI 10.1099/0022-1317-75-9-2513; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Markarian N, 2004, ARCH VIROL, V149, P397, DOI 10.1007/s00705-003-0215-5; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Palani PV, 2006, MOL PLANT MICROBE IN, V19, P758, DOI 10.1094/MPMI-19-0758; Palani PV, 2009, J GEN VIROL, V90, P507, DOI 10.1099/vir.0.004994-0; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; SCHOEMAKER HJ, 1974, J MOL BIOL, V84, P503, DOI 10.1016/0022-2836(74)90112-0; St-Pierre P, 2009, VIROLOGY, V383, P178, DOI 10.1016/j.virol.2008.11.008; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; Waterhouse PM, 2006, SCIENCE, V313, P54, DOI 10.1126/science.1130818; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yeh WB, 2004, VIROLOGY, V330, P105, DOI 10.1016/j.virol.2004.09.025; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zhang XM, 2008, J VIROL, V82, P2613, DOI 10.1128/JVI.02324-07	64	34	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11928	10.1371/journal.pone.0011928	http://dx.doi.org/10.1371/journal.pone.0011928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689857	Green Published, gold			2022-12-25	WOS:000280520400014
J	Butler, KL; Ambravaneswaran, V; Agrawal, N; Bilodeau, M; Toner, M; Tompkins, RG; Fagan, S; Irimia, D				Butler, Kathryn L.; Ambravaneswaran, Vijayakrishnan; Agrawal, Nitin; Bilodeau, Maryelizabeth; Toner, Mehmet; Tompkins, Ronald G.; Fagan, Shawn; Irimia, Daniel			Burn Injury Reduces Neutrophil Directional Migration Speed in Microfluidic Devices	PLOS ONE			English	Article							LEUKOCYTE CHEMOTAXIS INVITRO; POLYMORPHONUCLEAR LEUKOCYTES; CELL-MIGRATION; GRADIENT GENERATOR; THERMAL-INJURY; EARLY EXCISION; ORGAN FAILURE; INFECTION; COMPLEMENT; EXPRESSION	Thermal injury triggers a fulminant inflammatory cascade that heralds shock, end-organ failure, and ultimately sepsis and death. Emerging evidence points to a critical role for the innate immune system, and several studies had documented concurrent impairment in neutrophil chemotaxis with these post-burn inflammatory changes. While a few studies suggest that a link between neutrophil motility and patient mortality might exist, so far, cumbersome assays have prohibited exploration of the prognostic and diagnostic significance of chemotaxis after burn injury. To address this need, we developed a microfluidic device that is simple to operate and allows for precise and robust measurements of chemotaxis speed and persistence characteristics at single-cell resolution. Using this assay, we established a reference set of migration speed values for neutrophils from healthy subjects. Comparisons with samples from burn patients revealed impaired directional migration speed starting as early as 24 hours after burn injury, reaching a minimum at 72-120 hours, correlated to the size of the burn injury and potentially serving as an early indicator for concurrent infections. Further characterization of neutrophil chemotaxis using this new assay may have important diagnostic implications not only for burn patients but also for patients afflicted by other diseases that compromise neutrophil functions.	[Butler, Kathryn L.; Agrawal, Nitin; Bilodeau, Maryelizabeth; Toner, Mehmet; Tompkins, Ronald G.; Fagan, Shawn; Irimia, Daniel] Shriners Hosp Children, Massachusetts Gen Hosp, Dept Surg, Boston, MA USA; [Butler, Kathryn L.; Ambravaneswaran, Vijayakrishnan; Agrawal, Nitin; Bilodeau, Maryelizabeth; Toner, Mehmet; Tompkins, Ronald G.; Fagan, Shawn; Irimia, Daniel] Harvard Univ, Sch Med, Boston, MA USA; [Ambravaneswaran, Vijayakrishnan; Agrawal, Nitin; Toner, Mehmet; Irimia, Daniel] Shriners Hosp Children, Massachusetts Gen Hosp, Ctr Engn Med & Surg Serv, BioMEMS Resource Ctr, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Butler, KL (corresponding author), Shriners Hosp Children, Massachusetts Gen Hosp, Dept Surg, Boston, MA USA.	dirimia@hms.harvard.edu	Irimia, Daniel/A-4095-2008; Irimia, Daniel/S-5404-2019	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082	National Institutes of Health [R01M092804]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds from the National Institutes of Health (R01M092804) and the Shriners Hospitals for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Adams JM, 2001, J TRAUMA, V51, P452, DOI 10.1097/00005373-200109000-00005; Agrawal N, 2008, LAB CHIP, V8, P2054, DOI 10.1039/b813588f; Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; BABCOCK GF, 1990, CLIN IMMUNOL IMMUNOP, V54, P117, DOI 10.1016/0090-1229(90)90011-E; BJERKNES R, 1990, BLOOD CELLS, V16, P127; BJORNSON AB, 1993, J INFECT DIS, V168, P120, DOI 10.1093/infdis/168.1.120; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; BRANSKI LK, 2009, ANN SURG; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; Cheng XH, 2007, LAB CHIP, V7, P170, DOI 10.1039/b612966h; Chung BG, 2006, LAB CHIP, V6, P764, DOI 10.1039/b512667c; DAVIGNON LC, BURNS; DECHALAIN TMB, 1994, BURNS, V20, P416, DOI 10.1016/0305-4179(94)90033-7; DEITCH EA, 1990, J TRAUMA, V30, P259, DOI 10.1097/00005373-199003000-00003; Frevert CW, 2006, LAB CHIP, V6, P849, DOI 10.1039/b515560f; GERISCH G, 1981, J CELL SCI, V52, P1; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; HARTMAN RS, 1994, BIOPHYS J, V67, P2535, DOI 10.1016/S0006-3495(94)80743-X; Hasslen Sharon R., 1993, Journal of Burn Care and Rehabilitation, V14, P303, DOI 10.1097/00004630-199305000-00001; HERNDON DN, 1989, ANN SURG, V209, P547, DOI 10.1097/00000658-198905000-00006; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Ipaktchi K, 2006, CRIT CARE MED, V34, pS239, DOI 10.1097/01.CCM.0000232625.63460.D4; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Keenan TM, 2010, LAB CHIP, V10, P116, DOI 10.1039/b913494h; Kim D, 2009, LAB CHIP, V9, P1797, DOI 10.1039/b901613a; KIM Y, 1989, BURNS, V15, P93, DOI 10.1016/0305-4179(89)90137-X; Lakshman R, 2001, J CLIN PATHOL, V54, P7, DOI 10.1136/jcp.54.1.7; Lin F, 2005, ANN BIOMED ENG, V33, P475, DOI 10.1007/s10439-005-2503-6; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Liu YX, 2008, BIOMED MICRODEVICES, V10, P499, DOI 10.1007/s10544-007-9158-z; Malawista SE, 1997, P NATL ACAD SCI USA, V94, P11577, DOI 10.1073/pnas.94.21.11577; MANKTELOW A, 1986, J TRAUMA, V26, P143, DOI 10.1097/00005373-198602000-00008; Mileski W., 1993, Journal of Burn Care and Rehabilitation, V14, P610, DOI 10.1097/00004630-199311000-00005; MILESKI WJ, 1994, EUR J PEDIATR SURG, V4, P225, DOI 10.1055/s-2008-1066110; MILESKI WJ, 1993, J SURG RES, V54, P349, DOI 10.1006/jsre.1993.1056; MOORE FD, 1986, NEW ENGL J MED, V314, P948, DOI 10.1056/NEJM198604103141503; Murray CK, 2007, ARCH SURG-CHICAGO, V142, P639, DOI 10.1001/archsurg.142.7.639; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; NELSON RD, 1975, J IMMUNOL, V115, P1650; NWARIAKU FE, 1995, J TRAUMA, V39, P285, DOI 10.1097/00005373-199508000-00016; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; Ong YS, 2006, BURNS, V32, P145, DOI 10.1016/j.burns.2005.09.005; Pereira C, 2005, INT J BIOCHEM CELL B, V37, P1948, DOI 10.1016/j.biocel.2005.05.009; Pereira Clifford T, 2005, Adv Surg, V39, P245, DOI 10.1016/j.yasu.2005.05.005; RANSJO U, 1977, BURNS, V3, P171, DOI 10.1016/0305-4179(77)90006-7; Russom A, 2008, CLIN CHEM, V54, P891, DOI 10.1373/clinchem.2007.099150; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; Saffle JR, 2007, J BURN CARE RES, V28, P382, DOI 10.1097/BCR.0B013E318053D3A1; Salinas J, 2008, J TRAUMA, V64, pS321, DOI 10.1097/TA.0b013e31816bf4f7; SOLOMKIN JS, 1990, J TRAUMA, V30, pS80; SOLOMKIN JS, 1984, ANN SURG, V200, P742, DOI 10.1097/00000658-198412000-00012; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; TOMPKINS RG, 1988, ANN SURG, V208, P577, DOI 10.1097/00000658-198811000-00006; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; WARDEN GD, 1975, ANN SURG, V181, P363, DOI 10.1097/00000658-197503000-00019; WARDEN GD, 1974, J CLIN INVEST, V54, P1001, DOI 10.1172/JCI107815; White CE, 2008, CRIT CARE MED, V36, pS318, DOI 10.1097/CCM.0b013e31817e2d64; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Wu XW, 2002, ARCH SURG-CHICAGO, V137, P1049, DOI 10.1001/archsurg.137.9.1049; ZICHA D, 1991, J CELL SCI, V99, P769; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	66	89	92	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11921	10.1371/journal.pone.0011921	http://dx.doi.org/10.1371/journal.pone.0011921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689600	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520300030
J	Paungfoo-Lonhienne, C; Rentsch, D; Robatzek, S; Webb, RI; Sagulenko, E; Nasholm, T; Schmidt, S; Lonhienne, TGA				Paungfoo-Lonhienne, Chanyarat; Rentsch, Doris; Robatzek, Silke; Webb, Richard I.; Sagulenko, Evgeny; Nasholm, Torgny; Schmidt, Susanne; Lonhienne, Thierry G. A.			Turning the Table: Plants Consume Microbes as a Source of Nutrients	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; ROOT; GROWTH; NITROGEN; COLONIZATION; INFECTION; PROTEIN; EXPRESSION; EVOLUTION; SEEDLINGS	Interactions between plants and microbes in soil, the final frontier of ecology, determine the availability of nutrients to plants and thereby primary production of terrestrial ecosystems. Nutrient cycling in soils is considered a battle between autotrophs and heterotrophs in which the latter usually outcompete the former, although recent studies have questioned the unconditional reign of microbes on nutrient cycles and the plants' dependence on microbes for breakdown of organic matter. Here we present evidence indicative of a more active role of plants in nutrient cycling than currently considered. Using fluorescent-labeled non-pathogenic and non-symbiotic strains of a bacterium and a fungus (Escherichia coli and Saccharomyces cerevisiae, respectively), we demonstrate that microbes enter root cells and are subsequently digested to release nitrogen that is used in shoots. Extensive modifications of root cell walls, as substantiated by cell wall outgrowth and induction of genes encoding cell wall synthesizing, loosening and degrading enzymes, may facilitate the uptake of microbes into root cells. Our study provides further evidence that the autotrophy of plants has a heterotrophic constituent which could explain the presence of root-inhabiting microbes of unknown ecological function. Our discovery has implications for soil ecology and applications including future sustainable agriculture with efficient nutrient cycles.	[Paungfoo-Lonhienne, Chanyarat; Schmidt, Susanne; Lonhienne, Thierry G. A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Rentsch, Doris] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Robatzek, Silke] Sainsbury Lab, Norwich, Norfolk, England; [Webb, Richard I.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Sagulenko, Evgeny] Univ Queensland, Sch Biochem & Mol Biosci, Brisbane, Qld, Australia; [Nasholm, Torgny] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden	University of Queensland; University of Bern; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Queensland; University of Queensland; Swedish University of Agricultural Sciences	Paungfoo-Lonhienne, C (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	Chanyarat@uq.edu.au	Schmidt, Susanne/B-2780-2009; Robatzek, Silke/B-6844-2013; Lonhienne, Thierry/A-5828-2011; Paungfoo-Lonhienne, Chanyarat/A-5816-2011	Schmidt, Susanne/0000-0001-8369-1238; Paungfoo-Lonhienne, Chanyarat/0000-0002-8361-2058; Rentsch, Doris/0000-0003-4313-7683; Nasholm, Torgny/0000-0002-2275-2030	Australian Research Council [DP0986495]; The University of Queensland	Australian Research Council(Australian Research Council); The University of Queensland(University of Queensland)	This research was funded by the Australian Research Council (DP0986495 to SS, DR, TN, and SR) and The University of Queensland (to CPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon CW, 2006, PLANT-ASSOCIATED BACTERIA, P155; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; BAJWA R, 1985, NEW PHYTOL, V101, P469, DOI 10.1111/j.1469-8137.1985.tb02853.x; BARON C, 1995, TRENDS BIOTECHNOL, V13, P356, DOI 10.1016/S0167-7799(00)88981-7; BERG RH, 1988, J ELECTRON MICR TECH, V8, P371, DOI 10.1002/jemt.1060080406; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; CLARHOLM M, 1985, SOIL BIOL BIOCHEM, V17, P181, DOI 10.1016/0038-0717(85)90113-0; Coleman DJ, 2007, ANAL BIOCHEM, V371, P146, DOI 10.1016/j.ab.2007.08.027; ENGLISH PD, 1971, PLANT PHYSIOL, V47, P1, DOI 10.1104/pp.47.1.1; Ferguson BJ, 2010, J INTEGR PLANT BIOL, V52, P61, DOI 10.1111/j.1744-7909.2010.00899.x; Gaspar YM, 2004, PLANT PHYSIOL, V135, P2162, DOI 10.1104/pp.104.045542; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; James EK, 2002, MOL PLANT MICROBE IN, V15, P894, DOI 10.1094/MPMI.2002.15.9.894; JONES DL, 1994, PLANT SOIL, V158, P183, DOI 10.1007/BF00009493; Kovtunovych G, 1999, PLANT SOIL, V215, P1, DOI 10.1023/A:1004790122353; Kuklinsky-Sobral J, 2004, ENVIRON MICROBIOL, V6, P1244, DOI 10.1111/j.1462-2920.2004.00658.x; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MATTHYSSE AG, 1983, J BACTERIOL, V154, P906, DOI 10.1128/JB.154.2.906-915.1983; McCurdy DW, 2008, CURR OPIN PLANT BIOL, V11, P653, DOI 10.1016/j.pbi.2008.08.005; MENDGEN K, 1993, NEW PHYTOL, V124, P193, DOI 10.1111/j.1469-8137.1993.tb03809.x; Morgan JA, 2002, SCIENCE, V298, P1903, DOI 10.1126/science.1079808; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Paungfoo-Lonhienne C, 2010, PLANT PHYSIOL, V153, P799, DOI 10.1104/pp.110.154963; Puente ME, 1999, FEMS MICROBIOL ECOL, V29, P283, DOI 10.1111/j.1574-6941.1999.tb00619.x; Raven JA, 2009, J EXP BOT, V60, P3975, DOI 10.1093/jxb/erp282; Reinhold-Hurek B., 2007, P427, DOI 10.1007/978-1-4020-5843-1_30; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Robledo M, 2008, P NATL ACAD SCI USA, V105, P7064, DOI 10.1073/pnas.0802547105; Rothballer M, 2008, FEMS MICROBIOL ECOL, V66, P85, DOI 10.1111/j.1574-6941.2008.00582.x; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Triplett EW, 1996, PLANT SOIL, V186, P29, DOI 10.1007/BF00035052; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Zhu YM, 2003, PLANT PHYSIOL, V133, P1000, DOI 10.1104/pp.103.030726	51	92	94	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11915	10.1371/journal.pone.0011915	http://dx.doi.org/10.1371/journal.pone.0011915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689833	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520300026
J	Lescai, F; Franceschi, C				Lescai, Francesco; Franceschi, Claudio			The Impact of Phenocopy on the Genetic Analysis of Complex Traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIFACTOR-DIMENSIONALITY REDUCTION; SUSCEPTIBILITY LOCUS; EPISTASIS; PATTERNS; DISEASE; REPLICATION; DISCOVERY; FAMILY; CANCER	A consistent debate is ongoing on genome-wide association studies (GWAs). A key point is the capability to identify low-penetrance variations across the human genome. Among the phenomena reducing the power of these analyses, phenocopy level (PE) hampers very seriously the investigation of complex diseases, as well known in neurological disorders, cancer, and likely of primary importance in human ageing. PE seems to be the norm, rather than the exception, especially when considering the role of epigenetics and environmental factors towards phenotype. Despite some attempts, no recognized solution has been proposed, particularly to estimate the effects of phenocopies on the study planning or its analysis design. We present a simulation, where we attempt to define more precisely how phenocopy impacts on different analytical methods under different scenarios. With our approach the critical role of phenocopy emerges, and the more the PE level increases the more the initial difficulty in detecting gene-gene interactions is amplified. In particular, our results show that strong main effects are not hampered by the presence of an increasing amount of phenocopy in the study sample, despite progressively reducing the significance of the association, if the study is sufficiently powered. On the opposite, when purely epistatic effects are simulated, the capability of identifying the association depends on several parameters, such as the strength of the interaction between the polymorphic variants, the penetrance of the polymorphism and the alleles (minor or major) which produce the combined effect and their frequency in the population. We conclude that the neglect of the possible presence of phenocopies in complex traits heavily affects the analysis of their genetic data.	[Lescai, Francesco] UCL, Div Res Strategy, London, England; [Lescai, Francesco; Franceschi, Claudio] Alma Mater Studiorum Univ Bologna, Ctr L Galvani Biocomplex, Bologna, Italy; [Franceschi, Claudio] Alma Mater Studiorum Univ Bologna, Dept Expt Pathol, Bologna, Italy	University of London; University College London; University of Bologna; University of Bologna	Lescai, F (corresponding author), UCL, Div Res Strategy, London, England.	f.lescai@ucl.ac.uk	Lescai, Francesco/F-8680-2010; Franceschi, Claudio/L-4484-2017	Franceschi, Claudio/0000-0001-9841-6386; Lescai, Francesco/0000-0002-6399-9101				Bass MP, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P93; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; BUTCHER LM, 2008, BEHAV GENET; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Curtis D, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-30; DEBENEDICTIS G, 2006, SCI AGING KNOWLEDGE, pPE20, DOI DOI 10.1126/SAGEKE.2006.10.PE20; Dong CZ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001262; Dudek Scott M, 2006, Pac Symp Biocomput, P499, DOI 10.1142/9789812701626_0046; EDWARDS TL, 2007, 2007 ANN M AM SOC HU; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; Florez JC, 2007, DIABETES, V56, P3063, DOI 10.2337/db07-0451; Guthery SL, 2007, AM J HUM GENET, V81, P1221, DOI 10.1086/522239; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ionita-Laza I, 2007, AM J HUM GENET, V81, P607, DOI 10.1086/519748; Kayser M, 2008, AM J HUM GENET, V82, P411, DOI 10.1016/j.ajhg.2007.10.003; Kingsmore SF, 2008, NAT REV DRUG DISCOV, V7, P221, DOI 10.1038/nrd2519; Kooperberg C, 2001, GENET EPIDEMIOL, V21, pS626, DOI 10.1002/gepi.2001.21.s1.s626; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; LI C, 2008, GENET EPIDEMIOL; LI M, 2008, EUR J HUM GENET; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Macgregor S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1060; Moore JH, 2007, HUM HERED, V63, P120, DOI 10.1159/000099184; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2004, APPL SOFT COMPUT, V4, P79, DOI 10.1016/j.asoc.2003.08.003; Motsinger-Reif Alison A, 2008, BMC Res Notes, V1, P65, DOI 10.1186/1756-0500-1-65; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; Rao DC, 2008, ADV GENET, V60, P3, DOI 10.1016/S0065-2660(07)00401-4; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Schmidt M, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1133; Schwender H, 2008, BIOSTATISTICS, V9, P187, DOI 10.1093/biostatistics/kxm024; Singh SM, 2004, CLIN GENET, V65, P435, DOI 10.1111/j.1399-0004.2004.00269.x; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wider C, 2008, NEUROLOGY, V70, P1377, DOI 10.1212/01.wnl.0000275527.35752.c5; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wongseree W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-294; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Zeggini E, 2008, NAT GENET; Zubenko GS, 2001, MOL PSYCHIATR, V6, P413, DOI 10.1038/sj.mp.4000900	57	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11876	10.1371/journal.pone.0011876	http://dx.doi.org/10.1371/journal.pone.0011876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686705	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520200038
J	Li, P; Harris, D; Liu, ZM; Liu, J; Keating, M; Estrov, Z				Li, Ping; Harris, David; Liu, Zhiming; Liu, Jie; Keating, Michael; Estrov, Zeev			Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells	PLOS ONE			English	Article							BRACHYDACTYLY TYPE-B; NF-KAPPA-B; RECESSIVE ROBINOW-SYNDROME; MULTIPLE-MYELOMA CELLS; WNT SIGNALING PATHWAY; EMBRYONIC STEM-CELLS; DNA-BINDING; CONSTITUTIVE ACTIVATION; THERAPEUTIC TARGET; RNAI SCREEN	Background: The receptor tyrosine kinase like orphan receptor (ROR)-1 gene is overexpressed in chronic lymphocytic leukemia (CLL). Because Stat3 is constitutively activated in CLL and sequence analysis revealed that the ROR1 promoter harbors gamma-interferon activation sequence-like elements typically activated by Stat3, we hypothesized that Stat3 activates ROR1. Methodology/Principal Findings: Because IL-6 induced Stat3 phosphorylation and upregulated Ror1 protein levels in MM1 cells, we used these cells as a model. We transfected MM1 cells with truncated ROR1 promoter luciferase reporter constructs and found that IL-6 induced luciferase activity of ROR1-195 and upstream constructs. Co-transfection with Stat3 siRNA reduced the IL-6-induced luciferase activity, suggesting that IL-6 induced luciferase activity by activating Stat3. EMSA and the ChIP assay confirmed that Stat3 binds ROR1, and EMSA studies identified two Stat3 binding sites. In CLL cells, EMSA and ChIP studies determined that phosphorylated Stat3 bound to the ROR1 promoter at those two ROR1 promoter sites, and ChIP analysis showed that Stat3 co-immunoprecipitated DNA of STAT3, ROR1, and several Stat3-regulated genes. Finally, like STAT3-siRNA in MM1 cells, STAT3-shRNA downregulated STAT3, ROR1, and STAT3-regulated genes and Stat3 and Ror1 protein levels in CLL cells. Conclusion/Significance: Our data suggest that constitutively activated Stat3 binds to the ROR1 promoter and activates ROR1 in CLL cells.	[Li, Ping; Harris, David; Liu, Zhiming; Liu, Jie; Keating, Michael; Estrov, Zeev] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Li, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	zestrov@mdanderson.org			CLL Global Foundation	CLL Global Foundation	Funding for the project was received from the CLL Global Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Amit-Vazina M, 2005, BRIT J CANCER, V93, P70, DOI 10.1038/sj.bjc.6602637; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Bueso-Ramos Carlos E, 2004, Hematology, V9, P279, DOI 10.1080/10245330410001727046; Chatterjee M, 2002, BLOOD, V100, P3311, DOI 10.1182/blood-2002-01-0102; Chim CS, 2008, J CLIN PATHOL, V61, P1214, DOI 10.1136/jcp.2008.060152; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Ermakov S, 2007, OSTEOPOROSIS INT, V18, P1683, DOI 10.1007/s00198-007-0401-5; Ferrajoli A, 2007, CANCER RES, V67, P11291, DOI 10.1158/0008-5472.CAN-07-0593; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; Fujio Y, 2004, FEBS LETT, V573, P202, DOI 10.1016/j.febslet.2004.07.082; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Jin GY, 2009, BIOORG MED CHEM LETT, V19, P606, DOI 10.1016/j.bmcl.2008.12.067; Katoh M, 2007, INT J MOL MED, V19, P699; Katoh M, 2007, INT J MOL MED, V19, P273; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kim WB, 2007, J ENDOCRINOL, V193, P93, DOI 10.1677/JOE-06-0025; Liu TH, 2006, CANCER RES, V66, P653, DOI 10.1158/0008-5472.CAN-05-3712; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; McCall KD, 2007, ENDOCRINOLOGY, V148, P4226, DOI 10.1210/en.2007-0459; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI23409; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polakis P, 2000, GENE DEV, V14, P1837; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Shabani M, 2008, LEUKEMIA LYMPHOMA, V49, P1360, DOI 10.1080/10428190802124000; Sharma S, 2009, BLOOD, V114, P4179, DOI 10.1182/blood-2009-03-206482; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; WeberNordt RM, 1996, BLOOD, V88, P809; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yee KWL, 2006, MAYO CLIN PROC, V81, P1105, DOI 10.4065/81.8.1105; Yu CL, 1997, J IMMUNOL, V159, P5206; Zhang Q, 1996, P NATL ACAD SCI USA, V93, P9148, DOI 10.1073/pnas.93.17.9148; Zhang Q, 2002, J IMMUNOL, V168, P466, DOI 10.4049/jimmunol.168.1.466	50	47	50	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11859	10.1371/journal.pone.0011859	http://dx.doi.org/10.1371/journal.pone.0011859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686606	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520200023
J	Manthey, GM; Bailis, AM				Manthey, Glenn M.; Bailis, Adam M.			Rad51 Inhibits Translocation Formation by Non-Conservative Homologous Recombination in Saccharomyces cerevisiae	PLOS ONE			English	Article							DOUBLE-STRAND-BREAK; REPLICATION PROTEIN-A; DIRECT REPEAT RECOMBINATION; HUMAN GENOME ARCHITECTURE; NONHOMOLOGOUS DNA ENDS; COPY NUMBER VARIATION; CHROMOSOMAL TRANSLOCATIONS; PRESYNAPTIC FILAMENT; GENE CONVERSION; REPAIR GENE	Chromosomal translocations are a primary biological response to ionizing radiation (IR) exposure, and are likely to result from the inappropriate repair of the DNA double-strand breaks (DSBs) that are created. An abundance of repetitive sequences in eukaryotic genomes provides ample opportunity for such breaks to be repaired by homologous recombination (HR) between non-allelic repeats. Interestingly, in the budding yeast, Saccharomyces cerevisiae the central strand exchange protein, Rad51 that is required for DSB repair by gene conversion between unlinked repeats that conserves genomic structure also suppresses translocation formation by several HR mechanisms. In particular, Rad51 suppresses translocation formation by single-strand annealing (SSA), perhaps the most efficient mechanism for translocation formation by HR in both yeast and mammalian cells. Further, the enhanced translocation formation that emerges in the absence of Rad51 displays a distinct pattern of genetic control, suggesting that this occurs by a separate mechanism. Since hypomorphic mutations in RAD51 in mammalian cells also reduce DSB repair by conservative gene conversion and stimulate non-conservative repair by SSA, this mechanism may also operate in humans and, perhaps contribute to the genome instability that propels the development of cancer.	[Manthey, Glenn M.; Bailis, Adam M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Manthey, GM (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA.	abailis@coh.org		Bailis, Adam/0000-0001-5628-0468	National Institutes of Health [GM057484]; Department of Defense/Department of the Interior [1435-04-06-GT-63257]; Beckman Research Institute of the City of Hope; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense/Department of the Interior(United States Department of Defense); Beckman Research Institute of the City of Hope; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Institutes of Health (GM057484 to AMB), the Department of Defense/Department of the Interior (1435-04-06-GT-63257 to GMM), and the Beckman Research Institute of the City of Hope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADZUMA K, 1984, MOL CELL BIOL, V4, P2735, DOI 10.1128/MCB.4.12.2735; Aguilera A, 2001, TRENDS GENET, V17, P318, DOI 10.1016/S0168-9525(01)02309-5; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Asleson EN, 1999, GENETICS, V153, P681; Ayoub Nabieh, 2009, Curr Biol, V19, P1075, DOI 10.1016/j.cub.2009.05.057; BAILIS AM, 1995, MOL CELL BIOL, V15, P3998; BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; BEZZUBOVA O, 1993, NUCLEIC ACIDS RES, V21, P1577, DOI 10.1093/nar/21.7.1577; BEZZUBOVA OY, 1993, NUCLEIC ACIDS RES, V21, P5945, DOI 10.1093/nar/21.25.5945; BLANCK S, 2009, NUCL ACIDS RES; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Carvalho CMB, 2008, GENOME RES, V18, P1724, DOI 10.1101/gr.080697.108; CHENG R, 1993, MUTAT RES, V294, P223, DOI 10.1016/0921-8777(93)90005-2; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Colaiacovo MP, 1999, GENETICS, V151, P1409; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Davis AP, 2001, GENETICS, V159, P515; Fasullo M, 2005, MUTAT RES-FUND MOL M, V578, P158, DOI 10.1016/j.mrfmmm.2005.05.003; FASULLO M, 1994, MUTAT RES, V314, P121, DOI 10.1016/0921-8777(94)90076-0; FASULLO MT, 1988, MOL CELL BIOL, V8, P4370, DOI 10.1128/MCB.8.10.4370; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; GENBAUFFE FS, 1984, J BIOL CHEM, V259, P518; GOLDBERG RB, 1978, BIOCHEM GENET, V16, P45, DOI 10.1007/BF00484384; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; HERSHFIELD B, 1990, CHROMOSOMA, V99, P125, DOI 10.1007/BF01735328; HO KSY, 1975, MUTAT RES, V30, P327, DOI 10.1016/0165-1218(75)90058-0; Iadonato S P, 1996, Methods Mol Biol, V54, P75; Ivanov EL, 1996, GENETICS, V142, P693; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; KNIGHT W, 2006, 95 CONFIDENCE INTERV; Kojic M, 2008, MOL MICROBIOL, V67, P1156, DOI 10.1111/j.1365-2958.2008.06116.x; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Larminat F, 2002, ONCOGENE, V21, P5188, DOI 10.1038/sj.onc.1205659; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LIN FLM, 1990, MOL CELL BIOL, V10, P113, DOI 10.1128/MCB.10.1.113; Luria SE, 1943, GENETICS, V28, P491; Lyndaker AM, 2008, GENETICS, V179, P1807, DOI 10.1534/genetics.108.090654; Lyndaker AM, 2009, BIOESSAYS, V31, P315, DOI 10.1002/bies.200800195; MAESHIMA K, 1995, GENE, V160, P195, DOI 10.1016/0378-1119(95)00148-Y; MANIATIS TE, 1989, MOL CLONING LAB MANU, P2; Manthey GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007488; MARYON E, 1991, MOL CELL BIOL, V11, P3278, DOI 10.1128/MCB.11.6.3278; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; MCDONALD JP, 1994, GENETICS, V137, P393; Meyer DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003318; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; MOORE CW, 1978, MUTAT RES, V58, P41, DOI 10.1016/0165-1218(78)90094-0; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; MURIS DFR, 1994, MUTAT RES-DNA REPAIR, V315, P295, DOI 10.1016/0921-8777(94)90040-X; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Osakabe K, 2002, PLANT MOL BIOL, V50, P71, DOI 10.1023/A:1016047231597; Pannunzio NR, 2008, DNA REPAIR, V7, P788, DOI 10.1016/j.dnarep.2008.02.003; Pannunzio NR, 2010, CURR GENET, V56, P87, DOI 10.1007/s00294-009-0282-6; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Petalcorin MIR, 2006, J MOL BIOL, V361, P231, DOI 10.1016/j.jmb.2006.06.020; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; PRADO F, 1995, GENETICS, V139, P109; Prado FL, 2003, CURR GENET, V42, P185, DOI 10.1007/s00294-002-0346-3; Preston CR, 2002, GENETICS, V161, P711; Resnick M A, 1975, Basic Life Sci, V5B, P549; RESNICK MA, 1976, MOL GEN GENET, V143, P119, DOI 10.1007/BF00266917; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; RONG L, 1993, J BIOL CHEM, V268, P1252; RONNE H, 1988, P NATL ACAD SCI USA, V85, P2696, DOI 10.1073/pnas.85.8.2696; SAEKI T, 1980, MUTAT RES, V73, P251, DOI 10.1016/0027-5107(80)90192-X; Sakuraba Y, 2000, MOL GEN GENET, V264, P392, DOI 10.1007/s004380000342; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; SCHIESTL RH, 1989, CARCINOGENESIS, V10, P1445, DOI 10.1093/carcin/10.8.1445; SCHILD D, 1983, CURR GENET, V7, P85, DOI 10.1007/BF00365631; SCHILD D, 1983, CELLULAR RESPONSES D; Schildkraut E, 2005, NUCLEIC ACIDS RES, V33, P1574, DOI 10.1093/nar/gki295; SCHMIDTKE J, 1980, HUM GENET, V55, P1, DOI 10.1007/BF00329120; Seong C, 2009, J BIOL CHEM, V284, P24363, DOI 10.1074/jbc.M109.032953; Seong KY, 1997, MOL CELLS, V7, P284; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; SHEN ZY, 1995, GENOMICS, V25, P199, DOI 10.1016/0888-7543(95)80126-7; Sherman F., 1986, METHODS YEAST GENETI; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; SUGAWARA N, 1995, NATURE, V373, P84, DOI 10.1038/373084a0; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; SUNG P, 1993, J BIOL CHEM, V268, P26391; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; TOMKINSON AE, 1994, BIOCHEMISTRY-US, V33, P5305, DOI 10.1021/bi00183a038; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; Tsukamoto M, 2003, GENETICS, V165, P1703; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wu Y, 2008, J BIOL CHEM, V283, P14883, DOI 10.1074/jbc.M801097200; Wu Y, 2006, J BIOL CHEM, V281, P15441, DOI 10.1074/jbc.M601827200; Wu Y, 2006, J BIOL CHEM, V281, P40001, DOI 10.1074/jbc.M608071200; YOSHIMURA Y, 1993, NUCLEIC ACIDS RES, V21, P1665, DOI 10.1093/nar/21.7.1665; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	120	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11889	10.1371/journal.pone.0011889	http://dx.doi.org/10.1371/journal.pone.0011889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686691	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520200048
J	Curril, IM; Koide, M; Yang, CH; Segal, A; Wellman, GC; Spees, JL				Curril, Ingrid M.; Koide, Masayo; Yang, Calvin H.; Segal, Alan; Wellman, George C.; Spees, Jeffrey L.			Incomplete reprogramming after fusion of human multipotent stromal cells and bronchial epithelial cells	FASEB JOURNAL			English	Article						cell fusion; progenitor cell; CFTR; ENaC	HEMATOPOIETIC STEM-CELLS; MARROW-DERIVED CELLS; PURKINJE NEURONS; SKELETAL-MUSCLE; CHANNEL; HETEROKARYONS; PLASTICITY; REPAIR; FUSE; LUNG	Bone marrow-derived progenitor cells can fuse with cells of several different tissues, including lung, especially following injury. Despite many reports of cell fusion, few studies have examined the function of the resulting hybrid cells. We cocultured human multipotent stromal cells (hMSCs) and normal human bronchial epithelial cells (NHBEs) and observed the formation of hMSC/NHBE heterokaryons. The heterokaryons expressed several proteins characteristic of epithelial cells, such as keratin and occludin. Hybrid cells also expressed the mRNAs and proteins for 2 important ion channels that maintain bronchial and alveolar fluid balance: the cystic fibrosis transmembrane conductance regulator (CFTR) and the amiloride-sensitive epithelial Na+ channel (ENaC). By immunocytochemistry, CFTR was expressed in many hybrid cells but was absent or low in others. Whole-cell patch-clamp recordings demonstrated a glibenclamide-sensitive current in the presence of barium chloride, consistent with functional CFTR channels, in control NHBEs and hMSC/NHBE heterokaryons. Total cell capacitance measurements showed that the membrane surface area of heterokaryons was similar to that of NHBEs. Heterokaryons expressed the alpha- and gamma-ENaC subunits but did not express the beta-ENaC subunit, indicating the inability to form a complete ENaC channel. In addition, hybrid cells formed by the fusion of hMSCs with immortalized bronchial cells that expressed CFTR Delta F508 did not lead to reprogramming of the hMSC nucleus and expression of wild-type CFTR mRNA. Our data show that reprogramming can be incomplete following fusion of adult progenitor cells and somatic cells and may lead to altered cell function.-Curril, I. M., Koide, M., Yang, C. H., Segal, A., Wellman, G. C., Spees, J. L. Incomplete reprogramming after fusion of human multipotent stromal cells and bronchial epithelial cells. FASEB J. 24, 4856-4864 (2010). www.fasebj.org	[Segal, Alan; Spees, Jeffrey L.] Univ Vermont, Dept Med, Colchester, VT 05446 USA; [Curril, Ingrid M.; Spees, Jeffrey L.] Vermont Lung Ctr, Burlington, VT USA; [Curril, Ingrid M.; Spees, Jeffrey L.] Cell & Mol Biol Program, Burlington, VT USA; [Koide, Masayo; Wellman, George C.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Spees, JL (corresponding author), Univ Vermont, Dept Med, 208 S Pk Dr,Ste 2, Colchester, VT 05446 USA.	jeffrey.spees@uvm.edu			U.S. National Institutes of Health/National Heart, Lung, and Blood Institute [R01-HL-085210]; National Center for Research Resources Centers of Biomedical Research Excellence [P20 RR-155557]; Vermont Lung Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085210] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Vermont Lung Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Colette Charland (University of Vermont) for technical assistance with FACS. The authors thank Dr. Darwin Prockop (Texas A&M University Health Science Center, Temple, TX, USA) for providing hMSCs. The CFT1 cell line was created by Dr. James Yankaskas (University of North Carolina, Chapel Hill, NC, USA). The authors thank Dr. Albert Van der Vliet (University of Vermont) for providing and assistance with the CFTR delta F508 cell line and Dr. Alexander Aronshtam (University of Vermont) for help with DNA sequence analysis. This work was supported in part by U.S. National Institutes of Health/National Heart, Lung, and Blood Institute grant R01-HL-085210 (to J.L.S.) and National Center for Research Resources Centers of Biomedical Research Excellence grant P20 RR-155557 (Vermont Lung Center, Charles Irvin, principal investigator). I.C. was supported by the Vermont Lung Center T32 Pulmonary Training Program.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Bae JS, 2005, HUM GENE THER, V16, P1006, DOI 10.1089/hum.2005.16.1006; Caci E, 2009, AM J RESP CELL MOL, V40, P211, DOI 10.1165/rcmb.2007-0456OC; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Doyonnas R, 2004, P NATL ACAD SCI USA, V101, P13507, DOI 10.1073/pnas.0405361101; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Herzog ED, 2007, FASEB J, V21, pA144; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kang CS, 2009, AM J PHYSIOL-HEART C, V296, pH1949, DOI 10.1152/ajpheart.00903.2008; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Melin P, 2007, BBA-BIOMEMBRANES, V1768, P2438, DOI 10.1016/j.bbamem.2007.05.013; MOODY WJ, 1983, P NATL ACAD SCI-BIOL, V80, P3096, DOI 10.1073/pnas.80.10.3096; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Randrianarison N, 2008, AM J PHYSIOL-LUNG C, V294, pL409, DOI 10.1152/ajplung.00307.2007; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Spees JL, 2008, FASEB J, V22, P1226, DOI 10.1096/fj.07-8076com; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wiersema A, 2008, STEM CELL RES, V1, P150, DOI 10.1016/j.scr.2008.02.001; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104	27	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4856	4864		10.1096/fj.09-152991	http://dx.doi.org/10.1096/fj.09-152991			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20724526	Green Published			2022-12-25	WOS:000284824400025
J	Suh, MH; Meyer, PA; Gu, MG; Ye, P; Zhang, MC; Kaplan, CD; Lima, CD; Fu, JH				Suh, Man-Hee; Meyer, Peter A.; Gu, Meigang; Ye, Ping; Zhang, Mincheng; Kaplan, Craig D.; Lima, Christopher D.; Fu, Jianhua			A Dual Interface Determines the Recognition of RNA Polymerase II by RNA Capping Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; C-TERMINAL DOMAIN; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; IN-VIVO; PROCESSING FACTORS; SHUTTLE VECTORS; HEAT-SHOCK; PHOSPHORYLATION	RNA capping enzyme (CE) is recruited specifically to RNA polymerase II (Pol II) transcription sites to facilitate cotrans-criptional 5 '-capping of pre-mRNA and other Pol II transcripts. The current model to explain this specific recruitment of CE to Pol II as opposed to Pol I and Pol III rests on the interaction between CE and the phosphorylated C-terminal domain (CTD) of Pol II largest subunit Rpb1 and more specifically between the CE nucleotidyltransferase domain and the phosphorylated CTD. Through biochemical and diffraction analyses, we demonstrate the existence of a distinctive stoichiometric complex between CE and the phosphorylated Pol II (Pol IIO). Analysis of the complex revealed an additional and unexpected polymerase-CE interface (PCI) located on the multihelical Foot domain of Rpb1. We name this interface PCI1 and the previously known nucleotidyltransferase/phosphorylated CTD interface PCI2. Although PCI1 and PCI2 individually contribute to only weak interactions with CE, a dramatically stabilized and stoichiometric complex is formed when PCI1 and PCI2 are combined in cis as they occur in an intact phosphorylated Pol II molecule. Disrupting either PCI1 or PCI2 by alanine substitution or deletion diminishes CE association with Pol II and causes severe growth defects in vivo. Evidence from manipulating PCI1 indicates that the Foot domain contributes to the specificity in CE interaction with Pol II as opposed to Pol I and Pol III. Our results indicate that the dual interface based on combining PCI1 and PCI2 is required for directing CE to Pol II elongation complexes.	[Suh, Man-Hee; Meyer, Peter A.; Ye, Ping; Zhang, Mincheng; Fu, Jianhua] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Gu, Meigang; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Kaplan, Craig D.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Medical College of Wisconsin; Memorial Sloan Kettering Cancer Center; Texas A&M University System; Texas A&M University College Station	Fu, JH (corresponding author), Med Coll Wisconsin, Dept Biochem, 303 Basic Sci Bldg, Milwaukee, WI 53226 USA.	jfu@mcw.edu	Kaplan, Craig/AAO-4500-2021	Kaplan, Craig/0000-0002-7518-695X; Lima, Christopher/0000-0002-9163-6092	National Institutes of Health [GM064651, GM061906]; Cornell University, Ithaca [NY 14853]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061906, R01GM064651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell University, Ithaca; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM064651 ( to J. F.).; Supported by the National Institutes of Health Grant GM061906.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; Buratowski S, 2005, NATURE, V435, P1174, DOI 10.1038/4351174b; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chen CY, 2009, P NATL ACAD SCI USA, V106, P127, DOI 10.1073/pnas.0811689106; Chiu YL, 2002, MOL CELL, V10, P585, DOI 10.1016/S1097-2765(02)00630-5; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COPPOLA JA, 1983, P NATL ACAD SCI-BIOL, V80, P1251, DOI 10.1073/pnas.80.5.1251; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gu MG, 2010, STRUCTURE, V18, P216, DOI 10.1016/j.str.2009.12.009; Guarino LA, 1998, J VIROL, V72, P10003, DOI 10.1128/JVI.72.12.10003-10010.1998; Guiguen A, 2007, EMBO J, V26, P1552, DOI 10.1038/sj.emboj.7601627; GUNNERY S, 1995, MOL CELL BIOL, V15, P3597; HAGLER J, 1992, SCIENCE, V255, P983, DOI 10.1126/science.1546295; Hausmann S, 2003, J BIOL CHEM, V278, P30487, DOI 10.1074/jbc.M303060200; Ho CK, 1998, J BIOL CHEM, V273, P9577, DOI 10.1074/jbc.273.16.9577; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Hong SW, 2009, P NATL ACAD SCI USA, V106, P14276, DOI 10.1073/pnas.0903642106; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; Kim HJ, 2004, MOL CELL BIOL, V24, P6184, DOI 10.1128/MCB.24.14.6184-6193.2004; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Lo HJ, 1998, MOL CELL BIOL, V18, P665, DOI 10.1128/MCB.18.2.665; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Meyer PA, 2006, STRUCTURE, V14, P973, DOI 10.1016/j.str.2006.04.003; Meyer PA, 2009, J BIOL CHEM, V284, P12933, DOI 10.1074/jbc.M809199200; Moteki S, 2002, MOL CELL, V10, P599, DOI 10.1016/S1097-2765(02)00660-3; Myers LC, 2002, MOL CELL, V10, P883, DOI 10.1016/S1097-2765(02)00644-5; Natalizio BJ, 2009, J BIOL CHEM, V284, P8683, DOI 10.1074/jbc.M806919200; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Pei Y, 2003, J BIOL CHEM, V278, P7180, DOI 10.1074/jbc.M211713200; Pei Y, 2002, J BIOL CHEM, V277, P19639, DOI 10.1074/jbc.M200015200; Pei Y, 2001, J BIOL CHEM, V276, P28075, DOI 10.1074/jbc.M102170200; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Reyes-Reyes M, 2007, MOL CELL BIOL, V27, P926, DOI 10.1128/MCB.01361-06; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider S, 2010, MOL CELL BIOL, V30, P2353, DOI 10.1128/MCB.00116-10; Schwer B, 1996, RNA, V2, P574; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; SIKORSKI RS, 1989, GENETICS, V122, P19; Spahr H, 2009, P NATL ACAD SCI USA, V106, P9185, DOI 10.1073/pnas.0903361106; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Ursic D, 2008, RNA BIOL, V5, P1; WEST ML, 1995, GENETICS, V140, P1223; WOYCHIK NA, 1990, GENE DEV, V4, P313, DOI 10.1101/gad.4.3.313; Yue ZY, 1997, P NATL ACAD SCI USA, V94, P12898, DOI 10.1073/pnas.94.24.12898; Yuryev A, 1996, GENETICS, V143, P661; Zhou MS, 2003, P NATL ACAD SCI USA, V100, P12666, DOI 10.1073/pnas.1835726100	73	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34027	34038		10.1074/jbc.M110.145110	http://dx.doi.org/10.1074/jbc.M110.145110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20720002	hybrid, Green Published			2022-12-25	WOS:000283354000049
J	Allsopp, RC; Lalo, U; Evans, RJ				Allsopp, Rebecca C.; Lalo, Ulyana; Evans, Richard J.			Lipid Raft Association and Cholesterol Sensitivity of P2X1-4 Receptors for ATP CHIMERAS AND POINT MUTANTS IDENTIFY INTRACELLULAR AMINO-TERMINAL RESIDUES INVOLVED IN LIPID REGULATION OF P2X1 RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLYL-CYCLASE; GATED CHANNELS; P2X(7) RECEPTORS; CELLS; DESENSITIZATION; DISRUPTION; CAVEOLAE; DOMAIN; PHOSPHOINOSITIDES; PALMITOYLATION	Cholesterol-rich lipid rafts act as signaling microdomains and can regulate receptor function. We have shown in HEK293 cells recombinant P2X1-4 receptors (ATP-gated ion channels) are expressed in lipid rafts. Localization to flotillin-rich lipid rafts was reduced by the detergent Triton X-100. This sensitivity to Triton X-100 was concentration-and subunit-dependent, demonstrating differential association of P2X1-4 receptors with lipid rafts. The importance of raft association to ATP-evoked P2X receptor responses was determined in patch clamp studies. The cholesterol-depleting agents methyl-beta-cyclodextrin or filipin disrupt lipid rafts and reduced P2X1 receptor currents by > 90%. In contrast, ATP-evoked P2X2-4 receptor currents were unaffected by lipid raft disruption. To determine the molecular basis of cholesterol sensitivity, we generated chimeric receptors replacing portions of the cholesterol-sensitive P2X1 receptor with the corresponding region from the insensitive P2X2 receptor. These chimeras identified the importance of the intracellular amino-terminal region between the conserved protein kinase C site and the first transmembrane segment for the sensitivity to cholesterol depletion. Mutation of any of the variant residues between P2X1 and P2X2 receptors in this region in the P2X1 receptor (residues 20-23 and 27-29) to cysteine removed cholesterol sensitivity. Cholesterol depletion did not change the ATP sensitivity or cell surface expression of P2X1 receptors. This suggests that cholesterol is normally needed to facilitate the opening/gating of ATP-bound P2X1 receptor channels, and mutations in the pre-first transmembrane segment region remove this requirement.	[Allsopp, Rebecca C.; Lalo, Ulyana; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Bernier LP, 2008, MOL PHARMACOL, V74, P785, DOI 10.1124/mol.108.047019; Bernier LP, 2008, J NEUROSCI, V28, P12938, DOI 10.1523/JNEUROSCI.3038-08.2008; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Chaumont S, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162329; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DALZIEL AW, 1980, FEBS LETT, V122, P193, DOI 10.1016/0014-5793(80)80435-2; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Garcia-Marcos M, 2006, J LIPID RES, V47, P705, DOI 10.1194/jlr.M500408-JLR200; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Jacobs C, 2004, FEBS LETT, V565, P70, DOI 10.1016/j.febslet.2004.03.076; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jindrichova M, 2009, J NEUROCHEM, V109, P923, DOI 10.1111/j.1471-4159.2009.06021.x; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Liu Y, 2006, BIOTECHNOL ADV, V24, P1, DOI 10.1016/j.biotechadv.2005.04.002; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ostrom RS, 2002, MOL PHARMACOL, V61, P473, DOI 10.1124/mol.61.3.473; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Paukert M, 2001, J BIOL CHEM, V276, P21077, DOI 10.1074/jbc.M101465200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Ralevic V, 1998, PHARMACOL REV, V50, P413; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Vacca F, 2004, J NEUROSCI RES, V76, P653, DOI 10.1002/jnr.20069; Vacca F, 2009, J NEUROCHEM, V109, P1031, DOI 10.1111/j.1471-4159.2009.06029.x; Vial C, 2006, BIOCHEM BIOPH RES CO, V343, P415, DOI 10.1016/j.bbrc.2006.02.174; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Waheed AA, 2002, J BIOL CHEM, V277, P32409, DOI 10.1074/jbc.C200383200; Wen HR, 2009, J NEUROCHEM, V108, P331, DOI 10.1111/j.1471-4159.2008.05761.x; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200	47	39	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32770	32777		10.1074/jbc.M110.148940	http://dx.doi.org/10.1074/jbc.M110.148940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20699225	Green Published, hybrid			2022-12-25	WOS:000283048200012
J	Barbieri, CM; Mack, TR; Robinson, VL; Miller, MT; Stock, AM				Barbieri, Christopher M.; Mack, Timothy R.; Robinson, Victoria L.; Miller, Matthew T.; Stock, Ann M.			Regulation of Response Regulator Autophosphorylation through Interdomain Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL PHOSPHATE; RECEIVER DOMAIN; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURES; PHOSPHORYLATION; ACTIVATION; DYNAMICS; CHEY	DNA-binding response regulators (RRs) of the OmpR/PhoB subfamily alternate between inactive and active conformational states, with the latter having enhanced DNA-binding affinity. Phosphorylation of an aspartate residue in the receiver domain, usually via phosphotransfer from a cognate histidine kinase, stabilizes the active conformation. Many of the available structures of inactive OmpR/PhoB family proteins exhibit extensive interfaces between the N-terminal receiver and C-terminal DNA-binding domains. These interfaces invariably involve the alpha 4-beta 5-alpha 5 face of the receiver domain, the locus of the largest differences between inactive and active conformations and the surface that mediates dimerization of receiver domains in the active state. Structures of receiver domain dimers of DrrB, DrrD, and MtrA have been determined, and phosphorylation kinetics were analyzed. Analysis of phosphotransfer from small molecule phosphodonors has revealed large differences in autophosphorylation rates among OmpR/PhoB RRs. RRs with substantial domain interfaces exhibit slow rates of phosphorylation. Rates are greatly increased in isolated receiver domain constructs. Such differences are not observed between autophosphorylation rates of full-length and isolated receiver domains of a RR that lacks interdomain interfaces, and they are not observed in histidine kinase-mediated phosphotransfer. These findings suggest that domain interfaces restrict receiver domain conformational dynamics, stabilizing an inactive conformation that is catalytically incompetent for phosphotransfer from small molecule phosphodonors. Inhibition of phosphotransfer by domain interfaces provides an explanation for the observation that some RRs cannot be phosphorylated by small molecule phosphodonors in vitro and provides a potential mechanism for insulating some RRs from small molecule-mediated phosphorylation in vivo.	[Stock, Ann M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Barbieri, Christopher M.; Mack, Timothy R.; Robinson, Victoria L.; Stock, Ann M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Mack, Timothy R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Grad Sch Biomed Sci, Piscataway, NJ 08854 USA; [Barbieri, Christopher M.; Robinson, Victoria L.; Stock, Ann M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Miller, Matthew T.] Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Stock, AM (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.	stock@cabm.rutgers.edu		Barbieri, Christopher/0000-0002-3266-0201; Stock, Ann/0000-0002-0446-8079	National Institutes of Health [R37GM047958]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37GM047958 (to A. M. S.).	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; BACHHAWAT P, 2005, THESIS U MED DENT NE; Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bouche S, 1998, MOL MICROBIOL, V27, P787, DOI 10.1046/j.1365-2958.1998.00725.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckler DR, 2000, ANAL BIOCHEM, V283, P222, DOI 10.1006/abio.2000.4639; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Da Re S, 2002, PROTEIN SCI, V11, P2644, DOI 10.1110/ps.0220402; Da Re SS, 1999, FEBS LETT, V457, P323, DOI 10.1016/S0014-5793(99)01057-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser JS, 2007, MOL MICROBIOL, V65, P319, DOI 10.1111/j.1365-2958.2007.05785.x; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gardino AK, 2003, J MOL BIOL, V331, P245, DOI 10.1016/S0022-2836(03)00733-2; Gardino AK, 2007, METHOD ENZYMOL, V423, P149, DOI 10.1016/S0076-6879(07)23006-X; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Kato H, 2008, BIOSCI BIOTECH BIOCH, V72, P1072, DOI 10.1271/bbb.70816; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; MCCLEARY WR, 1993, J BACTERIOL, V175, P2793, DOI 10.1128/JB.175.10.2793-2798.1993; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nohaile M, 1997, J MOL BIOL, V273, P299, DOI 10.1006/jmbi.1997.1296; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Schuster M, 2001, P NATL ACAD SCI USA, V98, P6003, DOI 10.1073/pnas.101571298; Simonovic M, 2001, J BIOL CHEM, V276, P28637, DOI 10.1074/jbc.C100295200; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Wemmer DE, 2005, J BACTERIOL, V187, P8229, DOI 10.1128/JB.187.24.8229-8230.2005; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Zhao HY, 2009, ACTA CRYSTALLOGR F, V65, P719, DOI 10.1107/S1744309109022696	62	45	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32325	32335		10.1074/jbc.M110.157164	http://dx.doi.org/10.1074/jbc.M110.157164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702407	Green Published, hybrid			2022-12-25	WOS:000282683000045
J	Gong, QM; Stump, MR; Dunn, AR; Deng, V; Zhou, ZF				Gong, Qiuming; Stump, Matthew R.; Dunn, A. Russell; Deng, Vivianne; Zhou, Zhengfeng			Alternative Splicing and Polyadenylation Contribute to the Generation of hERG1 C-terminal Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA POLYADENYLATION; LONG-QT SYNDROME; K+ CHANNEL; I-KR; CARDIAC-ARRHYTHMIA; POTASSIUM CHANNEL; TUMOR-CELLS; GENES; EXPRESSION; SITE	The human ether-a-go-go-related gene 1 (hERG1) encodes the pore-forming subunit of the rapidly activating delayed rectifier potassium channel. Several hERG1 isoforms with different N- and C-terminal ends have been identified. The hERG1a, hERG1b, and hERG1-3.1 isoforms contain the full-length C terminus, whereas the hERG1(USO) isoforms, hERG1a(USO) and hERG1b(USO), lack most of the C-terminal domain and contain a unique C-terminal end. The mechanisms underlying the generation of hERG1(USO) isoforms are not understood. We show that hERG1 isoforms with different C-terminal ends are generated by alternative splicing and polyadenylation of hERG1 pre-mRNA. We identified an intrinsically weak, noncanonical poly(A) signal, AGUAAA, within intron 9 of hERG1 that modulates the expression of hERG1a and hERG1a(USO). Replacing AGUAAA with the strong, canonical poly(A) signal AAUAAA resulted in the predominant production of hERG1a(USO) and a marked decrease in hERG1 current. In contrast, eliminating the intron 9 poly(A) signal or increasing the strength of 5' splice site led to the predominant production of hERG1a and a significant increase inhERG1 current. We found significant variation in the relative abundance of hERG1 C-terminal isoforms in different human tissues. Taken together, these findings suggest that post-transcriptional regulation of hERG1 pre-mRNA may represent a novel mechanism to modulate the expression and function of hERG1 channels.	[Gong, Qiuming; Stump, Matthew R.; Dunn, A. Russell; Deng, Vivianne; Zhou, Zhengfeng] Oregon Hlth & Sci Univ, Dept Med, Div Cardiovasc Med, Portland, OR 97239 USA	Oregon Health & Science University	Zhou, ZF (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhouzh@ohsu.edu			National Institutes of Health [HL-68854]; Collins Trust; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collins Trust; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-68854 (to Z. Z.) and a Collins Trust Medical grant.; Supported by an American Heart Association postdoctoral fellowship.	Aydar E, 2006, J MEMBRANE BIOL, V211, P115, DOI 10.1007/s00232-006-0010-9; Brackenridge S, 1997, NUCLEIC ACIDS RES, V25, P2326, DOI 10.1093/nar/25.12.2326; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Gong QM, 2008, J MOL CELL CARDIOL, V44, P502, DOI 10.1016/j.yjmcc.2008.01.002; Gong QM, 2007, CIRCULATION, V116, P17, DOI 10.1161/CIRCULATIONAHA.107.708818; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Larsen AP, 2010, PFLUG ARCH EUR J PHY, V460, P803, DOI 10.1007/s00424-010-0855-8; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; LeesMiller JP, 1997, CIRC RES, V81, P719; London B, 1997, CIRC RES, V81, P870; Luo XB, 2008, AM J PHYSIOL-HEART C, V294, pH1371, DOI 10.1152/ajpheart.01026.2007; Pan ZH, 2006, GENE, V366, P325, DOI 10.1016/j.gene.2005.09.024; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; Salles FJ, 1999, METH MOL B, V118, P441; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Thomas CP, 2007, FASEB J, V21, P3885, DOI 10.1096/fj.07-8809com; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Trudeau MC, 1996, SCIENCE, V272, P1087; Tseng GN, 2001, J MOL CELL CARDIOL, V33, P835, DOI 10.1006/jmcc.2000.1317; van der Putten HHAGM, 2006, J THROMB HAEMOST, V4, P2285, DOI 10.1111/j.1538-7836.2006.02102.x; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	36	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32233	32241		10.1074/jbc.M109.095695	http://dx.doi.org/10.1074/jbc.M109.095695			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693282	Green Published, hybrid			2022-12-25	WOS:000282683000036
J	Hummelen, R; Fernandes, AD; Macklaim, JM; Dickson, RJ; Changalucha, J; Gloor, GB; Reid, G				Hummelen, Ruben; Fernandes, Andrew D.; Macklaim, Jean M.; Dickson, Russell J.; Changalucha, John; Gloor, Gregory B.; Reid, Gregor			Deep Sequencing of the Vaginal Microbiota of Women with HIV	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; IDENTIFICATION; ASSOCIATION; GENERATION; DIVERSITY	Background: Women living with HIV and co-infected with bacterial vaginosis (BV) are at higher risk for transmitting HIV to a partner or newborn. It is poorly understood which bacterial communities constitute BV or the normal vaginal microbiota among this population and how the microbiota associated with BV responds to antibiotic treatment. Methods and Findings: The vaginal microbiota of 132 HIV positive Tanzanian women, including 39 who received metronidazole treatment for BV, were profiled using Illumina to sequence the V6 region of the 16S rRNA gene. Of note, Gardnerella vaginalis and Lactobacillus iners were detected in each sample constituting core members of the vaginal microbiota. Eight major clusters were detected with relatively uniform microbiota compositions. Two clusters dominated by L. iners or L. crispatus were strongly associated with a normal microbiota. The L. crispatus dominated microbiota were associated with low pH, but when L. crispatus was not present, a large fraction of L. iners was required to predict a low pH. Four clusters were strongly associated with BV, and were dominated by Prevotella bivia, Lachnospiraceae, or a mixture of different species. Metronidazole treatment reduced the microbial diversity and perturbed the BV-associated microbiota, but rarely resulted in the establishment of a lactobacilli-dominated microbiota. Conclusions: Illumina based microbial profiling enabled high though-put analyses of microbial samples at a high phylogenetic resolution. The vaginal microbiota among women living with HIV in Sub-Saharan Africa constitutes several profiles associated with a normal microbiota or BV. Recurrence of BV frequently constitutes a different BV-associated profile than before antibiotic treatment.	[Hummelen, Ruben; Macklaim, Jean M.; Reid, Gregor] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada; [Hummelen, Ruben] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Fernandes, Andrew D.] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada; [Fernandes, Andrew D.; Macklaim, Jean M.; Dickson, Russell J.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Changalucha, John] Natl Inst Med Res, Mwanza Res Ctr, Mwanza, Tanzania; [Reid, Gregor] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Reid, Gregor] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Erasmus University Rotterdam; Erasmus MC; Western University (University of Western Ontario); Western University (University of Western Ontario); National Institute of Medical Research; Western University (University of Western Ontario); Western University (University of Western Ontario)	Hummelen, R (corresponding author), Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada.	gregor@uwo.ca	Gloor, Greg B/D-1671-2013; Reid, Gregor/ABE-8327-2020; Hummelen, Ruben/ABG-5746-2021	Reid, Gregor/0000-0001-9658-5696; Gloor, Gregory/0000-0001-5803-3380	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Partial funding of this project from the Natural Sciences and Engineering Research Council of Canada (NSERC) is acknowledged. AF is supported by an NSERC post-doctoral fellowship and RD is supported by an NSERC CGS-D scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; [Anonymous], TEACHING STAT; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Artinez RCRM, 2008, APPL ENVIRON MICROB, V74, P4539, DOI 10.1128/AEM.00284-08; Baisley K, 2009, SEX TRANSM INFECT, V85, P370, DOI 10.1136/sti.2008.035543; CHAO A, 1984, SCAND J STAT, V11, P265; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cu-Uvin S, 2001, CLIN INFECT DIS, V33, P894, DOI 10.1086/322613; David H. A., 2003, ORDER STAT, P458; EDGAR RC, UCLUST VERSION 2 0; Farquhar C, 2010, AIDS, V24, P153, DOI 10.1097/QAD.0b013e32832326d8; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Hillier SL, 2005, NEW ENGL J MED, V353, P1886, DOI 10.1056/NEJMp058191; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; JOUSIMIESSOMER H, 1997, CLIN INFECT DIS   S2, V25, P78; Kass R.E., 1989, STAT SCI, V4, P188, DOI [10.1214/ss/1177012480, DOI 10.1214/SS/1177012480]; Krebs Charles J, 1989, ECOLOGICAL METHODOLO; Kretschmann E, 2001, BIOINFORMATICS, V17, P920, DOI 10.1093/bioinformatics/17.10.920; Kullback S., 1959, INFORM THEORY STAT, P395; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Msuya Sia E, 2009, Reprod Health, V6, P4, DOI 10.1186/1742-4755-6-4; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; Noether G.E., 1981, TEACH STAT, V3, P41, DOI [10.1111/j.1467-9639.1981.tb00422.x, DOI 10.1111/J.1467-9639.1981.TB00422.X]; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; OCONNOR TJ, 1995, INT J STD AIDS, V6, P267, DOI 10.1177/095646249500600409; OKSANEN J, 2010, L P O B VEGAN COMMUN; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; RAVEL J, 2010, P NAT ACAD SCI U JUN, P1; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Srinivasan S., 2008, INTERDISCIP PERSPECT, V2008; Taha Taha E, 2007, PLoS Clin Trials, V2, pe10, DOI 10.1371/journal.pctr.0020010; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Wang CC, 2001, J INFECT DIS, V183, P1017, DOI 10.1086/319287; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	36	179	190	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12078	10.1371/journal.pone.0012078	http://dx.doi.org/10.1371/journal.pone.0012078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711427	Green Submitted, Green Published, gold			2022-12-25	WOS:000280859700003
J	Chow, J; Klein, EY; Laxminarayan, R				Chow, Jeffrey; Klein, Eili Y.; Laxminarayan, Ramanan			Cost-Effectiveness of "Golden Mustard" for Treating Vitamin A Deficiency in India	PLOS ONE			English	Article							MORTALITY; RICE; HEALTH; TRIAL; SUPPLEMENTATION; INTERVENTIONS; CHILDREN; IMPACT	Background: Vitamin A deficiency (VAD) is an important nutritional problem in India, resulting in an increased risk of severe morbidity and mortality. Periodic, high-dose vitamin A supplementation is the WHO-recommended method to prevent VAD, since a single dose can compensate for reduced dietary intake or increased need over a period of several months. However, in India only 34 percent of targeted children currently receive the two doses per year, and new strategies are urgently needed. Methodology: Recent advancements in biotechnology permit alternative strategies for increasing the vitamin A content of common foods. Mustard (Brassica juncea), which is consumed widely in the form of oil by VAD populations, can be genetically modified to express high levels of beta-carotene, a precursor to vitamin A. Using estimates for consumption, we compare predicted costs and benefits of genetically modified (GM) fortification of mustard seed with high-dose vitamin A supplementation and industrial fortification of mustard oil during processing to alleviate VAD by calculating the avertable health burden in terms of disability-adjusted life years (DALY). Principal Findings: We found that all three interventions potentially avert significant numbers of DALYs and deaths. Expanding vitamin A supplementation to all areas was the least costly intervention, at $23-$50 per DALY averted and $1,000-$6,100 per death averted, though cost-effectiveness varied with prevailing health subcenter coverage. GM fortification could avert 5 million-6 million more DALYs and 8,000-46,000 more deaths, mainly because it would benefit the entire population and not just children. However, the costs associated with GM fortification were nearly five times those of supplementation. Industrial fortification was dominated by both GM fortification and supplementation. The cost-effectiveness ratio of each intervention decreased with the prevalence of VAD and was sensitive to the efficacy rate of averted mortality. Conclusions: Although supplementation is the least costly intervention, our findings also indicate that GM fortification could reduce the VAD disease burden to a substantially greater degree because of its wider reach. Given the difficulties in expanding supplementation to areas without health subcenters, GM fortification of mustard seed is an attractive alternative, and further exploration of this technology is warranted.	[Chow, Jeffrey] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Klein, Eili Y.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Klein, Eili Y.; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA	Yale University; Princeton University; Princeton University	Chow, J (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	Ramanan@rff.org	Laxminarayan, Ramanan/ABD-5050-2021; Klein, Eili/C-3745-2012	Chow, Jeffrey/0000-0002-3351-7730; Klein, Eili/0000-0002-1304-5289	International Center for Tropical Agriculture (CIAT), Colombia	International Center for Tropical Agriculture (CIAT), Colombia	The report was produced under a grant from the International Center for Tropical Agriculture (CIAT), Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2004, Indian Pediatr, V41, P377; ARROYAVE G, 1981, AM J CLIN NUTR, V34, P41, DOI 10.1093/ajcn/34.1.41; Awasthi S, 2007, 6 MONTHLY VITAMIN A; Barwale R. B., 2004, AgBioForum, V7, P23; BEATON G, 1994, FOOD NUTR B, V15; Bhushan Chandra, 2006, FRONTLINE, V23; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Chakravarty I, 2000, J Indian Med Assoc, V98, P539; *CHAND NAT INF CEN, 2007, CHAND FIG EC IND 200; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; Christian P, 2002, J NUTR, V132, p2884S, DOI 10.1093/jn/132.9.2884S; COHEN N, 1987, AM J CLIN NUTR, V45, P970, DOI 10.1093/ajcn/45.5.970; DARY O, 1997, C 16 INT C NUTR S RE; DAULAIRE NMP, 1992, BMJ-BRIT MED J, V304, P207, DOI 10.1136/bmj.304.6821.207; Dawe D, 2002, FOOD POLICY, V27, P541, DOI 10.1016/S0306-9192(02)00065-9; Egana Nilva E., 2003, Journal of Nutritional & Environmental Medicine (Abingdon), V13, P169, DOI 10.1080/13590840310001619414; Fiedler JL, 2000, SOC SCI MED, V51, P223, DOI 10.1016/S0277-9536(99)00449-9; GEORGE C, 2005, COMMUNICATION   1202; HERRERA MG, 1992, LANCET, V340, P267, DOI 10.1016/0140-6736(92)92357-L; HOUSTON R, 2003, WHY THEY WORK ANAL 3; IIPS & ORC Macro, 2000, NATL FAMILY HLTH SUR; *IND COUNC MED RES, 2004, REC NAT WORKSH MICR; Kapil U, 2001, Indian Pediatr, V38, P37; Katz J, 2000, AM J CLIN NUTR, V71, P1570; LAKSHMAN A, 2006, COMMUNICATION   O630; MANORAMA R, 1991, FOOD CHEM, V42, P253, DOI 10.1016/0308-8146(91)90068-Y; Martines J, 1998, LANCET, V352, P1257, DOI 10.1016/S0140-6736(98)02487-8; Mason John, 2005, Food and Nutrition Bulletin, V26, P59; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Meenakshi JV, 2007, 2 HARVESTPLUS; *MI, 2006, IND MICR NAT INV PLA; *MICH STAT U, 2003, AGR BIOT SUPP PROJ; *MICR IN, 2005, CONTR VIT MIN DEF IN; Mora J.O., 2000, VITAMIN A SUGAR FORT; *NAT RES COUNC, 2004, BIOL CONF GEN ENG OR; National Nutrition Monitoring Bureau (NNMB), 2003, 22 NNMB; *NICH PIR IND LTD, 2006, HUM NUTR HLTH FORT; *NICH PIR IND LTD, 2006, PAMPHL NICORICH OIL; *NIN, 2001, ANN REP NIN HYD; *NNMB, 1999, REP 2 REP SURV RUR; NNMB, 2002, DIET NUTR STAT RUR P; *NRHM, ANN REP 2005 2006 GO; *NSS, 2001, NSS 55 ROUND; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Phillips M, 1996, SOC SCI MED, V42, P1661, DOI 10.1016/0277-9536(95)00317-7; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; RAO B. R. H., 1961, INDIAN JOUR PEDIATRICS, V28, P39, DOI 10.1007/BF02751166; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; SOLON F, 1979, AM J CLIN NUTR, V32, P1445, DOI 10.1093/ajcn/32.7.1445; Sommer A., 1996, VITAMIN A DEFICIENCY, P19; Stein AJ, 2008, WORLD DEV, V36, P144, DOI 10.1016/j.worlddev.2007.02.013; Stein AJ, 2006, NAT BIOTECHNOL, V24, P1200, DOI 10.1038/nbt1006-1200b; Swami H. M., 2002, Indian Journal of Pediatrics, V69, P675, DOI 10.1007/BF02722703; SWAMINATHAN MC, 1970, AM J CLIN NUTR, V23, P119; *TERI, 2006, VIT A SOC REV; Toteja G, 2001, MICRONUTRIENT DEFI 1; Toteja GS, 2004, MICRONUTRIENT PROFIL; VIJAYARAGHAVAN K, 1990, LANCET, V336, P1342, DOI 10.1016/0140-6736(90)92895-O; VIJAYARAGHAVAN K, 2006, MICRONUTRIENT POLICI; West K. P. Jr., 2001, Nutrition and health in developing countries, P267; WEST KP, 1995, AM J CLIN NUTR, V62, P143, DOI 10.1093/ajcn/62.1.143; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; World Bank, 1993, WORLD DEV REP INV HL; Zimmermann R, 2004, FOOD POLICY, V29, P147, DOI 10.1016/j.foodpol.2004.03.001	66	20	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12046	10.1371/journal.pone.0012046	http://dx.doi.org/10.1371/journal.pone.0012046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637IW	20706590	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900010
J	Hegele, M; Heuer, H				Hegele, Mathias; Heuer, Herbert			The Impact of Augmented Information on Visuo-Motor Adaptation in Younger and Older Adults	PLOS ONE			English	Article							SENSORIMOTOR ADAPTATION; PRISM ADAPTATION; EXPOSURE; MECHANISMS; CONCURRENT; COMPONENTS; STRATEGY; ERROR; LOCUS; TASK	Background: Adjustment to a visuo-motor rotation is known to be affected by ageing. According to previous studies, the age-related differences primarily pertain to the use of strategic corrections and the generation of explicit knowledge on which strategic corrections are based, whereas the acquisition of an (implicit) internal model of the novel visuo-motor transformation is unaffected. The present study aimed to assess the impact of augmented information on the age-related variation of visuo-motor adjustments. Methodology/ Principal Findings: Participants performed aiming movements controlling a cursor on a computer screen. Visual feedback of direction of cursor motion was rotated 75u relative to the direction of hand motion. Participants had to adjust to this rotation in the presence and absence of an additional hand-movement target that explicitly depicted the input-output relations of the visuo-motor transformation. An extensive set of tests was employed in order to disentangle the contributions of different processes to visuo-motor adjustment. Results show that the augmented information failed to affect the age-related variations of explicit knowledge, adaptive shifts, and aftereffects in a substantial way, whereas it clearly affected initial direction errors during practice and proprioceptive realignment. Conclusions: Contrary to expectations, older participants apparently made no use of the augmented information, whereas younger participants used the additional movement target to reduce initial direction errors early during practice. However, after a first block of trials errors increased, indicating a neglect of the augmented information, and only slowly declined thereafter. A hypothetical dual-task account of these findings is discussed. The use of the augmented information also led to a selective impairment of proprioceptive realignment in the younger group. The mere finding of proprioceptive realignment in adaptation to a visuo-motor rotation in a computer-controlled setup is noteworthy since visual and proprioceptive information pertain to different objects.	[Hegele, Mathias; Heuer, Herbert] IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Hegele, M (corresponding author), Univ Giessen, Dept Psychol & Sport Sci, Giessen, Germany.	mathias.hegele@sport.uni-giessen.de	Hegele, Mathias/D-1728-2014	Hegele, Mathias/0000-0002-1707-5506; Lauwereyns, Jan/0000-0003-0551-2550; Heuer, Herbert/0000-0002-0488-2878	Deutsche Forschungsgmeinschaft [He 1187/15-2]	Deutsche Forschungsgmeinschaft	The research reported in this paper was supported by grant He 1187/15-2 of the Deutsche Forschungsgmeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; Abeele S, 2001, EXP BRAIN RES, V139, P248, DOI 10.1007/s002210100768; Amthauer R., 1953, I S T INTELLIGENZ ST; Bock O, 2006, EXP BRAIN RES, V169, P400, DOI 10.1007/s00221-005-0153-4; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; BOCK O, 1992, BEHAV BRAIN RES, V51, P41, DOI 10.1016/S0166-4328(05)80310-9; Bock O, 1997, BEHAV BRAIN RES, V89, P267, DOI 10.1016/S0166-4328(97)00069-7; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; COHEN MM, 1974, PERCEPT MOTOR SKILL, V38, P1202, DOI 10.2466/pms.1974.38.3c.1202; COHEN MM, 1967, PERCEPT MOTOR SKILL, V24, P1295, DOI 10.2466/pms.1967.24.3c.1295; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; HAY JC, 1966, J EXP PSYCHOL, V71, P150, DOI 10.1037/h0022611; HEGELE M, 2010, CONSCIOUS C IN PRESS; Hegele M, 2010, PSYCHOL RES-PSYCH FO, V74, P21, DOI 10.1007/s00426-008-0221-z; Heuer H, 2007, ERGONOMICS, V50, P979, DOI 10.1080/00140130701240828; HEUER H, 1983, NEURAL NETWORKS, V11, P1317; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; Ishihara S., 2005, ISHIHARAS TESTS COLO; JAKOBSON LS, 1989, EXP BRAIN RES, V78, P575; KELSO JAS, 1975, J EXP PSYCHOL HUMAN, V1, P237, DOI 10.1037/0096-1523.1.3.237; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McNay EC, 1998, LEARN MEMORY, V4, P411, DOI 10.1101/lm.4.5.411; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pennel I, 2002, ERGONOMICS, V45, P1047, DOI 10.1080/00140130210166906; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; REDDING GM, 1988, PERCEPT PSYCHOPHYS, V44, P59, DOI 10.3758/BF03207476; Riby LM, 2004, EUR J COGN PSYCHOL, V16, P863, DOI 10.1080/09541440340000402; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Salthouse TA, 2006, PERSPECT PSYCHOL SCI, V1, P68, DOI 10.1111/j.1745-6916.2006.00005.x; Schoppe K.J, 1974, DIAGNOSTICA, V20, P43; Seidler RD, 2006, BRAIN RES BULL, V70, P337, DOI 10.1016/j.brainresbull.2006.06.008; SUELZENBRUECK S, 2010, OCCUP ERGON IN PRESS; Sulzenbruck S, 2009, CONSCIOUS COGN, V18, P145, DOI 10.1016/j.concog.2008.12.001; Tewes U., 1994, HAMBURG WECHSLER INT; UHLARIK JJ, 1973, J EXP PSYCHOL, V98, P223, DOI 10.1037/h0034364; UHLARIK JJ, 1971, J EXP PSYCHOL, V91, P233, DOI 10.1037/h0031786; Vercruyssen M., 1997, HDB HUMAN FACTORS OL, P55; Welch R. B., 1978, PERCEPTUAL MODIFICAT; Wong T, 2009, J NEUROPHYSIOL, V101, P614, DOI 10.1152/jn.90544.2008	45	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12071	10.1371/journal.pone.0012071	http://dx.doi.org/10.1371/journal.pone.0012071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636XC	20711507	gold, Green Published			2022-12-25	WOS:000280776800019
J	Ma, SG; Liu, AN; Carr, J; Post, W; Kronmal, R				Ma, Shuangge; Liu, Anna; Carr, Jeffrey; Post, Wendy; Kronmal, Richard			Statistical Modeling of Agatston Score in Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; COMPUTED-TOMOGRAPHY; YOUNG-ADULTS; CARDIA	The MESA (Multi-Ethnic Study of Atherosclerosis) is an ongoing study of the prevalence, risk factors, and progression of subclinical cardiovascular disease in a multi-ethnic cohort. It provides a valuable opportunity to examine the development and progression of CAC (coronary artery calcium), which is an important risk factor for the development of coronary heart disease. In MESA, about half of the CAC scores are zero and the rest are continuously distributed. Such data has been referred to as "zero-inflated data'' and may be described using two-part models. Existing two-part model studies have limitations in that they usually consider parametric models only, make the assumption of known forms of the covariate effects, and focus only on the estimation property of the models. In this article, we investigate statistical modeling of CAC in MESA. Building on existing studies, we focus on two-part models. We investigate both parametric and semiparametric, and both proportional and nonproportional models. For various models, we study their estimation as well as prediction properties. We show that, to fully describe the relationship between covariates and CAC development, the semiparametric model with nonproportional covariate effects is needed. In contrast, for the purpose of prediction, the parametric model with proportional covariate effects is sufficient. This study provides a statistical basis for describing the behaviors of CAC and insights into its biological mechanisms.	[Ma, Shuangge] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Liu, Anna] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA; [Carr, Jeffrey] Wake Forest Univ Hlth Sci, Div Radiol Sci, Winston Salem, NC USA; [Post, Wendy] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD USA; [Kronmal, Richard] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Yale University; University of Massachusetts System; University of Massachusetts Amherst; Wake Forest University; Wake Forest University School of Medicine; Johns Hopkins University; University of Washington; University of Washington Seattle	Ma, SG (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.	Shuangge.ma@yale.edu	Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237	National Science Foundation [DMS 0805984]; National Heart, Lung and Blood Institute [N01-HC-95159, N01-HC-95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095169] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R43HL095169] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study has been supported by DMS 0805984 from the National Science Foundation (Ma) and contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung and Blood Institute (Carr, Post, Kronmal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Berk KN, 2002, STAT METHODS MED RES, V11, P303, DOI 10.1191/0962280202sm293ra; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Budoff MJ, 2005, AM HEART J, V149, P695, DOI 10.1016/j.ahj.2004.07.034; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Gardin JM, 2005, AM J CARDIOL, V95, P626, DOI 10.1016/j.amjcard.2004.11.010; Han C, 2006, COMMUN STAT-THEOR M, V35, P99, DOI 10.1080/03610920500438614; Jamjoum Lama S, 2002, Med Sci Monit, V8, pCR775; KRONMAL R, 2005, RECOMMENDATION ANAL; LIU A, 2009, SEMIPARAMETRIC 2 PAR; Mazzone T, 2007, DIABETES, V56, P849, DOI 10.2337/db06-0935; McCullagh P, 1989, GEN LINEAR MODELS; Peyser PA, 2002, CIRCULATION, V106, P304, DOI 10.1161/01.CIR.0000022664.21832.5D; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Silverman B.W., 1986, DENSITY ESTIMATION S; VANDEVAART A, 1998, ASYMPTOTIC STAT; Wahba G., 1990, CBMS NSF REGIONAL C	20	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12036	10.1371/journal.pone.0012036	http://dx.doi.org/10.1371/journal.pone.0012036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711503	Green Published, gold			2022-12-25	WOS:000280776800016
J	Tripathi, SC; Matta, A; Kaur, J; Grigull, J; Chauhan, SS; Thakar, A; Shukla, NK; Duggal, R; DattaGupta, S; Ralhan, R; Siu, KWM				Tripathi, Satyendra Chandra; Matta, Ajay; Kaur, Jatinder; Grigull, Jorg; Chauhan, Shyam Singh; Thakar, Alok; Shukla, Nootan Kumar; Duggal, Ritu; DattaGupta, Siddhartha; Ralhan, Ranju; Siu, K. W. Michael			Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; INVASIVE BREAST-CANCER; PSORIASIN S100A7; ORAL-CANCER; DIFFERENTIAL EXPRESSION; PRECANCEROUS LESIONS; GENE FAMILY; IDENTIFICATION	Background: Tissue proteomic analysis of head and neck squamous cell carcinoma (HNSCC) and normal oral mucosa using iTRAQ (isobaric tag for relative and absolute quantitation) labeling and liquid chromatography-mass spectrometry, led to the identification of a panel of biomarkers including S100A7. In the multi-step process of head and neck tumorigenesis, the presence of dysplastic areas in the epithelium is proposed to be associated with a likely progression to cancer; however there are no established biomarkers to predict their potential of malignant transformation. This study aimed to determine the clinical significance of S100A7 overexpression in HNSCC. Methodology: Immunohistochemical analysis of S100A7 expression in HNSCC (100 cases), oral lesions (166 cases) and 100 histologically normal tissues was carried out and correlated with clinicopathological parameters and disease prognosis over 7 years for HNSCC patients. Overexpression of S100A7 protein was significant in oral lesions (squamous cell hyperplasia/dysplasia) and sustained in HNSCC in comparison with oral normal mucosa (p(trend)<0.001). Significant increase in nuclear S100A7 was observed in HNSCC as compared to dysplastic lesions (p = 0.005) and associated with well differentiated squamous cell carcinoma (p = 0.031). Notably, nuclear accumulation of S100A7 also emerged as an independent predictor of reduced disease free survival (p = 0.006, Hazard ratio (HR = 7.6), 95% CI = 1.3-5.1) in multivariate analysis underscoring its relevance as a poor prognosticator of HNSCC patients. Conclusions: Our study demonstrated nuclear accumulation of S100A7 may serve as predictor of poor prognosis in HNSCC patients. Further, increased nuclear accumulation of S100A7 in HNSCC as compared to dysplastic lesions warrants a large-scale longitudinal study of patients with dysplasia to evaluate its potential as a determinant of increased risk of transformation of oral premalignant lesions.	[Tripathi, Satyendra Chandra; Kaur, Jatinder; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Matta, Ajay; Ralhan, Ranju; Siu, K. W. Michael] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Matta, Ajay; Ralhan, Ranju; Siu, K. W. Michael] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Grigull, Jorg] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Thakar, Alok] All India Inst Med Sci, Dept Otorhinolaryngol, New Delhi 110029, India; [Shukla, Nootan Kumar] All India Inst Med Sci, Dr BRA Inst, Rotary Canc Hosp, Dept Surg, New Delhi 110029, India; [Duggal, Ritu] All India Inst Med Sci, Dept Dent Surg, New Delhi 110029, India; [DattaGupta, Siddhartha] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	All India Institute of Medical Sciences (AIIMS) New Delhi; York University - Canada; York University - Canada; York University - Canada; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; DR. B.R.A. Institute Rotary Cancer Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Tripathi, SC (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	ralhanr@yorku.ca; kwmsiu@yorku.ca	Thakar, Alok/V-7701-2019; Bhurji, Jatinder K/B-6767-2013; MATTA, AJAY/AFT-2977-2022; Tripathi, Satyendra Chandra/L-9352-2017	Tripathi, Satyendra Chandra/0000-0003-3917-9645; Kaur, Jatinder/0000-0003-1650-0707	Indian Council of Medical Research (ICMR), New Delhi, India; Ontario Institute for Cancer Research (OICR); Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Temmy Latner/Dynacare Family Foundation, Canada; Canadian Institutes of Health Research (CIHR); Ontario Research and Development Challenge Fund; Applied Biosystems/MDS Analytical Technologies	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Ontario Institute for Cancer Research (OICR); Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Temmy Latner/Dynacare Family Foundation, Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Research and Development Challenge Fund(General Electric); Applied Biosystems/MDS Analytical Technologies	SCT is a recipient of a Senior Research Fellowship from Indian Council of Medical Research (ICMR), New Delhi, India. RR gratefully acknowledges support from the Ontario Institute for Cancer Research (OICR), Joseph and Mildred Sonshine Centre for Head and Neck Diseases and Temmy Latner/Dynacare Family Foundation, Canada. KWMS acknowledges infrastructural support from the Canadian Institutes of Health Research (CIHR), Ontario Research and Development Challenge Fund and Applied Biosystems/MDS Analytical Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Anderson KS, 2009, BRIT J DERMATOL, V160, P325, DOI 10.1111/j.1365-2133.2008.08904.x; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Banerjee AG, 2005, MOL CANCER THER, V4, P865, DOI 10.1158/1535-7163.MCT-05-0033; Bettendorf O, 2004, ORAL ONCOL, V40, P110, DOI 10.1016/j.oraloncology.2003.08.010; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Celis JE, 1996, J UROLOGY, V155, P2105, DOI 10.1016/S0022-5347(01)66118-4; Celis JE, 2007, MOL ONCOL, V1, P97, DOI 10.1016/j.molonc.2007.02.005; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; El-Rifai W, 2002, CANCER RES, V62, P6823; Emberley ED, 2004, BREAST CANCER RES, V6, P153, DOI 10.1186/bcr816; Emberley ED, 2003, CLIN CANCER RES, V9, P2627; Enerback C, 2002, CANCER RES, V62, P43; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji JF, 2004, J CANCER RES CLIN, V130, P480, DOI 10.1007/s00432-004-0555-x; Jiang WG, 2004, INT J ONCOL, V25, P81; Kaur J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-168; Kesting MR, 2009, ORAL ONCOL, V45, P731, DOI 10.1016/j.oraloncology.2008.11.012; Leon R, 2009, BIOCHEMISTRY-US, V48, P10591, DOI 10.1021/bi901330g; Leygue E, 1996, CANCER RES, V56, P4606; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Matta A, 2008, J PROTEOME RES, V7, P2078, DOI 10.1021/pr7007797; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Moriyama-Kita M, 2005, CANCER LETT, V230, P211, DOI 10.1016/j.canlet.2004.12.046; Moriyama-Kita M, 2004, ORAL ONCOL, V40, P496, DOI 10.1016/j.oraloncology.2003.10.003; Moubayed N, 2007, J CANCER RES CLIN, V133, P253, DOI 10.1007/s00432-006-0164-y; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2009, J PROTEOME RES, V8, P300, DOI 10.1021/pr800501j; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sapkota D, 2008, J ORAL PATHOL MED, V37, P607, DOI 10.1111/j.1600-0714.2008.00683.x; Suzuki F, 2005, ONCOL REP, V14, P1493; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Tsai ST, 2005, ORAL ONCOL, V41, P349, DOI 10.1016/j.oraloncology.2004.09.006; Uma RS, 2007, ORAL ONCOL, V43, P27, DOI 10.1016/j.oraloncology.2005.12.024; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Warnakulasuriya KAAS, 2007, J ORAL PATHOL MED, V36, P63, DOI 10.1111/j.1600-0714.2007.00496.x; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Watson PH, 1998, INT J BIOCHEM CELL B, V30, P567, DOI 10.1016/S1357-2725(97)00066-6; Webb M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-17; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Zhang H, 2008, THORAX, V63, P352, DOI 10.1136/thx.2007.087015; Zhang H, 2007, LUNG CANCER, V57, P37, DOI 10.1016/j.lungcan.2007.02.020; Zhou G, 2008, ONCOGENE, V27, P3527, DOI 10.1038/sj.onc.1211015	52	49	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11939	10.1371/journal.pone.0011939	http://dx.doi.org/10.1371/journal.pone.0011939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689826	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520500006
J	Vermeij, WP; Backendorf, C				Vermeij, Wilbert P.; Backendorf, Claude			Skin Cornification Proteins Provide Global Link between ROS Detoxification and Cell Migration during Wound Healing	PLOS ONE			English	Article							PROLINE-RICH PROTEINS; CORNIFIED ENVELOPE; BARRIER FUNCTION; EXPRESSION; REGENERATION; MECHANISMS; PRECURSOR; STRESS; FAMILY; INJURY	Wound healing is a complex dynamic process characterised by a uniform flow of events in nearly all types of tissue damage, from a small skin scratch to myocardial infarction. Reactive oxygen species (ROS) are essential during the healing process at multiple stages, ranging from the initial signal that instigates the immune response, to the triggering of intracellular redox-dependent signalling pathways and the defence against invading bacteria. Excessive ROS in the wound milieu nevertheless impedes new tissue formation. Here we identify small proline-rich (SPRR) proteins as essential players in this latter process, as they directly link ROS detoxification with cell migration. A literature-based meta-analysis revealed their up-regulation in various forms of tissue injury, ranging from heart infarction and commensal-induced gut responses to nerve regeneration and burn injury. Apparently, SPRR proteins have a far more widespread role in wound healing and tissue remodelling than their established function in skin cornification. It is inferred that SPRR proteins provide injured tissue with an efficient, finely tuneable antioxidant barrier specifically adapted to the tissue involved and the damage inflicted. Their recognition as novel cell protective proteins combining ROS detoxification with cell migration will provide new venues to study and manage tissue repair and wound healing at a molecular level.	[Vermeij, Wilbert P.; Backendorf, Claude] Leiden Univ, Mol Genet Lab, Fac Sci, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Vermeij, WP (corresponding author), Leiden Univ, Mol Genet Lab, Fac Sci, Leiden, Netherlands.	backendo@chem.leidenuniv.nl		Vermeij, Wilbert/0000-0002-9690-1385	Leiden Institute of Chemistry	Leiden Institute of Chemistry	The research has been solely funded by the Leiden Institute of Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIA A, 2003, Patent No. 03075903; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cabral A, 2001, J CELL SCI, V114, P3837; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Collins AR, 1996, ENVIRON HEALTH PERSP, V104, P465, DOI 10.2307/3432805; Cooper L, 2005, GENOME BIOL, V6; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Demetris AJ, 2008, J HEPATOL, V48, P276, DOI 10.1016/j.jhep.2007.09.019; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; El Ghalbzouri A, 2004, LAB INVEST, V84, P102, DOI 10.1038/labinvest.3700014; Feezor RJ, 2004, PHYSIOL GENOMICS, V16, P341, DOI 10.1152/physiolgenomics.00101.2003; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; KOCHEVAR IE, 2004, SCI STKE, DOI DOI 10.1126/STKE.2212004PE7; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MICHAELI A, 1994, PHOTOCHEM PHOTOBIOL, V59, P284, DOI 10.1111/j.1751-1097.1994.tb05035.x; Morris JS, 2006, J CELL PHYSIOL, V206, P16, DOI 10.1002/jcp.20427; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nozaki I, 2005, LAB INVEST, V85, P109, DOI 10.1038/labinvest.3700213; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200	31	61	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11957	10.1371/journal.pone.0011957	http://dx.doi.org/10.1371/journal.pone.0011957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689819	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520500011
J	Greenwald, R; Fitzpatrick, AM; Gaston, B; Marozkina, NV; Erzurum, S; Teague, WG				Greenwald, Roby; Fitzpatrick, Anne M.; Gaston, Benjamin; Marozkina, Nadzeya V.; Erzurum, Serpil; Teague, W. Gerald			Breath Formate Is a Marker of Airway S-Nitrosothiol Depletion in Severe Asthma	PLOS ONE			English	Article							NITROSOGLUTATHIONE REDUCTASE; SMOOTH-MUSCLE; NITRIC-OXIDE; BRONCHODILATOR; NITROSYLATION; CONDENSATE; GLUTATHIONE; RELAXATION; CHILDREN; EVENTS	Background: Children with severe asthma have poor symptom control and elevated markers of airway oxidative and nitrosative stress. Paradoxically, they have decreased airway levels of S-nitrosothiols (SNOs), a class of endogenous airway smooth muscle relaxants. This deficiency results from increased activity of an enzyme that both reduces SNOs to ammonia and oxidizes formaldehyde to formic acid, a volatile carboxylic acid that is more easily detected in exhaled breath condensate (EBC) than SNOs. We therefore hypothesize that depletion of airway SNOs is related to asthma pathology, and breath formate concentration may be a proxy measure of SNO catabolism. Methods and Findings: We collected EBC samples from children and adolescents, including 38 with severe asthma, 46 with mild-to-moderate asthma and 16 healthy adolescent controls, and the concentration of ionic constituents was quantified using ion chromatography. The concentrations of EBC components with volatile conjugates were log-normally distributed. Formate was the principal ion that displayed a significant difference between asthma status classifications. The mean EBC formate concentration was 40% higher in samples collected from all asthmatics than from healthy controls (mean = 5.7 mu M, mean +/- standard deviation = 3.1-10.3 mu M vs. 4.0, 2.8-5.8 mu M, p = 0.05). EBC formate was higher in severe asthmatics than in mild-to-moderate asthmatics (6.8, 3.7-12.3 mu M vs. 4.9, 2.8-8.7 mu M, p = 0.012). In addition, formate concentration was negatively correlated with methacholine PC(20) (r = -0.39, p = 0.002, asthmatics only), and positively correlated with the NO-derived ion nitrite (r = 0.46, p<0.0001) as well as with total serum IgE (r = 0.28, p = 0.016, asthmatics only). Furthermore, formate was not significantly correlated with other volatile organic acids nor with inhaled corticosteroid dose. Conclusions: We conclude that EBC formate concentration is significantly higher in the breath of children with asthma than in those without asthma. In addition, amongst asthmatics, formate is elevated in the breath of those with severe asthma compared to those with mild-to-moderate asthma. We suggest that this difference is related to asthma pathology and may be a product of increased catabolism of endogenous S-nitrosothiols.	[Greenwald, Roby] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Fitzpatrick, Anne M.] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA; [Gaston, Benjamin; Marozkina, Nadzeya V.; Teague, W. Gerald] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Erzurum, Serpil] Cleveland Clin, Dept Med & Pathobiol, Cleveland, OH 44106 USA	Emory University; Rollins School Public Health; Emory University; University of Virginia; Cleveland Clinic Foundation	Greenwald, R (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	roby.greenwald@emory.edu; wgt2p@virginia.edu		Fitzpatrick, Anne/0000-0002-2933-5926	U.S. Centers for Disease Control and Prevention [5 U48 DP000043-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000043] Funding Source: NIH RePORTER	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by the U.S. Centers for Disease Control and Prevention (award 5 U48 DP000043-02 to WGT), http://www.cdc.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; DEBLEY JS, 2010, CHEST, V138; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Dwyer TM, 2004, LUNG, V182, P241, DOI 10.1007/s00408-004-2506-3; Fang KH, 2000, AM J PHYSIOL-LUNG C, V279, pL716, DOI 10.1152/ajplung.2000.279.4.L716; FERDINANDS JM, 2008, ENV HLTH, V7; Fitzpatrick AM, 2006, J ALLERGY CLIN IMMUN, V118, P1218, DOI 10.1016/j.jaci.2006.08.019; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V123, P146, DOI 10.1016/j.jaci.2008.10.047; GASTON B, 1994, J PHARMACOL EXP THER, V268, P978; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Greenwald R, 2009, PEDIATR PULM, V44, P768, DOI 10.1002/ppul.21055; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Hedberg JJ, 2003, EUR J BIOCHEM, V270, P1249, DOI 10.1046/j.1432-1033.2003.03486.x; Henderson EM, 2005, TRENDS MOL MED, V11, P481, DOI 10.1016/j.molmed.2005.09.009; Hoog JO, 2003, CHEM-BIOL INTERACT, V143, P175, DOI 10.1016/S0009-2797(02)00225-9; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Malashenko A, 2009, J AEROSOL MED PULM D, V22, P341, DOI 10.1089/jamp.2008.0696; Moore WC, 2006, J ALLERGY CLIN IMMUN, V117, P487, DOI 10.1016/j.jaci.2006.01.033; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Palmer LA, 2008, METHOD ENZYMOL, V440, P157, DOI 10.1016/S0076-6879(07)00809-9; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Que LG, 2009, AM J RESP CRIT CARE, V180, P226, DOI 10.1164/rccm.200901-0158OC; Schrammel A, 2003, FREE RADICAL BIO MED, V34, P1078, DOI 10.1016/S0891-5849(03)00038-8; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Thompson CM, 2008, J TOXICOL ENV HEAL A, V71, P244, DOI 10.1080/15287390701598259; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	33	36	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11919	10.1371/journal.pone.0011919	http://dx.doi.org/10.1371/journal.pone.0011919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689836	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520300029
J	Low, SK; Kuchiba, A; Zembutsu, H; Saito, A; Takahashi, A; Kubo, M; Daigo, Y; Kamatani, N; Chiku, S; Totsuka, H; Ohnami, S; Hirose, H; Shimada, K; Okusaka, T; Yoshida, T; Nakamura, Y; Sakamoto, H				Low, Siew-Kee; Kuchiba, Aya; Zembutsu, Hitoshi; Saito, Akira; Takahashi, Atsushi; Kubo, Michiaki; Daigo, Yataro; Kamatani, Naoyuki; Chiku, Suenori; Totsuka, Hirohiko; Ohnami, Sumiko; Hirose, Hiroshi; Shimada, Kazuaki; Okusaka, Takuji; Yoshida, Teruhiko; Nakamura, Yusuke; Sakamoto, Hiromi			Genome-Wide Association Study of Pancreatic Cancer in Japanese Population	PLOS ONE			English	Article							AFFECT TELOMERE LENGTH; TUMOR-SUPPRESSOR GENE; DUCTAL ADENOCARCINOMA; RISK; SUSCEPTIBILITY; MUTATIONS; CARCINOMA; RELATIVES; VARIANTS; YEAST	Pancreatic cancer shows very poor prognosis and is the fifth leading cause of cancer death in Japan. Previous studies indicated some genetic factors contributing to the development and progression of pancreatic cancer; however, there are limited reports for common genetic variants to be associated with this disease, especially in the Asian population. We have conducted a genome-wide association study (GWAS) using 991 invasive pancreatic ductal adenocarcinoma cases and 5,209 controls, and identified three loci showing significant association (P-value, 5 x 10(-7)) with susceptibility to pancreatic cancer. The SNPs that showed significant association carried estimated odds ratios of 1.29, 1.32, and 3.73 with 95% confidence intervals of 1.17-1.43, 1.19-1.47, and 2.24-6.21; P-value of 3.30 x 10(-7), 3.30 x 10(-7), and 4.41 x 10(-7); located on chromosomes 6p25.3, 12p11.21 and 7q36.2, respectively. These associated SNPs are located within linkage disequilibrium blocks containing genes that have been implicated some roles in the oncogenesis of pancreatic cancer.	[Low, Siew-Kee; Zembutsu, Hitoshi; Daigo, Yataro; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Low, Siew-Kee; Daigo, Yataro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Kuchiba, Aya; Saito, Akira; Chiku, Suenori; Totsuka, Hirohiko; Ohnami, Sumiko; Yoshida, Teruhiko; Sakamoto, Hiromi] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Tokyo, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Kanagawa, Japan; [Saito, Akira] StaGen Co Ltd, Stat Genet Anal Div, Tokyo, Japan; [Chiku, Suenori] Mizuho Informat & Res Inst Inc, Sci Solut Div, Tokyo, Japan; [Totsuka, Hirohiko] Hitachi Govt & Publ Corp Syst Engn Ltd, Ctr Res & Dev, Bioinfomat Grp, Tokyo, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Shimada, Kazuaki] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan	University of Tokyo; University of Tokyo; National Cancer Center - Japan; RIKEN; RIKEN; Mizuho Research & Technologies, Ltd.; Hitachi Limited; Keio University; National Cancer Center - Japan; National Cancer Center - Japan	Low, SK (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	tyoshida@ncc.go.jp; yusuke@ims.u-tokyo.ac.jp	Hirose, Hiroshi/F-8556-2014; Kubo, Michiaki/N-7947-2015	Daigo, Yataro/0000-0002-0915-3025; Low, Siew-Kee/0000-0003-2386-0698	Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government; Center for Genomic Medicine, RIKEN, Japan; National Institute of Biomedical Innovation (NiBio)	Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Genomic Medicine, RIKEN, Japan; National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation)	This work was conducted as a part of Biobank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government and Center for Genomic Medicine, RIKEN, Japan. It was also supported in part by the program for promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Anderson KE, 2006, CANC EPIDEMIOLOGY PR, P721; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; BARTON CM, 1991, BRIT J CANCER, V64, P1076, DOI 10.1038/bjc.1991.467; BERROZPE G, 1994, INT J CANCER, V58, P185, DOI 10.1002/ijc.2910580207; Buchler P, 2001, PANCREAS, V22, P331, DOI 10.1097/00006676-200105000-00001; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Cao DF, 2004, CANCER BIOL THER, V3, P1081, DOI 10.4161/cbt.3.11.1175; Catanzaro A, 2003, GASTROINTEST ENDOSC, V58, P836, DOI 10.1016/S0016-5107(03)02301-0; Del Chiaro M, 2007, PANCREATOLOGY, V7, P459, DOI 10.1159/000108963; FERNANDEZ E, 1994, CANCER EPIDEM BIOMAR, V3, P209; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hahn SA, 2003, JNCI-J NATL CANCER I, V95, P214, DOI 10.1093/jnci/95.3.214; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hruban RH, 2001, CANCER J, V7, P251; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kelsen DP, 1997, SURGERY, V122, P53, DOI 10.1016/S0039-6060(97)90264-6; Kobitsu K, 1997, MOL CARCINOGEN, V18, P153, DOI 10.1002/(SICI)1098-2744(199703)18:3<153::AID-MC4>3.0.CO;2-G; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; MacLeod SL, 2006, WORLD J GASTROENTERO, V12, P7433, DOI 10.3748/wjg.v12.i46.7433; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McWilliams RR, 2005, CANCER, V104, P388, DOI 10.1002/cncr.21166; Milne RL, 2009, PANCREATOLOGY, V9, P206, DOI 10.1159/000210261; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Rog O, 2005, CURR GENET, V47, P18, DOI 10.1007/s00294-004-0548-y; Stevens RJ, 2007, BRIT J CANCER, V96, P507, DOI 10.1038/sj.bjc.6603571; Tersmette AC, 2001, CLIN CANCER RES, V7, P738; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wong T, 2001, PANCREATOLOGY, V1, P486, DOI 10.1159/000055852; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yan L, 2005, GASTROENTEROLOGY, V128, P2124, DOI 10.1053/j.gastro.2005.03.006; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207	39	103	106	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11824	10.1371/journal.pone.0011824	http://dx.doi.org/10.1371/journal.pone.0011824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686608	gold, Green Submitted, Green Published			2022-12-25	WOS:000280520200008
J	Panici, JA; Harper, JM; Miller, RA; Bartke, A; Spong, A; Masternak, MM				Panici, Jacob A.; Harper, James M.; Miller, Richard A.; Bartke, Andrzej; Spong, Adam; Masternak, Michal M.			Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice	FASEB JOURNAL			English	Article						Ames dwarf; aging; stress resistance	AMES DWARF MICE; INSULIN SENSITIVITY; MULTIPLE FORMS; SPAN; MEN; FIBROBLASTS; PARAMETERS; FERTILITY; RECEPTOR; DISEASE	Hypopituitary Ames dwarf mice were injected either with growth hormone (GH) or thyroxine for a 6-wk period to see whether this intervention would reverse their long life span or the resistance of their cells to lethal stresses. Ames dwarf mice survived 987 +/- 24 d (median), longer than nonmutant control mice (664 +/- 48), but GH-injected dwarf mice did not differ from controls (707 +/- 9). Fibroblast cells from Ames dwarf mice were more resistant to cadmium than cells from nonmutant controls (LD50 values of 9.98 +/- 1.7 and 3.9 +/- 0.8, respectively), but GH injections into Ames dwarf mice restored the normal level of cadmium resistance (LD50 = 5.8 +/- 0.9). Similar restoration of normal resistance was observed for fibroblasts exposed to paraquat, methyl methanesulfonate, and rotenone (P<0.05 in each case for contrast of GH-treated vs. untreated dwarf mice; P<0.05 for dwarf vs. nonmutant control mice.) T4 injections into Ames dwarf mice, in contrast, did not restore normal life span. We conclude that the remarkable life-span extension of Ames dwarf mice, and the stress resistance of cells from these mice, depends on low levels of GH exposure in juvenile and very young adult mice.-Panici, J. A., Harper, J. M., Miller, R. A., Bartke, A., Spong, A., Masternak, M. M. Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. FASEB J. 24, 5073-5079 (2010). www.fasebj.org	[Masternak, Michal M.] So Illinois Univ, Sch Med, Dept Internal Med, Div Geriatr Med, Springfield, IL 62794 USA; [Harper, James M.; Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Harper, James M.; Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Ann Arbor Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA; [Masternak, Michal M.] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland	Southern Illinois University System; Southern Illinois University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Masternak, MM (corresponding author), So Illinois Univ, Sch Med, Dept Internal Med, Div Geriatr Med, 801 N Rutledge,Rm 4389,POB 19628, Springfield, IL 62794 USA.	mmasternak@siumed.edu	Bartke, Andzej/D-6640-2017	Bartke, Andzej/0000-0002-2569-557X; Harper, James/0000-0003-0765-8828	Ellison Medical Foundation, National Institute on Aging [AG031736, AG019899, AG023122]; NATIONAL INSTITUTE ON AGING [P01AG031736, R01AG019899, U19AG023122] Funding Source: NIH RePORTER	Ellison Medical Foundation, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by The Ellison Medical Foundation, National Institute on Aging grants AG031736, AG019899, and AG023122.	BARTKE A, 1965, J REPROD FERTIL, V10, P93, DOI 10.1530/jrf.0.0100093; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Conover CA, 2007, AGING CELL, V6, P727, DOI 10.1111/j.1474-9726.2007.00328.x; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH475, DOI 10.1152/ajpheart.00644.2008; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654; Lange KHW, 2002, J CLIN ENDOCR METAB, V87, P513, DOI 10.1210/jc.87.2.513; Leiser SF, 2006, MECH AGEING DEV, V127, P821, DOI 10.1016/j.mad.2006.08.003; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Liu H, 2007, ANN INTERN MED, V146, P104, DOI 10.7326/0003-4819-146-2-200701160-00005; Louis A, 2010, J GERONTOL A-BIOL, V65, P344, DOI 10.1093/gerona/glq018; Masternak MM, 2010, J GERONTOL A-BIOL, V65, P24, DOI 10.1093/gerona/glp172; Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024; Masternak MM, 2004, J GERONTOL A-BIOL, V59, P784; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; Papadakis Maxine A., 1996, Wound Repair and Regeneration, V4, P421, DOI 10.1046/j.1524-475X.1996.40405.x; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Salmon AB, 2008, J GERONTOL A-BIOL, V63, P232, DOI 10.1093/gerona/63.3.232; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244	31	108	108	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5073	5079		10.1096/fj.10-163253	http://dx.doi.org/10.1096/fj.10-163253			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20720157	Green Submitted, Green Published			2022-12-25	WOS:000284824400045
J	Pang, ZP; Xu, W; Cao, P; Sudhof, TC				Pang, Zhiping P.; Xu, Wei; Cao, Peng; Suedhof, Thomas C.			Calmodulin Suppresses Synaptotagmin-2 Transcription in Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATORY SYNAPSE FORMATION; PROTEIN-KINASE-II; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; CALCIUM SENSITIVITY; GENE-TRANSCRIPTION; CA2+ SENSOR; BINDING; CHANNELS; ACTIVATION	Calmodulin (CaM) is a ubiquitous Ca2+ sensor protein that plays a pivotal role in regulating innumerable neuronal functions, including synaptic transmission. In cortical neurons, most neurotransmitter release is triggered by Ca2+ binding to synaptotagmin-1; however, a second delayed phase of release, referred to as asynchronous release, is triggered by Ca2+ binding to an unidentified secondary Ca2+ sensor. To test whether CaM could be the enigmatic Ca2+ sensor for asynchronous release, we now use in cultured neurons short hairpin RNAs that suppress expression of similar to 70% of all neuronal CaM isoforms. Surprisingly, we found that in synaptotagmin-1 knock-out neurons, the CaM knockdown caused a paradoxical rescue of synchronous release, instead of a block of asynchronous release. Gene and protein expression studies revealed that both in wild-type and in synaptotagmin-1 knock-out neurons, the CaM knockdown altered expression of >200 genes, including that encoding synaptotagmin-2. Synaptotagmin-2 expression was increased several-fold by the CaM knockdown, which accounted for the paradoxical rescue of synchronous release in synaptotagmin-1 knock-out neurons by the CaM knockdown. Interestingly, the CaM knockdown primarily activated genes that are preferentially expressed in caudal brain regions, whereas it repressed genes in rostral brain regions. Consistent with this correlation, quantifications of protein levels in adult mice uncovered an inverse relationship of CaM and synaptotagmin-2 levels in mouse forebrain, brain stem, and spinal cord. Finally, we employed molecular replacement experiments using a knockdown rescue approach to show that Ca2+ binding to the C-lobe but not the N-lobe of CaM is required for suppression of synaptotagmin-2 expression in cortical neurons. Our data describe a previously unknown, Ca2+/CaM-dependent regulatory pathway that controls the expression of synaptic proteins in the rostral-caudal neuraxis.	[Pang, Zhiping P.; Xu, Wei; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Xu, Wei; Cao, Peng; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Pang, ZP (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	zpang@stanford.edu	Pang, Zhiping/AAF-5757-2020	Pang, Zhiping/0000-0002-6183-1233	National Institutes of Mental Health; National Alliance for Research on Schizophrenia and Depression	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression(NARSAD)	This work was supported, in whole or in part, by a National Institutes of Mental Health Grant (to T.C.S.). This work was also supported by awards from National Alliance for Research on Schizophrenia and Depression (to Z.P.P.).	BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Berton F, 1997, J NEUROSCI, V17, P1206; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; DELORENZO RJ, 1981, CELL CALCIUM, V2, P365, DOI 10.1016/0143-4160(81)90026-9; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GREENBERG ME, 1992, J PHYSIOLOGY-PARIS, V86, P99, DOI 10.1016/S0928-4257(05)80013-0; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Nakagawa Y, 2006, J MOL CELL CARDIOL, V41, P1010, DOI 10.1016/j.yjmcc.2006.08.010; NGHIEM P, 1994, NATURE, V371, P347, DOI 10.1038/371347a0; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; STEINHARDT RA, 1982, NATURE, V295, P154, DOI 10.1038/295154a0; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; TELEMAN A, 1986, BIOCHIM BIOPHYS ACTA, V873, P204, DOI 10.1016/0167-4838(86)90047-6; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320	44	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33930	33939		10.1074/jbc.M110.150151	http://dx.doi.org/10.1074/jbc.M110.150151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729199	hybrid, Green Published			2022-12-25	WOS:000283354000040
J	Lugari, A; Betzi, S; Decroly, E; Bonnaud, E; Hermant, A; Guillemot, JC; Debarnot, C; Borg, JP; Bouvet, M; Canard, B; Morelli, X; Lecine, P				Lugari, Adrien; Betzi, Stephane; Decroly, Etienne; Bonnaud, Emmanuel; Hermant, Aurelie; Guillemot, Jean-Claude; Debarnot, Claire; Borg, Jean-Paul; Bouvet, Mickael; Canard, Bruno; Morelli, Xavier; Lecine, Patrick			Molecular Mapping of the RNA Cap 2 '-O-Methyltransferase Activation Interface between Severe Acute Respiratory Syndrome Coronavirus nsp10 and nsp16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; SARS-CORONAVIRUS; MURINE CORONAVIRUS; VIRUS; METHYLTRANSFERASE; IDENTIFICATION; TRANSCRIPTION; GENOME; REPLICATION; MUTAGENESIS	Several protein-protein interactions within the SARS-CoV proteome have been identified, one of them being between nonstructural proteins nsp10 and nsp16. In this work, we have mapped key residues on the nsp10 surface involved in this interaction. Alanine-scanning mutagenesis, bioinformatics, and molecular modeling were used to identify several "hot spots," such as Val(42), Met(44), Ala(71), Lys(93), Gly(94), and Tyr(96), forming a continuous protein-protein surface of about 830 A 2, bearing very conserved amino acids among coronaviruses. Because nsp16 carries RNA cap 2'-O-methyltransferase (2'O-MTase) activity only in the presence of its interacting partner nsp10 (Bouvet, M., Debarnot, C., Imbert, I., Selisko, B., Snijder, E. J., Canard, B., and Decroly, E. (2010) PLoS Pathog. 6, e1000863), functional consequences of mutations on this surface were evaluated biochemically. Most changes that disrupted the nsp10-nsp16 interaction without structural perturbations were shown to abrogate stimulation of nsp16 RNA cap 2'O-MTase activity. More strikingly, the Y96A mutation abrogates stimulation of nsp16 2'O-MTase activity, whereas Y96F overstimulates it. Thus, the nsp10-nsp16 interface may represent an attractive target for antivirals against human and animal pathogenic coronaviruses.	[Lugari, Adrien; Betzi, Stephane; Morelli, Xavier] CNRS, F-13402 Marseille 20, France; [Lugari, Adrien; Betzi, Stephane; Morelli, Xavier] Aix Marseille Univ, IMR Lab UPR 3243, Inst Microbiol Mediterannee, F-13402 Marseille 20, France; [Decroly, Etienne; Guillemot, Jean-Claude; Debarnot, Claire; Bouvet, Mickael; Canard, Bruno] CNRS, F-13288 Marseille, France; [Decroly, Etienne; Guillemot, Jean-Claude; Debarnot, Claire; Bouvet, Mickael; Canard, Bruno] Univ Aix Marseille 1, UMR 6098, ESIL Case 925, F-13288 Marseille, France; [Decroly, Etienne; Guillemot, Jean-Claude; Debarnot, Claire; Bouvet, Mickael; Canard, Bruno] Univ Aix Marseille 2, UMR 6098, ESIL Case 925, F-13288 Marseille, France; [Bonnaud, Emmanuel; Hermant, Aurelie; Borg, Jean-Paul; Lecine, Patrick] INSERM, UMR891, Ctr Rech Cancerol Marseille, F-13009 Marseille, France; [Bonnaud, Emmanuel; Hermant, Aurelie; Borg, Jean-Paul; Lecine, Patrick] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Bonnaud, Emmanuel; Hermant, Aurelie; Borg, Jean-Paul; Lecine, Patrick] Univ Mediterranee, F-13007 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite	Lecine, P (corresponding author), Baylor Inst Immunol Res, INSERM, UMR899, 3434 Live Oak St, Dallas, TX 75024 USA.	patrick.lecine@inserm.fr	morelli, xavier/A-9218-2016; Betzi, Stephane/AAC-6103-2022; Borg, Jean-Paul/AAX-8096-2020; Lecine, Patrick/H-9338-2016	morelli, xavier/0000-0001-8101-7901; Betzi, Stephane/0000-0001-5935-5058; Borg, Jean-Paul/0000-0001-8418-3382; Lecine, Patrick/0000-0002-8091-7286; DECROLY, Etienne/0000-0002-6046-024X; Bouvet-Gueguen, Mickael/0000-0001-6541-689X; Lugari, Adrien/0000-0001-8337-6043; Canard, Bruno/0000-0003-4924-1991	European Union [LSHG-CT-2004-511960]; European Commission [SP22-CT-2004-511064]; French National Research agency [ANR-08-MIEN-032]; Fondation pour la Recherche Medicale; Direction Generale de l'Armement [07co404]	European Union(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); French National Research agency(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Direction Generale de l'Armement	This work was supported, at its initial phase, by the VIZIER integrated project (LSHG-CT-2004-511960) of the European Union 6th Framework and the Euro-Asian SARS-DTV Network (SP22-CT-2004-511064) from the European Commission specific research and technological development program "Integrating and Strengthening the European Research Area" and then by the French National Research agency, under reference "ANR-08-MIEN-032," the Fondation pour la Recherche Medicale (Programme Equipe FRM) (to B. C.), and Direction Generale de l'Armement Contract 07co404.	Almazan F, 2006, J VIROL, V80, P10900, DOI 10.1128/JVI.00385-06; ARMSTRONG CM, 2005, MODULAR SCALE YEAST, V4; BAKER SC, 1993, J VIROL, V67, P6056, DOI 10.1128/JVI.67.10.6056-6063.1993; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bouvet M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000863; Campanacci V, 2003, ACTA CRYSTALLOGR D, V59, P1628, DOI 10.1107/S0907444903016779; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; Donaldson EF, 2007, J VIROL, V81, P6356, DOI 10.1128/JVI.02805-06; Donaldson EF, 2007, J VIROL, V81, P7086, DOI 10.1128/JVI.00049-07; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; Imberta I, 2008, VIRUS RES, V133, P136, DOI 10.1016/j.virusres.2007.11.017; Issad Tarik, 2006, V332, P195; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Joseph JS, 2006, J VIROL, V80, P7894, DOI 10.1128/JVI.00467-06; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; LAI MMC, 1982, ADV EXP MED BIOL, V142, P69; LEMBO F, 2009, TECAN J, V1, P14; LU YQ, 1995, J VIROL, V69, P3554, DOI 10.1128/JVI.69.6.3554-3559.1995; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Matthes N, 2006, FEBS LETT, V580, P4143, DOI 10.1016/j.febslet.2006.06.061; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Pan JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003299; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Peyrane F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1119; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06; Sawicki SG, 2005, PLOS PATHOG, V1, P310, DOI 10.1371/journal.ppat.0010039; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Su D, 2006, J VIROL, V80, P7902, DOI 10.1128/JVI.00483-06; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; van Vliet ALW, 2002, EMBO J, V21, P6571, DOI 10.1093/emboj/cdf635; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; VIDAL M, 1997, YEAST 2 HYBRID SYSTE, P109; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; von Grotthuss M, 2003, CELL, V113, P701, DOI 10.1016/S0092-8674(03)00424-0; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang HL, 1996, VIROLOGY, V217, P527, DOI 10.1006/viro.1996.0147; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	46	44	46	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33230	33241		10.1074/jbc.M110.120014	http://dx.doi.org/10.1074/jbc.M110.120014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20699222	Green Published, hybrid			2022-12-25	WOS:000283048200060
J	Onishi, RM; Park, SJ; Hanel, W; Ho, AW; Maitra, A; Gaffen, SL				Onishi, Reiko M.; Park, Sangmi J.; Hanel, Walter; Ho, Allen W.; Maitra, Amarnath; Gaffen, Sarah L.			SEF/IL-17R (SEFIR) Is Not Enough AN EXTENDED SEFIR DOMAIN IS REQUIRED FOR IL-17RA-MEDIATED SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-17 RECEPTOR; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; ADAPTER PROTEIN; FAMILY-MEMBERS; HOST-DEFENSE; TARGET GENES; C/EBP-BETA; T-CELLS; INTERLEUKIN-17	IL-17, the hallmark cytokine of the Th17 population, mediates immunity to extracellular pathogens and promotes autoimmune immunopathology. The signaling mechanisms triggered by the IL-17 receptor (IL-17RA) and related receptors are strikingly different from other cytokine subclasses. Namely, IL-17Rs contain a conserved SEF/IL-17R (SEFIR) subdomain that engages Act1, leading to activation of TRAF6, NF-kappa B, and other events. Although the SEFIR is critical for signaling, the molecular details of the functional subdomains within IL-17RA remain poorly characterized. Here, we provide a detailed structure-function analysis delineating the C-terminal boundary of the SEFIR-containing region of IL-17RA. We show that functionality of this domain requires a large extension to the previously identified SEFIR motif. In contrast to the SEFIR, this extension is not conserved among IL-17R family members. Surprisingly, Act1 recruitment is not sufficient for downstream signaling activation, whereas ubiquitination of TRAF6 correlates tightly with functional receptors. We further demonstrate that IL-17RA exhibits signaling properties that are nonredundant with other IL-17R family members. Finally, we report that IL-17 signals synergistically with lymphotoxin-alpha 3, using the same signaling motifs within IL-17RA. These studies provide new insight into the structure-function relationships of IL-17RA and reveal distinct signaling differences among IL-17R family members.	Univ Pittsburgh, Dept Med, Div Clin Immunol & Rheumatol, Pittsburgh, PA 15261 USA; [Hanel, Walter; Ho, Allen W.; Maitra, Amarnath; Gaffen, Sarah L.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gaffen, SL (corresponding author), Univ Pittsburgh, Div Rheumatol, S703 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	sig65@pitt.edu	Ho, Allen/B-3017-2011	Ho, Allen/0000-0002-5861-0552	National Institutes of Health [AR054389]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR054389 (to S. L. G.).	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XX, 2008, CYTOKINE, V41, P105, DOI 10.1016/j.cyto.2007.09.015; Linden A., 2007, SCI STKE, V2007, pre4, DOI DOI 10.1126/STKE.3982007RE4; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Rong ZL, 2009, CELL RES, V19, P208, DOI 10.1038/cr.2008.320; Ruddy MJ, 2004, J LEUKOCYTE BIOL, V76, P135, DOI 10.1189/jlb.0204065; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	42	38	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32751	32759		10.1074/jbc.M110.121418	http://dx.doi.org/10.1074/jbc.M110.121418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729198	Green Published, hybrid			2022-12-25	WOS:000283048200010
J	Petersen, JL; Ronan, PJ				Petersen, Jason L.; Ronan, Patrick J.			Critical Role of 7,8-Didemethyl-8-hydroxy-5-deazariboflavin for Photoreactivation in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA PHOTOLYASE; ESCHERICHIA-COLI; COENZYME F-420; 8-HYDROXY-5-DEAZAFLAVIN-REDUCING HYDROGENASE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; NUCLEAR TRANSFORMATION; 2ND CHROMOPHORE; RADICAL SAM; FLAVIN; ENZYME	DNA photolyases use two noncovalently bound chromophores to catalyze photoreactivation, the blue light-dependent repair of DNA that has been damaged by ultraviolet light. FAD is the catalytic chromophore for all photolyases and is essential for photoreactivation. The identity of the second chromophore is often 7,8-didemethyl-8-hydroxy-5-deazariboflavin (FO). Under standard light conditions, the second chromophore is considered nonessential for photoreactivation because DNA photolyase bound to only FAD is sufficient to catalyze the repair of UV-damaged DNA. phr1 is a photoreactivation-deficient strain of Chlamydomonas. In this work, the PHR1 gene of Chlamydomonas was cloned through molecular mapping and shown to encode a protein similar to known FO synthases. Additional results revealed that the phr1 strain was deficient in an FO-like molecule and that this deficiency, as well as the phr1 photoreactivation deficiency, could be rescued by transformation with DNA constructs containing the PHR1 gene. Furthermore, expression of a PHR1 cDNA in Escherichia coli produced a protein that generated a molecule with characteristics similar to FO. Together, these results indicate that the Chlamydomonas PHR1 gene encodes an FO synthase and that optimal photoreactivation in Chlamydomonas requires FO, a molecule known to serve as a second chromophore for DNA photolyases.	Avera Res Inst, Basic Res Div, Sioux Falls, SD 57105 USA; [Petersen, Jason L.; Ronan, Patrick J.] Sioux Falls Vet Affairs Med Ctr, Res & Dev, Sioux Falls, SD 57117 USA; [Petersen, Jason L.] Univ S Dakota, Dept Internal Med, Sioux Falls, SD 57105 USA; [Ronan, Patrick J.] Univ S Dakota, Neurosci Grp, Sanford Sch Med, Sioux Falls, SD 57105 USA	University of South Dakota; University of South Dakota	Petersen, JL (corresponding author), Vet Affairs Med Ctr, Res & Dev 151,2501 W 22nd St, Sioux Falls, SD 57117 USA.	Jason.Petersen@avera.org		Petersen, Jason/0000-0003-4939-5149	NCRR [P20RR015567]; Avera Research Institute (Sioux Falls, SD); Great Plains Medical Research Foundation [GPMRF-001-2009]; Sioux Falls Veterans Affairs Medical Center (Sioux Falls, SD); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015567] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Avera Research Institute (Sioux Falls, SD); Great Plains Medical Research Foundation; Sioux Falls Veterans Affairs Medical Center (Sioux Falls, SD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR015567 from the NCRR (to P.J.R.). This work was also supported by Avera Research Institute (Sioux Falls, SD), the Great Plains Medical Research Foundation Grant GPMRF-001-2009 (to J.L.P.), and with resources and the use of facilities at the Sioux Falls Veterans Affairs Medical Center (Sioux Falls, SD).	Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Beukers R, 2008, DNA REPAIR, V7, P530, DOI 10.1016/j.dnarep.2007.11.010; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; COX JL, 1985, MUTAT RES, V146, P249, DOI 10.1016/0167-8817(85)90065-3; DAVIES WEA, 1971, J PHYS D APPL PHYS, V4, P318, DOI 10.1088/0022-3727/4/2/318; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; EKER AP, 1988, BIOCHEMISTRY-US, V27, P1758, DOI 10.1021/bi00405a056; EKER APM, 1981, PHOTOCHEM PHOTOBIOL, V33, P65, DOI 10.1111/j.1751-1097.1981.tb04298.x; EKER APM, 1990, J BIOL CHEM, V265, P8009; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FOX JA, 1987, BIOCHEMISTRY-US, V26, P4219, DOI 10.1021/bi00388a007; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glas AF, 2009, P NATL ACAD SCI USA, V106, P11540, DOI 10.1073/pnas.0812665106; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; GROSS CH, 1988, CURR GENET, V13, P503, DOI 10.1007/BF02427756; Grossman AR, 2003, EUKARYOT CELL, V2, P1137, DOI 10.1128/EC.2.6.1137-1150.2003; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; HAMMALVAREZ S, 1989, J BIOL CHEM, V264, P9649; HARRIS E, 1989, CHLAMYDOMONAS SOURCE, P608; HEELIS PF, 1987, BIOCHEMISTRY-US, V26, P4634, DOI 10.1021/bi00389a007; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; Jain M, 2007, NUCLEIC ACIDS RES, V35, P2074, DOI 10.1093/nar/gkm081; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; JORNS MS, 1987, BIOCHEMISTRY-US, V26, P6810, DOI 10.1021/bi00395a034; JORNS MS, 1990, BIOCHEMISTRY-US, V29, P552, DOI 10.1021/bi00454a032; KIENER A, 1989, J BIOL CHEM, V264, P13880; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kleiner O, 1999, EUR J BIOCHEM, V264, P161, DOI 10.1046/j.1432-1327.1999.00590.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MICHEL R, 1995, EUR J BIOCHEM, V233, P727, DOI 10.1111/j.1432-1033.1995.727_3.x; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V49, P805, DOI 10.1111/j.1751-1097.1989.tb05578.x; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P5706, DOI 10.1021/bi00476a010; Peccia J, 2001, APPL ENVIRON MICROB, V67, P4225, DOI 10.1128/AEM.67.9.4225-4232.2001; Petersen JL, 1999, PLANT MOL BIOL, V40, P1063, DOI 10.1023/A:1006279720960; Petersen JL, 2001, NUCLEIC ACIDS RES, V29, P4472, DOI 10.1093/nar/29.21.4472; PETERSEN JL, 2001, CHLAMYDOMONAS GENES; Rymarquis LA, 2005, PLANT PHYSIOL, V137, P557, DOI 10.1104/pp.104.054221; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; Schein AI, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e82; Shrager J, 2003, PLANT PHYSIOL, V131, P401, DOI 10.1104/pp.016899; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; TAKAO M, 1989, PHOTOCHEM PHOTOBIOL, V50, P633, DOI 10.1111/j.1751-1097.1989.tb04319.x; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d	51	10	10	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32467	32475		10.1074/jbc.M110.146050	http://dx.doi.org/10.1074/jbc.M110.146050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696762	hybrid, Green Published			2022-12-25	WOS:000282683000060
J	Wang, YT; Pan, YJ; Cho, CC; Lin, BC; Su, LH; Huang, YC; Sun, CH				Wang, Yi-Ting; Pan, Yu-Jiao; Cho, Chao-Cheng; Lin, Bo-Chi; Su, Li-Hsin; Huang, Yu-Chang; Sun, Chin-Hung			A Novel Pax-like Protein Involved in Transcriptional Activation of Cyst Wall Protein Genes in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA COMPLEX REVEALS; PAIRED DOMAIN; CELL-GROWTH; PRIMITIVE EUKARYOTE; CRYSTAL-STRUCTURE; BINDING-SITES; EXPRESSION; IDENTIFICATION; DIFFERENTIATION; ENCYSTATION	Giardia lamblia differentiates into infectious cysts to survive outside of the host. It is of interest to identify factors involved in up-regulation of cyst wall proteins (CWPs) during this differentiation. Pax proteins are important regulators of development and cell differentiation in Drosophila and vertebrates. No member of this gene family has been reported to date in yeast, plants, or protozoan parasites. We have identified a pax-like gene (pax1) encoding a putative paired domain in the G. lamblia genome. Epitope-tagged Pax1 localized to nuclei during both vegetative growth and encystation. Recombinant Pax1 specifically bound to the AT-rich initiator elements of the encystation-induced cwp1 to -3 and myb2 genes. Interestingly, overexpression of Pax1 increased cwp1 to -3 and myb2 gene expression and cyst formation. Deletion of the C-terminal paired domain or mutation of the basic amino acids of the paired domain resulted in a decrease of the transactivation function of Pax1. Our results indicate that the Pax family has been conserved during evolution, and Pax1 could up-regulate the key encystation-induced genes to regulate differentiation of the protozoan eukaryote, G. lamblia.	[Wang, Yi-Ting; Pan, Yu-Jiao; Cho, Chao-Cheng; Lin, Bo-Chi; Su, Li-Hsin; Huang, Yu-Chang; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [NSC 96-2320-B-002-040-MY3, NSC 98-2320-B-002-018-MY2]; National Health Research Institutes in Taiwan [NHRI-EX98-9510NC, NHRI-EX99-9510NC]; Department of Medical Research of National Taiwan University Hospital; National Taiwan University	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); Department of Medical Research of National Taiwan University Hospital; National Taiwan University(National Taiwan University)	This work was supported by National Science Council Grants NSC 96-2320-B-002-040-MY3 and NSC 98-2320-B-002-018-MY2 and National Health Research Institutes Grants NHRI-EX98-9510NC and NHRI-EX99-9510NC in Taiwan and was also supported in part by the Department of Medical Research of National Taiwan University Hospital and the Aim for the Top University Program of National Taiwan University.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; CAI JX, 1994, MECH DEVELOP, V47, P139, DOI 10.1016/0925-4773(94)90086-8; CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Chiu PW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000677; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Frost V, 2008, CRIT REV BIOCHEM MOL, V43, P371, DOI [10.1080/10409230802486208, 10.1080/10409230802486208 ]; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; Gosmain Y, 2007, J BIOL CHEM, V282, P35024, DOI 10.1074/jbc.M702795200; HAGMAN J, 1994, CURR OPIN IMMUNOL, V6, P222, DOI 10.1016/0952-7915(94)90095-7; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; Iwahara J, 2002, EMBO J, V21, P1197, DOI 10.1093/emboj/21.5.1197; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kalousova A, 1999, BIOCHEM BIOPH RES CO, V259, P510, DOI 10.1006/bbrc.1999.0809; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Nornes S, 1996, J BIOL CHEM, V271, P26914, DOI 10.1074/jbc.271.43.26914; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Pan YJ, 2009, J BIOL CHEM, V284, P17975, DOI 10.1074/jbc.M109.012047; Pellizzari L, 1999, BIOCHEM J, V337, P253, DOI 10.1042/0264-6021:3370253; Phelps DE, 1996, J BIOL CHEM, V271, P7978, DOI 10.1074/jbc.271.14.7978; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Stuart ET, 1996, CELL GROWTH DIFFER, V7, P405; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; Van Keulen H, 1998, J EUKARYOT MICROBIOL, V45, P637, DOI 10.1111/j.1550-7408.1998.tb04560.x; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1	77	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32213	32226		10.1074/jbc.M110.156620	http://dx.doi.org/10.1074/jbc.M110.156620			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699219	Green Published, hybrid			2022-12-25	WOS:000282683000034
J	El-Kalla, M; Onyskiw, C; Baksh, S				El-Kalla, M.; Onyskiw, C.; Baksh, S.			Functional importance of RASSF1A microtubule localization and polymorphisms	ONCOGENE			English	Article						RASSF1A; microtubule; polymorphism; Tubulin; tumor suppressor gene	TUMOR-SUPPRESSOR RASSF1A; TRANSCRIPTION FACTOR P120(E4F); DEATH INDUCER C19ORF5; CELL-DEATH; BINDING PROTEIN; SPINDLE POLES; GAMMA-TUBULIN; RAS; ASSOCIATION; FAMILY	Ras association domain family protein 1A (RASSF1A) is one of the more heavily methylated genes in human cancers. In addition to promoter-specific methylation, RASSF1A polymorphisms have been identified in cancer patients. RASSF1A is a tumor suppressor protein involved in death receptor-dependent apoptosis and it is localized to microtubules. Currently, the biological importance of RASSF1A microtubule localization and the functional consequences of RASSF1A polymorphisms is not under-stood. In this study, we have investigated both RASSF1A microtubule association and polymorphisms. Loss of RASSF1A microtubule association resulted in the nuclear appearance of RASSF1A and the loss of association with alpha-, gamma-and beta-tubulin. Moreover, the loss of microtubule localization of RASSF1A resulted in enhanced tumor-promoting potential, as determined by a xenograft transplantation model in nude mice. It is surprising that, several RASSF1A polymorphisms also lost the ability to associate with alpha-, gamma-and beta-tubulin and lost the ability to prevent tumor formation in a xenograft nude mouse model when compared with wild-type RASSF1A. Our results demonstrate a role for RASSF1A microtubule localization in eliciting its tumor suppressor function. In addition, some RASSF1A polymorphisms lack the tumor suppressor function of RASSF1A and, if present in patients, may be tumorigenic. Oncogene (2010) 29, 5729-5740; doi:10.1038/onc.2010.316; published online 9 August 2010	[El-Kalla, M.; Onyskiw, C.; Baksh, S.] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB T6G 2N8, Canada	University of Alberta	Baksh, S (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Room B066 Dent Pharm Bldg, Edmonton, AB T6G 2N8, Canada.	sbaksh@ualberta.ca	Baksh, Shairaz/GRX-2106-2022		CIHR [MOP-79494]; Women and Children's Health Research Institute [WCO14]; Stollery Children's Hospital Foundation [PD946]; Alberta Heritage Foundation for Medical Research [G220170170]; Canadian Foundation for Innovation [13118]	CIHR(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute; Stollery Children's Hospital Foundation; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank Dr Haya Abu Ghazaleh for her helpful discussions, Adrienne DeCorby-Baksh for her excellent technical assistance with our confocal imaging, Dr Victor Yu and Naiyang Fu for the MOAP-1 expression construct. This work was supported by grants from CIHR (MOP-79494) (MEK), the Women and Children's Health Research Institute (WCO14) (MEK), the Stollery Children's Hospital Foundation Donation Grant (PD946) (SB and MEK), Alberta Heritage Foundation for Medical Research (G220170170) (SB), and Canadian Foundation for Innovation/Alberta Small Equipment Grants Program (#13118).	Abu Ghazaleh H, 2010, APOPTOSIS, V15, P117, DOI 10.1007/s10495-009-0451-6; Adachi M, 2003, FEBS LETT, V551, P147, DOI 10.1016/S0014-5793(03)00915-3; Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175; Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Bhat KMR, 2007, CLIN CANCER RES, V13, P2849, DOI 10.1158/1078-0432.CCR-06-3040; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Cuschieri L, 2007, CELL CYCLE, V6, P2788, DOI 10.4161/cc.6.22.4941; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Fajas L, 2001, MOL CELL BIOL, V21, P2956, DOI 10.1128/MCB.21.8.2956-2966.2001; Fajas L, 2000, P NATL ACAD SCI USA, V97, P7738, DOI 10.1073/pnas.130198397; Fenton SL, 2004, CANCER RES, V64, P102, DOI 10.1158/0008-5472.CAN-03-2622; Fernandes ER, 1997, MOL CELL BIOL, V17, P1890, DOI 10.1128/MCB.17.4.1890; Fisk HA, 2002, CURR OPIN CELL BIOL, V14, P700, DOI 10.1016/S0955-0674(02)00385-X; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Gao BN, 2008, CANCER RES, V68, P22, DOI 10.1158/0008-5472.CAN-07-5183; Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Moshnikova A, 2006, J BIOL CHEM, V281, P8143, DOI 10.1074/jbc.M511837200; Moshnikova Anna, 2008, BMC Res Notes, V1, P13, DOI 10.1186/1756-0500-1-13; Parvin JD, 2009, ENVIRON MOL MUTAGEN, V50, P649, DOI 10.1002/em.20475; Pihan G, 2003, CANCER CELL, V4, P89, DOI 10.1016/S1535-6108(03)00195-8; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Rizos H, 2003, J BIOL CHEM, V278, P4981, DOI 10.1074/jbc.M210978200; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Senda Takao, 2005, Anatomical Science International, V80, P121, DOI 10.1111/j.1447-073x.2005.00106.x; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Song MS, 2005, J BIOL CHEM, V280, P3920, DOI 10.1074/jbc.M409115200; van der Weyden L, 2008, ONCOGENE, V27, P4503, DOI 10.1038/onc.2008.94; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5	46	27	28	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	42					5729	5740		10.1038/onc.2010.316	http://dx.doi.org/10.1038/onc.2010.316			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	668IT	20697344				2022-12-25	WOS:000283262500009
J	Burra, PV; Kalmar, L; Tompa, P				Burra, Prasad V.; Kalmar, Lajos; Tompa, Peter			Reduction in Structural Disorder and Functional Complexity in the Thermal Adaptation of Prokaryotes	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; AMINO-ACID-COMPOSITION; TRANSCRIPTION FACTORS; ENERGY CONTENT; LINEAR MOTIFS; LEA PROTEINS; RECOGNITION; BACTERIA; REGIONS; BINDING	Genomic correlates of evolutionary adaptation to very low or very high optimal growth temperature (OGT) values have been the subject of many studies. Whereas these provided a protein-structural rationale of the activity and stability of globular proteins/enzymes, the point has been neglected that adaptation to extreme temperatures could also have resulted from an increased use of intrinsically disordered proteins (IDPs), which are resistant to these conditions in vitro. Contrary to these expectations, we found a conspicuously low level of structural disorder in bacteria of very high (and very low) OGT values. This paucity of disorder does not reflect phylogenetic relatedness, i.e. it is a result of genuine adaptation to extreme conditions. Because intrinsic disorder correlates with important regulatory functions, we asked how these bacteria could exist without IDPs by studying transcription factors, known to harbor a lot of function-related intrinsic disorder. Hyperthermophiles have much less transcription factors, which have reduced disorder compared to their mesophilic counterparts. On the other hand, we found by systematic categorization of proteins with long disordered regions that there are certain functions, such as translation and ribosome biogenesis that depend on structural disorder even in hyperthermophiles. In all, our observations suggest that adaptation to extreme conditions is achieved by a significant functional simplification, apparent at both the level of the genome and individual genes/proteins.	[Burra, Prasad V.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kalmar, Lajos; Tompa, Peter] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Budapest, Hungary	University of California System; University of California San Diego; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Burra, PV (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	tompa@enzim.hu	Kalmar, Lajos/C-3040-2014	Kalmar, Lajos/0000-0003-3691-8350	Hungarian Scientific Research [OTKA K60694, NK71582]; Hungarian Ministry of Health [ETT 245/2006]	Hungarian Scientific Research(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health	This research was supported by grants OTKA K60694 and NK71582 from the Hungarian Scientific Research Fund and ETT 245/2006 from the Hungarian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Berezovsky IN, 2007, PLOS COMPUT BIOL, V3, P498, DOI 10.1371/journal.pcbi.0030052; Blochl E, 1997, EXTREMOPHILES, V1, P14; Burra PV, 2009, P NATL ACAD SCI USA, V106, P10505, DOI 10.1073/pnas.0812152106; CHEN X, 2009, J MOL BIOL; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Csizmok V, 2006, MOL CELL PROTEOMICS, V5, P265, DOI 10.1074/mcp.M500181-MCP200; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Deming JW, 2002, CURR OPIN MICROBIOL, V5, P301, DOI 10.1016/S1369-5274(02)00329-6; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galea CA, 2006, J PROTEOME RES, V5, P2839, DOI 10.1021/pr060328c; Georlette D, 2003, J BIOL CHEM, V278, P37015, DOI 10.1074/jbc.M305142200; Goldstein RA, 2007, PROTEIN SCI, V16, P1887, DOI 10.1110/ps.072947007; Huang SL, 2004, BIOINFORMATICS, V20, P276, DOI 10.1093/bioinformatics/btg403; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kalthoff C, 2003, J CHROMATOGR B, V786, P247, DOI 10.1016/S1570-0232(02)00908-X; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Minezaki Y, 2005, DNA RES, V12, P269, DOI 10.1093/dnares/dsi016; Mizuguchi K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S15; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Pasamontes A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-257; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Plaxco KW, 1997, NATURE, V386, P657, DOI 10.1038/386657a0; Puigbo P, 2008, TRENDS GENET, V24, P10, DOI 10.1016/j.tig.2007.10.005; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; RAJASEKAR K, 2010, J BIOL CHEM; Schroder O, 2002, BIOL CHEM, V383, P945, DOI 10.1515/BC.2002.101; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Sharma AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007159; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497; Singh J, 2009, PROTEIN EXPRES PURIF, V67, P15, DOI 10.1016/j.pep.2009.04.003; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Subramanyam MB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-141; Suhre K, 2003, J BIOL CHEM, V278, P17198, DOI 10.1074/jbc.M301327200; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tantos A, 2009, FEBS LETT, V583, P465, DOI 10.1016/j.febslet.2008.12.054; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2009, STRUCTURE FUNCTION I; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; von der Haar T, 2006, J MOL BIOL, V356, P982, DOI 10.1016/j.jmb.2005.12.034; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005	64	57	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12069	10.1371/journal.pone.0012069	http://dx.doi.org/10.1371/journal.pone.0012069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711457	Green Submitted, gold, Green Published			2022-12-25	WOS:000280849100015
J	Ek, CJ; Habgood, MD; Callaway, JK; Dennis, R; Dziegielewska, KM; Johansson, PA; Potter, A; Wheaton, B; Saunders, NR				Ek, C. Joakim; Habgood, Mark D.; Callaway, Jennifer K.; Dennis, Ross; Dziegielewska, Katarzyna M.; Johansson, Pia A.; Potter, Ann; Wheaton, Benjamin; Saunders, Norman R.			Spatio-Temporal Progression of Grey and White Matter Damage Following Contusion Injury in Rat Spinal Cord	PLOS ONE			English	Article							BLOOD-FLOW; PATHOPHYSIOLOGY; LOCOMOTION; RECOVERY; BRAIN; TRAUMA; LESION; IMPACT; DISPLACEMENT; OUTCOMES	Cellular mechanisms of secondary damage progression following spinal cord injury remain unclear. We have studied the extent of tissue damage from 15 min to 10 weeks after injury using morphological and biochemical estimates of lesion volume and surviving grey and white matter. This has been achieved by semi-quantitative immunocytochemical methods for a range of cellular markers, quantitative counts of white matter axonal profiles in semi-thin sections and semi-quantitative Western blot analysis, together with behavioural tests (BBB scores, ledged beam, random rung horizontal ladder and DigiGait (TM) analysis). We have developed a new computer-controlled electronic impactor based on a linear motor that allows specification of the precise nature, extent and timing of the impact. Initial (15 min) lesion volumes showed very low variance (1.92 +/- 0.23 mm(3), mean +/- SD, n = 5). Although substantial tissue clearance continued for weeks after injury, loss of grey matter was rapid and complete by 24 hours, whereas loss of white matter extended up to one week. No change was found between one and 10 weeks after injury for almost all morphological and biochemical estimates of lesion size or behavioural methods. These results suggest that previously reported apparent ongoing injury progression is likely to be due, to a large extent, to clearance of tissue damaged by the primary impact rather than continuing cell death. The low variance of the impactor and the comprehensive assessment methods described in this paper provide an improved basis on which the effects of potential treatment regimes for spinal cord injury can be assessed.	[Ek, C. Joakim; Habgood, Mark D.; Callaway, Jennifer K.; Dennis, Ross; Dziegielewska, Katarzyna M.; Johansson, Pia A.; Potter, Ann; Wheaton, Benjamin; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	University of Melbourne	Ek, CJ (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	n.saunders@unimelb.edu.au	Wheaton, Ben/AAC-7037-2021	Wheaton, Benjamin/0000-0003-0619-4777; Johansson, Pia/0000-0002-6938-4060; Saunders, Norman/0000-0001-6660-7639	Victorian Neurotrauma Initiative [DP048]	Victorian Neurotrauma Initiative	This work was supported by the Victorian Neurotrauma Initiative (Grant #DP048). For more information about this research fund, go to http://www.vni.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AR, 1911, JAMA 57, P878, DOI [10.1001/jama.1911.04260090100008, DOI 10.1001/JAMA.1911.04260090100008]; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Andrade MSR, 2008, TISSUE CELL, V40, P143, DOI 10.1016/j.tice.2007.11.002; BALENTINE JD, 1978, LAB INVEST, V39, P236; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; EDGERTON VR, 1992, J NEUROTRAUM, V9, pS119; Ghasemlou N, 2005, EXP NEUROL, V196, P9, DOI 10.1016/j.expneurol.2005.05.017; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GUHA A, 1989, STROKE, V20, P372, DOI 10.1161/01.STR.20.3.372; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670; Kim JH, 2009, J NEUROTRAUM, V26, P1395, DOI [10.1089/neu.2008.0728, 10.1089/neu.2008-0728]; Koopmans GC, 2009, EXP NEUROL, V216, P490, DOI 10.1016/j.expneurol.2009.01.005; KOYANAGI I, 1993, NEUROSURGERY, V32, P260, DOI 10.1227/00006123-199302000-00015; KOYANAGI I, 1993, NEUROSURGERY, V33, P277; LANGE W, 1978, ANAT EMBRYOL, V152, P325, DOI 10.1007/BF00350528; Lonjon N, 2010, J NEUROSURG-SPINE, V12, P106, DOI 10.3171/2009.7.SPINE0989; MUIR GD, 1995, J NEUROPHYSIOL, V74, P358, DOI 10.1152/jn.1995.74.1.358; Narayana PA, 2004, J NEUROSCI RES, V78, P749, DOI 10.1002/jnr.20275; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; NOYES DH, 1987, EXP NEUROL, V95, P535, DOI 10.1016/0014-4886(87)90298-6; Onose G, 2009, SPINAL CORD, V47, P716, DOI 10.1038/sc.2009.52; Oschipok LW, 2008, NEUROSCI LETT, V434, P113, DOI 10.1016/j.neulet.2008.01.048; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; Rossignol S, 1993, J Am Paraplegia Soc, V16, P190; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Schallert T, 2000, PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000, P329; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; STOKES BT, 1992, J NEUROTRAUM, V9, P187, DOI 10.1089/neu.1992.9.187; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1992, J NEUROTRAUM, V9, P139, DOI 10.1089/neu.1992.9.139; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; WALLACE MC, 1986, NEUROSURGERY, V18, P433; Wannier-Morino P, 2008, BRAIN RES, V1217, P96, DOI 10.1016/j.brainres.2007.11.019; WOOLLAM DHM, 1955, J NEUROL NEUROSUR PS, V18, P97, DOI 10.1136/jnnp.18.2.97; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; Yeo J D, 1984, Cent Nerv Syst Trauma, V1, P161; Young W, 2002, PROG BRAIN RES, V137, P231; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	58	68	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12021	10.1371/journal.pone.0012021	http://dx.doi.org/10.1371/journal.pone.0012021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711496	Green Published, gold			2022-12-25	WOS:000280776800012
J	Gautier, M; Hocking, TD; Foulley, JL				Gautier, Mathieu; Hocking, Toby Dylan; Foulley, Jean-Louis			A Bayesian Outlier Criterion to Detect SNPs under Selection in Large Data Sets	PLOS ONE			English	Article							ADAPTIVE GENETIC-DIVERGENCE; LOCI; POLYMORPHISM; FREQUENCY; SIGNATURES; INFERENCE; MARKERS; MODEL; SCAN; MAP	Background: The recent advent of high-throughput SNP genotyping technologies has opened new avenues of research for population genetics. In particular, a growing interest in the identification of footprints of selection, based on genome scans for adaptive differentiation, has emerged. Methodology/Principal Findings: The purpose of this study is to develop an efficient model-based approach to perform Bayesian exploratory analyses for adaptive differentiation in very large SNP data sets. The basic idea is to start with a very simple model for neutral loci that is easy to implement under a Bayesian framework and to identify selected loci as outliers via Posterior Predictive P-values (PPP-values). Applications of this strategy are considered using two different statistical models. The first one was initially interpreted in the context of populations evolving respectively under pure genetic drift from a common ancestral population while the second one relies on populations under migration-drift equilibrium. Robustness and power of the two resulting Bayesian model-based approaches to detect SNP under selection are further evaluated through extensive simulations. An application to a cattle data set is also provided. Conclusions/Significance: The procedure described turns out to be much faster than former Bayesian approaches and also reasonably efficient especially to detect loci under positive selection.	[Gautier, Mathieu; Hocking, Toby Dylan; Foulley, Jean-Louis] INRA, GABI UMR1313, Jouy En Josas, France; [Gautier, Mathieu] INRA, CBGP UMR1031, Montferrier Sur Lez, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut de Recherche pour le Developpement (IRD)	Gautier, M (corresponding author), INRA, GABI UMR1313, Jouy En Josas, France.	mathieu.gautier@jouy.inra.fr	gautier, mathieu/F-7429-2010; gautier, mathieu/AAU-8789-2020	gautier, mathieu/0000-0001-7257-5880; gautier, mathieu/0000-0001-7257-5880	French National Institute of Agronomic Research (INRA)	French National Institute of Agronomic Research (INRA)	This work was supported by the French National Institute of Agronomic Research (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; Bayarri MJ, 2007, STAT SCI, V22, P322, DOI 10.1214/07-STS235; BAZIN E, 2010, LIKELIHOOD IN PRESS; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2008, GENETICS, V179, P927, DOI 10.1534/genetics.107.084541; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 2004, BAYESIAN DATA ANAL; Guillot G, 2009, BIOINFORMATICS, V25, P552, DOI 10.1093/bioinformatics/btn665; Guo F, 2009, J AM STAT ASSOC, V104, P142, DOI 10.1198/jasa.2009.0010; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LEWONTIN RC, 1973, GENETICS, V74, P175; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Riebler A, 2008, GENETICS, V178, P1817, DOI 10.1534/genetics.107.081281; ROBERTSON A, 1975, GENETICS, V81, P775; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Vitalis R, 2001, GENETICS, V158, P1811; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405	31	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11913	10.1371/journal.pone.0011913	http://dx.doi.org/10.1371/journal.pone.0011913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689851	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520400010
J	de Herve, MGD; Gonzales, E; Hendel-Chavez, H; Decline, JL; Mourier, O; Abbed, K; Jacquemin, E; Taoufik, Y				de Herve, Marie-Ghislaine de Goer; Gonzales, Emmanuel; Hendel-Chavez, Houria; Decline, Jean-Luc; Mourier, Olivia; Abbed, Karim; Jacquemin, Emmanuel; Taoufik, Yassine			CD25 Appears Non Essential for Human Peripheral T-reg Maintenance In Vivo	PLOS ONE			English	Article							FOOD ALLERGY; LIVER-TRANSPLANTATION; STRUCTURAL BASIS; CELLS; INTERLEUKIN-2; TACROLIMUS; EXPRESSION; FOXP3; BASILIXIMAB; CHILDREN	Background: IL-2 has been reported to be critical for peripheral T-reg survival in mouse models. Here, we examined T-reg maintenance in a series of paediatric liver transplant recipients who received basiliximab, a therapeutic anti-CD25 monoclonal antibody. Methodology/Principal Findings: FoxP3(+) CD4 T cells were analyzed by flow cytometry before liver grafting and more than 9 months later. We found that in vivo CD25 blockade did not lead to Treg depletion: the proportion of FoxP3(+) cells among CD4 T cells and the level of FoxP3 expression were both unchanged. IL-2R beta expression was enhanced in FoxP3(+) cells both before and after basiliximab treatment, while the level of IL-2R gamma expression was similar in T-regs and non-T-regs. No significant change in the weak or absent expression of IL-7R alpha and IL-15R alpha expression on FoxP3(+) cells was observed. Although the proportion of FoxP3(+) cells among CD4 T cells did not vary, food allergies occurred more rapidly after liver grafting in patients who received basiliximab, raising questions as to T-reg functionality in vivo in the absence of functional CD25. Conclusions: CD25 appears non essential for human T-reg peripheral maintenance in vivo. However, our results raise questions as to T-reg functionality after therapeutic CD25 targeting.	[de Herve, Marie-Ghislaine de Goer; Hendel-Chavez, Houria; Abbed, Karim; Taoufik, Yassine] CHU Bicetre, Unite Immunol Biol, Le Kremlin Bicetre, France; [de Herve, Marie-Ghislaine de Goer; Hendel-Chavez, Houria; Taoufik, Yassine] INSERM 10 12, Fac Med, Le Kremlin Bicetre, France; [de Herve, Marie-Ghislaine de Goer; Taoufik, Yassine] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Gonzales, Emmanuel; Decline, Jean-Luc; Mourier, Olivia; Jacquemin, Emmanuel] CHU Bicetre, Serv Hepatol Pediat, Le Kremlin Bicetre, France; [Gonzales, Emmanuel; Decline, Jean-Luc; Mourier, Olivia; Jacquemin, Emmanuel] CHU Bicetre, Ctr Reference Natl Atresie Voies Biliaires, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	de Herve, MGD (corresponding author), CHU Bicetre, Unite Immunol Biol, Le Kremlin Bicetre, France.	yassine.taoufik@bct.aphp.fr	jacquemin, emmanuel/J-8673-2013; Gonzales, Emmanuel/J-8730-2013	GONZALES, Emmanuel/0000-0002-1546-3193	Assistance Publique-Hopitaux de Paris (AP-HP)	Assistance Publique-Hopitaux de Paris (AP-HP)	Funding was provided by Assistance Publique-Hopitaux de Paris (AP-HP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2009, CURR OPIN IMMUNOL, V21, P700, DOI 10.1016/j.coi.2009.07.012; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Arikan C, 2003, TRANSPLANT P, V35, P3039, DOI 10.1016/j.transproceed.2003.10.033; Bayer AL, 2008, J IMMUNOL, V181, P225, DOI 10.4049/jimmunol.181.1.225; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Binder M, 2007, CANCER RES, V67, P3518, DOI 10.1158/0008-5472.CAN-06-3919; Bluestone JA, 2008, AM J TRANSPLANT, V8, P2086, DOI 10.1111/j.1600-6143.2008.02377.x; Boyle RJ, 2005, LIVER TRANSPLANT, V11, P326, DOI 10.1002/lt.20368; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dell-Olio D, 2009, PEDIATR TRANSPLANT, V13, P670, DOI 10.1111/j.1399-3046.2009.01184.x; Du JM, 2010, J IMMUNOL, V184, P1361, DOI 10.4049/jimmunol.0903178; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gabe SM, 1998, GASTROENTEROLOGY, V115, P67, DOI 10.1016/S0016-5085(98)70366-X; Kahan BD, 1999, TRANSPLANTATION, V67, P276, DOI 10.1097/00007890-199901270-00016; Kelly D, 2004, LANCET, V364, P1054, DOI 10.1016/S0140-6736(04)17060-8; Levy Y, 2009, PEDIATR TRANSPLANT, V13, P63, DOI 10.1111/j.1399-3046.2007.00883.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pescovitz MD, 2008, CURR OPIN ORGAN TRAN, V13, P495, DOI 10.1097/MOT.0b013e328310b0ba; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanchez-Fueyo A, 2007, TRANSPL INT, V20, P534, DOI 10.1111/j.1432-2277.2007.00470.x; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Torgerson TR, 2007, GASTROENTEROLOGY, V132, P1705, DOI 10.1053/j.gastro.2007.02.044; von Boehmer H, 2003, J EXP MED, V198, P845, DOI 10.1084/jem.20031358; VONDRAN FW, 2009, TRANSPL INT; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang Z, 2009, CLIN EXP IMMUNOL, V155, P496, DOI 10.1111/j.1365-2249.2008.03847.x	37	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11784	10.1371/journal.pone.0011784	http://dx.doi.org/10.1371/journal.pone.0011784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689592	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520300006
J	Hanin, A; Sava, I; Bao, YY; Huebner, J; Hartke, A; Auffray, Y; Sauvageot, N				Hanin, Aurelie; Sava, Irina; Bao, YinYin; Huebner, Johannes; Hartke, Axel; Auffray, Yanick; Sauvageot, Nicolas			Screening of In Vivo Activated Genes in Enterococcus faecalis during Insect and Mouse Infections and Growth in Urine	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; EXPRESSION TECHNOLOGY; STREPTOCOCCUS-PNEUMONIAE; PATHOGENICITY ISLAND; LACTOCOCCUS-LACTIS; VIRULENCE GENES; TRANSCRIPTIONAL REGULATOR; PSEUDOMONAS-AERUGINOSA; LISTERIA-MONOCYTOGENES; AGGREGATION SUBSTANCE	Enterococcus faecalis is part of the commensal microbiota of humans and its main habitat is the gastrointestinal tract. Although harmless in healthy individuals, E. faecalis has emerged as a major cause of nosocomial infections. In order to better understand the transformation of a harmless commensal into a life-threatening pathogen, we developed a Recombination-based In Vivo Expression Technology for E. faecalis. Two R-IVET systems with different levels of sensitivity have been constructed in a E. faecalis V583 derivative strain and tested in the insect model Galleria mellonella, during growth in urine, in a mouse bacteremia and in a mouse peritonitis model. Our combined results led to the identification of 81 in vivo activated genes. Among them, the ef_3196/7 operon was shown to be strongly induced in the insect host model. Deletion of this operonic structure demonstrated that this two-component system was essential to the E. faecalis pathogenic potential in Galleria. Gene ef_0377, induced in insect and mammalian models, has also been further analyzed and it has been demonstrated that this ankyrin-encoding gene was also involved in E. faecalis virulence. Thus these R-IVET screenings led to the identification of new E. faecalis factors implied in in vivo persistence and pathogenic potential of this opportunistic pathogen.	[Hanin, Aurelie; Hartke, Axel; Auffray, Yanick; Sauvageot, Nicolas] Univ Caen, Lab Microbiol Environm, USC INRA 2017 EA956, F-14032 Caen, France; [Sava, Irina; Bao, YinYin; Huebner, Johannes] Univ Med Ctr, Dept Med, Div Infect Dis, Freiburg, Germany	INRAE; Universite de Caen Normandie; University of Freiburg	Hanin, A (corresponding author), Univ Caen, Lab Microbiol Environm, USC INRA 2017 EA956, F-14032 Caen, France.	nicolas.sauvageot@unicaen.fr	Hanin, Aurélie/AAQ-1072-2021	Hanin, Aurélie/0000-0003-4469-537X; Huebner, Johannes/0000-0003-1232-4646	French Ministre de l'Enseignement suparieur et de la Recherche; Agence Nationale de la Recherche [ANR-06-PATHO-008-01]	French Ministre de l'Enseignement suparieur et de la Recherche; Agence Nationale de la Recherche(French National Research Agency (ANR))	Auralie Hanin is a PhD student whose thesis was granted by the French Ministre de l'Enseignement suparieur et de la Recherche. This work was partly supported by grants from the Agence Nationale de la Recherche in the frame of a transnational ERA-NET PathoGenoMics program (ANR-06-PATHO-008-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Angelichio MJ, 2002, INFECT IMMUN, V70, P6518, DOI 10.1128/IAI.70.12.6518-6523.2002; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; BACHMANN H, 2010, ENV MICROBIOL; Bachmann H, 2008, APPL ENVIRON MICROB, V74, P4727, DOI 10.1128/AEM.00297-08; Ballering KS, 2009, J BACTERIOL, V191, P2806, DOI 10.1128/JB.01688-08; Benachour A, 2007, CURR MICROBIOL, V54, P342, DOI 10.1007/s00284-006-0358-1; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Camilli A, 1995, MOL MICROBIOL, V18, P671, DOI 10.1111/j.1365-2958.1995.mmi_18040671.x; Castillo AR, 2008, INFECT IMMUN, V76, P5632, DOI 10.1128/IAI.00627-08; Charpentier E, 2000, MOL MICROBIOL, V37, P717, DOI 10.1046/j.1365-2958.2000.02011.x; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2008, INFECT IMMUN, V76, P5668, DOI 10.1128/IAI.00930-08; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Gahan CGM, 2000, MOL MICROBIOL, V36, P498, DOI 10.1046/j.1365-2958.2000.01869.x; Gaspar F, 2009, MICROBIOL-SGM, V155, P3564, DOI 10.1099/mic.0.030775-0; Giard JC, 2003, REC RES DEV MICROBIO, V7, P325; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; Hancock LE, 2004, J BACTERIOL, V186, P7951, DOI 10.1128/JB.186.23.7951-7958.2004; HANCOCK LE, 2000, PATHOGENICITY ENTERO, P251; HOESS RH, 1984, P NATL ACAD SCI-BIOL, V81, P1026, DOI 10.1073/pnas.81.4.1026; Hollands A, 2010, J INFECT DIS, V202, P11, DOI 10.1086/653124; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Howell ML, 2000, J BACTERIOL, V182, P4545, DOI 10.1128/JB.182.16.4545-4556.2000; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Ibrahim YM, 2005, INFECT IMMUN, V73, P730, DOI 10.1128/IAI.73.2.730-740.2005; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; KONARSKAKOZLOWSKA M, 1981, GENE, V14, P195, DOI 10.1016/0378-1119(81)90115-3; KREFT B, 1992, INFECT IMMUN, V60, P25, DOI 10.1128/IAI.60.1.25-30.1992; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lebreton F, 2009, INFECT IMMUN, V77, P2832, DOI 10.1128/IAI.01218-08; MAHAN MJ, 1995, P NATL ACAD SCI USA, V92, P669, DOI 10.1073/pnas.92.3.669; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Nair S, 2000, INFECT IMMUN, V68, P7061, DOI 10.1128/IAI.68.12.7061-7068.2000; Osorio CG, 2005, INFECT IMMUN, V73, P972, DOI 10.1128/IAI.73.2.972-980.2005; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Park SY, 2007, INFECT IMMUN, V75, P1861, DOI 10.1128/IAI.01473-06; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Rainey PB, 2000, CURR OPIN BIOTECH, V11, P440, DOI 10.1016/S0958-1669(00)00132-4; Riboulet E, 2007, J MOL MICROB BIOTECH, V13, P140, DOI 10.1159/000103605; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Shankar N, 2004, INT J MED MICROBIOL, V293, P609, DOI 10.1078/1438-4221-00301; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Sood S, 2008, INDIAN J MED RES, V128, P111; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; TINOCO I, 1973, NATURE-NEW BIOL, V246, P40, DOI 10.1038/newbio246040a0; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660	58	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11879	10.1371/journal.pone.0011879	http://dx.doi.org/10.1371/journal.pone.0011879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686694	Green Submitted, gold, Green Published			2022-12-25	WOS:000280520200041
J	Patel, HB; Bombardieri, M; Sampaio, ALF; D'Acquisto, F; Gray, M; Grieco, P; Getting, SJ; Pitzalis, C; Perretti, M				Patel, Hetal B.; Bombardieri, Michele; Sampaio, Andre L. F.; D'Acquisto, Fulvio; Gray, Mohini; Grieco, Paolo; Getting, Stephen J.; Pitzalis, Costantino; Perretti, Mauro			Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis	FASEB JOURNAL			English	Article						G-protein-coupled receptor; melanocortins; bone erosion; osteoclasts; cytokines	MELANOCYTE-STIMULATING HORMONE; MAST-CELLS; OSTEOCLAST DIFFERENTIATION; INFLAMMATORY ARTHRITIS; RHEUMATOID-ARTHRITIS; PRECURSOR PROTEASES; ALPHA-MSH; EXPRESSION; RESOLUTION; DISEASE	The development of biological therapies has improved management of rheumatoid arthritis. However, costs and unresponsiveness to therapy in a sizeable proportion of patients limit their use, making it imperative to identify new targets for drug development programs. Here we investigated the melanocortin-receptor type 3 (MC3) pathway. Gene-deficient mice were subjected to a model of serum-transfer-induced arthritis and joints analyzed for gene expression (cytokines, MCs) and morphology. Pharmacological analyses were also conducted in this model. Osteoclastogenesis was studied from bone marrow cells. Mc(3)(-/-) mice displayed an exacerbated inflammatory arthritis, associated with prominent bone erosion and higher articular expression of Rankl. Osteoclastogenesis studied from Mc(3)(-/-) bone marrow cells revealed a higher degree of responsiveness to Rankl, linked to prolonged NF-kappa B activation compared to wild types. Up-regulation of a discrete set of inflammatory genes, including Il-1 beta, Il-6, and Nos2, was measured in Mc(3)(-/-) mice, and a marked up-regulation of joint Mc(3) accompanied arthritis resolution in wild-type mice. Administration of an MC3 agonist, D[Trp8]-gamma-MSH, attenuated disease incidence and severity in wild-type but not Mc(3)(-/)- mice. Overall, these findings identify MC3-mediated signaling as a beneficial pathway in experimental arthritis; hence this receptor is a novel target for the development of therapeutics for arthritis.-Patel, H. B., Bombardieri, M., Sampaio, A. L. F., D'Acquisto, F., Gray, M., Grieco, P., Getting, S. J., Pitzalis, C., Perretti, M. Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis. FASEB J. 24, 4835-4843 (2010). www.fasebj.org	[Patel, Hetal B.; Bombardieri, Michele; Sampaio, Andre L. F.; D'Acquisto, Fulvio; Pitzalis, Costantino; Perretti, Mauro] Queen Mary Univ, Barts & London Sch Med, William Harvey Res Inst, London EC1M 6BQ, England; [Gray, Mohini] Univ Edinburgh, Med Res Council Ctr Inflammat, Edinburgh, Midlothian, Scotland; [Grieco, Paolo] Univ Naples Federico 2, Dept Pharmaceut Chem & Toxicol, Naples, Italy; [Getting, Stephen J.] Univ Westminster, London W1R 8AL, England	University of London; Queen Mary University London; University of Edinburgh; University of Naples Federico II; University of Westminster	Perretti, M (corresponding author), Queen Mary Univ, Barts & London Sch Med, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	m.perretti@qmul.ac.uk	D'Acquisto, Fulvio/E-7204-2018; Grieco, Paolo/AAB-9034-2019	D'Acquisto, Fulvio/0000-0002-4513-1608; Grieco, Paolo/0000-0002-6854-8123; Pitzalis, Costantino/0000-0003-1326-5051	Arthritis Research UK [17299, 18049]; UK National Institute of Health Research; Medical Research Council [G9900991B] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); UK National Institute of Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Drs. Mike Seed and Alessandra Marrelli and Anthony Huggins for assistance with histology, TRAP staining, and EMSA analyses, respectively. M.P. declares a collaborative project on novel melanocortins with Action Pharma A/S (Copenhagen, Denmark). P.G. owns a patent on the synthesis of the MC3 agonist used in this study. C.P. and M.P. share senior authorship. The study was funded by Arthritis Research UK (grants 17299 and 18049). This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the UK National Institute of Health Research.	Adachi S, 1999, J IMMUNOL, V163, P3363; Alexander SPH, 2009, BRIT J PHARMACOL, V158, pS1, DOI 10.1111/j.1476-5381.2009.00499.x; Artuc M, 2006, J INVEST DERMATOL, V126, P1976, DOI 10.1038/sj.jid.5700318; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Ceriani Giuliana, 1994, Neuroimmunomodulation, V1, P28, DOI 10.1159/000097087; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Getting SJ, 2001, J LEUKOCYTE BIOL, V69, P98; Getting SJ, 2006, FASEB J, V20, P2234, DOI 10.1096/fj.06-6339com; Getting SJ, 2006, PHARMACOL THERAPEUT, V111, P1, DOI 10.1016/j.pharmthera.2005.06.022; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Grassel S, 2009, ARTHRITIS RHEUM-US, V60, P3017, DOI 10.1002/art.24846; Grieco P, 2000, J MED CHEM, V43, P4998, DOI 10.1021/jm000211e; GUTMAN AB, 1950, AM J MED, V9, P24, DOI 10.1016/0002-9343(50)90004-0; HENCH PS, 1949, P STAFF M MAYO CLIN, V24, P181; Huggins A, 2009, FASEB J, V23, P985, DOI 10.1096/fj.08-119040; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Leoni G, 2008, FASEB J, V22, P4228, DOI 10.1096/fj.08-113886; Lipton JM, 1997, IMMUNOL TODAY, V18, P140, DOI 10.1016/S0167-5699(97)01009-8; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; RITTER J, 1994, J RHEUMATOL, V21, P696; Ruschpler P, 2003, ARTHRITIS RES THER, V5, pR241, DOI 10.1186/ar783; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; Schlesinger N, 2008, DRUGS, V68, P407, DOI 10.2165/00003495-200868040-00002; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Solomon S, 2005, EUR J IMMUNOL, V35, P3064, DOI 10.1002/eji.200526167; STAR RA, 1995, P NATL ACAD SCI USA, V92, P8016, DOI 10.1073/pnas.92.17.8016; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tolar J, 2004, NEW ENGL J MED, V350, P735, DOI 10.1056/NEJM200402123500723; Zhong Q, 2005, BONE, V36, P820, DOI 10.1016/j.bone.2005.01.020; Zhou HF, 2009, FASEB J, V23, P2978, DOI 10.1096/fj.09-129874	46	40	41	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4835	4843		10.1096/fj.10-167759	http://dx.doi.org/10.1096/fj.10-167759			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20702773				2022-12-25	WOS:000284824400023
J	Bateman, AC; Karamanska, R; Busch, MG; Dell, A; Olsen, CW; Haslam, SM				Bateman, Allen C.; Karamanska, Rositsa; Busch, Marc G.; Dell, Anne; Olsen, Christopher W.; Haslam, Stuart M.			Glycan Analysis and Influenza A Virus Infection of Primary Swine Respiratory Epithelial Cells THE IMPORTANCE OF NeuAc alpha 2-6 GLYCANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOLYLNEURAMINIC ACID; RECEPTOR-BINDING SPECIFICITY; ACYL SIDE-CHAIN; SIALIC-ACID; GENETIC-CHARACTERIZATION; UNITED-STATES; PIGS; HEMAGGLUTININ; IDENTIFICATION; NEURAMINIDASE	To better understand influenza virus infection of pigs, we examined primary swine respiratory epithelial cells (SRECs, the primary target cells of influenza viruses in vivo), as a model system. Glycomic profiling of SRECs by mass spectrometry revealed a diverse range of glycans terminating in sialic acid or Gal alpha Gal. In terms of sialylation, alpha 2-6 linkage was more abundant than alpha 2-3, and NeuAc was more abundant than NeuGc. Virus binding and infection experiments were conducted to determine functionally important glycans for influenza virus infection, with a focus on recently emerged swine viruses. Infection of SRECs with swine and human viruses resulted in different infectivity levels. Glycan microarray analysis with a high infectivity "triple reassortant" virus ((A/Swine/MN/593/99 (H3N2)) that spread widely throughout the North American swine population and a lower infectivity human virus isolated from a single pig (A/Swine/ONT/00130/97 (H3N2)) showed that both viruses bound exclusively to glycans containing NeuAc alpha 2-6, with strong binding to sialylated polylactosamine and sialylatedN-glycans. Treatment with mannosamine precursors of sialic acid (to alter NeuAc/NeuGc abundances) and linkage-specific sialidases prior to infection indicated that the influenza viruses tested preferentially utilize NeuAc alpha 2-6-sialylated glycans to infect SRECs. Our data indicate that NeuAc alpha 2-6-terminated polylactosamine and sialylated N- glycans are important determinants for influenza viruses to infect SRECs. As NeuAc alpha 2-6 polylactosamine glycans play major roles in human virus infection, the importance of these receptor components in virus infection of swine cells has implications for transmission of viruses between humans and pigs and for pigs as possible adaptation hosts of novel human influenza viruses.	[Bateman, Allen C.; Busch, Marc G.; Olsen, Christopher W.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Bateman, Allen C.] Univ Wisconsin, Sch Vet Med, Cellular & Mol Biol Grad Program, Madison, WI 53706 USA; [Karamanska, Rositsa; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Imperial College London	Olsen, CW (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, 2015 Linden Dr, Madison, WI 53706 USA.	olsenc@svm.vetmed.wisc.edu; s.haslam@imperial.ac.uk			National Institutes of Health [R01 AI060646]; Wellcome Trust [082098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI060646 (to C. W. O.). This work was also supported by Grant 082098 from the Wellcome Trust (to S. M. H. and A. D.).	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bateman AC, 2008, J VIROL, V82, P8204, DOI 10.1128/JVI.00718-08; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Busch MG, 2008, VIRUS RES, V133, P269, DOI 10.1016/j.virusres.2008.01.014; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; FUKUDA MN, 1976, J BIOL CHEM, V251, P6218; GALILI U, 1988, J BIOL CHEM, V263, P17755; Gambaryan AS, 2005, VIRUS RES, V114, P15, DOI 10.1016/j.virusres.2005.05.005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Goldberg D, 2005, PROTEOMICS, V5, P865, DOI 10.1002/pmic.200401071; Gulati S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-22; Guo CT, 2007, GLYCOBIOLOGY, V17, P713, DOI 10.1093/glycob/cwm038; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; Karasin AI, 2000, J CLIN MICROBIOL, V38, P2453; Karasin AI, 2002, J CLIN MICROBIOL, V40, P1073, DOI 10.1128/JCM.40.3.1073-1079.2002; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Keppler OT, 1998, BIOCHEM BIOPH RES CO, V253, P437, DOI 10.1006/bbrc.1998.9650; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Landolt GA, 2006, J CLIN MICROBIOL, V44, P297, DOI 10.1128/JCM.44.2.297-301.2006; Landolt GA, 2003, J CLIN MICROBIOL, V41, P1936, DOI 10.1128/JCM.41.5.1936-1941.2003; Landolt Gabriele A., 2007, Animal Health Research Reviews, V8, P1, DOI 10.1017/S1466252307001272; Lugovtsev VY, 2009, VIROLOGY, V394, P218, DOI 10.1016/j.virol.2009.08.014; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Ma WJ, 2006, J VIROL, V80, P5092, DOI 10.1128/JVI.80.10.5092-5096.2006; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Miller-Podraza H, 2000, GLYCOBIOLOGY, V10, P975, DOI 10.1093/glycob/10.10.975; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; OGATA M, 2009, BIOMACROMOLECULES; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Suzuki T, 1997, FEBS LETT, V404, P192, DOI 10.1016/S0014-5793(97)00127-0; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Van Poucke SGM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-38; VINCENT AL, 2009, VIRUS GENES; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	57	75	77	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34016	34026		10.1074/jbc.M110.115998	http://dx.doi.org/10.1074/jbc.M110.115998			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20724471	Green Published, hybrid			2022-12-25	WOS:000283354000048
J	Fang, LH; Harkewicz, R; Hartvigsen, K; Wiesner, P; Choi, SH; Almazan, F; Pattison, J; Deer, E; Sayaphupha, T; Dennis, EA; Witztum, JL; Tsimikas, S; Miller, YI				Fang, Longhou; Harkewicz, Richard; Hartvigsen, Karsten; Wiesner, Philipp; Choi, Soo-Ho; Almazan, Felicidad; Pattison, Jennifer; Deer, Elena; Sayaphupha, Tiffany; Dennis, Edward A.; Witztum, Joseph L.; Tsimikas, Sotirios; Miller, Yury I.			Oxidized Cholesteryl Esters and Phospholipids in Zebrafish Larvae Fed a High Cholesterol Diet MACROPHAGE BINDING AND ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; APOPTOTIC CELLS; ACTIN POLYMERIZATION; LDL; ATHEROSCLEROSIS; 12/15-LIPOXYGENASE; ACCUMULATION; LIGANDS; CD36	A novel hypercholesterolemic zebrafish model has been developed to study early events of atherogenesis. This model utilizes optically transparent zebrafish larvae, fed a high cholesterol diet (HCD), to monitor processes of vascular inflammation in live animals. Because lipoprotein oxidation is an important factor in the development of atherosclerosis, in this study, we characterized the oxidized lipid milieu in HCD-fed zebrafish larvae. Using liquid chromatography-mass spectrometry, we show that feeding an HCD for only 2 weeks resulted in up to 70-fold increases in specific oxidized cholesteryl esters, identical to those present in human minimally oxidized LDL and in murine atherosclerotic lesions. The levels of oxidized phospholipids, suchas1-palmitoyl-2-oxovaleroyl-sn-glycero-3-phosphocholine, and of various lysophosphatidylcholines were also significantly elevated. Moreover, lipoproteins isolated from homogenates of HCD-fed larvae induced cell spreading as well as ERK1/2, Akt, and JNK phosphorylation in murine macrophages. Removal of apoB-containing lipoproteins from the zebrafish homogenates with an anti-human LDL antibody, as well as reducing lipid hydroperoxides with ebselen, resulted in inhibition of macrophage activation. The TLR4 deficiency in murine macrophages prevented their activation with zebrafish lipoproteins. Using biotinylated homogenates of HCD-fed larvae, we demonstrated that their components bound to murine macrophages, and this binding was effectively competed by minimally oxidized LDL but not by native LDL. These data provide evidence that molecular lipid determinants of proatherogenic macrophage phenotypes are present in large quantities in hypercholesterolemic zebrafish larvae and support the use of the HCD-fed zebrafish as a valuable model to study early events of atherogenesis.	[Fang, Longhou; Hartvigsen, Karsten; Wiesner, Philipp; Choi, Soo-Ho; Almazan, Felicidad; Pattison, Jennifer; Deer, Elena; Sayaphupha, Tiffany; Witztum, Joseph L.; Tsimikas, Sotirios; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Harkewicz, Richard; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Harkewicz, Richard; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Miller, YI (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	yumiller@ucsd.edu	Dennis, Edward A./M-5554-2019; Fang, Longhou/G-6582-2013	Dennis, Edward A./0000-0003-3738-3140; Fang, Longhou/0000-0003-1653-5221	National Institutes of Health [HL093767, HL081862, GM069338, HL088093, P30 CA23100]; University of California [18FT-0137]; Leducq Foundation; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081862, R01HL093767, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); Leducq Foundation(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093767 (to Y. I. M. and L. F.), HL081862 (to Y. I. M.), GM069338 (to E. A. D., J. L. W., R. H., and Y. I. M.), and HL088093 (to J. L. W. and Y. I. M.). This work was also supported by University of California Tobacco-related Disease Program Fellowship 18FT-0137 (to L. F.) as well as a grant from the Leducq Foundation (to J. L. W. and Y. I. M.). The University of California, San Diego Cancer Center Shared Imaging Resource is funded by National Institutes of Health Specialized Support Grant P30 CA23100.	Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Boullier A, 2006, ARTERIOSCL THROM VAS, V26, P1169, DOI 10.1161/01.ATV.0000210279.97308.9a; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Harkewicz R, 2008, J BIOL CHEM, V283, P10241, DOI 10.1074/jbc.M709006200; Hartvigsen K, 2009, J LIPID RES, V50, pS388, DOI 10.1194/jlr.R800100-JLR200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Miller YI, 2003, MOL BIOL CELL, V14, P4196, DOI 10.1091/mbc.E03-02-0063; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Miller YI, 2010, SUBCELL BIOCHEM, V51, P229, DOI 10.1007/978-90-481-8622-8_8; Oorni K, 2009, CURR OPIN LIPIDOL, V20, P421, DOI 10.1097/MOL.0b013e32832fa14d; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420	25	71	72	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32343	32351		10.1074/jbc.M110.137257	http://dx.doi.org/10.1074/jbc.M110.137257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20710028	hybrid, Green Published			2022-12-25	WOS:000282683000047
J	Fujisawa, M; Fackelmayer, OJ; Liu, J; Krulwich, TA; Hicks, DB				Fujisawa, Makoto; Fackelmayer, Oliver J.; Liu, Jun; Krulwich, Terry A.; Hicks, David B.			The ATP Synthase a-subunit of Extreme Alkaliphiles Is a Distinct Variant MUTATIONS IN THE CRITICAL ALKALIPHILE-SPECIFIC RESIDUE LYS-180 AND OTHER RESIDUES THAT SUPPORT ALKALIPHILE OXIDATIVE PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-FIRMUS OF4; AQUEOUS ACCESS PATHWAYS; C-RING ROTATION; ESCHERICHIA-COLI; ADENOSINE-TRIPHOSPHATE; PROTON TRANSLOCATION; ESSENTIAL ARGININE; F1F0-ATP SYNTHASE; ROTARY MECHANISM; CROSS-LINKING	A lysine residue in the putative proton uptake pathway of the ATP synthase a-subunit is found only in alkaliphilic Bacillus species and is proposed to play roles in proton capture, retention and passage to the synthase rotor. Here, Lys-180 was replaced with alanine (Ala), glycine (Gly), cysteine (Cys), arginine (Arg), or histidine (His) in the chromosome of alkaliphilic Bacillus pseudofirmus OF4. All mutants exhibited octylglucoside-stimulated ATPase activity and beta-subunit levels at least as high as wild-type. Purified mutant F1F0-ATP synthases all contained substantial a-subunit levels. The mutants exhibited diverse patterns of native (no octylglucoside) ATPase activity and a range of defects in malate growth and in vitro ATP synthesis at pH 10.5. ATP synthesis by the Ala, Gly, and His mutants was also impaired at pH 7.5 in the presence of a protonophoric uncoupler. Thus Lys-180 plays a role when the protonmotive force is reduced at near neutral, not just at high pH. The Arg mutant exhibited no ATP synthesis activity in the alkaliphile setting although activity was reported for a K180R mutant of a thermoalkaliphile synthase (McMillan, D. G., Keis, S., Dimroth, P., and Cook, G. M. (2007) J. Biol. Chem. 282, 17395-17404). The hypothesis that a-subunits from extreme alkaliphiles and the thermoalkaliphile represent distinct variants was supported by demonstration of the importance of additional alkaliphile-specific a-subunit residues, not found in the thermoalkaliphile, for malate growth of B. pseudofirmus OF4. Finally, a mutant B. pseudofirmus OF4 synthase with switched positions of Lys-180 (helix 4) and Gly-212 (helix 5) retained significant coupled synthase activity accompanied by proton leakiness.	[Fujisawa, Makoto; Fackelmayer, Oliver J.; Liu, Jun; Krulwich, Terry A.; Hicks, David B.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Hicks, DB (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl, New York, NY 10029 USA.	david.hicks@mssm.edu	Fackelmayer, Oliver/AAD-7638-2021		National Institutes of Health, NIGMS [GM28454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028454] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28454 from NIGMS.	Aksimentiev A, 2004, BIOPHYS J, V86, P1332, DOI 10.1016/S0006-3495(04)74205-8; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; CAIN BD, 1989, J BIOL CHEM, V264, P3292; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; DeLeon-Rangel J, 2003, ARCH BIOCHEM BIOPHYS, V418, P55, DOI 10.1016/S0003-9861(03)00391-6; Dimroth P, 2004, ADV MICROB PHYSIOL, V49, P175, DOI 10.1016/S0065-2911(04)49004-3; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Gilmour R, 1997, J BACTERIOL, V179, P863, DOI 10.1128/jb.179.3.863-870.1997; HARTZOG PE, 1994, J BIOL CHEM, V269, P32313; Hicks DB, 2010, BBA-BIOENERGETICS, V1797, P1362, DOI 10.1016/j.bbabio.2010.02.028; HICKS DB, 1990, J BIOL CHEM, V265, P20547; Ito M, 1997, J BACTERIOL, V179, P3851, DOI 10.1128/jb.179.12.3851-3857.1997; IVEY DM, 1992, RES MICROBIOL, V143, P467, DOI 10.1016/0923-2508(92)90092-3; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; KRULWICH TA, 1995, MOL MICROBIOL, V15, P403, DOI 10.1111/j.1365-2958.1995.tb02253.x; Krulwich TA, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P311; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Liu J, 2010, BBA-BIOENERGETICS, V1797, P35, DOI 10.1016/j.bbabio.2010.04.123; Liu J, 2009, J BIOL CHEM, V284, P8714, DOI 10.1074/jbc.M808738200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; McMillan DGG, 2007, J BIOL CHEM, V282, P17395, DOI 10.1074/jbc.M611709200; McMillan DGG, 2009, APPL ENVIRON MICROB, V75, P7649, DOI 10.1128/AEM.01639-09; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; QUIRK PG, 1991, BIOCHIM BIOPHYS ACTA, V1058, P131, DOI 10.1016/S0005-2728(05)80229-4; QUIRK PG, 1993, J BIOL CHEM, V268, P678; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; STURR MG, 1994, J BACTERIOL, V176, P3111, DOI 10.1128/jb.176.11.3111-3116.1994; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Vik SB, 2005, J BIOENERG BIOMEMBR, V37, P445, DOI 10.1007/s10863-005-9488-6; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Vorburger T, 2008, FEBS J, V275, P2137, DOI 10.1111/j.1742-4658.2008.06368.x; Wang ZX, 2004, J BIOL CHEM, V279, P26546, DOI 10.1074/jbc.M401206200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	62	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32105	32115		10.1074/jbc.M110.165084	http://dx.doi.org/10.1074/jbc.M110.165084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20716528	Green Published, hybrid			2022-12-25	WOS:000282683000024
J	Liu, YC; Sieprawska-Lupa, M; Whitman, WB; White, RH				Liu, Yuchen; Sieprawska-Lupa, Magdalena; Whitman, William B.; White, Robert H.			Cysteine Is Not the Sulfur Source for Iron-Sulfur Cluster and Methionine Biosynthesis in the Methanogenic Archaeon Methanococcus maripaludis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; LABILE SULFIDE; PROTEINS; MECHANISMS; BACTERIA; VOLTAE; ACID; PROKARYOTES; JANNASCHII; CHEMISTRY	Three multiprotein systems are known for iron-sulfur (Fe-S) cluster biogenesis in prokaryotes and eukaryotes as follows: the NIF (nitrogen fixation), the ISC (iron-sulfur cluster), and the SUF (mobilization of sulfur) systems. In all three, cysteine is the physiological sulfur source, and the sulfur is transferred from cysteine desulfurase through a persulfidic intermediate to a scaffold protein. However, the biochemical nature of the sulfur source for Fe-S cluster assembly in archaea is unknown, and many archaea lack homologs of cysteine desulfurases. Methanococcus maripaludis is a methanogenic archaeon that contains a high amount of protein-bound Fe-S clusters (45 nmol/mg protein). Cysteine in this archaeon is synthesized primarily via the tRNA-dependent SepRS/SepCysS pathway. When a Delta sepS mutant (a cysteine auxotroph) was grown with S-34-labeled sulfide and unlabeled cysteine, <8% of the cysteine, >92% of the methionine, and >87% of the sulfur in the Fe-S clusters in proteins were labeled, suggesting that the sulfur in methionine and Fe-S clusters was derived predominantly from exogenous sulfide instead of cysteine. Therefore, this investigation challenges the concept that cysteine is always the sulfur source for Fe-S cluster biosynthesis in vivo and suggests that Fe-S clusters are derived from sulfide in those organisms, which live in sulfide-rich habitats.	[Liu, Yuchen; Sieprawska-Lupa, Magdalena; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [White, Robert H.] Virginia Tech, Dept Biochem, Blacksburg, VA 24060 USA	University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University	Whitman, WB (corresponding author), Univ Georgia, Dept Microbiol, 541 Biol Sci Bldg, Athens, GA 30602 USA.	whitman@uga.edu	Whitman, William/AAC-5896-2020	Liu, Yuchen/0000-0003-0842-5882; Whitman, William/0000-0003-1229-0423	National Science Foundation [MCB 0231319]; Department of Energy; University of Georgia Graduate School	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); University of Georgia Graduate School	This work was supported by National Science Foundation Grant MCB 0231319 (to R. H. W.), a Department of Energy grant (to W. B. W.), and a Doctoral Completion Award from the University of Georgia Graduate School (to Y. L.).	BALCH WE, 1979, J BACTERIOL, V137, P256, DOI 10.1128/JB.137.1.256-263.1979; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Boyd JM, 2009, J BACTERIOL, V191, P1490, DOI 10.1128/JB.01469-08; DYBAS M, 1992, J BACTERIOL, V174, P5575, DOI 10.1128/JB.174.17.5575-5583.1992; Eccleston JF, 2006, J BIOL CHEM, V281, P8371, DOI 10.1074/jbc.M513455200; Edgcomb VP, 2004, APPL ENVIRON MICROB, V70, P2551, DOI 10.1128/AEM.70.4.2551-2555.2004; EDMOND JM, 1982, NATURE, V297, P187, DOI 10.1038/297187a0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FAHEY RC, 1981, ANAL BIOCHEM, V111, P357, DOI 10.1016/0003-2697(81)90573-X; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Frazzon J, 2002, BIOCHEM SOC T, V30, P680, DOI 10.1042/BST0300680; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; HAGEN KS, 1981, J AM CHEM SOC, V103, P4054, DOI 10.1021/ja00404a013; HARVEY AE, 1955, ANAL CHEM, V27, P26, DOI 10.1021/ac60097a009; Hauenstein SI, 2008, J BIOL CHEM, V283, P22007, DOI 10.1074/jbc.M801839200; Hendrickson EL, 2008, J BACTERIOL, V190, P2198, DOI 10.1128/JB.01805-07; HERSKOVITZ T, 1972, P NATL ACAD SCI USA, V69, P2437, DOI 10.1073/pnas.69.9.2437; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Hwang CC, 1996, BIOCHEMISTRY-US, V35, P6358, DOI 10.1021/bi9602472; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JONES WJ, 1983, ARCH MICROBIOL, V135, P91, DOI 10.1007/BF00408015; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lee HS, 2003, APPL MICROBIOL BIOT, V62, P459, DOI 10.1007/s00253-003-1306-7; Li T, 1999, FEBS LETT, V462, P302, DOI 10.1016/S0014-5793(99)01550-1; Lloyd KG, 2005, APPL ENVIRON MICROB, V71, P6383, DOI 10.1128/AEM.71.10.6383-6387.2005; MAHLER HR, 1954, J BIOL CHEM, V210, P165; Major TA, 2004, FEMS MICROBIOL LETT, V239, P117, DOI 10.1016/j.femsle.2004.08.027; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; NAGASAWA T, 1984, J BIOL CHEM, V259, P393; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; SHIEH J, 1988, J BACTERIOL, V170, P4091, DOI 10.1128/jb.170.9.4091-4096.1988; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stathopoulos C, 2001, P NATL ACAD SCI USA, V98, P14292, DOI 10.1073/pnas.201540498; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Tchong SI, 2005, BIOCHEMISTRY-US, V44, P1659, DOI 10.1021/bi0484769; Truong DH, 2006, DRUG METAB REV, V38, P733, DOI 10.1080/03602530600959607; Visser A, 1996, WATER SCI TECHNOL, V33, P99, DOI 10.1016/0273-1223(96)00324-1; WHITE RH, 1983, BIOCHEM BIOPH RES CO, V112, P66, DOI 10.1016/0006-291X(83)91798-9; WHITE RH, 1981, ANAL BIOCHEM, V114, P349, DOI 10.1016/0003-2697(81)90492-9; White RH, 2003, BBA-GEN SUBJECTS, V1624, P46, DOI 10.1016/j.bbagen.2003.09.005; WHITMAN WB, 1982, J BACTERIOL, V149, P852, DOI 10.1128/JB.149.3.852-863.1982; WHITMAN WB, 1986, SYST APPL MICROBIOL, V7, P235; YAMAGATA S, 1989, BIOCHIMIE, V71, P1125, DOI 10.1016/0300-9084(89)90016-3	51	63	64	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31923	31929		10.1074/jbc.M110.152447	http://dx.doi.org/10.1074/jbc.M110.152447			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20709756	Green Published, hybrid			2022-12-25	WOS:000282683000005
J	Zhang, SL; Frankel, LK; Bricker, TM				Zhang, Shulu; Frankel, Laurie K.; Bricker, Terry M.			The Sll0606 Protein Is Required for Photosystem II Assembly/Stability in the Cyanobacterium Synechocystis sp. PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SP STRAIN PCC-6803; OXYGEN-EVOLUTION; CORE COMPLEX; PROTEOMICS; REPAIR; IDENTIFICATION; ARCHITECTURE; CHLOROPHYLL; CAROTENOIDS	An insertional transposon mutation in the sll0606 gene was found to lead to a loss of photoautotrophy but not photoheterotrophy in the cyanobacterium Synechocystis sp. PCC 6803. Complementation analysis of this mutant (Tsll0606) indicated that an intact sll0606 gene could fully restore photoautotrophic growth. Gene organization in the vicinity of sll0606 indicates that it is not contained in an operon. No electron transport activity was detected in Tsll0606 using water as an electron donor and 2,6-dichlorobenzoquinone as an electron acceptor, indicating that Photosystem II (PS II) was defective. Electron transport activity using dichlorophenol indolephenol plus ascorbate as an electron donor to methyl viologen, however, was the same as observed in the control strain. This indicated that electron flow through Photosystem I was normal. Fluorescence induction and decay parameters verified that Photosystem II was highly compromised. The quantum yield for energy trapping by Photosystem II (F-V/F-M) in the mutant was less than 10% of that observed in the control strain. The small variable fluorescence yield observed after a single saturating flash exhibited aberrant Q(A)(-) reoxidation kinetics that were insensitive to dichloromethylurea. Immunological analysis indicated that whereas the D2 and CP47 proteins were modestly affected, the D1 and CP43 components were dramatically reduced. Analysis of two-dimensional blue native/lithium dodecyl sulfate-polyacrylamide gels indicated that no intact PS II monomer or dimers were observed in the mutant. The CP43-less PS II monomer did accumulate to detectable levels. Our results indicate that the Sll0606 protein is required for the assembly/stability of a functionally competent Photosystem II.	[Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE))	This work was supported by a grant from the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (to T. M. B. and L. K. F.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antal T, 2008, PHOTOSYNTH RES, V96, P217, DOI 10.1007/s11120-008-9301-6; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Bricker TM, 2004, J BACTERIOL, V186, P8144, DOI 10.1128/JB.186.23.8144-8148.2004; BRICKER TM, 1992, BIOCHEMISTRY-US, V31, P4623, DOI 10.1021/bi00134a012; BRICKER TM, 1996, OXYGENIC PHOTOSYNTHE, P113; BURNAP RL, 1991, BIOCHEMISTRY-US, V30, P440, DOI 10.1021/bi00216a020; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; IKEUCHI M, 1989, FEBS LETT, V242, P263, DOI 10.1016/0014-5793(89)80482-X; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Kufryk GI, 2003, J BACTERIOL, V185, P6615, DOI 10.1128/JB.185.22.6615-6623.2003; Kufryk GI, 2001, BIOCHEMISTRY-US, V40, P9247, DOI 10.1021/bi0026526; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; Nedbal L, 1999, J PHOTOCH PHOTOBIO B, V48, P154, DOI 10.1016/S1011-1344(99)00032-9; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; PUTNAMEVANS C, 1992, BIOCHEMISTRY-US, V31, P11482, DOI 10.1021/bi00161a029; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; ROGNER M, 1990, J BIOL CHEM, V265, P6189; ROGNER M, 1991, BIOCHEMISTRY-US, V30, P5387; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Rosenberg C, 1999, BIOCHEMISTRY-US, V38, P15994, DOI 10.1021/bi991326r; Schottkowski M, 2009, J BIOL CHEM, V284, P1813, DOI 10.1074/jbc.M806116200; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031; Swingley WD, 2008, MOL BIOL EVOL, V25, P643, DOI 10.1093/molbev/msn034; Thornton LE, 2005, ADV PHOTO RESPIRAT, V22, P121; Tyystjarvi E, 2004, ADV PHOTO RESPIRAT, V19, P363; VERMAAS WFJ, 1988, PHOTOSYNTH RES, V17, P97, DOI 10.1007/BF00047683; Wegener KM, 2008, J BIOL CHEM, V283, P27829, DOI 10.1074/jbc.M803918200; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zhang SL, 2008, J BACTERIOL, V190, P8234, DOI 10.1128/JB.01126-08; Zhang SL, 2004, J BACTERIOL, V186, P875, DOI 10.1128/JB.186.3.875-879.2004	47	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32047	32054		10.1074/jbc.M110.166983	http://dx.doi.org/10.1074/jbc.M110.166983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20724474	Green Published, hybrid			2022-12-25	WOS:000282683000018
J	Ponnusamy, MP; Lakshmanan, I; Jain, M; Das, S; Chakraborty, S; Dey, P; Batra, SK				Ponnusamy, M. P.; Lakshmanan, I.; Jain, M.; Das, S.; Chakraborty, S.; Dey, P.; Batra, S. K.			MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells	ONCOGENE			English	Article						MUC4; EMT; E-cadherin; N-cadherin; metastasis and ovarian cancer	N-CADHERIN; DIAGNOSTIC-SIGNIFICANCE; SURFACE EPITHELIUM; TUMOR PROGRESSION; GENE-EXPRESSION; ADHESION; GROWTH; REQUIREMENT; CARCINOMA; MOTILITY	The acquisition of invasiveness in ovarian cancer (OC) is accompanied by the process of epithelial-to-mesenchymal transition (EMT). The MUC4 mucin is overexpressed in ovarian tumors and has a role in the invasiveness of OC cells. The present study was aimed at evaluating the potential involvement of MUC4 in the metastasis of OC cells by inducing EMT. Ectopic overexpression of MUC4 in OC cells (SKOV3-MUC4) resulted in morphological alterations along with a decreased expression of epithelial markers (E-cadherin and cytokeratin (CK)-18) and an increased expression of mesenchymal markers (N-cadherin and vimentin) compared with the control cells (SKOV3-vector). Also, pro-EMT transcription factors TWIST1, TWIST2 and SNAIL showed an upregulation in SKOV3-MUC4 cells. We further investigated the pathways upstream of N-cadherin, such as focal adhesion kinase (FAK), MKK7, JNK1/2 and c-Jun, which were also activated in the SKOV3-MUC4 cells compared with SKOV3-vector cells. Inhibition of phospho-FAK (pFAK) and pJNK1/2 decreased N-cadherin expression in the MUC4-overexpressing cells, which further led to a significant decrease in cellular motility. Knockdown of N-cadherin decreased the activation of extracellular signal-regulated kinase-1/2 (ERK1/2), AKT and matrix metalloproteinase 9 (MMP9), and inhibited the motility in the SKOV3-MUC4 cells. Upon in vivo tumorigenesis and metastasis analysis, the SKOV3-MUC4 cells produced significantly larger tumors and demonstrated a higher incidence of metastasis to distance organs (peritoneal wall, colon, intestine, stomach, lymph nodes, liver and diaphragm). Taken together, our study reveals a novel role for MUC4 in inducing EMT through the upregulation of N-cadherin and promoting metastasis of OC cells. Oncogene (2010) 29, 5741-5754; doi:10.1038/onc.2010.309; published online 9 August 2010	[Batra, S. K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	sbatra@unmc.edu	chakraborty, subhankar/B-6550-2012	Palanimuthu Ponnusamy, Moorthy/0000-0001-5744-193X; lakshmanan, Imayavaramban/0000-0003-1733-2223	National Institutes of Health [CA78590, CA111294, CA127297, CA133774, CA131944]; Department of Defense [BC074639]; Susan G Komen Foundation [KG070826]; NATIONAL CANCER INSTITUTE [R01CA131944, U01CA111294, P50CA127297, R01CA133774, R01CA078590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work are supported by the grants from the National Institutes of Health (CA78590, CA111294, CA127297, CA133774 and CA131944), Department of Defense (BC074639) and the Susan G Komen Foundation (KG070826). We thank Ms Kristi L Berger for editing the paper. The authors acknowledge the invaluable technical support from Mr Erik Moore and Mrs Kavita Mallya. We also thank Janice A Tayor and James R Talaska of the confocal laser scanning microscope core facility at the UNMC for their support.	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; BEHRENS J, 1994, ACTA ANAT, V149, P165; Boman F, 2001, J PATHOL, V193, P339, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH798>3.0.CO;2-9; Carraway KL, 2001, J MAMMARY GLAND BIOL, V6, P323, DOI 10.1023/A:1011327708973; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Chauhan SC, 2006, MODERN PATHOL, V19, P1386, DOI 10.1038/modpathol.3800646; Chen HY, 1997, J CELL SCI, V110, P345; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; FIDLER IJ, 1990, CANCER RES, V50, P6130; FOLKMAN J, 1990, CANCER METAST REV, V9, P171, DOI 10.1007/BF00046358; Giuntoli RL, 1998, CANCER RES, V58, P5546; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hazan RB, 1996, CELL ADHES COMMUN, V4, P399, DOI 10.3109/15419069709004457; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Horn G, 2009, EXP CELL RES, V315, P1490, DOI 10.1016/j.yexcr.2009.02.011; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Kondo K, 1998, CANCER RES, V58, P2014; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lopez-Ferrer A, 2001, HUM PATHOL, V32, P1197, DOI 10.1053/hupa.2001.28938; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Moniaux N, 2007, BRIT J CANCER, V97, P345, DOI 10.1038/sj.bjc.6603868; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Moniaux N, 1999, BIOCHEM J, V338, P325, DOI 10.1042/0264-6021:3380325; Nollet S, 1998, BIOCHEM J, V332, P739, DOI 10.1042/bj3320739; Ponnusamy MP, 2008, BRIT J CANCER, V99, P520, DOI 10.1038/sj.bjc.6604517; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Sommers CL, 1996, J MAMMARY GLAND BIOL, V1, P219, DOI 10.1007/BF02013645; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Truant S, 2003, INT J CANCER, V104, P683, DOI 10.1002/ijc.11011	38	111	117	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	42					5741	5754		10.1038/onc.2010.309	http://dx.doi.org/10.1038/onc.2010.309			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	668IT	20697346	Green Accepted			2022-12-25	WOS:000283262500010
J	Kim, J; Matthews, NL; Park, S				Kim, Jejoong; Matthews, Natasha L.; Park, Sohee			An Event-Related fMRI Study of Phonological Verbal Working Memory in Schizophrenia	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; ACTIVATION; TASK; PERFORMANCE; DYSFUNCTION; DEFICITS; RISPERIDONE; SYMPTOMS; PET	Background: While much is known about the role of prefrontal cortex (PFC) in working memory (WM) deficits of schizophrenia, the nature of the relationship between cognitive components of WM and brain activation patterns remains unclear. We aimed to elucidate the neural correlates of the maintenance component of verbal WM by examining correct and error trials with event-related fMRI. Methodology/Findings: Twelve schizophrenia patients (SZ) and thirteen healthy control participants (CO) performed a phonological delayed-matching-to-sample-task in which a memory set of three nonsense words was presented, followed by a 6-seconds delay after which a probe nonsense word appeared. Participants decided whether the probe matched one of the targets, and rated the confidence of their decision. Blood-oxygen-level-dependent (BOLD) activity during WM maintenance was analyzed in relation to performance (correct/error) and confidence ratings. Frontal and parietal regions exhibited increased activation on correct trials for both groups. Correct and error trials were further segregated into true memory, false memory, guess, and true error trials. True memory trials were associated with increased bilateral activation of frontal and parietal regions in both groups but only CO showed deactivation in PFC. There was very little maintenance-related cortical activity during guess trials. False memory was associated with increased left frontal and parietal activation in both groups. Conclusion: These findings suggest that a wider network of frontal and parietal regions support WM maintenance in correct trials compared with error trials in both groups. Furthermore, a more extensive and dynamic pattern of recruitment of the frontal and parietal networks for true memory was observed in healthy controls compared with schizophrenia patients. These results underscore the value of parsing the sources of memory errors in fMRI studies because of the non-linear nature of the brain-behavior relationship, and suggest that group comparisons need to be interpreted in more specific behavioral contexts.	[Kim, Jejoong; Matthews, Natasha L.; Park, Sohee] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Kim, Jejoong; Matthews, Natasha L.; Park, Sohee] Vanderbilt Univ, Ctr Integrat & Cognit Neurosci, Nashville, TN 37240 USA; [Park, Sohee] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37240 USA; [Kim, Jejoong] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Matthews, Natasha L.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	Vanderbilt University; Vanderbilt University; Vanderbilt University; Seoul National University (SNU); University of Queensland	Kim, J (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	sohee.park@vanderbilt.edu		Matthews, Natasha/0000-0001-5683-7289; Park, Sohee/0000-0003-3797-4776	Discovery Grant;  [MH-073028]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073028] Funding Source: NIH RePORTER	Discovery Grant; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by MH-073028 and the Discovery Grant to Sohee Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PSYCH ASS, 1991, DIAGN STAT MAN MENT; Andreasen N. C., 1984, SCALE ASSESSMENT POS; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Angrilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004507; Baddeley A., 2007, WORKING MEMORY THOUG; Barch DM, 2007, AM J PSYCHIAT, V164, P1090, DOI 10.1176/appi.ajp.164.7.1090; Boulay Luc J, 2007, Cogn Neuropsychiatry, V12, P322, DOI 10.1080/13546800601069534; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Curtis CE, 2006, NEUROSCIENCE, V139, P173, DOI 10.1016/j.neuroscience.2005.04.070; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dietz NAE, 2005, HUM BRAIN MAPP, V26, P81, DOI 10.1002/hbm.20122; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GODLBERG TE, 2007, ARCH GEN PSYCHIAT, V64, P1115; Goldberg TE, 1998, NEUROIMAGE, V7, P296, DOI 10.1006/nimg.1998.0338; GOLDING AR, 1991, P AAAI 91, V1, P22; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Green MF, 1997, AM J PSYCHIAT, V154, P799; Green MF, 1996, AM J PSYCHIAT, V153, P321; Jansma JM, 2002, SCHIZOPHR RES, V53, P111; Karlsgodt KH, 2009, SCHIZOPHR RES, V108, P143, DOI 10.1016/j.schres.2008.12.025; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001760; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; Leung Hoi-Chung, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P553, DOI 10.3758/CABN.4.4.553; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Manoach DS, 1999, BIOL PSYCHIAT, V45, P1128, DOI 10.1016/S0006-3223(98)00318-7; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Park S, 1999, BIOL PSYCHIAT, V46, P392, DOI 10.1016/S0006-3223(98)00370-9; Park S.J., 2002, PRINCIPLES EXPT PSYC, P83; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ray MK, 2008, CEREB CORTEX, V18, P1421, DOI 10.1093/cercor/bhm175; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smith MR, 1996, CURR PROB CANCER, V20, P6, DOI 10.1016/S0147-0272(96)80303-5; Snyder PJ, 2008, PSYCHIAT RES, V160, P316, DOI 10.1016/j.psychres.2007.07.011; Surguladze SA, 2007, J CLIN PSYCHOPHARM, V27, P560, DOI 10.1097/jcp.0b013e31815a256c; Talairach J., 1988, COPLANAR STEREOTAXIC; Walter H, 2003, SCHIZOPHR RES, V61, P175, DOI 10.1016/S0920-9964(02)00225-6; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12068	10.1371/journal.pone.0012068	http://dx.doi.org/10.1371/journal.pone.0012068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20725639	gold, Green Published, Green Submitted			2022-12-25	WOS:000280849100014
J	Brunskill, EW; Potter, SS				Brunskill, Eric W.; Potter, S. Steven			Gene Expression Programs of Mouse Endothelial Cells in Kidney Development and Disease	PLOS ONE			English	Article							BONE MORPHOGENIC PROTEIN-7; GROWTH-FACTOR-BETA; DIABETIC-NEPHROPATHY; NITRIC-OXIDE; BLOOD-PRESSURE; VASCULAR POLE; APELIN; MOLECULE-1; PROTECTS; INJURY	Endothelial cells are remarkably heterogeneous in both morphology and function, and they play critical roles in the formation of multiple organ systems. In addition endothelial cell dysfunction can contribute to disease processes, including diabetic nephropathy, which is a leading cause of end stage renal disease. In this report we define the comprehensive gene expression programs of multiple types of kidney endothelial cells, and analyze the differences that distinguish them. Endothelial cells were purified from Tie2-GFP mice by cell dissociation and fluorescent activated cell sorting. Microarrays were then used to provide a global, quantitative and sensitive measure of gene expression levels. We examined renal endothelial cells from the embryo and from the adult glomerulus, cortex and medulla compartments, as well as the glomerular endothelial cells of the db/db mutant mouse, which represents a model for human diabetic nephropathy. The results identified the growth factors, receptors and transcription factors expressed by these multiple endothelial cell types. Biological processes and molecular pathways were characterized in exquisite detail. Cell type specific gene expression patterns were defined, finding novel molecular markers and providing a better understanding of compartmental distinctions. Further, analysis of enriched, evolutionarily conserved transcription factor binding sites in the promoters of co-activated genes begins to define the genetic regulatory network of renal endothelial cell formation. Finally, the gene expression differences associated with diabetic nephropathy were defined, providing a global view of both the pathogenic and protective pathways activated. These studies provide a rich resource to facilitate further investigations of endothelial cell functions in kidney development, adult compartments, and disease.	[Brunskill, Eric W.; Potter, S. Steven] Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Brunskill, EW (corresponding author), Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	steve.potter@cchmc.org			National Institutes of Health (NIH) [UO1DK070251, RO1DK081489]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070251, R01DK081489] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported by grants UO1DK070251 and RO1DK081489 from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2009, ORGANOGENESIS, V5, P275; Atkins RC, 2010, NEPHROL DIAL TRANSPL, V25, P331, DOI 10.1093/ndt/gfp757; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; Bechard D, 2001, J IMMUNOL, V167, P3099, DOI 10.4049/jimmunol.167.6.3099; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; BOSSU JL, 1992, FEBS LETT, V299, P239, DOI 10.1016/0014-5793(92)80123-X; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Broxmeyer HE, 2007, MOL CELL BIOL, V27, P5275, DOI 10.1128/MCB.01967-05; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; Clark TG, 1999, DEVELOPMENT, V126, P2631; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Cohen MP, 1996, EXP NEPHROL, V4, P166; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Emerson GG, 2001, AM J PHYSIOL-HEART C, V280, pH160; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; FURUTA T, 1993, AM J KIDNEY DIS, V21, P480, DOI 10.1016/S0272-6386(12)80393-3; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Goldie LC, 2008, ORGANOGENESIS, V4, P257, DOI [DOI 10.4161/ORG.4.4.7416, DOI 10.4161/org.4.4.7416]; Goligorsky MS, 2001, HYPERTENSION, V37, P744, DOI 10.1161/01.HYP.37.2.744; Guo Y, 2003, BLOOD, V102, P2428, DOI 10.1182/blood-2003-02-0634; He P, 2000, AM J PHYSIOL-HEART C, V278, pH1124, DOI 10.1152/ajpheart.2000.278.4.H1124; Hirata K, 1998, DIABETOLOGIA, V41, P185, DOI 10.1007/s001250050888; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Jia Yue Xia, 2007, Peptides, V28, P2023, DOI 10.1016/j.peptides.2007.07.016; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kato H, 2008, DIABETES, V57, P1459, DOI 10.2337/db08-0365; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Knoll KE, 2005, PHYSIOL GENOMICS, V21, P222, DOI 10.1152/physiolgenomics.00231.2004; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; KOO BH, AM J PATHOL, P1495; Krucken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Liu N, 2004, FEBS LETT, V569, P49, DOI 10.1016/j.febslet.2004.05.061; Lopez MLSS, 2003, AM J PHYSIOL-REG I, V284, pR1126, DOI 10.1152/ajpregu.00543.2002; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; MIN W, 1993, VIRCHOWS ARCH A, V423, P201, DOI 10.1007/BF01614771; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nemer G, 2002, DEVELOPMENT, V129, P4045; Neuhofer W, 2005, ANNU REV PHYSIOL, V67, P531, DOI 10.1146/annurev.physiol.67.031103.154456; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Osterby R, 1999, NEPHROL DIAL TRANSPL, V14, P348, DOI 10.1093/ndt/14.2.348; Osterby R, 1987, J Diabet Complications, V1, P122, DOI 10.1016/S0891-6632(87)80069-7; PALL AA, 1993, NEPHROL DIAL TRANSPL, V8, P1429; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Prabhakar SS, 2004, SEMIN NEPHROL, V24, P333, DOI 10.1016/j.semnephrol.2004.04.005; Sadanandam A, 2010, MICROVASC RES, V79, P1, DOI 10.1016/j.mvr.2009.10.005; Sassy-Prigent C, 2000, DIABETES, V49, P466, DOI 10.2337/diabetes.49.3.466; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Schwab K, 2006, DEV BIOL, V293, P540, DOI 10.1016/j.ydbio.2006.02.023; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sharghi-Namini S, 2008, BIOCHEM BIOPH RES CO, V371, P215, DOI 10.1016/j.bbrc.2008.04.047; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Shigematsu S, 1999, ENDOCR J, V46, pS59; Shin JW, 2008, BLOOD, V112, P2318, DOI 10.1182/blood-2008-05-156331; Skubitz KM, 2006, J LAB CLIN MED, V147, P250, DOI 10.1016/j.lab.2006.04.001; Stainier DYR, 1996, DEVELOPMENT, V123, P285; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Stojic J, 2008, NEUROSCI RES, V60, P40, DOI 10.1016/j.neures.2007.09.009; Stout LC, 2007, HUM PATHOL, V38, P1167, DOI 10.1016/j.humpath.2007.01.019; Stuart RO, 2003, KIDNEY INT, V64, P1997, DOI 10.1046/j.1523-1755.2003.00383.x; Stuart RO, 2001, P NATL ACAD SCI USA, V98, P5649, DOI 10.1073/pnas.091110798; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Valdembri D, 2001, FASEB J, V15, P225, DOI 10.1096/fj.01-0633fje; van Lunteren E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007832; Wada J, 2001, KIDNEY INT, V59, P1363, DOI 10.1046/j.1523-1755.2001.0590041363.x; Wang S, 2003, KIDNEY INT, V63, P2037, DOI 10.1046/j.1523-1755.2003.00035.x; Wang SN, 2006, J AM SOC NEPHROL, V17, P2504, DOI 10.1681/ASN.2006030278; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zent R, 2007, SEMIN NEPHROL, V27, P161, DOI 10.1016/j.semnephrol.2007.01.007; Zhong JC, 2007, REGUL PEPTIDES, V144, P109, DOI 10.1016/j.regpep.2007.06.010; Zhong JC, 2007, CARDIOVASC RES, V74, P388, DOI 10.1016/j.cardiores.2007.02.002; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	93	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12034	10.1371/journal.pone.0012034	http://dx.doi.org/10.1371/journal.pone.0012034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706631	gold, Green Published, Green Submitted			2022-12-25	WOS:000280811900005
J	Kuhbier, JW; Allmeling, C; Reimers, K; Hillmer, A; Kasper, C; Menger, B; Brandes, G; Guggenheim, M; Vogt, PM				Kuhbier, Joern W.; Allmeling, Christina; Reimers, Kerstin; Hillmer, Anja; Kasper, Cornelia; Menger, Bjoern; Brandes, Gudrun; Guggenheim, Merlin; Vogt, Peter M.			Interactions between Spider Silk and Cells - NIH/3T3 Fibroblasts Seeded on Miniature Weaving Frames	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; CLAVIPES DRAGLINE SILK; NEPHILA-CLAVIPES; IN-VITRO; FIBROIN; SCAFFOLDS; FIBERS; PROTEINS; PROLIFERATION; BIOMATERIALS	Background: Several materials have been used for tissue engineering purposes, since the ideal matrix depends on the desired tissue. Silk biomaterials have come to focus due to their great mechanical properties. As untreated silkworm silk has been found to be quite immunogenic, an alternative could be spider silk. Not only does it own unique mechanical properties, its biocompatibility has been shown already in vivo. In our study, we used native spider dragline silk which is known as the strongest fibre in nature. Methodology/Principal Findings: Steel frames were originally designed and manufactured and woven with spider silk, harvesting dragline silk directly out of the animal. After sterilization, scaffolds were seeded with fibroblasts to analyse cell proliferation and adhesion. Analysis of cell morphology and actin filament alignment clearly revealed adherence. Proliferation was measured by cell count as well as determination of relative fluorescence each after 1, 2, 3, and 5 days. Cell counts for native spider silk were also compared with those for trypsin-digested spider silk. Spider silk specimens displayed less proliferation than collagen-and fibronectin-coated cover slips, enzymatic treatment reduced adhesion and proliferation rates tendentially though not significantly. Nevertheless, proliferation could be proven with high significance (p<0.01). Conclusion/Significance: Native spider silk does not require any modification to its application as a biomaterial that can rival any artificial material in terms of cell growth promoting properties. We could show adhesion mechanics on intracellular level. Additionally, proliferation kinetics were higher than in enzymatically digested controls, indicating that spider silk does not require modification. Recent findings concerning reduction of cell proliferation after exposure could not be met. As biotechnological production of the hierarchical composition of native spider silk fibres is still a challenge, our study has a pioneer role in researching cellular mechanics on native spider silk fibres.	[Kuhbier, Joern W.; Allmeling, Christina; Reimers, Kerstin; Hillmer, Anja; Menger, Bjoern; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany; [Kasper, Cornelia] Leibniz Univ Hannover, Inst Tech Chem, Hannover, Germany; [Brandes, Gudrun] Hannover Med Sch, Ctr Anat, Inst Cell Biol & Electron Microscopy, D-3000 Hannover, Germany; [Guggenheim, Merlin] Univ Zurich Hosp, Dept Surg, Div Reconstruct Surg, CH-8091 Zurich, Switzerland	Hannover Medical School; Leibniz University Hannover; Hannover Medical School; University of Zurich; University Zurich Hospital	Kuhbier, JW (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.	joernkuhbier@gmx.de	Kasper, Cornelia/AAC-1924-2022; Vogt, Peter M./AAL-1332-2020	kasper, cornelia/0000-0003-2607-4326	Braukmann-Wittenberg Foundation	Braukmann-Wittenberg Foundation	This study was funded by a grant from the Braukmann-Wittenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Bell FI, 2002, NATURE, V416, P37, DOI 10.1038/416037a; BRINI E, 2006, BIOMATERIAL BIOMACRO, V7, P3139; Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1; Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8; Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6; Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012; Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462; Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005; JACKSON C, 1995, MACROMOLECULES, V28, P5975, DOI 10.1021/ma00121a042; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0; Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3; Liu CH, 2000, WORLD J GASTROENTERO, V6, P361; MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68; Maheshwari G, 2000, J CELL SCI, V113, P1677; Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006; Michal CA, 1996, BIOPHYS J, V70, P489, DOI 10.1016/S0006-3495(96)79594-2; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Riekel C, 2004, NATURWISSENSCHAFTEN, V91, P30, DOI 10.1007/s00114-003-0482-8; Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C; Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SALTHOUSE TN, 1980, OTOLARYNG HEAD NECK, V88, P658, DOI 10.1177/019459988008800606; Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R; Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Sponner A., 2007, PLOS ONE, V10, P1; Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365; VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810; Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255; Vollrath F, 2000, J Biotechnol, V74, P67; Vollrath F, 2002, IN VIVO, V16, P229; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; WEN CM, 1990, ANN ALLERGY, V65, P375; Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4; WORK RW, 1982, J ARACHNOL, V10, P1; WORK RW, 1976, TEXT RES J, V46, P485, DOI 10.1177/004051757604600704; Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004	54	42	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12032	10.1371/journal.pone.0012032	http://dx.doi.org/10.1371/journal.pone.0012032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711495	Green Published, gold, Green Accepted			2022-12-25	WOS:000280776800014
J	Gu, YZ; Gu, C				Gu, Yuanzheng; Gu, Chen			Dynamics of Kv1 Channel Transport in Axons	PLOS ONE			English	Article							MAMMALIAN CENTRAL NEURONS; K+ CHANNELS; INITIAL SEGMENT; ORGANELLE TRANSPORT; POTASSIUM CHANNELS; ION CHANNELS; PROTEIN EB1; DYNACTIN; TRACKING; MOTOR	Concerted actions of various ion channels that are precisely targeted along axons are crucial for action potential initiation and propagation, and neurotransmitter release. However, the dynamics of channel protein transport in axons remain unknown. Here, using time-lapse imaging, we found fluorescently tagged Kv1.2 voltage-gated K(+) channels (YFP-Kv1.2) moved bi-directionally in discrete puncta along hippocampal axons. Expressing Kv beta 2, a Kv1 accessory subunit, markedly increased the velocity, the travel distance, and the percentage of moving time of these puncta in both anterograde and retrograde directions. Suppressing the Kv beta 2-associated protein, plus-end binding protein EB1 or kinesin II/KIF3A, by siRNA, significantly decreased the velocity of YFP-Kv1.2 moving puncta in both directions. Kv beta 2 mutants with disrupted either Kv1.2-Kv beta 2 binding or Kv beta 2-EB1 binding failed to increase the velocity of YFP-Kv1.2 puncta, confirming a central role of Kv beta 2. Furthermore, fluorescently tagged Kv1.2 and Kv beta 2 co-moved along axons. Surprisingly, when co-moving with Kv1.2 and Kv beta 2, EB1 appeared to travel markedly faster than its plus-end tracking. Finally, using fission yeast S. pombe expressing YFP-fusion proteins as reference standards to calibrate our microscope, we estimated the numbers of YFP-Kv1.2 tetramers in axonal puncta. Taken together, our results suggest that proper amounts of Kv1 channels and their associated proteins are required for efficient transport of Kv1 channel proteins along axons.	[Gu, Yuanzheng] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Gu, YZ (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.	gu.49@osu.edu	Gu, Chen/E-3163-2011		Ohio State University; National Multiple Sclerosis Society [TA3012A1]; National Institute of Neurological Disorders and Stroke/National Institutes of Health (NINDS/NIH) [R01NS062720]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062720] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institute of Neurological Disorders and Stroke/National Institutes of Health (NINDS/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an Ohio State University startup fund, a Career Transition Fellowship Award from the National Multiple Sclerosis Society (Grant TA3012A1), and a research grant from National Institute of Neurological Disorders and Stroke/National Institutes of Health (NINDS/NIH) (R01NS062720) to C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Brown M, 2005, CELL METAB, V1, P3, DOI 10.1016/j.cmet.2004.12.007; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Duncan JE, 2006, PLOS GENET, V2, P1275, DOI 10.1371/journal.pgen.0020124; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Leenders AGM, 2008, J NEUROSCI, V28, P11333, DOI 10.1523/JNEUROSCI.3078-08.2008; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rivera J, 2007, EUR J NEUROSCI, V25, P136, DOI 10.1111/j.1460-9568.2006.05277.x; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Saheki Y, 2009, NAT NEUROSCI, V12, P1257, DOI 10.1038/nn.2383; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wu JQ, 2008, METHOD CELL BIOL, V89, P253, DOI 10.1016/S0091-679X(08)00609-2; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Zhou L, 1998, J NEUROSCI, V18, P7200	34	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11931	10.1371/journal.pone.0011931	http://dx.doi.org/10.1371/journal.pone.0011931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694152	gold, Green Published, Green Submitted			2022-12-25	WOS:000280574300006
J	Gordon, DP; Beaumont, J; MacDiarmid, A; Robertson, DA; Ahyong, ST				Gordon, Dennis P.; Beaumont, Jennifer; MacDiarmid, Alison; Robertson, Donald A.; Ahyong, Shane T.			Marine Biodiversity of Aotearoa New Zealand	PLOS ONE			English	Review							SOUTHERN KERMADEC ARC; HABITAT; SEDIMENT; DISTURBANCE; BIOSECURITY; IMPACTS; RANGE	The marine-biodiversity assessment of New Zealand (Aotearoa as known to Maori) is confined to the 200 nautical-mile boundary of the Exclusive Economic Zone, which, at 4.2 million km(2), is one of the largest in the world. It spans 30 degrees of latitude and includes a high diversity of seafloor relief, including a trench 10 km deep. Much of this region remains unexplored biologically, especially the 50% of the EEZ deeper than 2,000 m. Knowledge of the marine biota is based on more than 200 years of marine exploration in the region. The major oceanographic data repository is the National Institute of Water and Atmospheric Research (NIWA), which is involved in several Census of Marine Life field projects and is the location of the Southwestern Pacific Regional OBIS Node; NIWA is also data manager and custodian for fisheries research data owned by the Ministry of Fisheries. Related data sources cover alien species, environmental measures, and historical information. Museum collections in New Zealand hold more than 800,000 registered lots representing several million specimens. During the past decade, 220 taxonomic specialists (85 marine) from 18 countries have been engaged in a project to review New Zealand's entire biodiversity. The above-mentioned marine information sources, published literature, and reports were scrutinized to give the results summarized here for the first time (current to 2010), including data on endemism and invasive species. There are 17,135 living species in the EEZ. This diversity includes 4,315 known undescribed species in collections. Species diversity for the most intensively studied phylum-level taxa (Porifera, Cnidaria, Mollusca, Brachiopoda, Bryozoa, Kinorhyncha, Echinodermata, Chordata) is more or less equivalent to that in the ERMS (European Register of Marine Species) region, which is 5.5 times larger in area than the New Zealand EEZ. The implication is that, when all other New Zealand phyla are equally well studied, total marine diversity in the EEZ may be expected to equal that in the ERMS region. This equivalence invites testable hypotheses to explain it. There are 177 naturalized alien species in New Zealand coastal waters, mostly in ports and harbours. Marine-taxonomic expertise in New Zealand covers a broad number of taxa but is, proportionately, at or near its lowest level since the Second World War. Nevertheless, collections are well supported by funding and are continually added to. Threats and protection measures concerning New Zealand's marine biodiversity are commented on, along with potential and priorities for future research.	[Gordon, Dennis P.; Beaumont, Jennifer; MacDiarmid, Alison; Robertson, Donald A.; Ahyong, Shane T.] Natl Inst Water & Atmospher Res, Wellington, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Gordon, DP (corresponding author), Natl Inst Water & Atmospher Res, Wellington, New Zealand.	d.gordon@niwa.co.nz		Ahyong, Shane/0000-0002-2820-4158	New Zealand Foundation for Research, Science and Technology [C01X0502]	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	The New Zealand Foundation for Research, Science and Technology supported the decade-long project to review and inventory New Zealand's biodiversity that provided the data reviewed and analyzed here (Contract No. C01X0502 to Dennis Gordon). The Sloan Foundation supported some of the field work that yielded results or data mentioned in the manuscript, but none of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 1998, AUST J AGR RESOUR EC, V42, P1, DOI 10.1111/1467-8489.00034; AQUARONE MC, 2009, 46 LME; Arnold A, 2004, SHINING SPOTLIGHT BI; Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; BAGLEY NW, 2000, NIWA TECH REP, V72, P1; Ballantine WJ, 2008, HYDROBIOLOGIA, V606, P35, DOI 10.1007/s10750-008-9347-7; BEAUMONT J, 2010, MAPPING ENV VALUES N, P1; BEAUMONT J, 2008, MAPPING VALUES NZ CO, V1, P1; Bradford-Grieve J, 2006, SEA, P1451; BRADFORDGRIEVE J, 2008, NZ SCI REV, V65, P84; Campbell Hamish J., 2008, Proceedings of the Royal Society of Victoria, V120, P38; CARTER L, 1986, NEW ZEAL J MAR FRESH, V20, P665, DOI 10.1080/00288330.1986.9516187; Carter Rowan, 2005, New Zealand Natural Sciences, V30, P49; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Chang FH, 2003, J PLANKTON RES, V25, P737, DOI 10.1093/plankt/25.7.737; CHANG FH, 2003, CLIMATE UPDATE, V53, P4; Clark Malcolm, 2003, Journal of Northwest Atlantic Fishery Science, V31, P441; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; CLARK MR, 2001, INTERRIDGE NEWS, V10, P14; COSTELLO MJ, 2001, PATRIMOINES NATURELS, V50, P1; Coutts ADM, 2007, MAR POLLUT BULL, V54, P875, DOI 10.1016/j.marpolbul.2007.03.011; Cranfield HJ, 2003, CONT SHELF RES, V23, P1337, DOI 10.1016/S0278-4343(03)00122-5; CRANFIELD HJ, 1998, NIWA TECHNICAL REPOR, V1, P48; Cryer M, 2002, ECOL APPL, V12, P1824, DOI 10.1890/1051-0761(2002)012[1824:MOMBBT]2.0.CO;2; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; de Ronde CEJ, 2001, EARTH PLANET SC LETT, V193, P359, DOI 10.1016/S0012-821X(01)00534-9; Dodgshun T, 2003, SEAFOOD NZ, V11, P35; FOSTER BA, 1979, NEW ZEAL J MAR FRESH, V13, P143, DOI 10.1080/00288330.1979.9515788; GLASBY GP, 1990, MAR MINING, V9, P403; Gordon D., 2009, NZ INVENTORY BIODIVE, V1; Gordon D.P., 2008, VA MUS NAT HIST SPEC, V15, P37; Gordon Dennis P., 2000, Oceanography, V13, P41; GORDON DP, NZ INVENTOR IN PRESS, V2; GORDON DP, 2009, NZ INVENTORY BIODIVE, V1, P9; GORDON DP, NZ INVENTORY B UNPUB, V3; GOULD B, 2008, BIOSECURITY, V85, P18; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; GRIFFITHS GA, 1979, NATURE, V282, P61, DOI 10.1038/282061a0; Gust N, 2006, BIOL INVASIONS, V8, P339, DOI 10.1007/s10530-004-8243-y; GUST N, 2001, DESIGN BASELINE SURV; Hamilton A., 1896, DEEP SEA FAUNA NZ EX; HEATH RA, 1985, NEW ZEAL J MAR FRESH, V19, P79, DOI 10.1080/00288330.1985.9516077; Hewitt CD, 2001, 22 CRIMP, P1; Hewitt CL, 2004, NEW ZEAL J MAR FRESH, V38, P429, DOI 10.1080/00288330.2004.9517250; HEWITT CL, 1996, 4 CRIMP, P1; Hicks DM, 2004, J GEOL, V112, P471, DOI 10.1086/421075; HURST RJ, 2000, NIWA TECH REP, V84, P1; HUTCHING G, 2009, MARINE CONSERVATION; INGLIS G, 2006, DUNEDIN HARBOUR PORT; INGLIS G, 2008, PORT TIMARU 2 BASELI; JACKSON JA, 2009, LONG TERM EFFECTS CL, P1; Johnston Emma L., 2009, V204, P133; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Landis CA, 2008, GEOL MAG, V145, P173, DOI 10.1017/S0016756807004268; Lewis KB, 1996, NEW ZEAL J GEOL GEOP, V39, P181, DOI 10.1080/00288306.1996.9514704; MacDiarmid A.E., 2007, TREASURES SEA NGA TA; Minchin Dan, 2009, V204, P109; NELSON WA, 1997, NZ SCI REV, V54, P58; Orpin AR, 1997, MAR GEOL, V138, P51, DOI 10.1016/S0025-3227(96)00101-6; PEART R, 2010, MANAGING MARINE ENV, P245; Probert P. Keith, 1997, Aquatic Conservation, V7, P27, DOI 10.1002/(SICI)1099-0755(199703)7:1<27::AID-AQC214>3.3.CO;2-0; Putnam G., 1977, Tuatara, V22, P189; Rhodes LL, 2006, NEW ZEAL J MAR FRESH, V40, P211, DOI 10.1080/00288330.2006.9517414; RIDGWAY NM, 1984, NZ OCEANOGRAPHIC I S, V23, P1; Rodriguez L. O., 2000, IMPLEMENTING GTI REC; Rowden A.A., 2002, P1; Russell LK, 2008, BIOL INVASIONS, V10, P103, DOI 10.1007/s10530-007-9113-1; *S PAC REG ENV PRO, 1999, COAST MAN PROF DIR I; SHARPLES J, 1998, SEA, V11, P965; Smith AM, 2009, MAR FRESHWATER RES, V60, P475, DOI 10.1071/MF08321; Snelder TH, 2007, ENVIRON MANAGE, V39, P12, DOI 10.1007/s00267-005-0206-2; Stevens Leigh M., 1996, P321; Thompson R., 1994, 1 40 YEARS NZ OCEANO; Thrush SF, 1998, ECOL APPL, V8, P866, DOI 10.2307/2641273; Thrush SF, 2001, MAR ECOL PROG SER, V223, P277, DOI 10.3354/meps223277; Thrush SF, 1995, MAR ECOL PROG SER, V129, P141, DOI 10.3354/meps129141; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; WILLIAMS R, 2008, SURVEILLANCE, V35, P4; Winston Judith E., 1997, P81; Wotton DM, 2004, NEW ZEAL J MAR FRESH, V38, P553, DOI 10.1080/00288330.2004.9517260; Wright IC, 2006, J VOLCANOL GEOTH RES, V149, P263, DOI 10.1016/j.jvolgeores.2005.03.021; Wright IC, 2002, MAR GEOL, V185, P207, DOI 10.1016/S0025-3227(01)00285-7; WRIGHT IC, 2009, TE ARA ENCY NZ; ZELDIS J, 2009, GLOBAL CHANGE IGBP S	85	66	70	19	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e10905	10.1371/journal.pone.0010905	http://dx.doi.org/10.1371/journal.pone.0010905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689846	Green Published, gold			2022-12-25	WOS:000280520400003
J	Chang, Y; de Nadai, P; Azzaoui, I; Morales, O; Delhem, N; Vorng, H; Tomavo, S; Yahia, SA; Zhang, GZ; Wallaert, B; Chenivesse, C; Tsicopoulos, A				Chang, Ying; de Nadai, Patricia; Azzaoui, Imane; Morales, Olivier; Delhem, Nadira; Vorng, Han; Tomavo, Stanislas; Yahia, Saliha Ait; Zhang, Guizhen; Wallaert, Benoit; Chenivesse, Cecile; Tsicopoulos, Anne			The chemokine CCL18 generates adaptive regulatory T cells from memory CD4(+) T cells of healthy but not allergic subjects	FASEB JOURNAL			English	Article						polarization; tolerance; allergy	ACTIVATION IN-VITRO; GROWTH-FACTOR-BETA; DENDRITIC CELLS; ATOPIC-DERMATITIS; FOXP3 EXPRESSION; TGF-BETA; SUBSETS; CD25(+); CTLA-4; DIFFERENTIATION	The purpose of this study was to assess the direct effect of CCL18, a chemokine elevated in allergic diseases and induced by Th2 cytokines, on the polarization of human CD4(+) T cells. Purified human T cells from healthy subjects were pretreated or not with CCL18, and evaluated for cytokine production. CCL18-pretreated memory but not naive CD4(+) T cells exhibited an increased production of IL-10 (12.3 +/- 2.6 vs. 5.6 +/- 0.9 ng/ml for medium) and TGF-beta 1 but not IL-4, IFN-gamma, and IL-17 compared with control cells. Pretreatment of highly purified CD4(+) CD25(-) memory T cells with CCL18 led to their conversion to CD4(+) CD25(-) Foxp3(+) regulatory T cells able to inhibit the proliferation of CD4(+) CD25(-) effector T cells by both cytokine and cell contact-dependent mechanisms. However, this regulatory effect of CCL18 was lost when T cells originated from allergic subjects in relation with a decreased binding of CCL18 to these cells [0.7 +/- 0.3 mean fluorescence intensity (MFI)] as compared to those from healthy subjects (6.0 +/- 1.7 MFI). This study is the first to define a chemokine that generates adaptive regulatory T cells from CD4(+) CD25(-) memory T cells. This mechanism appears defective in allergic patients and may underlie the decreased tolerance observed in allergic diseases.-Chang, Y., de Nadai, P., Azzaoui, I., Morales, O., Delhem, N., Vorng, H., Tomavo, S., Ait Yahia, S., Zhang, G., Wallaert, B., Chenivesse, C., Tsicopoulos, A. The chemokine CCL18 generates adaptive regulatory Tcells from memory CD4(+) Tcells of healthy but not allergic subjects. FASEB J. 24, 5063-5072 (2010). www.fasebj.org	[Chang, Ying; de Nadai, Patricia; Azzaoui, Imane; Vorng, Han; Tomavo, Stanislas; Yahia, Saliha Ait; Wallaert, Benoit; Chenivesse, Cecile; Tsicopoulos, Anne] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Chang, Ying; de Nadai, Patricia; Azzaoui, Imane; Vorng, Han; Tomavo, Stanislas; Yahia, Saliha Ait; Wallaert, Benoit; Chenivesse, Cecile; Tsicopoulos, Anne] Inst Natl Sante & Rech Med, Lille, France; [Chang, Ying; de Nadai, Patricia; Azzaoui, Imane; Vorng, Han; Tomavo, Stanislas; Yahia, Saliha Ait; Wallaert, Benoit; Chenivesse, Cecile; Tsicopoulos, Anne] CNRS, UMR 8204, Lille, France; [Chang, Ying; de Nadai, Patricia; Azzaoui, Imane; Vorng, Han; Tomavo, Stanislas; Yahia, Saliha Ait; Wallaert, Benoit; Chenivesse, Cecile; Tsicopoulos, Anne] Univ Lille Nord France, Lille, France; [Delhem, Nadira; Zhang, Guizhen] China Japan Union Hosp, Cent Res Dept, Changchun, Peoples R China; [Morales, Olivier] CNRS, Inst Biol, UMR 8161, Lille, France; [Wallaert, Benoit; Chenivesse, Cecile; Tsicopoulos, Anne] Clin Malad Resp, Lille, France; [Wallaert, Benoit; Chenivesse, Cecile; Tsicopoulos, Anne] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Jilin University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Tsicopoulos, A (corresponding author), Inst Pasteur, Ctr Infect & Immun Lille, 1 Rue Prof Calmette,BP 245, F-59019 Lille, France.	anne.tsicopoulos@pasteur-lille.fr	Tsicopoulos, Anne/C-2260-2019; Chang, Ying/I-1362-2012; MORALES, Olivier/AAR-5337-2020; SALIHA, AIT YAHIA/B-8269-2018; Pope, Janet/G-3342-2011	Tsicopoulos, Anne/0000-0002-1579-2763; SALIHA, AIT YAHIA/0000-0003-1108-4222; Pope, Janet/0000-0003-1479-5302; Azzaoui, Imane/0000-0001-5603-6780; de NADAI, Patricia/0000-0001-6084-7447; MORALES, Olivier/0000-0002-2135-3265	Institut National de la Sante et de la Recherche Medicale and Societe Francaise d'Allergologie	Institut National de la Sante et de la Recherche Medicale and Societe Francaise d'Allergologie	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale and Societe Francaise d'Allergologie.	Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Allakhverdi Z, 2006, J ALLERGY CLIN IMMUN, V118, P1342, DOI 10.1016/j.jaci.2006.07.034; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; Birebent B, 2004, EUR J IMMUNOL, V34, P3485, DOI 10.1002/eji.200324632; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Callebaut I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-100; Cappello P, 2006, J IMMUNOL, V177, P6143, DOI 10.4049/jimmunol.177.9.6143; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; De Nadai P, 2006, J IMMUNOL, V176, P6286, DOI 10.4049/jimmunol.176.10.6286; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Gilet J, 2009, J INVEST DERMATOL, V129, P879, DOI 10.1038/jid.2008.333; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Gunther C, 2005, J IMMUNOL, V174, P1723, DOI 10.4049/jimmunol.174.3.1723; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hieshima K, 1997, J IMMUNOL, V159, P1140; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Kodelja V, 1998, J IMMUNOL, V160, P1411; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Lindhout E, 2001, J IMMUNOL, V166, P3284, DOI 10.4049/jimmunol.166.5.3284; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; Niedbala W, 2007, P NATL ACAD SCI USA, V104, P15478, DOI 10.1073/pnas.0703725104; Oflazoglu E, 2008, EUR J DERMATOL, V18, P41; Pyzik M, 2007, J LEUKOCYTE BIOL, V82, P335, DOI 10.1189/jlb.1006644; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; SEMNANI RT, 1994, J EXP MED, V180, P2125, DOI 10.1084/jem.180.6.2125; Shang LM, 2008, GASTROENTEROLOGY, V135, P529, DOI 10.1053/j.gastro.2008.04.020; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tasaki Y, 1999, GENOMICS, V55, P353, DOI 10.1006/geno.1998.5670; Taub DD, 1996, J IMMUNOL, V156, P2095; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vissers JLM, 2001, J LEUKOCYTE BIOL, V69, P785; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Vulcano M, 2003, J IMMUNOL, V170, P3843, DOI 10.4049/jimmunol.170.7.3843; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wimmer A, 2006, BLOOD, V108, P3722, DOI 10.1182/blood-2006-04-014399; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	54	34	36	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2010	24	12					5063	5072		10.1096/fj.10-162560	http://dx.doi.org/10.1096/fj.10-162560			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20702776				2022-12-25	WOS:000284824400044
J	Guo, X; Ward, MD; Tiedebohl, JB; Oden, YM; Nyalwidhe, JO; Semmes, OJ				Guo, Xin; Ward, Michael D.; Tiedebohl, Jessica B.; Oden, Yvonne M.; Nyalwidhe, Julius O.; Semmes, O. John			Interdependent Phosphorylation within the Kinase Domain T-loop Regulates CHK2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE-RESPONSE; PROTEIN-KINASE; WIP1 PHOSPHATASE; CANCER; AUTOPHOSPHORYLATION; OLIGOMERIZATION; ACTIVATION; RADIATION; CHROMATIN; REPAIR	Chk2 is a critical regulator of the cellular DNA damage repair response. Activation of Chk2 in response to IR-induced damage is initiated by phosphorylation of the Chk2 SQ/TQ cluster domain at Ser(19), Ser(33), Ser(35), and Thr(68). This precedes auto-phosphorylation of Thr(383)/Thr(387) in the T-loop region of the kinase domain an event that is a prerequisite for efficient kinase activity. We conducted an in-depth analysis of phosphorylation within the T-loop region (residues 366-406). We report four novel phosphorylation sites at Ser(372), Thr(378), Thr(389), and Tyr(390). Substitution mutation Y390F was defective for kinase function. The substitution mutation T378A ablated the IR induction of kinase activity. Interestingly, the substitution mutation T389A demonstrated a 6-fold increase in kinase activity when compared with wild-type Chk2. In addition, phosphorylation at Thr(389) was a prerequisite to phosphorylation at Thr(387) but not at Thr(383). Quantitative mass spectrometry analysis revealed IR-induced phosphorylation and subcellular distribution of Chk2 phosphorylated species. We observed IR-induced increase in phosphorylation at Ser(379), Thr(389), and Thr(383)/Thr(389). Phosphorylation at Tyr(390) was dramatically reduced following IR. Exposure to IR was also associated with changes in the ratio of chromatin/nuclearlocalization. IR-induced increase in chromatin localization was associated with phosphorylation at Thr(372), Thr(379), Thr(383), Thr(389), Thr(383)/Thr(387), and Thr(383)/Thr(389). Chk2 hyper-phosphorylated species at Thr(383)/Thr(387)/Thr(389) and Thr(383)/Thr(387)/Thr(389)/Tyr(390) relocalized from almost exclusively chromatin to predominately nuclear expression, suggesting a role for phosphorylation in regulation of chromatin targeting and egress. The differential impact of T-loop phosphorylation on Chk2 ubiquitylation suggests a co-dependence of these modifications. The results demonstrate that a complex interdependent network of phosphorylation events within the T-loop exchange region regulates dimerization/auto-phosphorylation, kinase activation, and chromatin targeting/egress of Chk2.	[Guo, Xin; Ward, Michael D.; Tiedebohl, Jessica B.; Oden, Yvonne M.; Nyalwidhe, Julius O.; Semmes, O. John] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Canc Biol & Infect Dis Res Ctr, Norfolk, VA 23507 USA	Eastern Virginia Medical School	Semmes, OJ (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Canc Biol & Infect Dis Res Ctr, 700 W Olney Rd,Lewis Hall, Norfolk, VA 23507 USA.	semmesoj@evms.edu	Semmes, Oliver/GQA-5179-2022		NCI, U.S. Public Health Services [CA76595]; NATIONAL CANCER INSTITUTE [R01CA076595] Funding Source: NIH RePORTER	NCI, U.S. Public Health Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA76595 (to O. J. S.) from the NCI, U.S. Public Health Services. The authors declare they have no conflict of interest.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Buscemi G, 2006, MOL CELL BIOL, V26, P7832, DOI 10.1128/MCB.00534-06; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gupta SK, 2007, J BIOL CHEM, V282, P29431, DOI 10.1074/jbc.M704110200; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; KONDRAT RW, 1978, SCIENCE, V199, P978, DOI 10.1126/science.199.4332.978; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Li J, 2005, J BIOL CHEM, V280, P37948, DOI 10.1074/jbc.M509299200; Liang XB, 2006, INT J MOL MED, V17, P703; Lovly CM, 2008, MOL CELL BIOL, V28, P5874, DOI 10.1128/MCB.00821-08; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Matsuoka S, 2001, CANCER RES, V61, P5362; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Unwin RD, 2009, NAT PROTOC, V4, P870, DOI 10.1038/nprot.2009.57; Wu XL, 2003, J BIOL CHEM, V278, P36163, DOI 10.1074/jbc.M303795200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002	26	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33348	33357		10.1074/jbc.M110.149609	http://dx.doi.org/10.1074/jbc.M110.149609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20713355	hybrid, Green Published			2022-12-25	WOS:000283048200070
J	Li, D; Wang, DA; Wang, Y; Ling, WH; Feng, XA; Xia, M				Li, Dan; Wang, Duan; Wang, Yun; Ling, Wenhua; Feng, Xiang; Xia, Min			Adenosine Monophosphate-activated Protein Kinase Induces Cholesterol Efflux from Macrophage-derived Foam Cells and Alleviates Atherosclerosis in Apolipoprotein E-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; X-RECEPTOR-ALPHA; ENDOTHELIAL-CELLS; SCAVENGER RECEPTORS; METABOLIC SYNDROME; AMPK; ABCG1; LIVER; BINDING; ABCA1	Increasing evidence suggests that adenosine monophosphate-activated protein kinase (AMPK) exerts protective effects for cardiovascular diseases apart from the regulation of energy homeostasis. However, the role of AMPK and its underlying mechanism on macrophage foam cell formation are poorly understood. In this study, we sought to investigate the potential effects of AMPK in modulating cholesterol deposition by using murine macrophage-derived foam cells. Incubation with 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) markedly attenuated the cholesterol ester accumulation in oxidized low density lipoprotein-loaded macrophages. Notably, AICAR treatment significantly increased ATP-binding cassette transporters G1 (Abcg1) mRNA and protein levels without affecting mRNA and protein expression of ABCA1, scavenger receptors, including scavenger receptor-A, CD36, and scavenger receptor-BI (SR-BI), and cholesterol synthesis-related genes. The up-regulation of Abcg1 by AICAR was independent of the liver X receptor/retinoid X receptor pathway but dependent on ERK activation. AICAR elevates Abcg1 expression through a post-transcriptional mechanism that stabilizes the mRNA. Using a heterologous system with luciferase as a reporter, we further identify the Abcg1 mRNA3'-UTR responsible for the regulatory effect of AICAR. Prevention of ABCG1 expression by small interfering RNA abolished the AICAR-mediated attenuation on foam cell formation. Furthermore, increased ABCG1 expression and reduced lipid accumulation were demonstrated in AICAR-treated macrophages isolated from apolipoprotein E-deficient mice (apoE(-/-) mice). AICAR treatment also inhibited atherosclerotic plaque formation in apoE(-/-) mice. Our findings elucidate a precise mechanism involved in the prevention of atherogenesis by AMPK.	[Li, Dan; Wang, Duan; Wang, Yun; Ling, Wenhua; Feng, Xiang; Xia, Min] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510080, Guangdong, Peoples R China; [Li, Dan; Ling, Wenhua; Feng, Xiang; Xia, Min] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xia, M (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Northern Campus,74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	xiamin@mail.sysu.edu.cn		Li, Dan/0000-0001-6458-6096	National Natural Science Foundation [30730079, 30700665]; Guangdong Natural Science Foundation [9151012003000002]; Foundation for the Author of National Excellent Doctoral Dissertation of China [200978]; Research Fund for the Doctoral Program of Higher Education of China [20070558276]; Sun Yat-Sen University [10ykzd04]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Sun Yat-Sen University	This work was supported by National Natural Science Foundation Grants 30730079 and 30700665, Guangdong Natural Science Foundation Grant 9151012003000002, Foundation for the Author of National Excellent Doctoral Dissertation of China Grant 200978, Research Fund for the Doctoral Program of Higher Education of China Grant 20070558276, and the Fundamental Research Funds for the Central Universities of Sun Yat-Sen University 10ykzd04.	Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Conway JP, 2006, J BIOL CHEM, V281, P27991, DOI 10.1074/jbc.M605026200; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Ishii N, 2009, J BIOL CHEM, V284, P34561, DOI 10.1074/jbc.M109.028043; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li D, 2010, ARTERIOSCL THROM VAS, V30, P1354, DOI 10.1161/ATVBAHA.110.204230; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu KY, 2010, CIRCULATION, V121, P1828, DOI 10.1161/CIRCULATIONAHA.109.876839; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mauldin JP, 2006, J BIOL CHEM, V281, P21216, DOI 10.1074/jbc.M510952200; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; OTTNAD E, 1995, P NATL ACAD SCI USA, V92, P1391, DOI 10.1073/pnas.92.5.1391; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rigamonti E, 2005, CIRC RES, V97, P682, DOI 10.1161/01.RES.0000184678.43488.9f; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sabol SL, 2005, J LIPID RES, V46, P2151, DOI 10.1194/jlr.M500080-JLR200; Schulz E, 2005, CIRCULATION, V111, P3473, DOI 10.1161/CIRCULATIONAHA.105.546812; Schulz E, 2008, CIRCULATION, V118, P1347, DOI 10.1161/CIRCULATIONAHA.108.784298; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Xia M, 2005, J BIOL CHEM, V280, P36792, DOI 10.1074/jbc.M505047200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	94	97	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33499	33509		10.1074/jbc.M110.159772	http://dx.doi.org/10.1074/jbc.M110.159772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20713354	hybrid, Green Published			2022-12-25	WOS:000283048200084
J	Sweet, SMM; Li, MX; Thomas, PM; Durbin, KR; Kelleher, NL				Sweet, Steve M. M.; Li, Mingxi; Thomas, Paul M.; Durbin, Kenneth R.; Kelleher, Neil L.			Kinetics of Re-establishing H3K79 Methylation Marks in Global Human Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 METHYLATION; CONSERVATIVE SEGREGATION; GENE-TRANSCRIPTION; MASS-SPECTROMETRY; MAMMALIAN-CELLS; NUCLEOSOME CORE; DNA-REPLICATION; HUMAN GENOME; H2B; EXPRESSION	We employ a stable isotope strategy wherein both histones and their methylations are labeled in synchronized human cells. This allows us to differentiate between old and new methylations on pre-existing versus newly synthesized histones. The strategy is implemented on K79 methylation in an isoform-specific manner for histones H3.1, H3.2, and H3.3. Although levels of H3.3K79 monomethylation are higher than that of H3.2/ H3.1, the rate of establishing the K79 methylation is the same for all three isoforms. Surprisingly, we find that pre-existing "old" histones continue to be K79-monomethylated and -dimethylated at a rate equal to the newly synthesized histones. These observations imply that some degree of positional "scrambling" of K79 methylation occurs through the cell cycle.	[Kelleher, Neil L.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Thomas, Paul M.] Northwestern Univ, Prote Ctr Excellence, Evanston, IL 60208 USA	University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University	Kelleher, NL (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	n-kelleher@northwestern.edu	Sweet, Steve/B-5528-2008; Thomas, Paul M/A-6233-2011	Sweet, Steve/0000-0002-3962-0421; Thomas, Paul M/0000-0003-2887-4765	National Institutes of Health [GM 067193-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 067193-08.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; KUMAR S, 1986, BIOCHEMISTRY-US, V25, P2055, DOI 10.1021/bi00356a033; LEFFAK IM, 1984, NATURE, V307, P82, DOI 10.1038/307082a0; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pesavento JJ, 2004, J AM CHEM SOC, V126, P3386, DOI 10.1021/ja039748i; PRIOR CP, 1980, CELL, V20, P597, DOI 10.1016/0092-8674(80)90306-2; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Scharf AND, 2009, NUCLEIC ACIDS RES, V37, P5032, DOI 10.1093/nar/gkp518; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Siuti N, 2010, ANAL BIOCHEM, V396, P180, DOI 10.1016/j.ab.2009.09.022; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Thomas CE, 2006, J PROTEOME RES, V5, P240, DOI 10.1021/pr050266a; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; YAMASU K, 1990, J BIOCHEM-TOKYO, V107, P15, DOI 10.1093/oxfordjournals.jbchem.a122999; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537	39	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32778	32786		10.1074/jbc.M110.145094	http://dx.doi.org/10.1074/jbc.M110.145094			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20699226	hybrid, Green Published			2022-12-25	WOS:000283048200013
J	Nemoto, N; Singh, CR; Udagawa, T; Wang, SZ; Thorson, E; Winter, Z; Ohira, T; Ii, M; Valasek, L; Brown, SJ; Asano, K				Nemoto, Naoki; Singh, Chingakham Ranjit; Udagawa, Tsuyoshi; Wang, Suzhi; Thorson, Elizabeth; Winter, Zachery; Ohira, Takahiro; Ii, Miki; Valasek, Leos; Brown, Susan J.; Asano, Katsura			Yeast 18 S rRNA Is Directly Involved in the Ribosomal Response to Stringent AUG Selection during Translation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START CODON SELECTION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; MESSENGER-RNA; 80S RIBOSOME; AMINOGLYCOSIDE ANTIBIOTICS; MULTIFACTOR COMPLEX; DECODING CENTER; GTP HYDROLYSIS; SUBUNIT	In eukaryotes, the 40 S ribosomal subunit serves as the platform of initiation factor assembly, to place itself precisely on the AUG start codon. Structural arrangement of the 18 S rRNA determines the overall shape of the 40 S subunit. Here, we present genetic evaluation of yeast 18 S rRNA function using 10 point mutations altering the polysome profile. All the mutants reduce the abundance of the mutant 40 S, making it limiting for translation initiation. Two of the isolated mutations, G875A, altering the core of the platform domain that binds eIF1 and eIF2, and A1193U, changing the h31 loop located below the P-site tRNA(i)(Met), show phenotypes indicating defective regulation of AUG selection. Evidence is provided that these mutations reduce the interaction with the components of the preinitiation complex, thereby inhibiting its function at different steps. These results indicate that the 18 S rRNA mutations impair the integrity of scanning-competent preinitiation complex, thereby altering the 40 S subunit response to stringent AUG selection. Interestingly, nine of the mutations alter the body/platform domains of 18 S rRNA, potentially affecting the bridges to the 60 S subunit, but they do not change the level of 18 S rRNA intermediates. Based on these results, we also discuss the mechanism of the selective degradation of the mutant 40 S subunits.	[Nemoto, Naoki; Singh, Chingakham Ranjit; Udagawa, Tsuyoshi; Wang, Suzhi; Thorson, Elizabeth; Winter, Zachery; Ohira, Takahiro; Ii, Miki; Brown, Susan J.; Asano, Katsura] Kansas State Univ, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA; [Wang, Suzhi; Brown, Susan J.] Kansas State Univ, Arthropod Genom Ctr, Div Biol, Manhattan, KS 66506 USA; [Valasek, Leos] Acad Sci Czech Republic, Inst Microbiol, Lab Regulat Gene Express, CR-14220 Prague, Czech Republic	Kansas State University; Kansas State University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Asano, K (corresponding author), Kansas State Univ, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA.	kasano@ksu.edu	Valášek, Leoš Shivaya/I-5743-2014	Valášek, Leoš Shivaya/0000-0001-8123-8667; Brown, Susan/0000-0002-7984-0445	National Institutes of Health [R01, GM64781]; Kansas State University Terry Johnson Cancer Center; Wellcome Trust [076456/Z/05/Z, AVOZ50200510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University Terry Johnson Cancer Center; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 Grant GM64781. This work was also supported by Innovative Award from Kansas State University Terry Johnson Cancer Center (to K. A.) and Wellcome Trust Grants 076456/Z/05/Z and Institutional Research Concept AVOZ50200510 (to L. V.).	Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Allen GS, 2007, MOL MICROBIOL, V63, P941, DOI 10.1111/j.1365-2958.2006.05574.x; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 2002, METHOD ENZYMOL, V351, P221; Asano K, 2007, GENE DEV, V21, P1280, DOI 10.1101/gad.1562707; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; CHERNOFF YO, 1994, EMBO J, V13, P906, DOI 10.1002/j.1460-2075.1994.tb06334.x; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Decatur WA, 2007, METHOD ENZYMOL, V425, P283, DOI 10.1016/S0076-6879(07)25013-X; Dong J, 2008, GENE DEV, V22, P2242, DOI 10.1101/gad.1696608; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; Hage Aziz El, 2004, RNA Biol, V1, P10; Hasenohrl D, 2009, RNA, V15, P2288, DOI 10.1261/rna.1662609; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Jirincova H, 1998, FOLIA BIOL-PRAGUE, V44, P73; Konstantinidis TC, 2006, BIOCHEMISTRY-US, V45, P3525, DOI 10.1021/bi052505d; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Liang XH, 2009, RNA, V15, P1716, DOI 10.1261/rna.1724409; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Noller HF, 2007, TRANSLATIONAL CONTRO, P41; Olsen DS, 2003, EMBO J, V22, P193, DOI 10.1093/emboj/cdg030; Ortiz PA, 2005, NUCLEIC ACIDS RES, V33, P5740, DOI 10.1093/nar/gki882; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Roll-Mecak A, 2001, TRENDS BIOCHEM SCI, V26, P705, DOI 10.1016/S0968-0004(01)02024-2; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Sangthong P, 2007, NUCLEIC ACIDS RES, V35, P3573, DOI 10.1093/nar/gkm283; Singh CR, 2007, J MOL BIOL, V370, P315, DOI 10.1016/j.jmb.2007.04.034; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Singh CR, 2007, METHOD ENZYMOL, V429, P139, DOI 10.1016/S0076-6879(07)29007-X; Singh CR, 2004, J BIOL CHEM, V279, P31910, DOI 10.1074/jbc.M313940200; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Tselika S, 2008, BIOCHIMIE, V90, P908, DOI 10.1016/j.biochi.2008.02.010; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Valasek L, 2001, J BIOL CHEM, V276, P43351, DOI 10.1074/jbc.M106887200; VandePeer Y, 1997, NUCLEIC ACIDS RES, V25, P111, DOI 10.1093/nar/25.1.111; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Velichutina IV, 2000, RNA, V6, P1174, DOI 10.1017/S1355838200000637; VENEMA J, 1995, YEAST, V11, P145, DOI 10.1002/yea.320110206; Wai HH, 2000, NUCLEIC ACIDS RES, V28, P3524, DOI 10.1093/nar/28.18.3524; Watanabe R, 2010, J BIOL CHEM, V285, P21922, DOI 10.1074/jbc.M110.132027; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P175, DOI 10.1093/nar/29.1.175; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000	61	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32200	32212		10.1074/jbc.M110.146662	http://dx.doi.org/10.1074/jbc.M110.146662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699223	hybrid, Green Published			2022-12-25	WOS:000282683000033
J	Szerlong, HJ; Prenni, JE; Nyborg, JK; Hansen, JC				Szerlong, Heather J.; Prenni, Jessica E.; Nyborg, Jennifer K.; Hansen, Jeffrey C.			Activator-dependent p300 Acetylation of Chromatin in Vitro ENHANCEMENT OF TRANSCRIPTION BY DISRUPTION OF REPRESSIVE NUCLEOSOME-NUCLEOSOME INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-VIRUS TYPE-1; HISTONE TAIL DOMAINS; HIGHER-ORDER STRUCTURE; RNA-POLYMERASE-III; ACETYLTRANSFERASE ACTIVITY; COACTIVATORS CBP/P300; RECOMBINANT HISTONES; TAX TRANSACTIVATION; H4-K16 ACETYLATION; CORE PARTICLE	Condensation of chromatin into higher order structures is mediated by intra- and interfiber nucleosome-nucleosome interactions. Our goals in this study were to determine the impact specific activator-dependent histone acetylation had on chromatin condensation and to ascertain whether acetylation-induced changes in chromatin condensation were related to changes in RNA polymerase II (RNAPII) activity. To accomplish this, an in vitro model system was constructed in which the purified transcriptional activators, Tax and phosphorylated CREB (cAMP-response element-binding protein), recruited the p300 histone acetyltransferase to nucleosomal templates containing the human T-cell leukemia virus type-1 promoter sequences. We find that activator-dependent p300 histone acetylation disrupted both inter-and intrafiber nucleosome-nucleosome interactions and simultaneously led to enhanced RNAPII transcription from the decondensed model chromatin. p300 histone acetyltransferase activity had two distinct components: non-targeted, ubiquitousactivityintheabsenceofactivatorsandactivator-dependent activity targeted primarily to promoter-proximal nucleosomes. Mass spectrometry identified several unique p300 acetylation sites on nucleosomal histone H3 (H3K9, H3K27, H3K36, and H3K37). Collectively, our data have important implications for understanding both the mechanism of RNAPII transcriptional regulation by chromatin and the molecular determinants of higher order chromatin structure.	[Szerlong, Heather J.; Prenni, Jessica E.; Nyborg, Jennifer K.; Hansen, Jeffrey C.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Hansen, JC (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Campus Delivery 1870, Ft Collins, CO 80523 USA.	jeffrey.c.hansen@colostate.edu		Prenni, Jessica/0000-0002-0337-8450	National Institutes of Health [GM45916, GM088409, CA055035]; American Heart Association; NATIONAL CANCER INSTITUTE [R55CA055035, R01CA055035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088409, R01GM045916, R29GM045916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45916 (to J. C. H.) and GM088409 and CA055035 (to J. K. N.). This work was also supported by an American Heart Association postdoctoral fellowship (to H. J. S.).	Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; DYNAN WS, 1987, GENETIC ENG PRINCIPL, V9, P75; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Geiger TR, 2008, MOL CELL BIOL, V28, P1383, DOI 10.1128/MCB.01657-07; Georges SA, 2003, MOL CELL BIOL, V23, P3392, DOI 10.1128/MCB.23.10.3392-3404.2003; Georges SA, 2002, MOL CELL BIOL, V22, P127, DOI 10.1128/MCB.22.1.127-137.2002; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; HANSEN JC, 1992, BIOCHEMISTRY-US, V31, P7977, DOI 10.1021/bi00149a032; Hansen JC, 2010, J CELL PHYSIOL, V224, P289, DOI 10.1002/jcp.22150; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Horowitz-Scherer RA, 2006, CHROMOSOMA, V115, P1, DOI 10.1007/s00412-005-0035-3; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Konesky KL, 2006, J VIROL, V80, P10542, DOI 10.1128/JVI.00631-06; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lemasson I, 2006, J BIOL CHEM, V281, P13075, DOI 10.1074/jbc.M512193200; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Lenzmeier BA, 1997, J VIROL, V71, P2577, DOI 10.1128/JVI.71.3.2577-2580.1997; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GH, 2010, MOL CELL, V38, P41, DOI 10.1016/j.molcel.2010.01.042; Lopez DI, 2007, PROTEIN EXPRES PURIF, V55, P406, DOI 10.1016/j.pep.2007.06.011; Lu HX, 2002, MOL CELL BIOL, V22, P4450, DOI 10.1128/MCB.22.13.4450-4462.2002; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; McBryant SJ, 2009, J BIOL CHEM, V284, P16716, DOI 10.1074/jbc.M109.011288; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nyborg JK, 2010, BBA-GENE REGUL MECH, V1799, P266, DOI 10.1016/j.bbagrm.2009.09.002; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Sharma N, 2008, P NATL ACAD SCI USA, V105, P7959, DOI 10.1073/pnas.0800534105; Shilatifard A, 2004, BBA-GENE STRUCT EXPR, V1677, P79, DOI 10.1016/j.bbaexp.2003.11.013; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Watanabe S, 2010, BBA-GENE REGUL MECH, V1799, P480, DOI 10.1016/j.bbagrm.2010.01.009; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Yang YW, 2003, ENDOCRINOLOGY, V144, P5658, DOI 10.1210/en.2003-0798; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445; Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303	71	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31954	31964		10.1074/jbc.M110.148718	http://dx.doi.org/10.1074/jbc.M110.148718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20720004	hybrid, Green Published			2022-12-25	WOS:000282683000008
J	Monahan, KB; Rozenberg, GI; Krishnamurthy, J; Johnson, SM; Liu, W; Bradford, MK; Horner, J; DePinho, RA; Sharpless, NE				Monahan, K. B.; Rozenberg, G. I.; Krishnamurthy, J.; Johnson, S. M.; Liu, W.; Bradford, M. K.; Horner, J.; DePinho, R. A.; Sharpless, N. E.			Somatic p16(INK4a) loss accelerates melanomagenesis	ONCOGENE			English	Article						melanoma; RAS; p16(INK4a)	TUMOR-SUPPRESSOR PTEN; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; CELL-MIGRATION; P53 GENE; GERMLINE MUTATIONS; MELANOCYTIC NEVI; ONCOGENIC RAS; SUN EXPOSURE; IN-VIVO	Loss of p16(INK4a)-RB and ARF-p53 tumor suppressor pathways, as well as activation of RAS-RAF signaling, is seen in a majority of human melanomas. Although heterozygous germline mutations of p16(INK4a) are associated with familial melanoma, most melanomas result from somatic genetic events: often p16(INK4a) loss and N-RAS or B-RAF mutational activation, with a minority possessing alternative genetic alterations such as activating mutations in K-RAS and/or p53 inactivation. To generate a murine model of melanoma featuring some of these somatic genetic events, we engineered a novel conditional p16(INK4a)-null allele and combined this allele with a melanocyte-specific, inducible CRE recombinase strain, a conditional p53-null allele and a loxP-stop-loxP activatable oncogenic K-Ras allele. We found potent synergy between melanocyte-specific activation of K-Ras and loss of p16(INK4a) and/or p53 in melanomagenesis. Mice harboring melanocyte-specific activated K-Ras and loss of p16(INK4a) and/or p53 developed invasive, unpigmented and nonmetastatic melanomas with short latency and high penetrance. In addition, the capacity of these somatic genetic events to rapidly induce melanomas in adult mice suggests that melanocytes remain susceptible to transformation throughout adulthood. Oncogene (2010) 29, 5809-5817; doi: 10.1038/onc.2010.314; published online 9 August 2010	[Monahan, K. B.; Rozenberg, G. I.; Krishnamurthy, J.; Johnson, S. M.; Liu, W.; Bradford, M. K.; Sharpless, N. E.] Univ N Carolina, Sch Med, Ctr Environm Hlth & Susceptibil, Dept Med,Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Monahan, K. B.; Rozenberg, G. I.; Krishnamurthy, J.; Johnson, S. M.; Liu, W.; Bradford, M. K.; Sharpless, N. E.] Univ N Carolina, Sch Med, Ctr Environm Hlth & Susceptibil, Dept Genet,Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Horner, J.; DePinho, R. A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci,Dept Med Oncol, Boston, MA 02115 USA; [Horner, J.; DePinho, R. A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci,Dept Med, Boston, MA 02115 USA; [Horner, J.; DePinho, R. A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci,Dept Genet, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Lineberger Canc Ctr, Dept Med, CB 7295,Mason Farm Rd, Chapel Hill, NC 27599 USA.	nes@med.unc.edu		Sharpless, Norman/0000-0001-7078-9455; DePinho, Ronald/0000-0002-5625-577X	NIH [AG024379, ES14635]; American Federation of Aging; Golfers Against Cancer Foundation; Sidney Kimmel Foundation; National Cancer Center; NATIONAL CANCER INSTITUTE [R01CA163896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES014635, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation of Aging; Golfers Against Cancer Foundation; Sidney Kimmel Foundation; National Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Eric Brown, Marcus Bosenberg, Vincent Hearing for advice and reagents. This work was supported by Grants from NIH (AG024379 and ES14635), as well as from the American Federation of Aging (to KJ), the Golfers Against Cancer Foundation, the Sidney Kimmel Foundation and the National Cancer Center (to KBM).	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Akslen LA, 1998, INT J CANCER, V79, P91; ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; BADER JL, 1985, AM J PEDIAT HEMATOL, V7, P341; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; BENNETT DC, 1989, DEVELOPMENT, V105, P379; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; English DR, 2005, CANCER EPIDEM BIOMAR, V14, P2873, DOI 10.1158/1055-9965.EPI-05-0520; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; FitzGerald MG, 1996, P NATL ACAD SCI USA, V93, P8541, DOI 10.1073/pnas.93.16.8541; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Grafstrom E, 2005, CLIN CANCER RES, V11, P2991, DOI 10.1158/1078-0432.CCR-04-1731; HARRISON SL, 1994, LANCET, V344, P1529, DOI 10.1016/S0140-6736(94)90348-4; Hewitt C, 2002, HUM MOL GENET, V11, P1273, DOI 10.1093/hmg/11.11.1273; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kannan K, 2003, P NATL ACAD SCI USA, V100, P1221, DOI 10.1073/pnas.0336397100; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Marino S, 2002, DEVELOPMENT, V129, P3513; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Pearson G, 2000, J BIOL CHEM, V275, P37303, DOI 10.1074/jbc.C000570200; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Ramsey MR, 2007, CANCER RES, V67, P4732, DOI 10.1158/0008-5472.CAN-06-3437; Rizos H, 2001, ONCOGENE, V20, P5543, DOI 10.1038/sj.onc.1204728; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2003, ONCOGENE, V22, P5055, DOI 10.1038/sj.onc.1206809; Sharpless NE, 2002, CANCER RES, V62, P2761; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shields JM, 2007, CANCER RES, V67, P1502, DOI 10.1158/0008-5472.CAN-06-3311; SmithSorensen B, 1996, HUM MUTAT, V7, P294, DOI 10.1002/(SICI)1098-1004(1996)7:4<294::AID-HUMU2>3.0.CO;2-9; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPANAKIS E, 1992, DEVELOPMENT, V114, P675; SPARROW LE, 1995, MELANOMA RES, V5, P93, DOI 10.1097/00008390-199504000-00004; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Zerp SF, 1999, BRIT J CANCER, V79, P921, DOI 10.1038/sj.bjc.6690147; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	55	44	46	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	43					5809	5817		10.1038/onc.2010.314	http://dx.doi.org/10.1038/onc.2010.314			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	672LY	20697345	Green Published, hybrid			2022-12-25	WOS:000283586200006
J	Tsuchiya, M; Piras, V; Giuliani, A; Tomita, M; Selvarajoo, K				Tsuchiya, Masa; Piras, Vincent; Giuliani, Alessandro; Tomita, Masaru; Selvarajoo, Kumar			Collective Dynamics of Specific Gene Ensembles Crucial for Neutrophil Differentiation: The Existence of Genome Vehicles Revealed	PLOS ONE			English	Article							COMPLEX NETWORKS; QUORUM; WAVES	Cell fate decision remarkably generates specific cell differentiation path among the multiple possibilities that can arise through the complex interplay of high-dimensional genome activities. The coordinated action of thousands of genes to switch cell fate decision has indicated the existence of stable attractors guiding the process. However, origins of the intracellular mechanisms that create "cellular attractor'' still remain unknown. Here, we examined the collective behavior of genome-wide expressions for neutrophil differentiation through two different stimuli, dimethyl sulfoxide (DMSO) and all-trans-retinoic acid (atRA). To overcome the difficulties of dealing with single gene expression noises, we grouped genes into ensembles and analyzed their expression dynamics in correlation space defined by Pearson correlation and mutual information. The standard deviation of correlation distributions of gene ensembles reduces when the ensemble size is increased following the inverse square root law, for both ensembles chosen randomly from whole genome and ranked according to expression variances across time. Choosing the ensemble size of 200 genes, we show the two probability distributions of correlations of randomly selected genes for atRA and DMSO responses overlapped after 48 hours, defining the neutrophil attractor. Next, tracking the ranked ensembles' trajectories, we noticed that only certain, not all, fall into the attractor in a fractal-like manner. The removal of these genome elements from the whole genomes, for both atRA and DMSO responses, destroys the attractor providing evidence for the existence of specific genome elements (named "genome vehicle'') responsible for the neutrophil attractor. Notably, within the genome vehicles, genes with low or moderate expression changes, which are often considered noisy and insignificant, are essential components for the creation of the neutrophil attractor. Further investigations along with our findings might provide a comprehensive mechanistic view of cell fate decision.	[Tsuchiya, Masa; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Tsuchiya, Masa; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar] Keio Univ, Sch Media & Governance, Kanagawa, Japan; [Giuliani, Alessandro] Ist Super Sanita, Environm & Hlth Dept, I-00161 Rome, Italy	Keio University; Keio University; Istituto Superiore di Sanita (ISS)	Tsuchiya, M (corresponding author), Keio Univ, Inst Adv Biosci, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp; kumar@ttck.keio.ac.jp	Piras, Vincent/K-3203-2012; Giuliani, Alessandro/K-7589-2016	Piras, Vincent/0000-0002-3427-0995; Giuliani, Alessandro/0000-0002-4640-804X; Selvarajoo, Kumar/0000-0002-0314-9666	CREST (Core Research of Evolutional Science & Technology) of Japan Science and Technology, Tsuruoka City, Yamagata prefecture government; Keio University; JASSO (Japan Student Services Organization)	CREST (Core Research of Evolutional Science & Technology) of Japan Science and Technology, Tsuruoka City, Yamagata prefecture government; Keio University; JASSO (Japan Student Services Organization)	This study is funded by the CREST (Core Research of Evolutional Science & Technology) of Japan Science and Technology, Tsuruoka City, Yamagata prefecture government, GCOE (Global Center of Excellence) program of Keio University and JASSO (Japan Student Services Organization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BUTTE AJ, 2000, ENTROPY, V2000, P418; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; FARMER JD, 1985, PHYS REV LETT, V55, P351, DOI 10.1103/PhysRevLett.55.351; Forman JE, 1998, ACS SYM SER, V682, P206; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KAUFFMAN SA, 1993, ORDER; Klein ES, 2000, J BIOL CHEM, V275, P19401, DOI 10.1074/jbc.M002472200; Komarova NL, 2005, B MATH BIOL, V67, P701, DOI 10.1016/j.bulm.2004.09.008; Lee YR, 2005, LEUKEMIA RES, V29, P401, DOI 10.1016/j.leukres.2004.09.010; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P1155, DOI 10.1093/nar/25.6.1155; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Steuer R, 2005, STUD CLASS DATA ANAL, P81, DOI 10.1007/3-540-26981-9_11; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuchiya M, 2009, PHYSICA A, V388, P1738, DOI 10.1016/j.physa.2008.12.030; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Tsuchyia M, 2007, FEBS J, V274, P2878, DOI 10.1111/j.1742-4658.2007.05822.x; UMBERGER DK, 1985, PHYS REV LETT, V55, P661, DOI 10.1103/PhysRevLett.55.661; Venables W.N., 2002, MODERN APPL STAT S P, Vfourth, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2_10]; WADDINGTON CH, 1957, MACMILLAN; YAKUSHEVICH LV, 2007, J BIOSCIENCE, V26, P305	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12116	10.1371/journal.pone.0012116	http://dx.doi.org/10.1371/journal.pone.0012116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20725638	gold, Green Published, Green Submitted			2022-12-25	WOS:000280849100029
J	Mocellin, S; Shrager, J; Scolyer, R; Pasquali, S; Verdi, D; Marincola, FM; Briarava, M; Gobbel, R; Rossi, C; Nitti, D				Mocellin, Simone; Shrager, Jeff; Scolyer, Richard; Pasquali, Sandro; Verdi, Daunia; Marincola, Francesco M.; Briarava, Marta; Gobbel, Randy; Rossi, Carlo; Nitti, Donato			Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology	PLOS ONE			English	Article							PERSONALIZED MEDICINE; TRANSLATIONAL RESEARCH; METASTATIC MELANOMA; SYSTEMS BIOLOGY; METAANALYSIS; CHEMOTHERAPY; MANAGEMENT; SIGNATURES; UPDATE; MAP	Background: The efficacy of current anticancer treatments is far from satisfactory and many patients still die of their disease. A general agreement exists on the urgency of developing molecularly targeted therapies, although their implementation in the clinical setting is in its infancy. In fact, despite the wealth of preclinical studies addressing these issues, the difficulty of testing each targeted therapy hypothesis in the clinical arena represents an intrinsic obstacle. As a consequence, we are witnessing a paradoxical situation where most hypotheses about the molecular and cellular biology of cancer remain clinically untested and therefore do not translate into a therapeutic benefit for patients. Objective: To present a computational method aimed to comprehensively exploit the scientific knowledge in order to foster the development of personalized cancer treatment by matching the patient's molecular profile with the available evidence on targeted therapy. Methods: To this aim we focused on melanoma, an increasingly diagnosed malignancy for which the need for novel therapeutic approaches is paradigmatic since no effective treatment is available in the advanced setting. Relevant data were manually extracted from peer-reviewed full-text original articles describing any type of anti-melanoma targeted therapy tested in any type of experimental or clinical model. To this purpose, Medline, Embase, Cancerlit and the Cochrane databases were searched. Results and Conclusions: We created a manually annotated database (Targeted Therapy Database, TTD) where the relevant data are gathered in a formal representation that can be computationally analyzed. Dedicated algorithms were set up for the identification of the prevalent therapeutic hypotheses based on the available evidence and for ranking treatments based on the molecular profile of individual patients. In this essay we describe the principles and computational algorithms of an original method developed to fully exploit the available knowledge on cancer biology with the ultimate goal of fruitfully driving both preclinical and clinical research on anticancer targeted therapy. In the light of its theoretical nature, the prediction performance of this model must be validated before it can be implemented in the clinical setting.	[Mocellin, Simone; Pasquali, Sandro; Verdi, Daunia; Briarava, Marta; Rossi, Carlo; Nitti, Donato] Univ Padua, Clin Chirurg Gen, Padua, Italy; [Shrager, Jeff; Gobbel, Randy] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy; [Scolyer, Richard] Stanford Univ, Symbol Syst Program, Palo Alto, CA 94304 USA; [Shrager, Jeff; Gobbel, Randy] CollabRx Inc, Palo Alto, CA USA; [Scolyer, Richard] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Scolyer, Richard] Melanoma Inst Australia, Sydney, NSW, Australia; [Scolyer, Richard] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia; [Marincola, Francesco M.] NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Marincola, Francesco M.] NIH, Ctr Human Immunol, Bethesda, MD 20892 USA	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; Stanford University; University of Sydney; Melanoma Institute Australia; University of Sydney; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA	Mocellin, S (corresponding author), Univ Padua, Clin Chirurg Gen, Padua, Italy.	simone.mocellin@unipd.it	Pasquali, Sandro/L-1790-2016; Rossi, Carlo Riccardo r/A-7685-2010; Gobbel, John R/C-9848-2016; Scolyer, Richard/AAE-8511-2019; MOCELLIN, SIMONE/AID-6338-2022	Pasquali, Sandro/0000-0003-4815-6293; Rossi, Carlo Riccardo r/0000-0001-7875-5655; Gobbel, John R/0000-0002-5959-7644; Scolyer, Richard/0000-0002-8991-0013; MOCELLIN, SIMONE/0000-0002-9433-8445; Verdi, Daunia/0000-0003-2282-2163	CLINICAL CENTER [ZIACL002118] Funding Source: NIH RePORTER	CLINICAL CENTER		Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Allgayer H, 2008, ADV MED SCI-POLAND, V53, P130, DOI 10.2478/v10039-008-0025-9; Amin W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-396; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Ely S, 2009, TRANSL RES, V154, P303, DOI 10.1016/j.trsl.2009.08.001; Fang XL, 2004, J CHEM INF COMP SCI, V44, P249, DOI 10.1021/ci034209i; Ficenec David, 2003, Briefings in Bioinformatics, V4, P260, DOI 10.1093/bib/4.3.260; Frueh FW, 2009, PHARMACOGENOMICS, V10, P1077, DOI [10.2217/pgs.09.62, 10.2217/PGS.09.62]; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Gomah ME, 2010, J MOL DIAGN, V12, P51, DOI 10.2353/jmoldx.2010.090082; Holmes MV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007960; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kanehisa Minoru, 2009, Genome Inform, V23, P212; Kirkwood JM, 2008, NAT CLIN PRACT ONCOL, V5, P2, DOI 10.1038/ncponc1004; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Krallinger M, 2009, ANN NY ACAD SCI, V1158, P14, DOI 10.1111/j.1749-6632.2008.03750.x; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Laubenbacher R, 2009, BBA-REV CANCER, V1796, P129, DOI 10.1016/j.bbcan.2009.06.001; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Lui P, 2007, CANCER TREAT REV, V33, P665, DOI 10.1016/j.ctrv.2007.06.004; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Macleod MR, 2005, BMJ-BRIT MED J, V331, P110, DOI 10.1136/bmj.331.7508.110-b; McConnell P, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-60; McDermott U, 2009, J CLIN ONCOL, V27, P5650, DOI 10.1200/JCO.2009.22.9054; Mocellin S, 2010, J NATL CANC I; Mocellin S, 2008, MELANOMA RES, V18, P163, DOI 10.1097/CMR.0b013e328300c50b; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Parkinson DR, 2009, CLIN PHARMACOL THER, V86, P23, DOI 10.1038/clpt.2009.76; Payne Philip R O, 2008, AMIA Annu Symp Proc, P566; Petrelli NJ, 2009, J CLIN ONCOL, V27, P6052, DOI 10.1200/JCO.2009.26.6171; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Riley LB, 2009, SURG CLIN N AM, V89, P1, DOI 10.1016/j.suc.2008.09.016; Rodriguez H, 2009, J PROTEOME RES, V8, P3689, DOI 10.1021/pr900023z; Shahnawaz K, 2019, MED FORUM, V30, P12; Sharkey RM, 2006, CA-CANCER J CLIN, V56, P226, DOI 10.3322/canjclin.56.4.226; Stokes TH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S18; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Tawbi HA, 2007, SEMIN ONCOL, V34, P532, DOI 10.1053/j.seminoncol.2007.09.008; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Wang Qing-hua, 2007, Journal of Ecology and Rural Environment, V23, P81; *WHO, 2004, MORT HLTH STAT CAUS; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; 2010, PHARMGKB PHARMACOGEN	56	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e11965	10.1371/journal.pone.0011965	http://dx.doi.org/10.1371/journal.pone.0011965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706624	Green Published, Green Submitted, gold			2022-12-25	WOS:000280811900001
J	Sompallae, R; Callegari, S; Kamranvar, SA; Masucci, MG				Sompallae, Ramakrishna; Callegari, Simone; Kamranvar, Siamak Akbari; Masucci, Maria G.			Transcription Profiling of Epstein-Barr Virus Nuclear Antigen (EBNA)-1 Expressing Cells Suggests Targeting of Chromatin Remodeling Complexes	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; LATENT INFECTION; EBNA-1; DNA; GENE; PROMOTER; ENHANCER; SITES; INACTIVATION; REPLICATION	The Epstein-Barr virus (EBV) encoded nuclear antigen (EBNA)-1 regulates virus replication and transcription, and participates in the remodeling of the cellular environment that accompanies EBV induced B-cell immortalization and malignant transformation. The putative cellular targets of these effects of EBNA-1 are largely unknown. To address this issue we have profiled the transcriptional changes induced by short-and long-term expression of EBNA-1 in the EBV negative B-cell lymphoma BJAB. Three hundred and nineteen cellular genes were regulated in a conditional transfectant shortly after EBNA-1 induction while a ten fold higher number of genes was regulated upon continuous EBNA-1 expression. Promoter analysis of the differentially regulated genes demonstrated a significant enrichment of putative EBNA-1 binding sites suggesting that EBNA-1 may directly influence the transcription of a subset of genes. Gene ontology analysis of forty seven genes that were consistently regulated independently on the time of EBNA-1 expression revealed an unexpected enrichment of genes involved in the maintenance of chromatin architecture. The interaction network of the affected gene products suggests that EBNA-1 may promote a broad rearrangement of the cellular transcription landscape by altering the expression of key components of chromatin remodeling complexes.	[Sompallae, Ramakrishna; Callegari, Simone; Kamranvar, Siamak Akbari; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Sompallae, R (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	maria.masucci@ki.se	Masucci, Maria/AAC-6666-2019	Masucci, Maria/0000-0002-5541-2809	Swedish Cancer Society; Swedish Medical Research Council; Karolinska Institutet, Stockholm, Sweden; European Community [LSHC-CT-2005-018704]	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet, Stockholm, Sweden; European Community(European Commission)	This study was supported by grants awarded by the Swedish Cancer Society, the Swedish Medical Research Council and Karolinska Institutet, Stockholm, Sweden and by the European Community Integrated Project on Infection and Cancer, INCA, Project no. LSHC-CT-2005-018704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardila-Osorio H, 1999, INT J CANCER, V81, P645, DOI 10.1002/(SICI)1097-0215(19990517)81:4<645::AID-IJC22>3.0.CO;2-0; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Choi YJ, 2009, FEBS LETT, V583, P1292, DOI 10.1016/j.febslet.2009.03.023; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cleynen I, 2008, INT J ONCOL, V32, P289; Cohen AJ, 1996, CANCER RES, V56, P831; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dresang LR, 2009, J VIROL, V83, P2930, DOI 10.1128/JVI.01974-08; DRESANG LR, 2009, J VIROL; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Flavell JR, 2008, BLOOD, V111, P292, DOI 10.1182/blood-2006-11-059881; GAHN TA, 1995, J VIROL, V69, P2633, DOI 10.1128/JVI.69.4.2633-2636.1995; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; He JL, 2006, METHOD ENZYMOL, V417, P247, DOI 10.1016/S0076-6879(06)17017-2; Horner D, 1995, INTERVIROLOGY, V38, P195, DOI 10.1159/000150433; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Kang MS, 2001, P NATL ACAD SCI USA, V98, P15233, DOI 10.1073/pnas.211556598; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kirchmaier AL, 1998, J VIROL, V72, P4657, DOI 10.1128/JVI.72.6.4657-4666.1998; Legagneux V, 2004, BIOL CELL, V96, P201, DOI 10.1016/j.biolcel.2004.01.003; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; Murray PG, 2001, J PATHOL, V194, P158, DOI 10.1002/path.873; O'Neil JD, 2008, J GEN VIROL, V89, P2833, DOI 10.1099/vir.0.2008/003392-0; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; REISMAN D, 1986, MOL CELL BIOL, V6, P3838, DOI 10.1128/MCB.6.11.3838; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Ruf IK, 1999, MOL CELL BIOL, V19, P1651; SAMPLE J, 1992, J VIROL, V66, P4654, DOI 10.1128/JVI.66.8.4654-4661.1992; Sansam CG, 2006, CELL CYCLE, V5, P621, DOI 10.4161/cc.5.6.2579; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheu LF, 1996, J PATHOL, V180, P243, DOI 10.1002/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7; Simon JA, 2009, NAT REV MOL CELL BIO; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; SUGDEN B, 1989, J VIROL, V63, P2644, DOI 10.1128/JVI.63.6.2644-2649.1989; SUNG NS, 1994, MOL CELL BIOL, V14, P7144, DOI 10.1128/MCB.14.11.7144; Suzuki K, 2007, SEMIN THROMB HEMOST, V33, P667, DOI 10.1055/s-2007-991534; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wood VHJ, 2007, ONCOGENE, V26, P4135, DOI 10.1038/sj.onc.1210496; WYSOKENSKI DA, 1989, J VIROL, V63, P2657, DOI 10.1128/JVI.63.6.2657-2666.1989; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	54	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12052	10.1371/journal.pone.0012052	http://dx.doi.org/10.1371/journal.pone.0012052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706582	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900014
J	Bemmo, A; Dias, C; Rose, AAN; Russo, C; Siegel, P; Majewski, J				Bemmo, Amandine; Dias, Christel; Rose, April A. N.; Russo, Caterina; Siegel, Peter; Majewski, Jacek			Exon-Level Transcriptome Profiling in Murine Breast Cancer Reveals Splicing Changes Specific to Tumors with Different Metastatic Abilities	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL-CELL SURVIVAL; VITAMIN-D-RECEPTOR; PROTEIN-KINASE; E-CADHERIN; GENE-EXPRESSION; HOMOZYGOUS DELETIONS; CARCINOMA CELLS; OVARIAN-CANCER; MAMMARY-TUMOR	Background: Breast cancer is the second most frequent type of cancer affecting women. We are increasingly aware that changes in mRNA splicing are associated with various characteristics of cancer. The most deadly aspect of cancer is metastasis, the process by which cancer spreads from the primary tumor to distant organs. However, little is known specifically about the involvement of alternative splicing in the formation of macroscopic metastases. Our study investigates transcript isoform changes that characterize tumors of different abilities to form growing metastases. Methods and Findings: To identify alternative splicing events (ASEs) that are associated with the fully metastatic phenotype in breast cancer, we used Affymetrix Exon Microarrays to profile mRNA isoform variations genome-wide in weakly metastatic (168FARN and 4T07) and highly metastatic (4T1) mammary carcinomas. Statistical analysis identified significant expression changes in 7606 out of 155,994 (4%) exons and in 1725 out of 189,460 (1%) intronic regions, which affect 2623 out of 16,654 (16%) genes. These changes correspond to putative alternative isoforms-several of which are novel-that are differentially expressed between tumors of varying metastatic phenotypes. Gene pathway analysis showed that 1224 of genes expressing alternative isoforms were involved in cell growth, cell interactions, cell proliferation, cell migration and cell death and have been previously linked to cancers and genetic disorders. We chose ten predicted splice variants for RT-PCR validation, eight of which were successfully confirmed (MED24, MFI2, SRRT, CD44, CLK1 and HNRNPH1). These include three novel intron retentions in CD44, a gene in which isoform variations have been previously associated with the metastasis of several cancers. Conclusion: Our findings reveal that various genes are differently spliced and/or expressed in association with the metastatic phenotype of tumor cells. Identification of metastasis-specific isoforms may contribute to the development of improved breast cancer stage identification and targeted therapies.	[Bemmo, Amandine; Dias, Christel; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Rose, April A. N.; Russo, Caterina; Siegel, Peter] McGill Univ, Dept Med, Montreal, PQ, Canada; [Siegel, Peter] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Siegel, Peter] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Bemmo, Amandine; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Bemmo, A (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	amandine.bemmo@mail.mcgill.ca	Rose, April/AAR-8222-2020	Rose, April/0000-0002-9845-4603	Canadian Institutes of Health Research; Genome Quebec; Genome Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Quebec; Genome Canada(Genome Canada)	Canadian Institutes of Health Research (www.cihr-irsc.gc.ca), Genome Quebec (www.genomequebec.com), Genome Canada (www.genomecanada.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2006, ID VAL ALT SPLIC EV; Affymetrix, 2005, GUID PROB LOG INT ER; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Aziz KA, 2000, BLOOD, V96, P3161; Barbour AP, 2003, CANCER RES, V63, P887; Bates RC, 2001, CANCER RES, V61, P5275; Bemmo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-529; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindels EMJ, 2000, CANCER RES, V60, P177; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brooks PC, 1996, CANCER METAST REV, V15, P187, DOI 10.1007/BF00437471; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Chiba N, 2000, J BIOL CHEM, V275, P10719, DOI 10.1074/jbc.275.15.10719; Corjay MH, 1998, LAB INVEST, V78, P847; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Duchesne S, 2009, ACAD RADIOL, V16, P61, DOI 10.1016/j.acra.2008.05.024; Dutertre M, 2010, CANCER RES, V70, P896, DOI 10.1158/0008-5472.CAN-09-2703; Evert BO, 2000, CELL TISSUE RES, V301, P189, DOI 10.1007/s004410000228; Faraldo MM, 1998, EMBO J, V17, P2139, DOI 10.1093/emboj/17.8.2139; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fujii K, 2001, J IMMUNOL, V167, P1198, DOI 10.4049/jimmunol.167.3.1198; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; JOHNSON KW, 1991, J BIOL CHEM, V266, P3402; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Karlgren M, 2007, EXPERT OPIN THER TAR, V11, P61, DOI 10.1517/14728222.11.1.61; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim S, 2002, J CLIN INVEST, V110, P933, DOI 10.1172/JCI200214268; Kronblad A, 2005, ONCOGENE, V24, P6835, DOI 10.1038/sj.onc.1208830; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Luo J, 1999, CANCER RES, V59, P3552; Marhaba R, 2004, J MOL HISTOL, V35, P211; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; MCCORMICK BA, 1992, PHARMACOL THERAPEUT, V53, P239, DOI 10.1016/0163-7258(92)90011-N; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mori Y, 2002, CANCER RES, V62, P3641; Muller-Pillasch F, 1998, BBA-GENE STRUCT EXPR, V1395, P88, DOI 10.1016/S0167-4781(97)00129-2; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Rose AAN, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1791; Rots NY, 1998, MOL CELL BIOL, V18, P1911, DOI 10.1128/MCB.18.4.1911; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; SATO T, 1992, CANCER RES, V52, P1643; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Stickeler E, 1999, ONCOGENE, V18, P3574, DOI 10.1038/sj.onc.1202671; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; van Golen CM, 2003, ONCOGENE, V22, P2664, DOI 10.1038/sj.onc.1206362; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Venables JP, 2008, CANCER RES, V68, P9525, DOI 10.1158/0008-5472.CAN-08-1769; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; Wallach-Dayan SB, 2008, MOL CANCER THER, V7, P1615, DOI 10.1158/1535-7163.MCT-07-2383; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang S, 1999, MOL CELL BIOL, V19, P7447; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zhang L, 2004, CANCER BIOL THER, V3, P1283, DOI 10.4161/cbt.3.12.1388	77	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11981	10.1371/journal.pone.0011981	http://dx.doi.org/10.1371/journal.pone.0011981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700505	Green Submitted, Green Published, gold			2022-12-25	WOS:000280687900004
J	Feng, GA; Simpson, JA; Chaluluka, E; Molyneux, ME; Rogerson, SJ				Feng, Gaoqian; Simpson, Julie A.; Chaluluka, Ebbie; Molyneux, Malcolm E.; Rogerson, Stephen J.			Decreasing Burden of Malaria in Pregnancy in Malawian Women and Its Relationship to Use of Intermittent Preventive Therapy or Bed Nets	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; INSECTICIDE-TREATED NETS; SULFADOXINE-PYRIMETHAMINE; BLANTYRE; TRANSMISSION; RESISTANCE; MORBIDITY; EFFICACY; ANEMIA; MORTALITY	Background: The World Health Organization recommends insecticidal bednets and intermittent preventive treatment to reduce malaria in pregnancy. Longitudinal data of malaria prevalence and pregnancy outcomes are valuable in gauging the impact of these antimalarial interventions. Methodology/Principal Findings: We recruited 8,131 women delivering in a single Malawian hospital over 9 years. We recorded demographic data, antenatal prescription of intermittent preventive therapy during pregnancy with sulfadoxine-pyrimethamine and bed net use, and examined finger-prick blood for malaria parasites and hemoglobin concentration. In 4,712 women, we examined placental blood for malaria parasites and recorded the infant's birth weight. Peripheral and placental parasitemia prevalence declined from 23.5% to 5.0% and from 25.2% to 6.8% respectively. Smaller declines in prevalence of low birth weight and anemia were observed. Coverage of intermittent preventive treatment and bednets increased. Number of sulfadoxine-pyrimethamine doses received correlated inversely with placental parasitemia (Odds Ratio (95% CI): 0.79 (0.68, 0.91)), maternal anemia (0.81, (0.73, 0.90)) and low birth weight from 1997-2001 (0.63 (0.53, 0.75)), but not from 2002-2006. Bednet use protected from peripheral parasitemia (0.47, (0.37, 0.60)) and placental parasitemia (0.41, (0.31, 0.54)) and low birth weight (0.75 (0.59, 0.95)) but not anemia throughout the study. Compared to women without nets who did not receive 2-dose sulfadoxine-pyrimethamine, women using nets and receiving 2-dose sulfadoxine-pyrimethamine were less likely to have parasitemia or low birth weight babies. Women receiving 2-dose sulfadoxine-pyrimethamine alone had little evidence of protection whereas bednets alone gave intermediate protection. Conclusions/Significance: Increased bednet coverage explains changes in parasitemia and birth weight among pregnant women better than sulfadoxine-pyrimethamine use. High bed net coverage, and sulfadoxine-pyrimethamine resistance, may be contributing to its apparent loss of effectiveness.	[Feng, Gaoqian; Rogerson, Stephen J.] Univ Melbourne, Dept Med RMH WH, Melbourne, Vic, Australia; [Simpson, Julie A.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic, Australia; [Chaluluka, Ebbie; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England	University of Melbourne; University of Melbourne; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool	Feng, GA (corresponding author), Univ Melbourne, Dept Med RMH WH, Melbourne, Vic, Australia.	sroger@unimelb.edu.au	Simpson, Julie A/P-7299-2014	Feng, Gaoqian/0000-0002-3605-038X; Simpson, Julie/0000-0002-2660-2013; Rogerson, Stephen/0000-0003-4287-1982	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Data collection was funded by a Wellcome Trust Senior Research fellowship to SJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alker AP, 2005, ANTIMICROB AGENTS CH, V49, P3919, DOI 10.1128/AAC.49.9.3919-3921.2005; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2008, WORLD MAL REP 2008; Ashwood-Smith Hannah, 2002, Malawi Med J, V14, P8; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Gamble C, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003755.PUB2; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Holtz TH, 2004, TROP MED INT HEALTH, V9, P77, DOI 10.1046/j.1365-3156.2003.01170.x; Kalilani L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001166; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Kwiek JJ, 2008, MALAWI MED J, V20, P80, DOI 10.4314/mmj.v20i3.10965; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; Malenga Grace, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS15, DOI 10.1016/j.trstmh.2009.02.003; Mathanga DP, 2006, TROP MED INT HEALTH, V11, P1367, DOI 10.1111/j.1365-3156.2006.01684.x; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; Nebie I, 2008, TROP MED INT HEALTH, V13, P229, DOI 10.1111/j.1365-3156.2007.01994.x; Njagi JK, 2003, T ROY SOC TROP MED H, V97, P277, DOI 10.1016/S0035-9203(03)90141-6; Nkhoma S, 2007, ACTA TROP, V102, P138, DOI 10.1016/j.actatropica.2007.04.006; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Rogerson SJ, 2000, T ROY SOC TROP MED H, V94, P549, DOI 10.1016/S0035-9203(00)90083-X; Rogerson SJ, 2000, AM J TROP MED HYG, V62, P335, DOI 10.4269/ajtmh.2000.62.335; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Taha TE, 1998, AIDS, V12, P197, DOI 10.1097/00002030-199802000-00010; TAHA TE, 1993, AM J EPIDEMIOL, V138, P318, DOI 10.1093/oxfordjournals.aje.a116861; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; WHO UNICEF, 2005, WORLD MALARIA REPORT	38	58	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12012	10.1371/journal.pone.0012012	http://dx.doi.org/10.1371/journal.pone.0012012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700457	Green Published, Green Submitted, gold			2022-12-25	WOS:000280687900011
J	Turbill, C; Ruf, T				Turbill, Christopher; Ruf, Thomas			Senescence Is More Important in the Natural Lives of Long- Than Short-Lived Mammals	PLOS ONE			English	Article							LIFE-SPAN; EVOLUTION; POPULATIONS; PREDICTION; SURVIVAL; PATTERNS; GROWTH; LIMITS; RATES; BIRDS	Background: Senescence has been widely detected among mammals, but its importance to fitness in wild populations remains controversial. According to evolutionary theories, senescence occurs at an age when selection is relatively weak, which in mammals can be predicted by adult survival rates. However, a recent analysis of senescence rates found more age-dependent mortalities in natural populations of longer lived mammal species. This has important implications to ageing research and for understanding the ecological relevance of senescence, yet so far these have not been widely appreciated. We re-address this question by comparing the mean and maximum life span of 125 mammal species. Specifically, we test the hypothesis that senescence occurs at a younger age relative to the mean natural life span in longer lived species. Methodology/Principal Findings: We show, using phylogenetically-informed generalised least squares models, a significant log-log relationship between mean life span, as calculated from estimates of adult survival for natural populations, and maximum recorded life span among mammals (R-2 = 0.57, p<0.0001). This provides further support for a key prediction of evolutionary theories of ageing. The slope of this relationship (0.353 +/- 0.052 s.e.m.), however, indicated that mammals with higher survival rates have a mean life span representing a greater fraction of their potential maximum life span: the ratio of maximum to mean life span decreased significantly from >10 in short-lived to similar to 1.5 in long-lived mammal species. Conclusions/Significance: We interpret the ratio of maximum to mean life span to be an index of the likelihood an individual will experience senescence, which largely determines maximum life span. Our results suggest that senescence occurs at an earlier age relative to the mean life span, and therefore is experienced by more individuals and remains under selection pressure, in long-compared to short-lived mammals. A minimum rate of somatic degradation may ultimately limit the natural life span of mammals. Our results also indicate that senescence and modulating factors like oxidative stress are increasingly important to the fitness of longer lived mammals (and vice versa).	[Turbill, Christopher; Ruf, Thomas] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria	University of Veterinary Medicine Vienna	Turbill, C (corresponding author), Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria.	christopher.turbill@fiwi.at		Ruf, Thomas/0000-0002-9235-7079; Turbill, Christopher/0000-0001-9810-7102	Austrian Science Fund (FWF)	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	C.T. was funded by a postdoctoral fellowship from the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOTKIN DB, 1974, AM NAT, V108, P181, DOI 10.1086/282898; Carnes BA, 2003, BIOGERONTOLOGY, V4, P31, DOI 10.1023/A:1022425317536; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; Finch CE, 1996, J GERONTOL A-BIOL, V51, pB183, DOI 10.1093/gerona/51A.3.B183; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; JACKSON DA, 1991, OECOLOGIA, V86, P147, DOI 10.1007/BF00317404; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; MAGALHAES JPD, 2007, GERONTOL A, V62, P149; McCarthy MA, 2008, AM NAT, V172, P216, DOI 10.1086/588074; MEDAVAR PB, 1952, UNSOLVED PROBEM BIOL; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; PERON G, 2010, P R SOC LOND B; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; R Development Core Team, 2009, R FDN STAT COMP; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Ricklefs RE, 2010, AGING CELL, V9, P273, DOI 10.1111/j.1474-9726.2009.00542.x; Ruf T, 2000, OIKOS, V90, P413, DOI 10.1034/j.1600-0706.2000.900223.x; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	35	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12019	10.1371/journal.pone.0012019	http://dx.doi.org/10.1371/journal.pone.0012019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700508	Green Published, gold, Green Submitted			2022-12-25	WOS:000280687900015
J	Sogawa, C; Mitsuhata, C; Kumagai-Morioka, K; Sogawa, N; Ohyama, K; Morita, K; Kozai, K; Dohi, T; Kitayama, S				Sogawa, Chiharu; Mitsuhata, Chieko; Kumagai-Morioka, Kei; Sogawa, Norio; Ohyama, Kazumi; Morita, Katsuya; Kozai, Katsuyuki; Dohi, Toshihiro; Kitayama, Shigeo			Expression and Function of Variants of Human Catecholamine Transporters Lacking the Fifth Transmembrane Region Encoded by Exon 6	PLOS ONE			English	Article							HUMAN NOREPINEPHRINE TRANSPORTER; PERIPHERAL-BLOOD LYMPHOCYTES; HUMAN DOPAMINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; NORADRENALINE TRANSPORTER; C-TERMINUS; SPLICE VARIANTS; PLASMA-MEMBRANE; TRAFFICKING; OLIGOMERIZATION	Background: The transporters for dopamine (DAT) and norepinephrine (NET) are members of the Na(+)- and Cl(-)-dependent neurotransmitter transporter family SLC6. There is a line of evidence that alternative splicing results in several isoforms of neurotransmitter transporters including NET. However, its relevance to the physiology and pathology of the neurotransmitter reuptake system has not been fully elucidated. Methodology/Principal Findings: We found novel isoforms of human DAT and NET produced by alternative splicing in human blood cells (DAT) and placenta (NET), both of which lacked the region encoded by exon 6. RT-PCR analyses showed a difference in expression between the full length (FL) and truncated isoforms in the brain and peripheral tissues, suggesting tissue-specific alternative splicing. Heterologous expression of the FL but not truncated isoforms of DAT and NET in COS-7 cells revealed transport activity. However, immunocytochemistry with confocal microscopy and a cell surface biotinylation assay demonstrated that the truncated as well as FL isoform was expressed at least in part in the plasma membrane at the cell surface, although the truncated DAT was distributed to the cell surface slower than FL DAT. A specific antibody to the C-terminus of DAT labeled the variant but not FL DAT, when cells were not treated with Triton for permeabilization, suggesting the C-terminus of the variant to be located extracellulary. Co-expression of the FL isoform with the truncated isoform in COS-7 cells resulted in a reduced uptake of substrates, indicating a dominant negative effect of the variant. Furthermore, an immunoprecipitation assay revealed physical interaction between the FL and truncated isoforms. Conclusions/Significance: The unique expression and function and the proposed membrane topology of the variants suggest the importance of isoforms of catecholamine transporters in monoaminergic signaling in the brain and peripheral tissues.	[Sogawa, Chiharu; Sogawa, Norio; Kitayama, Shigeo] Okayama Univ, Dept Dent Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Mitsuhata, Chieko; Kozai, Katsuyuki] Hiroshima Univ, Dept Pediat Dent, Grad Sch Biomed Sci, Hiroshima, Japan; [Kumagai-Morioka, Kei; Morita, Katsuya; Dohi, Toshihiro] Hiroshima Univ, Dept Dent Pharmacol, Grad Sch Biomed Sci, Hiroshima, Japan; [Ohyama, Kazumi] Okayama Univ, Sch Dent, RI Res Ctr, Okayama 700, Japan	Okayama University; Hiroshima University; Hiroshima University; Okayama University	Sogawa, C (corresponding author), Okayama Univ, Dept Dent Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	shigeok@md.okayama-u.ac.jp	SOGAWA, Chiharu/B-1994-2011		Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Programs from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARA SG, 1993, ANNU REV NEUROSCI, V16, P16; Amenta F, 2001, J NEUROIMMUNOL, V117, P133, DOI 10.1016/S0165-5728(01)00317-4; Bauman PA, 2002, ARCH BIOCHEM BIOPHYS, V404, P80, DOI 10.1016/S0003-9861(02)00232-1; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Borowsky B, 1998, J BIOL CHEM, V273, P29077, DOI 10.1074/jbc.273.44.29077; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Caronti B, 2001, J NEURAL TRANSM, V108, P803, DOI 10.1007/s007020170030; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Distelmaier F, 2004, J NEUROCHEM, V91, P537, DOI 10.1111/j.1471-4159.2004.02729.x; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Gu HH, 1996, J BIOL CHEM, V271, P18100, DOI 10.1074/jbc.271.30.18100; Hahn MK, 2003, J NEUROSCI, V23, P4470; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Kawarai T, 1997, GENE, V195, P11, DOI 10.1016/S0378-1119(97)00131-5; KIM DS, 1994, NEURAL PROCESS LETT, V1, P17, DOI 10.1007/BF02312396; Kitayama S, 1996, JPN J PHARMACOL, V72, P195, DOI 10.1254/jjp.72.195; Kitayama S, 2003, EUR J PHARMACOL, V479, P65, DOI 10.1016/j.ejphar.2003.08.057; Kitayama S, 1999, J BIOL CHEM, V274, P10731, DOI 10.1074/jbc.274.16.10731; Kitayama S, 2001, NEUROSCI LETT, V312, P108, DOI 10.1016/S0304-3940(01)02138-3; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Kocabas AM, 2003, J NEUROCHEM, V85, P1513, DOI 10.1046/j.1471-4159.2003.01793.x; LANGER SZ, 1988, PROG NEURO-PSYCHOPH, V12, P193, DOI 10.1016/0278-5846(88)90037-1; Li ZS, 2004, J NEUROSCI, V24, P1330, DOI 10.1523/JNEUROSCI.3982-03.2004; Masson J, 1999, PHARMACOL REV, V51, P439; Mata S, 2005, J NEUROIMMUNOL, V170, P134, DOI 10.1016/j.jneuroim.2005.08.007; Miller GM, 2001, MOL BRAIN RES, V87, P124, DOI 10.1016/S0169-328X(00)00288-6; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Porzgen P, 1998, BBA-GENE STRUCT EXPR, V1398, P365, DOI 10.1016/S0167-4781(98)00072-4; RAMAMOORTHY S, 1993, BIOCHEMISTRY-US, V32, P1346, DOI 10.1021/bi00056a021; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Sogawa C, 2007, BIOCHEM J, V401, P185, DOI 10.1042/BJ20060495; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Wagner E, 2002, J CELL SCI, V115, P3033; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	37	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11945	10.1371/journal.pone.0011945	http://dx.doi.org/10.1371/journal.pone.0011945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700532	Green Published, Green Submitted, gold			2022-12-25	WOS:000280605400005
J	Ogura, T; Krosnowski, K; Zhang, LN; Bekkerman, M; Lin, WH				Ogura, Tatsuya; Krosnowski, Kurt; Zhang, Lana; Bekkerman, Mikhael; Lin, Weihong			Chemoreception Regulates Chemical Access to Mouse Vomeronasal Organ: Role of Solitary Chemosensory Cells	PLOS ONE			English	Article							TASTE CELLS; RECEPTOR-CELLS; NERVE-FIBERS; BITTER; CHANNEL; RESPONSES; PROTEINS; TRPM5; COMMUNICATION; LOCALIZATION	Controlling stimulus access to sensory organs allows animals to optimize sensory reception and prevent damage. The vomeronasal organ (VNO) detects pheromones and other semiochemicals to regulate innate social and sexual behaviors. This semiochemical detection generally requires the VNO to draw in chemical fluids, such as bodily secretions, which are complex in composition and can be contaminated. Little is known about whether and how chemical constituents are monitored to regulate the fluid access to the VNO. Using transgenic mice and immunolabeling, we found that solitary chemosensory cells (SCCs) reside densely at the entrance duct of the VNO. In this region, most of the intraepithelial trigeminal fibers innervate the SCCs, indicating that SCCs relay sensory information onto the trigeminal fibers. These SCCs express transient receptor potential channel M5 (TRPM5) and the phospholipase C (PLC) beta 2 signaling pathway. Additionally, the SCCs express choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT) for synthesizing and packaging acetylcholine, a potential transmitter. In intracellular Ca2+ imaging, the SCCs responded to various chemical stimuli including high concentrations of odorants and bitter compounds. The responses were suppressed significantly by a PLC inhibitor, suggesting involvement of the PLC pathway. Further, we developed a quantitative dye assay to show that the amount of stimulus fluid that entered the VNOs of behaving mice is inversely correlated to the concentration of odorous and bitter substances in the fluid. Genetic knockout and pharmacological inhibition of TRPM5 resulted in larger amounts of bitter compounds entering the VNOs. Our data uncovered that chemoreception of fluid constituents regulates chemical access to the VNO and plays an important role in limiting the access of non-specific irritating and harmful substances. Our results also provide new insight into the emerging role of SCCs in chemoreception and regulation of physiological actions.	[Ogura, Tatsuya; Krosnowski, Kurt; Zhang, Lana; Bekkerman, Mikhael; Lin, Weihong] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	Ogura, T (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	Weihong@umbc.edu		Bekkerman, Michael/0000-0003-2201-6874	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01DC009269]; American Recovery and Reinvestment Act Administrative Supplement; University of Maryland, Baltimore County; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009269] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Recovery and Reinvestment Act Administrative Supplement; University of Maryland, Baltimore County; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project is supported by National Institutes of Health/National Institute on Deafness and Other Communication Disorders R01DC009269, American Recovery and Reinvestment Act Administrative Supplement, and University of Maryland, Baltimore County start-up funds to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; BRYANT B, 2000, CHEMISTHESIS COMMON, P73; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; ECCLES R, 1982, PHYSIOL BEHAV, V28, P1011, DOI 10.1016/0031-9384(82)90168-8; Elsaesser R, 2005, EUR J NEUROSCI, V21, P2692, DOI 10.1111/j.1460-9568.2005.04108.x; Farbman A, 2000, NEUROBIOLOGY TASTE S, P131; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Gulbransen BD, 2008, J NEUROPHYSIOL, V99, P2929, DOI 10.1152/jn.00066.2008; HALPERN M, 1980, PHYSIOL BEHAV, V24, P367, DOI 10.1016/0031-9384(80)90100-6; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; He J, 2010, J NEUROSCI, V30, P7473, DOI 10.1523/JNEUROSCI.0825-10.2010; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P411; Kardon R, 1995, Curr Opin Ophthalmol, V6, P20, DOI 10.1097/00055735-199512000-00004; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kozlova I, 2005, AM J PHYSIOL-LUNG C, V288, pL874, DOI 10.1152/ajplung.00303.2004; KROSNOWSKI K, 2009, CHEM SENSES IN PRESS, V34; Kuwabara Y, 2007, ENVIRON HEALTH PERSP, V115, P1609, DOI 10.1289/ehp.9848; Liman E. R., 2007, V179, P287; Lin WH, 2008, J NEUROPHYSIOL, V99, P1451, DOI 10.1152/jn.01195.2007; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; Lin WH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-114; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Margolskee Robert F., 1993, Current Opinion in Neurobiology, V3, P526, DOI 10.1016/0959-4388(93)90051-Y; Matsuda H, 1996, BRAIN RES, V712, P35; MEREDITH M, 1980, SCIENCE, V207, P1224, DOI 10.1126/science.7355286; MEREDITH M, 1994, PHYSIOL BEHAV, V56, P345, DOI 10.1016/0031-9384(94)90205-4; MEREDITH M, 1979, J PHYSIOL-LONDON, V286, P301, DOI 10.1113/jphysiol.1979.sp012620; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ogura T, 1997, J NEUROSCI, V17, P3580; Ogura T, 2007, CELL TISSUE RES, V330, P17, DOI 10.1007/s00441-007-0470-y; Ogura T, 2008, CHEM SENSES, V33, pS104; Osculati F, 2007, EUR J HISTOCHEM, V51, P65; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; PORAN NS, 1993, PHYSIOL BEHAV, V53, P959, DOI 10.1016/0031-9384(93)90275-K; POWERS JB, 1975, SCIENCE, V187, P961, DOI 10.1126/science.1145182; Robinson R, 2008, PLOS BIOL, V6, DOI 10.1371/journal.pbio.0060039; Rodriguez I, 2009, RESULTS PROBL CELL D, V47, P77, DOI 10.1007/400_2008_8; Sbarbati A, 2003, CELLS TISSUES ORGANS, V175, P51, DOI 10.1159/000073437; Sekerkova G, 2004, J NEUROSCI, V24, P5445, DOI 10.1523/JNEUROSCI.1279-04.2004; Swaney WT, 2009, BEHAV BRAIN RES, V200, P239, DOI 10.1016/j.bbr.2008.09.039; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Touhara K, 2008, CURR OPIN PHARMACOL, V8, P759, DOI 10.1016/j.coph.2008.09.001; Wise PM, 2009, ANN NY ACAD SCI, V1170, P206, DOI 10.1111/j.1749-6632.2009.03912.x; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; WYSOCKI CJ, 1985, J CHEM ECOL, V11, P1147, DOI 10.1007/BF01024105; WYSOCKI CJ, 1980, SCIENCE, V207, P781, DOI 10.1126/science.7352288; Zancanaro C, 1999, EUR J NEUROSCI, V11, P4473, DOI 10.1046/j.1460-9568.1999.00912.x; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zufall F, 2002, MICROSC RES TECHNIQ, V58, P251, DOI 10.1002/jemt.10152	63	62	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11924	10.1371/journal.pone.0011924	http://dx.doi.org/10.1371/journal.pone.0011924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689832	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520300033
J	Chiang, WC; Geel, TM; Altintas, MM; Sever, S; Ruiters, MHJ; Reiser, J				Chiang, Wen Chih; Geel, Tessa M.; Altintas, Mehmet M.; Sever, Sanja; Ruiters, Marcel H. J.; Reiser, Jochen			Establishment of Protein Delivery Systems Targeting Podocytes	PLOS ONE			English	Article							GLOMERULAR PROTEIN; TRPC6	Background: Podocytes are uniquely structured cells that are critical to the kidney filtration barrier. Their anatomic location on the outer side of the glomerular capillaries expose podocytes to large quantities of both plasma and urinary components and thus are reachable for drug delivery. Recent years have made clear that interference with podocyte-specific disease pathways can modulate glomerular function and influence severity and progression of glomerular disease. Methodology/Principal Findings: Here, we describe studies that show efficient transport of proteins into the mammalian cells mouse 3T3 fibroblasts and podocytes, utilizing an approach termed profection. We are using synthetic lipid structures that allow the safe packing of proteins or antibodies resulting in the subsequent delivery of protein into the cell. The uptake of lipid coated protein is facilitated by the intrinsic characteristic of cells such as podocytes to engulf particles that are physiologically retained in the extracellular matrix. Profection of the restriction enzyme MunI in 3T3 mouse fibroblasts caused an increase in DNA degradation. Moreover, purified proteins such as beta-galactosidase and the large GTPase dynamin could be profected into podocytes using two different profection reagents with the success rate of 95-100%. The delivered b-galactosidase enzyme was properly folded and able to cleave its substrate X-gal in podocytes. Diseased podocytes are also potential recipients of protein cargo as we also delivered fluorophore labeled IgG into puromycin treated podocytes. We are currently optimizing our protocol for in vivo profection. Conclusions: Protein transfer is developing as an exciting tool to study and target highly differentiated cells such as podocytes.	[Chiang, Wen Chih; Sever, Sanja; Reiser, Jochen] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Chiang, Wen Chih] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Geel, Tessa M.] Univ Groningen, Inst Drug Explorat GUIDE, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Altintas, Mehmet M.; Reiser, Jochen] Univ Miami, Leonard Miller Sch Med, Div Nephrol & Hypertens, Miami, FL USA; [Ruiters, Marcel H. J.] Synvolux Therapeut BV, Groningen, Netherlands	Harvard University; Massachusetts General Hospital; National Taiwan University; National Taiwan University Hospital; University of Groningen; University of Miami	Chiang, WC (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	jreiser@med.miami.edu	Altintas, Mehmet Mete/ABI-5904-2020; Altintas, Mehmet Mete/T-5333-2018	Altintas, Mehmet Mete/0000-0002-1871-6985; Chiang, Wen Chih/0000-0002-8844-0988	National Taiwan University Hospital; National Health Research Institute in Taiwan; Nephrology & Hypertension Division of the University of Miami; US National Institutes of Health (NIH) [DK073495, T32DK007540]; National Health Research Institute, Taiwan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007540, R01DK073495] Funding Source: NIH RePORTER	National Taiwan University Hospital(National Taiwan University); National Health Research Institute in Taiwan; Nephrology & Hypertension Division of the University of Miami; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	WC was sponsored by National Taiwan University Hospital and National Health Research Institute in Taiwan as well as by Divisional funds of the Nephrology & Hypertension Division of the University of Miami. JR is supported by the US National Institutes of Health (NIH) grant DK073495. MMA was supported by NIH training grant T32DK007540. MHJR is part of a commercial funder for this research. TMG also received materials from Synvolux Therapeutics to perform parts of the described experiments. The funders contributed the study design, data collection and analysis.; Wen Chih Chiang is a recipient of National Health Research Institute Physician Scientist Award, Taiwan. The authors thank Prof. V. Siksnys, Institute of Biotechnology, Vilnius, Lithuania for providing MunI.	Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Geel TM, 2009, EXP CELL RES, V315, P2487, DOI 10.1016/j.yexcr.2009.06.011; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hasegawa U, 2009, J CONTROL RELEASE, V140, P312, DOI 10.1016/j.jconrel.2009.06.025; Hirakura T, 2010, J CONTROL RELEASE, V142, P483, DOI 10.1016/j.jconrel.2009.11.023; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; van der Gun BTF, 2007, J CONTROL RELEASE, V123, P228, DOI 10.1016/j.jconrel.2007.08.014; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215	19	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11837	10.1371/journal.pone.0011837	http://dx.doi.org/10.1371/journal.pone.0011837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686602	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520200010
J	Ruffner, MA; Robbins, PD				Ruffner, Melanie A.; Robbins, Paul D.			Dendritic Cells Transduced to Express Interleukin 4 Reduce Diabetes Onset in Both Normoglycemic and Prediabetic Nonobese Diabetic Mice	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; NOD MOUSE; T-CELLS; RECOMBINANT ADENOVIRUS; DISEASE-MODELS; GENE-THERAPY; IL-4; CYTOKINES; INSULITIS; RESPONSES	Background: We and others have previously demonstrated that treatment with bone marrow derived DC genetically modified to express IL-4 reduce disease pathology in mouse models of collagen-induced arthritis and delayed-type hypersensitivity. Moreover, treatment of normoglycemic NOD mice with bone marrow derived DC, genetically modified to express interleukin 4 (IL-4), reduces the onset of hyperglycemia in a significant number of animals. However, the mechanism(s) through which DC expressing IL-4 function to prevent autoimmune diabetes and whether this treatment can reverse disease in pre-diabetic NOD mice are unknown. Methodology/Principal Findings: DC were generated from the bone marrow of NOD mice and transduced with adenoviral vectors encoding soluble murine IL-4 (DC/sIL-4), a membrane-bound IL-4 construct, or empty vector control. Female NOD mice were segregated into normoglycemic (<150mg/dL) and prediabetic groups (between 150 and 250 mg/dL) on the basis of blood glucose measurements, and randomized for adoptive transfer of 10(6) DC via a single i.v. injection. A single injection of DC/sIL-4, when administered to normoglycemic 12-week old NOD mice, significantly reduced the number of mice that developed diabetes. Furthermore, DC/sIL-4, but not control DC, decreased the number of mice progressing to diabetes when given to prediabetic NOD mice 12-16 weeks of age. DC/sIL-4 treatment also significantly reduced islet mononuclear infiltration and increased the expression of FoxP3 in the pancreatic lymph nodes of a subset of treated animals. Furthermore, DC/sIL-4 treatment altered the antigen-specific Th2:Th1 cytokine profiles as determined by ELISPOT of splenocytes in treated animals. Conclusions: Adoptive transfer of DC transduced to express IL-4 into both normoglycemic and prediabetic NOD mice is an effective treatment for T1D.	[Ruffner, Melanie A.; Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Ruffner, Melanie A.] Univ Pittsburgh, Sch Med, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ruffner, MA (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	probb@pitt.edu	Ruffner, Melanie/S-3352-2019	Ruffner, Melanie/0000-0002-2943-9944	Juvenile Diabetes Research Foundation [7-2005-1154]; National Institutes of Health (NIH) [F30 DK082217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK082217] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Juvenile Diabetes Research Foundation Grant 7-2005-1154 to P.D.R. and National Institutes of Health (NIH) F30 DK082217 Fellowship to M.A.R. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Angelini F, 2005, CLIN EXP IMMUNOL, V142, P341, DOI 10.1111/j.1365-2249.2005.02916.x; Bianco NR, 2009, ARTHRITIS RHEUM-US, V60, P380, DOI 10.1002/art.24229; Calderon B, 2008, P NATL ACAD SCI USA, V105, P6121, DOI 10.1073/pnas.0801973105; Cameron MJ, 1997, J IMMUNOL, V159, P4686; Creusot RJ, 2008, CLIN IMMUNOL, V127, P176, DOI 10.1016/j.clim.2007.12.009; Feili-Hariri M, 2003, HUM GENE THER, V14, P13, DOI 10.1089/10430340360464679; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Hill NJ, 2003, J IMMUNOL, V170, P1649, DOI 10.4049/jimmunol.170.4.1649; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kim SH, 2000, ARTHRITIS RES, V2, P293, DOI 10.1186/ar104; Kim SH, 2002, MOL THER, V6, P584, DOI 10.1006/mthe.2002.0712; King C, 2001, NAT MED, V7, P206, DOI 10.1038/84659; Klueh U, 2006, DIABETES TECHNOL THE, V8, P402, DOI 10.1089/dia.2006.8.402; Lo J, 2006, AUTOIMMUN REV, V5, P419, DOI 10.1016/j.autrev.2005.12.001; Ma LL, 2003, DIABETES, V52, P1976, DOI 10.2337/diabetes.52.8.1976; Machen J, 2004, J IMMUNOL, V173, P4331, DOI 10.4049/jimmunol.173.7.4331; Mollah ZUA, 2008, J IMMUNOL, V180, P3166, DOI 10.4049/jimmunol.180.5.3166; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Papaccio G, 2002, J CELL BIOCHEM, V86, P651, DOI 10.1002/jcb.10250; Perone MJ, 2006, J IMMUNOL, V177, P5278, DOI 10.4049/jimmunol.177.8.5278; Rapoport MJ, 2005, CYTOKINE, V30, P219, DOI 10.1016/j.cyto.2005.01.012; Rehman KK, 2008, MOL THER, V16, P1409, DOI 10.1038/mt.2008.116; Rodacki M, 2006, CLIN DEV IMMUNOL, V13, P101, DOI 10.1080/17402520600877182; Roep BO, 2004, NAT REV IMMUNOL, V4, P989, DOI 10.1038/nri1502; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Son YI, 2002, J IMMUNOL METHODS, V262, P145, DOI 10.1016/S0022-1759(02)00013-3; Tan PH, 2005, BLOOD, V105, P3824, DOI 10.1182/blood-2004-10-3880; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Weaver DJ, 2001, J IMMUNOL, V167, P1461, DOI 10.4049/jimmunol.167.3.1461; Zhong L, 1999, EUR J IMMUNOL, V29, P964, DOI 10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P	34	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11848	10.1371/journal.pone.0011848	http://dx.doi.org/10.1371/journal.pone.0011848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686610	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520200014
J	Koeberle, A; Shindou, H; Harayama, T; Shimizu, T				Koeberle, Andreas; Shindou, Hideo; Harayama, Takeshi; Shimizu, Takao			Role of lysophosphatidic acid acyltransferase 3 for the supply of highly polyunsaturated fatty acids in TM4 Sertoli cells	FASEB JOURNAL			English	Article						1-acylglycerol-3-phosphate-O-acyltransferase; phosphatidylcholine; phosphatidic acid; testis	RAT SERTOLI; LIPID-COMPOSITION; DOCOSAHEXAENOIC ACID; GERMINAL CELLS; METABOLISM; TESTIS; EXPRESSION; CLONING; PHARMACOKINETICS; BIOSYNTHESIS	Sertoli cells supply germ cells with nutrients, including highly polyunsaturated fatty acids (hPUFAs), which are essential for testicular function. We have previously reported high expression of lysophosphatidic acid acyltransferase (LPAAT)3 in mature mouse testis and suggested an arachidonoyl-transferase activity to LPA. To investigate the role of LPAAT3 in the storage and release of PUFAs, TM4 Sertoli cells were stably transfected with LPAAT3-small hairpin (sh) RNA. Arachidonoyl-, eicosapentaenoyl-, and docosapentaenoyl-containing phosphatidylcholine (PC) and linoleoyl-containing phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidylglycerol were significantly decreased as determined by liquid chromatography coupled to electrospray ionization mass spectrometry. Expression of murine LPAAT3 in Chinese hamster ovary (CHO)-K1 cells had essentially an opposite effect. The level of polyunsaturated PC correlated with cellular levels of free docosapentaenoic acid and eicosapentaenoic acid in TM4 and CHO-K1 cells, respectively. Activity assays using microsomal preparations as a source of LPAAT3 revealed an excessive PA synthesis from LPA acceptors for docosahexaenoyl-, arachidonoyl- and less pronounced for linoleoylCoA. Wepropose that the efficient incorporation of hPUFAs into PA-the precursor of several phospholipids, including PC-and the selective increase of the polyunsaturated PC pool in TM4 Sertoli cells might be required for the controlled release of hPUFAs and their supply to germ cells.-Koeberle, A., Shindou, H., Harayama, T., Shimizu, T. Role of lysophosphatidic acid acyltransferase 3 for the supply of highly polyunsaturated fatty acids in TM4 Sertoli cells. FASEB J. 24, 4929-4938 (2010). www.fasebj.org	[Shindou, Hideo] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Shindou, H (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan.	hshindou-tky@umin.ac.jp	Shimizu, Takao/AAV-7052-2021; Harayama, Takeshi/AAD-8852-2022; Koeberle, Andreas/ABB-2356-2020	Harayama, Takeshi/0000-0003-2255-4197; Koeberle, Andreas/0000-0001-6269-5088	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for Promotion of Sciences; Center for NanoBio Integration at The University of Tokyo; Ministry of Health, Labour; Uehara Memorial Foundation; Cell Science Research Foundation; Japan Society for the Promotion of Science for Young Scientists; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration at The University of Tokyo; Ministry of Health, Labour; Uehara Memorial Foundation(Uehara Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors thank Dr. J.-I. Miyazaki (Osaka University) for supplying the expression vector pCXN2. This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (T. S.) and a Global COE Program (The University of Tokyo) from the Japan Society for Promotion of Sciences (T. S.). T. S. and H. S. were supported by the Center for NanoBio Integration at The University of Tokyo. H. S. was supported by Health and Labour Sciences research grants (Research on Allergic Disease and Immunology) of the Ministry of Health, Labour; a Grant-in-Aid for Young Scientists (B) from the MEXT of Japan; and the Uehara Memorial Foundation and the Cell Science Research Foundation. T. H. was supported by research fellowships of the Japan Society for the Promotion of Science for Young Scientists. A. K. received a stipend from the Takeda Science Foundation.	BECKMAN JK, 1980, LIPIDS, V15, P389, DOI 10.1007/BF02534061; BECKMAN JK, 1979, LIPIDS, V14, P262, DOI 10.1007/BF02533912; BIERI JG, 1965, COMP BIOCHEM PHYSIOL, V15, P275, DOI 10.1016/0010-406X(65)90131-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CONIGLIO JG, 1975, BIOL REPROD, V12, P255, DOI 10.1095/biolreprod12.2.255; Connor WE, 1998, J LIPID RES, V39, P1404; DAVIS JT, 1966, BIOCHEM J, V98, P342, DOI 10.1042/bj0980342; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; FISHER DM, 1983, BIOCHIM BIOPHYS ACTA, V751, P27, DOI 10.1016/0005-2760(83)90253-9; GROGAN WM, 1982, LIPIDS, V17, P605, DOI 10.1007/BF02535366; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; Huyghe S, 2006, ENDOCRINOLOGY, V147, P2228, DOI 10.1210/en.2005-1571; HUYNH S, 1991, COMP BIOCHEM PHYS B, V99, P265, DOI 10.1016/0305-0491(91)90039-G; Knudsen J, 2000, J NUTR, V130, p294S, DOI 10.1093/jn/130.2.294S; LACY D, 1962, BRIT MED BULL, V18, P205, DOI 10.1093/oxfordjournals.bmb.a069979; Lin DS, 2004, J LIPID RES, V45, P529, DOI 10.1194/jlr.M300374-JLR200; LYNCH KM, 1951, ENDOCRINOLOGY, V49, P8, DOI 10.1210/endo-49-1-8; MARSEN TA, 1992, PROSTAG LEUKOTR ESS, V46, P191, DOI 10.1016/0952-3278(92)90069-U; NISSEN HP, 1983, ANDROLOGIA, V15, P264; Ogiso H, 2008, ANAL BIOCHEM, V375, P124, DOI 10.1016/j.ab.2007.12.027; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; OULHAJ H, 1992, COMP BIOCHEM PHYS B, V102, P897, DOI 10.1016/0305-0491(92)90099-D; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Retterstol K, 2001, LIPIDS, V36, P601, DOI 10.1007/s11745-001-0763-z; Retterstol K, 2001, REPRODUCTION, V121, P881, DOI 10.1530/reprod/121.6.881; ROBERT J, 1977, BIOCHIMIE, V59, P417, DOI 10.1016/S0300-9084(77)80318-0; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Rusca A, 2009, EUR J CLIN PHARMACOL, V65, P503, DOI 10.1007/s00228-008-0605-4; Saether T, 2003, BIOL REPROD, V69, P117, DOI 10.1095/biolreprod.102.014035; Schmidt JA, 2009, J CELL BIOL, V186, P211, DOI 10.1083/jcb.200904147; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Stamps AC, 1997, BIOCHEM J, V326, P455, DOI 10.1042/bj3260455; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200	38	30	30	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4929	4938		10.1096/fj.10-162818	http://dx.doi.org/10.1096/fj.10-162818			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20705908				2022-12-25	WOS:000284824400031
J	Belgnaoui, SM; Fryrear, KA; Nyalwidhe, JO; Guo, X; Semmes, OJ				Belgnaoui, S. Mehdi; Fryrear, Kimberly A.; Nyalwidhe, Julius O.; Guo, Xin; Semmes, O. John			The Viral Oncoprotein Tax Sequesters DNA Damage Response Factors by Tethering MDC1 to Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 TAX; DOUBLE-STRAND BREAKS; ONCOGENE-INDUCED SENESCENCE; NUCLEOTIDE EXCISION-REPAIR; HTLV-1 TAX; CELLULAR-TRANSFORMATION; I TAX; PROTEINS; CELLS; GENE	Infection with human T-cell leukemia virus induces cellular genomic instability mediated through the viral oncoprotein Tax. Here we present evidence that Tax undermines the cellular DNA damage response by sequestration of damage response factors. We show by confocal microscopy that Tax forms damage-independent nuclear foci that contain DNA-PK, BRCA1, and MDC1. Tax sequesters MDC1 to chromatin sites distinct from classic ionizing radiation-induced foci. The recruitment of MDC1 is competitive between the two foci. The N-terminal region of Tax is sufficient for foci localization, and the C-terminal half is critical for binding to MDC1 and recruitment of additional response factors. Tax expression and DNA damage response factor recruitment repressed the formation of ionizing radiation-induced Nbs1-containing foci. The Tax-induced "pseudo" DNA damage response results in phosphorylation and monoubiquitylation of H2AX, which is ablated by siRNA suppression of MDC1. These data support a model for virus-induced genomic instability in which viral oncogene-induced damage-independent foci compete with normal cellular DNA damage response.	[Belgnaoui, S. Mehdi; Fryrear, Kimberly A.; Nyalwidhe, Julius O.; Guo, Xin; Semmes, O. John] Eastern Virginia Med Sch, Canc Biol & Infect Dis Res Ctr, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23508 USA	Eastern Virginia Medical School	Semmes, OJ (corresponding author), Eastern Virginia Med Sch, Canc Biol & Infect Dis Res Ctr, Dept Microbiol & Mol Cell Biol, 700 W Olney Rd, Norfolk, VA 23508 USA.	Semmesoj@evms.edu	Semmes, Oliver/GQA-5179-2022		National Cancer Institute [CA76959]; NATIONAL CANCER INSTITUTE [R01CA076595, K07CA076959] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grant CA76959 (to O.J.S.) from the National Cancer Institute.	AKAGI T, 1993, J VIROL, V67, P1211, DOI 10.1128/JVI.67.3.1211-1217.1993; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Chandhasin C, 2008, J VIROL, V82, P6952, DOI 10.1128/JVI.02331-07; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Durkin SS, 2006, J BIOL CHEM, V281, P31705, DOI 10.1074/jbc.M607011200; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074/jbc.M804931200; Edwards DC, 2008, J VIROL, V82, P11714, DOI 10.1128/JVI.00356-08; Eliezer Y, 2009, J BIOL CHEM, V284, P426, DOI 10.1074/jbc.M807375200; Fryrear KA, 2009, J VIROL, V83, P5339, DOI 10.1128/JVI.00232-09; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; Gupta SK, 2007, J BIOL CHEM, V282, P29431, DOI 10.1074/jbc.M704110200; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Haoudi A, 2003, VIROLOGY, V305, P229, DOI 10.1006/viro.2002.1642; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeang KT, 2004, J BIOL CHEM, V279, P31991, DOI 10.1074/jbc.R400009200; JEANG KT, 1990, SCIENCE, V247, P1082, DOI 10.1126/science.2309119; KAMADA N, 1992, CANCER RES, V52, P1481; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; Kasai T, 2002, J BIOL CHEM, V277, P5187, DOI 10.1074/jbc.M110295200; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lukas C, 2005, CHROMOSOMA, V114, P146, DOI 10.1007/s00412-005-0011-y; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Miyake H, 1999, VIROLOGY, V253, P155, DOI 10.1006/viro.1998.9500; Nyborg JK, 2010, BBA-GENE REGUL MECH, V1799, P266, DOI 10.1016/j.bbagrm.2009.09.002; Park HU, 2006, ONCOGENE, V25, P438, DOI 10.1038/sj.onc.1209059; Park HU, 2004, ONCOGENE, V23, P4966, DOI 10.1038/sj.onc.1207644; Peloponese JM, 2007, INT J HEMATOL, V86, P101, DOI 10.1532/IJH97.07087; Philpott SM, 1999, J NATL CANCER I, V91, P933, DOI 10.1093/jnci/91.11.933; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Saggioro D, 2009, FRONT BIOSCI-LANDMRK, V14, P3338, DOI 10.2741/3456; Semmes OJ, 1996, J VIROL, V70, P6347, DOI 10.1128/JVI.70.9.6347-6357.1996; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sibon D, 2006, J CLIN INVEST, V116, P974, DOI 10.1172/JCI27198; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; TAJIMA K, 1998, JPN J CANC RES, V89; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046; Zane L, 2009, FRONT BIOSCI-LANDMRK, V14, P3935, DOI [10.2735/3502, 10.2741/3502]	55	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32897	32905		10.1074/jbc.M110.146373	http://dx.doi.org/10.1074/jbc.M110.146373			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729195	Green Published, hybrid			2022-12-25	WOS:000283048200027
J	Carreno, R; Brown, WS; Li, D; Hernandez, JA; Wang, Y; Kim, TK; Craft, JW; Komanduri, KV; Radvanyi, LG; Hwu, P; Molldrem, JJ; Legge, GB; McIntyre, BW; Ma, Q				Carreno, Roberto; Brown, Wells S.; Li, Dan; Hernandez, Jessica A.; Wang, Yang; Kim, Tae Kon; Craft, John W., Jr.; Komanduri, Krishna V.; Radvanyi, Laszlo G.; Hwu, Patrick; Molldrem, Jeffrey J.; Legge, Glen B.; McIntyre, Bradley W.; Ma, Qing			2E8 Binds to the High Affinity I-domain in a Metal Ion-dependent Manner A SECOND GENERATION MONOCLONAL ANTIBODY SELECTIVELY TARGETING ACTIVATED LFA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; LIGAND-MIMETIC ANTIBODY; IMMUNOLOGICAL SYNAPSE; INTEGRIN REGULATION; PLAQUE PSORIASIS; STRUCTURAL BASIS; CLINICAL-TRIALS; T-CELLS; LFA-1; ACTIVATION	The activation of leukocyte function-associated antigen-1 (LFA-1) plays a critical role in regulating immune responses. The metal ion-dependent adhesion site on the I-domain of LFA-1 alpha(L) subunit is the key recognition site for ligand binding. Upon activation, conformation changes in the I-domain can lead LFA-1 from the low affinity state to the high affinity (HA) state. Using the purified HA I-domain locked by disulfide bonds for immunization, we developed an mAb, 2E8, that specifically binds to cells expressing the HA LFA-1. The surface plasmon resonance analysis has shown that 2E8 only binds to the HA I-domain and that the dissociation constant (K-D) for HA I-domain is 197 nM. The binding of 2E8 to the HA I-domain is metal ion-dependent, and the affinity decreased as Mn2+ was replaced sequentially by Mg2+ and Ca2+. Surface plasmon resonance analysis demonstrates that 2E8 inhibits the interaction of HA I-domain and ICAM-1. Furthermore, we found that 2E8 can detect activated LFA-1 on both JY and Jurkat cells using flow cytometry and parallel plate adhesion assay. In addition, 2E8 inhibits JY cell adhesion to human umbilical vein endothelial cells and homotypic aggregation. 2E8 treatment reduces the proliferation of both human CD4(+) and CD8(+) T cells upon OKT3 stimulation without the impairment of their cytolytic function. Taken together, these data demonstrate that 2E8 is specific for the high affinity form of LFA-1 and that 2E8 inhibits LFA-1/ICAM-1 interactions. As a novel activation-specific monoclonal antibody, 2E8 is a potentially useful reagent for blocking high affinity LFA-1 and modulating T cell activation in research and therapeutics.	[Carreno, Roberto; Li, Dan; Wang, Yang; Molldrem, Jeffrey J.; Ma, Qing] Univ Texas MD Anderson Canc Ctr, Sect Transplantat Immunol, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Brown, Wells S.; McIntyre, Bradley W.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Hernandez, Jessica A.; Radvanyi, Laszlo G.; Hwu, Patrick] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Oncol, Houston, TX 77030 USA; [Kim, Tae Kon; Komanduri, Krishna V.] Univ Miami, Sylvester Comprehens Canc Ctr, Adult Stem Cell Transplant Program, Miami, FL 33136 USA; [Craft, John W., Jr.; Legge, Glen B.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Miami; University of Houston System; University of Houston	Ma, Q (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Transplantat Immunol, Dept Stem Cell Transplantat & Cellular Therapy, Unit 900,1515 Holcombe Blvd, Houston, TX 77030 USA.	qma@mdanderson.org	Komanduri, Krishna V./G-6012-2011	Komanduri, Krishna V./0000-0003-3715-5236; Craft, John/0000-0002-5679-5629	American Cancer Society [RSG-08-183-01-LIB]	American Cancer Society(American Cancer Society)	The work was supported by American Cancer Society Grant RSG-08-183-01-LIB (to Q. M.).	Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; BLAZAR BR, 1995, BLOOD, V85, P2607, DOI 10.1182/blood.V85.9.2607.bloodjournal8592607; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Carreno R, 2008, J BIOL CHEM, V283, P10642, DOI 10.1074/jbc.M704699200; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Dustin ML, 2003, ANN NY ACAD SCI, V987, P51, DOI 10.1111/j.1749-6632.2003.tb06032.x; Giblin PA, 2006, CURR PHARM DESIGN, V12, P2771, DOI 10.2174/138161206777947731; Gordon KB, 2003, JAMA-J AM MED ASSOC, V290, P3073, DOI 10.1001/jama.290.23.3073; He LW, 2005, J IMMUNOL METHODS, V304, P43, DOI 10.1016/j.jim.2005.06.005; HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305; Hogg N, 2004, IMMUNOL LETT, V92, P51, DOI 10.1016/j.imlet.2003.10.014; Huang LL, 2006, J LEUKOCYTE BIOL, V80, P905, DOI 10.1189/jlb.1105649; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Hynes RO, 2003, SCIENCE, V300, P755, DOI 10.1126/science.1084854; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; Legge GB, 2002, PROTEINS, V48, P151, DOI 10.1002/prot.10134; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Matthews JB, 2003, AM J TRANSPLANT, V3, P794, DOI 10.1046/j.1600-6135.2003.0154.x; Mitchell JS, 2009, IMMUNOL CELL BIOL, V87, P324, DOI 10.1038/icb.2008.103; Nicolls MR, 2006, AM J TRANSPLANT, V6, P27, DOI 10.1111/j.1600-6143.2005.01158.x; Pugashetti R, 2009, J DERMATOL TREAT, V20, P132, DOI 10.1080/09546630902984596; Scheinfeld N, 2006, EXPERT OPIN DRUG SAF, V5, P197, DOI 10.1517/14740338.5.2.197; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Zhang HM, 2009, P NATL ACAD SCI USA, V106, P18345, DOI 10.1073/pnas.0909301106	35	5	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32860	32868		10.1074/jbc.M110.111591	http://dx.doi.org/10.1074/jbc.M110.111591			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724473	Green Published, hybrid			2022-12-25	WOS:000283048200023
J	Kim, KK; Park, KS; Song, SB; Kim, KE				Kim, Kee Kwang; Park, Key Sun; Song, Seok Bean; Kim, Kyoon Eon			Insulin Represses Transcription of the Thyroid Stimulating Hormone beta-Subunit Gene through Increased Recruitment of Nuclear Factor I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONADOTROPIN-RELEASING-HORMONE; CELL-SPECIFIC EXPRESSION; GROWTH-HORMONE; PITUITARY-CELLS; GLUCOSE-TRANSPORTER; PROMOTER ACTIVITY; METABOLISM; ACTIVATION; RECEPTORS; ELEMENTS	Although the regulation of thyroid stimulating hormone beta-subunit gene (TSH beta) has been intensively studied, the functions of transcription factors involved are not fully understood. The authors found that the -615/-516 promoter region of the TSH beta interacts specifically with nuclear proteins derived from pituitary tissue or from cultured thyrotroph cells. The actual binding site at the nucleotide level, as revealed by DNase I protection assay, includes the consensus sequence for nuclear factor I (NFI). RT-PCR analysis indicated that NFI-B expression is restricted to thyrotroph cells in the anterior pituitary. EMSA and ChIP analysis showed that NFI-B binds most efficiently to the -588/-560 region of TSH beta promoter. The forced expressions of NFI-B markedly reduced TSH beta promoter activity and its mRNA expression. Furthermore, it was also shown that the -588/-560 region is involved in the insulin-mediated repression of the TSH beta. It was of particular interest to observe that NFI-B was recruited to the -588/-560 region of the TSH beta promoter in an insulin-dependent manner. Taken together, this study provides new insights of the delicate regulations of energy metabolism and hormonal homeostasis.	[Kim, Kee Kwang; Park, Key Sun; Song, Seok Bean; Kim, Kyoon Eon] Chungnam Natl Univ, Dept Biochem, Coll Nat Sci, Taejon 305764, South Korea	Chungnam National University	Kim, KE (corresponding author), Chungnam Natl Univ, Dept Biochem, Coll Nat Sci, Taejon 305764, South Korea.	kyoonkim@cnu.ac.kr	Kim, Kee/F-8784-2011	Kim, Keekwang/0000-0002-1088-3383; Kim, Kyoon/0000-0001-5133-1692	Chungnam National University	Chungnam National University	This study was financially supported by the research fund of Chungnam National University in 2008.	Ai D, 2007, MOL CELL BIOL, V27, P5765, DOI 10.1128/MCB.01848-06; Alarid ET, 1996, DEVELOPMENT, V122, P3319; ARMENTERO MT, 1994, P NATL ACAD SCI USA, V91, P11537, DOI 10.1073/pnas.91.24.11537; Belikov S, 2004, MOL CELL BIOL, V24, P3036, DOI 10.1128/MCB.24.7.3036-3047.2004; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; CARR FE, 1989, MOL ENDOCRINOL, V3, P717, DOI 10.1210/mend-3-4-717; CARR FE, 1989, MOL ENDOCRINOL, V3, P709, DOI 10.1210/mend-3-4-709; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chen WF, 2004, J CLIN ENDOCR METAB, V89, P2351, DOI 10.1210/jc.2003-032065; CHIN WW, 1993, RECENT PROG HORM RES, V48, P393; Cooke DW, 1999, J BIOL CHEM, V274, P12917, DOI 10.1074/jbc.274.18.12917; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; DARLING DS, 1989, MOL ENDOCRINOL, V3, P1359, DOI 10.1210/mend-3-9-1359; DATTA S, 1992, MOL ENDOCRINOL, V6, P815, DOI 10.1210/me.6.5.815; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Fekete C, 2006, ENDOCRINOLOGY, V147, P520, DOI 10.1210/en.2005-0956; Givens ML, 2004, MOL ENDOCRINOL, V18, P2950, DOI 10.1210/me.2003-0437; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hrytsenko O, 2007, BRAIN RES, V1135, P31, DOI 10.1016/j.brainres.2006.12.009; Hussain MA, 1996, EUR J ENDOCRINOL, V134, P563, DOI 10.1530/eje.0.1340563; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kim KK, 2007, ENDOCRINOLOGY, V148, P3468, DOI 10.1210/en.2006-1088; Lanni A, 2001, J ENDOCRINOL INVEST, V24, P897, DOI 10.1007/BF03343949; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; MAGNER JA, 1990, ENDOCR REV, V11, P354, DOI 10.1210/edrv-11-2-354; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MULLER MJ, 1990, METABOLISM, V39, P480, DOI 10.1016/0026-0495(90)90006-X; Norquay LD, 2003, MOL ENDOCRINOL, V17, P1027, DOI 10.1210/me.2003-0025; Norquay LD, 2001, BIOCHEM J, V354, P387, DOI 10.1042/0264-6021:3540387; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Ortega E, 2008, EUR J ENDOCRINOL, V158, P217, DOI 10.1530/EJE-07-0592; Richards MP, 2005, COMP BIOCHEM PHYS A, V141, P76, DOI 10.1016/j.cbpb.2005.04.006; Scassa ME, 2004, J BIOL CHEM, V279, P28082, DOI 10.1074/jbc.M401792200; SCHODERBEK WE, 1992, MOL ENDOCRINOL, V6, P893, DOI 10.1210/me.6.6.893; Schultes B, 2002, METABOLISM, V51, P1370, DOI 10.1053/meta.2002.35193; SMALL M, 1986, POSTGRAD MED J, V62, P445, DOI 10.1136/pgmj.62.728.445; Song SB, 2003, MOL CELL ENDOCRINOL, V199, P29, DOI 10.1016/S0303-7207(02)00334-9; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; STEPHENS JM, 1995, ENDOCR REV, V16, P529, DOI 10.1210/er.16.4.529; Szkudelski T, 2003, J PHYSIOL BIOCHEM, V59, P71, DOI 10.1007/BF03179872; Torrance CJ, 1997, ENDOCRINOLOGY, V138, P1204, DOI 10.1210/en.138.3.1204; Yaden BC, 2006, ENDOCRINOLOGY, V147, P324, DOI 10.1210/en.2005-0970; Yusta B, 1998, ENDOCRINOLOGY, V139, P4476, DOI 10.1210/en.139.11.4476; Zhang T, 2001, J BIOL CHEM, V276, P45604, DOI 10.1074/jbc.M107075200; ZOU LL, 1995, ENDOCRINOLOGY, V136, P5236, DOI 10.1210/en.136.11.5236	50	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32003	32011		10.1074/jbc.M110.107573	http://dx.doi.org/10.1074/jbc.M110.107573			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685655	Green Published, hybrid			2022-12-25	WOS:000282683000013
J	Sengupta, PK; Bouchie, MP; Kukuruzinska, MA				Sengupta, Pritam K.; Bouchie, Meghan P.; Kukuruzinska, Maria A.			N-Glycosylation Gene DPAGT1 Is a Target of the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN EXPRESSION; BETA-CATENIN; CELL-ADHESION; INTERCELLULAR-ADHESION; WNT PATHWAY; TRANSCRIPTION; PLAKOGLOBIN; ACTIVATION; CANCER; PROLIFERATION	Protein N-glycosylation and the Wnt/beta-catenin signaling pathways play critical roles in development and cancer. Although N-glycosylation has been shown to influence Wnt signaling through its effects on Wnt ligands, it is unclear whether the Wnt/beta-catenin pathway impacts protein N-glycosylation. In this study, we show that promoters of the first N-glycosylation gene, DPAGT1, from Chinese hamster ovary (CHO), Madin-Darby canine kidney (MDCK), and human epidermoid carcinoma (A253) cells contain the T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) consensus sequence. Treatment of cells with a Wnt activator, lithium chloride, up-regulated DPAGT1 transcript levels that correlated with an increase in the beta-catenin abundance. Furthermore, exposure of cells to a Wnt receptor ligand, Wnt3a, resulted in an increase in the DPAGT1 transcript levels that was abrogated by the Wnt inhibitor, Dick-kopf-1. DNA mobility shift assays revealed specific protein complexes at the DPAGT1 TCF/LEF binding region that were competed off with antibodies to either Tcf3/4 or beta-catenin. Chromatin immunoprecipitation analysis confirmed the presence of beta-catenin at the DPAGT1 promoter in vivo. In addition, the DPAGT1 TCF/LEF sequence drove the expression of the luciferase reporter gene. Furthermore, up-regulation of DPAGT1 transcripts by Wnt3a led to altered N-glycosylation of E-cadherin. Interestingly, the DPAGT1 TCF/LEF sequence also interacted with gamma-catenin, a close homologue of beta-catenin, although not in a lithium chloride-dependent manner. Our results provide the first evidence that the Wnt/beta-catenin signaling pathway regulates the metabolic pathway of protein N-glycosylation by targeting DPAGT1 expression. Moreover, they suggest the existence of another regulatory mechanism involving the interaction of Tcf with gamma-catenin at the DPAGT1 promoter.	[Sengupta, Pritam K.; Bouchie, Meghan P.; Kukuruzinska, Maria A.] Boston Univ, Dept Mol & Cell Biol, Boston, MA 02118 USA	Boston University	Kukuruzinska, MA (corresponding author), Boston Univ, Dept Mol & Cell Biol, 72 E Concord St,E428,Med Campus, Boston, MA 02118 USA.	mkukuruz@bu.edu		Kukukruzinska, Maria/0000-0001-5314-1454	NIDCR, National Institutes of Health [RO1 DE010183, RO1 DE015304]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015304, R01DE010183] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants RO1 DE010183 and RO1 DE015304 from NIDCR (to M. A. K.).	Anagnostou SH, 2008, BIOCHEM J, V416, P211, DOI 10.1042/BJ20081426; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Chen KH, 2008, CANCER LETT, V267, P37, DOI 10.1016/j.canlet.2008.03.005; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fernandes RP, 1999, HISTOCHEM CELL BIOL, V111, P153, DOI 10.1007/s004180050345; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Jamal BT, 2009, CELL HEALTH CYTOSKEL, V1, P67; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; Kukuruzinska MA, 1999, BBA-GEN SUBJECTS, V1426, P359, DOI 10.1016/S0304-4165(98)00136-6; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Mendelsohn RD, 2005, BBA-GEN SUBJECTS, V1723, P33, DOI 10.1016/j.bbagen.2005.01.017; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Nita-Lazar M, 2009, CANCER RES, V69, P5673, DOI 10.1158/0008-5472.CAN-08-4512; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shim JS, 2004, ONCOGENE, V23, P1704, DOI 10.1038/sj.onc.1207289; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; Soler C, 1999, FEBS LETT, V442, P178, DOI 10.1016/S0014-5793(98)01648-2; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tice DA, 2002, J BIOL CHEM, V277, P6118, DOI 10.1074/jbc.M111255200; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhurinsky J, 2000, J CELL SCI, V113, P3127; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	51	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31164	31173		10.1074/jbc.M110.149195	http://dx.doi.org/10.1074/jbc.M110.149195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20693288	Green Published, hybrid			2022-12-25	WOS:000282764600010
J	Pasay, C; Mounsey, K; Stevenson, G; Davis, R; Arlian, L; Morgan, M; Vyszenski-Moher, D; Andrews, K; McCarthy, J				Pasay, Cielo; Mounsey, Kate; Stevenson, Graeme; Davis, Rohan; Arlian, Larry; Morgan, Marjorie; Vyszenski-Moher, DiAnn; Andrews, Kathy; McCarthy, James			Acaricidal Activity of Eugenol Based Compounds against Scabies Mites	PLOS ONE			English	Article							DERMATOPHAGOIDES-PTERONYSSINUS ACARI; CROTAMITON 10-PERCENT CREAM; BUD OIL COMPOUNDS; CHEMICAL-COMPOSITION; SARCOPTES-SCABIEI; IN-VITRO; TYROPHAGUS-PUTRESCENTIAE; PYRETHROID ACARICIDES; DERMANYSSUS-GALLINAE; TETRANYCHUS-URTICAE	Backgound: Human scabies is a debilitating skin disease caused by the "itch mite'' Sarcoptes scabiei. Ordinary scabies is commonly treated with topical creams such as permethrin, while crusted scabies is treated with topical creams in combination with oral ivermectin. Recent reports of acaricide tolerance in scabies endemic communities in Northern Australia have prompted efforts to better understand resistance mechanisms and to identify potential new acaricides. In this study, we screened three essential oils and four pure compounds based on eugenol for acaricidal properties. Methodology/Principal Findings: Contact bioassays were performed using live permethrin-sensitive S. scabiei var suis mites harvested from pigs and permethrin-resistant S. scabiei var canis mites harvested from rabbits. Results of bioassays showed that clove oil was highly toxic against scabies mites. Nutmeg oil had moderate toxicity and ylang ylang oil was the least toxic. Eugenol, a major component of clove oil and its analogues -acetyleugenol and isoeugenol, demonstrated levels of toxicity comparable to benzyl benzoate, the positive control acaricide, killing mites within an hour of contact. Conclusions: The acaricidal properties demonstrated by eugenol and its analogues show promise as leads for future development of alternative topical acaricides to treat scabies.	[Pasay, Cielo; Mounsey, Kate; Andrews, Kathy; McCarthy, James] Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia; [Pasay, Cielo; Mounsey, Kate; Andrews, Kathy; McCarthy, James] Univ Queensland, Australian Ctr Int & Trop Hlth, Brisbane, Qld, Australia; [Stevenson, Graeme; Davis, Rohan; Andrews, Kathy] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Arlian, Larry; Morgan, Marjorie; Vyszenski-Moher, DiAnn] Wright State Univ, Dayton, OH 45435 USA	QIMR Berghofer Medical Research Institute; University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; Griffith University; University System of Ohio; Wright State University Dayton	Pasay, C (corresponding author), Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia.	Cielo.Pasay@qimr.edu.au	Stevenson, Graeme/C-2297-2009; Andrews, Katherine/F-9586-2011; Davis, Rohan A/B-1689-2008; McCarthy, James S/C-1681-2009	Andrews, Katherine/0000-0002-1591-8979; Davis, Rohan A/0000-0003-4291-7573; Mounsey, Kate/0000-0003-0579-9424; McCarthy, James/0000-0001-6596-9718	National Health and Medical Research Council, Canberra, ACT [496635]; Queensland Health Smart State Grant (Australia); United States National Institutes of Health; National Institute of Allergy and Infectious Diseases, Bethesda, MD [AI-017252]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017252, R21AI017252] Funding Source: NIH RePORTER	National Health and Medical Research Council, Canberra, ACT(National Health and Medical Research Council (NHMRC) of Australia); Queensland Health Smart State Grant (Australia); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Health and Medical Research Council, Canberra, ACT (Grant 496635)/Queensland Health Smart State Grant (Australia), United States National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD (Grant AI-017252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo CP, 2010, NAT PROD COMMUN, V5, P471; Carapetis JR, 1997, PEDIATR INFECT DIS J, V16, P494, DOI 10.1097/00006454-199705000-00008; Cavalcanti SCH, 2010, BIORESOURCE TECHNOL, V101, P829, DOI 10.1016/j.biortech.2009.08.053; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; Choi HY, 2010, J MED ENTOMOL, V47, P387, DOI 10.1603/ME09119; COSKEY RJ, 1979, ARCH DERMATOL, V115, P109, DOI 10.1001/archderm.1979.04010010075035; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Currie BJ, 2010, NEW ENGL J MED, V362, P717, DOI 10.1056/NEJMct0910329; Currie J, 2004, ACSMS HEALTH FIT J, V8, P12, DOI 10.1097/00135124-200407000-00005; Damiani N, 2009, PARASITOL RES, V106, P145, DOI 10.1007/s00436-009-1639-y; Elmhalli FH, 2009, EXP APPL ACAROL, V48, P251, DOI 10.1007/s10493-009-9236-4; Fichi G, 2007, EXP PARASITOL, V115, P168, DOI 10.1016/j.exppara.2006.07.005; FRASER J, 1994, MED J AUSTRALIA, V160, P806, DOI 10.5694/j.1326-5377.1994.tb125968.x; George DR, 2010, MED VET ENTOMOL, V24, P1, DOI 10.1111/j.1365-2915.2009.00855.x; George DR, 2009, EXP APPL ACAROL, V48, P43, DOI 10.1007/s10493-008-9225-z; HERNANDEZPEREZ E, 1983, J AM ACAD DERMATOL, V8, P121, DOI 10.1016/S0190-9622(83)80285-0; Ho S. H., 1994, Postharvest Biology and Technology, V4, P179, DOI 10.1016/0925-5214(94)90019-1; Hongratanaworakit T, 2004, PLANTA MED, V70, P632, DOI 10.1055/s-2004-827186; Jeong EY, 2009, PEST MANAG SCI, V65, P327, DOI 10.1002/ps.1684; Jukic M, 2006, CROAT CHEM ACTA, V79, P209; Kim EH, 2003, APPL ENTOMOL ZOOL, V38, P261, DOI 10.1303/aez.2003.261; Kim EH, 2003, J AGR FOOD CHEM, V51, P885, DOI 10.1021/jf0208278; Kim HK, 2008, EXP APPL ACAROL, V44, P1, DOI 10.1007/s10493-008-9129-y; KOLIOPOULUS G, PARASITOL RES   0420; Liu ZL, 2010, MOLECULES, V15, P2600, DOI 10.3390/molecules15042600; Macchioni F, 2002, J AGR FOOD CHEM, V50, P4586, DOI 10.1021/jf020270w; Miresmailli S, 2006, PEST MANAG SCI, V62, P366, DOI 10.1002/ps.1157; Mounsey K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000756; Mounsey Kate E., 2007, Invertebrate Neuroscience, V7, P149, DOI 10.1007/s10158-007-0050-6; Mounsey KE, 2008, FUTURE MICROBIOL, V3, P57, DOI 10.2217/17460913.3.1.57; Mounsey KE, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-43; Mounsey KE, 2009, ARCH DERMATOL, V145, P840, DOI 10.1001/archdermatol.2009.125; Oladimeji FA, 2000, J ETHNOPHARMACOL, V72, P305, DOI 10.1016/S0378-8741(00)00229-4; Olivero-Verbel J, 2010, PEST MANAG SCI, V66, P664, DOI 10.1002/ps.1927; Pasay C, 2008, MED VET ENTOMOL, V22, P82, DOI 10.1111/j.1365-2915.2008.00716.x; Pasay C, 2006, AM J TROP MED HYG, V74, P649, DOI 10.4269/ajtmh.2006.74.649; Pasay C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000354; Perrucci S., 1994, Parassitologia (Rome), V36, P269; ROTH WI, 1991, J AM ACAD DERMATOL, V24, P502, DOI 10.1016/S0190-9622(08)80078-3; Ribeiro VLS, 2010, BIORESOURCE TECHNOL, V101, P2506, DOI 10.1016/j.biortech.2009.11.016; Stashenko EE, 1996, HRC-J HIGH RES CHROM, V19, P353, DOI 10.1002/jhrc.1240190609; TAPLIN D, 1991, LANCET, V337, P1016, DOI 10.1016/0140-6736(91)92669-S; TAPLIN D, 1990, PEDIATR DERMATOL, V7, P67, DOI 10.1111/j.1525-1470.1990.tb01078.x; Tewary DK, 2006, J PEST SCI, V79, P209, DOI 10.1007/s10340-006-0135-8; Walton SF, 2000, T ROY SOC TROP MED H, V94, P92, DOI 10.1016/S0035-9203(00)90454-1; Walton SF, 2004, ARCH DERMATOL, V140, P563, DOI 10.1001/archderm.140.5.563; Williamson EM, 2007, NAT PROD COMMUN, V2, P1303; Yang YC, 2003, J AGR FOOD CHEM, V51, P4884, DOI 10.1021/jf034225f	48	73	78	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12079	10.1371/journal.pone.0012079	http://dx.doi.org/10.1371/journal.pone.0012079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711455	gold, Green Published			2022-12-25	WOS:000280849100018
J	Wang, HL; Yan, HP; Fu, A; Han, MJ; Hallahan, D; Han, ZZ				Wang, Hailun; Yan, Heping; Fu, Allie; Han, Miaojun; Hallahan, Dennis; Han, Zhaozhong			TIP-1 Translocation onto the Cell Plasma Membrane Is a Molecular Biomarker of Tumor Response to Ionizing Radiation	PLOS ONE			English	Article							PHAGE-DISPLAY; CANCER-PATIENTS; CYANOVIRIN-N; GROWTH; THERAPY; MARKERS; SURFACE; LUNG	Background: Tumor response to treatment has been generally assessed with anatomic and functional imaging. Recent development of in vivo molecular and cellular imaging showed promise in time-efficient assessment of the therapeutic efficacy of a prescribed regimen. Currently, the in vivo molecular imaging is limited with shortage of biomarkers and probes with sound biological relevance. We have previously shown in tumor-bearing mice that a hexapeptide (HVGGSSV) demonstrated potentials as a molecular imaging probe to distinguish the tumors responding to ionizing radiation (IR) and/or tyrosine kinase inhibitor treatment from those of non-responding tumors. Methodology/Principal Findings: In this study we have studied biological basis of the HVGGSSV peptide binding within the irradiated tumors by use of tumor-bearing mice and cultured cancer cells. The results indicated that Tax interacting protein 1 (TIP-1, also known as Tax1BP3) is a molecular target that enables the selective binding of the HVGGSSV peptide within irradiated xenograft tumors. Optical imaging and immunohistochemical staining indicated that a TIP-1 specific antibody demonstrated similar biodistribution as the peptide in tumor-bearing mice. The TIP-1 antibody blocked the peptide from binding within irradiated tumors. Studies on both of human and mouse lung cancer cells showed that the intracellular TIP-1 relocated to the plasma membrane surface within the first few hours after exposure to IR and before the onset of treatment associated apoptosis and cell death. TIP-1 relocation onto the cell surface is associated with the reduced proliferation and the enhanced susceptibility to the subsequent IR treatment. Conclusions/Significance: This study by use of tumor-bearing mice and cultured cancer cells suggested that imaging of the radiation-inducible TIP-1 translocation onto the cancer cell surface may predict the tumor responsiveness to radiation in a time-efficient manner and thus tailor radiotherapy of cancer.	[Wang, Hailun; Fu, Allie; Han, Miaojun; Han, Zhaozhong] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Wang, Hailun; Han, Zhaozhong] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Yan, Heping; Hallahan, Dennis] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Hallahan, Dennis] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; [Han, Zhaozhong] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Vanderbilt University	Wang, HL (corresponding author), Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA.	dhallahan@wustl.edu; zhaozhong.han@vanderbilt.edu	Wang, Hailun/T-5696-2019	Wang, Hailun/0000-0001-8651-2856	NIH [R01CA127482, P50 CA128323, R01CA112385, R01CA89674, R01CA125757]; NATIONAL CANCER INSTITUTE [R01CA125757, R01CA112385, P50CA128323, R01CA127482, R01CA089674] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by NIH grants R01CA127482 (Z Han), P50 CA128323 (Gore), R01CA112385, R01CA89674 and R01CA125757 (DE Hallahan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewine C, 2006, MOL BIOL CELL, V17, P4200, DOI 10.1091/mbc.E06-02-0129; Besser J, 2007, DEV GROWTH DIFFER, V49, P205, DOI 10.1111/j.1440-169x.2007.00921.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Hallahan D, 1996, CANCER RES, V56, P5150; Hallahan DE, 1998, CANCER RES, V58, P5216; Hampson L, 2004, INT J ONCOL, V25, P1249; Han Z, 2008, NAT MED, V14, P343, DOI 10.1038/nm1691; Han ZZ, 2006, TECHNOL CANCER RES T, V5, P437, DOI 10.1177/153303460600500412; Han ZZ, 2004, PEPTIDES, V25, P551, DOI 10.1016/j.peptides.2004.02.018; Han ZZ, 2004, COMB CHEM HIGH T SCR, V7, P55, DOI 10.2174/138620704772884823; Han ZZ, 2002, BIOCHEM BIOPH RES CO, V292, P1036, DOI 10.1006/bbrc.2002.6741; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Kanamori M, 2003, J BIOL CHEM, V278, P38758, DOI 10.1074/jbc.M306324200; Kay BK, 2004, CHEM BIOL, V11, P423, DOI 10.1016/j.chembiol.2004.04.004; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Levashova Z, 2010, J NUCL MED, V51, P959, DOI 10.2967/jnumed.109.072199; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Reynaud C, 2000, J BIOL CHEM, V275, P33962, DOI 10.1074/jbc.M000465200; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Svensson JP, 2006, PLOS MED, V3, P1904, DOI 10.1371/journal.pmed.0030422; Taguchi F, 2007, J NATL CANCER I, V99, P838, DOI 10.1093/jnci/djk195; Tenzer A, 2004, PROTEOMICS, V4, P2796, DOI 10.1002/pmic.200400811; Zhang LL, 2005, CIRCULATION, V112, P1601, DOI 10.1161/CIRCULATIONAHA.104.529537; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	29	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12051	10.1371/journal.pone.0012051	http://dx.doi.org/10.1371/journal.pone.0012051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711449	Green Published, Green Submitted, gold			2022-12-25	WOS:000280849100010
J	Danoviz, ME; Nakamuta, JS; Marques, FLN; dos Santos, L; Alvarenga, EC; dos Santos, AA; Antonio, EL; Schettert, IT; Tucci, PJ; Krieger, JE				Danoviz, Maria E.; Nakamuta, Juliana S.; Marques, Fabio L. N.; dos Santos, Leonardo; Alvarenga, Erica C.; dos Santos, Alexandra A.; Antonio, Ednei L.; Schettert, Isolmar T.; Tucci, Paulo J.; Krieger, Jose E.			Rat Adipose Tissue-Derived Stem Cells Transplantation Attenuates Cardiac Dysfunction Post Infarction and Biopolymers Enhance Cell Retention	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; STROMAL CELLS; FUNCTIONAL IMPROVEMENT; VENTRICULAR-FUNCTION; MUSCLE-CELLS; IN-VITRO; DIFFERENTIATION; SURVIVAL; REPAIR; HEART	Background: Cardiac cell transplantation is compromised by low cell retention and poor graft viability. Here, the effects of co-injecting adipose tissue-derived stem cells (ASCs) with biopolymers on cell cardiac retention, ventricular morphometry and performance were evaluated in a rat model of myocardial infarction (MI). Methodology/Principal Findings: Tc-99m-labeled ASCs (1 x 10(6) cells) isolated from isogenic Lewis rats were injected 24 hours post-MI using fibrin a, collagen (ASC/C), or culture medium (ASC/M) as vehicle, and cell body distribution was assessed 24 hours later by gamma-emission counting of harvested organs. ASC/F and ASC/C groups retained significantly more cells in the myocardium than ASC/M (13.8+/-2.0 and 26.8+/-2.4% vs. 4.8+/-0.7%, respectively). Then, morphometric and direct cardiac functional parameters were evaluated 4 weeks post-MI cell injection. Left ventricle (LV) perimeter and percentage of interstitial collagen in the spare myocardium were significantly attenuated in all ASC-treated groups compared to the non-treated (NT) and control groups (culture medium, fibrin, or collagen alone). Direct hemodynamic assessment under pharmacological stress showed that stroke volume (SV) and left ventricle end-diastolic pressure were preserved in ASC-treated groups regardless of the vehicle used to deliver ASCs. Stroke work (SW), a global index of cardiac function, improved in ASC/M while it normalized when biopolymers were co-injected with ASCs. A positive correlation was observed between cardiac ASCs retention and preservation of SV and improvement in SW post-MI under hemodynamic stress. Conclusions: We provided direct evidence that intramyocardial injection of ASCs mitigates the negative cardiac remodeling and preserves ventricular function post-MI in rats and these beneficial effects can be further enhanced by administrating co-injection of ASCs with biopolymers.	[Danoviz, Maria E.; Nakamuta, Juliana S.; dos Santos, Leonardo; Schettert, Isolmar T.; Krieger, Jose E.] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil; [Alvarenga, Erica C.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Marques, Fabio L. N.] Univ Sao Paulo, Sch Med, Nucl Med Ctr, Radiopharm Lab, Sao Paulo, Brazil; [dos Santos, Alexandra A.; Antonio, Ednei L.; Tucci, Paulo J.] Univ Fed Sao Paulo, Div Cardiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Danoviz, ME (corresponding author), Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil.	krieger@incor.usp.br	Alvarenga, Erika Costa/P-7596-2018; Pereira, Alexandre/HHN-1038-2022; Antonio, Ednei/AGG-9987-2022; Navarro Marques, Fabio Luiz/ABI-7774-2020; dos Santos, Leonardo/B-6509-2013; Krieger, Jose E/C-3117-2011; Schettert, Isolmar/D-1355-2012; Marques, Fabio LN/C-4153-2012; Tucci, Paulo/D-1441-2015	Alvarenga, Erika Costa/0000-0002-9480-9761; Antonio, Ednei/0000-0002-8254-5762; Navarro Marques, Fabio Luiz/0000-0001-7383-926X; dos Santos, Leonardo/0000-0002-4340-6364; Krieger, Jose E/0000-0001-5464-1792; Marques, Fabio LN/0000-0001-7383-926X; Tucci, Paulo/0000-0001-9793-670X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [01/0009-0, 05/54695-3, 04/06784-4]; Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Saude/Departamento Ciencia e Tecnologia (MCT/CNPq/MS/DECIT) [552324/20005-1, 10120104096700]; CNPq [141276/2004-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Saude/Departamento Ciencia e Tecnologia (MCT/CNPq/MS/DECIT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by grants from the public Brazilian Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP # 01/0009-0), Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Saude/Departamento Ciencia e Tecnologia (MCT/CNPq/MS/DECIT 552324/20005-1 and 10120104096700). MED and JSN were recipients of fellowships from FAPESP (05/54695-3 and 04/06784-4, respectively), and LS was a recipient of a fellowship from CNPq (141276/2004-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassaneze V, 2010, STEM CELLS DEV, V19, P371, DOI 10.1089/scd.2009.0195; Becker C, 2006, INT J CARDIOL, V113, P348, DOI 10.1016/j.ijcard.2005.11.060; Blande IS, 2009, TRANSFUSION, V49, P2680, DOI 10.1111/j.1537-2995.2009.02346.x; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DOSSANTOS L, 2009, INT J CARDIOL; DOSSANTOS L, 2010, CAN J PHYSL IN PRESS; Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Habermehl J, 2005, MACROMOL BIOSCI, V5, P821, DOI 10.1002/mabi.200500102; Heydarkhan-Hagvall S, 2008, CELLS TISSUES ORGANS, V187, P263, DOI 10.1159/000113407; Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264; Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345; MADONNA R, 2009, ARTERIOSCLER THROMB; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Mummery CL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000558; Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005; Ogawa R, 2004, BIOCHEM BIOPH RES CO, V313, P871, DOI 10.1016/j.bbrc.2003.12.017; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x; Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Schenke-Layland K, 2009, J SURG RES, V153, P217, DOI 10.1016/j.jss.2008.03.019; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Suzuki K, 2004, FASEB J, V18, P1153, DOI 10.1096/fj.03-1308fje; Tholpady SS, 2003, ANAT REC PART A, V272A, P398, DOI 10.1002/ar.a.10039; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Yasuda T, 2005, J THORAC CARDIOV SUR, V129, P904, DOI 10.1016/j.jtcvs.2004.06.027; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	49	79	83	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12077	10.1371/journal.pone.0012077	http://dx.doi.org/10.1371/journal.pone.0012077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711471	Green Submitted, gold, Green Published			2022-12-25	WOS:000280811900023
J	Kawamura, N; Tabata, H; Sun-Wada, GH; Wada, Y				Kawamura, Nobuyuki; Tabata, Hiroyuki; Sun-Wada, Ge-Hong; Wada, Yoh			Optic Nerve Compression and Retinal Degeneration in Tcirg1 Mutant Mice Lacking the Vacuolar-Type H+-ATPase a3 Subunit	PLOS ONE			English	Article							PROTON PUMP ATPASE; V-ATPASE; OSTEOCLAST DIFFERENTIATION; CILIARY EPITHELIUM; CELL-DEATH; MOUSE; OSTEOPETROSIS; ISOFORMS; ACIDIFICATION; KIDNEY	Background: Vacuolar-type proton transporting ATPase (V-ATPase) is involved in the proper development of visual function. Mutations in the Tcirg1 (also known as Atp6V0a3) locus, which encodes the a3 subunit of V-ATPase, cause severe autosomal recessive osteopetrosis (ARO) in humans. ARO is often associated with impaired vision most likely because of nerve compression at the optic canal. We examined the ocular phenotype of mice deficient in Tcirg1 function. Methodology/Principal Findings: X-ray microtomography showed narrowed foramina in the skull, suggesting that optic nerve compression occurred in the a3-deficient (Tcirg1(-/-)) mice. The retina of the mutant mice had normal architecture, but the number of apoptotic cells was increased at 2-3 wks after birth. In the ocular system, the a3 subunit accumulated in the choriocapillary meshwork in uveal tissues. Two other subunit isoforms a1 and a2 accumulated in the retinal photoreceptor layer. We found that the a4 subunit, whose expression has previously been shown to be restricted to several transporting epithelia, was enriched in pigmented epithelial cells of the retina and ciliary bodies. The expression of a4 in the uveal tissue was below the level of detection in wild-type mice, but it was increased in the mutant choriocapillary meshwork, suggesting that compensation may have occurred among the a subunit isoforms in the mutant tissues. Conclusions: Our findings suggest that a similar etiology of visual impairment is involved in both humans and mice; thus, a3-deficient mice may provide a suitable model for clinical and diagnostic purposes in cases of ARO.	[Kawamura, Nobuyuki; Tabata, Hiroyuki; Sun-Wada, Ge-Hong] Doshisha Womens Coll, Dept Biochem, Fac Pharmaceut Sci, Kyotanabe, Japan; [Wada, Yoh] Osaka Univ, Div Biol Sci, Inst Sci & Ind Res, Ibaraki, Japan	Osaka University	Kawamura, N (corresponding author), Doshisha Womens Coll, Dept Biochem, Fac Pharmaceut Sci, Kyotanabe, Japan.	yohwada@sanken.osaka-u.ac.jp		Kawamura, Nobuyuki/0000-0003-0664-749X	Ministry of Education, Culture, Science and Technology, Japan [20570142, 15079205, 21116002]	Ministry of Education, Culture, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid from Ministry of Education, Culture, Science and Technology, Japan (20570142 to GHSW; 15079205 and 21116002 to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askmyr M, 2009, EXP HEMATOL, V37, P302, DOI 10.1016/j.exphem.2008.10.010; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; DEGUCHI J, 1994, INVEST OPHTH VIS SCI, V35, P568; DICKIE MM, 1967, MOUSE NEWS LETT, V36; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; MAZZOLARI E, 2009, AM J HEMATOL; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; NUCKELS RJ, 2008, INVEST OPHTHALMOL VI; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Pyza E, 2004, J INSECT PHYSIOL, V50, P985, DOI 10.1016/j.jinsphys.2004.08.003; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Steward CG, 2003, NEUROPATH APPL NEURO, V29, P87, DOI 10.1046/j.1365-2990.2003.00474.x; Sun-Wada GH, 2007, CELL TISSUE RES, V329, P239, DOI 10.1007/s00441-007-0421-7; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Sun-Wada GH, 2005, J BIOENERG BIOMEMBR, V37, P415, DOI 10.1007/s10863-005-9482-z; Sun-Wada GH, 2003, J BIOL CHEM, V278, P44843, DOI 10.1074/jbc.M307197200; Tabata H, 2008, CELL TISSUE RES, V332, P447, DOI 10.1007/s00441-008-0597-5; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Vidarsson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004471; Villa A, 2009, CALCIFIED TISSUE INT, V84, P1, DOI 10.1007/s00223-008-9196-4; Wax MB, 1997, P NATL ACAD SCI USA, V94, P6752, DOI 10.1073/pnas.94.13.6752; Wu Q, 1997, AM J PHYSIOL-CELL PH, V273, pC1700, DOI 10.1152/ajpcell.1997.273.5.C1700; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	35	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12086	10.1371/journal.pone.0012086	http://dx.doi.org/10.1371/journal.pone.0012086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711468	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900026
J	Dumitriu, B; Bhattaram, P; Dy, P; Huang, YSA; Quayum, N; Jensen, J; Lefebvre, V				Dumitriu, Bogdan; Bhattaram, Pallavi; Dy, Peter; Huang, Yuanshuai; Quayum, Nayeem; Jensen, Jan; Lefebvre, Veronique			Sox6 Is Necessary for Efficient Erythropoiesis in Adult Mice under Physiological and Anemia-Induced Stress Conditions	PLOS ONE			English	Article							RED-BLOOD-CELLS; BCL-X-L; ERYTHROID-DIFFERENTIATION; DEFINITIVE ERYTHROPOIESIS; STAT5A(-/-)5B(-/-) MICE; OXIDATIVE STRESS; GENE; EXPRESSION; GLOBIN; INSIGHTS	Background: Definitive erythropoiesis is a vital process throughout life. Both its basal activity under physiological conditions and its increased activity under anemia-induced stress conditions are highly stimulated by the hormone erythropoietin. The transcription factor Sox6 was previously shown to enhance fetal erythropoiesis together and beyond erythropoietin signaling, but its importance in adulthood and mechanisms of action remain unknown. We used here Sox6 conditional null mice and molecular assays to address these questions. Methodology/Principal Findings: Sox6(fl/fl) ErGFPCre adult mice, which lacked Sox6 in erythroid cells, exhibited compensated anemia, erythroid cell developmental defects, and anisocytotic, short-lived red cells under physiological conditions, proving that Sox6 promotes basal erythropoiesis. Tamoxifen treatment of Sox6(fl/fl) CaggCreER mice induced widespread inactivation of Sox6 in a timely controlled manner and resulted in erythroblast defects before reticulocytosis, demonstrating that impaired erythropoiesis is a primary cause rather than consequence of anemia in the absence of Sox6. Twenty five percent of Sox6(fl/fl) ErGFPCre mice died 4 or 5 days after induction of acute anemia with phenylhydrazine. The others recovered slowly. They promptly increased their erythropoietin level and amplified their erythroid progenitor pool, but then exhibited severe erythroblast and reticulocyte defects. Sox6 is thus essential in the maturation phase of stress erythropoiesis that follows the erythropoietin-dependent amplification phase. Sox6 inactivation resulted in upregulation of embryonic globin genes, but embryonic globin chains remained scarce and apparently inconsequential. Sox6 inactivation also resulted in downregulation of erythroid terminal markers, including the Bcl2l1 gene for the anti-apoptotic factor Bcl-xL, and in vitro assays indicated that Sox6 directly upregulates Bcl2l1 downstream of and beyond erythropoietin signaling. Conclusions/Significance: This study demonstrates that Sox6 is necessary for efficient erythropoiesis in adult mice under both basal and stress conditions. It is primarily involved in enhancing the survival rate and maturation process of erythroid cells and acts at least in part by upregulating Bcl2l1.	[Dumitriu, Bogdan; Bhattaram, Pallavi; Dy, Peter; Huang, Yuanshuai; Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Dumitriu, Bogdan; Bhattaram, Pallavi; Dy, Peter; Huang, Yuanshuai; Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Orthopaed Res Ctr, Cleveland, OH 44106 USA; [Dumitriu, Bogdan] Cleveland Clin, Lerner Res Inst, Dept Internal Med, Cleveland, OH 44106 USA; [Quayum, Nayeem; Jensen, Jan] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Dumitriu, B (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA.	lefebvv@ccf.org		Jensen, Jan/0000-0003-0657-4032	Roche Foundation for Anemia Research; Cooley's Anemia Foundation; American Heart Association	Roche Foundation for Anemia Research; Cooley's Anemia Foundation; American Heart Association(American Heart Association)	This work was supported by a Roche Foundation for Anemia Research grant to VL and by postdoctoral fellowships from the Cooley's Anemia Foundation and the American Heart Association to BD. Acquisition of the Advia 120 instrument was made possible by a gift from Herbert and Judith Harvey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Bakker WJ, 2007, MOL CELL BIOL, V27, P3839, DOI 10.1128/MCB.01662-06; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; BHATTARAM P, 2010, NAT COMMUN IN PRESS; Broudy VC, 1996, BLOOD, V88, P75; Canonne-Hergaux F, 2001, BLOOD, V98, P3823, DOI 10.1182/blood.V98.13.3823; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Cohen-Barak O, 2007, EXP HEMATOL, V35, P358, DOI 10.1016/j.exphem.2006.11.009; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; Dumitriu B, 2006, GENESIS, V44, P219, DOI 10.1002/dvg.20210; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Hagiwara N, 2005, DEV DYNAM, V234, P301, DOI 10.1002/dvdy.20535; Hagiwara N, 2000, P NATL ACAD SCI USA, V97, P4180, DOI 10.1073/pnas.97.8.4180; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Longmore GD, 2006, J CLIN INVEST, V116, P626, DOI 10.1172/JCI27988; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Montel-Hagen A, 2009, CURR OPIN HEMATOL, V16, P165, DOI 10.1097/MOH.0b013e328329905c; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Noordermeer D, 2008, IUBMB LIFE, V60, P824, DOI 10.1002/iub.129; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Quayum N, 2008, EXP DIABETES RES, DOI 10.1155/2008/312060; Rhodes MM, 2005, BLOOD, V106, P1857, DOI 10.1182/blood-2004-11-4344; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; SCHRIER SL, 1994, ANNU REV MED, V45, P211; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Srinoun K, 2009, HAEMATOL-HEMATOL J, V94, P1211, DOI 10.3324/haematol.2009.005827; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tian CX, 2003, BLOOD, V101, P2235, DOI 10.1182/blood-2002-04-1217; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Wagner KU, 2000, DEVELOPMENT, V127, P4949; WALFAREN P, 2005, BLOOD, V105, P600; Wojchowski DM, 2006, BLOOD CELL MOL DIS, V36, P232, DOI 10.1016/j.bcmd.2006.01.007; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yi ZH, 2006, PLOS GENET, V2, P129, DOI 10.1371/journal.pgen.0020014; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	55	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12088	10.1371/journal.pone.0012088	http://dx.doi.org/10.1371/journal.pone.0012088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711497	gold, Green Published			2022-12-25	WOS:000280776800020
J	Bollo, M; Paredes, RM; Holstein, D; Zheleznova, N; Camacho, P; Lechleiter, JD				Bollo, Mariana; Paredes, R. Madelaine; Holstein, Deborah; Zheleznova, Nadezhda; Camacho, Patricia; Lechleiter, James D.			Calcineurin Interacts with PERK and Dephosphorylates Calnexin to Relieve ER Stress in Mammals and Frogs	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; KINASE-II; TRANSLATIONAL CONTROL; BINDING PROTEINS; CALCIUM-BINDING; CELL-SURVIVAL; PHOSPHORYLATION; APOPTOSIS; INHIBITION	Background: The accumulation of misfolded proteins within the endoplasmic reticulum (ER) triggers a cellular process known as the Unfolded Protein Response (UPR). One of the earliest responses is the attenuation of protein translation. Little is known about the role that Ca(2+) mobilization plays in the early UPR. Work from our group has shown that cytosolic phosphorylation of calnexin (CLNX) controls Ca(2+) uptake into the ER via the sarco-endoplasmic reticulum Ca(2+)-ATPase (SERCA) 2b. Methodology/Principal Findings: Here, we demonstrate that calcineurin (CN), a Ca(2+) dependent phosphatase, associates with the (PKR)-like ER kinase (PERK), and promotes PERK auto-phosphorylation. This association, in turn, increases the phosphorylation level of eukaryotic initiation factor-2 alpha (eIF2-alpha) and attenuates protein translation. Data supporting these conclusions were obtained from co-immunoprecipitations, pull-down assays, in-vitro kinase assays, siRNA treatments and [(35)S]-methionine incorporation measurements. The interaction of CN with PERK was facilitated at elevated cytosolic Ca(2+) concentrations and involved the cytosolic domain of PERK. CN levels were rapidly increased by ER stressors, which could be blocked by siRNA treatments for CN-A alpha in cultured astrocytes. Downregulation of CN blocked subsequent ER-stress-induced increases in phosphorylated elF2-alpha. CN knockdown in Xenopus oocytes predisposed them to induction of apoptosis. We also found that CLNX was dephosphorylated by CN when Ca(2+) increased. These data were obtained from [gamma(32)P]-CLNX immunoprecipitations and Ca(2+) imaging measurements. CLNX was dephosphorylated when Xenopus oocytes were treated with ER stressors. Dephosphorylation was pharmacologically blocked by treatment with CN inhibitors. Finally, evidence is presented that PERK phosphorylates CN-A at low resting levels of Ca(2+). We further show that phosphorylated CN-A exhibits decreased phosphatase activity, consistent with this regulatory mechanism being shut down as ER homeostasis is re-established. Conclusions/Significance: Our data suggest two new complementary roles for CN in the regulation of the early UPR. First, CN binding to PERK enhances inhibition of protein translation to allow the cell time to recover. The induction of the early UPR, as indicated by increased P-elF2 alpha, is critically dependent on a translational increase in CN-A alpha. Second, CN dephosphorylates CLNX and likely removes inhibition of SERCA2b activity, which would aid the rapid restoration of ER Ca(2+) homeostasis.	[Bollo, Mariana] Inst Invest Med Mercedes & Martin Ferreyra INIMEC, Cordoba, Argentina; [Paredes, R. Madelaine; Holstein, Deborah; Lechleiter, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Zheleznova, Nadezhda; Camacho, Patricia] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Bollo, M (corresponding author), Inst Invest Med Mercedes & Martin Ferreyra INIMEC, Cordoba, Argentina.	Lechleiter@uthscsa.edu			National Institutes of Health [R01 GM55372., PO1 AG19316-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by National Institutes of Health (http://www.nih.gov/) R01 GM55372 to Patricia Camacho and NIH PO1 AG19316-06 to Brian Herman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Carlberg M, 1996, CARCINOGENESIS, V17, P2589, DOI 10.1093/carcin/17.12.2589; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; EHRLICH BE, 1995, CURR OPIN NEUROBIOL, V5, P304, DOI 10.1016/0959-4388(95)80042-5; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HASHIMOTO Y, 1989, J BIOL CHEM, V264, P16524; HASHIMOTO Y, 1988, P NATL ACAD SCI USA, V85, P7001, DOI 10.1073/pnas.85.18.7001; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hofer AM, 1996, FASEB J, V10, P302, DOI 10.1096/fasebj.10.2.8641563; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; Kitamura M, 2010, NEPHROL DIAL TRANSPL, V25, P6, DOI 10.1093/ndt/gfp516; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Kumar R, 2001, J NEUROCHEM, V77, P1418, DOI 10.1046/j.1471-4159.2001.00387.x; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Ma TS, 1999, CELL CALCIUM, V26, P25, DOI 10.1054/ceca.1999.0049; Ma YL, 2001, RAPID COMMUN MASS SP, V15, P1693, DOI 10.1002/rcm.426; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Marciniak SJ, 2006, J CELL BIOL, V172, P201, DOI 10.1083/jcb.200508099; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Park EK, 2002, MOL CELL BIOL, V22, P3404, DOI 10.1128/MCB.22.10.3404-3414.2002; PERRINO BA, 1995, J BIOL CHEM, V270, P7012; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Saelim N, 2007, APOPTOSIS, V12, P1781, DOI 10.1007/s10495-007-0109-1; Sagoo JK, 1996, BIOCHEM J, V320, P879, DOI 10.1042/bj3200879; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2000, GENE DEV, V14, P2962, DOI 10.1101/gad.852300; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TROMBETTA SE, 1992, J BIOL CHEM, V267, P9236; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; von Ahsen O, 2000, METHOD ENZYMOL, V322, P183; WADA I, 1991, J BIOL CHEM, V266, P19599; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Wong HN, 1998, J BIOL CHEM, V273, P17227, DOI 10.1074/jbc.273.27.17227	59	62	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11925	10.1371/journal.pone.0011925	http://dx.doi.org/10.1371/journal.pone.0011925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700529	gold, Green Published, Green Submitted			2022-12-25	WOS:000280605400003
J	Sun, YT; Lodish, HF				Sun, Yutong; Lodish, Harvey F.			Adiponectin Deficiency Promotes Tumor Growth in Mice by Reducing Macrophage Infiltration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BREAST-CANCER CELLS; STIMULATES ANGIOGENESIS; ADIPOSE-TISSUE; NUDE-MICE; IDENTIFICATION; EXPRESSION; APOPTOSIS; RECEPTOR; OBESITY	Adiponectin is an adipocyte-derived plasma protein that has been implicated in regulating angiogenesis, but the role of adiponectin in regulating this process is still controversial. In this study, in order to determine whether adiponectin affects tumor growth and tumor induced vascularization, we implanted B16F10 melanoma and Lewis Lung Carcinoma cells subcutaneously into adiponectin knockout and wild-type control mice, and found that adiponectin deficiency markedly promoted the growth of both tumors. Immunohistochemical analyses indicated that adiponectin deficiency reduced macrophage recruitment to the tumor, but did not affect cancer cell mitosis, apoptosis, or tumor-associated angiogenesis. In addition, treatment with recombinant adiponectin did not affect the proliferation of cultured B16F10 tumor cells. Importantly, the restoration of microphage infiltration at an early stage of tumorigenesis by means of co-injection of B16F10 cells and macrophages reversed the increased tumor growth in adiponectin knockout mice. Thus, we conclude that the enhanced tumor growth observed in adiponectin deficient mice is likely due to the reduction of macrophage infiltration rather than enhanced angiogenesis.	[Sun, Yutong; Lodish, Harvey F.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Sun, YT (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu	; Stefanadis, Christodoulos/ABH-2232-2020	Sun, Yutong/0000-0002-9368-2957; Stefanadis, Christodoulos/0000-0001-5974-6454	Susan G. Komen for the Cure; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5R01DK047618-22]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047618] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from Susan G. Komen for the Cure (to Y.S.) and in part by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant 5R01DK047618-22 (to H. F. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Susan G. Komen for the Cure: http://ww5.komen.org/. U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): http://www.niddk.nih.gov/.	Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Arditi JD, 2007, HORM METAB RES, V39, P9, DOI 10.1055/s-2007-956518; Bonnotte B, 2001, J IMMUNOL, V167, P5077, DOI 10.4049/jimmunol.167.9.5077; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Denzel MS, 2009, CLIN CANCER RES, V15, P3256, DOI 10.1158/1078-0432.CCR-08-2661; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Fiumara A, 1997, J CLIN ENDOCR METAB, V82, P1615, DOI 10.1210/jc.82.5.1615; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kumar R, 1999, J LEUKOCYTE BIOL, V65, P102, DOI 10.1002/jlb.65.1.102; Lam JBB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004968; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Man K, 2010, CLIN CANCER RES, V16, P967, DOI 10.1158/1078-0432.CCR-09-1487; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Nishihara T, 2008, WORLD J GASTROENTERO, V14, P6473, DOI 10.3748/wjg.14.6473; OHASHI K, ADIPONECTIN PROMOTES, P6153; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	32	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11987	10.1371/journal.pone.0011987	http://dx.doi.org/10.1371/journal.pone.0011987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700533	Green Submitted, Green Published, gold			2022-12-25	WOS:000280605400020
J	Cranford, TW; Krysl, P; Amundin, M				Cranford, Ted W.; Krysl, Petr; Amundin, Mats			A New Acoustic Portal into the Odontocete Ear and Vibrational Analysis of the Tympanoperiotic Complex	PLOS ONE			English	Article							SOUND-TRANSMISSION; HEARING; PORPOISE; WHALES	Global concern over the possible deleterious effects of noise on marine organisms was catalyzed when toothed whales stranded and died in the presence of high intensity sound. The lack of knowledge about mechanisms of hearing in toothed whales prompted our group to study the anatomy and build a finite element model to simulate sound reception in odontocetes. The primary auditory pathway in toothed whales is an evolutionary novelty, compensating for the impedance mismatch experienced by whale ancestors as they moved from hearing in air to hearing in water. The mechanism by which high-frequency vibrations pass from the low density fats of the lower jaw into the dense bones of the auditory apparatus is a key to understanding odontocete hearing. Here we identify a new acoustic portal into the ear complex, the tympanoperiotic complex (TPC) and a plausible mechanism by which sound is transduced into the bony components. We reveal the intact anatomic geometry using CT scanning, and test functional preconceptions using finite element modeling and vibrational analysis. We show that the mandibular fat bodies bifurcate posteriorly, attaching to the TPC in two distinct locations. The smaller branch is an inconspicuous, previously undescribed channel, a cone-shaped fat body that fits into a thin-walled bony funnel just anterior to the sigmoid process of the TPC. The TPC also contains regions of thin translucent bone that define zones of differential flexibility, enabling the TPC to bend in response to sound pressure, thus providing a mechanism for vibrations to pass through the ossicular chain. The techniques used to discover the new acoustic portal in toothed whales, provide a means to decipher auditory filtering, beam formation, impedance matching, and transduction. These tools can also be used to address concerns about the potential deleterious effects of high-intensity sound in a broad spectrum of marine organisms, from whales to fish.	[Cranford, Ted W.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Krysl, Petr] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA; [Amundin, Mats] Kolmarden Wildlife Pk, Dept Res & Educ, Kolmarden, Sweden; [Amundin, Mats] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden	California State University System; San Diego State University; University of California System; University of California San Diego; Linkoping University	Cranford, TW (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	tcranfor@mail.sdsu.edu		Krysl, Petr/0000-0003-1761-5047	Fleet Industrial Supply Center (FISC) [N00244-08-1-0025]; Chief of Naval Operations Environmental Readiness Division [CNO-N45]; Naval Postgraduate School	Fleet Industrial Supply Center (FISC); Chief of Naval Operations Environmental Readiness Division; Naval Postgraduate School(United States Department of Defense)	Fleet Industrial Supply Center (FISC). Grant# N00244-08-1-0025. The funding flows from the Chief of Naval Operations Environmental Readiness Division (CNO-N45) and the Naval Postgraduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIADIS I, 1987, COMMUN APPL NUMER M, V3, P507, DOI 10.1002/cnm.1630030611; BEKESY GEORG v., 1948, JOUR ACOUSTICAL SOC AMER, V20, P749; Blevins R.D., 2001, FORMULAS NATURAL FRE; BOENNINGHAUS G, 1904, ARCH OTOLOGY, P196; BOENNINGHAUS G, 1904, ZOOL JB A, V19, P189; Bullock T.H., 1971, ORIENTATION NAVIGATI, P373; BULLOCK TH, 1968, Z VERGL PHYSIOL, V59, P117; Cranford T. W, 1988, ANIMAL SONAR PROCESS, P67; Cranford TW, 2008, ANAT REC, V291, P353, DOI 10.1002/ar.20652; Cranford Ted W., 2003, P27; Cranford TW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016001; Cranford TW, 1996, J MORPHOL, V228, P223; CRANFORD TW, 1992, THESIS U CALIFORNIA; CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3; deHaan Reysenbach, 1957, ACTA OTO-LARYNGOL, V134, P1; Fahy F, 2007, SOUND STRUCTURAL VIB; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; FLEISCHER G, 1973, 9 P ANN C BIOL SON D, P137; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Geisler Jonathan H., 2003, Journal of Mammalian Evolution, V10, P23, DOI 10.1023/A:1025552007291; Hato N, 2003, AUDIOL NEURO-OTOL, V8, P140, DOI 10.1159/000069475; Hemila S, 2001, HEARING RES, V151, P221, DOI 10.1016/S0378-5955(00)00232-X; Hemila S, 1999, HEARING RES, V133, P82, DOI 10.1016/S0378-5955(99)00055-6; HERZOG H, 1930, Z HALS NASEN OHRENH, V27, P402; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Hinton E., 1976, EARTHQ ENG STRUCT D, V4, P245, DOI [DOI 10.1002/EQE.4290040305, 10.1002/eqe.4290040305]; Hughes TJR, 2000, FINITE ELEMENT METHO; KELLOGG WN, 1952, SCIENCE, V116, P250, DOI 10.1126/science.116.3010.250; KELLOGG WN, 1953, J COMP PHYSIOL PSYCH, V46, P446, DOI 10.1037/h0060437; KELLOGG WN, 1953, SCIENCE, V117, P239, DOI 10.1126/science.117.3036.239; Ketten DR, 2000, SPR HDB AUD, V12, P43; Krysl P, 2008, INT J NUMER METH ENG, V76, P1020, DOI 10.1002/nme.2354; Krysl P., 2006, PRAGMATIC INTRO FINI; Lancaster W.C., 1990, Journal of Vertebrate Paleontology, V10, P117; MATHIEU WA, 1991, LISTENING BOOK DISCO; MCBRIDE AF, 1956, DEEP-SEA RES, V3, P153, DOI 10.1016/0146-6313(56)90096-X; MCCORMICK J G, 1970, Journal of the Acoustical Society of America, V48, P1418, DOI 10.1121/1.1912302; MCCORMICK JG, 1980, ANIMAL SONAR SYSTEMS, P449; MCGOWEN MR, 2009, MOL PHYLOG EVOL; MEAD JG, 2009, SMITHSONIAN CONTRIB, V627, P216; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; Norris K. S., 1964, P317; Norris K.S., 1972, P251; Norris K. S., 1969, P391; Norris K.S., 1974, PORPOISE WATCHER; Norris K.S., 1968, EVOLUTION ENV, P297; NORRIS KS, 1974, J ACOUST SOC AM, V56, P659, DOI 10.1121/1.1903305; NORRIS KS, 1980, ANIMAL SONAR SYSTEMS, P495; Nummela S, 2004, MAR MAMMAL SCI, V20, P491, DOI 10.1111/j.1748-7692.2004.tb01174.x; Nummela S, 1999, HEARING RES, V133, P61, DOI 10.1016/S0378-5955(99)00053-2; Nummela S, 1999, HEARING RES, V133, P71, DOI 10.1016/S0378-5955(99)00054-4; Nummela S, 2007, ANAT REC, V290, P716, DOI 10.1002/ar.20528; Popper A. N., 1980, CETACEAN BEHAV MECH, P1; Ridgway S. H., 2001, Aquatic Mammals, V27, P267; Ridgway S.H, 1983, HEARING OTHER SENSES, P247; Ridgway SH, 1999, MAR MAMMAL SCI, V15, P926, DOI 10.1111/j.1748-7692.1999.tb00861.x; Ridgway SH, 2001, J EXP BIOL, V204, P3829; Roache PJ, 1998, VERIFICATION VALIDAT; Sargent J.R., 1975, BIOCH BIOPHYSICAL PE, V2, P215; Yamada M., 1953, Scientific Reports of the Whales Research Institute Tokyo, V8, P1; Yost WA, 1994, FUNDAMENTALS HEARING	62	47	48	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11927	10.1371/journal.pone.0011927	http://dx.doi.org/10.1371/journal.pone.0011927			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694149	Green Published, gold			2022-12-25	WOS:000280574300005
J	Fan, XA; Klein, M; Flanagan-Steet, HR; Steet, R				Fan, Xiang; Klein, Maximilian; Flanagan-Steet, Heather R.; Steet, Richard			Selective Yolk Deposition and Mannose Phosphorylation of Lysosomal Glycosidases in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-OOCYTES; ORYZIAS-LATIPES; STORAGE DISORDERS; MEDAKA FISH; CATHEPSIN-D; DEGRADATION; EGGS; VITELLOGENIN; PROTEINASE; PLATELETS	The regulation and function of lysosomal hydrolases during yolk consumption and embryogenesis in zebrafish are poorly understood. In an effort to better define the lysosomal biochemistry of this organism, we analyzed the developmental expression, biochemical properties, and function of several glycosidases in zebrafish eggs, embryos, and adult tissues. Our results demonstrated that the specific activity of most enzymes increases during embryogenesis, likely reflecting a greater need for turnover within the embryo as yolk-derived nutrients are depleted. Analysis of glycosidase activity in zebrafish and medaka eggs revealed selective deposition of enzymes required for the degradation of N-linked glycans, including an abundance of acidic mannosidases. Treatment of zebrafish embryos with the alpha-mannosidase inhibitor swainsonine resulted in the accumulation of glycosylated vitellogenin fragments and demonstrated a function for maternally deposited acid alpha-mannosidase in yolk consumption. Surprisingly, we also found that, unlike mammals, acid alpha-glucosidase from zebrafish and medaka does not appear to be modified with mannose 6-phosphate residues. We further showed these residues were not acquired on human acid alpha-glucosidase when expressed in zebrafish embryos, suggesting unique differences in the ability of the human and zebrafish N-acetylglucosamine-1-phosphotransferase to recognize and modify certain lysosomal glycosidases. Together, these results provide novel insight into the role of acidic glycosidases during yolk utilization and the evolution of the mannose 6-phosphate targeting system in vertebrates.	[Fan, Xiang; Klein, Maximilian; Flanagan-Steet, Heather R.; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Steet, R (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu			NIGMS; National Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086524] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grant from NIGMS (to R. S.). This work was also supported by grants from the National Mucopolysaccharidosis Society.	Carnevali O, 1999, BIOL REPROD, V60, P140, DOI 10.1095/biolreprod60.1.140; FAGOTTO F, 1994, J CELL BIOL, V125, P1047, DOI 10.1083/jcb.125.5.1047; FAGOTTO F, 1995, J CELL SCI, V108, P3645; FAGOTTO F, 1990, ARCH INSECT BIOCHEM, V14, P217, DOI 10.1002/arch.940140403; Fialho E, 2005, ARCH BIOCHEM BIOPHYS, V436, P246, DOI 10.1016/j.abb.2005.01.005; Finn RN, 2007, BIOL REPROD, V76, P926, DOI 10.1095/biolreprod.106.059766; Flanagan-Steet H, 2009, AM J PATHOL, V175, P2063, DOI 10.2353/ajpath.2009.090210; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Galliano M, 2003, BIOCHEM J, V376, P433, DOI 10.1042/BJ20030413; Hemsley KM, 2010, J INHERIT METAB DIS, V33, P363, DOI 10.1007/s10545-010-9078-6; Jorgensen P, 2009, DEVELOPMENT, V136, P1539, DOI 10.1242/dev.032425; KITAJIMA K, 1989, DEV BIOL, V132, P544, DOI 10.1016/0012-1606(89)90249-2; Komazaki S, 1999, DEV GROWTH DIFFER, V41, P173; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Lehmann F, 2004, GLYCOBIOLOGY, V14, P959, DOI 10.1093/glycob/cwh120; MEDINA M, 1988, ARCH BIOCHEM BIOPHYS, V263, P355, DOI 10.1016/0003-9861(88)90646-7; Moro E, 2010, MATRIX BIOL, V29, P43, DOI 10.1016/j.matbio.2009.09.001; Nakamura K, 1996, COMP BIOCHEM PHYS B, V113, P835, DOI 10.1016/0305-0491(95)02102-7; OPRESKO L, 1980, CELL, V22, P47, DOI 10.1016/0092-8674(80)90153-1; OPRESKO LK, 1987, CELL, V51, P557, DOI 10.1016/0092-8674(87)90125-5; Roth Z, 2010, GLYCOCONJUGATE J, V27, P159, DOI 10.1007/s10719-009-9268-3; SEKO A, 1991, J BIOL CHEM, V266, P22110; Seko A, 1999, GLYCOBIOLOGY, V9, P887, DOI 10.1093/glycob/9.9.887; TAGUCHI T, 1993, J BIOL CHEM, V268, P2353; Vasta GR, 2004, GLYCOCONJUGATE J, V21, P503, DOI 10.1007/s10719-004-5541-7; WALL DA, 1985, J CELL BIOL, V101, P1651, DOI 10.1083/jcb.101.5.1651; WALLACE RA, 1983, CIBA F SYMP, V98, P228; WOJCHOWSKI DM, 1986, DEV BIOL, V116, P422, DOI 10.1016/0012-1606(86)90143-0	28	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32946	32953		10.1074/jbc.M110.158295	http://dx.doi.org/10.1074/jbc.M110.158295			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729204	Green Published, hybrid			2022-12-25	WOS:000283048200032
J	Matsumoto, E; Ishihara, A; Tamai, S; Nemoto, A; Iwase, K; Hiwasa, T; Shibata, S; Takiguchi, M				Matsumoto, Eriko; Ishihara, Akinori; Tamai, Saki; Nemoto, Ayako; Iwase, Katsuro; Hiwasa, Takaki; Shibata, Shigenobu; Takiguchi, Masaki			Time of Day and Nutrients in Feeding Govern Daily Expression Rhythms of the Gene for Sterol Regulatory Element-binding Protein (SREBP)-1 in the Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; LEUCINE ZIPPER PROTEIN; CIRCADIAN TRANSCRIPTION; POSITIONAL CLONING; LEPTIN RECEPTOR; ACID SYNTHESIS; MESSENGER-RNA; CLOCK GENES; INSULIN; PHOSPHORYLATION	Sterol regulatory element-binding protein-1 (SREBP-1) plays a central role in transcriptional regulation of genes for hepatic lipid synthesis that utilizes diet-derived nutrients such as carbohydrates and amino acids, and expression of SREBP-1 exhibits daily rhythms with a peak in the nocturnal feeding period under standard housing conditions of mice. Here, we report that the Srebp-1 expression rhythm shows time cue-independent and Clock mutation-sensitive circadian nature, and is synchronized with varied photoperiods apparently through entrainment of locomotor activity and food intake. Fasting caused diminution of Srebp-1 expression, while diabetic db/db and ob/ob mice showed constantly high expression with loss of rhythmicity. Time-restricted feedings during mid-light and mid-dark periods exhibited differential effects, the latter causing more severe damping of the oscillation. Therefore, "when to eat in a day (the light/dark cycle)," rather than "whenever to eat in a day," is a critical determinant to shape the daily rhythm of Srebp-1 expression. We further found that a high-carbohydrate diet and a high-protein diet, as well as a high-fat diet, cause phase shifts of the oscillation peak into the light period, underlining the importance of "what to eat." Daily rhythms of SREBP-1 protein levels and Akt phosphorylation levels also exhibited nutrient-responsive changes. Taken together, these findings provide a model for mechanisms by which time of day and nutrients in feeding shape daily rhythms of the Srebp-1 expression and possibly a number of other physiological functions with interindividual and interdaily differences in human beings and wild animals subjected to day-by-day changes in dietary timing and nutrients.	[Matsumoto, Eriko; Ishihara, Akinori; Tamai, Saki; Nemoto, Ayako; Iwase, Katsuro; Hiwasa, Takaki; Takiguchi, Masaki] Chiba Univ, Dept Biochem & Genet, Grad Sch Med, Chiba 2608670, Japan; [Shibata, Shigenobu] Waseda Univ, Dept Pharmacol, Sch Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Chiba University; Waseda University	Takiguchi, M (corresponding author), Chiba Univ, Dept Biochem & Genet, Grad Sch Med, Inohana 1-8-1, Chiba 2608670, Japan.	mtak@faculty.chiba-u.jp			Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan [18300228]; Fuji Foundation for Protein Research	Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fuji Foundation for Protein Research(Fuji Foundation for Protein Research)	This work was supported in part by Grant-in-Aid (18300228) for Scientific Research from the Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan, and Grant from Fuji Foundation for Protein Research.	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cunningham BA, 1998, THYROID, V8, P815, DOI 10.1089/thy.1998.8.815; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Hirao A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006909; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Ishihara A, 2007, J BIOL RHYTHM, V22, P324, DOI 10.1177/0748730407302107; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kudo T, 2004, DIABETOLOGIA, V47, P1425, DOI 10.1007/s00125-004-1461-0; LaFave LT, 2006, ENDOCRINOLOGY, V147, P4044, DOI 10.1210/en.2006-0473; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Sakao E, 2003, J BIOL CHEM, V278, P30450, DOI 10.1074/jbc.M304809200; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Yanagihara H, 2006, CHRONOBIOL INT, V23, P905, DOI 10.1080/07420520600827103; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	50	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33028	33036		10.1074/jbc.M109.089391	http://dx.doi.org/10.1074/jbc.M109.089391			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720008	Green Published, hybrid			2022-12-25	WOS:000283048200040
J	Kumar, TS; Kari, V; Choudhary, B; Nambiar, M; Akila, TS; Raghavan, SC				Kumar, Tadi Satish; Kari, Vijayalakshmi; Choudhary, Bibha; Nambiar, Mridula; Akila, T. S.; Raghavan, Sathees C.			Anti-apoptotic Protein BCL2 Down-regulates DNA End Joining in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; ACUTE LYMPHOBLASTIC-LEUKEMIA; LIGASE-IV; NONHOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; REPAIR CAPACITY; SINGLE-STRAND; MECHANISM; GENE; TRANSLOCATIONS	Cancer cells are often associated with secondary chromosomal rearrangements, such as deletions, inversions, and translocations, which could be the consequence of unrepaired/misrepaired DNA double strand breaks (DSBs). Nonhomologous DNA end joining is one of the most common pathways to repair DSBs in higher eukaryotes. By using oligomeric DNA substrates mimicking various endogenous DSBs in a cell-free system, we studied end joining (EJ) in different cancer cell lines. We found that the efficiency of EJ varies among cancer cells; however, there was no remarkable difference in the mechanism and expression of EJ proteins. Interestingly, cancer cells with lower levels of EJ possessed elevated expression of BCL2 and vice versa. Removal of BCL2 by immunoprecipitation or protein fractionation led to elevated EJ. More importantly, we show that overexpression of BCL2 or the addition of purified BCL2 led to the down-regulation of EJ. Further, we found that BCL2 interacts with KU proteins both in vitro and in vivo. Hence, our results suggest that EJ in cancer cells could be negatively regulated by the anti-apoptotic protein, BCL2, and this may contribute toward increased chromosomal abnormalities in cancer.	[Kumar, Tadi Satish; Kari, Vijayalakshmi; Choudhary, Bibha; Nambiar, Mridula; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Choudhary, Bibha; Akila, T. S.] Manipal Inst Regenerat Med, Bangalore 560071, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Manipal Academy of Higher Education (MAHE)	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	TADI, Satish K./AAY-2471-2020	TADI, Satish K./0000-0003-1422-1800	Lady Tata Memorial Trust, UK [TLCS/0520]; DAE, India [2008/37/5/BRNS]; IISc	Lady Tata Memorial Trust, UK; DAE, India(Department of Atomic Energy (DAE)); IISc	This work was supported by Lady Tata Memorial Trust, UK, Grant TLCS/0520; DAE, India, Grant 2008/37/5/BRNS; an IISc start up grant (to S. C. R.); and Dr. Raghavan Varadarajan.	Abrahams PJ, 1998, MUTAT RES-DNA REPAIR, V407, P189, DOI 10.1016/S0921-8777(98)00009-3; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Attarbaschi A, 2004, LEUKEMIA, V18, P1611, DOI 10.1038/sj.leu.2403471; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Brady N, 2003, CANCER RES, V63, P1798; CAMPANA D, 1993, BLOOD, V81, P1025; Chiruvella KK, 2008, FEBS LETT, V582, P4066, DOI 10.1016/j.febslet.2008.11.001; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; DERBYSHIRE MK, 1994, MOL CELL BIOL, V14, P156, DOI 10.1128/MCB.14.1.156; FAIRMAN MP, 1992, NUCLEIC ACIDS RES, V20, P4145, DOI 10.1093/nar/20.16.4145; FALZON M, 1993, J BIOL CHEM, V268, P10546; Finn WG, 1998, AM J HEMATOL, V59, P223, DOI 10.1002/(SICI)1096-8652(199811)59:3<223::AID-AJH7>3.0.CO;2-Y; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kobayashi T, 1998, ONCOGENE, V16, P1587, DOI 10.1038/sj.onc.1201681; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; KOVACS E, 1986, EUR J CANCER CLIN ON, V22, P863, DOI 10.1016/0277-5379(86)90375-5; Labhart P, 1999, EUR J BIOCHEM, V265, P849, DOI 10.1046/j.1432-1327.1999.00805.x; LAVIN MF, 1977, NUCLEIC ACIDS RES, V4, P4015, DOI 10.1093/nar/4.11.4015; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Liu YF, 1997, CANCER RES, V57, P1650; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Merel P, 2002, ONCOGENE, V21, P5654, DOI 10.1038/sj.onc.1205742; MIMORI T, 1986, J BIOL CHEM, V261, P375; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Naik AK, 2010, J BIOL CHEM, V285, P7587, DOI 10.1074/jbc.M109.089631; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; NICOLAS AL, 1995, NUCLEIC ACIDS RES, V23, P1036, DOI 10.1093/nar/23.6.1036; NORTH P, 1990, NUCLEIC ACIDS RES, V18, P6205, DOI 10.1093/nar/18.21.6205; Odero MD, 2001, GENE CHROMOSOME CANC, V31, P134, DOI 10.1002/gcc.1127; PETTERSSON M, 1992, BLOOD, V79, P495; Raghavan SC, 2004, DNA REPAIR, V3, P1297, DOI 10.1016/j.dnarep.2004.04.007; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Sathees CR, 1999, MUTAT RES-DNA REPAIR, V433, P1, DOI 10.1016/S0921-8777(98)00055-X; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; SHARMA S, 2010, CELL MOL LI IN PRESS; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; STRASSER A, 1993, ONCOGENE, V8, P1; THACKER J, 1992, NUCLEIC ACIDS RES, V20, P6183, DOI 10.1093/nar/20.23.6183; Tseng HM, 2002, J BIOL CHEM, V277, P45630, DOI 10.1074/jbc.M206861200; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang QH, 2008, MOL CELL, V29, P488, DOI 10.1016/j.molcel.2007.12.029; Wang Yan-Dong, 2006, Subcell Biochem, V40, P439; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yano K, 2009, J RADIAT RES, V50, P97, DOI 10.1269/jrr.08119; Youn CK, 2005, NAT CELL BIOL, V7, P137, DOI 10.1038/ncb1215; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	66	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32657	32670		10.1074/jbc.M110.140350	http://dx.doi.org/10.1074/jbc.M110.140350			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699221	hybrid, Green Published			2022-12-25	WOS:000282683000080
J	Li, XH; Lee, AYW				Li, Xinhua; Lee, Alan Yiu Wah			Semaphorin 5A and Plexin-B3 Inhibit Human Glioma Cell Motility through RhoGDI alpha- mediated Inactivation of Rac1 GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING PROTEIN-ACTIVITY; GDP DISSOCIATION INHIBITOR; HUMAN BREAST-CANCER; ACTIVE RAC; R-RAS; REGULATORY PROTEIN; RECEPTOR PLEXIN-B1; PANCREATIC-CANCER; TYROSINE KINASE; GENE-EXPRESSION	Semaphorins and plexins are implicated in the progression of various types of cancer, although the molecular basis has not been fully elucidated. Here, we report the expression of plexin-B3 in glioma cells, which upon stimulation by its ligand Sema5A results in significant inhibition of cell migration and invasion. A search for the underlying mechanism revealed direct interaction of plexin-B3 with RhoGDP dissociation inhibitor alpha (RhoGDI alpha), a negative regulator of RhoGTPases that blocks guanine nucleotide exchange and sequesters them away from the plasma membrane. Glioma cells challenged with Sema5A indeed showed a marked reduction in Rac1-GTP levels by 60%, with a concomitant disruption of lamellipodia. The inactivation of Rac1 was corroborated to contribute to the impediment of glioma cell invasion by Sema5A, as supported by the abolishment of effect upon forced expression of a constitutively active Rac1 mutant. Furthermore, silencing the endogenous expression of RhoGDI alpha in glioma cells was found to be sufficient in abrogating the down-regulation of Rac1-GTP and the ensuing suppression of glioma cell motility induced by Sema5A. Mechanistically, we provide evidence that Sema5A promotes Rac1 recruitment to RhoGDI alpha and reduces its membrane localization in a plexin-B3-dependent manner, thereby preventing Rac1 activation. This represents a novel signaling of semaphorin and plexin in the control of cell motility by indirect inactivation of Rac1 through RhoGDI alpha.	[Li, Xinhua; Lee, Alan Yiu Wah] Natl Univ Singapore, Neurobiol Ageing Program, Ctr Life Sci, Yong Loo Lin Sch Med,Dept Physiol,Life Sci Inst, Singapore 117456, Singapore	National University of Singapore	Lee, AYW (corresponding author), Natl Univ Singapore, Neurobiol Ageing Program, Ctr Life Sci, Yong Loo Lin Sch Med,Dept Physiol,Life Sci Inst, 28 Med Dr, Singapore 117456, Singapore.	phsleeyw@nus.edu.sg	Lee, Alan/E-8554-2011; LEE, Alan Yiu Wah/AAE-1845-2022; Lee, Alan Yiu Wah/AAD-4541-2020	Lee, Alan Yiu Wah/0000-0003-0635-4179	National University of Singapore; Biomedical Research Council of Singapore	National University of Singapore(National University of Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by research grants from the National University of Singapore and the Biomedical Research Council of Singapore (to A.Y.W.L.).	Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Balakrishnan A, 2009, HUM MUTAT, V30, P1167, DOI 10.1002/humu.21017; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Bauer NN, 2007, EXP CELL RES, V313, P3832, DOI 10.1016/j.yexcr.2007.08.017; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Correa RG, 2001, GENOMICS, V73, P343, DOI 10.1006/geno.2001.6525; Crowe DL, 2004, ANTICANCER RES, V24, P593; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; DerMardirossian CM, 2006, METHOD ENZYMOL, V406, P80, DOI 10.1016/S0076-6879(06)06007-1; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Iwadate Y, 2004, CANCER RES, V64, P2496, DOI 10.1158/0008-5472.CAN-03-1254; Jiang WG, 2003, CLIN CANCER RES, V9, P6432; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Kusy S, 2005, NEOPLASIA, V7, P457, DOI 10.1593/neo.04721; Ma PC, 2003, CANCER RES, V63, P6272; McDonough WS, 2005, NEOPLASIA, V7, P862, DOI 10.1593/neo.05190; MIURA Y, 1993, J BIOL CHEM, V268, P510; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Nakada M, 2006, CANCER RES, V66, P8492, DOI 10.1158/0008-5472.CAN-05-4211; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Newcombe AR, 1999, BIOCHEMISTRY-US, V38, P6879, DOI 10.1021/bi9829837; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Pan GQ, 2009, WORLD J GASTROENTERO, V15, P2800, DOI 10.3748/wjg.15.2800; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; Park CK, 2008, J CANCER RES CLIN, V134, P255, DOI 10.1007/s00432-007-0282-1; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Rieger J, 2003, GLIA, V42, P379, DOI 10.1002/glia.10210; Rody A, 2007, CLIN CANCER RES, V13, P1115, DOI 10.1158/1078-0432.CCR-06-2433; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Sadanandam A, 2007, OMICS, V11, P41, DOI 10.1089/omi.2006.0004; Sadanandam A, 2010, INT J CANCER, V127, P1373, DOI 10.1002/ijc.25166; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Sun JJ, 2004, J BIOL CHEM, V279, P42936, DOI 10.1074/jbc.M406493200; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; UEDA T, 1990, J BIOL CHEM, V265, P9373; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	66	60	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32436	32445		10.1074/jbc.M110.120451	http://dx.doi.org/10.1074/jbc.M110.120451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696765	hybrid, Green Published			2022-12-25	WOS:000282683000057
J	Nasrin, N; Wu, XP; Fortier, E; Feng, YJ; Bare, OC; Chen, SM; Ren, XL; Wu, ZD; Streeper, RS; Bordone, L				Nasrin, Nargis; Wu, Xiaoping; Fortier, Eric; Feng, Yajun; Bare, Olivia Claire; Chen, Sumiao; Ren, Xianglin; Wu, Zhidan; Streeper, Ryan S.; Bordone, Laura			SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-DEHYDROGENASE; AMINO-GROUPS; SIRTUINS; METABOLISM; GLUCOSE; RESTRICTION; PGC-1-ALPHA; ACETYLATION; INSIGHTS; NAD	SIRT4, a member of the sirtuin family, has been implicated in the regulation of insulin secretion by modulation of glutamate dehydrogenase. However, the role of this enzyme in the regulation of metabolism in other tissues is unknown. In this study we investigated whether depletion of SIRT4 would enhance liver and muscle metabolic functions. To do this SIRT4 was knocked down using an adenoviral shRNA in mouse primary hepatocytes and myotubes. We observed a significant increase in gene expression of mitochondrial and fatty acid metabolism enzymes in hepatocytes with reduced SIRT4 levels. SIRT4 knockdown also increased SIRT1 mRNA and protein levels both in vitro and in vivo. In agreement with the increased fatty acid oxidation (FAO) gene expression, we showed a significant increase in FAO in SIRT4 knockdown primary hepatocytes compared with control, and this effect was dependent on SIRT1. In primary myotubes, knockdown of SIRT4 resulted in increased FAO, cellular respiration, and pAMPK levels. When SIRT4 was knocked down in vivo by tail vein injection of a shRNA adenovirus, we observed a significant increase in hepatic mitochondrial and FAO gene expression consistent with the findings in primary hepatocytes. Taken together these findings demonstrate that SIRT4 inhibition increases fat oxidative capacity in liver and mitochondrial function in muscle, which might provide therapeutic benefits for diseases associated with ectopic lipid storage such as type 2 diabetes.	[Nasrin, Nargis; Wu, Xiaoping; Fortier, Eric; Feng, Yajun; Bare, Olivia Claire; Chen, Sumiao; Ren, Xianglin; Wu, Zhidan; Streeper, Ryan S.; Bordone, Laura] Novartis Inst BioMed Res Inc, Cardiovasc & Metab Dis Area, Cambridge, MA 02139 USA	Novartis	Bordone, L (corresponding author), 100 Technol Sq, Cambridge, MA 02139 USA.	laura.bordone@novartis.com	Feng, yajun/GSN-0428-2022	Wu, Zhidan/0000-0001-7289-9420				Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; COLMAN RF, 1966, J BIOL CHEM, V241, P3652; COLMAN RF, 1966, J BIOL CHEM, V241, P3661; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103	21	222	230	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31995	32002		10.1074/jbc.M110.124164	http://dx.doi.org/10.1074/jbc.M110.124164			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685656	hybrid, Green Published			2022-12-25	WOS:000282683000012
J	Vang, AG; Ben-Sasson, SZ; Dong, HL; Kream, B; DeNinno, MP; Claffey, MM; Housley, W; Clark, RB; Epstein, PM; Brocke, S				Vang, Amanda G.; Ben-Sasson, Shlomo Z.; Dong, Hongli; Kream, Barbara; DeNinno, Michael P.; Claffey, Michelle M.; Housley, William; Clark, Robert B.; Epstein, Paul M.; Brocke, Stefan			PDE8 Regulates Rapid Teff Cell Adhesion and Proliferation Independent of ICER	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; PROTEIN-KINASE-A; RELAPSING MULTIPLE-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; CAMP-SPECIFIC PHOSPHODIESTERASE; DIFFERENTIAL EXPRESSION; ADENOSINE RECEPTORS; LEUKOCYTE ADHESION	Background: Abolishing the inhibitory signal of intracellular cAMP by phosphodiesterases (PDEs) is a prerequisite for effector T (Teff) cell function. While PDE4 plays a prominent role, its control of cAMP levels in Teff cells is not exclusive. T cell activation has been shown to induce PDE8, a PDE isoform with 40- to 100-fold greater affinity for cAMP than PDE4. Thus, we postulated that PDE8 is an important regulator of Teff cell functions. Methodology/Principal Findings: We found that Teff cells express PDE8 in vivo. Inhibition of PDE8 by the PDE inhibitor dipyridamole (DP) activates cAMP signaling and suppresses two major integrins involved in Teff cell adhesion. Accordingly, DP as well as the novel PDE8-selective inhibitor PF-4957325-00 suppress firm attachment of Teff cells to endothelial cells. Analysis of downstream signaling shows that DP suppresses proliferation and cytokine expression of Teff cells from Crem(-/-) mice lacking the inducible cAMP early repressor (ICER). Importantly, endothelial cells also express PDE8. DP treatment decreases vascular adhesion molecule and chemokine expression, while upregulating the tight junction molecule claudin-5. In vivo, DP reduces CXCL12 gene expression as determined by in situ probing of the mouse microvasculature by cell-selective laser-capture microdissection. Conclusion/Significance: Collectively, our data identify PDE8 as a novel target for suppression of Teff cell functions, including adhesion to endothelial cells.	[Vang, Amanda G.; Housley, William; Clark, Robert B.; Brocke, Stefan] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA; [Vang, Amanda G.; Dong, Hongli; Epstein, Paul M.; Brocke, Stefan] Univ Connecticut, Ctr Hlth, Dept Pharmacol, Farmington, CT USA; [Ben-Sasson, Shlomo Z.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Dong, Hongli; Epstein, Paul M.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA; [Kream, Barbara; Clark, Robert B.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA; [Kream, Barbara] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT USA; [DeNinno, Michael P.; Claffey, Michelle M.] Pfizer Global Res & Dev, Groton Labs, Groton, CT USA	University of Connecticut; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Connecticut; University of Connecticut; University of Connecticut; Pfizer	Vang, AG (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA.	sbrocke@uchc.edu	Vang, Amana Gratton/AAE-7803-2022; Cote, Rick H/G-3363-2013	Vang, Amana Gratton/0000-0003-4534-7107; Cote, Rick H/0000-0002-1573-6526; Epstein, Paul/0000-0003-0681-8236	Connecticut Breast Health Initiative; Connecticut Department of Public Health; Smart Family Foundation; National Institutes of Health (NIH) [1R56 AI 072533-01 A1]; National Multiple Sclerosis Society [RG 4070-A-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072533] Funding Source: NIH RePORTER	Connecticut Breast Health Initiative; Connecticut Department of Public Health; Smart Family Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by institutional start up funds to S.B., the Connecticut Breast Health Initiative (P.E. and S.B.), the Connecticut Department of Public Health (P.E. and S.B.), the Smart Family Foundation (P.E.), National Institutes of Health (NIH) grant 1R56 AI 072533-01 A1 (R.C.), and National Multiple Sclerosis Society grant RG 4070-A-6 (R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ashikaga T, 1997, BIOCHEM PHARMACOL, V54, P1071, DOI 10.1016/S0006-2952(97)00287-6; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Bartolome RA, 2003, MOL BIOL CELL, V14, P54, DOI 10.1091/mbc.E02-05-0275; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Beavo Joseph A., 2007, P3; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bielekova B, 2009, MULT SCLER J, V15, P1206, DOI 10.1177/1352458509345903; Bodor J, 2000, J LEUKOCYTE BIOL, V67, P774, DOI 10.1002/jlb.67.6.774; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Chilcoat CD, 2008, J LEUKOCYTE BIOL, V83, P964, DOI 10.1189/jlb.0405192; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; COEUGNIET E, 1976, ACTA MED SCAND, V199, P99; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dong HL, 2006, BIOCHEM BIOPH RES CO, V345, P713, DOI 10.1016/j.bbrc.2006.04.143; Eigler A, 1997, SCAND J IMMUNOL, V45, P132, DOI 10.1046/j.1365-3083.1997.d01-377.x; Ekholm D, 1997, J IMMUNOL, V159, P1520; Fisher DA, 1998, BIOCHEM BIOPH RES CO, V246, P570, DOI 10.1006/bbrc.1998.8684; Ford ML, 2003, J IMMUNOL, V171, P6527, DOI 10.4049/jimmunol.171.12.6527; Frohman EM, 2001, J CLIN IMMUNOL, V21, P61, DOI 10.1023/A:1011016124524; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Giembycz MA, 2008, BRIT J PHARMACOL, V155, P288, DOI 10.1038/bjp.2008.297; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; Glavas NA, 2001, P NATL ACAD SCI USA, V98, P6319, DOI 10.1073/pnas.101131098; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Hoffmann R, 1998, BIOCHEM J, V333, P139, DOI 10.1042/bj3330139; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Jin S.L.C., 2006, CYCLIC NUCLEOTIDE PH, P323; Jung S, 1996, J NEUROIMMUNOL, V68, P1, DOI 10.1016/0165-5728(96)00051-3; Kim HH, 2008, ARTERIOSCL THROM VAS, V28, pS39, DOI 10.1161/ATVBAHA.107.160226; Kinnecom K, 2005, BRAIN RES PROTOC, V16, P1, DOI 10.1016/j.brainresprot.2005.08.002; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; Layseca-Espinosa E, 2003, J INVEST DERMATOL, V121, P81, DOI 10.1046/j.1523-1747.2003.12301.x; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Liu F, 2007, BONE, V40, P1135, DOI 10.1016/j.bone.2006.12.003; Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Moore CS, 2006, J PHARMACOL EXP THER, V319, P63, DOI 10.1124/jpet.106.106096; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Peter D, 2007, J IMMUNOL, V178, P4820, DOI 10.4049/jimmunol.178.8.4820; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Price GM, 2008, MICROVASC RES, V76, P46, DOI 10.1016/j.mvr.2008.02.003; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sanz MJ, 2007, BRIT J PHARMACOL, V152, P481, DOI 10.1038/sj.bjp.0707428; Schillace RV, 2006, CRIT REV IMMUNOL, V26, P113, DOI 10.1615/CritRevImmunol.v26.i2.20; Seybold J, 2005, BLOOD, V105, P3569, DOI 10.1182/blood-2004-07-2729; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2003, BIOCHEM PHARMACOL, V65, P493, DOI 10.1016/S0006-2952(02)01548-4; Soderling SH, 1998, P NATL ACAD SCI USA, V95, P8991, DOI 10.1073/pnas.95.15.8991; Sommer N, 1997, J NEUROIMMUNOL, V79, P54, DOI 10.1016/S0165-5728(97)00111-2; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Steinman L, 2004, SCIENCE, V305, P212, DOI 10.1126/science.1099896; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Sullivan GW, 2004, J LEUKOCYTE BIOL, V75, P127, DOI 10.1189/jlb.0603300; THOMPSON WJ, 1980, J CYCLIC NUCL PROT, V6, P25; Vastel L., 2007, Cell and Tissue Banking, V8, P205, DOI 10.1007/s10561-006-9030-z; Weyrich AS, 2005, CIRCULATION, V111, P633, DOI 10.1161/01.CIR.0000154607.90506.45; Wunder F, 2009, MOL PHARMACEUT, V6, P326, DOI 10.1021/mp800127n; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhuplatov SB, 2006, BASIC CLIN PHARMACOL, V99, P431, DOI 10.1111/j.1742-7843.2006.pto_516.x	72	48	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12011	10.1371/journal.pone.0012011	http://dx.doi.org/10.1371/journal.pone.0012011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711499	gold, Green Published, Green Submitted			2022-12-25	WOS:000280776800009
J	Sullivan, LA; Carbon, JG; Roland, CL; Toombs, JE; Nyquist-Andersen, M; Kavlie, A; Schlunegger, K; Richardson, JA; Brekken, RA				Sullivan, Laura A.; Carbon, Juliet G.; Roland, Christina L.; Toombs, Jason E.; Nyquist-Andersen, Mari; Kavlie, Anita; Schlunegger, Kyle; Richardson, James A.; Brekken, Rolf A.			r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; IMMUNE CELL INFILTRATION; TUMOR-GROWTH; ANGIOGENESIS; METASTASIS; LYMPHANGIOGENESIS; VASCULATURE; PROGRESSION; INHIBITION	Vascular endothelial growth factor (VEGF) is critical for physiological and pathological angiogenesis. Within the tumor microenvironment, VEGF functions as an endothelial cell survival factor, permeability factor, mitogen, and chemotactic agent. The majority of these functions are mediated by VEGF-induced activation of VEGF receptor 2 (VEGFR2), a high affinity receptor tyrosine kinase expressed by endothelial cells and other cell types in the tumor microenvironment. VEGF can also ligate other cell surface receptors including VEGFR1 and neuropilin-1 and -2. However, the importance of VEGF-induced activation of these receptors in tumorigenesis is still unclear. We report the development and characterization of r84, a fully human monoclonal antibody that binds human and mouse VEGF and selectively blocks VEGF from interacting with VEGFR2 but does not interfere with VEGF: VEGFR1 interaction. Selective blockade of VEGF binding to VEGFR2 by r84 is shown through ELISA, receptor binding assays, receptor activation assays, and cell-based functional assays. Furthermore, we show that r84 has potent anti-tumor activity and does not alter tissue histology or blood and urine chemistry after chronic high dose therapy in mice. In addition, chronic r84 therapy does not induce elevated blood pressure levels in some models. The ability of r84 to specifically block VEGF: VEGFR2 binding provides a valuable tool for the characterization of VEGF receptor pathway activation during tumor progression and highlights the utility and safety of selective blockade of VEGF-induced VEGFR2 signaling in tumors.	[Sullivan, Laura A.; Carbon, Juliet G.; Roland, Christina L.; Toombs, Jason E.; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Div Surg Oncol, Dept Surg, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Nyquist-Andersen, Mari; Kavlie, Anita] Affitech AS, Oslo, Norway; [Schlunegger, Kyle] Peregrine Pharmaceut Inc, Tustin, CA USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sullivan, LA (corresponding author), Univ Texas SW Med Ctr Dallas, Div Surg Oncol, Dept Surg, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	rolf.brekken@utsouthwestern.edu			Peregrine Pharmaceuticals; Simmons Comprehensive Cancer Center; Uniting Against Lung Cancer; UT SPORE in lung cancer [P50 CA070907]; Effie Marie Cain Scholarship in Angiogenesis Research; Affitech AS; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Peregrine Pharmaceuticals; Simmons Comprehensive Cancer Center; Uniting Against Lung Cancer; UT SPORE in lung cancer; Effie Marie Cain Scholarship in Angiogenesis Research; Affitech AS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a sponsored research agreement from Peregrine Pharmaceuticals (to R. A. Brekken), institutional funding from the Simmons Comprehensive Cancer Center, the Randall Bridwell Lung Cancer Research Grant from Uniting Against Lung Cancer (to R. A. Brekken, www.UnitingAgainstLungCancer.org), a development award from the UT SPORE in lung cancer (P50 CA070907) (to R. A. Brekken), the Effie Marie Cain Scholarship in Angiogenesis Research (to R. A. Brekken) and Affitech AS (M. Nyquist-Andersen, A. Kavlie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Ahmad S, 2006, CIRC RES, V99, P715, DOI 10.1161/01.RES.0000243989.46006.b9; Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Brekken RA, 1998, CANCER RES, V58, P1952; Brekken RA, 2000, CANCER RES, V60, P5117; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Dineen SP, 2008, CANCER RES, V68, P4340, DOI 10.1158/0008-5472.CAN-07-6705; Dowlati A, 2005, CLIN CANCER RES, V11, P7938, DOI 10.1158/1078-0432.CCR-04-2538; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Facemire CS, 2009, HYPERTENSION, V54, P652, DOI 10.1161/HYPERTENSIONAHA.109.129973; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fong GH, 1999, DEVELOPMENT, V126, P3015; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Huang XM, 1998, BIOCHEM BIOPH RES CO, V252, P643, DOI 10.1006/bbrc.1998.9717; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jayson GC, 2002, J NATL CANCER I, V94, P1484, DOI 10.1093/jnci/94.19.1484; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Nozaki M, 2006, J CLIN INVEST, V116, P422, DOI 10.1172/JCI26316; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Ran S, 2003, NEOPLASIA, V5, P297, DOI 10.1016/S1476-5586(03)80023-4; Roberts DM, 2004, AM J PATHOL, V164, P1531, DOI 10.1016/S0002-9440(10)63711-X; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Roodhart JM, 2008, CURR CLIN PHARMACOL, V3, P132, DOI 10.2174/157488408784293705; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Tonra JR, 2007, IMMUNOL INVEST, V36, P3, DOI 10.1080/08820130600991794; Vredenburgh JJ, 2009, NEURO-ONCOLOGY, V11, P80, DOI 10.1215/15228517-2008-075; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Whitehurst B, 2007, INT J CANCER, V121, P2181, DOI 10.1002/ijc.22937; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yan L, 2008, CANCER J, V14, P178, DOI 10.1097/PPO.0b013e318172d71a; Zhang Wei, 2002, Angiogenesis, V5, P35, DOI 10.1023/A:1021540120521	51	31	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12031	10.1371/journal.pone.0012031	http://dx.doi.org/10.1371/journal.pone.0012031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700512	gold, Green Published, Green Submitted			2022-12-25	WOS:000280687900019
J	Shui, G; Guan, XL; Gopalakrishnan, P; Xue, YK; Goh, JSY; Yang, HY; Wenk, MR				Shui, Guanghou; Guan, Xue Li; Gopalakrishnan, Pradeep; Xue, Yangkui; Goh, Joyce Sze Yuin; Yang, Hongyuan; Wenk, Markus R.			Characterization of Substrate Preference for Slc1p and Cst26p in Saccharomyces cerevisiae Using Lipidomic Approaches and an LPAAT Activity Assay	PLOS ONE			English	Article							ACID ACYLTRANSFERASE-BETA; CONGENITAL GENERALIZED LIPODYSTROPHY; MASS-SPECTROMETRY; LYSOPHOSPHOLIPID ACYLTRANSFERASES; PHOSPHATIDIC-ACID; GLOBAL ANALYSIS; BUDDING YEAST; BIOSYNTHESIS; MEMBRANE; IDENTIFICATION	Background: Phosphatidic acid (PA) is a key regulated intermediate and precursor for de novo biosynthesis of all glycerophospholipids. PA can be synthesized through the acylation of lysophosphatidic acid (LPA) by 1-acyl-3-phosphate acyltransferase (also called lysophosphatidic acid acyltransferase, LPAAT). Recent findings have substantiated the essential roles of acyltransferases in various biological functions. Methodologies/Principal Findings: We used a flow-injection-based lipidomic approach with similar to 200 multiple reaction monitoring (MRM) transitions to pre-screen fatty acyl composition of phospholipids in the yeast Saccharomyces cerevisiae mutants. Dramatic changes were observed in fatty acyl composition in some yeast mutants including Slc1p, a well-characterized LPAAT, and Cst26p, a recently characterized phosphatidylinositol stearoyl incorporating 1 protein and putative LPAAT in S. cerevisiae. A comprehensive high-performance liquid chromatography-based multi-stage MRM approach (more than 500 MRM transitions) was developed and further applied to quantify individual phospholipids in both strains to confirm these changes. Our data suggest potential fatty acyl substrates as well as fatty acyls that compensate for defects in both Cst26p and Slc1p mutants. These results were consistent with those from a non-radioactive LPAAT enzymatic assay using C17-LPA and acyl-CoA donors as substrates. Conclusions: We found that Slc1p utilized fatty acid (FA) 18:1 and FA 14:0 as substrates to synthesize corresponding PAs; moreover, it was probably the only acyltransferase responsible for acylation of saturated short-chain fatty acyls (12:0 and 10:0) in S. cerevisiae. We also identified FA 18:0, FA 16:0, FA 14:0 and exogenous FA 17:0 as preferred substrates for Cst26p because transformation with a GFP-tagged CST26 restored the phospholipid profile of a CST26 mutant. Our current findings expand the enzymes and existing scope of acyl-CoA donors for glycerophospholipid biosynthesis.	[Shui, Guanghou; Guan, Xue Li; Gopalakrishnan, Pradeep; Xue, Yangkui; Goh, Joyce Sze Yuin; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Shui, Guanghou] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yang, Hongyuan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	National University of Singapore; National University of Singapore; National University of Singapore; University of New South Wales Sydney	Shui, G (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore.	bchsgh@nus.edu.sg; bchmrw@nus.edu.sg	Yang, Hongyuan/AAR-1326-2020; Wenk, Markus Rene/D-1441-2014; Guan, Xue Li/D-2935-2014	Yang, Hongyuan/0000-0002-8482-6031; Guan, Xue Li/0000-0002-5189-8178; Shui, Guanghou/0000-0002-1621-9643	Singapore National Research Foundation [2007-04]; Singapore NMRC [R-183-000-224-213]	Singapore National Research Foundation(National Research Foundation, Singapore); Singapore NMRC(National Medical Research Council, Singapore)	This work was supported by the Singapore National Research Foundation under CRP Award No. 2007-04, Singapore NMRC Grant R-183-000-224-213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Bin Y, 2004, PLANT CELL PHYSIOL, V45, P503, DOI 10.1093/pcp/pch064; Bonham L, 2003, EXPERT OPIN THER TAR, V7, P643; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Diefenbach CSM, 2006, CANCER-AM CANCER SOC, V107, P1511, DOI 10.1002/cncr.22184; Dircks L, 1999, PROG LIPID RES, V38, P461, DOI 10.1016/S0163-7827(99)00012-0; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Esch SW, 2007, J LIPID RES, V48, P235, DOI 10.1194/jlr.D600034-JLR200; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Gopalacharyulu PV, 2009, MOL BIOSYST, V5, P276, DOI 10.1039/b815347g; Guan XL, 2006, FASEB J, V20, P1152, DOI 10.1096/fj.05-5362com; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; LE GM, 2009, FEBS J, V276, P6412; Lee LHW, 2009, INT J NEUROPSYCHOPH, V12, P953, DOI 10.1017/S146114570900995X; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Springett GM, 2005, CANCER RES, V65, P9415, DOI 10.1158/0008-5472.CAN-05-0516; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	37	28	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11956	10.1371/journal.pone.0011956	http://dx.doi.org/10.1371/journal.pone.0011956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694142	Green Published, Green Submitted, gold			2022-12-25	WOS:000280574300012
J	Chiang, F; Kuper, H; Lindfield, R; Keenan, T; Seyam, N; Magauran, D; Khalilia, N; Batta, H; Abdeen, Z; Sargent, N				Chiang, Far; Kuper, Hannah; Lindfield, Robert; Keenan, Tiarnan; Seyam, Na'el; Magauran, Denise; Khalilia, Nasrallah; Batta, Habes; Abdeen, Ziad; Sargent, Nicholas			Rapid Assessment of Avoidable Blindness in the Occupied Palestinian Territories	PLOS ONE			English	Article							VISUAL IMPAIRMENT; NATIONAL SURVEY; GLOBAL DATA; PREVALENCE; DISTRICT; EYE	Background: There are no recent data on the prevalence and causes of blindness in the Occupied Palestinian Territories. The aim of our study was to estimate the prevalence and causes of blindness and visual impairment in the population aged 50 years and above in the Occupied Palestinian Territories using the Rapid Assessment of Avoidable Blindness (RAAB) survey method. Methods and Findings: Clusters of 40 people who were 50 years and above were selected with probability proportionate to size using a multistage cluster random sampling method. Participants received a comprehensive ophthalmic examination in their homes, including visual acuity testing by one of three experienced ophthalmologists. The principal cause for visual loss was determined by an experienced ophthalmologist using portable diagnostic instruments. Information about previous cataract surgery, satisfaction with surgery and barriers to cataract surgery were collected. The prevalence of self-reported diabetes was also determined. The prevalence of bilateral blindness (VA<3/60 in the better eye with available correction) was 3.4% (95% CI: 2.7-4.0), 2.0% (95% CI: 1.4-2.5) for severe visual impairment (VA >= 3/60 and <6/60), and 7.4% (95% CI: 6.4-8.3) for visual impairment (VA >= 6/60 and <6/18). Avoidable causes (i.e. cataract, refractive error, aphakia, surgical complications, corneal scarring and phthysis) accounted for 80.0% of bilateral blindness, severe visual impairment (70.7%) and visual impairment (86.2%). Cataract was the main cause of blindness (55.0%). The prevalence of blindness was higher in Gaza (4.9%, 95% CI: 3.7-6.1%) than in the West Bank (2.5%, 95% CI: 1.9-3.1%) and among women (4.3%, 95% CI: 3.3-5.2%) compared to men (2.2%, 95% CI: 1.5-2.9%). Among people who had undergone cataract surgery in the past, only 54.5% of eyes obtained a good outcome (VA >= 6/18), 23.2% had a borderline outcome (VA<6/18 and >= 6/60) and 22.3% had a poor outcome (VA<6/60) with available correction. The prevalence of self-reported diabetes mellitus in >= 50 year age group was 26.4% (95% CI: 24.9-27.9). Conclusions: The prevalence of blindness suggests that significant numbers of people in the Occupied Palestinian Territories exist who do not access eye care - predominantly women and those residing in Gaza. Programmes need to focus on maximizing the use of current services by these excluded groups.	[Chiang, Far; Khalilia, Nasrallah; Batta, Habes; Sargent, Nicholas] St John Eye Hosp, Jerusalem, Israel; [Kuper, Hannah; Lindfield, Robert] London Sch Hyg & Trop Med, London WC1, England; [Keenan, Tiarnan] Manchester Royal Eye Hosp, Manchester M13 9WH, Lancs, England; [Seyam, Na'el] Mil Med Serv, Gaza, Israel; [Magauran, Denise] Epsom & St Helier Univ Hosp NHS Trust, Sutton, Surrey, England; [Abdeen, Ziad] Al Quds Univ, Al Quds Nutr & Hlth Res Inst, Jerusalem, Israel	University of London; London School of Hygiene & Tropical Medicine; Manchester Royal Eye Hospital	Chiang, F (corresponding author), St John Eye Hosp, Jerusalem, Israel.	njsargent@hotmail.com	Abdeen, Ziad/AAC-7889-2019		The Linbury Trust; Palestinian Authority Ministry of Health; National Institute for Health Research [ACF-2008-06-014] Funding Source: researchfish; Fight for Sight [1865/66] Funding Source: researchfish	The Linbury Trust; Palestinian Authority Ministry of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was principally funded by The Linbury Trust (www.linburytrust.org.uk). This funding agency did not take part directly nor influenced the conducting of the study in any way and did not take part in the preparation of the manuscript.; The authors wish to thank all the staff based at the St. John facilities in Jerusalem and Gaza for their contributions as well as the study participants. We would like to thank Anthony Chignell, Steven James and Charles Kanawati for initiating this study, Philip Mann for his assistance with the original proposal, and Assad Yousef Hussein and Jom'a El Jazzar for initiating the study in Gaza. We greatly appreciated the support and permission given by the Palestinian Authority Ministry of Health and local municipalities.	Amansakhatov S, 2002, BRIT J OPHTHALMOL, V86, P1207, DOI 10.1136/bjo.86.11.1207; [Anonymous], 2008, PAL FIG 2007; AVISAR R, 2003, HAREFUAH, V142, P160; Avisar Rahamim, 2003, Harefuah, V142, P94; Avisar R, 2006, ISRAEL MED ASSOC J, V8, P880; Fouad D, 2004, BRIT J OPHTHALMOL, V88, P614, DOI 10.1136/bjo.2003.026997; GOLYCHEV VN, 1991, VESTN OFTALMOL, P63; Habiyakire C, 2010, OPHTHAL EPIDEMIOL, V17, P90, DOI 10.3109/09286580903453514; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; Khandekar R, 2002, BRIT J OPHTHALMOL, V86, P957, DOI 10.1136/bjo.86.9.957; LANE SD, 1987, URBAN ANTHROP, V16, P151; Mansour AM, 1997, BRIT J OPHTHALMOL, V81, P905, DOI 10.1136/bjo.81.10.905; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Ngondi J, 2006, PLOS MED, V3, P2424, DOI 10.1371/journal.pmed.0030478; Oye JE, 2006, BRIT J OPHTHALMOL, V90, P538, DOI 10.1136/bjo.2005.082271; *PAL CENTR BUR STA, 2007, PAL FIG 2006; *PAL CENTR BUR STA, 2008, CENS FIN RES GAZ STR; *PAL CENTR BUR STA, 2007, 8 PAL CENTR BUR STAT; Palestinian Central Bureau of Statistics, 2004, ACC HLTH SERV SURV 2; Palestinian Central Bureau of Statistics, 2008, CENS FIN RES W BANK; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; THOMSON IM, 1984, BRIT J OPHTHALMOL, V68, P598, DOI 10.1136/bjo.68.8.598; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; *UN OFF COORD HUM, 2007, HUM IMP W BANK BARR; WADUD Z, 2006, BRIT J OPHTHALMOL; World Health Organization, 1988, COD INSTR WHO PBL EY, P1; World Health Organization, 2005, PREV BLINDN DIAB MEL, P9; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002	30	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11854	10.1371/journal.pone.0011854	http://dx.doi.org/10.1371/journal.pone.0011854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686616	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000280520200019
J	Fujimoto, J; Kadara, H; Men, TY; van Pelt, C; Lotan, D; Lotan, R				Fujimoto, Junya; Kadara, Humam; Men, Taoyan; van Pelt, Carolyn; Lotan, Dafna; Lotan, Reuben			Comparative Functional Genomics Analysis of NNK Tobacco-Carcinogen Induced Lung Adenocarcinoma Development in Gprc5a-Knockout Mice	PLOS ONE			English	Article							CIGARETTE-SMOKE; A/J MICE; EXPRESSION SIGNATURE; GENE-EXPRESSION; GREEN TEA; CANCER; TUMORIGENESIS; MOUSE; MODEL; IDENTIFICATION	Background: Improved understanding of lung cancer development and progression, including insights from studies of animal models, are needed to combat this fatal disease. Previously, we found that mice with a knockout (KO) of G-protein coupled receptor 5A (Gprc5a) develop lung tumors after a long latent period (12 to 24 months). Methodology/Principal Findings: To determine whether a tobacco carcinogen will enhance tumorigenesis in this model, we administered 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) i.p. to 2-months old Gprc5a-KO mice and sacrificed groups (n = 5) of mice at 6, 9, 12, and 18 months later. Compared to control Gprc5a-KO mice, NNK-treated mice developed lung tumors at least 6 months earlier, exhibited 2- to 4-fold increased tumor incidence and multiplicity, and showed a dramatic increase in lesion size. A gene expression signature, NNK-ADC, of differentially expressed genes derived by transcriptome analysis of epithelial cell lines from normal lungs of Gprc5a-KO mice and from NNK-induced adenocarcinoma was highly similar to differential expression patterns observed between normal and tumorigenic human lung cells. The NNK-ADC expression signature also separated both mouse and human adenocarcinomas from adjacent normal lung tissues based on publicly available microarray datasets. A key feature of the signature, up-regulation of Ube2c, Mcm2, and Fen1, was validated in mouse normal lung and adenocarcinoma tissues and cells by immunohistochemistry and western blotting, respectively. Conclusions/Significance: Our findings demonstrate that lung tumorigenesis in the Gprc5a-KO mouse model is augmented by NNK and that gene expression changes induced by tobacco carcinogen(s) may be conserved between mouse and human lung epithelial cells. Further experimentation to prove the reliability of the Gprc5a knockout mouse model for the study of tobacco-induced lung carcinogenesis is warranted.	[Fujimoto, Junya; Kadara, Humam; Men, Taoyan; Lotan, Dafna; Lotan, Reuben] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [van Pelt, Carolyn] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Fujimoto, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	rlotan@mdanderson.org			The Samuel Waxman Cancer Research Foundation; Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair; Cancer Center [P30 CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	The Samuel Waxman Cancer Research Foundation; Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from The Samuel Waxman Cancer Research Foundation, the Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair and P30 CA16672 Cancer Center Core Grant (Transgenic Animal Facility, DNA Sequencing, Veterinary Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALANSKY R, INT J CANC, V126, P1047; Bennett CN, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2125; D'Agostini F, 2009, CANCER PREV RES, V2, P546, DOI 10.1158/1940-6207.CAPR-08-0235; DEVEREUX TR, 1993, MOL CARCINOGEN, V8, P177, DOI 10.1002/mc.2940080308; Gabrielson E, 2006, RESPIROLOGY, V11, P533, DOI 10.1111/j.1440-1843.2006.00909.x; HECHT SS, 1989, CARCINOGENESIS, V10, P1901, DOI 10.1093/carcin/10.10.1901; Hecht SS, 2005, CARCINOGENESIS, V26, P1488, DOI 10.1093/carcin/bgi148; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hollander MC, 2008, NEOPLASIA, V10, P866, DOI 10.1593/neo.08406; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacks Tyler, 2005, Harvey Lect, V101, P1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kadara H, 2009, CANCER PREV RES, V2, P702, DOI 10.1158/1940-6207.CAPR-09-0084; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kassie F, 2008, CANCER PREV RES, V1, P568, DOI 10.1158/1940-6207.CAPR-08-0064; KLEINSZANTO AJP, 1992, P NATL ACAD SCI USA, V89, P6693, DOI 10.1073/pnas.89.15.6693; Lantry LE, 1999, CARCINOGENESIS, V20, P343, DOI 10.1093/carcin/20.2.343; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Liu PY, 2006, NAT GENET, V38, P888, DOI 10.1038/ng1849; Lu G, 2006, CANCER RES, V66, P11494, DOI 10.1158/0008-5472.CAN-06-1497; Lu Y, 2006, CANCER RES, V66, P1956, DOI 10.1158/0008-5472.CAN-05-3158; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Okamoto Y, 2003, CANCER RES, V63, P4167; Ramnath N, 2001, J CLIN ONCOL, V19, P4259, DOI 10.1200/JCO.2001.19.22.4259; Sabourin CLK, 1998, EXP LUNG RES, V24, P499, DOI 10.3109/01902149809087383; Sato M, 2003, ONCOGENE, V22, P7243, DOI 10.1038/sj.onc.1206977; Simon R, 2007, CANCER INFORM, V3, P11; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Steiling K, 2008, CANCER PREV RES, V1, P396, DOI 10.1158/1940-6207.CAPR-08-0174; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Sun SY, 1999, CANCER RES, V59, P2493; Tan DF, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-6; Tao QG, 2007, JNCI-J NATL CANCER I, V99, P1668, DOI 10.1093/jnci/djm208; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zhang ZQ, 2000, CANCER RES, V60, P901	40	27	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11847	10.1371/journal.pone.0011847	http://dx.doi.org/10.1371/journal.pone.0011847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686609	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200013
J	Rossi, SL; Nistor, G; Wyatt, T; Yin, HZ; Poole, AJ; Weiss, JH; Gardener, MJ; Dijkstra, S; Fischer, DF; Keirstead, HS				Rossi, Sharyn L.; Nistor, Gabriel; Wyatt, Tanya; Yin, Hong Zhen; Poole, Aleksandra J.; Weiss, John H.; Gardener, Matthew J.; Dijkstra, Sipke; Fischer, David F.; Keirstead, Hans S.			Histological and Functional Benefit Following Transplantation of Motor Neuron Progenitors to the Injured Rat Spinal Cord	PLOS ONE			English	Article							SCHWANN-CELL TRANSPLANTATION; NEUROTROPHIC FACTORS; PRECURSOR CELLS; AXONAL GROWTH; RECOVERY; DIFFERENTIATE; MOTONEURONS; CHANNELS; INCREASE	Background: Motor neuron loss is characteristic of cervical spinal cord injury (SCI) and contributes to functional deficit. Methodology/Principal Findings: In order to investigate the amenability of the injured adult spinal cord to motor neuron differentiation, we transplanted spinal cord injured animals with a high purity population of human motor neuron progenitors (hMNP) derived from human embryonic stem cells (hESCs). In vitro, hMNPs displayed characteristic motor neuron-specific markers, a typical electrophysiological profile, functionally innervated human or rodent muscle, and secreted physiologically active growth factors that caused neurite branching and neuronal survival. hMNP transplantation into cervical SCI sites in adult rats resulted in suppression of intracellular signaling pathways associated with SCI pathogenesis, which correlated with greater endogenous neuronal survival and neurite branching. These neurotrophic effects were accompanied by significantly enhanced performance on all parameters of the balance beam task, as compared to controls. Interestingly, hMNP transplantation resulted in survival, differentiation, and site-specific integration of hMNPs distal to the SCI site within ventral horns, but hMNPs near the SCI site reverted to a neuronal progenitor state, suggesting an environmental deficiency for neuronal maturation associated with SCI. Conclusions/Significance: These findings underscore the barriers imposed on neuronal differentiation of transplanted cells by the gliogenic nature of the injured spinal cord, and the physiological relevance of transplant-derived neurotrophic support to functional recovery.	[Rossi, Sharyn L.; Nistor, Gabriel; Wyatt, Tanya; Keirstead, Hans S.] Univ Calif Irvine, Sch Med, Reeve Irvine Res Ctr, Sue & Bill Gross Stem Cell Res Ctr,Dept Anat & Ne, Irvine, CA 92717 USA; [Yin, Hong Zhen; Weiss, John H.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Poole, Aleksandra J.] Calif Stem Cell Inc, Irvine, CA USA; [Gardener, Matthew J.] BioFocus, Saffron Walden, Essex, England; [Dijkstra, Sipke] Galapagos, Leiden, Netherlands; [Fischer, David F.] BioFocus, Leiden, Netherlands	University of California System; University of California Irvine; University of California System; University of California Irvine; Galapagos NV	Rossi, SL (corresponding author), Univ Calif Irvine, Sch Med, Reeve Irvine Res Ctr, Sue & Bill Gross Stem Cell Res Ctr,Dept Anat & Ne, Irvine, CA 92717 USA.	hansk@uci.edu	weiss, john/B-4283-2008	weiss, john/0000-0001-9323-7813; Fischer, David/0000-0002-6690-0197; Dijkstra, Sipke/0000-0003-2535-297X	California Institute for Regenerative Medicine [RC1-00345-1]; Families of Spinal Muscular Atrophy [445710-47005]; ALS association; Bill and Joan Jackson Scholars Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036548] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Families of Spinal Muscular Atrophy; ALS association; Bill and Joan Jackson Scholars Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by the California Institute for Regenerative Medicine (RC1-00345-1), Families of Spinal Muscular Atrophy (445710-47005), and the ALS association (TREAT ALS). Sharyn Rossi was supported by the California Institute of Regenerative Medicine Training Grant and the Bill and Joan Jackson Scholars Fund. Tanya Wyatt was supported by the Bill and Joan Jackson Scholars Fund. California Stem Cell, Inc. provided cells and reagents via a material transfer agreement with UCI, however, played no role in the funding of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RM, 1999, ANAL BIOCHEM, V267, P344, DOI 10.1006/abio.1998.3018; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; BRUNK U, 1968, ACTA HISTOCHEM, V31, P345; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr DA, 2003, J NEUROSCI, V23, P5131; Kloth V, 2006, BRAIN RES BULL, V70, P68, DOI 10.1016/j.brainresbull.2006.04.006; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LIEBL DJ, 2001, EXPT NEUROLOGY, V167; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Martin D, 1996, J NEUROSCI RES, V45, P588; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Rice T, 2007, J NEUROPATH EXP NEUR, V66, P184, DOI 10.1097/01.jnen.0000248552.07338.7f; Riley CP, 2004, J MOL HISTOL, V35, P771, DOI 10.1007/s10735-004-0778-9; Rosenbluth J, 1997, EXP NEUROL, V147, P172, DOI 10.1006/exnr.1997.6583; Schaal SM, 2007, CELL TRANSPLANT, V16, P207, DOI 10.3727/000000007783464768; Schallert T, 2002, PHARM CEREBRAL ISCHE, P201; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Shihabuddin Lamya S., 2008, V438, P55, DOI 10.1007/978-1-59745-133-8_6; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Steward O, 2008, J NEUROSCI, V28, P6836, DOI 10.1523/JNEUROSCI.5372-07.2008; Takami T, 2002, J NEUROSCI, V22, P6670; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; TIMM F, 1958, Dtsch Z Gesamte Gerichtl Med, V46, P706, DOI 10.1007/BF00665092; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Xiao M, 2007, NEUROBIOL DIS, V26, P363, DOI 10.1016/j.nbd.2007.01.012; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yin HZ, 1999, J COMP NEUROL, V409, P250; Zhang YW, 2006, STEM CELLS DEV, V15, P943, DOI 10.1089/scd.2006.15.943	45	71	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11852	10.1371/journal.pone.0011852	http://dx.doi.org/10.1371/journal.pone.0011852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686613	gold, Green Published			2022-12-25	WOS:000280520200017
J	Wang, T; Zheng, W; Xu, H; Zhou, JM; Wang, ZY				Wang, Tao; Zheng, Wei; Xu, He; Zhou, Jia-Min; Wang, Zhan-You			Clioquinol Inhibits Zinc-Triggered Caspase Activation in the Hippocampal CA1 Region of a Global Ischemic Gerbil Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; NEURONAL DEATH; TRANSIENT ISCHEMIA; TRANSGENIC MICE; CANCER-CELLS; IN-VITRO; APOPTOSIS; CHELATOR	Background: Excessive release of chelatable zinc from excitatory synaptic vesicles is involved in the pathogenesis of selective neuronal cell death following transient forebrain ischemia. The present study was designed to examine the neuroprotective effect of a membrane-permeable zinc chelator, clioquinol (CQ), in the CA1 region of the gerbil hippocampus after transient global ischemia. Methodology/Principal Findings: The common carotid arteries were occluded bilaterally, and CQ (10 mg/kg, i.p.) was injected into gerbils once a day. The zinc chelating effect of CQ was examined with TSQ fluorescence and autometallography. Neuronal death, the expression levels of caspases and apoptosis inducing factor (AIF) were evaluated using TUNEL, in situ hybridization and Western blotting, respectively. We were able to show for the first time that CQ treatment attenuates the ischemia-induced zinc accumulation in the CA1 pyramidal neurons, accompanied by less neuronal loss in the CA1 field of the hippocampus after ischemia. Furthermore, the expression levels of caspase-3, -9, and AIF were significantly decreased in the hippocampus of CQ-treated gerbils. Conclusions/Significance: The present study indicates that the neuroprotective effect of CQ is related to downregulation of zinc-triggered caspase activation in the hippocampal CA1 region of gerbils with global ischemia.	[Wang, Tao; Zheng, Wei; Xu, He; Zhou, Jia-Min; Wang, Zhan-You] China Med Univ, Coll Basic Med Sci, Minist Educ China, Key Lab Med Cell Biol, Shenyang, Peoples R China	China Medical University; Ministry of Education, China	Wang, T (corresponding author), China Med Univ, Coll Basic Med Sci, Minist Educ China, Key Lab Med Cell Biol, Shenyang, Peoples R China.	zhanyouw@hotmail.com		Wang, Zhan-You/0000-0003-0807-9916	Natural Science Foundation of China [30370452, 30770680]; Program for New Century Excellent Talents in University [NCET-04-0288]; Department of Education of Liaoning Province [20060948]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Department of Education of Liaoning Province	The study was supported by the Natural Science Foundation of China (30370452, 30770680), the Program for New Century Excellent Talents in University (NCET-04-0288), and the Research Project for Universities of the Department of Education of Liaoning Province (20060948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; ARAKI T, 1989, ACTA NEUROL SCAND, V80, P548, DOI 10.1111/j.1600-0404.1989.tb03925.x; BarKalifa R, 2009, EUR J PHARMACOL, V618, P15, DOI 10.1016/j.ejphar.2009.07.019; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Carboni S, 2005, J NEUROCHEM, V92, P1054, DOI 10.1111/j.1471-4159.2004.02925.x; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; DANSCHER G, 1982, HISTOCHEMISTRY, V76, P281, DOI 10.1007/BF00543951; DANSCHER G, 1985, HISTOCHEMISTRY, V83, P419, DOI 10.1007/BF00509203; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Diener HC, 2008, STROKE, V39, P1774, DOI 10.1161/STROKEAHA.107.506378; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Gao HL, 2009, NEUROTOX RES, V16, P416, DOI 10.1007/s12640-009-9072-7; Gupta S, 2006, BIOL PHARM BULL, V29, P957, DOI 10.1248/bpb.29.957; Hegde ML, 2009, J ALZHEIMERS DIS, V17, P457, DOI 10.3233/JAD-2009-1068; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Ibach B, 2005, PHARMACOPSYCHIATRY, V38, P178, DOI 10.1055/s-2005-871241; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Medvedeva YV, 2009, J NEUROSCI, V29, P1105, DOI 10.1523/JNEUROSCI.4604-08.2009; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; Park JA, 2000, J NEUROSCI, V20, P9096; Regland B, 2001, DEMENT GERIATR COGN, V12, P408, DOI 10.1159/000051288; Ritchie CW, 2004, EXPERT OPIN INV DRUG, V13, P1585, DOI 10.1517/13543784.13.12.1585; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Strosznajder R, 2006, ACTA NEUROBIOL EXP, V66, P15; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Xu H, 2011, HIPPOCAMPUS, V21, P495, DOI 10.1002/hipo.20767; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Zhang LH, 2010, NEUROBIOL AGING, V31, P74, DOI 10.1016/j.neurobiolaging.2008.02.018	42	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11888	10.1371/journal.pone.0011888	http://dx.doi.org/10.1371/journal.pone.0011888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686690	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200047
J	Livne, L; Epand, RF; Papahadjopoulos-Sternberg, B; Epand, RM; Mor, A				Livne, L.; Epand, R. F.; Papahadjopoulos-Sternberg, B.; Epand, R. M.; Mor, A.			OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria	FASEB JOURNAL			English	Article						host defense peptides; slow drug release; systemic therapy	PROTEOLIPOSOME-DERIVED COCHLEATE; DERMASEPTIN S4 DERIVATIVES; ACYL-LYSINE OLIGOMERS; ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL PROPERTIES; ESCHERICHIA-COLI; LYSYL OLIGOMER; AMPHOTERICIN-B; DRUG-DELIVERY; RAT MODELS	Antibiotic resistance has become a worldwide medical problem. To find new ways of overcoming this phenomenon, we investigated the role of the membrane-active oligo-acyl-lysyl (OAK) sequence C12K-7 alpha 8, in combination with essentially ineffective antibiotics. Determination of minimal inhibitory concentration (MIC) against gram-negative multidrug-resistant strains of Escherichia coli revealed combinations with sub-MIC OAK levels that acted synergistically with several antibiotics, thus lowering their MICs by several orders of magnitude. To shed light into the molecular basis for this synergism, we used both mutant strains and biochemical assays. Our results suggest that bacterial sensitization to antibiotics was derived mainly from the OAK's capacity to overcome the efflux-enhanced resistance mechanism, by promoting backdoor entry of otherwise excluded antibiotics. To facilitate simultaneous delivery of the pooled drugs to an infection site, we developed a novel OAK-based cochleate system with demonstrable stability in whole blood. To assess the potential therapeutic use of such cochleates, we performed preliminary experiments that imitate systemic treatment of neutropenic mice infected with lethal inoculums of multidrug resistance E. coli. Single-dose administration of erythromycin coencapsulated in OAK-based cochleates has decreased drug toxicity and increased therapeutic efficacy in a dose-dependent manner. Collectively, our findings suggest a potentially useful approach for fighting efflux-enhanced resistance mechanisms.-Livne, L., Epand, R. F., Papahadjopoulos-Sternberg, B., Epand, R. M., Mor, A. OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria. FASEB J. 24, 5092-5101 (2010). www.fasebj.org	[Livne, L.; Mor, A.] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel; [Epand, R. F.; Epand, R. M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Papahadjopoulos-Sternberg, B.] NanoAnalyt Lab, San Francisco, CA USA	Technion Israel Institute of Technology; McMaster University	Mor, A (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel.	amor@tx.technion.ac.il	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	Israel Science Foundation [283/08]; Canadian Institutes of Health Research [MOP 86608]	Israel Science Foundation(Israel Science Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the Israel Science Foundation (grant 283/08) and by grant MOP 86608 from the Canadian Institutes of Health Research.	Acar JF, 2000, MED CLIN N AM, V84, P1391, DOI 10.1016/S0025-7125(05)70294-7; Anantharaman A, 2010, ANTIMICROB AGENTS CH, V54, P1693, DOI 10.1128/AAC.01231-09; Auerbach T, 2010, P NATL ACAD SCI USA, V107, P1983, DOI 10.1073/pnas.0914100107; Bohnert HA, 2005, ANTIMICROB AGENTS CH, V49, P849, DOI 10.1128/AAC.49.2.849-852.2005; Boor KJ, 2006, PLOS BIOL, V4, P18, DOI 10.1371/journal.pbio.0040023; Bracho G, 2006, VACCINE, V24, pS30, DOI 10.1016/j.vaccine.2005.01.108; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cassell GH, 1997, FEMS IMMUNOL MED MIC, V18, P271, DOI 10.1016/S0928-8244(97)00057-6; Cirioni O, 2008, J ANTIMICROB CHEMOTH, V62, P1332, DOI 10.1093/jac/dkn393; Cirioni O, 2007, CRIT CARE MED, V35, P1717, DOI 10.1097/01.CCM.0000266685.25436.03; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; DARVEAU RP, 1991, ANTIMICROB AGENTS CH, V35, P1153, DOI 10.1128/AAC.35.6.1153; del Campo J, 2006, VACCINE, V24, pS50, DOI 10.1016/j.vaccine.2005.01.119; del Campo J, 2009, METHODS, V49, P301, DOI 10.1016/j.ymeth.2009.03.025; Delmas G, 2002, ANTIMICROB AGENTS CH, V46, P2704, DOI 10.1128/AAC.46.8.2704-2707.2002; Dzidic S, 2008, FOOD TECHNOL BIOTECH, V46, P11; Epand RF, 2009, BIOPHYS J, V97, P2250, DOI 10.1016/j.bpj.2009.08.006; Epand RM, 2008, DRUG NEWS PERSPECT, V21, P307, DOI 10.1358/dnp.2008.21.6.1246829; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Giacometti A, 2000, DIAGN MICR INFEC DIS, V38, P115, DOI 10.1016/S0732-8893(00)00175-9; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Gould-Fogerite S, 1998, ADV DRUG DELIVER REV, V32, P273, DOI 10.1016/S0169-409X(98)00014-3; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hardman J. G., 1996, GOODMAN GILMANS PHAR; Held-Kuznetsov V, 2009, FASEB J, V23, P4299, DOI 10.1096/fj.09-136358; HOBEN HJ, 1982, APPL ENVIRON MICROB, V44, P1246, DOI 10.1128/AEM.44.5.1246-1247.1982; Jana S, 2006, APPL MICROBIOL BIOT, V70, P140, DOI 10.1007/s00253-005-0279-0; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; LEVY O, 1994, J CLIN INVEST, V94, P672, DOI 10.1172/JCI117384; Lewis JS, 2007, ANTIMICROB AGENTS CH, V51, P4015, DOI 10.1128/AAC.00576-07; Livne L, 2009, CHEM BIOL, V16, P1250, DOI 10.1016/j.chembiol.2009.11.012; LORENZEN A, 1993, ANAL BIOCHEM, V214, P346, DOI 10.1006/abio.1993.1504; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Miclea RD, 2007, BBA-BIOMEMBRANES, V1768, P2890, DOI 10.1016/j.bbamem.2007.08.001; Minahk CJ, 2004, J ANTIMICROB CHEMOTH, V53, P240, DOI 10.1093/jac/dkh079; Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X; MOR A, 1994, J BIOL CHEM, V269, P31635; Navon-Venezia S, 2002, ANTIMICROB AGENTS CH, V46, P689, DOI 10.1128/AAC.46.3.689-694.2002; Otto M, 2009, CONTRIB MICROBIOL, V16, P136, DOI 10.1159/000219377; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V394, P483, DOI 10.1016/0005-2736(75)90299-0; PARASASSI T, 1994, BIOPHYS J, V66, P763, DOI 10.1016/S0006-3495(94)80852-5; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Parisien A, 2008, J APPL MICROBIOL, V104, P1, DOI 10.1111/j.1365-2672.2007.03498.x; Perez O, 2006, VACCINE, V24, pS1, DOI 10.1016/j.vaccine.2005.01.100; Perez O, 2004, IMMUNOL CELL BIOL, V82, P603, DOI 10.1111/j.1440-1711.2004.01293.x; Radzishevsky I, 2007, ANTIMICROB AGENTS CH, V51, P1753, DOI 10.1128/AAC.01288-06; Radzishevsky IS, 2008, CHEM BIOL, V15, P354, DOI 10.1016/j.chembiol.2008.03.006; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Ramani K, 2003, BBA-BIOMEMBRANES, V1618, P67, DOI 10.1016/j.bbamem.2003.10.009; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; Rotem S, 2008, FASEB J, V22, P2652, DOI 10.1096/fj.07-105015; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Rydlo T, 2006, ANTIMICROB AGENTS CH, V50, P490, DOI 10.1128/AAC.50.2.490-497.2006; Santangelo R, 2000, ANTIMICROB AGENTS CH, V44, P2356, DOI 10.1128/AAC.44.9.2356-2360.2000; Sarig H, 2010, FASEB J, V24, P1904, DOI 10.1096/fj.09-149427; Scott RW, 2008, CURR OPIN BIOTECH, V19, P620, DOI 10.1016/j.copbio.2008.10.013; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Steenbergen JN, 2009, J ANTIMICROB CHEMOTH, V64, P1130, DOI 10.1093/jac/dkp346; STERNBERG B, 1996, LIPOSOMES MODEL MEMB, V4; Syed UM, 2008, INT J PHARMACEUT, V363, P118, DOI 10.1016/j.ijpharm.2008.06.026; Ulvatne H, 2001, J ANTIMICROB CHEMOTH, V48, P203, DOI 10.1093/jac/48.2.203; Vaara M, 2008, ANTIMICROB AGENTS CH, V52, P3229, DOI 10.1128/AAC.00405-08; Walker SA, 1997, NATURE, V387, P61, DOI 10.1038/387061a0; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wright GD, 2003, CURR OPIN CHEM BIOL, V7, P563, DOI 10.1016/j.cbpa.2003.08.004; Wu GQ, 2009, CURR MICROBIOL, V59, P147, DOI 10.1007/s00284-009-9410-2; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; Zaknoon F, 2009, ANTIMICROB AGENTS CH, V53, P3422, DOI 10.1128/AAC.00010-09; Zarif L, 2005, METHOD ENZYMOL, V391, P314, DOI 10.1016/S0076-6879(05)91018-5; Zarif L, 2002, J CONTROL RELEASE, V81, P7, DOI 10.1016/S0168-3659(02)00010-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	76	31	32	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5092	5101		10.1096/fj.10-167809	http://dx.doi.org/10.1096/fj.10-167809			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20720156				2022-12-25	WOS:000284824400047
J	Binz, TM; Maffioli, SI; Sosio, M; Donadio, S; Muller, R				Binz, Tina M.; Maffioli, Sonia I.; Sosio, Margherita; Donadio, Stefano; Mueller, Rolf			Insights into an Unusual Nonribosomal Peptide Synthetase Biosynthesis IDENTIFICATION AND CHARACTERIZATION OF THE GE81112 BIOSYNTHETIC GENE CLUSTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; BIOCHEMICAL-CHARACTERIZATION; POLYKETIDE SYNTHASE; NATURAL-PRODUCTS; CARRIER PROTEIN; ASSEMBLY LINES; PIPECOLIC ACID; STREPTOMYCES; ANTIBIOTICS; DOMAINS	The GE81112 tetrapeptides (1-3) represent a structurally unique class of antibiotics, acting as specific inhibitors of prokaryotic protein synthesis. Here we report the cloning and sequencing of the GE81112 biosynthetic gene cluster from Streptomyces sp. L-49973 and the development of a genetic manipulation system for Streptomyces sp. L-49973. The biosynthetic gene cluster for the tetrapeptide antibiotic GE81112 (getA-N) was identified within a 61.7-kb region comprising 29 open reading frames (open reading frames), 14 of which were assigned to the biosynthetic gene cluster. Sequence analysis revealed the GE81112 cluster to consist of six nonribosomal peptide synthetase (NRPS) genes encoding incomplete di-domain NRPS modules and a single free standing NRPS domain as well as genes encoding other biosynthetic and modifying proteins. The involvement of the cloned gene cluster in GE81112 biosynthesis was confirmed by inactivating the NRPS gene getE resulting in a GE81112 production abolished mutant. In addition, we characterized the NRPS A-domains from the pathway by expression in Escherichia coli and in vitro enzymatic assays. The previously unknown stereochemistry of most chiral centers in GE81112 was established from a combined chemical and biosynthetic approach. Taken together, these findings have allowed us to propose a rational model for GE81112 biosynthesis. The results further open the door to developing new derivatives of these promising antibiotic compounds by genetic engineering.	[Binz, Tina M.; Mueller, Rolf] Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany; [Binz, Tina M.; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany; [Maffioli, Sonia I.; Sosio, Margherita; Donadio, Stefano] Naicons Scrl, I-20138 Milan, Italy	Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University	Muller, R (corresponding author), Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, Campus C2 3, D-66123 Saarbrucken, Germany.	rom@mx.uni-saarland.de	Müller, Rolf/B-1559-2008; maffioli, sonia/K-7575-2019	Müller, Rolf/0000-0002-1042-5665; Binz, Tina/0000-0001-6783-1202; Sosio, Margherita/0000-0003-4297-6936	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was funded in part by the Bundesministerium fur Bildung und Forschung and the Deutsche Forschungsgemeinschaft (to R. M.).	Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Baker DD, 2007, NAT PROD REP, V24, P1225, DOI 10.1039/b602241n; Brandi L, 2006, BIOCHEMISTRY-US, V45, P3692, DOI 10.1021/Bi052540K; Brandi L, 2006, P NATL ACAD SCI USA, V103, P39, DOI 10.1073/pnas.0507740102; Buntin K, 2008, ANGEW CHEM INT EDIT, V47, P4595, DOI 10.1002/anie.200705569; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Chen HW, 2001, BIOCHEMISTRY-US, V40, P11651, DOI 10.1021/bi0115434; Chen WQ, 2009, J BIOL CHEM, V284, P10627, DOI 10.1074/jbc.M807534200; Dong L, 2002, J ORG CHEM, V67, P4759, DOI 10.1021/jo0256078; Durr C, 2006, CHEM BIOL, V13, P365, DOI 10.1016/j.chembiol.2006.01.011; Eustaquio AS, 2003, CHEM BIOL, V10, P279, DOI 10.1016/S1074-5521(03)00051-6; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Gaitatzis N, 2001, P NATL ACAD SCI USA, V98, P11136, DOI 10.1073/pnas.201167098; Galm U, 2009, MOL BIOSYST, V5, P77, DOI 10.1039/b814075h; Garneau-Tsodikova S, 2006, BIOCHEMISTRY-US, V45, P8568, DOI 10.1021/bi060784e; Gatto GJ, 2006, J AM CHEM SOC, V128, P3838, DOI 10.1021/ja0587603; Girard A, 1998, TETRAHEDRON LETT, V39, P4259, DOI 10.1016/S0040-4039(98)00697-2; He M, 2006, J IND MICROBIOL BIOT, V33, P401, DOI 10.1007/s10295-006-0078-3; HECHT SM, 1979, J AM CHEM SOC, V101, P3982, DOI 10.1021/ja00508a055; Hojati Z, 2002, CHEM BIOL, V9, P1175, DOI 10.1016/S1074-5521(02)00252-1; Hopwood D, 2007, NAT REV DRUG DISCOV, V6, P8, DOI 10.1038/nrd2225; Hutchinson CR, 2003, P NATL ACAD SCI USA, V100, P3010, DOI 10.1073/pnas.0730689100; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Khaw LE, 1998, J BACTERIOL, V180, P809, DOI 10.1128/JB.180.4.809-814.1998; KIESER T, 2000, PRACTICAL STREPTOMYC, P562; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kopp M, 2004, J BIOTECHNOL, V107, P29, DOI 10.1016/j.jbiotec.2003.09.013; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Mendez C, 1998, FEMS MICROBIOL LETT, V158, P1; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Pfeifer V, 2001, J BIOL CHEM, V276, P38370, DOI 10.1074/jbc.M106580200; Rachid S, 2006, CHEM BIOL, V13, P667, DOI 10.1016/j.chembiol.2006.06.002; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Sambrook J, 2001, MOL CLONING LAB MANU; Samel SA, 2008, MOL BIOSYST, V4, P387, DOI 10.1039/b717538h; Sandmann A, 2004, CHEM BIOL, V11, P1071, DOI 10.1016/j.chembiol.2004.05.014; Silakowski B, 1999, J BIOL CHEM, V274, P37391, DOI 10.1074/jbc.274.52.37391; Singh GM, 2007, CHEM BIOL, V14, P31, DOI 10.1016/j.chembiol.2006.11.005; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Steffensky M, 2000, ANTIMICROB AGENTS CH, V44, P1214, DOI 10.1128/AAC.44.5.1214-1222.2000; Strieter ER, 2007, BIOCHEMISTRY-US, V46, P7549, DOI 10.1021/bi700243h; Thomas MG, 2002, CHEM BIOL, V9, P171, DOI 10.1016/S1074-5521(02)00100-X; TURGAY K, 1992, MOL MICROBIOL, V6, P529, DOI 10.1111/j.1365-2958.1992.tb01498.x; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEMBIOCHEM, V7, P748, DOI 10.1002/cbic.200500480; Walsh C., 2003, ANTIBIOTICS ACTIONS; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Wenzel SC, 2007, NAT PROD REP, V24, P1211, DOI 10.1039/b706416k; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yin XH, 2004, CHEMBIOCHEM, V5, P1274, DOI 10.1002/cbic.200400082; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199	56	27	28	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32710	32719		10.1074/jbc.M110.146803	http://dx.doi.org/10.1074/jbc.M110.146803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20710026	Green Published, hybrid			2022-12-25	WOS:000283048200006
J	Menon, MB; Schwermann, J; Singh, AK; Franz-Wachtel, M; Pabst, O; Seidler, U; Omary, MB; Kotlyarov, A; Gaestel, M				Menon, Manoj B.; Schwermann, Jessica; Singh, Anurag Kumar; Franz-Wachtel, Mirita; Pabst, Oliver; Seidler, Ursula; Omary, M. Bishr; Kotlyarov, Alexey; Gaestel, Matthias			p38 MAP Kinase and MAPKAP Kinases MK2/3 Cooperatively Phosphorylate Epithelial Keratins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED-CELLS; FILAMENT REORGANIZATION; PROTEIN-KINASES; OKADAIC ACID; DISEASE; STRESS; MUTATION; TISSUES; MICE; SITE	The MAPK-activated protein kinases (MAPKAP kinases) MK2 and MK3 are directly activated via p38 MAPK phosphorylation, stabilize p38 by complex formation, and contribute to the stress response. The list of substrates of MK2/3 is increasing steadily. We applied a phosphoproteomics approach to compare protein phosphorylation in MK2/3-deficient cells rescued or not by ectopic expression of MK2. In addition to differences in phosphorylation of the known substrates of MK2, HSPB1 and Bag-2, we identified strong differences in phosphorylation of keratin 8 (K8). The phosphorylation of K8-Ser(73) is catalyzed directly by p38, which in turn shows MK2-dependent expression. Notably, analysis of small molecule p38 inhibitors on K8-Ser(73) phosphorylation also demonstrated reduced phosphorylations of keratins K18-Ser(52) and K20-Ser(13) but not of K8-Ser(431) or K18-Ser(33). Interestingly, K18-Ser(52) and K20-Ser(13) are not directly phosphorylated by p38 in vitro, but by MK2. Furthermore, anisomycin-stimulated phosphorylations of K20Ser(13) and K18-Ser(52) are inhibited by small molecule inhibitors of both p38 and MK2. MK2 knockdown in HT29 cells leads to reduced K20-Ser(13) phosphorylation, which further supports the notion that MK2 is responsible for K20 phosphorylation in vivo. Physiologic relevance of these findings was confirmed by differences of K20-Ser(13) phosphorylation between the ileum of wild-type and MK2/3-deficient mice and by demonstrating p38- and MK2-dependent mucin secretion of HT29 cells. Therefore, MK2 and p38 MAPK function in concert to phosphorylate K8, K18, and K20 in intestinal epithelia.	[Kotlyarov, Alexey; Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; [Singh, Anurag Kumar; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Pabst, Oliver] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Franz-Wachtel, Mirita] Univ Tubingen, Proteome Ctr Tubingen, Interfac Inst Cell Biol, D-72076 Tubingen, Germany; [Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Hannover Medical School; Hannover Medical School; Hannover Medical School; Eberhard Karls University of Tubingen; University of Michigan System; University of Michigan	Gaestel, M (corresponding author), Hannover Med Sch, Inst Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gaestel.matthias@mh-hannover.de	Seidler, Ursula/HII-8049-2022; Menon, Manoj B./P-1543-2015; Gaestel, Matthias/A-6560-2013; Pabst, Oliver/H-5014-2016	Seidler, Ursula/0000-0002-9600-2769; Menon, Manoj B./0000-0001-5859-0347; Gaestel, Matthias/0000-0002-4944-4652; Pabst, Oliver/0000-0002-5533-883X; Singh, Anurag Kumar/0000-0003-0818-0993; Omary, Bishr/0000-0002-8624-2347	National Institutes of Health [DK47918]; Deutsche Forschungsgemeinschaft [Se 460/13-4]; Ministerium fur Wissenschaft und Kunst, Landesregierung Baden-Wurttemberg; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministerium fur Wissenschaft und Kunst, Landesregierung Baden-Wurttemberg; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47918 (to M. B. O.). This work was also supported by the Deutsche Forschungsgemeinschaft (M. G.), Deutsche Forschungsgemeinschaft Grant Se 460/13-4 (to U. S.). The Proteome Centrum Tubingen is supported by the Ministerium fur Wissenschaft und Kunst, Landesregierung Baden-Wurttemberg.	BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Barjaktarovic Z, 2009, J EXP BOT, V60, P779, DOI 10.1093/jxb/ern324; Cheng TJ, 1998, J CELL BIOCHEM, V71, P169; CHOU CF, 1993, J BIOL CHEM, V268, P4465; ENGEL K, 1995, J BIOL CHEM, V270, P27213, DOI 10.1074/jbc.270.45.27213; Feng L, 1999, J CELL SCI, V112, P2081; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; He T, 2002, J BIOL CHEM, V277, P10767, DOI 10.1074/jbc.M111436200; KASAHARA K, 1993, J BIOL CHEM, V268, P23531; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; KU NO, 1994, J CELL BIOL, V127, P161, DOI 10.1083/jcb.127.1.161; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; LESUFFLEUR T, 1993, J CELL SCI, V106, P771; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; LIAO J, 1995, J CELL BIOL, V131, P1291, DOI 10.1083/jcb.131.5.1291; Menon MB, 2009, CELL MOTIL CYTOSKEL, V66, P1041, DOI 10.1002/cm.20418; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Singh AK, 2010, AM J PHYSIOL-CELL PH, V298, pC1057, DOI 10.1152/ajpcell.00454.2009; SPECIAN RD, 1991, AM J PHYSIOL, V260, P183; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DA, 2004, HEPATOLOGY, V40, P459, DOI 10.1002/hep.20277; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; Trompette A, 2004, EUR J CELL BIOL, V83, P347, DOI 10.1078/0171-9335-00391; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Zhou Q, 2006, J BIOL CHEM, V281, P16453, DOI 10.1074/jbc.M512284200; Zhou XJ, 1999, J BIOL CHEM, V274, P12861, DOI 10.1074/jbc.274.18.12861	40	24	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33242	33251		10.1074/jbc.M110.132357	http://dx.doi.org/10.1074/jbc.M110.132357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724476	hybrid, Green Published			2022-12-25	WOS:000283048200061
J	Xing, L; Li, TC; Mayazaki, N; Simon, MN; Wall, JS; Moore, M; Wang, CY; Takeda, N; Wakita, T; Miyamura, T; Cheng, RH				Xing, Li; Li, Tian-Cheng; Mayazaki, Naoyuki; Simon, Martha N.; Wall, Joseph S.; Moore, Mary; Wang, Che-Yen; Takeda, Naokazu; Wakita, Takaji; Miyamura, Tatsuo; Cheng, R. Holland			Structure of Hepatitis E Virion-sized Particle Reveals an RNA-dependent Viral Assembly Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-LIKE PARTICLES; CAPSID PROTEIN; HEV; INFECTION; PROGRAM	Hepatitis E virus (HEV) induces acute hepatitis in humans with a high fatality rate in pregnant women. There is a need for anti-HEV research to understand the assembly process of HEV native capsid. Here, we produced a large virion-sized and a small T=1 capsid by expressing the HEV capsid protein in insect cells with and without the N-terminal 111 residues, respectively, for comparative structural analysis. The virion-sized capsid demonstrates a T=3 icosahedral lattice and contains RNA fragment in contrast to the RNA-free T= 1 capsid. However, both capsids shared common decameric organization. The in vitro assembly further demonstrated that HEV capsid protein had the intrinsic ability to form decameric intermediate. Our data suggest that RNA binding is the extrinsic factor essential for the assembly of HEV native capsids.	[Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Xing, Li; Mayazaki, Naoyuki] Huddinge Univ Hosp, Karolinska Inst, Struct Virol Sect, SE-14186 Stockholm, Sweden; [Li, Tian-Cheng; Takeda, Naokazu; Wakita, Takaji; Miyamura, Tatsuo] Natl Inst Infect Dis, Dept Virol 2, Tokyo 2080011, Japan; [Simon, Martha N.; Wall, Joseph S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of California System; University of California Davis; Karolinska Institutet; National Institute of Infectious Diseases (NIID); United States Department of Energy (DOE); Brookhaven National Laboratory	Cheng, RH (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	rhch@ucdavis.edu	Miyazaki, Naoyuki/D-7435-2012; Cheng, Holland/A-8973-2008; Miyazaki, Naoyuki/P-3436-2018	Miyazaki, Naoyuki/0000-0002-4880-7300; Miyazaki, Naoyuki/0000-0002-4880-7300; Wang, Joseph Che-Yen/0000-0001-6580-3531	National Institutes of Health; U.S. Department of Agriculture; STINT Foundation; Strategic Research Foundation; Swedish Research Council; Ministry of Health, Labor, and Welfare, Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); STINT Foundation; Strategic Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a grant from the National Institutes of Health Roadmap Project on Nanomedicine (to R. H. C.). This work was also supported by grants from the U.S. Department of Agriculture Hatch Fund, STINT Foundation, and Strategic Research Foundation (to R. H. C.). This study was also partly funded by a grant from the Swedish Research Council (to L. X.) and grants for Research on Emerging and Re-emerging Infectious Diseases, Research on Hepatitis, and Research on Food Safety from the Ministry of Health, Labor, and Welfare, Japan (to T.- C. L.).	Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Bertolotti-Ciarlet A, 2002, J VIROL, V76, P4044, DOI 10.1128/JVI.76.8.4044-4055.2002; BLOW DM, 1964, J MOL BIOL, V8, P65, DOI 10.1016/S0022-2836(64)80149-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; FISHER AJ, 1993, NATURE, V361, P176, DOI 10.1038/361176a0; Guu TSY, 2009, P NATL ACAD SCI USA, V106, P12992, DOI 10.1073/pnas.0904848106; Harrison SC, 2001, CURR OPIN STRUC BIOL, V11, P195, DOI 10.1016/S0959-440X(00)00189-5; He SZ, 2008, J GEN VIROL, V89, P245, DOI 10.1099/vir.0.83308-0; Ji YC, 2006, J STRUCT BIOL, V154, P1, DOI 10.1016/j.jsb.2005.06.009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Li TC, 2005, J VIROL, V79, P12999, DOI 10.1128/JVI.79.20.12999-13006.2005; Li TC, 2004, VACCINE, V22, P370, DOI 10.1016/j.vaccine.2003.08.004; Li TC, 2007, J VIROL, V81, P10890, DOI 10.1128/JVI.00807-07; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAIK SR, 1992, B WORLD HEALTH ORGAN, V70, P597; Nguyen HD, 2009, J AM CHEM SOC, V131, P2606, DOI 10.1021/ja807730x; Niikura M, 2002, VIROLOGY, V293, P273, DOI 10.1006/viro.2001.1240; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; PRASAD BVV, 1994, J MOL BIOL, V240, P256, DOI 10.1006/jmbi.1994.1439; PURDY MA, 1993, J MED VIROL, V41, P90, DOI 10.1002/jmv.1890410118; Riddell MA, 2000, J VIROL, V74, P8011, DOI 10.1128/JVI.74.17.8011-8017.2000; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; Schofield DJ, 2003, VACCINE, V22, P257, DOI 10.1016/j.vaccine.2003.07.008; Stockley PG, 2007, J MOL BIOL, V369, P541, DOI 10.1016/j.jmb.2007.03.020; Takamura S, 2004, GENE THER, V11, P628, DOI 10.1038/sj.gt.3302193; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; TIMMINS PA, 1994, STRUCTURE, V2, P1191, DOI 10.1016/S0969-2126(94)00121-9; Wall JS, 2000, METH MOL B, V148, P589; Wall JS, 1998, METHOD CELL BIOL, V53, P139; Wang CY, 2008, ACTA CRYSTALLOGR F, V64, P318, DOI 10.1107/S1744309108007197; Xing L, 1999, VIROLOGY, V265, P35, DOI 10.1006/viro.1999.0005; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013	39	112	116	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33175	33183		10.1074/jbc.M110.106336	http://dx.doi.org/10.1074/jbc.M110.106336			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720013	hybrid, Green Published			2022-12-25	WOS:000283048200055
J	Chu, KY; Lin, YL; Hendel, A; Kulpa, JE; Brownsey, RW; Johnson, JD				Chu, Kwan Yi; Lin, Yalin; Hendel, Alon; Kulpa, Jerzy E.; Brownsey, Roger W.; Johnson, James D.			ATP-Citrate Lyase Reduction Mediates Palmitate-induced Apoptosis in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FREE FATTY-ACIDS; DEPENDENT DIABETES-MELLITUS; INDUCED INSULIN-SECRETION; LONG-TERM EXPOSURE; ER STRESS; ISLETS; ACTIVATION; INHIBITION; KINASE	Elevated extracellular lipids, such as the free fatty acid palmitate, can induce pancreatic beta cell endoplasmic reticulum (ER) stress and apoptosis, thereby contributing to the initiation and progression of type 2 diabetes. ATP-citrate lyase (ACLY), a key enzyme in cellular lipid production, was identified as a palmitate target in a proteomic screen. We investigated the effects of palmitate on ACLY activity and phosphorylation and its role in beta cell ER stress and apoptosis. We demonstrated that treatment of MIN6 cells, mouse islets and human islets with palmitate reduced ACLY protein levels. These in vitro results were validated by our finding that islets from high fat-fed mice had a significant decrease in ACLY, similar to that previously observed in type 2 diabetic human islets. Palmitate decreased intracellular acetyl-CoA levels to a similar degree as the ACLY inhibitor, SB-204990, suggesting a reduction in ACLY activity. ACLY inhibitors alone were sufficient to induce CCAAT/enhancer- binding protein homologues protein (CHOP)-dependent ER stress and caspase-3-dependent apoptosis. Similarly, even modest shRNA-mediated knockdown of ACLY caused a significant increase in beta cell apoptosis and ER stress. The effects of chemical ACLY inhibition and palmitate were nonadditive and therefore potentially mediated by a common mechanism. Indeed, overexpression of ACLY prevented palmitate-induced beta cell death. These observations provide new evidence that ACLY expression and activity can be suppressed by exogenous lipids and demonstrate a critical role for ACLY in pancreatic beta cell survival. These findings add to the emerging body of evidence linking beta cell metabolism with programmed cell death.	[Johnson, James D.] Univ British Columbia, Diabet Res Grp, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, Vancouver, BC V6T 1Z3, Canada; [Kulpa, Jerzy E.; Brownsey, Roger W.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Johnson, JD (corresponding author), Univ British Columbia, Diabet Res Grp, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, 5358 Life Sci Bldg,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	jimjohn@interchange.ubc.ca		Johnson, James/0000-0002-7523-9433	Canadian Diabetes Association (CDA); Michael Smith Foundation for Health Research; Centre for Human Islet Transplantation and Beta Cell Regeneration; Canadian Institutes for Health Research; Juvenile Diabetes Research Foundation	Canadian Diabetes Association (CDA); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Centre for Human Islet Transplantation and Beta Cell Regeneration; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This project was funded by a grant-in-aid from the Canadian Diabetes Association (CDA) (to J.D.J.) and the Michael Smith Foundation for Health Research (to J.D.J. and the Centre for Human Islet Transplantation and Beta Cell Regeneration).; Supported by a New Investigator Award from the Canadian Institutes for Health Research, a Career Development Award from the Juvenile Diabetes Research Foundation, and a Scholarship from the CDA.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; ALLY A, 1992, J CHROMATOGR-BIOMED, V575, P19, DOI 10.1016/0378-4347(92)80499-G; Atkinson LL, 2002, DIABETES, V51, P1548, DOI 10.2337/diabetes.51.5.1548; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BERKHOUT TA, 1990, BIOCHEM J, V272, P181, DOI 10.1042/bj2720181; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CISTOLA DP, 1991, J CLIN INVEST, V87, P1431, DOI 10.1172/JCI115149; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; FRAZE E, 1985, J CLIN ENDOCR METAB, V61, P807, DOI 10.1210/jcem-61-5-807; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; GOLAY A, 1987, J CLIN ENDOCR METAB, V65, P512, DOI 10.1210/jcem-65-3-512; Gribble AD, 1998, J MED CHEM, V41, P3582, DOI 10.1021/jm980091z; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; HOUSTON B, 1985, BIOCHIM BIOPHYS ACTA, V844, P233, DOI 10.1016/0167-4889(85)90095-3; HUGHES K, 1992, BIOCHEM J, V288, P309, DOI 10.1042/bj2880309; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; KING MT, 1988, METHOD ENZYMOL, V166, P70; Knowles LM, 2008, J BIOL CHEM, V283, P31378, DOI 10.1074/jbc.M803384200; KNOWLES SE, 1974, BIOCHEM J, V142, P401, DOI 10.1042/bj1420401; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lee Y, 1997, DIABETES, V46, P408, DOI 10.2337/diabetes.46.3.408; LINN TC, 1979, J BIOL CHEM, V254, P1691; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Pearce NJ, 1998, BIOCHEM J, V334, P113, DOI 10.1042/bj3340113; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Sargsyan E, 2008, J ENDOCRINOL, V199, P41, DOI 10.1677/JOE-08-0251; SUZUKI M, 1981, J NUTR SCI VITAMINOL, V27, P595, DOI 10.3177/jnsv.27.595; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	56	46	48	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32606	32615		10.1074/jbc.M110.157172	http://dx.doi.org/10.1074/jbc.M110.157172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693577	Green Published, hybrid			2022-12-25	WOS:000282683000075
J	Weiss, TL; Chun, HJ; Okada, S; Vitha, S; Holzenburg, A; Laane, J; Devarenne, TP				Weiss, Taylor L.; Chun, Hye Jin; Okada, Shigeru; Vitha, Stanislav; Holzenburg, Andreas; Laane, Jaan; Devarenne, Timothy P.			Raman Spectroscopy Analysis of Botryococcene Hydrocarbons from the Green Microalga Botryococcus braunii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRUDE OILS; B-RACE; TRITERPENOID HYDROCARBONS; BRANCHED HYDROCARBON; NUTRIENT STATUS; ALGA; BIOSYNTHESIS; CELLS; STRAIN; SHALE	Botryococcus braunii, B race is a unique green microalga that produces large amounts of liquid hydrocarbons known as botryococcenes that can be used as a fuel for internal combustion engines. The simplest botryococcene (C-30) is metabolized by methylation to give intermediates of C-31, C-32, C-33, and C-34, with C-34 being the predominant botryococcene in some strains. In the present work we have used Raman spectroscopy to characterize the structure of botryococcenes in an attempt to identify and localize botryococcenes within B. braunii cells. The spectral region from 1600-1700 cm(-1) showed v(C=C) stretching bands specific for botryococcenes. Distinct botryococcene Raman bands at 1640 and 1647 cm(-1) were assigned to the stretching of the C=C bond in the botryococcene branch and the exomethylene C=C bonds produced by the methylations, respectively. A Raman band at 1670 cm(-1) was assigned to the backbone C=C bond stretching. Density function theory calculations were used to determine the Raman spectra of all botryococcenes to compare computed theoretical values with those observed. The analysis showed that the v(C=C) stretching bands at 1647 and 1670 cm(-1) are actually composed of several closely spaced bands arising from the six individual C=C bonds in the molecule. We also used confocal Raman microspectroscopy to map the presence and location of methylated botryococcenes within a colony of B. braunii cells based on the methylation-specific 1647 cm(-1) botryococcene Raman shift.	[Weiss, Taylor L.; Holzenburg, Andreas; Devarenne, Timothy P.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Chun, Hye Jin; Laane, Jaan] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Okada, Shigeru] Univ Tokyo, Lab Aquat Nat Prod Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Vitha, Stanislav; Holzenburg, Andreas] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX 77843 USA; [Holzenburg, Andreas] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Tokyo; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Devarenne, TP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	tpd8@tamu.edu	Laane, Jaan/O-4379-2014; Okada, Shigeru/U-8305-2017; Weiss, Taylor/E-6247-2012	Laane, Jaan/0000-0003-4423-6122; Okada, Shigeru/0000-0003-3663-7778; Weiss, Taylor/0000-0002-3967-0787; Vitha, Stanislav/0000-0003-3262-8399; Devarenne, Timothy/0000-0001-6032-8049	Texas A&M University Department of Biochemistry and Biophysics; Japan Society for the Promotion of Science [S-09103]; Robert A. Welch Foundation [A-0396]; National Science Foundation [BES-0421409]	Texas A&M University Department of Biochemistry and Biophysics; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Robert A. Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Texas A&M University Department of Biochemistry and Biophysics start-up funds (to T.P.D.), Japan Society for the Promotion of Science Research Fellowship S-09103 (to T.P.D.), Robert A. Welch Foundation Grant A-0396 (to J.L.), and National Science Foundation Grant BES-0421409 (to A.H.).	Achitouv E, 2004, PHYTOCHEMISTRY, V65, P3159, DOI 10.1016/j.phytochem.2004.09.015; Adam P, 2006, ORG GEOCHEM, V37, P584, DOI 10.1016/j.orggeochem.2006.01.001; Audino M, 2002, ORG GEOCHEM, V33, P979, DOI 10.1016/S0146-6380(02)00061-X; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; BRAHMA SK, 1983, APPL SPECTROSC, V37, P55, DOI 10.1366/0003702834634190; BRASSELL SC, 1986, ORG GEOCHEM, V10, P927, DOI 10.1016/S0146-6380(86)80030-4; CANE R F, 1977, Transactions of the Royal Society of South Australia, V101, P153; CASADEVALL E, 1984, TETRAHEDRON LETT, V25, P4123, DOI 10.1016/S0040-4039(01)90198-4; Chen M, 2004, SPECTROCHIM ACTA A, V60, P527, DOI 10.1016/S1386-1425(03)00258-0; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; COOKSEY KE, 1987, J MICROBIOL METH, V6, P333, DOI 10.1016/0167-7012(87)90019-4; Elsey D, 2007, J MICROBIOL METH, V68, P639, DOI 10.1016/j.mimet.2006.11.008; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; FRISCH MJ, 2004, GAUSSIAN VERSION 0 3; GALBRAITH MN, 1983, PHYTOCHEMISTRY, V22, P1441, DOI 10.1016/S0031-9422(00)84031-5; GLIKSON M, 1989, ORG GEOCHEM, V14, P595, DOI 10.1016/0146-6380(89)90039-9; GRUNG M, 1989, BIOCHEM SYST ECOL, V17, P263, DOI 10.1016/0305-1978(89)90001-X; Heraud P, 2006, J CHEMOMETR, V20, P193, DOI 10.1002/cem.990; Heraud P, 2007, FEMS MICROBIOL LETT, V275, P24, DOI 10.1111/j.1574-6968.2007.00861.x; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huang YY, 2010, BIOTECHNOL BIOENG, V105, P889, DOI 10.1002/bit.22617; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P1467, DOI 10.1016/S0031-9422(00)97766-5; HUANG Z, 1989, J AM CHEM SOC, V111, P2713, DOI 10.1021/ja00189a056; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P3034; KNIGHTS BA, 1970, PHYTOCHEMISTRY, V9, P1317, DOI 10.1016/S0031-9422(00)85325-X; Kubo Y, 2000, APPL SPECTROSC, V54, P1114, DOI 10.1366/0003702001950832; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; Lee H, 1998, KSME INT J, V12, P553, DOI 10.1007/BF02945716; Li BX, 2005, PHOTOSYNTH RES, V83, P297, DOI 10.1007/s11120-004-6555-5; Mastalerz M, 1996, ORG GEOCHEM, V24, P301, DOI 10.1016/0146-6380(96)00027-7; MAXWELL JR, 1968, PHYTOCHEMISTRY, V7, P2157, DOI 10.1016/S0031-9422(00)85672-1; MCKIRDY DM, 1986, NATURE, V320, P57, DOI 10.1038/320057a0; METZGER P, 1988, PHYTOCHEMISTRY, V27, P1383, DOI 10.1016/0031-9422(88)80199-7; METZGER P, 1987, PHYTOCHEMISTRY, V26, P129; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2995, DOI 10.1016/0031-9422(85)80043-1; METZGER P, 1986, PHYTOCHEMISTRY, V25, P1869, DOI 10.1016/S0031-9422(00)81165-6; METZGER P, 1990, J PHYCOL, V26, P258, DOI 10.1111/j.0022-3646.1990.00258.x; METZGER P, 1987, TETRAHEDRON LETT, V28, P3911; Metzger P, 2007, ORG GEOCHEM, V38, P566, DOI 10.1016/j.orggeochem.2006.12.003; MOLDOWAN JM, 1980, J CHEM SOC CHEM COMM, P912, DOI 10.1039/c39800000912; NONOMURA A M, 1988, Japanese Journal of Phycology, V36, P285; Okada S, 2004, ARCH BIOCHEM BIOPHYS, V422, P110, DOI 10.1016/j.abb.2003.12.004; Okada S, 1997, PHYTOCHEM ANALYSIS, V8, P198, DOI 10.1002/(SICI)1099-1565(199707)8:4&lt;198::AID-PCA360&gt;3.0.CO;2-E; Okada S, 1996, TETRAHEDRON LETT, V37, P1065, DOI 10.1016/0040-4039(95)02349-6; Okada S, 1995, J APPL PHYCOL, V7, P555, DOI 10.1007/BF00003942; Okada S, 1998, PHYTOCHEMISTRY, V47, P1111, DOI 10.1016/S0031-9422(97)00548-7; Sato Y, 2003, TETRAHEDRON LETT, V44, P7035, DOI 10.1016/S0040-4039(03)01784-2; Stasiuk LD, 1999, ORG GEOCHEM, V30, P1021, DOI 10.1016/S0146-6380(99)00046-7; Summons RE, 2002, ORG GEOCHEM, V33, P99, DOI 10.1016/S0146-6380(01)00147-4; TEMPLIER J, 1991, PHYTOCHEMISTRY, V30, P2209, DOI 10.1016/0031-9422(91)83616-S; TEMPLIER J, 1984, PHYTOCHEMISTRY, V23, P1017, DOI 10.1016/S0031-9422(00)82602-3; TESTA M, 2001, P OCEAN DRILLING PRO, V180, P1; TRAVERSE ALFRED, 1955, MICROPALEONTOLOGY, V1, P343, DOI 10.2307/1484478; WAGNER WD, 1986, APPL SPECTROSC, V40, P191, DOI 10.1366/0003702864509574; WOLF FR, 1985, PHYTOCHEMISTRY, V24, P733; WOLF FR, 1985, J PHYCOL, V21, P388; Wood BR, 2005, ANAL CHEM, V77, P4955, DOI 10.1021/ac050281z; Wu Q, 1998, ANAL CHEM, V70, P1782, DOI 10.1021/ac971098b; Wynn-Williams, 2004, INT J ASTROBIOL, V3, P125, DOI [10.1017/S1473550404002034, DOI 10.1017/S1473550404002034]	60	58	61	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32458	32466		10.1074/jbc.M110.157230	http://dx.doi.org/10.1074/jbc.M110.157230			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20705610	hybrid, Green Published			2022-12-25	WOS:000282683000059
J	Yang, HL; Ganguly, A; Cabral, F				Yang, Hailing; Ganguly, Anutosh; Cabral, Fernando			Inhibition of Cell Migration and Cell Division Correlates with Distinct Effects of Microtubule Inhibiting Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; BETA-TUBULIN; ALPHA-TUBULIN; DYNAMIC INSTABILITY; LIVING CELLS; PACLITAXEL RESISTANCE; ENDOTHELIAL-CELLS; SPINDLE FORMATION; MEIOTIC SPINDLE; IN-VITRO	Drugs that target microtubules are thought to inhibit cell division and cell migration by suppressing dynamic instability, a "search and capture" behavior that allows microtubules to probe their environment. Here, we report that subtoxic drug concentrations are sufficient to inhibit plus-end microtubule dynamic instability and cell migration without affecting cell division or microtubule assembly. The higher drug concentrations needed to inhibit cell division act through a novel mechanism that generates microtubule fragments by stimulating microtubule minus-end detachment from their organizing centers. The frequency of microtubule detachment in untreated cells increases at prophase suggesting that it is a regulated cellular process important for spindle assembly and function. We conclude that drugs produce differential dose-dependent effects at microtubule plus and minus-ends to inhibit different microtubule-mediated functions.	[Yang, Hailing; Ganguly, Anutosh; Cabral, Fernando] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Cabral, F (corresponding author), Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	fernando.r.cabral@uth.tmc.edu		Ganguly, Anutosh/0000-0002-7228-7827	National Institutes of Health [CA85935]; NATIONAL CANCER INSTITUTE [R01CA085935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA85935 (to F. C.).	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; ABRAHAM I, 1983, J CELL BIOL, V97, P1055, DOI 10.1083/jcb.97.4.1055; AHMAD FJ, 1995, J CELL SCI, V108, P2761; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; BARLOW S, 1994, J CELL BIOL, V126, P1017, DOI 10.1083/jcb.126.4.1017; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; CABRAL F, 1991, PHARMACOL THERAPEUT, V52, P159, DOI 10.1016/0163-7258(91)90006-8; CABRAL F, 1980, CELL, V20, P29, DOI 10.1016/0092-8674(80)90231-7; Cabral F., 2000, DRUG RESIST UPDATE, V3, P1; CABRAL FR, 1983, J CELL BIOL, V97, P22, DOI 10.1083/jcb.97.1.22; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Hari M, 2003, MOL CANCER THER, V2, P597; Hotchkiss KA, 2002, MOL CANCER THER, V1, P1191; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kamath K, 2005, J BIOL CHEM, V280, P12902, DOI 10.1074/jbc.M414477200; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; LIAO GJ, 1995, J CELL SCI, V108, P3473; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Pasquier E, 2005, CANCER RES, V65, P2433, DOI 10.1158/0008-5472.CAN-04-2624; Pourroy B, 2006, CANCER RES, V66, P3256, DOI 10.1158/0008-5472.CAN-05-3885; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; Rusan NM, 2005, J CELL BIOL, V168, P21, DOI 10.1083/jcb.200409153; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; SCHIBLER MJ, 1986, J CELL BIOL, V102, P1522, DOI 10.1083/jcb.102.4.1522; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Vacca A, 1999, BLOOD, V94, P4143, DOI 10.1182/blood.V94.12.4143.424k26_4143_4155; Wang XM, 1996, J CELL BIOL, V132, P345, DOI 10.1083/jcb.132.3.345; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Yang HL, 2007, J BIOL CHEM, V282, P27058, DOI 10.1074/jbc.M704101200; Yin SH, 2010, MOL CANCER THER, V9, P327, DOI 10.1158/1535-7163.MCT-09-0674	43	115	118	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32242	32250		10.1074/jbc.M110.160820	http://dx.doi.org/10.1074/jbc.M110.160820			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696757	hybrid, Green Published			2022-12-25	WOS:000282683000037
J	Yan, H; Venkatesan, K; Beaver, JE; Klitgord, N; Yildirim, MA; Hao, T; Hill, DE; Cusick, ME; Perrimon, N; Roth, FP; Vidal, M				Yan, Han; Venkatesan, Kavitha; Beaver, John E.; Klitgord, Niels; Yildirim, Muhammed A.; Hao, Tong; Hill, David E.; Cusick, Michael E.; Perrimon, Norbert; Roth, Frederick P.; Vidal, Marc			A Genome-Wide Gene Function Prediction Resource for Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; SACCHAROMYCES-CEREVISIAE; STRESS-RESPONSE; EXPRESSION; IDENTIFICATION; MICROARRAY; NETWORKS; CELLS; MACHINES; SYSTEM	Predicting gene functions by integrating large-scale biological data remains a challenge for systems biology. Here we present a resource for Drosophila melanogaster gene function predictions. We trained function-specific classifiers to optimize the influence of different biological datasets for each functional category. Our model predicted GO terms and KEGG pathway memberships for Drosophila melanogaster genes with high accuracy, as affirmed by cross-validation, supporting literature evidence, and large-scale RNAi screens. The resulting resource of prioritized associations between Drosophila genes and their potential functions offers a guide for experimental investigations.	[Yan, Han; Venkatesan, Kavitha; Klitgord, Niels; Yildirim, Muhammed A.; Hao, Tong; Hill, David E.; Cusick, Michael E.; Roth, Frederick P.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, CCSB, Boston, MA 02115 USA; [Yan, Han; Venkatesan, Kavitha; Klitgord, Niels; Yildirim, Muhammed A.; Hao, Tong; Hill, David E.; Cusick, Michael E.; Perrimon, Norbert; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Perrimon, Norbert] Howard Hughes Med Inst, Boston, MA 02115 USA; [Yildirim, Muhammed A.] Harvard Univ, Div Engn & Appl Sci, Appl Phys Program, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Beaver, John E.; Roth, Frederick P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard Medical School	Yan, H (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, CCSB, Boston, MA 02115 USA.	frederick_roth@hms.harvard.edu; marc_vidal@dfci.harvard.edu	Roth, Frederick P/H-6308-2011; Yildirim, Muhammed/J-3695-2014; Hill, David E/B-6617-2011; Klitgord, Niels/B-5121-2009	Yildirim, Muhammed/0000-0003-2826-1766; Perrimon, Norbert/0000-0001-7542-472X; Roth, Frederick/0000-0002-6628-649X	National Institutes of Health (NIH) [HG001715, HG004233, HG003224]; Canadian Institute for Advanced Research; Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG001715, R01HG003224, R01HG001715, P50HG004233, U01HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (NIH; HG001715, HG004233 and HG003224; http://www.nih.gov/), the Canadian Institute for Advanced Research (http://www2.cifar.ca/), and the Presidential Scholarship from Harvard University (http://www.harvard.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000351; Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEAVER J, 2010, BIOINFORMATICS  0521; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Boltz KA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-212; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brody T, 1999, TRENDS GENET, V15, P333, DOI 10.1016/S0168-9525(99)01775-8; Carney GE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-288; Carrera I, 2008, MOL CELL BIOL, V28, P5238, DOI 10.1128/MCB.00747-08; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Deng XX, 2006, GENETICS, V174, P1859, DOI 10.1534/genetics.106.064568; Deng XX, 2009, GENETICS, V182, P481, DOI 10.1534/genetics.109.102087; Deng Xutao, 2008, Int J Bioinform Res Appl, V4, P263, DOI 10.1504/IJBRA.2008.019574; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; Estrada B, 2006, PLOS GENET, V2, P160, DOI 10.1371/journal.pgen.0020016; Firth LC, 2007, DEV BIOL, V307, P521, DOI 10.1016/j.ydbio.2007.04.037; Flockhart I, 2006, NUCLEIC ACIDS RES, V34, pD489, DOI 10.1093/nar/gkj114; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Johansson AM, 2007, EMBO J, V26, P2307, DOI 10.1038/sj.emboj.7601604; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kotsiantis S B, 2007, INFORMATICA, V31, P249, DOI DOI 10.31449/INF.V31I3.148; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee HJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-32; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Maines JZ, 2007, DEVELOPMENT, V134, P1471, DOI 10.1242/dev.02810; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mezey JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-2; Mourikis P, 2006, P NATL ACAD SCI USA, V103, P1307, DOI 10.1073/pnas.0510564103; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Obozinski G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s6; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qin XL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r63; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Reinke V, 2002, NAT GENET, V32, P541, DOI 10.1038/ng1039; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Tasan M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s8; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tian WD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s7; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Umemori M, 2009, GENE REGUL SYST BIO, V3, P11; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Weber KE, 2008, GENETICS, V178, P1093, DOI 10.1534/genetics.107.078014; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; WITTEN IH, 2000, DATA MINING PRACTICA, V25; Wu XW, 2006, METH MOL B, V316, P35; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	76	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12139	10.1371/journal.pone.0012139	http://dx.doi.org/10.1371/journal.pone.0012139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711346	gold, Green Published			2022-12-25	WOS:000280859700024
J	Roelandt, P; Pauwelyn, KA; Sancho-Bru, P; Subramanian, K; Ordovas, L; Vanuytsel, K; Geraerts, M; Firpo, M; De Vos, R; Fevery, J; Nevens, F; Hu, WS; Verfaillie, CM				Roelandt, Philip; Pauwelyn, Karen Ann; Sancho-Bru, Pau; Subramanian, Kartik; Ordovas, Laura; Vanuytsel, Kim; Geraerts, Martine; Firpo, Meri; De Vos, Rita; Fevery, Johan; Nevens, Frederik; Hu, Wei-Shou; Verfaillie, Catherine M.			Human Embryonic and Rat Adult Stem Cells with Primitive Endoderm-Like Phenotype Can Be Fated to Definitive Endoderm, and Finally Hepatocyte-Like Cells	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; LIVER DEVELOPMENT; MOUSE EMBRYO; EFFICIENT DIFFERENTIATION; TRANSCRIPTION FACTOR; PROGENITOR CELLS; EXPRESSION; TRANSPLANTATION; CULTURES; LINES	Stem cell-derived hepatocytes may be an alternative cell source to treat liver diseases or to be used for pharmacological purposes. We developed a protocol that mimics mammalian liver development, to differentiate cells with pluripotent characteristics to hepatocyte-like cells. The protocol supports the stepwise differentiation of human embryonic stem cells (ESC) to cells with characteristics of primitive streak (PS)/mesendoderm (ME)/definitive endoderm (DE), hepatoblasts, and finally cells with phenotypic and functional characteristics of hepatocytes. Remarkably, the same protocol can also differentiate rat multipotent adult progenitor cells (rMAPCs) to hepatocyte-like cells, even though rMAPC are isolated clonally from cultured rat bone marrow (BM) and have characteristics of primitive endoderm cells. A fraction of rMAPCs can be fated to cells expressing genes consistent with a PS/ME/DE phenotype, preceding the acquisition of phenotypic and functional characteristics of hepatocytes. Although the hepatocyte-like progeny derived from both cell types is mixed, between 10-20% of cells are developmentally consistent with late fetal hepatocytes that have attained synthetic, storage and detoxifying functions near those of adult hepatocytes. This differentiation protocol will be useful for generating hepatocyte-like cells from rodent and human stem cells, and to gain insight into the early stages of liver development.	[Roelandt, Philip; Pauwelyn, Karen Ann; Sancho-Bru, Pau; Ordovas, Laura; Vanuytsel, Kim; Geraerts, Martine; Verfaillie, Catherine M.] Catholic Univ Leuven, Interdept Stem Cell Inst Leuven, Louvain, Belgium; [Roelandt, Philip; Pauwelyn, Karen Ann; Fevery, Johan; Nevens, Frederik] Univ Hosp Leuven, Hepatol Dept, Louvain, Belgium; [Subramanian, Kartik; Firpo, Meri; Hu, Wei-Shou] Univ Minnesota, Stem Cell Inst Minnesota, Minneapolis, MN USA; [Subramanian, Kartik; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [De Vos, Rita] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; KU Leuven; University Hospital Leuven	Roelandt, P (corresponding author), Catholic Univ Leuven, Interdept Stem Cell Inst Leuven, Louvain, Belgium.	Philip.roelandt@med.kuleuven.be; Ka.pauwelyn@gmail.com	Ordovas, Laura/AAA-2959-2019; Bose, Bipasha/H-3265-2019; Verfaillie, Catherine/H-5148-2013; Sancho-Bru, Pau/D-4900-2014	Ordovas, Laura/0000-0003-3982-1263; Bose, Bipasha/0000-0002-2312-9734; Verfaillie, Catherine/0000-0001-7564-4079; Sancho-Bru, Pau/0000-0001-5569-9259; Vanuytsel, Kim/0000-0002-8872-0736	National Institutes of Health [RO1-HL67932, RO1 DK58295, RO1-HL073221, U19-DK61244]; Alpha 1 Foundation; FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders) [G.0667.07, KAN 1.5163.09]; IWT; KULeuven SCIL Center of Excellence Award; BAEF (Belgian American Education Foundation); VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology); Agencia de Gestio d'Ajuts Universitaris i de Recerca, Beatriu de Pinos [2006 BP-A 10104]; Instituto Aragones de Ciencias de la Salud and Gobierno de Aragon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067932, R01HL073221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058295, U19DK061244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha 1 Foundation; FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders)(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KULeuven SCIL Center of Excellence Award; BAEF (Belgian American Education Foundation); VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology); Agencia de Gestio d'Ajuts Universitaris i de Recerca, Beatriu de Pinos; Instituto Aragones de Ciencias de la Salud and Gobierno de Aragon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to C. Verfaillie from the National Institutes of Health (RO1-HL67932, RO1 DK58295, RO1-HL073221 and U19-DK61244), the Alpha 1 Foundation, FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders, www.fwo.be) G.0667.07 Odysseus award, IWT-SBO grant (HepStem), and a KULeuven SCIL Center of Excellence Award. K. Pauwelyn was funded by FWO, BAEF (Belgian American Education Foundation, www.baef.be) and VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology, www.vvge.be). P. Sancho-Bru was funded by FWO (KAN 1.5163.09) and Agencia de Gestio d'Ajuts Universitaris i de Recerca, Beatriu de Pinos (2006 BP-A 10104). P. Roelandt was funded by IWT (Agentschap voor Innovatie door Wetenschap en Technologie - Agency for Innovation by Science and Technology, www.iwt.be) and VVGE. L. Ordovas was funded by Instituto Aragones de Ciencias de la Salud and Gobierno de Aragon. M. Geraerts was funded by FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breyer A, 2006, EXP HEMATOL, V34, P1596, DOI 10.1016/j.exphem.2006.07.013; Brolen G, 2010, J BIOTECHNOL, V145, P284, DOI 10.1016/j.jbiotec.2009.11.007; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Cesari F, 2008, NAT REV MOL CELL BIO, V9, P924, DOI 10.1038/nrm2545; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Debeb BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007216; Dhawan A, 2006, J INHERIT METAB DIS, V29, P431, DOI 10.1007/s10545-006-0245-8; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Farquhar MJ, 2008, J VIRAL HEPATITIS, V15, P849, DOI 10.1111/j.1365-2893.2008.01051.x; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Gong ZJ, 1999, HEPATOLOGY, V29, P576, DOI 10.1002/hep.510290238; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Ishii T, 2010, CELL TISSUE RES, V339, P505, DOI 10.1007/s00441-009-0906-7; Gomez-Lechon MJ, 2008, EXPERT OPIN DRUG MET, V4, P837, DOI 10.1517/17425255.4.7.837 ; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Nishimura M, 2007, DRUG METAB PHARMACOK, V22, P178, DOI 10.2133/dmpk.22.178; Robertson EJ, 2003, PHILOS T R SOC B, V358, P1351, DOI 10.1098/rstb.2003.1332; Roelandt P, 2010, NAT PROTOC, V5, P1324, DOI 10.1038/nprot.2010.80; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Sancho-Bru P, 2009, GUT, V58, P594, DOI 10.1136/gut.2008.171116; SANCHOBRU P, 2010, J HEPATOL IN PRESS; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; Sekhon SS, 2004, AM J PATHOL, V164, P2229, DOI 10.1016/S0002-9440(10)63779-0; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; SierraSantoyo A, 1996, J APPL TOXICOL, V16, P281, DOI 10.1002/(SICI)1099-1263(199607)16:4<281::AID-JAT344>3.0.CO;2-K; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Subramanian K, 2010, METHODS MOL BIOL, V636, P55, DOI 10.1007/978-1-60761-691-7_4; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	53	55	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12101	10.1371/journal.pone.0012101	http://dx.doi.org/10.1371/journal.pone.0012101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711405	Green Submitted, Green Published, gold			2022-12-25	WOS:000280849100023
J	Josseran, L; Fouillet, A; Caillere, N; Brun-Ney, D; Ilef, D; Brucker, G; Medeiros, H; Astagneau, P				Josseran, Loic; Fouillet, Anne; Caillere, Nadege; Brun-Ney, Dominique; Ilef, Daniele; Brucker, Gilles; Medeiros, Helena; Astagneau, Pascal			Assessment of a Syndromic Surveillance System Based on Morbidity Data: Results from the Oscour (R) Network during a Heat Wave	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; TIMELINESS; MORTALITY; FORCES	Background: Syndromic surveillance systems have been developed in recent years and are now increasingly used by stakeholders to quickly answer questions and make important decisions. It is therefore essential to evaluate the quality and utility of such systems. This study was designed to assess a syndromic surveillance system based on emergency departments' (ED) morbidity rates related to the health effects of heat waves. This study uses data collected during the 2006 heat wave in France. Methods: Data recorded from 15 EDs in the Ile-de-France (Paris and surrounding area) from June to August, 2006, were transmitted daily via the Internet to the French Institute for Public Health Surveillance. Items collected included diagnosis (ICD10), outcome, and age. Several aspects of the system have been evaluated (data quality, cost, flexibility, stability, and performance). Periods of heat wave are considered the most suitable time to evaluate the system. Results: Data quality did not vary significantly during the period. Age, gender and outcome were completed in a comprehensive manner. Diagnoses were missing or uninformative for 37.5% of patients. Stability was recorded as being 99.49% for the period overall. The average cost per day over the study period was estimated to be (sic)287. Diagnoses of hyperthermia, malaise, dehydration, hyponatremia were correlated with increased temperatures. Malaise was most sensitive in younger and elderly adults but also the less specific. However, overall syndrome groups were more sensitive with comparable specificity than individual diagnoses. Conclusion: This system satisfactorily detected the health impact of hot days (observed values were higher than expected on more than 90% of days on which a heat alert was issued). Our findings should reassure stakeholders about the reliability of health impact assessments during or following such an event. These evaluations are essential to establish the validity of the results of syndromic surveillance systems.	[Josseran, Loic; Fouillet, Anne; Caillere, Nadege; Ilef, Daniele; Medeiros, Helena] French Inst Publ Hlth Surveillance, Dept Alert Coordinat & Reg, St Maurice, France; [Brun-Ney, Dominique] AP HP, Paris, France; [Brucker, Gilles] GIP Esther, Paris, France; [Astagneau, Pascal] Univ Paris 06, Sch Med, Dept Publ Hlth, Paris, France	Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte	Josseran, L (corresponding author), French Inst Publ Hlth Surveillance, Dept Alert Coordinat & Reg, St Maurice, France.	l.josseran@invs.sante.fr	josseran, loic/F-3190-2019; Alkhalawi, Mohammed j/C-6111-2012; Astagneau, Pascal/AAF-3473-2020	josseran, loic/0000-0002-9021-1818; 	French National Institut for Public Health Surveillance	French National Institut for Public Health Surveillance	This study was funded by the French National Institut for Public Health Surveillance (www.invs.sante.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bourgeois FT, 2006, ANN EMERG MED, V47, P265, DOI 10.1016/j.annemergmed.2005.11.022; Bravata DM, 2004, ANN INTERN MED, V140, P910, DOI 10.7326/0003-4819-140-11-200406010-00013; Buehler James W, 2004, MMWR Recomm Rep, V53, P1; Chaudet H, 2005, STUD HEALTH TECHNOL, V116, P983; Cooper D L, 2002, Commun Dis Public Health, V5, P127; Curtis AB, 2001, AM J PREV MED, V20, P108, DOI 10.1016/S0749-3797(00)00284-1; Doroshenko Alexander, 2005, MMWR Suppl, V54, P117; Espino JU, 2004, STUD HEALTH TECHNOL, V107, P1192; Flamand C, 2008, Euro Surveill, V13; German RR, 2000, EPIDEMIOLOGY, V11, P720, DOI 10.1097/00001648-200011000-00020; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Jajosky RA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-29; Jefferson H, 2008, J PUBLIC HEALTH-UK, V30, P375, DOI 10.1093/pubmed/fdn026; Jones H W, 1945, Bull Med Libr Assoc, V33, P3; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Leonardi G, 2006, SOZ PRAVENTIV MED, V51, P194, DOI 10.1007/s00038-006-5039-0; Meynard JB, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-29; Pascal M, 2006, INT J BIOMETEOROL, V50, P144, DOI 10.1007/s00484-005-0003-x; RAMLOW JM, 1990, PUBLIC HEALTH REP, V105, P283; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Smith G E, 2006, Euro Surveill, V11, P220; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; van den Wijngaard C, 2008, EMERG INFECT DIS, V14, P917, DOI 10.3201/eid1406.071467; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; [No title captured]	28	56	56	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e11984	10.1371/journal.pone.0011984	http://dx.doi.org/10.1371/journal.pone.0011984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711252	Green Published, gold, Green Submitted			2022-12-25	WOS:000280776800001
J	Brettschneider, J; Czerwoniak, A; Senel, M; Fang, LB; Kassubek, J; Pinkhardt, E; Lauda, F; Kapfer, T; Jesse, S; Lehmensiek, V; Ludolph, AC; Otto, M; Tumani, H				Brettschneider, Johannes; Czerwoniak, Anne; Senel, Makbule; Fang, Lubin; Kassubek, Jan; Pinkhardt, Elmar; Lauda, Florian; Kapfer, Tamara; Jesse, Sarah; Lehmensiek, Vera; Ludolph, Albert C.; Otto, Markus; Tumani, Hayrettin			The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; B-CELLS; PREDICT CONVERSION; MRI CRITERIA; DIAGNOSIS; PATTERNS; ANTIBODIES; MIGRATION; CONSENSUS	Background: There is increasing recognition of the importance of B lymphocytes in the immunopathogenesis of multiple sclerosis (MS), encouraging the evaluation of B cell-associated biomarkers in the cerebrospinal fluid (CSF). We aimed to evaluate the relevance of the B cell chemoattractant CXCL13 as a prognostic marker in patients with clinically isolated syndrome (CIS) regarding conversion to MS, and to compare it to Barkhof criteria in magnetic resonance imaging (MRI), oligoclonal bands (OCB) and the polyspecific intrathecal B cell response against measles, rubella and varicella zoster virus (MRZR). Methodology/Principal Findings: CXCL13 was determined in a prospective study over 2 years including 46 patients that remained CIS over follow-up (CIS-CIS), 45 patients that developed MS (CIS-RRMS), and 30 controls using ELISA. CSF CXCL13 was significantly elevated in CIS-RRMS as compared to CIS-CIS and controls (p<0.001). It was significantly elevated in CIS with OCB (p<0.001), positive MRZR (p = 0.04), and gadolinium enhancement in MRI (p = 0.02) and showed a significant correlation with CSF leukocyte count (p<0.001) and QIgG (p<0.001). CXCL13 showed the best positive predictive value (PPV) of all parameters investigated (70%, 95%-CI: 53-84%), which could be further increased by combination with Barkhof criteria in MRI (80%). Conclusions/Significance: Our data indicate the relevance of CXCL13 in CIS to predict conversion to MS. It furthermore shows CXCL13 to be an important mediator in the inflammatory cascade associated with the polyspecific intrathecal B cell response that manifests itself in OCB and MRZR.	[Brettschneider, Johannes; Czerwoniak, Anne; Senel, Makbule; Fang, Lubin; Kassubek, Jan; Pinkhardt, Elmar; Lauda, Florian; Kapfer, Tamara; Jesse, Sarah; Lehmensiek, Vera; Ludolph, Albert C.; Otto, Markus; Tumani, Hayrettin] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany	Ulm University	Brettschneider, J (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	johannes.brettschneider@uni-ulm.de	Kassubek, Jan/F-2774-2015; Otto, Markus/F-4304-2015; Senel, Makbule/AAU-8687-2020; Kassubek, Jan/GPX-0910-2022; Senel, Makbule/AAQ-4635-2021; Kassubek, Jan/O-1740-2019	Kassubek, Jan/0000-0002-7106-9270; Otto, Markus/0000-0003-4273-4267; Kassubek, Jan/0000-0002-7106-9270; Senel, Makbule/0000-0002-2737-7495; Kassubek, Jan/0000-0002-7106-9270	University of Ulm	University of Ulm	This study was funded by the University of Ulm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; BOSCA I, 2010, J NEUROIMMUNOL; Brettschneider J, 2006, MULT SCLER J, V12, P143, DOI 10.1191/135248506ms1263oa; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Festa ED, 2009, MULT SCLER J, V15, P1271, DOI 10.1177/1352458509107017; Fischer L, 2009, CLIN CANCER RES, V15, P5968, DOI 10.1158/1078-0432.CCR-09-0108; Franciotta D, 2008, J NEUROIMMUNOL, V200, P125, DOI 10.1016/j.jneuroim.2008.06.004; Jarius S, 2008, J NEUROL NEUROSUR PS, V79, P1134, DOI 10.1136/jnnp.2007.133330; JARIUS S, 2008, J NEUROL SCI; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Korteweg T, 2006, LANCET NEUROL, V5, P221, DOI 10.1016/S1474-4422(06)70353-2; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Kuhle J, 2007, NEW ENGL J MED, V356, P371, DOI 10.1056/NEJMoa063602; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lund Frances E., 2005, V8, P25; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Michalowska-Wender G, 2008, PHARMACOL REP, V60, P549; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; Nelson PJ, 2001, IMMUNITY, V14, P377, DOI 10.1016/S1074-7613(01)00118-2; NEWCOMBE RG, 1992, BRIT MED J, V304, P381, DOI 10.1136/bmj.304.6823.381-c; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2003, CLIN CHEM LAB MED, V41, P331, DOI 10.1515/CCLM.2003.053; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Reiber H, 2001, CLIN CHEM LAB MED, V39, P324, DOI 10.1515/CCLM.2001.051; Rupprecht TA, 2005, NEUROLOGY, V65, P448, DOI 10.1212/01.wnl.0000171349.06645.79; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; SENEL M, 2009, J NEUROL NEUROSURG P; Silberstein SD, 2005, CEPHALALGIA, V25, P460, DOI 10.1111/j.1468-2982.2005.00878.x; Swanton JK, 2007, LANCET NEUROL, V6, P677, DOI 10.1016/S1474-4422(07)70176-X; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Thrower BW, 2007, NEUROLOGY, V68, pS12, DOI 10.1212/01.wnl.0000277704.56189.85; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; Whiting P, 2006, BMJ-BRIT MED J, V332, P875, DOI 10.1136/bmj.38771.583796.7C; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	43	96	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11986	10.1371/journal.pone.0011986	http://dx.doi.org/10.1371/journal.pone.0011986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700489	Green Submitted, Green Published, gold			2022-12-25	WOS:000280605400019
J	Husemoen, LLN; Jorgensen, T; Borch-Johnsen, K; Hansen, T; Pedersen, O; Linneberg, A				Husemoen, Lise Lotte N.; Jorgensen, Torben; Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf; Linneberg, Allan			The Association of Alcohol and Alcohol Metabolizing Gene Variants with Diabetes and Coronary Heart Disease Risk Factors in a White Population	PLOS ONE			English	Article							MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; DRINKING HABITS; BLOOD-PRESSURE; CONSUMPTION; POLYMORPHISM; ADH; GENOTYPE; INSULIN; ALDH2; METAANALYSIS	Background: Epidemiological studies have shown a J- or U-shaped relation between alcohol and type 2 diabetes and coronary heart disease (CHD). The underlying mechanisms are not clear. The aim was to examine the association between alcohol intake and diabetes and intermediate CHD risk factors in relation to selected ADH and ALDH gene variants. Methodology/Principal Findings: Cross-sectional study including 6,405 Northern European men and women aged 30-60 years from the general population of Copenhagen, Denmark. Data were collected with self-administered questionnaires, a physical examination, a 2 hour oral glucose tolerance test, and various blood tests. J shaped associations were observed between alcohol and diabetes, metabolic syndrome (MS), systolic and diastolic blood pressure, triglyceride, total cholesterol, and total homocysteine. Positive associations were observed with insulin sensitivity and HDL cholesterol, and a negative association with insulin release. Only a few of the selected ADH and ALDH gene variants was observed to have an effect. The ADH1c (rs1693482) fast metabolizing CC genotype was associated with an increased risk of impaired glucose tolerance (IGT)/diabetes compared to the CT and TT genotypes. Significant interactions were observed between alcohol and ADH1b (rs1229984) with respect to LDL and between alcohol and ALDH2 (rs886205) with respect to IGT/diabetes. Conclusions/Significance: The selected ADH and ALDH gene variants had only minor effects, and did not seem to markedly modify the health effects of alcohol drinking. The observed statistical significant associations would not be significant, if corrected for multiple testing.	[Husemoen, Lise Lotte N.; Jorgensen, Torben; Linneberg, Allan] Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; Aarhus University; University of Copenhagen; University of Southern Denmark	Husemoen, LLN (corresponding author), Res Ctr Prevent & Hlth, Glostrup, Denmark.	lloh@glo.regionh.dk	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Jørgensen, Torben/Z-1335-2018	Pedersen, Oluf/0000-0002-3321-3972; Linneberg, Allan/0000-0002-0994-0184; Hansen, Torben/0000-0001-8748-3831; Jorgensen, Torben/0000-0001-9453-2830	Danish Diabetes Association; Danish Medi-cal Research Council	Danish Diabetes Association; Danish Medi-cal Research Council(Danish Medical Research Council)	The study was supported by the Danish Diabetes Association (www.diabetes.dk) and Danish Medi-cal Research Council (www.fi.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, DEFINITION DIAGNOS 1; Balkau B, 1999, DIABETIC MED, V16, P442; Beulens JWJ, 2007, DIABETES, V56, P2388, DOI 10.2337/db07-0181; Borras E, 2000, HEPATOLOGY, V31, P984, DOI 10.1053/he.2000.5978; BOSRON WF, 1987, ENZYME, V37, P19, DOI 10.1159/000469238; Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Chou WY, 1999, ALCOHOL CLIN EXP RES, V23, P963, DOI 10.1111/j.1530-0277.1999.tb04213.x; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Cushman W C, 2001, J Clin Hypertens (Greenwich), V3, P166, DOI 10.1111/j.1524-6175.2001.00443.x; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Djousse L, 2005, AM J CARDIOL, V96, P227, DOI 10.1016/j.amjcard.2005.03.050; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p157S, DOI 10.1097/00000374-200105051-00027; Fagrell B, 1999, J INTERN MED, V246, P331, DOI 10.1046/j.1365-2796.1999.00576.x; Fischer M, 2007, ALCOHOL CLIN EXP RES, V31, P1654, DOI 10.1111/j.1530-0277.2007.00471.x; Gemma Simonetta, 2006, Ann Ist Super Sanita, V42, P8; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Harada S, 1999, ALCOHOL CLIN EXP RES, V23, P958, DOI 10.1111/j.1530-0277.1999.tb04212.x; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Hashimoto Y, 2002, CLIN CHEM, V48, P1043; HEMPEL J, 1984, FEBS LETT, V173, P367, DOI 10.1016/0014-5793(84)80807-8; Hines LA, 2005, ATHEROSCLEROSIS, V182, P293, DOI 10.1016/j.atherosclerosis.2005.02.005; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; Homann N, 2006, INT J CANCER, V118, P1998, DOI 10.1002/ijc.21583; HSU LC, 1991, J BIOL CHEM, V266, P12257; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Husemoen LLN, 2004, EUR J CLIN NUTR, V58, P1142, DOI 10.1038/sj.ejcn.1601942; Husemoen LLN, 2003, GENET EPIDEMIOL, V24, P322, DOI 10.1002/gepi.10239; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kannel WB, 1996, CLIN CHIM ACTA, V246, P59; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Linneberg A, 2006, CLIN EXP ALLERGY, V36, P714, DOI 10.1111/j.1365-2222.2006.02507.x; Linneberg A, 2010, CLIN EXP ALLERGY, V40, P123, DOI 10.1111/j.1365-2222.2009.03398.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nakamura Y, 2002, ATHEROSCLEROSIS, V164, P171, DOI 10.1016/S0021-9150(02)00059-X; OKAYAMA A, 1994, J HUM HYPERTENS, V8, P205; Peterson RJ, 1999, GENOME RES, V9, P844, DOI 10.1101/gr.9.9.844; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; SAVOLAINEN MJ, 1995, CURR OPIN LIPIDOL, V6, P243, DOI 10.1097/00041433-199508000-00009; Sesso HD, 1999, CURR OPIN NEPHROL HY, V8, P353, DOI 10.1097/00041552-199905000-00013; SHERMAN D, 1993, HUM GENET, V92, P477, DOI 10.1007/BF00216454; Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith LV, 2007, EUR J EPIDEMIOL, V22, P771, DOI 10.1007/s10654-007-9177-3; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; STEWART MJ, 1995, BIOCHEM BIOPH RES CO, V211, P144, DOI 10.1006/bbrc.1995.1789; Toft U, 2007, EUR J CLIN NUTR, V61, P270, DOI 10.1038/sj.ejcn.1602503; Tolstrup JS, 2008, PHARMACOGENOMICS J, V8, P220, DOI 10.1038/sj.tpj.6500471; TSURITANI I, 1995, AM J HYPERTENS, V8, P1053, DOI 10.1016/0895-7061(95)00222-B; Whitfield JB, 2003, ALCOHOL CLIN EXP RES, V27, P509, DOI 10.1097/01.ALC.0000057940.57330.70; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; Younis J, 2005, ATHEROSCLEROSIS, V180, P225, DOI 10.1016/j.atherosclerosis.2004.12.010	53	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11735	10.1371/journal.pone.0011735	http://dx.doi.org/10.1371/journal.pone.0011735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700531	gold, Green Published, Green Submitted			2022-12-25	WOS:000280605400001
J	Jayachandran, G; Ueda, K; Wang, BB; Roth, JA; Ji, L				Jayachandran, Gitanjali; Ueda, Kentaro; Wang, Bingbing; Roth, Jack A.; Ji, Lin			NPRL2 Sensitizes Human Non-Small Cell Lung Cancer (NSCLC) Cells to Cisplatin Treatment by Regulating Key Components in the DNA Repair Pathway	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME 3P21.3; CHK2 PROTEIN-KINASE; S-PHASE CHECKPOINT; HISTONE H2AX; IN-VITRO; DOWNSTREAM EFFECTOR; GENOMIC INSTABILITY; DAMAGE CHECKPOINT	NPRL2, one of the tumor suppressor genes residing in a 120-kb homozygous deletion region of human chromosome band 3p21.3, has a high degree of amino acid sequence homology with the nitrogen permease regulator 2 (NPR2) yeast gene, and mutations of NPRL2 in yeast cells are associated with resistance to cisplatin-mediated cell killing. Previously, we showed that restoration of NPRL2 in NPRL2-negative and cisplatin-resistant cells resensitize lung cancer cells to cisplatin treatment in vitro and in vivo. In this study, we show that sensitization of non-small cell lung cancer (NSCLC) cells to cisplatin by NPRL2 is accomplished through the regulation of key components in the DNA-damage checkpoint pathway. NPRL2 can phosphorylate ataxia telangiectasia mutated (ATM) kinase activated by cisplatin and promote downstream gamma-H2AX formation in vitro and in vivo, which occurs during apoptosis concurrently with the initial appearance of high-molecular-weight DNA fragments. Moreover, this combination treatment results in higher Chk1 and Chk2 kinase activity than does treatment with cisplatin alone and can activate Chk2 in pleural metastases tumor xenograft in mice. Activated Chk1 and Chk2 increase the expression of cell cycle checkpoint proteins, including Cdc25A and Cdc25C, leading to higher levels of G2/M arrest in tumor cells treated with NPRL2 and cisplatin than in tumor cells treated with cisplatin only. Our results therefore suggest that ectopic expression of NPRL2 activates the DNA damage checkpoint pathway in cisplatin-resistant and NPRL2-negative cells; hence, the combination of NPRL2 and cisplatin can resensitize cisplatin nonresponders to cisplatin treatment through the activation of the DNA damage checkpoint pathway, leading to cell arrest in the G2/M phase and induction of apoptosis. The direct implication of this study is that combination treatment with NPRL2 and cisplatin may overcome cisplatin resistance and enhance therapeutic efficacy.	[Jayachandran, Gitanjali; Ueda, Kentaro; Wang, Bingbing; Roth, Jack A.; Ji, Lin] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Roth, Jack A.; Ji, Lin] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA; [Ueda, Kentaro] Wakayama Med Univ, Sch Med, Wakayama, Japan	University of Texas System; UTMD Anderson Cancer Center; Wakayama Medical University	Jayachandran, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	lji@mdanderson.org			National Cancer Institute, National Institutes of Health [SPORE P50CA70907, R01CA116322, MMHCC U01CA10535201]; Department of Defense [DAMD17-02-1-0706]; University of Texas M. D. Anderson Cancer Center [CA-16672]; Texas State Legislature; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA116322, P50CA070907] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); University of Texas M. D. Anderson Cancer Center; Texas State Legislature; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by grants from the National Cancer Institute, National Institutes of Health, SPORE P50CA70907, R01CA116322, and MMHCC U01CA10535201; grants from the Department of Defense Lung Cancer Program PROSPECT (DAMD17-02-1-0706); The University of Texas M. D. Anderson Cancer Center Support Core Grant (CA-16672); and a grant from the Tobacco Settlement Funds as appropriated by the Texas State Legislature. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; EVANS DL, 1994, CANCER RES, V54, P1596; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fondon JW, 1998, P NATL ACAD SCI USA, V95, P7514, DOI 10.1073/pnas.95.13.7514; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Henkels KM, 1997, CANCER RES, V57, P4488; Ji L, 2002, CANCER RES, V62, P2715; Ji L, 1999, CANCER RES, V59, P3333; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lerman MI, 2000, CANCER RES, V60, P6116; Lin WC, 2001, GENE DEV, V15, P1833; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Mukhopadhyay T, 2002, CLIN CANCER RES, V8, P2963; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perez RP, 1998, EUR J CANCER, V34, P1535, DOI 10.1016/S0959-8049(98)00227-5; Reed E, 1998, CANCER TREAT REV, V24, P331, DOI 10.1016/S0305-7372(98)90056-1; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schenk PW, 2003, MOL PHARMACOL, V64, P259, DOI 10.1124/mol.64.2.259; SORENSON CM, 1990, JNCI-J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Talasz H, 2002, CELL DEATH DIFFER, V9, P27, DOI 10.1038/sj.cdd.4400925; Ueda K, 2006, CANCER RES, V66, P9682, DOI 10.1158/0008-5472.CAN-06-1483; Wistuba II, 2000, CANCER RES, V60, P1949; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	49	28	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11994	10.1371/journal.pone.0011994	http://dx.doi.org/10.1371/journal.pone.0011994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700484	Green Published, gold, Green Submitted			2022-12-25	WOS:000280605400026
J	Sridhar, J; Narmada, SR; Sabarinathan, R; Ou, HY; Deng, ZX; Sekar, K; Rafi, ZA; Rajakumar, K				Sridhar, Jayavel; Narmada, Suryanarayanan Ramkumar; Sabarinathan, Radhakrishnan; Ou, Hong-Yu; Deng, Zixin; Sekar, Kanagaraj; Rafi, Ziauddin Ahamed; Rajakumar, Kumar			sRNAscanner: A Computational Tool for Intergenic Small RNA Detection in Bacterial Genomes	PLOS ONE			English	Article							SMALL NONCODING RNAS; ESCHERICHIA-COLI; ENCODING GENES; SOLUBLE-RNAS; IDENTIFICATION; PREDICTION; TYPHIMURIUM; EXPRESSION; PROTEINS; STRESS	Background: Bacterial non-coding small RNAs (sRNAs) have attracted considerable attention due to their ubiquitous nature and contribution to numerous cellular processes including survival, adaptation and pathogenesis. Existing computational approaches for identifying bacterial sRNAs demonstrate varying levels of success and there remains considerable room for improvement. Methodology/Principal Findings: Here we have proposed a transcriptional signal-based computational method to identify intergenic sRNA transcriptional units (TUs) in completely sequenced bacterial genomes. Our sRNAscanner tool uses position weight matrices derived from experimentally defined E. coli K-12 MG1655 sRNA promoter and rho-independent terminator signals to identify intergenic sRNA TUs through sliding window based genome scans. Analysis of genomes representative of twelve species suggested that sRNAscanner demonstrated equivalent sensitivity to sRNAPredict2, the best performing bioinformatics tool available presently. However, each algorithm yielded substantial numbers of known and uncharacterized hits that were unique to one or the other tool only. sRNAscanner identified 118 novel putative intergenic sRNA genes in Salmonella enterica Typhimurium LT2, none of which were flagged by sRNAPredict2. Candidate sRNA locations were compared with available deep sequencing libraries derived from Hfq-co-immunoprecipitated RNA purified from a second Typhimurium strain (Sittka et al. (2008) PLoS Genetics 4: e1000163). Sixteen potential novel sRNAs computationally predicted and detected in deep sequencing libraries were selected for experimental validation by Northern analysis using total RNA isolated from bacteria grown under eleven different growth conditions. RNA bands of expected sizes were detected in Northern blots for six of the examined candidates. Furthermore, the 5'-ends of these six Northern-supported sRNA candidates were successfully mapped using 5'-RACE analysis. Conclusions/Significance: We have developed, computationally examined and experimentally validated the sRNAscanner algorithm. Data derived from this study has successfully identified six novel S. Typhimurium sRNA genes. In addition, the computational specificity analysis we have undertaken suggests that similar to 40% of sRNAscanner hits with high cumulative sum of scores represent genuine, undiscovered sRNA genes. Collectively, these data strongly support the utility of sRNAscanner and offer a glimpse of its potential to reveal large numbers of sRNA genes that have to date defied identification. sRNAscanner is available from: http://bicmku.in:8081/sRNAscanner or http://cluster.physics.iisc.ernet.in/sRNAscanner/.	[Sridhar, Jayavel; Rafi, Ziauddin Ahamed] Madurai Kamaraj Univ, Sch Biotechnol, Ctr Excellence Bioinformat, Madurai 625021, Tamil Nadu, India; [Narmada, Suryanarayanan Ramkumar; Sabarinathan, Radhakrishnan; Sekar, Kanagaraj] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India; [Sridhar, Jayavel; Rajakumar, Kumar] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Rajakumar, Kumar] Univ Hosp Leicester, NHS Trust, Dept Clin Microbiol, Leicester, Leics, England; [Ou, Hong-Yu; Deng, Zixin] Shanghai Jiao Tong Univ, Lab Microbial Metab, Shanghai 200030, Peoples R China; [Ou, Hong-Yu; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Madurai Kamaraj University; Indian Institute of Science (IISC) - Bangalore; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sridhar, J (corresponding author), Madurai Kamaraj Univ, Sch Biotechnol, Ctr Excellence Bioinformat, Madurai 625021, Tamil Nadu, India.	kr46@le.ac.uk	OU, Hong-Yu/O-5208-2019	OU, Hong-Yu/0000-0001-9439-1660; Sabarinathan, Radhakrishnan/0000-0001-8916-3954; Sambaturu, Narmada/0000-0002-2570-3699	Department of Biotechnology, Government of India; Department of Biotechnology for the Centre of Excellence in Bioinformatics, Madurai Kamaraj University; Commonwealth Scholarship Commission Split-Site Doctoral Award; Shanghai Rising-Star Program [Q7A14028]; National Natural Science Foundation of China [30700013/C010103]; Royal Society-National Natural Science Foundation of China [2007/R3]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology for the Centre of Excellence in Bioinformatics, Madurai Kamaraj University; Commonwealth Scholarship Commission Split-Site Doctoral Award; Shanghai Rising-Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society-National Natural Science Foundation of China(Royal Society of LondonNational Natural Science Foundation of China (NSFC))	This study was supported by project grants from Department of Biotechnology, Government of India to KS. ZAR and JS received financial support from Department of Biotechnology for the Centre of Excellence in Bioinformatics, Madurai Kamaraj University. JS was supported by a Commonwealth Scholarship Commission Split-Site Doctoral Award. HYO was supported by the Shanghai Rising-Star Program (Q7A14028) and National Natural Science Foundation of China grants (30700013/C010103). KR and ZD were supported by a Royal Society-National Natural Science Foundation of China, International Joint Project Grant (2007/R3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chen S, 2002, BIOSYSTEMS, V65, P157, DOI 10.1016/S0303-2647(02)00013-8; Chiapello H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-171; Dai SP, 2004, J BACTERIOL, V186, P5078, DOI 10.1128/jb.186.15.5078-5086.2004; Delihas N, 2001, J MOL BIOL, V313, P1, DOI 10.1006/jmbi.2001.5029; Douchin V, 2006, J BIOL CHEM, V281, P12253, DOI 10.1074/jbc.M600819200; Gershenzon NI, 2005, NUCLEIC ACIDS RES, V33, P2290, DOI 10.1093/nar/gki519; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; LINU MY, 1997, J BIOL CHEM, V272, P17502; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pichon C, 2003, BIOINFORMATICS, V19, P1707, DOI 10.1093/bioinformatics/btg235; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2009, RNA BIOL, V6, P266, DOI 10.4161/rna.6.3.8332; Sridhar J, 2007, OMICS, V11, P74, DOI 10.1089/omi.2006.0006; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Valverde C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-416; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; VOGEL J, 2008, HDB RNA BIOCH 3, P595; Wang FY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004027; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; ZWEIG MH, 1993, CLIN CHEM, V39, P561	46	41	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11970	10.1371/journal.pone.0011970	http://dx.doi.org/10.1371/journal.pone.0011970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700540	Green Published, gold, Green Submitted			2022-12-25	WOS:000280605400011
J	Munoz, J; Gomez, A; Green, AJ; Figuerola, J; Amat, F; Rico, C				Munoz, Joaquin; Gomez, Africa; Green, Andy J.; Figuerola, Jordi; Amat, Francisco; Rico, Ciro			Evolutionary Origin and Phylogeography of the Diploid Obligate Parthenogen Artemia parthenogenetica (Branchiopoda: Anostraca)	PLOS ONE			English	Article							BRINE; POPULATIONS; DISPERSAL; COEXISTENCE; DIVERSITY; CRUSTACEA; DISTANCE; SEX	Background: Understanding the evolutionary origin and the phylogeographic patterns of asexual taxa can shed light on the origin and maintenance of sexual reproduction. We assessed the geographic origin, genetic diversity, and phylogeographic history of obligate parthenogen diploid Artemia parthenogenetica populations, a widespread halophilic crustacean. Methodology/Principal Findings: We analysed a partial sequence of the Cytochrome c Oxidase Subunit I mitochondrial gene from an extensive set of localities (including Eurasia, Africa, and Australia), and examined their phylogeographic patterns and the phylogenetic relationships of diploid A. parthenogenetica and its closest sexual relatives. Populations displayed an extremely low level of mitochondrial genetic diversity, with one widespread haplotype shared by over 79% of individuals analysed. Phylogenetic and phylogeographic analyses indicated a multiple and recent evolutionary origin of diploid A. parthenogenetica, and strongly suggested that the geographic origin of parthenogenesis in Artemia was in Central Asia. Our results indicate that the maternal sexual ancestors of diploid A. parthenogenetica were an undescribed species from Kazakhstan and A. urmiana. Conclusions/Significance: We found evidence for multiple origin of parthenogenesis in Central Asia. Our results indicated that, shortly after its origin, diploid A. parthenogenetica populations underwent a rapid range expansion from Central Asia towards the Mediterranean region, and probably to the rest of its current geographic distribution. This contrasts with the restricted geographic distribution, strong genetic structure, and regional endemism of sexual Artemia lineages and other passively dispersed sexual continental aquatic invertebrates. We hypothesize that diploid parthenogens might have reached their current distribution in historical times, with a range expansion possibly facilitated by an increased availability of suitable habitat provided by anthropogenic activities, such as the spread of solar saltworks, aided by their natural dispersal vectors (i.e., waterbirds).	[Munoz, Joaquin; Green, Andy J.; Figuerola, Jordi; Rico, Ciro] Estac Biol Donana CSIC, Dept Wetland Ecol, Seville, Spain; [Gomez, Africa] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Amat, Francisco] CSIC, Inst Acuicultura Torre Sal, Ribera De Cabanes, Castellon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Hull; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Munoz, J (corresponding author), Estac Biol Donana CSIC, Dept Wetland Ecol, Seville, Spain.	quini@ebd.csic.es	Rico, Ciro/K-5725-2015; Figuerola, Jordi/B-7917-2008; Rico, Ciro/P-9750-2019; Green, Andy J/A-5189-2008; Munoz, Joaquin/B-9938-2009; Gomez, A/L-6505-2014	Rico, Ciro/0000-0002-0822-336X; Figuerola, Jordi/0000-0002-4664-9011; Rico, Ciro/0000-0002-0822-336X; Green, Andy J/0000-0002-1268-4951; Munoz, Joaquin/0000-0003-3623-2439; Gomez, A/0000-0002-1297-4502	Spanish Ministerio de Educacion y Ciencia [BOS2003-02846, CGL 2005-02306 BOS, CGL2006-05085/BOS]; NERC [NE/B501298/1]; Natural Environment Research Council [NE/B501298/1] Funding Source: researchfish	Spanish Ministerio de Educacion y Ciencia(Spanish Government); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by the Spanish Ministerio de Educacion y Ciencia (projects BOS2003-02846, CGL 2005-02306 BOS and CGL2006-05085/BOS, including FEDER funds). AG was supported by a NERC Advanced Fellowship (NE/B501298/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzopoulos TJ, 2009, INT REV HYDROBIOL, V94, P560, DOI 10.1002/iroh.200911147; Abatzopoulos TJ, 2002, BIOL J LINN SOC, V75, P333, DOI 10.1111/j.1095-8312.2002.tb02074.x; ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; ABREUGROBOIS FA, 1987, ARTEMIA RES ITS APPL, V1; Agh N, 2007, INT REV HYDROBIOL, V92, P48, DOI 10.1002/iroh.200610909; Amat Domenech F., 1980, P19; Barata C, 1996, J EXP MAR BIOL ECOL, V196, P313, DOI 10.1016/0022-0981(95)00137-9; Baxevanis AD, 2006, MOL PHYLOGENET EVOL, V40, P724, DOI 10.1016/j.ympev.2006.04.010; BEATON MJ, 1988, AM NAT, V132, P837, DOI 10.1086/284892; Bossier P, 2004, AQUACULTURE, V231, P93, DOI 10.1016/j.aquaculture.2003.11.001; BROWNE RA, 1990, EVOLUTION, V44, P1035, DOI 10.1111/j.1558-5646.1990.tb03824.x; Caceres CE, 1997, P NATL ACAD SCI USA, V94, P9171, DOI 10.1073/pnas.94.17.9171; Chaplin JA, 1997, HEREDITY, V78, P57; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De Gelas K, 2005, MOL ECOL, V14, P753, DOI 10.1111/j.1365-294X.2004.02434.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GAJARDO G, 2002, BASIC APPL BIOL, P225; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Haag CR, 2004, ANN ZOOL FENN, V41, P539; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; HARPENDING HC, 1998, TREE, V95, P1961; HONTORIA F, 1992, J PLANKTON RES, V14, P949, DOI 10.1093/plankt/14.7.949; Hou L, 2006, AQUAC RES, V37, P671, DOI 10.1111/j.1365-2109.2006.01480.x; Johnson SG, 2006, EVOLUTION, V60, P1417, DOI 10.1111/j.0014-3820.2006.tb01220.x; Kappas I, 2009, MOL PHYLOGENET EVOL, V52, P192, DOI 10.1016/j.ympev.2009.03.012; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Kearney M, 2006, MOL ECOL, V15, P1743, DOI 10.1111/j.1365-294X.2006.02898.x; Kearney MR, 2003, TRENDS ECOL EVOL, V18, P605, DOI 10.1016/j.tree.2003.09.021; Ketmaier V, 2008, AQUAT SCI, V70, P65, DOI 10.1007/s00027-007-7028-7; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kurlansky M, 2003, SALT WORLD HIST; Law JH, 2002, MOL ECOL, V11, P1471, DOI 10.1046/j.1365-294X.2002.01547.x; McMaster K, 2007, HYDROBIOLOGIA, V576, P39, DOI 10.1007/s10750-006-0291-0; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; Mills S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-225; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Munoz J, 2008, MOL ECOL, V17, P3160, DOI 10.1111/j.1365-294X.2008.03818.x; Mura G, 2005, J PLANKTON RES, V27, P895, DOI 10.1093/plankt/fbi063; Neiman M, 2009, ANN NY ACAD SCI, V1168, P185, DOI 10.1111/j.1749-6632.2009.04572.x; Nunes BS, 2006, ENVIRON POLLUT, V144, P453, DOI 10.1016/j.envpol.2005.12.037; Palumbi Stephen R., 1996, P205; PILLA EJS, 1994, HEREDITY, V73, P47, DOI 10.1038/hdy.1994.97; Sanchez MI, 2007, MAR BIOL, V151, P1407, DOI 10.1007/s00227-006-0577-9; Schneider S, 1999, GENETICS, V152, P1079; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Schon I, 2007, HYDROBIOLOGIA, V575, P33, DOI 10.1007/s10750-006-0276-z; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Triantaphyllidis GV, 1996, HYDROBIOLOGIA, V335, P97, DOI 10.1007/BF00015271; VANSTAPPEN G, 2002, BIOL AQUATIC ORGANIS, P171; VANSTAPPEN G, 2008, THESIS GHENT U BELGI; Weider LJ, 1999, EVOLUTION, V53, P777, DOI 10.1111/j.1558-5646.1999.tb05372.x; ZHANG L, 1992, GENETICA, V85, P211, DOI 10.1007/BF00132273; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161; Zierold T, 2009, FRESHWATER BIOL, V54, P1392, DOI 10.1111/j.1365-2427.2009.02191.x	58	36	36	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11932	10.1371/journal.pone.0011932	http://dx.doi.org/10.1371/journal.pone.0011932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694140	Green Published, gold, Green Submitted			2022-12-25	WOS:000280574300007
J	Sahlin, P; Jonsson, H				Sahlin, Patrik; Jonsson, Henrik			A Modeling Study on How Cell Division Affects Properties of Epithelial Tissues Under Isotropic Growth	PLOS ONE			English	Article							SHOOT APEX; ARABIDOPSIS; MORPHOGENESIS; EPIDERMIS	Cell proliferation affects both cellular geometry and topology in a growing tissue, and hence rules for cell division are key to understanding multicellular development. Epithelial cell layers have for long times been used to investigate how cell proliferation leads to tissue-scale properties, including organism-independent distributions of cell areas and number of neighbors. We use a cell-based two-dimensional tissue growth model including mechanics to investigate how different cell division rules result in different statistical properties of the cells at the tissue level. We focus on isotropic growth and division rules suggested for plant cells, and compare the models with data from the Arabidopsis shoot. We find that several division rules can lead to the correct distribution of number of neighbors, as seen in recent studies. In addition we find that when also geometrical properties are taken into account other constraints on the cell division rules result. We find that division rules acting in favor of equally sized and symmetrically shaped daughter cells can best describe the statistical tissue properties.	[Sahlin, Patrik; Jonsson, Henrik] Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden	Lund University	Sahlin, P (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden.	henrik@thep.lu.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was in part supported by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corson F, 2009, P NATL ACAD SCI USA, V106, P8453, DOI 10.1073/pnas.0812493106; Dumais J, 2007, CURR OPIN PLANT BIOL, V10, P58, DOI 10.1016/j.pbi.2006.11.014; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fischer K, 1998, PLANT J, V15, P119, DOI 10.1046/j.1365-313X.1998.00173.x; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hofmeister W, 1863, JB WISS BOT, V3, P259; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Lewis FT, 1926, ANAT REC, V33, P331, DOI 10.1002/ar.1090330502; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Sahlin P, 2009, L N INST COMP SCI SO, V4, P971; Smith LG, 2001, NAT REV MOL CELL BIO, V2, P33, DOI 10.1038/35048050; Thompson D. W., 1917, GROWTH FORM; von Sachs J, 1878, ARB BOT I WURZBURG, V2, P46	18	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11750	10.1371/journal.pone.0011750	http://dx.doi.org/10.1371/journal.pone.0011750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689588	gold, Green Submitted, Green Published			2022-12-25	WOS:000280520300003
J	Bloemendaal, ALA; Brouwer, EC; Fluit, AC				Bloemendaal, Alexander L. A.; Brouwer, Ellen C.; Fluit, Ad C.			Methicillin Resistance Transfer from Staphylocccus epidermidis to Methicillin-Susceptible Staphylococcus aureus in a Patient during Antibiotic Therapy	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; BIOSYNTHESIS; EMERGENCE	Background: The mecA gene, encoding methicillin resistance in staphylococci, is located on a mobile genetic element called Staphylococcal Cassette Chromosome mec (SCCmec). Horizontal, interspecies transfer of this element could be an important factor in the dissemination of methicillin-resistant S. aureus (MRSA). Previously, we reported the isolation of a closely related methicillin-susceptible Staphylococcus aureus (MSSA), MRSA and potential SCCmec donor Staphylococcus epidermidis isolate from the same patient. Based on fingerprint techniques we hypothesized that the S. epidermidis had transferred SCCmec to the MSSA to become MRSA. The aim of this study was to show that these isolates form an isogenic pair and that interspecies horizontal SCCmec transfer occurred. Methodology/Results: Whole genome sequencing of both isolates was performed and for the MSSA gaps were closed by conventional sequencing. The SCCmec of the S. epidermidis was also sequenced by conventional methods. The results show no difference in nucleotide sequence between the two isolates except for the presence of SCCmec in the MRSA. The SCCmec of the S. epidermidis and the MRSA are identical except for a single nucleotide in the ccrB gene, which results in a valine to alanine substitution. The main difference with the closely related EMRSA-16 is the presence of SaPI2 encoding toxic shock syndrome toxin and exfoliative toxin A in the MSSA-MRSA pair. No transfer of SCCmec from the S. epidermidis to the MSSA could be demonstrated in vitro. Conclusion: The MSSA and MRSA form an isogenic pair except for SCCmec. This strongly supports our hypothesis that the MRSA was derived from the MSSA by interspecies horizontal transfer of SCCmec from S. epidermidis O7.1.	[Bloemendaal, Alexander L. A.; Brouwer, Ellen C.; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Bloemendaal, Alexander L. A.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bloemendaal, ALA (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	a.c.fluit@umcutrecht.nl			European Union [HEALTH-F3-2008-222718]	European Union(European Commission)	A.C. Fluit was in part supported by European Union FP7 Grant no. HEALTH-F3-2008-222718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jansen WTM, 2006, ANTIMICROB AGENTS CH, V50, P2072, DOI 10.1128/AAC.01539-05; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49, DOI 10.1086/341078; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Nishifuji K, 2008, J DERMATOL SCI, V49, P21, DOI 10.1016/j.jdermsci.2007.05.007; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; TENBROEKESMITS NJ, 2010, NUCL ACIDS IN PRESS; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; Wielders C, 2001, LANCET, V358, P424; Wielders CLC, 2001, LANCET, V357, P1674, DOI 10.1016/S0140-6736(00)04832-7; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	18	78	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11841	10.1371/journal.pone.0011841	http://dx.doi.org/10.1371/journal.pone.0011841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686601	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520200011
J	Gattis, SG; Hernick, M; Fierke, CA				Gattis, Samuel G.; Hernick, Marcy; Fierke, Carol A.			Active Site Metal Ion in UDP-3-O-((R)-3-Hydroxymyristoyl)-N-acetylglucosamine Deacetylase (LpxC) Switches between Fe(II) and Zn(II) Depending on Cellular Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI UDP-3-O-(R-3-HYDROXYMYRISTOYL)-N-ACETYLGLUCOSAMINE DEACETYLASE; ESCHERICHIA-COLI; PEPTIDE DEFORMYLASE; CARBONIC-ANHYDRASE; MOLECULAR RECOGNITION; ANTIBIOTIC-ACTIVITY; CRYSTAL-STRUCTURE; IRON TRANSPORT; LABILE IRON; ZINC	UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) catalyzes the deacetylation of UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine to form UDP-3-O-myristoylglucosamine and acetate in Gram-negative bacteria. This second, and committed, step in lipid A biosynthesis is a target for antibiotic development. LpxC was previously identified as a mononuclear Zn(II) metalloenzyme; however, LpxC is 6-8-fold more active with the oxygen-sensitive Fe(II) cofactor (Hernick, M., Gattis, S. G., Penner-Hahn, J. E., and Fierke, C. A. (2010) Biochemistry 49, 2246-2255). To analyze the native metal cofactor bound to LpxC, we developed a pulldown method to rapidly purify tagged LpxC under anaerobic conditions. The metal bound to LpxC purified from Escherichia coli grown in minimal medium is mainly Fe(II). However, the ratio of iron/zinc bound to LpxC varies with the metal content of the medium. Furthermore, the iron/zinc ratio bound to native LpxC, determined by activity assays, has a similar dependence on the growth conditions. LpxC has significantly higher affinity for Zn(II) compared with Fe(II) with K-D values of 60 +/- 20 pM and 110 +/- 40 nM, respectively. However, in vivo concentrations of readily exchangeable iron are significantly higher than zinc, suggesting that Fe(II) is the thermodynamically favored metal cofactor for LpxC under cellular conditions. These data indicate that LpxC expressed in E. coli grown in standard medium predominantly exists as the Fe(II)-enzyme. However, the metal cofactor in LpxC can switch between iron and zinc in response to perturbations in available metal ions. This alteration may be important for regulating the LpxC activity upon changes in environmental conditions and may be a general mechanism of regulating the activity of metalloenzymes.	[Gattis, Samuel G.; Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Hernick, Marcy; Fierke, Carol A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fierke, CA (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	fierke@umich.edu		Hernick, Marcy/0000-0002-2839-5767	National Institutes of Health [GM40602]; NIGMS [GM07767]; Cystic Fibrosis Foundation [HERNIC05F0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767, R01GM040602, R29GM040602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM40602 (to C. A. F.) and PSTP Training Grant GM07767 (to S. G. G.) from NIGMS. This work was also supported by the Cystic Fibrosis Foundation Grant HERNIC05F0 (to M. H.).	Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; BEALL B, 1987, J BACTERIOL, V169, P5408, DOI 10.1128/jb.169.12.5408-5415.1987; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Campos-Bermudez VA, 2010, J INORG BIOCHEM, V104, P726, DOI 10.1016/j.jinorgbio.2010.03.005; Chan MK, 1997, BIOCHEMISTRY-US, V36, P13904, DOI 10.1021/bi9711543; D'souza VM, 1999, BIOCHEMISTRY-US, V38, P11079, DOI 10.1021/bi990872h; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Groche D, 1998, BIOCHEM BIOPH RES CO, V246, P342, DOI 10.1006/bbrc.1998.8616; Grzyska PK, 2007, J INORG BIOCHEM, V101, P797, DOI 10.1016/j.jinorgbio.2007.01.011; Hernick M, 2005, ARCH BIOCHEM BIOPHYS, V433, P71, DOI 10.1016/j.abb.2004.08.006; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Hernick M, 2006, BIOCHEMISTRY-US, V45, P14573, DOI 10.1021/bi061625y; Hernick M, 2006, BIOCHEMISTRY-US, V45, P15240, DOI 10.1021/bi061405k; Hernick M, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P547; Hernick M, 2010, BIOCHEMISTRY-US, V49, P2246, DOI 10.1021/bi902066t; Hunt JA, 1999, BIOCHEMISTRY-US, V38, P9054, DOI 10.1021/bi9900166; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; Jackman JE, 2000, J BIOL CHEM, V275, P11002, DOI 10.1074/jbc.275.15.11002; Jain RK, 2005, J AM CHEM SOC, V127, P4558, DOI 10.1021/ja0503074; KIEFER LL, 1994, BIOCHEMISTRY-US, V33, P15233, DOI 10.1021/bi00255a003; LIPPARD SJ, 1994, PRINCIPLES BIOINORGA, P21; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Manocha S, 2002, EXPERT OPIN INV DRUG, V11, P1795, DOI 10.1517/13543784.11.12.1795; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; McCall KA, 2004, BIOCHEMISTRY-US, V43, P3979, DOI 10.1021/bi0498914; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P1106, DOI 10.1021/bi048001h; Mdluli KE, 2006, ANTIMICROB AGENTS CH, V50, P2178, DOI 10.1128/AAC.00140-06; Meguro R, 2007, ARCH HISTOL CYTOL, V70, P1, DOI 10.1679/aohc.70.1; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; NILSSON B, 1991, METHOD ENZYMOL, V198, P3; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; PORTER DJT, 1993, J BIOL CHEM, V268, P24005; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rajagopalan PTR, 1997, J AM CHEM SOC, V119, P12418, DOI 10.1021/ja9734096; Rajagopalan PTR, 1998, J BIOL CHEM, V273, P22305, DOI 10.1074/jbc.273.35.22305; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; ROMANS AY, 1978, BIOINORG CHEM, V9, P217, DOI 10.1016/S0006-3061(78)80007-6; Seffernick JL, 2002, BIOCHEMISTRY-US, V41, P14430, DOI 10.1021/bi020415s; Tottey S, 2005, ACCOUNTS CHEM RES, V38, P775, DOI 10.1021/ar0300118; Tripp BC, 2004, J BIOL CHEM, V279, P6683, DOI 10.1074/jbc.M311648200; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; White RJ, 2003, CURR OPIN PHARMACOL, V3, P502, DOI 10.1016/S1471-4892(03)00115-2; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Wyckoff TJO, 1998, TRENDS MICROBIOL, V6, P154, DOI 10.1016/S0966-842X(98)01230-X; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; Zhu JG, 2003, BIOCHEMISTRY-US, V42, P4717, DOI 10.1021/bi034289j	60	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33788	33796		10.1074/jbc.M110.147173	http://dx.doi.org/10.1074/jbc.M110.147173			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20709752	Green Published, hybrid			2022-12-25	WOS:000283354000025
J	Chandrakesan, P; Ahmed, I; Anwar, T; Wang, Y; Sarkar, S; Singh, P; Peleg, S; Umar, S				Chandrakesan, Parthasarathy; Ahmed, Ishfaq; Anwar, Tariq; Wang, Yu; Sarkar, Shubhashish; Singh, Pomila; Peleg, Sara; Umar, Shahid			Novel Changes in NF-kappa B Activity during Progression and Regression Phases of Hyperplasia ROLE OF MEK, ERK, AND p38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; HYPERPROLIFERATING COLONIC EPITHELIA; RIBOSOMAL S6 KINASE; CITROBACTER-RODENTIUM INFECTION; IN-VIVO; BETA-CATENIN; DEPENDENT TRANSCRIPTION; INDEPENDENT MECHANISM; SIGNALING PATHWAYS; MUCOSAL INFECTION	Utilizing the Citrobacter rodentium-induced transmissible murine colonic hyperplasia (TMCH) model, we measured hyperplasia and NF-kappa B activation during progression (days 6 and 12 post-infection) and regression (days 20-34 post-infection) phases of TMCH. NF-kappa B activity increased at progression in conjunction with bacterial attachment and translocation to the colonic crypts and decreased 40% by day 20. NF-kappa B activity at days 27 and 34, however, remained 2-3-fold higher than uninfected control. Expression of the downstream target gene CXCL-1/KC in the crypts correlated with NF-kappa B activation kinetics. Phosphorylation of cellular I kappa B alpha kinase (IKK)alpha/beta (Ser(176/180)) was elevated during progression and regression of TMCH. Phosphorylation (Ser(32/36)) and degradation of I kappa B alpha, however, contributed to NF-kappa B activation only from days 6 to 20 but not at later time points. Phosphorylation of MEK1/2 (Ser(217/221)), ERK1/2 (Thr(202)/Tyr(204)), and p38 (Thr(180)/Tyr(182)) paralleled IKK alpha/beta kinetics at days 6 and 12 without declining with regressing hyperplasia. siRNAs to MEK, ERK, and p38 significantly blocked NF-kappa B activity in vitro, whereas MEK1/2-inhibitor (PD98059) also blocked increases in MEK1/2, ERK1/2, and IKK alpha/beta thereby inhibiting NF-kappa B activity in vivo. Cellular and nuclear levels of Ser(536)-phosphorylated (p65(536)) and Lys(310)-acetylated p65 subunit accompanied functional NF-kappa B activation during TMCH. RSK-1 phosphorylation at Thr(359)/Ser(363) in cellular/nuclear extracts and co-immuno-precipitation with cellular p65-NF-kappa B overlapped with p65(536) kinetics. Dietary pectin (6%) blocked NF-kappa B activity by blocking increases in p65 abundance and nuclear translocation thereby down-regulating CXCL-1/KC expression in the crypts. Thus, NF-kappa B activation persisted despite the lack of bacterial attachment to colonic mucosa beyond peak hyperplasia. The MEK/ERK/p38 pathway therefore seems to modulate sustained activation of NF-kappa B in colonic crypts in response to C. rodentium infection.	[Umar, Shahid] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Div Digest Dis & Nutr, Oklahoma City, OK 73104 USA; [Anwar, Tariq] Univ Ulster, Ctr Mol Biosci, Coleraine BT52 1SA, Londonderry, North Ireland; [Wang, Yu] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Sarkar, Shubhashish; Singh, Pomila] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Peleg, Sara] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormone Disorder Res, Houston, TX 77030 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Ulster University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center	Umar, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Div Digest Dis & Nutr, 975 NE 10th St, Oklahoma City, OK 73104 USA.	Shahid-Umar@ouhsc.edu	Chandrakesan, Parthasarathy/AAB-9136-2020	Chandrakesan, Parthasarathy/0000-0002-7587-9553	National Institutes of Health [R01 CA131413, R01 CA 97959, CA114264, R21 CA131936]; NCI; NATIONAL CANCER INSTITUTE [R01CA114264, R01CA097959, R21CA131936, R01CA131413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA131413 (to S. U.) and R01 CA 97959, CA114264 (to P. S.), and R21 CA131936 (to S. P.) from the NCI.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; BARTHOLD SW, 1976, LAB ANIM SCI, V26, P889; BARTHOLD SW, 1977, CANCER RES, V37, P4352; BLOBE GC, 1994, CANCER METAST REV, V13, P411, DOI 10.1007/BF00666107; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Bry L, 2006, INFECT IMMUN, V74, P673, DOI 10.1128/IAI.74.1.673-681.2006; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Dennis A, 2008, INFECT IMMUN, V76, P4978, DOI 10.1128/IAI.00736-08; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kuang E, 2009, J BIOL CHEM, V284, P13958, DOI 10.1074/jbc.M900025200; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Luperchio SA, 2001, MICROBES INFECT, V3, P333, DOI 10.1016/S1286-4579(01)01387-9; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; MacDonald TT, 2003, INT J MED MICROBIOL, V293, P87, DOI 10.1078/1438-4221-00247; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; PEIFER M, 1995, TRENDS CELL BIOL, V5, P224, DOI 10.1016/S0962-8924(00)89015-7; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; RISIO M, 1991, CANCER RES, V51, P1917; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Stewart DB, 1997, J BIOL CHEM, V272, P29652, DOI 10.1074/jbc.272.47.29652; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Umar S, 2008, ONCOGENE, V27, P5599, DOI 10.1038/onc.2008.169; Umar S, 2005, ONCOGENE, V24, P6709, DOI 10.1038/sj.onc.1208820; Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x; Umar S, 2000, AM J PHYSIOL-GASTR L, V278, pG765, DOI 10.1152/ajpgi.2000.278.5.G765; Umar S, 2000, AM J PHYSIOL-GASTR L, V279, pG223, DOI 10.1152/ajpgi.2000.279.1.G223; Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006; Umar S, 2009, J BIOL CHEM, V284, P22274, DOI 10.1074/jbc.M109.020941; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; VOGELSTEIN B, 1994, COLD SPRING HARB SYM, V59, P517, DOI 10.1101/SQB.1994.059.01.057; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	58	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33485	33498		10.1074/jbc.M110.129353	http://dx.doi.org/10.1074/jbc.M110.129353			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20710027	hybrid, Green Published			2022-12-25	WOS:000283048200083
J	Iizasa, H; Wulff, BE; Alla, NR; Maragkakis, M; Megraw, M; Hatzigeorgiou, A; Iwakiri, D; Takada, K; Wiedmer, A; Showe, L; Lieberman, P; Nishikura, K				Iizasa, Hisashi; Wulff, Bjorn-Erik; Alla, Nageswara R.; Maragkakis, Manolis; Megraw, Molly; Hatzigeorgiou, Artemis; Iwakiri, Dai; Takada, Kenzo; Wiedmer, Andreas; Showe, Louise; Lieberman, Paul; Nishikura, Kazuko			Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKITTS-LYMPHOMA CELLS; NASOPHARYNGEAL CARCINOMA; MICROPROCESSOR COMPLEX; HUMAN TRANSCRIPTOME; HUMAN BRAIN; RNA; EXPRESSION; BIOGENESIS; IDENTIFICATION; MIRNA	Certain primary transcripts of miRNA (pri-microRNAs) undergo RNA editing that converts adenosine to inosine. The Epstein-Barr virus (EBV) genome encodes multiple microRNA genes of its own. Here we report that primary transcripts of ebv-miR-BART6 (pri-miR-BART6) are edited in latently EBV-infected cells. Editing of wild-type pri-miR-BART6 RNAs dramatically reduced loading of miR-BART6-5p RNAs onto the microRNA-induced silencing complex. Editing of a mutation-containing pri-miR-BART6 found in Daudi Burkitt lymphoma and nasopharyngeal carcinoma C666-1 cell lines suppressed processing of miR-BART6 RNAs. Most importantly, miR-BART6-5p RNAs silence Dicer through multiple target sites located in the 3'-UTR of Dicer mRNA. The significance of miR-BART6 was further investigated in cells in various stages of latency. We found that miR-BART6-5p RNAs suppress the EBNA2 viral oncogene required for transition from immunologically less responsive type I and type II latency to the more immunoreactive type III latency as well as Zta and Rta viral proteins essential for lytic replication, revealing the regulatory function of miR-BART6 in EBV infection and latency. Mutation and A-to-I editing appear to be adaptive mechanisms that antagonize miR-BART6 activities.	[Iizasa, Hisashi; Wulff, Bjorn-Erik; Alla, Nageswara R.; Wiedmer, Andreas; Showe, Louise; Lieberman, Paul; Nishikura, Kazuko] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Iizasa, Hisashi; Iwakiri, Dai; Takada, Kenzo] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; [Maragkakis, Manolis; Hatzigeorgiou, Artemis] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Oncol, Vari 16672, Greece; [Maragkakis, Manolis] Univ Halle Wittenberg, Inst Comp Sci, D-06120 Halle, Germany; [Megraw, Molly] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	The Wistar Institute; Hokkaido University; Alexander Fleming Biomedical Sciences Research Center; Martin Luther University Halle Wittenberg; University of Pennsylvania	Nishikura, K (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	kazuko@wistar.org	Hatzigeorgiou, Artemis/Z-1976-2019; Alla, Nageswara/R-5202-2019; Iizasa, Hisashi/A-9821-2012; Maragkakis, Emmanouil/F-5427-2010; Takada, Kenzo/A-6666-2012; Megraw, Molly/D-1988-2009; Maragkakis, Manolis/AAN-3407-2020	Maragkakis, Emmanouil/0000-0002-3158-1763; Maragkakis, Manolis/0000-0002-3158-1763; Megraw, Molly/0000-0001-6793-6151	National Institutes of Health [CA010815, GM040536, HL099342]; Ellison Medical Foundation [AG-SS-2281-09]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA010815, GM040536, and HL099342. This work was also supported by the Ellison Medical Foundation (AG-SS-2281-09) and the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health (to K. N.).	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Cai XZ, 2006, PLOS PATHOG, V2, P236, DOI 10.1371/journal.ppat.0020023; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Dabiri GA, 1996, EMBO J, V15, P34, DOI 10.1002/j.1460-2075.1996.tb00331.x; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Edwards RH, 2008, J VIROL, V82, P9094, DOI 10.1128/JVI.00785-08; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gandy SZ, 2007, J VIROL, V81, P13544, DOI 10.1128/JVI.01521-07; Godshalk SE, 2008, CELL CYCLE, V7, P3595, DOI 10.4161/cc.7.22.7120; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Iwakiri D, 2005, ONCOGENE, V24, P1767, DOI 10.1038/sj.onc.1208357; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kelly GL, 2005, J VIROL, V79, P10709, DOI 10.1128/JVI.79.16.10709-10717.2005; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kiss C, 2003, P NATL ACAD SCI USA, V100, P4813, DOI 10.1073/pnas.0730710100; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Maruo S, 2001, J VIROL, V75, P9977, DOI 10.1128/JVI.75.20.9977-9982.2001; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; PEARSON GR, 1987, VIROLOGY, V160, P151, DOI 10.1016/0042-6822(87)90055-9; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SCHAEFER BC, 1995, P NATL ACAD SCI USA, V92, P10565, DOI 10.1073/pnas.92.23.10565; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SMITH PR, 1992, J VIROL, V66, P706, DOI 10.1128/JVI.66.2.706-714.1992; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; STROBEL SA, 1994, BIOCHEMISTRY-US, V33, P13824, DOI 10.1021/bi00250a037; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Tempera I, 2010, BBA-GENE REGUL MECH, V1799, P236, DOI 10.1016/j.bbagrm.2009.10.004; Tierney R, 2007, J VIROL, V81, P10092, DOI 10.1128/JVI.00358-07; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	68	172	189	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33358	33370		10.1074/jbc.M110.138362	http://dx.doi.org/10.1074/jbc.M110.138362			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20716523	Green Published, hybrid			2022-12-25	WOS:000283048200071
J	Yu, Y; Park, JW; Kwon, HM; Hwang, HO; Jang, IH; Masuda, A; Kurokawa, K; Nakayama, H; Lee, WJ; Dohmae, N; Zhang, JH; Lee, BL				Yu, Yang; Park, Ji-Won; Kwon, Hyun-Mi; Hwang, Hyun-Ok; Jang, In-Hwan; Masuda, Akiko; Kurokawa, Kenji; Nakayama, Hiroshi; Lee, Won-Jae; Dohmae, Naoshi; Zhang, Jinghai; Lee, Bok Luel			Diversity of Innate Immune Recognition Mechanism for Bacterial Polymeric meso-Diaminopimelic Acid-type Peptidoglycan in Insects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA TOLL; ANTIBACTERIAL DEFENSE; PROTEOLYTIC CASCADE; SERINE-PROTEASE; ACTIVATION; INFECTION; PATHWAY; LARVAE; PURIFICATION; COLEOPTERAN	In Drosophila, the synthesis of antimicrobial peptides in response to microbial infections is under the control of the Toll and immune deficiency (Imd) signaling pathway. The Toll signaling pathway responds mainly to the lysine-type peptidoglycan of Gram-positive bacteria and fungal beta-1,3-glucan, whereas the Imd pathway responds to the meso-diaminopimelic acid (DAP)-type peptidoglycan of Gram-negative bacteria and certain Gram-positive bacilli. Recently we determined the activation mechanism of a Toll signaling pathway biochemically using a large beetle, Tenebrio molitor. However, DAP-type peptidoglycan recognition mechanism and its signaling pathway are still unclear in the fly and beetle. Here, we show that polymeric DAP-type peptidoglycan, but not its monomeric form, formed a complex with Tenebrio peptidoglycan recognition protein-SA, and this complex activated the three-step proteolytic cascade to produce processed Spatzle, a Toll receptor ligand, and induced Drosophila defensin-like antimicrobial peptide in Tenebrio larvae similarly to polymeric lysine-type peptidoglycan. Monomeric DAP-type peptidoglycan induced Drosophila diptericin-like antimicrobial peptide in Tenebrio hemocytes. In addition, both polymeric and monomeric DAP-type peptidoglycans induced expression of Tenebrio peptidoglycan recognition protein-SC2, which is DAP-type peptidoglycan-selective N-acetylmuramyl-L-alanine amidase that functions as a DAP-type peptidoglycan scavenger, appearing to function as a negative regulator of the DAP-type peptidoglycan signaling by cleaving DAP-type peptidoglycan in Tenebrio larvae. Taken together, these results demonstrate that molecular recognition mechanism for polymeric DAP-type peptidoglycan is different between Tenebrio larvae and Drosophila adults, providing biochemical evidences of biological diversity of innate immune responses in insects.	[Yu, Yang; Park, Ji-Won; Kwon, Hyun-Mi; Hwang, Hyun-Ok; Kurokawa, Kenji; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Jang, In-Hwan; Lee, Won-Jae] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Masuda, Akiko; Nakayama, Hiroshi; Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Masuda, Akiko; Nakayama, Hiroshi; Dohmae, Naoshi] Japan Sci & Technol Agcy, Tokyo 1020075, Japan; [Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China	Pusan National University; Ewha Womans University; RIKEN; Japan Science & Technology Agency (JST); Shenyang Pharmaceutical University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Dohmae, Naoshi/C-2040-2011	Dohmae, Naoshi/0000-0002-5242-9410				Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; MOON HJ, 1994, J BIOCHEM-TOKYO, V116, P53, DOI 10.1093/oxfordjournals.jbchem.a124502; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tsuchiya M, 1996, FEMS IMMUNOL MED MIC, V15, P129, DOI 10.1016/0928-8244(96)00053-3; YOSHIDA H, 1986, BIOCHEM BIOPH RES CO, V141, P1177, DOI 10.1016/S0006-291X(86)80168-1; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200	41	50	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32937	32945		10.1074/jbc.M110.144014	http://dx.doi.org/10.1074/jbc.M110.144014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702416	Green Published, hybrid			2022-12-25	WOS:000283048200031
J	Ebikeme, C; Hubert, J; Biran, M; Gouspillou, G; Morand, P; Plazolles, N; Guegan, F; Diolez, P; Franconi, JM; Portais, JC; Bringaud, F				Ebikeme, Charles; Hubert, Jane; Biran, Marc; Gouspillou, Gilles; Morand, Pauline; Plazolles, Nicolas; Guegan, Fabien; Diolez, Philippe; Franconi, Jean-Michel; Portais, Jean-Charles; Bringaud, Frederic			Ablation of Succinate Production from Glucose Metabolism in the Procyclic Trypanosomes Induces Metabolic Switches to the Glycerol 3-Phosphate/Dihydroxyacetone Phosphate Shuttle and to Proline Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE LEVEL PHOSPHORYLATION; DEPENDENT FUMARATE REDUCTASE; INDUCIBLE EXPRESSION SYSTEM; MOLECULAR CHARACTERIZATION; OXIDATIVE-PHOSPHORYLATION; INTRACELLULAR METABOLITES; RESPIRATORY-CHAIN; ENERGY-METABOLISM; COA-TRANSFERASE; KREBS CYCLE	Trypanosoma brucei is a parasitic protist that undergoes a complex life cycle during transmission from its mammalian host (bloodstream forms) to the midgut of its insect vector (procyclic form). In both parasitic forms, most glycolytic steps take place within specialized peroxisomes, called glycosomes. Here, we studied metabolic adaptations in procyclic trypanosome mutants affected in their maintenance of the glycosomal redox balance. T. brucei can theoretically use three strategies to maintain the glycosomal NAD(+)/NADH balance as follows: (i) the glycosomal succinic fermentation branch; (ii) the glycerol 3-phosphate (Gly-3-P)/dihydroxyacetone phosphate (DHAP) shuttle that transfers reducing equivalents to the mitochondrion; and (iii) the glycosomal glycerol production pathway. We showed a hierarchy in the use of these glycosomal NADH-consuming pathways by determining metabolic perturbations and adaptations in single and double mutant cell lines using a combination of NMR, ion chromatography-MS/MS, and HPLC approaches. Although functional, the Gly-3-P/DHAP shuttle is primarily used when the preferred succinate fermentation pathway is abolished in the Delta pepck knock-out mutant cell line. In the absence of these two pathways (Delta pepck/(RNAi)FAD-GPDH.i mutant), glycerol production is used but with a 16-fold reduced glycolytic flux. In addition, the Delta pepck mutant cell line shows a 3.3-fold reduced glycolytic flux compensated by an increase of proline metabolism. The inability of the Delta pepck mutant to maintain a high glycolytic flux demonstrates that the Gly-3-P/DHAP shuttle is not adapted to the procyclic trypanosome context. In contrast, this shuttle was shown earlier to be the only way used by the bloodstream forms of T. brucei to sustain their high glycolytic flux.	[Hubert, Jane; Portais, Jean-Charles] ISBP INSA, INSA, INRA, CNRS,UMR5504,UMR792, F-31077 Toulouse, France; [Ebikeme, Charles; Biran, Marc; Gouspillou, Gilles; Morand, Pauline; Diolez, Philippe; Franconi, Jean-Michel; Bringaud, Frederic] Univ Victor Segalen Bordeaux 2, CNRS, UMR5536, Ctr Resonance Magnet Syst Biol, F-33076 Bordeaux, France; [Plazolles, Nicolas; Guegan, Fabien] Univ Victor Segalen Bordeaux 2, CNRS, UMR5234, Lab Microbiol Cellulaire & Mol & Pathogenic, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Portais, JC (corresponding author), ISBP INSA, INSA, INRA, CNRS,UMR5504,UMR792, 135 Ave Rangueil, F-31077 Toulouse, France.	jean-charles.portais@insa-toulouse.fr; bringaud@rmsb.u-bordeaux2.fr		Diolez, Philippe/0000-0002-7548-2070; Ebikeme, Charles/0000-0002-9989-6489; Gouspillou, Gilles/0000-0002-8543-3619; Portais, Jean-Charles/0000-0002-3480-0933; Guegan, Fabien Marc/0000-0001-9393-2920	CNRS; Universite Victor Segalen Bordeaux 2; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche (ANR) [ANR-MIME2007, ANR-BioSys2007]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Victor Segalen Bordeaux 2; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the CNRS, the Universite Victor Segalen Bordeaux 2, the Fondation pour la Recherche Medicale, and the Agence Nationale de la Recherche (ANR) Program Grants METABOTRYP (ANR-MIME2007) l and SysTryp (ANR-BioSys2007).	Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bringaud F, 1995, MOL BIOCHEM PARASIT, V74, P119, DOI 10.1016/0166-6851(95)02486-7; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; BROMAN K, 1983, MOL BIOCHEM PARASIT, V8, P79, DOI 10.1016/0166-6851(83)90036-1; BRUN R, 1979, ACTA TROP, V36, P289; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; CROSS GAM, 1975, PARASITOLOGY, V71, P311, DOI 10.1017/S0031182000046758; Dufour S, 1996, BIOCHEM J, V314, P743, DOI 10.1042/bj3140743; Ebikeme CE, 2008, PARASITOLOGY, V135, P585, DOI 10.1017/S0031182008004241; Fairlamb A. H., 1986, Carbohydrate metabolism in cultured cells., P183; Guerra DG, 2006, MOL BIOCHEM PARASIT, V149, P155, DOI 10.1016/j.molbiopara.2006.05.006; Harlow E., 1988, ANTIBODIES LAB MANUA; Kiefer P, 2007, ANAL BIOCHEM, V360, P182, DOI 10.1016/j.ab.2006.06.032; Kralova I, 2000, EUR J BIOCHEM, V267, P2323, DOI 10.1046/j.1432-1327.2000.01238.x; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Obungu VH, 1999, INDIAN J BIOCHEM BIO, V36, P305; OPPERDOES FR, 1981, MOL BIOCHEM PARASIT, V4, P291, DOI 10.1016/0166-6851(81)90062-1; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; Peacock L, 2006, PARASITOLOGY, V132, P651, DOI 10.1017/S0031182005009571; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Speijer D, 1997, MOL BIOCHEM PARASIT, V85, P171, DOI 10.1016/S0166-6851(96)02823-X; TURRENS JF, 1989, BIOCHEM J, V259, P363, DOI 10.1042/bj2590363; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wittmann C, 2004, ANAL BIOCHEM, V327, P135, DOI 10.1016/j.ab.2004.01.002; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	42	31	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32312	32324		10.1074/jbc.M110.124917	http://dx.doi.org/10.1074/jbc.M110.124917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702405	Green Published, hybrid			2022-12-25	WOS:000282683000044
J	Nose, Y; Wood, LK; Kim, BE; Prohaska, JR; Fry, RS; Spears, JW; Thiele, DJ				Nose, Yasuhiro; Wood, L. Kent; Kim, Byung-Eun; Prohaska, Joseph R.; Fry, Robert S.; Spears, Jerry W.; Thiele, Dennis J.			Ctr1 Is an Apical Copper Transporter in Mammalian Intestinal Epithelial Cells in Vivo That Is Controlled at the Level of Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; CACO-2 CELLS; EXPRESSION; DEGRADATION; ABSORPTION; MECHANISM; HCTR1; GENE; IDENTIFICATION	Copper is an essential trace element that functions in a diverse array of biochemical processes that include mitochondrial respiration, neurotransmitter biogenesis, connective tissue maturation, and reactive oxygen chemistry. The Ctr1 protein is a high-affinity Cu+ importer that is structurally and functionally conserved in yeast, plants, fruit flies, and humans and that, in all of these organisms, is localized to the plasma membrane and intracellular vesicles. Although intestinal epithelial cell-specific deletion of Ctr1 in mice demonstrated a critical role for Ctr1 in dietary copper absorption, some controversy exists over the localization of Ctr1 in intestinal epithelial cells in vivo. In this work, we assess the localization of Ctr1 in intestinal epithelial cells through two independent mechanisms. Using immunohistochemistry, we demonstrate that Ctr1 localizes to the apical membrane in intestinal epithelial cells of the mouse, rat, and pig. Moreover, biotinylation of intestinal luminal proteins from mice fed a control or a copper-deficient diet showed elevated levels of both total and apical membrane Ctr1 protein in response to transient dietary copper limitation. Experiments in cultured HEK293T cells demonstrated that alterations in the levels of the glycosylated form of Ctr1 in response to copper availability were a time-dependent, copper-specific posttranslational response. Taken together, these results demonstrate apical localization of Ctr1 in intestinal epithelia across three mammalian species and suggest that increased Ctr1 apical localization in response to dietary copper limitation may represent an adaptive response to homeostatically modulate Ctr1 availability at the site of intestinal copper absorption.	[Nose, Yasuhiro; Wood, L. Kent; Kim, Byung-Eun; Thiele, Dennis J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Prohaska, Joseph R.] Univ Minnesota, Sch Med, Dept Biochem & Mol Biol, Duluth, MN 55812 USA; [Fry, Robert S.; Spears, Jerry W.] N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA	Duke University; University of Minnesota System; University of Minnesota Duluth; University of North Carolina; North Carolina State University	Thiele, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	dennis.thiele@duke.edu			National Institute of Health [DK074192-09, HD039708-08]; American Heart Association [09POST2251047]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074192] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institute of Health Grants DK074192-09 (to D.J.T.) and HD039708-08 (to J.R.P.). This work was also supported by American Heart Association Postdoctoral Fellowship 09POST2251047 (to B.-E.K.).	AMERONGEN HM, 1989, J CELL BIOL, V109, P2129, DOI 10.1083/jcb.109.5.2129; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Bauerly KA, 2004, J NUTR BIOCHEM, V15, P155, DOI 10.1016/j.jnutbio.2003.10.008; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; CRAMPTON RF, 1965, J PHYSIOL-LONDON, V178, P111, DOI 10.1113/jphysiol.1965.sp007618; DAndrea L, 1996, J BIOL CHEM, V271, P28969, DOI 10.1074/jbc.271.46.28969; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Gybina AA, 2006, GENES NUTR, V1, P51, DOI 10.1007/BF02829936; Hayeshi R, 2008, EUR J PHARM SCI, V35, P383, DOI 10.1016/j.ejps.2008.08.004; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Kumar N, 2006, MAYO CLIN PROC, V81, P1371, DOI 10.4065/81.10.1371; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Linder M, 1991, BIOCH COPPER; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Neerman MF, 2007, LABMEDICINE, V38, P608, DOI 10.1309/P9P0CCTJLDJ7JJU8; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Petris MJ, 2004, PFLUG ARCH EUR J PHY, V447, P752, DOI 10.1007/s00424-003-1092-1; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Prohaska J.R., 2006, PRESENT KNOWLEDGE NU, V1, P458; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Seithel A, 2006, EUR J PHARM SCI, V28, P291, DOI 10.1016/j.ejps.2006.03.003; TURK E, 1994, J BIOL CHEM, V269, P15204; TURNLUND JR, 1989, AM J CLIN NUTR, V49, P870, DOI 10.1093/ajcn/49.5.870; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200	40	86	91	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32385	32392		10.1074/jbc.M110.143826	http://dx.doi.org/10.1074/jbc.M110.143826			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699218	Green Published, hybrid			2022-12-25	WOS:000282683000052
J	Lopez-Ramos, JC; Tomioka, Y; Morimatsu, M; Yamamoto, S; Ozaki, K; Ono, E; Delgado-Garcia, JM				Lopez-Ramos, Juan C.; Tomioka, Yukiko; Morimatsu, Masami; Yamamoto, Sayo; Ozaki, Kinuyo; Ono, Etsuro; Delgado-Garcia, Jose M.			Motor-Coordination-Dependent Learning, More than Others, Is Impaired in Transgenic Mice Expressing Pseudorabies Virus Immediate-Early Protein IE180	PLOS ONE			English	Article							LURCHER MUTANT MICE; ACOUSTIC STARTLE RESPONSE; CEREBELLAR PURKINJE-CELLS; AUJESZKYS-DISEASE VIRUS; LONG-TERM HABITUATION; PREPULSE INHIBITION; TRANSCRIPTIONAL ACTIVATION; DIFFERENTIAL ROLES; NERVOUS PATHWAY; GENE-EXPRESSION	The cerebellum in transgenic mice expressing pseudorabies virus immediate-early protein IE180 (TgIE96) was substantially diminished in size, and its histoarchitecture was severely disorganized, resulting in severe ataxia. TgIE96 mice can therefore be used as an experimental model to study the involvement of cerebellar circuits in different learning tasks. The performance of three-month-old TgIE96 mice was studied in various behavioral tests, including associative learning (classical eyeblink conditioning), object recognition, spatial orientation (water maze), startle response and prepulse inhibition, and passive avoidance, and compared with that of wild-type mice. Wild-type and TgIE96 mice presented similar reflexively evoked eyeblinks, and acquired classical conditioned eyelid responses with similar learning curves for both trace and delay conditioning paradigms. The two groups of mice also had similar performances during the object recognition test. However, they showed significant differences for the other three tests included in this study. Although both groups of animals were capable of swimming, TgIE96 mice failed to learn the water maze task during the allowed time. The startle response to a severe tone was similar in both control and TgIE96 mice, but the latter were unable to produce a significant prepulse inhibition. TgIE96 mice also presented evident deficits for the proper accomplishment of a passive avoidance test. These results suggest that the cerebellum is not indispensable for the performance of classical eyeblink conditioning and for object recognition tasks, but seems to be necessary for the proper performance of water maze, prepulse inhibition, and passive avoidance tests.	[Lopez-Ramos, Juan C.; Delgado-Garcia, Jose M.] Pablo Olavide Univ, Div Neurosci, Seville, Spain; [Tomioka, Yukiko; Morimatsu, Masami] Hokkaido Univ, Inst Med Genet, Div Dis Model Innovat, Sapporo, Hokkaido, Japan; [Yamamoto, Sayo; Ozaki, Kinuyo; Ono, Etsuro] Kyushu Univ, Sch Med Sci, Ctr Biomed Res, Biomed Labs, Fukuoka 812, Japan	Universidad Pablo de Olavide; Hokkaido University; Kyushu University	Lopez-Ramos, JC (corresponding author), Pablo Olavide Univ, Div Neurosci, Seville, Spain.	etsuro@anim.med.kyushu-u.ac.jp; jmdelgar@upo.es	Delgado-Garcia, Jose M./V-1567-2019; Morimatsu, Masami/A-6698-2012; Ramos, Juan Carlos López/K-9336-2014	Morimatsu, Masami/0000-0003-0740-0157; Lopez Ramos, Juan Carlos/0000-0003-0943-8802	Spanish Ministry of Science and Innovation [BFU2008-00899]; Junta de Andalucia (Spain) [BIO-122, CVI-02487]; Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain)	The research leading to these results has received funding from the Spanish Ministry of Science and Innovation (BFU2008-00899), the Junta de Andalucia (Spain, BIO-122 and CVI-02487), and the Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini MV, 1999, MOL BRAIN RES, V70, P164, DOI 10.1016/S0169-328X(99)00144-8; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Boele HJ, 2010, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.019.2009; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; BROWN SH, 1993, EXP BRAIN RES, V94, P478; CASTON J, 1995, DEV BRAIN RES, V86, P311, DOI 10.1016/0165-3806(95)00037-E; Cendelin J, 2009, CEREBELLUM, V8, P35, DOI 10.1007/s12311-008-0061-9; Chen L, 1996, J NEUROSCI, V16, P2829; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Delgado-Garcia J M, 2002, Cerebellum, V1, P289, DOI 10.1080/147342202320883597; DESPERATI C, 1989, NEUROSCI LETT, V100, P164, DOI 10.1016/0304-3940(89)90678-2; Dominguez-del-Toro E, 2004, EUR J NEUROSCI, V20, P1945, DOI 10.1111/j.1460-9568.2004.03643.x; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Eleore L, 2007, BEHAV NEUROSCI, V121, P1203, DOI 10.1037/0735-7044.121.6.1203; Fendt M, 2001, PSYCHOPHARMACOLOGY, V156, P216, DOI 10.1007/s002130100794; Gandhi CC, 2000, BEHAV BRAIN RES, V109, P37, DOI 10.1016/S0166-4328(99)00160-6; Glickstein M, 2008, CEREBELLUM, V7, P589, DOI 10.1007/s12311-008-0074-4; GREEN MR, 1983, CELL, V35, P137, DOI 10.1016/0092-8674(83)90216-7; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Gruart A, 2000, J NEUROPHYSIOL, V83, P836, DOI 10.1152/jn.2000.83.2.836; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Hilber P, 2001, NEUROSCIENCE, V102, P615, DOI 10.1016/S0306-4522(00)00509-1; Hilber P, 1998, BEHAV GENET, V28, P299, DOI 10.1023/A:1021675514883; Hobbs WE, 2001, J VIROL, V75, P3391, DOI 10.1128/JVI.75.7.3391-3403.2001; IHARA S, 1983, VIROLOGY, V131, P437, DOI 10.1016/0042-6822(83)90510-X; Inman M, 2001, J GEN VIROL, V82, P483, DOI 10.1099/0022-1317-82-3-483; Ioannides AA, 2005, PROG BRAIN RES, V148, P139, DOI 10.1016/S0079-6123(04)48012-1; Kishimoto Y, 2002, EUR J NEUROSCI, V16, P2416, DOI 10.1046/j.1460-9568.2002.02407.x; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; KRITAS SK, 1994, ACTA VET HUNG, V42, P309; KRITAS SK, 1994, VET MICROBIOL, V40, P323, DOI 10.1016/0378-1135(94)90120-1; Krizkova A, 2002, Cesk Fysiol, V51, P169; KUGELBERG E, 1952, BRAIN, V75, P385, DOI 10.1093/brain/75.3.385; Kumari V, 2003, PSYCHIAT RES-NEUROIM, V122, P99, DOI 10.1016/s0925-4927(02)00123-3; Lalonde R, 2008, NEUROBIOL LEARN MEM, V90, P472, DOI 10.1016/j.nlm.2008.05.004; LALONDE R, 1994, NEUROSCI BIOBEHAV R, V18, P161, DOI 10.1016/0149-7634(94)90022-1; LEATON RN, 1986, SCIENCE, V232, P513, DOI 10.1126/science.3961494; LEATON RN, 1991, BEHAV NEUROSCI, V105, P804, DOI 10.1037/0735-7044.105.6.804; LEDOUX JE, 1993, ANN NY ACAD SCI, V702, P149, DOI 10.1111/j.1749-6632.1993.tb17246.x; LeMarec N, 1997, EXP BRAIN RES, V116, P131, DOI 10.1007/PL00005733; Llinas R, 1993, Curr Opin Neurobiol, V3, P958, DOI 10.1016/0959-4388(93)90168-X; Lopez-Ramos JC, 2007, J APPL PHYSIOL, V103, P1479, DOI 10.1152/japplphysiol.00384.2007; Machado CJ, 2009, EMOTION, V9, P147, DOI 10.1037/a0014539; Martin LA, 2003, EUR J NEUROSCI, V18, P2002, DOI 10.1046/j.1460-9568.2003.02921.x; Morcuende S, 2001, NEUROTOX RES, V3, P527, DOI 10.1007/BF03033208; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ogura H, 2001, BEHAV GENET, V31, P317, DOI 10.1023/A:1012235510600; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Porras-Garcia E, 2010, J NEUROPHYSIOL, V104, P346, DOI 10.1152/jn.00180.2010; Roizman B., 2001, FIELDS VIROLOGY, V4th ed., P2399; Sanchez-Campusano R, 2009, J NEUROSCI, V29, P10750, DOI 10.1523/JNEUROSCI.2178-09.2009; SAWAKI M, 2008, MOL CELL NEUROSCI, V39, P478; SWARTZWELDER HS, 1981, PHYSIOL BEHAV, V26, P323; Taharaguchi S, 2003, VIROLOGY, V307, P243, DOI 10.1016/S0042-6822(02)00062-4; Taylor GA, 2008, GENES BRAIN BEHAV, V7, P786, DOI 10.1111/j.1601-183X.2008.00420.x; Terhune KP, 2005, J NEURO-OPHTHALMOL, V25, P273, DOI 10.1097/01.wno.0000189826.62010.48; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Tomioka Y, 2008, EUR J NEUROSCI, V27, P2115, DOI 10.1111/j.1460-9568.2008.06174.x; Van Alphen AM, 2002, ANN NY ACAD SCI, V978, P413; VANOIRSCHOT JT, 1990, VET MICROBIOL, V23, P85, DOI 10.1016/0378-1135(90)90139-M; Vozeh F, 1998, Cesk Fysiol, V47, P74; Wong ML, 1997, ARCH VIROL, V142, P2099, DOI 10.1007/s007050050228; Woody CD, 1999, BRAIN RES, V836, P79, DOI 10.1016/S0006-8993(99)01613-3; WU L, 1988, VIROLOGY, V167, P318, DOI 10.1016/0042-6822(88)90089-X; YUAN R, 1989, VIROLOGY, V172, P92, DOI 10.1016/0042-6822(89)90110-4	67	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12123	10.1371/journal.pone.0012123	http://dx.doi.org/10.1371/journal.pone.0012123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711341	Green Published, Green Submitted, gold			2022-12-25	WOS:000280859700015
J	Rapaport, F; Leslie, C				Rapaport, Franck; Leslie, Christina			Determining Frequent Patterns of Copy Number Alterations in Cancer	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; ARRAY; GENOME; EXPRESSION; CLASSIFICATION; HYBRIDIZATION; ABERRATIONS	Cancer progression is often driven by an accumulation of genetic changes but also accompanied by increasing genomic instability. These processes lead to a complicated landscape of copy number alterations (CNAs) within individual tumors and great diversity across tumor samples. High resolution array-based comparative genomic hybridization (aCGH) is being used to profile CNAs of ever larger tumor collections, and better computational methods for processing these data sets and identifying potential driver CNAs are needed. Typical studies of aCGH data sets take a pipeline approach, starting with segmentation of profiles, calls of gains and losses, and finally determination of frequent CNAs across samples. A drawback of pipelines is that choices at each step may produce different results, and biases are propagated forward. We present a mathematically robust new method that exploits probe-level correlations in aCGH data to discover subsets of samples that display common CNAs. Our algorithm is related to recent work on maximum-margin clustering. It does not require pre-segmentation of the data and also provides grouping of recurrent CNAs into clusters. We tested our approach on a large cohort of glioblastoma aCGH samples from The Cancer Genome Atlas and recovered almost all CNAs reported in the initial study. We also found additional significant CNAs missed by the original analysis but supported by earlier studies, and we identified significant correlations between CNAs.	[Rapaport, Franck; Leslie, Christina] Sloan Kettering Inst, Computat Biol Program, New York, NY USA	Memorial Sloan Kettering Cancer Center	Rapaport, F (corresponding author), Sloan Kettering Inst, Computat Biol Program, New York, NY USA.	cleslie@cbio.mskcc.org		Rapaport, Franck/0000-0001-6553-2110	National Science Foundation [IIS-0705580]; National Institutes of Health [1-U24-CA143840]; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [0835494] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation grant IIS-0705580 and National Institutes of Health grant 1-U24-CA143840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2009, BRIT J CANCER, V100, P511, DOI 10.1038/sj.bjc.6604884; BACH F, 2007, ADV NEURAL INFORM PR, V20; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin SF, 2007, ONCOGENE, V26, P1959, DOI 10.1038/sj.onc.1209985; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Franchini C, 2006, APOPTOSIS, V11, P2217, DOI 10.1007/s10495-006-0195-5; HASTIE T, 2004, NIPS; HOLMSTROM K, 1999, ADV MODEL OPTIM, V1, P47; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; MAGNANI I, 2005, IDENTIFICATION OLIGO; Mao X, 1999, BRIT J CANCER, V79, P724, DOI 10.1038/sj.bjc.6690116; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; Mark HFL, 1999, CANCER GENET CYTOGEN, V108, P26, DOI 10.1016/S0165-4608(98)00104-6; Michels E, 2007, GENE CHROMOSOME CANC, V46, P1098, DOI 10.1002/gcc.20496; Nagasaka T, 2007, BRAIN TUMOR PATHOL, V24, P1, DOI 10.1007/s10014-006-0209-6; Nakajima Go, 2008, Cancer Genomics & Proteomics, V5, P37; Neuvial P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-264; O'Hagan RC, 2003, CANCER RES, V63, P5352; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rapaport F, 2008, BIOINFORMATICS, V24, pI375, DOI 10.1093/bioinformatics/btn188; Rueda OM, 2010, CURR BIOINFORM, V5, P1; Shlens J., 2005, TUTORIAL PRINCIPAL C; SPEICHER MR, 1994, CANCER RES, V54, P3817; Spencer DV, 2007, CANCER GENET CYTOGEN, V179, P82, DOI 10.1016/j.cancergencyto.2007.08.007; Sturm JF, 1999, OPTIM METHOD SOFTW, V11-2, P625, DOI 10.1080/10556789908805766; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Tibshirani R, 2005, J R STAT SOC B, V67, P91, DOI 10.1111/j.1467-9868.2005.00490.x; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; TROLET J, 2009, INVEST OPHTHALMOL VI; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; XU L, 2005, ADV NEURAL INFORM PR, V17, P1537; Zhang K., 2007, P 24 INT C MACH LEAR, V227, P1119; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhao ZX, 2008, MACROMOL BIOSCI, V8, P25, DOI 10.1002/mabi.200700180	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12028	10.1371/journal.pone.0012028	http://dx.doi.org/10.1371/journal.pone.0012028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711339	Green Published, gold, Green Submitted			2022-12-25	WOS:000280859700002
J	Xu, HL; Balakrishnan, K; Malaterre, J; Beasley, M; Yan, YQ; Essers, J; Appeldoorn, E; Thomaszewski, JM; Vazquez, M; Verschoor, S; Lavin, MF; Bertonchello, I; Ramsay, RG; Mckay, MJ				Xu, Huiling; Balakrishnan, Kuhendra; Malaterre, Jordane; Beasley, Matthew; Yan, Yuqian; Essers, Jeroen; Appeldoorn, Esther; Thomaszewski, Jonathan M.; Vazquez, Melisa; Verschoor, Sandra; Lavin, Martin F.; Bertonchello, Ivan; Ramsay, Robert G.; Mckay, Michael J.			Rad21-Cohesin Haploinsufficiency Impedes DNA Repair and Enhances Gastrointestinal Radiosensitivity in Mice	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; RADIATION-INDUCED APOPTOSIS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; SACCHAROMYCES-CEREVISIAE; SMALL-INTESTINE; STEM-CELLS; HOMOLOGOUS RECOMBINATION; VERTEBRATE CELLS	Approximately half of cancer-affected patients receive radiotherapy (RT). The doses delivered have been determined upon empirical experience based upon average radiation responses. Ideally higher curative radiation doses might be employed in patients with genuinely normal radiation responses and importantly radiation hypersensitive patients would be spared the consequences of excessive tissue damage if they were indentified before treatment. Rad21 is an integral subunit of the cohesin complex, which regulates chromosome segregation and DNA damage responses in eukaryotes. We show here, by targeted inactivation of this key cohesin component in mice, that Rad21 is a DNA-damage response gene that markedly affects animal and cell survival. Biallelic deletion of Rad21 results in early embryonic death. Rad21 heterozygous mutant cells are defective in homologous recombination (HR)-mediated gene targeting and sister chromatid exchanges. Rad21(+/-) animals exhibited sensitivity considerably greater than control littermates when challenged with whole body irradiation (WBI). Importantly, Rad21(+/-) animals are significantly more sensitive to WBI than Atm heterozygous mutant mice. Since supralethal WBI of mammals most typically leads to death via damage to the gastrointestinal tract (GIT) or the haematopoietic system, we determined the functional status of these organs in the irradiated animals. We found evidence for GIT hypersensitivity of the Rad21 mutants and impaired bone marrow stem cell clonogenic regeneration. These data indicate that Rad21 gene dosage is critical for the ionising radiation (IR) response. Rad21 mutant mice thus represent a new mammalian model for understanding the molecular basis of irradiation effects on normal tissues and have important implications in the understanding of acute radiation toxicity in normal tissues.	[Xu, Huiling; Balakrishnan, Kuhendra; Malaterre, Jordane; Beasley, Matthew; Yan, Yuqian; Vazquez, Melisa; Verschoor, Sandra; Ramsay, Robert G.; Mckay, Michael J.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia; [Xu, Huiling; Ramsay, Robert G.] Univ Melbourne, Dept Pathol, Fac Med & Dent Sci, Parkville, Vic 3052, Australia; [Appeldoorn, Esther] Erasmus MC, Dept Cell Biol & Genet, Dept Radiobiol, Dept Vasc Surg, Rotterdam, Netherlands; [Thomaszewski, Jonathan M.; Mckay, Michael J.] Peter MacCallum Canc Ctr, Div Radiat Oncol, Melbourne, Vic, Australia; [Lavin, Martin F.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Bertonchello, Ivan] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; University of Melbourne; Erasmus University Rotterdam; Erasmus MC; Peter Maccallum Cancer Center; QIMR Berghofer Medical Research Institute; University of Melbourne	Xu, HL (corresponding author), Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia.	rob.ramsay@petermac.org; michael.mckay@act.gov.au	McKay, Michael/ABA-9029-2021; Lavin, Martin F/F-5961-2014; Ramsay, Robert G/C-3291-2015; Bertoncello, Ivan/B-9235-2008; Yan, Yuqian/AAU-5681-2020	Lavin, Martin F/0000-0002-5940-4769; Ramsay, Robert G/0000-0001-5003-0433; 	NHMRC [400207, 400310]; Cancer Council Victoria [081219]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	This work was supported in part by NHMRC grants 400207 and 400310 (www.nhmrc.gov.au) and Cancer Council Victoria grant 081219 (www.cancercouncil.com.au/cancercouncil/VIC). RGR is also supported by a NHMRC Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD MC, 1991, EXP HEMATOL, V19, P282; Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; BEDFORD JS, 1978, RADIAT RES, V76, P573, DOI 10.2307/3574806; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bradford GB, 1997, EXP HEMATOL, V25, P445; Bremer M, 2003, RADIOTHER ONCOL, V69, P155, DOI 10.1016/j.radonc.2003.08.004; Budzowska M, 2004, EMBO J, V23, P3548, DOI 10.1038/sj.emboj.7600353; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Geoffroy-Perez B, 2001, INT J CANCER, V93, P288, DOI 10.1002/ijc.1329; GERMAN JAA, 1994, ANAL SISTER CHROMATI; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Heo SJ, 1998, MOL GEN GENET, V257, P149, DOI 10.1007/s004380050634; Hogan B, 1994, MANIPULATING MOUSE E; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Maj JG, 2003, CANCER RES, V63, P4338; McKay MJ, 1996, GENOMICS, V36, P305, DOI 10.1006/geno.1996.0466; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Ramsay RG, 2004, MOL CANCER RES, V2, P354; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Spring K, 2001, CANCER RES, V61, P4561; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1986, AM J HUM GENET, V39, P573; Szuts D, 2005, EXP CELL RES, V311, P240, DOI 10.1016/j.yexcr.2005.09.009; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Thomas P, 2003, MUTAGENESIS, V18, P187, DOI 10.1093/mutage/18.2.187; Thompson Deborah, 2005, Hum Mutat, V25, P594, DOI 10.1002/humu.9344; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; WITHERS HR, 1969, RADIAT RES, V38, P598, DOI 10.2307/3572619; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Xu HL, 2004, EMBO REP, V5, P378, DOI 10.1038/sj.embor.7400121; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884	58	79	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12112	10.1371/journal.pone.0012112	http://dx.doi.org/10.1371/journal.pone.0012112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711430	Green Published, gold			2022-12-25	WOS:000280859700008
J	Skorupski, P; Chittka, L				Skorupski, Peter; Chittka, Lars			Photoreceptor Spectral Sensitivity in the Bumblebee, Bombus impatiens (Hymenoptera: Apidae)	PLOS ONE			English	Article							COLOR-VISION; INSECTS; OMMATIDIA; BEES	The bumblebee Bombus impatiens is increasingly used as a model in comparative studies of colour vision, or in behavioural studies relying on perceptual discrimination of colour. However, full spectral sensitivity data on the photoreceptor inputs underlying colour vision are not available for B. impatiens. Since most known bee species are trichromatic, with photoreceptor spectral sensitivity peaks in the UV, blue and green regions of the spectrum, data from a related species, where spectral sensitivity measurements have been made, are often applied to B impatiens. Nevertheless, species differences in spectral tuning of equivalent photoreceptor classes may result in peaks that differ by several nm, which may have small but significant effects on colour discrimination ability. We therefore used intracellular recording to measure photoreceptor spectral sensitivity in B. impatiens. Spectral peaks were estimated at 347, 424 and 539 nm for UV, blue and green receptors, respectively, suggesting that this species is a UV-blue-green trichromat. Photoreceptor spectral sensitivity peaks are similar to previous measurements from Bombus terrestris, although there is a significant difference in the peak sensitivity of the blue receptor, which is shifted in the short wave direction by 12-13 nm in B. impatiens compared to B. terrestris.	[Skorupski, Peter; Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England	University of London; Queen Mary University London	Skorupski, P (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England.	p.skorupski@qmul.ac.uk	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732				BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; BERNARD GD, 1978, NATURWISSENSCHAFTEN, V65, P442, DOI 10.1007/BF00405378; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P545; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Kelber A, 2006, INVERTEBRATE VISION, P250; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Laughlin SB, 1981, HDB SENSORY PHYSL B, VVII, P133; Lehrer M, 2005, J EXP BIOL, V208, P3233, DOI 10.1242/jeb.01790; MENZEL R, 1986, J COMP PHYSIOL A, V158, P165, DOI 10.1007/BF01338560; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P556, DOI 10.1113/jphysiol.1966.sp008002; Palacios AG, 1998, VISUAL NEUROSCI, V15, P319, DOI 10.1017/S0952523898152136; Paulk AC, 2008, J NEUROSCI, V28, P6319, DOI 10.1523/JNEUROSCI.1196-08.2008; Paulk AC, 2009, J COMP NEUROL, V513, P441, DOI 10.1002/cne.21993; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Spaethe J, 2005, J EXP BIOL, V208, P2347, DOI 10.1242/jeb.01634; Stavenga DG, 2004, J COMP PHYSIOL A, V190, P115, DOI 10.1007/s00359-003-0477-0; STAVENGA DG, 1993, VISION RES, V33, P1011, DOI 10.1016/0042-6989(93)90237-Q; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Wakakuwa M, 2007, PHOTOCHEM PHOTOBIOL, V83, P27, DOI 10.1562/2006-03-03-IR-831; Worden BD, 2005, J EXP BIOL, V208, P2045, DOI 10.1242/jeb.01582	24	45	48	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12049	10.1371/journal.pone.0012049	http://dx.doi.org/10.1371/journal.pone.0012049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711523	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000280811900012
J	Wang, IJ; Jhuang, MC; Chen, YH; Yeh, LK; Liu, CY; Young, TH				Wang, I-Jong; Jhuang, Min-Chao; Chen, Yu-Hsin; Yeh, Lung-Kun; Liu, Chia-Yang; Young, Tai-Horng			Chitosan Modification of Adenovirus to Modify Transfection Efficiency in Bovine Corneal Epithelial Cells	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; OCULAR DRUG-DELIVERY; POLYMER-COATED ADENOVIRUS; GROWTH-FACTOR RECEPTOR; IN-VITRO; POLYETHYLENE-GLYCOL; NEUTRALIZING ANTIBODIES; ENHANCED TRANSDUCTION; IMMUNE-RESPONSES; VIVO	Background: The purpose of this study is to modulate the transfection efficiency of adenovirus (Ad) on the cornea by the covalent attachment of chitosan on adenoviral capsids via a thioether linkage between chitosan modified with 2-iminothiolane and Ad cross-linked with N-[gamma-maleimidobutyryloxy] succinimide ester (GMBS). Methodology/Principal Findings: Modified Ad was obtained by reaction with the heterobifunctional crosslinking reagent, GMBS, producing maleimide-modified Ad (Ad-GMBS). Then, the chitosan-SH was conjugated to Ad-GMBS via a thioether bond at different ratios of Ad to GMBS to chitosan-SH. The sizes and zeta potentials of unmodified Ad and chitosan-modified Ads were measured, and the morphologies of the virus particles were observed under transmission electron microscope. Primary cultures of bovine corneal epithelial cells were transfected with Ads and chitosan-modified Ads in the absence or presence of anti-adenovirus antibodies. Chitosan modification did not significantly change the particle size of Ad, but the surface charge of Ad increased significantly from -24.3 mV to nearly neutral. Furthermore, primary cultures of bovine corneal epithelial cells were transfected with Ad or chitosan-modified Ad in the absence or presence of anti-Ad antibodies. The transfection efficiency was attenuated gradually with increasing amounts of GMBS. However, incorporation of chitosan partly restored transfection activity and rendered the modified antibody resistant to antibody neutralization. Conclusions/Significance: Chitosan can provide a platform for chemical modification of Ad, which offers potential for further in vivo applications.	[Wang, I-Jong] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10764, Taiwan; [Jhuang, Min-Chao; Chen, Yu-Hsin; Young, Tai-Horng] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan; [Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Young, Tai-Horng] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Yeh, Lung-Kun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Liu, Chia-Yang] Univ Cincinnati, Coll Med, Dept Ophthalmol & Cell Biol Neurosci & Anat, Cincinnati, OH USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; University of Cincinnati	Wang, IJ (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10764, Taiwan.	thyoung@ntu.edu.tw		Liu, Chia-yang/0000-0002-8398-5516; Wang, I-Jong/0000-0002-3045-0614	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Supported by National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Alonso MJ, 2003, J PHARM PHARMACOL, V55, P1451, DOI 10.1211/0022357022476; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Arcasoy SM, 1997, AM J RESP CELL MOL, V17, P422, DOI 10.1165/ajrcmb.17.4.2714; Arcasoy SM, 1997, GENE THER, V4, P32, DOI 10.1038/sj.gt.3300349; Bernkop-Schnurch A, 2003, INT J PHARMACEUT, V260, P229, DOI 10.1016/S0378-5173(03)00271-0; Bonsted A, 2006, J GENE MED, V8, P286, DOI 10.1002/jgm.853; Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8; Borras T, 1996, INVEST OPHTH VIS SCI, V37, P1282; Borras T, 2001, J GENE MED, V3, P437, DOI 10.1002/jgm.210; BUDENZ DL, 1995, INVEST OPHTH VIS SCI, V36, P2211; Carlson EC, 2004, INVEST OPHTH VIS SCI, V45, P2194, DOI 10.1167/iovs.03-1224; Chillon M, 1998, GENE THER, V5, P995, DOI 10.1038/sj.gt.3300665; Croyle MA, 2005, GENE THER, V12, P579, DOI 10.1038/sj.gt.3302441; Croyle MA, 2002, HUM GENE THER, V13, P1887, DOI 10.1089/104303402760372972; Croyle MA, 2001, J VIROL, V75, P4792, DOI 10.1128/JVI.75.10.4792-4801.2001; Croyle MA, 2001, MOL THER, V4, P22, DOI 10.1006/mthe.2001.0411; Croyle MA, 2000, HUM GENE THER, V11, P1713, DOI 10.1089/10430340050111368; de Campos AM, 2004, PHARM RES-DORDR, V21, P803, DOI 10.1023/B:PHAM.0000026432.75781.cb; De Campos AM, 2003, EUR J PHARM SCI, V20, P73, DOI 10.1016/S0928-0987(03)00178-7; de Salamanca AE, 2006, INVEST OPHTH VIS SCI, V47, P1416, DOI 10.1167/iovs.05-0495; Diebold Y, 2007, BIOMATERIALS, V28, P1553, DOI 10.1016/j.biomaterials.2006.11.028; Eto Y, 2005, J GENE MED, V7, P604, DOI 10.1002/jgm.699; Fasbender A, 1997, J BIOL CHEM, V272, P6479, DOI 10.1074/jbc.272.10.6479; Fisher KD, 2001, GENE THER, V8, P341, DOI 10.1038/sj.gt.3301389; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Harding SE, 2003, BIOCHEM SOC T, V31, P1036; HELMKE RJ, 1970, APPL MICROBIOL, V20, P986, DOI 10.1128/AEM.20.6.986-988.1970; Kawamata Y, 2002, BIOMATERIALS, V23, P4573, DOI 10.1016/S0142-9612(02)00203-X; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Lanciotti J, 2003, MOL THER, V8, P99, DOI 10.1016/S1525-0016(03)00139-4; MASHHOUR B, 1994, GENE THER, V1, P122; Masuko T, 2005, BIOMACROMOLECULES, V6, P880, DOI 10.1021/bm049352e; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; O'Neal D, 1998, J LIPID RES, V39, P2086; O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021; Ogawara KI, 2004, HUM GENE THER, V15, P433, DOI 10.1089/10430340460745766; Rosenblatt Mark I., 2004, International Ophthalmology Clinics, V44, P81, DOI 10.1097/00004397-200404430-00010; Stevenson M, 2007, CANCER GENE THER, V14, P335, DOI 10.1038/sj.cgt.7701022; Stevenson M, 2006, GENE THER, V13, P356, DOI 10.1038/sj.gt.3302655; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; TAO WH, 1995, INVEST OPHTH VIS SCI, V36, P2614; Tsubota K, 1998, EXP EYE RES, V67, P531, DOI 10.1006/exer.1998.0557; WILCOX GE, 1969, APPL MICROBIOL, V18, P268, DOI 10.1128/AEM.18.2.268-269.1969	45	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12085	10.1371/journal.pone.0012085	http://dx.doi.org/10.1371/journal.pone.0012085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711466	gold, Green Submitted, Green Published			2022-12-25	WOS:000280811900025
J	Egger, SW; Engelhardt, HR; Britten, KH				Egger, Seth W.; Engelhardt, Heidi R.; Britten, Kenneth H.			Monkey Steering Responses Reveal Rapid Visual-Motor Feedback	PLOS ONE			English	Article							OPTIC FLOW; NEURONAL RESPONSES; EYE-MOVEMENTS; RETINAL FLOW; DIRECTION; PERCEPTION; BEHAVIOR; PURSUIT; SMOOTH; HEAD	The neural mechanisms underlying primate locomotion are largely unknown. While behavioral and theoretical work has provided a number of ideas of how navigation is controlled, progress will require direct physiolgical tests of the underlying mechanisms. In turn, this will require development of appropriate animal models. We trained three monkeys to track a moving visual target in a simple virtual environment, using a joystick to control their direction. The monkeys learned to quickly and accurately turn to the target, and their steering behavior was quite stereotyped and reliable. Monkeys typically responded to abrupt steps of target direction with a biphasic steering movement, exhibiting modest but transient overshoot. Response latencies averaged approximately 300 ms, and monkeys were typically back on target after about 1 s. We also exploited the variability of responses about the mean to explore the time-course of correlation between target direction and steering response. This analysis revealed a broad peak of correlation spanning approximately 400 ms in the recent past, during which steering errors provoke a compensatory response. This suggests a continuous, visual-motor loop controls steering behavior, even during the epoch surrounding transient inputs. Many results from the human literature also suggest that steering is controlled by such a closed loop. The similarity of our results to those in humans suggests the monkey is a very good animal model for human visually guided steering.	[Egger, Seth W.; Engelhardt, Heidi R.; Britten, Kenneth H.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Britten, Kenneth H.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Egger, SW (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	khbritten@ucdavis.edu		/0000-0003-3688-7099	National Institutes of Health, National Eye Institute [EY10562]; Vision Core Center [EY12576]; PI Werner; NATIONAL EYE INSTITUTE [R01EY010562, P30EY012576] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Vision Core Center; PI Werner; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health, National Eye Institute. Two grants supported this work: EY10562 to KHB, and a Vision Core Center grant, EY12576, PI Werner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeddeker N, 2005, J EXP BIOL, V208, P1563, DOI 10.1242/jeb.01558; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Gibson JJ, 1950, PERCEPTION VISUAL WO; Heuer HW, 2004, J NEUROPHYSIOL, V91, P1314, DOI 10.1152/jn.00637.2003; Hildreth EC, 2000, J EXP PSYCHOL HUMAN, V26, P1106, DOI 10.1037//0096-1523.26.3.1106; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; Mennie N, 2007, EXP BRAIN RES, V179, P427, DOI 10.1007/s00221-006-0804-0; Page WK, 2008, CEREB CORTEX, V18, P727, DOI 10.1093/cercor/bhm109; Paolini M, 2000, J NEUROPHYSIOL, V84, P730, DOI 10.1152/jn.2000.84.2.730; REICHARDT W, 1976, Q REV BIOPHYS, V9, P311, DOI 10.1017/S0033583500002523; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Rushton SK, 1998, CURR BIOL, V8, P1191, DOI 10.1016/S0960-9822(07)00492-7; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; Stone LS, 1997, VISION RES, V37, P573, DOI 10.1016/S0042-6989(96)00204-0; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wilkie R, 2003, J EXP PSYCHOL HUMAN, V29, P363, DOI 10.1037/0096-1523.29.2.363; Wilkie RM, 2003, J VISION, V3, P677, DOI 10.1167/3.11.3; Wilkie RM, 2006, J EXP PSYCHOL HUMAN, V32, P88, DOI 10.1037/0096-1523.32.1.88; Wilkie RM, 2005, J EXP PSYCHOL HUMAN, V31, P901, DOI 10.1037/0096-1523.31.5.901; Wilkie RM, 2002, CURR BIOL, V12, P2014, DOI 10.1016/S0960-9822(02)01337-4; Zhang T, 2004, NEURON, V42, P993, DOI 10.1016/j.neuron.2004.06.008	28	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11975	10.1371/journal.pone.0011975	http://dx.doi.org/10.1371/journal.pone.0011975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694144	Green Published, gold			2022-12-25	WOS:000280574300017
J	Jung, O; Jansen, F; Mieth, A; Barbosa-Sicard, E; Pliquett, RU; Babelova, A; Morisseau, C; Hwang, SH; Tsai, C; Hammock, BD; Schaefer, L; Geisslinger, G; Amann, K; Brandes, RP				Jung, Oliver; Jansen, Felix; Mieth, Anja; Barbosa-Sicard, Eduardo; Pliquett, Rainer U.; Babelova, Andrea; Morisseau, Christophe; Hwang, Sung H.; Tsai, Cindy; Hammock, Bruce D.; Schaefer, Liliana; Geisslinger, Gerd; Amann, Kerstin; Brandes, Ralf P.			Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; BLOOD-PRESSURE REGULATION; EPOXYEICOSATRIENOIC ACIDS; EPOXYGENASE METABOLITES; GLOMERULAR INJURY; ARACHIDONIC-ACID; KIDNEY; PROTECTION; MASS; GLOMERULONEPHRITIS	Epoxyeicotrienoic acids (EETs) are cytochrome P450-dependent anti-hypertensive and anti-inflammatory derivatives of arachidonic acid, which are highly abundant in the kidney and considered reno-protective. EETs are degraded by the enzyme soluble epoxide hydrolase (sEH) and sEH inhibitors are considered treatment for chronic renal failure (CRF). We determined whether sEH inhibition attenuates the progression of CRF in the 5/6-nephrectomy model (5/6-Nx) in mice. 5/6-Nx mice were treated with a placebo, an ACE-inhibitor (Ramipril, 40 mg/kg), the sEH-inhibitor cAUCB or the CYP-inhibitor fenbendazole for 8 weeks. 5/6-Nx induced hypertension, albuminuria, glomerulosclerosis and tubulo-interstitial damage and these effects were attenuated by Ramipril. In contrast, cAUCB failed to lower the blood pressure and albuminuria was more severe as compared to placebo. Plasma EET-levels were doubled in 5/6 Nx-mice as compared to sham mice receiving placebo. Renal sEH expression was attenuated in 5/6-Nx mice but cAUCB in these animals still further increased the EET-level. cAUCB also increased 5-HETE and 15-HETE, which derive from peroxidation or lipoxygenases. Similar to cAUCB, CYP450 inhibition increased HETEs and promoted albuminuria. Thus, sEH-inhibition failed to elicit protective effects in the 5/6-Nx model and showed a tendency to aggravate the disease. These effects might be consequence of a shift of arachidonic acid metabolism into the lipoxygenase pathway.	[Jung, Oliver; Jansen, Felix; Mieth, Anja; Pliquett, Rainer U.; Babelova, Andrea; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Fachbereich Med, Frankfurt, Germany; [Jung, Oliver; Pliquett, Rainer U.] Klinikum Goethe Univ, Med Klin 3, Frankfurt, Germany; [Barbosa-Sicard, Eduardo] Klinikum Goethe Univ, Inst Vasc Signalling, Frankfurt, Germany; [Morisseau, Christophe; Hwang, Sung H.; Tsai, Cindy; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Morisseau, Christophe; Hwang, Sung H.; Tsai, Cindy; Hammock, Bruce D.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA; [Schaefer, Liliana] Klinikum Goethe Univ, Pharmazentrum Frankfurt, ZAFES, Inst Allgemeine Pharmakol, Frankfurt, Germany; [Geisslinger, Gerd] Klinikum Goethe Univ, Pharmazentrum Frankfurt, ZAFES, Inst Klin Pharmakol, Frankfurt, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of California System; University of California Davis; University of California System; University of California Davis; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Erlangen Nuremberg	Jung, O (corresponding author), Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Fachbereich Med, Frankfurt, Germany.	r.brandes@em.uni-frankfurt.de	Pliquett, Rainer U./ABG-1742-2020; Brandes, Ralf P/L-3058-2017; Babelova, Andrea/E-7768-2018	Pliquett, Rainer U./0000-0001-9684-0618; Brandes, Ralf P/0000-0002-8035-0048; Babelova, Andrea/0000-0001-9548-6602; Schaefer, Liliana/0000-0002-3318-3005	Deutsche Forschungsgemeinschaft [BR1839/4-2, SFB 423, Z2]; Exzellenzcluster 147 "Cardio-Pulmonary Systems''; Medical Faculty of the Goethe-University; LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); National Institute of Environmental Health Sciences [R01 ER02710]; National Institutes of Health [HL59699]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL059699, R01HL059699] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Exzellenzcluster 147 "Cardio-Pulmonary Systems''; Medical Faculty of the Goethe-University; LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Deutsche Forschungsgemeinschaft (BR1839/4-2 and SFB 423, Z2), the Exzellenzcluster 147 "Cardio-Pulmonary Systems'', the Medical Faculty of the Goethe-University, the LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF) and the National Institute of Environmental Health Sciences (grant R01 ER02710) and National Institutes of Health HL59699. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; Capdevila JH, 2001, BIOCHEM BIOPH RES CO, V285, P571, DOI 10.1006/bbrc.2001.5167; Chamberlain RM, 2007, EXP PHYSIOL, V92, P251, DOI 10.1113/expphysiol.2006.034751; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Chiurchiu C, 2005, J AM SOC NEPHROL, V16, pS58, DOI 10.1681/ASN.2004110968; Dimmler A, 2003, DIAGN MOL PATHOL, V12, P108, DOI 10.1097/00019606-200306000-00007; Dorrance AM, 2005, J CARDIOVASC PHARM, V46, P842, DOI 10.1097/01.fjc.0000189600.74157.6d; Fleming I, 2008, TRENDS CARDIOVAS MED, V18, P20, DOI 10.1016/j.tcm.2007.11.002; Fornage M, 2002, HYPERTENSION, V40, P485, DOI 10.1161/01.HYP.0000032278.75806.68; GRIFFIN KA, 1994, J AM SOC NEPHROL, V4, P2023; Guasch A, 1999, KIDNEY INT, V56, P261, DOI 10.1046/j.1523-1755.1999.00537.x; Haas CS, 2003, J AM SOC NEPHROL, V14, P2288, DOI 10.1097/01.ASN.0000082999.46030.FE; Hamad AM, 2004, DRUGS, V64, P2417, DOI 10.2165/00003495-200464210-00004; Hao CM, 2007, KIDNEY INT, V71, P1105, DOI 10.1038/sj.ki.5002192; Hwang SH, 2007, J MED CHEM, V50, P3825, DOI 10.1021/jm070270t; Ibrahim HN, 1998, J AM SOC NEPHROL, V9, P72; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2005, AM J PHYSIOL-RENAL, V289, pF496, DOI 10.1152/ajprenal.00350.2004; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Jung O, 2005, HYPERTENSION, V45, P759, DOI 10.1161/01.HYP.0000153792.29478.1d; Keserue B, 2008, FASEB J, V22, P4306, DOI 10.1096/fj.08-112821; Kim SK, 2003, AUTOMAT CONSTR, V12, P15, DOI 10.1016/S0926-5805(02)00033-X; Kim YS, 2005, J AM SOC NEPHROL, V16, P352, DOI 10.1681/ASN.2004070568; Klahr S, 2003, AM J KIDNEY DIS, V41, pS3, DOI 10.1053/ajkd.2003.50074; Lee SH, 2008, TRANSPL P, V40, P1353, DOI 10.1016/j.transproceed.2008.03.137; Liu JY, 2010, BIOCHEM PHARMACOL, V79, P880, DOI 10.1016/j.bcp.2009.10.025; Loch D, 2007, CELL BIOCHEM BIOPHYS, V47, P87, DOI 10.1385/CBB:47:1:87; Ma J, 2005, PROSTAG LEUKOTR ESS, V72, P13, DOI 10.1016/j.plefa.2004.06.004; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Moreno C, 2001, AM J HYPERTENS, V14, p90S, DOI 10.1016/S0895-7061(01)02075-1; Olearczyk JJ, 2009, CLIN SCI, V116, P61, DOI 10.1042/CS20080039; Parrish AR, 2009, CELL BIOL TOXICOL, V25, P217, DOI 10.1007/s10565-008-9071-0; Revermann M, 2010, CURR OPIN PHARMACOL, V10, P173, DOI 10.1016/j.coph.2009.12.002; Revermann M, 2010, ARTERIOSCL THROM VAS, V30, P909, DOI 10.1161/ATVBAHA.110.204099; Revermann M, 2009, J HYPERTENS, V27, P322, DOI 10.1097/HJH.0b013e32831aedfa; Ryan AD, 2010, CURR OPIN PHARMACOL, V10, P166, DOI 10.1016/j.coph.2010.02.005; SHIMAMURA T, 1975, AM J PATHOL, V79, P95; Simpkins AN, 2009, AM J PATHOL, V174, P2086, DOI 10.2353/ajpath.2009.080544; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; VENIANT M, 1994, KIDNEY INT, V46, P421, DOI 10.1038/ki.1994.290; Yu HT, 2003, ARCH INTERN MED, V163, P1417, DOI 10.1001/archinte.163.12.1417; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhao XY, 2004, J AM SOC NEPHROL, V15, P1244	47	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11979	10.1371/journal.pone.0011979	http://dx.doi.org/10.1371/journal.pone.0011979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694143	Green Published, gold, Green Submitted			2022-12-25	WOS:000280574300019
J	Gonzalez, AM; Marcel, TC; Kohutova, Z; Stam, P; van der Linden, CG; Niks, RE				Gonzalez, Ana M.; Marcel, Thierry C.; Kohutova, Zuzana; Stam, Piet; van der Linden, C. Gerard; Niks, Rients E.			Peroxidase Profiling Reveals Genetic Linkage between Peroxidase Gene Clusters and Basal Host and Non-Host Resistance to Rusts and Mildew in Barley	PLOS ONE			English	Article							CLASS-III PEROXIDASES; PUCCINIA-HORDEI; DISEASE RESISTANCE; QUANTITATIVE RESISTANCE; POWDERY MILDEW; CONSENSUS MAP; EXPRESSION; FAMILY; RICE; DIVERSITY	Background: Higher plants possess a large multigene family encoding secreted class III peroxidase (Prx) proteins. Peroxidases appear to be associated with plant disease resistance based on observations of induction during disease challenge and the presence or absence of isozymes in resistant vs susceptible varieties. Despite these associations, there is no evidence that allelic variation of peroxidases directly determines levels of disease resistance. Methodology/Principal Findings: The current study introduces a new strategy called Prx-Profiling. We showed that with this strategy a large number of peroxidase genes can be mapped on the barley genome. In order to obtain an estimate of the total number of Prx clusters we followed a re-sampling procedure, which indicated that the barley genome contains about 40 peroxidase gene clusters. We examined the association between the Prxs mapped and the QTLs for resistance of barley to homologous and heterologous rusts, and to the barley powdery mildew fungus. We report that 61% of the QTLs for partial resistance to P. hordei, 61% of the QTLs for resistance to B. graminis and 47% of the QTLs for non-host resistance to other Puccinia species co-localize with Prx based markers. Conclusions/Significance: We conclude that Prx-Profiling was effective in finding the genetic location of Prx genes on the barley genome. The finding that QTLs for basal resistance to rusts and powdery mildew fungi tend to co-locate with Prx clusters provides a base for exploring the functional role of Prx-related genes in determining natural differences in levels of basal resistance.	[Gonzalez, Ana M.; Marcel, Thierry C.; Kohutova, Zuzana; Stam, Piet; van der Linden, C. Gerard; Niks, Rients E.] Wageningen Univ & Res Ctr WUR, Lab Plant Breeding, Wageningen, Netherlands	Wageningen University & Research	Gonzalez, AM (corresponding author), Mision Biol Galicia CSIC, Plant Genet Resources Dept, Pontevedra, Spain.	Rients.Niks@wur.nl	Niks, Rients/Y-4720-2019; GONZÁLEZ, ANA/D-3944-2014; Marcel, Thierry/ABI-2242-2020	Niks, Rients/0000-0002-3912-3775; GONZÁLEZ, ANA/0000-0002-9952-0860; Marcel, Thierry/0000-0002-7452-4013	Xunta de Galicia [AA-123]; European Union [FOOD-CT-2005-513959]; Czech University of Agriculture	Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Union(European Commission); Czech University of Agriculture	Support for this research was provided by a contract from Xunta de Galicia through the program "Angeles Alvarino'' (number AA-123) to A. M. G (http://www.conselleriaiei.org); from the Bioexploit Integrated Project FOOD-CT-2005-513959 that resides under the 6th framework Programme of the European Union to T. C. M (http://www.bioexploit.net); and by the Czech University of Agriculture to Z.K. (http://www.msc.pef.czu.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghnoum R, 2010, MOL PLANT MICROBE IN, V23, P91, DOI 10.1094/MPMI-23-1-0091; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; COLLINGE DB, 1997, MECH ENV STRESS RESI, P335; Duroux L, 2003, J MOL EVOL, V57, P397, DOI 10.1007/s00239-003-2489-3; Faris JD, 1999, THEOR APPL GENET, V98, P219, DOI 10.1007/s001220051061; Fry S.C., 1986, MOL PHYSL ASPECTS PL, P169; GIESE H, 1994, HEREDITAS, V120, P267, DOI 10.1111/j.1601-5223.1994.00267.x; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jafary H, 2008, GENETICS, V178, P2327, DOI 10.1534/genetics.107.077552; Jafary H, 2006, MOL PLANT MICROBE IN, V19, P1270, DOI 10.1094/MPMI-19-1270; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Johrde A, 2008, MOL PLANT PATHOL, V9, P687, DOI 10.1111/J.1364-3703.2008.00494.X; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kristensen BK, 2001, MOL PLANT PATHOL, V2, P311, DOI 10.1046/j.1464-6722.2001.00079.x; Lavania M, 2006, CURR MICROBIOL, V52, P363, DOI 10.1007/s00284-005-5578-2; Mantovani P, 2006, GENOME, V49, P1473, DOI 10.1139/G06-100; Marcel TC, 2007, THEOR APPL GENET, V114, P487, DOI 10.1007/s00122-006-0448-2; Marcel TC, 2008, NEW PHYTOL, V177, P743, DOI 10.1111/j.1469-8137.2007.02298.x; Marcel TC, 2007, MOL PLANT MICROBE IN, V20, P1604, DOI 10.1094/MPMI-20-12-1604; Mochida K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-72; NIKS RE, 1986, PHYSIOL MOL PLANT P, V28, P309, DOI 10.1016/S0048-4059(86)80073-X; Niks RE, 2009, NEW PHYTOL, V182, P817, DOI 10.1111/j.1469-8137.2009.02849.x; OMANN F, 1994, GENOME, V37, P137, DOI 10.1139/g94-018; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; Passardi F, 2004, PHYTOCHEMISTRY, V65, P1879, DOI 10.1016/j.phytochem.2004.06.023; Passardi F, 2007, PHYTOCHEMISTRY, V68, P1605, DOI 10.1016/j.phytochem.2007.04.005; Pecchioni N, 1999, PLANT BREEDING, V118, P29, DOI 10.1046/j.1439-0523.1999.118001029.x; Pflieger S, 2001, MOL BREEDING, V7, P275, DOI 10.1023/A:1011605013259; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Sasaki K, 2004, PLANT CELL PHYSIOL, V45, P1442, DOI 10.1093/pcp/pch165; Shtaya MJY, 2006, EUPHYTICA, V151, P421, DOI 10.1007/s10681-006-9172-x; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THORDALCHRISTENSEN H, 1992, PHYSIOL MOL PLANT P, V40, P395, DOI 10.1016/0885-5765(92)90031-P; Tognolli M, 2002, GENE, V288, P129, DOI 10.1016/S0378-1119(02)00465-1; VALE GP, 1994, PHYSIOL MOL PLANT P, V44, P207, DOI 10.1016/S0885-5765(05)80005-0; van der Linden CG, 2005, REGNUM VEG, V143, P291; van der Linden CG, 2004, THEOR APPL GENET, V109, P384, DOI 10.1007/s00122-004-1642-8; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Tienderen PH, 2002, TRENDS ECOL EVOL, V17, P577, DOI 10.1016/S0169-5347(02)02624-1; VANCE CP, 1980, ANNU REV PHYTOPATHOL, V18, P259, DOI 10.1146/annurev.py.18.090180.001355; Vandepoele K, 2005, PLANT PHYSIOL, V137, P31, DOI 10.1104/pp.104.054700; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; VERA P, 1993, MOL PLANT MICROBE IN, V6, P790; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang GX, 2007, J INTEGR PLANT BIOL, V49, P1580, DOI 10.1111/j.1774-7909.2007.00574.x; Welinder KG, 2002, EUR J BIOCHEM, V269, P6063, DOI 10.1046/j.1432-1033.2002.03311.x; YOUNG SA, 1995, PLANT PHYSIOL, V107, P1333, DOI 10.1104/pp.107.4.1333; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207	57	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e10495	10.1371/journal.pone.0010495	http://dx.doi.org/10.1371/journal.pone.0010495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689842	Green Submitted, gold, Green Published			2022-12-25	WOS:000280520400002
J	Renaud, V; Godefroy, E; Larrieu, P; Fleury, F; Jotereau, F; Guilloux, Y				Renaud, Virginie; Godefroy, Emmanuelle; Larrieu, Pierre; Fleury, Fabrice; Jotereau, Francine; Guilloux, Yannick			Folding of Matrix Metalloproteinase-2 Prevents Endogenous Generation of MHC Class-I Restricted Epitope	PLOS ONE			English	Article							CYTOLYTIC T-LYMPHOCYTES; NEWLY SYNTHESIZED PROTEINS; DISULFIDE BONDS; ENDOPLASMIC-RETICULUM; HLA-A2 MELANOMAS; QUALITY-CONTROL; ANTIGEN; BINDING; CELLS; GENE	Background: We previously demonstrated that the matrix metalloproteinase-2 (MMP-2) contained an antigenic peptide recognized by a CD8 T cell clone in the HLA-A*0201 context. The presentation of this peptide on class I molecules by human melanoma cells required a cross-presentation mechanism. Surprisingly, the classical endogenous processing pathway did not process this MMP-2 epitope. Methodology/Principal Findings: By PCR directed mutagenesis we showed that disruption of a single disulfide bond induced MMP-2 epitope presentation. By Pulse-Chase experiment, we demonstrated that disulfide bonds stabilized MMP-2 and impeded its degradation. Finally, using drugs, we documented that mutated MMP-2 epitope presentation used the proteasome and retrotranslocation complex. Conclusions/Significance: These data appear crucial to us since they established the existence of a new inhibitory mechanism for the generation of a T cell epitope. In spite of MMP-2 classified as a self-antigen, the fact that cross-presentation is the only way to present this MMP-2 epitope underlines the importance to target this type of antigen in immunotherapy protocols.	[Renaud, Virginie; Larrieu, Pierre; Jotereau, Francine; Guilloux, Yannick] INSERM, UMR 892, Nantes, France; [Godefroy, Emmanuelle] NYU, Sch Med, Inst Canc, New York, NY USA; [Fleury, Fabrice; Jotereau, Francine; Guilloux, Yannick] Fac Sci & Tech Nantes, Nantes, France; [Fleury, Fabrice] CNRS, Unite Biotechnol Biocatalyse & Bioregulat, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); New York University; Nantes Universite; Centre National de la Recherche Scientifique (CNRS)	Renaud, V (corresponding author), INSERM, UMR 892, Nantes, France.	guilloux@nantes.inserm.fr	Jotereau, Francine/AAU-1735-2020; guilloux, yannick/L-4801-2015; Godefroy, Emmanuelle/AAQ-3082-2020; Jotereau, Francine/L-8668-2015	Jotereau, Francine/0000-0002-2508-4875; Godefroy, Emmanuelle/0000-0002-4981-6639; guilloux, yannick/0000-0003-2352-7238	Ligue Nationale contre le Cancer and Comite 44; Institut National de la Sante et de la Recherche Medical; Institut National du Cancer [PL074]; European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Tumor Immunology Network [503306]	Ligue Nationale contre le Cancer and Comite 44; Institut National de la Sante et de la Recherche Medical; Institut National du Cancer(Institut National du Cancer (INCA) France); European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Tumor Immunology Network	This work was supported by grants from the Ligue Nationale contre le Cancer and Comite 44, Institut National de la Sante et de la Recherche Medical, Institut National du Cancer (PL074), and the European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Tumor Immunology Network (503306). V. Renaud was supported by a doctoral fellowship from the Association pour la Recherche contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Blake N, 1997, IMMUNITY, V7, P791, DOI 10.1016/S1074-7613(00)80397-0; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Branza-Nichita N, 2002, BIOCHEM BIOPH RES CO, V296, P470, DOI 10.1016/S0006-291X(02)00907-5; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; COLLINS DS, 1991, J IMMUNOL, V147, P4054; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Godefroy E, 2005, J EXP MED, V202, P61, DOI 10.1084/jem.20042138; Godet Y, 2008, J EXP MED, V205, P2673, DOI 10.1084/jem.20081356; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guilloux Y, 1996, J EXP MED, V183, P1173, DOI 10.1084/jem.183.3.1173; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; JENSEN PE, 1991, J EXP MED, V174, P1121, DOI 10.1084/jem.174.5.1121; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Moreau-Aubry A, 2000, J EXP MED, V191, P1617, DOI 10.1084/jem.191.9.1617; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Moses MA, 1997, STEM CELLS, V15, P180, DOI 10.1002/stem.150180; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Sheu BC, 2001, CANCER RES, V61, P237; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; VANDERBRUGGEN P, 1992, CURR OPIN IMMUNOL, V4, P608, DOI 10.1016/0952-7915(92)90035-D; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11894	10.1371/journal.pone.0011894	http://dx.doi.org/10.1371/journal.pone.0011894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689590	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520300009
J	Morgan, JC; Irving, H; Okedi, LM; Steven, A; Wondji, CS				Morgan, John C.; Irving, Helen; Okedi, Loyce M.; Steven, Andrew; Wondji, Charles S.			Pyrethroid Resistance in an Anopheles funestus Population from Uganda	PLOS ONE			English	Article							AFRICAN MALARIA VECTOR; SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; GAMBIAE; CULICIDAE; DIPTERA; DDT; PERMETHRIN; MOZAMBIQUE; MUTATION	Background: The susceptibility status of Anopheles funestus to insecticides remains largely unknown in most parts of Africa because of the difficulty in rearing field-caught mosquitoes of this malaria vector. Here we report the susceptibility status of the An. funestus population from Tororo district in Uganda and a preliminary characterisation of the putative resistance mechanisms involved. Methodology/Principal Findings: A new forced egg laying technique used in this study significantly increased the numbers of field-caught females laying eggs and generated more than 4000 F-1 adults. WHO bioassays indicated that An. funestus in Tororo is resistant to pyrethroids (62% mortality after 1 h exposure to 0.75% permethrin and 28% mortality to 0.05% deltamethrin). Suspected DDT resistance was also observed with 82% mortality. However this population is fully susceptible to bendiocarb (carbamate), malathion (organophosphate) and dieldrin with 100% mortality observed after exposure to each of these insecticides. Sequencing of a fragment of the sodium channel gene containing the 1014 codon conferring pyrethroid/DDT resistance in An. gambiae did not detect the L1014F kdr mutation but a correlation between haplotypes and resistance phenotype was observed indicating that mutations in other exons may be conferring the knockdown resistance in this species. Biochemical assays suggest that resistance in this population is mediated by metabolic resistance with elevated level of GSTs, P450s and pNPA compared to a susceptible strain of Anopheles gambiae. RT-PCR further confirmed the involvement of P450s with a 12-fold over-expression of CYP6P9b in the Tororo population compared to the fully susceptible laboratory colony FANG. Conclusion: This study represents the first report of pyrethroid/DDT resistance in An. funestus from East Africa. With resistance already reported in southern and West Africa, this indicates that resistance in An. funestus may be more widespread than previously assumed and therefore this should be taken into account for the implementation and management of vector control programs in Africa.	[Morgan, John C.; Irving, Helen; Steven, Andrew; Wondji, Charles S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Okedi, Loyce M.] Natl Livestock Resources Res Inst, Tororo, Uganda	Liverpool School of Tropical Medicine; University of Liverpool	Morgan, JC (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	c.s.wondji@liverpool.ac.uk	Wondji, Charles/AAG-1510-2020	Wondji, Charles S./0000-0003-0791-3673	Wellcome Trust [083515/Z/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Research Career Development Fellowship 083515/Z/07/Z to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; [Anonymous], 1998, WHOCDCMAL98; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; Bashalkhanov S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-84; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Casimiro S, 2006, J MED ENTOMOL, V43, P267, DOI 10.1603/0022-2585(2006)043[0267:IRIAFD]2.0.CO;2; Casimiro SLR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-142; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Cuamba N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011010; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Ramphul U, 2009, T R SOC TROP MED HYG; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verhaeghen K, 2010, AM J TROP MED HYG, V82, P566, DOI 10.4269/ajtmh.2010.08-0668; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	27	117	119	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11872	10.1371/journal.pone.0011872	http://dx.doi.org/10.1371/journal.pone.0011872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686697	Green Published, gold, Green Accepted			2022-12-25	WOS:000280520200034
J	Scopelliti, PE; Borgonovo, A; Indrieri, M; Giorgetti, L; Bongiorno, G; Carbone, R; Podesta, A; Milani, P				Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Indrieri, Marco; Giorgetti, Luca; Bongiorno, Gero; Carbone, Roberta; Podesta, Alessandro; Milani, Paolo			The Effect of Surface Nanometre-Scale Morphology on Protein Adsorption	PLOS ONE			English	Article							ELECTRICAL DETECTION; NANOSTRUCTURED TIO2; DRUG-DELIVERY; DIFFERENTIATION; NANOTECHNOLOGY; OPPORTUNITIES; NANOMEDICINE; BIOMATERIALS; ENHANCEMENT; TOPOGRAPHY	Background: Protein adsorption is the first of a complex series of events that regulates many phenomena at the nano-bio interface, e. g. cell adhesion and differentiation, in vivo inflammatory responses and protein crystallization. A quantitative understanding of how nanoscale morphology influences protein adsorption is strategic for providing insight into all of these processes, however this understanding has been lacking until now. Methodology/Principal Findings: Here we introduce novel methods for quantitative high-throughput characterization of protein-surface interaction and we apply them in an integrated experimental strategy, to study the adsorption of a panel of proteins on nanostructured surfaces. We show that the increase of nanoscale roughness ( from 15 nm to 30 nm) induces a decrease of protein binding affinity (<= 90%) and a relevant increase in adsorbed proteins (<= 500%) beyond the corresponding increase of specific area. We demonstrate that these effects are caused by protein nucleation on the surface, which is promoted by surface nanoscale pores. Conclusions/Significance: These results show that the adsorption of proteins depends significantly on surface nanostructure and that the relevant morphological parameter regulating the protein adsorption process is the nanometric pore shape. These new findings improve our understanding of the role of nanostructures as a biomaterial design parameter and they have important implications for the general understanding of cell behavior on nanostructured surfaces.	[Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Indrieri, Marco; Giorgetti, Luca; Podesta, Alessandro; Milani, Paolo] Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy; [Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Indrieri, Marco; Giorgetti, Luca; Podesta, Alessandro; Milani, Paolo] Univ Milan, Dept Phys, Milan, Italy; [Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Bongiorno, Gero; Milani, Paolo] Fdn Filarete, Milan, Italy; [Giorgetti, Luca] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Carbone, Roberta] Tethis Srl, Milan, Italy	University of Milan; University of Milan; IRCCS European Institute of Oncology (IEO)	Scopelliti, PE (corresponding author), Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy.	paolo.milani@mi.infn.it	Milani, Paolo/AAN-5069-2021; Podestà, Alessandro/E-6568-2010	Podestà, Alessandro/0000-0002-4169-6679	University of Milan	University of Milan	This work was supported by the University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Barborini E, 2002, APPL PHYS LETT, V81, P3052, DOI 10.1063/1.1510579; Benesch T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021401; Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487; Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032; Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016; Carbone R, 2006, BIOMATERIALS, V27, P3221, DOI 10.1016/j.biomaterials.2006.01.056; Carbone R, 2007, BIOMATERIALS, V28, P2244, DOI 10.1016/j.biomaterials.2006.12.026; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020; Giorgetti L, 2008, LANGMUIR, V24, P11637, DOI 10.1021/la801910p; Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931; Han M, 2003, LANGMUIR, V19, P9868, DOI 10.1021/la030132g; Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3; Horcajada P, 2010, NAT MATER, V9, P172, DOI [10.1038/NMAT2608, 10.1038/nmat2608, 10.1038/NMAT260B]; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X; Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617; Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; MANUS JB, 2009, BIOMATERIALS, V30, P5094; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Page AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.065701; Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101; PAWLEY J, 2008, HDB BIOL CONFOCAL MI, P635; Podesta A, 2009, J PHYS CHEM C, V113, P18264, DOI 10.1021/jp905930r; Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9; Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923; Riedel M, 2001, BIOMATERIALS, V22, P2307, DOI 10.1016/S0142-9612(01)00011-4; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Rocker C, 2009, NAT NANOTECHNOL, V4, P577, DOI [10.1038/NNANO.2009.195, 10.1038/nnano.2009.195]; Saridakis E, 2009, TRENDS BIOTECHNOL, V27, P99, DOI 10.1016/j.tibtech.2008.10.008; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Talbot J, 2000, COLLOID SURFACE A, V165, P287, DOI 10.1016/S0927-7757(99)00409-4; Vicent MJ, 2006, TRENDS BIOTECHNOL, V24, P39, DOI 10.1016/j.tibtech.2005.11.006; Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	52	193	195	5	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11862	10.1371/journal.pone.0011862	http://dx.doi.org/10.1371/journal.pone.0011862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686681	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520200026
J	De Vita, S; Canzonetta, C; Mulligan, C; Delom, F; Groet, J; Baldo, C; Vanes, L; Dagna-Bricarelli, F; Hoischen, A; Veltman, J; Fisher, EMC; Tybulewicz, VLJ; Nizetic, D				De Vita, S.; Canzonetta, C.; Mulligan, C.; Delom, F.; Groet, J.; Baldo, C.; Vanes, L.; Dagna-Bricarelli, F.; Hoischen, A.; Veltman, J.; Fisher, E. M. C.; Tybulewicz, V. L. J.; Nizetic, D.			Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome	ONCOGENE			English	Article						chromosome 21; trisomy 21; gene expression; Down's syndrome; leukaemia; mouse models	ACUTE LYMPHOBLASTIC LEUKEMIAS; IN-VITRO DIFFERENTIATION; MEGAKARYOBLASTIC LEUKEMIA; TRANSCRIPTION FACTOR; MOUSE MODEL; MYELOID PROGENITOR; ACQUIRED MUTATIONS; FETAL LIVER; EXPRESSION; TRANSIENT	Children with Down's syndrome (DS) have 20-50-fold higher incidence of all leukaemias (lymphoid and myeloid), for reasons not understood. As incidence of many solid tumours is much lower in DS, we speculated that disturbed early haematopoietic differentiation could be the cause of increased leukaemia risk. If a common mechanism is behind the risk of both major leukaemia types, it would have to arise before the bifurcation to myeloid and lymphoid lineages. Using the transchromosomic system (mouse embryonic stem cells (ESCs)) bearing an extra human chromosome 21 (HSA21)) we analyzed the early stages of haematopoietic commitment (mesodermal colony formation) in vitro. We observed that trisomy 21 (T21) causes increased production of haemogenic endothelial cells, haematopoietic stem cell precursors and increased colony forming potential, with significantly increased immature progenitors. Transchromosomic colonies showed increased expression of Gata-2, c-Kit and Tie-2. A panel of partial T21 ESCs allowed us to assign these effects to HSA21 sub-regions, mapped by 3.5 kbp-resolution tiling arrays. The Gata-2 increase on one side, and c-Kit and Tie-2 increases on the other, could be attributed to two different, non-overlapping HSA21 regions. Using human-specific small interfering RNA silencing, we could demonstrate that an extra copy of RUNX1, but not ETS-2 or ERG, causes an increase in Tie-2/c-Kit levels. Finally, we detected significantly increased levels of RUNX1, C-KIT and PU.1 in human foetal livers with T21. We conclude that overdose of more than one HSA21 gene contributes to the disturbance of early haematopoiesis in DS, and that one of the contributors is RUNX1. As the observed T21-driven hyperproduction of multipotential immature precursors precedes the bifurcation to lymphoid and myeloid lineages, we speculate that this could create conditions of increased chance for acquisition of pre-leukaemogenic rearrangements/mutations in both lymphoid and myeloid lineages foetal haematopoiesis, contributing to the increased risk of both leukaemia types in DS. Oncogene (2010) 29, 6102-6114; doi:10.1038/onc.2010.351; published online 9 August 2010	[De Vita, S.; Canzonetta, C.; Mulligan, C.; Delom, F.; Groet, J.; Nizetic, D.] Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, Ctr Paediat, London, England; [Baldo, C.; Dagna-Bricarelli, F.] Galliera Hosp, Human Genet Lab, Genoa, Italy; [Vanes, L.; Tybulewicz, V. L. J.] MRC Natl Inst Med Res, London, England; [Hoischen, A.; Veltman, J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Fisher, E. M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England	University of London; Queen Mary University London; Ente Ospedaliero Ospedali Galliera; MRC National Institute for Medical Research; Radboud University Nijmegen; University of London; University College London	Nizetic, D (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Paediat, Blizard Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.	d.nizetic@qmul.ac.uk	Nizetic, Dean/F-9509-2015; Hoischen, Alexander/D-1282-2013; Baldo, Chiara/AAB-1435-2020; Veltman, Joris A/F-5128-2010; Delom, Frederic/J-2782-2014; Hoischen, Alexander/AGF-7293-2022; Fisher, Elizabeth MC/C-2168-2008	Hoischen, Alexander/0000-0002-8072-4476; Baldo, Chiara/0000-0001-7508-3953; Veltman, Joris A/0000-0002-3218-8250; Delom, Frederic/0000-0002-4600-7633; Hoischen, Alexander/0000-0002-8072-4476; Fisher, Elizabeth MC/0000-0003-2850-9936; Canzonetta, Claudia/0000-0002-8928-5537; Nizetic, Dean/0000-0001-5486-5761	EU Commission; Leukaemia Research Fund-UK [05075, 06003]; Italian Telethon [GTB07001]; MRC [U117527252]; MRC [MC_U117527252, G0601056] Funding Source: UKRI; Medical Research Council [MC_U117527252, G0601056] Funding Source: researchfish	EU Commission(European CommissionEuropean Commission Joint Research Centre); Leukaemia Research Fund-UK; Italian Telethon(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Gary Warnes for help with FACS analysis and Mike Kirwan for technical advice. This work was supported by the 'Aneuploidy' Grant from Framework Programme 6 from the EU Commission, and by the Gordon Piller Studentship (05075) and the specialist programme Grant (06003) from the Leukaemia Research Fund-UK. For FL material, we thank the MRC-Foetal Tissue Bank, and The Galliera Genetic Bank-'Telethon Genetic Biobank Network', which is supported by Italian Telethon Grants (Project no. GTB07001). We would also like to thank MRC funding number U117527252.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Kasim F, 2002, J PEDIAT HEMATOL ONC, V24, P9, DOI 10.1097/00043426-200201000-00004; Alford KA, 2010, BLOOD, V115, P2928, DOI 10.1182/blood-2009-06-227629; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Broxmeyer HE, 2003, P NATL ACAD SCI USA, V100, P645, DOI 10.1073/pnas.0237086100; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Carmichael CL, 2009, BLOOD, V113, P1929, DOI 10.1182/blood-2008-06-161422; Cavani S, 1998, BRIT J HAEMATOL, V103, P213, DOI 10.1046/j.1365-2141.1998.00924.x; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Choi K, 1998, DEVELOPMENT, V125, P725; Chou ST, 2008, BLOOD, V112, P4503, DOI 10.1182/blood-2008-05-157859; De Vita S, 2008, BRIT J HAEMATOL, V143, P300, DOI 10.1111/j.1365-2141.2008.07332.x; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Era T, 2000, BLOOD, V95, P870, DOI 10.1182/blood.V95.3.870.003k44_870_878; Eto K, 2003, METHOD ENZYMOL, V365, P142; Forestier E, 2008, BLOOD, V111, P1575, DOI 10.1182/blood-2007-09-114231; Groet J, 2003, LANCET, V361, P1617, DOI 10.1016/S0140-6736(03)13266-7; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hernandez D, 1999, HUM MOL GENET, V8, P923, DOI 10.1093/hmg/8.5.923; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Kearney L, 2009, BLOOD, V113, P646, DOI 10.1182/blood-2008-08-170928; Kirsammer G, 2008, BLOOD, V111, P767, DOI 10.1182/blood-2007-04-085670; Kitajima K, 2003, METHOD ENZYMOL, V365, P72; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Kitajima K, 2002, EMBO J, V21, P3060, DOI 10.1093/emboj/cdf301; Klusmann JH, 2010, GENE DEV, V24, P478, DOI 10.1101/gad.1856210; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; KRIVIT W, 1957, AMA J DIS CHILD, V94, P289, DOI 10.1001/archpedi.1957.04030040075012; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lepagnol-Bestel AM, 2009, HUM MOL GENET, V18, P1405, DOI 10.1093/hmg/ddp047; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Lugus JJ, 2009, BLOOD, V113, P563, DOI 10.1182/blood-2008-06-162750; Lundin C, 2009, BRIT J HAEMATOL, V146, P113, DOI 10.1111/j.1365-2141.2009.07689.x; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; McElwaine S, 2004, BRIT J HAEMATOL, V125, P729, DOI 10.1111/j.1365-2141.2004.04982.x; Mensah A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-131; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Ng AP, 2010, BLOOD, V115, P3966, DOI 10.1182/blood-2009-09-242107; NIIKAWA N, 1991, HUM GENET, V87, P561; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Ohta T, 1996, AM J HUM GENET, V58, P544; Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; Park C, 2005, EXP HEMATOL, V33, P965, DOI 10.1016/j.exphem.2005.06.003; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Rainis L, 2005, CANCER RES, V65, P7596, DOI 10.1158/0008-5472.CAN-05-0147; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Sakai E, 2009, EXP HEMATOL, V37, P334, DOI 10.1016/j.exphem.2008.11.007; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; Satge D, 1998, CANCER RES, V58, P448; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHEN JJ, 1995, AM J HUM GENET, V56, P915; Stankiewicz MJ, 2009, BLOOD, V113, P3337, DOI 10.1182/blood-2008-08-174813; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Taub JW, 2002, J PEDIAT HEMATOL ONC, V24, P6, DOI 10.1097/00043426-200201000-00003; Teyssier-Le Discorde M, 1999, BRIT J HAEMATOL, V107, P247, DOI 10.1046/j.1365-2141.1999.01725.x; Toki T, 2005, BLOOD, V105, P3100, DOI 10.1182/blood-2004-07-2826; Toki T, 2009, LEUKEMIA, V23, P95, DOI 10.1038/leu.2008.267; Tunstall-Pedoe O, 2008, BLOOD, V112, P4507, DOI 10.1182/blood-2008-04-152967; Wang Y, 2009, MOL CELL PROTEOMICS, V8, P585, DOI 10.1074/mcp.M800256-MCP200; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Yanagida M, 2005, ONCOGENE, V24, P4477, DOI 10.1038/sj.onc.1208675; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; ZIPURSKY A, 1994, LEUKEMIA RES, V18, P163, DOI 10.1016/0145-2126(94)90111-2; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	73	31	32	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	46					6102	6114		10.1038/onc.2010.351	http://dx.doi.org/10.1038/onc.2010.351			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	681XD	20697343	hybrid, Green Published			2022-12-25	WOS:000284356500003
J	Karassek, S; Berghaus, C; Schwarten, M; Goemans, CG; Ohse, N; Kock, G; Jockers, K; Neumann, S; Gottfried, S; Herrmann, C; Heumann, R; Stoll, R				Karassek, Sascha; Berghaus, Carsten; Schwarten, Melanie; Goemans, Christoph G.; Ohse, Nadine; Kock, Gerd; Jockers, Katharina; Neumann, Sebastian; Gottfried, Sebastian; Herrmann, Christian; Heumann, Rolf; Stoll, Raphael			Ras Homolog Enriched in Brain (Rheb) Enhances Apoptotic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-SPECIFIC H-1; N-15 BACKBONE ASSIGNMENT; INDUCED CELL-DEATH; TUBEROUS SCLEROSIS; ENDOPLASMIC-RETICULUM; COMMUNICATIONS TOOL; EMBRYONIC NEURONS; STRESS RESPONSES; NMR-SPECTROSCOPY; MAMMALIAN TARGET	Rheb is a homolog of Ras GTPase that regulates cell growth, proliferation, and regeneration via mammalian target of rapamycin (mTOR). Because of the well established potential of activated Ras to promote survival, we sought to investigate the ability of Rheb signaling to phenocopy Ras. We found that overexpression of lipid-anchored Rheb enhanced the apoptotic effects induced by UV light, TNF alpha, or tunicamycin in an mTOR complex 1 (mTORC1)-dependent manner. Knocking down endogenous Rheb or applying rapamycin led to partial protection, identifying Rheb as a mediator of cell death. Ras and c-Raf kinase opposed the apoptotic effects induced by UV light or TNF alpha but did not prevent Rheb-mediated apoptosis. To gain structural insight into the signaling mechanisms, we determined the structure of Rheb-GDP by NMR. The complex adopts the typical canonical fold of RasGTPases and displays the characteristic GDP-dependent picosecond to nanosecond backbone dynamics of the switch I and switch II regions. NMR revealed Ras effector-like binding of activated Rheb to the c-Raf-Ras-binding domain(RBD), but the affinity was 1000-fold lower than the Ras/RBD interaction, suggesting a lack of functional interaction. shRNA-mediated knockdown of apoptosis signal-regulating kinase 1 (ASK-1) strongly reduced UV or TNF alpha-induced apoptosis and suppressed enhancement by Rheb overexpression. In conclusion, Rheb-mTOR activation not only promotes normal cell growth but also enhances apoptosis in response to diverse toxic stimuli via an ASK-1-mediated mechanism. Pharmacological regulation of the Rheb/mTORC1 pathway using rapamycin should take the presence of cellular stress into consideration, as this may have clinical implications.	[Karassek, Sascha; Goemans, Christoph G.; Neumann, Sebastian; Gottfried, Sebastian; Heumann, Rolf] Ruhr Univ Bochum, Dept Mol Neurobiochem, Fac Chem & Biochem, D-44780 Bochum, Germany; [Berghaus, Carsten; Schwarten, Melanie; Kock, Gerd; Jockers, Katharina; Stoll, Raphael] Ruhr Univ Bochum, Dept Biomol NMR, Fac Chem & Biochem, D-44780 Bochum, Germany; [Ohse, Nadine; Herrmann, Christian] Ruhr Univ Bochum, Dept Phys Chem 1, Fac Chem & Biochem, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Heumann, R (corresponding author), Ruhr Univ Bochum, Dept Mol Neurobiochem, Fac Chem & Biochem, Univ Str 150, D-44780 Bochum, Germany.	rolf.heumann@rub.de; raphael.stoll@rub.de	Schwarten, Melanie/G-6407-2013; Heumann, Rolf/ABB-9675-2021; Heumann, Rolf/AAK-4390-2020	Schwarten, Melanie/0000-0001-8920-9668; Heumann, Rolf/0000-0003-4364-2655; Neumann, Sebastian/0000-0003-3706-9012	Deutsche Forschungsgemeinschaft [SFB 642, A6]; Bundesministerium fur Bildung und Forschung; Fonds der Chemischen Industrie, Protein Center; European Union [FP2005-RII3, 026145]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Fonds der Chemischen Industrie, Protein Center(Fonds der Chemischen Industrie); European Union(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 642, A6.; Supported by the Bundesministerium fur Bildung und Forschung, Fonds der Chemischen Industrie, Protein Center (Nordrhein-Westfalen Center of Excellence), and RUBiospek. To whom correspondence may be addressed: Dept. of Biomolecular NMR, Ruhr University of Bochum, D-44780 Bochum, Germany. Fax: 49-234-32-05466; E-mail: raphael.stoll@rub.de.; We are grateful to Sabine Laerbusch, Gregor Barchan, Martin Gartmann, and Hans-Jochen Hauswald for expert technical help. The 750-MHz spectra were recorded at the SON NMR Large Scale Facility in Utrecht, which is funded by European Union Project "EU-NMR-European Network of Research Infrastructures for Providing Access & Technological Advancement in Bio-NMR" (FP2005-RII3, Contract 026145). We are grateful also to Prof. Dr. von Kiedrowski for providing generous access to the DRX600 spectrometer.	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Bano D, 2007, STROKE, V38, P674, DOI 10.1161/01.STR.0000256294.46009.29; Berghaus C, 2007, BIOMOL NMR ASSIGM, V1, P45, DOI 10.1007/s12104-007-9013-4; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1989, BIOL CHEM H-S, V370, P615; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Chakrabarty K, 2007, EUR J NEUROSCI, V25, P1971, DOI 10.1111/j.1460-9568.2007.05457.x; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Goemans CG, 2008, CELL DEATH DIFFER, V15, P545, DOI 10.1038/sj.cdd.4402290; Hahn M, 2005, MOL CANCER THER, V4, P457; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hansen HH, 2004, NEUROBIOL DIS, V16, P440, DOI 10.1016/j.nbd.2004.03.013; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haubensak W, 1998, J CELL SCI, V111, P1483; Hayakawa T, 2006, MICROBES INFECT, V8, P1098, DOI 10.1016/j.micinf.2005.12.001; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Heumann R, 2000, J CELL BIOL, V151, P1537, DOI 10.1083/jcb.151.7.1537; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; JOHNSON RD, 1994, ABSTR PAP AM CHEM S, V207, P138; Karbowniczek M, 2006, J BIOL CHEM, V281, P25447, DOI 10.1074/jbc.M605273200; Kiel C, 2009, J BIOL CHEM, V284, P31893, DOI 10.1074/jbc.M109.031153; Kita K, 2000, BIOCHEM BIOPH RES CO, V274, P859, DOI 10.1006/bbrc.2000.3220; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Le Mellay V, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-14; Lessmann V, 1997, BRAIN RES, V763, P111; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Li YH, 2008, J BIOL CHEM, V283, P33784, DOI 10.1074/jbc.M802431200; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Ma DZ, 2010, J BIOL CHEM, V285, P8621, DOI 10.1074/jbc.M109.092353; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malagelada C, 2008, J NEUROSCI, V28, P14363, DOI 10.1523/JNEUROSCI.3928-08.2008; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Nowaczyk M, 2004, PHYS CHEM CHEM PHYS, V6, P4878, DOI 10.1039/b407316a; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Ronellenfitsch MW, 2009, BRAIN, V132, P1509, DOI 10.1093/brain/awp093; ROSCH P, 1986, BIOCHEM BIOPH RES CO, V135, P549, DOI 10.1016/0006-291X(86)90029-X; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheper W, 2009, CURR MED CHEM, V16, P615, DOI 10.2174/092986709787458506; Schwarten M, 2007, BIOMOL NMR ASSIGM, V1, P105, DOI 10.1007/s12104-007-9030-3; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Stoll R, 2003, PROTEIN SCI, V12, P510, DOI 10.1110/ps.0222603; Stoll R, 2000, J BIOMOL NMR, V17, P87, DOI 10.1023/A:1008306918293; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200	84	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33979	33991		10.1074/jbc.M109.095968	http://dx.doi.org/10.1074/jbc.M109.095968			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20685651	Green Published, hybrid			2022-12-25	WOS:000283354000045
J	Madeja, M; Steffen, W; Mesic, I; Garic, B; Zhorov, BS				Madeja, Michael; Steffen, Wibke; Mesic, Ivana; Garic, Bojan; Zhorov, Boris S.			Overlapping Binding Sites of Structurally Different Antiarrhythmics Flecainide and Propafenone in the Subunit Interface of Potassium Channel Kv2.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT LEFT-VENTRICLE; K+ CHANNEL; DRUG-BINDING; STEREOSELECTIVE BLOCK; AUTOIMMUNE-DISEASES; INSULIN-SECRETION; SODIUM-CHANNELS; MOLECULAR-BASIS; DOWN-REGULATION; LIGAND-BINDING	Kv2.1 channels, which are expressed in brain, heart, pancreas, and other organs and tissues, are important targets for drug design. Flecainide and propafenone are known to block Kv2.1 channels more potently than other Kv channels. Here, we sought to explore structural determinants of this selectivity. We demonstrated that flecainide reduced the K+ currents through Kv2.1 channels expressed in Xenopus laevis oocytes in a voltage and time-dependent manner. By systematically exchanging various segments of Kv2.1 with those from Kv1.2, we determined flecainide-sensing residues in the P-helix and inner helix S6. These residues are not exposed to the inner pore, a conventional binding region of open channel blockers. The flecainide-sensing residues also contribute to propafenone binding, suggesting overlapping receptors for the drugs. Indeed, propafenone and flecainide compete for binding in Kv2.1. We further used Monte Carlo-energy minimizations to map the receptors of the drugs. Flecainide docking in the Kv1.2-based homology model of Kv2.1 predicts the ligand ammonium group in the central cavity and the benzamide moiety in a niche between S6 and the P-helix. Propafenone also binds in the niche. Its carbonyl group accepts an H-bond from the P-helix, the amino group donates an H-bond to the P-loop turn, whereas the propyl group protrudes in the pore and blocks the access to the selectivity filter. Thus, besides the binding region in the central cavity, certain K+ channel ligands can expand in the subunit interface whose residues are less conserved between K+ channels and hence may be targets for design of highly desirable subtype-specific K+ channel drugs.	[Madeja, Michael; Steffen, Wibke] Univ Munster, Inst Physiol, Munster, Germany; [Madeja, Michael] Goethe Univ Frankfurt, Ctr Physiol, Hertie Res Grp, D-60323 Frankfurt, Germany; [Mesic, Ivana] Univ Darmstadt, Res Grp Mol & Cellular Neurophysiol, D-64289 Darmstadt, Germany; [Garic, Bojan; Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	University of Munster; Goethe University Frankfurt; Technical University of Darmstadt; McMaster University	Madeja, M (corresponding author), Univ Munster, Inst Physiol, Munster, Germany.	MadejaM@ghst.de; zhorov@mcmaster.ca	Zhorov, Boris S./V-8072-2019; Zhorov, Boris/T-9892-2019	Zhorov, Boris/0000-0002-3630-7114	Hertie Foundation; Natural Sciences and Engineering Research Council of Canada	Hertie Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Hertie Foundation (to M. M.) and from the Natural Sciences and Engineering Research Council of Canada (to B. S. Z.).	Ander M, 2008, BIOPHYS J, V94, P820, DOI 10.1529/biophysj.107.112045; Archer SL, 2004, CIRC RES, V95, P308, DOI 10.1161/01.RES.0000137173.42723.fb; Bruhova I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-5; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; Chung JJ, 2005, FEBS J, V272, P3743, DOI 10.1111/j.1742-4658.2005.04802.x; Decher N, 2004, J BIOL CHEM, V279, P394, DOI 10.1074/jbc.M307411200; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dreker T, 2005, MOL PHARMACOL, V68, P966, DOI 10.1124/mol.105.012401; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Huang BY, 2000, J CARDIOVASC ELECTR, V11, P1252, DOI 10.1046/j.1540-8167.2000.01252.x; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Kaczorowski GJ, 1999, CURR OPIN CHEM BIOL, V3, P448, DOI 10.1016/S1367-5931(99)80066-0; KAUDER O, 1991, Pfluegers Archiv European Journal of Physiology, V418, pR77; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; Madeja M, 2003, MOL PHARMACOL, V63, P547, DOI 10.1124/mol.63.3.547; MADEJA M, 1991, J NEUROSCI METH, V38, P267, DOI 10.1016/0165-0270(91)90178-3; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; MOMANY FA, 1975, J PHYS CHEM-US, V79, P2361, DOI 10.1021/j100589a006; Nishiyama A, 1998, CARDIOVASC RES, V40, P343, DOI 10.1016/S0008-6363(98)00135-7; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Qin DY, 2001, BIOCHEM BIOPH RES CO, V283, P549, DOI 10.1006/bbrc.2001.4825; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Rolf S, 2000, N-S ARCH PHARMACOL, V362, P22, DOI 10.1007/s002100000257; Rossokhin A, 2006, MOL PHARMACOL, V69, P1356, DOI 10.1124/mol.105.017970; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Schultz JH, 2001, CIRC RES, V88, P483, DOI 10.1161/01.RES.88.5.483; SNYDERS DJ, 1992, MOL PHARMACOL, V41, P322; Tikhonov DB, 2008, J BIOL CHEM, V283, P17594, DOI 10.1074/jbc.M800141200; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; VALENZUELA C, 1995, BIOPHYS J, V69, P418, DOI 10.1016/S0006-3495(95)79914-3; VALENZUELA C, 1995, CIRCULATION, V92, P3014, DOI 10.1161/01.CIR.92.10.3014; Wareing M, 2006, AM J PHYSIOL-REG I, V291, pR437, DOI 10.1152/ajpregu.00040.2006; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wible B, 1997, BRAIN RES, V761, P42, DOI 10.1016/S0006-8993(97)00315-6; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623; YALE HL, 1959, J MED PHARMACEUT CH, V1, P121, DOI 10.1021/jm50003a001; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	48	9	9	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33898	33905		10.1074/jbc.M110.159897	http://dx.doi.org/10.1074/jbc.M110.159897			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20709754	Green Published, hybrid			2022-12-25	WOS:000283354000036
J	Buzzo, CL; Campopiano, JC; Massis, LM; Lage, SL; Cassado, AA; Leme-Souza, R; Cunha, LD; Russo, M; Zamboni, DS; Amarante-Mendes, GP; Bortoluci, KR				Buzzo, Carina L.; Campopiano, Julia C.; Massis, Liliana M.; Lage, Silvia L.; Cassado, Alexandra A.; Leme-Souza, Rafael; Cunha, Larissa D.; Russo, Momtchilo; Zamboni, Dario S.; Amarante-Mendes, Gustavo P.; Bortoluci, Karina R.			A Novel Pathway for Inducible Nitric-oxide Synthase Activation through Inflammasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; LEGIONELLA-PNEUMOPHILA; GAMMA-INTERFERON; IMMUNE-RESPONSES; GENE-EXPRESSION; CELL-DEATH; MACROPHAGES; FLAGELLIN; IPAF; CASPASE-1	Innate immune recognition of flagellin is shared by transmembrane TLR5 and cytosolic Nlrc4 (NOD-like receptor family CARD (caspase activation recruitment domain) domain containing 4)/Naip5 (neuronal apoptosis inhibitory protein 5). TLR5 activates inflammatory genes through MYD88 pathway, whereas Nlrc4 and Naip5 assemble multiprotein complexes called inflammasomes, culminating in caspase-1 activation, IL-1 beta/IL-18 secretion, and pyroptosis. Although both TLR5 and Naip5/Nlrc4 pathways cooperate to clear infections, little is known about the relative anti-pathogen effector mechanisms operating through each of them. Here we show that the cytosolic flagellin (FLA-BSDot) was able to activate iNOS, an enzyme previously associated with TLR5 pathway. Using Nlrc4- or Naip5-deficient macrophages, we found that both receptors are involved in iNOS activation by FLA-BSDot. Moreover, distinct from extracellular flagellin (FLA-BS), iNOS activation by intracellular flagellin is completely abrogated in the absence of caspase-1. Interestingly, IL-1 beta and IL-18 do not seem to be important for FLA-BSDot-mediated iNOS production. Together, our data defined an additional anti-pathogen effector mechanism operated through Naip5 and Nlrc4 inflammasomes and illustrated a novel signaling transduction pathway that activates iNOS.	[Bortoluci, Karina R.] Univ Fed Sao Paulo, Dept Biol Sci, BR-04044010 Sao Paulo, Brazil; [Leme-Souza, Rafael; Russo, Momtchilo; Amarante-Mendes, Gustavo P.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508900 Sao Paulo, Brazil; [Massis, Liliana M.; Cunha, Larissa D.; Zamboni, Dario S.] Univ Sao Paulo, Dept Biol Celular, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, Brazil; [Amarante-Mendes, Gustavo P.] Inst Nacl Ciencia Tecnol, Inst Invest Imunol, BR-05508900 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Bortoluci, KR (corresponding author), Univ Fed Sao Paulo, Dept Biol Sci, Campus Diadema & CTC Mol,R Mirassol,207 Vila Clem, BR-04044010 Sao Paulo, Brazil.	kbortoluci@gmail.com	Campopiano, Julia/O-9979-2015; Bortoluci, Karina/C-6018-2012; Massis, Liliana Moura/G-3660-2013; Zamboni, Dario S/D-3024-2012; Bortoluci, Karina/P-9296-2019; Cassado, Alexandra/J-1680-2015; Mendes, Gustavo P Amarante/C-8187-2012; Cunha, Larissa D/I-4204-2012	Bortoluci, Karina/0000-0001-6780-5397; Massis, Liliana Moura/0000-0001-8938-9507; Zamboni, Dario S/0000-0002-7856-7512; Bortoluci, Karina/0000-0001-6780-5397; Mendes, Gustavo P Amarante/0000-0002-7851-6205; Dias da Cunha, Larissa/0000-0002-1290-0263; Lucena Lage, Silvia/0000-0001-8519-8164	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil); Brazilian Research Council (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil) and the Brazilian Research Council (CNPq).	Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Bastos KRB, 2002, J LEUKOCYTE BIOL, V71, P271; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fortier A, 2009, INFECT IMMUN, V77, P4794, DOI 10.1128/IAI.01546-08; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; GEBRAN SJ, 1994, INFECT IMMUN, V62, P3197, DOI 10.1128/IAI.62.8.3197-3205.1994; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Juttler E, 2007, MOL CELL NEUROSCI, V34, P612, DOI 10.1016/j.mcn.2007.01.004; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; MISKO TP, 1993, EUR J PHARMACOL, V233, P119, DOI 10.1016/0014-2999(93)90357-N; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Simberg D, 2004, CRIT REV THER DRUG, V21, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i4.10; Skerrett SJ, 1996, INFECT IMMUN, V64, P3236, DOI 10.1128/IAI.64.8.3236-3243.1996; SUMMERSGILL JT, 1992, J LEUKOCYTE BIOL, V52, P625, DOI 10.1002/jlb.52.6.625; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Totemeyer S, 2006, J IMMUNOL, V176, P4804, DOI 10.4049/jimmunol.176.8.4804; Weinlich R, 2008, CELL DEATH DIFFER, V15, P1901, DOI 10.1038/cdd.2008.128; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003	47	36	36	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32087	32095		10.1074/jbc.M110.124297	http://dx.doi.org/10.1074/jbc.M110.124297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702413	Green Published, hybrid			2022-12-25	WOS:000282683000022
J	Zhou, HY; Li, WL; Zhu, SY; Joo, JY; Do, JT; Xiong, W; Kim, JB; Zhang, K; Scholer, HR; Ding, S				Zhou, Hongyan; Li, Wenlin; Zhu, Saiyong; Joo, Jin Young; Do, Jeong Tae; Xiong, Wen; Kim, Jeong Beom; Zhang, Kang; Schoeler, Hans R.; Ding, Sheng			Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUND-STATE; SELF-RENEWAL; DIFFERENTIATION; NANOG; BETA; EXPRESSION; GENERATION; PLASTICITY; ENDODERM; EMBRYO	Epiblast stem cells (EpiSCs) are pluripotent cells derived from post-implantation late epiblasts in vitro. EpiSCs are incapable of contributing to chimerism, indicating that EpiSCs are less pluripotent and represent a later developmental pluripotency state compared with inner cell mass stage murine embryonic stem cells (mESCs). Using a chemical approach, we found that blockage of the TGF beta pathway or inhibition of histone demethylase LSD1 with small molecule inhibitors induced dramatic morphological changes in EpiSCs toward mESC phenotypes with simultaneous activation of inner cell mass-specific gene expression. However, full conversion of EpiSCs to the mESC-like state with chimerism competence could be readily generated only with the combination of LSD1, ALK5, MEK, FGFR, and GSK3 inhibitors. Our results demonstrate that appropriate synergy of epigenetic and signaling modulations could convert cells at the later developmental pluripotency state to the earlier mESC-like pluripotency state, providing new insights into pluripotency regulation.	[Zhou, Hongyan; Li, Wenlin; Zhu, Saiyong; Xiong, Wen; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Joo, Jin Young; Do, Jeong Tae; Kim, Jeong Beom; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Do, Jeong Tae] CHA Univ, CHA Stem Cell Inst, Lab Stem Cell & Dev Biol, Seoul 135081, South Korea; [Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Kang] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA	Scripps Research Institute; Max Planck Society; Pochon Cha University; University of California System; University of California San Diego; University of California System; University of California San Diego	Ding, S (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	sding@scripps.edu	zhou, hongyan/B-3689-2011; Zhang, Kang/Y-2740-2019; , HS/AAB-4434-2019	zhou, hongyan/0000-0001-5919-7715; Zhang, Kang/0000-0002-4549-1697; , HS/0000-0003-2643-5136; Do, Jeong Tae/0000-0001-6721-1441; Kim, Jeong Beom/0000-0001-6230-8826; li, wenlin/0000-0002-0842-222X	Fate Therapeutics; California Institute for Regenerative Medicine; NATIONAL EYE INSTITUTE [R01EY021374] Funding Source: NIH RePORTER	Fate Therapeutics; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Fate Therapeutics and the California Institute for Regenerative Medicine (to S. D.).	BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li QX, 2002, J BIOL CHEM, V277, P46447, DOI 10.1074/jbc.M203555200; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva N, 2008, REVSTAT-STAT J, V6, P253; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	92	102	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29676	29680		10.1074/jbc.C110.150599	http://dx.doi.org/10.1074/jbc.C110.150599			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20705612	Green Published, hybrid			2022-12-25	WOS:000281984300002
J	Dickson, TL; Mitchell, CE				Dickson, Timothy L.; Mitchell, Charles E.			Herbivore and Fungal Pathogen Exclusion Affects the Seed Production of Four Common Grassland Species	PLOS ONE			English	Article							TALLGRASS PRAIRIE; VIRUS-INFECTION; PLANT; COMMUNITY; HOST; POPULATIONS; DISEASE; ESTABLISHMENT; CONSEQUENCES; DIVERSITY	Insect herbivores and fungal pathogens can independently affect plant fitness, and may have interactive effects. However, few studies have experimentally quantified the joint effects of insects and fungal pathogens on seed production in non-agricultural populations. We examined the factorial effects of insect herbivore exclusion (via insecticide) and fungal pathogen exclusion (via fungicide) on the population-level seed production of four common graminoid species (Andropogon gerardii, Schizachyrium scoparium, Poa pratensis, and Carex siccata) over two growing seasons in Minnesota, USA. We detected no interactive effects of herbivores and pathogens on seed production. However, the seed production of all four species was affected by either insecticide or fungicide in at least one year of the study. Insecticide consistently doubled the seed production of the historically most common species in the North American tallgrass prairie, A. gerardii (big bluestem). This is the first report of insect removal increasing seed production in this species. Insecticide increased A. gerardii number of seeds per seed head in one year, and mass per seed in both years, suggesting that consumption of flowers and seed embryos contributed to the effect on seed production. One of the primary insect species consuming A. gerardii flowers and seed embryos was likely the Cecidomyiid midge, Contarinia wattsi. Effects on all other plant species varied among years. Herbivores and pathogens likely reduce the dispersal and colonization ability of plants when they reduce seed output. Therefore, impacts on seed production of competitive dominant species may help to explain their relatively poor colonization abilities. Reduced seed output by dominant graminoids may thereby promote coexistence with subdominant species through competition-colonization tradeoffs.	[Dickson, Timothy L.] Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA; [Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill	Dickson, TL (corresponding author), Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA.	DicksonTL@gmail.com	Mitchell, Charles E/I-3709-2014	Mitchell, Charles E/0000-0002-1633-1993	University of Minnesota Graduate School; Land Institute; United States National Science Foundation NSF/DEB [9411972]	University of Minnesota Graduate School(University of Minnesota System); Land Institute; United States National Science Foundation NSF/DEB(National Science Foundation (NSF))	Funding was provided by fellowships from the University of Minnesota Graduate School and the Land Institute to Charles Mitchell, and a United States National Science Foundation grant (NSF/DEB 9411972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, AM NAT, V157, P555, DOI 10.1086/319932; Alexander HM, 2000, OECOLOGIA, V122, P346, DOI 10.1007/s004420050040; ANDERSEN AN, 1988, OIKOS, V52, P337, DOI 10.2307/3565207; Blaney CS, 2001, J APPL ECOL, V38, P1104, DOI 10.1046/j.1365-2664.2001.00663.x; Bradley DJ, 2008, ECOL LETT, V11, P461, DOI 10.1111/j.1461-0248.2008.01162.x; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; CALUMPANG SMF, 1993, INT J PEST MANAGE, V39, P161, DOI 10.1080/09670879309371783; CARLSSON U, 1992, OECOLOGIA, V90, P509, DOI 10.1007/BF01875444; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; CARTER MR, 1988, J RANGE MANAGE, V41, P253, DOI 10.2307/3899180; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Craine JM, 2003, PLANT ECOL, V165, P85, DOI 10.1023/A:1021414615001; Crawley Michael J., 1997, P401; Daleo P, 2009, J ECOL, V97, P781, DOI 10.1111/j.1365-2745.2009.01508.x; Dickson TL, 2009, RESTOR ECOL, V17, P597, DOI 10.1111/j.1526-100X.2008.00427.x; Eviner VT, 2003, ECOLOGY, V84, P120, DOI 10.1890/0012-9658(2003)084[0120:GPFIAE]2.0.CO;2; Foster BL, 2004, J ECOL, V92, P435, DOI 10.1111/j.0022-0477.2004.00882.x; Foster BL, 2003, J ECOL, V91, P999, DOI 10.1046/j.1365-2745.2003.00830.x; Fournier V, 2006, ECOL APPL, V16, P2382, DOI 10.1890/1051-0761(2006)016[2382:MPEOAS]2.0.CO;2; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Gillings S, 2005, P ROY SOC B-BIOL SCI, V272, P733, DOI 10.1098/rspb.2004.3010; Hatcher MJ, 2006, ECOL LETT, V9, P1253, DOI 10.1111/j.1461-0248.2006.00964.x; Hatcher PE, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P133; HATCHER PE, 1995, BIOL REV, V70, P639, DOI 10.1111/j.1469-185X.1995.tb01655.x; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JAROSZ AM, 1992, OECOLOGIA, V89, P53, DOI 10.1007/BF00319015; JAROSZ AM, 1995, NEW PHYTOL, V129, P371, DOI 10.1111/j.1469-8137.1995.tb04308.x; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Littell RC, 2002, SAS LINEAR MODELS; LOUDA SM, 1982, ECOL MONOGR, V52, P25, DOI 10.2307/2937343; Mack R, 1985, STUDIES PLANT DEMOGR, P127; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Mitchell CE, 2003, ECOL LETT, V6, P147, DOI 10.1046/j.1461-0248.2003.00408.x; Morris WF, 2007, ECOLOGY, V88, P1021, DOI 10.1890/06-0442; Oerke E.C., 1994, CROP PRODUCTION CROP; Parker IM, 2007, ECOLOGY, V88, P1210, DOI 10.1890/06-1377; PAUL ND, 1987, J ECOL, V75, P61, DOI 10.2307/2260536; Remold SK, 2002, J ECOL, V90, P967, DOI 10.1046/j.1365-2745.2002.00731.x; Seabloom EW, 2009, J ECOL, V97, P1264, DOI 10.1111/j.1365-2745.2009.01550.x; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; TILMAN D, 1991, ECOLOGY, V72, P685, DOI 10.2307/2937208; TURNER CL, 1995, INT J PLANT SCI, V156, P216, DOI 10.1086/297243	45	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12022	10.1371/journal.pone.0012022	http://dx.doi.org/10.1371/journal.pone.0012022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711408	gold, Green Published			2022-12-25	WOS:000280849100006
J	Marionnet, C; Pierrard, C; Lejeune, F; Sok, J; Thomas, M; Bernerd, F				Marionnet, Claire; Pierrard, Cecile; Lejeune, Francois; Sok, Juliette; Thomas, Marie; Bernerd, Francoise			Different Oxidative Stress Response in Keratinocytes and Fibroblasts of Reconstructed Skin Exposed to Non Extreme Daily-Ultraviolet Radiation	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; DERMAL-EPIDERMAL JUNCTION; ANTIOXIDANT DEFENSE; UV-IRRADIATION; REDUCED TOLERANCE; B INJURY; IN-VITRO; METALLOTHIONEIN; EXPRESSION; GENE	Experiments characterizing the biological effects of sun exposure have usually involved solar simulators. However, they addressed the worst case scenario i.e. zenithal sun, rarely found in common outdoor activities. A non-extreme ultraviolet radiation (UV) spectrum referred as "daily UV radiation'' (DUVR) with a higher UVA (320-400 nm) to UVB (280-320 nm) irradiance ratio has therefore been defined. In this study, the biological impact of an acute exposure to low physiological doses of DUVR (corresponding to 10 and 20% of the dose received per day in Paris mid-April) on a 3 dimensional reconstructed skin model, was analysed. In such conditions, epidermal and dermal morphological alterations could only be detected after the highest dose of DUVR. We then focused on oxidative stress response induced by DUVR, by analyzing the modulation of mRNA level of 24 markers in parallel in fibroblasts and keratinocytes. DUVR significantly modulated mRNA levels of these markers in both cell types. A cell type differential response was noticed: it was faster in fibroblasts, with a majority of inductions and high levels of modulation in contrast to keratinocyte response. Our results thus revealed a higher sensitivity in response to oxidative stress of dermal fibroblasts although located deeper in the skin, giving new insights into the skin biological events occurring in everyday UV exposure.	[Marionnet, Claire; Pierrard, Cecile; Lejeune, Francois; Sok, Juliette; Thomas, Marie; Bernerd, Francoise] LOreal Rech, Clichy, France	L'Oreal Group	Marionnet, C (corresponding author), LOreal Rech, Clichy, France.	fbernerd@rd.loreal.com						APPLEGATE LA, 1995, PHOTOCHEM PHOTOBIOL, V61, P285, DOI 10.1111/j.1751-1097.1995.tb03973.x; APPLEGATE LA, 1995, PHOTODERMATOL PHOTO, V11, P95, DOI 10.1111/j.1600-0781.1995.tb00146.x; ATHAR M, 1992, PHARM SKIN; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; Bernerd F, 1998, CELL DEATH DIFFER, V5, P792, DOI 10.1038/sj.cdd.4400413; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Black AT, 2008, CARCINOGENESIS, V29, P219, DOI 10.1093/carcin/bgm242; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Christiaens FJ, 2005, PHOTOCHEM PHOTOBIOL, V81, P874, DOI 10.1562/2004-05-14-RA-167R1.1; *COPL, 1994, COPL SUN PROT FACT T; Durchdewald M, 2007, J INVEST DERMATOL, V127, P646, DOI 10.1038/sj.jid.5700585; GILCHREST BA, 1995, PHOTODAMAGE, P97; Godar DE, 2005, PHOTOCHEM PHOTOBIOL, V81, P736, DOI 10.1562/2004-09-07-IR-308R.1; Hanada K, 1998, J INVEST DERMATOL, V111, P582, DOI 10.1046/j.1523-1747.1998.00342.x; Hansen C, 1997, PHOTOCHEM PHOTOBIOL, V65, P550, DOI 10.1111/j.1751-1097.1997.tb08603.x; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Heinloth AN, 2003, RADIAT RES, V160, P273, DOI 10.1667/RR3047; Hornig-Do HT, 2007, J INVEST DERMATOL, V127, P1084, DOI 10.1038/sj.jid.5700666; Kannan S, 2006, CANCER RES, V66, P8421, DOI 10.1158/0008-5472.CAN-06-1181; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Krutmann J, 2006, PROG BIOPHYS MOL BIO, V92, P105, DOI 10.1016/j.pbiomolbio.2006.02.018; Krutmann J, 2005, SKIN AGING, P33; LAVKER RM, 1995, J AM ACAD DERMATOL, V32, P53, DOI 10.1016/0190-9622(95)90184-1; LAVKER RM, 1995, PHOTOCHEM PHOTOBIOL, V62, P348, DOI 10.1111/j.1751-1097.1995.tb05280.x; Leccia MT, 1998, EUR J DERMATOL, V8, P478; Lejeune F, 2008, PHOTODERMATOL PHOTO, V24, P249, DOI 10.1111/j.1600-0781.2008.00370.x; Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230; Marionnet C, 2006, EXP DERMATOL, V15, P625, DOI 10.1111/j.1600-0625.2006.00454.x; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Ogawa F, 2006, J INVEST DERMATOL, V126, P1128, DOI 10.1038/sj.jid.5700116; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Picot CR, 2007, EXP GERONTOL, V42, P859, DOI 10.1016/j.exger.2007.02.006; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Seite S, 2006, PHOTODERMATOL PHOTO, V22, P67, DOI 10.1111/j.1600-0781.2006.00209.x; Seite S, 2000, PHOTODERMATOL PHOTO, V16, P3, DOI 10.1034/j.1600-0781.2000.160103.x; Seite S, 1998, PROTECTION SKIN ULTR, P159; Sheehan JM, 2002, PHOTOCH PHOTOBIO SCI, V1, P365, DOI 10.1039/b108291d; SHINDO Y, 1993, J INVEST DERMATOL, V100, P260, DOI 10.1111/1523-1747.ep12469048; Taungjaruwinai WM, 2009, AM J DERMATOPATH, V31, P427, DOI 10.1097/DAD.0b013e3181882c21; Tyrrell RM, 2004, ANTIOXID REDOX SIGN, V6, P835, DOI 10.1089/1523086041798033; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wang WH, 2004, CLIN EXP DERMATOL, V29, P57, DOI 10.1111/j.1365-2230.2004.01424.x; Wlaschek M, 2001, J PHOTOCH PHOTOBIO B, V63, P41, DOI 10.1016/S1011-1344(01)00201-9; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Young AR, 2007, J INVEST DERMATOL, V127, P975, DOI 10.1038/sj.jid.5700606	50	68	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12059	10.1371/journal.pone.0012059	http://dx.doi.org/10.1371/journal.pone.0012059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706594	Green Submitted, Green Published, gold			2022-12-25	WOS:000280811900016
J	Dyer, MD; Neff, C; Dufford, M; Rivera, CG; Shattuck, D; Bassaganya-Riera, J; Murali, TM; Sobral, BW				Dyer, Matthew D.; Neff, Chris; Dufford, Max; Rivera, Corban G.; Shattuck, Donna; Bassaganya-Riera, Josep; Murali, T. M.; Sobral, Bruno W.			The Human-Bacterial Pathogen Protein Interaction Networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestis	PLOS ONE			English	Article							VIRULENCE FACTORS; LETHAL TOXIN; MACROPHAGES; APOPTOSIS; DATABASE; MAP; RESOURCE; INNATE; CELLS; SET	Background: Bacillus anthracis, Francisella tularensis, and Yersinia pestis are bacterial pathogens that can cause anthrax, lethal acute pneumonic disease, and bubonic plague, respectively, and are listed as NIAID Category A priority pathogens for possible use as biological weapons. However, the interactions between human proteins and proteins in these bacteria remain poorly characterized leading to an incomplete understanding of their pathogenesis and mechanisms of immune evasion. Methodology: In this study, we used a high-throughput yeast two-hybrid assay to identify physical interactions between human proteins and proteins from each of these three pathogens. From more than 250,000 screens performed, we identified 3,073 human-B. anthracis, 1,383 human-F. tularensis, and 4,059 human-Y. pestis protein-protein interactions including interactions involving 304 B. anthracis, 52 F. tularensis, and 330 Y. pestis proteins that are uncharacterized. Computational analysis revealed that pathogen proteins preferentially interact with human proteins that are hubs and bottlenecks in the human PPI network. In addition, we computed modules of human-pathogen PPIs that are conserved amongst the three networks. Functionally, such conserved modules reveal commonalities between how the different pathogens interact with crucial host pathways involved in inflammation and immunity. Significance: These data constitute the first extensive protein interaction networks constructed for bacterial pathogens and their human hosts. This study provides novel insights into host-pathogen interactions.	[Dyer, Matthew D.; Bassaganya-Riera, Josep; Sobral, Bruno W.] Virginia Bioinformat Inst, Blacksburg, VA USA; [Neff, Chris; Dufford, Max; Shattuck, Donna] Myriad Genet, Salt Lake City, UT USA; [Rivera, Corban G.; Murali, T. M.] Virginia Polytech Inst & State Univ, Dept Comp Sci, Blacksburg, VA 24061 USA	Myriad Genetics, Inc; Virginia Polytechnic Institute & State University	Dyer, MD (corresponding author), Life Technol, Foster City, CA USA.	murali@cs.vt.edu; sobral@vbi.vt.edu	Sobral, Bruno/GVU-7637-2022	Sobral, Bruno/0000-0003-3908-577X	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900040C, DHHSN266200400057C]; Myriad, INC.	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Myriad, INC.	This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900040C to Bruno Sobral and contract DHHSN266200400057C to Myriad. Facilities and equipment for doing the experiments was provided by Myriad, INC. Time for CN, MD, and DS was partially funded by Myriad, INC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fukao T, 2004, LANCET INFECT DIS, V4, P166, DOI 10.1016/S1473-3099(04)00940-5; Gilbert D, 2005, BRIEF BIOINFORM, V6, P194, DOI 10.1093/bib/6.2.194; Grande F, 2008, CURR PHARM DESIGN, V14, P385; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Haase R, 2005, J IMMUNOL, V175, P8209, DOI 10.4049/jimmunol.175.12.8209; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Jiao Z, 2007, SCAND J RHEUMATOL, V36, P428, DOI 10.1080/03009740701482800; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Narayanan M, 2007, J COMPUT BIOL, V14, P892, DOI 10.1089/cmb.2007.0025; Pallandre JR, 2007, J IMMUNOL, V179, P7593, DOI 10.4049/jimmunol.179.11.7593; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999; Popov SG, 2004, CELL MICROBIOL, V6, P225, DOI 10.1046/j.1462-5822.2003.00358.x; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rivera CG, 2009, LECT N BIOINFORMAT, V5462, P67, DOI 10.1007/978-3-642-00727-9_9; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; STARNBACH MN, 1994, J IMMUNOL, V153, P1603; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tewari K, 2006, P NATL ACAD SCI USA, V103, P16388, DOI 10.1073/pnas.0602565103; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791	47	103	104	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12089	10.1371/journal.pone.0012089	http://dx.doi.org/10.1371/journal.pone.0012089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711500	Green Submitted, Green Published, gold			2022-12-25	WOS:000280776800021
J	Lindgren, J; Caldwell, MW; Konishi, T; Chiappe, LM				Lindgren, Johan; Caldwell, Michael W.; Konishi, Takuya; Chiappe, Luis M.			Convergent Evolution in Aquatic Tetrapods: Insights from an Exceptional Fossil Mosasaur	PLOS ONE			English	Article							SQUAMATA; FISH; MELANOSOMES; DINOSAURS; REPTILIA; TISSUE; COLOR; SKIN	Mosasaurs (family Mosasauridae) are a diverse group of secondarily aquatic lizards that radiated into marine environments during the Late Cretaceous (98-65 million years ago). For the most part, they have been considered to be simple anguilliform swimmers - i.e., their propulsive force was generated by means of lateral undulations incorporating the greater part of the body - with unremarkable, dorsoventrally narrow tails and long, lizard-like bodies. Convergence with the specialized fusiform body shape and inferred carangiform locomotory style (in which only a portion of the posterior body participates in the thrust-producing flexure) of ichthyosaurs and metriorhynchid crocodyliform reptiles, along with cetaceans, has so far only been recognized in Plotosaurus, the most highly derived member of the Mosasauridae. Here we report on an exceptionally complete specimen (LACM 128319) of the moderately derived genus Platecarpus that preserves soft tissues and anatomical details (e.g., large portions of integument, a partial body outline, putative skin color markings, a downturned tail, branching bronchial tubes, and probable visceral traces) to an extent that has never been seen previously in any mosasaur. Our study demonstrates that a streamlined body plan and crescent-shaped caudal fin were already well established in Platecarpus, a taxon that preceded Plotosaurus by 20 million years. These new data expand our understanding of convergent evolution among marine reptiles, and provide insights into their evolution's tempo and mode.	[Lindgren, Johan] Lund Univ, Dept Earth & Ecosyst Sci, Lund, Sweden; [Caldwell, Michael W.; Konishi, Takuya] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Caldwell, Michael W.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Chiappe, Luis M.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA	Lund University; University of Alberta; University of Alberta	Lindgren, J (corresponding author), Lund Univ, Dept Earth & Ecosyst Sci, Lund, Sweden.	johan.lindgren@geol.lu.se	Caldwell, Michael/A-2622-2014	Caldwell, Michael/0000-0002-2377-3925; Chiappe, Luis/0000-0001-9661-0601	Swedish Research Council; Crafoord Foundation; Royal Swedish Academy of Sciences; Natural Sciences and Engineering Research Council of Canada; University of Alberta, Faculty of Science, Chair's Research Allowance; Dinosaur Institute of the Natural History Museum of Los Angeles County	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Royal Swedish Academy of Sciences; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Alberta, Faculty of Science, Chair's Research Allowance(University of Alberta); Dinosaur Institute of the Natural History Museum of Los Angeles County	This research was supported by the Swedish Research Council, the Crafoord Foundation, the Royal Swedish Academy of Sciences, the Natural Sciences and Engineering Research Council of Canada, the University of Alberta, Faculty of Science, Chair's Research Allowance, Alberta Ingenuity Fund (PhD Student Scholarship), and the Dinosaur Institute of the Natural History Museum of Los Angeles County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PA, 1988, PALEOBIOLOGY, V14, P331, DOI 10.1017/S0094837300012082; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; BERTA A, 2006, MARINE MAMMALS EVOLU; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Everhart Michael J., 2001, Transactions of the Kansas Academy of Science, V104, P59, DOI 10.1660/0022-8443(2001)104[0059:RTTBOT]2.0.CO;2; Geist Nicholas R., 2002, Journal of Vertebrate Paleontology, V22, p57A; Green R.F., 1972, P247; Hattin DE., 1982, KANSAS GEOL SURV B, V225, P1; HENRY RW, 1983, ANAT REC, V207, P435, DOI 10.1002/ar.1092070306; Hua Stephane, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V193, P1; Kear BP, 2006, BIOL LETTERS, V2, P113, DOI 10.1098/rsbl.2005.0374; King D., 1999, MONITORS BIOL VARANI; KONISHI T, 1869, J VERTEBR P IN PRESS; Konishi T, 2007, J VERTEBR PALEONTOL, V27, P59, DOI 10.1671/0272-4634(2007)27[59:NSOPPC]2.0.CO;2; Lindgren J, 2007, LETHAIA, V40, P153, DOI 10.1111/j.1502-3931.2007.00009.x; Lindgren J, 2009, BIOL LETTERS, V5, P528, DOI 10.1098/rsbl.2009.0097; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P510, DOI 10.1562/2004-10-19-RA-345.1; Long JH, 1996, J EXP BIOL, V199, P2139; MARTILL DM, 1990, NATURE, V346, P171, DOI 10.1038/346171a0; Martin JE, 2007, GEOL SOC AM SPEC PAP, V427, P167, DOI 10.1130/2007.2427(12); McGowan Christopher, 2003, pi; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; OSBORN HF, 1899, MEMOIRS AM MUSEUM NA, V1, P167; Pees M, 2009, VET RADIOL ULTRASOUN, V50, P487, DOI 10.1111/j.1740-8261.2009.01569.x; Russell D. A., 1967, PEABODY MUS NAT HIST, V23, P1; Sawlowicz Z, 2006, MINERALOGIA POLONICA, V29, P184; Schumacher B. A., 2007, 2 MOS M, P41; Smith KT, 2008, J VERTEBR PALEONTOL, V28, P85, DOI 10.1671/0272-4634(2008)28[85:ANASAW]2.0.CO;2; SNOW FH, 1878, T KANSAS ACAD SCI, V6, P54, DOI DOI 10.2307/3623557; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; Tsang KW, 2002, J WILDLIFE DIS, V38, P224, DOI 10.7589/0090-3558-38.1.224; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Wilby Philip R., 1997, Geobios Memoire Special (Villeurbanne), V20, P493; Williston S. W., 1899, KANSAS U Q, V8, P39; WILLISTON SW, 1897, KANSAS U Q, V6, P99; Witmer LM, 2001, SCIENCE, V293, P850, DOI 10.1126/science.1062681; YOUNG BA, 2008, FORT HAYS STUDIES, V3, P159; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	40	68	71	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e11998	10.1371/journal.pone.0011998	http://dx.doi.org/10.1371/journal.pone.0011998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711249	gold, Green Submitted, Green Published			2022-12-25	WOS:000280776800002
J	Deu, E; Yang, ZM; Wang, F; Klemba, M; Bogyo, M				Deu, Edgar; Yang, Zhimou; Wang, Flora; Klemba, Michael; Bogyo, Matthew			Use of Activity-Based Probes to Develop High Throughput Screening Assays That Can Be Performed in Complex Cell Extracts	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; IDENTIFICATION; PROTEASES; INHIBITORS; DISCOVERY	Background: High throughput screening (HTS) is one of the primary tools used to identify novel enzyme inhibitors. However, its applicability is generally restricted to targets that can either be expressed recombinantly or purified in large quantities. Methodology and Principal Findings: Here, we described a method to use activity-based probes (ABPs) to identify substrates that are sufficiently selective to allow HTS in complex biological samples. Because ABPs label their target enzymes through the formation of a permanent covalent bond, we can correlate labeling of target enzymes in a complex mixture with inhibition of turnover of a substrate in that same mixture. Thus, substrate specificity can be determined and substrates with sufficiently high selectivity for HTS can be identified. In this study, we demonstrate this method by using an ABP for dipeptidyl aminopeptidases to identify (Pro-Arg)(2)-Rhodamine as a specific substrate for DPAP1 in Plasmodium falciparum lysates and Cathepsin C in rat liver extracts. We then used this substrate to develop highly sensitive HTS assays (Z'>0.8) that are suitable for use in screening large collections of small molecules (i.e >300,000) for inhibitors of these proteases. Finally, we demonstrate that it is possible to use broad-spectrum ABPs to identify target-specific substrates. Conclusions: We believe that this approach will have value for many enzymatic systems where access to large amounts of active enzyme is problematic.	[Deu, Edgar; Yang, Zhimou; Bogyo, Matthew] Stanford Sch Med, Dept Pathol, Stanford, CA USA; [Wang, Flora; Klemba, Michael] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Bogyo, Matthew] Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA USA	Stanford University; Virginia Polytechnic Institute & State University; Stanford University	Deu, E (corresponding author), Stanford Sch Med, Dept Pathol, Stanford, CA USA.	mbogyo@stanford.edu	Yang, Zhimou/F-1798-2010	Yang, Zhimou/0000-0003-2967-6920; Bogyo, Matthew/0000-0003-3753-4412	NIH [R01 EB005011, R01 AI078947]; Burrough Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burrough Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by funding by NIH grants R01 EB005011 and R01 AI078947 and a New Investigator Award in Pathogenesis from the Burrough Wellcome Fund (all to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2010, MOL BIOTECHNOL, V45, P180, DOI 10.1007/s12033-010-9251-z; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; DEU E, 2010, CHEM BIOL UNPUB; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fonovic M, 2007, CURR PHARM DESIGN, V13, P253, DOI 10.2174/138161207779313623; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; LEYTUS SP, 1983, BIOCHEM J, V209, P299, DOI 10.1042/bj2090299; Liu JX, 1999, BIOORG MED CHEM LETT, V9, P3231; Luciani N, 2001, BIOCHEM J, V356, P813, DOI 10.1042/0264-6021:3560813; Rosse G, 2000, J COMB CHEM, V2, P461, DOI 10.1021/cc000019y; Wakata A, 2010, J AM CHEM SOC, V132, P1578, DOI 10.1021/ja907226n; WANG FKP, 2010, MOL BIOCH PARA UNPUB; Williams KP, 2009, METHODS MOL BIOL, V565, P107, DOI 10.1007/978-1-60327-258-2_5; Yuan F, 2006, J AM CHEM SOC, V128, P5616, DOI 10.1021/ja060835v; Zock JM, 2009, COMB CHEM HIGH T SCR, V12, P870, DOI 10.2174/138620709789383277	19	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11985	10.1371/journal.pone.0011985	http://dx.doi.org/10.1371/journal.pone.0011985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700487	Green Published, Green Submitted, gold			2022-12-25	WOS:000280605400018
J	Webb, TJ; Vanden Berghe, E; O'Dor, R				Webb, Thomas J.; Vanden Berghe, Edward; O'Dor, Ron			Biodiversity's Big Wet Secret: The Global Distribution of Marine Biological Records Reveals Chronic Under-Exploration of the Deep Pelagic Ocean	PLOS ONE			English	Article							DIVERSITY; SEA; IMPACTS; FISHES	Background: Understanding the distribution of marine biodiversity is a crucial first step towards the effective and sustainable management of marine ecosystems. Recent efforts to collate location records from marine surveys enable us to assemble a global picture of recorded marine biodiversity. They also effectively highlight gaps in our knowledge of particular marine regions. In particular, the deep pelagic ocean - the largest biome on Earth - is chronically under-represented in global databases of marine biodiversity. Methodology/Principal Findings: We use data from the Ocean Biogeographic Information System to plot the position in the water column of ca 7 million records of marine species occurrences. Records from relatively shallow waters dominate this global picture of recorded marine biodiversity. In addition, standardising the number of records from regions of the ocean differing in depth reveals that regardless of ocean depth, most records come either from surface waters or the sea bed. Midwater biodiversity is drastically under-represented. Conclusions/Significance: The deep pelagic ocean is the largest habitat by volume on Earth, yet it remains biodiversity's big wet secret, as it is hugely under-represented in global databases of marine biological records. Given both its value in the provision of a range of ecosystem services, and its vulnerability to threats including overfishing and climate change, there is a pressing need to increase our knowledge of Earth's largest ecosystem.	[Webb, Thomas J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Vanden Berghe, Edward] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [O'Dor, Ron] Consortium Ocean Leadership, Census Marine Life, Washington, DC USA	University of Sheffield; Rutgers State University New Brunswick	Webb, TJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	t.j.webb@sheffield.ac.uk	Webb, Tom/D-5224-2011	Webb, Tom/0000-0003-3183-8116	Royal Society; Sloan Foundation	Royal Society(Royal Society of London); Sloan Foundation(Alfred P. Sloan Foundation)	This work was made possible by a Royal Society (www.royalsoc.ac.uk) Research Fellowship to TJW, and by support from the Sloan Foundation (www.sloan.org/) to OBIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, NGDC24 NOAA NESDIS; ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; Berra TM, 1997, ENVIRON BIOL FISH, V50, P1, DOI 10.1023/A:1007354702142; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Costello MJ, 2006, MAR ECOL PROG SER, V316, P203, DOI 10.3354/meps316203; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fornwall Mark, 2000, Oceanography, V13, P31; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Grassle J. Frederick, 2000, Oceanography, V13, P5; Haddock SHD, 2004, HYDROBIOLOGIA, V530, P549, DOI 10.1007/s10750-004-2653-9; HOLT RD, 2010, NATURE, V463, P32; Jamieson A. J., 2008, P ROYAL SOC B, V276, P1037, DOI 10.1098/rspb.2008.1670; Kunzig R, 2003, SCIENCE, V302, P991, DOI 10.1126/science.1090808; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; O'Dor R, 2010, ESA PUBLICATION, V306; Osborn KJ, 2009, SCIENCE, V325, P964, DOI 10.1126/science.1172488; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; R Development Core Team, 2009, R FDN STAT COMP; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Robertson DR, 2008, DIVERS DISTRIB, V14, P891, DOI 10.1111/j.1472-4642.2008.00519.x; Robison BH, 2004, J EXP MAR BIOL ECOL, V300, P253, DOI 10.1016/j.jembe.2004.01.012; Robison BH, 2009, CONSERV BIOL, V23, P847, DOI 10.1111/j.1523-1739.2009.01219.x; Sizling AL, 2009, ECOLOGY, V90, P3575, DOI 10.1890/08-1129.1; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Somerfield PJ, 2009, MAR ECOL PROG SER, V382, P221, DOI 10.3354/meps08045; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; Vanden Berghe E, 2009, MAR ECOL PROG SER, V382, P225, DOI 10.3354/meps07826; VANDENBERGE E, 2010, ESA PUBLICATION; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Webb TJ, 2009, BIOL LETTERS, V5, P145, DOI 10.1098/rsbl.2008.0735	30	162	164	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e10223	10.1371/journal.pone.0010223	http://dx.doi.org/10.1371/journal.pone.0010223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689845	Green Published, gold, Green Accepted			2022-12-25	WOS:000280520400001
J	Liu, J; Chen, KP; Wang, JH; Zhang, CY				Liu, Jun; Chen, Keping; Wang, Jian-Hua; Zhang, Chiyu			Molecular Evolution of the Primate Antiviral Restriction Factor Tetherin	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANCIENT ADAPTIVE EVOLUTION; CODON-SUBSTITUTION MODELS; NUCLEOTIDE SUBSTITUTIONS; RETROVIRAL RESTRICTION; POSITIVE SELECTION; INDIVIDUAL SITES; HIV-1 INFECTION; PROTEIN; RELEASE	Background: Tetherin is a recently identified antiviral restriction factor that restricts HIV-1 particle release in the absence of the HIV-1 viral protein U (Vpu). It is reminiscent of APOBEC3G and TRIM5a that also antagonize HIV. APOBEC3G and TRIM5a have been demonstrated to evolve under pervasive positive selection throughout primate evolution, supporting the red-queen hypothesis. Therefore, one naturally presumes that Tetherin also evolves under pervasive positive selection throughout primate evolution and supports the red-queen hypothesis. Here, we performed a detailed evolutionary analysis to address this presumption. Methodology/Principal Findings: Results of non-synonymous and synonymous substitution rates reveal that Tetherin as a whole experiences neutral evolution rather than pervasive positive selection throughout primate evolution, as well as in non-primate mammal evolution. Sliding-window analyses show that the regions of the primate Tetherin that interact with viral proteins are under positive selection or relaxed purifying selection. In particular, the sites identified under positive selection generally focus on these regions, indicating that the main selective pressure acting on the primate Tetherin comes from virus infection. The branch-site model detected positive selection acting on the ancestral branch of the New World Monkey lineage, suggesting an episodic adaptive evolution. The positive selection was also found in duplicated Tetherins in ruminants. Moreover, there is no bias in the alterations of amino acids in the evolution of the primate Tetherin, implying that the primate Tetherin may retain broad spectrum of antiviral activity by maintaining structure stability. Conclusions/Significance: These results conclude that the molecular evolution of Tetherin may be attributed to the host-virus arms race, supporting the Red Queen hypothesis, and Tetherin may be in an intermediate stage in transition from neutral to pervasive adaptive evolution.	[Liu, Jun; Chen, Keping; Zhang, Chiyu] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Wang, Jian-Hua] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China	Jiangsu University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Liu, J (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	zhangcy1999@hotmail.com		Zhang, Chiyu/0000-0001-8735-9857	Jiangsu University	Jiangsu University	The study was supported by the Top-notch personnel Project of Jiangsu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Apetrei C, 2004, FRONT BIOSCI-LANDMRK, V9, P225, DOI 10.2741/1154; Arnaud F, 2010, J VIROL, V84, P4415, DOI 10.1128/JVI.00029-10; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Feldmann H, 2004, TRENDS MICROBIOL, V12, P433, DOI 10.1016/j.tim.2004.08.009; Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105; Gilbert C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000425; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lim ES, 2010, J VIROL, V84, P7124, DOI 10.1128/JVI.00468-10; Liu HF, 2005, GENE, V362, P109, DOI 10.1016/j.gene.2005.06.045; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Meslin FX, 2000, REV SCI TECH OIE, V19, P310, DOI 10.20506/rst.19.1.1214; Nei M, 2002, J HERED, V93, P157, DOI 10.1093/jhered/93.3.157; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ortiz M, 2008, GENES IMMUN, V9, P483, DOI 10.1038/gene.2008.40; Ortiz M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-11; Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tokarev A, 2009, AIDS RES HUM RETROV, V25, P1197, DOI 10.1089/aid.2009.0253; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	62	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11904	10.1371/journal.pone.0011904	http://dx.doi.org/10.1371/journal.pone.0011904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689591	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520300019
J	Boyd, JW; Oldenburg, EW; McMichael, GA				Boyd, James W.; Oldenburg, Eric W.; McMichael, Geoffrey A.			Color Photographic Index of Fall Chinook Salmon Embryonic Development and Accumulated Thermal Units	PLOS ONE			English	Article							TEMPERATURE; FISHES; TIME; EGGS	Background: Knowledge of the relationship between accumulated thermal units and developmental stages of Chinook salmon embryos can be used to determine the approximate date of egg fertilization in natural redds, thus providing insight into oviposition timing of wild salmonids. However, few studies have documented time to different developmental stages of embryonic Chinook salmon and no reference color photographs are available. The objectives of this study were to construct an index relating developmental stages of hatchery-reared fall Chinook salmon embryos to time and temperature (e.g., degree days) and provide high-quality color photographs of each identified developmental stage. Methodology/Principal Findings: Fall Chinook salmon eggs were fertilized in a hatchery environment and sampled approximately every 72 h post-fertilization until 50% hatch. Known embryonic developmental features described for sockeye salmon were used to describe development of Chinook salmon embryos. A thermal sums model was used to describe the relationship between embryonic development rate and water temperature. Mean water temperature was 8.0 degrees C (range; 3.9-11.7 degrees C) during the study period. Nineteen stages of embryonic development were identified for fall Chinook salmon; two stages in the cleavage phase, one stage in the gastrulation phase, and sixteen stages in the organogenesis phase. The thermal sums model used in this study provided similar estimates of fall Chinook salmon embryonic development rate in water temperatures varying from 3.9-11.7 degrees C (mean = 8 degrees C) to those from several other studies rearing embryos in constant 8 degrees C water temperature. Conclusions/Significance: The developmental index provides a reasonable description of timing to known developmental stages of Chinook salmon embryos and was useful in determining developmental stages of wild fall Chinook salmon embryos excavated from redds in the Columbia River. This index should prove useful to other researchers who wish to approximate fertilization dates of Chinook salmon eggs from natural redds, assuming the thermal history of embryos is known.	[Boyd, James W.; Oldenburg, Eric W.; McMichael, Geoffrey A.] Ecol Grp, Richland, WA USA		Boyd, JW (corresponding author), US Forest Serv, Eureka, MT USA.	jboyd03@fs.fed.us			Grant County Public Utility District #2, Washington	Grant County Public Utility District #2, Washington	Grant County Public Utility District #2, Washington funded this research (http://gcpud.org/). The funders had a role in study design, data collection and analysis, and decision to publish.	ALDERDICE DF, 1978, J FISH RES BOARD CAN, V35, P69, DOI 10.1139/f78-010; ATKINSON D, 1996, ANIMALS TEMPERATURE, P183; BALLARD WW, 1973, J EXP ZOOL, V184, P7, DOI 10.1002/jez.1401840103; BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119&lt;0927:TESADO&gt;2.3.CO;2; BLAXTER JHS, 1988, FISH PHYSIOL, V11, P1, DOI DOI 10.1016/S1546-5098(08)60198-3; CHAPMAN DW, 1986, T AM FISH SOC, V115, P537, DOI 10.1577/1548-8659(1986)115<537:EORFOT>2.0.CO;2; CRISP DT, 1981, FRESHWATER BIOL, V11, P361, DOI 10.1111/j.1365-2427.1981.tb01267.x; EMBODY G. G., 1934, TRANS AMER FISH SOC, V64, P281, DOI 10.1577/1548-8659(1934)64[281:ROTTTI]2.0.CO;2; FRY FEJ, 1971, FISH PHYSIOL, V11, P1; Norris T, 1868, AM FISH CULTURE EMBR; Ojanguren AF, 2003, J FISH BIOL, V62, P580, DOI 10.1046/j.1095-8649.2003.00049.x; Pennell W, 2001, FISH HATCHERY MANAGEMENT, SECOND EDITION, P187; Velsen F.J., 1980, CAN SPEC PUBL FISH A, V49, P1; Velsen F. P. J., 1987, CANADIAN DATA REPORT, V626, P67	14	8	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11877	10.1371/journal.pone.0011877	http://dx.doi.org/10.1371/journal.pone.0011877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686709	Green Submitted, gold, Green Published			2022-12-25	WOS:000280520200039
J	Carpintero, R; Gruaz, L; Brandt, KJ; Scanu, A; Faille, D; Combes, V; Grau, GE; Burger, D				Carpintero, Rakel; Gruaz, Lyssia; Brandt, Karim J.; Scanu, Anna; Faille, Dorothee; Combes, Valery; Grau, Georges E.; Burger, Danielle			HDL Interfere with the Binding of T Cell Microparticles to Human Monocytes to Inhibit Pro-Inflammatory Cytokine Production	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RECEPTOR ANTAGONIST PRODUCTION; ENDOTHELIAL MICROPARTICLES; PLATELET MICROPARTICLES; CONTACT-ACTIVATION; SYNOVIAL TISSUE; LYMPH-NODE; EXPRESSION; IL-1-BETA; ARTHRITIS	Background: Direct cellular contact with stimulated T cells is a potent mechanism that induces cytokine production in human monocytes in the absence of an infectious agent. This mechanism is likely to be relevant to T cell-mediated inflammatory diseases such as rheumatoid arthritis and multiple sclerosis. Microparticles (MP) generated by stimulated T cells (MPT) display similar monocyte activating ability to whole T cells, isolated T cell membranes, or solubilized T cell membranes. We previously demonstrated that high-density lipoproteins (HDL) inhibited T cell contact- and MPT-induced production of IL-1 beta but not of its natural inhibitor, the secreted form of IL-1 receptor antagonist (sIL-1Ra). Methodology/Principal Findings: Labeled MPT were used to assess their interaction with monocytes and T lymphocytes by flow cytometry. Similarly, interactions of labeled HDL with monocytes and MPT were assessed by flow cytometry. In parallel, the MPT-induction of IL-1 beta and sIL-1Ra production in human monocytes and the effect of HDL were assessed in cell cultures. The results show that MPT, but not MP generated by activated endothelial cells, bond monocytes to trigger cytokine production. MPT did not bind T cells. The inhibition of IL-1 beta production by HDL correlated with the inhibition of MPT binding to monocytes. HDL interacted with MPT rather than with monocytes suggesting that they bound the activating factor(s) of T cell surface. Furthermore, prototypical pro-inflammatory cytokines and chemokines such as TNF, IL-6, IL-8, CCL3 and CCL4 displayed a pattern of production induced by MPT and inhibition by HDL similar to IL-1 beta, whereas the production of CCL2, like that of sIL-1Ra, was not inhibited by HDL. Conclusions/Significance: HDL inhibit both MPT binding to monocytes and the MPT-induced production of some but not all cytokines, shedding new light on the mechanism by which HDL display their anti-inflammatory functions.	[Carpintero, Rakel; Gruaz, Lyssia; Brandt, Karim J.; Burger, Danielle] Univ Geneva, Hans Wilsdorf Lab, Inflammat & Allergy Res Grp, Div Immunol & Allergy,Dept Internal Med,Fac Med, Geneva, Switzerland; [Carpintero, Rakel; Gruaz, Lyssia; Brandt, Karim J.; Burger, Danielle] Univ Geneva, Univ Hosp, Geneva, Switzerland; [Scanu, Anna] Univ Padua, Dept Clin & Expt Med, Padua, Italy; [Faille, Dorothee; Combes, Valery; Grau, Georges E.] Univ Sydney, Dept Pathol, Camperdown, NSW, Australia	University of Geneva; University of Geneva; University of Padua; University of Sydney	Carpintero, R (corresponding author), Univ Geneva, Hans Wilsdorf Lab, Inflammat & Allergy Res Grp, Div Immunol & Allergy,Dept Internal Med,Fac Med, Geneva, Switzerland.	danielle.Burger@hcuge.ch	Grau, Georges/AGR-7139-2022; Faille, Dorothée/AFO-5088-2022; Burger, Danielle/A-1996-2008	Grau, Georges/0000-0002-0442-0462; Faille, Dorothée/0000-0003-4414-739X; SCANU, Anna/0000-0001-6497-5374; Combes, Valery/0000-0003-2178-3596; Brandt, Karim J./0000-0003-1042-5283	EU [MPCM LSHP-CT-2006-037749]; Swiss National Science Foundation [320000-116259]; Swiss Society for Multiple Sclerosis; Hans Wilsdorf Foundation; Basque Government (Spain); National Health and Medical Research Council of Australia; Australian Research Council; Rebecca Cooper Foundation, Sydney, Australia	EU(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society for Multiple Sclerosis; Hans Wilsdorf Foundation; Basque Government (Spain)(Basque Government); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Rebecca Cooper Foundation, Sydney, Australia	This work was supported by a grant to project MPCM # LSHP-CT-2006-037749 from the EU, the Swiss National Science Foundation (DB, grant # 320000-116259), the Swiss Society for Multiple Sclerosis (DB), and the Hans Wilsdorf Foundation (DB). RC is a recipient of a postdoctoral fellowship from the Basque Government (Spain). GG and VC are supported by grants from the National Health and Medical Research Council of Australia, the Australian Research Council and the Rebecca Cooper Foundation, Sydney, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; Ardoin SP, 2008, MOD RHEUMATOL, V18, P319, DOI 10.1007/s10165-008-0054-z; Banfi C, 2005, PROTEOMICS, V5, P4443, DOI 10.1002/pmic.200402017; Berckmans RJ, 2002, ARTHRITIS RHEUM-US, V46, P2857, DOI 10.1002/art.10587; Berckmans RJ, 2005, ARTHRITIS RES THER, V7, pR536, DOI 10.1186/ar1706; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brennan FM, 2002, ARTHRITIS RES THER, V4, pS177, DOI 10.1186/ar556; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Brogan PA, 2004, ARTHRITIS RHEUM, V50, P927, DOI 10.1002/art.20199; Burger D, 2000, EUR CYTOKINE NETW, V11, P346; Burger D, 2004, J IMMUNOL, V173, P1292, DOI 10.4049/jimmunol.173.2.1292; Burger D, 2004, PROG INFLAM RES, P165; BURGER D, 2007, CONT TARGETED THERAP, P85; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; Chizzolini C, 1997, EUR J IMMUNOL, V27, P171, DOI 10.1002/eji.1830270125; Coclet-Ninin J, 1997, EUR CYTOKINE NETW, V8, P345; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Distler JHW, 2005, P NATL ACAD SCI USA, V102, P2892, DOI 10.1073/pnas.0409781102; Faille D, 2009, FASEB J, V23, P3449, DOI 10.1096/fj.09-135822; Gruaz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009418; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Jimenez JJ, 2005, MULT SCLER J, V11, P310, DOI 10.1191/1352458505ms1184oa; Jungo F, 2001, CYTOKINE, V14, P272, DOI 10.1006/cyto.2001.0884; Jy W, 2004, FRONT BIOSCI-LANDMRK, V9, P3137, DOI 10.2741/1466; Knijff-Dutmer EAJ, 2002, ARTHRITIS RHEUM-US, V46, P1498, DOI 10.1002/art.10312; Larkin M, 2001, LANCET, V357, P1679, DOI 10.1016/S0140-6736(00)04867-4; Li YYY, 2008, IMMUNOL LETT, V117, P114, DOI 10.1016/j.imlet.2007.08.013; Messer L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2648; Minagar A, 2001, NEUROLOGY, V56, P1319, DOI 10.1212/WNL.56.10.1319; Molnarfi N, 2007, J IMMUNOL, V178, P446, DOI 10.4049/jimmunol.178.1.446; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; PATERSON PY, 1960, J EXP MED, V111, P119, DOI 10.1084/jem.111.1.119; PEARSON CM, 1964, J EXP MED, V120, P547, DOI 10.1084/jem.120.4.547; Pisetsky DS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2856; Pluskota E, 2008, BLOOD, V112, P2327, DOI 10.1182/blood-2007-12-127183; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Scanu A, 2008, J LEUKOCYTE BIOL, V83, P921, DOI 10.1189/jlb.0807551; Sebbag M, 1997, EUR J IMMUNOL, V27, P624, DOI 10.1002/eji.1830270308; Sheremata WA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-23; Vey E, 1997, CYTOKINE, V9, P480, DOI 10.1006/cyto.1997.0191; Vey E, 1996, EUR J IMMUNOL, V26, P2404, DOI 10.1002/eji.1830261021	44	33	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11869	10.1371/journal.pone.0011869	http://dx.doi.org/10.1371/journal.pone.0011869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686620	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200032
J	Zietsch, J; Ziegenhagen, N; Heppner, FL; Reuss, D; von Deimling, A; Holtkamp, N				Zietsch, Jan; Ziegenhagen, Nicolas; Heppner, Frank L.; Reuss, David; von Deimling, Andreas; Holtkamp, Nikola			The 4q12 Amplicon in Malignant Peripheral Nerve Sheath Tumors: Consequences on Gene Expression and Implications for Sunitinib Treatment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; IN-VITRO; C-KIT; PROGRESSION; SU11248; IMBALANCES; MUTATIONS; IMATINIB; CELLS	Background: Malignant peripheral nerve sheath tumors (MPNST) are highly aggressive tumors which originate from Schwann cells and develop in about 10% of neurofibromatosis type 1 (NF1) patients. The five year survival rate is poor and more effective therapies are needed. Sunitinib is a drug targeting receptor tyrosine kinases (RTK) like PDGFR alpha, c-Kit and VEGFR-2. These genes are structurally related and cluster on chromosomal segment 4q12. Methodology/Principal Findings: Here we characterize this region by multiplex ligation-dependent probe amplification (MLPA) in MPNST. Our probe set encompasses the 3 adjacent RTK genes (PDGFRA, KIT, KDR) and 6 flanking genes. We found amplification of several genes within this region in a subset of MPNST and MPNST cell lines. Transcript and protein expression of PDGFRA matched well with its increased copy number suggesting a central role of PDGFRA within the amplicon. Studying the effect of sunitinib on 5 MPNST cell lines revealed that cell line S462 harboring the 4q12 amplicon was extremely sensitive to the drug with an IC50 below 1.0 mu M. Moreover, sunitinib induced apoptosis and prevented PDGFAA induced signaling via PDGFR alpha as determined by western blotting. Co-expression of VEGF and its receptor VEGFR-2 (KDR) was present in MPNST cell lines suggesting an autocrine loop. We show that VEGF triggered signal transduction via the MAPK pathway, which could be blocked by sunitinib. Conclusions/Significance: Since multiple receptors targeted by sunitinib are expressed or over-expressed by MPNST cells sunitinib appears as an attractive drug for treatment of MPNST patients. Presence of the 4q12 amplicon and subsequent over-expression of PDGFRA might serve as predictive markers for efficacy of sunitinib.	[Zietsch, Jan; Ziegenhagen, Nicolas; Heppner, Frank L.; Holtkamp, Nikola] Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany; [Reuss, David; von Deimling, Andreas] Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany; [Reuss, David; von Deimling, Andreas] Deutsch Krebsforschungszentrum Heidelberg, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Zietsch, J (corresponding author), Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany.	nikola.holtkamp@charite.de	von Deimling, Andreas/F-7774-2013; Heppner, Frank/ABH-8393-2020	von Deimling, Andreas/0000-0002-5863-540X; Heppner, Frank/0000-0001-9816-8917	Bundesministerium fur Bildung und Forschung (BMBF) [01GM0841]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) program rare diseases (grant 01GM0841). URL: http://www.bmbf.de/press/2806.php The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Angelov L, 1999, CANCER RES, V59, P5536; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Chugh R, 2009, J CLIN ONCOL, V27, P3148, DOI 10.1200/JCO.2008.20.5054; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hermanson M, 1996, CANCER RES, V56, P164; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Holtkamp N, 2006, CARCINOGENESIS, V27, P664, DOI 10.1093/carcin/bgi273; Holtkamp N, 2007, NEOPLASIA, V9, P671, DOI 10.1593/neo.07304; Holtkamp N, 2007, NEURO-ONCOLOGY, V9, P291, DOI 10.1215/15228517-2007-009; HOUK BE, 2009, CANC CHEMOTHER PHARM; Huether A, 2005, BIOCHEM PHARMACOL, V70, P1568, DOI 10.1016/j.bcp.2005.09.007; Joensuu H, 2005, J PATHOL, V207, P224, DOI 10.1002/path.1823; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Koga T, 2002, J PATHOL, V197, P98, DOI 10.1002/path.1101; Kuchenbauer F, 2005, LEUKEMIA, V19, P2366, DOI 10.1038/sj.leu.2403957; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Nakagawa Y, 2006, ONCOL REP, V15, P297; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Serra E, 2001, NAT GENET, V28, P294, DOI 10.1038/90148; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Shih AH, 2006, CANCER LETT, V232, P139, DOI 10.1016/j.canlet.2005.02.002; Thomas SL, 2007, NEUROCHEM RES, V32, P1129, DOI 10.1007/s11064-007-9279-z; VONDEIMLING A, 1995, BRAIN PATHOL, V5, P153; Wasa J, 2008, CLIN EXP METASTAS, V25, P819, DOI 10.1007/s10585-008-9197-8; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang FC, 2006, HUM MOL GENET, V15, P2421, DOI 10.1093/hmg/ddl165; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637	31	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11858	10.1371/journal.pone.0011858	http://dx.doi.org/10.1371/journal.pone.0011858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686603	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520200022
J	Shaykhiev, R; Sierigk, J; Herr, C; Krasteva, G; Kummer, W; Bals, R				Shaykhiev, Renat; Sierigk, Johannes; Herr, Christian; Krasteva, Gabriela; Kummer, Wolfgang; Bals, Robert			The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS	FASEB JOURNAL			English	Article						host defense; mucosal immunity; innate immunity; endotoxin; Toll-like receptor	TOLL-LIKE RECEPTOR-4; PROINFLAMMATORY GENE-EXPRESSION; INNATE IMMUNE RECOGNITION; GROWTH-FACTOR RECEPTOR; HOST-DEFENSE; DEPENDENT ENDOCYTOSIS; GOLGI-APPARATUS; BACTERIAL LIPOPOLYSACCHARIDE; ADAPTIVE IMMUNITY; DENDRITIC CELLS	Epithelial cells (ECs) are usually hyporesponsive to various microbial products. Detection of lipopolysaccharide (LPS), the major component of gram-negative bacteria, is impeded, at least in part, by intracellular sequestration of its receptor, Toll-like receptor-4 (TLR4). In this study, using human bronchial ECs (hBECs) as a model of mucosal epithelium, we tested the hypothesis that the human LPS-binding, membrane-active cationic host defense peptide cathelicidin LL-37 augments epithelial response to LPS by facilitating its delivery to TLR4-containing intracellular compartments. We found that LL-37 significantly increases uptake of LPS by ECs with subsequent targeting to cholera toxin subunit B-labeled structures and lysosomes. This uptake is peptide specific, dose and time dependent, and involves the endocytotic machinery, functional lipid rafts, and epidermal growth factor receptor signaling. Cathelicidin-dependent LPS internalization resulted in significant increased release of the inflammatory cytokines IL-6 and IL-8. This indicates that, in ECs, this peptide may replace LPS-binding protein functions. In polarized ECs, the effect of LL-37 was restricted to the basolateral compartment of the epithelial membrane, suggesting that LL-37-mediated activation of ECs by LPS may be relevant to disease conditions associated with damage to the epithelial barrier. In summary, our study identified a novel role of LL-37 in host-microbe interactions as a host factor that licenses mucosal ECs to respond to LPS.-Shaykhiev, R., Sierigk, J., Herr, C., Krasteva, G., Kummer, W., Bals, R. The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS. FASEB J. 24, 4756-4766 (2010). www.fasebj.org	[Herr, Christian; Bals, Robert] Dept Internal Med V Pulmonol, D-66421 Homburg, Germany; [Shaykhiev, Renat; Sierigk, Johannes; Herr, Christian; Bals, Robert] Univ Marburg, Dept Internal Med, UGMLC, Div Pulmonol,Univ Hosp Giessen & Marburg, D-3550 Marburg, Germany; [Krasteva, Gabriela; Kummer, Wolfgang] Univ Giessen, UGMLC, Inst Anat & Cell Biol, Giessen, Germany	Philipps University Marburg; University Hospital of Giessen & Marburg; Justus Liebig University Giessen	Bals, R (corresponding author), Dept Internal Med V Pulmonol, D-66421 Homburg, Germany.	robert.bals@uks.eu	Krasteva-Christ, Gabriela/K-7253-2015; Krasteva-Christ, Gabriela/CAI-9036-2022; Shaykhiev, Renat/D-2855-2011; Herr, Christian/AAH-5291-2021	Krasteva-Christ, Gabriela/0000-0002-0113-521X; Krasteva-Christ, Gabriela/0000-0002-0113-521X; Herr, Christian/0000-0001-9422-6569; Kummer, Wolfgang/0000-0002-3946-0683	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft (DFG) [Ba 1641/8, SFB/TR 22 A8]; Excellence Cluster CardioPulmonary System (DFG); Medical Faculty of the Justus-Liebig-University (Giessen, Germany)	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Excellence Cluster CardioPulmonary System (DFG)(German Research Foundation (DFG)); Medical Faculty of the Justus-Liebig-University (Giessen, Germany)	The authors thank Prof. Dr. Jurgen Behr (University of Munich, Munich, Germany) for providing ECs and Thomas Damm and Annette Puchner for excellent technical assistance. This study was funded by the Bundesministerium fur Bildung und Forschung (PROGRESS, C1; ASCONET/COSYCONET) to R.B., by the Deutsche Forschungsgemeinschaft (DFG; Ba 1641/8 and SFB/TR 22 A8) to R.B., and by the Excellence Cluster CardioPulmonary System (DFG) to W. K. G. K. was supported by a postdoctoral stipend from the DFG Excellence Cluster CardioPulmonary System and a young scientist's grant from the Medical Faculty of the Justus-Liebig-University (Giessen, Germany).	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Agerberth B, 1999, AM J RESP CRIT CARE, V160, P283, DOI 10.1164/ajrccm.160.1.9807041; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Bals Robert, 2004, J Cyst Fibros, V3 Suppl 2, P49, DOI 10.1016/j.jcf.2004.05.010; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Felgentreff K, 2006, PEPTIDES, V27, P3100, DOI 10.1016/j.peptides.2006.07.018; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hornef MW, 2005, J ENDOTOXIN RES, V11, P124, DOI 10.1179/096805105X35224; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Hoshino K, 1999, J IMMUNOL, V162, P3749; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Kirikae T, 1998, INFECT IMMUN, V66, P1861, DOI 10.1128/IAI.66.5.1861-1868.1998; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nejsum LN, 2009, FRONT BIOSCI-LANDMRK, V14, P1088, DOI 10.2741/3295; Pang H, 2004, J CELL SCI, V117, P1421, DOI 10.1242/jcs.01009; Polosa R, 1999, AM J RESP CELL MOL, V20, P914, DOI 10.1165/ajrcmb.20.5.3308; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Triantafilou M, 2002, J CELL SCI, V115, P2603; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	58	32	34	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4756	4766		10.1096/fj.09-151332	http://dx.doi.org/10.1096/fj.09-151332			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20696857				2022-12-25	WOS:000284824400016
J	Takegahara, N; Kang, SJ; Nojima, S; Takamatsu, H; Okuno, T; Kikutani, H; Toyofuku, T; Kumanogoh, A				Takegahara, Noriko; Kang, Sujin; Nojima, Satoshi; Takamatsu, Hyota; Okuno, Tatsusada; Kikutani, Hitoshi; Toyofuku, Toshihiko; Kumanogoh, Atsushi			Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements	FASEB JOURNAL			English	Article						small GTPases; integrin; bone resorption	ALDRICH-SYNDROME PROTEIN; BONE-RESORPTION; MATRIX DEGRADATION; DENDRITIC CELLS; KINASE-ACTIVITY; RHO GTPASES; ORGANIZATION; INVADOPODIA; ADHESION; DYNAMICS	Podosomes are recently rediscovered highly dynamic actin-rich structural and functional modules that form close contact with the surrounding substrate. They play a role in the control of migration, tissue invasion, and matrix remodeling of highly motile cells, including lymphocytes, macrophages, dendritic cells, and osteoclasts. In osteoclasts, the compaction of podosomes induces the formation of a tight adhesive contact, the sealing zone, which defines a subosteoclastic environment specialized for bone resorption. Integrins and the Rho family small GTPases are key regulators of podosome rearrangements. However, it remains to be determined how the activation of integrins and Rho family GTPases is regulated during osteoclast podosome rearrangements. Here, we demonstrate a crucial role for the FERM domain-containing guanine nucleotide exchange factor (GEF), FARP2, in osteoclast podosome rearrangements and resorbing activity. We determine by live cell imaging and biochemical assays that FARP2 is required for localized activation of GTP-bound Rac1 into podosome-ring like structures. In addition, FARP2 is relevant to integrin beta 3 activity during osteoclastogenesis. Furthermore, FARP2 deficiency results in reduced formation of multinucleated osteoclasts and resorption pits compared to wild-type osteoclasts (controls). Collectively, our findings reveal an integral role of FARP2 for regulation of Rac1 and integrin beta 3 throughout podosome rearrangement in osteoclastogenesis.-Takegahara, N., Kang, S., Nojima, S., Takamatsu, H., Okuno, T., Kikutani, H., Toyofuku, T., Kumanogoh, A. Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements. FASEB J. 24, 4782-4792 (2010). www.fasebj.org	[Toyofuku, Toshihiko] Osaka Univ, Dept Immunopathol, World Premier Int Res Ctr, Immunol Frontier Res Ctr,Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Kikutani, Hitoshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 565, Japan; [Takegahara, Noriko] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Osaka University; Osaka University; University of Pennsylvania	Toyofuku, T (corresponding author), Osaka Univ, Dept Immunopathol, World Premier Int Res Ctr, Immunol Frontier Res Ctr,Res Inst Microbial Dis, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	toyofuku@ragtime.biken.osaka-u.ac.jp; kumanogo@ragtime.biken.osaka-u.ac.jp	Takegahara, Noriko/AAP-1694-2021		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare; National Institute of Biomedical Innovation; CREST; Japan Science and Technology Agency; Takeda Scientific Foundation; Asahi Glass Foundation; Mochida Memorial Foundation; Kato Memorial Bioscience Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Asahi Glass Foundation; Mochida Memorial Foundation; Kato Memorial Bioscience Foundation; Naito Foundation(Naito Memorial Foundation)	The authors thank T. Yazawa and T. Ishikawa for technical support. The authors are grateful to Y. Baba for critical advice, discussion, and encouragement. The authors are also grateful to Michiyuki Matsuda (Kyoto University, Kyoto, Japan) for providing materials. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Japan Society for the Promotion of Science to N.T., T.T. and A.K.; the Ministry of Health, Labor and Welfare, the program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, CREST, and the Target Protein Research Program of the Japan Science and Technology Agency to A.K.; the Takeda Scientific Foundation, the Asahi Glass Foundation, and the Mochida Memorial Foundation to N.T. and A.K; and the Kato Memorial Bioscience Foundation and the Naito Foundation to N.T.	Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Boettiger D, 2001, J BIOL CHEM, V276, P31684, DOI 10.1074/jbc.M103997200; Brass LF, 2008, ARTERIOSCL THROM VAS, V28, pS43, DOI 10.1161/ATVBAHA.107.161026; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Brown JA, 2009, MOL BIOL CELL, V20, P1167, DOI 10.1091/mbc.E08-01-0065; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Calle Y, 2004, J PATHOL, V204, P460, DOI 10.1002/path.1651; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Carman CV, 2008, CURR OPIN CELL BIOL, V20, P533, DOI 10.1016/j.ceb.2008.05.007; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Chou HC, 2006, CURR BIOL, V16, P2337, DOI 10.1016/j.cub.2006.10.037; CLOVER J, 1992, J CELL SCI, V103, P267; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Evans JG, 2006, EUR J CELL BIOL, V85, P145, DOI 10.1016/j.ejcb.2005.08.006; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Koyano Y, 1997, BIOCHEM BIOPH RES CO, V241, P369, DOI 10.1006/bbrc.1997.7826; Kubo T, 2002, J NEUROSCI, V22, P8504; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; NESBITT S, 1993, J BIOL CHEM, V268, P16737; Ory S, 2000, J CELL SCI, V113, P1177; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Spinardi L, 2006, EUR J CELL BIOL, V85, P191, DOI 10.1016/j.ejcb.2005.08.005; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	44	32	33	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4782	4792		10.1096/fj.10-158212	http://dx.doi.org/10.1096/fj.10-158212			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20702777				2022-12-25	WOS:000284824400018
J	An, LL; Wang, YL; Liu, YH; Yang, XA; Liu, CC; Hu, ZS; He, W; Song, WX; Hang, HY				An, Lili; Wang, Yulan; Liu, Yuheng; Yang, Xiao; Liu, Chunchun; Hu, Zhishang; He, Wei; Song, Wenxia; Hang, Haiying			Rad9 Is Required for B Cell Proliferation and Immunoglobulin Class Switch Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; MISMATCH REPAIR; GENOMIC INSTABILITY; CHECKPOINT COMPLEX; FISSION YEAST; S-PHASE; DAMAGE; CLAMP; HOMOLOGS; DELETION	B cell maturation and B cell-mediated antibody response require programmed DNA modifications such as the V(D)J recombination, the immunoglobulin (Ig) class switch recombination, and the somatic hypermutation to generate functional Igs. Many protein factors involved in DNA damage repair have been shown to be critical for the maturation and activation of B cells. Rad9 plays an important role in both DNA repair and cell cycle checkpoint control. However, its role in Ig generation has not been reported. In this study, we generated a conditional knock-out mouse line in which Rad9 is deleted specifically in B cells and investigated the function of Rad9 in B cells. The Rad9(-/-) B cells isolated from the conditional knock-out mice displayed impaired growth response and enhanced DNA lesions. Impaired Ig production in response to immunization in Rad9(-/-) mice was also detected. In addition, the Ig class switch recombination is deficient in Rad9(-/-) B cells. Taken together, Rad9 plays dual roles in generating functional antibodies and in maintaining the integrity of the whole genome in B cells.	[Hang, Haiying] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [An, Lili; Wang, Yulan; Liu, Yuheng; Yang, Xiao; Liu, Chunchun; Hu, Zhishang; He, Wei; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Ctr Computat & Syst Biol, Beijing 100101, Peoples R China; [Song, Wenxia] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University System of Maryland; University of Maryland College Park	Hang, HY (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	hh91@sun5.ibp.ac.cn	He, Wei/K-4776-2014		National Natural Science Foundation of China [30700407, 30530180]; National Protein Project of Ministry of Science and Technology [2006CB910902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Protein Project of Ministry of Science and Technology	This work was supported by National Natural Science Foundation of China Grant 30700407, National Natural Science Foundation of China Grant 30530180, and National Protein Project of Ministry of Science and Technology Grant 2006CB910902.	Bai HB, 2010, DNA REPAIR, V9, P478, DOI 10.1016/j.dnarep.2010.01.011; Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Bessho T, 2000, J BIOL CHEM, V275, P7451, DOI 10.1074/jbc.275.11.7451; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Chang DY, 2005, J BIOL CHEM, V280, P408, DOI 10.1074/jbc.M406800200; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; He W, 2008, NUCLEIC ACIDS RES, V36, P6406, DOI 10.1093/nar/gkn686; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Hu Z, 2008, CANCER RES, V68, P5552, DOI 10.1158/0008-5472.CAN-07-5670; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; LIEBERMAN HB, 1992, MOL GEN GENET, V232, P367, DOI 10.1007/BF00266239; Lu AL, 2006, FRONT BIOSCI-LANDMRK, V11, P3062, DOI 10.2741/2033; MURRAY JM, 1991, NUCLEIC ACIDS RES, V19, P3525, DOI 10.1093/nar/19.13.3525; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Revy P, 2005, ADV IMMUNOL, V87, P237, DOI 10.1016/S0065-2776(05)87007-5; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schrader CE, 2009, PHILOS T R SOC B, V364, P645, DOI 10.1098/rstb.2008.0200; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Xu Y, 2006, NAT REV IMMUNOL, V6, P261, DOI 10.1038/nri1804	37	16	17	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35267	35273		10.1074/jbc.M110.161208	http://dx.doi.org/10.1074/jbc.M110.161208			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20729201	Green Published, hybrid			2022-12-25	WOS:000283845300004
J	Pittelli, M; Formentini, L; Faraco, G; Lapucci, A; Rapizzi, E; Cialdai, F; Romano, G; Moneti, G; Moroni, F; Chiarugi, A				Pittelli, Maria; Formentini, Laura; Faraco, Giuseppe; Lapucci, Andrea; Rapizzi, Elena; Cialdai, Francesca; Romano, Giovanni; Moneti, Gloriano; Moroni, Flavio; Chiarugi, Alberto			Inhibition of Nicotinamide Phosphoribosyltransferase CELLULAR BIOENERGETICS REVEALS A MITOCHONDRIAL INSENSITIVE NAD POOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE; BIOSYNTHESIS INHIBITOR; DEPLETION; METABOLISM; FK866; DEATH; CELLS; IDENTIFICATION; LOCALIZATION; ACTIVATION	The NAD rescue pathway consists of two enzymatic steps operated by nicotinamide phosphoribosyltransferase (Nampt) and nicotinamide mononucleotide adenylyltransferases. Recently, the potent Nampt inhibitor FK866 has been identified and evaluated in clinical trials against cancer. Yet, how Nampt inhibition affects NAD contents and bioenergetics is in part obscure. It is also unknown whether NAD rescue takes place in mitochondria, and FK866 alters NAD homeostasis within the organelle. Here, we show that FK866-dependent reduction of the NAD contents is paralleled by a concomitant increase of ATP in various cell types, in keeping with ATP utilization for NAD resynthesis. We also show that poly-and mono(ADP-ribose) transferases rather than Sirt-1 are responsible for NAD depletion in HeLa cells exposed to FK866. Mass spectrometry reveals that the drug distributes in the cytosolic and mitochondrial compartment. However, the cytoplasmic but not the mitochondrial NAD pool is reduced upon acute or chronic exposure to the drug. Accordingly, Nampt does not localize within the organelles and their bioenergetics is not affected by the drug. In the mouse, FK866-dependent reduction of NAD contents in various organs is prevented by inhibitors of poly(ADP-ribose) polymerases or the NAD precursor kynurenine. For the first time, our data indicate that mitochondria lack the canonical NAD rescue pathway, broadening current understanding of cellular bioenergetics.	[Pittelli, Maria; Formentini, Laura; Faraco, Giuseppe; Lapucci, Andrea; Moroni, Flavio; Chiarugi, Alberto] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Cialdai, Francesca; Romano, Giovanni] Univ Florence, Laser Ctr Med Applicat CEO, I-50139 Florence, Italy; [Rapizzi, Elena] Univ Florence, Dept Clin Physiopathol, I-50139 Florence, Italy; [Moneti, Gloriano] Univ Florence, Interdept Ctr Mass Spectrometry, I-50139 Florence, Italy	University of Florence; University of Florence; University of Florence; University of Florence	Chiarugi, A (corresponding author), Viale Pieraccini 6, I-50139 Florence, Italy.	alberto.chiarugi@unifi.it	Lapucci, Andrea/AAA-6645-2019; Faraco, Giuseppe/AAP-6784-2020	Faraco, Giuseppe/0000-0001-8675-4580; LAPUCCI, Andrea/0000-0001-9613-7164; Formentini, Laura/0000-0001-5641-821X; Romano, Giovanni/0000-0001-8442-6671	Fondazione Giuseppe Tomasello ONLUS; Italian Ministry of Research and Technology; Associazione Italiana Sclerosi Multipla (AISM); University of Florence; Ente Cassa di Risparmio di Firenze	Fondazione Giuseppe Tomasello ONLUS; Italian Ministry of Research and Technology; Associazione Italiana Sclerosi Multipla (AISM)(Fondazione Italiana Sclerosi Multipla (FISM)); University of Florence; Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by grants from the Fondazione Giuseppe Tomasello ONLUS, Italian Ministry of Research and Technology (Prin 2007), Associazione Italiana Sclerosi Multipla (AISM), University of Florence, and Ente Cassa di Risparmio di Firenze.	Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Brenner C, 2005, STRUCTURE, V13, P1239, DOI 10.1016/j.str.2005.08.004; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Chance B, 2004, METHOD ENZYMOL, V385, P361; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Di Girolamo M, 2005, FEBS J, V272, P4565, DOI 10.1111/j.1742-4658.2005.04876.x; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Formentini L, 2009, J BIOL CHEM, V284, P17668, DOI 10.1074/jbc.M109.002931; Galli M, 2010, CANCER RES, V70, P8, DOI 10.1158/0008-5472.CAN-09-2465; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kang GB, 2009, MOL CELLS, V27, P667, DOI 10.1007/s10059-009-0088-x; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; SMETS LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P49, DOI 10.1016/0167-4889(90)90204-Q; Szabo C, 2006, TRENDS PHARMACOL SCI, V27, P626, DOI 10.1016/j.tips.2006.10.003; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Van Gool F, 2009, M S-MED SCI, V25, P551, DOI 10.1051/medsci/2009256-7551; Wosikowski K, 2002, CANCER RES, V62, P1057; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	54	141	146	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34106	34114		10.1074/jbc.M110.136739	http://dx.doi.org/10.1074/jbc.M110.136739			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20724478	Green Published, hybrid			2022-12-25	WOS:000283354000056
J	Zheng, YL; Amin, ND; Hu, YF; Rudrabhatla, P; Shukla, V; Kanungo, J; Kesavapany, S; Grant, P; Albers, W; Pant, HC				Zheng, Ya-Li; Amin, Niranjana D.; Hu, Ya-Fang; Rudrabhatla, Parvathi; Shukla, Varsha; Kanungo, Jyotshnabala; Kesavapany, Sashi; Grant, Philip; Albers, Wayne; Pant, Harish C.			A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; CELL-CYCLE; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; TRANSGENIC MODEL; A-BETA; PROTEIN; PHOSPHORYLATION; P25; NEUROFILAMENT	The activity of Cdk5-p35 is tightly regulated in the developing and mature nervous system. Stress-induced cleavage of the activator p35 to p25 and a p10 N-terminal domain induces deregulated Cdk5 hyperactivity and perikaryal aggregations of hyperphosphorylated Tau and neurofilaments, pathogenic hallmarks in neurodegenerative diseases, such as Alzheimer disease and amyotrophic lateral sclerosis, respectively. Previously, we identified a 125-residue truncated fragment of p35 called CIP that effectively and specifically inhibited Cdk5-p25 activity and Tau hyperphosphorylation induced by A beta peptides in vitro, in HEK293 cells, and in neuronal cells. Although these results offer a possible therapeutic approach to those neurodegenerative diseases assumed to derive from Cdk5-p25 hyperactivity and/or A beta induced pathology, CIP is too large for successful therapeutic regimens. To identify a smaller, more effective peptide, in this study we prepared a 24-residue peptide, p5, spanning CIP residues Lys(245)-Ala(277). p5 more effectively inhibited Cdk5-p25 activity than did CIP in vitro. In neuron cells, p5 inhibited deregulated Cdk5-p25 activity but had no effect on the activity of endogenous Cdk5-p35 or on any related endogenous cyclin-dependent kinases in HEK293 cells. Specificity of p5 inhibition in cortical neurons may depend on the p10 domain in p35, which is absent in p25. Furthermore, we have demonstrated that p5 reduced A beta(1-42)-induced Tau hyperphosphorylation and apoptosis in cortical neurons. These results suggest that p5 peptide may be a unique and useful candidate for therapeutic studies of certain neurodegenerative diseases.	[Zheng, Ya-Li; Amin, Niranjana D.; Rudrabhatla, Parvathi; Shukla, Varsha; Grant, Philip; Albers, Wayne; Pant, Harish C.] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Zheng, Ya-Li] Ningxia Peoples Hosp, Dept Nephrol, Ningxia 750021, Peoples R China; [Hu, Ya-Fang] NIDCR, Lab Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Kanungo, Jyotshnabala] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Kesavapany, Sashi] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117697, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); US Food & Drug Administration (FDA); National University of Singapore	Pant, HC (corresponding author), NINDS, Neurochem Lab, NIH, Bldg 49,Rm 2A28,9000 Rockville Pike, Bethesda, MD 20892 USA.	panth@ninds.nih.gov	Shukla, Varsha/G-5136-2010	Rudrabhatla, Parvathi/0000-0002-7537-3130	National Institutes of Health, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003104] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, intramural funds.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Alvarez A, 1999, FEBS LETT, V459, P421, DOI 10.1016/S0014-5793(99)01279-X; Alvarez A, 2001, EXP CELL RES, V264, P266, DOI 10.1006/excr.2001.5152; Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; Fischer A, 2003, CNS NEUROL DISORD-DR, V2, P375, DOI 10.2174/1568007033482706; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Glicksman MA, 2007, CURR ALZHEIMER RES, V4, P547, DOI 10.2174/156720507783018181; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; He LS, 2008, J BIOL CHEM, V283, P13252, DOI 10.1074/jbc.M706937200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Helal CJ, 2009, BIOORG MED CHEM LETT, V19, P5703, DOI 10.1016/j.bmcl.2009.08.019; Helal CJ, 2004, ORG LETT, V6, P1853, DOI 10.1021/ol049416y; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; Kanungo J, 2009, CELL MOL NEUROBIOL, V29, P1073, DOI 10.1007/s10571-009-9410-6; Kanungo J, 2009, BIOCHEM BIOPH RES CO, V386, P263, DOI 10.1016/j.bbrc.2009.06.038; Kanungo J, 2009, NEUROCHEM RES, V34, P1129, DOI 10.1007/s11064-008-9885-4; Kesavapany S, 2004, BBA-PROTEINS PROTEOM, V1697, P143, DOI 10.1016/j.bbapap.2003.11.020; Kesavapany Sashi, 2007, Biotechnology Journal, V2, P978, DOI 10.1002/biot.200700057; Kesavapany S, 2006, NEUROSIGNALS, V15, P157, DOI 10.1159/000095130; Knockaert M, 2002, J BIOL CHEM, V277, P25493, DOI 10.1074/jbc.M202651200; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lau LF, 2002, J MOL NEUROSCI, V19, P267, DOI 10.1385/JMN:19:3:267; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lim ACB, 2003, NEUROSIGNALS, V12, P230, DOI 10.1159/000074625; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; Liu M, 2008, BIOCHEMISTRY-US, V47, P8367, DOI 10.1021/bi800732v; Luque FA, 2009, INT REV NEUROBIOL, V84, P151, DOI 10.1016/S0074-7742(09)00408-5; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ohshima T, 1999, J NEUROSCI, V19, P6017, DOI 10.1523/JNEUROSCI.19-14-06017.1999; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 2001, NATURE, V411, P764, DOI 10.1038/35081149; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Rudrabhatla P, 2008, J BIOL CHEM, V283, P26737, DOI 10.1074/jbc.M801633200; Shea TB, 2004, J NEUROSCI RES, V76, P795, DOI 10.1002/jnr.20099; Shiradkar MR, 2007, BIOORGAN MED CHEM, V15, P6397, DOI 10.1016/j.bmc.2007.06.053; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Smith Wanli W., 2006, CNS & Neurological Disorders-Drug Targets, V5, P355, DOI 10.2174/187152706784111515; Tang D, 1996, Prog Cell Cycle Res, V2, P205; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Tsai LH, 2004, BBA-PROTEINS PROTEOM, V1697, P137, DOI 10.1016/j.bbapap.2003.11.019; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Veeranna, 1998, J NEUROSCI, V18, P4008; Webber KM, 2005, MECH AGEING DEV, V126, P1019, DOI 10.1016/j.mad.2005.03.024; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4; Zheng YL, 2007, MOL BIOL CELL, V18, P404, DOI 10.1091/mbc.E06-09-0851; Zheng YL, 2005, EMBO J, V24, P209, DOI 10.1038/sj.emboj.7600441; Zheng YL, 2003, J BIOL CHEM, V278, P24026, DOI 10.1074/jbc.M303079200; Zheng YL, 2002, EUR J BIOCHEM, V269, P4427, DOI 10.1046/j.1432-1033.2002.03133.x; Zhu YS, 2005, J NEUROCHEM, V94, P1535, DOI 10.1111/j.1471-4159.2005.03301.x	74	66	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34202	34212		10.1074/jbc.M110.134643	http://dx.doi.org/10.1074/jbc.M110.134643			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20720012	Green Published, hybrid			2022-12-25	WOS:000283354000065
J	Frank, CL; Ge, XC; Xie, ZG; Zhou, Y; Tsai, LH				Frank, Christopher L.; Ge, Xuecai; Xie, Zhigang; Zhou, Ying; Tsai, Li-Huei			Control of Activating Transcription Factor 4 (ATF4) Persistence by Multisite Phosphorylation Impacts Cell Cycle Progression and Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATED STRESS-RESPONSE; SCF UBIQUITIN LIGASE; SYNAPTIC PLASTICITY; GENE-EXPRESSION; TARGETED DISRUPTION; MEMORY; PHASE; MICE; OVEREXPRESSION; DEGRADATION	Organogenesis is a highly integrated process with a fundamental requirement for precise cell cycle control. Mechanistically, the cell cycle is composed of transitions and thresholds that are controlled by coordinated post-translational modifications. In this study, we describe a novel mechanism controlling the persistence of the transcription factor ATF4 by multisite phosphorylation. Proline-directed phosphorylation acted additively to regulate multiple aspects of ATF4 degradation. Stabilized ATF4 mutants exhibit decreased beta-TrCP degron phosphorylation, beta-TrCP interaction, and ubiquitination, as well as elicit early G(1) arrest. Expression of stabilized ATF4 also had significant consequences in the developing neocortex. Mutant ATF4 expressing cells exhibited positioning and differentiation defects that were attributed to early G(1) arrest, suggesting that neurogenesis is sensitive to ATF4 dosage. We propose that precise regulation of the ATF4 dosage impacts cell cycle control and impinges on neurogenesis.	[Frank, Christopher L.; Ge, Xuecai; Xie, Zhigang; Zhou, Ying; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Tsai, Li-Huei] Broad Inst Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Tsai, Li-Huei] MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Xie, Zhigang] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Xie, Zhigang] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Boston University; Boston University	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lhtsai@mit.edu		Xie, Zhigang/0000-0002-5794-2977	RIKEN; Howard Hughes Medical Institute	RIKEN; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by RIKEN and the Howard Hughes Medical Institute.	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heidebrecht HJ, 2001, LAB INVEST, V81, P1163, DOI 10.1038/labinvest.3780328; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Miyama S, 1997, CEREB CORTEX, V7, P678, DOI 10.1093/cercor/7.7.678; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Ritter B, 2004, DEV BRAIN RES, V149, P73, DOI 10.1016/j.devbrainres.2003.12.006; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sequeira SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000615; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Tarui T, 2005, CEREB CORTEX, V15, P1343, DOI 10.1093/cercor/bhi017; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vernon E, 2001, MOL CELL NEUROSCI, V17, P637, DOI 10.1006/mcne.2000.0960; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yukawa K, 1999, MOL BRAIN RES, V69, P124, DOI 10.1016/S0169-328X(99)00086-8	41	53	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33324	33337		10.1074/jbc.M110.140699	http://dx.doi.org/10.1074/jbc.M110.140699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724472	Green Published, hybrid			2022-12-25	WOS:000283048200068
J	Ishikawa, M; Nishijima, N; Shiota, J; Sakagami, H; Tsuchida, K; Mizukoshi, M; Fukuchi, M; Tsuda, M; Tabuchi, A				Ishikawa, Mitsuru; Nishijima, Naoki; Shiota, Jun; Sakagami, Hiroyuki; Tsuchida, Kunihiro; Mizukoshi, Miho; Fukuchi, Mamoru; Tsuda, Masaaki; Tabuchi, Akiko			Involvement of the Serum Response Factor Coactivator Megakaryoblastic Leukemia (MKL) in the Activin-regulated Dendritic Complexity of Rat Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE DIFFERENTIATION; TRANSCRIPTION FACTOR-B; MESSENGER-RNA; ADULT NEUROGENESIS; GENE-TRANSCRIPTION; SYNAPTIC ACTIVITY; SRF; BRAIN; BETA; HIPPOCAMPUS	Dynamic changes in neuronal morphology and transcriptional regulation play crucial roles in the neuronal network and function. Accumulating evidence suggests that the megakaryoblastic leukemia (MKL) family members, which function not only as actin-binding proteins but also as serum response factor (SRF) transcriptional coactivators, regulate neuronal morphology. However, the extracellular ligands and signaling pathways, which activate MKL-mediated morphological changes in neurons, remain unresolved. Here, we demonstrate that in addition to MKL1, MKL2, highly enriched in the forebrain, strongly contributes to the dendritic complexity, and this process is triggered by stimulation with activin, a member of the transforming growth factor beta (TGF-beta) superfamily. Activin promoted dendritic complexity in a SRF- and MKL-dependent manner without drastically affecting MKL localization and protein levels. In contrast, activin promoted the nuclear export of suppressor of cancer cell invasion (SCAI), which is a corepressor for SRF and MKL. Furthermore, overexpression of SCAI blocked activin-induced SRF transcriptional responses and dendritic complexity. Collectively, these results strongly suggest that activin-SCAI-MKL signaling is a novel pathway that regulates the dendritic morphology of rat cortical neurons by excluding SCAI from the nucleus and activating MKL/SRF-mediated gene expression.	[Ishikawa, Mitsuru; Nishijima, Naoki; Shiota, Jun; Mizukoshi, Miho; Fukuchi, Mamoru; Tsuda, Masaaki; Tabuchi, Akiko] Toyama Univ, Dept Biol Chem, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Sakagami, Hiroyuki] Kitasato Univ, Dept Anat, Sch Med, Kanagawa 2288555, Japan; [Tsuchida, Kunihiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Aichi 4701192, Japan	University of Toyama; Kitasato University; Fujita Health University	Tabuchi, A (corresponding author), Toyama Univ, Dept Biol Chem, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	atabuchi@pha.u-toyama.ac.jp	Ishikawa, Mitsuru/L-1822-2013; Tsuchida, Kunihiro/A-4501-2012	Tsuchida, Kunihiro/0000-0002-3983-5756; Fukuchi, Mamoru/0000-0002-6807-8707	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17790055, 19790052, 22590080, 20390023]; Hayashi Memorial Foundation for Female Natural Scientists; Foundation of the First Bank of Toyama; Takeda Science Foundation; Narishige Neuroscience Research Foundation; Tokyo Biochemical Research Foundation; Uehara Memorial Foundation; Comprehensive Brain Science Network	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Foundation of the First Bank of Toyama; Takeda Science Foundation(Takeda Science Foundation (TSF)); Narishige Neuroscience Research Foundation; Tokyo Biochemical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Comprehensive Brain Science Network	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Projects 17790055, 19790052, 22590080 (A. T.) and 20390023 (M. T.)) and by research grants from the Hayashi Memorial Foundation for Female Natural Scientists (A. T.), Foundation of the First Bank of Toyama (A. T.), the Takeda Science Foundation (A. T.), the Narishige Neuroscience Research Foundation (A. T.), the Tokyo Biochemical Research Foundation (A. T.), the Uehara Memorial Foundation (A. T.), and by the Comprehensive Brain Science Network.	Ageta H, 2010, LEARN MEMORY, V17, P176, DOI 10.1101/lm.16659010; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fukuchi M, 2004, J BIOL CHEM, V279, P47856, DOI 10.1074/jbc.M409090200; Funaba M, 1997, J NEUROENDOCRINOL, V9, P105, DOI 10.1046/j.1365-2826.1997.00558.x; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Ishimaru N, 2007, J NEUROCHEM, V100, P520, DOI 10.1111/j.1471-4159.2006.04216.x; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; O'Sullivan NC, 2010, CEREB CORTEX, V20, P1915, DOI 10.1093/cercor/bhp262; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Sakagami H, 1998, MOL BRAIN RES, V54, P311, DOI 10.1016/S0169-328X(97)00362-8; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sekiguchi M, 2009, NEUROSCI LETT, V452, P232, DOI 10.1016/j.neulet.2009.01.074; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Shiota J, 2006, J NEUROCHEM, V98, P1778, DOI 10.1111/j.1471-4159.2006.03992.x; Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tabuchi A, 2005, J NEUROCHEM, V94, P169, DOI 10.1111/j.1471-4159.2005.03179.x; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yasuda M, 2007, J NEUROCHEM, V103, P626, DOI 10.1111/j.1471-4159.2007.04851.x; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zheng F, 2009, MOL PSYCHIATR, V14, P332, DOI 10.1038/sj.mp.4002131	49	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32734	32743		10.1074/jbc.M110.118745	http://dx.doi.org/10.1074/jbc.M110.118745			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20709749	Green Published, hybrid			2022-12-25	WOS:000283048200008
J	Alessio, N; Squillaro, T; Cipollaro, M; Bagella, L; Giordano, A; Galderisi, U				Alessio, N.; Squillaro, T.; Cipollaro, M.; Bagella, L.; Giordano, A.; Galderisi, U.			The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways	ONCOGENE			English	Article						stem cells; senescence; apoptosis; p53; retinoblastoma; chromatin	RETINOBLASTOMA PROTEIN; STROMAL CELLS; DNA-REPAIR; TUMOR-SUPPRESSOR; GROWTH ARREST; P53; DIFFERENTIATION; APOPTOSIS; BINDING; GENE	We focused our attention on brahma-related gene 1 (BRG1), the ATPase subunit of the SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex, and analyzed its role in mesenchymal stem cell (MSC) biology. We hypothesized that deviation from the correct concentration of these proteins, which act at the highest level of gene regulation, may be deleterious for cells. We wanted to know what would happen if a cell had to cope with altered regulation of gene expression, either by upregulation or downregulation of BRG1. We assumed that cells would try to restore homeostasis or, alternatively, that the event could trigger senescence/apoptosis phenomena. To this end, in MSCs, we silenced BRG1gene. Knockdown of BRG1 expression induced a significant increase in senescent cells and decrease in apoptotic cells. It is interesting that BRG1 downregulation also induced an increase in heterochromatin. At the molecular level, these phenomena were associated with activation of retinoblastoma-like protein 2 (RB2)/P130-and P53-related pathways. Senescence was accompanied by reduced expression of some stemness-related genes. This is consistent with our previous research, which showed that BRG1 upregulation by ectopic expression also induced senescence processes. Together, these data suggest that BRG1 belongs to a class of genes whose expression is tightly regulated; hence, subtle alterations in BRG1 activity seem to negatively affect mechanisms regulating chromatin status and, in turn, impair cellular physiology. Oncogene (2010) 29, 5452-5463; doi:10.1038/onc.2010.285; published online 9 August 2010	[Cipollaro, M.; Galderisi, U.] Univ Naples 2, Biotechnol & Mol Biol Sect, Dept Expt Med, I-80138 Naples, Italy; [Alessio, N.; Squillaro, T.; Bagella, L.; Giordano, A.; Galderisi, U.] Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Alessio, N.; Bagella, L.] Univ Sassari, Dept Biomed Sci, Div Biochem & Biophys, I-07100 Sassari, Italy; [Squillaro, T.] Univ Siena, I-53100 Siena, Italy; [Giordano, A.] Univ Siena, Human Pathol & Oncol Dept, I-53100 Siena, Italy; [Giordano, A.] Human Hlth Fdn, Spoleto, Italy	Universita della Campania Vanvitelli; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Sassari; University of Siena; University of Siena	Galderisi, U (corresponding author), Univ Naples 2, Biotechnol & Mol Biol Sect, Dept Expt Med, Via Costantinopoli 16, I-80138 Naples, Italy.	umberto.galderisi@unina2.it	Giordano, Antonio/F-1927-2010; Alessio, Nicola/K-2119-2018	Giordano, Antonio/0000-0002-5959-016X; Alessio, Nicola/0000-0002-5019-2130; GALDERISI, Umberto/0000-0003-0909-7403; BAGELLA, Luigi/0000-0003-2815-037X; Cipollaro, Marilena/0000-0003-4350-4324	SHRO	SHRO	This work was partially supported by SHRO funds to UG and AG. We thank Maria Rosaria Cipollaro for technical assistance. We thank Dr Francesca Pentimalli for helpful discussion.; Author contributions: Tiziana Squillaro: conception and design, performed experiments; Nicola Alessio: conception and design, performed experiments; Marilena Cipollaro: assembly of data, data analysis and interpretation; Luigi Bagella: provision of study material, data analysis and interpretation and financial support; Antonio Giordano: conception and design, data analysis and interpretation and financial support; Umberto Galderisi: conception and design, data analysis and interpretation, paper writing and financial support.	Alves H, 2009, J CELL MOL MED; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Diggle CP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng083; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Fotedar R, 2004, CELL CYCLE, V3, P134; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Galderisi U, 1999, J CELL BIOCHEM, V73, P97, DOI 10.1002/(SICI)1097-4644(19990401)73:1<97::AID-JCB11>3.0.CO;2-M; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Hao MM, 1996, J BIOL CHEM, V271, P29380, DOI 10.1074/jbc.271.46.29380; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hill R, 2008, CELL CYCLE, V7, P2535; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lu H, 1997, MOL CELL BIOL, V17, P5923, DOI 10.1128/MCB.17.10.5923; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Marsden VS, 2006, BLOOD, V107, P1872, DOI 10.1182/blood-2005-05-2160; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; MORAN E, 1993, FASEB J, V7, P880, DOI 10.1096/fasebj.7.10.8344487; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; MULLERSIEBURG CE, 1995, STEM CELLS, V13, P477, DOI 10.1002/stem.5530130505; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Naidu SR, 2009, ONCOGENE, V28, P2492, DOI 10.1038/onc.2009.121; Napolitano MA, 2007, J CELL SCI, V120, P2904, DOI 10.1242/jcs.004002; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Ronen A, 2001, ENVIRON MOL MUTAGEN, V37, P241, DOI 10.1002/em.1033; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; von Zglinicki T, 2001, EXP GERONTOL, V36, P1049, DOI 10.1016/S0531-5565(01)00111-5; WANG HGH, 1995, J VIROL, V69, P7917, DOI 10.1128/JVI.69.12.7917-7924.1995; WANG HGH, 1993, J VIROL, V67, P4804, DOI 10.1128/JVI.67.8.4804-4813.1993; Wesierska-Gadek J, 2005, CELL MOL BIOL LETT, V10, P439; Yu K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000129; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	67	37	40	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	40					5452	5463		10.1038/onc.2010.285	http://dx.doi.org/10.1038/onc.2010.285			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	664FM	20697355				2022-12-25	WOS:000282945800003
J	Qian, T; Lee, JY; Park, JH; Kim, HJ; Kong, G				Qian, T.; Lee, J-Y; Park, J-H; Kim, H-J; Kong, G.			Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex	ONCOGENE			English	Article						Id1; polycomb group proteins; E3 ubiquitin ligase	CELL-CYCLE PROGRESSION; ESOPHAGEAL CANCER-CELLS; NF-KAPPA-B; BREAST-CANCER; PROTEASOME PATHWAY; STEM-CELLS; TRANSCRIPTIONAL REPRESSION; H2A UBIQUITYLATION; SIGNALING PATHWAY; DEPENDENT MANNER	The helix-loop-helix inhibitor of differentiation and DNA binding (Id1) is well known as an oncogene in various tumors. Although it has been reported that Id1 promotes several oncogenic processes, it is still unclear whether Id1 functions through epigenetic transcriptional regulation. In this study, we examined the effect of Id1 on polycomb group (PcG) proteins, which are crucial epigenetic gene silencers, and found that Id1 regulated the expression of Mel-18 and Bmi-1, both of which belong to polycomb repressive complex 1. We also confirmed that Id1 induced Mel-18 downregulation, which was mediated by the Akt pathway, and consequently upregulated the transcription of its target gene, c-Myc. Using a promoter-reporter, we demonstrated that Id1 regulated Bmi-1 transcription through c-Myc binding to its E-box in the promoter. Finally, we examined the activity of E3 ligase RING1b, whose catalytic activity is increased by binding with the RING finger protein Bmi-1, and found that Id1 overexpression enhanced RING1b E3 ligase activity leading to accumulation of H2A ubiquitination and ubiquitin/proteasome-mediated degradation of geminin. Taken together, our study provided a novel link between Id1 and PcG proteins and suggested that Id1 may contribute to tumor development through PcG-mediated epigenetic regulation. Oncogene (2010) 29, 5818-5827; doi: 10.1038/onc.2010.317; published online 9 August 2010	[Qian, T.; Park, J-H; Kim, H-J; Kong, G.] Hanyang Univ, Dept Pathol, Coll Med, Seoul 133791, South Korea; [Lee, J-Y; Kong, G.] Hanyang Univ, Inst Bioengn & Biopharmaceut Res, Seoul 133791, South Korea	Hanyang University; Hanyang University	Kong, G (corresponding author), Hanyang Univ, Dept Pathol, Coll Med, 17 Haengdang Dong, Seoul 133791, South Korea.	gkong@hanyang.ac.kr			Korean Government (MOEHRD) [KRF-2007-314-E00041]; Korean government (MEST) [20090081874]	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a Korea Research Foundation Grant (KRF-2007-314-E00041) funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) and a Korea Science and Engineering Foundation grant funded by the Korean government (MEST) (No. 20090081874).	Bernardi R, 2000, ONCOGENE, V19, P2447, DOI 10.1038/sj.onc.1203564; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Calses C, 2008, MOL CELL BIOL, V28, P1018, DOI 10.1128/MCB.01136-07; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Choi YS, 2005, MOL CELLS, V20, P241; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Gao HD, 2007, MOL CELL BIOCHEM, V305, P35, DOI 10.1007/s11010-007-9525-3; Geng H, 2010, CANCER RES, V70, P3239, DOI 10.1158/0008-5472.CAN-09-3186; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; Hattori T, 2003, GENES CELLS, V8, P889, DOI 10.1046/j.1365-2443.2003.00684.x; Jang KS, 2006, CANCER LETT, V244, P203, DOI 10.1016/j.canlet.2005.12.016; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Kim H, 2008, BREAST CANCER RES TR, V112, P287, DOI 10.1007/s10549-007-9871-6; Kim HJ, 2007, MOL CANCER RES, V5, P321, DOI 10.1158/1541-7786.MCR-06-0218; Kroll KL, 2007, FRONT BIOSCI, V12, P1395, DOI 10.2741/2156; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lee JY, 2009, ONCOGENE, V28, P824, DOI 10.1038/onc.2008.451; Lee JY, 2008, CANCER RES, V68, P4201, DOI 10.1158/0008-5472.CAN-07-2570; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li B, 2007, CARCINOGENESIS, V28, P2313, DOI 10.1093/carcin/bgm152; Li B, 2009, INT J CANCER, V125, P2576, DOI 10.1002/ijc.24675; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Lin JZ, 2010, CLIN CANCER RES, V16, P77, DOI 10.1158/1078-0432.CCR-08-2362; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Matsuo Fumie, 2002, Breast Cancer, V9, P33, DOI 10.1007/BF02967544; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Ohtsubo M, 2008, P NATL ACAD SCI USA, V105, P10396, DOI 10.1073/pnas.0800672105; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Singh J, 2002, ONCOGENE, V21, P1812, DOI 10.1038/sj.onc.1205252; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhao J, 2000, J CELL SCI, V113, P4363; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	46	16	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	43					5818	5827		10.1038/onc.2010.317	http://dx.doi.org/10.1038/onc.2010.317			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	672LY	20697353				2022-12-25	WOS:000283586200007
J	Cinner, JE; Bodin, O				Cinner, Joshua E.; Bodin, Orjan			Livelihood Diversification in Tropical Coastal Communities: A Network-Based Approach to Analyzing 'Livelihood Landscapes'	PLOS ONE			English	Article							ECONOMIC-GROWTH; INCOME DIVERSIFICATION; SOCIAL RESILIENCE; MARINE; DETERMINANTS; CONSERVATION; STRATEGIES; BIODIVERSITY; MANAGEMENT; FISHERIES	Background: Diverse livelihood portfolios are frequently viewed as a critical component of household economies in developing countries. Within the context of natural resources governance in particular, the capacity of individual households to engage in multiple occupations has been shown to influence important issues such as whether fishers would exit a declining fishery, how people react to policy, the types of resource management systems that may be applicable, and other decisions about natural resource use. Methodology/Principal Findings: This paper uses network analysis to provide a novel methodological framework for detailed systemic analysis of household livelihood portfolios. Paying particular attention to the role of natural resource-based occupations such as fisheries, we use network analyses to map occupations and their interrelationships-what we refer to as 'livelihood landscapes'. This network approach allows for the visualization of complex information about dependence on natural resources that can be aggregated at different scales. We then examine how the role of natural resource-based occupations changes along spectra of socioeconomic development and population density in 27 communities in 5 western Indian Ocean countries. Network statistics, including in-and out-degree centrality, the density of the network, and the level of network centralization are compared along a multivariate index of community-level socioeconomic development and a gradient of human population density. The combination of network analyses suggests an increase in household-level specialization with development for most occupational sectors, including fishing and farming, but that at the community-level, economies remained diversified. Conclusions/Significance: The novel modeling approach introduced here provides for various types of livelihood portfolio analyses at different scales of social aggregation. Our livelihood landscapes approach provides insights into communities' dependencies and usages of natural resources, and shows how patterns of occupational interrelationships relate to socioeconomic development and population density. A key question for future analysis is how the reduction of household occupational diversity, but maintenance of community diversity we see with increasing socioeconomic development influences key aspects of societies' vulnerability to environmental change or disasters.	[Cinner, Joshua E.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bodin, Orjan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Bodin, Orjan] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden	James Cook University; Stockholm University; Stockholm University	Cinner, JE (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	joshua.cinner@jcu.edu.au	Cinner, Joshua/AAA-6823-2021; Bodin, Örjan/A-5098-2010; Cinner, Joshua e/E-8966-2011	Bodin, Örjan/0000-0002-8218-1153; Cinner, Joshua e/0000-0003-2675-9317	Western Indian Ocean Marine Science Association; Australian Academy of Science; Stockholm Resilience Center; Beijer Institute for Ecological Economics; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Foundation for Strategic Environmental Research (Mistra)	Western Indian Ocean Marine Science Association; Australian Academy of Science; Stockholm Resilience Center; Beijer Institute for Ecological Economics; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Foundation for Strategic Environmental Research (Mistra)	This research was funded by the Western Indian Ocean Marine Science Association and the collaboration supported by the Australian Academy of Science, the Stockholm Resilience Center, and the Beijer Institute for Ecological Economics. The second author received funding from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), and the Foundation for Strategic Environmental Research (Mistra). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulai A, 2001, FOOD POLICY, V26, P437, DOI 10.1016/S0306-9192(01)00013-6; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; [Anonymous], 2006, TOURISM GLOBAL ENV C; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Barrett CB, 2001, FOOD POLICY, V26, P315, DOI 10.1016/S0306-9192(01)00014-8; Barrett CB, 2001, FOOD POLICY, V26, P367, DOI 10.1016/S0306-9192(01)00017-3; Bene C, 2010, WORLD DEV, V38, P933, DOI 10.1016/j.worlddev.2009.12.010; Berkes F, 2005, ECOSYSTEMS, V8, P967, DOI 10.1007/s10021-005-0140-4; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; Borgatti SP, UCINET WINDOWS SOFTW; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Boserup E., 1965, CONDITIONS AGR GROWT; Butts CT, 2006, SOC NETWORKS, V28, P283, DOI 10.1016/j.socnet.2005.07.003; CAMPBELL DJ, 1990, FOOD FOODWAYS, V4, P143; Carrier James G., 1989, WAGE TRADE EXCHANGE; Carter MR, 1997, ECON DEV CULT CHANGE, V45, P557, DOI 10.1086/452291; CHIROT D, 1982, ANNU REV SOCIOL, V8, P81, DOI 10.1146/annurev.so.08.080182.000501; Cinner JE, 2007, CORAL REEFS, V26, P1035, DOI 10.1007/s00338-007-0213-2; Cinner JE, 2010, MAR POLICY, V34, P22, DOI 10.1016/j.marpol.2009.04.003; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner J, 2009, ECOL SOC, V14; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Clausen R, 2008, SOC SCI RES, V37, P1310, DOI 10.1016/j.ssresearch.2007.10.002; Clausen R, 2008, CONSERV BIOL, V22, P458, DOI 10.1111/j.1523-1739.2007.00851.x; Coulthard S, 2008, GLOBAL ENVIRON CHANG, V18, P479, DOI 10.1016/j.gloenvcha.2008.04.003; Degenne A., 1999, INTRO SOCIAL NETWORK, DOI 10.4135/9781849209373; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Ellis F, 2000, J AGR ECON, V51, P289, DOI 10.1111/j.1477-9552.2000.tb01229.x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; GROSSMAN GM, 1993, MEXICO-U.S. FREE TRADE AGREEMENT, P13; GROSSMAN GM, 1995, Q J ECON, V110, P353, DOI 10.2307/2118443; Henry G.T., 1990, PRACTICAL SAMPLING, V21; Jansen HGP, 2006, AGR SYST, V88, P92, DOI 10.1016/j.agsy.2005.06.005; Koczberski G, 2005, AGR SYST, V85, P324, DOI 10.1016/j.agsy.2005.06.014; Kuznets S, 1955, AM ECON REV, V45, P1; Leach M, 1999, WORLD DEV, V27, P225, DOI 10.1016/S0305-750X(98)00141-7; Marshall NA, 2007, RURAL SOCIOL, V72, P359, DOI 10.1526/003601107781799254; Marshall NA, 2007, ECOL SOC, V12, DOI 10.5751/es-01940-120101; McClanahan TR, 2009, CONSERV BIOL, V23, P662, DOI 10.1111/j.1523-1739.2008.01154.x; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; Niehof A, 2004, FOOD POLICY, V29, P321, DOI 10.1016/j.foodpol.2004.07.009; Pender J, 2004, FOOD POLICY, V29, P339, DOI 10.1016/j.foodpol.2004.07.005; POLLNAC RB, 1998, RAPID ASSESSMENT MAN; Pomeroy RS, 2006, MAR POLICY, V30, P786, DOI 10.1016/j.marpol.2006.02.003; Rigg J, 1998, PROG HUM GEOG, V22, P497, DOI 10.1191/030913298667432980; Salafsky N, 2000, WORLD DEV, V28, P1421, DOI 10.1016/S0305-750X(00)00031-0; SEN A, 1981, Q J ECON, V96, P433, DOI 10.2307/1882681; Start D., 2005, RURAL TRANSFORMATION; Van Der Kooij A.J., 2007, PREDICTION ACCURACY; VANDERGEEST P, 1988, WORLD DEV, V16, P683, DOI 10.1016/0305-750X(88)90175-1; Wasserman S., 1994, SOCIAL NETWORK ANAL; York R, 2003, AM SOCIOL REV, V68, P279, DOI 10.2307/1519769	52	101	104	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e11999	10.1371/journal.pone.0011999	http://dx.doi.org/10.1371/journal.pone.0011999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637WJ	20711442	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000280849100004
J	Gannon, PO; Godin-Ethier, J; Hassler, M; Delvoye, N; Aversa, M; Poisson, AO; Peant, B; Fahmy, MA; Saad, F; Lapointe, R; Mes-Masson, AM				Gannon, Philippe O.; Godin-Ethier, Jessica; Hassler, Matthew; Delvoye, Nathalie; Aversa, Meghan; Poisson, Alexis O.; Peant, Benjamin; Fahmy, Mona Alam; Saad, Fred; Lapointe, Rejean; Mes-Masson, Anne-Marie			Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; L-ARGININE; TESTOSTERONE; INFILTRATION; CATABOLISM; POLYAMINES; RESPONSES; BENIGN; GENE; RNA	Background: Prostate cancer (PCa) is the most frequently diagnosed cancer in North American men. Androgen-deprivation therapy (ADT) accentuates the infiltration of immune cells within the prostate. However, the immunosuppressive pathways regulated by androgens in PCa are not well characterized. Arginase 2 (ARG2) expression by PCa cells leads to a reduced activation of tumor-specific T cells. Our hypothesis was that androgens could regulate the expression of ARG2 by PCa cells. Methodology/Principal Findings: In this report, we demonstrate that both ARG1 and ARG2 are expressed by hormone-sensitive (HS) and hormone-refractory (HR) PCa cell lines, with the LNCaP cells having the highest arginase activity. In prostate tissue samples, ARG2 was more expressed in normal and non-malignant prostatic tissues compared to tumor tissues. Following androgen stimulation of LNCaP cells with 10 nM R1881, both ARG1 and ARG2 were overexpressed. The regulation of arginase expression following androgen stimulation was dependent on the androgen receptor (AR), as a siRNA treatment targeting the AR inhibited both ARG1 and ARG2 overexpression. This observation was correlated in vivo in patients by immunohistochemistry. Patients treated by ADT prior to surgery had lower ARG2 expression in both nonmalignant and malignant tissues. Furthermore, ARG1 and ARG2 were enzymatically active and their decreased expression by siRNA resulted in reduced overall arginase activity and L-arginine metabolism. The decreased ARG1 and ARG2 expression also translated with diminished LNCaP cells cell growth and increased PBMC activation following exposure to LNCaP cells conditioned media. Finally, we found that interleukin-8 (IL-8) was also upregulated following androgen stimulation and that it directly increased the expression of ARG1 and ARG2 in the absence of androgens. Conclusion/Significance: Our data provides the first detailed in vitro and in vivo account of an androgen-regulated immunosuppressive pathway in human PCa through the expression of ARG1, ARG2 and IL-8.	[Gannon, Philippe O.; Godin-Ethier, Jessica; Delvoye, Nathalie; Aversa, Meghan; Poisson, Alexis O.; Peant, Benjamin; Fahmy, Mona Alam; Saad, Fred; Lapointe, Rejean; Mes-Masson, Anne-Marie] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Gannon, Philippe O.; Godin-Ethier, Jessica; Delvoye, Nathalie; Aversa, Meghan; Poisson, Alexis O.; Peant, Benjamin; Fahmy, Mona Alam; Saad, Fred; Lapointe, Rejean; Mes-Masson, Anne-Marie] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Hassler, Matthew] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Saad, Fred] Univ Montreal, CHUM, Dept Surg, Montreal, PQ, Canada; [Lapointe, Rejean; Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal	Gannon, PO (corresponding author), Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada.	fred.saad@umontreal.ca; rejean.lapointe@umontreal.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Peant, Benjamin/0000-0001-5090-0558	Sanofi Aventis; Canadian Uro-Oncology Group/AstraZeneca; Prostate Cancer Research Foundation of Canada; University of Montreal Chair in Prostate Cancer; Fonds de recherche en sante du Quebec (FRSQ); FRSQ; Institut du cancer de Montreal/Canderel; Universite de Montreal	Sanofi Aventis(Sanofi-Aventis); Canadian Uro-Oncology Group/AstraZeneca(AstraZeneca); Prostate Cancer Research Foundation of Canada; University of Montreal Chair in Prostate Cancer; Fonds de recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Institut du cancer de Montreal/Canderel; Universite de Montreal	The research was supported by a Sanofi Aventis research grant (F.S.), by a Canadian Uro-Oncology Group/AstraZeneca research award (F.S.) and by a grant from the Prostate Cancer Research Foundation of Canada (R.L.). The funders had no role in study design, data collection and analysis, data sharing, decision to publish, or preparation of the manuscript. Furthermore, F.S. holds the University of Montreal Chair in Prostate Cancer. R.L. is supported by a fellowship from the Fonds de recherche en sante du Quebec (FRSQ). P.O.G. is a recipient of a Ph.D. studentship from the FRSQ and received additional support from the Institut du cancer de Montreal/Canderel scholarship and from the Molecular Biology program of the Universite de Montreal.	Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Buga GM, 1998, AM J PHYSIOL-REG I, V275, pR1256, DOI 10.1152/ajpregu.1998.275.4.R1256; Chang SS, 2009, BJU INT, V103, P8, DOI 10.1111/j.1464-410X.2008.08256.x; Diallo JS, 2008, BRIT J CANCER, V99, P1613, DOI 10.1038/sj.bjc.6604730; Diallo JS, 2007, CLIN CANCER RES, V13, P7044, DOI 10.1158/1078-0432.CCR-07-1224; Gannon PO, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-18; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Gannon PO, 2006, PROSTATE, V66, P1710, DOI 10.1002/pros.20466; Godin-Ethier J, 2009, J IMMUNOL, V183, P7752, DOI 10.4049/jimmunol.0901004; Gopalakrishnan V, 1996, ANAL CHEM, V68, P3520, DOI 10.1021/ac960613n; Grandvaux N, 2005, FEBS J, V272, P3120, DOI 10.1111/j.1742-4658.2005.04726.x; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; HARRIS BE, 1983, CANCER RES, V43, P3008; JEMAL A, 2008, CA-CANCER J CLIN, V96, P58, DOI DOI 10.3322/CA.2007.0010; JIMMUNOL, 1963, J IMMUNOL, V3771, P3777; Kee K, 2004, J BIOL CHEM, V279, P27050, DOI 10.1074/jbc.M403323200; Keskinege A, 2001, CANCER DETECT PREV, V25, P76; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; Le Page C, 2005, PROSTATE, V65, P306, DOI 10.1002/pros.20291; LEPAGE C, 2006, BRIT J CANCER, V1912, P1; Lessard L, 2007, CELL SIGNAL, V19, P1093, DOI 10.1016/j.cellsig.2006.12.012; Levillain O, 2005, ENDOCRINOLOGY, V146, P950, DOI 10.1210/en.2004-1199; Lin MF, 2000, CELL BIOL INT, V24, P681, DOI 10.1006/cbir.2000.0433; Lu S, 2007, MOL CANCER THER, V6, P2057, DOI 10.1158/1535-7163.MCT-06-0735; MANTEUFFELCYMBOROWSKA M, 1995, INT J BIOCHEM CELL B, V27, P287, DOI 10.1016/1357-2725(94)00070-R; Mercader M, 2001, P NATL ACAD SCI USA, V98, P14565, DOI 10.1073/pnas.251140998; Miller AM, 2007, CANCER IMMUNOL IMMUN, V56, P81, DOI 10.1007/s00262-005-0110-x; Montironi R, 1998, J CLIN PATHOL, V51, P5, DOI 10.1136/jcp.51.1.5; Mumenthaler SM, 2008, INT J ONCOL, V32, P357; MUMENTHALER SM, 2008, DISRUPTION ARGINASE; MUNDER M, 1999, REGULATED EXPRESSION, V16, pTH1; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Olszewska A, 2007, FUNGAL GENET BIOL, V44, P1285, DOI 10.1016/j.fgb.2007.07.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRETLOW TG, 1985, CANCER RES, V45, P442; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Singh R, 2000, CANCER RES, V60, P3305; Tate DJ, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-14; XU QL, 1993, EUR J BIOCHEM, V211, P891, DOI 10.1111/j.1432-1033.1993.tb17622.x; YAMANAKA H, 1975, AM J PHYSIOL, V229, P1102, DOI 10.1152/ajplegacy.1975.229.4.1102	44	35	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12107	10.1371/journal.pone.0012107	http://dx.doi.org/10.1371/journal.pone.0012107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711410	Green Published, Green Submitted, gold			2022-12-25	WOS:000280849100026
J	Ning, K; Fermin, D				Ning, Kang; Fermin, Damian			SAW: A Method to Identify Splicing Events from RNA-Seq Data Based on Splicing Fingerprints	PLOS ONE			English	Article							IDENTIFICATION	Splicing event identification is one of the most important issues in the comprehensive analysis of transcription profile. Recent development of next-generation sequencing technology has generated an extensive profile of alternative splicing. However, while many of these splicing events are between exons that are relatively close on genome sequences, reads generated by RNA-Seq are not limited to alternative splicing between close exons but occur in virtually all splicing events. In this work, a novel method, SAW, was proposed for the identification of all splicing events based on short reads from RNA-Seq. It was observed that short reads not in known gene models are actually absent words from known gene sequences. An efficient method to filter and cluster these short reads by fingerprint fragments of splicing events without aligning short reads to genome sequences was developed. Additionally, the possible splicing sites were also determined without alignment against genome sequences. A consensus sequence was then generated for each short read cluster, which was then aligned to the genome sequences. Results demonstrated that this method could identify more than 90% of the known splicing events with a very low false discovery rate, as well as accurately identify, a number of novel splicing events between distant exons.	[Ning, Kang; Fermin, Damian] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ning, K (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	albertnk@gmail.com	Ning, Kang/ABD-3446-2020	Ning, Kang/0000-0003-3325-5387				Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; De Bona F, 2008, BIOINFORMATICS, V24, pI174, DOI 10.1093/bioinformatics/btn300; Elenitoba-Johnson KSJ, 2006, P NATL ACAD SCI USA, V103, P7402, DOI 10.1073/pnas.0506514103; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mo F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-537; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pinho AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-137; Trapnell C, 2009, BIOINFORMATICS; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wheeler DJ., 1994, DIGITAL SRC RES REPO	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12047	10.1371/journal.pone.0012047	http://dx.doi.org/10.1371/journal.pone.0012047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706591	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900011
J	Hur, YS; Kim, KD; Paek, SH; Yoo, SH				Hur, Yong Suk; Kim, Ki Deok; Paek, Sun Ha; Yoo, Seung Hyun			Evidence for the Existence of Secretory Granule (Dense-Core Vesicle)-Based Inositol 1,4,5-Trisphosphate-Dependent Ca2+ Signaling System in Astrocytes	PLOS ONE			English	Article							DEPENDENT GLUTAMATE RELEASE; CHROMOGRANIN-SECRETOGRANIN FAMILY; CYTOSOLIC CALCIUM OSCILLATIONS; FIBRILLARY ACIDIC PROTEIN; ADRENAL CHROMAFFIN CELLS; CULTURED ASTROCYTES; RECEPTOR/CA2+ CHANNEL; D-SERINE; HIPPOCAMPAL ASTROCYTES; ENDOPLASMIC-RETICULUM	Background: The gliotransmitters released from astrocytes are deemed to play key roles in the glial cell-neuron communication for normal function of the brain. The gliotransmitters, such as glutamate, ATP, D-serine, neuropeptide Y, are stored in vesicles of astrocytes and secreted following the inositol 1,4,5-trisphosphate (IP3)-induced intracellular Ca2+ releases. Yet studies on the identity of the IP3-dependent intracellular Ca2+ stores remain virtually unexplored. Principal Findings: We have therefore studied the potential existence of the IP3-sensitive intracellular Ca2+ stores in the cytoplasm of astrocytes using human brain tissue samples in contrast to cultured astrocytes that had primarily been used in the past. It was thus found that secretory granule marker proteins chromogranins and secretogranin II localize in the large dense core vesicles of astrocytes, thereby confirming the large dense core vesicles as bona fide secretory granules. Moreover, consistent with the major IP3-dependent intracellular Ca2+ store role of secretory granules in secretory cells, secretory granules of astrocytes also contained all three (types 1, 2, and 3) IP3R isoforms. Significance: Given that the secretory granule marker proteins chromogranins and secretogranin II are high-capacity, low-affinity Ca2+ storage proteins and chromogranins interact with the IP(3)Rs to activate the IP3R/Ca2+ channels, i.e., increase both the mean open time and the open probability of the channels, these results imply that secretory granules of astrocytes function as the IP3-sensitive intracellular Ca2+ store.	[Hur, Yong Suk; Kim, Ki Deok; Yoo, Seung Hyun] Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea; [Paek, Sun Ha] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea	Inha University; Seoul National University (SNU)	Hur, YS (corresponding author), Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea.	shyoo@inha.ac.kr	Paek, Sun Ha/J-2760-2012	HUR, YONGSUK/0000-0002-4069-7338	Brain Korea 21 Program of the Republic of Korea	Brain Korea 21 Program of the Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	The present work was funded in part by the Brain Korea 21 Program of the Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Anouar Y, 1996, FEBS LETT, V394, P295, DOI 10.1016/0014-5793(96)00976-3; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; BETTICA A, 1990, J HISTOCHEM CYTOCHEM, V38, P103, DOI 10.1177/38.1.2152935; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; BLONDEL O, 1995, TRENDS NEUROSCI, V18, P157, DOI 10.1016/0166-2236(95)93894-4; BLONDEL O, 1994, P NATL ACAD SCI USA, V91, P7777, DOI 10.1073/pnas.91.16.7777; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; CASEY RP, 1977, BIOCHEMISTRY-US, V16, P972, DOI 10.1021/bi00624a025; Chen XK, 2005, J NEUROSCI, V25, P9236, DOI 10.1523/JNEUROSCI.1640-05.2005; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Crippa D, 2006, J PHYSIOL-LONDON, V570, P567, DOI 10.1113/jphysiol.2005.094052; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Fellin Tommaso, 2006, Novartis Found Symp, V276, P208; FISCHERCOLBRIE R, 1990, J BIOL CHEM, V265, P9208; FISCHERCOLBRIE R, 1987, ANN NY ACAD SCI, V493, P120, DOI 10.1111/j.1749-6632.1987.tb27189.x; FISCHERCOLBRIE R, 1993, J NEUROCHEM, V60, P2312, DOI 10.1111/j.1471-4159.1993.tb03520.x; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; GERDES HH, 1989, J BIOL CHEM, V264, P12009; HAIGH JR, 1989, BIOCHEM J, V259, P485, DOI 10.1042/bj2590485; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HELLE KB, 1990, NEUROCHEM INT, V17, P165, DOI 10.1016/0197-0186(90)90139-K; Hua X, 2004, J NEUROSCI RES, V76, P86, DOI 10.1002/jnr.20061; Huh YH, 2007, BIOCHEMISTRY-US, V46, P14032, DOI 10.1021/bi701364p; Huh YH, 2006, BIOCHEMISTRY-US, V45, P1212, DOI 10.1021/bi051594r; Huh YH, 2005, FEBS LETT, V579, P5145, DOI 10.1016/j.febslet.2005.08.025; Huh YH, 2005, FEBS LETT, V579, P2597, DOI 10.1016/j.febslet.2005.03.076; Huh YH, 2005, BIOCHEMISTRY-US, V44, P6122, DOI 10.1021/bi048070w; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; Innocenti B, 2000, J NEUROSCI, V20, P1800; Jeremic A, 2001, J NEUROCHEM, V77, P664, DOI 10.1046/j.1471-4159.2001.00272.x; JOHNSON RG, 1976, J BIOL CHEM, V251, P2189; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kang SS, 2010, CANCER RES, V70, P1173, DOI 10.1158/0008-5472.CAN-09-2886; KENNEDY PGE, 1980, LAB INVEST, V43, P342; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kreft M, 2004, GLIA, V46, P437, DOI 10.1002/glia.20018; Krzan M, 2003, J NEUROSCI, V23, P1580; Maienschein V, 1999, GLIA, V26, P233, DOI 10.1002/(SICI)1098-1136(199905)26:3<233::AID-GLIA5>3.0.CO;2-2; Majo G, 1998, LIFE SCI, V62, P607, DOI 10.1016/S0024-3205(97)01156-9; Martineau M, 2008, GLIA, V56, P1271, DOI 10.1002/glia.20696; MARUYAMA Y, 1994, CELL CALCIUM, V16, P419, DOI 10.1016/0143-4160(94)90035-3; MARUYAMA Y, 1993, EMBO J, V12, P3017, DOI 10.1002/j.1460-2075.1993.tb05970.x; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Montana V, 2006, GLIA, V54, P700, DOI 10.1002/glia.20367; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; Paco S, 2009, J NEUROCHEM, V110, P143, DOI 10.1111/j.1471-4159.2009.06116.x; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Park HY, 2002, BIOCHEMISTRY-US, V41, P1259, DOI 10.1021/bi0156963; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Potokar M, 2008, GLIA, V56, P135, DOI 10.1002/glia.20597; Quesada I, 2003, BIOPHYS J, V85, P963, DOI 10.1016/S0006-3495(03)74535-4; Ramamoorthy P, 2008, J NEUROSCI, V28, P13815, DOI 10.1523/JNEUROSCI.5361-07.2008; Santello M, 2009, NEUROSCIENCE, V158, P253, DOI 10.1016/j.neuroscience.2008.03.039; SantoDomingo J, 2008, EUR J NEUROSCI, V28, P1265, DOI 10.1111/j.1460-9568.2008.06440.x; SCHIMMEL A, 1992, FEBS LETT, V314, P375, DOI 10.1016/0014-5793(92)81509-K; Srivastava M, 1999, P NATL ACAD SCI USA, V96, P13783, DOI 10.1073/pnas.96.24.13783; Striedinger K, 2007, GLIA, V55, P652, DOI 10.1002/glia.20494; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7; Xie L, 2006, TRAFFIC, V7, P429, DOI 10.1111/j.1600-0854.2006.00401.x; Yoo SH, 2007, BIOCHEMISTRY-US, V46, P14663, DOI 10.1021/bi701339m; Yoo SH, 2010, FASEB J, V24, P653, DOI 10.1096/fj.09-132456; YOO SH, 1995, BIOCHEMISTRY-US, V34, P8680, DOI 10.1021/bi00027a017; Yoo SH, 2000, J BIOL CHEM, V275, P12553, DOI 10.1074/jbc.275.17.12553; YOO SH, 1994, J BIOL CHEM, V269, P12001; Yoo SH, 2005, FEBS LETT, V579, P222, DOI 10.1016/j.febslet.2004.11.079; Yoo SH, 1996, J BIOL CHEM, V271, P17041, DOI 10.1074/jbc.271.29.17041; Yoo SH, 2002, J BIOL CHEM, V277, P16011, DOI 10.1074/jbc.M105594200; Yoo SH, 2001, J BIOL CHEM, V276, P45806, DOI 10.1074/jbc.M107532200; YOO SH, 1991, J BIOL CHEM, V266, P7740; YOO SH, 1990, J BIOL CHEM, V265, P13446; Yoo SH, 2000, J BIOL CHEM, V275, P15067, DOI 10.1074/jbc.M909391199; Yoo SH, 2000, TRENDS NEUROSCI, V23, P424, DOI 10.1016/S0166-2236(00)01621-0; Yoo SH, 2000, J BIOL CHEM, V275, P30293, DOI 10.1074/jbc.M001204200; Zhang XH, 2009, J NEUROSCI, V29, P7766, DOI 10.1523/JNEUROSCI.0389-09.2009; Zonta M, 2003, J PHYSIOL-LONDON, V553, P407, DOI 10.1113/jphysiol.2003.046706	94	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11973	10.1371/journal.pone.0011973	http://dx.doi.org/10.1371/journal.pone.0011973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700485	Green Published, Green Submitted, gold			2022-12-25	WOS:000280605400013
J	Kuizon, S; DiMaiuta, K; Walus, M; Jenkins, EC; Kuizon, M; Kida, E; Golabek, AA; Espinoza, DO; Pullarkat, RK; Junaid, MA				Kuizon, Salomon; DiMaiuta, Kathleen; Walus, Marius; Jenkins, Edmund C., Jr.; Kuizon, Marisol; Kida, Elizabeth; Golabek, Adam A.; Espinoza, Daniel O.; Pullarkat, Raju K.; Junaid, Mohammed A.			A Critical Tryptophan and Ca2+ in Activation and Catalysis of TPPI, the Enzyme Deficient in Classic Late-Infantile Neuronal Ceroid Lipofuscinosis	PLOS ONE			English	Article							TRIPEPTIDYL-PEPTIDASE-I; PEPSTATIN-INSENSITIVE PROTEINASE; MOUSE MODEL; SUBUNIT C; CLN2; DIAGNOSIS; ASSAY; PROTEASE; DISEASE; LINCL	Background: Tripeptidyl aminopeptidase I (TPPI) is a crucial lysosomal enzyme that is deficient in the fatal neurodegenerative disorder called classic late-infantile neuronal ceroid lipofuscinosis (LINCL). It is involved in the catabolism of proteins in the lysosomes. Recent X-ray crystallographic studies have provided insights into the structural/functional aspects of TPPI catalysis, and indicated presence of an octahedrally coordinated Ca2+. Methodology: Purified precursor and mature TPPI were used to study inhibition by NBS and EDTA using biochemical and immunological approaches. Site-directed mutagenesis with confocal imaging technique identified a critical W residue in TPPI activity, and the processing of precursor into mature enzyme. Principal Findings: NBS is a potent inhibitor of the purified TPPI. In mammalian TPPI, W542 is critical for tripeptidyl peptidase activity as well as autocatalysis. Transfection studies have indicated that mutants of the TPPI that harbor residues other than W at position 542 have delayed processing, and are retained in the ER rather than transported to lysosomes. EDTA inhibits the autocatalytic processing of the precursor TPPI. Conclusions/Significance: We propose that W542 and Ca2+ are critical for maintaining the proper tertiary structure of the precursor proprotein as well as the mature TPPI. Additionally, Ca2+ is necessary for the autocatalytic processing of the precursor protein into the mature TPPI. We have identified NBS as a potent TPPI inhibitor, which led in delineating a critical role for W542 residue. Studies with such compounds will prove valuable in identifying the critical residues in the TPPI catalysis and its structure-function analysis.	[Kuizon, Salomon; DiMaiuta, Kathleen; Jenkins, Edmund C., Jr.; Kuizon, Marisol; Pullarkat, Raju K.; Junaid, Mohammed A.] New York State Inst Basic Res Dev Disabil, Dept Dev Biochem, Staten Isl, NY 10314 USA; [Walus, Marius; Kida, Elizabeth; Golabek, Adam A.] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [Espinoza, Daniel O.] New York State Inst Basic Res Dev Disabil, Dept Mol Biol, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities	Kuizon, S (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Dev Biochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	mohammed.junaid@omr.state.ny.us		Jenkins, Edmund/0000-0002-6448-090X	New York State Office of Mental Retardation and Developmental Disabilities; National Institutes of Health [R01 NS047355]	New York State Office of Mental Retardation and Developmental Disabilities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by funds from the New York State Office of Mental Retardation and Developmental Disabilities, and the National Institutes of Health Grant R01 NS047355 (to A. A. G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altorjay A, 2005, WORLD J GASTROENTERO, V11, P5751, DOI 10.3748/wjg.v11.i37.5751; Autefage H, 2009, J BIOL CHEM, V284, P11507, DOI 10.1074/jbc.M807151200; Boustany R., 1996, HDB CLIN NEUROLOGY, V66, P671; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Elleder M, 1997, ACTA NEUROPATHOL, V93, P379, DOI 10.1007/s004010050629; Elleder M, 2008, ACTA NEUROPATHOL, V116, P119, DOI 10.1007/s00401-008-0349-3; Ezaki J, 2000, BIOCHEM BIOPH RES CO, V268, P904, DOI 10.1006/bbrc.2000.2207; FREISHEIM JH, 1969, BIOCHEMISTRY-US, V8, P2271, DOI 10.1021/bi00834a006; GALLAGHER T, 1993, PROTEINS, V16, P205, DOI 10.1002/prot.340160207; Golabek AA, 2003, J BIOL CHEM, V278, P7135, DOI 10.1074/jbc.M211872200; Golabek AA, 2008, J BIOL CHEM, V283, P16497, DOI 10.1074/jbc.M800458200; Golabek AA, 2006, BIOL CHEM, V387, P1091, DOI 10.1515/BC.2006.135; Guhaniyogi J, 2009, J BIOL CHEM, V284, P3985, DOI 10.1074/jbc.M806943200; IPPOLITO JA, 1990, J MOL BIOL, V215, P457, DOI 10.1016/S0022-2836(05)80364-X; Junaid MA, 2000, J NEUROCHEM, V74, P287, DOI 10.1046/j.1471-4159.2000.0740287.x; Junaid MA, 1999, NEUROSCI LETT, V264, P157, DOI 10.1016/S0304-3940(99)00095-6; Junaid MA, 2000, INT J BIOL MARKER, V15, P129, DOI 10.1177/172460080001500201; Junaid MA, 1999, CLIN CHIM ACTA, V281, P169, DOI 10.1016/S0301-2115(98)00333-9; Junaid MA, 2001, ADV GENET, V45, P93, DOI 10.1016/S0065-2660(01)45005-X; KIDA E, J NEUROPATHOL EXP NE, V60, P280; Kleijer WJ, 2001, PRENATAL DIAG, V21, P99, DOI 10.1002/1097-0223(200102)21:2<99::AID-PD988>3.0.CO;2-F; Kurachi Y, 2000, NEUROLOGY, V54, P1676, DOI 10.1212/WNL.54.8.1676; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Liu CG, 1998, GENOMICS, V50, P206, DOI 10.1006/geno.1998.5328; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundblad R.L., 2005, CHEM REAGENTS PROTEI, P247; Mitchison HM, 1999, NEUROBIOL DIS, V6, P321, DOI 10.1006/nbdi.1999.0267; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2004, BRAIN PATHOL, V14, P70, DOI 10.1111/j.1750-3639.2004.tb00500.x; Pal A, 2009, J BIOL CHEM, V284, P3976, DOI 10.1074/jbc.M806947200; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Passini MA, 2006, J NEUROSCI, V26, P1334, DOI 10.1523/JNEUROSCI.2676-05.2006; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Ramachandran L.K., 1967, METHOD ENZYMOL, V11, P283; Rawlings ND, 1999, BBA-PROTEIN STRUCT M, V1429, P496, DOI 10.1016/S0167-4838(98)00238-6; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sleat DE, 2008, MOL GENET METAB, V94, P222, DOI 10.1016/j.ymgme.2008.01.014; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sleat DE, 1998, BIOCHEM J, V334, P547, DOI 10.1042/bj3340547; Sohar I, 1999, J NEUROCHEM, V73, P700, DOI 10.1046/j.1471-4159.1999.0730700.x; Tian Y, 2006, J BIOL CHEM, V281, P6559, DOI 10.1074/jbc.M507336200; Tsiakas K, 2004, GLYCOBIOLOGY, V14, p1C, DOI 10.1093/glycob/cwh054; Tsukamoto T, 2006, CANCER-AM CANCER SOC, V106, P1489, DOI 10.1002/cncr.21764; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Vines D, 1998, BBA-PROTEIN STRUCT M, V1384, P233, DOI 10.1016/S0167-4838(98)00012-0; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Walus M, 2005, FEBS LETT, V579, P1383, DOI 10.1016/j.febslet.2005.01.035; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200; Young EP, 2000, PRENATAL DIAG, V20, P337; Zeman W., 1970, HDB CLINICAL NEUROLO, P588; Zhong NA, 2000, GENET TEST, V4, P243, DOI 10.1089/10906570050501452; ZHOU Y, 1994, J BIOL CHEM, V269, P18408	54	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11929	10.1371/journal.pone.0011929	http://dx.doi.org/10.1371/journal.pone.0011929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689811	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520500002
J	Schneider, JA; Dandona, R; Pasupneti, S; Lakshmi, V; Liao, CH; Yeldandi, V; Mayer, KH				Schneider, John A.; Dandona, Rakhi; Pasupneti, Shravani; Lakshmi, Vemu; Liao, Chuanhong; Yeldandi, Vijay; Mayer, Kenneth H.			Initial Commitment to Pre-Exposure Prophylaxis and Circumcision for HIV Prevention amongst Indian Truck Drivers	PLOS ONE			English	Article							RISK REDUCTION MODEL; CONDOM USE; ANDHRA-PRADESH; PLANNED BEHAVIOR; YOUNG MEN; ACCEPTABILITY; HEALTH; IMPACT; SEX; HIV/AIDS	Studies of HIV prevention interventions such as pre-exposure prophylaxis (PREP) and circumcision in India are limited. The present study sought to investigate Indian truck-drivers initial commitment to PREP and circumcision utilizing the AIDS Risk Reduction Model. Ninety truck-drivers completed an in-depth qualitative interview and provided a blood sample for HIV and HSV-2 testing. Truck-drivers exhibited low levels of initial commitment towards PREP and even lower for circumcision. However, potential leverage points for increasing commitment were realized in fear of infecting family rather than self, self-perceptions of risk, and for PREP focusing on cultural beliefs towards medication and physicians. Cost was a major barrier to both HIV prevention interventions. Despite these barriers, our findings suggest that the ARRM may be useful in identifying several leverage points that may be used by peers, health care providers and public health field workers to enhance initial commitment to novel HIV prevention interventions in India.	[Schneider, John A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Schneider, John A.; Liao, Chuanhong] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Dandona, Rakhi] Publ Hlth Fdn India, New Delhi, India; [Pasupneti, Shravani] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Lakshmi, Vemu] Nizams Inst Med Sci, Dept Microbiol, Hyderabad, Andhra Pradesh, India; [Yeldandi, Vijay] SHARE India, Hyderabad, Andhra Pradesh, India; [Mayer, Kenneth H.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Mayer, Kenneth H.] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA	University of Chicago; University of Chicago; Public Health Foundation of India; University of Chicago; Nizam's Institute of Medical Sciences; Brown University; Brown University	Schneider, JA (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jschnei1@medicine.bsd.uchicago.edu		Pasupneti, Shravani/0000-0002-7112-601X; Dandona, Rakhi/0000-0003-0926-788X	Lancet International Fellowship; National Center for Research Resources [KL2RR025000]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025000] Funding Source: NIH RePORTER	Lancet International Fellowship; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Lancet International Fellowship and grant KL2RR025000 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHAVI N, 2008, AIDS UNTOLD STORIES; Albarracin D, 2004, AIDS CARE, V16, P700, DOI 10.1080/09540120412331269558; Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142; Amirkhanian YA, 2003, AIDS EDUC PREV, V15, P205, DOI 10.1521/aeap.15.4.205.23832; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2005, NFHS3, VI; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BANDURA A, 1997, ESSENCE CONTROL; *BBC N, 2005, HIV IS OUT CONTR IND; Bhattacharya G, 2004, HEALTH EDUC BEHAV, V31, P101, DOI 10.1177/1090198103259204; Brecht ML, 2009, J BEHAV HEALTH SER R, V36, P247, DOI 10.1007/s11414-007-9106-y; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; CATANIA JA, 1990, HEALTH EDUC QUART, V17, P53, DOI 10.1177/109019819001700107; CATANIA JA, 1994, HEALTH PSYCHOL, V13, P548, DOI 10.1037/0278-6133.13.6.548; Chakraborty K, 2009, SOC PSYCH PSYCH EPID, V44, P482, DOI 10.1007/s00127-008-0468-0; Chandhiok N, 2007, REPROD HEALTH MATTER, V15, P53, DOI 10.1016/S0968-8080(07)29309-7; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Cornman DH, 2007, SOC SCI MED, V64, P1572, DOI 10.1016/j.socscimed.2006.11.011; Dandona L, 2008, INT J EPIDEMIOL, V37, P1274, DOI 10.1093/ije/dyn161; Datye V, 2006, HEALTH POLICY PLANN, V21, P343, DOI 10.1093/heapol/czl021; Fauci AS, 2007, CLIN INFECT DIS, V45, pS206, DOI 10.1086/522540; Fochsen G, 2006, QUAL HEALTH RES, V16, P1236, DOI 10.1177/1049732306293776; Gibney L, 2003, SOC SCI MED, V56, P1411, DOI 10.1016/S0277-9536(02)00138-7; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Greene J.C., 1989, EDUC EVAL POLICY AN, V11, P255, DOI [10.3102/01623737011003255, DOI 10.3102/01623737011003255]; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Hoffman S, 2003, AM J PUBLIC HEALTH, V93, P1897, DOI 10.2105/AJPH.93.11.1897; *IPS, 2005, HLTH HIV AIDS CAMP T; Janesick V, 2003, STRATEGIES QUALITATI; Kumar SGP, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-82; Lal A, 1999, J Assoc Physicians India, V47, P224; LANDIS JR, 1977, BIOMETRICS, V33, P174; Lyles CM, 2007, AM J PUBLIC HEALTH, V97, P133, DOI 10.2105/AJPH.2005.076182; Madhivanan P, 2008, AIDS, V22, P983, DOI 10.1097/QAD.0b013e3282ffde52; MALOW RM, 1994, AIDS EDUC PREV, V6, P113; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Mazumdar PG, 2007, J BIOSOC SCI, V39, P819, DOI 10.1017/S0021932007002106; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; MISHRA V, 2009, CONCURRENT SEXUAL PA; *NACO, 2007, COND PROM; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; ORNER P, 2004, PAVING PATH CHALLENG; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Pandey A, 2008, AIDS, V22, pS81, DOI 10.1097/01.aids.0000343766.00573.15; Rao KD, 2006, INT J QUAL HEALTH C, V18, P414, DOI 10.1093/intqhc/mzl049; Rosengarten M, 2009, SOC SCI MED, V69, P1049, DOI 10.1016/j.socscimed.2009.07.039; Rosenstock I.M., 1990, HLTH BEHAV HLTH ED T, P39; Ruan YH, 2009, AIDS PATIENT CARE ST, V23, P315, DOI 10.1089/apc.2008.0199; Schechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010; Schneider JA, 2009, INT J STD AIDS, V20, P39, DOI 10.1258/ijsa.2008.008163; Severy LJ, 2005, AIDS BEHAV, V9, P121, DOI 10.1007/s10461-005-1687-y; Sheeran P, 2001, HEALTH PSYCHOL, V20, P12, DOI 10.1037/0278-6133.20.1.12; SINGH YN, 1993, J ACQUIR IMMUNE DEFI, V6; Singhal A., 2003, COMBATING AIDS COMMU; Steinbrook R, 2008, NEW ENGL J MED, V358, P107, DOI 10.1056/NEJMp0708474; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Taylor S. J., 1984, INTRO QUALITATIVE RE; *UNAIDS, 2007, AIDS EP UPD; *UNAIDS, 2007, 3 WAV NAT AIDS CONTR; van de Vijver DAMC, 2009, J INFECT DIS, V199, P1310, DOI 10.1086/597804; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	67	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11922	10.1371/journal.pone.0011922	http://dx.doi.org/10.1371/journal.pone.0011922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633QZ	20689602	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520300031
J	Boellmann, F; Thomas, RS				Boellmann, Frank; Thomas, Russell S.			The Identification of Protein Kinase C Iota as a Regulator of the Mammalian Heat Shock Response Using Functional Genomic Screens	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HSF1; ACTIVATION; GENE; FACTOR-1; CELLS; REPRESSION; MECHANISM; COMPLEX; HSP70; PHOSPHORYLATION	Background: The heat shock response is widely used as a surrogate of the general protein quality control system within the cell. This system plays a significant role in aging and many protein folding diseases as well as the responses to other physical and chemical stressors. Methods/Principal Findings: In this study, a broad-based functional genomics approach was taken to identify potential regulators of the mammalian heat shock response. In the primary screen, a total of 13724 full-length genes in mammalian expression vectors were individually co-transfected into human embryonic kidney cells together with a human HSP70B promoter driving firefly luciferase. A subset of the full-length genes that showed significant activation in the primary screen were then evaluated for their ability to hyper-activate the HSP70B under heat shock conditions. Based on the results from the secondary assay and gene expression microarray analyses, eight genes were chosen for validation using siRNA knockdown. Of the eight genes, only PRKCI showed a statistically significant reduction in the heat shock response in two independent siRNA duplexes compared to scrambled controls. Knockdown of the PRKCI mRNA was confirmed using quantitative RT-PCR. Additional studies did not show a direct physical interaction between PRKCI and HSF1. Conclusions/Significance: The results suggest that PRKCI is an indirect co-regulator of HSF1 activity and the heat shock response. Given the underlying role of HSF1 in many human diseases and the response to environmental stressors, PRKCI represents a potentially new candidate for gene-environment interactions and therapeutic intervention.	[Boellmann, Frank; Thomas, Russell S.] Hamner Inst Hlth Sci, Ctr Genom Biol & Bioinformat, Res Triangle Pk, NC USA	The Hamner Institutes for Health Sciences	Boellmann, F (corresponding author), Hamner Inst Hlth Sci, Ctr Genom Biol & Bioinformat, Res Triangle Pk, NC USA.	rthomas@thehamner.org		Thomas, Russell/0000-0002-2340-0301	American Chemistry Council	American Chemistry Council	The research was supported through a grant provided by the American Chemistry Council's Long-Range Research Initiative (http://www.americanchemistry.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Ding XZ, 1996, J INVEST MED, V44, P144; Ding XZ, 1997, J CLIN INVEST, V99, P136, DOI 10.1172/JCI119124; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Halsey TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r104; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Hung JJ, 1998, J BIOL CHEM, V273, P31924, DOI 10.1074/jbc.273.48.31924; Khalil S, 2006, J CELL PHYSIOL, V207, P562, DOI 10.1002/jcp.20599; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Michiels F, 2002, NAT BIOTECHNOL, V20, P1154, DOI 10.1038/nbt746; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; RITOSSA F, 1963, DROSOPHILA INFORM SE, V122; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; SCHEDL P, 1978, CELL, V14, P921, DOI 10.1016/0092-8674(78)90346-X; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; STEINKRAUS KA, 2008, AGING CELL; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; van de Water B, 2006, TOXICOL LETT, V162, P83, DOI 10.1016/j.toxlet.2005.10.014; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; YAMAMOTO N, 1994, KIDNEY INT, V45, P1093, DOI 10.1038/ki.1994.146; Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11850	10.1371/journal.pone.0011850	http://dx.doi.org/10.1371/journal.pone.0011850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686607	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200015
J	Zhou, P; Gross, S; Liu, JH; Yu, BY; Feng, LL; Nolta, J; Sharma, V; Piwnica-Worms, D; Qiu, SX				Zhou, Ping; Gross, Shimon; Liu, Ji-Hua; Yu, Bo-Yang; Feng, Ling-Ling; Nolta, Jan; Sharma, Vijay; Piwnica-Worms, David; Qiu, Samuel X.			Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappa B and MAPK signaling pathways	FASEB JOURNAL			English	Article						hepatocellular toxin; apoptosis; TNF-alpha, herb products; bioluminescence imaging	TUMOR-NECROSIS-FACTOR; GENETICALLY ENCODED REPORTERS; SEVERE LIVER DEGENERATION; ALPHA-INDUCED APOPTOSIS; TNF-INDUCED APOPTOSIS; PIPER-METHYSTICUM; GLUTATHIONE DEPLETION; JNK ACTIVATION; EMBRYONIC LETHALITY; PROTEASOME ACTIVITY	Kava (Piper methysticum Foster, Piperaceae) organic solvent-extract has been used to treat mild to moderate anxiety, insomnia, and muscle fatigue in Western countries, leading to its emergence as one of the 10 best-selling herbal preparations. However, several reports of severe hepatotoxicity in kava consumers led the U. S. Food and Drug Administration and authorities in Europe to restrict sales of kava-containing products. Herein we demonstrate that flavokawain B (FKB), a chalcone from kava root, is a potent hepatocellular toxin, inducing cell death in HepG2 (LD50 = 15.3 +/- 0.2 mu M) and L-02 (LD50 = 32 mu M) cells. Hepatocellular toxicity of FKB is mediated by induction of oxidative stress, depletion of reduced glutathione (GSH), inhibition of IKK activity leading to NF-kappa B transcriptional blockade, and constitutive TNF-alpha-independent activation of mitogen-activated protein kinase (MAPK) signaling pathways, namely, ERK, p38, and JNK. We further demonstrate by noninvasive bioluminescence imaging that oral consumption of FKB leads to inhibition of hepatic NF-kappa B transcriptional activity in vivo and severe liver damage. Surprisingly, replenishment with exogenous GSH normalizes both TNF-alpha-dependent NF-kappa B as well as MAPK signaling and rescues hepatocytes from FKB-induced death. Our data identify FKB as a potent GSH-sensitive hepatotoxin, levels of which should be specifically monitored and controlled in kava-containing herb products.-Zhou, P., Gross, S., Liu, J.-H., Yu, B.-Y., Feng, L.-L., Nolta, J., Sharma, V., Piwnica-Worms, D., Qiu, S. X. Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappa B and MAPK signaling pathways. FASEB J. 24, 4722-4732 (2010). www.fasebj.org	[Feng, Ling-Ling; Qiu, Samuel X.] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Zhou, Ping; Nolta, Jan] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA; [Gross, Shimon; Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Gross, Shimon; Sharma, Vijay; Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Mol Imaging Ctr, St Louis, MO USA; [Zhou, Ping; Nolta, Jan] Univ Calif Davis, Stem Cell Program, Dept Internal Med, Sacramento, CA 95817 USA; [Liu, Ji-Hua; Yu, Bo-Yang] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Nanjing 210009, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; China Pharmaceutical University	Qiu, SX (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China.	sxqiu@scbg.ac.cn		Nolta, Jan/0000-0003-4576-8542	U.S. National Institutes of Health [P50 CA94056]; National Natural Science Foundation of China [30572320, 30973635]; Chinese Academy of Sciences [KSCX2-YW-R-217]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061848] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was jointly funded by U.S. National Institutes of Health grant P50 CA94056, National Natural Science Foundation of China grants (30572320, 30973635), a Chinese Academy of Sciences 100 Talents Program Endowment award to S.X.Q., and a grant from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-217).	BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bilia AR, 2002, LIFE SCI, V70, P2581, DOI 10.1016/S0024-3205(02)01555-2; *BUND ARZN MED, 2002, A VONARZNEIMITTELRIS; Cairney S, 2002, AUST NZ J PSYCHIAT, V36, P657, DOI 10.1046/j.1440-1614.2002.01027.x; Colell A, 1998, GASTROENTEROLOGY, V115, P1541, DOI 10.1016/S0016-5085(98)70034-4; Collett GP, 2004, CARCINOGENESIS, V25, P2183, DOI 10.1093/carcin/bgh233; Cuadrado A, 2004, ONCOGENE, V23, P4673, DOI 10.1038/sj.onc.1207636; Currie BJ, 2003, MED J AUSTRALIA, V178, P421, DOI 10.5694/j.1326-5377.2003.tb05279.x; Dharmaratne HRW, 2002, PHYTOCHEMISTRY, V59, P429; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Dragull K, 2003, PHYTOCHEMISTRY, V63, P193, DOI 10.1016/S0031-9422(03)00111-0; FDA,, 2003, FDA CONS ADV; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Folmer F, 2006, BIOCHEM PHARMACOL, V71, P1206, DOI 10.1016/j.bcp.2005.12.032; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Gow PJ, 2003, MED J AUSTRALIA, V178, P442, DOI 10.5694/j.1326-5377.2003.tb05286.x; Gross S, 2005, METHOD ENZYMOL, V399, P512, DOI 10.1016/S0076-6879(05)99035-6; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Gross S, 2006, CURR OPIN CHEM BIOL, V10, P334, DOI 10.1016/j.cbpa.2006.06.028; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu XT, 2001, CANCER RES, V61, P6290; Humberston CL, 2003, J TOXICOL-CLIN TOXIC, V41, P109, DOI 10.1081/CLT-120019123; Johnson BM, 2003, CHEM RES TOXICOL, V16, P733, DOI 10.1021/tx020113r; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kiningham KK, 2001, BIOCHEM J, V353, P147, DOI 10.1042/bj3530147; Lash LH, 2006, CHEM-BIOL INTERACT, V163, P54, DOI 10.1016/j.cbi.2006.03.001; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Lim STS, 2007, TOXICOL SCI, V97, P214, DOI 10.1093/toxsci/kfm035; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Luo JL, 2005, J CLIN IMMUNOL, V25, P541, DOI 10.1007/s10875-005-8217-6; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Mathews JM, 2002, DRUG METAB DISPOS, V30, P1153, DOI 10.1124/dmd.30.11.1153; Matsumaru K, 2003, HEPATOLOGY, V37, P1425, DOI 10.1053/jhep.2003.50230; McGhee HW, 2003, JAMA-J AM MED ASSOC, V289, P36; *MMWR, 2002, MMWR-MORBID MORTAL W, V51, P1065; Nagai H, 2002, HEPATOLOGY, V36, P55, DOI 10.1053/jhep.2002.33995; Nerurkar PV, 2004, TOXICOL SCI, V79, P106, DOI 10.1093/toxsci/kfh067; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Rex A, 2002, PROG NEURO-PSYCHOPH, V26, P855, DOI 10.1016/S0278-5846(01)00330-X; Rudolph D, 2000, GENE DEV, V14, P854; Russmann S, 2001, ANN INTERN MED, V135, P68, DOI 10.7326/0003-4819-135-1-200107030-00036; Singh YN, 2003, PLANTA MED, V69, P496, DOI 10.1055/s-2003-40658; Singh YN, 2002, CNS DRUGS, V16, P731, DOI 10.2165/00023210-200216110-00002; SINGH YN, 1992, J ETHNOPHARMACOL, V37, P13, DOI 10.1016/0378-8741(92)90003-A; Singh YN, 1997, HERBALGRAM, V39, P33; Stickel F, 2003, J HEPATOL, V39, P62, DOI 10.1016/S0168-8278(03)00175-2; STOLLER R, 2000, SCHWEIZERISCHE ARZTE, V81, P1335; Titcomb M, 1948, J POLYNESIAN SOC, V57, P105; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Whitton PA, 2003, PHYTOCHEMISTRY, V64, P673, DOI 10.1016/S0031-9422(03)00381-9; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Wu DF, 2003, J BIOL CHEM, V278, P1115, DOI 10.1074/jbc.M207856200; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Zhou P, 2006, J IMMUNOL, V177, P8777, DOI 10.4049/jimmunol.177.12.8777	60	81	86	1	42	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4722	4732		10.1096/fj.10-163311	http://dx.doi.org/10.1096/fj.10-163311			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20696856	Green Published			2022-12-25	WOS:000284824400013
J	Weinitschke, S; Hollemeyer, K; Kusian, B; Bowien, B; Smits, THM; Cook, AM				Weinitschke, Sonja; Hollemeyer, Klaus; Kusian, Bernhard; Bowien, Botho; Smits, Theo H. M.; Cook, Alasdair M.			Sulfoacetate Is Degraded via a Novel Pathway Involving Sulfoacetyl-CoA and Sulfoacetaldehyde in Cupriavidus necator H16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RALSTONIA-EUTROPHA; C-2 SULFONATES; GENE CLUSTERS; TAURINE; PURIFICATION; METABOLISM; ENZYMES; STRAIN; DEHYDROGENASE; REDUCTASE	Bacterial degradation of sulfoacetate, a widespread natural product, proceeds via sulfoacetaldehyde and requires a considerable initial energy input. Whereas the fate of sulfoacetaldehyde in Cupriavidus necator (Ralstonia eutropha) H16 is known, the pathway from sulfoacetate to sulfoacetaldehyde is not. The genome sequence of the organism enabled us to hypothesize that the inducible pathway, which initiates sau (sulfoacetate utilization), involved a four-gene cluster (sauRSTU; H16_A2746 to H16_A2749). The sauR gene, divergently orientated to the other three genes, probably encodes the transcriptional regulator of the presumed sauSTU operon, which is subject to inducible transcription. SauU was tentatively identified as a transporter of the major facilitator superfamily, and SauT was deduced to be a sulfoacetate-CoA ligase. SauT was a labile protein, but it could be separated and shown to generate AMP and an unknown, labile CoA-derivative from sulfoacetate, CoA, and ATP. This unknown compound, analyzed by MALDI-TOF-MS, had a relative molecular mass of 889.7, which identified it as protonated sulfoacetyl-CoA (calculated 889.6). SauS was deduced to be sulfoacetaldehyde dehydrogenase (acylating). The enzyme was purified 175-fold to homogeneity and characterized. Peptide mass fingerprinting confirmed the sauS locus w(H16_A2747). SauS converted sulfoacetyl-CoA and NADPH to sulfoacetaldehyde, CoA, and NADP(+), thus confirming the hypothesis.	[Weinitschke, Sonja; Smits, Theo H. M.; Cook, Alasdair M.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Hollemeyer, Klaus] Univ Saarland, Inst Biochem Engn, D-66041 Saarbrucken, Germany; [Kusian, Bernhard; Bowien, Botho] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Smits, Theo H. M.] Swiss Fed Res Stn, CH-8820 Wadenswil, Switzerland	University of Konstanz; Saarland University; University of Gottingen; Swiss Federal Research Station Agroscope	Cook, AM (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	alasdair.cook@uni-konstanz.de		Smits, Theo H.M./0000-0002-1237-235X	Deutsche Forschungsgemeinschaft [Co 206/6-1]; German Federal Ministry of Education and Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Supported by Grant Co 206/6-1 from the Deutsche Forschungsgemeinschaft.; Supported by the competence network "BiotechGenoMik" financed by the German Federal Ministry of Education and Research.	ALLEN JA, 1971, ADV MAR BIOL, V9, P205, DOI 10.1016/S0065-2881(08)60343-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruggeman C, 2004, MICROBIOL-SGM, V150, P805, DOI 10.1099/mic.0.26795-0; Chohan SN, 1998, APPL ENVIRON MICROB, V64, P2859; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; Cook AM, 2002, ARCH MICROBIOL, V179, P1, DOI 10.1007/s00203-002-0497-0; COOK AM, 1987, FEMS MICROBIOL LETT, V46, P93, DOI 10.1016/0378-1097(87)90059-0; DEMBITSKY VM, 1990, PHYTOCHEMISTRY, V29, P3417, DOI 10.1016/0031-9422(90)85249-F; Denger K, 2004, ARCH MICROBIOL, V182, P254, DOI 10.1007/s00203-004-0678-0; Denger K, 2001, ARCH MICROBIOL, V176, P89, DOI 10.1007/s002030100296; Denger K, 2008, MICROBIOL-SGM, V154, P256, DOI 10.1099/mic.0.2007/011650-0; DESOMER J, 1991, MOL MICROBIOL, V5, P2115, DOI 10.1111/j.1365-2958.1991.tb02141.x; Folkers K, 1944, J AM CHEM SOC, V66, P1083, DOI 10.1021/ja01235a007; Graham DE, 2002, J BIOL CHEM, V277, P13421, DOI 10.1074/jbc.M201011200; GUPTA SD, 1988, ARCH BIOCHEM BIOPHYS, V260, P125, DOI 10.1016/0003-9861(88)90432-8; Harwood J. L., 1980, The biochemistry of plants. A comprehensive treatise. Volume 4. Lipids: structure and function., P301; Harwood JL, 1979, BIOCHEM SOC T, V7, P440, DOI 10.1042/bst0070440; Hollemeyer K, 2007, RAPID COMMUN MASS SP, V21, P336, DOI 10.1002/rcm.2840; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; Jeffke T, 1999, J BACTERIOL, V181, P4374, DOI 10.1128/JB.181.14.4374-4380.1999; KENNEDY SIT, 1968, BIOCHEM J, V107, P497, DOI 10.1042/bj1070497; King JE, 1997, MICROBIOL-SGM, V143, P3907, DOI 10.1099/00221287-143-12-3907; Krejcik Z, 2008, ARCH MICROBIOL, V190, P159, DOI 10.1007/s00203-008-0386-2; Krejcik Z, 2010, MICROBIOL-SGM, V156, P1547, DOI 10.1099/mic.0.036699-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE RF, 1972, BIOCHIM BIOPHYS ACTA, V261, P35, DOI 10.1016/0304-4165(72)90309-1; leMaire M, 1996, ACS SYM SER, V635, P36; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Mampel J, 2004, BIOCHEM J, V383, P91, DOI 10.1042/BJ20040652; MARTELLI HL, 1964, BIOCHIM BIOPHYS ACTA, V93, P169, DOI 10.1016/0304-4165(64)90272-7; MARTELLI HL, 1970, BIOCHIM BIOPHYS ACTA, V208, P110, DOI 10.1016/0304-4165(70)90053-X; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; POWLOWSKI J, 1993, J BACTERIOL, V175, P377, DOI 10.1128/JB.175.2.377-385.1993; Ruff J, 2003, BIOCHEM J, V369, P275, DOI 10.1042/BJ20021455; Sambrook J., 1989, MOL CLONING, pA1; SHIBUYA ISAO, 1963, P627; SOHLING B, 1993, EUR J BIOCHEM, V212, P121, DOI 10.1111/j.1432-1033.1993.tb17641.x; SORBO B, 1987, METHOD ENZYMOL, V143, P3; STADTMAN TC, 1957, J BIOL CHEM, V228, P983; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; THURNHEER T, 1986, J GEN MICROBIOL, V132, P1215; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; Weinitschke S, 2010, APPL ENVIRON MICROB, V76, P618, DOI 10.1128/AEM.01818-09; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yin M, 2000, PHYSIOL BIOCHEM ZOOL, V73, P629, DOI 10.1086/317749	50	11	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35249	35254		10.1074/jbc.M110.127043	http://dx.doi.org/10.1074/jbc.M110.127043			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20693281	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000283845300002
J	Pitt, SJ; Funnell, TM; Sitsapesan, M; Venturi, E; Rietdorf, K; Ruas, M; Ganesan, A; Gosain, R; Churchill, GC; Zhu, MX; Parrington, J; Galione, A; Sitsapesan, R				Pitt, Samantha J.; Funnell, Tim M.; Sitsapesan, Mano; Venturi, Elisa; Rietdorf, Katja; Ruas, Margarida; Ganesan, A.; Gosain, Rajendra; Churchill, Grant C.; Zhu, Michael X.; Parrington, John; Galione, Antony; Sitsapesan, Rebecca			TPC2 Is a Novel NAADP-sensitive Ca2+ Release Channel, Operating as a Dual Sensor of Luminal pH and Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; ADENINE-DINUCLEOTIDE PHOSPHATE; CALCIUM-RELEASE; CA2+-RELEASE CHANNEL; RYANODINE RECEPTORS; MOBILIZES CALCIUM; 2-PORE CHANNELS; SMOOTH-MUSCLE; TRIGGER ZONE; FORM	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a molecule capable of initiating the release of intracellular Ca2+ required for many essential cellular processes. Recent evidence links two-pore channels (TPCs) with NAADP-induced release of Ca2+ from lysosome-like acidic organelles; however, there has been no direct demonstration that TPCs can act as NAADP-sensitive Ca2+ release channels. Controversial evidence also proposes ryanodine receptors as the primary target of NAADP. We show that TPC2, the major lysosomal targeted isoform, is a cation channel with selectivity for Ca2+ that will enable it to act as a Ca2+ release channel in the cellular environment. NAADP opens TPC2 channels in a concentration-dependent manner, binding to high affinity activation and low affinity inhibition sites. At the core of this process is the luminal environment of the channel. The sensitivity of TPC2 to NAADP is steeply dependent on the luminal [Ca2+] allowing extremely low levels of NAADP to open the channel. In parallel, luminal pH controls NAADP affinity for TPC2 by switching from reversible activation of TPC2 at low pH to irreversible activation at neutral pH. Further evidence earmarking TPCs as the likely pathway for NAADP-induced intracellular Ca2+ release is obtained from the use of Ned-19, the selective blocker of cellular NAADP-induced Ca2+ release. Ned-19 antagonizes NAADP-activation of TPC2 in a non-competitive manner at 1 mu M but potentiates NAADP activation at nanomolar concentrations. This single-channel study provides a long awaited molecular basis for the peculiar mechanistic features of NAADP signaling and a framework for understanding how NAADP can mediate key physiological events.	[Funnell, Tim M.; Rietdorf, Katja; Ruas, Margarida; Churchill, Grant C.; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; Univ Bristol, Ctr Nanosci & Quantum Informat, Bristol BS8 1TD, Avon, England; [Ganesan, A.; Gosain, Rajendra] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Oxford; University of Bristol; University of Bristol; University of Southampton; University of Texas System; University of Texas Health Science Center Houston	Galione, A (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	antony.galione@pharm.ox.ac.uk; r.sitsapesan@bris.ac.uk	Ganesan, A/F-6698-2011; Galione, Antony/E-5884-2011	Galione, Antony/0000-0002-4132-7646; Venturi, Elisa/0000-0001-9302-1537; Pitt, Samantha/0000-0003-2257-1595; Ruas, Margarida/0000-0002-4872-7618; Ganesan, A/0000-0003-4862-7999	British Heart Foundation; Wellcome Trust; BBSRC [BB/G008523/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the British Heart Foundation (to R. S.) and the Wellcome Trust (to A. G. and J. P.).	Bak J, 2002, BIOCHEM BIOPH RES CO, V295, P806, DOI 10.1016/S0006-291X(02)00761-1; BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; BUCK E, 1992, J BIOL CHEM, V267, P23560; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; CHU A, 1990, MOL PHARMACOL, V37, P735; Churamani D, 2006, BIOCHEM J, V397, P313, DOI 10.1042/BJ20060179; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Clapham DE, 2005, PHARMACOL REV, V57, P451, DOI 10.1124/pr.57.4.7; Colquhoun D., 1983, SINGLE CHANNEL RECOR, P483, DOI 10.1007/978-1-4615-7858-1_11; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; FATT P, 1958, J PHYSIOL-LONDON, V142, P516, DOI 10.1113/jphysiol.1958.sp006034; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Genazzani AA, 1997, TRENDS PHARMACOL SCI, V18, P108, DOI 10.1016/S0165-6147(96)01036-X; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe18; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J MEMBRANE BIOL, V173, P1, DOI 10.1007/s002320001001; LINDSAY ARG, 1994, J GEN PHYSIOL, V104, P425, DOI 10.1085/jgp.104.3.425; LINDSAY ARG, 1991, BIOCHIM BIOPHYS ACTA, V1064, P89, DOI 10.1016/0005-2736(91)90415-5; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lukyanenko V, 1996, PFLUG ARCH EUR J PHY, V432, P1047, DOI 10.1007/s004240050233; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Morgan AJ, 2008, METHODS, V46, P194, DOI 10.1016/j.ymeth.2008.09.013; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Pitt SJ, 2010, BIOPHYS J, V98, p682a; Rosen D, 2009, J BIOL CHEM, V284, P34930, DOI 10.1074/jbc.M109.016519; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Saftenku E, 2001, BIOPHYS J, V80, P2727, DOI 10.1016/S0006-3495(01)76241-8; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; SITSAPESAN R, 1991, J PHYSIOL-LONDON, V434, P469, DOI 10.1113/jphysiol.1991.sp018481; SITSAPESAN R, 1994, J MEMBRANE BIOL, V137, P215; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Sutko JL, 1997, PHARMACOL REV, V49, P53; TINKER A, 1992, J GEN PHYSIOL, V100, P479, DOI 10.1085/jgp.100.3.479; TUGBA D, 2010, J BIOL CHEM */* A J, V285, P24925; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	47	159	162	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35039	35046		10.1074/jbc.M110.156927	http://dx.doi.org/10.1074/jbc.M110.156927			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20720007	Green Published, hybrid			2022-12-25	WOS:000283659100078
J	Carlsson, S; Dahlback, B				Carlsson, Sofia; Dahlback, Bjorn			Dependence on Vitamin K-dependent Protein S for Eukaryotic Cell Secretion of the beta-Chain of C4b-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CHAIN; STRUCTURAL REQUIREMENTS; APOPTOTIC CELLS; BINDING-SITE; HUMAN-PLASMA; COMPLEX; EXPRESSION; C4BP; LINE; ESTABLISHMENT	The anticoagulant vitamin K-dependent protein S (PS) circulates in plasma in two forms, 30% free and 70% being bound to the complement regulatory protein C4b-binding protein (C4BP). The major C4BP isoform consists of 7 alpha-chains and 1 beta-chain (C4BP beta(+)), the chains being linked by disulfide bridges. PS binds to the beta-chain with high affinity. In plasma, PS is in molar excess over C4BP beta(+) and due to the high affinity, all C4BP beta(+) molecules contain a bound PS. Taken together with the observation that PS-deficient patients have decreased levels of C4BP beta(+), this raises the question of whether PS is important for secretion of the beta-chain from the cell. To test this hypothesis, HEK293 cells were stably and transiently transfected with beta-chain cDNA in combinations with cDNAs for PS and/or the alpha-chain. The concentration of beta-chains in the medium increased after co-transfection with PS cDNA, but not by alpha-chain cDNA, suggesting secretion of the beta-chains from the cells to be dependent on concomitant synthesis of PS, but not of the alpha-chains. Thus, beta-chains that were not disulfide-linked to the alpha-chains were secreted in complex with PS, either as monomers or dimers. Pulse-chase demonstrated that the complexes between PS and beta-chain were formed intracellularly, in the endoplasmic reticulum. In conclusion, our results demonstrate that successful secretion of beta-chains depends on intracellular complex formation with PS, but not on the alpha-chains. This provides an explanation for the decreased beta-chain levels observed in PS-deficient patients.	[Dahlback, Bjorn] Lund Univ, Skane Univ Hosp, Dept Lab Med, Div Clin Chem,Wallenberg Lab, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Dahlback, B (corresponding author), Lund Univ, Skane Univ Hosp, Dept Lab Med, Div Clin Chem,Wallenberg Lab, Entrance 46,Floor 6, SE-20502 Malmo, Sweden.	Bjorn.Dahlback@med.lu.se	Somajo, Sofia/ABB-8170-2021	Somajo, Sofia/0000-0003-0433-8079; Dahlback, Bjorn/0000-0003-1546-0328	Swedish Research Council [71430]; Swedish Heart and Lung Foundation; Soderberg Foundation; Alfred Osterlund Foundation; Swedish Cancer Society; University Hospital in Malmo	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Soderberg Foundation; Alfred Osterlund Foundation; Swedish Cancer Society(Swedish Cancer Society); University Hospital in Malmo	This work was supported by Swedish Research Council Grant 71430, grants from the Swedish Heart and Lung Foundation, the Soderberg Foundation, the Alfred Osterlund Foundation, the Swedish Cancer Society, and research funds from the University Hospital in Malmo.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; ARENZANA N, 1995, BIOCHEM J, V308, P613, DOI 10.1042/bj3080613; Benzakour O, 2000, BLOOD, V95, P2008, DOI 10.1182/blood.V95.6.2008; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 1998, BBA-PROTEIN STRUCT M, V1388, P181, DOI 10.1016/S0167-4838(98)00178-2; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Criado Garcia O, 1995, J Immunol, V155, P4037; Criado-Garcia O, 1999, EUR J CELL BIOL, V78, P657, DOI 10.1016/S0171-9335(99)80051-X; DAHLBACK B, 1983, BIOCHEM J, V209, P857, DOI 10.1042/bj2090857; DAHLBACK B, 1983, BIOCHEM J, V209, P837, DOI 10.1042/bj2090837; Dahlback B, 2005, FEBS LETT, V579, P3310, DOI 10.1016/j.febslet.2005.03.001; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DE FRUTOS PG, 1994, BLOOD, V84, P815; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Evenas P, 1999, EUR J BIOCHEM, V266, P935, DOI 10.1046/j.1432-1327.1999.00928.x; FAIR DS, 1986, BLOOD, V67, P1168; Fernandez JA, 1998, BLOOD CELL MOL DIS, V24, P101, DOI 10.1006/bcmd.1998.0175; Giri TK, 2002, J BIOL CHEM, V277, P15099, DOI 10.1074/jbc.M103036200; Hackeng TM, 2009, J THROMB HAEMOST, V7, P165, DOI 10.1111/j.1538-7836.2009.03363.x; HARDIG Y, 1995, BIOCHEM J, V308, P795; Hardig Y, 1996, J BIOL CHEM, V271, P20861, DOI 10.1074/jbc.271.34.20861; HE XH, 1994, THROMB HAEMOSTASIS, V71, P446; Hillarp A, 1997, J IMMUNOL, V158, P1315; HILLARP A, 1990, P NATL ACAD SCI USA, V87, P1183, DOI 10.1073/pnas.87.3.1183; HILLARP A, 1988, J BIOL CHEM, V263, P12759; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Kask L, 2002, BIOCHEMISTRY-US, V41, P9349, DOI 10.1021/bi025980+; Linse S, 1997, J BIOL CHEM, V272, P14658, DOI 10.1074/jbc.272.23.14658; MAILLARD C, 1992, ENDOCRINOLOGY, V130, P1599, DOI 10.1210/en.130.3.1599; MALM J, 1990, EUR J BIOCHEM, V187, P737, DOI 10.1111/j.1432-1033.1990.tb15361.x; MALM J, 1994, BIOCHEM J, V302, P845, DOI 10.1042/bj3020845; Maurissen LFA, 2008, BLOOD, V111, P3034, DOI 10.1182/blood-2007-06-089987; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; OGURA M, 1987, BLOOD, V70, P301; PHILLIPS DJ, 1993, J NEUROCHEM, V61, P344, DOI 10.1111/j.1471-4159.1993.tb03574.x; Sanchez-Pernaute O, 2006, ANN RHEUM DIS, V65, P1279, DOI 10.1136/ard.2006.052118; SANCHEZCORRAL P, 1995, J IMMUNOL, V155, P4030; van de Poel RHL, 1999, J BIOL CHEM, V274, P15144, DOI 10.1074/jbc.274.21.15144; van de Poel RHL, 1999, BLOOD CELL MOL DIS, V25, P279, DOI 10.1006/bcmd.1999.0255; van Wijnen M, 1998, BIOCHEM J, V330, P389; Webb JH, 2003, BLOOD COAGUL FIBRIN, V14, P355, DOI 10.1097/00001721-200306000-00006; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580; Webb JH, 2001, J BIOL CHEM, V276, P4330, DOI 10.1074/jbc.M006541200; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; ZOLLER B, 1995, BLOOD, V85, P3524, DOI 10.1182/blood.V85.12.3524.bloodjournal85123524	46	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32038	32046		10.1074/jbc.M110.148452	http://dx.doi.org/10.1074/jbc.M110.148452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693287	Green Published, hybrid			2022-12-25	WOS:000282683000017
J	Rao, SK; Pavicevic, Z; Du, ZY; Kim, JG; Fan, MY; Jiao, Y; Rosebush, M; Samant, S; Gu, WK; Pfeffer, LM; Nosrat, CA				Rao, Shailaja K.; Pavicevic, Zoran; Du, Ziyun; Kim, Jong-Gwan; Fan, Meiyun; Jiao, Yan; Rosebush, Molly; Samant, Sandeep; Gu, Weikuan; Pfeffer, Lawrence M.; Nosrat, Christopher A.			Pro-inflammatory Genes as Biomarkers and Therapeutic Targets in Oral Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; HUMAN PAPILLOMA-VIRUS; ENDOTHELIAL-CELLS; PROSTATE-CANCER; TUMOR-CELLS; TRANSCRIPTION FACTORS; CHEMOKINE RECEPTORS; BREAST-CANCER	Oral squamous cell carcinoma (OSCC) is a major health problem worldwide, and patients have a particularly poor 5-year survival rate. Thus, identification of the molecular targets in OSCC and subsequent innovative therapies are greatly needed. Prolonged exposure to alcohol, tobacco, and pathogenic agents are known risk factors and have suggested that chronic inflammation may represent a potential common denominator in the development of OSCC. Microarray analysis of gene expression in OSCC cell lines with high basal NF-kappa B activity and OSCC patient samples identified dysregulation of many genes involved in inflammation, wound healing, angiogenesis, and growth regulation. In particular IL-8, CCL5, STAT1, and VEGF gene expression was up-regulated in OSCC. Moreover, IL-8 protein levels were significantly higher in OSCC cell lines as compared with normal human oral keratinocytes. Targeting IL-8 expression by siRNA significantly reduced the survival of OSCC cells, indicating that it plays an important role in OSCC development and/or progression. Inhibiting the inflammatory pathway by aspirin and the proteasome/NF-kappa B pathway by bortezomib resulted in marked reduction in cell viability in OSCC lines. Taken together our studies indicate a strong link between inflammation and OSCC development and reveal IL-8 as a potential mediator. Treatment based on prevention of general inflammation and/or the NF-kappa B pathway shows promise in OSCCs.	[Nosrat, Christopher A.] Univ Tennessee, Hlth Sci Ctr, Dept Biosci Res, Coll Dent, Memphis, TN 38163 USA; [Rosebush, Molly] Univ Tennessee, Hlth Sci Ctr, Dept Biol & Diagnost Sci, Coll Dent, Memphis, TN 38163 USA; [Du, Ziyun; Fan, Meiyun; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Coll Med, Memphis, TN 38163 USA; [Samant, Sandeep] Univ Tennessee, Hlth Sci Ctr, Dept Otolaryngol, Coll Med, Memphis, TN 38163 USA; [Jiao, Yan; Gu, Weikuan] Univ Tennessee, Hlth Sci Ctr, Dept Orthoped Surg, Coll Med, Memphis, TN 38163 USA; [Rao, Shailaja K.; Pavicevic, Zoran; Du, Ziyun; Fan, Meiyun; Pfeffer, Lawrence M.; Nosrat, Christopher A.] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat Canc Res, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Nosrat, CA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Biosci Res, Coll Dent, Canc Res Bldg,Rm 120,19 S Manassas St, Memphis, TN 38163 USA.	cnosrat@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA133322]; College of Dentistry and Center for Integrative Cancer Research, University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA133322, R01CA140346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Dentistry and Center for Integrative Cancer Research, University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133322 (NCI). This work was also supported by the College of Dentistry and Center for Integrative Cancer Research, University of Tennessee Health Science Center.	Al-Swiahb JN, 2010, FUTURE ONCOL, V6, P837, DOI 10.2217/fon.10.35; ANDIA DC, 2010, J PERIODONT IN PRESS; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Chocolatewala NM, 2009, J CANCER RES THER, V5, P71, DOI 10.4103/0973-1482.52788; CLARK RAF, 1985, J AM ACAD DERMATOL, V13, P701, DOI 10.1016/S0190-9622(85)70213-7; de Castro J, 2000, VIRCHOWS ARCH, V437, P599, DOI 10.1007/s004280000266; de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008; Declercq J, 2008, INT J ONCOL, V32, P1041; Efimova EV, 2009, INT J RADIAT BIOL, V85, P421, DOI 10.1080/09553000902838566; Erreni M, 2009, METHOD ENZYMOL, V460, P105, DOI 10.1016/S0076-6879(09)05205-7; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; JALOULI J, 2010, ACTA OTOLAR IN PRESS; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Keibel A, 2009, CURR PHARM DESIGN, V15, P1949, DOI 10.2174/138161209788453167; Kim SJ, 2001, NEOPLASIA, V3, P33, DOI 10.1038/sj.neo.7900124; Kim YJ, 2010, CLIN CHIM ACTA, V411, P1264, DOI 10.1016/j.cca.2010.05.014; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Lee CH, 2005, INT J CANCER, V113, P475, DOI 10.1002/ijc.20619; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Li AH, 2001, CLIN CANCER RES, V7, P3298; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Liu HS, 2009, ORAL ONCOL, V45, P1032, DOI 10.1016/j.oraloncology.2009.06.007; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Miller LJ, 1998, ANTICANCER RES, V18, P77; Mineta H, 2000, ORAL ONCOL, V36, P194, DOI 10.1016/S1368-8375(99)00078-0; Nagler RM, 2009, ORAL ONCOL, V45, P1006, DOI 10.1016/j.oraloncology.2009.07.005; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perez-Sayans M, 2009, ONCOL REP, V22, P1277, DOI 10.3892/or_00000565; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Psyrri A, 2009, CURR OPIN ONCOL, V21, P201, DOI 10.1097/CCO.0b013e328329ab64; Reibel J, 2003, CRIT REV ORAL BIOL M, V14, P47, DOI 10.1177/154411130301400105; Royds JA, 1998, J CLIN PATHOL-MOL PA, V51, P55; Sheryka E, 2003, UROLOGY, V62, P162, DOI 10.1016/S0090-4295(03)00134-1; Shi Q, 1999, CLIN CANCER RES, V5, P3711; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; SILVERMAN S, 1984, CANCER, V53, P563; SKIPWORTH RJ, 2010, SUPPORT CAR IN PRESS; Slaton JW, 2001, AM J PATHOL, V158, P735, DOI 10.1016/S0002-9440(10)64016-3; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; STEENBERGEN RDM, 1995, CANCER RES, V55, P5465; SYRJANEN K, 1983, INT J GYNECOL OBSTET, V21, P261, DOI 10.1016/0020-7292(83)90015-2; Veltri RW, 1999, UROLOGY, V53, P139, DOI 10.1016/S0090-4295(98)00455-5; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; WAHL SM, 1992, J CLIN IMMUNOL, V12, P61, DOI 10.1007/BF00918135; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xie Q, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-77; Zabaleta J, 2009, CARCINOGENESIS, V30, P1358, DOI 10.1093/carcin/bgp124; Zhang XY, 2002, DIAGN MOL PATHOL, V11, P135, DOI 10.1097/00019606-200209000-00002	61	58	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32512	32521		10.1074/jbc.M110.150490	http://dx.doi.org/10.1074/jbc.M110.150490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702412	Green Published, hybrid			2022-12-25	WOS:000282683000065
J	Higgins-Gruber, SL; Mutucumarana, VP; Lin, PJ; Jorgenson, JW; Stafford, DW; Straight, DL				Higgins-Gruber, Shannon L.; Mutucumarana, Vasantha P.; Lin, Pen-Jen; Jorgenson, James W.; Stafford, Darrel W.; Straight, David L.			Effect of Vitamin K-dependent Protein Precursor Propeptide, Vitamin K Hydroquinone, and Glutamate Substrate Binding on the Structure and Function of gamma-Glutamyl Carboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYGLUTAMIC ACID DOMAIN; FACTOR-IX; TRANSITION-STATES; ENZYME-ACTIVITY; MECHANISM; SITE; REGION; EPOXIDATION; AFFINITIES; MUTATIONS	The gamma-glutamyl carboxylase utilizes four substrates to catalyze carboxylation of certain glutamic acid residues in vitamin K-dependent proteins. How the enzyme brings the substrates together to promote catalysis is an important question in understanding the structure and function of this enzyme. The propeptide is the primary binding site of the vitamin K-dependent proteins to carboxylase. It is also an effector of carboxylase activity. We tested the hypothesis that binding of substrates causes changes to the carboxylase and in turn to the substrate-enzyme interactions. In addition we investigated how the sequences of the propeptides affected the substrate-enzyme interaction. To study these questions we employed fluorescently labeled propeptides to measure affinity for the carboxylase. We also measured the ability of several propeptides to increase carboxylase catalytic activity. Finally we determined the effect of substrates: vitamin K hydroquinone, the pentapeptide FLEEL, and NaHCO3, on the stability of the propeptide-carboxylase complexes. We found a wide variation in the propeptide affinities for carboxylase. In contrast, the propeptides tested had similar effects on carboxylase catalytic activity. FLEEL and vitamin K hydroquinone both stabilized the propeptide-carboxylase complex. The two together had a greater effect than either alone. We conclude that the effect of propeptide and substrates on carboxylase controls the order of substrate binding in such a way as to ensure efficient, specific carboxylation.	[Mutucumarana, Vasantha P.; Lin, Pen-Jen; Stafford, Darrel W.; Straight, David L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Higgins-Gruber, Shannon L.; Jorgenson, James W.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mutucumarana, VP (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	vmutucum@email.unc.edu			National Institutes of Health [HL48318, HL06350]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048318, P01HL006350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL48318 and HL06350 (to D. W. S.).	Bouchard BA, 1999, BIOCHEMISTRY-US, V38, P9517, DOI 10.1021/bi9907375; CHEUNG A, 1989, ARCH BIOCHEM BIOPHYS, V274, P574, DOI 10.1016/0003-9861(89)90472-4; CHEUNG A, 1990, BIOCHIM BIOPHYS ACTA, V1039, P90, DOI 10.1016/0167-4838(90)90230-D; Chu K, 1996, J CLIN INVEST, V98, P1619, DOI 10.1172/JCI118956; Davis CH, 2007, J MOL GRAPH MODEL, V26, P409, DOI 10.1016/j.jmgm.2006.10.006; Davis CH, 2007, J PHYS CHEM A, V111, P7257, DOI 10.1021/jp068564y; Hallgren KW, 2002, BIOCHEMISTRY-US, V41, P15045, DOI 10.1021/bi026016e; KNOBLOCH JE, 1987, J BIOL CHEM, V262, P15334; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Li SY, 1997, BIOCHEMISTRY-US, V36, P6384, DOI 10.1021/bi962816b; Lin PJ, 2004, J BIOL CHEM, V279, P6560, DOI 10.1074/jbc.M312239200; MORRIS DP, 1993, J BIOL CHEM, V268, P8735; Mutucumarana VP, 2003, J BIOL CHEM, V278, P46488, DOI 10.1074/jbc.M307707200; Oldenburg J, 1997, BRIT J HAEMATOL, V98, P240, DOI 10.1046/j.1365-2141.1997.2213036.x; Presnell SR, 2001, BIOCHEMISTRY-US, V40, P11723, DOI 10.1021/bi010332w; Rishavy MA, 2008, BIOCHEMISTRY-US, V47, P9836, DOI 10.1021/bi800296r; Rishavy MA, 2006, BIOCHEMISTRY-US, V45, P13239, DOI 10.1021/bi0609523; SOUTE BAM, 1992, THROMB HAEMOSTASIS, V68, P521; Stanley TB, 1999, J BIOL CHEM, V274, P16940, DOI 10.1074/jbc.274.24.16940; Stanley TB, 1999, BIOCHEMISTRY-US, V38, P15681, DOI 10.1021/bi991544k; Sugiura I, 1996, J BIOL CHEM, V271, P17837, DOI 10.1074/jbc.271.30.17837; Sugiura I, 1997, P NATL ACAD SCI USA, V94, P9069, DOI 10.1073/pnas.94.17.9069; ULRICH MMW, 1988, J BIOL CHEM, V263, P9697; UOTILA L, 1988, ARCH BIOCHEM BIOPHYS, V264, P135, DOI 10.1016/0003-9861(88)90578-4; WU SM, 1990, J BIOL CHEM, V265, P13124	25	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31502	31508		10.1074/jbc.M110.143297	http://dx.doi.org/10.1074/jbc.M110.143297			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20716530	hybrid, Green Published			2022-12-25	WOS:000282764600044
J	Bai, WM; Xun, F; Li, Y; Zhang, WH; Li, LH				Bai, Wenming; Xun, Fen; Li, Yang; Zhang, Wenhao; Li, Linghao			Rhizome Severing Increases Root Lifespan of Leymus chinensis in a Typical Steppe of Inner Mongolia	PLOS ONE			English	Article							LONGEVITY; TURNOVER; SURVIVORSHIP; AVAILABILITY; DIAMETER; GROWTH; CARBON; DEPTH	Background: Root lifespan is an important trait that determines plants' ability to acquire and conserve soil resources. There have been several studies investigating characteristics of root lifespan of both woody and herbaceous species. However, most of the studies have focused on non-clonal plants, and there have been little data on root lifespan for clonal plants that occur widely in temperate grasslands. Methodology/Principal Findings: We investigated the effects of rhizome severing on overall root lifespan of Leymus chinensis, a clonal, dominant grass species in the temperate steppe in northern China, in a 2-year field study using modified rhizotron technique. More specifically, we investigated the effects of rhizome severing on root lifespan of roots born in different seasons and distributed at different soil depths. Rhizome severing led to an increase in the overall root lifespan from 81 to 103 days. The increase in root lifespan exhibited spatial and temporal characteristics such that it increased lifespan for roots distributed in the top two soil layers and for roots born in summer and spring, but it had no effect on lifespan of roots in the deep soil layer and born in autumn. We also examined the effect of rhizome severing on carbohydrate and N contents in roots, and found that root carbohydrate and N contents were not affected by rhizome severing. Further, we found that root lifespan of Stipa krylovii and Artemisia frigida, two dominant, non-clonal species in the temperate steppe, was significantly longer (118 d) than that of L. chinensis (81 d), and this value became comparable to that of L. chinensis under rhizome severing (103 d). Conclusions/Significance: We found that root lifespan in dominant, clonal L. chinensis was shorter than for the dominant, non-clonal species of S. krylovii and A. frigida. There was a substantial increase in the root lifespan of L. chinensis in response to severing their rhizomes, and this increase in root lifespan exhibited temporal and spatial characteristics. These findings suggest that the presence of rhizomes is likely to account for the observed short lifespan of clonal plant species in the temperate steppe.	[Bai, Wenming; Xun, Fen; Li, Yang; Zhang, Wenhao; Li, Linghao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Xun, Fen; Li, Yang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	llinghao@ibcas.ac.cn	Zhang, Wen-Hao/B-5805-2009	Zhang, Wen-Hao/0000-0003-2708-2221	State Key Basic Research Development Program of China [2010CB833502]; CAS [KZCX2-XB2-01, KSCX-YW-Z-1022]	State Key Basic Research Development Program of China; CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences)	This research was supported by a grant of the State Key Basic Research Development Program of China (2010CB833502) and the knowledge innovation program of CAS (KZCX2-XB2-01, KSCX-YW-Z-1022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Anderson LJ, 2003, NEW PHYTOL, V158, P489, DOI 10.1046/j.1469-8137.2003.00757.x; Baddeley JA, 2005, PLANT SOIL, V276, P15, DOI 10.1007/s11104-005-0263-6; Bai WM, 2008, FUNCT ECOL, V22, P583, DOI 10.1111/j.1365-2435.2008.01403.x; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Bates TR, 2002, HORTSCIENCE, V37, P313, DOI 10.21273/HORTSCI.37.2.313; *CHIN AC SCI, 1985, VEG INN MONGL, P516; Eissenstat DM, 2000, NEW PHYTOL, V147, P33, DOI 10.1046/j.1469-8137.2000.00686.x; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Farrar JF, 2000, NEW PHYTOL, V147, P43, DOI 10.1046/j.1469-8137.2000.00688.x; Gill RA, 2002, PLANT ECOL, V159, P241, DOI 10.1023/A:1015529507670; HASSID WZ, 1964, METHODS CARBOHYDRATE, V4, P33; HENDRICKS JJ, 1993, TRENDS ECOL EVOL, V8, P174, DOI 10.1016/0169-5347(93)90143-D; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hooker JE, 2000, ROOT METHODS: A HANDBOOK, P273; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Lopez B, 2001, NEW PHYTOL, V151, P437, DOI 10.1046/j.0028-646x.2001.00189.x; Norby RJ, 2000, NEW PHYTOL, V147, P3, DOI 10.1046/j.1469-8137.2000.00676.x; Stewart AM, 2008, OECOLOGIA, V157, P453, DOI 10.1007/s00442-008-1088-9; Van der Krift TAJ, 2002, FUNCT ECOL, V16, P198, DOI 10.1046/j.1365-2435.2002.00611.x; Wang Ya-Ying, 2007, Acta Botanica Yunnanica, V29, P74; [王昱生 Wang Yusheng], 2004, [生态学报, Acta Ecologica Sinica], V24, P900; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Wells CE, 2001, ECOLOGY, V82, P882, DOI 10.1890/0012-9658(2001)082[0882:MDISAA]2.0.CO;2; West JB, 2003, FUNCT ECOL, V17, P20, DOI 10.1046/j.1365-2435.2003.00695.x; Xu WenJing, 2006, Journal of Plant Ecology, V30, P104; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Zhang GuangHui, 2006, Acta Prataculturae Sinica, V15, P42; ZHU TC, 2004, BIOL ECOLOGICAL STUD, P90	30	13	17	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12125	10.1371/journal.pone.0012125	http://dx.doi.org/10.1371/journal.pone.0012125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711343	gold, Green Published, Green Submitted			2022-12-25	WOS:000280859700017
J	Castillo, S; Srithayakumar, V; Meunier, V; Kyle, CJ				Castillo, Sarrah; Srithayakumar, Vythegi; Meunier, Vanessa; Kyle, Christopher J.			Characterization of Major Histocompatibility Complex (MHC) DRB Exon 2 and DRA Exon 3 Fragments in a Primary Terrestrial Rabies Vector (Procyon lotor)	PLOS ONE			English	Article							NATURAL-SELECTION; EVOLUTIONARY RELATIONSHIPS; GENETIC-VARIATION; RACCOON; LOCI; RESISTANCE; DIVERSITY; ECOLOGY; VARIABILITY; SUPERTYPES	The major histocompatibility complex (MHC) presents a unique system to explore links between genetic diversity and pathogens, as diversity within MHC is maintained in part by pathogen driven selection. While the majority of wildlife MHC studies have investigated species that are of conservation concern, here we characterize MHC variation in a common and broadly distributed species, the North American raccoon (Procyon lotor). Raccoons host an array of broadly distributed wildlife diseases (e. g., canine distemper, parvovirus and raccoon rabies virus) and present important human health risks as they persist in high densities and in close proximity to humans and livestock. To further explore how genetic variation influences the spread and maintenance of disease in raccoons we characterized a fragment of MHC class II DRA exon 3 (250bp) and DRB exon 2 (228 bp). MHC DRA was found to be functionally monomorphic in the 32 individuals screened; whereas DRB exon 2 revealed 66 unique alleles among the 246 individuals screened. Between two and four alleles were observed in each individual suggesting we were amplifying a duplicated DRB locus. Nucleotide differences between DRB alleles ranged from 1 to 36 bp (0.4-15.8% divergence) and translated into 1 to 21 (1.3-27.6% divergence) amino acid differences. We detected a significant excess of nonsynonymous substitutions at the peptide binding region (P = 0.005), indicating that DRB exon 2 in raccoons has been influenced by positive selection. These data will form the basis of continued analyses into the spatial and temporal relationship of the raccoon rabies virus and the immunogenetic response in its primary host.	[Castillo, Sarrah; Srithayakumar, Vythegi] Trent Univ, Environm & Life Sci Gradate Program, Peterborough, ON K9J 7B8, Canada; [Meunier, Vanessa; Kyle, Christopher J.] Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada; [Castillo, Sarrah; Srithayakumar, Vythegi; Kyle, Christopher J.] Trent Univ, Nat Resources DNA Profiling & Forens Ctr, Peterborough, ON K9J 7B8, Canada	Trent University; Trent University; Trent University	Castillo, S (corresponding author), Trent Univ, Environm & Life Sci Gradate Program, Peterborough, ON K9J 7B8, Canada.	scastillo@nrdpfc.ca			Natural Sciences and Engineering Research Council of Canada [355850]; Rabies Research Unit of the Ontario Ministry of Natural Resources	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Rabies Research Unit of the Ontario Ministry of Natural Resources	This research was funded through a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to CJK (Grant # 355850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by collaboration funds to CJK from the Rabies Research Unit of the Ontario Ministry of Natural Resources. The Rabies Research Unit also provided samples for this research.	Alcaide M, 2010, MOL ECOL, V19, P691, DOI 10.1111/j.1365-294X.2009.04507.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSSON L, 1991, IMMUNOGENETICS, V33, P188, DOI 10.1007/BF01719239; Babik W, 2005, MOL ECOL, V14, P4249, DOI 10.1111/j.1365-294X.2005.02751.x; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Becker L, 2009, IMMUNOGENETICS, V61, P281, DOI 10.1007/s00251-009-0362-2; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Biedrzycka A, 2008, MOL ECOL, V17, P4801, DOI 10.1111/j.1365-294X.2008.03955.x; Bowen L, 2004, IMMUNOGENETICS, V56, P12, DOI 10.1007/s00251-004-0655-4; Breuer L., 2005, INTRO QUEUEING THEOR; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CAREY AB, 1983, J APPL ECOL, V20, P777, DOI 10.2307/2403126; Childs JE, 2000, P NATL ACAD SCI USA, V97, P13666, DOI 10.1073/pnas.240326697; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Cullingham CI, 2008, MOL ECOL, V17, P4874, DOI 10.1111/j.1365-294X.2008.03956.x; Cullingham CI, 2008, CAN J ZOOL, V86, P947, DOI 10.1139/Z08-072; Doherty P C, 1975, Nature, V256, P50; Gillett R. M., 2009, THESIS TRENT U PETER, P149; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Helgen KM, 2008, J MAMMAL, V89, P282, DOI 10.1644/07-MAMM-A-155R.1; Huchard E, 2006, IMMUNOGENETICS, V58, P805, DOI 10.1007/s00251-006-0156-8; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1994, PHILOS T ROY SOC B, V346, P359, DOI 10.1098/rstb.1994.0153; HUGHES AL, 1995, IMMUNOGENETICS, V42, P233, DOI 10.1007/BF00176440; HUGHES AL, 1990, MOL BIOL EVOL, V7, P491; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; HUGHES AL, 1993, IMMUNOGENETICS, V37, P337, DOI 10.1007/BF00216798; JENKINS SR, 1988, REV INFECT DIS, V10, pS620; Junge RE, 2007, J ZOO WILDLIFE MED, V38, P18, DOI 10.1638/05-123.1; Kennedy LJ, 2002, IMMUNOGENETICS, V54, P348, DOI 10.1007/s00251-002-0465-5; KENNEDY ML, 1984, J MAMMAL, V65, P195, DOI 10.2307/1381159; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Murray BW, 1998, IMMUNOGENETICS, V48, P242, DOI 10.1007/s002510050428; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Real LA, 2007, J R SOC INTERFACE, V4, P935, DOI 10.1098/rsif.2007.1041; Saitoh K, 2008, GENE, V423, P92, DOI 10.1016/j.gene.2008.06.025; Schad J, 2004, CONSERV GENET, V5, P299, DOI 10.1023/B:COGE.0000031137.50239.d3; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sun DX, 2004, BIOCHEM GENET, V42, P385, DOI 10.1023/B:BIGI.0000039812.46203.89; Szanto A, 2009, THESIS TRENT U PETER; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wheeler DC, 2008, J AGR BIOL ENVIR ST, V13, P388, DOI 10.1198/108571108X383483; Yuhki N, 1997, J IMMUNOL, V158, P2822; Zeisset I, 2009, MOL ECOL RESOUR, V9, P738, DOI 10.1111/j.1755-0998.2009.02535.x; Zeng CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-315	55	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12066	10.1371/journal.pone.0012066	http://dx.doi.org/10.1371/journal.pone.0012066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706587	Green Published, Green Submitted, gold			2022-12-25	WOS:000280811900020
J	Blackburn, DC; Bickford, DP; Diesmos, AC; Iskandar, DT; Brown, RM				Blackburn, David C.; Bickford, David P.; Diesmos, Arvin C.; Iskandar, Djoko T.; Brown, Rafe M.			An Ancient Origin for the Enigmatic Flat-Headed Frogs (Bombinatoridae: Barbourula) from the Islands of Southeast Asia	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PALAWAN ISLAND; DISCOGLOSSID FROGS; LARVAL CHARACTERS; GLOBAL PATTERNS; SE ASIA; DIVERSIFICATION; ANURA; MITOCHONDRIAL; PHILIPPINE	Background: The complex history of Southeast Asian islands has long been of interest to biogeographers. Dispersal and vicariance events in the Pleistocene have received the most attention, though recent studies suggest a potentially more ancient history to components of the terrestrial fauna. Among this fauna is the enigmatic archaeobatrachian frog genus Barbourula, which only occurs on the islands of Borneo and Palawan. We utilize this lineage to gain unique insight into the temporal history of lineage diversification in Southeast Asian islands. Methodology/Principal Findings: Using mitochondrial and nuclear genetic data, multiple fossil calibration points, and likelihood and Bayesian methods, we estimate phylogenetic relationships and divergence times for Barbourula. We determine the sensitivity of focal divergence times to specific calibration points by jackknife approach in which each calibration point is excluded from analysis. We find that relevant divergence time estimates are robust to the exclusion of specific calibration points. Barbourula is recovered as a monophyletic lineage nested within a monophyletic Costata. Barbourula diverged from its sister taxon Bombina in the Paleogene and the two species of Barbourula diverged in the Late Miocene. Conclusions/Significance: The divergences within Barbourula and between it and Bombina are surprisingly old and represent the oldest estimates for a cladogenetic event resulting in living taxa endemic to Southeast Asian islands. Moreover, these divergence time estimates are consistent with a new biogeographic scenario: the Palawan Ark Hypothesis. We suggest that components of Palawan's terrestrial fauna might have "rafted'' on emergent portions of the North Palawan Block during its migration from the Asian mainland to its present-day position near Borneo. Further, dispersal from Palawan to Borneo (rather than Borneo to Palawan) may explain the current day disjunct distribution of this ancient lineage.	[Blackburn, David C.; Brown, Rafe M.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Blackburn, David C.; Brown, Rafe M.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Bickford, David P.] Natl Univ Singapore, Singapore 117548, Singapore; [Diesmos, Arvin C.] Natl Museum Philippines, Manila, Philippines; [Iskandar, Djoko T.] Inst Teknol Bandung, Bandung, Java, Indonesia	University of Kansas; University of Kansas; National University of Singapore; National Museum of the Philippines; Institute Technology of Bandung	Blackburn, DC (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	david.c.blackburn@gmail.com	Blackburn, David/L-3812-2019; Iskasndar, Djoko/AAD-2204-2021; Diesmos, Arvin C./AGG-8542-2022; Bickford, David P/A-5306-2011	Blackburn, David/0000-0002-1810-9886; Iskasndar, Djoko/0000-0002-8923-6081; Bickford, David P/0000-0003-1478-3387	United States National Science Foundation [DEB-0640737, 0743491]; National University of Singapore [154-000-383-133]; Direct For Biological Sciences [0743491] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); National University of Singapore(National University of Singapore); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants from the United States National Science Foundation (http://www.nsf.gov; DEB-0640737 and 0743491 to RMB) and the National University of Singapore (http://www.nus.edu.sg; R-154-000-383-133) to DPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; [Anonymous], 2009, ENCY ISLANDS; ANTUNES MT, 1981, CR ACAD SCI II, V293, P1099; Baez AM, 2009, CRETACEOUS RES, V30, P829, DOI 10.1016/j.cretres.2009.01.002; Bickford D, 2008, CURR BIOL, V18, pR374, DOI 10.1016/j.cub.2008.03.010; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Bird P.R., 1993, J SE ASIAN EARTH SCI, V8, P449, DOI DOI 10.1016/0743-9547(93)90045-Q; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Brown RM, 2010, J HERPETOL, V44, P37, DOI 10.1670/08-316.1; Brown RN, 2009, HERPETOL MONOGR, V23, P1; Brown RM, 2002, BIOL J LINN SOC, V76, P393, DOI 10.1111/j.1095-8312.2002.tb01704.x; BROWN RM, 2009, ENCY ISLANDS, P723; Brown W.C., 1982, ADV HERPETOLOGY EVOL, P416; Cannatella D.C., 1985, THESIS U KANSAS LAWR, P404; CLARKE BT, 1987, J NAT HIST, V21, P879, DOI 10.1080/00222938700770531; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; deJong R, 1996, CLADISTICS, V12, P323, DOI 10.1111/j.1096-0031.1996.tb00018.x; den Tex RJ, 2010, MOL PHYLOGENET EVOL, V55, P711, DOI 10.1016/j.ympev.2009.12.023; DICKERSON RE, 1928, MONOGRAPHS BUREAU SC, V2, P1; Drewes, 2004, P CALIFORNIA ACAD SC, V55, P395; DRUMMOND AJ, 2009, BEAST V1 4 2 BAYESIA; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duellman W. E., 1986, BIOL AMPHIBIANS; DUELLMAN WE, 1975, U KANS OCCAS PAP MUS, V42, P1; Dupont-Nivet G, 2007, NATURE, V445, P635, DOI 10.1038/nature05516; DURKEE EF, 1993, B GEOLOGICAL SOC MAL, V33, P242; Encarnacion J, 1997, LITHOS, V42, P1, DOI 10.1016/S0024-4937(97)00026-1; ERSPAMER V, 1972, BRIT J PHARMACOL, V45, P333, DOI 10.1111/j.1476-5381.1972.tb08087.x; Esselstyn JA, 2004, P BIOL SOC WASH, V117, P271; ESSELSTYN JA, 2010, J BIOGEOGR IN PRESS; Esselstyn JA, 2008, J MAMMAL, V89, P815, DOI 10.1644/07-MAMM-A-285.1; Esselstyn JA, 2009, EVOLUTION, V63, P2595, DOI 10.1111/j.1558-5646.2009.00743.x; ESTES R, 1982, Journal of Vertebrate Paleontology, V2, P9; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; EVANS SE, 1990, PALAEONTOLOGY, V33, P299; Ford Linda S., 1993, Herpetological Monographs, V7, P94, DOI 10.2307/1466954; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gao KQ, 2001, J VERTEBR PALEONTOL, V21, P460, DOI 10.1671/0272-4634(2001)021[0460:MAFLPC]2.0.CO;2; Haas A, 2003, CLADISTICS, V19, P23, DOI 10.1111/j.1096-0031.2003.tb00405.x; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hamilton W., 1979, US GEOLOGICAL SURVEY, V1078, P345; Heaney L.R., 1985, Modern Quaternary Research in Southeast Asia, V9, P127; HEANEY LR, 1986, BIOL J LINN SOC, V28, P127, DOI 10.1111/j.1095-8312.1986.tb01752.x; HEANEY LR, 1991, B AM MUS NAT HIST, P145; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Henrici AC, 1998, J VERTEBR PALEONTOL, V18, P321, DOI 10.1080/02724634.1998.10011060; Henrici AC, 2006, ANN CARNEGIE MUS, V75, P11, DOI 10.2992/0097-4463(2006)75[11:EBANPA]2.0.CO;2; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hoegg S, 2004, MOL BIOL EVOL, V21, P1188, DOI 10.1093/molbev/msh081; HOLLOWAY NH, 1982, AAPG BULL, V66, P1355; Inger R.F, 1954, FIELDIANA, V33, P1; Inger RF, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P445; ISKANDAR DT, 1995, RAFFLES B ZOOL, V43, P309; ISKANDAR DT, 1978, COPEIA, P564; Jansa SA, 2006, SYST BIOL, V55, P73, DOI 10.1080/10635150500431254; Jones AW, 2008, BIOL J LINN SOC, V95, P620, DOI 10.1111/j.1095-8312.2008.01073.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LANZA B, 1975, Monitore Zoologico Italiano, V9, P153; LANZA B, 1976, Monitore Zoologico Italiano, V10, P311; Linkem CW, 2010, HERPETOLOGICA, V66, P67, DOI 10.1655/08-074.1; Loader SP, 2007, BIOL LETTERS, V3, P505, DOI 10.1098/rsbl.2007.0266; Maglia AM, 1998, HERPETOLOGICA, V54, P344; Marivaux L, 2006, ZOOL SCR, V35, P395, DOI 10.1111/j.1463-6409.2006.00235.x; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Milsom J, 2009, J GEOL SOC LONDON, V166, P985, DOI 10.1144/0016-76492009-067; Mitchell AHG., 1986, J SE ASIAN EARTH SCI, V1, P3, DOI DOI 10.1016/0743-9547(86)90003-6; MYERS GS, 1943, COPEIA, P148; Nunome M, 2007, ZOOL SCR, V36, P537, DOI 10.1111/j.1463-6409.2007.00296.x; NYLANDER JAA, 2004, MRMODELTEST V2 3 EVO; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oliveros CH, 2010, MOL PHYLOGENET EVOL, V54, P822, DOI 10.1016/j.ympev.2009.12.001; Outlaw DC, 2008, J BIOGEOGR, V35, P739, DOI 10.1111/j.1365-2699.2007.01821.x; PALUMBI SR, 1991, SIMPLE FOOLS G UNPUB; PARK RK, 1979, SEDIMENTARY HIST BAS; Pugener LA, 2003, ZOOL J LINN SOC-LOND, V139, P129, DOI 10.1046/j.1096-3642.2003.00075.x; Quek SP, 2007, MOL ECOL, V16, P2045, DOI 10.1111/j.1365-294X.2007.03294.x; Rage J.-C., 2003, CIENCIAS TERRA UNL, V15, P103; RAGE JC, 1989, Z PALAEONTOGRAPHIC A, V206, P1; Rambaut A, 2014, TRACER V1 6; Rambaut A, 2009, TREEANNOTATOR V1 5 3; Richards CM, 1998, HERPETOL J, V8, P41; Rocek Zbynek, 2000, Amphibian Biology, V4, P1332; Roelants K, 2005, SYST BIOL, V54, P111, DOI 10.1080/10635150590905894; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Saldivar-Sali A., 1981, 2 ASCOPE C EXH MAN P, P99; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; San Mauro D, 2004, GENE, V343, P357, DOI 10.1016/j.gene.2004.10.001; San Mauro D, 2010, MOL PHYLOGENET EVOL, V56, P554, DOI 10.1016/j.ympev.2010.04.019; Savage J.M., 1973, EVOLUTIONARY BIOL AN, P351; Siler CD, 2010, MOL PHYLOGENET EVOL, V55, P699, DOI 10.1016/j.ympev.2010.01.027; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukumaran J., 2008, SUMTREES SUMMARIZATI; Taylor B., 1980, Tectonic and geologic evolution of southeast asian seas and islands, P89, DOI 10.1029/GM023p0089; Taylor E. H., 1924, American Museum Novitates, Vno. 121, P1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Uyeda Josef C., 2007, Proceedings of the California Academy of Sciences, V58, P367; Van Bocxlaer I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-131; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; Vences M, 2004, J BIOGEOGR, V31, P593, DOI 10.1046/j.1365-2699.2003.01031.x; Welton LJ, 2009, HERPETOLOGICA, V65, P328, DOI 10.1655/08-057R1.1; Wiens JJ, 2007, AM NAT, V170, pS86, DOI 10.1086/519396; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Yuan W, 2000, NATURWISSENSCHAFTEN, V87, P417, DOI 10.1007/s001140050753; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	109	68	73	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12090	10.1371/journal.pone.0012090	http://dx.doi.org/10.1371/journal.pone.0012090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711504	gold, Green Published			2022-12-25	WOS:000280776800022
J	Gkirtzou, K; Tsamardinos, I; Tsakalides, P; Poirazi, P				Gkirtzou, Katerina; Tsamardinos, Ioannis; Tsakalides, Panagiotis; Poirazi, Panayiota			MatureBayes: A Probabilistic Algorithm for Identifying the Mature miRNA within Novel Precursors	PLOS ONE			English	Article							MICRORNA PRECURSORS; DIVISION; GENES	Background: MicroRNAs (miRNAs) are small, single stranded RNAs with a key role in post-transcriptional regulation of thousands of genes across numerous species. While several computational methods are currently available for identifying miRNA genes, accurate prediction of the mature miRNA remains a challenge. Existing approaches fall short in predicting the location of mature miRNAs but also in finding the functional strand(s) of miRNA precursors. Methodology/Principal Findings: Here, we present a computational tool that incorporates a Naive Bayes classifier to identify mature miRNA candidates based on sequence and secondary structure information of their miRNA precursors. We take into account both positive (true mature miRNAs) and negative (same-size non-mature miRNA sequences) examples to optimize sensitivity as well as specificity. Our method can accurately predict the start position of experimentally verified mature miRNAs for both human and mouse, achieving a significantly larger (often double) performance accuracy compared with two existing methods. Moreover, the method exhibits a very high generalization performance on miRNAs from two other organisms. More importantly, our method provides direct evidence about the features of miRNA precursors which may determine the location of the mature miRNA. We find that the triplet of positions 7, 8 and 9 from the mature miRNA end towards the closest hairpin have the largest discriminatory power, are relatively conserved in terms of sequence composition (mostly contain a Uracil) and are located within or in very close proximity to the hairpin loop, suggesting the existence of a possible recognition site for Dicer and associated proteins. Conclusions: This work describes a novel algorithm for identifying the start position of mature miRNA(s) produced by miRNA precursors. Our tool has significantly better (often double) performance than two existing approaches and provides new insights about the potential use of specific sequence/structural information as recognition signals for Dicer processing. Web Tool available at: http://mirna.imbb.forth.gr/MatureBayes.html	[Gkirtzou, Katerina; Tsamardinos, Ioannis; Tsakalides, Panagiotis] Univ Crete, Dept Comp Sci, Iraklion, Greece; [Gkirtzou, Katerina; Tsamardinos, Ioannis; Tsakalides, Panagiotis] Fdn Res & Technol Hellas, Inst Comp Sci, Iraklion, Greece; [Poirazi, Panayiota] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece	University of Crete; Foundation for Research & Technology - Hellas (FORTH); Foundation for Research & Technology - Hellas (FORTH)	Gkirtzou, K (corresponding author), Univ Crete, Dept Comp Sci, Iraklion, Greece.	poirazi@imbb.forth.gr	Tsakalides, Panagiotis/O-2063-2015	Tsakalides, Panagiotis/0000-0003-4918-603X; Poirazi, Panayiota/0000-0001-6152-595X	European Community [MTKD-CT-2005-029791]; European Commission [PIOF-GA-2008-219622]	European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the Marie Curie TOK-DEV ASPIRE grant [MTKD-CT-2005-029791] within the 6th European Community Framework Program (K.G., P.T.) and the Marie Curie Outgoing Fellowship [PIOF-GA-2008-219622] of the European Commission (P.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BEREZIKOV E, 2006, NAT GENET S1, V38; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gkirtzou K, 2008, IEEE INT C BIOINF BI, P291; HARRY Z, 2004, LECT NOTES COMPUTER, P501; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Kohavi R, 2001, INT JOINT C ART INT, P1137; Kong Yong, 2005, GeoActa, V3, P62; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Mitchell T.M, 2003, MACH LEARN; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Oulas A, 2009, IEEE T INF TECHNOL B, V13, P67, DOI 10.1109/TITB.2008.2007086; PBARTEL D, 2004, CELL, V116, P281; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sheng Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000946; TAO M, 2007, THERMODYNAMIC STRUCT; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Yousef M, 2009, FEBS J, V276, P2150, DOI 10.1111/j.1742-4658.2009.06933.x	37	89	92	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11843	10.1371/journal.pone.0011843	http://dx.doi.org/10.1371/journal.pone.0011843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700506	Green Published, Green Submitted, gold			2022-12-25	WOS:000280687900001
J	Neumann-Staubitz, P; Hall, SL; Kuo, J; Jackson, AP				Neumann-Staubitz, Petra; Hall, Stephanie L.; Kuo, Joseph; Jackson, Antony P.			Characterization of a Temperature-Sensitive Vertebrate Clathrin Heavy Chain Mutant as a Tool to Study Clathrin-Dependent Events In Vivo	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; TRANS-GOLGI NETWORK; PROTEIN-TRANSPORT; SACCHAROMYCES-CEREVISIAE; BETA-GLUCURONIDASE; ACTIN; EXPRESSION; MEMBRANE; INTERNALIZATION; TRIMERIZATION	Clathrin and clathrin-dependent events are evolutionary conserved although it is believed that there are differences in the requirement for clathrin in yeast and higher vertebrates. Clathrin is a long-lived protein and thus, with clathrin knockdowns only long-term consequences of clathrin depletion can be studied. Here, we characterize the first vertebrate temperature-sensitive clathrin heavy chain mutant as a tool to investigate responses to rapid clathrin inactivation in higher eukaryotes. Although we created this mutant using a clathrin cryo-electron microscopy model and a yeast temperature-sensitive mutant as a guide, the resulting temperature-sensitive clathrin showed an altered phenotype compared to the corresponding yeast temperature-sensitive clathrin. First, it seemed to form stable triskelions at the non-permissive temperature although endocytosis was impaired under these conditions. Secondly, as a likely consequence of the stable triskelions at the non-permissive temperature, clathrin also localized correctly to its target membranes. Thirdly, we did not observe missorting of the lysosomal enzyme beta-glucuronidase which could indicate that the temperature-sensitive clathrin is still operating at the non-permissive temperature at the Golgi or, that, like in yeast, more than one TGN trafficking pathway exists. Fourthly, in contrast to yeast, actin does not appear to actively compensate in general endocytosis. Thus, there seem to be differences between vertebrates and yeast which can be studied in further detail with this newly created tool.	[Neumann-Staubitz, Petra; Hall, Stephanie L.; Kuo, Joseph; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Neumann-Staubitz, Petra] Georg August Univ Goettingen, Dept Gen Microbiol, Inst Microbiol & Genet, Gottingen, Germany	University of Cambridge; University of Gottingen	Neumann-Staubitz, P (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	pneuman3@gwdg.de		Kuo, Joe/0000-0003-0140-5088; Jackson, Antony Philip/0000-0002-2895-7387	Deutsche Forschungsgemeinschaft DFG (German Research Foundation); Biotechnology and Biological Sciences Research Council [BB/D001242/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft DFG (German Research Foundation)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Deutsche Forschungsgemeinschaft DFG (German Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Baggett JJ, 2001, TRAFFIC, V2, P297, DOI 10.1034/j.1600-0854.2001.002005297.x; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; BROWN WJ, 1984, J CELL BIOL, V99, P320, DOI 10.1083/jcb.99.1.320; BURSTEDDE T, 2006, REV PROTOCOLS DT40 R; Chen CY, 1998, GENETICS, V150, P577; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Duncan MC, 2005, NATURE, V438, P571, DOI 10.1038/438571a; ENNS CA, 1983, J CELL BIOL, V97, P579, DOI 10.1083/jcb.97.2.579; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; FRA AM, 1994, J BIOL CHEM, V269, P30745; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Fukagawa T, 2001, NUCLEIC ACIDS RES, V29, P3796, DOI 10.1093/nar/29.18.3796; GABEL CA, 1984, J CELL BIOL, V99, P296, DOI 10.1083/jcb.99.1.296; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; LEMMON SK, 1991, J CELL BIOL, V112, P65, DOI 10.1083/jcb.112.1.65; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Medina FA, 2006, CELL CYCLE, V5, P1865, DOI 10.4161/cc.5.16.3132; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MUNN AL, 1991, MOL CELL BIOL, V11, P3868, DOI 10.1128/MCB.11.8.3868; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; PAYNE GS, 1987, MOL CELL BIOL, V7, P3888, DOI 10.1128/MCB.7.11.3888; PAYNE GS, 1988, J CELL BIOL, V106, P1453, DOI 10.1083/jcb.106.5.1453; PAYNE GS, 1985, SCIENCE, V230, P1009, DOI 10.1126/science.2865811; Pishvaee B, 1997, EMBO J, V16, P2227, DOI 10.1093/emboj/16.9.2227; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; RANDALL WC, 1939, PANTING TEMPERATURE, P761; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Royle SJ, 2006, J CELL SCI, V119, P4071, DOI 10.1242/jcs.03192; Sato K, 2009, P NATL ACAD SCI USA, V106, P1139, DOI 10.1073/pnas.0809541106; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; SEEGER M, 1992, J CELL BIOL, V118, P531, DOI 10.1083/jcb.118.3.531; Spang A, 2008, CELL MOL LIFE SCI, V65, P2781, DOI 10.1007/s00018-008-8349-y; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; TAN PK, 1993, J CELL BIOL, V123, P1707, DOI 10.1083/jcb.123.6.1707; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Vallejo J, 2005, FASEB J, V19, P586, DOI 10.1096/fj.04-2380fje; Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222; Wu XJ, 1998, J CHROMATOGR B, V708, P61, DOI 10.1016/S0378-4347(97)00673-7; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Ybe JA, 2003, TRAFFIC, V4, P850, DOI 10.1046/j.1600-0854.2003.0139.x	61	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12017	10.1371/journal.pone.0012017	http://dx.doi.org/10.1371/journal.pone.0012017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700507	Green Published, gold, Green Submitted			2022-12-25	WOS:000280687900014
J	Tiwary, R; Yu, WP; Li, J; Park, SK; Sanders, BG; Kline, K				Tiwary, Richa; Yu, Weiping; Li, Jing; Park, Sook-Kyung; Sanders, Bob G.; Kline, Kimberly			Role of Endoplasmic Reticulum Stress in alpha-TEA Mediated TRAIL/DR5 Death Receptor Dependent Apoptosis	PLOS ONE			English	Article							MAMMARY-TUMOR BURDEN; VITAMIN-E; CANCER-CELLS; C-JUN; UP-REGULATION; ACTIVATION; PROTEIN; EXPRESSION; JNK; INDUCTION	Background: alpha-TEA (RRR-alpha-tocopherol ether-linked acetic acid analog), a derivative of RRR-alpha-tocopherol (vitamin E) exhibits anticancer actions in vitro and in vivo in variety of cancer types. The objective of this study was to obtain additional insights into the mechanisms involved in alpha-TEA induced apoptosis in human breast cancer cells. Methodology/Principal Findings: alpha-TEA induces endoplasmic reticulum (ER) stress as indicated by increased expression of CCAAT/enhancer binding protein homologous protein (CHOP) as well as by enhanced expression or activation of specific markers of ER stress such as glucose regulated protein (GRP78), phosphorylated alpha subunit of eukaryotic initiation factor 2 (peIF-2 alpha), and spliced XBP-1 mRNA. Knockdown studies using siRNAs to TRAIL, DR5, JNK and CHOP as well as chemical inhibitors of ER stress and caspase-8 showed that: i) alpha-TEA activation of DR5/caspase-8 induces an ER stress mediated JNK/CHOP/DR5 positive amplification loop; ii) alpha-TEA downregulation of c-FLIP (L) protein levels is mediated by JNK/CHOP/DR5 loop via a JNK dependent Itch E3 ligase ubiquitination that further serves to enhance the JNK/CHOP/DR5 amplification loop by preventing c-FLIP's inhibition of caspase-8; and (iii) alpha-TEA downregulation of Bcl-2 is mediated by the ER stress dependent JNK/CHOP/DR5 signaling. Conclusion: Taken together, ER stress plays an important role in alpha-TEA induced apoptosis by enhancing DR5/caspase-8 proapoptotic signaling and suppressing anti-apoptotic factors c-FLIP and Bcl-2 via ER stress mediated JNK/CHOP/DR5/caspase-8 signaling.	[Tiwary, Richa; Yu, Weiping; Li, Jing; Park, Sook-Kyung; Sanders, Bob G.] Univ Texas Austin, Sch Biol Sci C0900, Austin, TX 78712 USA; [Kline, Kimberly] Univ Texas Austin, Dept Nutr Sci A2703, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Tiwary, R (corresponding author), Univ Texas Austin, Sch Biol Sci C0900, Austin, TX 78712 USA.	k.kline@mail.utexas.edu			Clayton Foundation for Research; National Institute of Environmental Health Sciences Center [ES007784]; Center for Molecular and Cellular Toxicology at the University of Texas at Austin; NIEHS/NIH [T32 ES07247]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007247, P30ES007784] Funding Source: NIH RePORTER	Clayton Foundation for Research; National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Molecular and Cellular Toxicology at the University of Texas at Austin; NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Clayton Foundation for Research, the National Institute of Environmental Health Sciences Center Grant ES007784, the Center for Molecular and Cellular Toxicology at the University of Texas at Austin and a NIEHS/NIH Toxicology Training Grant T32 ES07247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Anderson K, 2004, EXP BIOL MED, V229, P1169, DOI 10.1177/153537020422901112; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; HABENER, 1996, MOL CELL BIOL, V16, P1479; Hahn T, 2006, CANCER RES, V66, P9374, DOI 10.1158/0008-5472.CAN-06-2403; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernandez-Gutierrez S, 2006, APOPTOSIS, V11, P1101, DOI 10.1007/s10495-006-6984-z; Jia L, 2008, PROSTATE, V68, P427, DOI 10.1002/pros.20716; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kline K, 2007, VITAM HORM, V76, P435, DOI 10.1016/S0083-6729(07)76017-X; Kruyt FAE, 2008, CANCER LETT, V263, P14, DOI 10.1016/j.canlet.2008.02.003; Lawson KA, 2004, EXP BIOL MED, V229, P954, DOI 10.1177/153537020422900913; Lawson KA, 2003, MOL CANCER THER, V2, P437; Li J, 2004, EXP GERONTOL, V39, P735, DOI 10.1016/j.exger.2004.02.008; Li J, 2008, PROSTATE, V68, P849, DOI 10.1002/pros.20750; Lizaka T, 2007, TOXICOLOGY, V241, P146, DOI 10.1016/j.tox.2007.08.095; Naito M, 2004, MOL CELL BIOL, V24, P8418, DOI 10.1128/MCB.24.19.8418-8427.2004; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; SEOKHYUN KM, 2008, CANCER RES, V68, P2062; Shetty S, 2002, APOPTOSIS, V7, P413, DOI 10.1023/A:1020031023947; Shun MC, 2004, NUTR CANCER, V48, P95, DOI 10.1207/s15327914nc4801_13; Shun MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/824571; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; THAHN K, 2009, MOL CANCER THER, V8, P1570; Tuma RS, 2009, J NATL CANCER I, V101, P138, DOI 10.1093/jnci/djn507; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Wang J, 2008, HEPATOB PANCREAT DIS, V7, P45; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yu WP, 2006, APOPTOSIS, V11, P1813, DOI 10.1007/s10495-006-9234-5; Yu WP, 2009, MOL NUTR FOOD RES, V53, P1573, DOI 10.1002/mnfr.200900011; Yu WP, 2003, CANCER RES, V63, P2483; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	45	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11865	10.1371/journal.pone.0011865	http://dx.doi.org/10.1371/journal.pone.0011865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686688	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520200029
J	Giglio, S; Mancini, F; Pellegrino, M; Di Conza, G; Puxeddu, E; Sacchi, A; Pontecorvi, A; Moretti, F				Giglio, S.; Mancini, F.; Pellegrino, M.; Di Conza, G.; Puxeddu, E.; Sacchi, A.; Pontecorvi, A.; Moretti, F.			Regulation of MDM4 (MDMX) function by p76(MDM2): a new facet in the control of p53 activity	ONCOGENE			English	Article						p53; MDM4; MDM2; p76(MDM2); p90(MDM2)	DEGRADATION; HDMX; PHOSPHORYLATION; UBIQUITINATION; TRANSCRIPTS; STABILITY; REVEALS; ABILITY; ATM	Under basal growth conditions, p53 function is tightly controlled by the members of MDM family, MDM2 and MDM4. The Mdm2 gene codes, in addition to the full-length p90(MDM2), for a short protein, p76(MDM2) that lacks the p53-binding domain. Despite this property and at variance with p90(MDM2), this protein acts positively toward p53, although the molecular mechanism remains elusive. Here, we report that p76(MDM2) antagonizes MDM4 inhibitory function. We show that p76(MDM2) possesses intrinsic ubiquitinating and degrading activity, and through these activities controls MDM4 levels. Furthermore, the presence of p76(MDM2) decreases the association of MDM4 with p53 and p90(MDM2), and antagonizes p53 degradation by the heterodimer MDM4/ p90(MDM2). The p76(MDM2)-mediated regulation of MDM4 occurs in the cytoplasm, under basal growth conditions. Conversely, upon DNA damage, phosphorylation of MDM4Ser403 dissociates p76(MDM2) and prevents MDM4 degradation. The overall negative control of MDM4 by p76(MDM2) reflects on p53 function as p76(MDM2) impairs MDM4-mediated inhibition of p53 activity. In agreement with the positive role of p76(MDM2) toward p53, the p76(MDM2)/p90(MDM2) ratio significantly decreases in a group of thyroid tumor samples compared with normal counterparts. Overall, these findings reveal a new mechanism in the control of p53 basal activity that may account for the distinct sensitivity of tissues to stress signals depending on the balance among MDM proteins. Moreover, these data suggest an onco-suppressive function for a product of the Mdm2 gene. Oncogene (2010) 29, 5935-5945; doi:10.1038/onc.2010.324; published online 9 August 2010	[Giglio, S.; Mancini, F.; Pellegrino, M.; Di Conza, G.; Moretti, F.] CNR, Inst Neurobiol & Mol Med, Fdn Santa Lucia, I-6400143 Rome, Italy; [Giglio, S.; Mancini, F.; Pontecorvi, A.] Catholic Univ, Inst Med Pathol, Rome, Italy; [Di Conza, G.] Univ Messina, Dept Expt Clin Med & Pharmacol, Messina, Italy; [Puxeddu, E.] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy; [Sacchi, A.] Regina Elena Inst Canc Res, Lab Mol Oncogenesis, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Messina; University of Perugia; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Moretti, F (corresponding author), CNR, Inst Neurobiol & Mol Med, Fdn Santa Lucia, Via Fosso di Fiorano, I-6400143 Rome, Italy.	moretti@inmm.cnr.it	Mancini, Francesca/AAZ-1672-2021; Moretti, Fabiola/I-5647-2013; Puxeddu, Efisio/I-8188-2012; Pellegrino, Marsha/K-4500-2016; Di Conza, Giusy/GPP-1438-2022; mancini, francesca/K-6062-2016	Mancini, Francesca/0000-0002-2459-8815; Moretti, Fabiola/0000-0002-2691-1254; Pellegrino, Marsha/0000-0002-9002-3622; mancini, francesca/0000-0002-2459-8815; Di Conza, Giusy/0000-0003-1353-5867	Associazione Italiana Ricerca sul Cancro (AIRC), Ministero della Sanita	Associazione Italiana Ricerca sul Cancro (AIRC), Ministero della Sanita(Fondazione AIRC per la ricerca sul cancro)	The work was supported by research grants from Associazione Italiana Ricerca sul Cancro (AIRC), Ministero della Sanita. We are grateful to Dr Lozano for Mdm2<SUP>-/-</SUP> p53<SUP>-/-</SUP> MEFs, to Dr JC Marine for Mdm4<SUP>-/-</SUP> Mdm2<SUP>-/-</SUP> p53<SUP>-/-</SUP> MEFs and to Dr Jochemsen for phosphorylation-defective human MDM4S403A coding plasmid. We are also especially grateful to Dr Jochemsen for critical review and helpful comments to the paper.	BuesoRamos CE, 1996, BREAST CANCER RES TR, V37, P179, DOI 10.1007/BF01806499; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Cheng TH, 2007, MOL CELL BIOL, V27, P111, DOI 10.1128/MCB.00235-06; Dimitriadi M, 2008, BRIT J CANCER, V99, P1144, DOI 10.1038/sj.bjc.6604643; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Gentiletti F, 2002, ONCOGENE, V21, P867, DOI 10.1038/sj.onc.1205137; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Mancini F, 2009, CELL CYCLE, V8, P3854, DOI 10.4161/cc.8.23.10089; Mancini F, 2009, EMBO J, V28, P1926, DOI 10.1038/emboj.2009.154; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Migliorini D, 2002, J BIOL CHEM, V277, P7318, DOI 10.1074/jbc.M108795200; Ohtsubo C, 2009, CANCER SCI, V100, P1291, DOI 10.1111/j.1349-7006.2009.01180.x; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Perry ME, 2000, J BIOL CHEM, V275, P5733, DOI 10.1074/jbc.275.8.5733; Pikkarainen S, 2009, J BIOL CHEM, V284, P27195, DOI 10.1074/jbc.M109.037887; Prodosmo A, 2008, J MOL MED-JMM, V86, P585, DOI 10.1007/s00109-008-0322-6; Ralhan R, 2000, AM J PATHOL, V157, P587, DOI 10.1016/S0002-9440(10)64569-5; Salem MMAEL, 2009, FASEB J, V23, P3790, DOI 10.1096/fj.09-132621; Saucedo LJ, 1999, J BIOL CHEM, V274, P8161, DOI 10.1074/jbc.274.12.8161; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Wang YYV, 2009, CELL CYCLE, V8, P3443, DOI 10.4161/cc.8.21.9744; Zhou JX, 2009, J IMMUNOL, V183, P3188, DOI 10.4049/jimmunol.0803693	35	11	12	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	44					5935	5945		10.1038/onc.2010.324	http://dx.doi.org/10.1038/onc.2010.324			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	675PS	20697359				2022-12-25	WOS:000283843400007
J	Gonen, N; Assaraf, YG				Gonen, Nitzan; Assaraf, Yehuda G.			The Obligatory Intestinal Folate Transporter PCFT (SLC46A1) Is Regulated by Nuclear Respiratory Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MITOCHONDRIAL BIOGENESIS; CYTOCHROME-C-OXIDASE; METHOTREXATE SENSITIVITY; ANTIFOLATE RESISTANCE; HEME TRANSPORTER; CARRIER ACTIVITY; GENE-EXPRESSION; MOLECULAR-BASIS; CELLS; MALABSORPTION	Folates are essential vitamins that play a key role as one-carbon donors in a spectrum of biosynthetic pathways including RNA and DNA synthesis. The proton-coupled folate transporter (PCFT/SLC46A1) mediates obligatory intestinal folate absorption. Loss-of-function mutations in PCFT result in hereditary folate malabsorption, an autosomal recessive disorder characterized by very low folate levels in the blood and cerebrospinal fluid. Hereditary folate malabsorption manifests within the first months after birth with anemia, immune deficiency, and neurological deficits. Here we studied the role of inducible trans-activators of PCFT gene expression. Bioinformatics identified three putative nuclear respiratory factor 1 (NRF-1) binding sites in the minimal promoter. The following evidence establish that PCFT is an NRF-1-responsive gene; electrophoretic mobility shift assay showed NRF-1 binding to native but not mutant NRF-1 sites, whereas antibody-mediated supershift analysis and chromatin immunoprecipitation revealed NRF-1 binding to its consensus sites within the PCFT promoter. Moreover, mutational inactivation of individual or all NRF-1 binding sites resulted in 40-60% decrease in luciferase reporter activity. Consistently, overexpression of NRF-1 or a constitutively active NRF-1 VP-16 construct resulted in increased reporter activity and PCFT mRNA levels. Conversely, introduction of a dominant-negative NRF-1 construct markedly repressed reporter activity and PCFT mRNA levels; likewise, introduction of NRF-1 siRNA duplexes to cells resulted in decreased PCFT transcript levels. Moreover, NRF-1 silencing down-regulated genes encoding for key folate transporters and enzymes in folate metabolism. These novel findings identify NRF-1 as a major inducible transcriptional regulator of PCFT gene expression. The implications of this linkage between folate transport and metabolism with mitochondria biogenesis and respiration are discussed.	[Gonen, Nitzan; Assaraf, Yehuda G.] Technion Israel Inst Technol, Fred Wyszkowski Canc Res Lab, Fac Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Fred Wyszkowski Canc Res Lab, Fac Biol, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il	Gonen, Nitzan/AAL-7719-2021	Assaraf, Yehuda G./0000-0001-6692-8221; Gonen, Nitzan/0000-0002-3377-8324				APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Asangani IA, 2008, GENE, V410, P197, DOI 10.1016/j.gene.2007.12.009; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Assaraf YG, 2006, DRUG RESIST UPDATE, V9, P227, DOI 10.1016/j.drup.2006.09.001; Baar K, 2003, FASEB J, V17, P1666, DOI 10.1096/fj.03-0049com; BONKOVSKY H, 1990, HEPATOLOGY TXB LIVER; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAYTON KA, 1994, J BIOL CHEM, V269, P5313; Chang CM, 2007, BRIT J NUTR, V97, P855, DOI 10.1017/S0007114507666410; Chen SH, 1997, NUCLEIC ACIDS RES, V25, P1809, DOI 10.1093/nar/25.9.1809; Dang TN, 2010, GLIA, V58, P55, DOI 10.1002/glia.20901; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; Dhar SS, 2009, BBA-MOL CELL RES, V1793, P1604, DOI 10.1016/j.bbamcr.2009.07.001; DIXON KH, 1994, J BIOL CHEM, V269, P17; Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Fan XC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn535; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Gonen N, 2008, BIOCHEM BIOPH RES CO, V376, P787, DOI 10.1016/j.bbrc.2008.09.074; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Ifergan I, 2008, VITAM HORM, V79, P99, DOI 10.1016/S0083-6729(08)00404-4; JANSEN G, 1999, RECEPTOR CARRIER MED, P293; Kamen BA, 2004, ADV DRUG DELIVER REV, V56, P1085, DOI 10.1016/j.addr.2004.01.002; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; Kherrouche Z, 2004, BIOCHEM J, V383, P529, DOI 10.1042/BJ20040935; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Laftah AH, 2009, BRIT J NUTR, V101, P1150, DOI 10.1017/S0007114508066762; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; McCarty EA, 2004, J BIOL CHEM, V279, P33829, DOI 10.1074/jbc.M403677200; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; OHLSSON H, 1986, CELL, V45, P35, DOI 10.1016/0092-8674(86)90535-0; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; ROTHBERG KG, 1990, J CELL BIOL, V110, P637, DOI 10.1083/jcb.110.3.637; Salani R, 2007, INT J GYNECOL PATHOL, V26, P141, DOI 10.1097/01.pgp.0000229994.02815.f9; SCARPULLA RC, 1981, J BIOL CHEM, V256, P6480; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Sofer Y, 2007, J CHILD NEUROL, V22, P783, DOI 10.1177/0883073807304004; Stark M, 2009, BIOCHEM BIOPH RES CO, V388, P79, DOI 10.1016/j.bbrc.2009.07.116; STOCKSTAD ELR, 1990, FOLIC ACID METABOLIS, P1; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; WONG SC, 1995, J BIOL CHEM, V270, P17468, DOI 10.1074/jbc.270.29.17468; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969	57	33	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33602	33613		10.1074/jbc.M110.135640	http://dx.doi.org/10.1074/jbc.M110.135640			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20724482	Green Published, hybrid			2022-12-25	WOS:000283354000005
J	Kato, M; Wang, L; Putta, S; Wang, M; Yuan, H; Sun, GD; Lanting, L; Todorov, I; Rossi, JJ; Natarajan, R				Kato, Mitsuo; Wang, Lin; Putta, Sumanth; Wang, Mei; Yuan, Hang; Sun, Guangdong; Lanting, Linda; Todorov, Ivan; Rossi, John J.; Natarajan, Rama			Post-transcriptional Up-regulation of Tsc-22 by Ybx1, a Target of miR-216a, Mediates TGF-beta-induced Collagen Expression in Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; UPSTREAM STIMULATORY FACTOR-2; TRANSCRIPTION FACTORS TFE3; MESSENGER-RNA; TRANSFORMING GROWTH-FACTOR-BETA-1; DIABETIC-NEPHROPATHY; PROMOTER ACTIVITY; TRANSGENIC MICE; GENE ACTIVATION; LEUCINE-ZIPPER	Increased accumulation of extracellular matrix proteins and hypertrophy induced by transforming growth factor-beta 1 (TGF-beta)in renal mesangial cells (MC) are hallmark features of diabetic nephropathy. Although the post-transcriptional regulation of key genes has been implicated in these events, details are not fully understood. Here we show that TGF-beta increased microRNA-216a (miR-216a) levels in mouse MC, with parallel down-regulation of Ybx1, a miR-216a target and RNA-binding protein. TGF-beta also enhanced protein levels of Tsc-22 (TGF-beta-stimulated clone 22) and collagen type I alpha-2 (Col1a2) expression in MC through far upstream enhancer E-boxes by interaction of Tsc-22 with an E-box regulator, Tfe3. Ybx1 colocalized with processing bodies in MC and formed a ribonucleoprotein complex with Tsc-22 mRNA, and this complex formation was reduced by TGF-beta, miR-216a mimics, or Ybx1 shRNA to increase Tsc-22 protein levels but enhanced by miR-216a inhibitor oligonucleotides. Chromatin immunoprecipitation (ChIP) assays revealed that TGF-beta could increase the occupancies of Tsc-22 and Tfe3 on enhancer E-boxes of Col1a2. Co-immunoprecipitation assays revealed that TGF-beta promoted the interaction of Tsc-22 with Tfe3. These results demonstrate that post-transcriptional regulation of Tsc-22 mediated through Ybx1, a miR-216a target, plays a key role in TGF-beta -induced Col1a2 in MC related to the pathogenesis of diabetic nephropathy.	[Kato, Mitsuo; Putta, Sumanth; Wang, Mei; Yuan, Hang; Sun, Guangdong; Lanting, Linda; Todorov, Ivan; Natarajan, Rama] City Hope Natl Med Ctr, Gonda Diabet Ctr, Duarte, CA 91010 USA; [Wang, Lin; Putta, Sumanth; Todorov, Ivan; Rossi, John J.; Natarajan, Rama] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Rossi, John J.] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Beckman Res Inst, Duarte, CA 91010 USA; [Yuan, Hang; Sun, Guangdong] Jilin Univ, Div Nephrol, Hosp 2, Changchun 130041, Peoples R China	City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Jilin University	Natarajan, R (corresponding author), 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org	Kato, Mitsuo/D-5411-2009	Kato, Mitsuo/0000-0002-1783-1084	National Institutes of Health [NIDDK R21 DK076669, R01 DK058191, R01 DK081705]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK076669, R01DK058191, R01DK081705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIDDK R21 DK076669, R01 DK058191, and R01 DK081705 (to R. N.).	Bader AG, 2008, ONCOGENE, V27, P1179, DOI 10.1038/sj.onc.1210719; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Banas MC, 2007, J HISTOCHEM CYTOCHEM, V55, P275, DOI 10.1369/jhc.6A7083.2006; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BECKMANN H, 1991, GENE DEV, V5, P1057, DOI 10.1101/gad.5.6.1057; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; Brosius Frank C, 2010, Expert Rev Endocrinol Metab, V5, P51; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chen CY, 2000, GENE DEV, V14, P1236; Choi SJ, 2005, MOL CELL BIOCHEM, V271, P23, DOI 10.1007/s11010-005-3456-7; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Hua XX, 2000, J BIOL CHEM, V275, P33205, DOI 10.1074/jbc.C000568200; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Huan CM, 2006, NAT IMMUNOL, V7, P1082, DOI 10.1038/ni1378; Hubchak SC, 2009, AM J PHYSIOL-RENAL, V297, pF1316, DOI 10.1152/ajprenal.00345.2009; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Kutz SM, 2006, EXP CELL RES, V312, P1093, DOI 10.1016/j.yexcr.2005.12.027; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Murray D, 2000, J BIOL CHEM, V275, P3610, DOI 10.1074/jbc.275.5.3610; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Rossi JJ, 2005, NAT CELL BIOL, V7, P643, DOI 10.1038/ncb0705-643; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; Shi LH, 2009, AM J PHYSIOL-RENAL, V296, pF257, DOI 10.1152/ajprenal.90493.2008; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; Sugawara F, 2003, DIABETES RES CLIN PR, V60, P191, DOI 10.1016/S0168-8227(03)00038-X; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Terraz C, 2001, J BIOL CHEM, V276, P37011, DOI 10.1074/jbc.M104185200; Todorov I, 2006, PANCREAS, V32, P130, DOI 10.1097/01.mpa.0000202945.78331.93; Uchida D, 2003, BIOCHEM BIOPH RES CO, V305, P846, DOI 10.1016/S0006-291X(03)00854-4; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang SX, 2004, J BIOL CHEM, V279, P34311, DOI 10.1074/jbc.M401629200; Weigert C, 2004, J BIOL CHEM, V279, P15908, DOI 10.1074/jbc.M313524200; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907; Zhu YQ, 2005, DIABETES, V54, P1976, DOI 10.2337/diabetes.54.7.1976	60	140	148	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34004	34015		10.1074/jbc.M110.165027	http://dx.doi.org/10.1074/jbc.M110.165027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20713358	hybrid, Green Published			2022-12-25	WOS:000283354000047
J	Belanger, F; Stepinski, J; Darzynkiewicz, E; Pelletier, J				Belanger, Francois; Stepinski, Janusz; Darzynkiewicz, Edward; Pelletier, Jerry			Characterization of hMTr1, a Human Cap1 2 '-O-Ribose Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC MESSENGER-RNAS; SPLICED LEADER RNA; BLOCKED 5' TERMINI; TRYPANOSOMA-BRUCEI; VACCINIA VIRUS; HELA-CELLS; RIBOSE METHYLATION; POLYMERASE-II; PROTEIN; PURIFICATION	Cellular eukaryotic mRNAs are capped at their 5` ends with a 7-methylguanosine nucleotide, a structural feature that has been shown to be important for conferring mRNA stability, stimulating mRNA biogenesis (splicing, poly(A) addition, nucleocytoplasmic transport), and increasing translational efficiency. Whereas yeast mRNAs have no additional modifications to the cap, called cap0, higher eukaryotes are methylated at the 2`-O-ribose of the first or the first and second transcribed nucleotides, called cap1 and cap2, respectively. In the present study, we identify the methyltransferase responsible for cap1 formation in human cells, which we call hMTr1 (also known as FTSJD2 and ISG95). We show in vitro that hMTr1 catalyzes specific methylation of the 2`-O-ribose of the first nucleotide of a capped RNA transcript. Using si RNA-mediated knockdown of hMTr1 in HeLa cells, we demonstrate that hMTr1 is responsible for cap1 formation in vivo.	[Belanger, Francois; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Belanger, Francois; Pelletier, Jerry] McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; [Belanger, Francois; Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Stepinski, Janusz; Darzynkiewicz, Edward] Univ Warsaw, Fac Phys, Div Biophys, Inst Expt Phys, PL-02089 Warsaw, Poland	McGill University; McGill University; McGill University; University of Warsaw	Pelletier, J (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Sci Bldg,Rm 810,3655 Promenade Sir W, Montreal, PQ H3G 1Y6, Canada.	jerry.pelletier@mcgill.ca			Canadian Institutes of Health Research [MOP-79385]; Fonds de Recherche en Sante du Quebec; Howard Hughes Medical Institute [55005604]; National Science Support Project [PBZMNiSW-07/I/2007]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Support Project	This work was supported by Canadian Institutes of Health Research Grant MOP-79385 (to J. P.).; Supported by a Fonds de Recherche en Sante du Quebec postdoctoral fellowship.; Supported by Howard Hughes Medical Institute Grant 55005604 and National Science Support Project 2008-2010 PBZMNiSW-07/I/2007.	Arhin GK, 2006, MOL BIOCHEM PARASIT, V147, P137, DOI 10.1016/j.molbiopara.2006.01.011; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BANGS JD, 1992, J BIOL CHEM, V267, P9805; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Cole MD, 2009, ONCOGENE, V28, P1169, DOI 10.1038/onc.2008.463; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; ENSINGER MJ, 1976, J BIOL CHEM, V251, P5283; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; FREISTADT MS, 1988, J BIOL CHEM, V263, P15071; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P1904, DOI 10.1073/pnas.72.5.1904; Galloway SE, 2008, VIROLOGY, V382, P69, DOI 10.1016/j.virol.2008.08.041; Geiss GK, 2003, J VIROL, V77, P6367, DOI 10.1128/JVI.77.11.6367-6375.2003; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003; Haline-Vaz T, 2008, BIOCHEM BIOPH RES CO, V372, P719, DOI 10.1016/j.bbrc.2008.05.137; Hall MP, 2006, NUCLEIC ACIDS RES, V34, P5594, DOI 10.1093/nar/gkl573; JACQUEMONT B, 1977, J VIROL, V22, P160, DOI 10.1128/JVI.22.1.160-167.1977; Jankowska M, 1996, COLLECT CZECH CHEM C, V61, pS197; KEITH JM, 1978, J BIOL CHEM, V253, P5033; Kuge H, 1998, NUCLEIC ACIDS RES, V26, P3208, DOI 10.1093/nar/26.13.3208; Kuge H, 1995, EMBO J, V14, P6301, DOI 10.1002/j.1460-2075.1995.tb00320.x; KUSMIEREK J, 1978, NUCL ACIDS RES SPECI, V4, pS73; LANGBERG SR, 1981, J BIOL CHEM, V256, P54; Li Y, 2008, MOL CELL BIOL, V28, P939, DOI 10.1128/MCB.01727-07; Mittra B, 2008, J BIOL CHEM, V283, P3161, DOI 10.1074/jbc.M707367200; MUTHUKRISHNAN S, 1978, J BIOL CHEM, V253, P1710; Niedzwiecka A, 2007, METHOD ENZYMOL, V430, P209, DOI 10.1016/S0076-6879(07)30009-8; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pei Y, 2003, J BIOL CHEM, V278, P7180, DOI 10.1074/jbc.M211713200; PELLETIER J, 1985, MOL CELL BIOL, V5, P3222, DOI 10.1128/MCB.5.11.3222; PERRY KL, 1987, P NATL ACAD SCI USA, V84, P8190, DOI 10.1073/pnas.84.23.8190; Rahmeh AA, 2009, J VIROL, V83, P11043, DOI 10.1128/JVI.01426-09; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; SCHNIERLE BS, 1992, P NATL ACAD SCI USA, V89, P2897, DOI 10.1073/pnas.89.7.2897; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwer B, 2000, GENETICS, V155, P1561; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; SRIPATI CE, 1976, J BIOL CHEM, V251, P2898; VENKATESAN S, 1980, J BIOL CHEM, V255, P2829; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; YOSHIKAWA M, 1967, TETRAHEDRON LETT, P5065; Zamudio JR, 2007, MOL CELL BIOL, V27, P6084, DOI 10.1128/MCB.00647-07; Zamudio JR, 2006, EUKARYOT CELL, V5, P905, DOI 10.1128/EC.00080-06; Zamudio JR, 2009, MOL MICROBIOL, V72, P1100, DOI 10.1111/j.1365-2958.2009.06696.x	45	92	98	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33037	33044		10.1074/jbc.M110.155283	http://dx.doi.org/10.1074/jbc.M110.155283			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20713356	Green Published, hybrid			2022-12-25	WOS:000283048200041
J	Huang, HP; Yu, CY; Chen, HF; Chen, PH; Chuang, CY; Lin, SJ; Huang, ST; Chan, WH; Ueng, TH; Ho, HN; Kuo, HC				Huang, Hsiang-Po; Yu, Chun-Ying; Chen, Hsin-Fu; Chen, Pin-Hsun; Chuang, Ching-Yu; Lin, Sung-Jan; Huang, Shih-Tsung; Chan, Wei-Hung; Ueng, Tzuu-Huei; Ho, Hong-Nerng; Kuo, Hung-Chih			Factors from Human Embryonic Stem Cell-derived Fibroblast-like Cells Promote Topology-dependent Hepatic Differentiation in Primate Embryonic and Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE-LIKE CELLS; EFFICIENT DIFFERENTIATION; GROWTH-FACTOR; LIVER DEVELOPMENT; ONCOSTATIN-M; IN-VITRO; ENDODERM; GENERATION; LINES; TRANSPLANTATION	The future clinical use of embryonic stem cell (ESC)-based hepatocyte replacement therapy depends on the development of an efficient procedure for differentiation of hepatocytes from ESCs. Here we report that a high density of human ESC-derived fibroblast-like cells (hESdFs) supported the efficient generation of hepatocyte-like cells with functional and mature hepatic phenotypes from primate ESCs and human induced pluripotent stem cells. Molecular and immunocytochemistry analyses revealed that hESdFs caused a rapid loss of pluripotency and induced a sequential endoderm-to-hepatocyte differentiation in the central area of ESC colonies. Knockdown experiments demonstrated that pluripotent stem cells were directed toward endodermal and hepatic lineages by FGF2 and activin A secreted from hESdFs. Furthermore, we found that the central region of ESC colonies was essential for the hepatic endoderm-specific differentiation, because its removal caused a complete disruption of endodermal differentiation. In conclusion, we describe a novel in vitro differentiation model and show that hESdF-secreted factors act in concert with regional features of ESC colonies to induce robust hepatic endoderm differentiation in primate pluripotent stem cells.	[Huang, Hsiang-Po; Chen, Pin-Hsun] Natl Taiwan Univ Hosp, Div Med Res, Taipei 10002, Taiwan; [Yu, Chun-Ying; Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ Hosp, Div Reprod Endocrinol & Infertil, Taipei 10002, Taiwan; [Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 10002, Taiwan; [Chan, Wei-Hung] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei 10002, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ, Inst Clin Genom, Taipei 10617, Taiwan; [Ueng, Tzuu-Huei] Natl Taiwan Univ, Inst Toxicol, Taipei 10617, Taiwan; [Kuo, Hung-Chih] Taipei Med Univ, Inst Clin Med, Taipei 11031, Taiwan; [Chuang, Ching-Yu; Kuo, Hung-Chih] Acad Sinica, Genom Res Ctr, Taipei 11574, Taiwan; [Huang, Shih-Tsung; Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11574, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Taipei Medical University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Kuo, HC (corresponding author), 128,Sec 2,Acad Rd, Taipei, Taiwan.	kuohuch@gate.sinica.edu.tw	Yu, Chun-ying/AAE-8368-2020; yu, chun ying/ABB-3212-2020; NTU, Ref07/AAX-7890-2021; Kuo, Hung-Chih/H-7810-2014	Yu, Chun-ying/0000-0002-7320-7876; yu, chun ying/0000-0002-7320-7876; Kuo, Hung-Chih/0000-0003-1336-1203; Ho, Hong-Nerng/0000-0002-7207-0089; Lin, Sung-Jan/0000-0003-1325-3464; CHEN, HSIN-FU/0000-0002-7748-4440; HUANG, HSIANG-PO/0000-0002-3382-305X	Academia Sinica [5202402020-0]; National Science Council of Taiwan [97-3111-B-001-009, 98-2811-B-001-022, 97-2321-B-002-020-MY3]; National Science Council [97-3112-B-001-016]	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Summit Project II Intramural Grant 5202402020-0 from Academia Sinica (to H.-C. K.), Stem Cell Priority Grants 97-3111-B-001-009 and 98-2811-B-001-022 (to H.-C. K.), and Grant 97-2321-B-002-020-MY3 (to H.-P. H.) from the National Science Council of Taiwan.; We thank Drs. Chun-Jen Liu and Yung-Ming Jeng for sera and liver sections, respectively, from HBV-infected patients. We thank the National RNAi Core Facility (supported by National Science Council Grant 97-3112-B-001-016) for lentiviral shRNA clones and the Affymetrix Gene Expression Service Lab of Academia Sinica for microarray assays.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Akhter J, 2007, SURG-J R COLL SURG E, V5, P155, DOI 10.1016/S1479-666X(07)80043-6; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen HF, 2007, HUM REPROD, V22, P567, DOI 10.1093/humrep/del412; Chen HF, 2009, HUM REPROD, V24, P1114, DOI 10.1093/humrep/dep003; Chen HF, 2009, HUM REPROD, V24, P71, DOI 10.1093/humrep/den345; Chiao E, 2008, STEM CELLS, V26, P2032, DOI 10.1634/stemcells.2007-0964; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Deutsch G, 2001, DEVELOPMENT, V128, P871; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Fukumitsu K, 2009, TISSUE ENG PT A, V15, P3847, DOI [10.1089/ten.tea.2009.0357, 10.1089/ten.TEA.2009.0357]; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kamiya A, 2001, FEBS LETT, V492, P90, DOI 10.1016/S0014-5793(01)02140-8; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Momose Y, 2009, BIOL PHARM BULL, V32, P619, DOI 10.1248/bpb.32.619; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Runge DM, 1999, J HEPATOL, V30, P265, DOI 10.1016/S0168-8278(99)80073-7; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Saito K, 2006, WORLD J GASTROENTERO, V12, P6818, DOI 10.3748/wjg.v12.i42.6818; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Soto-Gutierrez A, 2007, NAT PROTOC, V2, P347, DOI 10.1038/nprot.2007.18; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsukada H, 2006, IN VITRO CELL DEV-AN, V42, P83; Weber H, 1996, DEVELOPMENT, V122, P1975; WORTELBOER H M, 1987, Molecular Toxicology, V1, P373; Yamamoto H, 2003, HEPATOLOGY, V37, P983, DOI 10.1053/jhep.2003.50202; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691	46	22	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33510	33519		10.1074/jbc.M110.122093	http://dx.doi.org/10.1074/jbc.M110.122093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720011	hybrid, Green Published			2022-12-25	WOS:000283048200085
J	Li, QA; Su, YY; Wang, H; Li, L; Wang, QO; Bao, L				Li, Qian; Su, Yuan-Yuan; Wang, Hao; Li, Lei; Wang, Qiong; Bao, Lan			Transmembrane Segments Prevent Surface Expression of Sodium Channel Na(v)1.8 and Promote Calnexin-dependent Channel Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM-RETENTION; II MEMBRANE-PROTEINS; QUALITY-CONTROL; NEUROPATHIC PAIN; NMDA RECEPTOR; SUBUNIT; TRAFFICKING; MOTIF; PATHWAYS; SIGNALS	The voltage-gated sodium channel (Na-v) 1.8 contributes substantially to the rising phase of action potential in small dorsal root ganglion neurons. Na(v)1.8 is majorly localized intracellularly and its expression on the plasma membrane is regulated by exit from the endoplasmic reticulum (ER). Previous work has identified an ER-retention/retrieval motif in the first intracellular loop of Na(v)1.8, which prevents its surface expression. Here we report that the transmembrane segments of Na(v)1.8 also cause this channel retained in the ER. Using transferrin receptor and CD8 alpha as model molecules, immunocytochemistry showed that the first, second, and third transmembrane segments in each domain of Na(v)1.8 reduced their surface expression. Alanine-scanning analysis revealed acidic amino acids as critical factors in the odd transmembrane segments. Furthermore, co-immunoprecipitation experiments showed that calnexin interacted with acidic amino acid-containing sequences through its transmembrane segment. Overexpression of calnexin resulted in increased degradation of those proteins through the ER-associated degradation pathway, whereas down-regulation of calnexin reversed the phenotype. Thus our results reveal a critical role and mechanism of transmembrane segments in surface expression and degradation of Na(v)1.8.	[Li, Qian; Su, Yuan-Yuan; Wang, Hao; Li, Lei; Wang, Qiong; Bao, Lan] Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Bao, L (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	baolan@sibs.ac.cn	Li, Qian/AAE-8688-2022; Li, Qian/P-4417-2015	Li, Qian/0000-0003-1300-3377; Li, Qian/0000-0003-1300-3377	National Basic Research Program of China [2007CB914501, 2010CB912001]; National Natural Science Foundation of China [30570574, 30623003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2007CB914501 and 2010CB912001, National Natural Science Foundation of China Grants 30570574 and 30623003.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Gold MS, 2003, J NEUROSCI, V23, P158; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Liu TI, 2001, J NEUROPHYSIOL, V85, P61, DOI 10.1152/jn.2001.85.1.61; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Novakovic SD, 1998, J NEUROSCI, V18, P2174; Ogata N, 2002, JPN J PHARMACOL, V88, P365, DOI 10.1254/jjp.88.365; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ren Z, 2003, J NEUROSCI, V23, P6608; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; STEVENS TL, 1994, J IMMUNOL, V152, P4397; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Tang BL, 1997, EUR J CELL BIOL, V73, P98; Vacher H, 2007, FASEB J, V21, P906, DOI 10.1096/fj.06-7229com; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang ZN, 2008, J CELL SCI, V121, P3243, DOI 10.1242/jcs.026856	57	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32977	32987		10.1074/jbc.M110.143024	http://dx.doi.org/10.1074/jbc.M110.143024			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720009	Green Published, hybrid			2022-12-25	WOS:000283048200035
J	Nam, HJ; Kang, JK; Kim, SK; Ahn, KJ; Seok, H; Park, SJ; Chang, JS; Pothoulakis, C; Lamont, JT; Kim, H				Nam, Hyo Jung; Kang, Jin Ku; Kim, Sung-Kuk; Ahn, Keun Jae; Seok, Heon; Park, Sang Joon; Chang, Jong Soo; Pothoulakis, Charalabos; Lamont, John Thomas; Kim, Ho			Clostridium difficile Toxin A Decreases Acetylation of Tubulin, Leading to Microtubule Depolymerization through Activation of Histone Deacetylase 6, and This Mediates Acute Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-RHO; PLUS-ENDS; IN-VIVO; HDAC6; ENTERITIS; RECEPTOR; DYNAMICS; STRESS; MODULATION; PACLITAXEL	Clostridium difficile toxin A is known to cause actin disaggregation through the enzymatic inactivation of intracellular Rho proteins. Based on the rapid and severe cell rounding of toxin A-exposed cells, we speculated that toxin A may be involved in post-translational modification of tubulin, leading to microtubule instability. In the current study, we observed that toxin A strongly reduced alpha-tubulin acetylation in human colonocytes and mouse intestine. Fractionation analysis demonstrated that toxin A-induced alpha-tubulin deacetylation yielded monomeric tubulin, indicating the presence of microtubule depolymerization. Inhibition of the glucosyltransferase activity against Rho proteins of toxin A by UDP-2`,3`-dialdehyde significantly abrogated toxin A-induced alpha-tubulin deacetylation. In colonocytes treated with trichostatin A (TSA), an inhibitor of the HDAC6 tubulin deacetylase, toxin A-induced alpha-tubulin deacetylation and loss of tight junction were completely blocked. Administration of TSA also attenuated proinflammatory cytokine production, mucosal damage, and epithelial cell apoptosis in mouse intestine exposed to toxin A. These results suggest that toxin A causes microtubule depolymerization by activation of HDAC6-mediated tubulin deacetylation. Indeed, blockage of HDAC6 by TSA markedly attenuates alpha-tubulin deacetylation, proinflammatory cytokine production, and mucosal damage in a toxin A-induced mouse enteritis model. Tubulin deacetylation is an important component of the intestinal inflammatory cascade following toxin A-mediated Rho inactivation in vitro and in vivo.	[Nam, Hyo Jung; Kang, Jin Ku; Kim, Sung-Kuk; Chang, Jong Soo; Kim, Ho] Daejin Univ, Coll Nat Sci, Dept Life Sci, Pochon 487711, Gyeonggido, South Korea; [Ahn, Keun Jae] Yonsei Univ, Coll Med, Dept Dermatol, Seoul 102752, South Korea; [Ahn, Keun Jae] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul 102752, South Korea; [Seok, Heon] Ulsan Natl Inst Sci & Technol, Sch Nanobiotechnol & Chem Engn, Ulsan 689798, South Korea; [Park, Sang Joon] Kyungpook Natl Univ, Coll Vet Med, Dept Vet Histol, Taegu 702701, South Korea; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Lamont, John Thomas] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA	Daejin University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ulsan National Institute of Science & Technology (UNIST); Kyungpook National University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kim, H (corresponding author), Daejin Univ, Coll Nat Sci, Dept Life Sci, Pochon 487711, Gyeonggido, South Korea.	hokim@daejin.ac.kr			Ministry of Health and Welfare, Republic of Korea [A080933]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea, Grant A080933.	Arregui L, 2002, J EUKARYOT MICROBIOL, V49, P312, DOI 10.1111/j.1550-7408.2002.tb00376.x; Banerjee PP, 2007, J EXP MED, V204, P2305, DOI 10.1084/jem.20061893; Bicek AD, 2009, MOL BIOL CELL, V20, P2943, DOI 10.1091/mbc.E08-09-0909; Castagliuolo I, 1998, J CLIN INVEST, V101, P1547, DOI 10.1172/JCI2039; Castagliuolo I, 1997, AM J PHYSIOL-GASTR L, V273, pG333, DOI 10.1152/ajpgi.1997.273.2.G333; Chang JS, 2005, J BIOL CHEM, V280, P6897, DOI 10.1074/jbc.M406350200; Chen JG, 2002, CANCER RES, V62, P1935; Eiserich JP, 1999, P NATL ACAD SCI USA, V96, P6365, DOI 10.1073/pnas.96.11.6365; Fernandez N, 2009, P NATL ACAD SCI USA, V106, P7846, DOI 10.1073/pnas.0813228106; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Han Y, 1998, BIOCHEMISTRY-US, V37, P6636, DOI 10.1021/bi9719760; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; JUST I, 1994, J BIOL CHEM, V269, P10706; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Karvonen U, 2006, EXP CELL RES, V312, P3165, DOI 10.1016/j.yexcr.2006.06.018; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kim H, 2005, GASTROENTEROLOGY, V129, P1875, DOI 10.1053/j.gastro.2005.09.011; Kim H, 2005, J BIOL CHEM, V280, P21237, DOI 10.1074/jbc.M413842200; Kim H, 2007, GASTROENTEROLOGY, V133, P875, DOI 10.1053/j.gastro.2007.06.063; Kim H, 2009, EXP CELL RES, V315, P3336, DOI 10.1016/j.yexcr.2009.05.020; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lamont J Thomas, 2002, Trans Am Clin Climatol Assoc, V113, P167; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Malorni W, 2003, J IMMUNOL, V171, P4195, DOI 10.4049/jimmunol.171.8.4195; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; MEJILLANO MR, 1991, J BIOL CHEM, V266, P657; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Popova JS, 2003, J BIOL CHEM, V278, P34299, DOI 10.1074/jbc.M301748200; POTHOULAKIS C, 1988, J CLIN INVEST, V81, P1741, DOI 10.1172/JCI113514; Pothoulakis C, 1996, J CLIN INVEST, V98, P641, DOI 10.1172/JCI118835; POTHOULAKIS C, 1993, GASTROENTEROL CLIN N, V22, P623; Pothoulakis C, 2001, AM J PHYSIOL-GASTR L, V280, pG178, DOI 10.1152/ajpgi.2001.280.2.G178; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Verdier-Pinard P, 2000, MOL PHARMACOL, V57, P568, DOI 10.1124/mol.57.3.568; VONEICHELSTREIBER C, 1990, MED MICROBIOL IMMUN, V179, P271, DOI 10.1007/BF00192465; Warny M, 2000, J CLIN INVEST, V105, P1147, DOI 10.1172/JCI7545; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	48	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32888	32896		10.1074/jbc.M110.162743	http://dx.doi.org/10.1074/jbc.M110.162743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20696758	hybrid, Green Published			2022-12-25	WOS:000283048200026
J	Wirtz, M; Birke, H; Heeg, C; Muller, C; Hosp, F; Throm, C; Konig, S; Feldman-Salit, A; Rippe, K; Petersen, G; Wade, RC; Rybin, V; Scheffzek, K; Hell, R				Wirtz, Markus; Birke, Hannah; Heeg, Corinna; Mueller, Christopher; Hosp, Fabian; Throm, Christian; Koenig, Stephan; Feldman-Salit, Anna; Rippe, Karsten; Petersen, Gabriele; Wade, Rebecca C.; Rybin, Vladimir; Scheffzek, Klaus; Hell, Ruediger			Structure and Function of the Hetero-oligomeric Cysteine Synthase Complex in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; MITOCHONDRIAL SERINE ACETYLTRANSFERASE; ESCHERICHIA-COLI; PROTEIN COMPLEX; THIOL LYASE; BIOSYNTHESIS; PURIFICATION; MECHANISM; SEQUENCE; DOMAIN	Cysteine synthesis in bacteria and plants is catalyzed by serine acetyltransferase (SAT) and O-acetylserine (thiol)-lyase (OAS-TL), which form the hetero-oligomeric cysteine synthase complex (CSC). In plants, but not in bacteria, the CSC is assumed to control cellular sulfur homeostasis by reversible association of the subunits. Application of size exclusion chromatography, analytical ultracentrifugation, and isothermal titration calorimetry revealed a hexameric structure of mitochondrial SAT from Arabidopsis thaliana (AtSATm) and a 2: 1 ratio of the OAS-TL dimer to the SAT hexamer in the CSC. Comparable results were obtained for the composition of the cytosolic SAT from A. thaliana (AtSATc) and the cytosolic SAT from Glycine max (Glyma16g03080, GmSATc) and their corresponding CSCs. The hexameric SAT structure is also supported by the calculated binding energies between SAT trimers. The interaction sites of dimers of AtSATm trimers are identified using peptide arrays. A negative Gibbs free energy (Delta G = -33 kcal mol(-1)) explains the spontaneous formation of the AtCSCs, whereas the measured SAT: OAS-TL affinity (K-D = 30 nM) is 10 times weaker than that of bacterial CSCs. Free SAT from bacteria is > 100-fold more sensitive to feedback inhibition by cysteine than AtSATm/c. The sensitivity of plant SATs to cysteine is further decreased by CSC formation, whereas the feedback inhibition of bacterial SAT by cysteine is not affected by CSC formation. The data demonstrate highly similar quaternary structures of the CSCs from bacteria and plants but emphasize differences with respect to the affinity of CSC formation (K-D()) and the regulation of cysteine sensitivity of SAT within the CSC.	[Koenig, Stephan] Heidelberg Univ, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany; [Feldman-Salit, Anna; Wade, Rebecca C.] Heidelberg Inst Theoret Studies, D-69118 Heidelberg, Germany; [Petersen, Gabriele] Heidelberg Univ, Inst Zool, D-69120 Heidelberg, Germany; [Rybin, Vladimir; Scheffzek, Klaus] EMBL Heidelberg, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Heidelberg Institute for Theoretical Studies; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)		rhell@hip.uni-heidelberg.de	Hell, Ruediger/E-5436-2014; Wirtz, Markus/G-5917-2010; Birke, Hannah/I-5511-2013; Wade, Rebecca/L-1489-2019; Rippe, Karsten/A-3562-2012	Wirtz, Markus/0000-0001-7790-4022; Wade, Rebecca/0000-0001-5951-8670; Rippe, Karsten/0000-0001-9951-9395; Konig, Stephan/0000-0002-1597-3628; Hell, Ruediger/0000-0002-6238-4818; Throm, Christian Robert/0000-0003-2914-7025	Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQuant Graduate School Molecular Machines); Schmeil-Stiftung, Heidelberg; Deutsche Forschungsgemeinschaft [He1848/5-2, He1848/13-1]; Klaus Tschira Foundation	Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQuant Graduate School Molecular Machines); Schmeil-Stiftung, Heidelberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klaus Tschira Foundation	This work was supported by the Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQuant Graduate School Molecular Machines), the Schmeil-Stiftung, Heidelberg, and the Deutsche Forschungsgemeinschaft Grants He1848/5-2 and He1848/13-1 (to H. B. and C. H.) and by the Klaus Tschira Foundation (to A. F.-S. and R. C. W.).	BECKER MA, 1969, J BIOL CHEM, V244, P6023; Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Bogdanova N, 1997, PLANT J, V11, P251, DOI 10.1046/j.1365-313X.1997.11020251.x; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; DENK D, 1987, J GEN MICROBIOL, V133, P515; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Hindson VJ, 2000, J BIOL CHEM, V275, P461, DOI 10.1074/jbc.275.1.461; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P514; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu FL, 2006, J BIOL CHEM, V281, P27405, DOI 10.1074/jbc.M604548200; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; Petersen G, 2001, J BIOL CHEM, V276, P10178, DOI 10.1074/jbc.M006967200; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sirko A, 2004, J EXP BOT, V55, P1881, DOI 10.1093/jxb/erh151; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2004, J EXP BOT, V55, P1785, DOI 10.1093/jxb/erh201; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Wirtz M, 2007, PLANT CELL, V19, P625, DOI 10.1105/tpc.106.043125; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	32	70	72	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32810	32817		10.1074/jbc.M110.157446	http://dx.doi.org/10.1074/jbc.M110.157446			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720017	Green Published, hybrid			2022-12-25	WOS:000283048200017
J	Wurstle, ML; Laussmann, MA; Rehm, M				Wuerstle, Maximilian L.; Laussmann, Maike A.; Rehm, Markus			The Caspase-8 Dimerization/Dissociation Balance Is a Highly Potent Regulator of Caspase-8,-3,-6 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED-INHIBITOR; APOPTOSIS PROTEIN XIAP; INTERCHAIN PROTEOLYSIS; ACTIVATION; DIMERIZATION; CANCER; DEATH; FAS; REQUIREMENT; VARIABILITY	Apoptosis is driven by positive feedback activation between aspartate-specific cysteinyl proteases (caspases). These feedback loops ensure the swift and efficient elimination of cells upon initiation of apoptosis execution. At the same time, the signaling network must be insensitive to erroneous, mild caspase activation to avoid unwanted, excessive cell death. Sublethal caspase activation in fact was shown to be a requirement for the differentiation of multiple cell types but might also occur accidentally during short, transient cellular stress conditions. Here we carried out an in silico comparison of the molecular mechanisms that so far have been identified to impair the amplification of caspase activities via the caspase-8, -3, -6 loop. In a systems model resembling HeLa cervical cancer cells, the dimerization/dissociation balance of caspase-8 potently suppressed the amplification of caspase responses, surprisingly outperforming or matching known caspase-8 and -3 inhibitors such as bifunctional apoptosis repressor or x-linked inhibitor of apoptosis protein. These findings were further substantiated in global sensitivity analyses based on combinations of protein concentrations from the sub-to superphysiological range to screen the full spectrum of biological variability that can be expected within cell populations and between distinct cell types. Additional modeling showed that the combined effects of x-linked inhibitor of apoptosis protein and caspase-8 dimerization/dissociation processes can also provide resistance to larger inputs of active caspases. Our study therefore highlights a central and so far underappreciated role of caspase-8 dimerization/dissociation in avoiding unwanted cell death by lethal amplification of caspase responses via the caspase-8, -3, -6 loop.	[Rehm, Markus] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Wuerstle, Maximilian L.; Laussmann, Maike A.; Rehm, Markus] Royal Coll Surgeons Ireland, Syst Biol Grp, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Rehm, M (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, RCSI York House,York St, Dublin 2, Ireland.	mrehm@rcsi.ie	Rehm, Markus/C-3398-2012	Rehm, Markus/0000-0001-6149-9261	National Biophotonics and Imaging Platform Ireland; Irish Government; European Union; Health Research Board Ireland [RP/2006/258]; Royal College of Surgeons in Ireland Research Committee	National Biophotonics and Imaging Platform Ireland; Irish Government; European Union(European Commission); Health Research Board Ireland; Royal College of Surgeons in Ireland Research Committee	This work was supported by National Biophotonics and Imaging Platform Ireland funded under the Higher Education Authority Program for Research in Third-Level Institutions Cycle 4, co-funded by the Irish Government and the European Union - Investing in your future, as well as by grants from the Health Research Board Ireland (RP/2006/258) and the Royal College of Surgeons in Ireland Research Committee (to M. R.).	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hellwig CT, 2008, J BIOL CHEM, V283, P21676, DOI 10.1074/jbc.M802889200; Huber H, 2009, ESSENTIALS OF APOPTOSIS, SECOND EDITION, P283, DOI 10.1007/978-1-60327-381-7_12; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Logue SE, 2008, BIOCHEM SOC T, V36, P1, DOI 10.1042/BST0360001; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Murphy BM, 2004, J BIOL CHEM, V279, P36916, DOI 10.1074/jbc.M402039200; O'Connor CL, 2008, BBA-MOL CELL RES, V1783, P1903, DOI 10.1016/j.bbamcr.2008.05.025; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Roth W, 2003, CELL DEATH DIFFER, V10, P1178, DOI 10.1038/sj.cdd.4401287; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Wilson TR, 2009, ONCOGENE, V28, P63, DOI 10.1038/onc.2008.366; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597	40	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33209	33218		10.1074/jbc.M110.113860	http://dx.doi.org/10.1074/jbc.M110.113860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702410	Green Published, hybrid			2022-12-25	WOS:000283048200058
J	Guo, NX; Li, XA; Mann, MM; Funderburgh, ML; Du, YQ; Funderburgh, JL				Guo, Naxin; Li, Xuan; Mann, Mary M.; Funderburgh, Martha L.; Du, Yiqin; Funderburgh, James L.			Hyaluronan Synthesis Mediates the Fibrotic Response of Keratocytes to Transforming Growth Factor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MYOFIBROBLAST TRANSDIFFERENTIATION; HUMAN TENON FIBROBLASTS; CORNEAL KERATOCYTES; ACTIN EXPRESSION; PHENOTYPE; CELLS; PROLIFERATION; ACCUMULATION; INHIBITION; SECRETION	TGF beta induces fibrosis in healing corneal wounds, and in vitro corneal keratocytes up-regulate expression of several fibrosis-related genes in response to TGF beta. Hyaluronan (HA) accumulates in healing corneas, and HA synthesis is induced by TGF beta by up-regulation of HA synthase 2. This study tested the hypothesis that HA acts as an extracellular messenger, enhancing specific fibrotic responses of keratocytes to TGF beta. HA synthesis inhibitor 4-methylumbelliferone (4MU) blocked TGF beta induction of HA synthesis in a concentration-dependent manner. 4MU also inhibited TGF beta-induced up-regulation of alpha-smooth muscle actin, collagen type III, and extra domain A-fibronectin. Chemical analogs of 4MU also inhibited fibrogenic responses in proportion to their inhibition of HA synthesis. 4MU, however, showed no effect on TGF beta induction of luciferase by the 3TP-Lux reporter plasmid. Inhibition of HA using siRNA to HA synthase 2 reduced TGF beta up-regulation of smooth muscle actin, fibronectin, and cell division. Similarly, brief treatment of keratocytes with hyaluronidase reduced TGF beta responses. These results suggest that newly synthesized cell-associated HA acts as an extracellular enhancer of wound healing and fibrosis in keratocytes by augmenting a limited subset of the cellular responses to TGF beta.	[Guo, Naxin; Li, Xuan; Mann, Mary M.; Funderburgh, Martha L.; Du, Yiqin; Funderburgh, James L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Funderburgh, JL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, 1009 EEINS,203 Lothrop St, Pittsburgh, PA 15213 USA.	jlfunder@pitt.edu	Du, Yiqin/A-7727-2018; DU, YIQIN/AAO-1566-2020	DU, YIQIN/0000-0002-4330-0957	National Institutes of Health [EY09368, P30-EY08098]; Research to Prevent Blindness; Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE [P30EY008098, R01EY009368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY09368 (to J. L. F.) and Core Grant P30-EY08098. This work was also supported by Research to Prevent Blindness and the Eye and Ear Foundation of Pittsburgh.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Berryhill BL, 2003, EXP EYE RES, V77, P85, DOI 10.1016/S0014-4835(03)00060-5; CINTRON C, 1988, INVEST OPHTH VIS SCI, V29, P767; Du YQ, 2007, INVEST OPHTH VIS SCI, V48, P5038, DOI 10.1167/iovs.07-0587; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; FITZSIMMONS TD, 1994, INVEST OPHTH VIS SCI, V35, P2774; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Funderburgh ML, 2008, MOL VIS, V14, P308; Guo NX, 2007, J BIOL CHEM, V282, P12475, DOI 10.1074/jbc.M609280200; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jester JV, 1996, CORNEA, V15, P505; Jester JV, 1997, CORNEA, V16, P177; Kim S, 2008, CELL SIGNAL, V20, P1313, DOI 10.1016/j.cellsig.2008.02.020; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Li FZ, 2005, WORLD J SURG, V29, P306, DOI 10.1007/s00268-004-7813-6; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Morohashi H, 2006, BIOCHEM BIOPH RES CO, V345, P1454, DOI 10.1016/j.bbrc.2006.05.037; Sebe A, 2008, NEPHROL DIAL TRANSPL, V23, P1537, DOI 10.1093/ndt/gfm789; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926	28	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32012	32019		10.1074/jbc.M110.127183	http://dx.doi.org/10.1074/jbc.M110.127183			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685654	Green Published, hybrid			2022-12-25	WOS:000282683000014
J	Jack, BHA; Crossley, M				Jack, Briony H. A.; Crossley, Merlin			GATA Proteins Work Together with Friend of GATA (FOG) and C-terminal Binding Protein (CTBP) Co-regulators to Control Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; KRUPPEL-LIKE FACTOR; TRANSCRIPTION FACTOR GATA-1; FACTOR GENE; HEART MORPHOGENESIS; REPRESSOR COMPLEX; IN-VIVO; COREPRESSOR; COFACTOR; FAMILY	GATA transcription factors have been implicated in controlling adipogenesis in Drosophila and in mammals. In mammals, both GATA2 and GATA3 have been shown to be present in preadipocytes, and their silencing allows the onset of adipogenesis. Overexpression of GATA proteins blocks adipogenesis in cellular assays. GATA factors have been found to operate through recruiting cofactors of the Friend of GATA (FOG) family. FOG proteins, in turn, recruit co-regulators, including C-terminal binding proteins (CTBPs). We have investigated whether FOGs and CTBPs influence adipogenesis. We found that both FOG1 and FOG2 are expressed in cells prior to adipogenesis but are down-regulated as adipogenesis proceeds. Overexpression of FOG1 or FOG2 interferes with adipogenesis. Mutant versions of FOG2 unable to bind CTBP or GATA proteins are impaired in their inability to inhibit adipogenesis. Finally, a mutant version of GATA2, unable to associate with FOGs, also displays abnormal activity and causes enhanced cell proliferation. These results implicate FOGs and CTBPs as partners of GATA proteins in the control of adipocyte proliferation and differentiation.	[Jack, Briony H. A.; Crossley, Merlin] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Jack, Briony H. A.; Crossley, Merlin] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Crossley, M (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	m.crossley@unsw.edu.au	Crossley, Merlin/D-7888-2011	Crossley, Merlin/0000-0003-2057-3642	Australian Research Council; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grant funding from the Australian Research Council and the National Health and Medical Research Council (to M.C.).	Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Hayes SA, 2001, DEVELOPMENT, V128, P1193; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Katz SG, 2002, MOL CELL BIOL, V22, P3121, DOI 10.1128/MCB.22.9.3121-3128.2002; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; LEE ME, 1991, J BIOL CHEM, V266, P16188; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Martin D, 2001, MOL CELL BIOL, V21, P164, DOI 10.1128/MCB.21.1.164-174.2001; Matthews JM, 2000, EUR J BIOCHEM, V267, P1030, DOI 10.1046/j.1432-1327.2000.01095.x; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Sam S, 1996, MECH DEVELOP, V60, P197, DOI 10.1016/S0925-4773(96)00615-6; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Svensson EC, 2000, NAT GENET, V25, P353, DOI 10.1038/77146; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	42	28	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32405	32414		10.1074/jbc.M110.141317	http://dx.doi.org/10.1074/jbc.M110.141317			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20705609	hybrid, Green Published			2022-12-25	WOS:000282683000054
J	Andreyeva, A; Leshchyns'ka, I; Knepper, M; Betzel, C; Redecke, L; Sytnyk, V; Schachner, M				Andreyeva, Aksana; Leshchyns'ka, Iryna; Knepper, Michael; Betzel, Christian; Redecke, Lars; Sytnyk, Vladimir; Schachner, Melitta			CHL1 Is a Selective Organizer of the Presynaptic Machinery Chaperoning the SNARE Complex	PLOS ONE			English	Article							CYSTEINE-STRING PROTEIN; ADHESION MOLECULE L1; CLOSE HOMOLOG; MICE DEFICIENT; CALL GENE; ASSOCIATION; BINDING; CSP; PHOSPHORYLATION; OLIGOMERIZATION	Proteins constituting the presynaptic machinery of vesicle release undergo substantial conformational changes during the process of exocytosis. While changes in the conformation make proteins vulnerable to aggregation and degradation, little is known about synaptic chaperones which counteract these processes. We show that the cell adhesion molecule CHL1 directly interacts with and regulates the activity of the synaptic chaperones Hsc70, CSP and alpha SGT. CHL1, Hsc70, CSP and alpha SGT form predominantly CHL1/Hsc70/alpha SGT and CHL1/CSP complexes in synapses. Among the various complexes formed by CHL1, Hsc70, CSP and alpha SGT, SNAP25 and VAMP2 induce chaperone activity only in CHL1/Hsc70/alpha SGT and CHL1/CSP complexes, respectively, indicating a remarkable selectivity of a presynaptic chaperone activity for proteins of the exocytotic machinery. In mice with genetic ablation of CHL1, chaperone activity in synapses is reduced and the machinery for synaptic vesicle exocytosis and, in particular, the SNARE complex is unable to sustain prolonged synaptic activity. Thus, we reveal a novel role for a cell adhesion molecule in selective activation of the presynaptic chaperone machinery.	[Andreyeva, Aksana; Leshchyns'ka, Iryna; Knepper, Michael; Sytnyk, Vladimir; Schachner, Melitta] Univ Hamburg, Zentrum Mol Neurobiol, Hamburg, Germany; [Betzel, Christian; Redecke, Lars] Univ Hamburg, Inst Biochem & Mol Biol, Hamburg, Germany; [Leshchyns'ka, Iryna; Sytnyk, Vladimir] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Andreyeva, Aksana] Univ Dusseldorf, Inst Neuro & Sensory Physiol, Dusseldorf, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of New South Wales Sydney; Heinrich Heine University Dusseldorf; Shantou University; Rutgers State University New Brunswick	Andreyeva, A (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Hamburg, Germany.	v.sytnyk@unsw.edu.au; Schachner@Biology.Rutgers.Edu	Sytnyk, Vladimir/A-3878-2010; Redecke, Lars/A-5611-2013; Betzel, Christian/G-8105-2018	Betzel, Christian/0000-0002-3879-5019; Sytnyk, Vladimir/0000-0003-1927-2199; Leshchyns'ka, Iryna/0000-0002-2025-5831	New Jersey Commission for Spinal Cord Research; Deutsche Forschungsgemeinschaft	New Jersey Commission for Spinal Cord Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Melitta Schachner is supported by the New Jersey Commission for Spinal Cord Research. This work was supported by the Deutsche Forschungsgemeinschaft (to MS, IL, VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Angeloni D, 1999, PSYCHIATR GENET, V9, P165, DOI 10.1097/00041444-199909000-00011; Aufricht C, 1998, AM J PHYSIOL-RENAL, V274, pF268, DOI 10.1152/ajprenal.1998.274.2.F268; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; DEBYE P, 1949, J APPL PHYS, V20, P518, DOI 10.1063/1.1698419; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Evans GJO, 2003, TRAFFIC, V4, P653, DOI 10.1034/j.1600-0854.2003.00127.x; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Georgieva D, 2004, BIOCHEM BIOPH RES CO, V323, P1278, DOI 10.1016/j.bbrc.2004.08.230; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Irintchev A, 2004, BRAIN RES, V1029, P131, DOI 10.1016/j.brainres.2004.09.042; Jakovcevski I, 2009, J COMP NEUROL, V513, P496, DOI 10.1002/cne.21981; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kolata S, 2008, J NEUROSCI, V28, P13505, DOI 10.1523/JNEUROSCI.2127-08.2008; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Morellini F, 2007, MOL CELL NEUROSCI, V34, P121, DOI 10.1016/j.mcn.2006.10.006; Nikonenko AG, 2006, EUR J NEUROSCI, V23, P1839, DOI 10.1111/j.1460-9568.2006.04710.x; Ohtsuka K, 2000, BRAIN RES BULL, V53, P141, DOI 10.1016/S0361-9230(00)00325-7; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pratte M, 2009, PHYSIOL BEHAV, V97, P394, DOI 10.1016/j.physbeh.2009.03.009; Rolf B, 2003, J NEUROSCI RES, V71, P835, DOI 10.1002/jnr.10533; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Smith GB, 2005, J BIOL CHEM, V280, P32669, DOI 10.1074/jbc.M501806200; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Thoidis G, 1998, P NATL ACAD SCI USA, V95, P183, DOI 10.1073/pnas.95.1.183; Tobaben S, 2003, J BIOL CHEM, V278, P38376, DOI 10.1074/jbc.M301558200; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Tsuang Ming T, 2004, World Psychiatry, V3, P73; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514	54	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12018	10.1371/journal.pone.0012018	http://dx.doi.org/10.1371/journal.pone.0012018			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711454	Green Published, gold, Green Submitted			2022-12-25	WOS:000280849100005
J	Cox, MB; Cairns, MJ; Gandhi, KS; Carroll, AP; Moscovis, S; Stewart, GJ; Broadley, S; Scott, RJ; Booth, DR; Lechner-Scott, J				Cox, Mathew B.; Cairns, Murray J.; Gandhi, Kaushal S.; Carroll, Adam P.; Moscovis, Sophia; Stewart, Graeme J.; Broadley, Simon; Scott, Rodney J.; Booth, David R.; Lechner-Scott, Jeannette		ANZgene Multiple Sclerosis Genetic	MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood	PLOS ONE			English	Article							SCLEROSIS SUSCEPTIBILITY LOCI; MULTIPLE-SCLEROSIS; DIFFERENTIATION; RECEPTOR; DISEASE; DICER; RISK	It is well established that Multiple Sclerosis (MS) is an immune mediated disease. Little is known about what drives the differential control of the immune system in MS patients compared to unaffected individuals. MicroRNAs (miRNAs) are small non-coding nucleic acids that are involved in the control of gene expression. Their potential role in T cell activation and neurodegenerative disease has recently been recognised and they are therefore excellent candidates for further studies in MS. We investigated the transcriptome of currently known miRNAs using miRNA microarray analysis in peripheral blood samples of 59 treatment naive MS patients and 37 controls. Of these 59, 18 had a primary progressive, 17 a secondary progressive and 24 a relapsing remitting disease course. In all MS subtypes miR-17 and miR-20a were significantly under-expressed in MS, confirmed by RT-PCR. We demonstrate that these miRNAs modulate T cell activation genes in a knock-in and knock-down T cell model. The same T cell activation genes are also up-regulated in MS whole blood mRNA, suggesting these miRNAs or their analogues may provide useful targets for new therapeutic approaches.	[Cox, Mathew B.; Cairns, Murray J.; Carroll, Adam P.; Moscovis, Sophia; Scott, Rodney J.; Lechner-Scott, Jeannette] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2308, Australia; [Cairns, Murray J.; Carroll, Adam P.] Schizophrenia Res Inst, Sydney, NSW, Australia; [Gandhi, Kaushal S.; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Broadley, Simon] Griffith Univ, Dept Neurol, Gold Coast, Qld, Australia	Hunter Medical Research Institute; University of Newcastle; University of Sydney; Westmead Institute for Medical Research; Griffith University	Cox, MB (corresponding author), Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2308, Australia.	Rodney.scott@newcastle.edu.au	Scott, Rodney J/B-2827-2013; MOSCATO, PABLO ALBERTO/G-7668-2013	Scott, Rodney J/0000-0001-7724-3404; Lechner-Scott, Jeannette/0000-0002-3850-447X; Stankovich, Jim/0000-0001-9344-7749; Cairns, Murray/0000-0003-2490-2538; Field, Judith/0000-0002-7089-0999; Kilpatrick, Trevor/0000-0003-3999-085X	Multiple Sclerosis Research Australia; Australian Research Council [LPO776744]; Macquarie Group Foundation; John Hunter Charitable Trust; University of Newcastle; NSW Health; Henderson Foundation; M.C. Ainsworth Research Fellowship	Multiple Sclerosis Research Australia; Australian Research Council(Australian Research Council); Macquarie Group Foundation; John Hunter Charitable Trust; University of Newcastle; NSW Health; Henderson Foundation; M.C. Ainsworth Research Fellowship	This work was supported by Multiple Sclerosis Research Australia (www.msra.org.au) and the Australian Research Council (www.arc.gov.au under the Linkage Projects Scheme [LPO776744]). MBC is supported by a special grant from Macquarie Group Foundation, the John Hunter Charitable Trust Fund and the University of Newcastle. MJC is supported by the Schizophrenia Research Institute (www.schizophreniaresearcorg.au), utilizing funding from NSW Health, the Henderson Foundation and an M.C. Ainsworth Research Fellowship in Epigenetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), 2009, NAT GENET, V41, P824; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEVERIDGE NJ, 2009, CELL SIGNAL, V1845, P17; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; COMI G, 2009, MULT SCLER, V2, pS155; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Corvol JC, 2008, P NATL ACAD SCI USA, V105, P11839, DOI 10.1073/pnas.0805065105; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; GANDHI KS, HUM MOL GENET; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hauser S.L., 2008, HARRISONS PRINCIPLES; Howe CJ, 2003, ASSAY DRUG DEV TECHN, V1, P537, DOI 10.1089/154065803322302790; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; LINDBERG RLP, 2010, EUROPEAN J IMMUNOLOG, V9999; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; PLOS O, PLOS ONE, P6; Podojil JR, 2009, IMMUNOL REV, V229, P337, DOI 10.1111/j.1600-065X.2009.00773.x; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Satoh J, 2008, DIS MARKERS, V25, P27, DOI 10.1155/2008/824640; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Weinshenker BG, 2003, LANCET, V361, P889, DOI 10.1016/S0140-6736(03)12784-5; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	33	218	230	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12132	10.1371/journal.pone.0012132	http://dx.doi.org/10.1371/journal.pone.0012132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711463	Green Published, gold, Green Submitted			2022-12-25	WOS:000280849100032
J	McCormack, AL; Mak, SK; Henderson, JM; Bumcrot, D; Farrer, MJ; Di Monte, DA				McCormack, Alison L.; Mak, Sally K.; Henderson, Jaimie M.; Bumcrot, David; Farrer, Matthew J.; Di Monte, Donato A.			alpha-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; IN-VITRO; MUTATION; DEGRADATION; MECHANISMS; INCLUSIONS; EXPRESSION; AUTOPHAGY; DEMENTIA	The protein alpha-synuclein is involved in the pathogenesis of Parkinson's disease and other neurodegenerative disorders. Its toxic potential appears to be enhanced by increased protein expression, providing a compelling rationale for therapeutic strategies aimed at reducing neuronal alpha-synuclein burden. Here, feasibility and safety of alpha-synuclein suppression were evaluated by treating monkeys with small interfering RNA (siRNA) directed against alpha-synuclein. The siRNA molecule was chemically modified to prevent degradation by exo- and endonucleases and directly infused into the left substantia nigra. Results compared levels of alpha-synuclein mRNA and protein in the infused (left) vs. untreated (right) hemisphere and revealed a significant 40-50% suppression of alpha-synuclein expression. These findings could not be attributable to non-specific effects of siRNA infusion since treatment of a separate set of animals with luciferase-targeting siRNA produced no changes in alpha-synuclein. Infusion with alpha-synuclein siRNA, while lowering alpha-synuclein expression, had no overt adverse consequences. In particular, it did not cause tissue inflammation and did not change (i) the number and phenotype of nigral dopaminergic neurons, and (ii) the concentrations of striatal dopamine and its metabolites. The data represent the first evidence of successful anti-alpha-synuclein intervention in the primate substantia nigra and support further development of RNA interference-based therapeutics.	[McCormack, Alison L.; Di Monte, Donato A.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [McCormack, Alison L.; Di Monte, Donato A.] SRI Int, Menlo Pk, CA 94025 USA; [Mak, Sally K.] Parkinsons Inst, Sunnyvale, CA USA; [Henderson, Jaimie M.] Stanford Univ, Stanford, CA 94305 USA; [Bumcrot, David] Alnylam Pharmaceut, Cambridge, MA USA; [Farrer, Matthew J.] Mayo Clin, Coll Med, Jacksonville, FL 32224 USA	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); SRI International; Stanford University; Mayo Clinic	McCormack, AL (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.	donato.dimonte@dzne.de		Farrer, Matthew/0000-0003-1159-5321; Di Monte, Donato/0000-0002-8296-836X; Henderson, Jaimie/0000-0002-3276-2267	Michael J. Fox Foundation; Backus Foundation; Phinney Foundation; Parkinson's Disease Foundation	Michael J. Fox Foundation; Backus Foundation; Phinney Foundation; Parkinson's Disease Foundation	This work was supported by grants from the Michael J. Fox Foundation, the Backus Foundation, the Phinney Foundation and the Parkinson's Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Al-Wandi A, 2010, NEUROBIOL AGING, V31, P796, DOI 10.1016/j.neurobiolaging.2008.11.001; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; COOKSON MR, 2009, CELL DEATH DIFFER, V4, P9; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; DROPYRIDINE, 1967, J NEUROPATHOL EXP NE, V793, P802; Drury S, 2009, DIAGN MOL PATHOL, V18, P103, DOI 10.1097/PDM.0b013e31817c1ae2; EMMERS R, 1963, BRAIN; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fountaine TM, 2008, EUR J NEUROSCI, V28, P2459, DOI 10.1111/j.1460-9568.2008.06527.x; Gonzalez-Alegre P, 2007, NAT CLIN PRACT NEURO, V3, P394, DOI 10.1038/ncpneuro0551; GORBATYUK OS, 2010, MOL THER; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; LEWIS J, 2008, IN VIVO, V3, P19; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Mak SK, 2009, EXP NEUROL, V220, P359, DOI 10.1016/j.expneurol.2009.09.021; MCCORMACK A, 2008, PATHOLOGIC MODIFICAT, V6, P1; McCormack AL, 2004, J COMP NEUROL, V471, P387, DOI 10.1002/cne.20036; PLOS O, PLOS ONE, P7; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; Sapru MK, 2006, EXP NEUROL, V198, P382, DOI 10.1016/j.expneurol.2005.12.024; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Trojanowski JQ, 2007, NEUROPATH APPL NEURO, V33, P615, DOI 10.1111/j.1365-2990.2007.00907.x; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	37	114	140	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12122	10.1371/journal.pone.0012122	http://dx.doi.org/10.1371/journal.pone.0012122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711464	Green Published, Green Submitted, gold			2022-12-25	WOS:000280849100030
J	Gasc, A; Duryea, MC; Cox, RM; Kern, A; Calsbeek, R				Gasc, Amandine; Duryea, M. C.; Cox, Robert M.; Kern, Andrew; Calsbeek, Ryan			Invasive Predators Deplete Genetic Diversity of Island Lizards	PLOS ONE			English	Article							CONSERVATION; CONSEQUENCES; POPULATIONS; IMPACT; RATS	Invasive species can dramatically impact natural populations, especially those living on islands. Though numerous examples illustrate the ecological impact of invasive predators, no study has examined the genetic consequences for native populations subject to invasion. Here we capitalize on a natural experiment in which a long-term study of the brown anole lizard (Anolis sagrei) was interrupted by rat invasion. An island population that was devastated by rats recovered numerically following rat extermination. However, population genetic analyses at six microsatellite loci suggested a possible loss of genetic diversity due to invasion when compared to an uninvaded island studied over the same time frame. Our results provide partial support for the hypothesis that invasive predators can impact the genetic diversity of resident island populations.	[Gasc, Amandine; Duryea, M. C.; Cox, Robert M.; Kern, Andrew; Calsbeek, Ryan] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	Gasc, A (corresponding author), Museum Natl Hist Nat, Dept Syst & Evolut, F-75231 Paris, France.	ryan.calsbeek@dartmouth.edu		Calsbeek, Ryan/0000-0002-9236-4092	National Science Foundation [DEB-0816862]	National Science Foundation(National Science Foundation (NSF))	Research was supported by a National Science Foundation grant (DEB-0816862) to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Bardeleben C, 2004, MOL ECOL NOTES, V4, P176, DOI 10.1111/j.1471-8286.2004.00602.x; Beaumont MA, 2002, GENETICS, V162, P2025; Calsbeek R, 2008, EVOLUTION, V62, P478, DOI 10.1111/j.1558-5646.2007.00282.x; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Donlan CJ, 2003, BIOL CONSERV, V114, P29, DOI 10.1016/S0006-3207(02)00401-9; Driscoll CA, 2002, GENOME RES, V12, P414, DOI 10.1101/gr.185702; Eales J, 2010, BIOL INVASIONS, V12, P77, DOI 10.1007/s10530-009-9431-6; Fordham DA, 2010, BIODIVERS CONSERV, V19, P329, DOI 10.1007/s10531-008-9529-7; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Frankham R, 1999, GENET RES, V74, P237, DOI 10.1017/S001667239900405X; Hadfield MG, 2009, BIOL INVASIONS, V11, P1595, DOI 10.1007/s10530-008-9409-9; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Kingsford RT, 2009, CONSERV BIOL, V23, P834, DOI 10.1111/j.1523-1739.2009.01287.x; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Koper N, 2010, BIOL CONSERV, V143, P220, DOI 10.1016/j.biocon.2009.10.006; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; Miller KA, 2009, MOL ECOL, V18, P3792, DOI 10.1111/j.1365-294X.2009.04315.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Neigel JE, 2010, MOL ECOL, V19, P1073, DOI 10.1111/j.1365-294X.2010.04536.x; Peacock MM, 2009, MOL ECOL, V18, P3603, DOI 10.1111/j.1365-294X.2009.04308.x; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; RAYMOND M, 1994, GENEPOP VER 3 0; Ryan ME, 2009, P NATL ACAD SCI USA, V106, P11166, DOI 10.1073/pnas.0902252106; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; SCHOENER A, 1984, OECOLOGIA, V63, P289, DOI 10.1007/BF00390655; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Thomson D, 2005, BIOL INVASIONS, V7, P615, DOI 10.1007/s10530-004-5853-3; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229	34	18	18	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12061	10.1371/journal.pone.0012061	http://dx.doi.org/10.1371/journal.pone.0012061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706576	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900017
J	Chang, CH; Berke, JD; Maren, S				Chang, Chun-hui; Berke, Joshua D.; Maren, Stephen			Single-Unit Activity in the Medial Prefrontal Cortex during Immediate and Delayed Extinction of Fear in Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; INFRALIMBIC CORTEX; LEARNED FEAR; NEURONS; MEMORY; CONSOLIDATION; INTERNEURONS; EXCITABILITY; MAINTENANCE	Delivering extinction trials minutes after fear conditioning yields only a short-term fear suppression that fully recovers the following day. Because extinction has been reported to increase CS-evoked spike firing and spontaneous bursting in the infralimbic (IL) division of the medial prefrontal cortex (mPFC), we explored the possibility that this immediate extinction deficit is related to altered mPFC function. Single-units were simultaneously recorded in rats from neurons in IL and the prelimbic (PrL) division of the mPFC during an extinction session conducted 10 minutes (immediate) or 24 hours (delayed) after auditory fear conditioning. In contrast to previous reports, IL neurons exhibited CS-evoked responses early in extinction training in both immediate and delayed conditions and these responses decreased in magnitude over the course of extinction training. During the retention test, CS-evoked firing in IL was significantly greater in animals that failed to acquire extinction. Spontaneous bursting during the extinction and test sessions was also different in the immediate and delayed groups. There were no group differences in PrL activity during extinction or retention testing. Alterations in both spontaneous and CS-evoked neuronal activity in the IL may contribute to the immediate extinction deficit.	[Chang, Chun-hui; Berke, Joshua D.; Maren, Stephen] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Berke, Joshua D.; Maren, Stephen] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chang, CH (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	maren@umich.edu	Maren, Stephen/B-6182-2014; Maren, Stephen/A-7091-2009	Maren, Stephen/0000-0002-9342-7411; Maren, Stephen/0000-0002-9342-7411; Chang, Chun-hui/0000-0003-0914-2518	National Institutes of Health [R01MH065961]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by a National Institutes of Health grant (R01MH065961) to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav Irit, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/30873; Barrett D, 2003, J NEUROSCI, V23, P5740; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bisson JI, 1997, BRIT J PSYCHIAT, V171, P78, DOI 10.1192/bjp.171.1.78; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; Campfield KM, 2001, J TRAUMA STRESS, V14, P327, DOI 10.1023/A:1011117018705; Chang CH, 2009, LEARN MEMORY, V16, P62, DOI 10.1101/lm.1085009; Collins DR, 1999, J NEUROSCI, V19, P836; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Everly G.S., 1999, CRITICAL INCIDENT ST; Garakani A, 2006, MT SINAI J MED, V73, P941; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Garcia R, 2006, LEARN MEMORY, V13, P14, DOI 10.1101/lm.60406; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Gray MJ, 2005, BEHAV MODIF, V29, P189, DOI 10.1177/0145445504270884; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2003, J NEUROSCI, V23, P8410; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Kim SC, 2010, J NEUROSCI, V30, P832, DOI 10.1523/JNEUROSCI.4145-09.2010; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; Maren S, 2005, NEUROSCIENTIST, V11, P89, DOI 10.1177/1073858404269232; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2006, P NATL ACAD SCI USA, V103, P18020, DOI 10.1073/pnas.0608398103; Maroun M, 2003, J NEUROSCI, V23, P4406; Maroun M, 2006, EUR J NEUROSCI, V24, P2917, DOI 10.1111/j.1460-9568.2006.05169.x; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; McNally Richard J, 2003, Psychol Sci Public Interest, V4, P45, DOI 10.1111/1529-1006.01421; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; Muigg P, 2008, EUR J NEUROSCI, V28, P2299, DOI 10.1111/j.1460-9568.2008.06511.x; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Norrholm SD, 2008, BEHAV NEUROSCI, V122, P1016, DOI 10.1037/a0012604; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pare D, 1996, J NEUROSCI, V16, P3334; Pavlov I.P., 1927, CONDITIONED REFLEXES; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rasmusson AM, 1997, ANN NY ACAD SCI, V821, P332, DOI 10.1111/j.1749-6632.1997.tb48290.x; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Schiller D, 2008, LEARN MEMORY, V15, P394, DOI 10.1101/lm.909208; Shi WX, 2003, J PHARMACOL EXP THER, V305, P680, DOI 10.1124/jpet.102.046359; Sotres-Bayon F, 2009, CEREB CORTEX, V19, P474, DOI 10.1093/cercor/bhn099; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wiltschko AB, 2010, NEUROPSYCHOPHARMACOL, V35, P1261, DOI 10.1038/npp.2009.226; Woods AM, 2008, LEARN MEMORY, V15, P909, DOI 10.1101/lm.1078508	60	85	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11971	10.1371/journal.pone.0011971	http://dx.doi.org/10.1371/journal.pone.0011971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700483	gold, Green Published, Green Submitted			2022-12-25	WOS:000280605400012
J	Sinclair, MS; Perea-Martinez, I; Dvoryanchikov, G; Yoshida, M; Nishimori, K; Roper, SD; Chaudhari, N				Sinclair, Michael S.; Perea-Martinez, Isabel; Dvoryanchikov, Gennady; Yoshida, Masahide; Nishimori, Katsuhiko; Roper, Stephen D.; Chaudhari, Nirupa			Oxytocin Signaling in Mouse Taste Buds	PLOS ONE			English	Article							RECEPTOR-CELLS; SUCROSE SOLUTION; SODIUM APPETITE; GENE DELETION; III CELLS; MICE; RAT; BEHAVIOR; SWEET; COMMUNICATION	Background: The neuropeptide, oxytocin (OXT), acts on brain circuits to inhibit food intake. Mutant mice lacking OXT (OXT knockout) overconsume salty and sweet (i.e. sucrose, saccharin) solutions. We asked if OXT might also act on taste buds via its receptor, OXTR. Methodology/Principal Findings: Using RT-PCR, we detected the expression of OXTR in taste buds throughout the oral cavity, but not in adjacent non-taste lingual epithelium. By immunostaining tissues from OXTR-YFP knock-in mice, we found that OXTR is expressed in a subset of Glial-like (Type I) taste cells, and also in cells on the periphery of taste buds. Single-cell RT-PCR confirmed this cell-type assignment. Using Ca2+ imaging, we observed that physiologically appropriate concentrations of OXT evoked [Ca2+](i) mobilization in a subset of taste cells (EC50 similar to 33 nM). OXT-evoked responses were significantly inhibited by the OXTR antagonist, L-371,257. Isolated OXT-responsive taste cells were neither Receptor (Type II) nor Presynaptic (Type III) cells, consistent with our immunofluorescence observations. We also investigated the source of OXT peptide that may act on taste cells. Both RT-PCR and immunostaining suggest that the OXT peptide is not produced in taste buds or in their associated nerves. Finally, we also examined the morphology of taste buds from mice that lack OXTR. Taste buds and their constituent cell types appeared very similar in mice with two, one or no copies of the OXTR gene. Conclusions/Significance: We conclude that OXT elicits Ca2+ signals via OXTR in murine taste buds. OXT-responsive cells are most likely a subset of Glial-like (Type I) taste cells. OXT itself is not produced locally in taste tissue and is likely delivered through the circulation. Loss of OXTR does not grossly alter the morphology of any of the cell types contained in taste buds. Instead, we speculate that OXT-responsive Glial-like (Type I) taste bud cells modulate taste signaling and afferent sensory output. Such modulation would complement central pathways of appetite regulation that employ circulating homeostatic and satiety signals.	[Sinclair, Michael S.; Roper, Stephen D.; Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA; [Perea-Martinez, Isabel; Dvoryanchikov, Gennady; Roper, Stephen D.; Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Yoshida, Masahide; Nishimori, Katsuhiko] Tohoku Univ, Dept Mol & Cell Biol, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan	University of Miami; University of Miami; Tohoku University	Sinclair, MS (corresponding author), Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA.	NChaudhari@med.miami.edu		Roper, Stephen/0000-0001-6049-8320; Sinclair, Michael/0000-0002-3636-5920; Tilahin, Shimelis/0000-0001-8975-8026	American Heart Association [0815215E]; National Institutes of Health/NIDCD [DC006021, DC006308, DC010073, DC00037]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006308, R21DC010073, R01DC006021, R56DC006308] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by American Heart Association Predoctoral Fellowship 0815215E (M. S.) and National Institutes of Health/NIDCD grants DC006021, DC006308, DC010073 (N.C.) and DC00037 (S. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico JA, 2005, AM J PHYSIOL-REG I, V289, pR1798, DOI 10.1152/ajpregu.00558.2005; Amico JA, 2001, AM J PHYSIOL-REG I, V281, pR1368, DOI 10.1152/ajpregu.2001.281.5.R1368; ARLETTI R, 1990, PHYSIOL BEHAV, V48, P825, DOI 10.1016/0031-9384(90)90234-U; ARLETTI R, 1989, PEPTIDES, V10, P89, DOI 10.1016/0196-9781(89)90082-X; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bigiani A, 2007, J NEUROPHYSIOL, V98, P2483, DOI 10.1152/jn.00716.2007; Billings LB, 2006, BEHAV BRAIN RES, V171, P134, DOI 10.1016/j.bbr.2006.03.028; BLACKBURN RE, 1992, NEUROENDOCRINOLOGY, V56, P255, DOI 10.1159/000126236; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; CHAUDHARI N, 2010, J CELL BIOL IN PRESS; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Gilbertson TA, 1998, ANN NY ACAD SCI, V855, P860, DOI 10.1111/j.1749-6632.1998.tb10676.x; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hayato R, 2007, J PHYSIOL-LONDON, V584, P473, DOI 10.1113/jphysiol.2007.138370; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; HUANG W, 1995, AM J PHYSIOL-REG I, V268, pR634, DOI 10.1152/ajpregu.1995.268.3.R634; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Kim JW, 2006, CHEM SENSES, V31, P213, DOI 10.1093/chemse/bjj021; KU CY, 1995, ENDOCRINOLOGY, V136, P1509, DOI 10.1210/en.136.4.1509; Lawton DM, 2000, EUR J NEUROSCI, V12, P3163, DOI 10.1046/j.1460-9568.2000.00207.x; Leng G, 2008, PROG BRAIN RES, V170, P137, DOI 10.1016/S0079-6123(08)00413-5; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; Medler KF, 2003, J NEUROSCI, V23, P2608; Miedlar JA, 2007, AM J PHYSIOL-REG I, V293, pR1063, DOI 10.1152/ajpregu.00228.2007; MURRAY RG, 1993, MICROSC RES TECHNIQ, V26, P209, DOI 10.1002/jemt.1070260304; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; OLSON BR, 1991, PEPTIDES, V12, P113, DOI 10.1016/0196-9781(91)90176-P; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Parent AS, 2008, ENDOCRINOLOGY, V149, P1358, DOI 10.1210/en.2007-1054; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; Roberts CD, 2009, J PHYSIOL-LONDON, V587, P1657, DOI 10.1113/jphysiol.2009.170555; Sabatier N, 2007, BIOCHEM SOC T, V35, P1247, DOI 10.1042/BST0351247; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sclafani A, 2007, AM J PHYSIOL-REG I, V292, pR1828, DOI 10.1152/ajpregu.00826.2006; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Stricker EM, 1996, REGUL PEPTIDES, V66, P83, DOI 10.1016/S0167-0115(96)00058-4; STRICKER EM, 1987, BEHAV NEUROSCI, V101, P560, DOI 10.1037/0735-7044.101.4.560; Swaab DF, 2004, INT REV CYTOL, V240, P305, DOI 10.1016/S0074-7696(04)40003-5; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; TASAKA K, 1991, OBSTET GYNECOL, V77, P101; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Vila G, 2009, J ENDOCRINOL, V203, P175, DOI 10.1677/JOE-09-0227; WILLIAMS PD, 1995, J MED CHEM, V38, P4634, DOI 10.1021/jm00023a002; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009	58	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11980	10.1371/journal.pone.0011980	http://dx.doi.org/10.1371/journal.pone.0011980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700536	Green Submitted, gold, Green Published			2022-12-25	WOS:000280605400016
J	Keary, N; Voss, J; Lehmann, K; Bischof, HJ; Lowel, S				Keary, Nina; Voss, Joe; Lehmann, Konrad; Bischof, Hans-Joachim; Loewel, Siegrid			Optical Imaging of Retinotopic Maps in a Small Songbird, the Zebra Finch	PLOS ONE			English	Article							MACAQUE STRIATE CORTEX; GUTTATA-CASTANOTIS-GOULD; PIGEON COLUMBA-LIVIA; OWL TYTO-ALBA; VISUAL-WULST; FUNCTIONAL-ANATOMY; TAENIOPYGIA-GUTTATA; OCULAR DOMINANCE; AVIAN TELENCEPHALON; RECEPTIVE-FIELDS	Background: The primary visual cortex of mammals is characterised by a retinotopic representation of the visual field. It has therefore been speculated that the visual wulst, the avian homologue of the visual cortex, also contains such a retinotopic map. We examined this for the first time by optical imaging of intrinsic signals in zebra finches, a small songbird with laterally placed eyes. In addition to the visual wulst, we visualised the retinotopic map of the optic tectum which is homologue to the superior colliculus in mammals. Methodology/Principal Findings: For the optic tectum, our results confirmed previous accounts of topography based on anatomical studies and conventional electrophysiology. Within the visual wulst, the retinotopy revealed by our experiments has not been illustrated convincingly before. The frontal part of the visual field (0 degrees +/- 30 degrees azimuth) was not represented in the retinotopic map. The visual field from 30 degrees-60 degrees azimuth showed stronger magnification compared with more lateral regions. Only stimuli within elevations between about 20 degrees and 40 degrees above the horizon elicited neuronal activation. Activation from other elevations was masked by activation of the preferred region. Most interestingly, we observed more than one retinotopic representation of visual space within the visual wulst, which indicates that the avian wulst, like the visual cortex in mammals, may show some compartmentation parallel to the surface in addition to its layered structure. Conclusion/Significance: Our results show the applicability of the optical imaging method also for small songbirds. We obtained a more detailed picture of retinotopic maps in birds, especially on the functional neuronal organisation of the visual wulst. Our findings support the notion of homology of visual wulst and visual cortex by showing that there is a functional correspondence between the two areas but also raise questions based on considerable differences between avian and mammalian retinotopic representations.	[Keary, Nina; Voss, Joe; Bischof, Hans-Joachim] Univ Bielefeld, Lehrstuhl Verhaltensforsch, Bielefeld, Germany; [Lehmann, Konrad; Loewel, Siegrid] Univ Jena, Inst Allgemeine Zool & Tierphysiol, Jena, Germany	University of Bielefeld; Friedrich Schiller University of Jena	Keary, N (corresponding author), Univ Bielefeld, Lehrstuhl Verhaltensforsch, Bielefeld, Germany.	nina.keary@uni-bielefeld.de	Lehmann, Konrad/AAJ-1017-2020	Lehmann, Konrad/0000-0001-8215-5804	Human Frontier Science Program (HFSP); Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF); Bielefeld University; Deutsche Forschungsgemeinschaft (DFG) [BI 245/18]	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); Bielefeld University; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by grants from the Human Frontier Science Program (HFSP) (http://www.hfsp.org/), the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) (http://www.bmbf.de/), Bielefeld University (http://www.uni-bielefeld.de/) and the Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/index.jsp), grant number BI 245/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron J, 2007, EUR J NEUROSCI, V26, P1950, DOI 10.1111/j.1460-9568.2007.05783.x; Basole A, 2006, PROG BRAIN RES, V154, P121, DOI 10.1016/S0079-6123(06)54006-3; BISCHOF HJ, 1981, BRAIN RES BULL, V7, P435, DOI 10.1016/0361-9230(81)90042-3; BISCHOF HJ, 1988, J COMP PHYSIOL A, V163, P329, DOI 10.1007/BF00604008; BREDENKOTTER M, 1990, VISUAL NEUROSCI, V5, P155, DOI 10.1017/S0952523800000201; BREDENKOTTER M, 1990, BRAIN RES, V515, P343, DOI 10.1016/0006-8993(90)90620-Q; Brodmann, 1909, VERGLEICHENDE LOKALI; CLARKE PGH, 1976, Q J EXP PHYSIOL CMS, V61, P351, DOI 10.1113/expphysiol.1976.sp002366; DENTON CJ, 1981, EXP NEUROL, V74, P482, DOI 10.1016/0014-4886(81)90186-2; Engelage Jurgen, 1993, P137; FROST BJ, 1976, VISION RES, V16, P1229, DOI 10.1016/0042-6989(76)90046-8; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Gunturkun O, 1999, BEHAV BRAIN RES, V98, P193, DOI 10.1016/S0166-4328(98)00084-9; Gunturkun Onur, 1993, P115; HAMDI FA, 1954, Q J EXP PHYSIOL CMS, V39, P111, DOI 10.1113/expphysiol.1954.sp001053; HOLDEN AL, 1971, J PHYSIOL-LONDON, V214, pP44; HOLDEN AL, 1969, J PHYSIOL-LONDON, V201, pP56; Hubener M, 1997, J NEUROSCI, V17, P9270; HUGHES CP, 1974, BRAIN RES, V80, P365, DOI 10.1016/0006-8993(74)91023-3; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; JASSIKGE.D, 1972, BRAIN RES, V40, P303, DOI 10.1016/0006-8993(72)90136-9; KAAS JH, 1995, BRAIN BEHAV EVOLUT, V46, P187, DOI 10.1159/000113273; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KARTEN HJ, 1973, J COMP NEUROL, V150, P253, DOI 10.1002/cne.901500303; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Liu GB, 2003, BRAIN RES, V961, P153, DOI 10.1016/S0006-8993(02)03747-2; LOWEL S, 1988, EXP BRAIN RES, V71, P33; LOWEL S, 1987, EXP BRAIN RES, V68, P661; Manger PR, 2002, EUR J NEUROSCI, V16, P743, DOI 10.1046/j.1460-9568.2002.02119.x; MARTIN GR, 1983, VISION RES, V23, P911, DOI 10.1016/0042-6989(83)90061-5; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; Meinertzhagen Ian A., 1993, P1363; MEY J, 1992, J HIRNFORSCH, V33, P673; MICELI D, 1990, BRAIN RES, V518, P317, DOI 10.1016/0006-8993(90)90990-S; MICELI D, 1979, NEURAL MECHANISMS BE, P223; NIXDORF BE, 1982, BRAIN RES, V248, P9, DOI 10.1016/0006-8993(82)91142-8; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; Pettigrew J. D., 1978, Frontiers in Visual Science, P328; PETTIGREW JD, 1979, PROC R SOC SER B-BIO, V204, P435, DOI 10.1098/rspb.1979.0038; PETTIGREW JD, 1976, SCIENCE, V193, P675, DOI 10.1126/science.948741; PLASS L, 1997, THESIS BIELEFELD U B; Plumbley MD, 1999, NETWORK-COMP NEURAL, V10, P41, DOI 10.1088/0954-898X/10/1/003; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; REMY M, 1991, J COMP NEUROL, V305, P57, DOI 10.1002/cne.903050107; REVZIN AM, 1970, BRAIN BEHAV EVOLUT, V3, P195; Rosa MGP, 2005, PHILOS T R SOC B, V360, P665, DOI 10.1098/rstb.2005.1626; Rosa MGP, 1997, J NEUROPHYSIOL, V77, P3193, DOI 10.1152/jn.1997.77.6.3193; Schmidt A, 1999, J COMP PHYSIOL A, V185, P69, DOI 10.1007/s003590050367; Schmidt A, 2001, J COMP PHYSIOL A, V187, P913, DOI 10.1007/s00359-001-0264-8; SHATZ CJ, 1977, BRAIN RES, V131, P103, DOI 10.1016/0006-8993(77)90031-2; Shimizu T, 1999, BEHAV BRAIN RES, V98, P183, DOI 10.1016/S0166-4328(98)00083-7; SHIMIZU T, 1990, J COMP NEUROL, V300, P346, DOI 10.1002/cne.903000307; SPARKS DL, 1988, BRAIN BEHAV EVOLUT, V31, P49, DOI 10.1159/000116575; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TOOTELL RBH, 1988, J NEUROSCI, V8, P1610; TOOTELL RBH, 1988, J NEUROSCI, V8, P1500; TOOTELL RBH, 1988, J NEUROSCI, V8, P1594; TOOTELL RBH, 1988, J NEUROSCI, V8, P1569; UHLRICH DJ, 1982, VISION RES, V22, P429, DOI 10.1016/0042-6989(82)90188-2; VANESSEN DC, 1979, ANNU REV NEUROSCI, V2, P227, DOI 10.1146/annurev.ne.02.030179.001303; VOSS J, 2005, THESIS BIELEFELD U B; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; WILSON P, 1980, BRAIN RES, V188, P333, DOI 10.1016/0006-8993(80)90035-9; WILSON P, 1980, BRAIN RES, V188, P319, DOI 10.1016/0006-8993(80)90034-7; WOODS EJ, 1977, EXP BRAIN RES, V27, P347; Wylie DRW, 2009, CAN J EXP PSYCHOL, V63, P328, DOI 10.1037/a0016826	69	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11912	10.1371/journal.pone.0011912	http://dx.doi.org/10.1371/journal.pone.0011912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694137	Green Submitted, Green Published, gold			2022-12-25	WOS:000280574300004
J	Wang, XT; Chorley, BN; Pittman, GS; Kleeberger, SR; Brothers, J; Liu, G; Spira, A; Bell, DA				Wang, Xuting; Chorley, Brian N.; Pittman, Gary S.; Kleeberger, Steven R.; Brothers, John, II; Liu, Gang; Spira, Avrum; Bell, Douglas A.			Genetic Variation and Antioxidant Response Gene Expression in the Bronchial Airway Epithelium of Smokers at Risk for Lung Cancer	PLOS ONE			English	Article							OXIDATIVE STRESS; CIGARETTE-SMOKE; NEGATIVE REGULATION; GENOME; POLYMORPHISMS; NRF2; ACTIVATION; SUSCEPTIBILITY; INDUCTION; EXPOSURE	Prior microarray studies of smokers at high risk for lung cancer have demonstrated that heterogeneity in bronchial airway epithelial cell gene expression response to smoking can serve as an early diagnostic biomarker for lung cancer. As a first step in applying functional genomic analysis to population studies, we have examined the relationship between gene expression variation and genetic variation in a central molecular pathway (NRF2-mediated antioxidant response) associated with smoking exposure and lung cancer. We assessed global gene expression in histologically normal airway epithelial cells obtained at bronchoscopy from smokers who developed lung cancer (SC, n = 20), smokers without lung cancer (SNC, n = 24), and never smokers (NS, n = 8). Functional enrichment analysis showed that the NRF2-mediated, antioxidant response element (ARE)-regulated genes, were significantly lower in SC, when compared with expression levels in SNC. Importantly, we found that the expression of MAFG (a binding partner of NRF2) was correlated with the expression of ARE genes, suggesting MAFG levels may limit target gene induction. Bioinformatically we identified single nucleotide polymorphisms (SNPs) in putative ARE genes and to test the impact of genetic variation, we genotyped these putative regulatory SNPs and other tag SNPs in selected NRF2 pathway genes. Sequencing MAFG locus, we identified 30 novel SNPs and two were associated with either gene expression or lung cancer status among smokers. This work demonstrates an analysis approach that integrates bioinformatics pathway and transcription factor binding site analysis with genotype, gene expression and disease status to identify SNPs that may be associated with individual differences in gene expression and/or cancer status in smokers. These polymorphisms might ultimately contribute to lung cancer risk via their effect on the airway gene expression response to tobacco-smoke exposure.	[Wang, Xuting; Chorley, Brian N.; Pittman, Gary S.; Bell, Douglas A.] NIEHS, Environm Genom Sect, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Kleeberger, Steven R.] NIEHS, Environm Genet Sect, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA; [Brothers, John, II; Liu, Gang; Spira, Avrum] Boston Univ, Sect Computat Biomed, Dept Med, Boston, MA 02215 USA; [Brothers, John, II; Liu, Gang; Spira, Avrum] Boston Univ, Ctr Pulm, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Boston University; Boston University	Wang, XT (corresponding author), NIEHS, Environm Genom Sect, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	BELL1@niehs.nih.gov	Kleeberger, Steven R/F-1807-2019; Bell, Douglas A/C-7687-2019	Kleeberger, Steven R/0000-0003-2948-8452; Bell, Douglas A/0000-0001-7700-0840; Wang, Xuting/0000-0001-6781-8008; Liu, Gang/0000-0001-9270-6796; Spira, Avrum/0000-0003-1467-0489	National Institute of Environmental Health Sciences, National Institutes of Health [Z01 ES100475]; National Institute of Health [U01ES016035, R01CA124640]; NATIONAL CANCER INSTITUTE [R01CA124640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100513, ZIAES046008, U01ES016035, Z01ES100475] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health (Z01 ES100475) and grants to Avrum Spira from the National Institute of Health (U01ES016035, R01CA124640).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beane J, 2008, CANCER PREV RES, V1, P56, DOI 10.1158/1940-6207.CAPR-08-0011; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Churg A, 2005, TOXICOL APPL PHARM, V208, P37, DOI 10.1016/j.taap.2005.01.013; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; FIGUEROA JD, 2008, CARCINOGENESIS; Hubner RH, 2009, MOL MED, V15, P203, DOI 10.2119/molmed.2008.00130; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kiyohara C, 2006, EPIDEMIOLOGY, V17, P89, DOI 10.1097/01.ede.0000187627.70026.23; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rangasamy T, 2009, AM J PHYSIOL-LUNG C, V296, pL888, DOI 10.1152/ajplung.90369.2008; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Shields P G, 1999, Ann Oncol, V10 Suppl 5, pS7; Siedlinski M, 2008, AM J RESP CRIT CARE, V178, P13, DOI 10.1164/rccm.200711-1749OC; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Steiling K, 2008, CANCER PREV RES, V1, P396, DOI 10.1158/1940-6207.CAPR-08-0174; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomso DJ, 2005, P NATL ACAD SCI USA, V102, P6431, DOI 10.1073/pnas.0501721102; Wang SS, 2006, CARCINOGENESIS, V27, P1828, DOI 10.1093/carcin/bgl013; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; *WHO, 2006, FACTS SMOK HLTH; Wu XF, 2004, ONCOGENE, V23, P6500, DOI 10.1038/sj.onc.1207811; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725	42	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11934	10.1371/journal.pone.0011934	http://dx.doi.org/10.1371/journal.pone.0011934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689807	Green Published, gold			2022-12-25	WOS:000280520500003
J	Zhang, WL; Deng, ZL; Chen, LA; Zuo, GW; Luo, Q; Shi, QO; Zhang, BQ; Wagner, ER; Rastegar, F; Kim, SH; Jiang, W; Shen, JK; Huang, EY; Gao, YH; Gao, JL; Zhou, JZ; Luo, JY; Huang, JY; Luo, XJ; Bi, Y; Su, YX; Yang, K; Liu, H; Luu, HH; Haydon, RC; He, TC; He, BC				Zhang, Wenli; Deng, Zhong-Liang; Chen, Liang; Zuo, Guo-Wei; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Wagner, Eric R.; Rastegar, Farbod; Kim, Stephanie H.; Jiang, Wei; Shen, Jikun; Huang, Enyi; Gao, Yanhong; Gao, Jian-Li; Zhou, Jian-Zhong; Luo, Jinyong; Huang, Jiayi; Luo, Xiaoji; Bi, Yang; Su, Yuxi; Yang, Ke; Liu, Hao; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan; He, Bai-Cheng			Retinoic Acids Potentiate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; COLLAGEN-X PROMOTER; STEM-CELLS; OSTEOBLAST DIFFERENTIATION; NUCLEAR RECEPTORS; RECOMBINANT ADENOVIRUSES; MOUSE; BMP; TISSUE	Background: As one of the least studied bone morphogenetic proteins (BMPs), BMP9 is one of the most osteogenic BMPs. Retinoic acid (RA) signaling is known to play an important role in development, differentiation and bone metabolism. In this study, we investigate the effect of RA signaling on BMP9-induced osteogenic differentiation of mesenchymal progenitor cells (MPCs). Methodology/Principal Findings: Both primary MPCs and MPC line are used for BMP9 and RA stimulation. Recombinant adenoviruses are used to deliver BMP9, RAR alpha and RXR alpha into MPCs. The in vitro osteogenic differentiation is monitored by determining the early and late osteogenic markers and matrix mineralization. Mouse perinatal limb explants and in vivo MPC implantation experiments are carried out to assess bone formation. We find that both 9CRA and ATRA effectively induce early osteogenic marker, such as alkaline phosphatase (ALP), and late osteogenic markers, such as osteopontin (OPN) and osteocalcin (OC). BMP9-induced osteogenic differentiation and mineralization is synergistically enhanced by 9CRA and ATRA in vitro. 9CRA and ATRA are shown to induce BMP9 expression and activate BMPR Smad-mediated transcription activity. Using mouse perinatal limb explants, we find that BMP9 and RAs act together to promote the expansion of hypertrophic chondrocyte zone at growth plate. Progenitor cell implantation studies reveal that co-expression of BMP9 and RXRa or RARa significantly increases trabecular bone and osteoid matrix formation. Conclusion/Significance: Our results strongly suggest that retinoid signaling may synergize with BMP9 activity in promoting osteogenic differentiation of MPCs. This knowledge should expand our understanding about how BMP9 cross-talks with other signaling pathways. Furthermore, a combination of BMP9 and retinoic acid (or its agonists) may be explored as effective bone regeneration therapeutics to treat large segmental bony defects, non-union fracture, and/or osteoporotic fracture.	[Zhang, Wenli; Shi, Qiong; Zhou, Jian-Zhong; Liu, Hao] Sichuan Univ, W China Hosp, Dept Orthopaed Surg, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Wenli; Deng, Zhong-Liang; Chen, Liang; Zuo, Guo-Wei; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Wagner, Eric R.; Rastegar, Farbod; Kim, Stephanie H.; Jiang, Wei; Shen, Jikun; Huang, Enyi; Gao, Yanhong; Gao, Jian-Li; Zhou, Jian-Zhong; Luo, Jinyong; Huang, Jiayi; Luo, Xiaoji; Bi, Yang; Su, Yuxi; Yang, Ke; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan; He, Bai-Cheng] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Deng, Zhong-Liang; Chen, Liang; Zuo, Guo-Wei; Zhang, Bing-Qiang; Luo, Jinyong; Huang, Jiayi; Luo, Xiaoji; He, Tong-Chuan] Chongqing Med Univ, Key Lab Diagnost Med Designated, Chinese Minist Educ, Chongqing, Peoples R China; [Deng, Zhong-Liang; Chen, Liang; Zuo, Guo-Wei; Zhang, Bing-Qiang; Luo, Jinyong; Huang, Jiayi; Luo, Xiaoji; He, Tong-Chuan] Chongqing Med Univ, Key Lab Diagnost Med Designated, Affiliated Hosp, Chongqing, Peoples R China; [Luo, Qing; Bi, Yang; Su, Yuxi; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Pediat Res Inst, Stem Cell Biol & Therapy Lab, Chongqing, Peoples R China; [Huang, Enyi] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China; [Gao, Yanhong] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Geriatr, Shanghai 200030, Peoples R China; [Yang, Ke] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China; [He, Bai-Cheng] Chongqing Med Univ, Dept Pharmacol, Chongqing, Peoples R China	Sichuan University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing University; Shanghai Jiao Tong University; Army Medical University; Chongqing Medical University	Zhang, WL (corresponding author), Sichuan Univ, W China Hosp, Dept Orthopaed Surg, Chengdu 610064, Sichuan, Peoples R China.	tche@surgery.bsd.uchicago.edu; hebaicheng99@yahoo.com	; GAO, JianLi/J-4997-2017	Wagner, Eric/0000-0001-9241-5702; Zhang, Wenli/0000-0002-4989-7950; GAO, JianLi/0000-0002-5977-0021	Brinson Foundation; National Institutes of Health [CA106569, AT004418, AR50142, AR054381]; Ministry of Science and Technology of China [2007AA2z400]; Natural Science Foundation of China [30901530, 30800658, 30772211]; Natural Science Foundation Project of Chongqing Science and Technology Commission [2008BB5396, 2009BB5060]; NATIONAL CANCER INSTITUTE [R01CA106569] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054381, K08AR050142] Funding Source: NIH RePORTER	Brinson Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing Science and Technology Commission(Natural Science Foundation of Chongqing); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by research grants from the Brinson Foundation (TCH), the National Institutes of Health (CA106569, AT004418, AR50142, and AR054381 to TCH, RCH and HHL), The 863 Program of Ministry of Science and Technology of China (#2007AA2z400 to LC, TCH, ZLD), the Natural Science Foundation of China (#30901530 to XL, #30800658 to JL, and #30772211 to ZLD), and the Natural Science Foundation Project of Chongqing Science and Technology Commission #2008BB5396 (LC) and #2009BB5060 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; Cash DE, 1997, J CELL BIOL, V136, P445, DOI 10.1083/jcb.136.2.445; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen RS, 2003, CHEM VAPOR DEPOS, V9, P301, DOI 10.1002/cvde.200304153; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Cohen AJ, 2006, J CELL BIOCHEM, V99, P269, DOI 10.1002/jcb.20937; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Drissi MH, 2003, J CELL BIOCHEM, V90, P1287, DOI 10.1002/jcb.10677; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Garattini E, 2004, CURR PHARM DESIGN, V10, P433, DOI 10.2174/1381612043453351; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Hatakeyama S, 1996, BIOCHEM MOL BIOL INT, V38, P1235; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; HE BC, CLIN CANC RES; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Li XF, 2003, ENDOCRINOLOGY, V144, P2514, DOI 10.1210/en.2002-220969; Liu Z, 2004, J NEUROTRAUM, V21, P1479, DOI 10.1089/neu.2004.21.1479; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo J, 2005, CURR GENE THER, V5, P167, DOI 10.2174/1566523053544218; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mic FA, 2002, DEVELOPMENT, V129, P2271; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Park BH, 2001, CURR OPIN ONCOL, V13, P78, DOI 10.1097/00001622-200101000-00015; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ringe J, 2008, J TISSUE ENG REGEN M, V2, P136, DOI 10.1002/term.75; ROGERS MB, 1992, MOL BIOL CELL, V3, P189, DOI 10.1091/mbc.3.2.189; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sinanan ACM, 2004, BIOTECHNOL APPL BIOC, V40, P25, DOI 10.1042/BA20030185; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Virdi AS, 1998, CELL MOL BIOL, V44, P1237; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Wang AX, 2008, BIOCHEM BIOPH RES CO, V375, P435, DOI 10.1016/j.bbrc.2008.08.036; Weston AD, 2000, J CELL BIOL, V148, P679, DOI 10.1083/jcb.148.4.679; Yoshizawa T, 2004, MOL CELL BIOL, V24, P3460, DOI 10.1128/MCB.24.8.3460-3472.2004; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	79	107	119	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11917	10.1371/journal.pone.0011917	http://dx.doi.org/10.1371/journal.pone.0011917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689834	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520300027
J	Meng, G; Zhao, YM; Bai, XY; Liu, Y; Green, TJ; Luo, M; Zheng, XF				Meng, Geng; Zhao, Yanmei; Bai, Xiaoyun; Liu, Yong; Green, Todd J.; Luo, Ming; Zheng, Xiaofeng			Structure of Human Stabilin-1 Interacting Chitinase-like Protein (SI-CLP) Reveals a Saccharide-binding Cleft with Lower Sugar-binding Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN CHITINASE; CRYSTAL-STRUCTURE; INFLAMMATION; YM1; MACROPHAGES; SOFTWARE; COMPLEX	Human secreted protein stabilin-1 interacting chitinase-like protein (SI-CLP) has been identified as a novel member of Glyco_18 domain-containing proteins that is involved in host defense and inflammatory reactions. Efficient secretion of SI-CLP is mediated by its interaction with the endocytic/sorting receptor stabilin-1. SI-CLP is expressed abundantly in macrophages and neutrophils and is up-regulated by Th2 cytokine IL-4 and glucocorticoid, which suggest that SI-CLP could be a marker for adverse effects of glucocorticoid therapy. To gain insight into the biological function of SI-CLP, we determined the crystal structure of SI-CLP at 2.7 angstrom resolution by x-ray crystallography and found that it featured a typical triose-phosphate isomerase barrel fold with a putative saccharide-binding cleft. Comparison with other chitinase-like proteins showed the cleft to be atypically wide and open. The saccharide-binding capacity of SI-CLP was investigated, and its ligand-binding specificity was found to relate to the length of the oligosaccharides, with preference for chitotetraose. Further investigations reveal that SI-CLP could bind LPS in vitro and neutralize its endotoxin effect on macrophages. Our results demonstrate the saccharide-binding property of SI-CLP by structure and in vitro biochemical analyses and suggest the possible roles of SI-CLP in pathogen sensing and endotoxin neutralization.	[Meng, Geng; Zhao, Yanmei; Bai, Xiaoyun; Liu, Yong; Zheng, Xiaofeng] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; [Meng, Geng; Zhao, Yanmei; Bai, Xiaoyun; Liu, Yong; Zheng, Xiaofeng] Peking Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Green, Todd J.; Luo, Ming] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Peking University; Peking University; University of Alabama System; University of Alabama Birmingham	Zheng, XF (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	Meng, Geng/ACY-1510-2022	Green, Todd/0000-0003-1158-4710	National Science Foundation of China [30870487]; National Basic Research Program of China [2010CB911800, 2006AA02A314]; International Centre for Genetic Engineering and Biotechnology [CRP/CHN09-01]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International Centre for Genetic Engineering and Biotechnology	This work was supported by National Science Foundation of China Grant 30870487, National Basic Research Program of China 973 Program Grant 2010CB911800 and 863 Program Grant 2006AA02A314, and the International Centre for Genetic Engineering and Biotechnology Project CRP/CHN09-01. Portions of this research as x-ray diffraction data collection were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Dai XY, 2005, BIOCHEM BIOPH RES CO, V332, P593, DOI 10.1016/j.bbrc.2005.04.163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Kzhyshkowska J, 2006, BLOOD, V107, P3221, DOI 10.1182/blood-2005-07-2843; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Meng G, 2009, PROTEIN PEPTIDE LETT, V16, P336, DOI 10.2174/092986609787601660; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; Steenbakkers PGA, 2003, J IMMUNOL, V170, P5719, DOI 10.4049/jimmunol.170.11.5719; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	21	25	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39898	39904		10.1074/jbc.M110.130781	http://dx.doi.org/10.1074/jbc.M110.130781			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20724479	Green Published, hybrid			2022-12-25	WOS:000285185500034
J	Garcia-Haro, L; Garcia-Gimeno, MA; Neumann, D; Beullens, M; Bollen, M; Sanz, P				Garcia-Haro, Luisa; Garcia-Gimeno, Maria Adelaida; Neumann, Dietbert; Beullens, Monique; Bollen, Mathieu; Sanz, Pascual			The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells	FASEB JOURNAL			English	Article						beta-cell function; glucose regulation; metabolic regulation; energy metabolism	SKELETAL-MUSCLE; SNF1; PHOSPHORYLATION; SUBUNIT; ENERGY; BINDING; ROLES; LKB1; INHIBITION; UPSTREAM	Mammalian AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase that acts as a sensor of cellular energy status. It is activated by phosphorylation of the catalytic subunit on Thr172. The main objective of this study was the identification of a phosphatase involved in the regulation of AMPK activity. Mouse MIN6 beta cells were used to study the glucose-induced regulation of the phosphorylation of AMPK. Small interfering RNA (siRNA) technology was used to deplete putative phosphatase candidate genes that could affect AMPK regulation. The effect of the siRNAs used in the study was compared with the effect observed using a negative control siRNA. A protein phosphatase complex composed of the catalytic subunit of protein phosphatase-1 (PP1) and the regulatory subunit R6 participates in the glucose-induced dephosphorylation of AMPK. R6 interacts physically with the beta-subunit of the AMPK complex and recruits PP1 to dephosphorylate the catalytic alpha-subunit on Thr172. siRNA depletion of R6 decreases glucose-induced insulin secretion due to the presence of a constitutively active AMPK complex. The characterization of the PP1-R6 complex identifies this holoenzyme as a possible target for therapeutic intervention with the aim of regulating the activity of AMPK in pancreatic beta cells.-Garcia- Haro, L., Garcia-Gimeno, M. A., Neumann, D., Beullens, M., Bollen, M., Sanz, P. The PP1-R6 protein phosphatase holoenzyme is involved in the glucoseinduced dephosphorylation and inactivation of AMP activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells. FASEB J. 24, 5080-5091 (2010). www.fasebj.org	[Garcia-Haro, Luisa; Garcia-Gimeno, Maria Adelaida; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia 46010, Spain; [Garcia-Haro, Luisa; Garcia-Gimeno, Maria Adelaida; Sanz, Pascual] Ctr Invest Red Enfermecedes Raras, Valencia, Spain; [Neumann, Dietbert] Swiss Fed Inst Technol, Inst Cell Biol, Zurich, Switzerland; [Beullens, Monique; Bollen, Mathieu] Univ Leuven, Dept Mol Cell Biol, Lab Biosignaling & Therapeut, Leuven, Belgium	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Swiss Federal Institutes of Technology Domain; ETH Zurich; KU Leuven	Sanz, P (corresponding author), CSIC, Inst Biomed Valencia, Jaime Roig 11, Valencia 46010, Spain.	sanz@ibv.csic.es	García-Gimeno, María Adelaida/K-9855-2014; Sanz, Pascual/K-2751-2014	García-Gimeno, María Adelaida/0000-0002-6483-3912; Sanz, Pascual/0000-0002-2399-4103; , Luisa/0000-0003-0519-9322; Neumann, Dietbert/0000-0002-4316-684X	Spanish Ministry of Education and Science [SAF2008-01907]; Generalitat Valenciana (Prometeo) [2009/051]; European Commission [LSHM-CT-2004-005272]	Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana (Prometeo)(Center for Forestry Research & Experimentation (CIEF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank Dr. Jun-Ichi Miyazaki (Osaka University, Osaka, Japan) for the MIN6 beta cells, Dr. Joan Guinovart (Institute for Research in Biomedicine, Barcelona, Spain) for the generous gift of anti-glucokinase antibodies, and Dr. Matthew Gentry (University of Kentucky, Lexington, KY, USA) for the pcDNA3.1/myc-His-R6 plasmid. This work was supported by a grant from the Spanish Ministry of Education and Science (SAF2008-01907), by a grant from Generalitat Valenciana (Prometeo 2009/051), and by EXGENESIS, an Integrated Project (LSHM-CT-2004-005272) of the European Commission (to P.S.).	Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Browne GJ, 2001, BIOCHEM J, V360, P449, DOI 10.1042/0264-6021:3600449; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Itani SI, 2003, DIABETES, V52, P1635, DOI 10.2337/diabetes.52.7.1635; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Leclerc I, 2004, DIABETES, V53, pS67, DOI 10.2337/diabetes.53.suppl_3.S67; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Mangat S, 2010, EUKARYOT CELL, V9, P173, DOI 10.1128/EC.00267-09; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Momcilovic M, 2008, J BIOL CHEM, V283, P19521, DOI 10.1074/jbc.M803624200; Mountjoy PD, 2007, DIABETOLOGIA, V50, P168, DOI 10.1007/s00125-006-0473-3; Mukhtar MH, 2008, AM J PHYSIOL-REG I, V294, pR766, DOI 10.1152/ajpregu.00593.2007; Munro S, 2005, FEBS J, V272, P1478, DOI 10.1111/j.1742-4658.2005.04585.x; Orlova M, 2008, YEAST, V25, P745, DOI 10.1002/yea.1628; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Rutter GA, 2004, DIABETOLOGIA, V47, P1861, DOI 10.1007/s00125-004-1541-1; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Scholz R, 2009, J BIOL CHEM, V284, P27425, DOI 10.1074/jbc.M109.047670; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sugden C, 1999, PLANT J, V19, P433, DOI 10.1046/j.1365-313X.1999.00532.x; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; TANG PM, 1991, J BIOL CHEM, V266, P15782; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xavier GD, 2000, P NATL ACAD SCI USA, V97, P4023, DOI 10.1073/pnas.97.8.4023; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490	56	57	57	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5080	5091		10.1096/fj.10-166306	http://dx.doi.org/10.1096/fj.10-166306			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20724523				2022-12-25	WOS:000284824400046
J	Li, B; Castano, AP; Hudson, TE; Nowlin, BT; Lin, SL; Bonventre, JV; Swanson, KD; Duffield, JS				Li, Bing; Castano, Ana P.; Hudson, Thomas E.; Nowlin, Brian T.; Lin, Shuei-Liong; Bonventre, Joseph V.; Swanson, Kenneth D.; Duffield, Jeremy S.			The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair	FASEB JOURNAL			English	Article						autophagy; macrophages; phagocytosis	EPITHELIAL-CELLS; APOPTOTIC CELLS; KIDNEY INJURY; DICTYOSTELIUM-DISCOIDEUM; PHAGOSOME MATURATION; THERAPEUTIC TARGET; IN-VIVO; MACROPHAGES; AUTOPHAGY; PATHWAY	Kidney damage due to injury rarely resolves completely, and there are currently no therapies capable of promoting repair. In addition to understanding mechanisms by which tissues are damaged, illuminating mechanisms of repair and regeneration is also of great importance. Here we show that the melanoma-associated, transmembrane glycoprotein, Gpnmb, is up-regulated 15-fold following ischemic damage in kidney tissue and by more than 10-fold in macrophages and 3-fold in surviving epithelial cells. Gpnmb-expressing macrophages and epithelial cells were found to contain apoptotic bodies at 3 times the rate of non-expressing cells. Either mutation of Gpnmb or ablation of inflammatory macrophages prevents normal repair of the kidney. Significantly, the kidneys from postischemic Gpnmb mutant mice exhibited a 5-fold increase in apoptotic cellular debris compared to wild-type mice. These mice also experienced an 85% increase in mortality following bilateral ischemic kidney. Finally, we demonstrate that Gpnmb is a phagocytic protein that is necessary for recruitment of the autophagy protein LC3 to the phagosome where these proteins are colocalized and for lysosomal fusion with the phagosome and hence bulk degradation of their content. Therefore, Gpnmb is a novel prorepair gene that is necessary for crosstalk between the macroautophagic degradation pathway and phagocytosis.-Li, B., Castano, A. P., Hudson, T. E., Nowlin, B. T., Lin, S.-L., Bonventre, J. V., Swanson, K. D., Duffield, J. S. The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. FASEB J. 24, 4767-4781 (2010). www.fasebj.org	[Duffield, Jeremy S.] Brigham & Womens Hosp, Inflammat Res Lab, Div Renal, Boston, MA 02115 USA; [Li, Bing; Castano, Ana P.; Hudson, Thomas E.; Nowlin, Brian T.; Lin, Shuei-Liong; Bonventre, Joseph V.; Duffield, Jeremy S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Li, Bing] Harbin Med Coll, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China; [Swanson, Kenneth D.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harbin Medical University; Harvard University; Beth Israel Deaconess Medical Center	Duffield, JS (corresponding author), Brigham & Womens Hosp, Inflammat Res Lab, Div Renal, 5th Floor,4 Blackfan Circle, Boston, MA 02115 USA.	kswanson@bidmc.harvard.edu; jduffield@rics.bwh.harvard.edu	Lin, Shuei-Liong/AGR-2002-2022	Lin, Shuei-Liong/0000-0002-1041-5571	U.S. National Institutes of Health (NIH) [DK073299, DK84077]; American Society of Nephrology; Kidney Research UK; NIH [GM041890]; Genzyme Renal Initiatives Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084077, R01DK072381, K08DK073299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890, R37GM041890] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; Kidney Research UK(Kidney Research UK (KRUK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Renal Initiatives Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Ira Tabas (Columbia University, New York, NY, USA) for advice, Dr. Eileen O'Leary [Harvard Medical School (HMS)] for assistance with constructs, Dr. Peter Libby (HMS) and Galina Sukhova (HMS) for mouse aorta tissue sections, Dr. Noburu Mizushima (Tokyo Metropolitan Institutes of Science, Tokyo, Japan) for the LC3-EGFP-C1 construct, Dr. Jagesh S. Shah (HMS) for the RFP construct, Dr. Ben Humphreys (HMS) for KIM-1-GFP vector, Dr. Toshio Kitamura (University of Tokyo, Tokyo, Japan) for pMXs-puro vector, Dr. Martin Pollak (HMS) and Dr. Johannes Schlondorff (HMS) for advice, Dr. Joel Henderson and Dr. Helmut Rennke (HMS) for assistance with electronmicroscopy, and Dr. Lewis Cantley for his support of K. D. S. This work was supported by U.S. National Institutes of Health (NIH) grants DK073299 and DK84077, a Gottschalk award from the American Society of Nephrology, Genzyme Renal Initiatives Program, and a Kidney Research UK Senior Fellowship. K.D.S. was supported by an NIH grant (GM041890) to Lewis C. Cantley.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arnoult D, 2001, MOL BIOL CELL, V12, P3016, DOI 10.1091/mbc.12.10.3016; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Castano AP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000111; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Hanayama R, 2006, CURR DIRECT AUTOIMMU, V9, P162; HOASHI T, FASEB J, V24, P1616; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; ICHIMURA T, 2004, J AM SOC NEPHROL, V15, pA716; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; KEVANY BM, PHYSL BETHESDA, V25, P8; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Oda T, 1998, KIDNEY INT, V53, P1190, DOI 10.1046/j.1523-1755.1998.00886.x; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rees AJ, 2008, NEPHROL DIAL TRANSPL, V23, P3394, DOI 10.1093/ndt/gfn480; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; SIGEL MB, 1983, METHOD ENZYMOL, V93, P3; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	42	92	95	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4767	4781		10.1096/fj.10-154757	http://dx.doi.org/10.1096/fj.10-154757			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20709912	Green Published			2022-12-25	WOS:000284824400017
J	Kanai, M; Crowe, MS; Zheng, Y; Vande Woude, GF; Fukasawa, K				Kanai, M.; Crowe, M. S.; Zheng, Y.; Vande Woude, G. F.; Fukasawa, K.			RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication	ONCOGENE			English	Article						centrosome; Rho; ROCK II; CDK2; cyclin E; NPM/B23	CDK2/CYCLIN E; KINASE; GTPASES; NUCLEOPHOSMIN/B23; INVOLVEMENT; TARGET; CYCLE; CDK2	CDK2-cyclin E triggers centrosome duplication, and nucleophosmin (NPM/B23) is found to be one of its targets. NPM/B23 phosphorylated by CDK2-cyclin E acquires a high binding affinity to Rho-associated kinase (ROCK II), and physically associates with ROCK II. The NPM/B23-binding results in superactivation of ROCK II, which is a critical event for initiation of centrosome duplication. The activation of ROCK II also requires the binding of Rho small GTPase to the auto-inhibitory region; hence the availability of the active Rho protein is an important aspect of the centrosomally localized ROCK II to properly initiate centrosome duplication. There are three isoforms of Rho (RhoA, B and C), all of which are capable of binding to and priming the activation of ROCK II. Here, we investigated which Rho isoform(s) are involved in the activation of ROCK II in respect to the initiation of centrosome duplication. We found that both RhoA and RhoC, but not RhoB, were required for initiation of centrosome duplication, and overactivation of RhoA, as well as RhoC, but not RhoB, promoted centrosome duplication and centrosome amplification. Oncogene (2010) 29, 6040 6050; doi:10.1038/onc.2010.328; published online 9 August 2010	[Kanai, M.; Crowe, M. S.; Fukasawa, K.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; [Zheng, Y.] Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol, Cincinnati, OH USA; [Zheng, Y.] Univ Cincinnati, Childrens Hosp Res Fdn, Mol Dev Biol Program, Cincinnati, OH USA; [Vande Woude, G. F.] Van Andel Res Inst, Grand Rapids, MI USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Van Andel Institute	Fukasawa, K (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, 12902 Magnolia Dr,SRB 2, Tampa, FL 33612 USA.	Kenji.Fukasawa@moffitt.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Crowe, Matthew/0000-0001-5251-0238	National Institute of Health [CA90522]; James & Esther King Biomedical Research Program [09KN-05-23139]; NATIONAL CANCER INSTITUTE [R01CA090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087328] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James & Esther King Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M Rowland and B Nepon-Sixt for technical assistance and core staff at the analytical microscopy core facility and molecular biology core facility in H Lee Moffitt Cancer Center. We also thank Dr Sebti for providing RhoB cDNA. This study is supported by the National Institute of Health (CA90522 to KF) and James & Esther King Biomedical Research Program (09KN-05-23139 to MK).	Aoki T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-56; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Chevrier V, 2002, J CELL BIOL, V157, P807, DOI 10.1083/jcb.200203034; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Hinchcliffe EH, 2002, ONCOGENE, V21, P6154, DOI 10.1038/sj.onc.1205826; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Kabuyama Y, 2009, MOL CELL PROTEOMICS, V8, P2308, DOI 10.1074/mcp.M900178-MCP200; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Milia J, 2005, CELL DEATH DIFFER, V12, P492, DOI 10.1038/sj.cdd.4401586; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Reed SI, 1997, CANCER SURV, V29, P7; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Salisbury JL, 2007, J CELL PHYSIOL, V213, P420, DOI 10.1002/jcp.21226; Shinomiya N, 2004, CANCER RES, V64, P7962, DOI 10.1158/0008-5472.CAN-04-1043; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tarapore P, 2002, CELL CYCLE, V1, P75, DOI 10.4161/cc.1.1.103; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang L, 2003, J BIOL CHEM, V278, P44617, DOI 10.1074/jbc.M308929200; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wolf A, 2006, NAT CELL BIOL, V8, P1432, DOI 10.1038/ncb1504	39	10	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	45					6040	6050		10.1038/onc.2010.328	http://dx.doi.org/10.1038/onc.2010.328			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	678VA	20697357	Green Accepted			2022-12-25	WOS:000284108700006
J	Liu, Y; Chen, N; Cui, X; Zheng, X; Deng, L; Price, S; Karantza, V; Minden, A				Liu, Y.; Chen, N.; Cui, X.; Zheng, X.; Deng, L.; Price, S.; Karantza, V.; Minden, A.			The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis	ONCOGENE			English	Article						Pak4; mammary epithelial cells; breast cancer; apoptosis; cell survival	ANCHORAGE-INDEPENDENT GROWTH; EPITHELIAL ACINI; CELL POLARITY; CANCER; APOPTOSIS; RECEPTOR; ACTIVATION; SURVIVAL; BINDING; MODEL	The Pak4 serine/threonine kinase is highly expressed in many cancer cell lines and human tumors. Although several studies have addressed the role for Pak4 in transformation of fibroblasts, most human cancers are epithelial in origin. Epithelial cancers are associated not only with changes in cell growth but also with changes in the cellular organization within the three-dimensional (3D) architecture of the affected tissues. In this study we used immortalized mouse mammary epithelial cells (iMMECs) as a model system to study the role for Pak4 in mammary tumorigenesis. iMMECs are an excellent model system for studying breast cancer, as they can grow in 3D-epithelial cell culture, in which they form acinar structures that recapitulate in vivo mammary morphogenesis. Although Pak4 is expressed at low levels in wild-type iMMECs, it is overexpressed in response to oncogenes, such as oncogenic Ras and Her2/neu. In this study we found that overexpression of Pak4 in iMMECs leads to changes in 3D acinar architecture that are consistent with oncogenic transformation. These include decreased central acinar cell death, abrogation of lumen formation, cell polarity alterations and deregulation of acinar size and cell number. Furthermore, iMMECs overexpressing Pak4 form tumors when implanted into the fat pads of athymic mice. Our results suggest that overexpression of Pak4 triggers events that are important for the transformation of mammary epithelial cells. This is likely to be owing to the ability of Pak4 to inhibit apoptosis and promote cell survival and thus subsequent uncontrolled proliferation, and to its ability to deregulate cell shape and polarity. Oncogene (2010) 29, 5883-5894; doi:10.1038/onc.2010.329; published online 9 August 2010	[Liu, Y.; Cui, X.; Zheng, X.; Minden, A.] Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Chen, N.; Price, S.; Karantza, V.] Canc Inst New Jersey, Dept Med, New Brunswick, NJ USA; [Chen, N.; Karantza, V.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Med Oncol, Dept Internal Med, Piscataway, NJ 08854 USA; [Deng, L.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Minden, A (corresponding author), Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernest Mario Sch Pharm, 164 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	aminden@rci.rutgers.edu	Chen, Ning/AAM-9513-2021	Chen, Ning/0000-0002-8191-6744	 [R01 CA076342];  [R00 CA133181]; NATIONAL CANCER INSTITUTE [R00CA133181, R01CA076342] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Chung S Yang and Dr Zhihong Yang for providing human colon cancer cell lines. This work was supported by R01 CA076342 to AM and R00 CA133181 to VK.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Chandramouly G, 2007, J CELL SCI, V120, P1596, DOI 10.1242/jcs.03439; Chen SY, 2008, COMMUN COMPUT PHYS, V4, pI; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Degenhardt K, 2006, CLIN CANCER RES, V12, P5298, DOI 10.1158/1078-0432.CCR-06-0439; Gnesutta N, 2003, MOL CELL BIOL, V23, P7838, DOI 10.1128/MCB.23.21.7838-7848.2003; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Karantza-Wadsworth V, 2008, METHOD ENZYMOL, V446, P61, DOI 10.1016/S0076-6879(08)01604-2; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Konska G, 1998, INT J ONCOL, V12, P361; Li XF, 2005, J BIOL CHEM, V280, P41192, DOI 10.1074/jbc.M506884200; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	22	50	53	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2010	29	44					5883	5894		10.1038/onc.2010.329	http://dx.doi.org/10.1038/onc.2010.329			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	675PS	20697354	Green Accepted			2022-12-25	WOS:000283843400003
J	Titz, B; Low, T; Komisopoulou, E; Chen, SS; Rubbi, L; Graeber, TG				Titz, B.; Low, T.; Komisopoulou, E.; Chen, S. S.; Rubbi, L.; Graeber, T. G.			The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization	ONCOGENE			English	Article						adaptor protein; BCR-ABL1; phospho-complex; quantitative mass spectrometry; signaling network; systems biology	CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; BCR-ABL KINASE; ADAPTER PROTEIN; PARKINSONS-DISEASE; NEGATIVE REGULATOR; MASS-SPECTROMETRY; TYROSINE KINASE; BINDING-SITE	BCR-ABL1 is a fusion tyrosine kinase, which causes multiple types of leukemia. We used an integrated proteomic approach that includes label-free quantitative protein complex and phosphorylation profiling by mass spectrometry to systematically characterize the proximal signaling network of this oncogenic kinase. The proximal BCR-ABL1 signaling network shows a modular and layered organization with an inner core of three leukemia transformation-relevant adaptor protein complexes (Grb2/Gab2/Shc1 complex, CrkI complex and Dok1/Dok2 complex). We introduced an 'interaction directionality' analysis, which annotates static protein networks with information on the directionality of phosphorylation-dependent interactions. In this analysis, the observed network structure was consistent with a step-wise phosphorylation-dependent assembly of the Grb2/Gab2/Shc1 and the Dok1/Dok2 complexes on the BCR-ABL1 core. The CrkI complex demonstrated a different directionality, which supports a candidate assembly on the Nedd9 (Hef1, CasL) scaffold. As adaptor protein family members can compensate for each other in leukemic transformation, we compared members of the Dok and Crk protein families and found both overlapping and differential binding patterns. We identified an additional level of regulation for the CrkII protein via binding to 14-3-3 proteins, which was independent from its inhibitory phosphorylation. We also identified novel components of the inner core complexes, including the kinases Pragmin (Sgk223) and Lrrk1 (Lrrk2 paralog). Pragmin was found as a component of the CrkI complex and is a potential link between BCR-ABL1/CrkI and RhoA signaling. Lrrk1 is an unusual kinase with a GTPase domain. We detected Lrrk1 as a component of the Grb2/Gab2/Shc1 complex and found that it functionally interacts with the regulator of small GTPases Arap1 (Centd2) and possibly participates in the mitogen-activated protein kinase response to cellular stresses. This modular and phosphorylation-driven interaction network provides a framework for the integration of pleiotropic signaling effects of BCR-ABL1 toward leukemic transformation. Oncogene (2010) 29, 5895-5910; doi:10.1038/onc.2010.331; published online 9 August 2010	[Titz, B.; Low, T.; Komisopoulou, E.; Chen, S. S.; Rubbi, L.; Graeber, T. G.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging, Calif Nanosyst Inst,Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Graeber, TG (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging, Calif Nanosyst Inst,Jonsson Comprehens Canc Ctr, 570 Westwood Plaza,Bldg 114, Los Angeles, CA 90095 USA.	tgraeber@mednet.ucla.edu	Titz, Bjoern/G-6317-2017; Titz, Björn/B-9516-2008	Titz, Bjoern/0000-0003-4414-4105; Graeber, Thomas/0000-0001-8574-9181	NIH NHGRI [HG002807]; University of California, Cancer Research Coordinating Committee; German Academic Exchange Service; UCLA, USHHS [T32 CA009056]; NATIONAL CANCER INSTITUTE [T32CA009056] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG002807] Funding Source: NIH RePORTER	NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of California, Cancer Research Coordinating Committee(University of California System); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); UCLA, USHHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by grants to TGG from the NIH NHGRI (HG002807) and the University of California, Cancer Research Coordinating Committee, and by postdoctoral fellowships of the German Academic Exchange Service to BT and the UCLA Tumor Biology Program USHHS Ruth L Kirschstein Institutional National Research Service Award # T32 CA009056 to SSC. TGG is an Alfred P Sloan Research Fellow. We thank M Negishi, D Korr and T Burckstummer for kindly providing plasmids. Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center and Center for AIDS Research Flow Cytometry Core.	Altun-Gultekin ZF, 1998, MOL CELL BIOL, V18, P3044, DOI 10.1128/MCB.18.5.3044; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; BAIER T, 2009, R D COM SERVER; Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Daniele T, 2008, TRAFFIC, V9, P2221, DOI 10.1111/j.1600-0854.2008.00823.x; de Jong R, 1997, J BIOL CHEM, V272, P32649, DOI 10.1074/jbc.272.51.32649; Di Cristofano A, 2001, J EXP MED, V194, P275, DOI 10.1084/jem.194.3.275; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Faisal A, 2004, J BIOL CHEM, V279, P3202, DOI 10.1074/jbc.M310010200; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Goss VL, 2006, BLOOD, V107, P4888, DOI 10.1182/blood-2005-08-3399; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Graeber TG, 2010, P NATL ACAD SCI USA, V107, P6112, DOI 10.1073/pnas.1001149107; Harada JN, 2005, GENOME RES, V15, P1136, DOI 10.1101/gr.3889305; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; Hemmeryckx B, 2002, ONCOGENE, V21, P3225, DOI 10.1038/sj.onc.1205452; Heo HY, 2010, EXP CELL RES, V316, P649, DOI 10.1016/j.yexcr.2009.09.014; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Hughan SC, 2007, J THROMB HAEMOST, V5, P387, DOI 10.1111/j.1538-7836.2007.02307.x; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Johnson KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007439; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Kantarjian HM, 2007, CLIN CANCER RES, V13, P1089, DOI 10.1158/1078-0432.CCR-06-2147; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Korr D, 2006, CELL SIGNAL, V18, P910, DOI 10.1016/j.cellsig.2005.08.015; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Liou AKF, 2008, NEUROBIOL DIS, V32, P116, DOI 10.1016/j.nbd.2008.06.016; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Million RP, 2000, BLOOD, V96, P664; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; NICHOLS GL, 1994, BLOOD, V84, P2912; Niki M, 2004, J EXP MED, V200, P1689, DOI 10.1084/jem.20041306; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; ODA T, 1994, J BIOL CHEM, V269, P22925; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Pflieger D, 2008, MOL CELL PROTEOMICS, V7, P326, DOI 10.1074/mcp.M700282-MCP200; Prakash A, 2006, MOL CELL PROTEOMICS, V5, P423, DOI 10.1074/mcp.M500133-MCP200; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; R Development Core Team, 2009, R FDN STAT COMP; Raetz EA, 2008, J CLIN ONCOL, V26, P3971, DOI 10.1200/JCO.2008.16.1414; Ramshaw HS, 2007, BLOOD, V110, P3582, DOI 10.1182/blood-2007-01-070391; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Sarmann J, 2009, J BIOL CHEM, V284, P16482, DOI 10.1074/jbc.M808255200; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Sasaoka T, 2001, ENDOCRINOLOGY, V142, P5226, DOI 10.1210/en.142.12.5226; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Sonoyama J, 2002, J BIOL CHEM, V277, P8076, DOI 10.1074/jbc.M111501200; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Yasuda T, 2004, J EXP MED, V200, P1681, DOI 10.1084/jem.20041247; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x; Yu WD, 2008, CARCINOGENESIS, V29, P1717, DOI 10.1093/carcin/bgn098; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	92	33	33	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	44					5895	5910		10.1038/onc.2010.331	http://dx.doi.org/10.1038/onc.2010.331			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	675PS	20697350	Green Accepted			2022-12-25	WOS:000283843400004
J	Coon, BG; Burgner, J; Camonis, JH; Aguilar, RC				Coon, Brian G.; Burgner, John; Camonis, Jacques H.; Aguilar, R. Claudio			The Epsin Family of Endocytic Adaptors Promotes Fibrosarcoma Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; RAL-BINDING PROTEIN-1; ACTIN CYTOSKELETON; PUTATIVE EFFECTOR; PROSTATE-CANCER; CELL-MIGRATION; CLATHRIN; RLIP76; IDENTIFICATION; DOMAIN	Abnormalities in the process of endocytosis are classically linked to malignant transformation through the deficient down-regulation of signaling receptors. The present study describes a non-classical mechanism that does not require internalization by which endocytic proteins affect cell migration and basement membrane invasion. Specifically, we found that the endocytic adaptor epsin binds and regulates the biological properties of the signaling molecule RalBP1 (Ral-binding protein 1). Epsin interacted with the N terminus of RalBP1 via its characteristic epsin N-terminal homology (ENTH) domain. A combination of siRNA-mediated knock-down and transfection of siRNA-resistant constructs in fibrosarcoma cells demonstrated that impairment of the epsin-RalBP1 interaction led to cell migration and basement membrane invasion defects. We found the ENTH domain was necessary and sufficient to sustain normal cell migration and invasion. Because all the epsin endocytic motifs reside in the C-terminal part of the molecule, these results suggest that this novel regulatory circuit does not require endocytosis. In addition, cells depleted of epsin-RalBP1 complex displayed deficient activation of Rac1 and Arf6 suggesting a signaling function for this novel interaction. Further, overexpression of either epsin or RalBP1 enhanced migration and invasion of fibrosarcoma cells. Collectively, our results indicate that epsin regulates RalBP1 function in Rac1-and Arf6-dependent pathways to ultimately affect cell migration and invasion. We propose that the observed up-regulation of both epsin and RalBP1 in certain cancers contributes to their invasive characteristics.	[Coon, Brian G.; Aguilar, R. Claudio] Purdue Univ, Dept Biol Sci, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Burgner, John] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Camonis, Jacques H.] Inst Curie, F-75248 Paris 05, France; [Camonis, Jacques H.] Inserm U830, F-75248 Paris 05, France	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Aguilar, RC (corresponding author), 201 S Univ Dr,Hansen Life Sci Bldg,Room 321, W Lafayette, IN 47907 USA.	Claudio@purdue.edu			American Cancer Society-Purdue Center for Cancer Research; Dept. of Biological Sciences, Purdue University	American Cancer Society-Purdue Center for Cancer Research; Dept. of Biological Sciences, Purdue University	This work was supported by an American Cancer Society-Purdue Center for Cancer Research institutional grant and by start-up funds from the Dept. of Biological Sciences, Purdue University (to R. C. A.).	Aguilar RC, 2006, P NATL ACAD SCI USA, V103, P4116, DOI 10.1073/pnas.0510513103; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; Boissel L, 2007, DEV BIOL, V312, P331, DOI 10.1016/j.ydbio.2007.09.027; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Coon BG, 2009, HUM MOL GENET, V18, P4478, DOI 10.1093/hmg/ddp407; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Homayouni R, 2003, MOL BRAIN RES, V115, P121, DOI 10.1016/S0169-328X(03)00176-1; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Lebreton S, 2004, MECH DEVELOP, V121, P1481, DOI 10.1016/j.mod.2004.07.008; Mukherjee D, 2009, J CELL SCI, V122, P2453, DOI 10.1242/jcs.041137; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Natsume W, 2006, MOL BIOL CELL, V17, P2592, DOI 10.1091/mbc.E05-10-0909; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Northup John, 2004, Methods Mol Biol, V261, P93; Oosterhoff JK, 2003, ONCOGENE, V22, P2920, DOI 10.1038/sj.onc.1206397; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Park SH, 1995, ONCOGENE, V11, P2349; Pawlowski KM, 2009, J PHYSIOL PHARMACOL, V60, P85; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Rosse C, 2003, J BIOL CHEM, V278, P30597, DOI 10.1074/jbc.M302191200; Sakakibara T, 2004, FEBS LETT, V566, P294, DOI 10.1016/j.febslet.2004.03.101; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Singhal SS, 2008, FEBS LETT, V582, P3408, DOI 10.1016/j.febslet.2008.09.001; Singhal SS, 2007, CANCER RES, V67, P4382, DOI 10.1158/0008-5472.CAN-06-4124; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P1074, DOI 10.1016/j.bcp.2008.11.013; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Spradling KD, 2001, J BIOL CHEM, V276, P29257, DOI 10.1074/jbc.M101663200; Wang JB, 2005, J BIOL CHEM, V280, P22883, DOI 10.1074/jbc.M414375200; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang YC, 2007, P NATL ACAD SCI USA, V104, P8328, DOI 10.1073/pnas.0701103104; Wang YH, 2006, MOL PHARMACEUT, V3, P566, DOI 10.1021/mp060002b; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Yadav S, 2004, BIOCHEMISTRY-US, V43, P16243, DOI 10.1021/bi0482811	50	24	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33073	33081		10.1074/jbc.M110.124123	http://dx.doi.org/10.1074/jbc.M110.124123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20709745	Green Published, hybrid			2022-12-25	WOS:000283048200045
J	Choi, YK; Kim, CK; Lee, H; Jeoung, D; Ha, KS; Kwon, YG; Kim, KW; Kim, YM				Choi, Yoon Kyung; Kim, Chun-Ki; Lee, Hansoo; Jeoung, Dooil; Ha, Kwon-Soo; Kwon, Young-Guen; Kim, Kyu-Won; Kim, Young-Myeong			Carbon Monoxide Promotes VEGF Expression by Increasing HIF-1 alpha Protein Level via Two Distinct Mechanisms, Translational Activation and Stabilization of HIF-1 alpha Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-I; HEME OXYGENASE; ANGIOGENIC ACTIVITY; GENE-TRANSFER; HIF-ALPHA; HYPOXIA; CELLS; INHIBITION; KINASE	Carbon monoxide (CO) plays a significant role in vascular functions. We here examined the molecular mechanism by which CO regulates HIF-1 (hypoxia-inducible transcription factor-1)-dependent expression of vascular endothelial growth factor (VEGF), which is an important angiogenic factor. We found that astrocytes stimulated with CORM-2 (CO-releasing molecule) promoted angiogenesis by increasing VEGF expression and secretion. CORM-2 also induced HO-1 (hemeoxygenase-1) expression and increased nuclear HIF-1 alpha protein level, without altering its promoter activity and mRNA level. VEGF expression was inhibited by treatment with HIF-1 alpha siRNA and a hemeoxygenase inhibitor, indicating that CO stimulates VEGF expression via up-regulation of HIF-1 alpha protein level, which is partially associated with HO-1 induction. CORM-2 activated the translational regulatory proteins p70(S6k) and eIF-4E as well as phosphorylating their upstream signal mediators Akt and ERK. These translational signal events and HIF-1 alpha protein level were suppressed by inhibitors of phosphatidylinositol 3-kinase (PI3K), MEK, and mTOR, suggesting that the PI3K/Akt/mTOR and MEK/ERK pathways are involved in a translational increase in HIF-1 alpha. In addition, CORM-2 also increased stability of the HIF-1 alpha protein by suppressing its ubiquitination, without altering the proline hydroxylase-dependent HIF-1 alpha degradation pathway. CORM-2 increased HIF-1 alpha/HSP90 alpha interaction, which is responsible for HIF-1 alpha stabilization, and HSP90-specific inhibitors decreased this interaction, HIF-1 alpha protein level, and VEGF expression. Furthermore, HSP90 alpha knockdown suppressed CORM-2-induced increases in HIF-1 alpha and VEGF protein levels. These results suggest that CO stimulates VEGF production by increasing HIF-1 alpha protein level via two distinct mechanisms, translational stimulation and protein stabilization of HIF-1 alpha.	[Choi, Yoon Kyung; Kim, Chun-Ki; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Dept Chem, Vasc Syst Res Ctr, Chunchon 200701, Kangwon Do, South Korea; [Choi, Yoon Kyung; Kim, Chun-Ki; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Kangwon Do, South Korea; [Lee, Hansoo; Jeoung, Dooil] Kangwon Natl Univ, Div Biol Sci, Coll Nat Sci, Chunchon 200701, Kangwon Do, South Korea; [Kwon, Young-Guen] Yonsei Univ, Dept Biochem, Coll Sci, Seoul 120749, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, NeuroVasc Coordinat Res Ctr, Coll Pharm, Seoul 151742, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Yonsei University; Seoul National University (SNU); Seoul National University (SNU)	Kim, YM (corresponding author), Kangwon Natl Univ, Dept Chem, Vasc Syst Res Ctr, Chunchon 200701, Kangwon Do, South Korea.	ymkim@kangwon.ac.kr	Choi, Yoon Kyung/AGX-0481-2022; Kim, Kyu Won/AAJ-7213-2020; Ha, Kwon-Soo/AAU-4417-2020	Choi, Yoon Kyung/0000-0003-0242-9612; Kim, Chunki/0000-0003-2410-9118; Ha, Kwon-Soo/0000-0002-4219-1787	Korea Science and Engineering Foundation [2009-0062785]; Korean government	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean government(Korean Government)	This work was supported by Korea Science and Engineering Foundation Grant 2009-0062785 and a grant from the Korea Research Foundation (Regional Research Universities Program/Medical and Bio-Materials Research Center) funded by the Korean government.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; BALLA G, 1992, J BIOL CHEM, V267, P18148; Battish R, 2000, AM J PHYSIOL-GASTR L, V278, pG148, DOI 10.1152/ajpgi.2000.278.1.G148; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Calabrese V, 2004, ANTIOXID REDOX SIGN, V6, P895, DOI 10.1089/1523086041798051; Chauveau C, 2002, AM J TRANSPLANT, V2, P581, DOI 10.1034/j.1600-6143.2002.20702.x; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; COUNTS DF, 1978, P NATL ACAD SCI USA, V75, P2145, DOI 10.1073/pnas.75.5.2145; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Deramaudt BMJM, 1998, J CELL BIOCHEM, V68, P121, DOI 10.1002/(SICI)1097-4644(19980101)68:1<121::AID-JCB12>3.0.CO;2-K; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Foresti R, 2008, INTENS CARE MED, V34, P649, DOI 10.1007/s00134-008-1011-1; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee BS, 2006, BIOCHEM BIOPH RES CO, V343, P965, DOI 10.1016/j.bbrc.2006.03.058; Lee MS, 2001, CANCER RES, V61, P3290; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Leffler CW, 2006, AM J PHYSIOL-HEART C, V291, pH2897, DOI 10.1152/ajpheart.00722.2006; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Moon EJ, 2003, FASEB J, V17, P382, DOI 10.1096/fj.03-0153fje; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Pae HO, 2005, ENDOCRINOLOGY, V146, P2229, DOI 10.1210/en.2004-1431; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; RYTER SW, 2004, SCI STKE, pRE6; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Sunavala-Dossabhoy G, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-1; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848	54	112	123	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32116	32125		10.1074/jbc.M110.131284	http://dx.doi.org/10.1074/jbc.M110.131284			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20724477	Green Published, hybrid			2022-12-25	WOS:000282683000025
J	Behrens, ME; Grandgenett, PM; Bailey, JM; Singh, PK; Yi, CH; Yu, F; Hollingsworth, MA				Behrens, M. E.; Grandgenett, P. M.; Bailey, J. M.; Singh, P. K.; Yi, C-H; Yu, F.; Hollingsworth, M. A.			The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF	ONCOGENE			English	Article						MUC1; CTGF; signal transduction; transcriptional activation; pancreatic cancer	TISSUE-GROWTH-FACTOR; CARCINOMA-ASSOCIATED ANTIGEN; CYTOPLASMIC TAIL; IN-VITRO; C-SRC; CANCER; BETA; EXPRESSION; CELLS; P53	The MUC1 cytoplasmic tail (MUC1.CT) conducts signals from spatial and extracellular cues (growth factor and cytokine stimulation) to evoke a reprogramming of the cellular transcriptional profile. Specific phosphorylated forms of the MUC1.CT achieve this function by differentially associating with transcription factors and redirecting their transcriptional regulatory capabilities at specific gene regulatory elements. The specificity of interaction between MUC1.CT and several transcription factors is dictated by the phosphorylation pattern of the 18 potential phosphorylation motifs within the MUC1.CT. To better appreciate the scope of differential gene expression triggered by MUC1.CT activation, we performed microarray gene expression analysis and chromatin immunoprecipitation (ChIP)-chip promoter analysis and identified the genome-wide transcriptional targets of MUC1.CT signaling in pancreatic cancer. On a global scale, MUC1.CT preferentially targets genes related to invasion, angiogenesis and metastasis, suggesting that MUC1.CT signaling contributes to establishing a reactive tumor microenvironment during tumor progression to metastatic disease. We examined in detail the molecular mechanisms of MUC1.CT signaling that induces the expression of connective tissue growth factor (CTGF/CCN2), a potent mediator of ECM remodeling and angiogenesis. We demonstrate a robust induction of CTGF synthesis and secretion in response to serum factors that is enabled only when MUC1 is highly expressed. We demonstrate the requirement of phosphorylation at distinct tyrosine motifs within the MUC1.CT for MUC1-induced CTGF expression and demonstrate a phosphorylation-specific localization of MUC1.CT to the CTGF promoter. We found that MUC1 reorganizes transcription factor occupancy of genomic regions upstream of the CTGF gene, directing beta-catenin and mutant p53 to CTGF gene regulatory elements to promote CTGF expression and destabilizing the interaction at these regions of the transcriptional repressor, c-Jun. With this example we illustrate the capacity of MUC1.CT to mediate transcription factor activity in a context-dependent manner to achieve wide spread and robust changes in gene expression and facilitate creation of the reactive tumor microenvironment. Oncogene (2010) 29, 5667-5677; doi:10.1038/onc.2010.327; published online 9 August 2010	[Behrens, M. E.; Grandgenett, P. M.; Bailey, J. M.; Singh, P. K.; Yi, C-H; Hollingsworth, M. A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Behrens, M. E.; Singh, P. K.; Hollingsworth, M. A.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Yu, F.] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Hollingsworth, MA (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	mahollin@unmc.edu	Yu, Fang/B-9874-2013	Bailey-Lundberg, Jennifer/0000-0002-4750-106X; Singh, Pankaj/0000-0001-8903-0131	NCI NIH HHS [P50 CA127297, R01 CA057362, U01 CA111294] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA127297, U01CA111294, R01CA057362] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agata N, 2008, CANCER RES, V68, P6136, DOI 10.1158/0008-5472.CAN-08-0464; Aikawa T, 2006, MOL CANCER THER, V5, P1108, DOI 10.1158/1535-7163.MCT-05-0516; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Carson DD, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127pe35; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Gao JC, 2009, INT J ONCOL, V35, P337, DOI 10.3892/ijo_00000345; Gatto M, 2008, LAB INVEST, V88, P986, DOI 10.1038/labinvest.2008.63; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Husson H, 2002, BLOOD, V99, P282, DOI 10.1182/blood.V99.1.282; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Masaki Y, 1999, HEPATO-GASTROENTEROL, V46, P2240; Masuko Kayo, 2010, BMC Res Notes, V3, P5, DOI 10.1186/1756-0500-3-5; McDermott KM, 2001, INT J CANCER, V94, P783, DOI 10.1002/ijc.1554; Pemberton LF, 1996, J BIOL CHEM, V271, P2332, DOI 10.1074/jbc.271.4.2332; Qu CF, 2004, BRIT J CANCER, V91, P2086, DOI 10.1038/sj.bjc.6602232; Raina D, 2008, CANCER BIOL THER, V7, P1959, DOI 10.4161/cbt.7.12.6956; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Sun YB, 2004, J CELL BIOCHEM, V92, P258, DOI 10.1002/jcb.20044; Takagi J, 2002, BIOCHEMISTRY-US, V41, P4339, DOI 10.1021/bi016047u; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; Yang DH, 1998, J CLIN ENDOCR METAB, V83, P2593, DOI 10.1210/jc.83.7.2593; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478; Yuan ZL, 2009, J SURG RES, V157, pE39, DOI 10.1016/j.jss.2008.09.005; Zarrinkalam KH, 2003, KIDNEY INT, V64, P331, DOI 10.1046/j.1523-1755.2003.00069.x	39	59	61	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	42					5667	5677		10.1038/onc.2010.327	http://dx.doi.org/10.1038/onc.2010.327			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	668IT	20697347	Green Accepted			2022-12-25	WOS:000283262500003
J	Bohbot, JD; Dickens, JC				Bohbot, Jonathan D.; Dickens, Joseph C.			Insect Repellents: Modulators of Mosquito Odorant Receptor Activity	PLOS ONE			English	Article							AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; ALLOSTERIC SITE; DEET; DIPTERA; CULICIDAE; OVIPOSITION; INHIBITION; RESPONSES; SS220	Background: DEET, 2-undecanone (2-U), IR3535 and Picaridin are widely used as insect repellents to prevent interactions between humans and many arthropods including mosquitoes. Their molecular action has only recently been studied, yielding seemingly contradictory theories including odorant-dependent inhibitory and odorant-independent excitatory activities on insect olfactory sensory neurons (OSNs) and odorant receptor proteins (ORs). Methodology/Principal Findings: Here we characterize the action of these repellents on two Aedes aegypti ORs, AaOR2 and AaOR8, individually co-expressed with the common co-receptor AaOR7 in Xenopus oocytes; these ORs are respectively activated by the odors indole (AaOR2) and (R)-(2)-1-octen3-ol (AaOR8), odorants used to locate oviposition sites and host animals. In the absence of odorants, DEET activates AaOR2 but not AaOR8, while 2-U activates AaOR8 but not AaOR2; IR3535 and Picaridin do not activate these ORs. In the presence of odors, DEET strongly inhibits AaOR8 but not AaOR2, while 2-U strongly inhibits AaOR2 but not AaOR8; IR3535 and Picaridin strongly inhibit both ORs. Conclusions/Significance: These data demonstrate that repellents can act as olfactory agonists or antagonists, thus modulating OR activity, bringing concordance to conflicting models.	[Bohbot, Jonathan D.; Dickens, Joseph C.] ARS, Invas Insect Biocontrol & Behav Lab, Henry A Wallace Beltsville Agr Res Ctr, Inst Plant Sci,USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Bohbot, JD (corresponding author), ARS, Invas Insect Biocontrol & Behav Lab, Henry A Wallace Beltsville Agr Res Ctr, Inst Plant Sci,USDA, Beltsville, MD USA.	joseph.dickens@ars.usda.gov	Dickens, Dick/AGY-7295-2022		US Department of Defense through the Armed Forces Pest Management Board (AFPMB)	US Department of Defense through the Armed Forces Pest Management Board (AFPMB)(United States Department of Defense)	This work was supported in part by a grant to J.C.D. from the Deployed War Fighter Protection (DWFP) Research Program, funded by the US Department of Defense through the Armed Forces Pest Management Board (AFPMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bissinger BW, 2009, EXP APPL ACAROL, V48, P239, DOI 10.1007/s10493-008-9235-x; Boeckh J, 1996, PESTIC SCI, V48, P359, DOI 10.1002/(SICI)1096-9063(199612)48:4&lt;359::AID-PS490&gt;3.0.CO;2-Z; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Carroll JF, 2005, MED VET ENTOMOL, V19, P101, DOI 10.1111/j.0269-283X.2005.00559.x; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; DAVIS EE, 1976, J COMP PHYSIOL, V105, P43, DOI 10.1007/BF01380052; Debboun M, 2007, INSECT REPELLENTS PR; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Du YJ, 1999, J MED ENTOMOL, V36, P158, DOI 10.1093/jmedent/36.2.158; FARRAR RR, 1987, ENTOMOL EXP APPL, V43, P17, DOI 10.1007/BF00350369; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; Haas Sebastian, 2006, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V15, P127; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hill SR, 2009, CHEM SENSES, V34, P231, DOI 10.1093/chemse/bjn080; Hoffmann EJ, 2003, J MED ENTOMOL, V40, P607, DOI 10.1603/0022-2585-40.5.607; Hoffmann EJ, 2002, J MED ENTOMOL, V39, P935, DOI 10.1603/0022-2585-39.6.935; Hogenkamp DJ, 2007, J MED CHEM, V50, P3369, DOI 10.1021/jm070083v; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Klun JA, 2006, J MED ENTOMOL, V43, P34, DOI 10.1603/0022-2585(2006)043[0034:RADEOS]2.0.CO;2; KUTHIALA A, 1992, J MED ENTOMOL, V29, P639, DOI 10.1093/jmedent/29.4.639; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MCCABE ET, 1954, J ORG CHEM, V19, P493, DOI 10.1021/jo01369a003; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Ng HJ, 2007, P NATL ACAD SCI USA, V104, P8059, DOI 10.1073/pnas.0701321104; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Plettner E, 2010, J AGR FOOD CHEM, V58, P3708, DOI 10.1021/jf904139e; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; SCHRECK CE, 1970, J ECON ENTOMOL, V63, P1576, DOI 10.1093/jee/63.5.1576; Siju KP, 2010, J INSECT PHYSIOL, V56, P659, DOI 10.1016/j.jinsphys.2010.02.002; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; SUMIKAWA K, 1981, NATURE, V292, P862, DOI 10.1038/292862a0; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; WANG G, 2010, PLOS ONE, V4, pE7032; Witting-Bissinger BE, 2008, J MED ENTOMOL, V45, P891, DOI 10.1603/0022-2585(2008)45[891:NARBIA]2.0.CO;2; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	44	94	104	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12138	10.1371/journal.pone.0012138	http://dx.doi.org/10.1371/journal.pone.0012138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20725637	Green Published, gold, Green Submitted			2022-12-25	WOS:000280849100033
J	Cox, B; Briscoe, J; Ulloa, F				Cox, Barny; Briscoe, James; Ulloa, Fausto			SUMOylation by Pias1 Regulates the Activity of the Hedgehog Dependent Gli Transcription Factors	PLOS ONE			English	Article							PROTEIN-KINASE-A; SONIC HEDGEHOG; NEGATIVE REGULATOR; NEURAL-TUBE; SPINAL-CORD; SUPPRESSOR; DEGRADATION; MODIFIER; PHOSPHORYLATION; UBIQUITINATION	Background: Hedgehog (Hh) signaling, a vital signaling pathway for the development and homeostasis of vertebrate tissues, is mediated by members of the Gli family of zinc finger transcription factors. Hh signaling increases the transcriptional activity of Gli proteins, at least in part, by inhibiting their proteolytic processing. Conversely, phosphorylation by cAMP-dependent protein kinase (PKA) inhibits Gli transcriptional activity by promoting their ubiquitination and proteolysis. Whether other post-translational modifications contribute to the regulation of Gli protein activity has been unclear. Methodology/Principal Findings: Here we provide evidence that all three Gli proteins are targets of small ubiquitin-related modifier (SUMO)-1 conjugation. Expression of SUMO-1 or the SUMO E3 ligase, Pias1, increased Gli transcriptional activity in cultured cells. Moreover, PKA activity reduced Gli protein SUMOylation. Strikingly, in the embryonic neural tube, the forced expression of Pias1 increased Gli activity and induced the ectopic expression of the Gli dependent gene Nkx2.2. Conversely, a point mutant of Pias1, that lacks ligase activity, blocked the endogenous expression of Nkx2.2. Conclusions/Significance: Together, these findings provide evidence that Pias1-dependent SUMOylation influences Gli protein activity and thereby identifies SUMOylation as a post-translational mechanism that regulates the hedgehog signaling pathway.	[Cox, Barny; Briscoe, James; Ulloa, Fausto] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Cox, B (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	james.briscoe@nimr.mrc.ac.uk	Ulloa, Fausto/AAB-2787-2019	Briscoe, James/0000-0002-1020-5240	Medical Research Council (United Kingdom); European Molecular Biology Organization; Medical Research Council [MC_U117560541] Funding Source: researchfish; MRC [MC_U117560541] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (United Kingdom). F. U. was supported by an European Molecular Biology Organization Long-Term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Chari NS, 2007, ADV ANAT PATHOL, V14, P344, DOI 10.1097/PAP.0b013e3180ca8a1d; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; PHAM A, 1995, GENETICS, V140, P587; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shimada K, 2008, BONE, V42, P886, DOI 10.1016/j.bone.2008.01.009; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	55	36	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e11996	10.1371/journal.pone.0011996	http://dx.doi.org/10.1371/journal.pone.0011996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711444	gold, Green Published, Green Submitted			2022-12-25	WOS:000280849100003
J	Nakamura, K; Maki, N; Trinh, A; Trask, HW; Gui, JA; Tomlinson, CR; Tsonis, PA				Nakamura, Kenta; Maki, Nobuyasu; Trinh, Albert; Trask, Heidi W.; Gui, Jiang; Tomlinson, Craig R.; Tsonis, Panagiotis A.			miRNAs in Newt Lens Regeneration: Specific Control of Proliferation and Evidence for miRNA Networking	PLOS ONE			English	Article							BREAST-CANCER CELLS; EPITHELIAL-CELLS; MICROARRAY DATA; UP-REGULATION; SELF-RENEWAL; STEM-CELLS; MICRORNA; EXPRESSION; DIFFERENTIATION; GROWTH	Background: Lens regeneration in adult newts occurs via transdifferentiation of the pigment epithelial cells (PECs) of the dorsal iris. The same source of cells from the ventral iris is not able to undergo this process. In an attempt to understand this restriction we have studied in the past expression patterns of miRNAs. Among several miRNAs we have found that mir-148 shows an up-regulation in the ventral iris, while members of the let-7 family showed down-regulation in dorsal iris during dedifferentiation. Methodology/Principal Findings: We have performed gain-and loss-of-function experiments of mir-148 and let-7b in an attempt to delineate their function. We find that up-regulation of mir-148 caused significant decrease in the proliferation rates of ventral PECs only, while up-regulation of let-7b affected proliferation of both dorsal and ventral PECs. Neither miRNA was able to affect lens morphogenesis or induction. To further understand how this effect of miRNA up-regulation is mediated we examined global expression of miRNAs after up-regulation of mir148 and let-7b. Interestingly, we identified a novel level of mirRNA regulation, which might indicate that miRNAs are regulated as a network. Conclusion/Significance: The major conclusion is that different miRNAs can control proliferation in the dorsal or ventral iris possibly by a different mechanism. Of interest is that down-regulation of the let-7 family members has also been documented in other systems undergoing reprogramming, such as in stem cells or oocytes. This might indicate that reprogramming during newt regeneration shares common molecular signatures with reprogramming in stem or germ cells. On the other hand that miRNAs can regulate the levels of other miRNAs is a novel level of regulation, which might provide new insights on their function.	[Nakamura, Kenta; Maki, Nobuyasu; Trinh, Albert; Tsonis, Panagiotis A.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Nakamura, Kenta; Maki, Nobuyasu; Trinh, Albert; Tsonis, Panagiotis A.] Univ Dayton, Ctr Tissue Regenerat & Engn, Dayton, OH 45469 USA; [Trask, Heidi W.; Gui, Jiang; Tomlinson, Craig R.] Dartmouth Coll, Dept Med, Lebanon, NH 03756 USA; [Trask, Heidi W.; Gui, Jiang; Tomlinson, Craig R.] Dartmouth Coll, Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA	University of Dayton; University of Dayton; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Nakamura, K (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.	panagiotis.tsonis@notes.udayton.edu	Tomlinson, Craig/F-1319-2017	Tomlinson, Craig/0000-0003-0923-1449	National Institutes of Health (NIH) [EY10540]; NATIONAL EYE INSTITUTE [R01EY010540] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a National Institutes of Health (NIH) grant EY10540 to PAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Barh D, 2010, CURR ONCOL, V17, P70; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Del Rio-Tsonis K, 2003, DEV DYNAM, V226, P211, DOI 10.1002/dvdy.10224; DILEVA G, 2010, J NATL CANC I; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Faber J, 2008, CANCER CELL, V13, P467, DOI 10.1016/j.ccr.2008.05.013; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Grogg MW, 2005, NATURE, V438, P858, DOI 10.1038/nature04175; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Hayashi T, 2002, DIFFERENTIATION, V70, P101, DOI 10.1046/j.1432-0436.2002.700205.x; HU Y, 2010, INT J CANC; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lan FF, 2010, INT J CANC; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Madhavan M, 2006, P NATL ACAD SCI USA, V103, P14848, DOI 10.1073/pnas.0601949103; Makarev E, 2007, FEBS LETT, V581, P1865, DOI 10.1016/j.febslet.2007.03.082; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; RAMACHANDRAN R, 2009, NEUROREHABILITATION, V23; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; SAWADA K, 1993, JPN J OPHTHALMOL, V37, P355; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Sehm T, 2009, DEV BIOL, V334, P468, DOI 10.1016/j.ydbio.2009.08.008; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; Trask HW, 2009, RNA, V15, P1917, DOI 10.1261/rna.1677409; Tsonis PA, 2004, EXP EYE RES, V78, P161, DOI 10.1016/j.exer.2003.10.022; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Wan HY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-16; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021; Zhao Yue, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P526	54	32	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12058	10.1371/journal.pone.0012058	http://dx.doi.org/10.1371/journal.pone.0012058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711456	Green Submitted, gold, Green Published			2022-12-25	WOS:000280849100011
J	Richlan, F; Sturm, D; Schurz, M; Kronbichler, M; Ladurner, G; Wimmer, H				Richlan, Fabio; Sturm, Denise; Schurz, Matthias; Kronbichler, Martin; Ladurner, Gunther; Wimmer, Heinz			A Common Left Occipito-Temporal Dysfunction in Developmental Dyslexia and Acquired Letter-By-Letter Reading?	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; WHITE-MATTER; BRAIN CONNECTIVITY; CHILDREN; ABNORMALITIES; ORTHOGRAPHY; CORTEX; LENGTH; ENGLISH; FMRI	Background: We used fMRI to examine functional brain abnormalities of German-speaking dyslexics who suffer from slow effortful reading but not from a reading accuracy problem. Similar to acquired cases of letter-by-letter reading, the developmental cases exhibited an abnormal strong effect of length (i.e., number of letters) on response time for words and pseudowords. Results: Corresponding to lesions of left occipito-temporal (OT) regions in acquired cases, we found a dysfunction of this region in our developmental cases who failed to exhibit responsiveness of left OT regions to the length of words and pseudowords. This abnormality in the left OT cortex was accompanied by absent responsiveness to increased sublexical reading demands in phonological inferior frontal gyrus (IFG) regions. Interestingly, there was no abnormality in the left superior temporal cortex which-corresponding to the onological deficit explanation-is considered to be the prime locus of the reading difficulties of developmental dyslexia cases. Conclusions: The present functional imaging results suggest that developmental dyslexia similar to acquired letter-by-letter reading is due to a primary dysfunction of left OT regions.	[Richlan, Fabio; Sturm, Denise; Schurz, Matthias; Kronbichler, Martin; Wimmer, Heinz] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Richlan, Fabio; Sturm, Denise; Schurz, Matthias; Kronbichler, Martin; Wimmer, Heinz] Salzburg Univ, Ctr Neurocognit Res, A-5020 Salzburg, Austria; [Richlan, Fabio; Kronbichler, Martin; Ladurner, Gunther] Paracelsus Private Med Univ, Dept Neurol, Christian Doppler Clin, Salzburg, Austria	Salzburg University; Salzburg University; Paracelsus Private Medical University	Richlan, F (corresponding author), Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria.	fabio.richlan@sbg.ac.at	Richlan, Fabio/C-6285-2008; Kronbichler, Martin/A-5599-2008; Kronbichler, Martin/AAY-1519-2021	Richlan, Fabio/0000-0001-5373-3425; Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Schurz, Matthias/0000-0002-6344-9943	Austrian Science Foundation [P18832-B02]; European Union	Austrian Science Foundation(Austrian Science Fund (FWF)); European Union(European Commission)	This research was supported by grants of the Austrian Science Foundation (http://www.fwf.ac.at), grant number P18832-B02, and the European Union's 6th Framework Programme (http://ec.europa.eu/research/fp6), project NEURODYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro M, 2003, APPL PSYCHOLINGUIST, V24, P621, DOI 10.1017/S0142716403000316; Baayen R. H., 1993, CELEX LEXICAL DATABA; Barca L, 2006, BRAIN LANG, V98, P347, DOI 10.1016/j.bandl.2006.05.001; Beaulieu C, 2005, NEUROIMAGE, V25, P1266, DOI 10.1016/j.neuroimage.2004.12.053; Ben-Shachar M, 2007, CURR OPIN NEUROBIOL, V17, P258, DOI 10.1016/j.conb.2007.03.006; Bergmann J, 2008, COGN NEUROPSYCHOL, V25, P653, DOI 10.1080/02643290802221404; Binder JR, 2003, J COGNITIVE NEUROSCI, V15, P372, DOI 10.1162/089892903321593108; Bitan T, 2005, J NEUROSCI, V25, P5397, DOI 10.1523/JNEUROSCI.0864-05.2005; Blau V, 2009, CURR BIOL, V19, P503, DOI 10.1016/j.cub.2009.01.065; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Brambati SM, 2004, NEUROLOGY, V63, P742, DOI 10.1212/01.WNL.0000134673.95020.EE; Bruno JL, 2008, NEUROIMAGE, V39, P1988, DOI 10.1016/j.neuroimage.2007.10.044; Cao F, 2008, BRAIN LANG, V107, P91, DOI 10.1016/j.bandl.2007.12.009; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Davies R, 2007, ANN DYSLEXIA, V57, P179, DOI 10.1007/s11881-007-0010-1; De Luca M, 2002, BRAIN LANG, V80, P617, DOI 10.1006/brln.2001.2637; De Luca M, 2008, COGN BEHAV NEUROL, V21, P227, DOI 10.1097/WNN.0b013e318190d162; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Eckert MA, 2005, CORTEX, V41, P304, DOI 10.1016/S0010-9452(08)70268-5; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Fiebach CJ, 2007, NEUROIMAGE, V36, P901, DOI 10.1016/j.neuroimage.2007.04.004; Frackowiak R.S.J., 2004, HUMAN BRAIN FUNCTION, V2nd ed, P793, DOI [10.1016/B978-012264841-0/50042-1, DOI 10.1016/B978-012264841-0/50042-1]; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; FRYE RE, 2010, CEREB CORTE IN PRESS; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Gonzalez JEJ, 2000, J LEARN DISABIL-US, V33, P44, DOI 10.1177/002221940003300108; Hagtvet BE, 2003, DYSLEXIA DIFFERENT L, P181; Hawelka S, 2010, COGNITION, V115, P367, DOI 10.1016/j.cognition.2009.11.004; Heim S, 2009, HUM BRAIN MAPP, V30, P392, DOI 10.1002/hbm.20512; Henry C, 2005, NEUROPSYCHOLOGIA, V43, P1983, DOI 10.1016/j.neuropsychologia.2005.04.007; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Kronbichler M, 2008, HUM BRAIN MAPP, V29, P613, DOI 10.1002/hbm.20425; Kronbichler M, 2007, J COGNITIVE NEUROSCI, V19, P1584, DOI 10.1162/jocn.2007.19.10.1584; Kronbichler M, 2006, NEUROPSYCHOLOGIA, V44, P1822, DOI 10.1016/j.neuropsychologia.2006.03.010; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Landerl K., 1997, SALZBURGER LESE RECH; Lyytinen H., 2006, HDB ORTHOGRAPHY LITE, P47; Maurer U, 2007, BRAIN, V130, P3200, DOI 10.1093/brain/awm193; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; Mechelli A, 2005, J COGNITIVE NEUROSCI, V17, P1753, DOI 10.1162/089892905774589190; Porpodas C., 2006, HDB ORTHOGRAPHY LITE, P189; Pugh KR, 2008, J COGNITIVE NEUROSCI, V20, P1146, DOI 10.1162/jocn.2008.20079; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Richards T, 2008, AM J NEURORADIOL, V29, P1134, DOI 10.3174/ajnr.A1007; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Sandak R, 2004, SCI STUD READ, V8, P273, DOI 10.1207/s1532799xssr0803_6; Schurz M, 2010, NEUROIMAGE, V49, P2649, DOI 10.1016/j.neuroimage.2009.10.082; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; Sharma P., 2004, FAM BUS REV, V17, P1, DOI DOI 10.1111/J.1741-6248.2004.00001.X; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Silani G, 2005, BRAIN, V128, P2453, DOI 10.1093/brain/awh579; Snowling M., 2000, DYSLEXIA; Spinelli D, 2005, DEV NEUROPSYCHOL, V27, P217, DOI 10.1207/s15326942dn2702_2; TEWES U, 1991, HAMBURGERWECHSLER IN; Tsapkini K, 2010, CORTEX, V46, P185, DOI 10.1016/j.cortex.2009.02.025; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; WIMMER H, 1993, APPL PSYCHOLINGUIST, V14, P1, DOI 10.1017/S0142716400010122; WIMMER H, 2010, CORTEX IN PRESS; YAP R, 1993, READ WRIT, V5, P261, DOI 10.1007/BF01027391; Ziegler JC, 2003, J EXP CHILD PSYCHOL, V86, P169, DOI 10.1016/S0022-0965(03)00139-5; Ziegler JC, 2001, PSYCHOL SCI, V12, P379, DOI 10.1111/1467-9280.00370; Zoccolotti P, 2005, BRAIN LANG, V93, P369, DOI 10.1016/j.bandl.2004.10.010; Zoccolotti P, 1999, APPL PSYCHOLINGUIST, V20, P191, DOI 10.1017/S0142716499002027	70	69	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12073	10.1371/journal.pone.0012073	http://dx.doi.org/10.1371/journal.pone.0012073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637WJ	20711448	gold, Green Published			2022-12-25	WOS:000280849100016
J	Gob, E; Schmitt, J; Benavente, R; Alsheimer, M				Goeb, Eva; Schmitt, Johannes; Benavente, Ricardo; Alsheimer, Manfred			Mammalian Sperm Head Formation Involves Different Polarization of Two Novel LINC Complexes	PLOS ONE			English	Article							NUCLEAR-MEMBRANE PROTEIN; NEUROMUSCULAR-JUNCTION; ACTIN CYTOSKELETON; EXPRESSION PATTERN; MEIOTIC TELOMERES; DOMAIN PROTEINS; SUN-DOMAIN; RAT TESTIS; LAMIN B3; ENVELOPE	Background: LINC complexes are nuclear envelope bridging protein structures formed by interaction of SUN and KASH proteins. They physically connect the nucleus with the peripheral cytoskeleton and are critically involved in a variety of dynamic processes, such as nuclear anchorage, movement and positioning and meiotic chromosome dynamics. Moreover, they are shown to be essential for maintaining nuclear shape. Findings: Based on detailed expression analysis and biochemical approaches, we show here that during mouse sperm development, a terminal cell differentiation process characterized by profound morphogenic restructuring, two novel distinctive LINC complexes are established. They consist either of spermiogenesis-specific Sun3 and Nesprin1 or Sun1 eta, a novel non-nuclear Sun1 isoform, and Nesprin3. We could find that these two LINC complexes specifically polarize to opposite spermatid poles likely linking to sperm-specific cytoskeletal structures. Although, as shown in co-transfection/immunoprecipitation experiments, SUN proteins appear to arbitrarily interact with various KASH partners, our study demonstrates that they actually are able to confine their binding to form distinct LINC complexes. Conclusions: Formation of the mammalian sperm head involves assembly and different polarization of two novel spermiogenesis-specific LINC complexes. Together, our findings suggest that theses LINC complexes connect the differentiating spermatid nucleus to surrounding cytoskeletal structures to enable its well-directed shaping and elongation, which in turn is a critical parameter for male fertility.	[Goeb, Eva; Schmitt, Johannes; Benavente, Ricardo; Alsheimer, Manfred] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany	University of Wurzburg	Gob, E (corresponding author), Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany.	alsheimer@biozentrum.uni-wuerzburg.de	Benavente, Ricardo/GNW-2855-2022		Deutsche Forschungsgemeinschaft [AI 1090/1-1]; Graduate School of the University of Wurzburg [GK 1048]; Elitenetzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of the University of Wurzburg; Elitenetzwerk Bayern	This work was supported by the Deutsche Forschungsgemeinschaft Grant AI 1090/1-1 (http://www.dfg.de), the Graduate School GK 1048 of the University of Wurzburg (http://www.gk-1048.uni-wuerzburg.de) and the Elitenetzwerk Bayern (https://www.elitenetzwerk.bayern.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelfalk C, 2009, J CELL BIOL, V187, P185, DOI 10.1083/jcb.200808016; Alsheimer M, 1996, EXP CELL RES, V228, P181, DOI 10.1006/excr.1996.0315; Alsheimer M, 1998, J CELL SCI, V111, P2227; Alsheimer M, 2005, EUR J CELL BIOL, V84, P445, DOI 10.1016/j.ejcb.2004.11.003; Alsheimer M., 2009, V5, P81, DOI 10.1159/000166621; Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Burke B, 2009, DEV CELL, V17, P587, DOI 10.1016/j.devcel.2009.10.018; Chi YH, 2009, DEVELOPMENT, V136, P965, DOI 10.1242/dev.029868; Clermont Y., 1993, FRONT ENDOCRINOL, P332; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dadoune JP, 2003, MICROSC RES TECHNIQ, V61, P56, DOI 10.1002/jemt.10317; Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Fan J, 2004, J CELL SCI, V117, P619, DOI 10.1242/jcs.00892; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; Fridkin A, 2009, CELL MOL LIFE SCI, V66, P1518, DOI 10.1007/s00018-008-8713-y; Fujita E, 2007, AM J PATHOL, V171, P1800, DOI 10.2353/ajpath.2007.070261; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; Guttman JA, 1999, ANAT RECORD, V254, P418, DOI 10.1002/(SICI)1097-0185(19990301)254:3<418::AID-AR13>3.0.CO;2-C; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hasan S, 2006, FEBS LETT, V580, P1263, DOI 10.1016/j.febslet.2006.01.039; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Ho HC, 2010, J ANAT, V216, P525, DOI 10.1111/j.1469-7580.2009.01204.x; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Johnson KJ, 2004, BIOL REPROD, V70, P303, DOI 10.1095/biolreprod.103.021758; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; LONGO FJ, 1987, J CELL BIOL, V105, P1105, DOI 10.1083/jcb.105.3.1105; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Malkov M, 1998, BIOL REPROD, V59, P84, DOI 10.1095/biolreprod59.1.84; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Mejat A, 2010, NUCLEUS-PHILA, V1, P40, DOI 10.4161/nucl.1.1.10530; Mylonis I, 2004, J BIOL CHEM, V279, P11626, DOI 10.1074/jbc.M311949200; Olins AL, 2009, EUR J CELL BIOL, V88, P203, DOI 10.1016/j.ejcb.2008.10.001; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Schutz W, 2005, EUR J CELL BIOL, V84, P649, DOI 10.1016/j.ejcb.2005.03.001; Schutz W, 2005, EXP CELL RES, V307, P285, DOI 10.1016/j.yexcr.2005.03.023; SEIFERT GJ, 1992, EUR J CELL BIOL, V59, P138; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Toshimori K, 2003, ARCH HISTOL CYTOL, V66, P383, DOI 10.1679/aohc.66.383; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; Wiche G, 1998, J CELL SCI, V111, P2477; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhen YY, 2002, J CELL SCI, V115, P3207	68	101	106	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12072	10.1371/journal.pone.0012072	http://dx.doi.org/10.1371/journal.pone.0012072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711465	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900030
J	Fett, ME; Pilsl, A; Paquet, D; van Bebber, F; Haass, C; Tatzelt, J; Schmid, B; Winklhofer, KF				Fett, Mareike E.; Pilsl, Anna; Paquet, Dominik; van Bebber, Frauke; Haass, Christian; Tatzelt, Joerg; Schmid, Bettina; Winklhofer, Konstanze F.			Parkin Is Protective against Proteotoxic Stress in a Transgenic Zebrafish Model	PLOS ONE			English	Article							UBIQUITIN-PROTEIN LIGASE; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS; DEFICIENT MICE; MOLECULAR CHAPERONES; INDUCED APOPTOSIS; OXIDATIVE STRESS; UP-REGULATION; HEAT-SHOCK	Background: Mutations in the gene encoding the E3 ubiquitin ligase parkin (PARK2) are responsible for the majority of autosomal recessive parkinsonism. Similarly to other knockout mouse models of PD-associated genes, parkin knockout mice do not show a substantial neuropathological or behavioral phenotype, while loss of parkin in Drosophila melanogaster leads to a severe phenotype, including reduced lifespan, apoptotic flight muscle degeneration and male sterility. In order to study the function of parkin in more detail and to address possible differences in its role in different species, we chose Danio rerio as a different vertebrate model system. Methodology/Principal Findings: We first cloned zebrafish parkin to compare its biochemical and functional aspects with that of human parkin. By using an antisense knockdown strategy we generated a zebrafish model of parkin deficiency (knockdown efficiency between 50% and 60%) and found that the transient knockdown of parkin does not cause morphological or behavioral alterations. Specifically, we did not observe a loss of dopaminergic neurons in parkin-deficient zebrafish. In addition, we established transgenic zebrafish lines stably expressing parkin by using a Gal4/UAS-based bidirectional expression system. While parkin-deficient zebrafish are more vulnerable to proteotoxicity, increased parkin expression protected transgenic zebrafish from cell death induced by proteotoxic stress. Conclusions/Significance: Similarly to human parkin, zebrafish parkin is a stress-responsive protein which protects cells from stress-induced cell death. Our transgenic zebrafish model is a novel tool to characterize the protective capacity of parkin in vivo.	[Fett, Mareike E.; Pilsl, Anna; Paquet, Dominik; van Bebber, Frauke; Haass, Christian; Tatzelt, Joerg; Schmid, Bettina; Winklhofer, Konstanze F.] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Paquet, Dominik; van Bebber, Frauke; Haass, Christian; Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE, Munich, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Fett, ME (corresponding author), Univ Munich, Adolf Butenandt Inst, Munich, Germany.	Konstanze.Winklhofer@med.uni-muenchen.de		Tatzelt, Jorg/0000-0001-5017-5528; Winklhofer, Konstanze/0000-0002-7256-8231; Paquet, Dominik/0000-0003-2065-1639	Deutsche Forschungsgemeinschaft [SFB 596]; German Ministry for Education and Research; Helmholtz Alliance Mental Health in an Ageing Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance Mental Health in an Ageing Society	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 596: Molecular Mechanisms of Neurodegeneration), the German Ministry for Education and Research (NGFN plus: Functional Genomics of Parkinson's Disease), and the Helmholtz Alliance Mental Health in an Ageing Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Higashi Y, 2004, J NEUROCHEM, V89, P1490, DOI 10.1111/j.1471-4159.2004.02445.x; Hyun DH, 2005, J NEUROSCI RES, V82, P232, DOI 10.1002/jnr.20638; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Muqit MMK, 2004, J NEUROL NEUROSUR PS, V75, P1762, DOI 10.1136/jnnp.2003.018614; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; PAQUET D, 2009, J CLIN INVEST; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Pyati UJ, 2007, SEMIN CANCER BIOL, V17, P154, DOI 10.1016/j.semcancer.2006.11.007; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Rosen KM, 2006, J BIOL CHEM, V281, P12809, DOI 10.1074/jbc.M512649200; SAINI N, 2010, NEUROBIOL D IN PRESS; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schlehe JS, 2008, J BIOL CHEM, V283, P13771, DOI 10.1074/jbc.M707494200; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Stemple DL, 2004, NAT REV GENET, V5, P145, DOI 10.1038/nrg1273; Tan EK, 2005, HUM GENET, V118, P484, DOI 10.1007/s00439-005-0038-4; Tucker B, 2007, ZEBRAFISH, V4, P113, DOI 10.1089/zeb.2007.0508; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang HQ, 2007, ANTIOXID REDOX SIGN, V9, P533, DOI 10.1089/ars.2006.1522; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Woods IG, 2008, NAT BIOTECHNOL, V26, P650, DOI 10.1038/nbt0608-650; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x	63	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11783	10.1371/journal.pone.0011783	http://dx.doi.org/10.1371/journal.pone.0011783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689587	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520300005
J	Hunter, JP; Guatelli-Steinberg, D; Weston, TC; Durner, R; Betsinger, TK				Hunter, John P.; Guatelli-Steinberg, Debbie; Weston, Theresia C.; Durner, Ryan; Betsinger, Tracy K.			Model of Tooth Morphogenesis Predicts Carabelli Cusp Expression, Size, and Symmetry in Humans	PLOS ONE			English	Article							MEASUREMENT ERROR; TRAIT; ASSOCIATIONS; MORPHOLOGY; HYPOCONE; TEETH	Background: The patterning cascade model of tooth morphogenesis accounts for shape development through the interaction of a small number of genes. In the model, gene expression both directs development and is controlled by the shape of developing teeth. Enamel knots (zones of nonproliferating epithelium) mark the future sites of cusps. In order to form, a new enamel knot must escape the inhibitory fields surrounding other enamel knots before crown components become spatially fixed as morphogenesis ceases. Because cusp location on a fully formed tooth reflects enamel knot placement and tooth size is limited by the cessation of morphogenesis, the model predicts that cusp expression varies with intercusp spacing relative to tooth size. Although previous studies in humans have supported the model's implications, here we directly test the model's predictions for the expression, size, and symmetry of Carabelli cusp, a variation present in many human populations. Methodology/Principal Findings: In a dental cast sample of upper first molars (M1s) (187 rights, 189 lefts, and 185 antimeric pairs), we measured tooth area and intercusp distances with a Hirox digital microscope. We assessed Carabelli expression quantitatively as an area in a subsample and qualitatively using two typological schemes in the full sample. As predicted, low relative intercusp distance is associated with Carabelli expression in both right and left samples using either qualitative or quantitative measures. Furthermore, asymmetry in Carabelli area is associated with asymmetry in relative intercusp spacing. Conclusions/Significance: These findings support the model's predictions for Carabelli cusp expression both across and within individuals. By comparing right-left pairs of the same individual, our data show that small variations in developmental timing or spacing of enamel knots can influence cusp pattern independently of genotype. Our findings suggest that during evolution new cusps may first appear as a result of small changes in the spacing of enamel knots relative to crown size.	[Hunter, John P.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Newark, OH USA; [Hunter, John P.] Ohio State Univ, Sch Earth Sci, Newark, OH USA; [Guatelli-Steinberg, Debbie; Weston, Theresia C.; Durner, Ryan] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Guatelli-Steinberg, Debbie] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Betsinger, Tracy K.] SUNY Coll Oneonta, Dept Anthropol, Oneonta, NY 13820 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University; State University of New York (SUNY) System	Hunter, JP (corresponding author), Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Newark, OH USA.	hunter.360@osu.edu	Hunter, John/A-2573-2013		The Ohio State University Newark	The Ohio State University Newark	The Ohio State University Newark supported this study through a Faculty-Initiated Student Assistantship Grant and a Scholarly Activity Grant for Publications Costs to the senior author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; BRABANT H, 1971, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V7, P329, DOI 10.3406/bmsap.1971.2024; Brues A.M., 1977, PEOPLE RACES; Garn S.M., 1971, HUMAN RACES; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; Harris EF, 2007, AM J PHYS ANTHROPOL, V132, P238, DOI 10.1002/ajpa.20503; Hsu JW, 1997, J FORENSIC SCI, V42, P802; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Irish JD, 2003, J HUM EVOL, V45, P113, DOI 10.1016/S0047-2484(03)00090-3; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KEENE HJ, 1968, ARCH ORAL BIOL, V13, P1023, DOI 10.1016/0003-9969(68)90018-6; Kondo S, 2006, AM J PHYS ANTHROPOL, V129, P196, DOI 10.1002/ajpa.20271; Korenhof C. A. W., 1960, MORPHOGENETICAL ASPE; Kraus BS, 1965, HUMAN DENTITION BIRT; KURTEN B, 1953, ACTA ZOOL FENN, V73, P1; LOMBARDI AV, 1975, J DENT RES, V54, P239; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; MEREDITH HV, 1954, J DENT RES, V33, P435, DOI 10.1177/00220345540330031601; REID C, 1991, AM J PHYS ANTHROPOL, V84, P427, DOI 10.1002/ajpa.1330840407; Reid C, 1995, ASPECTS DENT BIOL PA, P299; ROHLF FJ, 1983, EVOLUTION, V37, P180, DOI 10.1111/j.1558-5646.1983.tb05526.x; SAKAI T, 1971, J ANTHROPOL SOC NIP, V79, P297; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; SASAKI K, 1997, ANTHR SCI, V105; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; SCOTT GR, 1978, J DENT RES, V57, P570, DOI 10.1177/00220345780570040601; SCOTT GR, 1979, J DENT RES, V58, P1403, DOI 10.1177/00220345790580041701; Sokal R. R., 2012, BIOMETRY; Sperber H., 1974, THESIS WITWATERSRAND; Townsend G, 2003, J DENT RES, V82, P350, DOI 10.1177/154405910308200505; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; WOOD BA, 1988, J ANAT, V161, P1; Wright S., 1968, EVOLUTION GENETICS P, P373; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588	37	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11844	10.1371/journal.pone.0011844	http://dx.doi.org/10.1371/journal.pone.0011844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20689576	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520200012
J	Manno, S; Mohandas, N; Takakuwa, Y				Manno, Sumie; Mohandas, Narla; Takakuwa, Yuichi			ATP-dependent Mechanism Protects Spectrin against Glycation in Human Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE STABILITY; DIABETES-MELLITUS; BETA-SPECTRIN; CROSS-LINK; PHOSPHATIDYLSERINE; GLYCOSYLATION; PROTEINS; SITES; IDENTIFICATION; HEMOGLOBIN	Human erythrocytes are continuously exposed to glucose, which reacts with the amino terminus of the beta-chain of hemoglobin (Hb) to form glycated Hb, HbA1c, levels of which increase with the age of the circulating cell. In contrast to extensive insights into glycation of hemoglobin, little is known about glycation of erythrocyte membrane proteins. In the present study, we explored the conditions under which glucose and ribose can glycate spectrin, both on the intact membrane and in solution and the functional consequences of spectrin glycation. Although purified spectrin could be readily glycated, membrane-associated spectrin could be glycated only after ATP depletion and consequent translocation of phosphatidylserine (PS) from the inner to the outer lipid monolayer. Glycation of membrane-associated spectrin led to a marked decrease in membrane deformability. We further observed that only PS-binding spectrin repeats are glycated. We infer that the absence of glycation in situ is the consequence of the interaction of the target lysine and arginine residues with PS and thus is inaccessible for glycation. The reduced membrane deformability after glycation in the absence of ATP is likely the result of the inability of the glycated spectrin repeats to undergo the obligatory unfolding as a consequence of interhelix cross-links. We thus postulate that through the use of an ATP-driven phospholipid translocase (flippase), erythrocytes have evolved a protective mechanism against spectrin glycation and thus maintain their optimal membrane function during their long circulatory life span.	[Manno, Sumie; Takakuwa, Yuichi] Tokyo Womens Med Univ, Dept Biochem, Shinjuku Ku, Tokyo 1628666, Japan; [Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA	Tokyo Women's Medical University; New York Blood Center	Takakuwa, Y (corresponding author), Tokyo Womens Med Univ, Dept Biochem, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	takakuwa@research.twmu.ac.jp			National Institutes of Health [HL 31579, DK26263, DK32094]; Ministry of Education Culture, Sports, Science, and Technology of Japan [19590289]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026263, P01DK032094, R37DK026263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 31579 DK26263 and DK32094. This work was also supported by Grant-in-aid for Scientific Research 19590289 from the Ministry of Education Culture, Sports, Science, and Technology of Japan.	An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; An XL, 2004, BIOCHEMISTRY-US, V43, P310, DOI 10.1021/bi035653h; Begg GE, 2000, J BIOL CHEM, V275, P3279, DOI 10.1074/jbc.275.5.3279; Bierhaus A, 1998, CARDIOVASC RES, V37, P586, DOI 10.1016/S0008-6363(97)00233-2; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; CHASIS JA, 1985, J CLIN INVEST, V75, P1919, DOI 10.1172/JCI111907; COHEN AM, 1986, BLOOD, V68, P920; CONNOR J, 1988, BIOCHEMISTRY-US, V27, P848, DOI 10.1021/bi00403a002; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; GARLICK RL, 1983, J CLIN INVEST, V71, P1062, DOI 10.1172/JCI110856; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; IBERG N, 1986, J BIOL CHEM, V261, P3542; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Law R, 2003, BIOPHYS J, V84, P533, DOI 10.1016/S0006-3495(03)74872-3; MACDONALD RI, 1993, BIOCHEMISTRY-US, V32, P6957, DOI 10.1021/bi00078a021; MAKSYMIW R, 1987, BIOCHEMISTRY-US, V26, P2983, DOI 10.1021/bi00385a005; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; MICHALAK K, 1993, GEN PHYSIOL BIOPHYS, V12, P163; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nunomura W, 2000, J BIOL CHEM, V275, P24540, DOI 10.1074/jbc.M002492200; SELL DR, 1989, J BIOL CHEM, V264, P21597; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; WATKINS NG, 1987, J BIOL CHEM, V262, P7207; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827	26	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33923	33929		10.1074/jbc.M110.126896	http://dx.doi.org/10.1074/jbc.M110.126896			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20724481	hybrid, Green Published			2022-12-25	WOS:000283354000039
J	Debierre-Grockiego, F; Niehus, S; Coddeville, B; Elass, E; Poirier, F; Weingart, R; Schmidt, RR; Mazurier, J; Guerardel, Y; Schwarz, RT				Debierre-Grockiego, Francoise; Niehus, Sebastian; Coddeville, Bernadette; Elass, Elisabeth; Poirier, Francoise; Weingart, Ralf; Schmidt, Richard R.; Mazurier, Joel; Guerardel, Yann; Schwarz, Ralph T.			Binding of Toxoplasma gondii Glycosylphosphatidylinositols to Galectin-3 Is Required for Their Recognition by Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA PRODUCTION; LEISHMANIA-MAJOR; ACTIVATION; INFECTION; PROTEIN; IMMUNE; TLR2; EXPRESSION; RESPONSES; RECEPTOR	We showed that the production of tumor necrosis factor (TNF) alpha by macrophages in response to Toxoplasma gondii glycosylphosphatidylinositols (GPIs) requires the expression of both Toll-like receptors TLR2 and TLR4, but not of their coreceptor CD14. Galectin-3 is a beta-galactoside-binding protein with immune-regulatory effects, which associates with TLR2. We demonstrate here by using the surface plasmon resonance method that the GPIs of T. gondii bind to human galectin-3 with strong affinity and in a dose-dependent manner. The use of a synthetic glycan and of the lipid moiety cleaved from the GPIs shows that both parts are involved in the interaction with galectin-3. GPIs of T. gondii also bind to galectin-1 but with a lower affinity and only through the lipid moiety. At the cellular level, the production of TNF-alpha induced by T. gondii GPIs in macrophages depends on the expression of galectin-3 but not of galectin-1. This study is the first identification of a galectin-3 ligand of T. gondii origin, and galectin-3 might be a co-receptor presenting the GPIs to the TLRs on macrophages.	[Debierre-Grockiego, Francoise; Niehus, Sebastian; Schwarz, Ralph T.] Univ Marburg, AG Parasitol, Inst Virol, D-35043 Marburg, Germany; [Debierre-Grockiego, Francoise] Univ INRA 0483 Immunol Parasitair, UMR, Unite Format Rech Sci Pharmaceut, F-37200 Tours, France; [Coddeville, Bernadette; Elass, Elisabeth; Mazurier, Joel; Guerardel, Yann; Schwarz, Ralph T.] Univ Lille Nord France, CNRS, UMR 8576, Unit Struct & Funct Glycobiol,Inst Federatif Rech, F-59000 Lille, France; [Poirier, Francoise] Inst Jacques Monod, Lab Genet & Dev Mammiferes, F-75013 Paris, France; [Weingart, Ralf; Schmidt, Richard R.] Univ Konstanz, Fachbereich Chem, D-78457 Constance, Germany	Philipps University Marburg; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universite Paris Cite; University of Konstanz	Debierre-Grockiego, F (corresponding author), Univ Marburg, AG Parasitol, Inst Virol, D-35043 Marburg, Germany.	francoise.debierre@univ-tours.fr	Debierre-Grockiego, Francoise/AAD-4322-2021	Guerardel, Yann/0000-0003-4967-9512; elass, elisabeth/0000-0002-2573-2959	Deutsche Forschungsgemeinschaft; Universite des Sciences et Technologies de Lille 1; Institut Federatif de Recherche [147]; Centre National de la Recherche Scientifique (Unite Mixte de Recherche CNRS) [8576]; Groupement des Entreprises Francaises dans la Lutte Contre le Cancer and Association pour la Recherche Sur le Cancer [1113]; Deutscher Akademischer Austausch Dienst/Egide	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Universite des Sciences et Technologies de Lille 1; Institut Federatif de Recherche; Centre National de la Recherche Scientifique (Unite Mixte de Recherche CNRS)(Centre National de la Recherche Scientifique (CNRS)); Groupement des Entreprises Francaises dans la Lutte Contre le Cancer and Association pour la Recherche Sur le Cancer; Deutscher Akademischer Austausch Dienst/Egide(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Deutsche Forschungsgemeinschaft (R. T. S.), the Universite des Sciences et Technologies de Lille 1 (Y.G.), the Institut Federatif de Recherche 147, the Centre National de la Recherche Scientifique (Unite Mixte de Recherche CNRS no. 8576, Director Dr. J.C. Michalski), the Groupement des Entreprises Francaises dans la Lutte Contre le Cancer and Association pour la Recherche Sur le Cancer Grant 1113 (to F. P.), and the PROCOPE of Deutscher Akademischer Austausch Dienst/Egide (R. T. S. and Y.G.).	Alves CMOS, 2010, IMMUNOBIOLOGY, V215, P475, DOI 10.1016/j.imbio.2009.08.001; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Barboni E, 2005, FEBS LETT, V579, P6749, DOI 10.1016/j.febslet.2005.11.005; Bernardes ES, 2006, AM J PATHOL, V168, P1910, DOI 10.2353/ajpath.2006.050636; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Debierre-Grockiego F, 2003, J BIOL CHEM, V278, P32987, DOI 10.1074/jbc.M304791200; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Debierre-Grockiego F, 2007, INFECT IMMUN, V75, P2886, DOI 10.1128/IAI.01431-06; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Ferraz LC, 2008, EUR J IMMUNOL, V38, P2762, DOI 10.1002/eji.200737986; Giordanengo L, 2001, CLIN EXP IMMUNOL, V124, P266, DOI 10.1046/j.1365-2249.2001.01512.x; GRIMWOOD BG, 1979, EXP PARASITOL, V48, P282, DOI 10.1016/0014-4894(79)90110-3; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HSU DK, 1992, J BIOL CHEM, V267, P14167; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miller MC, 2009, GLYCOBIOLOGY, V19, P1034, DOI 10.1093/glycob/cwp084; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Pekari K, 2001, J ORG CHEM, V66, P7432, DOI 10.1021/jo015840q; Pelletier I, 2003, J BIOL CHEM, V278, P22223, DOI 10.1074/jbc.M302693200; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; Roda O, 2009, GASTROENTEROLOGY, V136, P1379, DOI 10.1053/j.gastro.2008.12.039; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Weber KB, 2004, AM J CLIN PATHOL, V122, P524, DOI 10.1309/UUQTE505PTN5QJ7M; YANG ZG, 1994, J LEUKOCYTE BIOL, V55, P483, DOI 10.1002/jlb.55.4.483	32	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32744	32750		10.1074/jbc.M110.137588	http://dx.doi.org/10.1074/jbc.M110.137588			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729207	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000283048200009
J	Seki, T; Abe-Seki, N; Kikawada, T; Takahashi, H; Yamamoto, K; Adachi, N; Tanaka, S; Hide, I; Saito, N; Sakai, N				Seki, Takahiro; Abe-Seki, Nana; Kikawada, Takahiro; Takahashi, Hideyuki; Yamamoto, Kazuhiro; Adachi, Naoko; Tanaka, Shigeru; Hide, Izumi; Saito, Naoaki; Sakai, Norio			Effect of Trehalose on the Properties of Mutant gamma PKC, Which Causes Spinocerebellar Ataxia Type 14, in Neuronal Cell Lines and Cultured Purkinje Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-GAMMA; NEURODEGENERATIVE DISEASE; CEREBELLAR-ATAXIA; AGGREGATE FORMATION; MOUSE MODEL; PRKCG GENE; PROTEIN; MUTATIONS; FAMILY; PATHOGENESIS	Several missense mutations in the protein kinase C gamma (gamma PKC) gene have been found to cause spinocerebellar ataxia type 14 (SCA14), an autosomal dominant neurodegenerative disease. We previously demonstrated that the mutant gamma PKC found in SCA14 is susceptible to aggregation, which induces apoptotic cell death. The disaccharide trehalose has been reported to inhibit aggregate formation and to alleviate symptoms in cellular and animal models of Huntington disease, Alzheimer disease, and prion disease. Here, we show that trehalose can be incorporated into SH-SY5Y cells and reduces the aggregation of mutant gamma PKC-GFP, thereby inhibiting apoptotic cell death in SH-SY5Y cells and primary cultured Purkinje cells (PCs). Trehalose acts by directly stabilizing the conformation of mutant gamma PKC without affecting protein turnover. Trehalose was also found to alleviate the improper development of dendrites in PCs expressing mutant gamma PKC-GFP without aggregates but not in PCs with aggregates. In PCs without aggregates, trehalose improves the mobility and translocation of mutant gamma PKC-GFP, probably by inhibiting oligomerization and thereby alleviating the improper development of dendrites. These results suggest that trehalose counteracts various cellular dysfunctions that are triggered by mutant gamma PKC in both neuronal cell lines and primary cultured PCs by inhibiting oligomerization and aggregation of mutant gamma PKC.	[Seki, Takahiro; Abe-Seki, Nana; Yamamoto, Kazuhiro; Tanaka, Shigeru; Hide, Izumi; Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan; [Kikawada, Takahiro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Takahashi, Hideyuki; Adachi, Naoko; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan	Hiroshima University; National Institute of Agrobiological Sciences - Japan; Kobe University	Sakai, N (corresponding author), 1-2-3 Kasumi,Minami Ku, Hiroshima 7348551, Japan.	nsakai@hiroshima-u.ac.jp	Kikawada, Takahiro/A-1289-2010; Tanaka, Shigeru/O-3908-2015; Sakai, Norio/AAM-5822-2021	Kikawada, Takahiro/0000-0002-2329-9282; Tanaka, Shigeru/0000-0003-3247-9098; Sakai, Norio/0000-0002-6648-8761; Seki, Takahiro/0000-0002-9894-4768; Adachi, Naoko/0000-0002-8797-0717	Ministry of Education, Sports and Culture; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; Suzuken Memorial Foundation; Tokyo Biochemical Research Foundation; Japanese Smoking Research Association	Ministry of Education, Sports and Culture; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Suzuken Memorial Foundation; Tokyo Biochemical Research Foundation; Japanese Smoking Research Association	This study was supported by a grant-in-aid for scientific research from the Ministry of Education, Sports and Culture and by grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Naito Foundation, the Suzuken Memorial Foundation, the Tokyo Biochemical Research Foundation, and the Japanese Smoking Research Association.	Adachi N, 2008, J BIOL CHEM, V283, P19854, DOI 10.1074/jbc.M801492200; Agorogiannis EI, 2004, NEUROPATH APPL NEURO, V30, P215, DOI 10.1111/j.1365-2990.2004.00558.x; Asai H, 2009, HUM MOL GENET, V18, P3533, DOI 10.1093/hmg/ddp298; Attanasio F, 2007, BIOCHEM BIOPH RES CO, V354, P899, DOI 10.1016/j.bbrc.2007.01.061; Beranger F, 2008, BIOCHEM BIOPH RES CO, V374, P44, DOI 10.1016/j.bbrc.2008.06.094; Cagnoli C, 2006, BRAIN, V129, P235, DOI 10.1093/brain/awh651; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Chen DH, 2005, NEUROLOGY, V64, P1258, DOI 10.1212/01.WNL.0000156801.64549.6B; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; Dalski A, 2006, J NEUROL, V253, P1111, DOI 10.1007/s00415-006-0209-9; Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422; Duenas AM, 2006, BRAIN, V129, P1357, DOI 10.1093/brain/awl081; Elbein A D, 1974, Adv Carbohydr Chem Biochem, V30, P227, DOI 10.1016/S0065-2318(08)60266-8; Elliott GD, 2006, CRYOBIOLOGY, V52, P114, DOI 10.1016/j.cryobiol.2005.10.009; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Hiramoto K, 2006, MOVEMENT DISORD, V21, P1355, DOI 10.1002/mds.20970; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Klebe S, 2007, ARCH NEUROL-CHICAGO, V64, P913, DOI 10.1001/archneur.64.6.913; Lin DB, 2007, BIOCHEM BIOPH RES CO, V362, P982, DOI 10.1016/j.bbrc.2007.08.093; Lin DB, 2007, EXP EYE RES, V85, P113, DOI 10.1016/j.exer.2007.03.007; Lins RD, 2004, PROTEINS, V55, P177, DOI 10.1002/prot.10632; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Nolte D, 2007, MOVEMENT DISORD, V22, P265, DOI 10.1002/mds.21269; Oliver A. E., 2004, CELL PRESERV TECHNOL, V2, P35, DOI DOI 10.1089/153834404322708745; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SAITO N, 1988, J NEUROSCI, V8, P369; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Seki T, 2005, J BIOL CHEM, V280, P29096, DOI 10.1074/jbc.M501716200; Seki T, 2007, EUR J NEUROSCI, V26, P3126, DOI 10.1111/j.1460-9568.2007.05933.x; Seki T, 2006, GENES CELLS, V11, P1051, DOI 10.1111/j.1365-2443.2006.01003.x; Seki T, 2009, NEUROBIOL DIS, V33, P260, DOI 10.1016/j.nbd.2008.10.013; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Verbeek DS, 2008, J CELL SCI, V121, P2339, DOI 10.1242/jcs.027698; Verbeek DS, 2005, BRAIN, V128, P436, DOI 10.1093/brain/awh378; Vlak MHM, 2006, MOVEMENT DISORD, V21, P1025, DOI 10.1002/mds.20851; Watanabe M, 2002, J EXP BIOL, V205, P2799; Wieczorek S, 2007, MOVEMENT DISORD, V22, P2135, DOI 10.1002/mds.21673; Yamamoto K, 2010, GENES CELLS, V15, P425, DOI 10.1111/j.1365-2443.2010.01395.x	49	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33252	33264		10.1074/jbc.M110.146704	http://dx.doi.org/10.1074/jbc.M110.146704			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705605	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000283048200062
J	Lazard, M; Blanquet, S; Fisicaro, P; Labarraque, G; Plateau, P				Lazard, Myriam; Blanquet, Sylvain; Fisicaro, Paola; Labarraque, Guillaume; Plateau, Pierre			Uptake of Selenite by Saccharomyces cerevisiae Involves the High and Low Affinity Orthophosphate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE-TRANSPORTER; YEAST; TOXICITY; SELENATE; SULFATE; SYSTEM; GENE; TRANSLOCATION; METABOLISM	Although the general cytotoxicity of selenite is well established, the mechanism by which this compound crosses cellular membranes is still unknown. Here, we show that in Saccharomyces cerevisiae, the transport system used opportunistically by selenite depends on the phosphate concentration in the growth medium. Both the high and low affinity phosphate transporters are involved in selenite uptake. When cells are grown at low P-i concentrations, the high affinity phosphate transporter Pho84p is the major contributor to selenite uptake. When phosphate is abundant, selenite is internalized through the low affinity P-i transporters (Pho87p, Pho90p, and Pho91p). Accordingly, inactivation of the high affinity phosphate transporter Pho84p results in increased resistance to selenite and reduced uptake in low P-i medium, whereas deletion of SPL2, a negative regulator of low affinity phosphate uptake, results in exacerbated sensitivity to selenite. Measurements of the kinetic parameters for selenite and phosphate uptake demonstrate that there is a competition between phosphate and selenite ions for both P-i transport systems. In addition, our results indicate that Pho84p is very selective for phosphate as compared with selenite, whereas the low affinity transporters discriminate less efficiently between the two ions. The properties of phosphate and selenite transport enable us to propose an explanation to the paradoxical increase of selenite toxicity when phosphate concentration in the growth medium is raised above 1 mM.	[Lazard, Myriam; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, Biochim Lab, CNRS, UMR7654, F-91128 Palaiseau, France; [Fisicaro, Paola; Labarraque, Guillaume] Lab Natl Metrol & Essais, Dept Biomed & Inorgan Chem, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris; Laboratoire National de Metrologie et d'Essais (LNE)	Lazard, M (corresponding author), Ecole Polytech, Biochim Lab, CNRS, UMR7654, F-91128 Palaiseau, France.	myriam.lazard@polytechnique.edu		Lazard, Myriam/0000-0002-7154-1352				Auesukaree C, 2003, BIOCHEM BIOPH RES CO, V306, P843, DOI 10.1016/S0006-291X(03)01068-4; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BISSON LF, 1982, GENETICS, V102, P341; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; BURNS DJW, 1977, EUR J BIOCHEM, V81, P45, DOI 10.1111/j.1432-1033.1977.tb11925.x; Cherest H, 1997, GENETICS, V145, P627; Cost GJ, 1996, YEAST, V12, P939, DOI 10.1002/(SICI)1097-0061(199608)12:10<939::AID-YEA988>3.0.CO;2-L; DARDEL F, 1994, COMPUT APPL BIOSCI, V10, P273; FALCONE G, 1963, J BACTERIOL, V85, P754, DOI 10.1128/JB.85.4.754-762.1963; Ganyc D, 2008, FEBS LETT, V582, P299, DOI 10.1016/j.febslet.2007.12.022; Gharieb MM, 2004, MYCOL RES, V108, P1415, DOI 10.1017/S0953756204001418; Hopper JL, 1999, PLANT SOIL, V210, P199, DOI 10.1023/A:1004639906245; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Hurlimann HC, 2009, EMBO REP, V10, P1003, DOI 10.1038/embor.2009.105; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Li HF, 2008, NEW PHYTOL, V178, P92, DOI 10.1111/j.1469-8137.2007.02343.x; LINDBLOWKULL C, 1985, J BACTERIOL, V163, P1267, DOI 10.1128/JB.163.3.1267-1269.1985; Martinez P, 1998, J BACTERIOL, V180, P2253, DOI 10.1128/JB.180.8.2253-2256.1998; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Pereira Y, 2008, TOXICOL SCI, V106, P400, DOI 10.1093/toxsci/kfn193; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Persson BL, 1999, BBA-REV BIOMEMBRANES, V1422, P255, DOI 10.1016/S0304-4157(99)00010-6; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Pinson B, 2004, J BIOL CHEM, V279, P35273, DOI 10.1074/jbc.M405398200; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Riedel GF, 1996, ENVIRON TOXICOL CHEM, V15, P1577, DOI 10.1002/etc.5620150923; Rosen BR, 2009, ENVIRON INT, V35, P512, DOI 10.1016/j.envint.2008.07.023; ROTHSTEIN A, 1963, J GEN PHYSIOL, V46, P1075, DOI 10.1085/jgp.46.5.1075; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; Turner RJ, 1998, BIOMETALS, V11, P223, DOI 10.1023/A:1009290213301; Wykoff DD, 2001, GENETICS, V159, P1491; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022; Zvyagilskaya RA, 2008, FEMS YEAST RES, V8, P685, DOI 10.1111/j.1567-1364.2008.00408.x	35	43	47	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32029	32037		10.1074/jbc.M110.139865	http://dx.doi.org/10.1074/jbc.M110.139865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688911	Green Published, hybrid			2022-12-25	WOS:000282683000016
J	Shi, ZD; Rockey, DC				Shi, Zengdun; Rockey, Don C.			Interferon-gamma-mediated Inhibition of Serum Response Factor-dependent Smooth Muscle-specific Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELLS; RNASE-L; MOLECULAR REGULATION; TGF-BETA; ACTIN; ALPHA; DIFFERENTIATION; ACTIVATION; MYOCARDIN; FIBROSIS	IFN gamma exerts multiple biological effects on effector cells by regulating many downstream genes, including smooth muscle-specific genes. However, the molecular mechanisms underlying IFN gamma-induced inhibition of smooth muscle-specific gene expression remain unclear. In this study, we have shown that serum response factor (SRF), a common transcriptional factor important in cell proliferation, migration, and differentiation, is targeted by IFN gamma in a STAT1-dependent manner. We show that the molecular mechanism by which IFN gamma regulates SRF is via activation of the 2-5A-RNase L system, which triggers SRF mRNA decay and reduced SRF expression. As a result, decreased SRF expression reduces expression of SRF target genes such as smooth muscle alpha-actin and smooth muscle myosin heavy chain. Additionally, IFN gamma reduced p300 and acetylated histone-3 binding in both smooth muscle alpha-actin and SRF promoters, epigenetically decreasing smooth muscle alpha-actin and SRF transcriptional activation. Our data reveal that SRF is a novel IFN gamma-regulated gene and further elucidate the molecular pathway between IFN gamma, IFN gamma-regulated genes, and SRF and its target genes.	[Shi, Zengdun; Rockey, Don C.] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Rockey, DC (corresponding author), Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	don.rockey@utsouthwestern.edu			National Institutes of Health [R01 DK 60338, R01 DK 50574]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050574, R01DK063308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK 60338 and R01 DK 50574 (to D.C.R.).	Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Fujita T, 2006, INT J MOL MED, V17, P605; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; HANSSON GK, 1989, J EXP MED, V170, P1595, DOI 10.1084/jem.170.5.1595; Herrmann J, 2007, BBA-MOL BASIS DIS, V1772, P1250, DOI 10.1016/j.bbadis.2007.10.006; Higashi K, 2003, J BIOL CHEM, V278, P5156, DOI 10.1074/jbc.M208724200; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Khabar KSA, 2003, J BIOL CHEM, V278, P20124, DOI 10.1074/jbc.M208766200; Liang SL, 2006, IUBMB LIFE, V58, P508, DOI 10.1080/15216540600838232; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Meeson AP, 2007, EMBO J, V26, P1902, DOI 10.1038/sj.emboj.7601635; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Mizzen CA, 1998, CELL MOL LIFE SCI, V54, P6, DOI 10.1007/s000180050121; Muir AJ, 2006, J VIRAL HEPATITIS, V13, P322, DOI 10.1111/j.1365-2893.2005.00689.x; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; ROCKEY DC, 1992, HEPATOLOGY, V16, P776, DOI 10.1002/hep.1840160325; ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shao R, 2003, MOL BIOL CELL, V14, P2327, DOI 10.1091/mbc.02-06-0093; Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663; Tau G, 1999, ALLERGY, V54, P1233, DOI 10.1034/j.1398-9995.1999.00099.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95	38	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32415	32424		10.1074/jbc.M110.164863	http://dx.doi.org/10.1074/jbc.M110.164863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685657	Green Published, hybrid			2022-12-25	WOS:000282683000055
J	Rose, AAN; Annis, MG; Dong, ZF; Pepin, F; Hallett, M; Park, M; Siegel, PM				Rose, April A. N.; Annis, Matthew G.; Dong, Zhifeng; Pepin, Francois; Hallett, Michael; Park, Morag; Siegel, Peter M.			ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties	PLOS ONE			English	Article							MELANOMA PROTEIN-B; DC-HIL; OSTEOBLAST DIFFERENTIATION; THERAPEUTIC TARGET; AURISTATIN-E; EXPRESSION; OSTEOACTIVIN; GPNMB; IDENTIFICATION; MACROPHAGES	Background: Glycoprotein non-metastatic melanoma protein B (GPNMB)/Osteoactivin (OA) is a transmembrane protein expressed in approximately 40-75% of breast cancers. GPNMB/OA promotes the migration, invasion and metastasis of breast cancer cells; it is commonly expressed in basal/triple-negative breast tumors and is associated with shorter recurrence-free and overall survival times in patients with breast cancer. Thus, GPNMB/OA represents an attractive target for therapeutic intervention in breast cancer; however, little is known about the functions of GPNMB/OA within the primary tumor microenvironment. Methodology/Principal Findings: We have employed mouse and human breast cancer cells to investigate the effects of GPNMB/OA on tumor growth and angiogenesis. GPNMB/OA-expressing tumors display elevated endothelial recruitment and reduced apoptosis when compared to vector control-derived tumors. Primary human breast cancers characterized by high vascular density also display elevated levels of GPNMB/OA when compared to those with low vascular density. Using immunoblot and ELISA assays, we demonstrate the GPNMB/OA ectodomain is shed from the surface of breast cancer cells. Transient siRNA-mediated knockdown studies of known sheddases identified ADAM10 as the protease responsible for GPNMB/OA processing. Finally, we demonstrate that the shed extracellular domain (ECD) of GPNMB/OA can promote endothelial migration in vitro. Conclusions/Significance: GPNMB/OA expression promotes tumor growth, which is associated with enhanced endothelial recruitment. We identify ADAM10 as a sheddase capable of releasing the GPNMB/OA ectodomain from the surface of breast cancer cells, which induces endothelial cell migration. Thus, ectodomain shedding may serve as a novel mechanism by which GPNMB/OA promotes angiogenesis in breast cancer.	[Rose, April A. N.; Annis, Matthew G.; Dong, Zhifeng; Hallett, Michael; Park, Morag; Siegel, Peter M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Rose, April A. N.; Annis, Matthew G.; Dong, Zhifeng; Park, Morag; Siegel, Peter M.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Park, Morag; Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Pepin, Francois] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; McGill University	Rose, AAN (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada.	peter.siegel@mcgill.ca	Rose, April/AAR-8222-2020	Rose, April/0000-0002-9845-4603; Hallett, Michael/0000-0001-6738-6786; Annis, Matthew/0000-0002-8776-004X	Canadian Breast Cancer Research Alliance/Canadian Institutes of Health Research [MOP-84386]; Canadian Institutes of Health Research [CTP-79857]; McGill University Health Centre Foundation; "Banque de Tissues et de donnees" of the "Reseau de recherche sur le cancer" of the Fonds de recherche en sante du Quebec; Fonds de recherche en sante du Quebec; Canadian Cancer Society	Canadian Breast Cancer Research Alliance/Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University Health Centre Foundation; "Banque de Tissues et de donnees" of the "Reseau de recherche sur le cancer" of the Fonds de recherche en sante du Quebec; Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work is supported by grants from the Canadian Breast Cancer Research Alliance/Canadian Institutes of Health Research (MOP-84386 to P. M. S.) and the Canadian Institutes of Health Research (CTP-79857 to M. P. and P. M. S.). Tissue banking activities at McGill were supported by the McGill University Health Centre Foundation and the "Banque de Tissues et de donnees" of the "Reseau de recherche sur le cancer" of the Fonds de recherche en sante du Quebec (M. P.). A.A.N.R. was supported by a studentship from the Fonds de recherche en sante du Quebec and M. G. A. was supported by a post-doctoral fellowship from the Canadian Institutes of Health Research. M. P. holds the Diane and Sal Guerrera Chair in Cancer Genetics at McGill University and P. M. S. acknowledges support from both the Canadian Cancer Society and the Fonds de recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; ABDELMAGID SM, 2010, J CELL BIOC IN PRESS; Ahn JH, 2002, BLOOD, V100, P1742, DOI 10.1182/blood.V100.5.1742.h81702001742_1742_1754; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Ghilardi C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-201; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kohga K, 2009, CANCER RES, V69, P8050, DOI 10.1158/0008-5472.CAN-09-0789; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Mettouchi A, 2006, EUR J CELL BIOL, V85, P243, DOI 10.1016/j.ejcb.2005.09.010; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Naumovski L, 2010, CURR OPIN MOL THER, V12, P248; Onaga M, 2003, J HEPATOL, V39, P779, DOI 10.1016/S0168-8278(03)00361-1; Pahl MV, 2010, CLIN J AM SOC NEPHRO, V5, P56, DOI 10.2215/CJN.03390509; PEPIN F, 2010, PNAS IN PRESS; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Qian XZ, 2008, MOL ONCOL, V2, P81, DOI 10.1016/j.molonc.2008.02.002; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Rose AAN, 2010, FUTURE ONCOL, V6, P55, DOI 10.2217/FON.09.138; Rucci Nadia, 2010, Front Biosci (Schol Ed), V2, P907; Selim AA, 2003, CRIT REV EUKAR GENE, V13, P265; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; TOMIHARI M, 2010, CANC RES; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; Williams MD, 2010, MELANOMA RES, V20, P184, DOI 10.1097/CMR.0b013e3283364a08; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	41	123	125	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12093	10.1371/journal.pone.0012093	http://dx.doi.org/10.1371/journal.pone.0012093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711474	gold, Green Submitted, Green Published			2022-12-25	WOS:000280811900031
J	Schmidt, KH; Viebranz, E; Doerfler, L; Lester, C; Rubenstein, A				Schmidt, Kristina H.; Viebranz, Emilie; Doerfler, Lillian; Lester, Christina; Rubenstein, Aaron			Formation of Complex and Unstable Chromosomal Translocations in Yeast	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; SACCHAROMYCES-CEREVISIAE HOMOLOG; ROTHMUND-THOMSON-SYNDROME; GENOME INSTABILITY; DNA-REPLICATION; ANAPHASE BRIDGES; RECQ FAMILY; REARRANGEMENTS; SGS1; SUPPRESSION	Genome instability, associated with chromosome breakage syndromes and most human cancers, is still poorly understood. In the yeast Saccharomyces cerevisiae, numerous genes with roles in the preservation of genome integrity have been identified. DNA-damage-checkpoint-deficient yeast cells that lack Sgs1, a RecQ-like DNA helicase related to the human Bloom's-syndrome-associated helicase BLM, show an increased rate of genome instability, and we have previously shown that they accumulate recurring chromosomal translocations between three similar genes, CAN1, LYP1 and ALP1. Here, the chromosomal location, copy number and sequence similarity of the translocation targets ALP1 and LYP1 were altered to gain insight into the formation of complex translocations. Among 844 clones with chromosomal rearrangements, 93 with various types of simple and complex translocations involving CAN1, LYP1 and ALP1 were identified. Breakpoint sequencing and mapping showed that the formation of complex translocation types is strictly dependent on the location of the initiating DNA break and revealed that complex translocations arise via a combination of interchromosomal translocation and template-switching, as well as from unstable dicentric intermediates. Template-switching occurred between sequences on the same chromosome, but was inhibited if the genes were transferred to different chromosomes. Unstable dicentric translocations continuously gave rise to clones with multiple translocations in various combinations, reminiscent of intratumor heterogeneity in human cancers. Base substitutions and evidence of DNA slippage near rearrangement breakpoints revealed that translocation formation can be accompanied by point mutations, and their presence in different translocation types within the same clone provides evidence that some of the different translocation types are derived from each other rather than being formed de novo. These findings provide insight into eukaryotic genome instability, especially the formation of translocations and the sources of intraclonal heterogeneity, both of which are often associated with human cancers.	[Schmidt, Kristina H.; Viebranz, Emilie; Doerfler, Lillian; Lester, Christina; Rubenstein, Aaron] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Schmidt, KH (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	kschmidt@usf.edu			National Institutes of Health [R01 GM081425]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM081425 to K.H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chan KL, 2009, CELL CYCLE, V8, P3065, DOI 10.4161/cc.8.19.9513; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chester N, 2006, MOL CELL BIOL, V26, P6713, DOI 10.1128/MCB.00296-06; Cobb JA, 2002, FEBS LETT, V529, P43, DOI 10.1016/S0014-5793(02)03269-6; Frei C, 2000, GENE DEV, V14, P81; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; HOJO ETS, 1995, MUTAT RES-ENVIR MUTA, V334, P59; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Morrow DM, 1997, GENETICS, V147, P371; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Paek AL, 2009, GENE DEV, V23, P2861, DOI 10.1101/gad.1862709; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Putnam CD, 2009, DNA REPAIR, V8, P974, DOI 10.1016/j.dnarep.2009.04.021; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; ROSIN MP, 1985, HUM GENET, V71, P187, DOI 10.1007/BF00284570; Schmidt KH, 2006, P NATL ACAD SCI USA, V103, P18196, DOI 10.1073/pnas.0608566103; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; Schmidt KH, 2006, METHOD ENZYMOL, V409, P462, DOI 10.1016/S0076-6879(05)09027-0; Selvarajah S, 2006, CHROMOSOMA, V115, P459, DOI 10.1007/s00412-006-0074-4; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; Wang LL, 2003, J NATL CANCER I, V95, P669, DOI 10.1093/jnci/95.9.669; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12007	10.1371/journal.pone.0012007	http://dx.doi.org/10.1371/journal.pone.0012007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711256	gold, Green Published, Green Submitted			2022-12-25	WOS:000280776800008
J	Williams, RJ; Anandanadesan, A; Purves, D				Williams, Richard J.; Anandanadesan, Ananthi; Purves, Drew			The Probabilistic Niche Model Reveals the Niche Structure and Role of Body Size in a Complex Food Web	PLOS ONE			English	Article							PREY; STABILITY; PATTERNS	The niche model has been widely used to model the structure of complex food webs, and yet the ecological meaning of the single niche dimension has not been explored. In the niche model, each species has three traits, niche position, diet position and feeding range. Here, a new probabilistic niche model, which allows the maximum likelihood set of trait values to be estimated for each species, is applied to the food web of the Benguela fishery. We also developed the allometric niche model, in which body size is used as the niche dimension. About 80% of the links in the empirical data are predicted by the probabilistic niche model, a significant improvement over recent models. As in the niche model, species are uniformly distributed on the niche axis. Feeding ranges are exponentially distributed, but diet positions are not uniformly distributed below the predator. Species traits are strongly correlated with body size, but the allometric niche model performs significantly worse than the probabilistic niche model. The best-fit parameter set provides a significantly better model of the structure of the Benguela food web than was previously available. The methodology allows the identification of a number of taxa that stand out as outliers either in the model's poor performance at predicting their predators or prey or in their parameter values. While important, body size alone does not explain the structure of the one-dimensional niche.	[Williams, Richard J.; Anandanadesan, Ananthi; Purves, Drew] Microsoft Res, Cambridge, England	Microsoft	Williams, RJ (corresponding author), Microsoft Res, Cambridge, England.	ricw@microsoft.com	Williams, Richard J/B-8344-2011	Williams, Richard J/0000-0001-8847-3213				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2009, ECOL LETT, V12, P652, DOI 10.1111/j.1461-0248.2009.01321.x; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Cohen J.E., 1990, COMMUNITY FOOD WEBS; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; COHEN JE, 1977, P NATL ACAD SCI USA, V74, P4533, DOI 10.1073/pnas.74.10.4533; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Drossel B, 2004, J THEOR BIOL, V229, P539, DOI 10.1016/j.jtbi.2004.04.033; Dunne J. A, 2006, ECOLOGICAL NETWORKS; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Hilborn Ray, 1997, V28; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Loeuille N, 2005, P NATL ACAD SCI USA, V102, P5761, DOI 10.1073/pnas.0408424102; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Morton RD, 1996, OIKOS, V75, P493, DOI 10.2307/3545891; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; Stouffer DB, 2006, P NATL ACAD SCI USA, V103, P19015, DOI 10.1073/pnas.0603844103; Stouffer DB, 2007, P ROY SOC B-BIOL SCI, V274, P1931, DOI 10.1098/rspb.2007.0571; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; WARREN PH, 1987, OECOLOGIA, V74, P231, DOI 10.1007/BF00379364; Warren Philip H., 1996, P142; Williams RJ, 2008, J ANIM ECOL, V77, P512, DOI 10.1111/j.1365-2656.2008.01362.x; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x	36	133	134	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12092	10.1371/journal.pone.0012092	http://dx.doi.org/10.1371/journal.pone.0012092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711506	Green Published, gold			2022-12-25	WOS:000280776800023
J	Liu, L; Mason, RP				Liu, Li; Mason, Ralph P.			Imaging beta-Galactosidase Activity in Human Tumor Xenografts and Transgenic Mice Using a Chemiluminescent Substrate	PLOS ONE			English	Article							LACZ GENE-EXPRESSION; IN-VIVO; REPORTER MOLECULE; SENSITIVE METHOD; TRANSFECTION	Background: Detection of enzyme activity or transgene expression offers potential insight into developmental biology, disease progression, and potentially personalized medicine. Historically, the lacZ gene encoding the enzyme beta-galactosidase has been the most common reporter gene and many chromogenic and fluorogenic substrates are well established, but limited to histology or in vitro assays. We now present a novel approach for in vivo detection of b-galactosidase using optical imaging to detect light emission following administration of the chemiluminescent 1,2-dioxetane substrate Galacto-Light PlusTM. Methodology and Principal Findings: B-gal activity was visualized in stably transfected human MCF7-lacZ tumors growing in mice. LacZ tumors were identified versus contralateral wild type tumors as controls, based on two-to tenfold greater light emission following direct intra tumoral or intravenous administration of reporter substrate. The 1,2-dioxetane substrate is commercially available as a kit for microplate-based assays for beta-gal detection, and we have adapted it for in vivo application. Typically, 100 mu l substrate mixture was administered intravenously and light emission was detected from the lacZ tumor immediately with gradual decrease over the next 20 mins. Imaging was also undertaken in transgenic ROSA26 mice following subcutaneous or intravenous injection of substrate mixture. Conclusion and Significance: Light emission was detectable using standard instrumentation designed for more traditional bioluminescent imaging. Use of 1,2-dioxetane substrates to detect enzyme activity offers a new paradigm for non-invasive biochemistry in vivo.	[Liu, Li; Mason, Ralph P.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.	Ralph.Mason@UTSouthwestern.edu	Liu, LI/B-6912-2013; Mason, Ralph/C-8472-2012	Liu, LI/0000-0002-9731-6145; Mason, Ralph/0000-0001-7517-3721	Department of Defense Breast Cancer Initiative [BC022001 DAMD 17-03-1-0343-01]; National Cancer Institute [R21 CA120774, U24 CA126608]; Department of Radiology and Simmons Comprehensive Cancer Center; National Institutes of Health [1S10RR024757]; NATIONAL CANCER INSTITUTE [U24CA126608, R21CA120774] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024757, P41RR002584] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Initiative(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Radiology and Simmons Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by Department of Defense Breast Cancer Initiative grant BC022001 DAMD 17-03-1-0343-01 (RPM) and National Cancer Institute R21 CA120774 (RPM) in conjunction with the Southwestern Small Animal Imaging Research Program (SW-SAIRP), which is supported by National Cancer Institute U24 CA126608, the Department of Radiology and Simmons Comprehensive Cancer Center. The IVIS Spectrum was purchased under a National Institutes of Health Shared Instrumentation Grant 1S10RR024757. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Celen S, 2009, BIOORGAN MED CHEM, V17, P5117, DOI 10.1016/j.bmc.2009.05.056; Chang YT, 2007, BIOCONJUGATE CHEM, V18, P1716, DOI 10.1021/bc070019s; Chilvers KF, 2001, J APPL MICROBIOL, V91, P1118, DOI 10.1046/j.1365-2672.2001.01484.x; Contero A, 2009, METHODS MOL BIOL, V574, P37, DOI 10.1007/978-1-60327-321-3_4; CUI W, 2010, MAGN RESON MED; Cui WN, 2004, MAGN RESON MED, V51, P616, DOI 10.1002/mrm.10719; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; James AL, 2000, LETT APPL MICROBIOL, V30, P336, DOI 10.1046/j.1472-765X.2000.00669.x; Kodibagkar VD, 2006, MAGN RESON IMAGING, V24, P959, DOI 10.1016/j.mri.2006.04.003; Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983; Lee KH, 2004, EUR J NUCL MED MOL I, V31, P433, DOI 10.1007/s00259-003-1395-7; Li L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717531; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Liu L, 2007, FASEB J, V21, P2014, DOI 10.1096/fj.06-7366lsf; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Masuda-Nishimura I, 2000, LETT APPL MICROBIOL, V30, P130, DOI 10.1046/j.1472-765X.2000.00683.x; Murakami T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2007947; Olesen CEM, 2000, METHOD ENZYMOL, V326, P175; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; Thorne SH, 2005, P IEEE, V93, P750, DOI 10.1109/JPROC.2005.844261; Tung CH, 2004, CANCER RES, V64, P1579, DOI 10.1158/0008-5472.CAN-03-3226; Van Dort ME, 2008, MOL IMAGING, V7, P187, DOI 10.2310/7290.2008.00020; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Yu JX, 2008, NMR BIOMED, V21, P704, DOI 10.1002/nbm.1244; Yu JX, 2004, BIOCONJUGATE CHEM, V15, P1334, DOI 10.1021/bc049936d; Zhang GJ, 2009, ASSAY DRUG DEV TECHN, V7, DOI 10.1089/adt.2009.0195; Zhao DW, 2008, FASEB J, V22, P2445, DOI 10.1096/fj.07-103713; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051	35	53	55	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12024	10.1371/journal.pone.0012024	http://dx.doi.org/10.1371/journal.pone.0012024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700459	Green Submitted, gold, Green Published			2022-12-25	WOS:000280687900016
J	Rinderknecht, M; Villa, A; Ballmer-Hofer, K; Neri, D; Detmar, M				Rinderknecht, Matthias; Villa, Alessandra; Ballmer-Hofer, Kurt; Neri, Dario; Detmar, Michael			Phage-Derived Fully Human Monoclonal Antibody Fragments to Human Vascular Endothelial Growth Factor-C Block Its Interaction with VEGF Receptor-2 and 3	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; LYMPH-NODE METASTASIS; TUMOR LYMPHANGIOGENESIS; MELANOMA METASTASIS; CELL PROLIFERATION; FACTOR (VEGF)-C; GASTRIC-CANCER; BINDING; DOMAIN; SPECIFICITY	Vascular endothelial growth factor C (VEGF-C) is a key mediator of lymphangiogenesis, acting via its receptors VEGF-R2 and VEGF-R3. High expression of VEGF-C in tumors correlates with increased lymphatic vessel density, lymphatic vessel invasion, sentinel lymph node metastasis and poor prognosis. Recently, we found that in a chemically induced skin carcinoma model, increased VEGF-C drainage from the tumor enhanced lymphangiogenesis in the sentinel lymph node and facilitated metastatic spread of cancer cells via the lymphatics. Hence, interference with the VEGF-C/VEGF-R3 axis holds promise to block metastatic spread, as recently shown by use of a neutralizing anti-VEGF-R3 antibody and a soluble VEGF-R3 (VEGF-C/D trap). By antibody phage-display, we have developed a human monoclonal antibody fragment (single-chain Fragment variable, scFv) that binds with high specificity and affinity to the fully processed mature form of human VEGF-C. The scFv binds to an epitope on VEGF-C that is important for receptor binding, since binding of the scFv to VEGF-C dose-dependently inhibits the binding of VEGF-C to VEGF-R2 and VEGF-R3 as shown by BIAcore and ELISA analyses. Interestingly, the variable heavy domain (V(H)) of the anti-VEGF-C scFv, which contains a mutation typical for camelid heavy chain-only antibodies, is sufficient for binding VEGF-C. This reduced the size of the potentially VEGF-C-blocking antibody fragment to only 14.6 kDa. Anti-VEGF-C V(H)-based immunoproteins hold promise to block the lymphangiogenic activity of VEGF-C, which would present a significant advance in inhibiting lymphatic-based metastatic spread of certain cancer types.	[Rinderknecht, Matthias; Neri, Dario; Detmar, Michael] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Villa, Alessandra] Swiss Fed Inst Technol, Philochem AG, Zurich, Switzerland; [Ballmer-Hofer, Kurt] Paul Scherrer Inst, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Rinderknecht, M (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Neri, Dario/P-4368-2016	Neri, Dario/0000-0001-5234-7370; Ballmer-Hofer, Kurt/0000-0002-3800-9129	National Institutes of Health [CA69184]; Swiss National Science Foundation [3100A0-108207, 3100A-116507, 2-77633-09]; Austrian Science Foundation [S9408-B11]; Cancer League Zurich; Oncosuisse [OC2 01200-08-2007]; Commission of the European Communities [LSHC-CT-2005-518178]; ETH Zurich; NATIONAL CANCER INSTITUTE [R01CA069184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Foundation(Austrian Science Fund (FWF)); Cancer League Zurich; Oncosuisse; Commission of the European Communities(European Commission); ETH Zurich(ETH Zurich); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA69184 (www.nih.gov), Swiss National Science Foundation grant 3100A0-108207 (www.snf.ch), Austrian Science Foundation grant S9408-B11 (www.fwf.ac.at), Cancer League Zurich (www.krebsliga-zh.ch), Oncosuisse (www.oncosuisse.ch) and Commission of the European Communities grant LSHC-CT-2005-518178 (www.cordis.europa.eu) issued to M. D.; Swiss National Science Foundation grant 3100A-116507 and Oncosuisse grant OC2 01200-08-2007 issued to K. B.-H.; and ETH Zurich and Swiss National Science Foundation grant 2-77633-09 issued to D.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2000, EUR J BIOCHEM, V267, P2505, DOI 10.1046/j.1432-1327.2000.01257.x; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Brack SS, 2006, CLIN CANCER RES, V12, P3200, DOI 10.1158/1078-0432.CCR-05-2804; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Dias S, 2002, BLOOD, V99, P2179, DOI 10.1182/blood.V99.6.2179; GRIBBEN JG, 1990, LANCET, V335, P434, DOI 10.1016/0140-6736(90)90665-R; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Jeltsch M, 2006, J BIOL CHEM, V281, P12187, DOI 10.1074/jbc.M511593200; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P1751; Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599; Karpusas M, 1998, CELL MOL LIFE SCI, V54, P1203, DOI 10.1007/s000180050248; Kodama M, 2008, CLIN CANCER RES, V14, P7205, DOI 10.1158/1078-0432.CCR-08-0818; KONDO R, 1993, J MOL EVOL, V36, P517, DOI 10.1007/BF00556356; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Matsuura M, 2009, AM J PATHOL, V175, P1709, DOI 10.2353/ajpath.2009.081139; Moehler TM, 2003, CRIT REV ONCOL HEMAT, V45, P227, DOI 10.1016/S1040-8428(02)00135-X; Muyldermans S, 1999, J MOL RECOGNIT, V12, P131, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<131::AID-JMR454>3.0.CO;2-M; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Orlandini M, 2006, J BIOL CHEM, V281, P17961, DOI 10.1074/jbc.M600413200; Rinderknecht M, 2008, J CELL PHYSIOL, V216, P347, DOI 10.1002/jcp.21494; Rinderknecht M, 2009, CANCER METAST BIOL T, V13, P55, DOI 10.1007/978-90-481-2247-9_4; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Scheidegger P, 1999, BIOL CHEM, V380, P1449, DOI 10.1515/BC.1999.187; Schliemann C, 2009, BLOOD, V113, P2275, DOI 10.1182/blood-2008-05-160747; Shimizu K, 2004, CANCER SCI, V95, P328, DOI 10.1111/j.1349-7006.2004.tb03211.x; Shin HY, 2002, PHYSIOL GENOMICS, V11, P245, DOI 10.1152/physiolgenomics.00068.2002; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Silacci M, 2005, PROTEOMICS, V5, P2340, DOI 10.1002/pmic.200401273; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, FASEB J, V16, P922, DOI 10.1096/fj.01-0945rev; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423, DOI 10.1110/ps.8.7.1423; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; Tomanek RJ, 2002, DEV DYNAM, V225, P233, DOI 10.1002/dvdy.10158; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Viti F, 2000, METHOD ENZYMOL, V326, P480; VOGEL F, 1977, J MOL EVOL, V9, P159, DOI 10.1007/BF01732746; Zhang Q, 2008, J BIOL CHEM, V283, P13491, DOI 10.1074/jbc.M708055200	46	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11941	10.1371/journal.pone.0011941	http://dx.doi.org/10.1371/journal.pone.0011941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689828	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520400016
J	Gill, JC; Wang, OL; Kakar, S; Martinelli, E; Carroll, RS; Kaiser, UB				Gill, John C.; Wang, Oulu; Kakar, Shelley; Martinelli, Enzo; Carroll, Rona S.; Kaiser, Ursula B.			Reproductive Hormone-Dependent and -Independent Contributions to Developmental Changes in Kisspeptin in GnRH-Deficient Hypogonadal Mice	PLOS ONE			English	Article							KISS1 GENE-EXPRESSION; SEXUAL-DIFFERENTIATION; GONADOTROPIN-SECRETION; HYPOTHALAMUS; NEURONS; ACTIVATION; RECEPTOR; BRAIN; ESTROGEN; FEEDBACK	Kisspeptin is a potent activator of GnRH-induced gonadotropin secretion and is a proposed central regulator of pubertal onset. In mice, there is a neuroanatomical separation of two discrete kisspeptin neuronal populations, which are sexually dimorphic and are believed to make distinct contributions to reproductive physiology. Within these kisspeptin neuron populations, Kiss1 expression is directly regulated by sex hormones, thereby confounding the roles of sex differences and early activational events that drive the establishment of kisspeptin neurons. In order to better understand sex steroid hormone-dependent and -independent effects on the maturation of kisspeptin neurons, hypogonadal (hpg) mice deficient in GnRH and its downstream effectors were used to determine changes in the developmental kisspeptin expression. In hpg mice, sex differences in Kiss1 mRNA levels and kisspeptin immunoreactivity, typically present at 30 days of age, were absent in the anteroventral periventricular nucleus (AVPV). Although immunoreactive kisspeptin increased from 10 to 30 days of age to levels intermediate between wild type (WT) females and males, corresponding increases in Kiss1 mRNA were not detected. In contrast, the hpg arcuate nucleus (ARC) demonstrated a 10-fold increase in Kiss1 mRNA between 10 and 30 days in both females and males, suggesting that the ARC is a significant center for sex steroid-independent pubertal kisspeptin expression. Interestingly, the normal positive feedback response of AVPV kisspeptin neurons to estrogen observed in WT mice was lost in hpg females, suggesting that exposure to reproductive hormones during development may contribute to the establishment of the ovulatory gonadotropin surge mechanism. Overall, these studies suggest that the onset of pubertal kisspeptin expression is not dependent on reproductive hormones, but that gonadal sex steroids critically shape the hypothalamic kisspeptin neuronal subpopulations to make distinct contributions to the activation and control of the reproductive hormone cascade at the time of puberty.	[Gill, John C.; Kakar, Shelley; Martinelli, Enzo; Carroll, Rona S.; Kaiser, Ursula B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Gill, John C.; Kakar, Shelley; Martinelli, Enzo; Carroll, Rona S.; Kaiser, Ursula B.] Harvard Reprod Endocrine Sci Ctr, Boston, MA USA; [Wang, Oulu] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Gill, JC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA.	JCGILL@PARTNERS.ORG			Eunice Kennedy Shriver NICHD/NIH [U54 HD28138]; Building Interdisciplinary Research Careers in Women's Health (BIRCWH) [Harvard K12 HD051959]; NIH Office of Research in Women's Health;  [R01 HD61577]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028138, K12HD051959] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD061577] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Building Interdisciplinary Research Careers in Women's Health (BIRCWH); NIH Office of Research in Women's Health; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Eunice Kennedy Shriver NICHD/NIH through cooperative agreement U54 HD28138 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (UBK), by R01 HD61577 (UBK), and by the Harvard K12 HD051959 Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Program supported by the NIH Office of Research in Women's Health (JCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; ANDREWS WW, 1981, ENDOCRINOLOGY, V109, P2022, DOI 10.1210/endo-109-6-2022; Bakker J, 2010, HORM BEHAV, V57, P390, DOI 10.1016/j.yhbeh.2009.11.005; Bentsen AH, 2010, PEPTIDES, V31, P275, DOI 10.1016/j.peptides.2009.11.017; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; Chappell PE, 1997, ENDOCRINOLOGY, V138, P4147, DOI 10.1210/en.138.10.4147; Clarkson J, 2009, ENDOCRINOLOGY; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Colledge WH, 2009, TRENDS ENDOCRIN MET, V20, P115, DOI 10.1016/j.tem.2008.10.005; CONTE FA, 1975, J CLIN ENDOCR METAB, V40, P670, DOI 10.1210/jcem-40-4-670; CORE AC, 2002, GNRH MASTER MOL; Fetissov SO, 2005, EUR J NEUROSCI, V22, P3217, DOI 10.1111/j.1460-9568.2005.04513.x; Gonzalez-Martinez D, 2008, ENDOCRINOLOGY, V149, P2333, DOI 10.1210/en.2007-1422; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; HASHIZUME K, 1995, EXP ANIM TOKYO, V44, P241, DOI 10.1538/expanim.44.241; Homma T, 2009, BIOL REPROD, V81, P1216, DOI 10.1095/biolreprod.109.078311; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kauffman AS, 2007, J NEUROSCI, V27, P8826, DOI 10.1523/JNEUROSCI.2099-07.2007; Kauffman AS, 2007, ENDOCRINOLOGY, V148, P1774, DOI 10.1210/en.2006-1540; Kauffman AS, 2010, MOL CELL ENDOCRINOL, V324, P51, DOI 10.1016/j.mce.2010.01.017; Kauffman AS, 2009, AM J PHYSIOL-ENDOC M, V297, pE1212, DOI 10.1152/ajpendo.00461.2009; Kauffman AS, 2009, PEPTIDES, V30, P83, DOI 10.1016/j.peptides.2008.06.014; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lima FB, 2008, BRAIN RES, V1227, P76, DOI 10.1016/j.brainres.2008.05.078; MA YJ, 1994, MOL CELL NEUROSCI, V5, P246, DOI 10.1006/mcne.1994.1029; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Plant TM, 2004, HUM REPROD UPDATE, V10, P67, DOI 10.1093/humupd/dmh001; Ramaswamy S, 2008, ENDOCRINOLOGY, V149, P4387, DOI 10.1210/en.2008-0438; RAMIREZ DV, 1963, ENDOCRINOLOGY, V72, P452, DOI 10.1210/endo-72-3-452; Rance NE, 2009, PEPTIDES, V30, P111, DOI 10.1016/j.peptides.2008.05.016; Roa J, 2006, ENDOCRINOLOGY, V147, P2864, DOI 10.1210/en.2005-1463; Rometo AM, 2008, J NEUROENDOCRINOL, V20, P1376, DOI 10.1111/j.1365-2826.2008.01796.x; Rometo AM, 2007, J CLIN ENDOCR METAB, V92, P2744, DOI 10.1210/jc.2007-0553; Smith JT, 2005, ENDOCRINOLOGY, V146, P2976, DOI 10.1210/en.2005-0323; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Takase K, 2009, J NEUROENDOCRINOL, V21, P527, DOI 10.1111/j.1365-2826.2009.01868.x; Wang Y, 2005, BIOL REPROD, V73, P610, DOI 10.1095/biolreprod.105.039602	44	66	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11911	10.1371/journal.pone.0011911	http://dx.doi.org/10.1371/journal.pone.0011911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689830	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520300025
J	Fu, XP; Tao, LH; Rivera, A; Williamson, S; Song, XT; Ahmed, N; Zhang, XL				Fu, Xinping; Tao, Lihua; Rivera, Armando; Williamson, Shana; Song, Xiao-Tong; Ahmed, Nabil; Zhang, Xiaoliu			A Simple and Sensitive Method for Measuring Tumor-Specific T Cell Cytotoxicity	PLOS ONE			English	Article							MEDIATED CYTOTOXICITY; TARGET-CELLS; ASSAY; PIGGYBAC; RECEPTORS	A simple and sensitive method to quantitatively measure the cytolytic effect of tumor-specific T killer cells is highly desirable for basic and clinical studies. Chromium ((51)Cr) release assay has been the "gold standard'' for quantifying cytolytic activities of cytotoxic T lymphocytes (CTLs) against target cells and this method is still being used in many laboratories. However, a major drawback of this method is the use of radioactive materials, which is inconvenient to handle because of environmental safety concerns and expensive due to the short half-life of the isotope. Consequently, several nonradioactive methods have been reported recently. Here we report a new method that we recently developed for quantifying antigen-specific cytolytic activity of CTLs. This method fully exploits the high sensitivity and the relative simplicity of luciferase quantitative assay. We initially expected the released luciferase in the supernatant to be the adequate source for monitoring cell death. However, to our total surprise, incubation of these killer T cells with the tumor cell targets did not result in significant release of luciferase in the culture medium. Instead, we found that the remaining luciferase inside the cells could accurately reflect the overall cell viability.	[Fu, Xinping; Tao, Lihua; Rivera, Armando; Zhang, Xiaoliu] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Williamson, Shana; Zhang, Xiaoliu] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Song, Xiao-Tong; Ahmed, Nabil] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine	Fu, XP (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	shaunzhang@uh.edu	Song, Xiao-Tong/AAI-8424-2020	Zhang, Shaun/0000-0002-2085-3997	NIH/National Cancer Institute [R01CA106671, R01CA132792]; NATIONAL CANCER INSTITUTE [R01CA132792, R01CA106671] Funding Source: NIH RePORTER	NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/National Cancer Institute grants R01CA106671 and R01CA132792 (to XZ). http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, CANCER RES, V67, P5957, DOI 10.1158/0008-5472.CAN-06-4309; Andre ND, 2004, J CLIN LAB ANAL, V18, P27, DOI 10.1002/jcla.20006; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Ayres FM, 2003, IMMUNOL INVEST, V32, P219, DOI 10.1081/IMM-120025102; Chen K, 2005, J IMMUNOL METHODS, V300, P100, DOI 10.1016/j.jim.2005.02.010; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Haynes NM, 2002, BLOOD, V100, P3155, DOI 10.1182/blood-2002-04-1041; Hoppner M, 2002, J IMMUNOL METHODS, V267, P157, DOI 10.1016/S0022-1759(02)00167-9; Kurschus FC, 2008, P NATL ACAD SCI USA, V105, P13799, DOI 10.1073/pnas.0801724105; Li X, 2001, MOL GENET GENOMICS, V266, P190, DOI 10.1007/s004380100525; Nakazawa Y, 2009, J IMMUNOTHER, V32, P826, DOI 10.1097/CJI.0b013e3181ad762b; Nelson DL, 2001, CURR PROTOC IMMUNOL, V7, P27, DOI [10.1002/0471142735.im0727s08, 10.1002/0471142735.IM0727S08, DOI 10.1002/0471142735.IM0727S08]; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; van Baalen CA, 2005, J INFECT DIS, V192, P1183, DOI 10.1086/444546; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028	16	47	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11867	10.1371/journal.pone.0011867	http://dx.doi.org/10.1371/journal.pone.0011867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686618	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520200030
J	Panebra, A; Wang, WC; Malone, MM; Pitter, DRG; Weiss, ST; Hawkins, GA; Liggett, SB				Panebra, Alfredo; Wang, Wayne C.; Malone, Molly M.; Pitter, Demar R. G.; Weiss, Scott T.; Hawkins, Gregory A.; Liggett, Stephen B.			Common ADRB2 Haplotypes Derived from 26 Polymorphic Sites Direct beta(2)-Adrenergic Receptor Expression and Regulation Phenotypes	PLOS ONE			English	Article							HEART-FAILURE; THERAPY; ASTHMA	Background: The beta(2)-adrenergic receptor (beta(2)AR) is expressed on numerous cell-types including airway smooth muscle cells and cardiomyocytes. Drugs (agonists or antagonists) acting at these receptors for treatment of asthma, chronic obstructive pulmonary disease, and heart failure show substantial interindividual variability in response. The ADRB2 gene is polymorphic in noncoding and coding regions, but virtually all ADRB2 association studies have utilized the two common nonsynonymous coding SNPs, often reaching discrepant conclusions. Methodology/Principal Findings: We constructed the 8 common ADRB2 haplotypes derived from 26 polymorphisms in the promoter, 5'UTR, coding, and 3'UTR of the intronless ADRB2 gene. These were cloned into an expression construct lacking a vector-based promoter, so that beta(2)AR expression was driven by its promoter, and steady state expression could be modified by polymorphisms throughout ADRB2 within a haplotype. "Whole-gene'' transfections were performed with COS-7 cells and revealed 4 haplotypes with increased cell surface beta(2)AR protein expression compared to the others. Agonist-promoted downregulation of beta(2)AR protein expression was also haplotype-dependent, and was found to be increased for 2 haplotypes. A phylogenetic tree of the haplotypes was derived and annotated by cellular phenotypes, revealing a pattern potentially driven by expression. Conclusions/Significance: Thus for obstructive lung disease, the initial bronchodilator response from intermittent administration of beta-agonist may be influenced by certain beta(2)AR haplotypes (expression phenotypes), while other haplotypes may influence tachyphylaxis during the response to chronic therapy (downregulation phenotypes). An ideal clinical outcome of high expression and less downregulation was found for two haplotypes. Haplotypes may also affect heart failure antagonist therapy, where beta(2)AR increase inotropy and are anti-apoptotic. The haplotype-specific expression and regulation phenotypes found in this transfection-based system suggest that the density of genetic information in the form of these haplotypes, or haplotype-clusters with similar phenotypes can potentially provide greater discrimination of phenotype in human disease and pharmacogenomic association studies.	[Panebra, Alfredo; Wang, Wayne C.; Malone, Molly M.; Pitter, Demar R. G.; Liggett, Stephen B.] Univ Maryland, Cardiopulm Genom Program, Baltimore, MD 21201 USA; [Weiss, Scott T.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; [Hawkins, Gregory A.] Wake Forest Univ, Winston Salem, NC 27109 USA	University System of Maryland; University of Maryland Baltimore; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Wake Forest University	Panebra, A (corresponding author), Univ Maryland, Cardiopulm Genom Program, Baltimore, MD 21201 USA.	sligg001@umaryland.edu	liggett, stephen b/E-7453-2012	Panebra, Alfredo/0000-0002-2520-9746; Liggett, Stephen B./0000-0002-0128-3669	United States National Institutes of Health [HL065899, HL045967]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL045967, U01HL065899, R37HL045967, R01HL045967] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by a United States National Institutes of Health grant HL065899 and HL045967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PJ, 1995, AM J RESP CRIT CARE, V152, P838, DOI 10.1164/ajrccm.152.3.7663795; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Bristow M, 2003, CIRCULATION, V107, P1100, DOI 10.1161/01.CIR.0000054530.87613.36; Dorn GW, 2009, MOL PHARMACOL, V76, P466, DOI 10.1124/mol.109.056572; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; HALL IP, 2006, PHARMACOGENETICS, P91; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; LIGGETT SB, 1996, BETA2 AGONISTS ASTHM, P19; Liggett SB, 2005, RECEPTORS, P339; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo K, 1996, GENE, V182, P13, DOI 10.1016/S0378-1119(96)00438-6; McGraw DW, 1998, J CLIN INVEST, V102, P1927, DOI 10.1172/JCI4862; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Panebra A, 2008, AM J PHYSIOL-LUNG C, V294, pL190, DOI 10.1152/ajplung.00277.2007; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Small KM, 2000, J BIOL CHEM, V275, P23059, DOI 10.1074/jbc.M000796200; Small KM, 2004, P NATL ACAD SCI USA, V101, P13020, DOI 10.1073/pnas.0405074101; TURKI J, 1995, AM J PHYSIOL-LUNG C, V269, pL709, DOI 10.1152/ajplung.1995.269.5.L709; van Campen LCMC, 1998, J CARDIOVASC PHARM, V32, pS31, DOI 10.1097/00005344-199806321-00006; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; WORTSMAN J, 1984, AM J MED, V77, P779, DOI 10.1016/0002-9343(84)90512-6	25	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11819	10.1371/journal.pone.0011819	http://dx.doi.org/10.1371/journal.pone.0011819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686604	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200006
J	Teng, ACT; Kuraitis, D; Deeke, SA; Ahmadi, A; Dugan, SG; Cheng, BLM; Crowson, MG; Burgon, PG; Suuronen, EJ; Chen, HH; Stewart, AFR				Teng, Allen C. T.; Kuraitis, Drew; Deeke, Shelley A.; Ahmadi, Ali; Dugan, Stephen G.; Cheng, Brian L. M.; Crowson, Matthew G.; Burgon, Patrick G.; Suuronen, Erik J.; Chen, Hsiao-Huei; Stewart, Alexandre F. R.			IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression	FASEB JOURNAL			English	Article						vascular endothelial growth factor; transcription factors; VGLL4; TEAD4	ENDOTHELIAL GROWTH-FACTOR; TRANSCRIPTION FACTOR RTEF-1; ENHANCER FACTOR-I; GENE-EXPRESSION; CHORIORETINAL ATROPHY; WING FORMATION; TEF-1 FAMILY; PROTEIN; DIFFERENTIATION; IDENTIFICATION	We sought to identify an essential component of the TEAD4/VGLL4 transcription factor complex that controls vascular endothelial growth factor A (VEGFA) expression in muscle. A yeast 2-hybrid screen was used to clone a novel component of the TEAD4 complex from a human heart cDNA library. We identified interferon response factor 2 binding protein 2 (IRF2BP2) and confirmed its presence in the TEAD4/VGLL4 complex in vivo by coimmunoprecipitation and mammalian 2-hybrid assays. Coexpression of IRF2BP2 with TEAD4/VGLL4 or TEAD1 alone potently activated, whereas knockdown of IRF2BP2 reduced, VEGFA expression in C2C12 muscle cells. Thus, IRF2BP2 is required to activate VEGFA expression. In mouse embryos, IRF2BP2 was ubiquitously expressed but became progressively enriched in the fetal heart, skeletal muscles, and lung. Northern blot analysis revealed high levels of IRF2BP2 mRNA in adult human heart and skeletal muscles, but immunoblot analysis showed low levels of IRF2BP2 protein in skeletal muscle, indicating post-transcriptional regulation of IRF2BP2 expression. IRF2BP2 protein levels are markedly increased by ischemia in skeletal and cardiac muscle compared to normoxic controls. IRF2BP2 is a novel ischemia-induced coactivator of VEGFA expression that may contribute to revascularization of ischemic cardiac and skeletal muscles.-Teng, A. C. T., Kuraitis, D., Deeke, S. A., Ahmadi, A., Dugan, S. G., Cheng, B. L. M., Crowson, M. G., Burgon, P. G., Suuronen, E. J., Chen, H.-H., Stewart, A. F. R. IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression. FASEB J. 24, 4825-4834 (2010). www.fasebj.org	[Teng, Allen C. T.; Kuraitis, Drew; Deeke, Shelley A.; Ahmadi, Ali; Dugan, Stephen G.; Cheng, Brian L. M.; Crowson, Matthew G.; Burgon, Patrick G.; Suuronen, Erik J.; Stewart, Alexandre F. R.] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Chen, Hsiao-Huei] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute	Stewart, AFR (corresponding author), Univ Ottawa, Inst Heart, 40 Ruskin Rd,H3100, Ottawa, ON K1Y 4W7, Canada.	astewart@ottawaheart.ca	Crowson, Matthew/L-7356-2013; Stewart, Alexandre F.R./A-5677-2011; Crowson, Matthew/X-6751-2019; Burgon, Patrick/ABB-1027-2021	Crowson, Matthew/0000-0001-9950-0985; Crowson, Matthew/0000-0001-9950-0985; Stewart, Alexandre/0000-0003-2673-9164; Burgon, Patrick/0000-0003-4771-023X; Chen, Hsiao-Huei/0000-0003-2914-6057	Canadian Institutes of Health Research [AFRS MOP77682, PGB MOP82748, HHC MOP179197]; Heart and Stroke Foundation of Ontario [ES NA6121, HHC NA6301]; Ontario Graduate Scholarship in Science and Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Graduate Scholarship in Science and Technology	This work was supported by operating grants from the Canadian Institutes of Health Research (AFRS MOP77682, PGB MOP82748, HHC MOP179197), by a grant in aid from the Heart and Stroke Foundation of Ontario (ES NA6121, HHC NA6301), by a master's studentship award from the Heart and Stroke Foundation of Ontario (D.K.), and by an Ontario Graduate Scholarship in Science and Technology (A.T.).	Appukuttan B, 2007, INVEST OPHTH VIS SCI, V48, P3775, DOI 10.1167/iovs.06-1172; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Barth AS, 2009, CIRC-CARDIOVASC GENE, V2, P371, DOI 10.1161/CIRCGENETICS.108.832345; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Brasen JH, 2001, ARTERIOSCL THROM VAS, V21, P1720, DOI 10.1161/hq1101.098230; Breen E, 2008, HIGH ALT MED BIOL, V9, P158, DOI 10.1089/ham.2008.1010; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen HH, 2004, GENESIS, V39, P273, DOI 10.1002/gene.20055; Chen HH, 2004, J BIOL CHEM, V279, P30800, DOI 10.1074/jbc.M400154200; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; Desper R, 2004, MOL BIOL EVOL, V21, P587, DOI 10.1093/molbev.msh049; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Faresse N, 2008, EMBO J, V27, P1804, DOI 10.1038/emboj.2008.109; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fossdal R, 2004, HUM MOL GENET, V13, P975, DOI 10.1093/hmg/ddh106; Gunther S, 2004, NUCLEIC ACIDS RES, V32, P791, DOI 10.1093/nar/gkh248; Gupta M, 2001, J BIOL CHEM, V276, P10413, DOI 10.1074/jbc.M008625200; Gupta MP, 1997, MOL CELL BIOL, V17, P3924, DOI 10.1128/MCB.17.7.3924; Harpster MH, 2006, MAMM GENOME, V17, P701, DOI 10.1007/s00335-005-0120-1; Heger S, 2007, J CLIN INVEST, V117, P2145, DOI 10.1172/JCI31752; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Jonasson F, 2007, ACTA OPHTHALMOL SCAN, V85, P862, DOI 10.1111/j.1600-0420.2007.01002.x; Koeppel M, 2009, NUCLEIC ACIDS RES, V37, P322, DOI 10.1093/nar/gkn940; Krishnan J, 2008, CIRC RES, V103, P1139, DOI 10.1161/01.RES.0000338613.89841.c1; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Mielcarek M, 2002, MECH DEVELOP, V119, pS269, DOI 10.1016/S0925-4773(03)00127-8; Mielcarek M, 2009, GENE EXPR PATTERNS, V9, P129, DOI 10.1016/j.gep.2008.12.002; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Sudarsan V, 2001, DEV CELL, V1, P829, DOI 10.1016/S1534-5807(01)00089-2; Teng ACT, 2009, FASEB J, V23, P1705, DOI 10.1096/fj.08-120998; Tsika RW, 2008, J BIOL CHEM, V283, P36154, DOI 10.1074/jbc.M807461200; Ueyama T, 2000, J BIOL CHEM, V275, P17476, DOI 10.1074/jbc.M001970200; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vaudin P, 1999, DEVELOPMENT, V126, P4807; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200	47	50	53	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4825	4834		10.1096/fj.10-167049	http://dx.doi.org/10.1096/fj.10-167049			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20702774				2022-12-25	WOS:000284824400022
J	Jimenez-Vidal, M; Srivastava, J; Putney, LK; Barber, DL				Jimenez-Vidal, Maite; Srivastava, Jyoti; Putney, Luanna K.; Barber, Diane L.			Nuclear-localized Calcineurin Homologous Protein CHP1 Interacts with Upstream Binding Factor and Inhibits Ribosomal RNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR UBF; POLYMERASE-I TRANSCRIPTION; TERMINAL ACTIVATION DOMAIN; CA2+-BINDING PROTEIN; GENE-TRANSCRIPTION; NA+/H+ EXCHANGER; DEPENDENT MANNER; PHOSPHORYLATION; P22; MICROTUBULES	Calcineurin homologous protein 1 (CHP1) is a widely expressed, 22-kDa myristoylated EF-hand Ca2+-binding protein that shares a high degree of similarity with the regulatory B subunit of calcineurin (65%) and with calmodulin (59%). CHP1 localizes to the plasma membrane, the Golgi apparatus, and the nucleus and functions to regulate trafficking of early secretory vesicles, activation of T cells, and expression and transport of the Na-H exchanger NHE1. Although CHP1 contains nuclear export signals, whether its nuclear and cytoplasmic localization is regulated and has distinct functions remain unknown. We show that CHP1 is predominantly in the nucleus in quiescent fibro-basts, is translocated to cytoplasmic compartments with growth medium, and that translocation is inhibited by mutations in the nuclear export motifs. In a screen for proteins co-precipitating with CHP1 in quiescent cells we identified the upstream binding factor UBF, a DNA-binding protein and component of the RNA polymerase I complex regulating RNA synthesis. The CHP1-UBF interaction is restricted to the nucleus and inhibited by Ca2+. Nuclear retention of CHP1 attenuates the abundance of UBF in the nucleolus and inhibits RNA synthesis when quiescent cells are transferred to growth medium. These data show UBF as a newly identified CHP1-binding protein and regulation of RNA synthesis as a newly identified function for nuclear-localized CHP1, which is distinct from CHP1 functions in the cytosol.	[Jimenez-Vidal, Maite; Srivastava, Jyoti; Putney, Luanna K.; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, HSW618, San Francisco, CA 94143 USA.	diane.barber@ucsf.edu			National Institutes of Health [GM47413, F32 GM63465]; National Center for Research Resources, National Institutes of Health [C06RR16490]; Spanish Ministry of Science and Education; Office of Ethics, Compliance and Audit Services, University of California, Office of the President, Oakland [CA 94607-5200]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM063465, R01GM047413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Spanish Ministry of Science and Education(Spanish Government); Office of Ethics, Compliance and Audit Services, University of California, Office of the President, Oakland(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47413 (to D. L. B.). Work was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06RR16490 from the National Center for Research Resources, National Institutes of Health.; Supported by a postdoctoral fellowship from the Spanish Ministry of Science and Education.; Supported by National Institutes of Health Postdoctoral Fellowship F32 GM63465. Present address: Director of Research Compliance, Office of Ethics, Compliance and Audit Services, University of California, Office of the President, Oakland, CA 94607-5200.	Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Bell P, 1997, J CELL SCI, V110, P2053; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Comai L, 2004, ADV PROTEIN CHEM, V67, P123; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; Drakas R, 2004, P NATL ACAD SCI USA, V101, P9272, DOI 10.1073/pnas.0403328101; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; Jin Q, 2007, IN VIVO, V21, P593; Jordan P, 1996, J CELL BIOL, V133, P225, DOI 10.1083/jcb.133.2.225; Kuwahara H, 2003, J BIOCHEM, V134, P245, DOI 10.1093/jb/mvg137; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Matsumoto M, 2001, J BIOCHEM, V130, P217, DOI 10.1093/oxfordjournals.jbchem.a002975; Matsushita M, 2007, AM J PHYSIOL-CELL PH, V293, pC246, DOI 10.1152/ajpcell.00464.2006; Nagita M, 2003, J BIOCHEM, V134, P919, DOI 10.1093/jb/mvg223; Nakamura N, 2002, J BIOCHEM, V132, P483, DOI 10.1093/oxfordjournals.jbchem.a003246; Naoe Y, 2005, J BIOL CHEM, V280, P32372, DOI 10.1074/jbc.M503390200; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Tuan JC, 1999, MOL CELL BIOL, V19, P2872; VOIT R, 1995, NUCLEIC ACIDS RES, V23, P2593, DOI 10.1093/nar/23.14.2593	29	10	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36260	36266		10.1074/jbc.M110.165555	http://dx.doi.org/10.1074/jbc.M110.165555			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20720019	hybrid, Green Published			2022-12-25	WOS:000284146100005
J	Ishii, K; Hamamoto, H; Imamura, K; Adachi, T; Shoji, M; Nakayama, K; Sekimizu, K				Ishii, Kenichi; Hamamoto, Hiroshi; Imamura, Katsutoshi; Adachi, Tatsuo; Shoji, Mikio; Nakayama, Koji; Sekimizu, Kazuhisa			Porphyromonas gingivalis Peptidoglycans Induce Excessive Activation of the Innate Immune System in Silkworm Larvae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTOR; CELL-WALL COMPONENTS; BOMBYX-MORI; PARALYTIC PEPTIDE; MELANIZATION CASCADE; HOST-DEFENSE; DROSOPHILA; PROTEIN; PROPHENOLOXIDASE; INFECTION	Porphyromonas gingivalis, a pathogen that causes inflammation in human periodontal tissue, killed silkworm (Bombyx mori, Lepidoptera) larvae when injected into the blood (hemolymph). Silkworm lethality was not rescued by antibiotic treatment, and heat-killed bacteria were also lethal. Heat-killed bacteria of mutant P. gingivalis strains lacking virulence factors also killed silkworms. Silkworms died after injection of peptidoglycans purified from P. gingivalis (pPG), and pPG toxicity was blocked by treatment with mutanolysin, a peptidoglycan-degrading enzyme. pPG induced silkworm hemolymph melanization at the same dose as that required to kill the animal. pPG injection increased caspase activity in silkworm tissues. pPG-induced silkworm death was delayed by injecting melanization-inhibiting reagents (a serine protease inhibitor and 1-phenyl-2-thiourea), antioxidants (N-acetyl-L-cysteine, glutathione, and catalase), and a caspase inhibitor (Ac-DEVD-CHO). Thus, pPG induces excessive activation of the innate immune response, which leads to the generation of reactive oxygen species and apoptotic cell death in the host tissue.	[Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo 1130033, Japan; [Shoji, Mikio; Nakayama, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Div Microbiol & Oral Infect, Dept Mol Microbiol & Immunol, Nagasaki 8528588, Japan	University of Tokyo; Nagasaki University	Sekimizu, K (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Shoji, Mikio/J-8283-2018; Ishii, Kenichi/H-5469-2019; Hamamoto, Hiroshi/G-6397-2019	Shoji, Mikio/0000-0002-7605-4721; Hamamoto, Hiroshi/0000-0001-9315-7442	Japan Society for the Promotion of Science [21790063, 2110519]; National Institute of Biomedical Innovation; Genome Pharmaceuticals Co. Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Genome Pharmaceuticals Co. Ltd.	This work was supported by Grant-in-aid for Young Scientists (B) 21790063 and Grant-in-aid for Japan Society for the Promotion of Science Fellows 2110519 from Japan Society for the Promotion of Science. This work was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation and grants from Genome Pharmaceuticals Co. Ltd.	Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; ASHIDA M, 1981, INSECT BIOCHEM, V11, P57, DOI 10.1016/0020-1790(81)90041-X; Bainbridge BW, 2001, ACTA ODONTOL SCAND, V59, P131, DOI 10.1080/000163501750266710; BARNARD MR, 1985, CAN J MICROBIOL, V31, P154, DOI 10.1139/m85-030; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; DUNCAN CL, 1968, APPL MICROBIOL, V16, P82, DOI 10.1128/AEM.16.1.82-89.1968; Filipe SR, 2005, EMBO REP, V6, P327, DOI 10.1038/sj.embor.7400371; Gibson FC, 2006, J DENT RES, V85, P106, DOI 10.1177/154405910608500202; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2009, COMP BIOCHEM PHYS C, V149, P334, DOI 10.1016/j.cbpc.2008.08.008; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huang QH, 2001, BBA-MOL CELL RES, V1499, P191, DOI 10.1016/S0167-4889(00)00105-1; Iketani M, 1999, INSECT BIOCHEM MOLEC, V29, P19, DOI 10.1016/S0965-1748(98)00099-X; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Miura K, 2002, PEPTIDES, V23, P2111, DOI 10.1016/S0196-9781(02)00254-1; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; O'Brien-Simpson NM, 2001, INFECT IMMUN, V69, P7527, DOI 10.1128/IAI.69.12.7527-7534.2001; Ortolani O, 2000, AM J RESP CRIT CARE, V161, P1907, DOI 10.1164/ajrccm.161.6.9903043; Pavel S, 2004, EUR J CANCER, V40, P1423, DOI 10.1016/j.ejca.2003.11.035; Pei ZF, 2002, J BIOL CHEM, V277, P48677, DOI 10.1074/jbc.M208810200; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Sekimizu K, 2005, J BIOCHEM, V137, P199, DOI 10.1093/jb/mvi019; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Shinzawa N, 2009, CELL HOST MICROBE, V6, P244, DOI 10.1016/j.chom.2009.07.010; Smit NPM, 2008, PHOTOCHEM PHOTOBIOL, V84, P550, DOI 10.1111/j.1751-1097.2007.00242.x; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Uehara A, 2005, J IMMUNOL, V175, P6076, DOI 10.4049/jimmunol.175.9.6076; VASSTRAND EN, 1979, INFECT IMMUN, V25, P775, DOI 10.1128/IAI.25.3.775-780.1979; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	47	40	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33338	33347		10.1074/jbc.M110.112987	http://dx.doi.org/10.1074/jbc.M110.112987			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702417	hybrid, Green Published			2022-12-25	WOS:000283048200069
J	Ali, SS; Marcondes, MCG; Bajova, H; Dugan, LL; Conti, B				Ali, Sameh S.; Marcondes, Maria-Cecilia Garibaldi; Bajova, Hilda; Dugan, Laura L.; Conti, Bruno			Metabolic Depression and Increased Reactive Oxygen Species Production by Isolated Mitochondria at Moderately Lower Temperatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; BODY-TEMPERATURE; UNCOUPLING PROTEINS; ENERGY-METABOLISM; SPIN TRAPS; RAT-BRAIN; LIFE-SPAN; SUPEROXIDE; MECHANISM	Temperature (T) reduction increases lifespan, but the mechanisms are not understood. Because reactive oxygen species (ROS) contribute to aging, we hypothesized that lowering T might decrease mitochondrial ROS production. We measured respiratory response and ROS production in isolated mitochondria at 32, 35, and 37 degrees C. Lowering T decreased the rates of resting (state 4) and phosphorylating (state 3) respiration phases. Surprisingly, this respiratory slowdown was associated with an increase of ROS production and hydrogen peroxide release and with elevation of the mitochondrial membrane potential, Delta Psi(m). We also found that at lower T mitochondria produced more carbon-centered lipid radicals, a species known to activate uncoupling proteins. These data indicate that reduced mitochondrial ROS production is not one of the mechanisms mediating lifespan extension at lower T. They suggest instead that increased ROS leakage may mediate mitochondrial responses to hypothermia.	[Ali, Sameh S.; Marcondes, Maria-Cecilia Garibaldi; Bajova, Hilda; Conti, Bruno] Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA; [Ali, Sameh S.; Dugan, Laura L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego	Ali, SS (corresponding author), Scripps Res Inst, Dept Mol & Integrat Neurosci, 10550 N Torrey Pines Rd SR307, La Jolla, CA 92037 USA.	bconti@scripps.edu		Ali, Sameh Saad/0000-0002-0339-6106; Conti, Bruno/0000-0002-9185-5201	NIA/National Institutes of Health [K25AG026379, AG028040]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG033679, R01AG028040, K25AG026379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027936] Funding Source: NIH RePORTER	NIA/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by NIA/National Institutes of Health Grants K25AG026379 (to S.S.A.) and AG028040. This work was also supported by The Ellison Medical Foundation.	Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Anzai K, 2003, ARCH BIOCHEM BIOPHYS, V415, P251, DOI 10.1016/S0003-9861(03)00260-1; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BROOKS GA, 1971, AM J PHYSIOL, V220, P1053, DOI 10.1152/ajplegacy.1971.220.4.1053; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chalier F, 2002, J CHEM SOC PERK T 2, P2110, DOI 10.1039/b206909c; CHANCE B, 1955, J BIOL CHEM, V217, P429; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; DEDUKHOVA VI, 1991, FEBS LETT, V295, P51, DOI 10.1016/0014-5793(91)81382-I; Dufour S, 1996, BIOCHEM J, V314, P743, DOI 10.1042/bj3140743; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Horvath TL, 1999, J NEUROSCI, V19, P10417; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; LIU RK, 1972, GERONTOLOGY, V18, P363, DOI 10.1159/000211944; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Quick KL, 2008, NEUROBIOL AGING, V29, P117, DOI 10.1016/j.neurobiolaging.2006.09.014; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Stolze K, 2000, FREE RADICAL BIO MED, V29, P1005, DOI 10.1016/S0891-5849(00)00401-9; Swegert CV, 1999, MECH AGEING DEV, V112, P27, DOI 10.1016/S0047-6374(99)00051-2; Villamena FA, 2004, ANTIOXID REDOX SIGN, V6, P619, DOI 10.1089/152308604773934387; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; ZAMZAMI N, 2003, METH MOL B, V282, P103; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	40	47	49	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32522	32528		10.1074/jbc.M110.155432	http://dx.doi.org/10.1074/jbc.M110.155432			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20716522	Green Published, hybrid			2022-12-25	WOS:000282683000066
J	Irannejad, R; Wedegaertner, PB				Irannejad, Roshanak; Wedegaertner, Philip B.			Regulation of Constitutive Cargo Transport from the trans-Golgi Network to Plasma Membrane by Golgi-localized G Protein beta gamma Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; COPI-COATED VESICLES; TRIMERIC G-PROTEINS; KINASE-D; ENDOPLASMIC-RETICULUM; SIGNALING COMPLEXES; MEDIATED REGULATION; PHOSPHOLIPASE-C; RECEPTOR KINASE; ALPHA-SUBUNITS	Observations of Golgi fragmentation upon introduction of G protein beta gamma (G beta gamma) subunits into cells have implicated G beta gamma in a pathway controlling the fission at the trans-Golgi network (TGN) of plasma membrane (PM)-destined transport carriers. However, the subcellular location where G beta gamma acts to provoke Golgi fragmentation is not known. Additionally, a role for G beta gamma in regulating TGN-to-PM transport has not been demonstrated. Here we report that constitutive or inducible targeting of G beta gamma to the Golgi, but not other subcellular locations, causes phospholipase C- and protein kinase D-dependent vesiculation of the Golgi in HeLa cells; Golgi-targeted beta(1)gamma(2) also activates protein kinase D. Moreover, the novel G beta gamma inhibitor, gallein, and the G beta gamma-sequestering protein, GRK2ct, reveal that G beta gamma is required for the constitutive PM transport of two model cargo proteins, VSV-G and ss-HRP. Importantly, Golgi-targeted GRK2ct, but not a PM-targeted GRK2ct, also blocks protein transport to the PM. To further support a role for Golgi-localized G beta gamma, endogenous G beta was detected at the Golgi in HeLa cells. These results are the first to establish a role for Golgi-localized G beta gamma in regulating protein transport from the TGN to the cell surface.	[Irannejad, Roshanak; Wedegaertner, Philip B.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Wedegaertner, PB (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,839 BLSB, Philadelphia, PA 19107 USA.	P_Wedegaertner@mail.jci.tju.edu			National Institutes of Health [GM56444]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM056444, R56GM056444, R01GM056444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56444 (to P.B.W.). This work was also supported by an award from the American Heart Association (to R.I.).	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Arozarena I, 2004, MOL CELL BIOL, V24, P1516, DOI 10.1128/MCB.24.4.1516-1530.2004; AUSUBEL F.M., 1992, SHORT PROTOCOLS MOL, P23; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BARR FA, 1991, FEBS LETT, V294, P239, DOI 10.1016/0014-5793(91)81438-E; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Czondor K, 2009, MOL BIOL CELL, V20, P2108, DOI 10.1091/mbc.E08-09-0957; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Dupre DJ, 2006, CELL SIGNAL, V18, P1549, DOI 10.1016/j.cellsig.2006.03.009; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Evanko DS, 2001, J BIOL CHEM, V276, P23945, DOI 10.1074/jbc.M101154200; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Ghanekar Y, 2005, TRENDS CELL BIOL, V15, P511, DOI 10.1016/j.tcb.2005.08.001; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Helms JB, 1998, J BIOL CHEM, V273, P15203, DOI 10.1074/jbc.273.24.15203; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Kim MS, 2008, CIRC RES, V103, P252, DOI 10.1161/CIRCRESAHA.108.178681; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Michaelson D, 2002, MOL BIOL CELL, V13, P3294, DOI 10.1091/mbc.E02-02-0095; Onken B, 2006, P NATL ACAD SCI USA, V103, P9045, DOI 10.1073/pnas.0603318103; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sehgal PB, 2007, AM J PHYSIOL-LUNG C, V292, pL1526, DOI 10.1152/ajplung.00463.2006; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Stow JL, 1998, BBA-MOL CELL RES, V1404, P161, DOI 10.1016/S0167-4889(98)00055-X; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Takida S, 2004, FEBS LETT, V567, P209, DOI 10.1016/j.febslet.2004.04.062; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008; Yoshikawa DM, 2000, BIOCHEMISTRY-US, V39, P11340, DOI 10.1021/bi0005557; Yost EA, 2007, MOL PHARMACOL, V72, P812, DOI 10.1124/mol.107.038075	68	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32393	32404		10.1074/jbc.M110.154963	http://dx.doi.org/10.1074/jbc.M110.154963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20720014	Green Published, hybrid			2022-12-25	WOS:000282683000053
J	Martin, L; Kimball, SR; Gardner, LB				Martin, Leenus; Kimball, Scot R.; Gardner, Lawrence B.			Regulation of the Unfolded Protein Response by eIF2B delta Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GENE-EXPRESSION; TRANSLATIONAL REGULATION; INTERPROTEIN INTERACTIONS; STRESS-RESPONSE; FACTOR EIF2B; SUBUNITS; EIF2-ALPHA; HYPOXIA; CELLS	Cells respond to a variety of stresses, including unfolded proteins in the endoplasmic reticulum (ER), by phosphorylating a subunit of translation initiation factor eIF2, eIF2 alpha. eIF2 alpha phosphorylation inactivates the eIF2B complex. The inactivation of eIF2B not only suppresses the initiation of protein translation but paradoxically up-regulates the translation and expression of transcription factor ATF-4. Both of these processes are important for the cellular response to ER stress, also termed the unfolded protein response. Here we demonstrate that cellular response resulting from eIF2 alpha phosphorylation is attenuated in several cancer cell lines. The deficiency of the unfolded protein response in these cells correlates with the expression of a specific isoform of a regulatory eIF2B subunit, eIF2B delta variant 1 (V1). Replacement of total eIF2B delta with V1 renders cells insensitive to eIF2 alpha phosphorylation; specifically, they neither up-regulate ATF-4 and ATF-4 targets nor suppress protein translation. Expression of variant 2 eIF2B delta in ER stress response-deficient cells restores the stress response. Our data suggest that V1 does not interact with the eIF2 complex, a requisite for eIF2B inhibition by eIF2 alpha phosphorylation. Together, these data delineate a novel physiological mechanism to regulate the ER stress response with a large potential impact on a variety of diseases that result in ER stress.	[Gardner, Lawrence B.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Gardner, Lawrence B.] NYU, Sch Med, New York Univ Canc Inst, New York, NY 10016 USA; [Kimball, Scot R.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	New York University; New York University; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gardner, LB (corresponding author), NYU, Sch Med, Dept Pharmacol, Tisch 451B,550 1st Ave, New York, NY 10016 USA.	lawrence.gardner@nyumc.org		Gardner, Lawrence/0000-0003-0191-0172	National Institutes of Health [DK13499, DK08164]; Making Headway Foundation; New York Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499, R01DK081641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Making Headway Foundation; New York Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK13499 (to S. R. K.) and DK08164 (to L. B. G). This work was also supported by grants from the Making Headway Foundation and New York Community Trust (to L. B. G).	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; DEALDANA CRV, 1994, MOL CELL BIOL, V14, P3208, DOI 10.1128/MCB.14.5.3208; Fabian JR, 1998, PROTEIN EXPRES PURIF, V13, P16, DOI 10.1006/prep.1998.0860; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; Gallagher JW, 2008, CANCER RES, V68, P8752, DOI 10.1158/0008-5472.CAN-08-1042; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kimball SR, 1998, J BIOL CHEM, V273, P3039, DOI 10.1074/jbc.273.5.3039; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Lin CQ, 2000, CANCER RES, V60, P1332; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Patterson AD, 2006, MOL CELL BIOL, V26, P1644, DOI 10.1128/MCB.26.5.1644-1653.2006; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Rajesh K, 2008, BIOCHEM BIOPH RES CO, V374, P336, DOI 10.1016/j.bbrc.2008.07.022; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Singh RN, 2007, FRONT BIOSCI, V12, P3263, DOI 10.2741/2310; Suragani RNVS, 2006, PROTEIN EXPRES PURIF, V47, P225, DOI 10.1016/j.pep.2005.10.003; Suragani RNVS, 2005, BIOCHEM BIOPH RES CO, V338, P1766, DOI 10.1016/j.bbrc.2005.10.150; Tang RP, 2009, BLOOD, V114, P2993, DOI 10.1182/blood-2009-05-223115; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005	48	11	11	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31944	31953		10.1074/jbc.M110.153148	http://dx.doi.org/10.1074/jbc.M110.153148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20709751	Green Published, hybrid			2022-12-25	WOS:000282683000007
J	Mo, X; Nguyen, NX; Mu, FT; Yang, WJ; Luo, SZ; Fan, HZ; Andrews, RK; Berndt, MC; Li, RH				Mo, Xi; Nguyen, Nam X.; Mu, Fi-Tjen; Yang, Wenjun; Luo, Shi-Zhong; Fan, Huizhou; Andrews, Robert K.; Berndt, Michael C.; Li, Renhao			Transmembrane and Trans-subunit Regulation of Ectodomain Shedding of Platelet Glycoprotein Ib alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; VON-WILLEBRAND-FACTOR; IX COMPLEX; CYTOPLASMIC DOMAIN; CONVERTING-ENZYME; CALMODULIN INHIBITORS; PROTEOLYTIC CLEAVAGE; HEMOSTATIC FUNCTION; ADHESION MOLECULE; PLASMA-MEMBRANE	Ectodomain shedding of transmembrane proteins may be regulated by their cytoplasmic domains. To date, the effecting cytoplasmic domain and the shed extracellular domain have been in the same polypeptide. In this study, shedding of GPIb alpha, the ligand-binding subunit of the platelet GPIb-IX complex and a marker for platelet senescence and storage lesion, was assessed in Chinese hamster ovary cells with/without functional GPIb alpha sheddase ADAM17. Mutagenesis of the GPIb-IX complex, which contains GPIb alpha, GPIb beta, and GPIX subunits, revealed that the intracellular membrane-proximal calmodulin-binding region of GPIb beta is critical for ADAM17-dependent shedding of GPIb alpha induced by the calmodulin inhibitor, W7. Perturbing the interaction between GPIb alpha and GPIb beta subunits further lessened the restraint of GPIb beta on GPIb alpha shedding. However, contrary to the widely accepted model of calmodulin regulation of ectodomain shedding, the R152E/L153E mutation in the GPIb beta cytoplasmic domain disrupted calmodulin binding to GPIb beta but had little effect on GPIb alpha shedding. Analysis of induction of GPIb alpha shedding by membrane-permeable GPIb beta-derived peptides implicated the association of GPIb beta with an unidentified intracellular protein in mediating regulation of GPIb alpha shedding. Overall, these results provide evidence for a novel trans-subunit mechanism for regulating ectodomain shedding.	[Li, Renhao] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Mu, Fi-Tjen; Andrews, Robert K.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Luo, Shi-Zhong] Beijing Univ Chem Technol, Beijing Key Lab Bioproc, Sch Life Sci & Technol, Beijing 100029, Peoples R China; [Fan, Huizhou] Univ Med & Dent New Jersey, Dept Physiol & Biophys, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Berndt, Michael C.] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland	University of Texas System; University of Texas Health Science Center Houston; Monash University; Beijing University of Chemical Technology; Rutgers State University New Brunswick; Rutgers State University Medical Center; University College Cork	Li, RH (corresponding author), 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA.	Renhao.Li@uth.tmc.edu	Li, Renhao/B-1257-2012; Fan, Huizhou/E-5835-2012; Berndt, Michael C/D-5580-2012	Li, Renhao/0000-0002-5806-5080; Andrews, Robert Keith/0000-0001-9577-8082; FAN, HUIZHOU/0000-0002-4903-926X	National Institutes of Health [HL082808, GM084175]; American Heart Association [0565078Y]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082808 and GM084175 and American Heart Association Grant 0565078Y.	Andrews RK, 2001, BLOOD, V98, P681, DOI 10.1182/blood.V98.3.681; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Blobel CP, 2002, INFLAMM RES, V51, P83, DOI 10.1007/BF02684007; Canault M, 2010, BLOOD, V115, P1835, DOI 10.1182/blood-2009-03-211706; Chattopadhyay S, 2005, J BIOL CHEM, V280, P33847, DOI 10.1074/jbc.M501718200; Clemetson KJ, 2007, THROMB HAEMOSTASIS, V98, P63, DOI 10.1160/TH07-05-0327; CLEMETSON KJ, 1981, P NATL ACAD SCI-BIOL, V78, P2712, DOI 10.1073/pnas.78.5.2712; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; Dong JF, 1997, BIOCHEMISTRY-US, V36, P12421, DOI 10.1021/bi970636b; Dong JY, 2000, J BIOL CHEM, V275, P557, DOI 10.1074/jbc.275.1.557; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Gardiner EE, 2004, BLOOD, V104, P3611, DOI 10.1182/blood-2004-04-1549; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Lambert DW, 2008, FEBS LETT, V582, P385, DOI 10.1016/j.febslet.2007.11.085; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Li XJ, 2004, J BIOL CHEM, V279, P27365, DOI 10.1074/jbc.M401690200; Llovera M, 2004, J NEUROCHEM, V88, P422, DOI 10.1046/j.1471-4159.2003.02178.x; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; Luo SZ, 2007, J THROMB HAEMOST, V5, P2494, DOI 10.1111/j.1538-7836.2007.02785.x; Luo SZ, 2008, J MOL BIOL, V382, P448, DOI 10.1016/j.jmb.2008.07.037; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Mangin P, 2004, BLOOD, V104, P420, DOI 10.1182/blood-2003-08-2881; Martin K, 2003, J THROMB HAEMOST, V1, P2643, DOI 10.1046/j.1538-7836.2003.00478.x; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Mo X, 2008, J THROMB HAEMOST, V6, P1789, DOI 10.1111/j.1538-7836.2008.03088.x; Mo X, 2008, FEBS LETT, V582, P3270, DOI 10.1016/j.febslet.2008.08.036; Mo X, 2006, J BIOL CHEM, V281, P23050, DOI 10.1074/jbc.M600924200; Mullberg J, 1997, FEBS LETT, V401, P235, DOI 10.1016/S0014-5793(96)01480-9; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rabie T, 2005, J BIOL CHEM, V280, P14462, DOI 10.1074/jbc.M500041200; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; Wong MX, 2004, FEBS LETT, V568, P70, DOI 10.1016/j.febslet.2004.04.094	45	14	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32096	32104		10.1074/jbc.M110.111864	http://dx.doi.org/10.1074/jbc.M110.111864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20716526	Green Published, hybrid			2022-12-25	WOS:000282683000023
J	Coureuil, M; Ugolin, N; Tavernier, M; Chevillard, S; Barroca, V; Fouchet, P; Allemand, I				Coureuil, Mathieu; Ugolin, Nicolas; Tavernier, Marie; Chevillard, Sylvie; Barroca, Vilma; Fouchet, Pierre; Allemand, Isabelle			Puma and Trail/Dr5 Pathways Control Radiation-Induced Apoptosis in Distinct Populations of Testicular Progenitors	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; BH3-ONLY PROTEINS PUMA; BCL-2 FAMILY-MEMBERS; GERM-CELLS; IN-VIVO; DIFFERENTIATING SPERMATOGONIA; MOUSE TESTIS; P53; MICE; GENE	Spermatogonia-stem cells and progenitors of adult spermatogenesis-are killed through a p53-regulated apoptotic process after gamma-irradiation but the death effectors are still poorly characterized. Our data demonstrate that both intrinsic and extrinsic apoptotic pathways are involved, and especially that spermatogonia can be split into two main populations, according to apoptotic effectors. Following irradiation both Dr5 and Puma genes are upregulated in the alpha(6)-integrin-positive Side Population (SP) fraction, which is highly enriched in spermatogonia. Flow cytometric analysis confirms an increased number of Dr5-expressing SP cells, and Puma-beta isoform accumulates in alpha(6)-integrin positive cellular extracts, enriched in spermatogonia. Trail-/- or Puma-/- spermatogonia display a reduced sensitivity to radiation-induced apoptosis. The TUNEL kinetics strongly suggest that the extrinsic and intrinsic pathways, via Trail/Dr5 and Puma respectively, could be engaged in distinct subpopulations of spermatogonia. Indeed flow cytometric studies show that Dr5 receptor is constitutively present on more than half of the undifferentiated progenitors (Kit(-) alpha(+)(6) SP) and half of the differentiated ones (Kit(+) a(6)(+) SP). In addition after irradiation, Puma is not detected in the Dr5-positive cellular fraction isolated by immunomagnetic purification, while Puma is present in the Dr5-negative cell extracts. In conclusion, adult testicular progenitors are divided into distinct sub-populations by apoptotic effectors, independently of progenitor types (immature Kit-negative versus mature Kit-positive), underscoring differential radiosensitivities characterizing the stem cell/progenitors compartment.	[Coureuil, Mathieu; Tavernier, Marie; Barroca, Vilma; Fouchet, Pierre; Allemand, Isabelle] Univ Paris 07, CEA, INSERM,Inst Cellular & Mol Radiobiol, Lab Gametogenesis Apoptosis & Genotox,U967, Fontenay Aux Roses, France; [Ugolin, Nicolas; Chevillard, Sylvie] CEA, Expt Cancerol Lab, Inst Cellular & Mol Radiobiol, Fontenay Aux Roses, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Coureuil, M (corresponding author), Univ Paris 05, INSERM, Fac Med, U1002, Paris, France.	isabelle.allemand@cea.fr	Coureuil, Mathieu/D-4793-2017	Coureuil, Mathieu/0000-0001-7655-9685; Chevillard, Sylvie/0000-0001-5889-4041; allemand, isabelle/0000-0002-8861-7632; Fouchet, Pierre/0000-0003-0891-079X	Electricite de France; Association pour la Recherche contre le Cancer [5796]	Electricite de France; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	The authors' work was supported by Electricite de France, and by the Association pour la Recherche contre le Cancer (Grant 5796 and a PhD studentship to M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Braghiroli L, 1998, BIOL REPROD, V59, P111, DOI 10.1095/biolreprod59.1.111; Brunetti G, 2007, ANN NY ACAD SCI, V1116, P316, DOI 10.1196/annals.1402.011; Callus BA, 2008, J MOL BIOL, V384, P313, DOI 10.1016/j.jmb.2008.09.041; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1170, DOI 10.1095/biolreprod65.4.1170; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Coultas L, 2005, EMBO J, V24, P3963, DOI 10.1038/sj.emboj.7600857; Coureui M, 2006, CELL DEATH DIFFER, V13, P1927, DOI 10.1038/sj.cdd.4401887; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Embree-Ku M, 2002, BIOL REPROD, V66, P1456, DOI 10.1095/biolreprod66.5.1456; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Falciatori I, 2003, FASEB J, V17, P376, DOI 10.1096/fj.03-0744fje; Finnberg N, 2005, MOL CELL BIOL, V25, P2000, DOI 10.1128/MCB.25.5.2000-2013.2005; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Hasegawa M, 1998, RADIAT RES, V149, P263, DOI 10.2307/3579959; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kasai S, 2003, DEV BIOL, V264, P202, DOI 10.1016/S0012-1606(03)00400-7; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; McKee CM, 2006, APOPTOSIS, V11, P2237, DOI 10.1007/s10495-006-0288-1; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Flaherty J, 2006, APOPTOSIS, V11, P2103, DOI 10.1007/s10495-006-0196-4; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Ravi R, 2002, CANCER RES, V62, P1583; Richburg JH, 2000, ENDOCRINOLOGY, V141, P787, DOI 10.1210/en.141.2.787; Russell LD, 2002, BIOL REPROD, V66, P950, DOI 10.1095/biolreprod66.4.950; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002	41	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12134	10.1371/journal.pone.0012134	http://dx.doi.org/10.1371/journal.pone.0012134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711434	gold, Green Published, Green Submitted			2022-12-25	WOS:000280859700021
J	Zhu, H; Yue, JY; Pan, Z; Wu, H; Cheng, Y; Lu, HM; Ren, XC; Yao, M; Shen, ZY; Yang, JM				Zhu, Hua; Yue, Jingyin; Pan, Zui; Wu, Hao; Cheng, Yan; Lu, Huimei; Ren, Xingcong; Yao, Ming; Shen, Zhiyuan; Yang, Jin-Ming			Involvement of Caveolin-1 in Repair of DNA Damage through Both Homologous Recombination and Non-Homologous End Joining	PLOS ONE			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; POOR-PROGNOSIS; BASAL-LIKE; FREE SURVIVAL; UP-REGULATION; SHEAR-STRESS; LUNG-CANCER; CARCINOMA; OVEREXPRESSION	Background: Caveolin-1 (Cav-1), the major component of caveolae, is a 21-24 kDa integral membrane protein that interacts with a number of signaling molecules. By acting as a scaffolding protein, Cav-1 plays crucial roles in the regulation of various physiologic and patho-physiologic processes including oncogenic transformation and tumorigenesis, and tumor invasion and metastasis. Methodology/Principal Findings: In the present study we sought to explore the role of Cav-1 in response to DNA damage and the mechanism involved. We found that the level of Cav-1 was up-regulated rapidly in cells treated with ionizing radiation. The up-regulation of Cav-1 following DNA damage occurred only in cells expressing endogenous Cav-1, and was associated with the activation of DNA damage response pathways. Furthermore, we demonstrated that the expression of Cav-1 protected cells against DNA damage through modulating the activities of both the homologous recombination (HR) and non-homologous end joining (NHEJ) repair systems, as evidenced by the inhibitory effects of the Cav-1-targeted siRNA on cell survival, HR frequency, phosphorylation of DNA-dependent protein kinase (DNA-PK), and nuclear translocation of epidermal growth factor receptor (EGFR) following DNA damage, and by the stimulatory effect of the forced expression of Cav-1 on NHEJ frequency. Conclusion/Significance: Our results indicate that Cav-1 may play a critical role in sensing genotoxic stress and in orchestrating the response of cells to DNA damage through regulating the important molecules involved in maintaining genomic integrity.	[Zhu, Hua; Wu, Hao; Yao, Ming] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ USA; [Cheng, Yan; Ren, Xingcong; Yang, Jin-Ming] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; [Cheng, Yan; Ren, Xingcong; Yang, Jin-Ming] Penn State Univ, Penn State Hershey Canc Inst, Coll Med, Hershey, PA USA; [Cheng, Yan; Ren, Xingcong; Yang, Jin-Ming] Milton S Hershey Med Ctr, Hershey, PA USA; [Yue, Jingyin; Lu, Huimei; Shen, Zhiyuan] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA; [Pan, Zui] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhu, H (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ USA.	zhuhu2@umdnj.edu; jyang2@hmc.psu.edu	Zhu, Hua/G-4409-2010	Shen, Zhiyuan/0000-0003-2834-0309; Zhu, Hua/0000-0001-7136-7326; Pan, Zui/0000-0003-4105-901X	National Cancer Institute [CA109371, CA066077, CA137738]; NATIONAL CANCER INSTITUTE [R21CA109371, R01CA066077] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Cancer Institute CA109371 (Yang), CA066077 (Yang) and CA137738 (Shen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2006, J VET SCI, V7, P309, DOI 10.4142/jvs.2006.7.4.309; Aldred MA, 2003, CANCER RES, V63, P2864; Ando T, 2007, ONCOL REP, V18, P601; Bagnoli M, 2000, ONCOGENE, V19, P4754, DOI 10.1038/sj.onc.1203839; Bender FC, 2000, CANCER RES, V60, P5870; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bouras T, 2004, CANCER BIOL THER, V3, P931, DOI 10.4161/cbt.3.10.1147; Burgermeister E, 2008, CANCER LETT, V268, P187, DOI 10.1016/j.canlet.2008.03.055; Burgermeister E, 2007, CANCER RES, V67, P8519, DOI 10.1158/0008-5472.CAN-07-1125; Campbell L, 2003, BRIT J CANCER, V89, P1909, DOI 10.1038/sj.bjc.6601359; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Engelman JA, 1998, FEBS LETT, V436, P403, DOI 10.1016/S0014-5793(98)01134-X; Frank PG, 2006, J CLIN INVEST, V116, P1222, DOI 10.1172/JCI28509; Glait C, 2006, EXP CELL RES, V312, P3899, DOI 10.1016/j.yexcr.2006.08.016; Glait C, 2006, FEBS LETT, V580, P5268, DOI 10.1016/j.febslet.2006.08.071; Hayashi K, 2001, CANCER RES, V61, P2361; HEHLGANS S, 2009, RADIOTHER ONCOL; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Joo HJ, 2004, BJU INT, V93, P291, DOI 10.1111/j.1464-410X.2004.04604.x; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; Kato T, 2004, CANCER LETT, V214, P121, DOI 10.1016/j.canlet.2004.04.017; Lavie Y, 2001, ADV DRUG DELIVER REV, V49, P317, DOI 10.1016/S0169-409X(01)00144-2; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li TH, 2006, AM J PATHOL, V168, P1998, DOI 10.2353/ajpath.2006.051089; Lio YC, 2004, J BIOL CHEM, V279, P42313, DOI 10.1074/jbc.M405212200; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Lu HM, 2007, NUCLEIC ACIDS RES, V35, P7160, DOI 10.1093/nar/gkm732; Milovanova T, 2008, BBA-MOL CELL RES, V1783, P1866, DOI 10.1016/j.bbamcr.2008.05.010; Patel HH, 2007, FASEB J, V21, P1565, DOI 10.1096/fj.06-7719com; Patlolla JMR, 2004, ONCOL REP, V11, P957; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Rajjayabun PH, 2001, UROLOGY, V58, P811, DOI 10.1016/S0090-4295(01)01337-1; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Ravid D, 2006, ADV ENZYME REGUL, V46, P163, DOI 10.1016/j.advenzreg.2006.01.022; Pinilla SMR, 2006, BREAST CANCER RES TR, V99, P85, DOI 10.1007/s10549-006-9184-1; Sagara Y, 2004, BRIT J CANCER, V91, P959, DOI 10.1038/sj.bjc.6602029; Satoh T, 2003, CANCER-AM CANCER SOC, V97, P1225, DOI 10.1002/cncr.11198; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shatz M, 2004, LEUKEMIA RES, V28, P907, DOI 10.1016/j.leukres.2004.03.013; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Tanase CP, 2008, EXPERT REV MOL DIAGN, V8, P395, DOI 10.1586/14737159.8.4.395; Wang Y, 2008, BIOCHEM BIOPH RES CO, V370, P201, DOI 10.1016/j.bbrc.2008.03.031; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Wu P, 2008, BIOCHEM BIOPH RES CO, V376, P215, DOI 10.1016/j.bbrc.2008.08.146; Zhu H, 2004, FEBS LETT, V576, P369, DOI 10.1016/j.febslet.2004.09.041; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007; Zhu H, 2008, J PHARMACOL SCI, V106, P287, DOI 10.1254/jphs.FP0071192	56	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12055	10.1371/journal.pone.0012055	http://dx.doi.org/10.1371/journal.pone.0012055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700465	Green Published, gold, Green Submitted			2022-12-25	WOS:000280687900024
J	Hendriksen, H; Prins, J; Olivier, B; Oosting, RS				Hendriksen, Hendrikus; Prins, Jolanda; Olivier, Berend; Oosting, Ronald S.			Environmental Enrichment Induces Behavioral Recovery and Enhanced Hippocampal Cell Proliferation in an Antidepressant-Resistant Animal Model for PTSD	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DENTATE GYRUS; NEUROTROPHIC FACTORS; PHYSICAL-ACTIVITY; MEMORY DEFICITS; MOUSE MODEL; NEUROGENESIS; DEPRESSION; EXERCISE; RATS	Background: Post traumatic stress disorder (PTSD) can be considered the result of a failure to recover after a traumatic experience. Here we studied possible protective and therapeutic aspects of environmental enrichment (with and without a running wheel) in Sprague Dawley rats exposed to an inescapable foot shock procedure (IFS). Methodology/Principal Findings: IFS induced long-lasting contextual and non-contextual anxiety, modeling some aspects of PTSD. Even 10 weeks after IFS the rats showed reduced locomotion in an open field. The antidepressants imipramine and escitalopram did not improve anxiogenic behavior following IFS. Also the histone deacetylase (HDAC) inhibitor sodium butyrate did not alleviate the IFS induced immobility. While environmental enrichment (EE) starting two weeks before IFS did not protect the animals from the behavioral effects of the shocks, exposure to EE either immediately after the shock or one week later induced complete recovery three weeks after IFS. In the next set of experiments a running wheel was added to the EE to enable voluntary exercise (EE/VE). This also led to reduced anxiety. Importantly, this behavioral recovery was not due to a loss of memory for the traumatic experience. The behavioral recovery correlated with an increase in cell proliferation in hippocampus, a decrease in the tissue levels of noradrenalin and increased turnover of 5-HT in prefrontal cortex and hippocampus. Conclusions/Significance: This animal study shows the importance of (physical) exercise in the treatment of psychiatric diseases, including post-traumatic stress disorder and points out the possible role of EE in studying the mechanism of recovery from anxiety disorders.	[Hendriksen, Hendrikus; Prins, Jolanda; Olivier, Berend; Oosting, Ronald S.] Univ Utrecht, Dept Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Utrecht University	Hendriksen, H (corresponding author), Univ Utrecht, Dept Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	h.hendriksen@uu.nl		Hendriksen, Hendrikus/0000-0001-8526-6526				Arkin Sharon, 2007, Am J Alzheimers Dis Other Demen, V22, P62, DOI 10.1177/1533317506295377; Arnsten AFT, 2000, PROG BRAIN RES, V126, P183; Baker DG, 2009, EXPERT OPIN EMERG DR, V14, P251, DOI 10.1517/14728210902972494; Barf TA, 1996, J MED CHEM, V39, P4717, DOI 10.1021/jm9604890; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; BIJLSMA EY, 2009, BEHAV BRAIN RES; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Bremner J Douglas, 2008, Prog Brain Res, V167, P171; Breuer ME, 2007, BIOL PSYCHIAT, V61, P990, DOI 10.1016/j.biopsych.2006.08.032; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Castren E, 2010, CNS DRUGS, V24, P1, DOI 10.2165/11530010-000000000-00000; Cohen Judith A, 2005, J Trauma Dissociation, V6, P109, DOI 10.1300/J229v06n02_10; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Davis LL, 2006, CNS DRUGS, V20, P465, DOI 10.2165/00023210-200620060-00003; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fischer FR, 2007, J SPINAL CORD MED, V30, P147, DOI 10.1080/10790268.2007.11753926; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Marchetti C, 2010, BIOL PSYCHIAT, V67, P146, DOI 10.1016/j.biopsych.2009.09.017; MARLATT MW, 2010, BRAIN RES; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Moraska A, 2001, AM J PHYSIOL-REG I, V281, pR484, DOI 10.1152/ajpregu.2001.281.2.R484; Newman Caren L, 2007, Int J Emerg Ment Health, V9, P133; Pereira LO, 2007, NEUROBIOL LEARN MEM, V87, P101, DOI 10.1016/j.nlm.2006.07.003; PERRATON LG, 2009, J EVAL CLIN PRACT; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Ravindran LN, 2009, BRAIN RES, V1293, P24, DOI 10.1016/j.brainres.2009.03.037; Rodriguez-Romaguera J, 2009, BIOL PSYCHIAT, V65, P887, DOI 10.1016/j.biopsych.2009.01.009; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; SCHLOESSER RJ, 2010, MOL PSYCHIAT; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; Stein DJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002795.pub2; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VANDIJKEN HH, 1992, PHYSIOL BEHAV, V52, P945, DOI 10.1016/0031-9384(92)90375-C; VANDIJKEN HH, 1992, PHYSIOL BEHAV, V51, P787, DOI 10.1016/0031-9384(92)90117-K; Vinkers CH, 2009, NEUROSCIENCE, V159, P39, DOI 10.1016/j.neuroscience.2008.12.009; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Wolff M, 2008, HIPPOCAMPUS, V18, P996, DOI 10.1002/hipo.20457; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Yoo MJ, 2007, J MICROBIOL BIOTECHN, V17, P2033	56	53	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11943	10.1371/journal.pone.0011943	http://dx.doi.org/10.1371/journal.pone.0011943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700523	Green Published, gold, Green Submitted			2022-12-25	WOS:000280605400004
J	Rotblat, B; Belanis, L; Liang, H; Haklai, R; Elad-Zefadia, G; Hancock, JF; Kloog, Y; Plowman, SJ				Rotblat, Barak; Belanis, Liron; Liang, Hong; Haklai, Roni; Elad-Zefadia, Galit; Hancock, John F.; Kloog, Yoel; Plowman, Sarah J.			H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output	PLOS ONE			English	Article							K-RAS; PLASMA-MEMBRANE; LIVE CELLS; ASSOCIATION; GALECTIN-1; ACTIVATION; PROTEINS; GTP; LOCALIZATION; DYNAMICS	H-Ras is a binary switch that is activated by multiple co-factors and triggers several key cellular pathways one of which is MAPK. The specificity and magnitude of downstream activation is achieved by the spatio-temporal organization of the active H-Ras in the plasma membrane. Upon activation, the GTP bound H-Ras binds to Galectin-1 (Gal-1) and becomes transiently immobilized in short-lived nanoclusters on the plasma membrane from which the signal is propagated to Raf. In the current study we show that stabilizing the H-Ras-Gal-1 interaction, using bimolecular fluorescence complementation (BiFC), leads to prolonged immobilization of H-Ras. GTP in the plasma membrane which was measured by fluorescence recovery after photobleaching (FRAP), and increased signal out-put to the MAPK module. EM measurements of Raf recruitment to the H-Ras. GTP nanoclusters demonstrated that the enhanced signaling observed in the BiFC stabilized HRas. GTP nanocluster was attributed to increased H-Ras immobilization rather than to an increase in Raf recruitment. Taken together these data demonstrate that the magnitude of the signal output from a GTP-bound H-Ras nanocluster is proportional to its stability.	[Rotblat, Barak; Belanis, Liron; Haklai, Roni; Elad-Zefadia, Galit; Kloog, Yoel] Tel Aviv Univ, Dept Neurobiol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Liang, Hong; Hancock, John F.; Plowman, Sarah J.] Univ Texas Hlth Sci Center Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA	Tel Aviv University; University of Texas System; University of Texas Health Science Center Houston	Rotblat, B (corresponding author), Univ British Columbia, Dept Pathol, Vancouver, BC, Canada.	John.F.Hancock@uth.tmc.edu; kloog@post.tau.ac.il; Sarah.J.Plowman@uth.tmc.edu	Rotblat, Barak/H-5970-2019	Rotblat, Barak/0000-0003-2985-7115; Hancock, John/0000-0003-0542-4710	Binational Science Foundation, BSF [2005344]; Prajs-Drimmer Institute for the Development of Anti-Degenerative Disease Drugs; National Institute of General Medical Sciences [R01GM066717]; International Human Frontier Science Program Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	Binational Science Foundation, BSF(US-Israel Binational Science Foundation); Prajs-Drimmer Institute for the Development of Anti-Degenerative Disease Drugs; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by awards from the Binational Science Foundation, BSF Grant 2005344 (YK), the Prajs-Drimmer Institute for the Development of Anti-Degenerative Disease Drugs and the National Institute of General Medical Sciences, R01GM066717 (JFH). BR is supported by The International Human Frontier Science Program Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Lommerse PHM, 2006, BIOPHYS J, V91, P1090, DOI 10.1529/biophysj.105.079053; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; PETERSON NO, 1986, METHOD ENZYMOL, V30, P454; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Rotblat B, 2006, CANCER RES, V66, P1974, DOI 10.1158/0008-5472.CAN-05-3791; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615	24	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11991	10.1371/journal.pone.0011991	http://dx.doi.org/10.1371/journal.pone.0011991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700538	Green Published, Green Submitted, gold			2022-12-25	WOS:000280605400023
J	Michaud, F; Coulombe, F; Gaudreault, E; Paquet-Bouchard, C; Rola-Pleszczynski, M; Gosselin, J				Michaud, Francois; Coulombe, Francois; Gaudreault, Eric; Paquet-Bouchard, Carine; Rola-Pleszczynski, Marek; Gosselin, Jean			Epstein-Barr Virus Interferes with the Amplification of IFN alpha Secretion by Activating Suppressor of Cytokine Signaling 3 in Primary Human Monocytes	PLOS ONE			English	Article							REGULATORY FACTOR-7; INDUCED APOPTOSIS; INDUCTION; TRANSCRIPTION; INHIBITION; GENE; PROTEIN; CELLS; EBV; INFECTIONS	Background: Epstein-Barr virus is recognized to cause lymphoproliferative disorders and is also associated with cancer. Evidence suggests that monocytes are likely to be involved in EBV pathogenesis, especially due to a number of cellular functions altered in EBV-infected monocytes, a process that may affect efficient host defense. Because type I interferons (IFNs) are crucial mediators of host defense against viruses, we investigated the effect of EBV infection on the IFN alpha pathway in primary human monocytes. Methodology/Principal Findings: Infection of monocytes with EBV induced IFN alpha secretion but inhibited the positive feedback loop for the amplification of IFN alpha . We showed that EBV infection induced the expression of suppressor of cytokine signaling 3 (SOCS3) and, to a lesser extent, SOCS1, two proteins known to interfere with the amplification of IFN alpha secretion mediated by the JAK/STAT signal transduction pathway. EBV infection correlated with a blockage in the activation of JAK/STAT pathway members and affected the level of phosphorylated IFN regulatory factor 7 (IRF7). Depletion of SOCS3, but not SOCS1, by small interfering RNA (siRNA) abrogated the inhibitory effect of EBV on JAK/STAT pathway activation and significantly restored IFN alpha secretion. Finally, transfection of monocytes with the viral protein Zta caused the upregulation of SOCS3, an event that could not be recapitulated with mutated Zta. Conclusions/Significance: We propose that EBV protein Zta activates SOCS3 protein as an immune escape mechanism that both suppresses optimal IFN alpha secretion by human monocytes and favors a state of type I IFN irresponsiveness in these cells. This immunomodulatory effect is important to better understand the aspects of the immune response to EBV.	[Michaud, Francois; Coulombe, Francois; Gaudreault, Eric; Paquet-Bouchard, Carine; Gosselin, Jean] Univ Laval, CHUQ Res Ctr CHUL, Innate Immunol Lab, Quebec City, PQ, Canada; [Michaud, Francois; Coulombe, Francois; Gaudreault, Eric; Paquet-Bouchard, Carine; Gosselin, Jean] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [Rola-Pleszczynski, Marek] Univ Sherbrooke, Fac Med, Dept Pediat, Div Immunol, Sherbrooke, PQ, Canada	Laval University; Laval University; University of Sherbrooke	Michaud, F (corresponding author), Univ Laval, CHUQ Res Ctr CHUL, Innate Immunol Lab, Quebec City, PQ, Canada.	jean.gosselin@crchul.ulaval.ca			Canadian Institutes of Health Research; Fondation Dr. Georges Phenix	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Dr. Georges Phenix	This project was supported by a grant from the Canadian Institutes of Health Research to JG. EG is a recipient of a studentship from Fondation Dr. Georges Phenix. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; AMAN P, 1990, EMBO J, V9, P147, DOI 10.1002/j.1460-2075.1990.tb08090.x; BENTZ G, 2001, VIROLOGY, V3, P7; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Cohen JI, 1999, J VIROL, V73, P7627, DOI 10.1128/JVI.73.9.7627-7632.1999; Du ZM, 2005, P NATL ACAD SCI USA, V102, P10267, DOI 10.1073/pnas.0408854102; GOSSELIN J, 1991, EUR J IMMUNOL, V21, P203, DOI 10.1002/eji.1830210130; Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hashimoto K, 2009, VIROLOGY, V391, P162, DOI 10.1016/j.virol.2009.06.026; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Ichikawa T, 2002, BIOCHEM BIOPH RES CO, V294, P414, DOI 10.1016/S0006-291X(02)00502-8; Jabs WJ, 2002, BLOOD, V99, P1512, DOI 10.1182/blood.V99.5.1512; KANDA K, 1992, MOL CELL BIOL, V12, P4930, DOI 10.1128/MCB.12.11.4930; Kasahara Y, 2002, CRIT REV ONCOL HEMAT, V44, P283, DOI 10.1016/S1040-8428(02)00119-1; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Larochelle B, 1998, BLOOD, V92, P291, DOI 10.1182/blood.V92.1.291.413k34_291_299; Li D, 2009, J IMMUNOL, V182, P1799, DOI 10.4049/jimmunol.0802686; Lieberman PM, 1997, MOL CELL BIOL, V17, P6624, DOI 10.1128/MCB.17.11.6624; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; MAHOT S, 2003, J GEN VIROL, V974, pEB1; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; Najjar I, 2005, J VIROL, V79, P4936, DOI 10.1128/JVI.79.8.4936-4943.2005; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Ruf IK, 2005, J VIROL, V79, P14562, DOI 10.1128/JVI.79.23.14562-14569.2005; Ruvolo V, 2003, J VIROL, V77, P3690, DOI 10.1128/JVI.77.6.3690-3701.2003; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Savard M, 2000, J VIROL, V74, P2612, DOI 10.1128/JVI.74.6.2612-2619.2000; Savard M, 2000, J IMMUNOL, V164, P6467, DOI 10.4049/jimmunol.164.12.6467; Savard M, 2006, VIRUS RES, V119, P134, DOI 10.1016/j.virusres.2006.02.008; Shah KM, 2009, ONCOGENE, V28, P3903, DOI 10.1038/onc.2009.249; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; STRAUS SE, 1993, ANN INTERN MED, V118, P45, DOI 10.7326/0003-4819-118-1-199301010-00009; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Tardif M, 2002, J BIOL CHEM, V277, P24148, DOI 10.1074/jbc.M109036200; Tugizov S, 2007, J VIROL, V81, P5484, DOI 10.1128/JVI.00171-07; Vuong BQ, 2004, MOL CELL BIOL, V24, P9092, DOI 10.1128/MCB.24.20.9092-9101.2004; Wang JT, 2009, J VIROL, V83, P1856, DOI 10.1128/JVI.01099-08; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; Yasukawa H, 2003, J CLIN INVEST, V111, P469, DOI 10.1172/JCI200316491; Yokota S, 2005, VIROLOGY, V338, P173, DOI 10.1016/j.virol.2005.04.028; Yokota S, 2004, J VIROL, V78, P6282, DOI 10.1128/JVI.78.12.6282-6286.2004; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	47	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11908	10.1371/journal.pone.0011908	http://dx.doi.org/10.1371/journal.pone.0011908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689596	Green Submitted, gold, Green Published			2022-12-25	WOS:000280520300022
J	Chen, N; Yu, JD; Qian, H; Ge, RJ; Wang, JH				Chen, Na; Yu, Jiandong; Qian, Hao; Ge, Rongjing; Wang, Jin-Hui			Axons Amplify Somatic Incomplete Spikes into Uniform Amplitudes in Mouse Cortical Pyramidal Neurons	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; THRESHOLD POTENTIALS; REFRACTORY PERIODS; DENDRITIC SPIKES; SODIUM-CHANNELS; PROPAGATION; CELL; PLASTICITY; NERVE; SITE	Background: Action potentials are the essential unit of neuronal encoding. Somatic sequential spikes in the central nervous system appear various in amplitudes. To be effective neuronal codes, these spikes should be propagated to axonal terminals where they activate the synapses and drive postsynaptic neurons. It remains unclear whether these effective neuronal codes are based on spike timing orders and/or amplitudes. Methodology/Principal Findings: We investigated this fundamental issue by simultaneously recording the axon versus soma of identical neurons and presynaptic vs. postsynaptic neurons in the cortical slices. The axons enable somatic spikes in low amplitude be enlarged, which activate synaptic transmission in consistent patterns. This facilitation in the propagation of sequential spikes through the axons is mechanistically founded by the short refractory periods, large currents and high opening probability of axonal voltage-gated sodium channels. Conclusion/Significance: An amplification of somatic incomplete spikes into axonal complete ones makes sequential spikes to activate consistent synaptic transmission. Therefore, neuronal encoding is likely based on spike timing order, instead of graded analogues.	[Chen, Na; Yu, Jiandong; Qian, Hao; Ge, Rongjing; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, N (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	jhw@ibp.ac.cn		QIAN, HAO/0000-0001-5771-5865	National Award for Outstanding Young Scientist [30325021]; Natural Science Foundation China (NSFC) [30621130077, 30870517, 30990261, 30700204]; National Basic Research Program [2006CB500804]; CAS Program [KSCX2-YWR-39]	National Award for Outstanding Young Scientist; Natural Science Foundation China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); CAS Program	This study is supported by the National Award for Outstanding Young Scientist (30325021), Natural Science Foundation China (NSFC 30621130077, 30870517 and 30990261), National Basic Research Program (2006CB500804), CAS Program in Knowledge Innovation (KSCX2-YWR-39) to JHW, as well as NSFC (30700204) to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Websites:http://www.nsfc.gov.cn/Portal0/default124.htm for NSFC; http://www.973.gov.cn/ for National Basic Research Program.	ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; BROCK LG, 1953, J PHYSIOL-LONDON, V122, P429, DOI 10.1113/jphysiol.1953.sp005013; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P938, DOI 10.1016/j.bbrc.2006.06.003; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P281, DOI 10.1016/j.bbrc.2006.05.120; Chen WR, 2002, J NEUROPHYSIOL, V88, P2755, DOI 10.1152/jn.00057.2002; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; DAYAN P, 2001, MODEL NEURON, V1, P1; EDWARDS C, 1958, J PHYSIOL-LONDON, V143, P138, DOI 10.1113/jphysiol.1958.sp006049; Epsztein J, 2010, SCIENCE, V327, P474, DOI 10.1126/science.1182773; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FRAZIER DT, 1970, J PHARMACOL EXP THER, V171, P45; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Goldman L, 1995, BIOPHYS J, V69, P2364, DOI 10.1016/S0006-3495(95)80105-0; Gulledge AT, 2003, J NEUROSCI, V23, P11363; Hanson JE, 2004, J NEUROSCI, V24, P329, DOI 10.1523/JNEUROSCI.3937-03.2004; HILLE B, 2001, VOLTAGE GATED CALCIU, P95; HILLE B, 2001, CLASSIC BIOPHYSICS S, P25; Hodgkin AL, 1937, J PHYSIOL-LONDON, V90, P183, DOI 10.1113/jphysiol.1937.sp003507; Hodgkin AL, 1939, NATURE, V144, P710, DOI 10.1038/144710a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Luscher HR, 1998, J NEUROPHYSIOL, V80, P715, DOI 10.1152/jn.1998.80.2.715; MacKenzie PJ, 1996, NEURON, V16, P783, DOI 10.1016/S0896-6273(00)80098-7; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; Rieke F, 1998, SPIKES EXPLORING NEU, P1; Roberts CB, 2008, ENDOCRINOLOGY, V149, P3355, DOI 10.1210/en.2008-0152; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P432; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	46	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11868	10.1371/journal.pone.0011868	http://dx.doi.org/10.1371/journal.pone.0011868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686619	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520200031
J	McKenna, DD; Farrell, BD				McKenna, Duane D.; Farrell, Brian D.			9-Genes Reinforce the Phylogeny of Holometabola and Yield Alternate Views on the Phylogenetic Placement of Strepsiptera	PLOS ONE			English	Article							HOST-PARASITOID ASSOCIATIONS; MOLECULAR PHYLOGENETICS; FELSENSTEIN ZONE; INSECT ORDERS; GENES; EVOLUTION; COLEOPTERA; PARSIMONY; SUBORDERS; INFERENCE	Background: The extraordinary morphology, reproductive and developmental biology, and behavioral ecology of twisted wing parasites (order Strepsiptera) have puzzled biologists for centuries. Even today, the phylogenetic position of these enigmatic "insects from outer space'' [1] remains uncertain and contentious. Recent authors have argued for the placement of Strepsiptera within or as a close relative of beetles (order Coleoptera), as sister group of flies (order Diptera), or even outside of Holometabola. Methodology/Principal Findings: Here, we combine data from several recent studies with new data (for a total of 9 nuclear genes and similar to 13 kb of aligned data for 34 taxa), to help clarify the phylogenetic placement of Strepsiptera. Our results unequivocally support the monophyly of Neuropteroidea (= Neuropterida + Coleoptera) + Strepsiptera, but recover Strepsiptera either derived from within polyphagan beetles (order Coleoptera), or in a position sister to Neuropterida. All other supra-ordinal- and ordinal-level relationships recovered with strong nodal support were consistent with most other recent studies. Conclusions/Significance: These results, coupled with the recent proposed placement of Strepsiptera sister to Coleoptera, suggest that while the phylogenetic neighborhood of Strepsiptera has been identified, unequivocal placement to a specific branch within Neuropteroidea will require additional study.	[McKenna, Duane D.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Farrell, Brian D.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Memphis; Harvard University	McKenna, DD (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	dmckenna@memphis.edu			National Science Foundation [DEB-0531768]	National Science Foundation(National Science Foundation (NSF))	This paper is based in part upon work supported by the National Science Foundation under Grant No. DEB-0531768. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutel RG, 2006, SYST ENTOMOL, V31, P202, DOI 10.1111/j.1365-3113.2006.00341.x; Beutel RG, 2000, CLADISTICS, V16, P103, DOI 10.1111/j.1096-0031.2000.tb00350.x; Bonneton F, 2006, INSECT MOL BIOL, V15, P351, DOI 10.1111/j.1365-2583.2006.00654.x; BOVING A. G., 1931, Entomologica Americana, V11, P1; Bravo F, 2009, CLADISTICS, V25, P614, DOI 10.1111/j.1096-0031.2009.00264.x; Buschbeck E, 1999, SCIENCE, V286, P1178, DOI 10.1126/science.286.5442.1178; Buschbeck EK, 2003, J COMP PHYSIOL A, V189, P617, DOI 10.1007/s00359-003-0443-x; CARMEAN D, 1995, NATURE, V373, P666, DOI 10.1038/373666b0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chalwatzis N, 1996, ANN ENTOMOL SOC AM, V89, P788, DOI 10.1093/aesa/89.6.788; CROWSON RA, 1960, ANNU REV ENTOMOL, V5, P111, DOI 10.1146/annurev.en.05.010160.000551; Crowson RA, 1981, BIOL COLEOPTERA; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Friedrich F, 2010, CLADISTICS, V26, P579, DOI 10.1111/j.1096-0031.2010.00305.x; Grimaldi David, 2005, pi; Handlirsch A., 1903, SITZ AK WISS WIEN, V112, P716; Hayward DC, 2005, DEV GENES EVOL, V215, P213, DOI 10.1007/s00427-004-0461-x; Hennig W., 1981, INSECT PHYLOGENY; Huelsenbeck John P., 2001, Tijdschrift voor Entomologie, V144, P165; Huelsenbeck JP, 1998, SYST BIOL, V47, P519; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Hwang UW, 1998, MOL PHYLOGENET EVOL, V9, P470, DOI 10.1006/mpev.1998.0518; KATHIRITHAMBY J, 1989, SYST ENTOMOL, V14, P41, DOI 10.1111/j.1365-3113.1989.tb00265.x; Kathirithamby J, 1998, INT J INSECT MORPHOL, V27, P39, DOI 10.1016/S0020-7322(97)00031-7; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; KATOH K, 2008, RECENT DEV MAFFT MUL; KINZELBACH R, 1990, American Entomologist, V36, P292; Kinzelbach RK, 1978, TIERWELT DEUTSCHLAND, V65, P166; Kirby W, 1815, T LINNEAN SOC LONDON, V11, P86, DOI [10.1111/j.1096-3642.1813.tb00040.x, DOI 10.1111/J.1096-3642.1813.TB00040.X]; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; KRISTENSEN N P, 1975, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V13, P1; Kristensen N.P., 1991, P125; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Kukalova-Peck J, 2004, EUR J ENTOMOL, V101, P95, DOI 10.14411/eje.2004.018; KUKALOVAPECK J, 1993, CAN ENTOMOL, V125, P181, DOI 10.4039/Ent125181-2; LATREILLE PA, 1809, GENERA CRUST INSECT, V4, P388; Lawrence J.F., 1995, P779; Longhorn SJ, 2010, MOL PHYLOGENET EVOL, V55, P846, DOI 10.1016/j.ympev.2010.03.024; McKenna DD, 2005, MOL PHYLOGENET EVOL, V37, P117, DOI 10.1016/j.ympev.2005.06.011; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; McKenna Duane D., 2009, P278; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Pierce W. D, 1909, B US NATL MUSEUM, V66, P1; PIERCE WD, 1904, SOME HYPERMETAMORPHI, V4, P15; Pohl H, 2005, CLADISTICS, V21, P328, DOI 10.1111/j.1096-0031.2005.00074.x; Pohl H, 2004, ARTHROPOD STRUCT DEV, V33, P31, DOI 10.1016/j.asd.2003.10.001; Pohl H, 2002, ZOOL SCR, V31, P123, DOI 10.1046/j.0300-3256.2001.00078.x; Pohl H, 2008, ZOOLOGY, V111, P318, DOI 10.1016/j.zool.2007.06.008; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Proffitt F, 2005, SCIENCE, V307, P343, DOI 10.1126/science.307.5708.343; RASNITSYN AP, 2002, HIST INSECTS, P157, DOI DOI 10.1007/0-306-47577-4; Rokas A, 1999, INSECT MOL BIOL, V8, P527, DOI 10.1046/j.1365-2583.1999.00149.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSS HH, 1982, TXB ENTOMOLOGY, P4; Rossi P, 1793, B SOC PHILOMATHIQUE, V1, P49; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; SWOFFORD DL, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Whiting MF, 2002, ZOOL SCR, V31, P3, DOI 10.1046/j.0300-3256.2001.00093.x; WHITING MF, 1994, NATURE, V368, P696, DOI 10.1038/368696a0; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Whiting MF, 1995, J NEW YORK ENTOMOL S, V103, P1; Whiting Michael F., 2005, P3; Wiegmann Brian M., 2009, P260; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Wild AL, 2008, MOL PHYLOGENET EVOL, V48, P877, DOI 10.1016/j.ympev.2008.05.023; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zwickl D., 2006, GARLI GENETIC ALGORI; [No title captured]	77	58	60	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11887	10.1371/journal.pone.0011887	http://dx.doi.org/10.1371/journal.pone.0011887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686704	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200046
J	Kiank, C; Zeden, JP; Drude, S; Domanska, G; Fusch, G; Otten, W; Schuett, C				Kiank, Cornelia; Zeden, Jan-Philip; Drude, Solveig; Domanska, Grazyna; Fusch, Gerhard; Otten, Winfried; Schuett, Christine			Psychological Stress-Induced, IDO1-Dependent Tryptophan Catabolism: Implications on Immunosuppression in Mice and Humans	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; INDOLEAMINE 2,3-DIOXYGENASE; INTERFERON-GAMMA; DENDRITIC CELLS; KYNURENIC ACID; INDUCTION; BARRIER; DEPRESSION; RESPONSES; SUSCEPTIBILITY	It is increasingly recognized that psychological stress influences inflammatory responses and mood. Here, we investigated whether psychological stress ( combined acoustic and restraint stress) activates the tryptophan (Trp) catabolizing enzyme indoleamine 2,3-dioxygenase 1(IDO1) and thereby alters the immune homeostasis and behavior in mice. We measured IDO1 mRNA expression and plasma levels of Trp catabolites after a single 2-h stress session and in repeatedly stressed (4.5-days stress, 2-h twice a day) naive BALB/c mice. A role of cytokines in acute stress-induced IDO1 activation was studied after IFN gamma and TNF alpha blockade and in IDO1(-/-) mice. RU486 and 1-Methyl-L-tryptophan (1-MT) were used to study role of glucocorticoids and IDO1 on Trp depletion in altering the immune and behavioral response in repeatedly stressed animals. Clinical relevance was addressed by analyzing IDO1 activity in patients expecting abdominal surgery. Acute stress increased the IDO1 mRNA expression in brain, lung, spleen and Peyer's patches (max. 14.1 +/- 4.9-fold in brain 6-h after stress) and resulted in a transient depletion of Trp (-25.2 +/- 6.6%) and serotonin (-27.3 +/- 4.6%) from the plasma measured 6-h after stress while kynurenine levels increased 6-h later (11.2 +/- 9.3%). IDO1 mRNA up-regulation was blocked by anti-TNF alpha and anti-IFN gamma treatment. Continuous IDO1 blockade by 1-MT but not RU486 treatment normalized the anti-bacterial defense and attenuated increased IL-10 inducibility in splenocytes after repeated stress as it reduced the loss of body weight and behavioral alterations. Moreover, kynurenic acid which remained increased in 1-MT treated repeatedly stressed mice was identified to reduce the TNFa inducibility of splenocytes in vitro and in vivo. Thus, psychological stress stimulates cytokine-driven IDO1 activation and Trp depletion which seems to have a central role for developing stress-induced immunosuppression and behavioral alteration. Since patients showed Trp catabolism already prior to surgery, IDO is also a possible target enzyme for humans modulating immune homeostasis and mood.	[Kiank, Cornelia; Zeden, Jan-Philip; Drude, Solveig; Domanska, Grazyna; Schuett, Christine] Ernst Moritz Arndt Univ Greifswald, Dept Immunol, DFG Grad Sch GK840, Greifswald, Germany; [Fusch, Gerhard] Ernst Moritz Arndt Univ Greifswald, Dept Pediat, Greifswald, Germany; [Otten, Winfried] Res Inst Biol Farm Anim FBN, Res Unit Behav Physiol, Dummerstorf, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Forschungsinstitut fur Nutztierbiologie (FBN)	Kiank, C (corresponding author), Univ Calif Los Angeles, Dept Med, Ctr Neurobiol Stress, CURE Digest Dis Res Ctr,GLA VA HS, Los Angeles, CA 90024 USA.	ckiank@mednet.ucla.edu	Fusch, Gerhard/ABG-1096-2021; Otten, Winfried/V-8376-2019	Fusch, Gerhard/0000-0003-4026-3211; Otten, Winfried/0000-0002-5613-5356	Deutsche Forschungsgemeinschaft (DFG) [GRK-840, B1, C1]; Fonds der Chemischen Industrie; Alfried Krupp von Bohlen and Halbach Stiftung, Essen, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Alfried Krupp von Bohlen and Halbach Stiftung, Essen, Germany	Grant support: Deutsche Forschungsgemeinschaft (DFG, GRK-840, projects B1, C1); Fonds der Chemischen Industrie (C.S.); Alfried Krupp von Bohlen and Halbach Stiftung, Essen, Germany (C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau F, 2007, J PHYSIOL-LONDON, V580, P347, DOI 10.1113/jphysiol.2006.120907; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Brenk M, 2009, J IMMUNOL, V183, P145, DOI 10.4049/jimmunol.0803277; Calcagni E, 2006, ANN NY ACAD SCI, V1069, P62, DOI 10.1196/annals.1351.006; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Dai XC, 2010, J HISTOCHEM CYTOCHEM, V58, P17, DOI 10.1369/jhc.2009.953604; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Demaude J, 2006, GUT, V55, P655, DOI 10.1136/gut.2005.078675; Depke M, 2008, ENDOCRINOLOGY, V149, P2714, DOI 10.1210/en.2008-0038; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Firk C, 2009, CLIN NUTR, V28, P266, DOI 10.1016/j.clnu.2009.03.002; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Iqbal J, 2006, BIOCHEM BIOPH RES CO, V342, P1312, DOI 10.1016/j.bbrc.2006.02.109; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Kiank C, 2006, BRAIN BEHAV IMMUN, V20, P359, DOI 10.1016/j.bbi.2005.10.151; KIANK C, 2009, BRAIN BEHAV IMMUN, V23, pS42; Kiank C, 2008, BRAIN BEHAV IMMUN, V22, P1173, DOI 10.1016/j.bbi.2008.05.003; Kiank C, 2007, SHOCK, V27, P305, DOI 10.1097/01.shk.0000239754.82711.c0; Kim WS, 2010, KOREAN J ANESTHESIOL, V58, P328, DOI 10.4097/kjae.2010.58.4.328; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Kuc D, 2008, AMINO ACIDS, V35, P503, DOI 10.1007/s00726-007-0631-z; Lob S, 2008, BLOOD, V111, P2152, DOI 10.1182/blood-2007-10-116111; Logters TT, 2009, SHOCK, V32, P29, DOI 10.1097/SHK.0b013e31819714fa; MacKenzie CR, 2003, ADV EXP MED BIOL, V527, P67; Mazzon E, 2002, GUT, V51, P507, DOI 10.1136/gut.51.4.507; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Muller A, 2009, J CELL MOL MED, V13, P1125, DOI 10.1111/j.1582-4934.2008.00542.x; Muller Norbert, 2006, Expert Rev Neurother, V6, P1017, DOI 10.1586/14737175.6.7.1017; Myint AM, 2007, J AFFECT DISORDERS, V98, P143, DOI 10.1016/j.jad.2006.07.013; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; OLESEN J, 2006, J NEUROL NEUROSUR S1, V77, P1; Paluszkiewicz P, 2009, AMINO ACIDS, V37, P637, DOI 10.1007/s00726-008-0183-x; Qiu BS, 1999, NAT MED, V5, P1178, DOI 10.1038/13503; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Robinson OJ, 2009, PSYCHOPHARMACOLOGY, V205, P227, DOI 10.1007/s00213-009-1533-4; Russo S, 2009, WORLD J BIOL PSYCHIA, V10, P258, DOI [10.1080/15622970701513764, 10.3109/15622970701513764]; Ruzek MC, 1997, J EXP MED, V185, P1185, DOI 10.1084/jem.185.7.1185; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Schmidt MV, 2008, ANN NY ACAD SCI, V1148, P174, DOI 10.1196/annals.1410.017; Tattevin P, 2010, J INFECT DIS, V201, P956, DOI 10.1086/650996; Teitelbaum AA, 2008, AM J PHYSIOL-GASTR L, V295, pG452, DOI 10.1152/ajpgi.90210.2008; Valenzuela-Millan J, 2010, CIR CIR, V78, P147; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wang YX, 2010, BRAIN BEHAV IMMUN, V24, P201, DOI 10.1016/j.bbi.2009.06.152; Weighardt H, 2002, ANN SURG, V235, P560, DOI 10.1097/00000658-200204000-00015; World Health Organization, 2010, MENT HLTH DEPR	54	73	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11825	10.1371/journal.pone.0011825	http://dx.doi.org/10.1371/journal.pone.0011825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20689575	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520100009
J	Guan, F; Schaffer, L; Handa, K; Hakomori, SI				Guan, Feng; Schaffer, Lana; Handa, Kazuko; Hakomori, Sen-itiroh			Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-beta	FASEB JOURNAL			English	Article						cobalt chloride; epithelial molecule; gene transfection; glycogene; glycosphingolipid	EMBRYONIC CORNEAL EPITHELIUM; CELL MOTILITY; CANCER-CELLS; EXTRACELLULAR-MATRIX; MONOCLONAL-ANTIBODIES; GM3 GANGLIOSIDE; CARCINOMA CELLS; UP-REGULATION; EXPRESSION; MECHANISMS	The epithelial-to-mesenchymal transition (EMT) is a basic cellular process that plays a key role in normal embryonic development and in cancer progression/metastasis. Our previous study indicated that EMT processes of mouse and human epithelial cells induced by TGF-beta display clear reduction of gangliotetraosylceramide (Gg4) and ganglioside GM2, suggesting a close association of glycosphingolipids (GSLs) with EMT. In the present study, using normal murine mammary gland (NMuMG) cells, we found that levels of Gg4 and of mRNA for the UDP-Gal: beta 1-3galactosyltransferase-4 (beta 3GalT4) gene, responsible for reduction of Gg4, were reduced in EMT induced by hypoxia (similar to 1% O-2) or CoCl2 (hypoxia mimic), similarly to that for TGF-beta-induced EMT. An increase in the Gg4 level by its exogenous addition or by transfection of the beta 3GalT4 gene inhibited the hypoxia-induced or TGF-beta-induced EMT process, including changes in epithelial cell morphology, enhanced motility, and associated changes in epithelial vs. mesenchymal molecules. We also found that Gg4 is closely associated with E-cadherin and beta-catenin. These results suggest that the beta 3GalT4 gene, responsible for Gg4 expression, is down-regulated in EMT; and Gg4 has a regulatory function in the EMT process in NMuMG cells, possibly through interaction with epithelial molecules important to maintain epithelial cell membrane organization.-Guan, F., Schaffer, L., Handa, K., and Hakomori, S. Functional role of gangliotetraosylceramide in epithelialto-mesenchymal transition process induced by hypoxia and by TGF-beta. FASEB J. 24, 4889-4903 (2010). www.fasebj.org	[Guan, Feng; Handa, Kazuko; Hakomori, Sen-itiroh] Pacific NW Res Fdn, Div Biomembrane Res, Seattle, WA 98122 USA; [Guan, Feng; Handa, Kazuko; Hakomori, Sen-itiroh] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; [Guan, Feng; Handa, Kazuko; Hakomori, Sen-itiroh] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Schaffer, Lana] Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Scripps Research Institute	Hakomori, SI (corresponding author), Pacific NW Res Fdn, Div Biomembrane Res, 720 Broadway, Seattle, WA 98122 USA.	hakomori@u.washington.edu			U.S. National Institutes of Health (NIH) National Cancer Institute [2R01-CA080054]; NIH National Institute of General Medical Sciences [GM62116]; NATIONAL CANCER INSTITUTE [R01CA080054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Ronald L. Schnaar (The Johns Hopkins University, Baltimore, MD, USA) for the kind donation of GD1a-1 and anti-GD1a antibody, Levi Lowder for construction of the expression vector, and Steve Anderson for assistance with preparation of the manuscript and figures. This work was funded primarily by the U.S. National Institutes of Health (NIH) National Cancer Institute (grant 2R01-CA080054 to S. H.) and in part by the NIH National Institute of General Medical Sciences (grant GM62116 to the Consortium for Functional Glycomics).	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Bektas M, 2003, GLYCOCONJUGATE J, V20, P39, DOI 10.1023/B:GLYC.0000016741.88476.8b; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; FENDERSON BA, 1984, J EXP MED, V160, P1591, DOI 10.1084/jem.160.5.1591; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; GOODMAN SL, 1985, CELL, V41, P1029, DOI 10.1016/S0092-8674(85)80083-0; Graham CH, 1999, INT J CANCER, V80, P617, DOI 10.1002/(SICI)1097-0215(19990209)80:4<617::AID-IJC22>3.0.CO;2-C; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; HAKOMORI SI, 1977, VIROLOGY, V76, P485, DOI 10.1016/0042-6822(77)90231-8; HAKOMORI SI, 1971, VIROLOGY, V44, P609, DOI 10.1016/0042-6822(71)90375-8; HANSEN JES, 1990, J VIROL, V64, P2833, DOI 10.1128/JVI.64.6.2833-2840.1990; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130; Kawakami Y, 2002, J BIOL CHEM, V277, P34349, DOI 10.1074/jbc.M200771200; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kirkland SC, 2009, BRIT J CANCER, V101, P320, DOI 10.1038/sj.bjc.6605143; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lopez PHH, 2008, BRAIN, V131, P1926, DOI 10.1093/brain/awn074; MAXZUD MK, 1995, J BIOL CHEM, V270, P20207, DOI 10.1074/jbc.270.34.20207; Mitsuzuka K, 2005, J BIOL CHEM, V280, P35545, DOI 10.1074/jbc.M505630200; Miyazaki H, 1997, J BIOL CHEM, V272, P24794, DOI 10.1074/jbc.272.40.24794; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Ono M, 2001, BIOCHEMISTRY-US, V40, P6414, DOI 10.1021/bi0101998; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Prinetti A, 2010, GLYCOBIOLOGY, V20, P62, DOI 10.1093/glycob/cwp143; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rofstad EK, 2002, CANCER RES, V62, P1847; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STRAUS AH, 1989, EXP CELL RES, V183, P126, DOI 10.1016/0014-4827(89)90423-0; SUGRUE SP, 1982, DEV BIOL, V92, P97, DOI 10.1016/0012-1606(82)90154-3; SUGRUE SP, 1986, J CELL BIOL, V102, P1907, DOI 10.1083/jcb.102.5.1907; SUGRUE SP, 1981, J CELL BIOL, V91, P45, DOI 10.1083/jcb.91.1.45; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Todeschini AR, 2008, P NATL ACAD SCI USA, V105, P1925, DOI 10.1073/pnas.0709619104; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; VANGSTED AJ, 1991, CANCER RES, V51, P2879; Vengellur A, 2004, TOXICOL SCI, V82, P638, DOI 10.1093/toxsci/kfh278; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yamamura S, 1997, BIOCHEM BIOPH RES CO, V236, P218, DOI 10.1006/bbrc.1997.6933; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615; YOUNG WW, 1990, P NATL ACAD SCI USA, V87, P6838, DOI 10.1073/pnas.87.17.6838; YOUNG WW, 1979, J EXP MED, V150, P1008, DOI 10.1084/jem.150.4.1008; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	63	50	52	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4889	4903		10.1096/fj.10-162107	http://dx.doi.org/10.1096/fj.10-162107			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20720159	Green Published			2022-12-25	WOS:000284824400028
J	Wijesekara, N; Krishnamurthy, M; Bhattacharjee, A; Suhail, A; Sweeney, G; Wheeler, MB				Wijesekara, Nadeeja; Krishnamurthy, Mansa; Bhattacharjee, Alpana; Suhail, Aamir; Sweeney, Gary; Wheeler, Michael B.			Adiponectin-induced ERK and Akt Phosphorylation Protects against Pancreatic Beta Cell Apoptosis and Increases Insulin Gene Expression and Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-INDUCED APOPTOSIS; LOW GLUCOSE; KINASE-B; RESISTANCE; RECEPTOR; GROWTH; HYPOADIPONECTINEMIA; PROLIFERATION; STIMULATION; DYSFUNCTION	The functional impact of adiponectin on pancreatic beta cells is so far poorly understood. Although adiponectin receptors (AdipoR1/2) were identified, their involvement in adiponectin-induced signaling and other molecules involved is not clearly defined. Therefore, we investigated the role of adiponectin in beta cells and the signaling mediators involved. MIN6 beta cells and mouse islets were stimulated with globular (2.5 mu g/ml) or full-length (5 mu g/ml) adiponectin under serum starvation, and cell viability, proliferation, apoptosis, insulin gene expression, and secretion were measured. Lysates were subjected to Western blot analysis to determine phosphorylation of AMP-activated protein kinase (AMPK), Akt, or ERK. Functional significance of signaling was confirmed using dominant negative mutants or pharmacological inhibitors. Participation of AdipoRs was assessed by overexpression or siRNA. Adiponectin failed to activate AMPK after 10 min or 1- and 24-h stimulation. ERK was significantly phosphorylated after 24-h treatment with adiponectin, whereas Akt was activated at all time points examined. 24-h stimulation with adiponectin significantly increased cell viability by decreasing cellular apoptosis, and this was prevented by dominant negative Akt, wortmannin (PI3K inhibitor), and U0126 (MEK inhibitor). Moreover, adiponectin regulated insulin gene expression and glucose-stimulated insulin secretion, which was also prevented by wortmannin and U0126 treatment. Interestingly, the data also suggest adiponectin-induced changes in Akt and ERK phosphorylation and caspase-3 may occur independent of the level of AdipoR expression. This study demonstrates a lack of AMPK involvement and implicates Akt and ERK in adiponectin signaling, leading to protection against apoptosis and stimulation of insulin gene expression and secretion in pancreatic beta cells.	[Wijesekara, Nadeeja; Krishnamurthy, Mansa; Bhattacharjee, Alpana; Suhail, Aamir; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	University of Toronto; York University - Canada	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle Rm 3352, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Wijesekara, Nadeeja/AAW-7230-2021	Wheeler, Michael B./0000-0002-7480-7267	Canadian Institute of Health Research [MOP-12898]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grant MOP-12898 (to M. B. W.).	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bacha F, 2004, DIABETES CARE, V27, P547, DOI 10.2337/diacare.27.2.547; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Ching JK, 2008, FASEB J, V22; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Cong L, 2007, ENDOCR-RELAT CANCER, V14, P713, DOI 10.1677/ERC-07-0065; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Fei HQ, 2008, MOL CELL BIOCHEM, V315, P75, DOI 10.1007/s11010-008-9791-8; Gu WQ, 2006, ENDOCRINE, V30, P217, DOI 10.1385/ENDO:30:2:217; Hayakawa J, 2000, CANCER RES, V60, P5988; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Huypens P, 2005, LIFE SCI, V77, P1273, DOI 10.1016/j.lfs.2005.03.008; Jung TW, 2009, ENDOCR J, V56, P377, DOI 10.1507/endocrj.K08E-354; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lin P, 2009, TOHOKU J EXP MED, V217, P59, DOI 10.1620/tjem.217.59; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Musso G, 2005, AM J GASTROENTEROL, V100, P2438, DOI 10.1111/j.1572-0241.2005.00297.x; Ogunwobi OO, 2006, REGUL PEPTIDES, V134, P105, DOI 10.1016/j.regpep.2006.02.001; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Rakatzi I, 2004, DIABETOLOGIA, V47, P249, DOI 10.1007/s00125-003-1293-3; Retnakaran R, 2005, DIABETOLOGIA, V48, P993, DOI 10.1007/s00125-005-1710-x; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	54	164	171	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33623	33631		10.1074/jbc.M109.085084	http://dx.doi.org/10.1074/jbc.M109.085084			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20709750	Green Published, hybrid			2022-12-25	WOS:000283354000007
J	Bear, MD; Li, M; Liu, YL; Giel-Moloney, MA; Fanburg, BL; Toksoz, D				Bear, Michael D.; Li, Min; Liu, Yinglin; Giel-Moloney, Maryann A.; Fanburg, Barry L.; Toksoz, Deniz			The Lbc Rho Guanine Nucleotide Exchange Factor/alpha-Catulin Axis Functions in Serotonin-induced Vascular Smooth Muscle Cell Mitogenesis and RhoA/ROCK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; PROTEIN-KINASE-A; NF-KAPPA-B; SIGNAL-TRANSDUCTION; PULMONARY-HYPERTENSION; NUCLEAR TRANSLOCATION; ANCHORING PROTEIN; ALPHA-CATULIN; PROLIFERATION; ONCOGENE	Serotonin (5-hydroxytryptamine, 5-HT) is mitogenic for several cell types including pulmonary arterial smooth muscle cells (PASMC), and is associated with the abnormal vascular smooth muscle remodeling that occurs in pulmonary arterial hypertension. RhoA/Rho kinase (ROCK) function is required for 5-HT-induced PASMC mitogenesis, and 5-HT activates RhoA; however, the signaling steps are poorly defined. Rho guanine nucleotide exchange factors (Rho GEFs) transduce extracellular signals to Rho, and we found that 5-HT treatment of PASMC led to increased membrane-associated Lbc Rho GEF, suggesting modulation by 5-HT. Lbc knockdown by siRNA attenuated 5-HT-induced thymidine uptake in PASMC, indicating a role in PASMC mitogenesis. 5-HT triggered Rho-dependent serum response factor-mediated reporter activation in PASMC, and this was reduced by Lbc depletion. Lbc knockdown reduced 5-HT-induced RhoA/ROCK activation, but not p42/44 ERK MAP kinase activation, suggesting that Lbc is an intermediary between 5-HT and RhoA/ROCK, but not ERK. 5-HT stimulation of PASMC led to increased association between Lbc, RhoA, and the alpha-catulin scaffold. Furthermore, alpha-catulin knockdown attenuated 5-HT-induced PASMC thymidine uptake. 5-HT-induced PASMC mitogenesis was reduced by dominant-negative G(q) protein, suggesting cooperation with Lbc/alpha-catulin. These results for the first time define a Rho GEF involved in vascular smooth muscle cell growth and serotonin signaling, and suggest that Lbc Rho GEF family members play distinct roles. Thus, the Lbc/alpha-catulin axis participates in 5-HT-induced PASMC mitogenesis and RhoA/ROCK signaling, and may be an interventional target in diseases involving vascular smooth muscle remodeling.	[Bear, Michael D.; Li, Min; Liu, Yinglin; Fanburg, Barry L.; Toksoz, Deniz] Tufts Med Ctr, Tupper Res Inst, Div Pulm & Crit Care, Boston, MA 02111 USA; [Giel-Moloney, Maryann A.] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Toksoz, D (corresponding author), Tufts Med Ctr, Tupper Res Inst, Div Pulm & Crit Care, 800 Washington St,TMC 257, Boston, MA 02111 USA.	dtoksoz@tuftsmedicalcenter.org			National Institutes of Health [HL085260]; American Heart Association [0756021T]; Tufts University of Medicine [P30 NS047243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Tufts University of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085260 (to B. L. F.) and American Heart Association Grant 0756021T (to D. T.).; We thank Kozo Kaibuchi and Matthew Hart for plasmids, and Alenka Lovy-Wheeler for assistance in the Tufts Imaging Center for Neuroscience Research, Tufts University of Medicine, supported by Grant P30 NS047243 (Jackson).	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; Chen LY, 2004, J BIOL CHEM, V279, P7208, DOI 10.1074/jbc.M309542200; Day RM, 2006, BIOCHEM PHARMACOL, V71, P386, DOI 10.1016/j.bcp.2005.10.035; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Do E Z, 2009, CIRC J, V73, P1731, DOI 10.1253/circj.CJ-09-0135; Dutt P, 2004, CELL SIGNAL, V16, P201, DOI 10.1016/S0898-6568(03)00132-3; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esteve JM, 2007, CELL BIOCHEM BIOPHYS, V47, P33, DOI 10.1385/CBB:47:1:33; Fanburg BL, 1997, AM J PHYSIOL-LUNG C, V272, pL795, DOI 10.1152/ajplung.1997.272.5.L795; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Guilluy C, 2009, AM J RESP CRIT CARE, V179, P1151, DOI 10.1164/rccm.200805-691OC; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janssens B, 1999, BBA-GENE STRUCT EXPR, V1447, P341, DOI 10.1016/S0167-4781(99)00170-0; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Klussmann E, 2001, FEBS LETT, V507, P264, DOI 10.1016/S0014-5793(01)02995-7; LEE SL, 1991, CIRC RES, V68, P1362, DOI 10.1161/01.RES.68.5.1362; Lee SL, 1999, AM J PHYSIOL-LUNG C, V277, pL282, DOI 10.1152/ajplung.1999.277.2.L282; Li M, 2007, AM J PHYSIOL-LUNG C, V293, pL463, DOI 10.1152/ajplung.00133.2007; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; Liu YL, 2004, CIRC RES, V95, P579, DOI 10.1161/01.RES.0000141428.53262.a4; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MacLean MR, 2009, CURR OPIN PHARMACOL, V9, P281, DOI 10.1016/j.coph.2009.02.005; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Olson MF, 1997, ONCOGENE, V15, P2827, DOI 10.1038/sj.onc.1201594; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ramage AG, 2008, TRENDS PHARMACOL SCI, V29, P472, DOI 10.1016/j.tips.2008.06.009; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Sterpetti P, 2006, AM J PHYSIOL-GASTR L, V290, pG624, DOI 10.1152/ajpgi.00128.2005; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; TOKSOZ D, 1994, ONCOGENE, V9, P621; Toksoz D, 2002, HISTOL HISTOPATHOL, V17, P915, DOI 10.14670/HH-17.915; Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; Xiang Y, 2008, J CELL BIOCHEM, V103, P920, DOI 10.1002/jcb.21461; Zhang ZC, 1998, MAT SCI ENG B-SOLID, V54, P149, DOI 10.1016/S0921-5107(98)00157-3; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	50	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32919	32926		10.1074/jbc.M109.062513	http://dx.doi.org/10.1074/jbc.M109.062513			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20696764	hybrid, Green Published			2022-12-25	WOS:000283048200029
J	Pakala, SB; Reddy, SDN; Bui-Nguyen, TM; Rangparia, SS; Bommana, A; Kumar, R				Pakala, Suresh B.; Reddy, Sirigiri Divijendra Natha; Bui-Nguyen, Tri M.; Rangparia, Siddharth S.; Bommana, Anitha; Kumar, Rakesh			MTA1 Coregulator Regulates LPS Response via MyD88-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; KAPPA-B; NEGATIVE REGULATION; TRANSCRIPTIONAL REPRESSION; ESTROGEN-RECEPTOR; CANCER; INFLAMMATION; GENE; PATHWAYS; IMMUNITY	Although metastasis tumor antigen 1 (MTA1) contributes to the responsiveness of macrophages to LPS, the underlying mechanism remains unknown. Here, we investigated the role of MTA1 in the regulation of expression and function of MyD88, a proximal component of NF-kappa B signaling. We discovered that MTA1 targets MyD88 and that MyD88 is a NF-kappa B-responsive gene in LPS-stimulated macrophages. We found that MTA1 is required for MyD88-dependent stimulation of NF-kappa B signaling and expression of proinflammatory cytokines such as IL-1 beta, MIP2, and TNF-alpha as MTA1 depletion leads to a substantial reduction in the expression of NF-kappa B target genes. In addition, LPS-mediated stimulation of MyD88 transcription was accompanied by an enhanced recruitment of MTA1, RNA polymerase II, and p65RelA complex to the NF-kappa B consensus sites in the MyD88 promoter. Interestingly, the recruitment of both MTA1 and MyD88 expression is effectively blocked by NF-kappa B inhibitor parthenolide. Selective knockdown of MyD88 by a dominant negative mutant of MyD88 or selective siRNA also impairs the ability of LPS to stimulate the NF-kappa B target genes. These findings reveal an inherent coregulatory role of MTA1 upon the expression of MyD88 and suggest that MTA1 regulation of MyD88 may constitute at least one of the mechanisms by which MTA1 stimulates LPS-induced NF-kappa B signaling in stimulated macrophages.	[Pakala, Suresh B.; Reddy, Sirigiri Divijendra Natha; Bui-Nguyen, Tri M.; Rangparia, Siddharth S.; Bommana, Anitha; Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Inst Coregulator Biol, Washington, DC 20037 USA	George Washington University	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Inst Coregulator Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendranathareddy/A-9857-2010	Kumar, Rakesh/0000-0001-7664-0803; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 (to R. K.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Beutler B, 2004, IMMUNITY, V21, P134, DOI 10.1016/j.immuni.2004.07.014; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bui-Nguyen TM, 2010, ONCOGENE, V29, P1179, DOI 10.1038/onc.2009.404; Chang J, 2009, P NATL ACAD SCI USA, V106, P18327, DOI 10.1073/pnas.0905815106; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Iimuro Y, 2007, J GASTROEN HEPATOL, V22, pS57, DOI 10.1111/j.1440-1746.2006.04651.x; Ikebe M, 2009, J SURG ONCOL, V100, P725, DOI 10.1002/jso.21392; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Noman Abu Shadat M, 2009, Innate Immun, V15, P33, DOI 10.1177/1753425908099317; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TOH Y, 1994, J BIOL CHEM, V269, P22958; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	43	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32787	32792		10.1074/jbc.M110.151340	http://dx.doi.org/10.1074/jbc.M110.151340			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702415	Green Published, hybrid			2022-12-25	WOS:000283048200014
J	Rimer, M				Rimer, Mendell			Modulation of Agrin-induced Acetylcholine Receptor Clustering by Extracellular Signal-regulated Kinases 1 and 2 in Cultured Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTIVE NEUROMUSCULAR SYNAPTOGENESIS; ACTIVATED PROTEIN-KINASE; MUSCLE-CELLS; POSTSYNAPTIC MEMBRANES; BETA-DYSTROGLYCAN; GENE-EXPRESSION; MOTOR-NEURONS; PHORBOL ESTER; IN-VIVO; SYNAPSE	Agrin released by motoneurons induces and/or maintains acetylcholine receptor (AChR) clustering and other aspects of postsynaptic differentiation at the vertebrate neuromuscular junction. Agrin acts by binding and activating a receptor complex containing LDL receptor protein 4 (Lrp4) and muscle-specific kinase (MuSK). Two critical downstream components of this signaling cascade, Dox-7 and rapsyn, have been identified. However, additional intracellular essential elements remain unknown. Prior observations by others and us suggested antagonistic interactions between agrin and neuregulin-1 (Nrg-1) signaling in cultured myotubes and developing muscle fibers in vivo. A hallmark of Nrg-1 signaling in skeletal muscle cells is the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2). ERK1/2 are also activated in most cells by phorbol 12-myristate 13-acetate, a classical inhibitor of agrin-induced AChR clustering in myotubes. Here, it was investigated whether agrin activates ERK1/2 directly and whether such activation modulates agrin-induced AChR clustering. Agrin induced a rapid but transient activation of ERK1/2 in myotubes that was Lrp4/MuSK-dependent. However, blocking this ERK1/2 activation did not prevent but potentiated AChR clustering induced by agrin. ERK1/2 activation was dispensable for Nrg-1-mediated inhibition of the AChR clustering activity of agrin, but was indispensable for such activity by phorbol 12-myristate 13-acetate. Together, these results suggest agrin-induced activation of ERK1/2 is a negative modulator of agrin signaling in skeletal muscle cells.	[Rimer, Mendell] Texas A&M Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Rimer, M (corresponding author), 228 Joe H Reynolds Med Bldg, College Stn, TX 77843 USA.	mjrimer@medicine.tamhsc.edu			Texas A&M Health Science Center College of Medicine	Texas A&M Health Science Center College of Medicine	This work was supported by the Texas A&M Health Science Center College of Medicine.	Al-Shanti N, 2008, J ENDOCRINOL, V198, P243, DOI 10.1677/JOE-08-0151; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Burgess RW, 2002, J NEUROCHEM, V83, P271, DOI 10.1046/j.1471-4159.2002.01102.x; BURSZTAJN S, 1988, BIOL CELL, V63, P57, DOI 10.1016/0248-4900(88)90108-6; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Cartaud A, 1998, J BIOL CHEM, V273, P11321, DOI 10.1074/jbc.273.18.11321; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FROEHNER SC, 1984, J CELL BIOL, V99, P88, DOI 10.1083/jcb.99.1.88; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Heathcote RD, 2000, DEV BIOL, V227, P595, DOI 10.1006/dbio.2000.9906; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Jacobson C, 1998, J NEUROSCI, V18, P6340; Kahl J, 2003, J NEUROSCI, V23, P392, DOI 10.1523/JNEUROSCI.23-02-00392.2003; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Madhavan R, 2006, J NEUROBIOL, V66, P1511, DOI 10.1002/neu.20320; Martin PT, 1997, DEVELOPMENT, V124, P3909; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Mittaud P, 2004, MOL CELL BIOL, V24, P7841, DOI 10.1128/MCB.24.18.7841-7854.2004; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Ponomareva ON, 2006, MOL CELL NEUROSCI, V31, P334, DOI 10.1016/j.mcn.2005.10.004; Rimer M, 2004, MOL CELL NEUROSCI, V26, P271, DOI 10.1016/j.mcn.2004.02.002; ROSS A, 1988, J CELL BIOL, V107, P1139, DOI 10.1083/jcb.107.3.1139; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Si JT, 1999, MOL BRAIN RES, V67, P18, DOI 10.1016/S0169-328X(99)00028-5; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Tansey MG, 1996, J CELL BIOL, V134, P465, DOI 10.1083/jcb.134.2.465; Trinidad JC, 2004, J BIOL CHEM, V279, P31622, DOI 10.1074/jbc.M400044200; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	41	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32370	32377		10.1074/jbc.M110.144774	http://dx.doi.org/10.1074/jbc.M110.144774			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696763	Green Published, hybrid			2022-12-25	WOS:000282683000050
J	Varkey, J; Isas, JM; Mizuno, N; Jensen, MB; Bhatia, VK; Jao, CC; Petrlova, J; Voss, JC; Stamou, DG; Steven, AC; Langen, R				Varkey, Jobin; Isas, Jose Mario; Mizuno, Naoko; Jensen, Martin Borch; Bhatia, Vikram Kjoller; Jao, Christine C.; Petrlova, Jitka; Voss, John C.; Stamou, Dimitrios G.; Steven, Alasdair C.; Langen, Ralf			Membrane Curvature Induction and Tubulation Are Common Features of Synucleins and Apolipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND ALPHA-SYNUCLEIN; BIN/AMPHIPHYSIN/RVS BAR DOMAIN; A-I; SECONDARY STRUCTURE; PARKINSONS-DISEASE; AMPHIPATHIC HELICES; TRANSGENIC MICE; BETA-SYNUCLEIN; LIPID-BILAYERS; ENDOPHILIN	Synucleins and apolipoproteins have been implicated in a number of membrane and lipid trafficking events. Lipid interaction for both types of proteins is mediated by 11 amino acid repeats that form amphipathic helices. This similarity suggests that synucleins and apolipoproteins might have comparable effects on lipid membranes, but this has not been shown directly. Here, we find that alpha-synuclein, beta-synuclein, and apolipoprotein A-1 have the conserved functional ability to induce membrane curvature and to convert large vesicles into highly curved membrane tubules and vesicles. The resulting structures are morphologically similar to those generated by amphiphysin, a curvature-inducing protein involved in endocytosis. Unlike amphiphysin, however, synucleins and apolipoproteins do not require any scaffolding domains and curvature induction is mediated by the membrane insertion and wedging of amphipathic helices alone. Moreover, we frequently observed that alpha-synuclein caused membrane structures that had the appearance of nascent budding vesicles. The ability to function as a minimal machinery for vesicle budding agrees well with recent findings that alpha-synuclein plays a role in vesicle trafficking and enhances endocytosis. Induction of membrane curvature must be under strict regulation in vivo; however, as we find it can also cause disruption of membrane integrity. Because the degree of membrane curvature induction depends on the concerted action of multiple proteins, controlling the local protein density of tubulating proteins may be important. How cellular safeguarding mechanisms prevent such potentially toxic events and whether they go awry in disease remains to be determined.	[Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Mizuno, Naoko; Steven, Alasdair C.] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Jensen, Martin Borch; Bhatia, Vikram Kjoller; Stamou, Dimitrios G.] Univ Copenhagen, Bionanotechnol Lab, Dept Neurosci & Pharmacol, Lundbeck Fdn Ctr Biomembranes Nanomed, DK-2100 Copenhagen, Denmark; [Petrlova, Jitka; Voss, John C.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Lundbeckfonden; University of Copenhagen; University of California System; University of California Davis	Langen, R (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, 1501 San Pablo St,121 ZNI, Los Angeles, CA 90033 USA.	langen@usc.edu	Stamou, Dimitrios/D-5042-2016; Mizuno, Naoko/AAY-1926-2021; Varkey, Jobin/I-5845-2019	Stamou, Dimitrios/0000-0001-8456-8995; Mizuno, Naoko/0000-0002-1594-2821; Voss, John/0000-0001-9279-209X	National Institutes of Health [GM063915, R01 AG029246]; NIAMS; Larry L. Hillblom foundation; Danish Research Councils; University of Copenhagen; Lundbeck foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Larry L. Hillblom foundation; Danish Research Councils(Det Frie Forskningsrad (DFF)); University of Copenhagen; Lundbeck foundation(Lundbeckfonden); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM063915 (to R.L.), R01 AG029246 (to J.C.V.), and the Intramural Research Program of NIAMS (to A.C.S.). This work was also supported by the Larry L. Hillblom foundation (to R.L.) and the Danish Research Councils, the University of Copenhagen and the Lundbeck foundation (to D.G.S.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Ayton GS, 2009, BIOPHYS J, V97, P1616, DOI 10.1016/j.bpj.2009.06.036; Ayton GS, 2009, CURR OPIN STRUC BIOL, V19, P138, DOI 10.1016/j.sbi.2009.03.001; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Bendix PM, 2009, P NATL ACAD SCI USA, V106, P12341, DOI 10.1073/pnas.0903052106; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Borbat P, 2006, J AM CHEM SOC, V128, P10004, DOI 10.1021/ja063122l; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Cabin DE, 2002, J NEUROSCI, V22, P8797; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Cui HS, 2009, BIOPHYS J, V97, P2746, DOI 10.1016/j.bpj.2009.08.043; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Fujita Y, 2006, ACTA NEUROPATHOL, V112, P261, DOI 10.1007/s00401-006-0114-4; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Golovko MY, 2009, MOL CELL BIOCHEM, V326, P55, DOI 10.1007/s11010-008-0008-y; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee SJ, 2008, ACTA NEUROBIOL EXP, V68, P509; LUO CC, 1986, J MOL BIOL, V187, P325, DOI 10.1016/0022-2836(86)90436-5; Madine J, 2008, MOL MEMBR BIOL, V25, P518, DOI 10.1080/09687680802467977; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; MISHRA VK, 1995, J BIOL CHEM, V270, P1602, DOI 10.1074/jbc.270.4.1602; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; SEGREST JP, 1977, CHEM PHYS LIPIDS, V18, P7, DOI 10.1016/0009-3084(77)90023-8; SEGREST JP, 1992, J LIPID RES, V33, P141; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; TYTLER EM, 1993, J BIOL CHEM, V268, P22112; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	76	223	227	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32486	32493		10.1074/jbc.M110.139576	http://dx.doi.org/10.1074/jbc.M110.139576			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693280	Green Published, hybrid			2022-12-25	WOS:000282683000062
J	Bledzka, K; Bialkowska, K; Nie, HQ; Qin, J; Byzova, T; Wu, CY; Plow, EF; Ma, YQ				Bledzka, Kamila; Bialkowska, Katarzyna; Nie, Huiqin; Qin, Jun; Byzova, Tatiana; Wu, Chuanyue; Plow, Edward F.; Ma, Yan-Qing			Tyrosine Phosphorylation of Integrin beta(3) Regulates Kindlin-2 Binding and Integrin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TALIN PHOSPHORYLATION; PLATELET-AGGREGATION; LEUKOCYTE ADHESION; CYTOPLASMIC TAILS; ALPHA(IIB)BETA(3); COACTIVATOR; MECHANISMS; PROVIDES; CELL	Kindlins are essential for integrin activation in cell systems and do so by working in a cooperative fashion with talin via their direct interaction with integrin beta cytoplasmic tails (CTs). Kindlins interact with the membrane-distal NxxY motif, which is distinct from the talin-binding site within the membrane-proximal NxxY motif. The Tyr residues in both motifs can be phosphorylated, and it has been suggested that this modification of the membrane-proximal NxxY motif negatively regulates interaction with the talin head domain. However, the influence of Tyr phosphorylation of the membrane-distal NxxY motif on kindlin binding is unknown. Using mutational analyses and phosphorylated peptides, we show that phosphorylation of the membrane-distal NITY759 motif in the beta(3) CT disrupts kindlin-2 recognition. Phosphorylation of this membrane-distal Tyr also disables the ability of kindlin-2 to coactivate the integrin. In direct binding studies, peptides corresponding to the non-phosphorylated beta(3) CT interacted well with kindlin-2, whereas the Tyr(759)-phosphorylated peptide failed to bind kindlin-2 with measurable affinity. These observations indicate that transitions between the phosphorylated and non-phosphorylated states of the integrin beta(3) CT determine reactivity with kindlin-2 and govern the role of kindlin-2 in regulating integrin activation.	[Bledzka, Kamila; Bialkowska, Katarzyna; Nie, Huiqin; Qin, Jun; Byzova, Tatiana; Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; [Wu, Chuanyue] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh		may@ccf.org		Byzova, Tatiana/0000-0002-2615-875X; Qin, Jun/0000-0002-2647-9270	National Institutes of Health, NHLBI [P01 HL073311, R01 HL096062]; American Heart Association [10SDG2610277]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096062, P01HL073311] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL073311 and R01 HL096062 from NHLBI. This work was also supported by Scientist Development Grant 10SDG2610277 from the American Heart Association.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chandhoke SK, 2004, J CELL SCI, V117, P1431, DOI 10.1242/jcs.00987; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; Gao CL, 2005, J BIOL CHEM, V280, P15422, DOI 10.1074/jbc.M414457200; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Herz C, 2006, J BIOL CHEM, V281, P36082, DOI 10.1074/jbc.M606259200; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Phillips DR, 2001, CURR OPIN CELL BIOL, V13, P546, DOI 10.1016/S0955-0674(00)00250-7; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045	36	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30370	30374		10.1074/jbc.C110.134247	http://dx.doi.org/10.1074/jbc.C110.134247			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20702409	Green Published, hybrid			2022-12-25	WOS:000282135500003
J	Gatenby, RA; Frieden, BR				Gatenby, Robert A.; Frieden, B. Roy			Coulomb Interactions between Cytoplasmic Electric Fields and Phosphorylated Messenger Proteins Optimize Information Flow in Cells	PLOS ONE			English	Article							DYNAMICS; MEMBRANE	Background: Normal membrane (CM) to the nucleus. Movement of messenger proteins in the cytoplasm is thought to be dependent on random walk. However, Brownian motion will disperse messenger proteins throughout the cytosol resulting in slow and highly variable transit times. We propose that a critical component of information transfer is an intracellular electric field generated by distribution of charge on the nuclear membrane (NM). While the latter has been demonstrated experimentally for decades, the role of the consequent electric field has been assumed to be minimal due to a Debye length of about 1 nanometer that results from screening by intracellular Cl- and K+. We propose inclusion of these inorganic ions in the Debye-Huckel equation is incorrect because nuclear pores allow transit through the membrane at a rate far faster than the time to thermodynamic equilibrium. In our model, only the charged, mobile messenger proteins contribute to the Debye length. Findings: Using this revised model and published data, we estimate the NM possesses a Debye-Huckel length of a few microns and find this is consistent with recent measurement using intracellular nano-voltmeters. We demonstrate the field will accelerate isolated messenger proteins toward the nucleus through Coulomb interactions with negative charges added by phosphorylation. We calculate transit times as short as 0.01 sec. When large numbers of phosphorylated messenger proteins are generated by increasing concentrations of extracellular ligands, we demonstrate they generate a self-screening environment that regionally attenuates the cytoplasmic field, slowing movement but permitting greater cross talk among pathways. Preliminary experimental results with phosphorylated RAF are consistent with model predictions. Conclusion: This work demonstrates that previously unrecognized Coulomb interactions between phosphorylated messenger proteins and intracellular electric fields will optimize information transfer from the CM to the NM in cells.	[Gatenby, Robert A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiol, Tampa, FL 33682 USA; [Gatenby, Robert A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Integrated Math Oncol, Tampa, FL 33682 USA; [Frieden, B. Roy] Univ Arizona, Coll Opt Sci, Tucson, AZ USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Arizona	Gatenby, RA (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiol, Tampa, FL 33682 USA.	robert.gatenby@moffitt.org			National Cancer Institute (NCI) [1U54CA143970-01]; NATIONAL CANCER INSTITUTE [U54CA143970] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Cancer Institute (NCI) under grant 1U54CA143970-01. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Born M, 1999, PRINCIPLES OPTICS, V461; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Bray D, 2008, CELL MOVEMENTS MOL M; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Castilho L., 2008, ANIMAL CELL TECHNOLO, VVolume 39; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; DUNCAN R, 1982, CLIN CHEM, V28, P749; FRIEDEN BR, 2001, PROBABILITY STAT OPT; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gatenby RA, 2004, MUTAT RES-FUND MOL M, V568, P259, DOI 10.1016/j.mrfmmm.2004.04.018; Gatenby RA, 2002, CANCER RES, V62, P3675; GATENBY RA, 2007, EXPLORATORY DATA ANA, P74; Gatenby RA, 2007, B MATH BIOL, V69, P635, DOI 10.1007/s11538-006-9141-5; JOHNSON HA, 1970, SCIENCE, V168, P1545, DOI 10.1126/science.168.3939.1545; Kholodenko BN, 2000, BIOCHEM J, V350, P901, DOI 10.1042/0264-6021:3500901; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Krammer BE, 1996, BIOELECTROCH BIOENER, V40, P67, DOI 10.1016/0302-4598(95)01895-6; LOEWENSTEIN WR, 1963, J GEN PHYSIOL, V46, P1123, DOI 10.1085/jgp.46.6.1123; LOEWENSTEIN WR, 1962, NATURE, V195, P462, DOI 10.1038/195462a0; LUO L, 2006, DIAGNOSTIC PATHOLOGY, V1, P1; Narzi D, 2008, J MOL BIOL, V382, P978, DOI 10.1016/j.jmb.2008.07.061; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Tyner KM, 2007, BIOPHYS J, V93, P1163, DOI 10.1529/biophysj.106.092452; Vidal M, 2005, FEBS LETT, V579, P1834, DOI 10.1016/j.febslet.2005.02.030; Yeh IC, 2004, P NATL ACAD SCI USA, V101, P12177, DOI 10.1073/pnas.0402699101	27	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12084	10.1371/journal.pone.0012084	http://dx.doi.org/10.1371/journal.pone.0012084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711447	Green Submitted, gold, Green Published			2022-12-25	WOS:000280849100021
J	Canderan, G; Gruarin, P; Montagna, D; Fontana, R; Melloni, G; Traversari, C; Dellabona, P; Casorati, G				Canderan, Glenda; Gruarin, Paola; Montagna, Daniela; Fontana, Raffaella; Melloni, Giulio; Traversari, Catia; Dellabona, Paolo; Casorati, Giulia			An Efficient Strategy to Induce and Maintain In Vitro Human T Cells Specific for Autologous Non-Small Cell Lung Carcinoma	PLOS ONE			English	Article							TCR GENE-TRANSFER/; HUMAN MELANOMAS; TUMOR-ANTIGEN; LYMPHOCYTES-T; CANCER; IMMUNOTHERAPY; REPERTOIRE; EXPRESSION; VECTOR; MAINTENANCE	Background: The efficient expansion in vitro of cytolytic CD8(+) T cells (CTLs) specific for autologous tumors is crucial both for basic and translational aspects of tumor immunology. We investigated strategies to generate CTLs specific for autologous Non-Small Cell Lung Carcinoma (NSCLC), the most frequent tumor in mankind, using circulating lymphocytes. Principal Findings: Classic Mixed Lymphocyte Tumor Cultures with NSCLC cells consistently failed to induce tumor-specific CTLs. Cross-presentation in vitro of irradiated NSCLC cells by autologous dendritic cells, by contrast, induced specific CTL lines from which we obtained a high number of tumor-specific T cell clones (TCCs). The TCCs displayed a limited TCR diversity, suggesting an origin from few tumor-specific T cell precursors, while their TCR molecular fingerprints were detected in the patient's tumor infiltrating lymphocytes, implying a role in the spontaneous anti-tumor response. Grafting NSCLC-specific TCR into primary allogeneic T cells by lentiviral vectors expressing human V-mouse C chimeric TCR alpha/beta chains overcame the growth limits of these TCCs. The resulting, rapidly expanding CD4(+) and CD8(+) T cell lines stably expressed the grafted chimeric TCR and specifically recognized the original NSCLC. Conclusions: This study defines a strategy to efficiently induce and propagate in vitro T cells specific for NSCLC starting from autologous peripheral blood lymphocytes.	[Canderan, Glenda; Gruarin, Paola; Dellabona, Paolo; Casorati, Giulia] Ist Sci San Raffaele, Expt Immunol Unit, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Montagna, Daniela] Univ Pavia, Dept Pediat, Immunol Lab, I-27100 Pavia, Italy; [Fontana, Raffaella] Ist Sci San Raffaele, Div Mol Oncol, Canc Gene Therapy Unit, I-20132 Milan, Italy; [Melloni, Giulio] Ist Sci San Raffaele, Dept Thorac Surg, I-20132 Milan, Italy; [Traversari, Catia] MolMed SPA, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pavia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Canderan, G (corresponding author), VGTI FL, Port St Lucie, FL USA.	dellabona.paolo@hsr.it; casorati.giulia@hsr.it	Dellabona, Paolo/G-5416-2012; Canderan, Glenda/V-3421-2019; Montagna, Daniela/AAK-9380-2020; Casorati, Giulia/J-7141-2018	Dellabona, Paolo/0000-0002-1414-633X; MONTAGNA, DANIELA/0000-0002-1533-579X; Casorati, Giulia/0000-0002-5102-4112	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Health; Fondazione Cariplo	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC), Fondazione Cariplo, and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Further, MolMed S.P.A. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JD, 2008, J IMMUNOTHER, V31, P1, DOI 10.1097/CJI.0b013e31815c193f; ANICHINI A, 1986, J EXP MED, V163, P215, DOI 10.1084/jem.163.1.215; Berard F, 2000, J EXP MED, V192, P1535, DOI 10.1084/jem.192.11.1535; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Dorrschuck A, 2004, BLOOD, V104, P2591, DOI 10.1182/blood-2004-02-0459; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Flamand L, 1998, P NATL ACAD SCI USA, V95, P3111, DOI 10.1073/pnas.95.6.3111; FOSSATI G, 1984, INT J CANCER, V33, P591, DOI 10.1002/ijc.2910330508; GENEVEE C, 1992, EUR J IMMUNOL, V22, P1261, DOI 10.1002/eji.1830220522; GILBERT SF, 1975, CELL, V5, P11, DOI 10.1016/0092-8674(75)90086-0; Hart DP, 2008, GENE THER, V15, P625, DOI 10.1038/sj.gt.3303078; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoffmann TK, 2000, CANCER RES, V60, P3542; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; KNUTH A, 1984, P NATL ACAD SCI-BIOL, V81, P3511, DOI 10.1073/pnas.81.11.3511; Levitsky V, 1998, J IMMUNOL, V161, P594; Mami-Chouaib F, 2002, IMMUNOL REV, V188, P114, DOI 10.1034/j.1600-065X.2002.18810.x; MAVILIO F, 1994, BLOOD, V83, P1988; Montagna D, 2001, BLOOD, V98, P3359, DOI 10.1182/blood.V98.12.3359; Montagna D, 2006, BLOOD, V108, P3843, DOI 10.1182/blood-2006-05-021535; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; MUKHERJI B, 1983, J EXP MED, V158, P240, DOI 10.1084/jem.158.1.240; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Russo V, 2000, P NATL ACAD SCI USA, V97, P2185, DOI 10.1073/pnas.040540197; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; Stauss HJ, 2007, MOL THER, V15, P1744, DOI 10.1038/sj.mt.6300216; Tabi Z, 2001, J IMMUNOL, V166, P5695, DOI 10.4049/jimmunol.166.9.5695; Thomas S, 2007, J IMMUNOL, V179, P5803, DOI 10.4049/jimmunol.179.9.5803; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; VANKY F, 1982, J EXP MED, V155, P83, DOI 10.1084/jem.155.1.83; Vavassori M, 1996, J IMMUNOL, V157, P5739; VOSE BM, 1983, CANCER IMMUNOL IMMUN, P227; Wack A, 1996, J IMMUNOL METHODS, V196, P181, DOI 10.1016/0022-1759(96)00114-7; Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12014	10.1371/journal.pone.0012014	http://dx.doi.org/10.1371/journal.pone.0012014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711505	Green Published, gold			2022-12-25	WOS:000280776800010
J	Glaser, RL; Meola, MA				Glaser, Robert L.; Meola, Mark A.			The Native Wolbachia Endosymbionts of Drosophila melanogaster and Culex quinquefasciatus Increase Host Resistance to West Nile Virus Infection	PLOS ONE			English	Article							PARTIAL CYTOPLASMIC INCOMPATIBILITY; AMERICAN MOSQUITOS DIPTERA; VECTOR COMPETENCE; STATISTICAL-ANALYSIS; GENE-SEQUENCES; CULICIDAE; DENSITY; CALIFORNIA; SYMBIONT; STRAINS	Background: The bacterial endosymbiont Wolbachia pipientis has been shown to increase host resistance to viral infection in native Drosophila hosts and in the normally Wolbachia-free heterologous host Aedes aegypti when infected by Wolbachia from Drosophila melanogaster or Aedes albopictus. Wolbachia infection has not yet been demonstrated to increase viral resistance in a native Wolbachia-mosquito host system. Methodology/Principal Findings: In this study, we investigated Wolbachia-induced resistance to West Nile virus (WNV; Flaviviridae) by measuring infection susceptibility in Wolbachia-infected and Wolbachia-free D. melanogaster and Culex quinquefasciatus, a natural mosquito vector of WNV. Wolbachia infection of D. melanogaster induces strong resistance to WNV infection. Wolbachia-infected flies had a 500-fold higher ID50 for WNV and produced 100,000-fold lower virus titers compared to flies lacking Wolbachia. The resistance phenotype was transmitted as a maternal, cytoplasmic factor and was fully reverted in flies cured of Wolbachia. Wolbachia infection had much less effect on the susceptibility of D. melanogaster to Chikungunya (Togaviridae) and La Crosse (Bunyaviridae) viruses. Wolbachia also induces resistance to WNV infection in Cx. quinquefasciatus. While Wolbachia had no effect on the overall rate of peroral infection by WNV, Wolbachia-infected mosquitoes produced lower virus titers and had 2 to 3-fold lower rates of virus transmission compared to mosquitoes lacking Wolbachia. Conclusions/Significance: This is the first demonstration that Wolbachia can increase resistance to arbovirus infection resulting in decreased virus transmission in a native Wolbachia-mosquito system. The results suggest that Wolbachia reduces vector competence in Cx. quinquefasciatus, and potentially in other Wolbachia-infected mosquito vectors.	[Glaser, Robert L.; Meola, Mark A.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Glaser, Robert L.] SUNY Albany, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Glaser, RL (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	glaser@wadsworth.org			National Institute of Allergy and Infectious Diseases [AI076258]; New York State Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076258] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New York State Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by funding from the National Institute of Allergy and Infectious Diseases (AI076258) and the New York State Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN THG, 1977, MOSQ NEWS, V37, P130; Anderson CL, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-10; Bernard KA, 2001, EMERG INFECT DIS, V7, P679; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; BOUCHON D, 1998, P R SOC LOND B, V265; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Bourtzis K, 1996, GENETICS, V144, P1063; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; Clark ME, 2005, GENETICS, V170, P1667, DOI 10.1534/genetics.104.038901; Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844; Ebel GD, 2001, EMERG INFECT DIS, V7, P650; Echaubard P, 2010, HEREDITY, V104, P15, DOI 10.1038/hdy.2009.100; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Fry AJ, 2002, EVOLUTION, V56, P1976, DOI 10.1111/j.0014-3820.2002.tb00123.x; Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; HANNOUN C, 1971, ARTHROPOD CELL CULTU, P227; Harcombe W, 2004, J INVERTEBR PATHOL, V87, P45, DOI 10.1016/j.jip.2004.07.003; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hertig M, 1924, J MED RES, V44, P329; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1998, GENETICS, V148, P221; HOFFMANN AA, 1988, ENTOMOL EXP APPL, V48, P61, DOI 10.1007/BF00343386; HOLDEN PR, 1993, GENET RES, V62, P23, DOI 10.1017/S0016672300031529; Hurst GDD, 2001, HEREDITY, V87, P220, DOI 10.1046/j.1365-2540.2001.00917.x; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Iturbe-Ormaetxe I, 2007, CURR OPIN MICROBIOL, V10, P221, DOI 10.1016/j.mib.2007.05.002; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Mercot H, 2004, GENETICA, V120, P51, DOI 10.1023/B:GENE.0000017629.31383.8f; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Mouton L, 2007, BIOL LETT-UK, V3, P210, DOI 10.1098/rsbl.2006.0590; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen K, 2001, HEREDITY, V86, P731, DOI 10.1046/j.1365-2540.2001.00892.x; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Panteleev DY, 2007, RUSS J GENET+, V43, P1066, DOI 10.1134/S1022795407090153; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; Peng Y, 2008, APPL ENVIRON MICROB, V74, P3943, DOI 10.1128/AEM.02607-07; Rasgon JL, 2003, GENETICS, V165, P2029; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	72	244	267	9	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11977	10.1371/journal.pone.0011977	http://dx.doi.org/10.1371/journal.pone.0011977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700535	Green Submitted, Green Published, gold			2022-12-25	WOS:000280605400015
J	Xia, JH; Feng, F; Lin, G; Wang, CM; Yue, GH				Xia, Jun Hong; Feng, Felicia; Lin, Grace; Wang, Chun Ming; Yue, Gen Hua			A First Generation BAC-Based Physical Map of the Asian Seabass (Lates calcarifer)	PLOS ONE			English	Article							GENOME DUPLICATION; RESTRICTION FRAGMENTS; FINGERPRINT ANALYSIS; GROWTH TRAITS; LINKAGE MAP; EVOLUTION; CLONES; BARRAMUNDI	Background: The Asian seabass (Lates calcarifer) is an important marine foodfish species in Southeast Asia and Australia. Genetic improvement of this species has been achieved to some extent through selective breeding programs since 1990s. Several genomic tools such as DNA markers, a linkage map, cDNA and BAC libraries have been developed to assist selective breeding. A physical map is still lacking, although it is essential for positional cloning of genes located in quantitative trait loci (QTL) and assembly of whole genome sequences. Methodology/Principal Findings: A genome-wide physical map of the Asian seabass was constructed by restriction fingerprinting of 38,208 BAC clones with SNaPshot HICF FPC technique. A total of 30,454 were assembled into 2,865 contigs. The physical length of the assembled contigs summed up to 665 Mb. Analyses of some contigs using different methods demonstrated the reliability of the assembly. Conclusions/Significance: The present physical map is the first physical map for Asian seabass. This physical map will facilitate the fine mapping of QTL for economically important traits and the positional cloning of genes located in QTL. It will also be useful for the whole genome sequencing and assembly. Detailed information about BAC-contigs and BAC clones are available upon request.	[Xia, Jun Hong; Feng, Felicia; Lin, Grace; Wang, Chun Ming; Yue, Gen Hua] Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Xia, JH (corresponding author), Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015; Lin, Grace XL/F-9883-2011	Yue, GH/0000-0002-3537-2248; Lin, Grace XL/0000-0003-0867-3827	Ministry of National Development	Ministry of National Development	This study is funded by Ministry of National Development for the project: "To ensure self-sufficiency of safe seafood for Singapore through the development of aquaculture genomic tools for marker-assisted selective breeding of tropical marine foodfish". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carey G, 1999, CYTOBIOS, V100, P137; Chang YL, 2001, GENETICS, V159, P1231; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; Froese R., 2014, FISHBASE; GARDNER RC, 1982, DNA-J MOLEC CELL BIO, V1, P109, DOI 10.1089/dna.1.1982.1.109; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Hardie DC, 2004, CAN J FISH AQUAT SCI, V61, P1636, DOI 10.1139/F04-106; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Katagiri T, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-89; LARSON H, 1999, ORDER PERCIFORMES SU, P2429; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MEKSEM K, 2005, HDB GENOME MAPPING G, P285; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Nelson WM, 2005, PLANT PHYSIOL, V139, P27, DOI 10.1104/pp.105.061978; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Quiniou SMA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-40; Ren CW, 2003, GENOME RES, V13, P2754, DOI 10.1101/gr.1499303; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SODERLUND C, 2000, GENOME RES, V11, P934; Tao QZ, 2001, GENETICS, V158, P1711; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wang CM, 2008, AQUAC RES, V39, P1612, DOI 10.1111/j.1365-2109.2008.02034.x; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-139; Warren RL, 2006, GENOME RES, V16, P768, DOI 10.1101/gr.5090606; Xu P, 2007, GENOMICS, V90, P380, DOI 10.1016/j.ygeno.2007.05.008; Xu YX, 2006, ANIM GENET, V37, P266, DOI 10.1111/j.1365-2052.2006.01423.x; Xu ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni037; Xu ZY, 2004, GENOMICS, V84, P941, DOI 10.1016/j.ygeno.2004.08.014; You FM, 2007, BIOINFORMATICS, V23, P240, DOI 10.1093/bioinformatics/btl494; Yue GH, 2009, AQUACULTURE, V293, P22, DOI 10.1016/j.aquaculture.2009.03.053	40	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11974	10.1371/journal.pone.0011974	http://dx.doi.org/10.1371/journal.pone.0011974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700486	Green Submitted, Green Published, gold			2022-12-25	WOS:000280605400014
J	de Morree, A; Hulsik, DL; Impagliazzo, A; van Haagen, HHHBM; de Galan, P; van Remoortere, A; 't Hoen, PAC; van Ommen, GB; Frants, RR; van der Maarel, SM				de Morree, Antoine; Hulsik, David Lutje; Impagliazzo, Antonietta; van Haagen, Herman H. H. B. M.; de Galan, Paula; van Remoortere, Alexandra; 't Hoen, Peter A. C.; van Ommen, Gertjan B.; Frants, Rune R.; van der Maarel, Silvere M.			Calpain 3 Is a Rapid-Action, Unidirectional Proteolytic Switch Central to Muscle Remodeling	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; SUBCELLULAR-LOCALIZATION; PROTEIN COMPLEX; IN-VIVO; P94; PREDICTION; MUTATION; PATHWAY; SPECIFICITY; AUTOLYSIS	Calpain 3 (CAPN3) is a cysteine protease that when mutated causes Limb Girdle Muscular Dystrophy 2A. It is thereby the only described Calpain family member that genetically causes a disease. Due to its inherent instability little is known of its substrates or its mechanism of activity and pathogenicity. In this investigation we define a primary sequence motif underlying CAPN3 substrate cleavage. This motif can transform non-related proteins into substrates, and identifies >300 new putative CAPN3 targets. Bioinformatic analyses of these targets demonstrate a critical role in muscle cytoskeletal remodeling and identify novel CAPN3 functions. Among the new CAPN3 substrates are three E3 SUMO ligases of the Protein Inhibitor of Activated Stats (PIAS) family. CAPN3 can cleave PIAS proteins and negatively regulates PIAS3 sumoylase activity. Consequently, SUMO2 is deregulated in patient muscle tissue. Our study thus uncovers unexpected crosstalk between CAPN3 proteolysis and protein sumoylation, with strong implications for muscle remodeling.	[de Morree, Antoine; Impagliazzo, Antonietta; van Haagen, Herman H. H. B. M.; de Galan, Paula; 't Hoen, Peter A. C.; van Ommen, Gertjan B.; Frants, Rune R.; van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Ctr Human Genet, Leiden, Netherlands; [Hulsik, David Lutje] Univ Utrecht, Dept Cellular Architecture & Dynam, Inst Biomembranes, Utrecht, Netherlands; [van Remoortere, Alexandra] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Morree, A (corresponding author), Leiden Univ, Med Ctr, Ctr Human Genet, Leiden, Netherlands.	maarel@lumc.nl	't Hoen, Peter/A-4857-2012; Hoen, Peter A 't/D-3950-2018; van der Maarel, Silvere/X-3631-2018	Hoen, Peter A 't/0000-0003-4450-3112; van der Maarel, Silvere/0000-0001-8103-711X; de Morree, Antoine/0000-0002-8316-4531	Dutch Prinses Beatrix Fonds	Dutch Prinses Beatrix Fonds	This work was supported by a grant from the Dutch Prinses Beatrix Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baghdiguian S, 2001, J MOL MED, V79, P254, DOI 10.1007/s001090100225; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Carillo S, 1996, BIOCHEM J, V313, P245, DOI 10.1042/bj3130245; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Dargelos E, 2002, J BIOTECHNOL, V96, P271, DOI 10.1016/S0168-1656(02)00052-4; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Diaz BG, 2004, J BIOL CHEM, V279, P27656, DOI 10.1074/jbc.M313290200; Duguez S, 2006, FEBS J, V273, P3427, DOI 10.1111/j.1742-4658.2006.05351.x; Fanin M, 2004, HUM MUTAT, V24, P52, DOI 10.1002/humu.20058; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; GARNHAM C, 2009, BIOCHEMISTRY; Guyon JR, 2003, MUSCLE NERVE, V28, P472, DOI 10.1002/mus.10465; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Krahn M, 2006, CLIN GENET, V69, P444, DOI 10.1111/j.1399-0004.2006.00603.x; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Krippahl L, 2003, PROTEINS, V52, P19, DOI 10.1002/prot.10387; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; MURPHY RM, 2009, J BIOL CHEM; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; SAKAI K, 1987, J BIOCHEM-TOKYO, V101, P911, DOI 10.1093/oxfordjournals.jbchem.a121959; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; Sigrist CJA, 2005, BIOINFORMATICS, V21, P4060, DOI 10.1093/bioinformatics/bti614; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; STUELSATZ P, 2010, J BIOL CHEM; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Welm AL, 2002, J BIOL CHEM, V277, P33848, DOI 10.1074/jbc.M204096200	54	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11940	10.1371/journal.pone.0011940	http://dx.doi.org/10.1371/journal.pone.0011940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694146	Green Published, gold, Green Submitted			2022-12-25	WOS:000280574300008
J	Friedman, EB; Sun, Y; Moore, JT; Hung, HT; Meng, QC; Perera, P; Joiner, WJ; Thomas, SA; Eckenhoff, RG; Sehgal, A; Kelz, MB				Friedman, Eliot B.; Sun, Yi; Moore, Jason T.; Hung, Hsiao-Tung; Meng, Qing Cheng; Perera, Priyan; Joiner, William J.; Thomas, Steven A.; Eckenhoff, Roderic G.; Sehgal, Amita; Kelz, Max B.			A Conserved Behavioral State Barrier Impedes Transitions between Anesthetic-Induced Unconsciousness and Wakefulness: Evidence for Neural Inertia	PLOS ONE			English	Article							GENERAL-ANESTHETICS; DROSOPHILA-MELANOGASTER; SLEEP; HALOTHANE; BRAIN; ELECTROENCEPHALOGRAM; NOREPINEPHRINE; NARCOLEPSY; AROUSAL; WAKING	One major unanswered question in neuroscience is how the brain transitions between conscious and unconscious states. General anesthetics offer a controllable means to study these transitions. Induction of anesthesia is commonly attributed to drug-induced global modulation of neuronal function, while emergence from anesthesia has been thought to occur passively, paralleling elimination of the anesthetic from its sites in the central nervous system (CNS). If this were true, then CNS anesthetic concentrations on induction and emergence would be indistinguishable. By generating anesthetic dose-response data in both insects and mammals, we demonstrate that the forward and reverse paths through which anesthetic-induced unconsciousness arises and dissipates are not identical. Instead they exhibit hysteresis that is not fully explained by pharmacokinetics as previously thought. Single gene mutations that affect sleep-wake states are shown to collapse or widen anesthetic hysteresis without obvious confounding effects on volatile anesthetic uptake, distribution, or metabolism. We propose a fundamental and biologically conserved concept of neural inertia, a tendency of the CNS to resist behavioral state transitions between conscious and unconscious states. We demonstrate that such a barrier separates wakeful and anesthetized states for multiple anesthetics in both flies and mice, and argue that it contributes to the hysteresis observed when the brain transitions between conscious and unconscious states.	[Friedman, Eliot B.; Hung, Hsiao-Tung] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Sun, Yi; Moore, Jason T.; Meng, Qing Cheng; Perera, Priyan; Eckenhoff, Roderic G.; Kelz, Max B.] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Joiner, William J.; Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Thomas, Steven A.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Moore, Jason T.; Kelz, Max B.] Univ Penn, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA; [Hung, Hsiao-Tung; Sehgal, Amita; Kelz, Max B.] Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; [Friedman, Eliot B.; Kelz, Max B.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Friedman, EB (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	kelzma@uphs.upenn.edu	Kelz, Max/E-4054-2010	Kelz, Max/0000-0002-2803-6078; Eckenhoff, Roderic/0000-0002-5581-746X	American Recovery and Reinvestment Act (ARRA) [K08 GM077357]; Foundation for Anesthesia Education and Research; University of Pennsylvania's Institute for Translational Medicine and Therapeutics; R.W. Johnson Foundation; Parker B. Francis Fellowship; University of Pennsylvania Department of Anesthesiology and Critical Care;  [R01 GM088156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM077357, R01GM088156] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act (ARRA); Foundation for Anesthesia Education and Research; University of Pennsylvania's Institute for Translational Medicine and Therapeutics; R.W. Johnson Foundation; Parker B. Francis Fellowship; University of Pennsylvania Department of Anesthesiology and Critical Care; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K08 GM077357, the American Recovery and Reinvestment Act (ARRA) funds through grant K08 GM077357, R01 GM088156, The Foundation for Anesthesia Education and Research (www.faer.org), University of Pennsylvania's Institute for Translational Medicine and Therapeutics (www.itmat.upenn.edu), the Harold Amos Medical Faculty Development Program from the R.W. Johnson Foundation (www.amfdp.org), the Parker B. Francis Fellowship program (www.francisfellowships.org), and the University of Pennsylvania Department of Anesthesiology and Critical Care (www.uphs.upenn.edu/dripps). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2009, ANESTHESIOLOGY, V110, P766, DOI 10.1097/ALN.0b013e31819c461c; ALLADA R, 1993, ANESTH ANALG, V77, P19; Berridge CW, 1996, J NEUROSCI, V16, P6999; Berridge CW, 2001, BEHAV NEUROSCI, V115, P165, DOI 10.1037//0735-7044.115.1.165; Bruhn J, 2000, ANESTHESIOLOGY, V93, P981, DOI 10.1097/00000542-200010000-00018; Burrow B, 2005, J CLIN ANESTH, V17, P21, DOI 10.1016/j.jclinane.2004.03.007; Campbell JL, 2001, J NEUROBIOL, V49, P339, DOI 10.1002/neu.10009; CAMPBELL JL, 2009, J NEUROGENET, P1; Chatterjee A, 2008, CURR OPIN BIOTECH, V19, P475, DOI 10.1016/j.copbio.2008.08.010; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Correa AM, 1998, AM J PHYSIOL-CELL PH, V275, pC1009, DOI 10.1152/ajpcell.1998.275.4.C1009; Eckenhoff MF, 1998, J PHARMACOL EXP THER, V285, P371; Fort P, 2009, EUR J NEUROSCI, V29, P1741, DOI 10.1111/j.1460-9568.2009.06722.x; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Gamo S, 2002, CURR DRUG TARGETS, V3, P31, DOI 10.2174/1389450023348118; Gompf H, 2009, ANESTHESIOLOGY, V111, P1001, DOI 10.1097/ALN.0b013e3181b764b3; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Jonson B, 1999, THORAX, V54, P82, DOI 10.1136/thx.54.1.82; Keifer JC, 1996, ANESTHESIOLOGY, V84, P945, DOI 10.1097/00000542-199604000-00023; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kreuer S, 2004, ANESTH ANALG, V98, P692, DOI 10.1213/01.ANE.0000103182.78466.EF; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Lighton JRB, 2005, CURR BIOL, V15, pR965, DOI 10.1016/j.cub.2005.11.020; Lydic R, 2005, ANESTHESIOLOGY, V103, P1268; MCCORMICK DA, 1991, PROG BRAIN RES, V88, P293; McKay IDH, 2006, ANESTH ANALG, V102, P91, DOI 10.1213/01.ane.0000184825.65124.24; Mesa A, 2000, ANESTHESIOLOGY, V92, P1194, DOI 10.1097/00000542-200004000-00040; MILLER RD, 1968, ANESTHESIOLOGY, V29, P1153, DOI 10.1097/00000542-196811000-00012; MUELLER RA, 1975, ANESTHESIOLOGY, V42, P143, DOI 10.1097/00000542-197502000-00006; Ohno K, 2008, FRONT NEUROENDOCRIN, V29, P70, DOI 10.1016/j.yfrne.2007.08.001; Ouyang M, 2004, J NEUROPHYSIOL, V92, P2071, DOI 10.1152/jn.00226.2004; ROIZEN MF, 1978, ANESTHESIOLOGY, V49, P252, DOI 10.1097/00000542-197810000-00005; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; SETHNA JP, 1993, PHYS REV LETT, V70, P3347, DOI 10.1103/PhysRevLett.70.3347; SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033, DOI 10.1152/jappl.1990.68.3.1033; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; Steyn-Ross DA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011918; Steyn-Ross ML, 2004, PROG BIOPHYS MOL BIO, V85, P369, DOI 10.1016/j.pbiomolbio.2004.02.001; Sun Yi, 2006, BMC Anesthesiol, V6, P13, DOI 10.1186/1471-2253-6-13; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Thomas SA, 1998, J NEUROCHEM, V70, P2468; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; TINKLENBERG JA, 1991, ANN NY ACAD SCI, V625, P532, DOI 10.1111/j.1749-6632.1991.tb33884.x; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; van Swinderen B, 2003, BEHAV PROCESS, V64, P133, DOI 10.1016/S0376-6357(03)00131-1; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300; Walcourt A, 2001, ANESTH ANALG, V92, P535, DOI 10.1213/00000539-200102000-00047; Weber B, 2009, ANESTHESIOLOGY, V110, P313, DOI 10.1097/ALN.0b013e3181942df2	53	154	158	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11903	10.1371/journal.pone.0011903	http://dx.doi.org/10.1371/journal.pone.0011903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689589	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520300018
J	Bhattacharjee, RN; Banerjee, B; Akira, S; Hande, MP				Bhattacharjee, Rabindra N.; Banerjee, Birendranath; Akira, Shizuo; Hande, M. Prakash			Telomere-Mediated Chromosomal Instability Triggers TLR4 Induced Inflammation and Death in Mice	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE; CYTOGENETIC DAMAGE; CANCER DEVELOPMENT; CELLS; LENGTH; PERSISTENCE; INDUCTION; STRESS	Background: Telomeres are essential to maintain chromosomal stability. Cells derived from mice lacking telomerase RNA component (mTERC(-/-) mice) display elevated telomere-mediated chromosome instability. Age-dependent telomere shortening and associated chromosome instability reduce the capacity to respond to cellular stress occurring during inflammation and cancer. Inflammation is one of the important risk factors in cancer progression. Controlled innate immune responses mediated by Toll-like receptors (TLR) are required for host defense against infection. Our aim was to understand the role of chromosome/genome instability in the initiation and maintenance of inflammation. Methodology/Principal Findings: We examined the function of TLR4 in telomerase deficient mTERC(-/-) mice harbouring chromosome instability which did not develop any overt immunological disorder in pathogen-free condition or any form of cancers at this stage. Chromosome instability was measured in metaphase spreads prepared from wildtype (mTERC(+/+)), mTERC(+/-) and mTERC(-/-) mouse splenocytes. Peritoneal and/or bone marrow-derived macrophages were used to examine the responses of TLR4 by their ability to produce inflammatory mediators TNF alpha and IL6. Our results demonstrate that TLR4 is highly up-regulated in the immune cells derived from telomerase-null (mTERC(-/-)) mice and lipopolysaccharide, a natural ligand for TLR4 stabilises NF-kappa B binding to its promoter by down-regulating ATF-3 in mTERC(-/-) macrophages. Conclusions/Significance: Our findings implied that background chromosome instability in the cellular level stabilises the action of TLR4-induced NF-kappa B action and sensitises cells to produce excess pro-inflammatory mediators. Chromosome/genomic instability data raises optimism for controlling inflammation by non-toxic TLR antagonists among high-risk groups.	[Bhattacharjee, Rabindra N.; Akira, Shizuo] Osaka Univ, Exploratory Res Adv Technol ERATO, Akira Innate Immun Project, Osaka, Japan; [Bhattacharjee, Rabindra N.; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka, Japan; [Bhattacharjee, Rabindra N.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Banerjee, Birendranath; Hande, M. Prakash] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Akira, Shizuo] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan	Osaka University; Osaka University; Western University (University of Western Ontario); National University of Singapore; Osaka University	Bhattacharjee, RN (corresponding author), Osaka Univ, Exploratory Res Adv Technol ERATO, Akira Innate Immun Project, Osaka, Japan.	rbhatta4@uwo.ca; phsmph@nus.edu.sg	Akira, Shizuo/C-3134-2009; Hande, M. Prakash/B-1645-2008	Hande, M. Prakash/0000-0002-4511-6256	Academic Research Fund, Ministry of Education, Singapore [T206B3108]; Japan Science and Technology Agency; Japanese Ministry of Education, Culture, Sports, Science and Technology; Osaka University	Academic Research Fund, Ministry of Education, Singapore(National University of SingaporeMinistry of Education, Singapore); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University	MPH acknowledges the support from Academic Research Fund, Ministry of Education, Singapore (T206B3108) for funding. This work was supported in part by Exploratory Research for Advanced Technology of Japan Science and Technology Agency, grants of the Japanese Ministry of Education, Culture, Sports, Science and Technology, and from the 21st Century Center of Excellence Program of Osaka University to SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; BLACKBURN EH, 1991, TRENDS BIOCHEM SCI, V16, P378, DOI 10.1016/0968-0004(91)90155-O; BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; di Fagagna FD, 1999, NAT GENET, V23, P76; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech Michael, 2008, V410, P185; Forst B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010374; Guachalla LM, 2009, AGING-US, V1, P303, DOI 10.18632/aging.100030; Hande MP, 1996, INT J RADIAT BIOL, V70, P375, DOI 10.1080/095530096144842; Hande MP, 1997, MUTAGENESIS, V12, P125; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lou ZJ, 2009, AGING-US, V1, P608, DOI 10.18632/aging.100066; Newman JPA, 2008, J CELL PHYSIOL, V214, P796, DOI 10.1002/jcp.21276; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Poonepalli A, 2005, CANCER RES, V65, P10977, DOI 10.1158/0008-5472.CAN-05-2336; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Wiemann SU, 2005, ONCOGENE, V24, P1501, DOI 10.1038/sj.onc.1208308	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11873	10.1371/journal.pone.0011873	http://dx.doi.org/10.1371/journal.pone.0011873			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686699	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200035
J	Woo, CH; Le, NT; Shishido, T; Chang, E; Lee, H; Heo, KS; Mickelsen, DM; Lu, Y; McClain, C; Spangenberg, T; Yan, C; Molina, CA; Yang, J; Patterson, C; Abe, J				Woo, Chang-Hoon; Le, Nhat-Tu; Shishido, Tetsuro; Chang, Eugene; Lee, Hakjoo; Heo, Kyung-Sun; Mickelsen, Deanne M.; Lu, Yan; McClain, Carolyn; Spangenberg, Thomas; Yan, Chen; Molina, Carlos A.; Yang, Jay; Patterson, Cam; Abe, Jun-ichi			Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor	FASEB JOURNAL			English	Article						cell signaling; MAP kinase; ICER; cardiomyocyte apoptosis	HEAT-SHOCK PROTEINS; QUALITY CONTROL; MYOCARDIAL-INFARCTION; CARDIOMYOCYTE APOPTOSIS; CHAPERONE FUNCTIONS; ENDOTHELIAL-CELLS; TRANSGENIC MICE; ISCHEMIC-INJURY; FEEDBACK LOOP; IN-VIVO	Growing evidence indicates a critical role of ubiquitin-proteosome system in apoptosis regulation. A cardioprotective effect of ubiquitin (Ub) ligase of the C terminus of Hsc70-interacting protein (CHIP) on myocytes has been reported. In the current study, we found that the cardioprotective effect of insulin growth factor-1 (IGF-1) was mediated by ERK5-CHIP signal module via inducible cAMP early repressor (ICER) destabilization. In vitro runoff assay and Ub assay showed ICER as a substrate of CHIP Ub ligase. Both disruption of ERK5-CHIP binding with inhibitory helical linker domain fragment (aa 101-200) of CHIP and the depletion of ERK5 by siRNA inhibited CHIP Ub ligase activity, which suggests an obligatory role of ERK5 on CHIP activation. Depletion of CHIP, using siRNA, inhibited IGF-1-mediated reduction of isoproterenol-mediated ICER induction and apoptosis. In diabetic mice subjected to myocardial infarction, the CHIP Ub ligase activity was decreased, with an increase in ICER expression. These changes were attenuated significantly in a cardiac-specific constitutively active form of MEK5 alpha transgenic mice (CA-MEK5 alpha-Tg) previously shown to have greater functional recovery. Furthermore, pressure overload-mediated ICER induction was enhanced in heterozygous CHIP+/- mice. We identified ICER as a novel CHIP substrate and that the ERK5-CHIP complex plays an obligatory role in inhibition of ICER expression, cardiomyocyte apoptosis, and cardiac dysfunction.-Woo, C.-H., Le, N.-T., Shishido, T., Chang, E., Lee, H., Heo, K.-S., Mickelsen, D. M., Lu, Y., McClain, C., Spangenberg, T., Yan, C., Molina, C. A., Yang, J., Patterson, C., Abe, J.-I. Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor. FASEB J. 24, 4917-4928 (2010). www.fasebj.org	[Abe, Jun-ichi] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Shishido, Tetsuro; Abe, Jun-ichi] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Molina, Carlos A.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ USA; [Yang, Jay] Univ Wisconsin, Dept Anesthesiol, Madison, WI USA; [Patterson, Cam] Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC USA	University of Rochester; Yamagata University; Montclair State University; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill	Abe, J (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, 601 Elmwood Ave,Box CVRI, Rochester, NY 14642 USA.			Heo, Kyung-Sun/0000-0003-3800-7665; Yan, Chen/0000-0002-1397-6358	American Heart Association [0930360N, 0740013N]; U.S. National Institutes of Health [HL-88637, HL-077789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088400, R01HL108551, P01HL077789, R01HL102746, R37HL065619, R01HL088637, R01HL064839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061728] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants from the American Heart Association to C.-H. W. (Scientist Development grant 0930360N) and J.-I.A. (Established Investigator Award 0740013N), and from the U.S. National Institutes of Health to J.-I.A.(HL-88637 and HL-077789). The authors declare no conflicts of interest.	Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Cameron SJ, 2004, FEBS LETT, V566, P255, DOI 10.1016/j.febslet.2004.03.120; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Ding B, 2000, CIRCULATION, V101, P2854, DOI 10.1161/01.CIR.101.24.2854; Ding B, 2005, P NATL ACAD SCI USA, V102, P14771, DOI 10.1073/pnas.0506489102; Ding B, 2005, CIRCULATION, V111, P2469, DOI 10.1161/01.CIR.0000165128.39715.87; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Hwang JR, 2005, CELL STRESS CHAPERON, V10, P147, DOI 10.1379/CSC-90R.1; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; KIMURA TE, CIRC RES, V106, P961; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Liu QH, 2009, CIRC RES, V105, pE19; Martin JL, 1997, CIRCULATION, V96, P4343; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Patterson C, 2007, CIRCULATION, V115, P1456, DOI 10.1161/CIRCULATIONAHA.106.649863; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Shishido T, 2008, CIRC RES, V102, P1416, DOI 10.1161/CIRCRESAHA.107.168138; Tomita H, 2003, CIRC RES, V93, P12, DOI 10.1161/01.RES.0000079794.57578.F1; Trost SU, 1998, J CLIN INVEST, V101, P855, DOI 10.1172/JCI265; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Wang XJ, 2008, J MOL CELL CARDIOL, V45, P11, DOI 10.1016/j.yjmcc.2008.03.025; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Woo CH, 2008, CIRC RES, V102, P538, DOI 10.1161/CIRCRESAHA.107.156877; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yan C, 2007, CIRC RES, V100, P510, DOI 10.1161/01.RES.0000259045.49371.9c; Yehia G, 2001, J BIOL CHEM, V276, P35272, DOI 10.1074/jbc.M105404200; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004	38	38	39	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4917	4928		10.1096/fj.10-162636	http://dx.doi.org/10.1096/fj.10-162636			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20724525	Green Published			2022-12-25	WOS:000284824400030
J	Haubold, M; Gilsbach, R; Hein, L				Haubold, Miriam; Gilsbach, Ralf; Hein, Lutz			alpha(2B)-Adrenoceptor Deficiency Leads to Postnatal Respiratory Failure in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II CELLS; HEART-FAILURE; CULTURE; LUNG; AUTORECEPTORS; MORPHOGENESIS; HYPERTENSION; INHIBITION; EXPRESSION; FIBROSIS	alpha(2)-Adrenoceptors belong to the family of adrenergic receptors, which regulate the neuronal release of norepinephrine as part of a negative feedback loop. Among the alpha(2)-adrenoceptors, the alpha(2B)-subtype may also influence developmental signaling pathways involved in angiogenesis of the placenta. Thus, the aim of the present study was to determine whether alpha(2B)-adrenoceptors are also involved in other developmental processes beyond placental angiogenesis. Ablation of alpha(2B)-adrenoceptors led to lethality of mutant mice during the first hours after birth. Despite normal breathing and drinking behavior, mutant mice developed cyanosis, which could be traced back to a defect in lung morphology with significantly reduced alveolar volume and thickened interalveolar septi. In alpha(2B)-deficient lungs and in isolated alveolar type II cells, expression of sonic hedgehog (SHH) was significantly increased, resulting in mesenchymal proliferation. In vitro alpha(2B)-adrenoreceptor stimulation suppressed expression of sonic hedgehog and the cell cycle genes cyclin D1 and Ki67. In vivo inhibition of enhanced SHH signaling by the smoothened antagonist cyclopamine partially rescued perinatal lethality, lung morphology, and altered gene expression in mutant mice. Thus, alpha(2B)-adrenoceptors in lung epithelia play an important role in suppressing sonic hedgehog-mediated proliferation of mesenchymal cells and thus prevent respiratory failure.	[Hein, Lutz] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Hein, L (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Albert Str 25, D-79104 Freiburg, Germany.	lutz.hein@pharmakol.uni-freiburg.de	Hein, Lutz/GRJ-8644-2022	Gilsbach, Ralf/0000-0002-0895-1535	Deutsche Forschungsgemeinschaft [He 2073/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant He 2073/2-2).	Beetz N, 2009, J CLIN INVEST, V119, P3597, DOI 10.1172/JCI38433; Beetz N, 2009, CARDIOVASC RES, V84, P396, DOI 10.1093/cvr/cvp251; Bellusci S, 1997, DEVELOPMENT, V124, P53; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Cussac D, 2001, BRIT J PHARMACOL, V133, P1387, DOI 10.1038/sj.bjp.0704203; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; Gilsbach R, 2010, CARDIOVASC RES, V86, P432, DOI 10.1093/cvr/cvq014; Gilsbach R, 2009, MOL PHARMACOL, V75, P1160, DOI 10.1124/mol.109.054544; Gilsbach Ralf, 2008, V184, P261; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Huhtinen A, 2008, EUR J PHARMACOL, V587, P48, DOI 10.1016/j.ejphar.2008.03.049; KALINA M, 1988, HISTOCHEMISTRY, V88, P175, DOI 10.1007/BF00493301; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Link RE, 1996, SCIENCE, V273, P803, DOI 10.1126/science.273.5276.803; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; Miller LAD, 2004, DEV DYNAM, V231, P57, DOI 10.1002/dvdy.20105; Muthig V, 2007, CIRC RES, V101, P682, DOI 10.1161/CIRCRESAHA.107.151563; Otto C, 2004, CIRCULATION, V110, P3245, DOI 10.1161/01.CIR.0000147235.53360.59; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Philipp M, 2002, NAT GENET, V31, P311, DOI 10.1038/ng919; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; STARKE K, 1975, NATURE, V254, P440, DOI 10.1038/254440a0; Talke P, 2005, ANESTHESIOLOGY, V102, P536, DOI 10.1097/00000542-200503000-00010; Trendelenburg AU, 2003, N-S ARCH PHARMACOL, V368, P504, DOI 10.1007/s00210-003-0829-x	30	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34213	34219		10.1074/jbc.M110.129205	http://dx.doi.org/10.1074/jbc.M110.129205			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729197	hybrid, Green Published			2022-12-25	WOS:000283354000066
J	Dai, H; Kustigian, L; Carney, D; Case, A; Considine, T; Hubbard, BP; Perni, RB; Riera, TV; Szczepankiewicz, B; Vlasuk, GP; Stein, RL				Dai, Han; Kustigian, Lauren; Carney, David; Case, April; Considine, Thomas; Hubbard, Basil P.; Perni, Robert B.; Riera, Thomas V.; Szczepankiewicz, Bruce; Vlasuk, George P.; Stein, Ross L.			SIRT1 Activation by Small Molecules KINETIC AND BIOPHYSICAL EVIDENCE FOR DIRECT INTERACTION OF ENZYME AND ACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-DEGRADING ENZYME; MITOCHONDRIAL-FUNCTION; SUBSTRATE-SPECIFICITY; SIRTUINS; RESVERATROL; MECHANISM; PROTECTS; SRT1720; EXPRESSION; PATHWAYS	SIRT1 is a protein deacetylase that has emerged as a therapeutic target for the development of activators to treat diseases of aging. SIRT1-activating compounds (STACs) have been developed that produce biological effects consistent with direct SIRT1 activation. At the molecular level, the mechanism by which STACs activate SIRT1 remains elusive. In the studies reported herein, the mechanism of SIRT1 activation is examined using representative compounds chosen from a collection of STACs. These studies reveal that activation of SIRT1 by STACs is strongly dependent on structural features of the peptide substrate. Significantly, and in contrast to studies reporting that peptides must bear a fluorophore for their deacetylation to be accelerated, we find that some STACs can accelerate the SIRT1-catalyzed deacetylation of specific unlabeled peptides composed only of natural amino acids. These results, together with others of this study, are at odds with a recent claim that complex formation between STACs and fluorophore-labeled peptides plays a role in the activation of SIRT1 (Pacholec, M., Chrunyk, B., Cunningham, D., Flynn, D., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., Qiu, X., Stockman, B., Thanabal, V., Varghese, A., Ward, J., Withka, J., and Ahn, K. (2010) J. Biol. Chem. 285, 8340-8351). Rather, the data suggest that STACs interact directly with SIRT1 and activate SIRT1-catalyzed deacetylation through an allosteric mechanism.	[Riera, Thomas V.; Szczepankiewicz, Bruce; Vlasuk, George P.; Stein, Ross L.] Sirtris, Cambridge, MA 02139 USA; [Hubbard, Basil P.] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Stein, RL (corresponding author), Sirtris Pharmaceut, 200 Technol Sq,Ste 300, Cambridge, MA 02139 USA.	rstein@sirtrispharma.com		Hubbard, Basil/0000-0003-4353-9674; Riera, Thomas/0000-0001-7427-2728				AHARONY D, 1986, J BIOL CHEM, V261, P1512; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bemis J., 2008, Patent, Patent No. [WO 2008156866A1, 2008156866]; Bemis JE, 2009, BIOORG MED CHEM LETT, V19, P2350, DOI 10.1016/j.bmcl.2008.11.106; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; ELIASSON R, 1994, J BIOL CHEM, V269, P26052; ERLANGER BF, 1976, EUR J BIOCHEM, V61, P287, DOI 10.1111/j.1432-1033.1976.tb10021.x; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Haynes NE, 2010, J MED CHEM, V53, P3618, DOI 10.1021/jm100039a; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Marcotte PA, 2004, ANAL BIOCHEM, V332, P90, DOI 10.1016/j.ab.2004.05.039; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; Salzmann T., 2007, WO Patent, Patent No. 2007019346; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Segel IH., 1975, ENZYME KINETICS, P227; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Vu C. B., 2010, Patent Appl., Patent No. [PCT WO 2010/003048, 2010003048]; Vu CB, 2009, J MED CHEM, V52, P1275, DOI 10.1021/jm8012954; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	42	181	194	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32695	32703		10.1074/jbc.M110.133892	http://dx.doi.org/10.1074/jbc.M110.133892			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702418	Green Published, hybrid			2022-12-25	WOS:000283048200004
J	Lee, SJ; Richardson, CC				Lee, Seung-Joo; Richardson, Charles C.			Molecular Basis for Recognition of Nucleoside Triphosphate by Gene 4 Helicase of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA HELICASE; CRYSTAL-STRUCTURE; PRIMASE-HELICASE; HEXAMERIC HELICASES; LINKER REGION; PROTEIN; HYDROLYSIS; MECHANISM; REPLICATION; SPECIFICITY	The translocation of DNA helicases on single-stranded DNA and the unwinding of double-stranded DNA are fueled by the hydrolysis of nucleoside triphosphates (NTP). Although most helicases use ATP in these processes, the DNA helicase encoded by gene 4 of bacteriophage T7 uses dTTP most efficiently. To identify the structural requirements of the NTP, we determined the efficiency of DNA unwinding by T7 helicase using a variety of NTPs and their analogs. The 5-methyl group of thymine was critical for the efficient unwinding of DNA, although the presence of a 3'-ribosyl hydroxyl group partially overcame this requirement. The NTP-binding pocket of the protein was examined by randomly substituting amino acids for several amino acid residues (Thr-320, Arg-504, Tyr-535, and Leu-542) that the crystal structure suggests interact with the nucleotide. Although positions 320 and 542 required aliphatic residues of the appropriate size, an aromatic side chain was necessary at position 535 to stabilize NTP for efficient unwinding. A basic side chain of residue 504 was essential to interact with the 4-carbonyl of the thymine base of dTTP. Replacement of this residue with a small aliphatic residue allowed the accommodation of other NTPs, resulting in the preferential use of dATP and the use of dCTP, a nucleotide not normally used. Results from this study suggest that the NTP must be stabilized by specific interactions within the NTP-binding site of the protein to achieve efficient hydrolysis. These interactions dictate NTP specificity.	[Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, 240 Long Wood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Ayora S, 2002, NUCLEIC ACIDS RES, V30, P2280, DOI 10.1093/nar/30.11.2280; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Belon CA, 2009, J MOL BIOL, V388, P851, DOI 10.1016/j.jmb.2009.03.059; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; CLAUDE A, 1991, J BIOL CHEM, V266, P10358; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Dubaele S, 2006, BIOORG MED CHEM LETT, V16, P923, DOI 10.1016/j.bmcl.2005.10.110; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Griep MA, 2007, BIOORGAN MED CHEM, V15, P7203, DOI 10.1016/j.bmc.2007.07.057; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hughes MD, 2003, J MOL BIOL, V331, P973, DOI 10.1016/S0022-2836(03)00833-7; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; KOLODNER R, 1977, P NATL ACAD SCI USA, V74, P1525, DOI 10.1073/pnas.74.4.1525; KORNBERG A, 1992, DNA REPLICATION, P54; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; LI XY, 1992, J BIOL CHEM, V267, P25321; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1983, J BIOL CHEM, V258, P4009; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; SALUJA D, 1995, J BACTERIOL, V177, P1104, DOI 10.1128/jb.177.4.1104-1111.1995; Satapathy AK, 2009, J BIOL CHEM, V284, P14286, DOI 10.1074/jbc.M900557200; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200; Tran NQ, 2010, MOL MICROBIOL, V77, P492, DOI 10.1111/j.1365-2958.2010.07221.x; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825	38	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31462	31471		10.1074/jbc.M110.156067	http://dx.doi.org/10.1074/jbc.M110.156067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20688917	Green Published, hybrid			2022-12-25	WOS:000282764600040
J	Gurung, RL; Lim, SN; Khaw, AK; Soon, JFF; Shenoy, K; Ali, SM; Jayapal, M; Sethu, S; Baskar, R; Hande, MP				Gurung, Resham Lal; Lim, Shi Ni; Khaw, Aik Kia; Soon, Jasmine Fen Fen; Shenoy, Kirthan; Ali, Safiyya Mohamed; Jayapal, Manikandan; Sethu, Swaminathan; Baskar, Rajamanickam; Hande, M. Prakash			Thymoquinone Induces Telomere Shortening, DNA Damage and Apoptosis in Human Glioblastoma Cells	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; DENSELY IONIZING-RADIATION; MAMMALIAN TELOMERES; CATALYTIC SUBUNIT; HUMAN CANCER; INHIBITION; EXPOSURE; LENGTH; DEATH; PKCS	Background: A major concern of cancer chemotherapy is the side effects caused by the non-specific targeting of both normal and cancerous cells by therapeutic drugs. Much emphasis has been placed on discovering new compounds that target tumour cells more efficiently and selectively with minimal toxic effects on normal cells. Methodology/Principal Findings: The cytotoxic effect of thymoquinone, a component derived from the plant Nigella sativa, was tested on human glioblastoma and normal cells. Our findings demonstrated that glioblastoma cells were more sensitive to thymoquinone-induced antiproliferative effects. Thymoquinone induced DNA damage, cell cycle arrest and apoptosis in the glioblastoma cells. It was also observed that thymoquinone facilitated telomere attrition by inhibiting the activity of telomerase. In addition to these, we investigated the role of DNA-PKcs on thymoquinone mediated changes in telomere length. Telomeres in glioblastoma cells with DNA-PKcs were more sensitive to thymoquinone mediated effects as compared to those cells deficient in DNA-PKcs. Conclusions/Significance: Our results indicate that thymoquinone induces DNA damage, telomere attrition by inhibiting telomerase and cell death in glioblastoma cells. Telomere shortening was found to be dependent on the status of DNA-PKcs. Collectively, these data suggest that thymoquinone could be useful as a potential chemotherapeutic agent in the management for brain tumours.	[Gurung, Resham Lal; Lim, Shi Ni; Khaw, Aik Kia; Soon, Jasmine Fen Fen; Shenoy, Kirthan; Ali, Safiyya Mohamed; Jayapal, Manikandan; Sethu, Swaminathan; Hande, M. Prakash] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Baskar, Rajamanickam] Natl Canc Ctr, Dept Radiat Oncol, Div Cellular & Mol Res, Singapore, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS)	Gurung, RL (corresponding author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore.	phsmph@nus.edu.sg	Hande, M. Prakash/B-1645-2008; Sethu, Swaminathan/R-8577-2019; Jayapal, Manikandan/H-9847-2012	Hande, M. Prakash/0000-0002-4511-6256; J, manikandan/0000-0001-6744-8852; Sethu, Swaminathan/0000-0001-9210-2554	Ministry of Education, Singapore [T206B3108, WBS: 185-000-153-112]; National Medical Research Council, Ministry of Health, Singapore [NMRC/EDG/0052/2009, WBS: R-185-000-192-275]	Ministry of Education, Singapore(Ministry of Education, Singapore); National Medical Research Council, Ministry of Health, Singapore(National Medical Research Council, Singapore)	This work was supported by the grants from Academic Research Fund, Ministry of Education, Singapore (T206B3108; WBS: 185-000-153-112) and National Medical Research Council, Ministry of Health, Singapore (NMRC/EDG/0052/2009; WBS: R-185-000-192-275). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggarwal BB, 2008, PLANTA MED, V74, P1560, DOI 10.1055/s-2008-1074578; Bailey SM, 2004, DNA REPAIR, V3, P225, DOI 10.1016/j.dnarep.2003.10.013; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Chen GG, 2005, J CELL PHYSIOL, V203, P127, DOI 10.1002/jcp.20230; de Lange T, 1999, SCIENCE, V283, P947, DOI 10.1126/science.283.5404.947; di Fagagna FD, 1999, NAT GENET, V23, P76; El-Mahdy MA, 2005, INT J CANCER, V117, P409, DOI 10.1002/ijc.21205; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Falchetti ML, 2000, INT J CANCER, V88, P895, DOI 10.1002/1097-0215(20001215)88:6<895::AID-IJC9>3.0.CO;2-V; Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Hande MP, 2005, GENE CHROMOSOME CANC, V44, P1, DOI 10.1002/gcc.20217; Hande MP, 2004, CYTOGENET GENOME RES, V104, P116, DOI 10.1159/000077475; Hande MP, 2003, AM J HUM GENET, V72, P1162, DOI 10.1086/375041; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hande P, 1999, GENOMICS, V56, P221, DOI 10.1006/geno.1998.5668; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Holgersson A, 2005, INT J RADIAT ONCOL, V61, P915, DOI 10.1016/j.ijrobp.2004.10.036; Jeggo PA, 1997, MUTAT RES-DNA REPAIR, V384, P1, DOI 10.1016/S0921-8777(97)00009-8; Kondo Y, 1998, ONCOGENE, V16, P2243, DOI 10.1038/sj.onc.1201754; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; LALUNISTURNER MJ, 1993, RADIAT RES, V134, P349; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Padhye Subhash, 2008, Cancer Ther, V6, P495; Poonepalli A, 2005, CANCER RES, V65, P10977, DOI 10.1158/0008-5472.CAN-05-2336; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shay JW, 2005, CANCER CELL, V7, P1, DOI 10.1016/j.ccr.2004.12.012; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shiraishi S, 2002, CANCER-AM CANCER SOC, V95, P249, DOI 10.1002/cncr.10677; Shoieb AM, 2003, INT J ONCOL, V22, P107; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Virsik-Kopp P, 2003, INT J RADIAT BIOL, V79, P61, DOI 10.1080/0955300021000038644; Vuorela P, 2004, CURR MED CHEM, V11, P1375, DOI 10.2174/0929867043365116; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Worthen DR, 1998, ANTICANCER RES, V18, P1527; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124	41	111	113	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12124	10.1371/journal.pone.0012124	http://dx.doi.org/10.1371/journal.pone.0012124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711342	gold, Green Submitted, Green Published			2022-12-25	WOS:000280859700016
J	Morillo-Huesca, M; Clemente-Ruiz, M; Andujar, E; Prado, F				Morillo-Huesca, Macarena; Clemente-Ruiz, Marta; Andujar, Eloisa; Prado, Felix			The SWR1 Histone Replacement Complex Causes Genetic Instability and Genome-Wide Transcription Misregulation in the Absence of H2A.Z	PLOS ONE			English	Article							VARIANT H2A.Z; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CHECKPOINT ACTIVATION; DNA; YEAST; INO80; RECRUITMENT; EXCHANGE; ADAPTATION	The SWR1 complex replaces the canonical histone H2A with the variant H2A.Z (Htz1 in yeast) at specific chromatin regions. This dynamic alteration in nucleosome structure provides a molecular mechanism to regulate transcription, gene silencing, chromosome segregation and DNA repair. Here we show that genetic instability, sensitivity to drugs impairing different cellular processes and genome-wide transcriptional misregulation in htz1 Delta can be partially or totally suppressed if SWR1 is not formed (swr1 Delta), if it forms but cannot bind to chromatin (swc2 Delta) or if it binds to chromatin but lacks histone replacement activity (swc5 Delta and the ATPase-dead swr1-K727G). These results suggest that in htz1 Delta the nucleosome remodelling activity of SWR1 affects chromatin integrity because of an attempt to replace H2A with Htz1 in the absence of the latter. This would impair transcription and, either directly or indirectly, other cellular processes. Specifically, we show that in htz1 Delta, the SWR1 complex causes an accumulation of recombinogenic DNA damage by a mechanism dependent on phosphorylation of H2A at Ser129, a modification that occurs in response to DNA damage, suggesting that the SWR1 complex impairs the repair of spontaneous DNA damage in htz1 Delta. In addition, SWR1 causes DSBs sensitivity in htz1 Delta; consistently, in the absence of Htz1 the SWR1 complex bound near an endonuclease HO-induced DSB at the mating-type (MAT) locus impairs DSB-induced checkpoint activation. Our results support a stepwise mechanism for the replacement of H2A with Htz1 and demonstrate that a tight control of this mechanism is essential to regulate chromatin dynamics but also to prevent the deleterious consequences of an incomplete nucleosome remodelling.	[Morillo-Huesca, Macarena; Clemente-Ruiz, Marta; Prado, Felix] CABIMER CSIC, Dept Mol Biol, Seville, Spain; [Andujar, Eloisa] CABIMER CSIC, Genom Unit, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Morillo-Huesca, M (corresponding author), CABIMER CSIC, Dept Mol Biol, Seville, Spain.	felix.prado@cabimer.es	Morillo-Huesca, Macarena/H-5144-2015; Prado, Felix/G-7700-2015	Morillo-Huesca, Macarena/0000-0002-2914-4871; Prado, Felix/0000-0001-9805-782X; Andujar, Eloisa/0000-0002-8434-5078	Spanish Ministry of Education and Science [BFU2006-08336]; Junta de Andalucia [P07-CVI-032000]; Spanish Research Council (CSIC)	Spanish Ministry of Education and Science(Spanish Government); Junta de Andalucia(Junta de Andalucia); Spanish Research Council (CSIC)	The research was funded by the Spanish Ministry of Education and Science (BFU2006-08336 grant) and the Junta de Andalucia (P07-CVI-032000). M.C-R. was a recipient of a pre-doctoral training grant from the Spanish Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Amberg DC., 2005, METHODS YEAST GENETI; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Desmoucelles C, 2002, J BIOL CHEM, V277, P27036, DOI 10.1074/jbc.M111433200; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hecht A, 1999, METHOD ENZYMOL, V304, P399; HORIKAWA I, 1995, BIOCHEM BIOPH RES CO, V208, P999, DOI 10.1006/bbrc.1995.1433; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 2005, GENE, V363, P183, DOI 10.1016/j.gene.2005.09.007; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu XW, 1996, MOL CELL BIOL, V16, P4305; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; NAUMOV G, 1992, YEAST, V8, P599, DOI 10.1002/yea.320080804; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Prado F, 2005, MOL CELL BIOL, V25, P1526, DOI 10.1128/MCB.25.4.1526-1536.2005; PRADO F, 1995, GENETICS, V139, P109; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; SIKORSKI RS, 1989, GENETICS, V122, P19; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yang XF, 2007, NAT STRUCT MOL BIOL, V14, P540, DOI 10.1038/nsmb1238; Zhang CJ, 2005, FLUID PHASE EQUILIBR, V231, P1, DOI 10.1016/j.fluid.2005.03.018; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	57	75	76	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12143	10.1371/journal.pone.0012143	http://dx.doi.org/10.1371/journal.pone.0012143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711347	gold, Green Submitted, Green Published			2022-12-25	WOS:000280859700025
J	Kunin, M; Dmitrieva, NI; Gallazzini, M; Shen, RF; Wang, GH; Burg, MB; Ferraris, JD				Kunin, Margarita; Dmitrieva, Natalia I.; Gallazzini, Morgan; Shen, Rong-Fong; Wang, Guanghui; Burg, Maurice B.; Ferraris, Joan D.			Mediator of DNA Damage Checkpoint 1 (MDC1) Contributes to High NaCl-Induced Activation of the Osmoprotective Transcription Factor TonEBP/OREBP	PLOS ONE			English	Article							ENHANCER-BINDING PROTEIN; STIMULATES TRANSCRIPTION; NUCLEAR-LOCALIZATION; INDUCIBLE KINASE; PHOSPHORYLATION; ATM; TRANSACTIVATION; TONEBP/NFAT5; INDUCTION; BREAKS	Background: Hypertonicity, such as induced by high NaCl, increases the activity of the transcription factor TonEBP/OREBP whose target genes increase osmoprotective organic osmolytes and heat shock proteins. Methodology: We used mass spectrometry to analyze proteins that coimmunoprecipitate with TonEBP/OREBP in order to identify ones that might contribute to its high NaCl-induced activation. Principal Findings: We identified 20 unique peptides from Mediator of DNA Damage Checkpoint 1 (MDC1) with high probability. The identification was confirmed by Western analysis. We used small interfering RNA knockdown of MDC1 to characterize its osmotic function. Knocking down MDC1 reduces high NaCl-induced increases in TonEBP/OREBP transcriptional and transactivating activity, but has no significant effect on its nuclear localization. We confirm six previously known phosphorylation sites in MDC1, but do not find evidence that high NaCl increases phosphorylation of MDC1. It is suggestive that MDC1 acts as a DNA damage response protein since hypertonicity reversibly increases DNA breaks, and other DNA damage response proteins, like ATM, also associate with TonEBP/OREBP and contribute to its activation by hypertonicity. Conclusions/Significance: MDC1 associates with TonEBP/OREBP and contributes to high NaCl-induced increase of that factor's transcriptional activity.	[Kunin, Margarita; Dmitrieva, Natalia I.; Gallazzini, Morgan; Burg, Maurice B.; Ferraris, Joan D.] NHLBI, Kidney & Electrolyte Metab Lab, Bethesda, MD 20892 USA; [Shen, Rong-Fong; Wang, Guanghui] NHLBI, Prote Core Facil, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kunin, M (corresponding author), Chaim Sheba Med Ctr, Dept Hypertens & Nephrol, IL-52621 Tel Hashomer, Israel.	maurice_burg@nih.gov	Dmitrieva, Natalia/A-2924-2013; Gallazzini, Morgan/E-5465-2011; Dmitrieva, Natalia/Q-9175-2019	Dmitrieva, Natalia/0000-0001-8074-6950; Gallazzini, Morgan/0000-0002-7185-7162; Dmitrieva, Natalia/0000-0001-8074-6950; Kunin, Margarita/0000-0003-4889-0420	National Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006134, ZICHL005903, ZIAHL001283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000576] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGNASCO S, 1986, J BIOL CHEM, V261, P5872; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; Colla E, 2006, BIOCHEM J, V393, P411, DOI 10.1042/BJ20051082; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Dmitrieva NI, 2008, AM J PHYSIOL-RENAL, V295, pF1678, DOI 10.1152/ajprenal.90424.2008; Dmitrieva NI, 2005, AM J PHYSIOL-RENAL, V289, pF2, DOI 10.1152/ajprenal.00041.2005; Dmitrieva NI, 2005, P NATL ACAD SCI USA, V102, P10730, DOI 10.1073/pnas.0504870102; Dmitrieva NI, 2004, P NATL ACAD SCI USA, V101, P2317, DOI 10.1073/pnas.0308463100; Dmitrieva NI, 2003, AM J PHYSIOL-RENAL, V285, pF266, DOI 10.1152/ajprenal.00060.2003; Ferraris JD, 1999, AM J PHYSIOL-CELL PH, V276, pC667, DOI 10.1152/ajpcell.1999.276.3.C667; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Ferraris JD, 2007, METHOD ENZYMOL, V428, P279, DOI 10.1016/S0076-6879(07)28016-4; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Irarrazabal CE, 2008, J BIOL CHEM, V283, P2554, DOI 10.1074/jbc.M703490200; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Kultz D, 2001, P NATL ACAD SCI USA, V98, P1999, DOI 10.1073/pnas.98.4.1999; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lou Zhenkun, 2004, Methods Mol Biol, V281, P179; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Mochan TA, 2003, CANCER RES, V63, P8586; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rauchman MI, 1997, AM J PHYSIOL-RENAL, V273, pF9, DOI 10.1152/ajprenal.1997.273.1.F9; SPYCHER C, 2008, CELL BIOL, V181, P227; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Tong EHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008435; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Zhang Z, 2005, AM J PHYSIOL-RENAL, V289, pF506, DOI 10.1152/ajprenal.00417.2004; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12108	10.1371/journal.pone.0012108	http://dx.doi.org/10.1371/journal.pone.0012108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711462	Green Submitted, Green Published, gold			2022-12-25	WOS:000280849100027
J	Yao, JR; Wang, CL; Walsh, SA; Hu, SM; Sawatzke, AB; Dang, D; Segar, JL; Ponto, LLB; Sunderland, JJ; Norris, AW				Yao, Jianrong; Wang, Chunlin; Walsh, Susan A.; Hu, Shanming; Sawatzke, Alexander B.; Dang, Diana; Segar, Jeffrey L.; Ponto, Laura L. B.; Sunderland, John J.; Norris, Andrew W.			Localized Fetomaternal Hyperglycemia: Spatial and Kinetic Definition by Positron Emission Tomography	PLOS ONE			English	Article							FETAL-GROWTH; BLOOD-FLOW; MATERNAL METABOLISM; ADULT-RATS; GLUCOSE; RESISTANCE; SECRETION; INFUSION; EXPOSURE; POTENCY	Background: Complex but common maternal diseases such as diabetes and obesity contribute to adverse fetal outcomes. Understanding of the mechanisms involved is hampered by difficulty in isolating individual elements of complex maternal states in vivo. We approached this problem in the context of maternal diabetes and sought an approach to expose the developing fetus in vivo to isolated hyperglycemia in the pregnant rat. Methodology and Principal Findings: We hypothesized that glucose infused into the arterial supply of one uterine horn would more highly expose fetuses in the ipsilateral versus contralateral uterine horn. To test this, the glucose tracer [F-18] fluorodeoxyglucose (FDG) was infused via the left uterine artery. Regional glucose uptake into maternal tissues and fetuses was quantified using positron emission tomography (PET). Upon infusion, FDG accumulation began in the left-sided placentae, subsequently spreading to the fetuses. Over two hours after completion of the infusion, FDG accumulation was significantly greater in left compared to right uterine horn fetuses, favoring the left by 1.9 +/- 0.1 and 2.8 +/- 0.3 fold under fasted and hyperinsulinemic conditions (p<10(-11) n = 32-35 and p<10(-12) n = 27-45) respectively. By contrast, centrally administered [H-3]-2-deoxyglucose accumulated equally between the fetuses of the two uterine horns. Induction of significant hyperglycemia (10(3) mg/dL) localized to the left uterine artery was sustained for at least 48 hours while maternal euglycemia was maintained. Conclusions and Significance: This approach exposes selected fetuses to localized hyperglycemia in vivo, minimizing exposure of the mother and thus secondary effects. Additionally, a set of less exposed internal control fetuses are maintained for comparison, allowing direct study of the in vivo fetal effects of isolated hyperglycemia. Broadly, this approach can be extended to study a variety of maternal-sided perturbations suspected to directly affect fetal health.	[Yao, Jianrong; Wang, Chunlin; Hu, Shanming; Sawatzke, Alexander B.; Dang, Diana; Segar, Jeffrey L.; Norris, Andrew W.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Walsh, Susan A.; Ponto, Laura L. B.; Sunderland, John J.] Univ Iowa, Carver Coll Med, Small Anim Imaging Core, Iowa City, IA USA; [Ponto, Laura L. B.; Sunderland, John J.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Yao, JR (corresponding author), Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA.	andrew-norris@uiowa.edu	Norris, Andrew W/O-5499-2018	Norris, Andrew W/0000-0001-8396-9543; Sunderland, John/0000-0002-0891-1234; Walsh, Susan/0000-0002-6632-5583; Segar, Jeffrey/0000-0001-7311-8948; Ponto, Laura/0000-0003-1197-6714	American Diabetes Association [1-08-RA-142]; National Institutes of Health (NIH) [R01-DK081548, P30 CA086862]; Burlington Care for Kids; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081548] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burlington Care for Kids; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Diabetes Association's Amaranth Diabetes Fund 1-08-RA-142 ( to A.W.N.), National Institutes of Health (NIH) R01-DK081548 (to A.W.N.), NIH P30 CA086862 (cancer center support grant for the University of Iowa Small Animal Imaging Core), and the Burlington Care for Kids fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON RN, 1976, BIOCHEM J, V156, P233, DOI 10.1042/bj1560233; Bertuzzi A, 1997, BRIT J NUTR, V78, P143, DOI 10.1079/BJN19970126; BIHOREAU MT, 1986, DIABETES, V35, P979, DOI 10.2337/diabetes.35.9.979; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; BRUCE N, 1979, BIOL REPROD, V21, P229, DOI 10.1095/biolreprod21.1.229; BUCHANAN TA, 1994, DIABETES, V43, P656, DOI 10.2337/diabetes.43.5.656; BUCHANAN TA, 2000, DIABETES MELLITUS FU, P852; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; DASTON GP, 1989, TERATOLOGY, V40, P555, DOI 10.1002/tera.1420400603; Eriksson UJ, 2009, SEMIN FETAL NEONAT M, V14, P85, DOI 10.1016/j.siny.2008.11.001; EVEN MD, 1994, J REPROD FERTIL, V102, P245; Fauque P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009218; Finnell RH, 2002, ANNU REV PHARMACOL, V42, P181, DOI 10.1146/annurev.pharmtox.42.083001.110955; FLAKE AW, 1986, J PEDIATR SURG, V21, P481, DOI 10.1016/S0022-3468(86)80216-0; FRASER I, 1984, J LEUKOCYTE BIOL, V36, P647, DOI 10.1002/jlb.36.5.647; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; GAUGUIER D, 1991, DIABETES, V40, P109, DOI 10.2337/diab.40.2.S109; Greene EC, 1935, T AM PHILOS SOC, V27, P370; HIRANO T, 1990, DIABETES RES CLIN PR, V9, P231, DOI 10.1016/0168-8227(90)90050-4; Holemans K, 2003, J SOC GYNECOL INVEST, V10, P392, DOI 10.1016/S1071-5576(03)00134-5; KHERA KS, 1987, CRIT REV TOXICOL, V17, P345, DOI 10.3109/10408448709029326; LASUNCION MA, 1983, BIOL NEONATE, V44, P85; Loeken MR, 2008, DIABETES, V57, P3187, DOI 10.2337/db08-1201; Maayan-Metzger A, 2009, NEONATOLOGY, V96, P80, DOI 10.1159/000203337; Massa HM, 1997, BIOL REPROD, V57, P43, DOI 10.1095/biolreprod57.1.43; MAYER M, 1992, CHEMOSPHERE, V25, P1195, DOI 10.1016/0045-6535(92)90129-F; MOORE DCP, 1989, TERATOLOGY, V40, P237, DOI 10.1002/tera.1420400305; Oakes ND, 1999, J LIPID RES, V40, P1155; Parman T, 1999, NAT MED, V5, P582, DOI 10.1038/8466; Rasmussen SA, 2008, AM J OBSTET GYNECOL, V198, P611, DOI 10.1016/j.ajog.2008.04.021; Richter SH, 2010, NAT METHODS, V7, P167, DOI 10.1038/nmeth0310-167; RIZZO T, 1991, NEW ENGL J MED, V325, P911, DOI 10.1056/NEJM199109263251303; SADLER TW, 1989, DIABETES, V38, P70, DOI 10.2337/diabetes.38.1.70; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Schmatz M, 2010, J PERINATOL, V30, P441, DOI 10.1038/jp.2009.182; SCHNEIDEREIT M, 1985, LAB ANIM, V19, P240, DOI 10.1258/002367785780893674; Scialli AR, 2010, REPROD TOXICOL, V29, P247, DOI 10.1016/j.reprotox.2009.10.010; Segar EM, 2009, CLIN SCI, V117, P129, DOI 10.1042/CS20080550; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; STYRUD J, 1995, PEDIATR RES, V37, P343, DOI 10.1203/00006450-199503000-00015; Weiss SJ, 2007, J CHILD PSYCHOL PSYC, V48, P773, DOI 10.1111/j.1469-7610.2007.01745.x; Wells Peter G, 2005, Toxicol Appl Pharmacol, V207, P354, DOI 10.1016/j.taap.2005.01.061; Zawiejska A, 2008, J PHYSIOL PHARMACOL, V59, P5	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12027	10.1371/journal.pone.0012027	http://dx.doi.org/10.1371/journal.pone.0012027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700464	Green Submitted, Green Published, gold			2022-12-25	WOS:000280687900018
J	Stieren, E; Werchan, WP; El Ayadi, A; Li, FZ; Boehning, D				Stieren, Emily; Werchan, Walter P.; El Ayadi, Amina; Li, Fuzhen; Boehning, Darren			FAD Mutations in Amyloid Precursor Protein Do Not Directly Perturb Intracellular Calcium Homeostasis	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; BETA-PROTEIN; MUTANT PRESENILIN-1; MISSENSE MUTATION; APP GENE; IN-VIVO; A-BETA; CA2+; ENTRY; MICE	Disturbances in intracellular calcium homeostasis are likely prominent and causative factors leading to neuronal cell death in Alzheimer's disease (AD). Familial AD (FAD) is early-onset and exhibits autosomal dominant inheritance. FAD-linked mutations have been found in the genes encoding the presenilins and amyloid precursor protein (APP). Several studies have shown that mutated presenilin proteins can directly affect calcium release from intracellular stores independently of A beta production. Although less well established, there is also evidence that APP may directly modulate intracellular calcium homeostasis. Here, we directly examined whether overexpression of FAD-linked APP mutants alters intracellular calcium dynamics. In contrast to previous studies, we found that overexpression of mutant APP has no effects on basal cytosolic calcium, ER calcium store size or agonist-induced calcium release and subsequent entry. Thus, we conclude that mutated APP associated with FAD has no direct effect on intracellular calcium homeostasis independently of A beta production.	[Stieren, Emily; Werchan, Walter P.; El Ayadi, Amina; Li, Fuzhen; Boehning, Darren] Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77550 USA; [Boehning, Darren] Univ Texas Galveston, Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Boehning, D (corresponding author), Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77550 USA.	dfboehni@utmb.edu	; Boehning, Darren/I-8539-2015	El Ayadi, Amina/0000-0002-3657-0633; Boehning, Darren/0000-0001-7920-6922	National Institutes of Health [R21AG031948, F30AG030878]; Jean C. and William D. Willis Neuroscience Research Endowment; NATIONAL INSTITUTE ON AGING [F30AG030878, R21AG031948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jean C. and William D. Willis Neuroscience Research Endowment; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (www.nih.gov) grants R21AG031948 (D. Boehning) and F30AG030878 (E. Stieren) and funds provided by the Jean C. and William D. Willis Neuroscience Research Endowment (E. Stieren). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; De Strooper B, 2000, J CELL SCI, V113, P1857; Duyckaerts C, 1997, NEUROBIOL AGING, V18, pS33, DOI 10.1016/S0197-4580(97)00067-5; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Herms J, 2003, J BIOL CHEM, V278, P2484, DOI 10.1074/jbc.M206769200; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; KAMINO K, 1992, AM J HUM GENET, V51, P998; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Murrell JR, 2000, ARCH NEUROL-CHICAGO, V57, P885, DOI 10.1001/archneur.57.6.885; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Rojas G, 2008, EXP NEUROL, V209, P234, DOI 10.1016/j.expneurol.2007.09.024; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2005, ARCH NEUROL-CHICAGO, V62, P192, DOI 10.1001/archneur.62.2.192; Solovyova N, 2002, CELL CALCIUM, V32, P49, DOI 10.1016/S0143-4160(02)00094-5; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11992	10.1371/journal.pone.0011992	http://dx.doi.org/10.1371/journal.pone.0011992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700539	Green Published, gold, Green Submitted			2022-12-25	WOS:000280605400024
J	Saleem, RA; Long-O'Donnell, R; Dilworth, DJ; Armstrong, AM; Jamakhandi, AP; Wan, Y; Knijnenburg, TA; Niemisto, A; Boyle, J; Rachubinski, RA; Shmulevich, I; Aitchison, JD				Saleem, Ramsey A.; Long-O'Donnell, Rose; Dilworth, David J.; Armstrong, Abraham M.; Jamakhandi, Arvind P.; Wan, Yakun; Knijnenburg, Theo A.; Niemisto, Antti; Boyle, John; Rachubinski, Richard A.; Shmulevich, Ilya; Aitchison, John D.			Genome-Wide Analysis of Effectors of Peroxisome Biogenesis	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PROTEIN FAMILY; FATTY-ACID; IMPORT; UBIQUITINATION; RECEPTOR; MATRIX; PEX5P; INHERITANCE	Peroxisomes are intracellular organelles that house a number of diverse metabolic processes, notably those required for beta-oxidation of fatty acids. Peroxisomes biogenesis can be induced by the presence of peroxisome proliferators, including fatty acids, which activate complex cellular programs that underlie the induction process. Here, we used multi-parameter quantitative phenotype analyses of an arrayed mutant collection of yeast cells induced to proliferate peroxisomes, to establish a comprehensive inventory of genes required for peroxisome induction and function. The assays employed include growth in the presence of fatty acids, and confocal imaging and flow cytometry through the induction process. In addition to the classical phenotypes associated with loss of peroxisomal functions, these studies identified 169 genes required for robust signaling, transcription, normal peroxisomal development and morphologies, and transmission of peroxisomes to daughter cells. These gene products are localized throughout the cell, and many have indirect connections to peroxisome function. By integration with extant data sets, we present a total of 211 genes linked to peroxisome biogenesis and highlight the complex networks through which information flows during peroxisome biogenesis and function.	[Saleem, Ramsey A.; Long-O'Donnell, Rose; Dilworth, David J.; Armstrong, Abraham M.; Jamakhandi, Arvind P.; Wan, Yakun; Knijnenburg, Theo A.; Niemisto, Antti; Boyle, John; Shmulevich, Ilya; Aitchison, John D.] Inst Syst Biol, Seattle, WA USA; [Rachubinski, Richard A.] Univ Alberta, Dept Cell Biol, Fac Med & Dent, Edmonton, AB, Canada; [Niemisto, Antti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland	Institute for Systems Biology (ISB); University of Alberta; Tampere University	Saleem, RA (corresponding author), Inst Syst Biol, Seattle, WA USA.	jaitchis@systemsbiology.org		Boyle, John/0000-0002-5378-5361	U.S. National Institutes of Health [GM075152, GM076547, RR022220]; Luxembourg Centre for Systems Biomedicine; University of Luxembourg; Academy of Finland [121830]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075152, P50GM076547] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Luxembourg Centre for Systems Biomedicine; University of Luxembourg; Academy of Finland(Academy of Finland); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM075152, GM076547 and RR022220 from the U.S. National Institutes of Health. We also thank the Luxembourg Centre for Systems Biomedicine and the University of Luxembourg for support. AN is supported by the Academy of Finland (application number 121830, Postdoctoral Researcher's Project 2008-2010; application number 213462, Finnish Programme for Centres of Excellence in Research 2006-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Eckert JH, 2003, J CELL SCI, V116, P3623, DOI 10.1242/jcs.00678; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fagarasanu M, 2005, J CELL BIOL, V169, P765, DOI 10.1083/jcb.200503083; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Karpichev IV, 2008, J BIOL CHEM, V283, P10264, DOI 10.1074/jbc.M708215200; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; KOLLING R, 1994, YEAST, V10, P1211, DOI 10.1002/yea.320100909; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Ma C, 2009, MOL BIOL CELL, V20, P3680, DOI 10.1091/mbc.E09-01-0037; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Mrsa V, 1999, YEAST, V15, P813, DOI 10.1002/(SICI)1097-0061(199907)15:10A<813::AID-YEA421>3.0.CO;2-Y; NAVARRO B, 1994, BIOCHEM BIOPH RES CO, V202, P960, DOI 10.1006/bbrc.1994.2023; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; NIEMISTO A, 2007, C P IEEE ENG MED BIO, P5559; Niemisto Antti, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2353; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; Purdue PE, 1998, J CELL BIOL, V143, P1859; Ratushny AV, 2008, BIOPHYS J, V95, P3715, DOI 10.1529/biophysj.108.134064; RATUSHNY AV, 2008, BIOPHYS J; RODEL G, 1987, MOL GEN GENET, V206, P45, DOI 10.1007/BF00326534; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Rottensteiner H, 2003, J BIOL CHEM, V278, P27605, DOI 10.1074/jbc.M304097200; Saleem RA, 2006, BBA-MOL CELL RES, V1763, P1541, DOI 10.1016/j.bbamcr.2006.09.005; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Simon E., 1892, Histoire naturelle des araignees, V1, P1; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Smith JJ, 2009, CURR OPIN CELL BIOL, V21, P119, DOI 10.1016/j.ceb.2009.01.009; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Wan YK, 2009, MOL CELL BIOL, V29, P2346, DOI 10.1128/MCB.01233-08; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Wolinski H, 2009, J PROTEOME RES, V8, P20, DOI 10.1021/pr800782n	54	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11953	10.1371/journal.pone.0011953	http://dx.doi.org/10.1371/journal.pone.0011953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694151	Green Submitted, gold, Green Published			2022-12-25	WOS:000280574300009
J	Xie, J; Qureshi, AA; Li, YH; Han, JL				Xie, Jing; Qureshi, Abrar A.; Li, Yunhui; Han, Jiali			ABO Blood Group and Incidence of Skin Cancer	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; PHENOTYPIC CHARACTERISTICS; SUN EXPOSURE; RISK-FACTORS; ANTIGENS; EXPRESSION	Background: Previous studies have examined the association between ABO blood group and the risk of some malignancies. However, no prospective cohort study to date has examined the association between ABO blood group and the risk of skin cancer. Methodology/Principal Findings: Using two large cohorts in the US, we examined ABO blood type and incidence of skin cancer, including melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC). We followed up study participants (70,650 female nurses and 24,820 male health professionals) on their diagnosis of incident skin cancer from cohort baseline (1976 in women and 1986 in men) until 2006. Study participants reported their blood type in 1996 in both cohorts. During the follow-up, 685 participants developed melanoma, 1,533 developed SCC and 19,860 developed BCC. We used Cox proportional hazards models to calculate the hazard ratios (HR) and 95% confidence intervals (CI) of each type of skin cancer. We observed that non-O blood group (A, AB, and B combined) was significantly associated with a decreased risk of non-melanoma skin cancer overall. Compared to participants with blood group O, participants with non-O blood group had a 14% decreased risk of developing SCC (multivariable HR: 0.86; 95% CI: 0.78, 0.95) and a 4% decreased risk of developing BCC (multivariable HR: 0.96; 95% CI: 0.93, 0.99). The decreased risk of melanoma for non-O blood group was not statistically significant (multivariable HR: 0.91; 95% CI: 0.78, 1.05). Conclusion/Significance: In two large independent populations, non-O blood group was associated with a decreased risk of skin cancer. The association was statistically significant for non-melanoma skin cancer. Additional studies are needed to confirm these associations and to define the mechanisms by which ABO blood type or closely linked genetic variants may influence skin cancer risk.	[Xie, Jing; Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Xie, Jing; Qureshi, Abrar A.; Han, Jiali] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp,Clin Res Program, Boston, MA 02115 USA; [Qureshi, Abrar A.; Li, Yunhui; Han, Jiali] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Xie, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	jiali.han@channing.harvard.edu			National Cancer Institute [CA087969, CA055075, CA122838]; NATIONAL CANCER INSTITUTE [R01CA122838, P01CA087969] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was funded by the National Cancer Institute (CA087969, CA055075, and CA122838).	AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; American Cancer Society, 2022, CANC FACTS FIGURES 2; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; English DR, 1997, CANCER CAUSE CONTROL, V8, P271, DOI 10.1023/A:1018440801577; GHAZIZADEH M, 1983, UROL RES, V11, P267, DOI 10.1007/BF00256344; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Hunter D J, 1992, Ann Epidemiol, V2, P231, DOI 10.1016/1047-2797(92)90055-U; Hussein MR, 2005, J CUTAN PATHOL, V32, P191, DOI 10.1111/j.0303-6987.2005.00281.x; Le Pendu J, 2001, APMIS, V109, P9; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; Nakagoe T, 2001, J GASTROEN HEPATOL, V16, P176, DOI 10.1046/j.1440-1746.2001.02425.x; Naldi L, 2005, CANCER CAUSE CONTROL, V16, P893, DOI 10.1007/s10552-005-2300-4; Naldi L, 2005, ANN EPIDEMIOL, V15, P545, DOI 10.1016/j.annepidem.2004.10.005; Nozoe T, 2004, DIS ESOPHAGUS, V17, P146, DOI 10.1111/j.1442-2050.2004.00392.x; Reid ME, 2004, SEMIN HEMATOL, V41, P93, DOI 10.1053/j.seminhematol.2004.01.001; TURSEN U, 2005, DERMATOLOGY ONLINE J, V11; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020	17	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11972	10.1371/journal.pone.0011972	http://dx.doi.org/10.1371/journal.pone.0011972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694147	Green Published, Green Submitted, gold			2022-12-25	WOS:000280574300016
J	Graf, M; Cellerino, A; Englert, C				Graf, Michael; Cellerino, Alessandro; Englert, Christoph			Gender Separation Increases Somatic Growth in Females but Does Not Affect Lifespan in Nothobranchius furzeri	PLOS ONE			English	Article							CALLOSOBRUCHUS-MACULATUS; HISTORY EVOLUTION; AGING RESEARCH; MODEL SYSTEM; FRUIT-FLIES; REPRODUCTION; COST; LONGEVITY; MORTALITY; VERTEBRATE	According to life history theory, physiological and ecological traits and parameters influence an individual's life history and thus, ultimately, its lifespan. Mating and reproduction are costly activities, and in a variety of model organisms, a negative correlation of longevity and reproductive effort has been demonstrated. We are employing the annual killifish Nothobranchius furzeri as a vertebrate model for ageing. N. furzeri is the vertebrate displaying the shortest known lifespan in captivity with particular strains living only three to four months under optimal laboratory conditions. The animals show explosive growth, early sexual maturation and age-dependent physiological and behavioural decline. Here, we have used N. furzeri to investigate a potential reproduction-longevity trade-off in both sexes by means of gender separation. Though female reproductive effort and offspring investment were significantly reduced after separation, as investigated by analysis of clutch size, eggs in the ovaries and ovary mass, the energetic surplus was not reallocated towards somatic maintenance. In fact, a significant extension of lifespan could not be observed in either sex. This is despite the fact that separated females, but not males, grew significantly larger and heavier than the respective controls. Therefore, it remains elusive whether lifespan of an annual species evolved in periodically vanishing habitats can be prolonged on the cost of reproduction at all.	[Graf, Michael; Cellerino, Alessandro; Englert, Christoph] FLI, Leibniz Inst Age Res, Jena, Germany	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Englert, C (corresponding author), FLI, Leibniz Inst Age Res, Jena, Germany.	cenglert@fli-leibniz.de	Cellerino, Alessandro/AAB-4398-2020; Cellerino, Alessandro/M-9380-2013; Cellerino, Alessandro/AAJ-7453-2020	Cellerino, Alessandro/0000-0003-3834-0097; Cellerino, Alessandro/0000-0003-3834-0097; Cellerino, Alessandro/0000-0003-3834-0097; Englert, Christoph/0000-0002-5931-3189	Leibniz Institute for Age Research	Leibniz Institute for Age Research	This work was supported by the host institution, namely the Leibniz Institute for Age Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes AI, 2003, ANIM BEHAV, V66, P199, DOI 10.1006/anbe.2003.2122; Borski RJ, 1996, ENDOCRINOLOGY, V137, P3253, DOI 10.1210/en.137.8.3253; Carey JR, 2002, EXP GERONTOL, V37, P507, DOI 10.1016/S0531-5565(01)00230-3; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Erdfelder E., 2004, ALLGEMEINE PSYCHOL D, P148; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; HIRSHFIELD MF, 1980, ECOLOGY, V61, P282, DOI 10.2307/1935187; Holmes DJ, 2001, EXP GERONTOL, V36, P869, DOI 10.1016/S0531-5565(00)00247-3; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; NEUMANN W, 2008, PRACHTGRUNDKARPFLING, P16; PARTRIDGE L, 1988, SCIENCE, V241, P1449, DOI 10.1126/science.241.4872.1449; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Paukku S, 2005, J INSECT PHYSIOL, V51, P1220, DOI 10.1016/j.jinsphys.2005.06.012; RAGLAND SS, 1973, EXP GERONTOL, V8, P135, DOI 10.1016/0531-5565(73)90003-X; READ AF, 1989, J ZOOL, V219, P329, DOI 10.1111/j.1469-7998.1989.tb02584.x; Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16; Reinhardt K, 1999, J INSECT BEHAV, V12, P283, DOI 10.1023/A:1020854403805; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; REZNICK D, 1983, ECOLOGY, V64, P862, DOI 10.2307/1937209; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Ricklefs RE, 2007, ECOL LETT, V10, P867, DOI 10.1111/j.1461-0248.2007.01085.x; Roff Derek A., 1992; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; TATAR M, 1993, EVOLUTION, V47, P1302, DOI [10.1111/j.1558-5646.1993.tb02156.x, 10.2307/2410149]; Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039; Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x; Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Vezina F, 2005, J EXP BIOL, V208, P2533, DOI 10.1242/jeb.01675; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461	35	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11958	10.1371/journal.pone.0011958	http://dx.doi.org/10.1371/journal.pone.0011958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689818	gold, Green Published			2022-12-25	WOS:000280520500012
J	Tsao, D; Minton, AP; Dokholyan, NV				Tsao, Douglas; Minton, Allen P.; Dokholyan, Nikolay V.			A Didactic Model of Macromolecular Crowding Effects on Protein Folding	PLOS ONE			English	Article							DISCRETE MOLECULAR-DYNAMICS; COARSE-GRAINED STRATEGY; EXCLUDED-VOLUME; PHYSIOLOGICAL CONSEQUENCES; CONCENTRATED-SOLUTIONS; BINDING STABILITY; THERMODYNAMICS; AGGREGATION; SIMULATIONS; CONFINEMENT	A didactic model is presented to illustrate how the effect of macromolecular crowding on protein folding and association is modeled using current analytical theory and discrete molecular dynamics. While analytical treatments of crowding may consider the effect as a potential of average force acting to compress a polypeptide chain into a compact state, the use of simulations enables the presence of crowding reagents to be treated explicitly. Using an analytically solvable toy model for protein folding, an approximate statistical thermodynamic method is directly compared to simulation in order to gauge the effectiveness of current analytical crowding descriptions. Both methodologies are in quantitative agreement under most conditions, indication that both current theory and simulation methods are capable of recapitulating aspects of protein folding even by utilizing a simplistic protein model.	[Tsao, Douglas] Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA; [Minton, Allen P.] NIDDKD, Sect Phys Biochem, Lab Biochem & Genet, NIH,US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Dokholyan, Nikolay V.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tsao, D (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA.	dokh@med.unc.edu	Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025; Minton, Allen/0000-0001-8459-1247	National Institutes of Health [R01GM080742]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health grant R01GM080742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Batra J, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22425; Batra J, 2009, BIOPHYS J, V97, P906, DOI 10.1016/j.bpj.2009.05.032; BOUBLIK T, 1974, MOL PHYS, V27, P1415, DOI 10.1080/00268977400101191; Cheung JK, 2005, BIOPHYS J, V89, P2372, DOI 10.1529/biophysj.105.062067; Cheung MS, 2007, J PHYS CHEM B, V111, P8250, DOI 10.1021/jp068201y; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; COTTER MA, 1977, J CHEM PHYS, V66, P1098, DOI 10.1063/1.434044; Davis CH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051921; Ding F, 2005, TRENDS BIOTECHNOL, V23, P450, DOI 10.1016/j.tibtech.2005.07.001; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dokholyan NV, 2000, J MOL BIOL, V296, P1183, DOI 10.1006/jmbi.1999.3534; Emperador A, 2008, BIOPHYS J, V95, P2127, DOI 10.1529/biophysj.107.119115; Ferreon ACM, 2004, BIOCHEMISTRY-US, V43, P13357, DOI 10.1021/bi048666j; Goldenberg DP, 2003, J MOL BIOL, V326, P1615, DOI 10.1016/S0022-2836(03)00033-0; HAN JN, 1993, BIOPHYS J, V65, P1155, DOI 10.1016/S0006-3495(93)81145-7; Homouz D, 2008, P NATL ACAD SCI USA, V105, P11754, DOI 10.1073/pnas.0803672105; Homouz D, 2009, J MOL BIOL, V391, P933, DOI 10.1016/j.jmb.2009.06.073; Kinjo AR, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051902; Kinjo AR, 2003, BIOPHYS J, V85, P3521, DOI 10.1016/S0006-3495(03)74772-9; Kudlay A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118101; LEBOWITZ JL, 1965, J CHEM PHYS, V43, P774, DOI 10.1063/1.1696842; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; MINTON AP, 2000, BIOPHYS J IN PRESS; Mittal J, 2010, BIOPHYS J, V98, P315, DOI 10.1016/j.bpj.2009.10.009; Pincus DL, 2009, J PHYS CHEM B, V113, P359, DOI 10.1021/jp807755b; Qin SB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031919; Qin SB, 2009, BIOPHYS J, V97, P12, DOI 10.1016/j.bpj.2009.03.066; REISS H, 1959, J CHEM PHYS, V31, P369, DOI 10.1063/1.1730361; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Rivera E, 2009, BIOPHYS J, V96, P4552, DOI 10.1016/j.bpj.2009.03.039; Samiotakis A, 2009, INT J MOL SCI, V10, P572, DOI 10.3390/ijms10020572; Sharma S, 2008, FRONT BIOSCI-LANDMRK, V13, P4795, DOI 10.2741/3039; Sharma S, 2007, BIOPHYS J, V92, P1457, DOI 10.1529/biophysj.106.094805; Shen VK, 2006, BIOPHYS J, V90, P1949, DOI 10.1529/biophysj.105.076497; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Tsao D, 2010, PHYS CHEM CHEM PHYS, V12, P3491, DOI 10.1039/b924236h; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2004, J MOL RECOGNIT, V17, P368, DOI 10.1002/jmr.711; Zhou HX, 2004, BIOCHEMISTRY-US, V43, P2141, DOI 10.1021/bi036269n; Zhou YQ, 1997, J CHEM PHYS, V107, P10691, DOI 10.1063/1.474186; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	53	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11936	10.1371/journal.pone.0011936	http://dx.doi.org/10.1371/journal.pone.0011936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689808	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520500004
J	Huang, T; Wang, P; Ye, ZQ; Xu, H; He, ZS; Feng, KY; Hu, LL; Cui, WR; Wang, K; Dong, XO; Xie, L; Kong, XY; Cai, YD; Li, YX				Huang, Tao; Wang, Ping; Ye, Zhi-Qiang; Xu, Heng; He, Zhisong; Feng, Kai-Yan; Hu, LeLe; Cui, WeiRen; Wang, Kai; Dong, Xiao; Xie, Lu; Kong, Xiangyin; Cai, Yu-Dong; Li, Yixue			Prediction of Deleterious Non-Synonymous SNPs Based on Protein Interaction Network and Hybrid Properties	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENE-EXPRESSION PROFILES; EVOLUTIONARY INFORMATION; DATABASE; SEQUENCE; DISEASE; ATTRIBUTES; MUTATIONS; SIFT	Non-synonymous SNPs (nsSNPs), also known as Single Amino acid Polymorphisms (SAPs) account for the majority of human inherited diseases. It is important to distinguish the deleterious SAPs from neutral ones. Most traditional computational methods to classify SAPs are based on sequential or structural features. However, these features cannot fully explain the association between a SAP and the observed pathophysiological phenotype. We believe the better rationale for deleterious SAP prediction should be: If a SAP lies in the protein with important functions and it can change the protein sequence and structure severely, it is more likely related to disease. So we established a method to predict deleterious SAPs based on both protein interaction network and traditional hybrid properties. Each SAP is represented by 472 features that include sequential features, structural features and network features. Maximum Relevance Minimum Redundancy (mRMR) method and Incremental Feature Selection (IFS) were applied to obtain the optimal feature set and the prediction model was Nearest Neighbor Algorithm (NNA). In jackknife cross-validation, 83.27% of SAPs were correctly predicted when the optimized 263 features were used. The optimized predictor with 263 features was also tested in an independent dataset and the accuracy was still 80.00%. In contrast, SIFT, a widely used predictor of deleterious SAPs based on sequential features, has a prediction accuracy of 71.05% on the same dataset. In our study, network features were found to be most important for accurate prediction and can significantly improve the prediction performance. Our results suggest that the protein interaction context could provide important clues to help better illustrate SAP's functional association. This research will facilitate the post genome-wide association studies.	[Huang, Tao; Ye, Zhi-Qiang; Dong, Xiao; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao; Ye, Zhi-Qiang; Feng, Kai-Yan; Dong, Xiao; Xie, Lu; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Wang, Ping; Xu, Heng; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Wang, Ping; Xu, Heng; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Hu, LeLe; Wang, Kai; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [He, Zhisong; Cui, WeiRen] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn; yxli@sibs.ac.cn	Ye, Zhi-Qiang/N-8513-2014; Xu, Heng/AAS-3465-2021	Ye, Zhi-Qiang/0000-0002-8822-6148; Xu, Heng/0000-0002-7748-2621; WANG, kai/0000-0002-6194-0480; cai, yudong/0000-0001-5664-7979	National High Technology Research and Development Program of China [2006AA02Z330]; National Basic Research Program of China [2004CB518603, 2010CB529206]; National Natural Science Foundation of China [30800641]; Chinese Academy of Sciences [KSCX1-YW-R-74]; China Postdoctoral Science Foundation [20090460669]; SA-SIBS (Sanofi-Aventis - Shanghai Institutes for Biological Sciences)	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); SA-SIBS (Sanofi-Aventis - Shanghai Institutes for Biological Sciences)	This work was supported by the National High Technology Research and Development Program of China (2006AA02Z330), the National Basic Research Program of China (2004CB518603, 2010CB529206), the National Natural Science Foundation of China (30800641), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-74), the China Postdoctoral Science Foundation (20090460669) and the SA-SIBS (Sanofi-Aventis - Shanghai Institutes for Biological Sciences) Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bao L, 2005, BIOINFORMATICS, V21, P2185, DOI 10.1093/bioinformatics/bti365; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Cai YD, 2006, J THEOR BIOL, V238, P395, DOI 10.1016/j.jtbi.2005.05.035; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Care MA, 2007, BIOINFORMATICS, V23, P664, DOI 10.1093/bioinformatics/btl649; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Dobson RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-217; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Herrgard S, 2003, PROTEINS, V53, P806, DOI 10.1002/prot.10458; Hu J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-297; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones D, 2008, NAT REV DRUG DISCOV, V7, P874, DOI 10.1038/nrd2748; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kohavi R., 1997, ARTIFICIAL INTELLIGE; Krishnan VG, 2003, BIOINFORMATICS, V19, P2199, DOI 10.1093/bioinformatics/btg297; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Ruepp A, 2006, NUCLEIC ACIDS RES, V34, pD568, DOI 10.1093/nar/gkj074; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Ye ZQ, 2007, BIOINFORMATICS, V23, P1444, DOI 10.1093/bioinformatics/btm119; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	40	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11900	10.1371/journal.pone.0011900	http://dx.doi.org/10.1371/journal.pone.0011900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689580	gold, Green Published, Green Submitted			2022-12-25	WOS:000280520300015
J	Marguet, P; Tanouchi, Y; Spitz, E; Smith, C; You, LC				Marguet, Philippe; Tanouchi, Yu; Spitz, Eric; Smith, Cameron; You, Lingchong			Oscillations by Minimal Bacterial Suicide Circuits Reveal Hidden Facets of Host-Circuit Physiology	PLOS ONE			English	Article							PROGRAMMED POPULATION-CONTROL; ACYL-HOMOSERINE LACTONES; ESCHERICHIA-COLI K-12; AMP RECEPTOR PROTEIN; COPY NUMBER CONTROL; VIBRIO-FISCHERI; PLASMID REPLICATION; CYCLIC-AMP; GENE-E; BIOLOGY	Synthetic biology seeks to enable programmed control of cellular behavior though engineered biological systems. These systems typically consist of synthetic circuits that function inside, and interact with, complex host cells possessing preexisting metabolic and regulatory networks. Nevertheless, while designing systems, a simple well-defined interface between the synthetic gene circuit and the host is frequently assumed. We describe the generation of robust but unexpected oscillations in the densities of bacterium Escherichia coli populations by simple synthetic suicide circuits containing quorum components and a lysis gene. Contrary to design expectations, oscillations required neither the quorum sensing genes (luxR and luxI) nor known regulatory elements in the P-luxI promoter. Instead, oscillations were likely due to density-dependent plasmid amplification that established a population-level negative feedback. A mathematical model based on this mechanism captures the key characteristics of oscillations, and model predictions regarding perturbations to plasmid amplification were experimentally validated. Our results underscore the importance of plasmid copy number and potential impact of "hidden interactions'' on the behavior of engineered gene circuits - a major challenge for standardizing biological parts. As synthetic biology grows as a discipline, increasing value may be derived from tools that enable the assessment of parts in their final context.	[Marguet, Philippe] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Tanouchi, Yu; Spitz, Eric; Smith, Cameron; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA; [You, Lingchong] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Marguet, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	you@duke.edu	Smith, Cameron/B-7683-2011	Smith, Cameron/0000-0002-6347-7506	David and Lucile Packard Foundation; NIH	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by the David and Lucile Packard Foundation and the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JC, 2005, J MOL BIOL; Andrianantoandro E., 2006, MOL SYSTEMS BIOL; Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Atlung T, 1999, PLASMID, V41, P110, DOI 10.1006/plas.1998.1386; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Balbas Paulina, 2004, Methods Mol Biol, V267, P77; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bernhardt TG, 2000, P NATL ACAD SCI USA, V97, P4297, DOI 10.1073/pnas.97.8.4297; BREMER H, 1986, J THEOR BIOL, V123, P453, DOI 10.1016/S0022-5193(86)80213-2; BRENDEL V, 1993, J MOL BIOL, V229, P860, DOI 10.1006/jmbi.1993.1092; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; CASHEL M, 1996, MOL BIOL, P1458; Chin JW, 2006, CURR OPIN STRUC BIOL, V16, P551, DOI 10.1016/j.sbi.2006.06.011; CLEWELL DB, 1972, J BACTERIOL, V110, P667, DOI 10.1128/JB.110.2.667-676.1972; Collins CH, 2005, MOL MICROBIOL, V55, P712, DOI 10.1111/j.1365-2958.2004.04437.x; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Drubin DA, 2007, GENE DEV, V21, P242, DOI 10.1101/gad.1507207; DUNLAP PV, 1988, J BACTERIOL, V170, P4040, DOI 10.1128/jb.170.9.4040-4046.1988; DUNLAP PV, 1992, J BIOLUM CHEMILUM, V7, P203, DOI 10.1002/bio.1170070307; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; FRENKEL L, 1986, DNA CELL BIOL, V544, P322; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; GALLANT J, 1972, J BIOL CHEM, V247, P6055; HECKER M, 1983, MOL GEN GENET, V190, P355, DOI 10.1007/BF00330665; HENRICH B, 1982, MOL GEN GENET, V185, P493, DOI 10.1007/BF00334146; KEASLING JD, 1989, J THEOR BIOL, V141, P447, DOI 10.1016/S0022-5193(89)80230-9; LAGOSKY PA, 1980, J BACTERIOL, V144, P499, DOI 10.1128/JB.144.2.499-508.1980; MARATEA D, 1985, GENE, V40, P39, DOI 10.1016/0378-1119(85)90022-8; Marguet P, 2007, J R SOC INTERFACE, V4, P607, DOI 10.1098/rsif.2006.0206; Mileyko Y, 2008, P NATL ACAD SCI USA, V105, P16659, DOI 10.1073/pnas.0806239105; PAULSSON J, 2001, Q REV BIOPHYS, V1, P59; Sayut DJ, 2006, ACS CHEM BIOL, V1, P692, DOI 10.1021/cb6004245; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; SEO JH, 1985, BIOTECHNOL BIOENG, V27, P156, DOI 10.1002/bit.260270209; Spira B, 2008, MICROBIOL-SGM, V154, P2887, DOI 10.1099/mic.0.2008/018457-0; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; STRICKER J, 2008, NATURE; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Teich A, 1998, J BIOTECHNOL, V64, P197, DOI 10.1016/S0168-1656(98)00108-4; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Urbanczyk H, 2007, INT J SYST EVOL MICR, V57, P2823, DOI 10.1099/ijs.0.65081-0; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Wang ZJ, 2006, MICROBIOL-SGM, V152, P3467, DOI 10.1099/mic.0.29134-0; Wang ZJ, 2002, PLASMID, V47, P69, DOI 10.1006/plas.2001.1562; Weiss LE, 2008, BIOTECHNOL BIOENG, V100, P1251, DOI 10.1002/bit.21862; WU K, 2009, MOL MICROBIOL; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; YOUNG KD, 1982, J VIROL, V44, P993, DOI 10.1128/JVI.44.3.993-1002.1982; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06	57	47	48	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11909	10.1371/journal.pone.0011909	http://dx.doi.org/10.1371/journal.pone.0011909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689598	gold, Green Published			2022-12-25	WOS:000280520300023
J	McVicar, CM; Colhoun, LM; Abrahams, JL; Kitson, CL; Hamilton, R; Medina, RJ; Durga, D; Gardiner, TA; Rudd, PM; Stitt, AW				McVicar, Carmel M.; Colhoun, Liza M.; Abrahams, Jodie L.; Kitson, Claire L.; Hamilton, Ross; Medina, Reinhold J.; Durga, Dash; Gardiner, Tom A.; Rudd, Pauline M.; Stitt, Alan W.			Differential Modulation of Angiogenesis by Erythropoiesis-Stimulating Agents in a Mouse Model of Ischaemic Retinopathy	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; MYOCARDIAL-INFARCTION; RETINAL NEOVASCULARIZATION; CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; TISSUE PROTECTION; EPO; DEGENERATION; MACROPHAGES; INHIBITION	Background: Erythropoiesis stimulating agents (ESAs) are widely used to treat anaemia but concerns exist about their potential to promote pathological angiogenesis in some clinical scenarios. In the current study we have assessed the angiogenic potential of three ESAs; epoetin delta, darbepoetin alfa and epoetin beta using in vitro and in vivo models. Methodology/Principal Findings: The epoetins induced angiogenesis in human microvascular endothelial cells at high doses, although darbepoetin alfa was pro-angiogenic at low-doses (1-20 IU/ml). ESA-induced angiogenesis was VEGF-mediated. In a mouse model of ischaemia-induced retinopathy, all ESAs induced generation of reticulocytes but only epoetin beta exacerbated pathological (pre-retinal) neovascularisation in comparison to controls (p<0.05). Only epoetin delta induced a significant revascularisation response which enhanced normality of the vasculature (p<0.05). This was associated with mobilisation of haematopoietic stem cells and their localisation to the retinal vasculature. Darbepoetin alfa also increased the number of active microglia in the ischaemic retina relative to other ESAs (p<0.05). Darbepoetin alfa induced retinal TNF alpha and VEGF mRNA expression which were up to 4 fold higher than with epoetin delta (p<0.001). Conclusions: This study has implications for treatment of patients as there are clear differences in the angiogenic potential of the different ESAs.	[McVicar, Carmel M.; Colhoun, Liza M.; Kitson, Claire L.; Hamilton, Ross; Medina, Reinhold J.; Durga, Dash; Gardiner, Tom A.; Stitt, Alan W.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland; [Abrahams, Jodie L.; Rudd, Pauline M.] Univ Coll Dublin, Dublin Oxford Glycobiol Lab, Natl Inst Bioproc Res & Training, Conway Inst, Dublin 2, Ireland	Queens University Belfast; University College Dublin	McVicar, CM (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland.	a.stitt@qub.ac.uk	Stitt, Alan/A-9842-2009; Wilson, Matthew H/K-3193-2013; Medina, Reinhold J/A-7949-2015; Hamilton, Ross/B-3659-2013	Stitt, Alan/0000-0002-8647-9918; Medina, Reinhold J/0000-0003-4351-7010; Gardiner, Tom/0000-0003-4907-2630; Abrahams, Jodie/0000-0002-2988-7843; Hamilton, Ross/0000-0001-9794-8452	Shire (Hampshire, UK); Fight for Sight [1688]	Shire (Hampshire, UK); Fight for Sight	Part of this research was funded by a grant from Shire (Hampshire, UK) and Fight for Sight grant no. 1688. AWS and PR have received travel funding from Shire. The funders agreed to the study design. They had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal RK, 2008, J IMMUNOL, V180, P5423, DOI 10.4049/jimmunol.180.8.5423; ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; *DAHANCA, 2006, INT AN DAHANCA 10; Davies M, 2006, MOL VIS, V12, P467; Ferrario M, 2007, EUR HEART J, V28, P1805, DOI 10.1093/eurheartj/ehm065; Frei U, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-5; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Gassmann M, 2003, ADV EXP MED BIOL, V543, P323; Gebarowska D, 2002, AM J PATHOL, V160, P307, DOI 10.1016/S0002-9440(10)64374-X; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Haroon ZSA, 2003, AM J PATHOL, V163, P993, DOI 10.1016/S0002-9440(10)63459-1; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Hernandez C, 2006, DIABETES CARE, V29, P2028, DOI 10.2337/dc06-0556; Hirata A, 2006, J AM COLL CARDIOL, V48, P176, DOI 10.1016/j.jacc.2006.04.008; Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023; Janmaat ML, 2010, BLOOD, V115, P1453, DOI 10.1182/blood-2009-07-230870; Jelkmann W, 2004, ANN HEMATOL, V83, P673, DOI 10.1007/s00277-004-0911-6; Kettenmann H, 2006, NAT NEUROSCI, V9, P1463, DOI 10.1038/nn1206-1463; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Lappin TR, 2007, ONCOLOGIST, V12, P362, DOI 10.1634/theoncologist.12-4-362; Li WY, 2010, OPHTHAL SURG LAS IM, V41, P18, DOI 10.3928/15428877-20091230-03; LI Y, 2006, J CEREB BLOOD FLOW M; Liu J, 2006, GLIA, V53, P360, DOI 10.1002/glia.20289; Llop E, 2008, ANAL BIOCHEM, V383, P243, DOI 10.1016/j.ab.2008.08.027; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Nishiya D, 2006, J PHARMACOL SCI, V101, P31, DOI 10.1254/jphs.FP0050966; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Scott SD, 2002, PHARMACOTHERAPY, V22, p160S, DOI 10.1592/phco.22.14.160S.33398; Simpson D, 2000, MOL VIS, V6, P178; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Tsai JC, 2005, CURR EYE RES, V30, P1025, DOI 10.1080/02713680500320729; Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; Westenbrink BD, 2008, CARDIOVASC DRUG THER, V22, P265, DOI 10.1007/s10557-008-6094-y; Yu YP, 2005, NEUROSCI LETT, V387, P5, DOI 10.1016/j.neulet.2005.07.008	51	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11870	10.1371/journal.pone.0011870	http://dx.doi.org/10.1371/journal.pone.0011870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686695	gold, Green Submitted, Green Published			2022-12-25	WOS:000280520200033
J	Clapp, KM; Peng, HM; Morishima, Y; Lau, M; Walker, VJ; Pratt, WB; Osawa, Y				Clapp, Kelly M.; Peng, Hwei-Ming; Morishima, Yoshihiro; Lau, Miranda; Walker, Vyvyca J.; Pratt, William B.; Osawa, Yoichi			C331A Mutant of Neuronal Nitric-oxide Synthase Is Labilized for Hsp70/CHIP (C Terminus of HSC70-interacting Protein)-dependent Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90/HSP70-BASED CHAPERONE MACHINERY; DEPENDENT E3 LIGASE; SYSTEM IN-VIVO; PROTEOLYTIC DEGRADATION; CYTOCHROME-P450 2E1; ESCHERICHIA-COLI; PROSTHETIC HEME; CHIP; PROTEIN; ENZYME	It is established that suicide inactivation of neuronal nitricoxide synthase (nNOS) by drugs and other xenobiotics leads to ubiquitination and proteasomal degradation of the enzyme. The exact mechanism is not known, although it is widely thought that the covalent alteration of the active site during inactivation triggers the degradation. A mechanism that involves recognition of the altered nNOS by Hsp70 and its cochaperone CHIP, an E3-ubiquitin ligase, has been proposed. To further address how alterations of the active site trigger ubiquitination of nNOS, we examined a C331A nNOS mutant, which was reported to have impaired ability to bind L-arginine and tetrahydrobiopterin. We show here that C331A nNOS is highly susceptible to ubiquitination by a purified system containing ubiquitinating enzymes and chaperones, by the endogenous ubiquitinating system in reticulocyte lysate fraction II, and by intact HEK293 cells. The involvement of the altered heme cleft in regulating ubiquitination is confirmed by the finding that the slowly reversible inhibitor of nNOS, NG-nitro-L-arginine, but not its inactive D-isomer, protects the C331A nNOS from ubiquitination in all these experimental systems. We also show that both Hsp70 and CHIP play a major role in the ubiquitination of C331A nNOS, although Hsp90 protects from ubiquitination. Thus, these studies further strengthen the link between the mobility of the substrate-binding cleft and chaperone-dependent ubiquitination of nNOS. These results support a general model of chaperone-mediated protein quality control and lead to a novel mechanism for substrate stabilization based on nNOS interaction with the chaperone machinery.	[Clapp, Kelly M.; Peng, Hwei-Ming; Morishima, Yoshihiro; Lau, Miranda; Walker, Vyvyca J.; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Osawa, Y (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	osawa@umich.edu			National Institutes of Health [GM077430, DA022354]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM077430 and DA022354.	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 2000, J BIOL CHEM, V275, P26018, DOI 10.1074/jbc.275.34.26018; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; DEMONTELLANO PRO, 1990, PHARMACOL THERAPEUT, V48, P95, DOI 10.1016/0163-7258(90)90020-3; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dunbar AY, 2006, DRUG METAB DISPOS, V34, P1448, DOI 10.1124/dmd.106.009951; Dunbar AY, 2004, MOL PHARMACOL, V66, P964, DOI 10.1124/mol.104.000125; Hemmens B, 1998, BIOCHEM J, V332, P337, DOI 10.1042/bj3320337; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kamada Y, 2005, MOL BRAIN RES, V142, P19, DOI 10.1016/j.molbrainres.2005.09.003; Kanelakis KC, 2003, METHOD ENZYMOL, V364, P159; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Martasek P, 1998, J BIOL CHEM, V273, P34799, DOI 10.1074/jbc.273.52.34799; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Morishima Y, 2003, J BIOL CHEM, V278, P48754, DOI 10.1074/jbc.M309814200; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Noguchi S, 2000, J BIOL CHEM, V275, P2376, DOI 10.1074/jbc.275.4.2376; OSAWA Y, 1991, J BIOL CHEM, V266, P3208; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; OSAWA Y, 1993, J BIOL CHEM, V268, P2953; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; PERNECKY SJ, 1993, P NATL ACAD SCI USA, V90, P2651, DOI 10.1073/pnas.90.7.2651; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; SCHMIDT HHHW, 1992, MOL PHARMACOL, V41, P615; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; TIERNEY DJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P9, DOI 10.1016/0003-9861(92)90358-4; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	43	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33642	33651		10.1074/jbc.M110.159178	http://dx.doi.org/10.1074/jbc.M110.159178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729196	Green Published, hybrid			2022-12-25	WOS:000283354000009
J	Debeurme, F; Picciocchi, A; Dagher, MC; Grunwald, D; Beaumel, S; Fieschi, F; Stasia, MJ				Debeurme, Franck; Picciocchi, Antoine; Dagher, Marie-Claire; Grunwald, Didier; Beaumel, Sylvain; Fieschi, Franck; Stasia, Marie-Jose			Regulation of NADPH Oxidase Activity in Phagocytes RELATIONSHIP BETWEEN FAD/NADPH BINDING AND OXIDASE COMPLEX ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SITE-DIRECTED MUTAGENESIS; CELL-FREE SYSTEM; FLAVOCYTOCHROME B(558); CYTOCHROME B(558); ESCHERICHIA-COLI; NOX-FAMILY; FERREDOXIN-NADP(+) REDUCTASE; FUNCTIONAL-ANALYSIS; GP91(PHOX) SUBUNIT	The X+-linked chronic granulomatous disease (X+-CGD) variants are natural mutants characterized by defective NADPH oxidase activity but with normal Nox2 expression. According to the three-dimensional model of the cytosolic Nox2 domain, most of the X+-CGD mutations are located in/or close to the FAD/NADPH binding regions. A structure/function study of this domain was conducted in X+-CGD PLB-985 cells exactly mimicking 10 human variants: T341K, C369R, G408E, G408R, P415H, P415L, Delta 507QKT509-HIW Ainsert, C537R, L546P, and E568K. Diaphorase activity is defective in all these mutants. NADPH oxidase assembly is normal for P415H/P415L and T341K mutants where mutation occurs in the consensus sequences of NADPH-and FAD-binding sites, respectively. This is in accordance with their buried position in the three-dimensional model of the cytosolic Nox2 domain. FAD incorporation is abolished only in the T341K mutant explaining its absence of diaphorase activity. This demonstrates that NADPH oxidase assembly can occur without FAD incorporation. In addition, a defect of NADPH binding is a plausible explanation for the diaphorase activity inhibition in the P415H, P415L, and C537R mutants. In contrast, Cys-369, Gly-408, Leu-546, and Glu-568 are essential for NADPH oxidase complex assembly. However, according to their position in the three-dimensional model of the cytosolic domain of Nox2, only Cys-369 could be in direct contact with cytosolic factors during oxidase assembly. In addition, the defect in oxidase assembly observed in the C369R, G408E, G408R, and E568K mutants correlates with the lack of FAD incorporation. Thus, the NADPH oxidase assembly process and FAD incorporation are closely related events essential for the diaphorase activity of Nox2.	[Debeurme, Franck; Picciocchi, Antoine; Dagher, Marie-Claire; Beaumel, Sylvain; Stasia, Marie-Jose] Univ Grenoble 1, Univ Hosp Grenoble, Chron Granulomatous Dis Diag & Res Ctr, Therex TIMC Imag UMR CNRS 5525, F-38043 Grenoble 9, France; [Fieschi, Franck] CEA, Inst Biol Struct, F-38027 Grenoble, France; [Fieschi, Franck] CNRS, UMR 5075, F-38027 Grenoble, France; [Fieschi, Franck] Univ Grenoble 1, F-38041 Grenoble, France; [Grunwald, Didier] iRTSV CEA, F-38054 Grenoble 9, France	CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Stasia, MJ (corresponding author), Univ Grenoble 1, Univ Hosp Grenoble, Chron Granulomatous Dis Diag & Res Ctr, Therex TIMC Imag UMR CNRS 5525, F-38043 Grenoble 9, France.	mjstasia@chu-grenoble.fr	beaumel, sylvain/M-7397-2014; DAGHER, Marie-Claire/M-6145-2014; Fieschi, Franck/W-2748-2019; STASIA, Marie José/M-7165-2014	DAGHER, Marie-Claire/0000-0001-6878-3169; STASIA, Marie jose/0000-0003-4466-4880; FIESCHI, Franck/0000-0003-1194-8107	United States Immunodeficiency Network [N01-AI-30070]; Primary Immunodeficiency Disease Consortium; Joseph Fourier University Medical School; Delegation for Clinical Research and Innovations, Grenoble, France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030070] Funding Source: NIH RePORTER	United States Immunodeficiency Network; Primary Immunodeficiency Disease Consortium; Joseph Fourier University Medical School; Delegation for Clinical Research and Innovations, Grenoble, France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant N01-AI-30070 from United States Immunodeficiency Network and the Primary Immunodeficiency Disease Consortium. This work was also supported by grants from Joseph Fourier University Medical School and the Delegation for Clinical Research and Innovations, Grenoble, France.	ALIVERTI A, 1995, BIOCHEMISTRY-US, V34, P8371, DOI 10.1021/bi00026a019; ALIVERTI A, 1993, BIOCHEMISTRY-US, V32, P6374, DOI 10.1021/bi00076a010; BALBRIDGE CW, 1933, AM J PHYSIOL, V103, P235; Baniulis D, 2005, BBA-PROTEINS PROTEOM, V1752, P186, DOI 10.1016/j.bbapap.2005.07.018; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 1999, J BIOL CHEM, V274, P10451, DOI 10.1074/jbc.274.15.10451; Bionda C, 2004, HUM GENET, V115, P418, DOI 10.1007/s00439-004-1173-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALCATERRA NB, 1995, BIOCHEMISTRY-US, V34, P12842, DOI 10.1021/bi00039a045; COHENTANUGI L, 1991, EUR J BIOCHEM, V202, P649, DOI 10.1111/j.1432-1033.1991.tb16419.x; CROSS AR, 1994, J BIOL CHEM, V269, P21448; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; FILLAT MF, 1990, BIOCHIM BIOPHYS ACTA, V1040, P301, DOI 10.1016/0167-4838(90)90091-S; Hashida S, 2004, J BIOL CHEM, V279, P26378, DOI 10.1074/jbc.M309724200; Henderson LM, 1998, J BIOL CHEM, V273, P33216, DOI 10.1074/jbc.273.50.33216; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; LEUSEN JHW, 1994, J CLIN INVEST, V93, P2120, DOI 10.1172/JCI117207; Leusen JHW, 2000, BLOOD, V95, P666; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Li XJ, 2005, J BIOL CHEM, V280, P14962, DOI 10.1074/jbc.M500226200; Marcoux J, 2010, J BIOL CHEM, V285, P28980, DOI 10.1074/jbc.M110.139824; Miyano K, 2003, BIOCHEMISTRY-US, V42, P184, DOI 10.1021/bi0269052; Niviere V, 1999, J BIOL CHEM, V274, P18252, DOI 10.1074/jbc.274.26.18252; Niviere V, 1996, J BIOL CHEM, V271, P16656, DOI 10.1074/jbc.271.28.16656; Niviere V, 1998, BIOCHEMISTRY-US, V37, P11879, DOI 10.1021/bi980396f; Paclet MH, 2004, BIOCHEM J, V382, P981, DOI 10.1042/BJ20040954; Park MY, 1997, BIOCHEM BIOPH RES CO, V234, P531, DOI 10.1006/bbrc.1997.6672; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Vergnaud S, 2000, EUR J BIOCHEM, V267, P1059, DOI 10.1046/j.1432-1327.2000.01097.x; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Yu LX, 1999, BLOOD, V94, P2497, DOI 10.1182/blood.V94.7.2497.419k11_2497_2504; YUBISUI T, 1991, J BIOL CHEM, V266, P66; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	43	34	37	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33197	33208		10.1074/jbc.M110.151555	http://dx.doi.org/10.1074/jbc.M110.151555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724480	Green Published, hybrid			2022-12-25	WOS:000283048200057
J	Hu, JJ; Wang, FC; Yuan, Y; Zhu, XQ; Wang, YX; Zhang, Y; Kou, ZH; Wang, SF; Gao, SR				Hu, Jianjun; Wang, Fengchao; Yuan, Ye; Zhu, Xiaoquan; Wang, Yixuan; Zhang, Yu; Kou, Zhaohui; Wang, Shufang; Gao, Shaorong			Novel Importin-alpha Family Member Kpna7 Is Required for Normal Fertility and Fecundity in the Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZYGOTIC GENE ACTIVATION; NUCLEAR-LOCALIZATION SIGNAL; CRYSTAL-STRUCTURE; DNA METHYLATION; PIWI; PIRNAS; CELL; EXPRESSION; CHROMATIN; DIFFERENTIATION	Nuclear importing system and nuclear factors play important roles in mediating nuclear reprogramming and zygotic gene activation. However, the components and mechanisms that mediate nuclearly specific targeting of the nuclear proteins during nuclear reprogramming and zygotic gene activation remain largely unknown. Here, we identified a novel member of the importin-alpha family, AW146299(KPNA7), which is predominantly expressed in mouse oocytes and zygotes and localizes to the nucleus or spindle. Mutation of Kpna7 gene caused reproductivity reduction and sex imbalance by inducing preferential fetal lethality in females. Parthenogenesis analysis showed that the cell cycle of activated one-cell embryos is loss of control and ahead of schedule but finally failed to develop into blastocyst stage. Further RT-PCR and epigenetic modification analysis showed that knocking out of Kpna7 induced abnormalities of gene expression (dppa2, dppa4, and piwil2) and epigenetic modifications (down-regulation of histone H3K27me3). Biochemical analysis showed that KPNA7 interacts with KPNB1 (importin-beta 1). In summary, we identified a novel Kpna7 gene that is required for normal fertility and fecundity.	[Hu, Jianjun; Wang, Fengchao; Yuan, Ye; Zhu, Xiaoquan; Wang, Yixuan; Zhang, Yu; Kou, Zhaohui; Wang, Shufang; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing	Gao, SR (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	gaoshaorong@nibs.ac.cn	wang, yixuan/GXW-2866-2022; Hu, Jianjun/Q-1877-2015; Wang, Yixuan/GZK-6559-2022	Wang, Shufang/0000-0001-5768-9687	Ministry of Science and Technology of China [2008AA022311, 2010CB944900, 2008AA1011005]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the Ministry of Science and Technology of China Grants 2008AA022311, 2010CB944900, and 2008AA1011005.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brinkmann U, 1998, AM J HUM GENET, V62, P509, DOI 10.1086/301773; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Endo T, 2005, MOL REPROD DEV, V71, P123, DOI 10.1002/mrd.20288; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Horn PJ, 2006, CHROMOSOME RES, V14, P83, DOI 10.1007/s10577-005-1018-1; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kavi HH, 2006, TRENDS BIOCHEM SCI, V31, P485, DOI 10.1016/j.tibs.2006.07.002; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Kwon SH, 2008, MOL CELLS, V26, P217; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; LATHAM KE, 1991, DEVELOPMENT, V112, P921; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; Minami N, 2007, J REPROD DEVELOP, V53, P707, DOI 10.1262/jrd.19029; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Obata Y, 2000, HUM REPROD, V15, P874, DOI 10.1093/humrep/15.4.874; Park KE, 2009, MOL REPROD DEV, V76, P1033, DOI 10.1002/mrd.21061; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Solter D, 2004, COLD SPRING HARB SYM, V69, P11, DOI 10.1101/sqb.2004.69.11; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wang SF, 2009, BIOL REPROD, V80, P555, DOI 10.1095/biolreprod.108.073197; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038	52	52	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33113	33122		10.1074/jbc.M110.117044	http://dx.doi.org/10.1074/jbc.M110.117044			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20699224	Green Published, hybrid			2022-12-25	WOS:000283048200049
J	Menn, B; Bach, S; Blevins, TL; Campbell, M; Meijer, L; Timsit, S				Menn, Benedicte; Bach, Stephane; Blevins, Teri L.; Campbell, Mark; Meijer, Laurent; Timsit, Serge			Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke Models	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH; PROTEIN-KINASES; ROSCOVITINE; ACTIVATION; PHARMACOKINETICS; MACHINERY; NEURONS; INJURY	Background: Although quite challenging, neuroprotective therapies in ischemic stroke remain an interesting strategy to counter mechanisms of ischemic injury and reduce brain tissue damage. Among potential neuroprotective drug, cyclin-dependent kinases (CDK) inhibitors represent interesting therapeutic candidates. Increasing evidence indisputably links cell cycle CDKs and CDK5 to the pathogenesis of stroke. Although recent studies have demonstrated promising neuroprotective efficacies of pharmacological CDK inhibitors in related animal models, none of them were however clinically relevant to human treatment. Methodology/Principal Findings: In the present study, we report that systemic delivery of (S)-roscovitine, a well known inhibitor of mitotic CDKs and CDK5, was neuroprotective in a dose-dependent manner in two models of focal ischemia, as recommended by STAIR guidelines. We show that (S)-roscovitine was able to cross the blood brain barrier. (S)-roscovitine significant in vivo positive effect remained when the compound was systemically administered 2 hrs after the insult. Moreover, we validate one of (S)-roscovitine in vivo target after ischemia. Cerebral increase of CDK5/p25 activity was observed 3 hrs after the insult and prevented by systemic (S)-roscovitine administration. Our results show therefore that roscovitine protects in vivo neurons possibly through CDK5 dependent mechanisms. Conclusions/Significance: Altogether, our data bring new evidences for the further development of pharmacological CDK inhibitors in stroke therapy.	[Menn, Benedicte] Neurokin SA, Inst Neurobiol Med, Marseille, France; [Bach, Stephane; Meijer, Laurent] CNRS, Stn Biol Roscoff, USR3151, Roscoff, France; [Blevins, Teri L.; Campbell, Mark] MDS Pharma Serv, Efficacy Pharmacol, Bothell, WA USA; [Timsit, Serge] CHRU Brest, Fac Med & Sci St Brest, Dept Neurol, Brest, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CHU Brest; Universite de Bretagne Occidentale	Menn, B (corresponding author), Neurokin SA, Inst Neurobiol Med, Marseille, France.	serge.timsit@chu-brest.fr	BACH, Stéphane/ABD-5865-2020; MEIJER, Laurent/ABE-7465-2021	, laurent/0000-0003-3511-4916; Timsit, Serge/0000-0003-0346-8576	French Ministry of the ANVAR; PRO-KINASE [LSHB-CT-2004-503467]; Association France Alzheimer; Neurokin S.A.	French Ministry of the ANVAR; PRO-KINASE; Association France Alzheimer; Neurokin S.A.	This study was supported by the French Ministry of the ANVAR (ST), the EEC grant from the PRO-KINASE Research Project (LSHB-CT-2004-503467; ST and LM) and the "Association France Alzheimer'' (LM). BM is Neurokin S. A. employee. TLB and MC are MDS PS employees. MDS PS was not a funder of the work and was used as a CRO to perform an external validation of our data as recommended by STAIR guidelines. MDS PS received payment from Neurokin S.A. for its service. ANVAR, the PRO-KINASE Research Project, and the "Association France Alzheimer'' had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Neurokin S. A. was a funder of this work and had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aldoss IT, 2009, EXPERT OPIN INV DRUG, V18, P1957, DOI 10.1517/13543780903418445; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P557, DOI 10.1080/10408440802014287; Chavez JC, 2009, STROKE, V40, pE558, DOI 10.1161/STROKEAHA.109.559914; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Frade JM, 2000, J CELL SCI, V113, P1139; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Guegan C, 1998, EXP NEUROL, V154, P371, DOI 10.1006/exnr.1998.6913; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Padmanabhan J, 2007, DEV NEUROBIOL, V67, P818, DOI 10.1002/dneu.20394; Phan TG, 2002, CLIN EXP PHARMACOL P, V29, P1, DOI 10.1046/j.1440-1681.2002.03609.x; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Sacco RL, 2007, LANCET, V369, P331, DOI 10.1016/S0140-6736(07)60155-X; Sallam H, 2008, PHARMACOL RES, V58, P32, DOI 10.1016/j.phrs.2008.05.010; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Strickley RG, 2004, PHARM RES-DORDR, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; Timsit S, 1999, EUR J NEUROSCI, V11, P263, DOI 10.1046/j.1460-9568.1999.00434.x; Timsit Serge, 2007, Biotechnology Journal, V2, P958, DOI 10.1002/biot.200700072; Vita M, 2005, EUR J PHARM SCI, V25, P91, DOI 10.1016/j.ejps.2005.02.001; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wen Y, 2007, BBA-MOL BASIS DIS, V1772, P473, DOI 10.1016/j.bbadis.2006.10.011; Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0; Zhang Q, 2009, GLIA, V57, P908, DOI 10.1002/glia.20816	44	72	81	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12117	10.1371/journal.pone.0012117	http://dx.doi.org/10.1371/journal.pone.0012117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711428	Green Published, Green Submitted, gold			2022-12-25	WOS:000280859700011
J	Villumsen, S; Pedersen, R; Krogfelt, KA; Jensen, JS				Villumsen, Steen; Pedersen, Rebecca; Krogfelt, Karen Angeliki; Jensen, Jorgen Skov			Expanding the Diagnostic Use of PCR in Leptospirosis: Improved Method for DNA Extraction from Blood Cultures	PLOS ONE			English	Article							PATHOGENIC LEPTOSPIRA; TAQMAN ASSAY; DISEASE	Background: Leptospirosis is a neglected zoonosis of ubiquitous distribution. Symptoms are often non-specific and may range from flu-like symptoms to multi-organ failure. Diagnosis can only be made by specific diagnostic tests like serology and PCR. In non-endemic countries, leptospirosis is often not suspected before antibiotic treatment has been initiated and consequently, relevant samples for diagnostic PCR are difficult to obtain. Blood cultures are obtained from most hospitalized patients before antibiotic therapy and incubated for at least five days, thus providing an important source of blood for PCR diagnosis. However, blood cultures contain inhibitors of PCR that are not readily removed by most DNA-extraction methods, primarily sodium polyanetholesulfonate (SPS). Methodology/Principal Findings: In this study, two improved DNA extraction methods for use with blood cultures are presented and found to be superior in recovering DNA of Leptospira interrogans when compared with three previously described methods. The improved methods were easy and robust in use with all tested brands of blood culture media. Applied to 96 blood cultures obtained from 36 patients suspected of leptospirosis, all seven patients with positive convalescence serology were found positive by PCR if at least one anaerobic and one aerobic blood culture, sampled before antibiotic therapy were tested. Conclusions/Significance: This study suggests that a specific and early diagnosis can be obtained in most cases of severe leptospirosis for up to five days after initiation of antimicrobial therapy, if PCR is applied to blood cultures already sampled as a routine procedure in most septic patients.	[Villumsen, Steen; Pedersen, Rebecca; Krogfelt, Karen Angeliki; Jensen, Jorgen Skov] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Villumsen, S (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark.	jsj@ssi.dk	Krogfelt, Karen Angeliki/P-2430-2018; Jensen, Jørgen/I-2917-2012; Jensen, Jørgen Skov/H-5159-2019; Krogfelt, Karen Angeliki A/O-8145-2016	Jensen, Jørgen Skov/0000-0002-7464-7435; Krogfelt, Karen Angeliki A/0000-0001-7536-3453	Statens Serum Institut, Copenhagen, Denmark	Statens Serum Institut, Copenhagen, Denmark	This study was financed by Statens Serum Institut, Copenhagen, Denmark, only. No external funders supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askling HH, 2009, EMERG INFECT DIS, V15, P1805, DOI 10.3201/eid1511.091157; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Fonseca CD, 2006, J INFECTION, V52, P15, DOI 10.1016/j.jinf.2005.02.022; Fredricks DN, 1998, J CLIN MICROBIOL, V36, P2810, DOI 10.1128/JCM.36.10.2810-2816.1998; Gebert S, 2008, J INFECTION, V57, P307, DOI 10.1016/j.jinf.2008.07.013; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hartskeerl RA, 2006, INT COURSE LAB METHO; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Krojgaard LH, 2009, EPIDEMIOL INFECT, V137, P1586, DOI 10.1017/S0950268809002647; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Miller BC, 2000, J MICROBIOL METH, V42, P139, DOI 10.1016/S0167-7012(00)00174-3; Slack A, 2007, DIAGN MICR INFEC DIS, V57, P361, DOI 10.1016/j.diagmicrobio.2006.10.004; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13	14	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12095	10.1371/journal.pone.0012095	http://dx.doi.org/10.1371/journal.pone.0012095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711446	Green Submitted, Green Published, gold			2022-12-25	WOS:000280849100022
J	Noguchi, Y; Nishikata, N; Shikata, N; Kimura, Y; Aleman, JO; Young, JD; Koyama, N; Kelleher, JK; Takahashi, M; Stephanopoulos, G				Noguchi, Yasushi; Nishikata, Natsumi; Shikata, Nahoko; Kimura, Yoshiko; Aleman, Jose O.; Young, Jamey D.; Koyama, Naoto; Kelleher, Joanne K.; Takahashi, Michio; Stephanopoulos, Gregory			Ketogenic Essential Amino Acids Modulate Lipid Synthetic Pathways and Prevent Hepatic Steatosis in Mice	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; REGULATES FOOD-INTAKE; FATTY LIVER-DISEASE; UNCOUPLING PROTEIN-3; ENERGY-EXPENDITURE; IMPROVES GLUCOSE; DE-NOVO; MUSCLE; RAT	Background: Although dietary ketogenic essential amino acid (KAA) content modifies accumulation of hepatic lipids, the molecular interactions between KAAs and lipid metabolism are yet to be fully elucidated. Methodology/Principal Findings: We designed a diet with a high ratio (E/N) of essential amino acids (EAAs) to non-EAAs by partially replacing dietary protein with 5 major free KAAs (Leu, Ile, Val, Lys and Thr) without altering carbohydrate and fat content. This high-KAA diet was assessed for its preventive effects on diet-induced hepatic steatosis and whole-animal insulin resistance. C57B6 mice were fed with a high-fat diet, and hyperinsulinemic ob/ob mice were fed with a high-fat or high-sucrose diet. The high-KAA diet improved hepatic steatosis with decreased de novo lipogensis (DNL) fluxes as well as reduced expressions of lipogenic genes. In C57B6 mice, the high-KAA diet lowered postprandial insulin secretion and improved glucose tolerance, in association with restored expression of muscle insulin signaling proteins repressed by the high-fat diet. Lipotoxic metabolites and their synthetic fluxes were also evaluated with reference to insulin resistance. The high-KAA diet lowered muscle and liver ceramides, both by reducing dietary lipid incorporation into muscular ceramides and preventing incorporation of DNL-derived fatty acids into hepatic ceramides. Conclusion: Our results indicate that dietary KAA intake improves hepatic steatosis and insulin resistance by modulating lipid synthetic pathways.	[Noguchi, Yasushi; Aleman, Jose O.; Young, Jamey D.; Kelleher, Joanne K.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kelleher, Joanne K.] Massachusetts Gen Hosp, Shriners Burn Hosp, Boston, MA 02114 USA; [Noguchi, Yasushi; Nishikata, Natsumi; Shikata, Nahoko; Kimura, Yoshiko; Koyama, Naoto; Takahashi, Michio] Ajinomoto Co Inc, Res Inst Hlth Fundamentals, Kanagawa, Japan	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Ajinomoto Co Inc	Noguchi, Y (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu	Young, Jamey/A-5857-2012	Aleman, Jose/0000-0003-3753-6717; Koyama, Naoto/0000-0003-2005-915X	National Institutes of Health (NIH) Bioengineering Research Partnership [DK58533]; NIH Metabolomics Roadmap Initiative [DK070291]; NIH [DK072856]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK072856, R01DK058533, R33DK070291] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Bioengineering Research Partnership(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Metabolomics Roadmap Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) Bioengineering Research Partnership Grant DK58533 and NIH Metabolomics Roadmap Initiative DK070291. J.D.Y. was supported by NIH grant DK072856. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassilian S, 2002, AM J PHYSIOL-ENDOC M, V282, pE507, DOI 10.1152/ajpendo.00211.2001; Bernstein AM, 2007, J AM DIET ASSOC, V107, P644, DOI 10.1016/j.jada.2007.01.002; Blazquez C, 2001, FEBS LETT, V489, P149, DOI 10.1016/S0014-5793(01)02089-0; Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Eisenstein J, 2002, NUTR REV, V60, P189, DOI 10.1301/00296640260184264; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Hasty AH, 1999, J LIPID RES, V40, P1529; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Klaus S, 2005, J NUTR, V135, P1854, DOI 10.1093/jn/135.8.1854; Krebs M, 2005, EUR J CLIN INVEST, V35, P351, DOI 10.1111/j.1365-2362.2005.01506.x; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Lee WNP, 2000, AM J PHYSIOL-ENDOC M, V279, pE425, DOI 10.1152/ajpendo.2000.279.2.E425; Lowenstein J M, 1975, Methods Enzymol, V35, P279, DOI 10.1016/0076-6879(75)35165-3; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Noguchi Y, 2008, PHYSIOL GENOMICS, V34, P315, DOI 10.1152/physiolgenomics.00007.2008; PELLETT P L, 1984, American Journal of Clinical Nutrition, V40, P718, DOI 10.1093/ajcn/40.3.718; PENG Y, 1973, J NUTR, V103, P608, DOI 10.1093/jn/103.4.608; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Putman CT, 2003, J PHYSIOL-LONDON, V551, P169, DOI 10.1113/jphysiol.2003.04069; RAO PBR, 1960, J NUTR, V71, P327, DOI 10.1093/jn/71.3.327; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; SINGAL SA, 1953, J BIOL CHEM, V200, P867; Solerte SB, 2004, AM J CARDIOL, V93, p23A, DOI 10.1016/i.amjcard.2003.11.006; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Tilg H, 2005, NAT CLIN PRACT GASTR, V2, P148, DOI 10.1038/ncpgasthep0116; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Vieu C, 2002, J LIPID RES, V43, P510; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; WILLIAMS JN, 1963, NATURE, V200, P472, DOI 10.1038/200472a0; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	49	44	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12057	10.1371/journal.pone.0012057	http://dx.doi.org/10.1371/journal.pone.0012057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706589	Green Published, Green Submitted, gold			2022-12-25	WOS:000280811900015
J	Rohwer, N; Dame, C; Haugstetter, A; Wiedenmann, B; Detjen, K; Schmitt, CA; Cramer, T				Rohwer, Nadine; Dame, Christof; Haugstetter, Anja; Wiedenmann, Bertram; Detjen, Katharina; Schmitt, Clemens A.; Cramer, Thorsten			Hypoxia-Inducible Factor 1 alpha Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-kappa B	PLOS ONE			English	Article							CELL CARCINOMA; FACTOR-I; CHEMORESISTANCE; INHIBITION; FACTOR-1-ALPHA; RESISTANCE; SENESCENCE; PATHWAY; OVEREXPRESSION; CONTRIBUTES	Background: Reduced chemosensitivity of solid cancer cells represents a pivotal obstacle in clinical oncology. Hence, the molecular characterization of pathways regulating chemosensitivity is a central prerequisite to improve cancer therapy. The hypoxia-inducible factor HIF-1 alpha has been linked to chemosensitivity while the underlying molecular mechanisms remain largely elusive. Therefore, we comprehensively analysed HIF-1 alpha's role in determining chemosensitivity focussing on responsible molecular pathways. Methodology and Principal Findings: RNA interference was applied to inactivate HIF-1 alpha or p53 in the human gastric cancer cell lines AGS and MKN28. The chemotherapeutic agents 5-fluorouracil and cisplatin were used and chemosensitivity was assessed by cell proliferation assays as well as determination of cell cycle distribution and apoptosis. Expression of p53 and p53 target proteins was analyzed by western blot. NF-kappa B activity was characterized by means of electrophoretic mobility shift assay. Inactivation of HIF-1 alpha in gastric cancer cells resulted in robust elevation of chemosensitivity. Accordingly, HIF-1 alpha-competent cells displayed a significant reduction of chemotherapy-induced senescence and apoptosis. Remarkably, this phenotype was completely absent in p53 mutant cells while inactivation of p53 per se did not affect chemosensitivity. HIF-1 alpha markedly suppressed chemotherapy-induced activation of p53 and p21 as well as the retinoblastoma protein, eventually resulting in cell cycle arrest. Reduced formation of reactive oxygen species in HIF-1 alpha-competent cells was identified as the molecular mechanism of HIF-1 alpha-mediated inhibition of p53. Furthermore, loss of HIF-1 alpha abrogated, in a p53-dependent manner, chemotherapy-induced DNA-binding of NF-kappa B and expression of anti-apoptotic NF-kappa B target genes. Accordingly, reconstitution of the NF-kappa B subunit p65 reversed the increased chemosensitivity of HIF-1 alpha-deficient cells. Conclusion and Significance: In summary, we identified HIF-1 alpha as a potent regulator of p53 and NF-kappa B activity under conditions of genotoxic stress. We conclude that p53 mutations in human tumors hold the potential to confound the efficacy of HIF-1-inhibitors in cancer therapy.	[Rohwer, Nadine; Wiedenmann, Bertram; Detjen, Katharina; Cramer, Thorsten] Charite Univ Med Berlin, Med Klin Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany; [Dame, Christof] Charite Univ Med Berlin, Klin Neonatol, Berlin, Germany; [Rohwer, Nadine] Free Univ Berlin, Fachbereich Biol, Berlin, Germany; [Haugstetter, Anja; Schmitt, Clemens A.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Rohwer, Nadine; Haugstetter, Anja; Detjen, Katharina; Schmitt, Clemens A.; Cramer, Thorsten] Charite Univ Med Berlin, Mol Krebsforschungszentrum, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohwer, N (corresponding author), Charite Univ Med Berlin, Med Klin Schwerpunkt Hepatol & Gastroenterol, Campus Virchow Klinikum, Berlin, Germany.	thorsten.cramer@charite.de	Schmitt, Clemens A/S-9479-2017; Cramer, Thorsten/S-2479-2016	Schmitt, Clemens A/0000-0002-4731-2226; Cramer, Thorsten/0000-0002-6462-239X; Rohwer, Nadine/0000-0001-6170-1327; Wiedenmann, Bertram/0000-0002-7890-2552	Deutsche Forschungsgemeinschaft [CR 133/2-1, 133/2-2, 133/2-3, Graduiertenkolleg 276/4]; Berliner Krebsgesellschaft e.V. [CRFF200804]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berliner Krebsgesellschaft e.V.	This study was supported by grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) to TC (CR 133/2-1, 133/2-2 and 133/2-3), and NR (Graduiertenkolleg 276/4 - "Signalerkennung und - umsetzung''). TC was also supported by a grant from the Berliner Krebsgesellschaft e.V. (http://www.berliner-krebsgesellschaft.de, CRFF200804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Birner P, 2000, CANCER RES, V60, P4693; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Brown LM, 2006, MOL PHARMACOL, V69, P411, DOI 10.1124/mol.105.015743; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Cramer T, 2008, CELL SIGNAL, V20, P60, DOI 10.1016/j.cellsig.2007.08.016; Culmsee C, 2003, J NEUROSCI, V23, P8586; Cusack JC, 2001, CANCER RES, V61, P3535; Cusack JC, 2000, CANCER RES, V60, P2323; Dame C, 2004, J BIOL CHEM, V279, P2955, DOI 10.1074/jbc.M310404200; Frede S, 2007, METHOD ENZYMOL, V435, P405, DOI 10.1016/S0076-6879(07)35021-0; Gatti L, 2005, METH MOLEC MED, V111, P127; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Hammond EM, 2006, CLIN CANCER RES, V12, P5007, DOI 10.1158/1078-0432.CCR-06-0613; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Holley AK, 2009, FUTURE ONCOL, V5, P117, DOI 10.2217/14796694.5.1.117; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Liu L, 2007, MOL CELL BIOCHEM, V303, P151, DOI 10.1007/s11010-007-9467-9; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Morin PJ, 2003, DRUG RESIST UPDATE, V6, P169, DOI 10.1016/S1368-7646(03)00059-1; Nakamura J, 2009, ONCOL REP, V22, P693, DOI 10.3892/or_00000489; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Patiar S, 2006, ENDOCR-RELAT CANCER, V13, pS61, DOI 10.1677/erc.1.01290; Plath T, 2000, J CELL BIOL, V150, P1467, DOI 10.1083/jcb.150.6.1467; Ravi R, 1998, CANCER RES, V58, P4531; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Wirthner R, 2008, CARCINOGENESIS, V29, P2306, DOI 10.1093/carcin/bgn231; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhong H, 1999, CANCER RES, V59, P5830	55	97	103	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12038	10.1371/journal.pone.0012038	http://dx.doi.org/10.1371/journal.pone.0012038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706634	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000280811900006
J	Pond, SK; Delport, W; Muse, SV; Scheffler, K				Pond, Sergei Kosakovsky; Delport, Wayne; Muse, Spencer V.; Scheffler, Konrad			Correcting the Bias of Empirical Frequency Parameter Estimators in Codon Models	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION; SEQUENCE EVOLUTION; PROTEIN; RATES	Markov models of codon substitution are powerful inferential tools for studying biological processes such as natural selection and preferences in amino acid substitution. The equilibrium character distributions of these models are almost always estimated using nucleotide frequencies observed in a sequence alignment, primarily as a matter of historical convention. In this note, we demonstrate that a popular class of such estimators are biased, and that this bias has an adverse effect on goodness of fit and estimates of substitution rates. We propose a "corrected" empirical estimator that begins with observed nucleotide counts, but accounts for the nucleotide composition of stop codons. We show via simulation that the corrected estimates outperform the de facto standard F3 x 4 estimates not just by providing better estimates of the frequencies themselves, but also by leading to improved estimation of other parameters in the evolutionary models. On a curated collection of 856 sequence alignments, our estimators show a significant improvement in goodness of fit compared to the F3 x 4 approach. Maximum likelihood estimation of the frequency parameters appears to be warranted in many cases, albeit at a greater computational cost. Our results demonstrate that there is little justification, either statistical or computational, for continued use of the F3 x 4-style estimators.	[Pond, Sergei Kosakovsky] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Delport, Wayne] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Muse, Spencer V.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Scheffler, Konrad] Univ Stellenbosch, Div Comp Sci, Dept Math Sci, ZA-7600 Stellenbosch, South Africa	University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; North Carolina State University; Stellenbosch University	Pond, SK (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	spond@ucsd.edu	Delport, Wayne/C-1744-2008; Pond, Sergei LK/G-9830-2012	Pond, Sergei LK/0000-0003-4817-4029; Scheffler, Konrad/0000-0002-6041-8367	Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative [NSF-0714991]; National Institutes of Health [AI47745]; University of California, San Diego Center for AIDS Research/NIAID [AI36214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047745, R21AI047745, P30AI036214, R56AI047745] Funding Source: NIH RePORTER	Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Center for AIDS Research/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative through Grant NSF-0714991, the National Institutes of Health, AI47745 and by a University of California, San Diego Center for AIDS Research/NIAID Developmental Award to S. L. K. P. (AI36214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Conant GC, 2009, MOL BIOL EVOL, V26, P1155, DOI 10.1093/molbev/msp031; Delport W, 2009, BRIEF BIOINFORM, V10, P97, DOI 10.1093/bib/bbn049; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; LACERDA M, 2010, MOL BIOL EVOL; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seoighe C, 2007, MOL BIOL EVOL, V24, P1025, DOI 10.1093/molbev/msm021; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087	13	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11230	10.1371/journal.pone.0011230	http://dx.doi.org/10.1371/journal.pone.0011230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689581	Green Published, gold			2022-12-25	WOS:000280520300001
J	Robbins, D; Gu, X; Shi, RH; Liu, JF; Wang, F; Ponville, J; McCord, JM; Zhao, YF				Robbins, Delira; Gu, Xin; Shi, Runhua; Liu, Jianfeng; Wang, Fei; Ponville, Jacqulyne; McCord, Joe M.; Zhao, Yunfeng			The Chemopreventive Effects of Protandim: Modulation of p53 Mitochondrial Translocation and Apoptosis during Skin Carcinogenesis	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; IMMUNODEFICIENT MICE; CANCER-CELLS; 12-O-TETRADECANOYLPHORBOL-13-ACETATE; PATHWAY; MODEL; COMBINATION; ACTIVATION; EXTRACT; MOUSE	Protandim, a well defined dietary combination of 5 well-established medicinal plants, is known to induce endogenous antioxidant enzymes, such as manganese superoxide dismutase (MnSOD). Our previous studies have shown through the induction of various antioxidant enzymes, products of oxidative damage can be decreased. In addition, we have shown that tumor multiplicity and incidence can be decreased through the dietary administration of Protandim in the two-stage skin carcinogenesis mouse model. It has been demonstrated that cell proliferation is accommodated by cell death during DMBA/TPA treatment in the two-stage skin carcinogenesis model. Therefore, we investigated the effects of the Protandim diet on apoptosis; and proposed a novel mechanism of chemoprevention utilized by the Protandim dietary combination. Interestingly, Protandim suppressed DMBA/TPA induced cutaneous apoptosis. Recently, more attention has been focused on transcription-independent mechanisms of the tumor suppressor, p53, that mediate apoptosis. It is known that cytoplasmic p53 rapidly translocates to the mitochondria in response to pro-apoptotic stress. Our results showed that Protandim suppressed the mitochondrial translocation of p53 and mitochondrial outer membrane proteins such as Bax. We examined the levels of p53 and MnSOD expression/activity in murine skin JB6 promotion sensitive (P+) and promotion-resistant (P-) epidermal cells. Interestingly, p53 was induced only in P+ cells, not P- cells; whereas MnSOD is highly expressed in P- cells when compared to P+ cells. In addition, wild-type p53 was transfected into JB6 P-cells. We found that the introduction of wild-type p53 promoted transformation in JB6 P- cells. Our results suggest that suppression of p53 and induction of MnSOD may play an important role in the tumor suppressive activity of Protandim.	[Robbins, Delira; Zhao, Yunfeng] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA; [Gu, Xin] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71105 USA; [Wang, Fei] Jilin Univ, Coll Life Sci, Changchun 130023, Jilin Province, Peoples R China; [Ponville, Jacqulyne] Nicholls State Univ, Dept Chem, Thibodaux, LA 70310 USA; [McCord, Joe M.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [McCord, Joe M.] Hlth Sci Ctr, Aurora, CO USA; [Shi, Runhua] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Jilin University; University of Louisiana System; Nicholls State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Robbins, D (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.	yzhao1@lsuhsc.edu	McCord, Joe/GWU-8607-2022	Robichaux, Jacqulyne/0000-0001-8812-7054				Avila GE, 2005, J PHARMACOL EXP THER, V315, P170, DOI 10.1124/jpet.105.087585; BOWDEN GT, 1995, MOL MECH INVOLVED SK, P99; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Chaurasia SS, 2000, PHARMACOL RES, V41, P663, DOI 10.1006/phrs.1999.0634; Chen J, 2006, APOPTOSIS, V11, P943, DOI 10.1007/s10495-006-6715-5; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Hota SK, 2009, NEUROBIOL DIS, V34, P23, DOI 10.1016/j.nbd.2008.12.006; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005284; Manna SK, 1999, J IMMUNOL, V163, P6800; MARCHENKO ND, 2005, J BIOL CHEM, V280, P19166; Nelson SK, 2006, FREE RADICAL BIO MED, V40, P341, DOI 10.1016/j.freeradbiomed.2005.08.043; Pani G, 2004, CURR MED CHEM, V11, P1299, DOI 10.2174/0929867043365297; Pani G, 2009, INT J BIOCHEM CELL B, V41, P1002, DOI 10.1016/j.biocel.2008.10.011; POLYAK K, 1997, NATURE, V389, P237; Potapovich AI, 2003, BIOCHEMISTRY-MOSCOW+, V68, P514, DOI 10.1023/A:1023947424341; Tang XW, 2007, J CLIN INVEST, V117, P3753, DOI 10.1172/JCI32481; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Zhang XP, 2007, CLIN CANCER RES, V13, P7181, DOI 10.1158/1078-0432.CCR-07-1133; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zhao YF, 2002, ONCOGENE, V21, P3836, DOI 10.1038/sj.onc.1205477; Zhao Yunfeng, 2003, Methods Mol Biol, V218, P177; Zheng X, 2006, CLIN CANCER RES, V12, P3444, DOI 10.1158/1078-0432.CCR-05-2823	26	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11902	10.1371/journal.pone.0011902	http://dx.doi.org/10.1371/journal.pone.0011902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689586	Green Published, gold			2022-12-25	WOS:000280520300017
J	Lai, XH; Shirley, RL; Crosa, L; Kanistanon, D; Tempel, R; Ernst, RK; Gallagher, LA; Manoil, C; Heffron, F				Lai, Xin-He; Shirley, Renee L.; Crosa, Lidia; Kanistanon, Duangjit; Tempel, Rebecca; Ernst, Robert K.; Gallagher, Larry A.; Manoil, Colin; Heffron, Fred			Mutations of Francisella novicida that Alter the Mechanism of Its Phagocytosis by Murine Macrophages	PLOS ONE			English	Article							TULARENSIS SUBSP NOVICIDA; BRUCELLA-ABORTUS; IN-VITRO; VIRULENCE DETERMINANTS; NONPHAGOCYTIC CELLS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; HOST-CELLS; O-ANTIGENS; WILD-TYPE	Infection with the bacterial pathogen Francisella tularensis tularensis (F. tularensis) causes tularemia, a serious and debilitating disease. Francisella tularensis novicida strain U112 (abbreviated F. novicida), which is closely related to F. tularensis, is pathogenic for mice but not for man, making it an ideal model system for tularemia. Intracellular pathogens like Francisella inhibit the innate immune response, thereby avoiding immune recognition and death of the infected cell. Because activation of inflammatory pathways may lead to cell death, we reasoned that we could identify bacterial genes involved in inhibiting inflammation by isolating mutants that killed infected cells faster than the wild-type parent. We screened a comprehensive transposon library of F. novicida for mutant strains that increased the rate of cell death following infection in J774 macrophage-like cells, as compared to wild-type F. novicida. Mutations in 28 genes were identified as being hypercytotoxic to both J774 and primary macrophages of which 12 were less virulent in a mouse infection model. Surprisingly, we found that F. novicida with mutations in four genes (lpcC, manB, manC and kdtA) were taken up by and killed macrophages at a much higher rate than the parent strain, even upon treatment with cytochalasin D (cytD), a classic inhibitor of macrophage phagocytosis. At least 10-fold more mutant bacteria were internalized by macrophages as compared to the parent strain if the bacteria were first fixed with formaldehyde, suggesting a surface structure is required for the high phagocytosis rate. However, bacteria were required to be viable for macrophage toxicity. The four mutant strains do not make a complete LPS but instead have an exposed lipid A. Interestingly, other mutations that result in an exposed LPS core were not taken up at increased frequency nor did they kill host cells more than the parent. These results suggest an alternative, more efficient macrophage uptake mechanism for Francisella that requires exposure of a specific bacterial surface structure(s) but results in increased cell death following internalization of live bacteria.	[Lai, Xin-He; Crosa, Lidia; Tempel, Rebecca; Heffron, Fred] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Lai, Xin-He; Shirley, Renee L.] Virogenomics Inc, Tigard, OR USA; [Kanistanon, Duangjit; Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Gallagher, Larry A.; Manoil, Colin] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Oregon Health & Science University; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle	Lai, XH (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	laixinhe@gmail.com; heffronf@ohsu.edu	Gallagher, Larry/L-1605-2013	Ernst, Robert/0000-0001-5016-8694	Virogenomics;  [U54 AI05714]	Virogenomics; 	Funded in part by grant U54 AI05714; Xin-He Lai and Renee Shirley were both partially funded by Virogenomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Their role in the work was solely based on determining if the genes described in the paper could be used in vaccines-work that is not described in this paper.	ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Brissette CA, 1999, ORAL MICROBIOL IMMUN, V14, P137, DOI 10.1034/j.1399-302X.1999.140301.x; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Chakraborty S, 2008, INFECT IMMUN, V76, P2852, DOI 10.1128/IAI.01726-07; CHANG CM, 1975, IMMUNOCHEMISTRY, V12, P19, DOI 10.1016/0019-2791(75)90045-2; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DETILLEUX PG, 1990, INFECT IMMUN, V58, P2320, DOI 10.1128/IAI.58.7.2320-2328.1990; Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Guo H, 2008, CURR TOP MED CHEM, V8, P141; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09; Kanipes MI, 2003, J BIOL CHEM, V278, P16356, DOI 10.1074/jbc.M301255200; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Ludu JS, 2008, FEMS MICROBIOL LETT, V278, P86, DOI 10.1111/j.1574-6968.2007.00979.x; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; McLendon MK, 2007, INFECT IMMUN, V75, P5518, DOI 10.1128/IAI.01288-06; Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; Pei J, 2008, INFECT IMMUN, V76, P30, DOI 10.1128/IAI.00379-07; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Platz GJ, 2010, INFECT IMMUN, V78, P1022, DOI 10.1128/IAI.00992-09; Prior JL, 2003, J MED MICROBIOL, V52, P845, DOI 10.1099/jmm.0.05184-0; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHRAMM N, 1995, INFECT IMMUN, V63, P324, DOI 10.1128/IAI.63.1.324-332.1995; Sjostedt A. B., 2005, BERGEYS MANUAL SYS B, VII, P199; Stead C, 2005, J BACTERIOL, V187, P3374, DOI 10.1128/JB.187.10.3374-3383.2005; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Wang XY, 2006, BIOCHEMISTRY-US, V45, P14427, DOI 10.1021/bi061767s; Weiss DS, 2007, ANN NY ACAD SCI, V1105, P219, DOI 10.1196/annals.1409.005; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; WICK MJ, 1994, INFECT IMMUN, V62, P4542, DOI 10.1128/IAI.62.10.4542-4548.1994; Zogaj X, 2008, MICROBIOL-SGM, V154, P2139, DOI 10.1099/mic.0.2008/018077-0	48	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11857	10.1371/journal.pone.0011857	http://dx.doi.org/10.1371/journal.pone.0011857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686600	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200021
J	Levin, TC; Glazer, AM; Pachter, L; Brem, RB; Eisen, MB				Levin, Tera C.; Glazer, Andrew M.; Pachter, Lior; Brem, Rachel B.; Eisen, Michael B.			Exploring the Genetic Basis of Variation in Gene Predictions with a Synthetic Association Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFICATION	Identifying DNA polymorphisms that affect molecular processes like transcription, splicing, or translation typically requires genotyping and experimentally characterizing tissue from large numbers of individuals, which remains expensive and time consuming. Here we introduce an alternative strategy: a "synthetic association study'' in which we computationally predict molecular phenotypes on artificial genomes containing randomly sampled combinations of polymorphic alleles, and perform a classical association study to identify genotypes underlying variation in these computationally predicted annotations. We applied this method to characterize the effects on gene structure of 32,792 single-nucleotide polymorphisms between two strains of the antibiotic producing fungus Penicilium chrysogenum. Although these SNPs represent only 0.1 percent of the nucleotides in the genome, they collectively altered 1.8 percent of predicted gene models between these strains. To determine which SNPs or combinations of SNPs were responsible for this variation, we predicted protein-coding genes in 500 intermediate genomes, each identical except for randomly chosen alleles at each SNP position. Of 30,468 gene models in the genome, 557 varied across these 500 genomes. 226 of these polymorphic gene models (40%) were perfectly correlated with individual SNPs, all of which were within or immediately proximal to the affected gene. The genetic architectures of the other 321 were more complex, with several examples of SNP epistasis that would have been difficult to predict a priori. We expect that many of the SNPs that affect computational gene structure reflect a biologically unrealistic sensitivity of the gene prediction algorithm to sequence changes, and we propose that genome annotation algorithms could be improved by minimizing their sensitivity to natural polymorphisms. However, many of the SNPs we identified are likely to affect transcript structure in vivo, and the synthetic association study approach can be easily generalized to any computed genome annotation to uncover relationships between genotype and important molecular phenotypes.	[Levin, Tera C.; Glazer, Andrew M.; Pachter, Lior; Brem, Rachel B.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Levin, TC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@berkeley.edu		Pachter, Lior/0000-0002-9164-6231; Glazer, Andrew/0000-0002-3938-4713; Levin, Tera/0000-0001-7883-8522; Eisen, Michael/0000-0002-7528-738X				Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chi KR, 2009, NATURE, V461, P712, DOI 10.1038/461712a; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; HERSBACH GJM, 1984, DRUGS PHARM SCI, V22, P45; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P179; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	18	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11645	10.1371/journal.pone.0011645	http://dx.doi.org/10.1371/journal.pone.0011645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686598	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000280520200001
J	Swindell, WR; Johnston, A; Gudjonsson, JE				Swindell, William R.; Johnston, Andrew; Gudjonsson, Johann E.			Transcriptional Profiles of Leukocyte Populations Provide a Tool for Interpreting Gene Expression Patterns Associated with High Fat Diet in Mice	PLOS ONE			English	Article							CHOLESTEROL ABSORPTION EFFICIENCY; ADIPOSE-TISSUE INFLAMMATION; INSULIN-RESISTANCE; INDUCED OBESITY; HEPATIC STEATOSIS; INBRED STRAINS; MACROPHAGE INFILTRATION; LY-6C(HI) MONOCYTES; CALORIC RESTRICTION; LIVER INFLAMMATION	Background: Microarray experiments in mice have shown that high fat diet can lead to elevated expression of genes that are disproportionately associated with immune functions. These effects of high fat (atherogenic) diet may be due to infiltration of tissues by leukocytes in coordination with inflammatory processes. Methodology/Principal Findings: The Novartis strain-diet-sex microarray database (GSE10493) was used to evaluate the hepatic effects of high fat diet (4 weeks) in 12 mouse strains and both genders. We develop and apply an algorithm that identifies "signature transcripts'' for many different leukocyte populations (e.g., T cells, B cells, macrophages) and uses this information to derive an in silico "inflammation profile''. Inflammation profiles highlighted monocytes, macrophages and dendritic cells as key drivers of gene expression patterns associated with high fat diet in liver. In some strains (e.g., NZB/BINJ, B6), we estimate that 50-60% of transcripts elevated by high fat diet might be due to hepatic infiltration by these cell types. Interestingly, DBA mice appeared to exhibit resistance to localized hepatic inflammation associated with atherogenic diet. A common characteristic of infiltrating cell populations was elevated expression of genes encoding components of the toll-like receptor signaling pathway (e.g., Irf5 and Myd88). Conclusions/Significance: High fat diet promotes infiltration of hepatic tissue by leukocytes, leading to elevated expression of immune-associated transcripts. The intensity of this effect is genetically controlled and sensitive to both strain and gender. The algorithm developed in this paper provides a framework for computational analysis of tissue remodeling processes and can be usefully applied to any in vivo setting in which inflammatory processes play a prominent role.	[Swindell, William R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Johnston, Andrew; Gudjonsson, Johann E.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA	Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Swindell, WR (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	wswindell@genetics.med.harvard.edu	Johnston, Andrew/I-7904-2014	Johnston, Andrew/0000-0002-1313-9402	National Institutes of Health (NIH) [T32-AR007197]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007197] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) grant T32-AR007197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Bigorgne AE, 2008, GASTROENTEROLOGY, V134, P1459, DOI 10.1053/j.gastro.2008.02.055; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Carter CP, 1997, J NUTR, V127, P1344, DOI 10.1093/jn/127.7.1344; Coenen KR, 2009, DIABETOLOGIA, V52, P318, DOI 10.1007/s00125-008-1221-7; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Desai MS, 2008, J LEUKOCYTE BIOL, V83, P1336, DOI 10.1189/jlb.0607390; Florez H, 2006, DIABETES RES CLIN PR, V71, P92, DOI 10.1016/j.diabres.2005.05.003; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Hageman RS, 2010, PHYSIOL GENOMICS, V42, P55, DOI 10.1152/physiolgenomics.00072.2009; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; KIRK EA, 1995, J LIPID RES, V36, P1522; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kreeft AJ, 2005, ATHEROSCLEROSIS, V182, P249, DOI 10.1016/j.atherosclerosis.2005.01.049; Lalor Patricia F, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004155; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lohmann C, 2009, ATHEROSCLEROSIS, V207, P360, DOI 10.1016/j.atherosclerosis.2009.05.004; Lundman P, 2007, NUTR METAB CARDIOVAS, V17, P195, DOI 10.1016/j.numecd.2005.11.009; McNeill E, 2010, CLIN SCI, V118, P641, DOI 10.1042/CS20090488; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Prieur X, 2010, BBA-MOL CELL BIOL L, V1801, P327, DOI 10.1016/j.bbalip.2009.09.017; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rull A, 2009, CYTOKINE, V48, P273, DOI 10.1016/j.cyto.2009.08.006; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; Stienstra R, 2007, ENDOCRINOLOGY, V148, P2753, DOI 10.1210/en.2007-0014; Stokes KY, 2003, CIRCULATION, V107, P2140, DOI 10.1161/01.CIR.0000062687.80186.A0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633; Tamura Y, 2010, J ATHEROSCLER THROMB, V17, P219, DOI 10.5551/jat.3368; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Wang DQH, 2001, J LIPID RES, V42, P1820; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zhu MZ, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-43	59	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11861	10.1371/journal.pone.0011861	http://dx.doi.org/10.1371/journal.pone.0011861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686622	Green Published, Green Submitted, gold			2022-12-25	WOS:000280520200025
J	Oner, SS; An, NF; Vural, A; Breton, B; Bouvier, M; Blumer, JB; Lanier, SM				Oner, Sukru Sadik; An, Ningfei; Vural, Ali; Breton, Billy; Bouvier, Michel; Blumer, Joe B.; Lanier, Stephen M.			Regulation of the AGS3 center dot G alpha(i) Signaling Complex by a Seven-transmembrane Span Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN BETA-GAMMA; GUANINE-NUCLEOTIDE EXCHANGE; ASYMMETRIC CELL DIVISIONS; RESONANCE ENERGY-TRANSFER; G-ALPHA-I; SPINDLE ORIENTATION; POINT MUTATION; GOLOCO MOTIF; GI-ALPHA; DISSOCIATION INHIBITOR	G-protein signaling modulators (GPSM) play diverse functional roles through their interaction with G-protein subunits. AGS3 (GPSM1) contains four G-protein regulatory motifs (GPR) that directly bind G alpha(i) free of G alpha gamma providing an unusual scaffold for the "G-switch" and signaling complexes, but the mechanism by which signals track into this scaffold are not well understood. We report the regulation of the AGS3 center dot G alpha(i) signaling module by a cell surface, seven-transmembrane receptor. AGS3 and G alpha(i1) tagged with Renilla luciferase or yellow fluorescent protein expressed in mammalian cells exhibited saturable, specific bioluminescence resonance energy transfer indicating complex formation in the cell. Activation of alpha(2)-adrenergic receptors or mu-opioid receptors reduced AGS3-RLuc center dot G alpha(i1)-YFP energy transfer by over 30%. The agonist- mediated effects were inhibited by pertussis toxin and co-expression of RGS4, but were not altered by G beta gamma sequestration with the carboxyl terminus of GRK2 center dot G alpha(i)-dependent and agonist-sensitive bioluminescence resonance energy transfer was also observed between AGS3 and cell-surface receptors typically coupled to G alpha(i) and/or G alpha(o) indicating that AGS3 is part of a larger signaling complex. Upon receptor activation, AGS3 reversibly dissociates from this complex at the cell cortex. Receptor coupling to both G alpha beta gamma and GPR center dot G alpha(i) offer additional flexibility for systems to respond and adapt to challenges and orchestrate complex behaviors.	[Oner, Sukru Sadik; An, Ningfei; Vural, Ali; Blumer, Joe B.; Lanier, Stephen M.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Breton, Billy; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	Medical University of South Carolina; Universite de Montreal	Lanier, SM (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Colcock Hall,179 Ashley Ave, Charleston, SC 29425 USA.	lanier@musc.edu	Bouvier, Michel/H-2758-2014; Oner, Sukru/K-8032-2012	Bouvier, Michel/0000-0003-1128-0100; Oner, Sukru/0000-0002-8864-7356; Lanier, Stephen/0000-0002-2740-7607; Blumer, Joe/0000-0002-0020-3815	National Institutes of Health [NS24821, DA025896, GM086510]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS24821 (to S. M. L.), DA025896 (to S. M. L.), GM086510 (to J. B. B.) and a grant from the Canadian Institutes of Health Research (to M. B.).	Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2002, CURR BIOL, V12, P1928, DOI 10.1016/S0960-9822(02)01298-8; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Fan PD, 2009, MOL PHARMACOL, V76, P526, DOI 10.1124/mol.109.057802; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Groves B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008877; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; JAHANGEER S, 1993, P NATL ACAD SCI USA, V90, P8782, DOI 10.1073/pnas.90.19.8782; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Ma HZ, 2003, BIOCHEMISTRY-US, V42, P8085, DOI 10.1021/bi034561p; Nadella R, 2010, J AM SOC NEPHROL, V21, P1275, DOI 10.1681/ASN.2009121224; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schaefer M, 2001, EXP CELL RES, V271, P66, DOI 10.1006/excr.2001.5371; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Vural A, 2010, MOL CELL BIOL, V30, P1528, DOI 10.1128/MCB.01018-09; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	73	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33949	33958		10.1074/jbc.M110.138073	http://dx.doi.org/10.1074/jbc.M110.138073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20716524	Green Published, hybrid			2022-12-25	WOS:000283354000042
J	Summermatter, S; Baum, O; Santos, G; Hoppeler, H; Handschin, C				Summermatter, Serge; Baum, Oliver; Santos, Gesa; Hoppeler, Hans; Handschin, Christoph			Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha (PGC-1 alpha) Promotes Skeletal Muscle Lipid Refueling in Vivo by Activating de Novo Lipogenesis and the Pentose Phosphate Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; INSULIN SENSITIVITY; MITOCHONDRIAL-FUNCTION; GLUCOSE-TOLERANCE; CHRONIC DISEASE; ADIPOSE-TISSUE; EXERCISE; RESISTANCE; HUMANS; PGC-1	Exercise induces a pleiotropic adaptive response in skeletal muscle, largely through peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha). PGC-1 alpha enhances lipid oxidation and thereby provides energy for sustained muscle contraction. Its potential implication in promoting muscle refueling remains unresolved, however. Here, we investigated a possible role of elevated PGC-1 alpha levels in skeletal muscle lipogenesis in vivo and the molecular mechanisms that underlie PGC-1 alpha-mediated de novo lipogenesis. To this end, we studied transgenic mice with physiological overexpression of PGC-1 alpha and human muscle biopsies pre-and post-exercise. We demonstrate that PGC-1 alpha enhances lipogenesis in skeletal muscle through liver X receptor alpha-dependent activation of the fatty acid synthase (FAS) promoter and by increasing FAS activity. Using chromatin immunoprecipitation, we establish a direct interaction between PGC-1 alpha and the liver X receptor-responsive element in the FAS promoter. Moreover, we show for the first time that increased glucose uptake and activation of the pentose phosphate pathway provide substrates for RNA synthesis and cofactors for de novo lipogenesis. Similarly, we observed increased lipogenesis and lipid levels in human muscle biopsies that were obtained post-exercise. Our findings suggest that PGC-1 alpha coordinates lipogenesis, intramyocellular lipid accumulation, and substrate oxidation in exercised skeletal muscle in vivo.	[Summermatter, Serge; Santos, Gesa; Handschin, Christoph] Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland; [Summermatter, Serge; Handschin, Christoph] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Summermatter, Serge; Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8057 Zurich, Switzerland; [Baum, Oliver; Hoppeler, Hans] Univ Bern, Inst Anat, CH-3009 Bern, Switzerland	University of Basel; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Bern	Handschin, C (corresponding author), Univ Basel, Div Pharmacol Neurobiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	christoph.handschin@unibas.ch	Handschin, Christoph/E-6886-2015; Baum, Oliver/E-6367-2012	Handschin, Christoph/0000-0003-0603-1097; Baum, Oliver/0000-0001-5706-0942; Summermatter, Serge/0000-0003-4870-0148	Swiss National Science Foundation [SNF PP00A-110746]; Muscular Dystrophy Association; SwissLife "Jubilaumsstiftung fur Volksgesundheit und Medizinische Forschung"; Swiss Society for Research on Muscle Diseases; Swiss Diabetes Association; Roche Research Foundation; United Mitochondrial Disease Foundation; Association Francaise contre les Myopathies; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Muscular Dystrophy Association(Muscular Dystrophy Association); SwissLife "Jubilaumsstiftung fur Volksgesundheit und Medizinische Forschung"; Swiss Society for Research on Muscle Diseases; Swiss Diabetes Association; Roche Research Foundation; United Mitochondrial Disease Foundation; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); University of Basel	This work was supported by Swiss National Science Foundation Grant SNF PP00A-110746, the Muscular Dystrophy Association, the SwissLife "Jubilaumsstiftung fur Volksgesundheit und Medizinische Forschung," the Swiss Society for Research on Muscle Diseases, the Swiss Diabetes Association, the Roche Research Foundation, the United Mitochondrial Disease Foundation, the Association Francaise contre les Myopathies, and the University of Basel.	Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bergman BC, 2010, J APPL PHYSIOL, V108, P1134, DOI 10.1152/japplphysiol.00684.2009; BERK PD, 1990, P NATL ACAD SCI USA, V87, P3484, DOI 10.1073/pnas.87.9.3484; Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Booth FW, 2008, EUR J APPL PHYSIOL, V102, P381, DOI 10.1007/s00421-007-0606-5; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chen SY, 2006, INT J OBESITY, V30, P40, DOI 10.1038/sj.ijo.0803073; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Espinoza DO, 2010, FASEB J, V24, P1003, DOI 10.1096/fj.09-133728; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; FUNGWE TV, 1994, J LIPID RES, V35, P311; Geiser J, 2001, INT J SPORTS MED, V22, P579, DOI 10.1055/s-2001-18521; GLAZER RI, 1971, J NEUROCHEM, V18, P1569, DOI 10.1111/j.1471-4159.1971.tb00018.x; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Goodyear LJ, 2008, NEW ENGL J MED, V359, P1842, DOI 10.1056/NEJMcibr0806723; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu TC, 2008, J SPORT SCI, V26, P919, DOI 10.1080/02640410801885925; Morifuji M, 2005, NUTRITION, V21, P1052, DOI 10.1016/j.nut.2005.01.010; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Ninfali P, 1997, BRAIN RES PROTOC, V1, P357, DOI 10.1016/S1385-299X(97)00011-1; PENICAUD L, 1991, BIOCHEM J, V279, P303, DOI 10.1042/bj2790303; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; RANDLE PJ, 1963, LANCET, V1, P785; Richter EA, 2008, CELL METAB, V8, P96, DOI 10.1016/j.cmet.2008.07.004; Rico-Sanz J, 2000, LIPIDS, V35, P1313, DOI 10.1007/s11745-000-0647-2; Rimbert V, 2009, FEBS LETT, V583, P2927, DOI 10.1016/j.febslet.2009.07.059; ROGERS MA, 1990, J APPL PHYSIOL, V68, P1833, DOI 10.1152/jappl.1990.68.5.1833; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Russell AP, 2004, INT J OBESITY, V28, pS66, DOI 10.1038/sj.ijo.0802859; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413; Stellingwerff T, 2007, AM J PHYSIOL-ENDOC M, V292, pE1715, DOI 10.1152/ajpendo.00678.2006; Sugden MC, 2007, BRIT J NUTR, V97, P809, DOI 10.1017/S0007114507659054; van Loon LJC, 2004, AM J PHYSIOL-ENDOC M, V287, pE558, DOI 10.1152/ajpendo.00464.2003; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	47	85	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32793	32800		10.1074/jbc.M110.145995	http://dx.doi.org/10.1074/jbc.M110.145995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20716531	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000283048200015
J	Xicohtencatl-Cortes, J; Saldana, Z; Deng, WY; Castaneda, E; Freer, E; Tarr, PI; Finlay, BB; Puente, JL; Giron, JA				Xicohtencatl-Cortes, Juan; Saldana, Zeus; Deng, Wanyin; Castaneda, Elsa; Freer, Enrique; Tarr, Phil I.; Finlay, B. Brett; Luis Puente, Jose; Giron, Jorge A.			Bacterial Macroscopic Rope-like Fibers with Cytopathic and Adhesive Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; III SECRETION SYSTEMS; EPITHELIAL-CELLS; SERINE-PROTEASE; AMYLOID FIBRILS; THIOFLAVINE-T; EXTRACELLULAR PROTEINS; PATHOGENICITY ISLAND; ESPC; ADHERENCE	We present a body of ultrastructural, biochemical, and genetic evidence that demonstrates the oligomerization of virulence-associated autotransporter proteins EspC or EspP produced by deadly human pathogens enterohemorrhagic and enteropathogenic Escherichia coli into novel macroscopic rope-like structures (> 1 cm long). The rope-like structures showed high aggregation and insolubility, stability to anionic detergents and high temperature, and binding to Congo Red and thioflavin T dyes. These are properties also exhibited by human amyloidogenic proteins. These macroscopic ropes were not observed in cultures of nonpathogenic Escherichia coli or isogenic espP or espC deletion mutants of enterohemorrhagic or enteropathogenic Escherichia coli but were produced by an Escherichia coli K-12 strain carrying a plasmid expressing espP. Purified recombinant EspP monomers were able to self-assemble into macroscopic ropes upon incubation, suggesting that no other protein was required for assembly. The ropes bound to and showed cytopathic effects on cultured epithelial cells, served as a substratum for bacterial adherence and biofilm formation, and protected bacteria from antimicrobial compounds. We hypothesize that these ropes play a biologically significant role in the survival and pathogenic scheme of these organisms.	[Giron, Jorge A.] Univ Florida, Dept Mol Genet & Microbiol, Emerging Pathogens Inst, Gainesville, FL 32610 USA; Hosp Infantil Mexico Dr Federico Gomez, Lab Bacteriol Intestinal, Mexico City 06720, DF, Mexico; [Deng, Wanyin; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Castaneda, Elsa] Benemerita Univ Autonoma Puebla, Ctr Invest Ciencias Microbiol, Puebla 72000, Mexico; [Freer, Enrique] Univ Costa Rica, Ctr Invest Estruct Microscop, San Jose, Costa Rica; Washington Univ, Dept Pediat, St Louis, MO 63105 USA; [Luis Puente, Jose] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62210, Morelos, Mexico	State University System of Florida; University of Florida; Hospital Infantil de Mexico Federico Gomez; University of British Columbia; Benemerita Universidad Autonoma de Puebla; Universidad Costa Rica; Washington University (WUSTL); Universidad Nacional Autonoma de Mexico	Giron, JA (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Emerging Pathogens Inst, 1600 SW Archer Rd,POB 100266, Gainesville, FL 32610 USA.	jagiron@ufl.edu	Saldana, Zeus/GLR-4422-2022; Xicohtencatl-Cortes, Juan/ABD-5463-2020	Saldana, Zeus/0000-0002-2710-2846; Puente, Jose/0000-0002-8411-4974	National Institutes of Health [AI66012, AI63211]; DGAPA [IN201703-3]; CONACyT [42918Q]; Canadian Institutes of Health Research; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063211, R01AI066012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DGAPA; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI66012 and AI63211 (to J. A. G.). This work was also supported by DGAPA Grant IN201703-3 and CONACyT Grant 42918Q (to J. L. P.) and grants from Canadian Institutes of Health Research and Howard Hughes Medical Institute to BBF.	Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Djafari S, 1997, MOL MICROBIOL, V25, P771, DOI 10.1046/j.1365-2958.1997.5141874.x; Drago-Serrano ME, 2006, FEMS MICROBIOL LETT, V265, P35, DOI 10.1111/j.1574-6968.2006.00463.x; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Dziva F, 2007, FEMS MICROBIOL LETT, V271, P258, DOI 10.1111/j.1574-6968.2007.00724.x; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; Giron JA, 2005, COLONIZATION OF MUCOSAL SURFACES, P213; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Guyer DM, 2002, INFECT IMMUN, V70, P4539, DOI 10.1128/IAI.70.8.4539-4546.2002; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Low AS, 2006, INFECT IMMUN, V74, P2233, DOI 10.1128/IAI.74.4.2233-2244.2006; Mellies JL, 2001, INFECT IMMUN, V69, P315, DOI 10.1128/IAI.69.1.315-324.2001; MENDELSON NH, 1982, J BACTERIOL, V151, P438, DOI 10.1128/JB.151.1.438-449.1982; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; NAIKI H, 1990, LAB INVEST, V62, P768; NAIKI H, 1991, LAB INVEST, V65, P104; Navarro-Garcia F, 2004, INFECT IMMUN, V72, P3609, DOI 10.1128/IAI.72.6.3609-3621.2004; Ogino T, 2006, J BACTERIOL, V188, P2801, DOI 10.1128/JB.188.8.2801-2811.2006; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Puttamreddy S, 2010, INFECT IMMUN, V78, P2377, DOI 10.1128/IAI.00156-10; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Roberts PH, 2001, J MICROBIOL METH, V43, P171, DOI 10.1016/S0167-7012(00)00222-0; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Salinger N, 2009, APPL ENVIRON MICROB, V75, P275, DOI 10.1128/AEM.01734-08; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; Vidal JE, 2006, INFECT IMMUN, V74, P2293, DOI 10.1128/IAI.74.4.2293-2303.2006; Vidal JE, 2008, CELL MICROBIOL, V10, P1975, DOI 10.1111/j.1462-5822.2008.01181.x; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727	43	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32336	32342		10.1074/jbc.M110.162248	http://dx.doi.org/10.1074/jbc.M110.162248			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688909	Green Published, hybrid			2022-12-25	WOS:000282683000046
J	Kreisler, A; Strissel, PL; Strick, R; Neumann, SB; Schumacher, U; Becker, CM				Kreisler, A.; Strissel, P. L.; Strick, R.; Neumann, S. B.; Schumacher, U.; Becker, C-M			Regulation of the NRSF/REST gene by methylation and CREB affects the cellular phenotype of small-cell lung cancer	ONCOGENE			English	Article						NRSF/REST; CREB; AKT2; small-cell lung cancer; methylation	RESTRICTIVE SILENCER FACTOR; GLYCINE RECEPTOR; FIBRONECTIN GENE; CYCLIC-AMP; EXPRESSION; TRANSCRIPTION; REST; REPRESSOR; DIFFERENTIATION; CARCINOMA	The neuron-restrictive silencer factor/RE1-silencing transcription factor (NRSF/REST) is a negative regulator of gene expression restricting the expression of neuronal genes to the nervous system. NRSF/REST is highly expressed in non-neuronal tissues like the lung. In previous work, we identified small-cell lung cancer (SCLC) cell lines with no detectable NRSF/REST expression that, as a consequence, expressed neuronal markers like L1-cell adhesion molecule (L1-CAM) and neural cell adhesion molecule (NCAM). The loss of NRSF/REST expression was linked to malignant progression; however, its mechanistic role remained elusive. Here, we show that NRSF/REST itself, rather than one of its regulated genes, acts like a classic tumour suppressor, being in part regulated by methylation. In SCLCs, NRSF/REST is positively regulated by CREB, with an NRSF/REST promoter fragment showing cell type specificity. Downstream, NRSF/REST directly regulates AKT2, in which NRSF/REST loss leads to an epidermal growth factor-mediated de-regulation of AKT-Serine473 phosphorylation, important for cellular proliferation and survival. Assaying anchorage-independent growth, we observed that with reduced NRSF/REST expression, proliferation was significantly enhanced, whereas NRSF/REST rescue decreased the potential of cells to grow anchorage independently. Our observations support the fact that NRSF/REST may act as an important modulator of malignant progression in SCLC. Oncogene (2010) 29, 5828-5838; doi: 10.1038/onc.2010.321; published online 9 August 2010	[Strissel, P. L.; Strick, R.; Neumann, S. B.] Univ Klinikum Erlangen, Mol Med Lab, Frauenklin, D-91054 Erlangen, Germany; [Kreisler, A.; Becker, C-M] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Zentrum, Erlangen, Germany; [Schumacher, U.] Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Anat 2, Hamburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Strissel, PL (corresponding author), Univ Klinikum Erlangen, Mol Med Lab, Frauenklin, Univ Str 21-23, D-91054 Erlangen, Germany.	pamela.strissel@uk-erlangen.de	Wang, Weili/D-1546-2011		Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of University of Erlangen-Nurnberg; Johannes und Frieda Marohn-Stiftung	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of University of Erlangen-Nurnberg; Johannes und Frieda Marohn-Stiftung	We thank Barbara Orlicz-Welcz, Rosa Weber, Florentine Koppitz, Sonja Oeser and Eli Stiegler for dedicated technical assistance and the group of Michael Wegner for their help with the luciferase assays. We thank Magnus von Knebel-Doeberitz from the University of Heidelberg for the NRSF/REST expression vector pcNRSFwt. This project was supported by a grant from the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of University of Erlangen-Nurnberg to CM Becker and PL Strissel and a grant from the Johannes und Frieda Marohn-Stiftung.	Anbazhagan R, 1999, CANCER RES, V59, P5119; Arboleda MJ, 2003, CANCER RES, V63, P196; BARCO A, 2006, ROLE CREB CBP BRAIN; BOWLUS CL, 1991, J BIOL CHEM, V266, P1122; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; CARNEY DN, 1985, CANCER RES, V45, P2913; Chong S, 2006, RADIOGRAPHICS, V26, P41, DOI 10.1148/rg.261055057; Ciombor Kristen Keon, 2006, Curr Treat Options Oncol, V7, P59, DOI 10.1007/s11864-006-0032-7; Coulson JM, 2005, CURR BIOL, V15, pR665, DOI 10.1016/j.cub.2005.08.032; Coulson JM, 2000, CANCER RES, V60, P1840; Ekici M, 2008, J BIOL CHEM, V283, P9257, DOI 10.1074/jbc.M709388200; FERGUSON AT, 1995, CANCER RES, V55, P2279; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; Fuller GN, 2005, MOL CANCER THER, V4, P343; GAZDAR AF, 1980, CANCER RES, V40, P3502; GRIFFIN CA, 1985, CANCER RES, V45, P272; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Gurrola-Diaz C, 2003, ONCOGENE, V22, P5636, DOI 10.1038/sj.onc.1206790; Kitamura H, 2009, ENDOCR PATHOL, V20, P101, DOI 10.1007/s12022-009-9072-4; Koenigsberger C, 2000, P NATL ACAD SCI USA, V97, P2291, DOI 10.1073/pnas.050578797; Kojima T, 2001, MOL BRAIN RES, V90, P174, DOI 10.1016/S0169-328X(01)00107-3; Laufs TL, 2004, NEUROSCI LETT, V362, P83, DOI 10.1016/j.neulet.2004.02.072; Lee BH, 1998, EXP MOL MED, V30, P240, DOI 10.1038/emm.1998.35; Lenz B, 2006, EXP CELL RES, V312, P4049, DOI 10.1016/j.yexcr.2006.09.004; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; MABRY M, 1988, P NATL ACAD SCI USA, V85, P6523, DOI 10.1073/pnas.85.17.6523; Magin A, 2002, NEUROCHEM INT, V40, P195, DOI 10.1016/S0197-0186(01)00091-2; Moss AC, 2009, CLIN CANCER RES, V15, P274, DOI 10.1158/1078-0432.CCR-08-1163; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Onganer PU, 2005, BRIT J CANCER, V93, P1197, DOI 10.1038/sj.bjc.6602857; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Pio R, 2009, J THORAC ONCOL, V4, P674, DOI 10.1097/JTO.0b013e3181a520dc; Rasband W., 2006, IMAGEJ; Reddy BY, 2009, P NATL ACAD SCI USA, V106, P4408, DOI 10.1073/pnas.0809130106; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schug J, 2003, CURRENT PROTOCOLS BI; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Smith B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S15; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Strissel PL, 2008, INT J CANCER, V123, P2871, DOI 10.1002/ijc.23900; Strissel PL, 2000, HUM MOL GENET, V9, P1671, DOI 10.1093/hmg/9.11.1671; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P20; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Zimmermann S, 1997, CANCER IMMUNOL IMMUN, V44, P1, DOI 10.1007/s002620050348	54	55	57	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2010	29	43					5828	5838		10.1038/onc.2010.321	http://dx.doi.org/10.1038/onc.2010.321			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	672LY	20697351				2022-12-25	WOS:000283586200008
J	Adiba, S; Nizak, C; van Baalen, M; Denamur, E; Depaulis, F				Adiba, Sandrine; Nizak, Clement; van Baalen, Minus; Denamur, Erick; Depaulis, Frantz			From Grazing Resistance to Pathogenesis: The Coincidental Evolution of Virulence Factors	PLOS ONE			English	Article							HIGH-PATHOGENICITY ISLAND; ESCHERICHIA-COLI; ENTAMOEBA-HISTOLYTICA; HOST MODEL; DICTYOSTELIUM-DISCOIDEUM; ACANTHAMOEBA-POLYPHAGA; LEGIONELLA-PNEUMOPHILA; DIFFERENTIAL DETECTION; BACTERIAL PATHOGENS; PHYLOGENETIC GROUP	To many pathogenic bacteria, human hosts are an evolutionary dead end. This begs the question what evolutionary forces have shaped their virulence traits. Why are these bacteria so virulent? The coincidental evolution hypothesis suggests that such virulence factors result from adaptation to other ecological niches. In particular, virulence traits in bacteria might result from selective pressure exerted by protozoan predator. Thus, grazing resistance may be an evolutionarily exaptation for bacterial pathogenicity. This hypothesis was tested by subjecting a well characterized collection of 31 Escherichia coli strains (human commensal or extra-intestinal pathogenic) to grazing by the social haploid amoeba Dictyostelium discoideum. We then assessed how resistance to grazing correlates with some bacterial traits, such as the presence of virulence genes. Whatever the relative population size (bacteria/amoeba) for a non-pathogenic bacteria strain, D. discoideum was able to phagocytise, digest and grow. In contrast, a pathogenic bacterium strain killed D. discoideum above a certain bacteria/amoeba population size. A plating assay was then carried out using the E. coli collection faced to the grazing of D. discoideum. E. coli strains carrying virulence genes such as iroN, irp2, fyuA involved in iron uptake, belonging to the B2 phylogenetic group and being virulent in a mouse model of septicaemia were resistant to the grazing from D. discoideum. Experimental proof of the key role of the irp gene in the grazing resistance was evidenced with a mutant strain lacking this gene. Such determinant of virulence may well be originally selected and (or) further maintained for their role in natural habitat: resistance to digestion by free-living protozoa, rather than for virulence per se.	[Adiba, Sandrine; van Baalen, Minus] Univ Paris, CNRS, Ecol Lab, Univ Paris 06,UMR7625, Paris, France; [Nizak, Clement] CNRS, Spectrometrie Phys Lab, UMR5588, Grenoble, France; [Denamur, Erick] Univ Paris Diderot, Paris, France; [Denamur, Erick] INSERM, U722, Paris, France; [Adiba, Sandrine; van Baalen, Minus; Depaulis, Frantz] Ecole Normale Super, CNRS, Ecol Lab, UMR7625, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Adiba, S (corresponding author), Univ Paris, CNRS, Ecol Lab, Univ Paris 06,UMR7625, Paris, France.	sadiba@snv.jussieu.fr	Nizak, Clement/HGV-1085-2022; van Baalen, Minus/J-9285-2012; Nizak, Clement/L-1334-2013	Nizak, Clement/0000-0002-4591-8240; Nizak, Clement/0000-0002-4591-8240; Depaulis, Frantz/0000-0001-5761-2751; ADIBA, SANDRINE/0000-0003-4308-2870; van Baalen, Minus/0000-0002-3713-5967	Fondation pour la Recherche Medicale; ANR Biodiversity	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR Biodiversity(French National Research Agency (ANR))	E. D. was partially supported by the Fondation pour la Recherche Medicale and F. D. by the ANR Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2005, AM NAT, V165, pE155, DOI 10.1086/430053; ANDERSON RM, 1982, POPULATION BIOL INFE; Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1111/j.1574-6968.1999.tb13516.x; BARKER J, 1994, MICROBIOL-UK, V140, P1253, DOI 10.1099/00221287-140-6-1253; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Brown MRW, 1999, TRENDS MICROBIOL, V7, P46, DOI 10.1016/S0966-842X(98)01425-5; BRYANT RJ, 1982, APPL ENVIRON MICROB, V43, P747, DOI 10.1128/AEM.43.4.747-752.1982; BURNS D, 2000, INFECT IMMUN, V68, P2939; Cardelli J, 2001, TRAFFIC, V2, P311, DOI 10.1034/j.1600-0854.2001.002005311.x; Carniel E, 2001, MICROBES INFECT, V3, P561, DOI 10.1016/S1286-4579(01)01412-5; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; CLARHOLM M, 1981, MICROBIAL ECOL, V7, P343, DOI 10.1007/BF02341429; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002; DESJARDINS P, 1995, J MOL EVOL, V41, P440, DOI 10.1007/BF00160315; Diard M, 2007, MICROBES INFECT, V9, P214, DOI 10.1016/j.micinf.2006.11.009; Doherty CP, 2007, J NUTR, V137, P1341, DOI 10.1093/jn/137.5.1341; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; FAUST MA, 1976, WATER RES, V10, P619, DOI 10.1016/0043-1354(76)90143-3; Fotedar R, 2007, J CLIN MICROBIOL, V45, P1035, DOI 10.1128/JCM.02144-06; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Froquet R, 2007, APPL ENVIRON MICROB, V73, P5657, DOI 10.1128/AEM.00908-07; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; HABTE M, 1977, ARCH MICROBIOL, V113, P181, DOI 10.1007/BF00492022; Hamzah Z, 2006, J CLIN MICROBIOL, V44, P3196, DOI 10.1128/JCM.00778-06; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Jung SY, 2007, INT J PARASITOL, V37, P417, DOI 10.1016/j.ijpara.2006.10.012; Kim KJ, 2003, CELL MICROBIOL, V5, P245, DOI 10.1046/j.1462-5822.2003.t01-1-00271.x; KING CH, 1988, APPL ENVIRON MICROB, V54, P3023, DOI 10.1128/AEM.54.12.3023-3033.1988; Latunde-Dada GO, 2009, BIOESSAYS, V31, P1309, DOI 10.1002/bies.200900101; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; LEVIN BR, 1990, PARASITOLOGY, V100, pS103, DOI 10.1017/S0031182000073054; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Noegel AA, 2000, J CELL SCI, V113, P759; Orsi N, 2004, BIOMETALS, V17, P189, DOI 10.1023/B:BIOM.0000027691.86757.e2; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Power ML, 2005, ENVIRON MICROBIOL, V7, P631, DOI 10.1111/j.1462-2920.2005.00729.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; RIVERA F, 1986, ENVIRON RES, V39, P364, DOI 10.1016/S0013-9351(86)80062-7; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Rupper A, 2001, BBA-GEN SUBJECTS, V1525, P205, DOI 10.1016/S0304-4165(01)00106-4; Schubert S, 2002, INFECT IMMUN, V70, P5335, DOI 10.1128/IAI.70.9.5335-5337.2002; SMITH HW, 1965, J PATHOL BACTERIOL, V89, P95, DOI 10.1002/path.1700890112; Solo-Gabriele HM, 2000, APPL ENVIRON MICROB, V66, P230, DOI 10.1128/AEM.66.1.230-237.2000; Solomon JM, 2000, TRENDS MICROBIOL, V8, P478, DOI 10.1016/S0966-842X(00)01852-7; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Steinert M, 2000, NATURWISSENSCHAFTEN, V87, P1, DOI 10.1007/s001140050001; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Troll H, 1997, J CLIN MICROBIOL, V35, P1701, DOI 10.1128/JCM.35.7.1701-1705.1997; van Baalen M, 2001, OIKOS, V95, P211, DOI 10.1034/j.1600-0706.2001.950203.x; VANDONSEL DJ, 1971, WATER RES, V5, P1079, DOI 10.1016/0043-1354(71)90040-6; VANDONSEL DJ, 1967, APPL MICROBIOL, V15, P1362, DOI 10.1128/AEM.15.6.1362-1370.1967; WEEKERS PHH, 1993, APPL ENVIRON MICROB, V59, P2317, DOI 10.1128/AEM.59.7.2317-2319.1993; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101	74	80	82	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e11882	10.1371/journal.pone.0011882	http://dx.doi.org/10.1371/journal.pone.0011882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711443	Green Published, gold			2022-12-25	WOS:000280849100001
J	Catterson, JH; Knowles-Barley, S; James, K; Heck, MMS; Harmar, AJ; Hartley, PS				Catterson, James H.; Knowles-Barley, Seymour; James, Katherine; Heck, Margarete M. S.; Harmar, Anthony J.; Hartley, Paul S.			Dietary Modulation of Drosophila Sleep-Wake Behaviour	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; AMINO-ACIDS; LIFE-SPAN; MELANOGASTER; DOPAMINE; AROUSAL; GENES; DEPRIVATION; MAINTENANCE	Background: A complex relationship exists between diet and sleep but despite its impact on human health, this relationship remains uncharacterized and poorly understood. Drosophila melanogaster is an important model for the study of metabolism and behaviour, however the effect of diet upon Drosophila sleep remains largely unaddressed. Methodology/Principal Findings: Using automated behavioural monitoring, a capillary feeding assay and pharmacological treatments, we examined the effect of dietary yeast and sucrose upon Drosophila sleep-wake behaviour for three consecutive days. We found that dietary yeast deconsolidated the sleep-wake behaviour of flies by promoting arousal from sleep in males and shortening periods of locomotor activity in females. We also demonstrate that arousal from nocturnal sleep exhibits a significant ultradian rhythmicity with a periodicity of 85 minutes. Increasing the dietary sucrose concentration from 5% to 35% had no effect on total sucrose ingestion per day nor any affect on arousal, however it did lengthen the time that males and females remained active. Higher dietary sucrose led to reduced total sleep by male but not female flies. Locomotor activity was reduced by feeding flies Metformin, a drug that inhibits oxidative phosphorylation, however Metformin did not affect any aspects of sleep. Conclusions: We conclude that arousal from sleep is under ultradian control and regulated in a sex-dependent manner by dietary yeast and that dietary sucrose regulates the length of time that flies sustain periods of wakefulness. These findings highlight Drosophila as an important model with which to understand how diet impacts upon sleep and wakefulness in mammals and humans.	[Catterson, James H.; James, Katherine; Heck, Margarete M. S.; Harmar, Anthony J.; Hartley, Paul S.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Knowles-Barley, Seymour] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Catterson, JH (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	P.S.Hartley@ed.ac.uk		Hartley, Paul/0000-0003-2782-0490; Catterson, James/0000-0003-4231-0114; Harmar, Anthony/0000-0002-3838-9264	Medical Research Council [G9719726]; British Heart Foundation; Tuberous Sclerosis Association; Wellcome Trust; MRC [G9719726] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Tuberous Sclerosis Association; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council program grant (G9719726) awarded to AJH; the British Heart Foundation and the Tuberous Sclerosis Association support PSH, JHC and KJ. MH is supported by a Wellcome Trust University Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaghi A, 2007, AM J CLIN NUTR, V85, P426, DOI 10.1093/ajcn/85.2.426; Afaghi A, 2008, NUTR NEUROSCI, V11, P146, DOI 10.1179/147683008X301540; Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; CONNOLLY KJ, 1966, NATURE, V209, P224, DOI 10.1038/209224a0; CROCKER A, NEURON, V65, P670; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; DOWSE HB, 1989, BEHAV GENET, V19, P529, DOI 10.1007/BF01066252; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; ERIKSSON E, 1980, J NEURAL TRANSM, V48, P305, DOI 10.1007/BF01250665; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gruntenko NE, 2005, J INSECT PHYSIOL, V51, P959, DOI 10.1016/j.jinsphys.2005.04.010; Harbison ST, 2008, GENETICS, V178, P2341, DOI 10.1534/genetics.107.081232; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; HARDELAND R, 1971, AM NAT, V105, P198, DOI 10.1086/282717; Hazel MH, 2003, J EXP BIOL, V206, P79, DOI 10.1242/jeb.00058; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hitze B, 2009, EUR J CLIN NUTR, V63, P739, DOI 10.1038/ejcn.2008.41; ISHIMOTO H, GENETICS; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Power JM, 1995, J BIOL RHYTHM, V10, P267, DOI 10.1177/074873049501000309; REFINETTI R, 1993, PHYSIOL BEHAV, V54, P869, DOI 10.1016/0031-9384(93)90294-P; Rontoyanni VG, 2007, NUTRITION, V23, P773, DOI 10.1016/j.nut.2007.07.005; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; ShannahoffKhalsa DS, 1996, AM J PHYSIOL-REG I, V270, pR873, DOI 10.1152/ajpregu.1996.270.4.R873; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Tuomilehto H, 2009, DIABETES CARE, V32, P1965, DOI 10.2337/dc08-1980; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; WU X, 2008, BONE; Wurtman RJ, 2003, AM J CLIN NUTR, V77, P128, DOI 10.1093/ajcn/77.1.128; WURTMAN RJ, 1975, AM J CLIN NUTR, V28, P638, DOI 10.1093/ajcn/28.6.638; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	50	54	55	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12062	10.1371/journal.pone.0012062	http://dx.doi.org/10.1371/journal.pone.0012062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706579	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000280811900018
J	Bernal-Mizrachi, E; Cras-Meneur, C; Ye, BR; Johnson, JD; Permutt, MA				Bernal-Mizrachi, Ernesto; Cras-Meneur, Corentin; Ye, Bo Ra; Johnson, James D.; Permutt, M. Alan			Transgenic Overexpression of Active Calcineurin in beta-Cells Results in Decreased beta-Cell Mass and Hyperglycemia	PLOS ONE			English	Article							STIMULATED INSULIN-RELEASE; HUMAN PANCREATIC-ISLETS; KINESIN HEAVY-CHAIN; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; CHRONIC EXPOSURE; GENE-EXPRESSION; GLUCOSE; APOPTOSIS; TRANSCRIPTION	Background: Glucose modulates beta-cell mass and function through an initial depolarization and Ca2+ influx, which then triggers a number of growth regulating signaling pathways. One of the most important downstream effectors in Ca2+ signaling is the calcium/Calmodulin activated serine threonine phosphatase, calcineurin. Recent evidence suggests that calcineurin/NFAT is essential for beta-cell proliferation, and that in its absence loss of beta-cells results in diabetes. We hypothesized that in contrast, activation of calcineurin might result in expansion of beta-cell mass and resistance to diabetes. Methodology/Principal Findings: To determine the role of activation of calcineurin signaling in the regulation of pancreatic beta-cell mass and proliferation, we created mice that expressed a constitutively active form of calcineurin under the insulin gene promoter (caCn(RIP)). To our surprise, these mice exhibited glucose intolerance. In vitro studies demonstrated that while the second phase of Insulin secretion is enhanced, the overall insulin secretory response was conserved. Islet morphometric studies demonstrated decreased beta-cell mass suggesting that this was a major component responsible for altered Insulin secretion and glucose intolerance in caCn(RIP) mice. The reduced beta-cell mass was accompanied by decreased proliferation and enhanced apoptosis. Conclusions: Our studies identify calcineurin as an important factor in controlling glucose homeostasis and indicate that chronic depolarization leading to increased calcineurin activity may contribute, along with other genetic and environmental factors, to beta-cell dysfunction and diabetes.	[Bernal-Mizrachi, Ernesto; Cras-Meneur, Corentin; Ye, Bo Ra] Univ Michigan, Div Metab, Brehm Ctr Type Diabet 1, Ann Arbor, MI 48109 USA; [Johnson, James D.] Univ British Columbia, Dept Surg, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1W5, Canada; [Permutt, M. Alan] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO USA	University of Michigan System; University of Michigan; University of British Columbia; Washington University (WUSTL)	Bernal-Mizrachi, E (corresponding author), Univ Michigan, Div Metab, Brehm Ctr Type Diabet 1, Ann Arbor, MI 48109 USA.	ebernal@umich.edu	Cras-Méneur, Corentin/A-2628-2008; Cras-Meneur, Corentin/K-7728-2019	Cras-Méneur, Corentin/0000-0001-8921-8927; Cras-Meneur, Corentin/0000-0001-8921-8927; Johnson, James/0000-0002-7523-9433	National Institutes of Health [R01DK073716-01, R37DK16746, P60-DK020579-31]; American Diabetes Association; Juvenile Diabetes Research Foundation; Canadian Institutes for Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK016746, R37DK016746, P60DK020579, R01DK084236, R01DK073716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01DK073716-01 (E. B. M.), R37DK16746 (M. A. P.) and a Career Development Award from the American Diabetes Association (E. B. M.). J.D.J is supported by grants from the Juvenile Diabetes Research Foundation and the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the support of the Radioimmunoassay, Mouse Genetic core and beta-cell Morphology Cores of The Washington University Diabetes Research & Training Center (NIH grant P60-DK020579-31). We also thank the Morphology core from Washington University Digestive Diseases Research Core Center (DDRCC) for histology sections (5P30 DK052574). We would like to acknowledge John Williams and Grzegorz Tadeusz Gurda for providing adenoviruses.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Baksh S, 2000, ONCOGENE, V19, P2820, DOI 10.1038/sj.onc.1203585; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2000, J BIOL CHEM, V275, P25681, DOI 10.1074/jbc.M003424200; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Bernal-Mizrachi E, 2003, DIABETES-METAB RES, V19, P32, DOI 10.1002/dmrr.331; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cousin SP, 1999, BIOCHEM J, V344, P649, DOI 10.1042/0264-6021:3440649; DAWSON VL, 1993, P NATL ACAD SCI USA, V90, P3256, DOI 10.1073/pnas.90.8.3256; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FRANKLIN JL, 1994, ANN NY ACAD SCI, V747, P195; Girish V, 2004, Indian J Cancer, V41, P47; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; HEROLD KC, 1993, TRANSPLANTATION, V55, P186, DOI 10.1097/00007890-199301000-00035; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; KAISER N, 1991, ENDOCRINOLOGY, V129, P2067, DOI 10.1210/endo-129-4-2067; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; KINCAID RL, 1986, BIOCHEM BIOPH RES CO, V140, P320, DOI 10.1016/0006-291X(86)91093-4; Lawrence MC, 2002, DIABETES, V51, P691, DOI 10.2337/diabetes.51.3.691; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; LEAHY JL, 1986, J CLIN INVEST, V77, P908, DOI 10.1172/JCI112389; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Meng YX, 1997, ENDOCRINOLOGY, V138, P1979, DOI 10.1210/en.138.5.1979; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Paris M, 2003, ENDOCRINOLOGY, V144, P2717, DOI 10.1210/en.2002-221112; Persaud SJ, 1996, BIOCHEM J, V313, P119, DOI 10.1042/bj3130119; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Redmon JB, 1996, J CLIN INVEST, V98, P2786, DOI 10.1172/JCI119105; ROBERTSON RP, 1989, DIABETES, V38, P1501, DOI 10.2337/diabetes.38.12.1501; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; UNGER RH, 1985, DIABETOLOGIA, V28, P119; van Duijnhoven EM, 2001, J AM SOC NEPHROL, V12, P583, DOI 10.1681/ASN.V123583; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339	52	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11969	10.1371/journal.pone.0011969	http://dx.doi.org/10.1371/journal.pone.0011969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689817	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520500013
J	Hsu, CL; Neilsen, CV; Bryce, PJ				Hsu, Chia-Lin; Neilsen, Colleen V.; Bryce, Paul J.			IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation	PLOS ONE			English	Article							HUMAN BASOPHILS; FAMILY-MEMBER; CYTOKINE; RECEPTOR; INTERLEUKIN-33; ST2; ACTIVATION; PHOSPHORYLATION; RECRUITMENT; MATURATION	Background: IL-33 is a recently characterized IL-1 family cytokine and found to be expressed in inflammatory diseases, including severe asthma and inflammatory bowl disease. Recombinant IL-33 has been shown to enhance Th2-associated immune responses and potently increase mast cell proliferation and cytokine production. While IL-33 is constitutively expressed in endothelial and epithelial cells, where it may function as a transcriptional regulator, cellular sources of IL-33 and its role in inflammation remain unclear. Methodology/Principal Findings: Here, we identify mast cells as IL-33 producing cells. IgE/antigen activation of bone marrow-derived mast cells or a murine mast cell line (MC/9) significantly enhanced IL-33. Conversely, recombinant IL-33 directly activated mast cells to produce several cytokines including IL-4, IL-5 and IL-6 but not IL-33. We show that expression of IL-33 in response to IgE-activation required calcium and that ionomycin was sufficient to induce IL-33. In vivo, peritoneal mast cells expressed IL-33 and IL-33 levels were significantly lower within the skin of mast cell deficient mice, compared to littermate controls. Local activation of mast cells promotes edema, followed by the recruitment of inflammatory cells. We demonstrate using passive cutaneous anaphylaxis, a mast cell-dependent model, that deficiency in ST2 or antibody blockage of ST2 or IL-33 ablated the late phase inflammatory response but that the immediate phase response was unaffected. IL-33 levels in the skin were significantly elevated only during the late phase. Conclusions/Significance: Our findings demonstrate that mast cells produce IL-33 after IgE-mediated activation and that the IL-33/ST2 pathway is critical for the progression of IgE-dependent inflammation.	[Hsu, Chia-Lin; Neilsen, Colleen V.; Bryce, Paul J.] Northwestern Univ, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hsu, CL (corresponding author), Northwestern Univ, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-bryce@northwestern.edu			National Institute of Allergy and Infectious Diseases [R01AI076456]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076456] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported from grant R01AI076456 from the National Institute of Allergy and Infectious Diseases to PJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; BELTRAN CJ, 2009, INFLAMM BOWEL DIS; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hogaboam G, 1998, J IMMUNOL, V160, P6166; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Kaneko M, 2000, J ALLERGY CLIN IMMUN, V105, P1202, DOI 10.1067/mai.2000.106731; Kang NI, 2008, INT ARCH ALLERGY IMM, V147, P315, DOI 10.1159/000144039; Kim SJ, 2007, LIFE SCI, V81, P863, DOI 10.1016/j.lfs.2007.06.027; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Lorentz A, 2000, J IMMUNOL, V164, P43, DOI 10.4049/jimmunol.164.1.43; Lorentz A, 2001, IMMUNOL REV, V179, P57, DOI 10.1034/j.1600-065X.2001.790106.x; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Matsuda A, 2009, INVEST OPHTH VIS SCI, V50, P4646, DOI 10.1167/iovs.08-3365; Matsushima H, 2004, J IMMUNOL, V173, P531, DOI 10.4049/jimmunol.173.1.531; Mazzoni A, 2006, J IMMUNOL, V177, P3577, DOI 10.4049/jimmunol.177.6.3577; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ochi H, 2000, P NATL ACAD SCI USA, V97, P10509, DOI 10.1073/pnas.180318697; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Okayama Y, 2001, J IMMUNOL, V166, P4705, DOI 10.4049/jimmunol.166.7.4705; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Rankin AL, 2010, J IMMUNOL, V184, P1526, DOI 10.4049/jimmunol.0903306; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Robinson DS, 2002, IMMUNITY, V16, P755, DOI 10.1016/S1074-7613(02)00331-X; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081	55	187	197	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11944	10.1371/journal.pone.0011944	http://dx.doi.org/10.1371/journal.pone.0011944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689814	Green Published, gold, Green Submitted			2022-12-25	WOS:000280520500008
J	Szucs, A; Berton, F; Nowotny, T; Sanna, P; Francesconi, W				Szucs, Attila; Berton, Fulvia; Nowotny, Thomas; Sanna, Pietro; Francesconi, Walter			Consistency and Diversity of Spike Dynamics in the Neurons of Bed Nucleus of Stria Terminalis of the Rat: A Dynamic Clamp Study	PLOS ONE			English	Article							CORTICAL-NEURONS; INHIBITORY INTERNEURONS; SYNAPTIC CONDUCTANCE; NEOCORTICAL NEURONS; IN-VIVO; PRECISION; INPUTS; ORGANIZATION; RELIABILITY; INTEGRATION	Neurons display a high degree of variability and diversity in the expression and regulation of their voltage-dependent ionic channels. Under low level of synaptic background a number of physiologically distinct cell types can be identified in most brain areas that display different responses to standard forms of intracellular current stimulation. Nevertheless, it is not well understood how biophysically different neurons process synaptic inputs in natural conditions, i.e., when experiencing intense synaptic bombardment in vivo. While distinct cell types might process synaptic inputs into different patterns of action potentials representing specific "motifs'' of network activity, standard methods of electrophysiology are not well suited to resolve such questions. In the current paper we performed dynamic clamp experiments with simulated synaptic inputs that were presented to three types of neurons in the juxtacapsular bed nucleus of stria terminalis (jcBNST) of the rat. Our analysis on the temporal structure of firing showed that the three types of jcBNST neurons did not produce qualitatively different spike responses under identical patterns of input. However, we observed consistent, cell type dependent variations in the fine structure of firing, at the level of single spikes. At the millisecond resolution structure of firing we found high degree of diversity across the entire spectrum of neurons irrespective of their type. Additionally, we identified a new cell type with intrinsic oscillatory properties that produced a rhythmic and regular firing under synaptic stimulation that distinguishes it from the previously described jcBNST cell types. Our findings suggest a sophisticated, cell type dependent regulation of spike dynamics of neurons when experiencing a complex synaptic background. The high degree of their dynamical diversity has implications to their cooperative dynamics and synchronization.	[Szucs, Attila] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Berton, Fulvia; Sanna, Pietro; Francesconi, Walter] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Nowotny, Thomas] Univ Sussex, Sch Informat, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England; [Szucs, Attila] Hungarian Acad Sci, Balaton Limnol Res Inst, Dept Expt Zool, H-8237 Tihany, Hungary; [Berton, Fulvia] Univ Pisa, Dept Biol, Pisa, Italy	University of California System; University of California San Diego; Scripps Research Institute; University of Sussex; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; University of Pisa	Szucs, A (corresponding author), Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA.	aszucs@ucsd.edu	Nowotny, Thomas/C-3883-2012	Nowotny, Thomas/0000-0002-4451-915X	National Institutes of Health [RC1AA019195, AA016587, AA017371, DA013821]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017371, RC1AA019195, R01AA016587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institutes of Health (Grants RC1AA019195, AA016587, AA017371 and DA013821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; Aradi I, 2004, J NEUROPHYSIOL, V91, P2849, DOI 10.1152/jn.00916.2003; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Dong HW, 2000, BRAIN RES, V859, P1, DOI 10.1016/S0006-8993(99)02246-5; Dumon EC, 2008, NEUROSCIENCE, V153, P232, DOI 10.1016/j.neuroscience.2008.01.039; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Francesconi W, 2009, PROG NEURO-PSYCHOPH, V33, P1347, DOI 10.1016/j.pnpbp.2009.08.003; Francesconi W, 2009, J NEUROSCI, V29, P5389, DOI 10.1523/JNEUROSCI.5129-08.2009; Hammack SE, 2007, J NEUROPHYSIOL, V98, P638, DOI 10.1152/jn.00382.2007; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; HEIMER L, 1991, BASAL FOREBRAIN ANAT, V295, P1; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Kreuz T, 2007, J NEUROSCI METH, V165, P151, DOI 10.1016/j.jneumeth.2007.05.031; Nowotny T, 2006, J NEUROSCI METH, V158, P287, DOI 10.1016/j.jneumeth.2006.05.034; Piwkowska Z, 2008, J NEUROSCI METH, V169, P302, DOI 10.1016/j.jneumeth.2007.11.010; Sanna PP, 2000, P NATL ACAD SCI USA, V97, P8653, DOI 10.1073/pnas.140219097; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Steriade M, 2004, NAT REV NEUROSCI, V5, P121, DOI 10.1038/nrn1325; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; SUN N, 1993, J COMP NEUROL, V330, P381, DOI 10.1002/cne.903300308; Szucs A, 2004, NEUROSCIENCE, V126, P1063, DOI 10.1016/j.neuroscience.2004.04.015; Tateno T, 2009, J NEUROPHYSIOL, V101, P1056, DOI 10.1152/jn.91057.2008; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Xu-Friedman MA, 2005, J NEUROPHYSIOL, V94, P2512, DOI 10.1152/jn.01307.2004; Zsiros V, 2005, J NEUROPHYSIOL, V93, P3248, DOI 10.1152/jn.01027.2004	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11920	10.1371/journal.pone.0011920	http://dx.doi.org/10.1371/journal.pone.0011920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689810	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000280520500001
J	Ward-Paige, C; Flemming, JM; Lotze, HK				Ward-Paige, Christine; Flemming, Joanna Mills; Lotze, Heike K.			Overestimating Fish Counts by Non-Instantaneous Visual Censuses: Consequences for Population and Community Descriptions	PLOS ONE			English	Article							SIZE-STRUCTURE; REEF; SHARKS; DENSITY; BIOMASS; CARCHARIAS; ABUNDANCE; TRANSECT; IDENTIFICATION; FISHERIES	Background: Increasingly, underwater visual censuses (UVC) are used to assess fish populations. Several studies have demonstrated the effectiveness of protected areas for increasing fish abundance or provided insight into the natural abundance and structure of reef fish communities in remote areas. Recently, high apex predator densities (>100,000 individuals.km(-2)) and biomasses (>4 tonnes.ha(-1)) have been reported for some remote islands suggesting the occurrence of inverted trophic biomass pyramids. However, few studies have critically evaluated the methods used for sampling conspicuous and highly mobile fish such as sharks. Ideally, UVC are done instantaneously, however, researchers often count animals that enter the survey area after the survey has started, thus performing non-instantaneous UVC. Methodology/Principal Findings: We developed a simulation model to evaluate counts obtained by divers deploying non-instantaneous belt-transect and stationary-point-count techniques. We assessed how fish speed and survey procedure (visibility, diver speed, survey time and dimensions) affect observed fish counts. Results indicate that the bias caused by fish speed alone is huge, while survey procedures had varying effects. Because the fastest fishes tend to be the largest, the bias would have significant implications on their biomass contribution. Therefore, caution is needed when describing abundance, biomass, and community structure based on non-instantaneous UVC, especially for highly mobile species such as sharks. Conclusions/Significance: Based on our results, we urge that published literature state explicitly whether instantaneous counts were made and that survey procedures be accounted for when non-instantaneous counts are used. Using published density and biomass values of communities that include sharks we explore the effect of this bias and suggest that further investigation may be needed to determine pristine shark abundances and the existence of inverted biomass pyramids. Because such studies are used to make important management and conservation decisions, incorrect estimates of animal abundance and biomass have serious and significant implications.	[Ward-Paige, Christine; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Ward-Paige, C (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	globalshark@gmail.com		Ward-Paige, Christine A./0000-0002-2394-9898; Mills Flemming, Joanna/0000-0002-3517-3089; Lotze, Heike/0000-0001-6258-1304	Natural Sciences and Engineering Research Council of Canada; Lenfest Ocean Program; Pew Charitable Trusts; RAM	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lenfest Ocean Program; Pew Charitable Trusts; RAM	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada to R. A. Myers, H. K. Lotze, J. Mills Flemming, by the Lenfest Ocean Program and The Pew Charitable Trusts with grants to R. A. Myers and H. K. Lotze. These funders did not play a role in conducting the study or in preparing the manuscript.; We thank W. Blanchard for helping to write the simulation AnimDens, C. Minto for initial simulation discussion, and B. Worm, D. Tittensor, H. Whitehead, L. Lucifora, V. Garcia and C. Mora for discussions and valuable comments on the manuscript. We thank RAM for the support and encouragement he always provided.	Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Ault JS, 2006, B MAR SCI, V78, P633; Bansemer CS, 2008, MAR FRESHWATER RES, V59, P322, DOI 10.1071/MF07184; BOHNSACK JA, 1986, NMFSSEFC215 NOAA; Bradshaw CJA, 2007, J ANIM ECOL, V76, P480, DOI 10.1111/j.1365-2656.2006.01201.x; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Buck KR, 1996, AQUAT MICROB ECOL, V10, P283; Buray N, 2009, CYBIUM, V33, P21; Cheal AJ, 1997, MAR ECOL PROG SER, V158, P241, DOI 10.3354/meps158241; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Eggleston DB, 2004, B MAR SCI, V75, P175; Forrester GE, 2008, ECOLOGY, V89, P2980, DOI 10.1890/07-1546.1; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; GRAY J, 1971, HOW FISHES SWIM, P228; Gubili C, 2009, MAR BIOL, V156, P2199, DOI 10.1007/s00227-009-1233-y; GUTMAN M, 1990, J RANGE MANAGE, V43, P535, DOI 10.2307/4002359; Harborne AR, 2008, ECOL APPL, V18, P1689, DOI 10.1890/07-0454.1; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Heupel MR, 2007, PAC SCI, V61, P383, DOI 10.2984/1534-6188(2007)61[383:EAORSA]2.0.CO;2; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Johansen JL, 2007, MAR FRESHWATER RES, V58, P233, DOI 10.1071/MF06136; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; PIONTKOVSKI SA, 1995, MAR ECOL PROG SER, V117, P219, DOI 10.3354/meps117219; *R CDT, 2005, R LANG ENV STAT COMP; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Rowat D, 2009, ORYX, V43, P591, DOI 10.1017/S0030605309990408; Sale P.F., 1983, Coral Reefs, V2, P37, DOI 10.1007/BF00304730; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SMITH MPL, 1989, ENVIRON BIOL FISH, V26, P29, DOI 10.1007/BF00002473; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Tittensor DP, 2007, ECOL LETT, V10, P760, DOI 10.1111/j.1461-0248.2007.01076.x; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; WATSON RA, 1995, ECOL MODEL, V77, P205, DOI 10.1016/0304-3800(93)E0085-H; Watson RA, 1997, ECOL MODEL, V104, P103, DOI 10.1016/S0304-3800(97)00117-8; WEBB PW, 1982, FISH B-NOAA, V80, P803	46	137	138	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11722	10.1371/journal.pone.0011722	http://dx.doi.org/10.1371/journal.pone.0011722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661304	Green Published, Green Submitted, gold			2022-12-25	WOS:000280243300022
J	Nogueira, C; Kim, KH; Sung, H; Paraiso, KHT; Dannenberg, JH; Bosenberg, M; Chin, L; Kim, M				Nogueira, C.; Kim, K-H; Sung, H.; Paraiso, K. H. T.; Dannenberg, J-H; Bosenberg, M.; Chin, L.; Kim, M.			Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis	ONCOGENE			English	Article						melanoma; PTEN; RAS; E-cadherin; AKT2; mouse model	TUMOR-SUPPRESSOR GENE; PTEN/MMAC1 ALTERATIONS; MALIGNANT-MELANOMA; BRAF MUTATIONS; UP-REGULATION; KINASE-B; BREAST; LEADS; INACTIVATION; NEOPLASIA	Mitogen-activated protein kinase (MAPK) and AKT pathways are frequently co-activated in melanoma through overexpression of receptor tyrosine kinases, mutations in their signaling surrogates, such as RAS and BRAF, or loss of negative regulators such as PTEN. As RAS can be a positive upstream regulator of PI3-K, it has been proposed that the loss of PTEN and the activation of RAS are redundant events in melanoma pathogenesis. Here, in genetically engineered mouse models of cutaneous melanomas, we sought to better understand the genetic interactions between HRAS activation and PTEN inactivation in melanoma genesis and progression in vivo. We showed that HRAS activation cooperates with Pten+/- and Ink4a/Arf-/- to increase melanoma penetrance and promote metastasis. Correspondingly, gain-and loss-of-function studies established that Pten loss increases invasion and migration of melanoma cells and non-transformed melanocytes, and such biological activity correlates with a shift to phosphorylation of AKT2 isoform and E-cadherin down-regulation. Thus, Pten inactivation can drive the genesis and promote the metastatic progression of RAS activated Ink4a/Arf deficient melanomas. Oncogene (2010) 29, 6222-6232; doi:10.1038/onc.2010.349; published online 16 August 2010	[Chin, L.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Chin, L.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Nogueira, C.; Dannenberg, J-H; Chin, L.; Kim, M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Nogueira, C.] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP Med Fac, P-4100 Oporto, Portugal; [Kim, K-H; Sung, H.; Paraiso, K. H. T.; Kim, M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Comprehens Melanoma Res Ctr,Mol Oncol Dept, Tampa, FL 33612 USA; [Bosenberg, M.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Universidade do Porto; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Vermont	Chin, L (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, 44 Binney St, Boston, MA 02115 USA.	Lynda_Chin@dfci.harvard.edu; Minjung.Kim@moffitt.org	Nogueira, Cristina/N-4574-2015	Nogueira, Cristina/0000-0002-0853-5304; Kim, Minjung/0000-0002-5682-6640; KIM, KWAN HYUN/0000-0003-4975-2839	FCT [PRAXIS/BD/21794/99]; Claudia Adams Barr Program; Dermatology Foundation; Melanoma Research Foundation; Damon-Runyon Cancer Research Foundation; Dutch Cancer Society; NIH [UO1 CA84313, RO1 CA93947]; Bankhead Coley Pilot Research Award; American Cancer Society [93-032-13]; NATIONAL CANCER INSTITUTE [U01CA084313, R01CA093947] Funding Source: NIH RePORTER	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Claudia Adams Barr Program; Dermatology Foundation; Melanoma Research Foundation; Damon-Runyon Cancer Research Foundation; Dutch Cancer Society(KWF Kankerbestrijding); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead Coley Pilot Research Award; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	C Nogueira was supported by a fellowship from FCT (PRAXIS/BD/21794/99). M Kim was supported by the Claudia Adams Barr Program, the Dermatology Foundation, and Melanoma Research Foundation. JH Dannenberg was supported by Damon-Runyon Cancer Research Foundation and the Dutch Cancer Society. This work was supported by grants from the NIH (UO1 CA84313; RO1 CA93947) to L Chin and from the Bankhead Coley Pilot Research Award and American Cancer Society Institutional Research Grant (#93-032-13) to M Kim. We thank Dr Jin Q Cheng (Moffitt Cancer Center) for helpful discussion and adenoviruses for PTEN and DN-AKT2 expression, and Dr Ronald A DePinho for critical reading of this paper.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Arboleda MJ, 2003, CANCER RES, V63, P196; Bardeesy N, 2005, MOL CELL BIOL, V25, P4176, DOI 10.1128/MCB.25.10.4176-4188.2005; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Birck A, 2000, J INVEST DERMATOL, V114, P277, DOI 10.1046/j.1523-1747.2000.00877.x; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Dhawan P, 2002, CANCER RES, V62, P7335; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Forbes SA, 2008, CURR PROTOC HUM GENE, V57, DOI DOI 10.11.1-10.11.26; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guldberg P, 1997, CANCER RES, V57, P3660; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Ikeda T, 2000, ONCOL REP, V7, P567; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; JAFARI M, 1995, J CANCER RES CLIN, V121, P23, DOI 10.1007/BF01202725; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Lahtz C, 2010, J INVEST DERMATOL, V130, P620, DOI 10.1038/jid.2009.226; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Mirmohammadsadegh A, 2006, CANCER RES, V66, P6546, DOI 10.1158/0008-5472.CAN-06-0384; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2003, ONCOGENE, V22, P5055, DOI 10.1038/sj.onc.1206809; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stahl JM, 2003, CANCER RES, V63, P2881; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Sviderskaya EV, 1997, J INVEST DERMATOL, V108, P30, DOI 10.1111/1523-1747.ep12285621; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Tsao H, 2000, CANCER RES, V60, P1800; Tsao HS, 1998, ONCOGENE, V16, P3397, DOI 10.1038/sj.onc.1201881; Vogelmann R, 2005, J CELL SCI, V118, P4901, DOI 10.1242/jcs.02594; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; You MJ, 2002, P NATL ACAD SCI USA, V99, P1455, DOI 10.1073/pnas.022632099; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200	58	71	75	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	47					6222	6232		10.1038/onc.2010.349	http://dx.doi.org/10.1038/onc.2010.349			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	685CG	21686270	Green Accepted			2022-12-25	WOS:000284601700004
J	Kiebala, M; Polesskaya, O; Yao, ZQ; Perry, SW; Maggirwar, SB				Kiebala, Michelle; Polesskaya, Oksana; Yao, Zhenqiang; Perry, Seth W.; Maggirwar, Sanjay B.			Nuclear Factor-Kappa B Family Member RelB Inhibits Human Immunodeficiency Virus-1 Tat-Induced Tumor Necrosis Factor-Alpha Production	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1 ASSOCIATED DEMENTIA; UP-REGULATES EXPRESSION; TYPE-1 GENE-EXPRESSION; HUMAN FETAL MICROGLIA; TNF-ALPHA; TRANSCRIPTION FACTORS; CHEMOKINE EXPRESSION; RECEPTOR ACTIVATION; NEURONAL INJURY	Human Immunodeficiency Virus-1 (HIV-1)-associated neurocognitive disorder (HAND) is likely neuroinflammatory in origin, believed to be triggered by inflammatory and oxidative stress responses to cytokines and HIV protein gene products such as the HIV transactivator of transcription (Tat). Here we demonstrate increased messenger RNA for nuclear factor- kappa B (NF-kappa B) family member, transcription factor RelB, in the brain of doxycycline-induced Tat transgenic mice, and increased RelB synthesis in Tat-exposed microglial cells. Since genetic ablation of RelB in mice leads to multi-organ inflammation, we hypothesized that Tat-induced, newly synthesized RelB inhibits cytokine production by microglial cells, possibly through the formation of transcriptionally inactive RelB/RelA complexes. Indeed, tumor necrosis factor-alpha (TNF alpha) production in monocytes isolated from RelB deficient mice was significantly higher than in monocytes isolated from RelB expressing controls. Moreover, RelB overexpression in microglial cells inhibited Tat-induced TNF alpha synthesis in a manner that involved transcriptional repression of the TNF alpha promoter, and increased phosphorylation of RelA at serine 276, a prerequisite for increased RelB/RelA protein interactions. The Rel-homology-domain within RelB was necessary for this interaction. Overexpression of RelA itself, in turn, significantly increased TNF alpha promoter activity, an effect that was completely blocked by RelB overexpression. We conclude that RelB regulates TNF alpha cytokine synthesis by competitive interference binding with RelA, which leads to downregulation of TNF alpha production. Moreover, because Tat activates both RelB and TNF alpha in microglia, and because Tat induces inflammatory TNF alpha synthesis via NF-kappa B, we posit that RelB serves as a cryoprotective, anti-inflammatory, counter-regulatory mechanism for pathogenic NF-kappa B activation. These findings identify a novel regulatory pathway for controlling HIV-induced microglial activation and cytokine production that may have important therapeutic implications for the management of HAND.	[Kiebala, Michelle; Polesskaya, Oksana; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Yao, Zhenqiang] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Perry, Seth W.] Univ Rochester, Sch Med & Dent, Dept Neurol, Ctr Neural Dev & Dis, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Kiebala, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	sanjay_maggirwar@urmc.rochester.edu	Polesskaya, Oksana/AAX-9283-2021; Zhu, Yingjie/W-3315-2017	Perry, Seth W/0000-0002-1503-6634; Zhu, Yingjie/0000-0003-1849-6019; Xu, Hongxi/0000-0001-6238-4511	National Institutes of Health [RO1 NS054578, RO1 NS066801, R21 MH084718, T32 AI49105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH084718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, R01NS066801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the following National Institutes of Health grants: RO1 NS054578 and RO1 NS066801 (to SBM); R21 MH084718 (to SWP); T32 AI49105 (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037; Archibald SL, 2004, ARCH NEUROL-CHICAGO, V61, P369, DOI 10.1001/archneur.61.3.369; Avison MJ, 2004, J NEUROVIROL, V10, P223, DOI 10.1080/13550280490463532; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; BIDDISON WE, 2001, CURR PROTOC CELL BIO, pCH2; *BIO RAD LAB I LIF, B BIO RAD LAB I LIF, V2890; Bissel SJ, 2002, AM J PATHOL, V160, P927, DOI 10.1016/S0002-9440(10)64915-2; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bossi P, 1998, CLIN INFECT DIS, V26, P1072, DOI 10.1086/520301; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; BRAKE DA, 1990, J CELL BIOL, V111, P1275, DOI 10.1083/jcb.111.3.1275; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; CARDENAS V, 2009, J NEUROVIROL, P1; CHANAKYA HN, 1997, BIOENERGY NEWS, V1, P11; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Chen YS, 2009, NEUROIMAGE, V47, P1154, DOI 10.1016/j.neuroimage.2009.04.030; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; D'Aversa TG, 2002, AM J PATHOL, V160, P559, DOI 10.1016/S0002-9440(10)64875-4; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; DOBRZANSKI P, 1993, MOL CELL BIOL, V13, P1572, DOI 10.1128/MCB.13.3.1572; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Everall IP, 1999, BRAIN PATHOL, V9, P209; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gongvatana A, 2009, J NEUROVIROL, V15, P187, DOI 10.1080/13550280902769756; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Guillemard E, 2004, VIROLOGY, V329, P371, DOI 10.1016/j.virol.2004.08.030; Harhaj E, 1996, VIROLOGY, V216, P284, DOI 10.1006/viro.1996.0062; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herbein G, 2008, CURR HIV RES, V6, P117, DOI 10.2174/157016208783884985; HOWARD OMZ, 1993, P NATL ACAD SCI USA, V90, P2335, DOI 10.1073/pnas.90.6.2335; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Ju SM, 2009, EXP MOL MED, V41, P86, DOI 10.3858/emm.2009.41.2.011; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; Langford TD, 2003, BRAIN PATHOL, V13, P195; LERNBECHER T, 1994, EMBO J, V13, P4060, DOI 10.1002/j.1460-2075.1994.tb06723.x; Letendre Scott L, 2009, Top HIV Med, V17, P46; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Maggirwar SB, 2000, J NEUROCHEM, V74, P527, DOI 10.1046/j.1471-4159.2000.740527.x; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; MAJOR EO, 2009, ANN REV MED; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Masliah E, 2000, AIDS, V14, P69, DOI 10.1097/00002030-200001070-00008; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Mayne M, 1998, NEUROIMMUNOMODULAT, V5, P184, DOI 10.1159/000026336; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; MERRILL JE, 1991, FASEB J, V5, P2391, DOI 10.1096/fasebj.5.10.2065887; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; MULLEROEHRING EM, 2009, NEUROPSYCHOLOGIA; Nath A, 2000, ANN NEUROL, V47, P186, DOI 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; NGUYEN TP, 2009, AM J PATHOL; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Oberdorfer P, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/348507; Perry SW, 2002, J NEUROVIROL, V8, P611, DOI 10.1080/13550280290101021; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; Pfefferbaum A, 2009, AIDS, V23, P1977, DOI 10.1097/QAD.0b013e32832e77fe; Quiterio S, 2003, BIOMED PHARMACOTHER, V57, P49, DOI 10.1016/S0753-3322(02)00332-3; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; Rezaie P, 1999, DEV BRAIN RES, V115, P71, DOI 10.1016/S0165-3806(99)00043-7; RUBEN S, 1989, J VIROL, V63, P1; Rumbaugh JA, 2006, CURR PHARM DESIGN, V12, P1023, DOI 10.2174/138161206776055877; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Shatrov VA, 1997, EUR CYTOKINE NETW, V8, P37; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Sui Z, 2006, J IMMUNOL, V177, P702, DOI 10.4049/jimmunol.177.1.702; SWINGLER S, 1994, BIOCHEM BIOPH RES CO, V203, P623, DOI 10.1006/bbrc.1994.2228; TORNATORE C, 1991, J VIROL, V65, P6094, DOI 10.1128/JVI.65.11.6094-6100.1991; Tozzi V, 2007, JAIDS-J ACQ IMM DEF, V45, P174, DOI 10.1097/QAI.0b013e318042e1ee; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Weih F, 1997, J IMMUNOL, V158, P5211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; WILEY CA, 1991, ANN NEUROL, V29, P651, DOI 10.1002/ana.410290613; Wohlschlaeger J, 2009, CLIN NEUROL NEUROSUR, V111, P422, DOI 10.1016/j.clineuro.2008.12.006; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Xia YY, 1997, AM J PATHOL, V151, P375; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080	109	278	329	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11875	10.1371/journal.pone.0011875	http://dx.doi.org/10.1371/journal.pone.0011875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20957043	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520200037
